PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Bes, A; Kunkel, R; Lance, JW; Nappi, G; Pfaffenrath, V; Rose, FC; Schoenberg, BS; Soyka, D; Tfelt-Hansen, P; Welch, KMA; Wilkinson, M; Olesen, J; Bousser, MG; Diener, HC; Dodick, D; First, M; Goadsby, PJ; Gobel, H; Lainez, MJA; Lance, JW; Lipton, RB; Nappi, G; Sakai, F; Schoenen, J; Silberstein, SD; Steiner, TJ; Olesen, J; Bendtsen, L; Dodick, D; Ducros, A; Evers, S; First, M; Goadsby, PJ; Hershey, A; Katsarava, Z; Levin, M; Pascual, J; Russell, MB; Schwedt, T; Steiner, TJ; Tassorelli, C; Terwindt, GM; Vincent, M; Wang, SJ; Olesen, J; Evers, S; Charles, A; Hershey, A; Lipton, R; First, M; Bolay, H; Lanteri-Minet, M; MacGregor, EA; Takeshima, T; Schytz, HW; Ashina, S; Goicochea, MT; Hirata, K; Holroyd, K; Lampl, C; Lipton, RB; Mitsikostas, DD; Schoenen, J; Goadsby, P; Boes, C; Bordini, C; Cittadini, E; Cohen, A; Leone, M; May, A; Newman, L; Pareja, J; Park, JW; Rozen, T; Waldenlind, E; Wang, SJ; Ducros, A; Evers, S; Fuh, JL; Ozge, A; Pareja, JA; Pascual, J; Peres, M; Young, W; Yu, SY; Schwedt, T; Abu-Arafeh, I; Gladstone, J; Huang, SJ; Jensen, R; Lainez, JMA; Obelieniene, D; Sandor, P; Scher, AI; Ducros, A				Bes, Andre; Kunkel, Robert; Lance, James W.; Nappi, Giuseppe; Pfaffenrath, Volker; Rose, Frank Clifford; Schoenberg, Bruce S.; Soyka, Dieter; Tfelt-Hansen, Peer; Welch, K. Michael A.; Wilkinson, Marica; Olesen, Jes; Bousser, Marie-Germaine; Diener, Hans-Christoph; Dodick, David; First, Michael; Goadsby, Peter J.; Goebel, Hartmut; Lainez, Miguel J. A.; Lance, James W.; Lipton, Richard B.; Nappi, Giuseppe; Sakai, Fumihiko; Schoenen, Jean; Silberstein, Stephen D.; Steiner, Timothy J.; Olesen, Jes; Bendtsen, Lars; Dodick, David; Ducros, Anne; Evers, Stefan; First, Michael; Goadsby, Peter J.; Hershey, Andrew; Katsarava, Zaza; Levin, Morris; Pascual, Julio; Russell, Michael B.; Schwedt, Todd; Steiner, Timothy J.; Tassorelli, Cristina; Terwindt, Gisela M.; Vincent, Maurice; Wang, Shuu-Jiun; Olesen, J.; Evers, S.; Charles, A.; Hershey, A.; Lipton, R.; First, M.; Bolay, H.; Lanteri-Minet, M.; MacGregor, E. A.; Takeshima, T.; Schytz, H. W.; Ashina, S.; Goicochea, M. T.; Hirata, K.; Holroyd, K.; Lampl, C.; Lipton, R. B.; Mitsikostas, D. D.; Schoenen, J.; Goadsby, P.; Boes, C.; Bordini, C.; Cittadini, E.; Cohen, A.; Leone, M.; May, A.; Newman, L.; Pareja, J.; Park, J-W; Rozen, T.; Waldenlind, E.; Wang, S-J; Ducros, A.; Evers, S.; Fuh, J-L; Ozge, A.; Pareja, J. A.; Pascual, J.; Peres, M.; Young, W.; Yu, S-Y; Schwedt, T.; Abu-Arafeh, I.; Gladstone, J.; Huang, S-J; Jensen, R.; Lainez, J. M. A.; Obelieniene, D.; Sandor, P.; Scher, A. I.; Ducros, A.		IHS	The International Classification of Headache Disorders, 3rd edition (beta version)	CEPHALALGIA			English	Article							TENSION-TYPE HEADACHE; DAILY-PERSISTENT HEADACHE; TRAUMATIC BRAIN-INJURY; CHRONIC PAROXYSMAL HEMICRANIA; MEDICATION-OVERUSE HEADACHE; CENTRAL-NERVOUS-SYSTEM; MYOFASCIAL TRIGGER POINTS; ICE-CREAM HEADACHE; FAMILIAL HEMIPLEGIC MIGRAINE; TOLOSA-HUNT-SYNDROME				jes.olesen@regionh.dk; peter.goadsby@ucsf.edu; Schwedt.Todd@mayo.edu; anne.ducros@lrb.aphp.fr	Mitsikostas, Dimos D./AAD-7023-2019; Gobel, Hartmut/AAE-4719-2020; Peres, Mario/U-6148-2019; Diener, Hans-Christoph/AAF-7275-2019; Nixdorf, Donald/AAE-8206-2020; Ashina, Sait/I-1766-2019; Lipton, Richard B/B-5060-2011; Tassorelli, Cristina/AAC-1483-2019; Goadsby, Peter J/Z-1970-2019; Peres, Mario F/B-1660-2010; Abu-Arafeh, Ishaq/H-7417-2019; Ashina, Sait/AAC-7681-2019; Vincent, Maurice B/B-1415-2009; Evers, Silvia/ABG-2128-2020; Hershey, Andrew D./K-1245-2019; DUCROS, Anne/D-1899-2010; katsarava, zaza/AAH-6404-2019; Nappi, Giuseppe/AAF-4962-2021; Bolay, Hayrunnisa/ABG-8829-2020; Kurth, Tobias/A-9243-2012	Mitsikostas, Dimos D./0000-0002-4691-3388; Peres, Mario/0000-0002-0068-1905; Nixdorf, Donald/0000-0003-1757-9592; Ashina, Sait/0000-0003-3973-6640; Tassorelli, Cristina/0000-0003-1513-2113; Goadsby, Peter J/0000-0003-3260-5904; Abu-Arafeh, Ishaq/0000-0003-1252-0153; Evers, Silvia/0000-0003-1026-570X; Hershey, Andrew D./0000-0002-1598-7536; DUCROS, Anne/0000-0001-5560-5013; katsarava, zaza/0000-0002-9932-1159; Nappi, Giuseppe/0000-0003-4274-5281; Bolay, Hayrunnisa/0000-0002-3357-7733; Scher, Ann/0000-0003-4599-9834; Kurth, Tobias/0000-0001-7169-2620; Marchioni, Enrico/0000-0003-0414-8128; mainardi, federico/0000-0003-2075-4363			Aaseth K, 2010, CEPHALALGIA, V30, P152, DOI 10.1111/j.1468-2982.2009.01877.x; Aaseth K, 2011, EUR J PAIN, V15, P186, DOI 10.1016/j.ejpain.2010.06.005; ABBOTT PJ, 1986, MED J AUSTRALIA, V145, P518, DOI 10.5694/j.1326-5377.1986.tb139455.x; Abhinav K, 2012, CLIN NEUROL NEUROSUR, V114, P361, DOI 10.1016/j.clineuro.2011.11.018; Abu-Bakra M, 2001, J LARYNGOL OTOL, V115, P629; ABUARAFEH I, 1995, ARCH DIS CHILD, V72, P413, DOI 10.1136/adc.72.5.413; Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Afridi S, 2003, J NEUROL NEUROSUR PS, V74, P680, DOI 10.1136/jnnp.74.5.680; Aggarwal VR, 2007, J OROFAC PAIN, V21, P203; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Aidi Saadia, 1999, Headache, V39, P559, DOI 10.1046/j.1526-4610.1999.3908559.x; Airaghi L, 1999, SEMINARS HEADACHE MA, V4, P1; Akhtar N D, 2001, Semin Pediatr Neurol, V8, P27, DOI 10.1053/spen.2001.23329; Akinci A, 2008, J AAPOS, V12, P290, DOI 10.1016/j.jaapos.2007.11.018; Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-7; ALAHURULA V, 1981, HEADACHE, V21, P240, DOI 10.1111/j.1526-4610.1981.hed2106240.x; ALAHURULA V, 1982, CEPHALALGIA, V2, P189, DOI 10.1046/j.1468-2982.1982.0204189.x; Alberti A, 2005, ACTA NEUROL SCAND, V111, P309, DOI 10.1111/j.1600-0404.2005.00372.x; ALDRICH MS, 1990, ARCH INTERN MED, V150, P1265, DOI 10.1001/archinte.150.6.1265; Alfano DP, 2006, BRAIN COGNITION, V60, P194; Alfieri A, 2011, J LARYNGOL OTOL, V125, P765, DOI 10.1017/S002221511100079X; Allen DT, 2000, J AM DENT ASSOC, V131, P1738, DOI 10.14219/jada.archive.2000.0120; Allet JL, 2006, CURR OPIN PSYCHIATR, V19, P413, DOI 10.1097/01.yco.0000228764.25732.21; ALLGULANDER C, 1986, ACTA PSYCHIAT SCAND, V73, P465, DOI 10.1111/j.1600-0447.1986.tb02713.x; Altura BM, 2000, J MENT SCI, V104, P972; Alvarez FK, 2007, J ORAL PATHOL MED, V36, P347, DOI 10.1111/j.1600-0714.2006.00489.x; Ambrose HE, 2011, J CLIN MICROBIOL, V49, P3576, DOI 10.1128/JCM.00862-11; Ambrosini A, 2005, NEUROLOGY, V65, P1826, DOI 10.1212/01.wnl.0000187072.71931.c0; Ambrosini A, 2001, ACTA NEUROL BELG, V101, P166; Amorim JA, 2012, CEPHALALGIA, V32, P916, DOI 10.1177/0333102412453951; AMY JR, 1987, HEADACHE, V27, P351, DOI 10.1111/j.1526-4610.1987.hed2706351.x; ANDERSSON PG, 1975, HEADACHE, V15, P118, DOI 10.1111/j.1526-4610.1975.hed1502118.x; [Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P400; Antonaci F, 2001, Curr Pain Headache Rep, V5, P387, DOI 10.1007/s11916-001-0030-1; Antonaci F, 2001, CEPHALALGIA, V21, P573, DOI 10.1046/j.0333-1024.2001.00207.x; Antoniazzi AL, 2003, CEPHALALGIA, V23, P146, DOI 10.1046/j.1468-2982.2003.00510.x; Antoniazzi Ana Luisa de Lima, 2007, Curr Pain Headache Rep, V11, P297; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; APPENZELLER O, 1972, HEADACHE, V12, P126; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; Ardekian Leon, 2003, Oral Maxillofac Surg Clin North Am, V15, P243, DOI 10.1016/S1042-3699(03)00014-1; Arnold M, 2006, J NEUROL NEUROSUR PS, V77, P1021, DOI 10.1136/jnnp.2006.094359; Arredondo M, 2012, AIDS RES HUM RETROV, V28, P889, DOI [10.1089/aid.2011.0149, 10.1089/AID.2011.0149]; Arruda MA, 2010, CEPHALALGIA, V30, P1056, DOI 10.1177/0333102409361214; Ashina M, 1999, PAIN, V79, P201, DOI 10.1016/S0304-3959(98)00167-5; Ashina M, 1999, LANCET, V353, P287, DOI 10.1016/S0140-6736(98)01079-4; Ashina M, 2000, BRAIN, V123, P1830, DOI 10.1093/brain/123.9.1830; Ashina M, 2004, CEPHALALGIA, V24, P161, DOI 10.1111/j.1468-2982.2003.00644.x; Ashina M, 2003, CEPHALALGIA, V23, P109, DOI 10.1046/j.1468-2982.2003.00520.x; Ashina M, 2002, BRAIN, V125, P320, DOI 10.1093/brain/awf029; Ashina M, 2000, CEPHALALGIA, V20, P919, DOI 10.1046/j.1468-2982.2000.00150.x; Ashina Messoud, 2002, Expert Opin Pharmacother, V3, P395, DOI 10.1517/14656566.3.4.395; Ashina S, 2006, CEPHALALGIA, V26, P940, DOI 10.1111/j.1468-2982.2006.01150.x; Ashina S, 2005, EUR J NEUROL, V12, P543, DOI 10.1111/j.1468-1331.2005.01023.x; Ashina S, 2004, PAIN, V108, P108, DOI 10.1016/j.pain.2003.12.012; ASKMARK H, 1989, HEADACHE, V29, P441, DOI 10.1111/j.1526-4610.1989.hed2907441.x; Aurora SK, 2009, CEPHALALGIA, V29, P597, DOI 10.1111/j.1468-2982.2008.01811.x; Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; BARTLESON JD, 1981, NEUROLOGY, V31, P1257, DOI 10.1212/WNL.31.10.1257; Bartsch T, 2005, HEADACHE CURRENTS, V2, P42, DOI DOI 10.1111/j.1743-5013.2005.20201.x; BASSI P, 1991, ACTA NEUROL SCAND, V84, P277, DOI 10.1111/j.1600-0404.1991.tb04954.x; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck HG, 1940, J AMER MED ASSOC, V115, P1; Belcastro V, 2011, J HEADACHE PAIN, V12, P289, DOI 10.1007/s10194-011-0318-4; BENDTSEN L, 1995, CEPHALALGIA, V15, P205, DOI 10.1046/j.1468-2982.1995.015003205.x; Bendtsen L, 1996, ARCH NEUROL-CHICAGO, V53, P373, DOI 10.1001/archneur.1996.00550040113021; Bendtsen L, 2000, CEPHALALGIA, V20, P603, DOI 10.1046/j.1468-2982.2000.00087.x; Bendtsen L, 2000, CEPHALALGIA, V20, P486, DOI 10.1046/j.1468-2982.2000.00070.x; Bendtsen L, 2004, NEUROLOGY, V62, P1706, DOI 10.1212/01.WNL.0000127282.90920.8C; Bendtsen L, 1996, PAIN, V65, P259, DOI 10.1016/0304-3959(95)00239-1; Bendtsen L, 2010, EUR J NEUROL, V17, P1318, DOI 10.1111/j.1468-1331.2010.03070.x; Bendtsen L, 1996, J NEUROL NEUROSUR PS, V61, P285, DOI 10.1136/jnnp.61.3.285; Bendtsen L, 2010, CEPHALALGIA, V30, P1, DOI 10.1111/j.1468-2982.2009.01948.x; Bendtsen L, 2006, CURR OPIN NEUROL, V19, P305; Benoliel R, 1998, CEPHALALGIA, V18, P85, DOI 10.1046/j.1468-2982.1998.1802085.x; Benoliel R, 2012, J OROFAC PAIN, V26, P49; Benoliel R, 2009, J OROFAC PAIN, V23, P330; Bento MS, 2000, HEADACHE, V40, P52, DOI 10.1046/j.1526-4610.2000.00010.x; BERG MJ, 1995, NEUROLOGY, V45, P1648, DOI 10.1212/WNL.45.9.1648; Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350; Berger JR, 2010, SEMIN NEUROL, V30, P66, DOI 10.1055/s-0029-1244996; Berilgen MS, 2011, CEPHALALGIA, V31, P1266, DOI 10.1177/0333102411413159; Berilgen MS, 2006, CEPHALALGIA, V26, P707, DOI 10.1111/j.1468-2982.2006.01096.x; Bezov D, 2010, HEADACHE, V50, P1144, DOI 10.1111/j.1526-4610.2010.01699.x; Bharucha DX, 2007, PEDIATR NEUROL, V37, P59, DOI 10.1016/j.pediatrneurol.2007.03.008; Bhatoe HS, 1998, BRIT J NEUROSURG, V12, P165; BICKERSTAFF ER, 1961, LANCET, V1, P15; Biehl K, 2007, CEPHALALGIA, V27, P1271, DOI 10.1111/j.1468-2982.2007.01381.x; Bigal ME, 2007, CEPHALALGIA, V27, P230, DOI 10.1111/j.1468-2982.2006.01274.x; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Bigal ME, 2008, CURR PAIN HEADACHE R, V12, P292, DOI 10.1007/s11916-008-0049-7; Bigal ME, 2008, HEADACHE, V48, P7, DOI 10.1111/j.1526-4610.2007.00969.x; Bigal ME, 2004, NEUROLOGY, V63, P843, DOI 10.1212/01.WNL.0000137039.08724.18; Bigal ME, 2002, CEPHALALGIA, V22, P432, DOI 10.1046/j.1468-2982.2002.00384.x; Bigal ME, 2005, HEADACHE, V45, P582, DOI 10.1111/j.1526-4610.2005.05112.x; Bigal ME, 2004, CEPHALALGIA, V24, P483, DOI 10.1111/j.1468-2982.2004.00691.x; Bing R, 1930, NERVENARZT, V3, P506; Biousse V, 1999, NEUROLOGY, V53, P1537, DOI 10.1212/WNL.53.7.1537; BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235; BIRD N, 1992, HEADACHE, V32, P35, DOI 10.1111/j.1526-4610.1992.hed3201035.x; Birk S, 2006, CEPHALALGIA, V26, P1304, DOI 10.1111/j.1468-2982.2006.01218.x; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; BLACKY RA, 1987, AM J CARDIOL, V60, P730, DOI 10.1016/0002-9149(87)90394-8; Blau JN, 2004, HEADACHE, V44, P411, DOI 10.1111/j.1526-4610.2004.04092.x; Bloudek LM, 2012, J HEADACHE PAIN, V13, P361, DOI 10.1007/s10194-012-0460-7; Blumenthal HJ, 2001, HEADACHE, V41, P883, DOI 10.1046/j.1526-4610.2001.041009883.x; Boes CJ, 1998, HEADACHE, V38, P787, DOI 10.1046/j.1526-4610.1998.3810787.x; Boes CJ, 2005, NEUROLOGY, V64, P1093, DOI 10.1212/01.WNL.0000154470.19225.49; Boes CJ, 2003, CEPHALALGIA, V23, P24, DOI 10.1046/j.1468-2982.2003.00406.x; BOGDUK N, 1985, MED J AUSTRALIA, V143, P202, DOI 10.5694/j.1326-5377.1985.tb122915.x; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Bogduk N, 2005, PHYS MED REH CLIN N, V14, P455; Bogduk N, 1997, HEADACHE, P369; BOHR V, 1983, J INFECTION, V7, P102, DOI 10.1016/S0163-4453(83)90443-7; Bonnet G F, 1971, Sem Hop, V47, P2441; Bono G, 2006, CLIN EXP HYPERTENS, V28, P233, DOI 10.1080/10641960600549116; BORDINI C, 1991, HEADACHE, V31, P20, DOI 10.1111/j.1526-4610.1991.hed3101020.x; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Borkum JM, 2010, CURR PAIN HEADACHE R, V14, P55, DOI 10.1007/s11916-009-0084-z; Botha SS, 2010, CEPHALALGIA, V30, P1495, DOI 10.1177/0333102410370876; BOUHASSIRA D, 1994, CEPHALALGIA, V14, P168, DOI 10.1046/j.1468-2982.1994.1402168.x; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Bousser MG, 2000, CEPHALALGIA, V20, P155, DOI 10.1046/j.1468-2982.2000.00035.x; BOWEN J, 1993, HEADACHE, V33, P238, DOI 10.1111/j.1526-4610.1993.hed3305238.x; Bowsher D, 2000, PAIN CLINIC, V12, P93, DOI 10.1163/156856900750229843; Bowsher D, 1998, NEUROLOGY, V51, P1352, DOI 10.1212/WNL.51.5.1352; Bowsher D, 1997, POSTGRAD MED J, V73, P623, DOI 10.1136/pgmj.73.864.623; Brantberg K, 2011, ACTA OTO-LARYNGOL, V131, P722, DOI 10.3109/00016489.2011.556661; Breen JC, 1996, NEUROLOGY, V46, P175, DOI 10.1212/WNL.46.1.175; BREW BJ, 1993, NEUROLOGY, V43, P1098, DOI 10.1212/WNL.43.6.1098; BREWERTON TD, 1992, HEADACHE, V32, P217, DOI 10.1111/j.1526-4610.1992.hed3205217.x; BROESKE D, 1993, J CHILD NEUROL, V8, P235, DOI 10.1177/088307389300800305; BROOKS RG, 1986, ANN NEUROL, V20, P91, DOI 10.1002/ana.410200116; BRUYN GW, 1984, CEPHALALGIA, V4, P191, DOI 10.1046/j.1468-2982.1984.0403191.x; Bruyn GW, 1986, HEADACHE HDB CLIN NE, V4, P487; Buchgreitz L, 2008, PAIN, V137, P623, DOI 10.1016/j.pain.2007.10.023; Buchgreitz L, 2006, PAIN, V123, P19, DOI 10.1016/j.pain.2006.01.040; Buchgreitz L, 2008, BRAIN, V131, P3232, DOI 10.1093/brain/awn199; Burkhart CG, 2006, INT J DERMATOL, V45, P1116, DOI 10.1111/j.1365-4632.2006.02790.x; Burtscher M, 2011, CEPHALALGIA, V31, P706, DOI 10.1177/0333102410394678; Buse D, 2012, HEADACHE, V52, P3, DOI 10.1111/j.1526-4610.2011.02046.x; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; BUSSONE G, 1991, CEPHALALGIA, V11, P123, DOI 10.1046/j.1468-2982.1991.1103123.x; Buzzi MG, 2003, CEPHALALGIA, V23, P672; Buzzi MG, 2003, HEADACHE, V43, P404, DOI 10.1046/j.1526-4610.2003.03076.x; Byrum EP, 2009, AM J NEURORADIOL, V30, P1059, DOI 10.3174/ajnr.A1382; Cady RK, 2005, MAYO CLIN PROC, V80, P908, DOI 10.4065/80.7.908; Cakirer S, 2003, EUR J RADIOL, V45, P83, DOI 10.1016/S0720-048X(02)00012-8; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/art.2; CALABRESE LH, 1992, CLEV CLIN J MED, V59, P293, DOI 10.3949/ccjm.59.3.293; CALL GK, 1988, STROKE, V19, P1159, DOI 10.1161/01.STR.19.9.1159; Caminero AB, 1998, CEPHALALGIA, V18, P159, DOI 10.1046/j.1468-2982.1998.1803159.x; Canestri P, 2001, CEPHALALGIA, V21, P288; Canuet L, 2008, EPILEPSY BEHAV, V13, P570, DOI 10.1016/j.yebeh.2008.05.013; Cao Y, 1999, ARCH NEUROL-CHICAGO, V56, P548, DOI 10.1001/archneur.56.5.548; Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402; CAPLAN LR, 1991, NEUROLOGY, V41, P55, DOI 10.1212/WNL.41.1.55; Cariga P, 2002, SPINAL CORD, V40, P77, DOI 10.1038/sj.sc.3101259; Carroll D, 1970, Headache, V10, P9, DOI 10.1111/j.1526-4610.1970.hed1001009.x; CASELLI RJ, 1993, RHEUM DIS CLIN N AM, V19, P941; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Castillo J, 1999, HEADACHE, V39, P190, DOI 10.1046/j.1526-4610.1999.3903190.x; Cathcart S, 2008, EUR J NEUROL, V15, P552, DOI 10.1111/j.1468-1331.2008.02124.x; Cathcart S, 2010, CEPHALALGIA, V30, P285, DOI 10.1111/j.1468-2982.2009.01917.x; Cathcart S, 2010, HEADACHE, V50, P403, DOI 10.1111/j.1526-4610.2009.01545.x; Centonze V, 2001, CEPHALALGIA, V21, P71, DOI 10.1046/j.1468-2982.2001.00152.x; Chabriat H, 1996, REV NEUROL-FRANCE, V152, P536; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; CHABRIAT H, 1995, NEUROLOGY, V45, P1086, DOI 10.1212/WNL.45.6.1086; CHAKERES DW, 1989, RADIOL CLIN N AM, V27, P265; Chakravarty A, 2006, CEPHALALGIA, V26, P202, DOI 10.1111/j.1468-2982.2005.01027.x; Chakravarty A, 2005, CEPHALALGIA, V25, P795, DOI 10.1111/j.1468-2982.2005.00958.x; CHALSTREY S, 1991, J ROY SOC MED, V84, P193; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Chapman KM, 2003, HEADACHE, V43, P892, DOI 10.1046/j.1526-4610.2003.03168.x; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Chen PK, 2009, CEPHALALGIA, V29, P1079, DOI 10.1111/j.1468-2982.2009.01844.x; Chen PK, 2011, CEPHALALGIA, V31, P829, DOI 10.1177/0333102411403635; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2009, CEPHALALGIA, V29, P401, DOI 10.1111/j.1468-2982.2008.01744.x; Chen SP, 2010, ANN NEUROL, V67, P648, DOI 10.1002/ana.21951; Chen SP, 2004, EUR NEUROL, V24, P231; Chen WT, 2011, BRAIN, V134, P2387, DOI 10.1093/brain/awr157; Chen WT, 2001, HEADACHE, V41, P823, DOI 10.1046/j.1526-4610.2001.01150.x; Chen YY, 2004, CEPHALALGIA, V24, P694, DOI 10.1111/j.1468-2982.2004.00739.x; CHENG TMW, 1993, NEUROLOGY, V43, P2298, DOI 10.1212/WNL.43.11.2298; Cheshire WP, 2001, HEADACHE, V41, P235, DOI 10.1046/j.1526-4610.2001.111006235.x; Chhiber SS, 2010, NEUROL INDIA, V58, P654, DOI 10.4103/0028-3886.68698; Christensen MB, 2005, CEPHALALGIA, V25, P1061, DOI 10.1111/j.1468-2982.2005.00962.x; Chronicle EP, 1996, CEPHALALGIA, V16, P525, DOI 10.1046/j.1468-2982.1996.1608525.x; CHUN CH, 1986, MEDICINE, V65, P415, DOI 10.1097/00005792-198611000-00006; Ciancaglini R, 2001, J DENT, V29, P93, DOI 10.1016/S0300-5712(00)00042-7; Cittadini E, 2008, BRAIN, V131, P1142, DOI 10.1093/brain/awn010; Cittadini E, 2010, BRAIN, V133, P1973, DOI 10.1093/brain/awq137; CLARK GT, 1995, CEPHALALGIA, V15, P511, DOI 10.1046/j.1468-2982.1995.1506511.x; Clarke C, 2006, POSTGRAD MED J, V82, P748, DOI 10.1136/pgmj.2006.047662; Cleophas TJM, 1996, ANGIOLOGY, V47, P679, DOI 10.1177/000331979604700707; Close LG, 1997, SEMIN NEUROL, V17, P351, DOI 10.1055/s-2008-1040948; Cochius J I, 1989, Clin Exp Neurol, V26, P183; Cohen AS, 2006, BRAIN, V129, P2746, DOI 10.1093/brain/awl202; Cohen ME, 1994, BRAIN TUMORS CHILDRE; COHN DF, 1979, EUR NEUROL, V18, P373, DOI 10.1159/000115107; Colby CC, 2011, ARCH OTOLARYNGOL, V137, P248, DOI 10.1001/archoto.2011.25; Cologno D, 1998, CEPHALALGIA, V18, P690, DOI 10.1046/j.1468-2982.1998.1810690.x; CONNOR RCR, 1962, LANCET, V2, P1072; Contini C., 2008, Parassitologia (Rome), V50, P45; CORBETT JJ, 1983, NEUROLOGY, V33, P1386, DOI 10.1212/WNL.33.10.1386; Corral F, 2001, ARCH NEUROL-CHICAGO, V58, P1143, DOI 10.1001/archneur.58.7.1143; Couch JR, 2009, EUR J NEUROL, V16, DOI 10.1111/j.1468-1331.2008.02362.x; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; COUCH JR, 1983, HEADACHE, V23, P94; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; Cruccu G, 2008, EUR J NEUROL, V15, P1013, DOI 10.1111/j.1468-1331.2008.02185.x; Cruccu G, 2009, PAIN, V143, P186, DOI 10.1016/j.pain.2008.12.026; CSALA B, 1994, NERVENARZT, V65, P75; Cuadrado ML, 2010, CEPHALALGIA, V30, P200, DOI 10.1111/j.1468-2982.2009.01895.x; Cuadrado ML, 2009, CEPHALALGIA, V29, P583, DOI 10.1111/j.1468-2982.2008.01815.x; Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275; Cure J, 2007, HEADACHE, V47, P1091, DOI 10.1111/j.1526-4610.2007.00878.x; Curioso EP, 1999, NEUROLOGY, V52, pA471; CUTRER FM, 1992, HEADACHE, V32, P300, DOI 10.1111/j.1526-4610.1992.hed3206300.x; Cutrer FM, 2004, NEUROL CLIN, V22, P133, DOI 10.1016/S0733-8619(03)00092-6; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; D'Andrea G, 2002, CEPHALALGIA, V22, P485, DOI 10.1046/j.1468-2982.2002.00399.x; Da Motta LA, 1991, J NEUROSURG SCI, V43, P25; DALTON K, 1975, HEADACHE, V15, P188, DOI 10.1111/j.1526-4610.1975.hed1503188.x; DANGOND F, 1993, HEADACHE, V33, P257, DOI 10.1111/j.1526-4610.1993.hed3305257.x; Daroff RB, 1998, HEADACHE, V38, P661, DOI 10.1046/j.1526-4610.1998.3809661.x; Daum K M, 1988, J Am Optom Assoc, V59, P691; Davies PTG, 2011, J HEADACHE PAIN, V12, P287, DOI 10.1007/s10194-011-0344-2; DAVIS LE, 1983, ANN NEUROL, V13, P192, DOI 10.1002/ana.410130215; DAY JW, 1986, LANCET, V2, P1247; de Arcaya AA, 1999, HEADACHE, V39, P321; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Gray LC, 2005, ANAESTHESIA, V60, P693, DOI 10.1111/j.1365-2044.2005.03997.x; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Noronha RJ, 2003, J NEUROL NEUROSUR PS, V74, P752, DOI 10.1136/jnnp.74.6.752; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; De Vuyst D, 2001, JBR-BTR, V84, P60; DeBenedittis G, 1996, NEUROSURGERY, V38, P466, DOI 10.1097/00006123-199603000-00008; DeBenedittis G, 1996, CEPHALALGIA, V16, P503, DOI 10.1046/j.1468-2982.1996.1607503.x; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; DEMARINIS M, 1992, CEPHALALGIA, V12, P197; DEMARINIS M, 1991, HEADACHE, V31, P159; DEMARINIS M, 1991, J NEUROL NEUROSUR PS, V54, P314, DOI 10.1136/jnnp.54.4.314; Denes E, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13107; Denier C, 2004, ANN NEUROL, V55, P213, DOI 10.1002/ana.10804; DENNING DW, 1988, BIOMED PHARMACOTHER, V42, P11; Depreitere B, 2003, ACTA NEUROCHIR, V145, P541, DOI 10.1007/s00701-003-0020-7; Desmond RA, 2006, ANTIMICROB AGENTS CH, V50, P2409, DOI 10.1128/AAC.00227-06; DEXTER JD, 1978, HEADACHE, V18, P91, DOI 10.1111/j.1526-4610.1978.hed1802091.x; DHOPESH V, 1991, HEADACHE, V31, P17, DOI 10.1111/j.1526-4610.1991.hed3101017.x; DHUNA A, 1991, J NEUROL NEUROSUR PS, V54, P803, DOI 10.1136/jnnp.54.9.803; Di Fabio R, 2012, HEADACHE, V52, P385, DOI 10.1111/j.1526-4610.2011.01994.x; Diamond S, 2000, HEADACHE Q-CURR TREA, V11, P177; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Diener HC, 2012, NAT REV NEUROL, V8, P162, DOI 10.1038/nrneurol.2012.13; DIENER HC, 1989, J NEUROL, V236, P9, DOI 10.1007/BF00314210; Diener HC, 2006, HEADACHES, P971; Dieterich M, 1999, J NEUROL, V246, P883, DOI 10.1007/s004150050478; Diethrich EB, 1996, J ENDOVASC SURG, V3, P42, DOI 10.1583/1074-6218(1996)003<0042:SITCAI>2.0.CO;2; Dignan F, 2001, ARCH DIS CHILD, V84, P415, DOI 10.1136/adc.84.5.415; Dinwiddie SH, 2010, J ECT, V26, P116, DOI 10.1097/YCT.0b013e3181b07c0a; Dlamini N, 2011, J CHILD NEUROL, V26, P1203, DOI 10.1177/0883073811408904; Dodick DW, 2000, CEPHALALGIA, V20, P509, DOI 10.1046/j.1468-2982.2000.00073.x; Dodick DW, 2000, HEADACHE, V40, P748, DOI 10.1046/j.1526-4610.2000.00131.x; Dodick DW, 1999, CEPHALALGIA, V19, P118, DOI 10.1046/j.1468-2982.1999.019002118.x; Dodick DW, 2000, HEADACHE, V40, P830, DOI 10.1046/j.1526-4610.2000.00150.x; Dodick DW, 1998, NEUROLOGY, V50, P1510, DOI 10.1212/WNL.50.5.1510; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Domachowske JB, 1996, PEDIATR INFECT DIS J, V15, P871, DOI 10.1097/00006454-199610000-00008; Domingues RB, 2006, CEPHALALGIA, V26, P879, DOI 10.1111/j.1468-2982.2006.01100.x; Donnet A, 2009, CEPHALALGIA, V29, P928, DOI 10.1111/j.1468-2982.2008.01826.x; Donnet A, 2009, NEUROLOGY, V72, pA419; Doran M, 2004, J NEUROL, V251, P100, DOI 10.1007/s00415-004-0219-4; Drake KW, 2009, NEUROLOGY, V73, P1780, DOI 10.1212/WNL.0b013e3181c34b69; Drangsholt M, 2001, J EVID-BASED DENT PR, V1, P41, DOI DOI 10.1067/med.2001.116846; Dreier JP, 2005, NEUROLOGY, V64, P2145, DOI 10.1212/01.WNL.0000176298.63840.99; DREXLER ED, 1990, POSTGRAD MED, V87, P164; Drigo P, 2000, BRAIN DEV-JPN, V22, P169, DOI 10.1016/S0387-7604(00)00099-1; Drigo P, 2001, BRAIN DEV-JPN, V23, P38, DOI 10.1016/S0387-7604(01)00175-9; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Drummond P D, 1984, Clin Exp Neurol, V20, P93; Du Y, 2011, J CLIN NEUROSCI, V18, P902, DOI 10.1016/j.jocn.2010.11.011; Ducros A, 2012, BMJ-BRIT MED J, V345, pe8557; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; DUNN DW, 1976, AM J DIS CHILD, V130, P1099, DOI 10.1001/archpedi.1976.02120110061008; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Dworkin SF, 2010, J ORAL REHABIL, V37, P734, DOI 10.1111/j.1365-2842.2010.02090.x; Eastwood JD, 1998, AM J NEURORADIOL, V19, P1789; EDIS RH, 1988, LANCET, V1, P993; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Edmonds RC, 1992, DIVING SUBAQUATIVE M, P404; Egermark I, 2001, ACTA ODONTOL SCAND, V59, P40, DOI 10.1080/000163501300035788; EHNI G, 1984, NEW ENGL J MED, V310, P127; EKBOM K, 1968, ARCH NEUROL-CHICAGO, V19, P487, DOI 10.1001/archneur.1968.00480050057005; EKBOM K, 1994, CEPHALALGIA, V14, P266, DOI 10.1046/j.1468-2982.1994.1404266.x; Ekbom K, 1947, ACTA PSYCHIAT SCAND, V46, P106; Eliav E, 2007, J AM DENT ASSOC, V138, P628, DOI 10.14219/jada.archive.2007.0234; ELMALLAKH RS, 1991, HEADACHE, V31, P584; ELMALLAKH RS, 1987, HEADACHE, V27, P442; Empl M, 2003, CEPHALALGIA, V23, P584; Englund M, 2003, AVIAT SPACE ENVIR MD, V74, P236; Epstein JB, 2001, ORAL SURG ORAL MED O, V92, P236, DOI 10.1067/moe.2001.114158; EPSTEIN MA, 1990, J CHILD NEUROL, V5, P27, DOI 10.1177/088307389000500105; EPSTEIN MT, 1975, LANCET, V1, P543, DOI 10.1016/s0140-6736(75)91558-5; Eriksen MK, 2006, HEADACHE, V46, P286, DOI 10.1111/j.1526-4610.2006.00286.x; Eriksen MK, 2005, CEPHALALGIA, V25, P801, DOI 10.1111/j.1468-2982.2005.00955.x; Eriksen MK, 2004, CEPHALALGIA, V24, P564, DOI 10.1111/j.1468-2982.2003.00718.x; Eulenberg A, 1878, LEHRBUCH NERVENKRANK; Evans Randolph W, 2003, Curr Pain Headache Rep, V7, P303, DOI 10.1007/s11916-003-0051-z; Evans RW, 2000, HEADACHE, V40, P696, DOI 10.1046/j.1526-4610.2000.040008696.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Evans RW, 1996, NEUROL CLIN, V14, P1, DOI 10.1016/S0733-8619(05)70240-1; Evans RW, 2001, HEADACHE, V41, P830, DOI 10.1046/j.1526-4610.2001.01152.x; Evers S, 2000, PAIN, V85, P191, DOI 10.1016/S0304-3959(99)00266-3; Evers S, 2003, NEUROLOGY, V60, P905, DOI 10.1212/01.WNL.0000046582.21771.9C; Evers S, 1999, CLIN NEUROPHARMACOL, V22, P201; Evers S, 2009, HEADACHE, V49, P1234, DOI 10.1111/j.1526-4610.2009.01498.x; FANCIULLACCI M, 1992, CLIN PHARMACOL THER, V51, P302, DOI 10.1038/clpt.1992.26; FANCIULLACCI M, 1995, PAIN, V60, P119, DOI 10.1016/0304-3959(94)00097-X; Farazmand P, 2011, INT J STD AIDS, V22, P306, DOI 10.1258/ijsa.2010.010405; FARQUHAR HG, 1956, BRIT MED J, V1, P1082, DOI 10.1136/bmj.1.4975.1082; Fasano V A, 1982, Adv Neurol, V33, P399; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fazzone HE, 2003, OPHTHALMOLOGY, V110, P1646, DOI 10.1016/S0161-6420(03)00477-9; FENICHEL GM, 1967, J PEDIATR-US, V71, P114, DOI 10.1016/S0022-3476(67)80239-7; FENICHEL NM, 1948, ANN INTERN MED, V29, P456, DOI 10.7326/0003-4819-29-3-456; Fernandez-De-Las-Penas C, 2007, CEPHALALGIA, V27, P383, DOI 10.1111/j.1468-2982.2007.01295.x; Fernandez-de-las-Penas C, 2007, CEPHALALGIA, V27, P182, DOI 10.1111/j.1468-2982.2007.01253.x; Fernandez-de-las-Penas C, 2007, CLIN J PAIN, V23, P346, DOI 10.1097/AJP.0b013e31803b3770; Fernandez-de-las-Penas C, 2007, HEADACHE, V47, P662, DOI 10.1111/j.1526-4610.2006.00632.x; Fernandez-de-las-Penas C, 2006, MANUAL THER, V11, P225, DOI 10.1016/j.math.2006.07.003; Fernandez-De-Las-Penas C, 2006, HEADACHE, V46, P1264, DOI 10.1111/j.1526-4610.2006.00440.x; Fernandez-De-Las-Penas C, 2006, HEADACHE, V46, P1195, DOI 10.1111/j.1526-4610.2006.00511.x; Fernandaz-de-las-Penas C, 2009, CURR OPIN NEUROL, V22, P254, DOI 10.1097/WCO.0b013e32832973ce; FERRO JM, 1995, HEADACHE, V35, P544, DOI 10.1111/j.1526-4610.1995.hed3509544.x; Ferro JM, 1998, NEUROLOGY, V50, P203, DOI 10.1212/WNL.50.1.203; FERRO JM, 1995, HEADACHE, V35, P315, DOI 10.1111/j.1526-4610.1995.hed3506315.x; Fisher C, 1968, HDB CLIN NEUROLOGY, V5, P124; Fisher C M, 1971, Clin Neurosurg, V18, P267; Fisher C M, 1968, Trans Am Neurol Assoc, V93, P211; FISHER CM, 1980, CAN J NEUROL SCI, V7, P9; FISHER CM, 1982, HEADACHE, V22, P60, DOI 10.1111/j.1526-4610.1982.hed2202060.x; Fitzek S, 2001, ANN NEUROL, V49, P493; FLEETCROFT R, 1985, J ROY SOC MED, V78, P676, DOI 10.1177/014107688507800817; Fleisher DR, 1999, J PEDIATR-US, V134, P533, DOI 10.1016/S0022-3476(99)70234-9; Fontalba-Navas M, 2011, NEUROLOGIA, V26, P60, DOI 10.1016/j.nrl.2010.03.011; Forbes HS, 1924, ARCH NEURO PSYCHIATR, V11, P264, DOI 10.1001/archneurpsyc.1924.02190330014002; Forderreuther S, 2002, HEADACHE, V42, P649, DOI 10.1046/j.1526-4610.2002.02154.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Forssell H, 2002, PAIN, V99, P41, DOI 10.1016/S0304-3959(02)00052-0; Forssell H, 2007, NEUROLOGY, V69, P1451, DOI 10.1212/01.wnl.0000277274.83301.c0; FRANCKE E, 1987, POSTGRAD MED, V82, P175, DOI 10.1080/00325481.1987.11699934; Fredriksen TA, 2000, CLIN EXP RHEUMATOL, V18, pS16; Frese A, 2007, CEPHALALGIA, V27, P1265, DOI 10.1111/j.1468-2982.2007.01449.x; Frese A, 2003, NEUROLOGY, V61, P796, DOI 10.1212/01.WNL.0000083988.98336.A3; Friedenberg S, 2000, HEADACHE, V40, P487, DOI 10.1046/j.1526-4610.2000.00074.x; Friedman DI, 2004, J NEURO-OPHTHALMOL, V24, P138, DOI 10.1097/00041327-200406000-00009; Friedman J, 2001, NEUROL CLIN, V19, P681, DOI 10.1016/S0733-8619(05)70040-2; Fritsche G, 2010, PAIN, V151, P404, DOI 10.1016/j.pain.2010.07.032; FROMM GH, 1990, NEUROLOGY, V40, P1493, DOI 10.1212/WNL.40.10.1493; Fuentes B, 1998, CEPHALALGIA, V18, P570, DOI 10.1046/j.1468-2982.1998.1808570.x; Fuh JL, 2007, CEPHALALGIA, V27, P1005, DOI 10.1111/j.1468-2982.2007.01365.x; Fuh JL, 2005, PAIN, V119, P49, DOI 10.1016/j.pain.2005.09.034; Fuh JL, 2003, CEPHALALGIA, V23, P977, DOI 10.1046/j.1468-2982.2003.00620.x; Fumal A, 2005, CEPHALALGIA, V25, P754, DOI 10.1111/j.1468-2982.2004.00945.x; Fumal A, 2008, LANCET NEUROL, V7, P70, DOI 10.1016/S1474-4422(07)70325-3; Furlan JC, 2011, NEUROLOGY, V77, P792, DOI 10.1212/WNL.0b013e31822afff1; Fusco C, 2003, BRAIN DEV-JPN, V25, P237, DOI 10.1016/S0387-7604(02)00216-4; Gaist D, 1998, BMJ-BRIT MED J, V316, P1352, DOI 10.1136/bmj.316.7141.1352; Gaist D, 1996, EUR J CLIN PHARMACOL, V50, P161, DOI 10.1007/s002280050086; Gambini O, 2010, NEUROL SCI, V31, P111, DOI 10.1007/s10072-010-0300-y; Garg RK, 2001, CEPHALALGIA, V21, P78, DOI 10.1046/j.1468-2982.2001.00171.x; Garza I, 2008, HEADACHE, V48, P1120, DOI 10.1111/j.1526-4610.2008.01149.x; GEDDE-DAHL T W, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P31; Gee JR, 2003, HEADACHE, V43, P276, DOI 10.1046/j.1526-4610.2003.03053.x; Gelfand AA, 2012, J CHILD NEUROL, V27, P759, DOI 10.1177/0883073811426502; Gelfand AA, 2010, NEUROLOGY, V75, pE16, DOI 10.1212/WNL.0b013e3181ebdd53; Gentile S, 2009, CEPHALALGIA, V29, P687, DOI 10.1111/j.1468-2982.2008.01803.x; Gerling J, 1998, NEURO-OPHTHALMOLOGY, V19, P93, DOI 10.1076/noph.19.2.93.3947; GHOSE K, 1984, NEUROPSYCHOBIOLOGY, V12, P122, DOI 10.1159/000118123; Giffin NJ, 2002, DEV MED CHILD NEUROL, V44, P490; Gil-Gouveia R, 2007, J NEUROL, V254, P646, DOI 10.1007/s00415-006-0424-4; Gil-Gouveia R, 2007, J NEUROL, V254, P591, DOI 10.1007/s00415-006-0330-9; Gil-Gouveia RS, 2008, J HEADACHE PAIN, V9, P327, DOI 10.1007/s10194-008-0057-3; GilPeralta A, 1996, STROKE, V27, P2271, DOI 10.1161/01.STR.27.12.2271; GINSBERG MD, 1985, J TOXICOL-CLIN TOXIC, V23, P281, DOI 10.3109/15563658508990635; Gipponi S, 2010, NEUROL SCI, V31, P171, DOI 10.1007/s10072-010-0322-5; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Goadsby PJ, 2008, HEADACHE, V48, P799, DOI 10.1111/j.1526-4610.2008.01157.x; Goadsby PJ, 1997, BRAIN, V120, P193, DOI 10.1093/brain/120.1.193; Goadsby PJ, 2006, BMJ-BRIT MED J, V332, P25, DOI 10.1136/bmj.332.7532.25; Goadsby PJ, 2005, HEADACHE, V45, pS14, DOI 10.1111/j.1526-4610.2005.4501003.x; Goadsby PJ, 2002, J NEUROL NEUROSUR PS, V72, P297, DOI 10.1136/jnnp.72.3.297; Goadsby PJ, 2002, J NEUROL NEUROSUR PS, V72, P6; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Goadsby PJ, 2001, CEPHALALGIA, V21, P82, DOI 10.1046/j.1468-2982.2001.00175.x; Goadsby PJ, 2001, HEADACHE, V41, P608, DOI 10.1046/j.1526-4610.2001.041006608.x; Gobel H, 2001, PAIN, V91, P195, DOI 10.1016/S0304-3959(01)00292-5; Gobel H, 2000, HEADACHES, P899; Gobel H, 2000, HEADACHES, P891; Gobel H, 2000, HEADACHES, P905; Gobel H, 1997, MUNCHEN MED WOCHEN, V139, P456; Goksan B, 2009, CEPHALALGIA, V29, P635, DOI 10.1111/j.1468-2982.2008.01781.x; Goksel BK, 2006, HEADACHE, V46, P40, DOI 10.1111/j.1526-4610.2006.00295.x; GomezAranda F, 1997, BRAIN, V120, P1105, DOI 10.1093/brain/120.7.1105; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gordon GE, 2001, OPHTHAL PHYSL OPT, V21, P45; GORE ME, 1980, LANCET, V1, P251; GORELICK PB, 1986, NEUROLOGY, V36, P1445, DOI 10.1212/WNL.36.11.1445; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1046/j.1360-0443.1995.9056072.x; GOTO Y, 1989, J NEUROL, V236, P448, DOI 10.1007/BF00328504; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Grace A, 1997, CEPHALALGIA, V17, P195, DOI 10.1046/j.1468-2982.1997.1703195.x; Grande RB, 2011, EUR J NEUROL, V18, P129, DOI 10.1111/j.1468-1331.2010.03094.x; Grande RB, 2009, CEPHALALGIA, V29, P1149, DOI 10.1111/j.1468-2982.2009.01842.x; Grande RB, 2009, J NEUROL NEUROSUR PS, V80, P784, DOI 10.1136/jnnp.2008.168864; GRANELLA F, 1994, CEPHALALGIA, V14, P16, DOI 10.1046/j.1468-2982.1994.1401016.x; GRANELLA F, 1987, CEPHALALGIA, V7, P15, DOI 10.1046/j.1468-2982.1987.0701015.x; Grazzi L, 2011, NEUROL SCI, V32, P299, DOI 10.1007/s10072-011-0696-z; Green MW, 2001, MED CLIN N AM, V85, P1085, DOI 10.1016/S0025-7125(05)70361-8; Greenough Glen P, 2002, Sleep Med, V3, P361, DOI 10.1016/S1389-9457(02)00006-0; Grosberg BM, 2006, CEPHALALGIA, V26, P1275, DOI 10.1111/j.1468-2982.2006.01206.x; Grosberg Brian M, 2007, Curr Pain Headache Rep, V11, P310, DOI 10.1007/s11916-007-0209-1; Guerrero AL, 2012, CEPHALALGIA, V32, P649, DOI 10.1177/0333102412447537; Guerrero AL, 2010, HEADACHE, V50, P451, DOI 10.1111/j.1526-4610.2009.01607.x; Guidetti V, 1998, CEPHALALGIA, V18, P455, DOI 10.1046/j.1468-2982.1998.1807455.x; Guillon B, 1998, J NEUROL SCI, V153, P146, DOI 10.1016/S0022-510X(97)00287-6; Gus M, 2001, ARCH INTERN MED, V161, P252, DOI 10.1001/archinte.161.2.252; Gutierrez-Morlote J, 2002, CEPHALALGIA, V22, P765, DOI 10.1046/j.1468-2982.2002.00418.x; Haan J, 2000, NEUROLOGY, V55, P1588, DOI 10.1212/WNL.55.10.1588; Haan J, 2002, CEPHALALGIA, V22, P552, DOI 10.1046/j.1468-2982.2002.00420.x; HAAS DC, 1982, ANN NEUROL, V11, P197; HAAS DC, 1991, HEADACHE, V31, P509, DOI 10.1111/j.1526-4610.1991.hed3108509.x; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hajj-Ali RA, 2011, LANCET NEUROL, V10, P561, DOI 10.1016/S1474-4422(11)70081-3; HANINGTON E, 1968, Headache, V8, P84, DOI 10.1111/j.1526-4610.1968.hed0803084.x; Hannerz J, 1998, CEPHALALGIA, V18, P124, DOI 10.1046/j.1468-2982.1998.1803123-4.x; HANNERZ J, 1993, CEPHALALGIA, V13, P361, DOI 10.1046/j.1468-2982.1993.1305361.x; Hansen JM, 2012, NEUROLOGY, V79, P2044, DOI 10.1212/WNL.0b013e3182749eed; Hansen JM, 2011, HEADACHE, V51, P1289, DOI 10.1111/j.1526-4610.2011.01963.x; Hansen JM, 2010, NEUROLOGY, V74, P594, DOI 10.1212/WNL.0b013e3181cff79d; HARNER SG, 1993, AM J OTOL, V14, P552; HARRIS KG, 1994, AM J NEURORADIOL, V15, P317; HARRIS LF, 1985, SOUTH MED J, V78, P704, DOI 10.1097/00007611-198506000-00022; Harris W, 1936, BRIT MED J, V1936, P457; Hayashi T, 2000, NEUROL MED-CHIR, V40, P419, DOI 10.2176/nmc.40.419; HECKERLING PS, 1987, ANN INTERN MED, V107, P174, DOI 10.7326/0003-4819-107-2-174; Heckman Bernadette Davantes, 2006, Curr Pain Headache Rep, V10, P439, DOI 10.1007/s11916-006-0075-2; Heckmann JG, 1997, HEADACHE, V37, P597; HEDGES TR, 1976, STROKE, V7, P379, DOI 10.1161/01.STR.7.4.379; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Helbok R, 2009, J NEUROL, V256, P168, DOI 10.1007/s00415-009-0122-0; Henrikson T, 1997, ACTA ODONTOL SCAND, V55, P229, DOI 10.3109/00016359709115422; HERING R, 1991, LANCET, V337, P1442, DOI 10.1016/0140-6736(91)93129-W; Hernandez A, 1998, EUR J NEUROL, V5, P499, DOI 10.1046/j.1468-1331.1998.550499.x; Herrero-Velazquez S, 2011, REV NEUROLOGIA, V53, P531, DOI 10.33588/rn.5309.2011421; Hill DL, 2007, J NEURO-OPHTHALMOL, V27, P3, DOI 10.1097/WNO.0b013e3180335222; HODGES J, 1986, Q J MED, V59, P387; HOLLANDER H, 1987, AM J MED, V83, P813, DOI 10.1016/0002-9343(87)90635-8; Holle D, 2011, ANN NEUROL, V69, P533, DOI 10.1002/ana.22188; Holle D, 2010, CEPHALALGIA, V30, P1435, DOI 10.1177/0333102410375727; Holle D, 2011, CEPHALALGIA, V31, P286, DOI 10.1177/0333102410381146; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; HORTON B T, 1952, J Lancet, V72, P92; HORTON B T, 1963, Headache, V2, P214; Hottenga JJ, 2005, CEPHALALGIA, V25, P1168, DOI 10.1111/j.1468-2982.2005.00994.x; Hou CC, 2011, EUR J PHARMACOL, V667, P6, DOI 10.1016/j.ejphar.2011.05.075; HUBBARD DR, 1993, SPINE, V18, P1803, DOI 10.1097/00007632-199310000-00015; HUNDER GG, 1990, RHEUM DIS CLIN N AM, V16, P399; Hung CI, 2009, J AFFECT DISORDERS, V117, P108, DOI 10.1016/j.jad.2008.12.015; Iizuka T, 2012, J NEUROL NEUROSUR PS, V83, P205, DOI 10.1136/jnnp-2011-300843; ILLE O, 1995, STROKE, V26, P488, DOI 10.1161/01.STR.26.3.488; Irimia P, 2008, CEPHALALGIA, V28, P626, DOI 10.1111/j.1468-2982.2008.01565.x; Ito M, 2004, CEPHALALGIA, V24, P23, DOI 10.1111/j.1468-2982.2004.00628.x; Ito M, 2003, PSYCHIAT CLIN NEUROS, V57, P385, DOI 10.1046/j.1440-1819.2003.01136.x; Ivanhoe CB, 1997, ARCH PHYS MED REHAB, V78, P1272, DOI 10.1016/S0003-9993(97)90343-9; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Jaaskelainen SK, 2005, PAIN, V117, P349, DOI 10.1016/j.pain.2005.06.028; Jaaskelainen SK, 1997, PAIN, V73, P455, DOI 10.1016/S0304-3959(97)00140-1; Jacome DE, 2001, CEPHALALGIA, V21, P697, DOI 10.1046/j.1468-2982.2001.00223.x; Jafarian S, 2007, CEPHALALGIA, V27, P899, DOI 10.1111/j.1468-2982.2007.01351.x; JAMESON MD, 1990, MED CLIN N AM, V74, P945, DOI 10.1016/S0025-7125(16)30528-4; Janke EA, 2004, PAIN, V111, P230, DOI 10.1016/j.pain.2004.06.007; JENSEN K, 1986, ACTA NEUROL SCAND, V73, P359, DOI 10.1111/j.1600-0404.1986.tb03290.x; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Cuadrado ML, 2010, J HEADACHE PAIN, V11, P75, DOI 10.1007/s10194-009-0172-9; Olivarius de Fine B, 1971, P SCAND MIGR SOC ANN, P8; Traumatic Brain Injury (TBI) Task Force for the US Department of the Army, 2008, TBI TASK FORC REP SU; AEBELHOLTKRABBE A, 1980, PAIN, V8, P253, DOI 10.1016/0304-3959(88)90012-7; [Anonymous], 1999, CEPHALALGIA, V19, P67, DOI 10.1046/j.1468-2982.1999.1901067.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Jarosch-von Schweder L, 2011, J ECT, V27, P296, DOI 10.1097/YCT.0b013e31821ff3bd; Jensen R, 1999, CEPHALALGIA, V19, P602, DOI 10.1046/j.1468-2982.1999.019006602.x; Jensen R, 1996, PAIN, V64, P251, DOI 10.1016/0304-3959(95)00114-X; JENSEN R, 1993, PAIN, V52, P193, DOI 10.1016/0304-3959(93)90131-8; JENSEN R, 1992, PAIN, V48, P197, DOI 10.1016/0304-3959(92)90059-K; Jensen R, 1998, HEADACHE, V38, P10, DOI 10.1046/j.1526-4610.1998.3801010.x; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jensen R, 2010, CEPHALALGIA, V30, P1214, DOI 10.1177/0333102410361403; JENSEN TS, 1982, ACTA NEUROL SCAND, V65, P182; Jensen TS, 2000, HEADACHES, P781; JONES HR, 1989, BRAIN, V112, P1295; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kaczorowski M, 2002, BRIT MED J, V325, P1445, DOI 10.1136/bmj.325.7378.1445; Kalita J, 2011, PAIN MED, V12, P282, DOI 10.1111/j.1526-4637.2010.01046.x; Kallela M, 1999, CEPHALALGIA, V19, P151, DOI 10.1046/j.1468-2982.1999.1903151.x; Kandan SR, 2010, BRIT J NEUROSURG, V24, P441, DOI 10.3109/02688697.2010.487131; Karaali-Savrun F, 2002, SEIZURE-EUR J EPILEP, V11, P67, DOI 10.1053/seiz.2001.0583; Katsarava Z, 2011, CEPHALALGIA, V31, P520, DOI 10.1177/0333102410383590; Katsarava Z, 2001, NEUROLOGY, V57, P1694, DOI 10.1212/WNL.57.9.1694; KATUSIC S, 1990, ANN NEUROL, V27, P89, DOI 10.1002/ana.410270114; KATUSIC S, 1991, NEUROEPIDEMIOLOGY, V10, P266, DOI 10.1159/000110283; KAUBE H, 1994, BRIT MED J, V308, P1573, DOI 10.1136/bmj.308.6943.1573d; Kaur A, 2000, NEUROSURGERY, V47, P633; Kelman L, 2004, HEADACHE, V44, P865, DOI 10.1111/j.1526-4610.2004.04168.x; Kennard C, 1991, CLIN NEUROLOGY, P446; Kennedy PG, 1998, NEUROPATHOL APPL NEU, V14, P395; Kennedy PG, 1988, OJM, V86, P533; KENNEY RA, 1972, AM J CLIN NUTR, V25, P140; Kenny TJ, 2001, OTOLARYNG HEAD NECK, V125, P40, DOI 10.1067/mhn.2001.116779; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kirchmann M, 2006, NEUROLOGY, V66, P880, DOI 10.1212/01.wnl.0000203647.48422.dd; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kirkland KE, 2012, HEADACHE, V52, P455, DOI 10.1111/j.1526-4610.2011.02025.x; Kirveskari P, 2001, J ORAL REHABIL, V28, P572, DOI 10.1046/j.1365-2842.2001.00704.x; Kivelev J, 2010, J NEUROSURG, V112, P140, DOI 10.3171/2009.3.JNS081693; KLAPPER J, 1994, HEADACHE, V34, P521, DOI 10.1111/j.1526-4610.1994.hed3409521.x; KLIMEK A, 1987, CEPHALALGIA, V7, P161, DOI 10.1046/j.1468-2982.1987.0702161.x; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735; Knackstedt H, 2010, CEPHALALGIA, V30, P1468, DOI 10.1177/0333102410368442; Koerbel A, 2005, BRIT J RADIOL, V78, P646, DOI 10.1259/bjr/60601877; KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107; Kreiner M, 1996, J CRANIO MAXILL SURG, V24, P289, DOI 10.1016/S1010-5182(96)80061-8; Kristiansen HA, 2012, CEPHALALGIA, V32, P451, DOI 10.1177/0333102411431900; Kristiansen HA, 2011, J HEADACHE PAIN, V12, P63, DOI 10.1007/s10194-010-0265-5; Kruszewski P, 2000, J HYPERTENS, V18, P437, DOI 10.1097/00004872-200018040-00013; Kruuse C, 2002, J CEREBR BLOOD F MET, V22, P1124, DOI 10.1097/00004647-200209000-00010; Kruuse C, 2000, J CEREBR BLOOD F MET, V20, P1372, DOI 10.1097/00004647-200009000-00012; Krymchantowski AV, 2010, CURR PAIN HEADACHE R, V14, P321, DOI 10.1007/s11916-010-0122-x; KUDROW DB, 1989, HEADACHE, V29, P280, DOI 10.1111/j.1526-4610.1989.hed2905280.x; Kudrow L, 1980, CLUSTER HEADACHE MEC; KULALI A, 1990, ACTA NEUROCHIR, V107, P140, DOI 10.1007/BF01405793; KUMAR KL, 1993, J GEN INTERN MED, V8, P333, DOI 10.1007/BF02600150; Kumar R, 1997, J NEUROL NEUROSUR PS, V62, P649, DOI 10.1136/jnnp.62.6.649; Kung E, 2009, CEPHALALGIA, V29, P17, DOI 10.1111/j.1468-2982.2008.01647.x; Kurtuncu M, 2013, CEPHALALGIA, V33, P123, DOI 10.1177/0333102412463494; Kwan P, 2008, EPILEPSIA, V49, P1099, DOI 10.1111/j.1528-1167.2008.01574.x; La Mantia L, 2006, CEPHALALGIA, V26, P772, DOI 10.1111/j.1468-2982.2006.01115.x; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lake AE, 2005, HEADACHE, V45, P493, DOI 10.1111/j.1526-4610.2005.05101.x; Lake AE, 2001, MED CLIN N AM, V85, P1055, DOI 10.1016/S0025-7125(05)70359-X; Lam DK, 2001, J OROFAC PAIN, V15, P146; LANCE JW, 1976, J NEUROL NEUROSUR PS, V39, P1226, DOI 10.1136/jnnp.39.12.1226; LANCE JW, 1980, J NEUROL NEUROSUR PS, V43, P97, DOI 10.1136/jnnp.43.2.97; Lance JW, 1998, HEADACHE, V38, P315, DOI 10.1046/j.1526-4610.1998.3804315.x; Lance JW, 2001, CEPHALALGIA, V21, P84, DOI 10.1046/j.1468-2982.2001.00160.x; LANCE JW, 1976, ARCH NEUROL-CHICAGO, V33, P281, DOI 10.1001/archneur.1976.00500040065011; Landtblom AM, 2002, CEPHALALGIA, V22, P354, DOI 10.1046/j.1468-2982.2002.00368.x; Lanfranconi S, 2009, J NEUROL SCI, V285, P227, DOI 10.1016/j.jns.2009.06.009; LANGEMARK M, 1993, ARCH NEUROL-CHICAGO, V50, P1061, DOI 10.1001/archneur.1993.00540100056015; LANGEMARK M, 1989, PAIN, V38, P203, DOI 10.1016/0304-3959(89)90239-X; LANGEMARK M, 1987, CEPHALALGIA, V7, P249, DOI 10.1046/j.1468-2982.1987.0704249.x; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; LASSEN LH, 1995, NEUROREPORT, V6, P1475, DOI 10.1097/00001756-199507310-00003; Laurell K, 2011, EUR J NEUROL, V18, P1220, DOI 10.1111/j.1468-1331.2011.03364.x; Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lazaro C, 2003, REGION ANESTH PAIN M, V28, P315, DOI 10.1016/S1098-7339(03)00178-0; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Lee AG, 1999, J AM GERIATR SOC, V47, P1364, DOI 10.1111/j.1532-5415.1999.tb07442.x; Lee CC, 2000, AM J EMERG MED, V18, P328, DOI 10.1016/S0735-6757(00)90130-X; LEFKOWITZ D, 1982, ARCH NEUROL-CHICAGO, V39, P130, DOI 10.1001/archneur.1982.00510140064019; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leistad RB, 2006, CEPHALALGIA, V26, P64, DOI 10.1111/j.1468-2982.2005.00997.x; Leker RR, 1999, EUR J NEUROL, V6, P601, DOI 10.1046/j.1468-1331.1999.650601.x; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lempert T, 2009, ANN NY ACAD SCI, V1164, P242, DOI 10.1111/j.1749-6632.2009.03852.x; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Leniger T, 2001, EPILEPSIA, V42, P1176, DOI 10.1046/j.1528-1157.2001.37500.x; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; LEON AS, 1989, ARCH INTERN MED, V149, P2318, DOI 10.1001/archinte.149.10.2318; Leone M, 2000, NEUROLOGY, V55, P136, DOI 10.1212/WNL.55.1.136; Leone M, 1998, PAIN, V78, P1, DOI 10.1016/S0304-3959(98)00116-X; LEONE M, 1995, HEADACHE, V35, P461, DOI 10.1111/j.1526-4610.1995.hed3508461.x; Leotta N, 2005, J PAEDIATR CHILD H, V41, P508, DOI 10.1111/j.1440-1754.2005.00693.x; Levine HL, 2000, ARCH OTOLARYNGOL, V126, P234; LEVITON A, 1975, HEADACHE, V15, P207, DOI 10.1111/j.1526-4610.1975.hed1503207.x; Levy MJ, 2005, BRAIN, V128, P1921, DOI 10.1093/brain/awh525; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lewis J, 1998, HEADACHE, V38, P684, DOI 10.1046/j.1526-4610.1998.3809684.x; Li B U, 2001, Semin Pediatr Neurol, V8, P13, DOI 10.1053/spen.2001.23456; Li BUK, 2008, J PEDIATR GASTR NUTR, V47, P379, DOI 10.1097/MPG.0b013e318173ed39; Li D, 2002, CEPHALALGIA, V22, P66, DOI 10.1046/j.1468-2982.2002.00326.x; Liang JF, 2008, CEPHALALGIA, V28, P209, DOI 10.1111/j.1468-2982.2007.01496.x; Lichten EM, 1996, HEADACHE, V36, P367, DOI 10.1046/j.1526-4610.1996.3606367.x; LIE JT, 1992, HUM PATHOL, V23, P164, DOI 10.1016/0046-8177(92)90238-X; Limmroth V, 1999, LANCET, V353, P378, DOI 10.1016/S0140-6736(05)74950-3; Limmroth V, 2002, NEUROLOGY, V59, P1011, DOI 10.1212/WNL.59.7.1011; Lindelof K, 2010, CEPHALALGIA, V30, P860, DOI 10.1177/0333102409354783; Lindelof K, 2009, CLIN NEUROPHYSIOL, V120, P1364, DOI 10.1016/j.clinph.2009.04.013; Linn FHH, 2002, NEUROLOGIST, V8, P279, DOI 10.1097/00127893-200209000-00001; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; Linn FHH, 1999, J NEUROL, V246, P946, DOI 10.1007/s004150050488; Lipton RB, 2004, NEUROLOGY, V63, P427, DOI 10.1212/01.WNL.0000133301.66364.9B; LIPTON RB, 1989, HEADACHE, V29, P225, DOI 10.1111/j.1526-4610.1989.hed22904225.x; Lipton RB, 1997, HEADACHE, V37, P392, DOI 10.1046/j.1526-4610.1997.3706392.x; Lipton RB, 1997, NEUROLOGY, V49, P813, DOI 10.1212/WNL.49.3.813; Lisotto C, 2004, CEPHALALGIA, V24, P1001, DOI 10.1111/j.1468-2982.2004.00784.x; List T, 2001, J OROFAC PAIN, V15, P218; List T, 2008, PAIN, V139, P333, DOI 10.1016/j.pain.2008.05.002; LIU GT, 1995, NEUROLOGY, V45, P664, DOI 10.1212/WNL.45.4.664; Loh KC, 1997, QJM-MON J ASSOC PHYS, V90, P51; Loh NK, 1999, ARCH INTERN MED, V159, P1765, DOI 10.1001/archinte.159.15.1765; LORD SM, 1994, J NEUROL NEUROSUR PS, V57, P1187, DOI 10.1136/jnnp.57.10.1187; Lord SM., 1996, J MUSCULOSKELET PAIN, V4, P81; LUCAS RN, 1973, BRIT J PSYCHIAT, V122, P199, DOI 10.1192/bjp.122.2.198; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucchesi LM, 2010, CEPHALALGIA, V30, P1477, DOI 10.1177/0333102410368440; LUDA E, 1991, HEADACHE, V31, P582, DOI 10.1111/j.1526-4610.1991.hed3109582.x; LUNDBERG PO, 1988, FRONT GYN E, P149; Lundqvist C, 2012, PAIN, V153, P682, DOI 10.1016/j.pain.2011.12.008; LUTZ G, 1991, CEPHALALGIA, V11, P353, DOI 10.1177/0333102491011S11189; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; MacGowan DJL, 1997, NEUROLOGY, V49, P120, DOI 10.1212/WNL.49.1.120; MacGregor EA, 1998, BRIT J FAM PLAN, V24, P53; Mack KJ, 2009, CURR PAIN HEADACHE R, V13, P47, DOI 10.1007/s11916-009-0010-4; Mack KJ, 2004, PEDIATR NEUROL, V31, P122, DOI 10.1016/j.pediatrneurol.2004.02.006; Maggioni F, 2008, HEADACHE, V48, P1129, DOI 10.1111/j.1526-4610.2008.01091.x; Magnusson T, 2000, J OROFAC PAIN, V14, P310; MAGOS AL, 1986, BRIT J OBSTET GYNAEC, V93, P1290, DOI 10.1111/j.1471-0528.1986.tb07868.x; Mainardi F, 2012, CEPHALALGIA, V32, P592, DOI 10.1177/0333102412441720; Maizels M, 2004, HEADACHE, V44, P983, DOI 10.1111/j.1526-4610.2004.04192.x; Malek AM, 1998, NEUROIMAG CLIN N AM, V8, P445; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mannelli M, 1999, EUR J ENDOCRINOL, V141, P619, DOI 10.1530/eje.0.1410619; MANZONI GC, 1991, CEPHALALGIA, V11, P169, DOI 10.1046/j.1468-2982.1991.1104169.x; MANZONI GC, 1983, CEPHALALGIA, V3, P21, DOI 10.1046/j.1468-2982.1983.0301021.x; Manzoni GC, 1998, CEPHALALGIA, V18, P138, DOI 10.1046/j.1468-2982.1998.1803138.x; Manzoni GC, 2011, J HEADACHE PAIN, V12, P585, DOI 10.1007/s10194-011-0393-6; Marazziti D, 1999, INT CLIN PSYCHOPHARM, V14, P247, DOI 10.1097/00004850-199907000-00007; Marcusson A, 2001, EUR J ORTHODONT, V23, P193, DOI 10.1093/ejo/23.2.193; MARKHAM CH, 1992, CURR OPIN NEUROL NEU, V5, P301; MARKS DA, 1993, NEUROLOGY, V43, P2476, DOI 10.1212/WNL.43.12.2476; MARKUS HS, 1991, J NEUROL NEUROSUR PS, V54, P1117, DOI 10.1136/jnnp.54.12.1117; Martelletti Paolo, 2005, J Headache Pain, V6, P261, DOI 10.1007/s10194-005-0202-1; Martin TJ, 2001, WOLFFS HEADACHE OTHE, P459; Martinez-Salio A, 2000, HEADACHE, V40, P682, DOI 10.1046/j.1526-4610.2000.040008682.x; MARTINS IP, 1993, HEADACHE, V33, P227, DOI 10.1111/j.1526-4610.1993.hed3305227.x; MARTINS IP, 1995, HEADACHE, V35, P107, DOI 10.1111/j.1526-4610.1995.hed3502107.x; Martsen BH, 1990, J NEUROL NEUROSUR PS, V53, P1029; MAS JL, 1986, STROKE, V17, P1019, DOI 10.1161/01.STR.17.5.1019; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; Mathew NT, 2006, CURR NEUROL NEUROSCI, V6, P100, DOI 10.1007/s11910-996-0031-x; MATHEW NT, 1982, HEADACHE, V22, P66, DOI 10.1111/j.1526-4610.1982.hed2202066.x; MATHEW NT, 1990, HEADACHE, V30, P634, DOI 10.1111/j.1526-4610.1990.hed3010634.x; MATHEW NT, 1987, HEADACHE, V27, P102, DOI 10.1111/j.1526-4610.1987.hed2702102.x; Mathias CJ, 1999, J NEUROL, V246, P893, DOI 10.1007/s004150050479; Mattsson P, 2001, CEPHALALGIA, V21, P230, DOI 10.1046/j.1468-2982.2001.00211.x; Maurino J, 2001, ARCH NEUROL-CHICAGO, V58, P629, DOI 10.1001/archneur.58.4.629; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 1999, J CEREBR BLOOD F MET, V19, P115; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCabe DJH, 1999, STROKE, V30, P2483, DOI 10.1161/01.STR.30.11.2483; McCluskey PJ, 1999, OPHTHALMOLOGY, V106, P2380, DOI 10.1016/S0161-6420(99)90543-2; McCrory P, 1997, PHYSICIAN SPORTSMED, V25, P33, DOI 10.3810/psm.1997.02.1133; MCFADZEAN RM, 1991, NEUROSURGERY, V29, P669, DOI 10.1227/00006123-199111000-00005; MCINTYRE PB, 1991, MED J AUSTRALIA, V154, P653, DOI 10.5694/j.1326-5377.1991.tb121250.x; Mea E, 2009, CEPHALALGIA, V29, P418, DOI 10.1111/j.1468-2982.2008.01747.x; Mea E, 2011, NEUROL SCI, V32, P291, DOI 10.1007/s10072-011-0698-x; Meineri P, 2004, NEUROL SCI, V25, pS281, DOI 10.1007/s10072-004-0310-8; Melo TP, 1996, NEUROLOGY, V47, P494, DOI 10.1212/WNL.47.2.494; MENDEZ MF, 1993, J NEUROPSYCH CLIN N, V5, P283; Merlino G, 2007, HEADACHE, V47, P919, DOI 10.1111/j.1526-4610.2007.00829.x; MERRITT JE, 1990, HEADACHE, V30, P575, DOI 10.1111/j.1526-4610.1990.hed3009575.x; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; MICHULTKA DM, 1989, BEHAV RES THER, V27, P411, DOI 10.1016/0005-7967(89)90012-0; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Mills RJ, 2010, BRIT J RADIOL, V83, P493, DOI 10.1259/bjr/65228893; Mirsattari SM, 1999, HEADACHE, V39, P3, DOI 10.1046/j.1526-4610.1999.3901003.x; Missori P, 2000, ACTA NEUROCHIR, V142, P697, DOI 10.1007/s007010070115; Mitsikostas DD, 2008, CEPHALALGIA, V28, P139, DOI 10.1111/j.1468-2982.2007.01473.x; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Molina OF, 2000, CRANIO, V18, P205, DOI 10.1080/08869634.2000.11746134; Monzillo PH, 2000, ARQ NEURO-PSIQUIAT, V58, P518, DOI 10.1590/S0004-282X2000000300019; Moon J, 2010, CEPHALALGIA, V30, P1527, DOI 10.1177/0333102410368445; Moore PM, 1994, SEMIN NEUROL, V14, P313; MORALES F, 1994, CEPHALALGIA, V14, P301, DOI 10.1046/j.1468-2982.1994.1404301.x; Moreau T, 1998, CEPHALALGIA, V18, P687, DOI 10.1046/j.1468-2982.1998.1810687.x; Mork H, 2004, CEPHALALGIA, V24, P466, DOI 10.1111/j.1468-2982.2004.00709.x; Mork H, 2003, EUR J NEUROL, V10, P249, DOI 10.1046/j.1468-1331.2003.00570.x; Morrison DG, 2003, OPHTHALMOLOGY, V110, P115, DOI 10.1016/S0161-6420(02)01444-6; MORRISON DP, 1990, CEPHALALGIA, V10, P273, DOI 10.1046/j.1468-2982.1990.1006273.x; MOSEK A, 1995, NEUROLOGY, V45, P1953, DOI 10.1212/WNL.45.11.1953; Mueller D, 2011, CEPHALALGIA, V31, P1542, DOI 10.1177/0333102411424619; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Mulero P, 2011, J HEADACHE PAIN, V12, P535, DOI 10.1007/s10194-011-0353-1; Mulleners WM, 1996, NEUROLOGY, V47, P302, DOI 10.1212/WNL.47.1.302; MUNARI LM, 1994, CEPHALALGIA, V14, P127, DOI 10.1046/j.1468-2982.1994.1402127.x; MURPHREE HB, 1967, FED PROC, V26, P1468; Murphy E, 2001, J Ir Dent Assoc, V47, P46; Mutton Kenneth, 2011, Infectious Disorders - Drug Targets, V11, P206; Nakatomi H, 1997, STROKE, V28, P1278, DOI 10.1161/01.STR.28.6.1278; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nappi RE, 2001, MATURITAS, V38, P157, DOI 10.1016/S0378-5122(00)00215-2; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Neff BA, 2012, OTOL NEUROTOL, V33, P1235, DOI 10.1097/MAO.0b013e31825d644a; Nestoriuc Y, 2008, J CONSULT CLIN PSYCH, V76, P379, DOI 10.1037/0022-006X.76.3.379; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06; NEWMAN DS, 1989, HEADACHE, V29, P82, DOI 10.1111/j.1526-4610.1989.hed2902082.x; NEWMAN LC, 1990, NEUROLOGY, V40, P1904, DOI 10.1212/WNL.40.12.1904-a; NEWMAN LC, 1994, NEUROLOGY, V44, P2111, DOI 10.1212/WNL.44.11.2111; NICHOLS FT, 1990, STROKE, V21, P555, DOI 10.1161/01.STR.21.4.555; NICHOLS FT, 1993, HEADACHE, V33, P87, DOI 10.1111/j.1526-4610.1993.hed3302087.x; Nicholson RA, 2010, CURR PAIN HEADACHE R, V14, P47, DOI 10.1007/s11916-009-0087-9; Nicolodi M, 1997, INT J CLIN PHARM RES, V17, P79; Norval DA, 2004, SAMJ S AFR MED J, V94, P450; Nowak DA, 2003, CEPHALALGIA, V23, P218, DOI 10.1046/j.1468-2982.2003.00507.x; O'Connor AB, 2008, PAIN, V137, P96, DOI 10.1016/j.pain.2007.08.024; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Obermann M, 2007, NEUROLOGY, V69, P835, DOI 10.1212/01.wnl.0000269670.30045.6b; Obermann M, 2007, CEPHALALGIA, V27, P504, DOI 10.1111/j.1468-2982.2007.01316.x; Obermann M, 2010, CEPHALALGIA, V30, P528, DOI 10.1111/j.1468-2982.2009.01972.x; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI 10.1586/ERN.09.84; Odabasi Z, 1997, CLIN NEUROL NEUROSUR, V99, P151, DOI 10.1016/S0303-8467(97)00013-9; Ogawa K, 2010, ACTA NEUROL BELG, V110, P190; OGUS H, 1978, J ROY SOC MED, V71, P748; Oh AK, 2001, AM J MED GENET, V100, P287, DOI 10.1002/ajmg.1294; Ojaimi J, 1998, CEREBROVASC DIS, V8, P102, DOI 10.1159/000015826; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; OLESEN J, 1993, BRAIN, V116, P187, DOI 10.1093/brain/116.1.187; OLESEN J, 1991, PAIN, V46, P125, DOI 10.1016/0304-3959(91)90066-7; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; Osterberg A, 2005, EUR J PAIN, V9, P531, DOI 10.1016/j.ejpain.2004.11.005; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Ostergard JR, 2000, HEADACHES, P789; Ozge Aynur, 2006, J Headache Pain, V7, P37, DOI 10.1007/s10194-006-0264-8; Ozge C, 2005, EUR J PAIN, V9, P383, DOI 10.1016/j.ejpain.2004.09.007; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; PACHNER AR, 1984, YALE J BIOL MED, V57, P481; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Page H, 1981, JAMA, V246, P719, DOI 10.1001/jama.246.7.719; Pakalnis A, 2001, J CHILD NEUROL, V16, P731, DOI 10.1177/088307380101601005; Pareja JA, 2008, CEPHALALGIA, V28, P257, DOI 10.1111/j.1468-2982.2007.01515.x; Pareja JA, 2008, CEPHALALGIA, V28, P186, DOI 10.1111/j.1468-2982.2007.01490.x; Pareja JA, 2005, CEPHALALGIA, V25, P305, DOI 10.1111/j.1468-2982.2004.00864.x; Pareja JA, 2004, HEADACHE, V44, P611, DOI 10.1111/j.1526-4610.2004.446011.x; Pareja JA, 2002, NEUROLOGY, V58, P1678, DOI 10.1212/WNL.58.11.1678; Pareja JA, 1996, CEPHALALGIA, V16, P93, DOI 10.1046/j.1468-2982.1996.1602093.x; Pareja JA, 2012, CURR NEUROL NEUROSCI, V12, P118, DOI 10.1007/s11910-011-0247-2; Pareja JA, 2012, J HEADACHE PAIN, V13, P175, DOI 10.1007/s10194-011-0407-4; Parisi P, 2012, CEPHALALGIA, V32, P723, DOI 10.1177/0333102412447536; Parisi P, 2010, EPILEPSIA, V51, P932, DOI 10.1111/j.1528-1167.2009.02407.x; Parissis D, 2011, HEADACHE, V51, P1285, DOI 10.1111/j.1526-4610.2011.01884.x; Pascual J, 1996, NEUROLOGY, V46, P1520, DOI 10.1212/WNL.46.6.1520; PASCUAL J, 1993, CEPHALALGIA, V13, P205, DOI 10.1046/j.1468-2982.1993.1303205.x; Pascual J, 2008, J HEADACHE PAIN, V9, P259, DOI 10.1007/s10194-008-0063-5; Pascual Julio, 2005, Curr Pain Headache Rep, V9, P272, DOI 10.1007/s11916-005-0036-1; Pascual-Castroviejo I, 2008, CAN J NEUROL SCI, V35, P301, DOI 10.1017/S0317167100008878; Patel A, 2002, NEUROSURGERY, V50, P705, DOI 10.1097/00006123-200204000-00004; Patil SA, 2012, J IMMUNOASS IMMUNOCH, V33, P140, DOI 10.1080/15321819.2011.606862; Patton LL, 2007, ORAL SURG ORAL MED O, V103, P1; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; PEARCE J, 1971, J NEUROL NEUROSUR PS, V34, P154, DOI 10.1136/jnnp.34.2.154; Pearce JMS, 1996, J NEUROL NEUROSUR PS, V61, P324, DOI 10.1136/jnnp.61.3.324; Peng KP, 2011, CEPHALALGIA, V31, P1561, DOI 10.1177/0333102411424620; Peres MFP, 2011, CEPHALALGIA, V31, P250, DOI 10.1177/0333102410383588; Peres MFP, 2006, EXPERT OPIN INV DRUG, V15, P367, DOI 10.1517/13543784.15.4.367; Perini F, 1998, CEPHALALGIA, V18, P493, DOI 10.1046/j.1468-2982.1998.1807493.x; Perucca P, 2010, NEUROLOGY, V75, P373, DOI 10.1212/WNL.0b013e3181ea1612; PESTRONK A, 1983, NEW ENGL J MED, V308, P226; PFAFFENRATH V, 1993, CEPHALALGIA, V13, P84, DOI 10.1177/0333102493013S1218; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Pinto A, 2001, ORAL SURG ORAL MED O, V92, P180, DOI 10.1067/moe.2001.114006; Poceta JS, 1995, HEADACHE, V35, P586, DOI 10.1111/j.1526-4610.1995.hed3510586.x; Polycarpou N, 2005, INT ENDOD J, V38, P169, DOI 10.1111/j.1365-2591.2004.00923.x; PONEPRASERT B, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P599; Porcelli M. Jay, 1995, Journal of the American Osteopathic Association, V95, P718; PORTENOY RK, 1984, STROKE, V15, P1009, DOI 10.1161/01.STR.15.6.1009; Poulikakos P J, 2010, J Infect Public Health, V3, P192, DOI 10.1016/j.jiph.2010.09.006; Prakash S, 2010, J HEADACHE PAIN, V11, P59, DOI 10.1007/s10194-009-0171-x; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Pulec Jack L, 2002, Ear Nose Throat J, V81, P30; Putzki N, 2009, EUR J NEUROL, V16, P262, DOI 10.1111/j.1468-1331.2008.02406.x; Queiroz LP, 2011, CEPHALALGIA, V31, P1652, DOI 10.1177/0333102411430263; Queral-Godoy E, 2006, J ORAL MAXIL SURG, V64, P402, DOI 10.1016/j.joms.2005.11.010; Radat F, 2005, CEPHALALGIA, V25, P165, DOI 10.1111/j.1468-2982.2004.00839.x; Radat F, 1999, HEADACHE, V39, P477, DOI 10.1046/j.1526-4610.1999.3907477.x; Radat F, 2000, REV NEUROL S4, V156, p4S62; Radat F, 2011, HEADACHE, V51, P789, DOI 10.1111/j.1526-4610.2011.01883.x; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rains JC, 2001, CEPHALALGIA, V21, P584, DOI 10.1046/j.1468-2982.2001.00210.x; RAMADAN NM, 1995, HEADACHE, V35, P21, DOI 10.1111/j.1526-4610.1995.hed3501021.x; RAMADAN NM, 1991, NEUROLOGY, V41, P1084, DOI 10.1212/WNL.41.7.1084; RamirezLassepas M, 1997, ARCH NEUROL-CHICAGO, V54, P1506, DOI 10.1001/archneur.1997.00550240058013; Rapoport A, 1996, HEADACHE, V36, P14, DOI 10.1046/j.1526-4610.1996.3601014.x; RAPS EC, 1993, ARCH NEUROL-CHICAGO, V50, P265, DOI 10.1001/archneur.1993.00540030031010; Rashed H, 1999, DIGEST DIS SCI, V44, p74S; RASKIN NH, 1988, HEADACHE, V28, P534, DOI 10.1111/j.1526-4610.1988.hed2808534.x; RASKIN NH, 1995, NEUROLOGY, V45, P1784, DOI 10.1212/WNL.45.9.1784; RASKIN NH, 1990, HEADACHE, V30, P550, DOI 10.1111/j.1526-4610.1990.hed30s2550.x; RASKIN NH, 1976, HEADACHE, V16, P222, DOI 10.1111/j.1526-4610.1976.hed1605222.x; RASKIN NH, 1980, NEUROLOGY, V30, P203, DOI 10.1212/WNL.30.2.203; RASMUSSEN BK, 1991, CEPHALALGIA, V11, P129, DOI 10.1046/j.1468-2982.1991.1103129.x; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RASMUSSEN P, 1991, ACTA NEUROCHIR, V108, P100, DOI 10.1007/BF01418516; RASMUSSEN P, 1991, ACTA NEUROCHIR, V108, P53, DOI 10.1007/BF01407667; RASMUSSEN P, 1990, ACTA NEUROCHIR, V107, P121, DOI 10.1007/BF01405790; Relja G, 2005, CEPHALALGIA, V25, P56, DOI 10.1111/j.1468-2982.2004.00808.x; Renton T, 2010, BRIT DENT J, V209, DOI 10.1038/sj.bdj.2010.978; Renton T, 2011, J OROFAC PAIN, V25, P333; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Riederer F, 2010, J HEADACHE PAIN, V11, P335, DOI 10.1007/s10194-010-0207-2; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rinaldi R, 1997, HEADACHE, V37, P443, DOI 10.1046/j.1526-4610.1997.3707443.x; Robbins MS, 2010, NEUROLOGY, V74, P1358, DOI 10.1212/WNL.0b013e3181dad5de; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Rocha Filho P, 2010, J STROKE CEREBROVASC, V30, P509; Rocha PAS, 2008, CEPHALALGIA, V28, P41, DOI 10.1111/j.1468-2982.2007.01465.x; Rocha-Filho PAS, 2010, CEPHALALGIA, V30, P560, DOI 10.1111/j.1468-2982.2009.02010.x; Rogawski MA, 2008, ARCH NEUROL-CHICAGO, V65, P709, DOI 10.1001/archneur.65.6.709; Romberg MH, 1840, LEHRBUCH NERVENKRANK; Rosman NP, 2009, J CHILD NEUROL, V24, P155, DOI 10.1177/0883073808322338; Rothrock JF, 1997, NEUROLOGY, V48, P261, DOI 10.1212/WNL.48.1.261; ROTHROCK JF, 1988, ARCH NEUROL-CHICAGO, V45, P63, DOI 10.1001/archneur.1988.00520250069023; ROWSELL AR, 1973, HEADACHE, V13, P65; Rozen TD, 2006, CEPHALALGIA, V26, P1182, DOI 10.1111/j.1468-2982.2006.01187.x; Rozen T, 2007, HEADACHE, V47, P1050, DOI 10.1111/j.1526-4610.2006.00722.x; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ruscheweyh R, 2010, CEPHALALGIA, V30, P249, DOI 10.1111/j.1468-2982.2009.01893.x; RUSHTON JG, 1981, ARCH NEUROL-CHICAGO, V38, P201, DOI 10.1001/archneur.1981.00510040027002; Russell George, 2002, Paediatr Drugs, V4, P1; Russell MB, 1996, EUR J NEUROL, V3, P424, DOI 10.1111/j.1468-1331.1996.tb00243.x; Russell MB, 1996, CEPHALALGIA, V16, P431, DOI 10.1046/j.1468-2982.1996.1606431.x; RUSSELL MB, 1995, J MED GENET, V32, P954, DOI 10.1136/jmg.32.12.954; SAGE JI, 1985, NEUROLOGY, V35, P1470, DOI 10.1212/WNL.35.10.1470; Salhofer-Polanyi S, 2012, HEADACHE, V52, P1236, DOI 10.1111/j.1526-4610.2012.02166.x; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.21226; San-Juan OD, 2007, CEPHALALGIA, V27, P456, DOI 10.1111/j.1468-2982.2007.01307.x; Sanahuja J, 2005, CEPHALALGIA, V25, P547, DOI 10.1111/j.1468-2982.2005.00882.x; Sances G, 2009, EPILEPSIA, V50, P2487, DOI 10.1111/j.1528-1167.2009.02265.x; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Sandstrom M, 2001, OCCUP MED-OXFORD, V51, P25, DOI 10.1093/occmed/51.1.25; SANTONI JR, 1993, INTERNAL MED, V32, P530, DOI 10.2169/internalmedicine.32.530; Saper JR, 1983, NEUROL CLIN, V1, P465; Sardella A, 2009, Minerva Stomatol, V58, P289; Sardella A, 2012, ARCH ORAL BIOL, V57, P94, DOI 10.1016/j.archoralbio.2011.07.007; SARKOZI J, 1984, ARTHRITIS RHEUM, V27, P708, DOI 10.1002/art.1780270618; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Sauerbrei A, 2002, J CLIN VIROL, V25, pS45, DOI 10.1016/S1386-6532(02)00033-1; Savage COS, 2000, BRIT MED J, V320, P1325, DOI 10.1136/bmj.320.7245.1325; Scala A, 2003, CRIT REV ORAL BIOL M, V14, P275, DOI 10.1177/154411130301400405; SCHACHTER SC, 1995, J EPILEPSY, V8, P41, DOI 10.1016/0896-6974(94)00007-M; Schaller B, 2003, OTOLARYNG HEAD NECK, V128, P387, DOI 10.1067/mhn.2003.104; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Scherer A, 2001, ROFO-FORTSCHR RONTG, V173, P315, DOI 10.1055/s-2001-12464; Schievink WI, 2008, AM J NEURORADIOL, V29, P853, DOI 10.3174/ajnr.A0956; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Schievink WI, 2011, HEADACHE, V51, P1442, DOI 10.1111/j.1526-4610.2011.01911.x; Schiffman E, 2013, J OROFACIAL IN PRESS; Schiffman E, 2012, CEPHALALGIA, V32, P683, DOI 10.1177/0333102412446312; SCHIFFMAN SS, 1987, NEW ENGL J MED, V317, P1181, DOI 10.1056/NEJM198711053171903; Schmidt-Hansen PT, 2007, PAIN, V129, P113, DOI 10.1016/j.pain.2006.09.037; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; SCHNIDER P, 1994, CEPHALALGIA, V14, P162, DOI 10.1046/j.1468-2982.1994.1402162.x; Schnider P, 1996, CEPHALALGIA, V16, P481, DOI 10.1046/j.1468-2982.1996.1607481.x; SCHOENEN J, 1991, CEPHALALGIA, V11, P135, DOI 10.1046/j.1468-2982.1991.1103135.x; SCHOENEN J, 1991, PAIN, V47, P145, DOI 10.1016/0304-3959(91)90198-7; SCHON F, 1987, J NEUROL NEUROSUR PS, V50, P1148, DOI 10.1136/jnnp.50.9.1148; Schoonman GG, 2006, CEPHALALGIA, V26, P1209, DOI 10.1111/j.1468-2982.2006.01195.x; Schoonman GG, 2006, CEPHALALGIA, V26, P816, DOI 10.1111/j.1468-2982.2006.01112.x; Schoser BGH, 1997, J NEUROL, V244, P101, DOI 10.1007/s004150050057; Schulz UG, 2009, STROKE, V40, P3740, DOI 10.1161/STROKEAHA.109.558163; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1001/jama.279.5.381; Schwedt TJ, 2006, HEADACHE, V46, P520, DOI 10.1111/j.1526-4610.2006.00386_3.x; Schwedt Todd J, 2007, Curr Pain Headache Rep, V11, P56, DOI 10.1007/s11916-007-0023-9; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Seiden AM, 2001, OTOLARYNG CLIN N AM, V34, P227, DOI 10.1016/S0030-6665(05)70308-X; Selekler HM, 2004, CEPHALALGIA, V24, P293, DOI 10.1111/j.1468-2982.2004.00674.x; Selekler HM, 2004, EUR NEUROL, V51, P6, DOI 10.1159/000074910; Seller EM, 1998, CLIN PHARMACOL THER, V63, P121; SELLICK JA, 1989, J AM OSTEOPATH ASSOC, V89, P806; SELTZER S, 1982, CEPHALALGIA, V2, P111, DOI 10.1046/j.1468-2982.1982.0202111.x; Serrano-Duenas Marcos, 2007, Expert Rev Neurother, V7, P245, DOI 10.1586/14737175.7.3.245; Seven H, 2005, EUR ARCH OTO-RHINO-L, V262, P847, DOI 10.1007/s00405-004-0903-0; SEYMOUR JJ, 1995, AM J EMERG MED, V13, P43, DOI 10.1016/0735-6757(95)90240-6; SHARIF AA, 1995, NEUROLOGY, V45, P1929, DOI 10.1212/WNL.45.10.1929; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sheftell FD, 2007, NEUROL SCI, V28, pS203, DOI 10.1007/s10072-007-0777-1; Shin JH, 2007, CEPHALALGIA, V27, P1101, DOI 10.1111/j.1468-2982.2007.01395.x; Shoja MM, 2010, CHILD NERV SYST, V26, P373, DOI 10.1007/s00381-009-0965-9; SHUAIB A, 1988, ARCH NEUROL-CHICAGO, V45, P911, DOI 10.1001/archneur.1988.00520320109024; SHUAIB A, 1989, CEPHALALGIA, V9, P59, DOI 10.1046/j.1468-2982.1989.0901059.x; SICUTERI F, 1987, HEADACHE, V27, P180, DOI 10.1111/j.1526-4610.1987.hed2704180.x; Sidman R, 1996, ACAD EMERG MED, V3, P827, DOI 10.1111/j.1553-2712.1996.tb03526.x; Siegel AM, 1999, EPILEPSIA, V40, P845, DOI 10.1111/j.1528-1157.1999.tb00790.x; Silber E, 2003, NEUROLOGY, V60, P1167, DOI 10.1212/01.WNL.0000055876.26737.B9; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Silberstein SD, 1996, NEUROLOGY, V47, P871, DOI 10.1212/WNL.47.4.871; SILBERSTEIN SD, 1994, HEADACHE, V34, P1, DOI 10.1111/j.1526-4610.1994.hed3401001.x; Silberstein SD, 2000, NEUROLOGY, V54, P219, DOI 10.1212/WNL.54.1.219; SILBERT PL, 1991, J NEUROL NEUROSUR PS, V54, P417, DOI 10.1136/jnnp.54.5.417; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; SINGER JI, 1980, J PEDIATR-US, V96, P559, DOI 10.1016/S0022-3476(80)80866-3; Singh RR, 2009, INDIAN J PEDIATR, V76, P1109, DOI 10.1007/s12098-009-0233-8; Singhal AB, 2011, ARCH NEUROL-CHICAGO, V68, P1005, DOI 10.1001/archneurol.2011.68; Sjaastad O, 1997, FUNCT NEUROL, V12, P305; Sjaastad O, 2008, ACTA NEUROL SCAND, V117, P173, DOI 10.1111/j.1600-0404.2007.00962.x; Sjaastad O, 2005, CEPHALALGIA, V25, P581, DOI 10.1111/j.1468-2982.2005.00927.x; Sjaastad O, 2003, CEPHALALGIA, V23, P803, DOI 10.1046/j.1468-2982.2003.00588.x; Sjaastad O, 2002, CEPHALALGIA, V22, P784, DOI 10.1046/j.1468-2982.2002.00466.x; SJAASTAD O, 1974, HEADACHE, V14, P105; Sjaastad O, 2002, FUNCT NEUROL, V17, P35; SJAASTAD O, 1989, CEPHALALGIA, V9, P147, DOI 10.1046/j.1468-2982.1989.0902147.x; Sjaastad O, 2001, CEPHALALGIA, V21, P207, DOI 10.1046/j.1468-2982.2001.00189.x; Sjostrand C, 2000, CEPHALALGIA, V20, P653, DOI 10.1046/j.1468-2982.2000.00104.x; SLIVKA A, 1995, HEADACHE, V35, P1, DOI 10.1111/j.1526-4610.1995.hed3501001.x; Sliwka U, 1998, AVIAT SPACE ENVIR MD, V69, P299; Sluder G, 1910, AM J MED SCI, V140, P868, DOI 10.1097/00000441-191012000-00009; Smith M, 2002, NEUROLOGY, V58, P1308, DOI 10.1212/WNL.58.8.1308-a; Smitherman TA, 2008, CURR PAIN HEADACHE R, V12, P305, DOI 10.1007/s11916-008-0051-0; SOLOMON S, 1985, CEPHALALGIA, V5, P83, DOI 10.1046/j.1468-2982.1985.0502083.x; SOLOMON S, 1987, J AM GERIATR SOC, V35, P163, DOI 10.1111/j.1532-5415.1987.tb01348.x; Solomon S, 2001, ARCH NEUROL-CHICAGO, V58, P661, DOI 10.1001/archneur.58.4.661; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; SOMERVIL.BW, 1972, NEUROLOGY, V22, P355, DOI 10.1212/WNL.22.4.355; SOMERVILLE BW, 1975, NEUROLOGY, V25, P239, DOI 10.1212/WNL.25.3.239; SOMERVILLE BW, 1975, NEUROLOGY, V25, P245, DOI 10.1212/WNL.25.3.245; SOMERVILLE BW, 1971, NEUROLOGY, V21, P853, DOI 10.1212/WNL.21.8.853; Sonnesen L, 1998, EUR J ORTHODONT, V20, P543, DOI 10.1093/ejo/20.5.543; Soriani S, 1996, HEADACHE, V36, P565, DOI 10.1046/j.1526-4610.1996.3609565.x; SPITZER WO, 1995, SPINE, V20, pS1; Sprenger T, 2010, J CLIN NEUROSCI, V17, P547, DOI 10.1016/j.jocn.2009.09.030; Stewart W, 2001, CEPHALALGIA, V21, P279; Stosch RSV, 2008, CEPHALALGIA, V28, P908, DOI 10.1111/j.1468-2982.2008.01633_1.x; Stovner LJ, 2009, EUR J NEUROL, V16, pE14, DOI 10.1111/j.1468-1331.2008.02359.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; STRAUBE A, 1993, HEADACHE, V33, P446, DOI 10.1111/j.1526-4610.1993.hed3308446.x; Sturm JW, 2000, CEPHALALGIA, V20, P132, DOI 10.1046/j.1468-2982.2000.00053.x; STURZENEGGER M, 1994, HEADACHE, V34, P187, DOI 10.1111/j.1526-4610.1994.hed3404187.x; STURZENEGGER MH, 1985, HEADACHE, V25, P408; SWANSON JW, 1978, NEUROLOGY, V28, P782, DOI 10.1212/WNL.28.8.782; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Syvertsen M, 2007, J HEADACHE PAIN, V8, P224, DOI 10.1007/s10194-007-0398-3; Szatmary Z, 2006, J NEUROL NEUROSUR PS, V77, P693, DOI 10.1136/jnnp.2005.082719; Takase Y, 2004, CEPHALALGIA, V24, P955, DOI 10.1111/j.1468-2982.2004.00771.x; Takeuchi S, 2010, J CLIN NEUROSCI, V17, P153, DOI 10.1016/j.jocn.2009.03.043; TARASOFF L, 1993, FOOD CHEM TOXICOL, V31, P1019, DOI 10.1016/0278-6915(93)90012-N; Tatrow K, 2003, HEADACHE, V43, P755, DOI 10.1046/j.1526-4610.2003.03133.x; ter Berg HWM, 2001, HEADACHE, V41, P326; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; TFELTHANSEN P, 1981, CEPHALALGIA, V1, P29, DOI 10.1111/j.1468-2982.1981.tb00005.x; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thibault M, 2007, CAN J ANAESTH, V54, P544, DOI 10.1007/BF03022318; Thielen KR, 1998, MAYO CLIN PROC, V73, P444; Thiessen Paul N, 2002, Pediatr Rev, V23, P39, DOI 10.1542/pir.23-2-39; THOMAS JE, 1966, J AMER MED ASSOC, V197, P754, DOI 10.1001/jama.197.10.754; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Thomsen LL, 2003, NEUROLOGY, V60, P595, DOI 10.1212/01.WNL.0000046524.25369.7D; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Thomsen LL, 1994, EUR J NEUROL, V1, P71; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tietjen GE, 2000, NEUROEPIDEMIOLOGY, V19, P13, DOI 10.1159/000026233; Tolle Thomas, 2006, Pain Pract, V6, P153, DOI 10.1111/j.1533-2500.2006.00079.x; TONJUM T, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P175; Tosun F, 2000, HEADACHE, V40, P237, DOI 10.1046/j.1526-4610.2000.00034.x; Troost T, 2000, HEADACHES, P511; Wyngaarden JB, 1992, CECILS TXB MED, P1310; TROOST BT, 1979, ANN NEUROL, V5, P199, DOI 10.1002/ana.410050216; Tuveson B, 2009, PAIN, V143, P84, DOI 10.1016/j.pain.2009.02.002; TYCHSEN L, 1984, OPHTHALMOLOGY, V91, P1075; Tzourio C, 2002, NEUROLOGY, V59, P435, DOI 10.1212/WNL.59.3.435; Tzourio C, 2000, CEPHALALGIA, V20, P190, DOI 10.1046/j.1468-2982.2000.00041.x; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vahedi K, 2007, NEUROLOGY, V69, P1564, DOI 10.1212/01.wnl.0000295994.46586.e7; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57; Vail HH, 1932, ANN OTO RHINOL LARYN, V41, P837; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; VANAST WJ, 1986, HEADACHE, V26, P317; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VANDUSSELDORP M, 1990, BRIT MED J, V300, P1558, DOI 10.1136/bmj.300.6739.1558; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3; Vein AA, 2009, CEPHALALGIA, V29, P683, DOI 10.1111/j.1468-2982.2008.01775.x; Velioglu SK, 1999, CEPHALALGIA, V19, P797, DOI 10.1046/j.1468-2982.1999.1909797.x; Verdelho A, 2008, CEPHALALGIA, V28, P346, DOI 10.1111/j.1468-2982.2007.01514.x; VERNAY D, 1989, HEADACHE, V29, P350, DOI 10.1111/j.1526-4610.1989.hed2906350.x; Verrotti A, 2011, EPILEPSY BEHAV, V21, P52, DOI 10.1016/j.yebeh.2011.03.004; Versino M, 2003, FUNCT NEUROL, V18, P97; VERWEIJ RD, 1988, ARCH NEUROL-CHICAGO, V45, P1019, DOI 10.1001/archneur.1988.00520330109018; VIJAYAN N, 1995, HEADACHE, V35, P98, DOI 10.1111/j.1526-4610.1995.hed3502098.x; Voigt K, 2010, J PSYCHOSOM RES, V68, P403, DOI 10.1016/j.jpsychores.2010.01.015; VONKORFF M, 1995, PAIN, V62, P179, DOI 10.1016/0304-3959(94)00263-E; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WAIND APB, 1956, BRIT MED J, V1, P901, DOI 10.1136/bmj.1.4972.901; WALKER J, 1993, SOUTHERN MED J, V86, P1202, DOI 10.1097/00007611-199311000-00002; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Wang SJ, 2010, CURR PAIN HEADACHE R, V14, P41, DOI 10.1007/s11916-009-0083-0; Wang YF, 2008, CEPHALALGIA, V28, P1298, DOI 10.1111/j.1468-2982.2008.01679.x; Wasay M, 2010, J HEADACHE PAIN, V11, P137, DOI 10.1007/s10194-010-0186-3; WATSON P, 1985, HEADACHE, V25, P123, DOI 10.1111/j.1526-4610.1985.hed2503123.x; Wei JH, 2008, CEPHALALGIA, V28, P892, DOI 10.1111/j.1468-2982.2008.01590.x; WEINKE T, 1989, J NEUROL, V236, P38, DOI 10.1007/BF00314216; Weir B, 1998, SUBARACHNOID HEMORRH, P144; Weiss AH, 2004, PEDIATR NEUROL, V30, P64, DOI 10.1016/S0887-8994(03)00424-7; WEISS NS, 1972, NEW ENGL J MED, V287, P631, DOI 10.1056/NEJM197209282871303; Welch KMA, 1999, DIGEST DIS SCI, V44, p26S; West B, 2001, LARYNGOSCOPE, V111, P581, DOI 10.1097/00005537-200104000-00006; Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9; WIJDICKS EFM, 1988, LANCET, V2, P1020; Wijman CAC, 1998, STROKE, V29, P1539, DOI 10.1161/01.STR.29.8.1539; Wilker SC, 2009, BRIT J OPHTHALMOL, V93, P1657, DOI 10.1136/bjo.2008.155150; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Witham TF, 2000, AM J EMERG MED, V18, P88, DOI 10.1016/S0735-6757(00)90058-5; Woda A, 1999, J OROFAC PAIN, V13, P172; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yang WH, 1997, J ALLERGY CLIN IMMUN, V99, P757, DOI 10.1016/S0091-6749(97)80008-5; Yanguela J, 2004, NEUROLOGY, V62, P1134, DOI 10.1212/01.WNL.0000118841.97273.5D; Yanguela J, 2002, NEUROLOGY, V58, P802, DOI 10.1212/WNL.58.5.802; Yankovsky AE, 2005, EPILEPSIA, V46, P1241, DOI 10.1111/j.1528-1167.2005.64804.x; Yeh YC, 2010, CEPHALALGIA, V30, P1329, DOI 10.1177/0333102410364675; YEN PT, 1995, OTOLARYNG HEAD NECK, V113, P15, DOI 10.1016/S0194-5998(95)70139-7; YOUNG GB, 1983, BRAIN, V106, P537, DOI 10.1093/brain/106.3.537; Young WB, 2010, NEUROLOGY, V74, P1338, DOI 10.1212/WNL.0b013e3181de7fb9; Yutzy S, 2003, PSYCHIATRY, P1419; Zakrzewska JM, 2002, CLIN J PAIN, V18, P14, DOI 10.1097/00002508-200201000-00003; Zampaglione B, 1996, HYPERTENSION, V27, P144, DOI 10.1161/01.HYP.27.1.144; Zaragoza-Casares P, 2009, HEADACHE, V49, P476, DOI 10.1111/j.1526-4610.2008.01259.x; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P1, DOI 10.1097/00001199-199902000-00003; Zeeberg P, 2009, CEPHALALGIA, V29, P214, DOI 10.1111/j.1468-2982.2008.01710.x; Zeeberg P, 2006, NEUROLOGY, V66, P1894, DOI 10.1212/01.wnl.0000217914.30994.bd; Zhang S R, 1989, Zhonghua Nei Ke Za Zhi, V28, P202; Zukerman E, 2000, NEUROLOGY, V54, P1524, DOI 10.1212/WNL.54.7.1524	1072	3398	3488	18	247	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JUL	2013	33	9					629	808		10.1177/0333102413485658			180	Clinical Neurology; Neurosciences	Neurosciences & Neurology	163WI	WOS:000320368000002	23771276	Green Accepted	Y	N	2021-06-18	
J	Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB				Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB			ATP mediates rapid microglial response to local brain injury in vivo	NATURE NEUROSCIENCE			English	Article							ASTROCYTES; CELLS; ACTIVATION; RELEASE; PROTEIN; EXPRESSION; MOTILITY	Parenchymal microglia are the principal immune cells of the brain. Time-lapse two-photon imaging of GFP-labeled microglia demonstrates that the fine termini of microglial processes are highly dynamic in the intact mouse cortex. Upon traumatic brain injury, microglial processes rapidly and autonomously converge on the site of injury without cell body movement, establishing a potential barrier between the healthy and injured tissue. This rapid chemotactic response can be mimicked by local injection of ATP and can be inhibited by the ATP-hydrolyzing enzyme apyrase or by blockers of G protein - coupled purinergic receptors and connexin channels, which are highly expressed in astrocytes. The baseline motility of microglial processes is also reduced significantly in the presence of apyrase and connexin channel inhibitors. Thus, extracellular ATP regulates microglial branch dynamics in the intact brain, and its release from the damaged tissue and surrounding astrocytes mediates a rapid microglial response towards injury.	NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program, New York, NY 10016 USA	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; Davalos, Dimitrios/G-8627-2011; Grutzendler, Jaime/F-3691-2010; Jung, Steffen/K-1409-2012	Davalos, Dimitrios/0000-0001-9038-6688; Jung, Steffen/0000-0003-4290-5716; Yang, Guang/0000-0002-5739-9126; Dustin, Michael/0000-0003-4983-6389			Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.3.CO;2-0; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; SMITH SJ, 1990, SYMP MED H, V23, P49; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	40	2192	2254	14	223	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					752	758		10.1038/nn1472			7	Neurosciences	Neurosciences & Neurology	929KP	WOS:000229345300015	15895084				2021-06-18	
J	Hoge, CW; McGurk, D; Thomas, JL; Cox, AL; Engel, CC; Castro, CA				Hoge, Charles W.; McGurk, Dennis; Thomas, Jeffrey L.; Cox, Anthony L.; Engel, Charles C.; Castro, Carl A.			Mild traumatic brain injury in US Soldiers returning from Iraq	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; MENTAL-HEALTH PROBLEMS; GULF-WAR; AFGHANISTAN; CONCUSSION; DEPRESSION; DEPLOYMENT; ILLNESS; CARE	Background: An important medical concern of the Iraq war is the potential long-term effect of mild traumatic brain injury, or concussion, particularly from blast explosions. However, the epidemiology of combat-related mild traumatic brain injury is poorly understood. Methods: We surveyed 2525 U.S. Army infantry soldiers 3 to 4 months after their return from a year-long deployment to Iraq. Validated clinical instruments were used to compare soldiers reporting mild traumatic brain injury, defined as an injury with loss of consciousness or altered mental status (e.g., dazed or confused), with soldiers who reported other injuries. Results: Of 2525 soldiers, 124 (4.9%) reported injuries with loss of consciousness, 260 (10.3%) reported injuries with altered mental status, and 435 (17.2%) reported other injuries during deployment. Of those reporting loss of consciousness, 43.9% met criteria for post-traumatic stress disorder (PTSD), as compared with 27.3% of those reporting altered mental status, 16.2% with other injuries, and 9.1% with no injury. Soldiers with mild traumatic brain injury, primarily those who had loss of consciousness, were significantly more likely to report poor general health, missed workdays, medical visits, and a high number of somatic and postconcussive symptoms than were soldiers with other injuries. However, after adjustment for PTSD and depression, mild traumatic brain injury was no longer significantly associated with these physical health outcomes or symptoms, except for headache. Conclusions: Mild traumatic brain injury (i.e., concussion) occurring among soldiers deployed in Iraq is strongly associated with PTSD and physical health problems 3 to 4 months after the soldiers return home. PTSD and depression are important mediators of the relationship between mild traumatic brain injury and physical health problems.	[Hoge, Charles W.; McGurk, Dennis; Thomas, Jeffrey L.; Cox, Anthony L.; Castro, Carl A.] USA, Div Psychiat & Neurosci, Walter Reed Army Inst Res, Med Res & Mat Command, Silver Spring, MD 20910 USA; [Engel, Charles C.] Deployment Hlth Clin Ctr, Washington, DC USA; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, Washington, DC USA	Hoge, CW (corresponding author), USA, Div Psychiat & Neurosci, Walter Reed Army Inst Res, Med Res & Mat Command, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	charles.hoge@us.army.mil		McGurk, Dennis/0000-0003-4126-5980			BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BLIESE PD, IN PRESS J CONSULT C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; *DEF VET BRAIN INJ, 3 QUEST DVBIC TBI SC; *DEP VET AFF, 2007, VHA DIR 2007 013 SCR; Engel C.C., 1999, STRATEGIES PROTECT H, P173; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; GLASSER R, 2008, WASHINGTON POST 0418, pB1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V296, P2678, DOI 10.1001/jama.296.22.2678-b; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; *IND REV GROUP, 2007, REB TRUST REP REH CA; Jones E, 2002, BRIT MED J, V324, P397; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Katon WJ, 2006, J TRAUMA STRESS, V19, P611, DOI 10.1002/jts.20147; Kroenke K, 2003, INT J METH PSYCH RES, V12, P34, DOI 10.1002/mpr.140; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; MEARES S, IN PRESS J NEUROL NE; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; *VET HLTH ADM, 2001, CLIN PRACT GUID POST; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	50	1863	1878	6	312	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					453	463		10.1056/NEJMoa072972			11	Medicine, General & Internal	General & Internal Medicine	256IW	WOS:000252722900003	18234750				2021-06-18	
J	GRONWALL, DMA				GRONWALL, DMA			PACED AUDITORY SERIAL-ADDITION TASK - MEASURE OF RECOVERY FROM CONCUSSION	PERCEPTUAL AND MOTOR SKILLS			English	Article									AUCKLAND HOSP,DEPT NEUROSURG,AUCKLAND,NEW ZEALAND							AKERLUND E, 1953, ACTA CHIR SCAND S174; CAIRNS H, 1942, P ROY SOC MED, V35, P299; GRONWALL D, 1974, LANCET, P605; GRONWALL D, 1974, PSYCHOLOGICAL EFFECT; GRONWALL D, 1975, LANCET          1122, P995; GRONWALL DMA, IN PRESS; Landy P J, 1968, Proc Aust Assoc Neurol, V5, P463; LIDVALL HF, 1974, ACTA NEUROL SCAN S56, V50; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; SAMPSON H, 1961, AUST J PSYCHOL, V13, P185, DOI 10.1080/00049536108256002	10	1654	1665	0	77	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills		1977	44	2					367	373		10.2466/pms.1977.44.2.367			7	Psychology, Experimental	Psychology	DD984	WOS:A1977DD98400006	866038				2021-06-18	
J							Alzheimers Assoc	Alzheimer's Association Report 2015 Alzheimer's disease facts and figures	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Dementia; Diagnostic criteria; Prevalence; Incidence; Mortality; Morbidity; Caregivers; Family caregiver; Spouse caregiver; Sandwich generation caregiver; Health care costs; Health care expenditures; Long-term care costs; Medicare spending; Medicaid spending; Disclosure awareness; Disclosure practices; Medicare Current Beneficiary Survey (MCBS); Activities of daily living (ADLs); Instrumental activities of daily living (IADLs)	MILD COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED COHORT; NURSING-HOME RESIDENTS; TRAUMATIC BRAIN-INJURY; VASCULAR RISK-FACTORS; OF-LIFE CARE; DEMENTIA CAREGIVER INTERVENTION; SHARED DECISION-MAKING; EARLY-STAGE DEMENTIA	This report discusses the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, costs of care and the overall effect on caregivers and society. It also examines the challenges encountered by health care providers when disclosing an AD diagnosis to patients and caregivers. An estimated 5.3 million Americans have AD; 5.1 million are age >= 65 years, and approximately 200,000 are age <65 years and have younger onset AD. By mid-century, the number of people living with AD in the United States is projected to grow by nearly 10 million, fueled in large part by the aging baby boom generation. Today, someone in the country develops AD every 67 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, resulting in nearly 1 million new cases per year, and the estimated prevalence is expected to range from 11 million to 16 million In 2013, official death certificates recorded 84,767 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age >= 65 years. Between 2000 and 2013, deaths resulting from heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, whereas deaths from AD increased 71%. The actual number of deaths to which AD contributes (or deaths with AD) is likely much larger than the number of deaths from AD recorded on death certificates. In 2015, an estimated 700,000 Americans age >= 65 years will die with AD, and many of them will die from complications caused by AD. In 2014, more than 15 million family members and other unpaid caregivers provided an estimated 17.9 billion hours of care to people with AD and other dementias, a contribution valued at more than $217 billion. Average per-person Medicare payments for services to beneficiaries age >= 65 years with AD and other dementias are more than two and a half times as great as payments for all beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2015 for health care, long-term care and hospice services for people age >= 65 years with dementia are expected to be $226 billion. Among people with a diagnosis of AD or another dementia, fewer than half report having been told of the diagnosis by their health care provider. Though the benefits of a prompt, clear and accurate disclosure of an AD diagnosis are recognized by the medical profession, improvements to the disclosure process are needed. These improvements may require stronger support systems for health care providers and their patients.								AARP Public Policy Institute, 2009, 50 09 CHRON CAR CALL; Acton GJ, 2001, RES NURS HEALTH, V24, P349, DOI 10.1002/nur.1036; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert S. M., 2010, METLIFE STUDY WORKIN; Allen M, 2005, EDUC GERONTOL, V31, P521, DOI 10.1080/03601270590962497; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer Europe, DISCL DIAGN PEOPL DE; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Alzheimer's Association, 2015, TELL TRUTH DIAGN; Alzheimer's Disease Education and Referral Center, 2011, NIH PUBL; American Health Care Association, 2013, LTC STATS NURS FAC O; American Health Care Association, 2014, LTC STATS NURS FAC O; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Aneshensel C.S., 1995, PROFILES CAREGIVING; [Anonymous], 1997, Am J Psychiatry, V154, P1; [Anonymous], 2011, TABULATIONS BA UNPUB; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; Association of American Medical Colleges, 2012 PHYS SPEC DAT B; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bamford C, 2004, INT J GERIATR PSYCH, V19, P151, DOI 10.1002/gps.1050; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Barnes LL, 2003, NEUROLOGY, V60, P1777, DOI 10.1212/01.WNL.0000065892.67099.2A; Barrett AM, 2006, J AM GERIATR SOC, V54, P1968, DOI 10.1111/j.1532-5415.2006.00992.x; Bass DM, 2013, J AM GERIATR SOC, V61, P1377, DOI 10.1111/jgs.12362; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Batsch N.L., 2012, WORLD ALZHEIMER REPO; BAUMGARTEN M, 1992, J CLIN EPIDEMIOL, V45, P61, DOI 10.1016/0895-4356(92)90189-T; Beck C, 1999, INT J GERIATR PSYCH, V14, P197, DOI 10.1002/(SICI)1099-1166(199903)14:3<197::AID-GPS972>3.0.CO;2-Q; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Bloudek LM, 2011, J ALZHEIMERS DIS, V26, P627, DOI 10.3233/JAD-2011-110458; Borson S, 2014, CLIN GERIATR MED, V30, P395, DOI 10.1016/j.cger.2014.05.001; Bouldin ED, CAREGIVING US CAREGI; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Brody AA, 2013, GERONTOL GERIATR EDU, V34, P225, DOI 10.1080/02701960.2013.801342; BRODY EM, 1981, GERONTOLOGIST, V21, P471, DOI 10.1093/geront/21.5.471; Brody H, 2005, PRIMARY CARE, V32, P645, DOI 10.1016/j.pop.2005.06.004; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Burgio LD, 2009, GERONTOLOGIST, V49, P103, DOI 10.1093/geront/gnp012; BURNS A, 1990, AGE AGEING, V19, P341, DOI 10.1093/ageing/19.5.341; Callahan CM, 2014, HEALTH AFFAIR, V33, P626, DOI 10.1377/hlthaff.2013.1260; Callahan CM, 2012, J AM GERIATR SOC, V60, P813, DOI 10.1111/j.1532-5415.2012.03905.x; Campbell P, 2008, INT J GERIATR PSYCH, V23, P1078, DOI 10.1002/gps.2071; Carpenter B, 2004, GERONTOLOGIST, V44, P149, DOI 10.1093/geront/44.2.149; Carpenter BD, 2008, J AM GERIATR SOC, V56, P405, DOI 10.1111/j.1532-5415.2007.01600.x; Carter CL, 2012, J WOMENS HEALTH, V21, P1018, DOI 10.1089/jwh.2012.3789; Centers for Medicare and Medicaid Services, 2008, MOR CLASS LONG TERM; Centers for Medicare and Medicaid Services, 2012, CMS PUBL, V11347; Centers for Medicare and Medicaid Services Center for Strategic Planning., HLTH EXP STAT RES 19; Chassin L, 2010, J APPL DEV PSYCHOL, V31, P38, DOI 10.1016/j.appdev.2009.06.001; Chattillion EA, 2012, PSYCHOL HEALTH, V27, P1134, DOI 10.1080/08870446.2011.637559; Chene G, 2015, ALZHEIMERS DEMENT, V11, P310, DOI 10.1016/j.jalz.2013.10.005; Cheung KS, 2014, INT J GERIATR PSYCHI; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Clarfield AM, 2003, ARCH INTERN MED, V163, P2219, DOI 10.1001/archinte.163.18.2219; Clark PC, 2005, J AM GERIATR SOC, V53, P2012, DOI 10.1111/j.1532-5415.2005.53569.x; Cochrane Summaries, DEM CHRON COGN IMP; Connell CM, 2004, GERONTOLOGIST, V44, P500, DOI 10.1093/geront/44.4.500; Cornett PF, 2008, ARCH CLIN NEUROPSYCH, V23, P251, DOI 10.1016/j.acn.2008.01.001; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Czaja SJ, 2013, AM J GERIAT PSYCHIAT, V21, P1071, DOI 10.1016/j.jagp.2013.02.019; Dassel K. B., 2014, GERONTOLOGIST; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Derksen E, 2006, AGING MENT HEALTH, V10, P525, DOI 10.1080/13607860600638024; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Dilworth-Anderson P, 2008, ALZHEIMERS DEMENT, V4, P305, DOI 10.1016/j.jalz.2008.03.001; Doblhammer G, 2014, ALZH ASS IN IN PRESS; Dodge HH, 2014, J GERONTOL A-BIOL, V69, P687, DOI 10.1093/gerona/glt181; Douaud G, 2013, J NEUROSCI, V33, P2147, DOI 10.1523/JNEUROSCI.4437-12.2013; Eldercare Workforce Alliance, 2012, GER WORKF SHORT LOOM; Epstein-Lubow G, 2012, AM J GERIAT PSYCHIAT, V20, P815, DOI 10.1097/JGP.0b013e318235b62f; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feng ZL, 2014, HEALTH AFFAIR, V33, P683, DOI 10.1377/hlthaff.2013.1179; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Fisk JD, 2007, ALZHEIMERS DEMENT, V3, P404, DOI 10.1016/j.jalz.2007.07.008; Fitten LJ, 2001, J AM GERIATR SOC, V49, P1301, DOI 10.1046/j.1532-5415.2001.49257.x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fonareva I, 2014, INT PSYCHOGERIATR, V26, P725, DOI 10.1017/S1041610214000039; Fortinsky RH, 2004, GERONTOLOGIST, V44, P739, DOI 10.1093/geront/44.6.739; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fredman L, 2006, PREV MED, V43, P226, DOI 10.1016/j.ypmed.2006.04.009; Fredman L, 2010, J AM GERIATR SOC, V58, P937, DOI 10.1111/j.1532-5415.2010.02808.x; French DD, 2014, HEALTH AFFAIR, V33, P613, DOI 10.1377/hlthaff.2013.1221; Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5; Furney SJ, 2011, J ALZHEIMERS DIS, V26, P395, DOI 10.3233/JAD-2011-0044; Galluzzi S, 2013, J NEUROL, V260, P640, DOI 10.1007/s00415-012-6694-0; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Ganzini Linda, 2005, J Am Med Dir Assoc, V6, pS100, DOI 10.1016/j.jamda.2005.03.021; Garand L, 2014, AM J GERIAT PSYCHIAT, V22, P771, DOI 10.1016/j.jagp.2013.07.007; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Gaugler JE, 2002, INT J AGING HUM DEV, V54, P205, DOI 10.2190/FACK-QE61-Y2J8-5L68; Gaugler JE, 2008, DEMENTIA FAMILIES IN; Gaugler JE, 2014, CLIN GERIATR MED, V30, P493, DOI 10.1016/j.cger.2014.04.003; Gaugler JE, 2013, GERONTOLOGIST, V53, P985, DOI 10.1093/geront/gns193; Gaugler JE, 2011, AM J ALZHEIMERS DIS, V26, P218, DOI 10.1177/1533317511399570; Gaugler JE, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-85; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Geldmacher DS, 2013, APPL HEALTH ECON HEA, V11, P407, DOI 10.1007/s40258-013-0038-9; Genworth Financial Inc, GENW 2014 COST CAR S; Gillespie R., 2013, J CLIN NURS; Gilligan AM, 2013, AM J ALZHEIMERS DIS, V28, P84, DOI 10.1177/1533317512467679; Gitlin LN, 2010, GERONTOLOGIST, V50, P847, DOI 10.1093/geront/gnq057; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN., 2012, PUBLIC HLTH AGING SO, P181; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Gonyea JG, 2014, GERONTOLOGIST; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Griffin J. M., 2013, EFFECTIVENESS FAMILY; Grossberg GT., 2010, PRIM CARE COMPANION, V12; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; GUTTMAN R, 1999, DIAGNOSIS MANAGEMENT; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hammer LB, 2008, PSYCHOL-MANAG J, V11, P93, DOI 10.1080/10887150801967324; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Harrington M, PHYS ACTIVITY ALZRIS; HealthyPeople.gov, DEM INCL ALZH DIS; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Hebert LE, 2001, AM J EPIDEMIOL, V153, P132, DOI 10.1093/aje/153.2.132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Hepburn KW, 2003, GERONTOLOGIST, V43, P908, DOI 10.1093/geront/43.6.908; Hepburn KW, 2001, J AM GERIATR SOC, V49, P450, DOI 10.1046/j.1532-5415.2001.49090.x; HHS Office of the Assistant Secretary for Planning and Evaluation Office of Disability Aging and Long-Term Care Policy, 2012, LONG TERM CAR INS AS; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Holroyd S, 2002, INT J GERIATR PSYCH, V17, P218, DOI 10.1002/gps.552; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Honea RA, 2012, J ALZHEIMERS DIS, V31, P659, DOI 10.3233/JAD-2012-120676; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Horvath Kathy J, 2013, Int J Alzheimers Dis, V2013, P913606, DOI 10.1155/2013/913606; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iliffe S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-142; Institute for Social Research, 2009, NAT FOOTB LEAG PLAYE; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jacobson G, 2014, INCOME ASSETS MEDICA; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jellinger KA, 2007, ALZHEIMERS DEMENT, V3, P40, DOI 10.1016/j.jalz.2006.09.002; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jha A, 2001, INT J GERIATR PSYCH, V16, P879, DOI 10.1002/gps.412; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.06.001, 10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007]; Johnson R. W., 2006, PROFILE FRAIL OLDER; Jones Adrienne L, 2009, Vital Health Stat 13, P1; Judge KS, 2013, GERONTOLOGIST, V53, P280, DOI 10.1093/geront/gns076; Kaduszkiewicz H, 2008, PATIENT EDUC COUNS, V70, P220, DOI 10.1016/j.pec.2007.10.010; Kaiser Commission on Medicaid and the Uninsured, 2013, LONG TERM SERV SUPP; Kally Z, 2014, J GERONTOL SOC WORK, V57, P681, DOI 10.1080/01634372.2013.850584; Kally Z, 2014, J GERONTOL SOC WORK, V57, P710, DOI 10.1080/01634372.2013.854856; Kang JH, 2012, NEUROBIOL AGING, V33, P1129, DOI 10.1016/j.neurobiolaging.2010.10.007; Karnieli-Miller O, 2007, PATIENT EDUC COUNS, V67, P307, DOI 10.1016/j.pec.2007.03.014; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kasper J.D., 2013, 5 J HOPK U SCH PUBL; Kasper J F, 1992, QRB Qual Rev Bull, V18, P183; Kasper JD., 2014, DISABILITY CARE NEED; KATZMAN R, 1976, ARCH NEUROL-CHICAGO, V33, P217, DOI 10.1001/archneur.1976.00500040001001; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kivipelto M, 2013, ALZHEIMERS DEMENT, V9, P657, DOI 10.1016/j.jalz.2012.09.012; Klug MG, 2014, HEALTH AFFAIR, V33, P605, DOI 10.1377/hlthaff.2013.1061; Koch T, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-52; Kohler L, 2014, CURR ALZHEIMER RES, V11, P538, DOI 10.2174/1567205011666140618100727; Kramer NA., 2000, PROFESSIONAL PSYCHOL, P227; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lecouturier J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-95; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lim WS, 2005, ALZ DIS ASSOC DIS, V19, P214, DOI 10.1097/01.wad.0000189051.48688.ed; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Llanque SM, 2012, AM J ALZHEIMERS DIS, V27, P23, DOI 10.1177/1533317512439794; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Logsdon RG, 2008, LANCET, V372, P182, DOI 10.1016/S0140-6736(08)61048-X; Logsdon RG, 2007, PSYCHOL AGING, V22, P28, DOI 10.1037/0882-7974.22.1.28; Logsdon RG, 2010, J GERONTOL B-PSYCHOL, V65, P691, DOI 10.1093/geronb/gbq054; Long KH, 2014, HEALTH AFFAIR, V33, P596, DOI 10.1377/hlthaff.2013.1257; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Lykens K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089290; Maayan N, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004396.PUB3; MACERA CA, 1992, J AM GERIATR SOC, V40, P479, DOI 10.1111/j.1532-5415.1992.tb02015.x; Maguire CP, 1996, BRIT MED J, V313, P529, DOI 10.1136/bmj.313.7056.529; Maguire CP, 2002, INT PSYCHOGERIATR, V14, P123, DOI 10.1017/S1041610202008335; Manly J, 2004, CRITICAL PERSPECTIVE, P95; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Manton K C, 2005, Adv Gerontol, V16, P30; Marzanski M, 2000, J MED ETHICS, V26, P108, DOI 10.1136/jme.26.2.108; Marziali E, 2006, J AM MED DIR ASSOC, V7, P154, DOI 10.1016/j.jamda.2005.07.007; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mausbach BT, 2014, PSYCHOL AGING, V29, P776, DOI 10.1037/a0037626; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; Mausbach BT, 2012, HEALTH PSYCHOL, V31, P433, DOI 10.1037/a0027783; Mausbach BT, 2010, J AM COLL CARDIOL, V55, P2599, DOI 10.1016/j.jacc.2009.11.093; McCabe MP, 2007, AGING MENT HEALTH, V11, P505, DOI 10.1080/13607860601086405; McCaffrey R, 2013, J INTERPROF CARE, V27, P534, DOI 10.3109/13561820.2013.817384; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medicare Payment Advisory Commission (MedPAC), 2012, REP C MED PAYM POL L; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Menne HL, 2014, J GERONTOL SOC WORK, V57, P626, DOI 10.1080/01634372.2013.870276; Metlife Mature Market Institute, 2012, MARK SURV LONG TERM; MetLife Mature Market Institute and LifePlans Inc, 2006, METLIFE STUD ALZH DI; Meyers BS, 1997, BRIT MED J, V314, P321, DOI 10.1136/bmj.314.7077.321; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Mitchell G, 2006, GERONTOLOGIST, V46, P483, DOI 10.1093/geront/46.4.483; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mittelman M., 2013, CAREGIVING ALZHEIMER, P17; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Mittelman MS, 2014, HEALTH AFFAIR, V33, P587, DOI 10.1377/hlthaff.2013.1334; Mittelman MS, 2003, COUNSELING ALZHEIMER; Mollica RL, 2012, ASSISTED LIVING RESI; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moody's Investors Service, 2012, SPEC COMM LONG TERM; Moore RC, 2013, BEHAV RES THER, V51, P623, DOI 10.1016/j.brat.2013.07.005; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Narme P, 2014, J ALZHEIMERS DIS, V38, P359, DOI 10.3233/JAD-130893; National Alliance for Caregiving and AARP, 2009, CAR IN THE US; National Alliance for Caregiving and AARP, 2009, CAR US UNPUB; National Alliance for Caregiving and United Hospital Fund, 2005, YOUNG CAR US REP FIN; National Center for Health Statistics, 2013, NATL VITAL STAT REPO, V64; National Institutes of Health, TRAUMATIC BRAIN INJU; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Odenheimer G, 2013, AM J OCCUP THER, V67, P704, DOI 10.5014/ajot.2013.676004; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; OLICHNEY JM, 1995, J AM GERIATR SOC, V43, P890, DOI 10.1111/j.1532-5415.1995.tb05532.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Orgeta V, 2014, INT J GERIATR PSYCH, V29, P771, DOI 10.1002/gps.4060; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Ostwald SK, 1999, GERONTOLOGIST, V39, P299, DOI 10.1093/geront/39.3.299; Patterson CJS, 1999, CAN MED ASSOC J, V160, pS1; Peacock SC, 2013, PALLIAT SUPPORT CARE, V11, P155, DOI 10.1017/S1478951512000831; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Peng HL, 2013, PERSPECT PSYCHIATR C, V49, P135, DOI 10.1111/ppc.12005; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Phillips J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653598; Pinner G, 2003, INT PSYCHOGERIATR, V15, P279, DOI 10.1017/S1041610203009530; Pinner G, 2002, INT PSYCHOGERIATR, V14, P127, DOI 10.1017/S1041610202008347; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pope ND, 2012, J WOMEN AGING, V24, P242, DOI 10.1080/08952841.2012.639676; Port CL, 2005, GERONTOLOGIST, V45, P87, DOI 10.1093/geront/45.suppl_1.87; POST SG, 1995, J AM GERIATR SOC, V43, P1423, DOI 10.1111/j.1532-5415.1995.tb06625.x; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Pratt R., 2003, DEMENTIA, V2, P181, DOI 10.1177/; Pucci E, 2003, J MED ETHICS, V29, P51, DOI 10.1136/jme.29.1.51; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rami L, 2012, INT J GERIATR PSYCH, V27, P127, DOI 10.1002/gps.2696; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/nrneurol.2011.2; Reuben DB, 2013, J AM GERIATR SOC, V61, P2214, DOI 10.1111/jgs.12562; Rice K, 1997, BRIT MED J, V314, P376; Riley LD, 2005, FAM J, V13, P52, DOI 10.1177/1066480704270099; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rocca WA, 1998, AM J EPIDEMIOL, V148, P51, DOI 10.1093/oxfordjournals.aje.a009560; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Roepke SK, 2012, STRESS, V15, P121, DOI 10.3109/10253890.2011.596866; Ronnemaa E, 2011, DEMENT GERIATR COGN, V31, P460, DOI 10.1159/000330020; Rubin RM, 2009, J FAM ECON ISS, V30, P252, DOI 10.1007/s10834-009-9155-x; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Sajeev G, DIABETES; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Samia LW, 2014, J GERONTOL SOC WORK, V57, P640, DOI 10.1080/01634372.2013.859201; Sando SB, 2008, INT J GERIATR PSYCH, V23, P1156, DOI 10.1002/gps.2043; Sarkamo T, 2014, GERONTOLOGIST, V54, P634, DOI 10.1093/geront/gnt100; Satizabal CL, 2014, ALZH ASS IN IN PRESS; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schmand B, 2012, J ALZHEIMERS DIS, V29, P641, DOI 10.3233/JAD-2012-111703; Schmand B, 2011, J AM GERIATR SOC, V59, P1705, DOI 10.1111/j.1532-5415.2011.03539.x; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1998, HEALTH PSYCHOL, V17, P107, DOI 10.1037/h0092707; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schumacher LAP, 2012, THER RECREAT J, V46, P42; Seeher K, 2013, ALZHEIMERS DEMENT, V9, P346, DOI 10.1016/j.jalz.2012.01.012; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shaffer JL, 2013, RADIOLOGY, V266, P583, DOI 10.1148/radiol.12120010; Shah A, 1999, INT J GERIATR PSYCH, V14, P803, DOI 10.1002/(SICI)1099-1166(199910)14:10<803::AID-GPS23>3.0.CO;2-Z; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Shaw WS, 1999, J PSYCHOSOM RES, V46, P215, DOI 10.1016/S0022-3999(98)00084-1; Shriver M, 2010, SHRIVER REPORT WOMAN; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smits CHM, 2007, INT J GERIATR PSYCH, V22, P1181, DOI 10.1002/gps.1805; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spillman BC., 2014, INFORMAL CAREGIVING; Spinney L, 2014, NATURE, V510, P26, DOI 10.1038/510026a; SPITZE G, 1990, RES AGING, V12, P182, DOI 10.1177/0164027590122003; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stone RI, 2012, PUBLIC HLTH AGING SO; Strang Vicki R, 2006, Clin Nurs Res, V15, P27, DOI 10.1177/1054773805282356; Stricker NH, 2012, BRAIN IMAGING BEHAV, V6, P599, DOI 10.1007/s11682-012-9171-6; Suehs BT, 2013, AM J ALZHEIMERS DIS, V28, P384, DOI 10.1177/1533317513488911; Tan ZS, 2014, HEALTH AFFAIR, V33, P619, DOI 10.1377/hlthaff.2013.1294; Teno J, 2014, HEALTH AFFAIR, V33, P675, DOI 10.1377/hlthaff.2013.1248; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 2012, GERONTOLOGIST, V52, P452, DOI 10.1093/geront/gnr132; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tinetti ME, 2012, J AM GERIATR SOC, V60, P1448, DOI 10.1111/j.1532-5415.2012.04077.x; Tremont G, 2015, ALZHEIMERS DEMENT, V11, P541, DOI 10.1016/j.jalz.2014.05.1752; U.S. Centers for Medicare and Medicaid Services, MED HOSP DAT; U.S. Department of Labor Bureau of Labor Statistics, 2014, US DEP LAB SER; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; van Hout HP, 2006, AGING MENT HEALTH, V10, P151, DOI 10.1080/13607860500310468; Vernooij-Dassen M., 2006, DEMENTIA, V5, P397, DOI DOI 10.1177/1471301206067114; Verrees M, 2004, AM FAM PHYSICIAN, V70, P1071; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Vincent GK, 2010, NEXT 4 DECADES OLDER; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; von Kanel R, 2006, J GERONTOL A-BIOL, V61, P963, DOI 10.1093/gerona/61.9.963; von Kanel R, 2014, BEHAV SLEEP MED, V12, P358, DOI 10.1080/15402002.2013.819470; von Kanel R, 2012, GERONTOLOGY, V58, P354, DOI 10.1159/000334219; von Kanel R, 2012, PSYCHOSOM MED, V74, P214, DOI 10.1097/PSY.0b013e3182408c14; Vos S, 2012, NEUROBIOL AGING, V33, P2272, DOI 10.1016/j.neurobiolaging.2011.12.017; Waite A, 2004, BRIT J CLIN PSYCHOL, V43, P313, DOI 10.1348/0144665031753005; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang L, 2012, ALZ DIS ASSOC DIS, V26, P314, DOI 10.1097/WAD.0b013e31823c0cf4; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Werner Perla, 2013, Alzheimers Dement, V9, pe74, DOI 10.1016/j.jalz.2012.02.006; Weuve J, 2015, EPIDEMIOLOGY, V26, pE4, DOI 10.1097/EDE.0000000000000199; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; Whitebird RR, 2013, GERONTOLOGIST, V53, P676, DOI 10.1093/geront/gns126; WHO, 2004, INT STAT CLASS DIS R; Wilkinson H, 2003, AGING MENT HEALTH, V7, P300, DOI 10.1080/1360786031000120705; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Wilson RS, 2012, PSYCHOL AGING, V27, P1008, DOI 10.1037/a0029857; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406; Yang Z, 2012, HEALTH SERV RES, V47, P1660, DOI 10.1111/j.1475-6773.2011.01365.x; Zaleta AK, 2012, ALZ DIS ASSOC DIS, V26, P232, DOI 10.1097/WAD.0b013e3182351c04; Zaleta AK, 2010, AM J ALZHEIMERS DIS, V25, P513, DOI 10.1177/1533317510372924; Zarit, 2009, AGING FAMILIES CAREG, P85; Zarit SH, 2013, CAREGIVING ALZHEIMER, P51; Zarit SH, 2009, AGING FAMILIES CAREG, P131; Zarit SH, 2014, GERONTOLOGIST, V54, P570, DOI 10.1093/geront/gnt045; Zarit SH, 2013, AGING MENT HEALTH, V17, P197, DOI 10.1080/13607863.2012.717252; Zarit SH, 2012, AGING MENT HEALTH, V16, P673, DOI 10.1080/13607863.2012.692768; Zarit SH, 2011, J GERONTOL B-PSYCHOL, V66, P538, DOI 10.1093/geronb/gbr030	417	1386	1408	24	480	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2015	11	3					332	384		10.1016/j.jalz.2015.02.003			53	Clinical Neurology	Neurosciences & Neurology	CF3RB	WOS:000352465100012	25984581		Y	N	2021-06-18	
J	HALLIWELL, B; CHIRICO, S				HALLIWELL, B; CHIRICO, S			LIPID-PEROXIDATION - ITS MECHANISM, MEASUREMENT, AND SIGNIFICANCE	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						LIPID PEROXIDATION; ALDEHYDE; PEROXYL RADICAL; FREE RADICAL; TBA TEST; DIENE CONJUGATION; OXIDATIVE STRESS	LOW-DENSITY-LIPOPROTEIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; THIOBARBITURIC ACID-REACTIVITY; UNSATURATED FATTY-ACIDS; FREE-RADICAL ACTIVITY; OXYGEN FREE-RADICALS; HUMAN BLOOD-PLASMA; BIOLOGICAL-SYSTEMS; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE	An increased concentration of end products of lipid peroxidation is the evidence most frequently quoted for the involvement of free radicals in human disease. However, it is likely that increased oxidative damage occurs in most, if not all, human diseases and plays a significant pathological role in only some of them. For example, peroxidation appears to be important in atherosclerosis and in worsening the initial tissue injury caused by ischemic or traumatic brain damage. Oxidative stress can damage many biological molecules; indeed, proteins and DNA are often more significant targets of injury than are lipids, and lipid peroxidation often occurs late in the injury process. Many assays are available to measure lipid peroxidation, but no single assay is an accurate measure of the whole process. Application of simple diene-conjugate and thiobarbituric acid (TBA) assays to human tissues and body fluids can produce artifacts. An HPLC-based TBA test can eliminate some of these artifacts.	UNIV LONDON KINGS COLL, PHARMACOL GRP, LONDON WC2R 2LS, ENGLAND	HALLIWELL, B (corresponding author), UNIV CALIF DAVIS, SACRAMENTO MED CTR, DAVIS MED CTR, 4301 X ST, SACRAMENTO, CA 95817 USA.		Halliwell, Barry/C-8318-2009				AIKENS J, 1991, J BIOL CHEM, V266, P15091; AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024; ARUOMA OI, 1989, BIOCHEM J, V264, P863, DOI 10.1042/bj2640863; ARUOMA OI, 1989, BIOCHEM J, V258, P617, DOI 10.1042/bj2580617; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; BANNI S, 1990, CARCINOGENESIS, V11, P2053, DOI 10.1093/carcin/11.11.2053; BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759; BIELSKI BHJ, 1991, FREE RADICAL RES COM, V12-3, P469; BIRD RP, 1983, ANAL BIOCHEM, V128, P240, DOI 10.1016/0003-2697(83)90371-8; Buege J A, 1978, Methods Enzymol, V52, P302; BURTON GW, 1990, LIPIDS, V25, P199, DOI 10.1007/BF02535748; BURTON GW, 1989, ANN NY ACAD SCI, V570, P7; CECCHINI R, 1990, FREE RADICAL RES COM, V10, P245, DOI 10.3109/10715769009149893; CHEN GM, 1990, FREE RADICAL RES COM, V9, P317, DOI 10.3109/10715769009145690; COCHRANE CG, 1991, MOL ASPECTS MED, V12, P137, DOI 10.1016/0098-2997(91)90009-B; COGHLAN JG, 1991, LANCET, V338, P1145, DOI 10.1016/0140-6736(91)92002-J; COMPORTI M, 1987, CHEM PHYS LIPIDS, V45, P143, DOI 10.1016/0009-3084(87)90064-8; CORONGIU FP, 1986, CHEM-BIOL INTERACT, V59, P147, DOI 10.1016/S0009-2797(86)80062-X; DENNIS KJ, 1989, FREE RADICAL BIO MED, V7, P187, DOI 10.1016/0891-5849(89)90013-0; DORMANDY TL, 1987, CHEM PHYS LIPIDS, V45, P353, DOI 10.1016/0009-3084(87)90072-7; DUPUY C, 1991, J BIOL CHEM, V266, P3739; Eklow-Lastbom L, 1986, Free Radic Res Commun, V2, P57, DOI 10.3109/10715768609088055; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; FAIRBANK J, 1988, LANCET, V2, P329; FRANKEL EN, 1989, LIPIDS, V24, P976, DOI 10.1007/BF02544544; FRANKEL EN, 1991, J SCI FOOD AGR, V54, P495, DOI 10.1002/jsfa.2740540402; FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; GRONER Y, 1990, J PHYSIOLOGY PARIS, V84, P53; Gutteridge J M, 1983, J Appl Biochem, V5, P293; Gutteridge J M, 1986, Free Radic Res Commun, V1, P173, DOI 10.3109/10715768609083149; GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5; GUTTERIDGE JMC, 1983, BIOCHIM BIOPHYS ACTA, V759, P38, DOI 10.1016/0304-4165(83)90186-1; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; GUTTERIDGE JMC, 1978, BIOCHEM MED METAB B, V19, P127, DOI 10.1016/0006-2944(78)90013-3; GUTTERIDGE JMC, 1988, OXYGEN RADICALS TISS, P9; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; HALLIWELL B, 1984, LANCET, V1, P1396; Halliwell B, 1989, FREE RADICALS BIOL M; HOLLEY AE, 1991, FREE RADICAL RES COM, V15, P51, DOI 10.3109/10715769109049125; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; JACK C I A, 1991, Clinical Science (London), V81, p17P; JAIN SK, 1985, J CLIN INVEST, V76, P281, DOI 10.1172/JCI111958; JANZEN EG, 1990, FREE RADICAL RES COM, V10, P63, DOI 10.3109/10715769009145934; KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T; KANNER J, 1987, CRC CR REV FOOD SCI, V25, P317, DOI 10.1080/10408398709527457; KANNER J, 1991, J AGR FOOD CHEM, V39, P242, DOI 10.1021/jf00002a003; KANOFSKY JR, 1991, J BIOL CHEM, V266, P9039; KAPPUS H, 1987, CHEM PHYS LIPIDS, V45, P105, DOI 10.1016/0009-3084(87)90062-4; KIM EH, 1991, ARCH BIOCHEM BIOPHYS, V288, P324, DOI 10.1016/0003-9861(91)90202-T; KOSUGI H, 1987, ANAL BIOCHEM, V165, P456, DOI 10.1016/0003-2697(87)90296-X; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; LARGILLIERE C, 1988, ANAL BIOCHEM, V170, P123, DOI 10.1016/0003-2697(88)90098-X; LAURINDO FRM, 1991, CIRCULATION, V83, P1705, DOI 10.1161/01.CIR.83.5.1705; MAIORINO M, 1991, J BIOL CHEM, V266, P7728; MALY FE, 1990, FREE RADICAL RES COM, V8, P143, DOI 10.3109/10715769009087987; MARSHALL PJ, 1985, ANAL BIOCHEM, V145, P192, DOI 10.1016/0003-2697(85)90347-1; MARTIN H, 1991, BIOCHEM BIOPH RES CO, V175, P123, DOI 10.1016/S0006-291X(05)81209-4; MEIER B, 1990, FREE RADICAL RES COM, V8, P149, DOI 10.3109/10715769009087988; MINOTTI G, 1987, CHEM PHYS LIPIDS, V44, P191, DOI 10.1016/0009-3084(87)90050-8; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1991, FREE RADICAL BIO MED, V10, P195, DOI 10.1016/0891-5849(91)90076-F; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; OWEN S, 1991, NEW ENGL J MED, V325, P586; PORTA EA, 1991, ARCH GERONTOL GERIAT, V12, P303, DOI 10.1016/0167-4943(91)90036-P; RADI R, 1991, J BIOL CHEM, V266, P4244; REAVEN P, 1991, AM J CLIN NUTR, V54, P701; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; RICHARDS DMC, 1988, BIOCHIM BIOPHYS ACTA, V946, P281, DOI 10.1016/0005-2736(88)90403-8; SARAN M, 1990, FREE RADICAL RES COM, V10, P221, DOI 10.3109/10715769009149890; SCOTT MD, 1989, BLOOD, V74, P2542; SHAPIRO BM, 1991, SCIENCE, V252, P533, DOI 10.1126/science.1850548; SHIMIZU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P271, DOI 10.1016/0003-9861(81)90091-6; SHUKLA VKS, 1991, LIPIDS, V26, P23, DOI 10.1007/BF02544019; SIES H, 1991, J PHOTOCH PHOTOBIO B, V8, P211, DOI 10.1016/1011-1344(91)80061-L; Sies H., 1991, OXIDATIVE STRESS OXI; SLATER TF, 1984, BIOCHEM J, V222, P1; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STOCKS J, 1974, CLIN SCI MOL MED, V47, P223, DOI 10.1042/cs0470223; SUGIHARA T, 1991, BLOOD, V77, P2757; TAPPEL AL, 1968, GERIATRICS, V23, P97; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; THOMAS DW, 1991, ANAL BIOCHEM, V198, P104, DOI 10.1016/0003-2697(91)90513-S; THOMPSON S, 1985, CHEM-BIOL INTERACT, V55, P357, DOI 10.1016/S0009-2797(85)80142-3; TOUATI D, 1989, FREE RADICAL RES COM, V8, P1, DOI 10.3109/10715768909087967; URSINI F, 1989, FREE RADICAL BIO MED, V6, P31, DOI 10.1016/0891-5849(89)90156-1; von Sonntag C, 1987, CHEM BASIS RAD BIOL; Walling C., 1982, OXIDASES RELATED RED, P85	103	1385	1437	2	50	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	MAY	1993	57	5		S			715	725					11	Nutrition & Dietetics	Nutrition & Dietetics	LB148	WOS:A1993LB14800004					2021-06-18	
J	Nyska, A; Kohen, R				Nyska, A; Kohen, R			Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification	TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	Annual Meeting of the Society-of-Toxicologic-Pathologists	JUN, 2000	PHOENIX, AZ	Soc Toxicol Pathologists		antioxidants; pro-oxidant; reducing power; cyclic voltammetry; oxidative damage markers	CLOSED-HEAD INJURY; NITRIC-OXIDE SYNTHASE; MOLECULAR-WEIGHT ANTIOXIDANTS; FREE-RADICAL THEORY; NF-KAPPA-B; DNA-DAMAGE; VITAMIN-E; IN-VIVO; LIPID-PEROXIDATION; HEME OXYGENASE-1	Reactive oxygen species (ROS) and other radicals are involved in a variety of biological phenomena, such as mutation, carcinogenesis, degenerative and other diseases, inflammation, aging, and development. ROS are well recognized for playing a dual role as deleterious and beneficial species. The objectives of this review are to describe oxidative stress phenomena, terminology, definitions, and basic chemical characteristics of the species involved; examine the biological targets susceptible to oxidation and the defense mechanisms of the organism against these reactive metabolites; and analyze methodologies, including immunohistochemical markers, used in toxicological pathology in the visualization of oxidative stress phenomena. Direct detection of ROS and other free radicals is difficult, because these molecules are short-lived and highly reactive in a nonspecific manner. Ongoing oxidative damage is, thus, generally analyzed by measurement of secondary products including derivatives of amino acids, nuclei acids, and lipid peroxidation. Attention has been focused on electrochemical methods based on voltammetry measurements for evaluating the total reducing power of biological fluids and tissues. This approach can function as a tool to assess the antioxidant-reducing profile of a biological site and follow changes in pathological situations. This review thus includes different topics essential for understanding oxidative stress phenomena and provides tools for those intending to conduct study and research in this field.	Hebrew Univ Jerusalem, Fac Med, Dept Pharmaceut, Sch Pharm, IL-91120 Jerusalem, Israel; NIEHS, Lab Expt Pathol, Res Triangle Pk, NC 27709 USA	Kohen, R (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmaceut, Sch Pharm, POB 12065, IL-91120 Jerusalem, Israel.	ronko@cc.huji.ac.il					Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; Akerboom T P, 1981, Methods Enzymol, V77, P373; Albertini R, 1998, FREE RADICAL RES, V29, P75, DOI 10.1080/10715769800300091; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Ames B N, 1986, Prog Clin Biol Res, V206, P3; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Ames BN, 2001, MUTAT RES-FUND MOL M, V475, P7, DOI 10.1016/S0027-5107(01)00070-7; Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Balentine J.D., 1982, PATHOLOGY OXYGEN TOX; Baltaci S, 2001, BJU INT, V88, P100, DOI 10.1046/j.1464-410x.2001.02231.x; Bard A. J., 1980, ELECTROCHEMICAL METH; BARHOUMI R, 1993, CYTOMETRY, V14, P747, DOI 10.1002/cyto.990140707; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Battino M, 2002, J CLIN PERIODONTOL, V29, P189, DOI 10.1034/j.1600-051X.2002.290301x.x; BAUD L, 1986, AM J PHYSIOL, V251, pF765; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Beckman KB, 1998, PHYSIOL REV, V78, P547; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Berry EM, 1999, MED HYPOTHESES, V53, P397, DOI 10.1054/mehy.1998.0786; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Biaglow JE, 1997, FREE RADICAL BIO MED, V22, P1129, DOI 10.1016/S0891-5849(96)00527-8; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; Blau S, 2000, PHARM RES-DORDR, V17, P1077, DOI 10.1023/A:1026401611961; Blau S, 1999, MOL CELL BIOCHEM, V194, P185, DOI 10.1023/A:1006994800272; Blau S, 2000, DIGEST DIS SCI, V45, P1180, DOI 10.1023/A:1005510321278; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Cabelli D.E., 1995, ACTIVE OXYGEN CHEM, P66, DOI DOI 10.1007/978-94-007-0874-7_3; Canas P E, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P13; Cao GH, 1998, CLIN CHEM, V44, P1309; Carr A, 1999, FASEB J, V13, P1007; CHANCE B, 1979, PHYSIOL REV, V59, P527; Chinev S, 1998, EUR J ANAESTH, V15, P686, DOI 10.1097/00003643-199811000-00010; Chiou GCY, 2001, J OCUL PHARMACOL TH, V17, P189, DOI 10.1089/10807680151125555; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; CLARK JM, 1988, EXP LUNG RES, V14, P897, DOI 10.3109/01902148809064182; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; COMPORTI M, 1989, CHEM-BIOL INTERACT, V72, P1, DOI 10.1016/0009-2797(89)90016-1; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; CZAPSKI G, 1995, FREE RADICAL BIO MED, V19, P785, DOI 10.1016/0891-5849(95)00081-8; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Digiesi V, 2001, Ann Ital Med Int, V16, P93; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Droge W, 2002, PHYSIOL REV, V82, P47; Dubois RN, 1998, FASEB J, V12, P1063; Elangovan V, 2000, FREE RADICAL RES, V32, P125, DOI 10.1080/10715760000300131; ELSAYED NM, 1992, TOXICOLOGY, V72, P153, DOI 10.1016/0300-483X(92)90109-R; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Engelsing K, 2001, MECH TIME-DEPEND MAT, V5, P27, DOI 10.1023/A:1009858702188; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Esterbauer H, 1996, PATHOL BIOL, V44, P25; Ezra R, 1996, EUR J PHARM BIOPHARM, V42, P291; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Farre AL, 2001, HYPERTENSION, V38, P1400, DOI 10.1161/hy1201.099612; FENTON HJH, 1894, J CHEM SOC P, V10, P157; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FREI B, 1990, ADV EXP MED BIOL, V264, P155; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; GILBERT DL, 1981, OXYGEN LIVING PROCES, P1; Ginsburg I, 1998, MED HYPOTHESES, V51, P337, DOI 10.1016/S0306-9877(98)90059-7; GINSBURG I, 1995, INFLAMMATION, V19, P101, DOI 10.1007/BF01534384; Gitto E, 2001, INTENS CARE MED, V27, P1116, DOI 10.1007/s001340100977; Goldstein S, 1999, CHEM RES TOXICOL, V12, P132, DOI 10.1021/tx9802522; Gottschling BC, 2001, TOXICOL SCI, V64, P28, DOI 10.1093/toxsci/64.1.28; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; GREEF R, 1999, INSTRUMENTAL METHODS, P68; GREEF R, 1999, INSTRUMENTAL METHODS, P178; Gross GJ, 1999, ANN THORAC SURG, V68, P1898, DOI 10.1016/S0003-4975(99)01035-8; Grune T, 1997, FASEB J, V11, P526; Gul Mustafa, 2000, Indian Journal of Experimental Biology, V38, P625; GUTTERIDGE JMC, 1993, FREE RADICAL RES COM, V19, P141, DOI 10.3109/10715769309111598; Gutteridge JMC, 1998, FREE RADICAL RES, V28, P1, DOI 10.3109/10715769809097871; Haber F., 1934, P ROY SOC          A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/rspa.1934.0221]; Halliwell B, 2000, AM J CLIN NUTR, V72, P1082; Halliwell B, 1999, MUTAT RES-GEN TOX EN, V443, P37, DOI 10.1016/S1383-5742(99)00009-5; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Halliwell B, 2001, MUTAT RES-FUND MOL M, V475, P29, DOI 10.1016/S0027-5107(01)00072-0; Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4; HALLIWELL B, 1995, BIOCHEM PHARMACOL, V49, P1341, DOI 10.1016/0006-2952(95)00088-H; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Halliwell B, 1997, FREE RADICAL RES, V27, P239, DOI 10.3109/10715769709065762; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; HAMMER C, 1988, COMP BIOCHEM PHYS B, V90, P7, DOI 10.1016/0305-0491(88)90030-2; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hawkins CL, 2001, ARCH BIOCHEM BIOPHYS, V395, P137, DOI 10.1006/abbi.2001.2581; Heineman W. R., 1996, LAB TECHNIQUES ELECT; Helbock HJ, 1999, METHOD ENZYMOL, V300, P156; Henderson CJ, 1998, CHEM-BIOL INTERACT, V112, P69, DOI 10.1016/S0009-2797(97)00176-2; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43, DOI 10.1007/BF03179812; Hrbac J, 2000, DRUG DEVELOP RES, V50, P516, DOI 10.1002/1098-2299(200007/08)50:3/4<516::AID-DDR35>3.0.CO;2-B; Hur GM, 1999, BIOCHEM BIOPH RES CO, V261, P917, DOI 10.1006/bbrc.1999.1143; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Ishikawa K, 2001, CIRCULATION, V104, P1831, DOI 10.1161/hc3901.095897; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; Jaffe B., 1976, CRUCIBLES STORY CHEM; JENNER P, 1993, ACTA NEUROL SCAND, V87, P6; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Jialal I, 2001, CURR OPIN LIPIDOL, V12, P49, DOI 10.1097/00041433-200102000-00009; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Kaltschmidt B, 1999, ANTIOXID REDOX SIGN, V1, P129, DOI 10.1089/ars.1999.1.2-129; Kanner J, 2001, FREE RADICAL BIO MED, V31, P1388, DOI 10.1016/S0891-5849(01)00718-3; Kasprzak KS, 2002, FREE RADICAL BIO MED, V32, P958, DOI 10.1016/S0891-5849(02)00809-2; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kawanishi S, 2002, FREE RADICAL BIO MED, V32, P822, DOI 10.1016/S0891-5849(02)00779-7; Kilmartin PA, 2001, ANTIOXID REDOX SIGN, V3, P941, DOI 10.1089/152308601317203495; Knight TR, 2001, TOXICOL SCI, V62, P212, DOI 10.1093/toxsci/62.2.212; KOHEN R, 1992, J BIOL CHEM, V267, P21349; Kohen R, 2000, TOXICOLOGY, V148, P149, DOI 10.1016/S0300-483X(00)00206-7; Kohen R, 1999, BIOMED PHARMACOTHER, V53, P181, DOI 10.1016/S0753-3322(99)80087-0; Kohen R, 1999, METHOD ENZYMOL, V300, P428; Kohen R, 2000, FREE RADICAL BIO MED, V28, P871, DOI 10.1016/S0891-5849(00)00191-X; KOHEN R, 1992, FREE RADICAL RES COM, V17, P239, DOI 10.3109/10715769209079516; Kohen R, 1999, METHOD ENZYMOL, V300, P285; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; KOHEN R, 2000, FREE RADICALS CHEM B, P348; KOHEN R, 1993, S ANT DIS PREV STOCK; KOHEN R, IN PRESS REDOX GENOM; KOREN HS, 1995, ENVIRON HEALTH PERSP, V103, P235, DOI 10.2307/3432379; Krebs H A, 1967, Adv Enzyme Regul, V5, P409, DOI 10.1016/0065-2571(67)90029-5; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; KUTHAN H, 1982, BIOCHEM J, V203, P551, DOI 10.1042/bj2030551; LARDINOIS OM, 1995, FREE RADICAL RES, V22, P251, DOI 10.3109/10715769509147544; Laroux FS, 2001, ACTA PHYSIOL SCAND, V173, P113, DOI 10.1046/j.1365-201X.2001.00891.x; Latha B, 2001, BURNS, V27, P309, DOI 10.1016/S0305-4179(00)00127-3; LAWRENCE JD, 2000, J NUTR, V130, P2739; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; LESNEFSKY EJ, 1994, ADV EXP MED BIOL, V366, P129; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Levine RL, 2000, METH MOL B, V99, P15; Levy JH, 1996, J CARDIOVASC PHARM, V27, pS31; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lijinsky W, 1999, MUTAT RES-GEN TOX EN, V443, P129, DOI 10.1016/S1383-5742(99)00015-0; LISSI E, 1995, FREE RADICAL BIO MED, V18, P153, DOI 10.1016/0891-5849(94)00117-3; Liu YR, 2001, NEUROREPORT, V12, P1841, DOI 10.1097/00001756-200107030-00016; Llesuy S, 2001, BIOL RES, V34, P51; Mason R.P., 1996, FREE RADICALS PRACTI, P11; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; May JM, 2000, FREE RADICAL BIO MED, V28, P1421, DOI 10.1016/S0891-5849(00)00269-0; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McGeer PL, 1998, J NEURAL TRANSM-SUPP, P159; Meral A, 2000, PEDIATR HEMAT ONCOL, V17, P687, DOI 10.1080/08880010050211402; Mercuri F, 2000, Diabetes Technol Ther, V2, P589, DOI 10.1089/15209150050502014; Mihm MJ, 2002, BRIT J PHARMACOL, V135, P581, DOI 10.1038/sj.bjp.0704495; Mitchinson MJ, 1999, LANCET, V353, P381, DOI 10.1016/S0140-6736(05)74955-2; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moor E, 2001, NEUROSCI LETT, V316, P169, DOI 10.1016/S0304-3940(01)02394-1; MOTCHNIK PA, 1994, METHOD ENZYMOL, V234, P269; Murphy MP, 1998, GEN PHARMACOL, V31, P179, DOI 10.1016/S0306-3623(97)00418-7; Nagy IZ, 2001, ANN NY ACAD SCI, V928, P187; Naito Y, 1998, DIGEST DIS SCI, V43, p30S; Najemnik C, 1999, ACTA MED AUST, V26, P148; Nantel F, 1999, BRIT J PHARMACOL, V128, P853, DOI 10.1038/sj.bjp.0702866; NOEL M, 1990, CYCLIC VOLTAMMETRY F, P62; Nyska A, 2002, TOXICOL PATHOL, V30, P283, DOI 10.1080/019262302753559623; Nyska A, 2001, ARCH TOXICOL, V75, P618, DOI 10.1007/s002040100278; O'Neill RD, 1998, CRIT REV NEUROBIOL, V12, P69, DOI 10.1615/CritRevNeurobiol.v12.i1-2.40; Obata T, 2001, BRAIN RES, V906, P170, DOI 10.1016/S0006-8993(01)02238-7; Oberley TD, 2000, PROSTATE, V44, P144, DOI 10.1002/1097-0045(20000701)44:2<144::AID-PROS7>3.0.CO;2-G; Ochiai M, 1999, JPN J CANCER RES, V90, P1338, DOI 10.1111/j.1349-7006.1999.tb00717.x; Onorato JM, 1998, ANN NY ACAD SCI, V854, P277, DOI 10.1111/j.1749-6632.1998.tb09909.x; Opara EC, 2002, J R SOC PROMO HEALTH, V122, P28, DOI 10.1177/146642400212200112; Ornoy A, 1999, TERATOLOGY, V60, P376, DOI 10.1002/(SICI)1096-9926(199912)60:6<376::AID-TERA10>3.0.CO;2-Q; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; PACKER L, 1994, METHOD ENZYMOL, V105, P299; PACKER L, 1990, METHOD ENZYMOL, V105, P234; PACKER L, 1984, METHOD ENZYMOL, V105, P186; Paolini M, 1999, LIFE SCI, V64, pPL273, DOI 10.1016/S0024-3205(99)00167-8; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5; PENTLAND AP, 1994, ADV EXP MED BIOL, V366, P87; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; Poulsen HE, 2000, FREE RADICAL RES, V33, pS33; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; PRIESTLY J, 1775, ALEMBIC CLUB REPRINT, V2, P168; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; PUPPI A, 1991, ACTA PHYSIOL HUNG, V77, P43; PUPPI A, 1983, ACTA BIOL HUNG, V34, P323; Raina AK, 2000, CLIN CHEM LAB MED, V38, P93, DOI 10.1515/CCLM.2000.015; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Ray RS, 2001, DRUG CHEM TOXICOL, V24, P191, DOI 10.1081/DCT-100102610; Reiter RJ, 2002, NEUROENDOCRINOL LETT, V23, P3; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Rice-Evans CA, 1991, TECHNIQUES FREE RADI; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; RICEEVANS CA, 1994, NEW COMPREHENSIVE BI, V28; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Rioux N, 1998, CANCER RES, V58, P5354; Rodrigues MR, 2002, BIOCHEM BIOPH RES CO, V292, P869, DOI 10.1006/bbrc.2002.6724; ROTH RN, 1994, CLIN DERMATOL, V12, P141, DOI 10.1016/0738-081X(94)90265-8; Rotilio G, 2000, IUBMB LIFE, V50, P309, DOI 10.1080/15216540051081074; ROUILLON JD, 1987, J PHARMACOL METHOD, V17, P179, DOI 10.1016/0160-5402(87)90029-5; SALVEMINI D, 1995, BRIT J PHARMACOL, V114, P1171, DOI 10.1111/j.1476-5381.1995.tb13330.x; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Saugstad OD, 2001, CURR OPIN OBSTET GYN, V13, P147, DOI 10.1097/00001703-200104000-00009; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seiler F, 2001, AM J RESP CELL MOL, V24, P492, DOI 10.1165/ajrcmb.24.4.4181; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Sen CK, 1996, FASEB J, V10, P709; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Shadyro OI, 2002, INT J RADIAT BIOL, V78, P211, DOI 10.1080/09553000110104065; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Sies H., 1985, OXIDATIVE STRESS; Skoog DA, 1988, FUNDAMENTALS ANAL CH, P303; SODUM RS, 1989, CHEM RES TOXICOL, V2, P23, DOI 10.1021/tx00007a004; Srigiridhar K, 2001, MOL CELL BIOCHEM, V219, P91, DOI 10.1023/A:1011023111048; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stocker A, 2000, ANTIOXID REDOX SIGN, V2, P397, DOI 10.1089/15230860050192170; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Sutherland JC, 2001, ELECTROPHORESIS, V22, P843, DOI 10.1002/1522-2683()22:5<843::AID-ELPS843>3.0.CO;2-9; SUTTON HC, 1989, FREE RADICAL BIO MED, V6, P53, DOI 10.1016/0891-5849(89)90160-3; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Takahashi S, 1998, TOXICOL PATHOL, V26, P247, DOI 10.1177/019262339802600209; Tan DX, 2001, FASEB J, V15, P2294; Theriault A, 1999, CLIN BIOCHEM, V32, P309, DOI 10.1016/S0009-9120(99)00027-2; Thomas SR, 2000, FREE RADICAL BIO MED, V28, P1795, DOI 10.1016/S0891-5849(00)00236-7; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Toyokuni S, 1997, LAB INVEST, V76, P365; Traber K, 1999, METHOD ENZYMOL, V299, P300; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Upham BL, 2001, TOXICOL SCI, V64, P1; VANROSSUM JP, 1991, EXP GERONTOL, V26, P37, DOI 10.1016/0531-5565(91)90060-Y; Venditti P, 2002, J BIOENERG BIOMEMBR, V34, P115, DOI 10.1023/A:1015175925756; VICTORIN K, 1994, MUTAT RES, V317, P43, DOI 10.1016/0165-1110(94)90011-6; VITTORIO N, 1984, ANAL BIOCHEM, V141, P423, DOI 10.1016/0003-2697(84)90065-4; von Sonntag C, 1987, CHEM BASIS RAD BIOL; WALLING C, 1975, P NATL ACAD SCI USA, V72, P140, DOI 10.1073/pnas.72.1.140; Wang J, 2002, ANTIOXID REDOX SIGN, V4, P161, DOI 10.1089/152308602753625933; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Wolin MS, 2000, ARTERIOSCL THROM VAS, V20, P1430, DOI 10.1161/01.ATV.20.6.1430; Wormser U, 2000, TOXICOL APPL PHARM, V169, P33, DOI 10.1006/taap.2000.9056; Zaken V, 2000, Early Pregnancy, V4, P110; Zaken V, 2001, TERATOLOGY, V64, P33, DOI 10.1002/tera.1045; Zhang XJ, 2000, FREE RADICAL BIO MED, V29, P730, DOI 10.1016/S0891-5849(00)00375-0; Zhang YJ, 2002, CARCINOGENESIS, V23, P207, DOI 10.1093/carcin/23.1.207; Zimmermann KC, 1999, CANCER RES, V59, P198	273	1360	1423	5	170	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	NOV-DEC	2002	30	6					620	650		10.1080/01926230290166724			31	Pathology; Toxicology	Pathology; Toxicology	615KB	WOS:000179243400002	12512863	Bronze			2021-06-18	
J	CHESNUT, RM; MARSHALL, LF; KLAUBER, MR; BLUNT, BA; BALDWIN, N; EISENBERG, HM; JANE, JA; MARMAROU, A; FOULKES, MA				CHESNUT, RM; MARSHALL, LF; KLAUBER, MR; BLUNT, BA; BALDWIN, N; EISENBERG, HM; JANE, JA; MARMAROU, A; FOULKES, MA			THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD-INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							CEREBRAL BLOOD-FLOW; DAMAGE; ANTAGONISTS; PREDICTION; PRESSURE; GERBILS; TRAUMA; COMA	As triage and resuscitation protocols evolve, it is critical to determine the major extracranial variables influencing outcome in the setting of severe head injury. We prospectively studied the outcome from severe head injury (GCS score less-than-or-equal-to 8) in 717 cases in the Traumatic Coma Data Bank. We investigated the impact on outcome of hypotension (SBP < 90 mm Hg) and hypoxia (PaO2 less-than-or-equal-to 60 mm Hg or apnea or cyanosis in the field) as secondary brain insults, occurring from injury through resuscitation. Hypoxia and hypotension were independently associated with significant increases in morbidity and mortality from severe head injury. Hypotension was profoundly detrimental, occurring in 34.6% of these patients and associated with a 150% increase in mortality. The increased morbidity and mortality related to severe trauma to an extracranial organ system appeared primarily attributable to associated hypotension. Improvements in trauma care delivery over the past decade have not markedly altered the adverse influence of hypotension. Hypoxia and hypotension are common and detrimental secondary brain insults. Hypotension, particularly, is a major determinant of outcome from severe head injury. Resuscitation protocols for brain injured patients should assiduously avoid hypovolemic shock on an absolute basis.	SAN DIEGO VET ADM HOSP,DIV NEUROL SURG,LA JOLLA,CA; UCSD,MED CTR,DEPT COMMUNITY & FAMILY MED,SAN DIEGO,CA; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298; UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550; UNIV VIRGINIA,MED CTR,SCH MED,CHARLOTTESVILLE,VA 22901; NINCDS,BETHESDA,MD 20892	CHESNUT, RM (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DIV NEUROL SURG H-893,225 DICKINSON ST,SAN DIEGO,CA 92103, USA.			Chesnut, Randall/0000-0001-6377-3666	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032340, N01NS032341, N01NS032339] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-NS-3-2339, N01-NS-3-2341, N01-NS-3-2340] Funding Source: Medline		ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; BASKIN DS, 1986, J NEUROSURG, V64, P99, DOI 10.3171/jns.1986.64.1.0099; BECKMAN DL, 1985, CENTRAL NERVOUS SYST, P417; Bishop Y.M., 2007, DISCRETE MULTIVARIAT; BOAST CA, 1988, BRAIN RES, V442, P345, DOI 10.1016/0006-8993(88)91522-3; BRAUGHLER JM, 1985, CENTRAL NERVOUS SYST, P417; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; Enevoldsen E, 1986, Acta Neurochir Suppl (Wien), V36, P133; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Frost E A, 1977, Neurosurgery, V1, P300; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; HICKS TP, 1986, EXCITATORY AMINO ACI; HOSABUCHI Y, 1982, SCIENCE, V215, P69; Hosmer D. W., 1989, APPLIED LOGISTIC REG; JENNETT B, 1975, LANCET, V1, P480; KARPIAK SE, 1978, STROKE, V18, P184; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meguro K, 1988, Neurol Med Chir (Tokyo), V28, P34, DOI 10.2176/nmc.28.34; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MIZOI K, 1986, Neurological Research, V8, P75; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SABEL BA, 1984, SCIENCE, V225, P340, DOI 10.1126/science.6740316; SCHUMACKER PT, 1979, AM REV RESPIR DIS, V119, P33; SEELIG JM, 1986, INTRACRANIAL PRESSUR, V6, P675; SHREWSBURYGEE J, 1988, EXP BRAIN RES, V70, P342; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; 1985, ABBREVIATED INJURY S	42	1322	1370	1	74	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	1993	34	2					216	222		10.1097/00005373-199302000-00006			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	KX010	WOS:A1993KX01000006	8459458				2021-06-18	
J	Kigerl, KA; Gensel, JC; Ankeny, DP; Alexander, JK; Donnelly, DJ; Popovich, PG				Kigerl, Kristina A.; Gensel, John C.; Ankeny, Daniel P.; Alexander, Jessica K.; Donnelly, Dustin J.; Popovich, Phillip G.			Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord	JOURNAL OF NEUROSCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING FACTOR; TRAUMATIC BRAIN-INJURY; GROUP BOX-1 PROTEIN; TOLL-LIKE RECEPTORS; ALTERNATIVE ACTIVATION; AUTONOMIC DYSREFLEXIA; FUNCTIONAL RECOVERY; AXON REGENERATION; MONONUCLEAR PHAGOCYTES	Macrophages dominate sites of CNS injury in which they promote both injury and repair. These divergent effects may be caused by distinct macrophage subsets, i.e., "classically activated" proinflammatory (M1) or "alternatively activated" anti-inflammatory (M2) cells. Here, we show that an M1 macrophage response is rapidly induced and then maintained at sites of traumatic spinal cord injury and that this response overwhelms a comparatively smaller and transient M2 macrophage response. The high M1/M2 macrophage ratio has significant implications for CNS repair. Indeed, we present novel data showing that only M1 macrophages are neurotoxic and M2 macrophages promote a regenerative growth response in adult sensory axons, even in the context of inhibitory substrates that dominate sites of CNS injury (e.g., proteoglycans and myelin). Together, these data suggest that polarizing the differentiation of resident microglia and infiltrating blood monocytes toward an M2 or "alternatively" activated macrophage phenotype could promote CNS repair while limiting secondary inflammatory-mediated injury.	[Popovich, Phillip G.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Kigerl, Kristina A.; Gensel, John C.; Ankeny, Daniel P.; Alexander, Jessica K.; Donnelly, Dustin J.; Popovich, Phillip G.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Alexander, Jessica K.; Popovich, Phillip G.] Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA; [Donnelly, Dustin J.; Popovich, Phillip G.] Ohio State Univ, Med Scientist Program, Columbus, OH 43210 USA	Popovich, PG (corresponding author), Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, 786 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	phillip.popovich@osumc.edu		, John/0000-0001-8980-108X; Kigerl, Kristina/0000-0002-1652-0882	National Institutes of Health-National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Craig H. Neilsen Foundation; The Paralysis Project of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037846] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke, the Craig H. Neilsen Foundation, and The Paralysis Project of America. We thank Drs. Ron Hart for assisting with the microarray data analysis, Sarah Busch and Jerry Silver for helping us to establish CSPG spot assays, and Marie Filbin and Marco Domeniconi for providing MAG CHO cells and helping us to establish the neurite growth assay on myelin.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BURGESS AW, 1985, J BIOL CHEM, V260, P6004; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Canning DR, 1996, INT J DEV NEUROSCI, V14, P153, DOI 10.1016/0736-5748(96)00004-4; Chang HT, 2007, SPINAL CORD, V45, P174, DOI 10.1038/sj.sc.3101910; Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; DING AH, 1988, J IMMUNOL, V141, P2407; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; Golz G, 2006, EUR J NEUROSCI, V24, P2721, DOI 10.1111/j.1460-9568.2006.05155.x; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hou S, 2009, NEUROSCIENCE, V159, P369, DOI 10.1016/j.neuroscience.2008.12.022; Hou SP, 2008, J COMP NEUROL, V509, P382, DOI 10.1002/cne.21771; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Liu RY, 2001, J NEUROSCI, V21; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; SHOLL DA, 1953, J ANAT, V87, P387; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Smith DS, 1997, J NEUROSCI, V17, P646; Soares HD, 1995, J NEUROSCI, V15, P8223; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701	79	1310	1358	5	132	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 28	2009	29	43					13435	13444		10.1523/JNEUROSCI.3257-09.2009			10	Neurosciences	Neurosciences & Neurology	512RA	WOS:000271266600003	19864556	Bronze, Green Accepted, Green Published			2021-06-18	
J	McCrory, P; Meeuwisse, WH; Aubry, M; Cantu, B; Dvorak, J; Echemendia, RJ; Engebretsen, L; Johnston, K; Kutcher, JS; Raftery, M; Sills, A; Benson, BW; Davis, GA; Ellenbogen, RG; Guskiewicz, K; Herring, SA; Iverson, GL; Jordan, BD; Kissick, J; McCrea, M; McIntosh, AS; Maddocks, D; Makdissi, M; Purcell, L; Putukian, M; Schneider, K; Tator, CH; Turner, M				McCrory, Paul; Meeuwisse, Willem H.; Aubry, Mark; Cantu, Bob; Dvorak, Jiri; Echemendia, Ruben J.; Engebretsen, Lars; Johnston, Karen; Kutcher, Jeffrey S.; Raftery, Martin; Sills, Allen; Benson, Brian W.; Davis, Gavin A.; Ellenbogen, Richard G.; Guskiewicz, Kevin; Herring, Stanley A.; Iverson, Grant L.; Jordan, Barry D.; Kissick, James; McCrea, Michael; McIntosh, Andrew S.; Maddocks, David; Makdissi, Michael; Purcell, Laura; Putukian, Margot; Schneider, Kathryn; Tator, Charles H.; Turner, Michael			Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport held in Zurich, November 2012	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; HEAD-INJURIES; POSTURAL CONTROL; LONG-TERM; POSTCONCUSSION SYNDROME; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION		[McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3084, Australia; [Meeuwisse, Willem H.] Univ Calgary, Hotchkiss Brain Inst, Fac Kinesiol, Calgary, AB, Canada; [Meeuwisse, Willem H.] Sport Injury Prevent Res Ctr, Fac Med, Calgary, AB, Canada; [Aubry, Mark] IOC Med Commiss Games Grp, Ottawa, ON, Canada; [Aubry, Mark; Kissick, James] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Cantu, Bob] Boston Univ, Med Ctr, Dept Neurosurg, Boston, MA USA; [Cantu, Bob] Boston Univ, Med Ctr, Ctr Study Traumat Encephalopathy, Boston, MA USA; [Dvorak, Jiri] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Dvorak, Jiri] Schulthess Clin Zurich, Zurich, Switzerland; [Dvorak, Jiri] F MARC FIFA Med Assessment & Res Ctr, Zurich, Switzerland; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Kansas City, MO 64110 USA; [Engebretsen, Lars] Oslo Univ Hosp, Dept Orthopaed Surg, Oslo, Norway; [Engebretsen, Lars] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Engebretsen, Lars] Oslo Sports Trauma Res Ctr, Oslo, Norway; [Engebretsen, Lars] Int Olymp Comm, Lausanne, Switzerland; [Johnston, Karen] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Johnston, Karen] Concuss Management Program Athlet Edge Sports Med, Toronto, ON, Canada; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Michigan NeuroSport, Ann Arbor, MI USA; [Raftery, Martin] Int Rugby Board, Dublin, Ireland; [Sills, Allen] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Dept Neurosurg Orthopaed Surg & Rehabil, Nashville, TN USA; [Benson, Brian W.] Univ Calgary, Fac Med, Dept Clin Neurosci, Calgary, AB, Canada; [Benson, Brian W.] Univ Calgary, Dept Family Med, Calgary, AB, Canada; [Benson, Brian W.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada; [Davis, Gavin A.] Austin & Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Theodore S Roberts Endowed Chair, Seattle, WA 98195 USA; [Guskiewicz, Kevin] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med Orthopaed & Sports Med, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Herring, Stanley A.] Team Phys Seattle Seahawks & Seattle Mariners, Seattle Sports Concuss Program, Seattle, WA USA; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Jordan, Barry D.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Jordan, Barry D.] Burke Rehabil Hosp, White Plains, NY USA; [Jordan, Barry D.] New York State Athlet Commiss, New York, NY USA; [Kissick, James] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI USA; [McIntosh, Andrew S.] Monash Univ, Monash Injury Res Inst, Australian Ctr Res Injury Sports & Prevent, Clayton, Vic 3800, Australia; [McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Sydney, NSW 2052, Australia; [McIntosh, Andrew S.] McIntosh Consultancy & Res Pty Ltd, Sydney, NSW, Australia; [Maddocks, David] Perry Maddocks Trollope Lawyers, Melbourne, Vic, Australia; [Makdissi, Michael] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Makdissi, Michael] Univ Melbourne, Melbourne Physiotherapy Dept, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Purcell, Laura] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Purcell, Laura] McMaster Univ, David Braley Sport Med & Rehabil Ctr, Hamilton, ON, Canada; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Putukian, Margot] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Tator, Charles H.] Toronto Western Hosp, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Tator, Charles H.] Krembil Neurosci Ctr, Toronto, ON, Canada; [Tator, Charles H.] ThinkFirst Canada, Toronto, ON, Canada; [Turner, Michael] British Horseracing Author, London, England	McCrory, P (corresponding author), Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3084, Australia.	paulmccr@bigpond.net.au		McCrory, Paul/0000-0003-4850-0568; Schneider, Kathryn/0000-0002-5951-5899; Guskiewicz, Kevin/0000-0002-8682-2130; Iverson, Grant/0000-0001-7348-9570			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SD, 2004, CAN MED ASSOC J, V170, P16; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg Joseph, 2005, Neurosurgery, V56, pE1166; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen JK, 2004, CLIN J SPORT MED, V14, P379; Chen JK, 2004, BRIT J SPORT MED, V38, P659; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Curnow WJ, 2008, HEALTH PROMOT J AUST, V19, P10; Davidhizar R, 2002, Accid Emerg Nurs, V10, P149, DOI 10.1054/aaen.2002.0365; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Denke NJ, 2008, J EMERG NURS, V34, P363, DOI 10.1016/j.jen.2008.04.013; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.039362; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Finch C, 2000, SPORT HLTH, V18, P35; Finch C, 1993, 51 MON U ACC RES CTR; Finch CF, 2003, J SCI MED SPORT, V6, P505, DOI 10.1016/S1440-2440(03)80275-X; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; FUKUHARA T, 1994, BRAIN RES, V657, P333, DOI 10.1016/0006-8993(94)90987-3; Gabbe B, 2003, J SCI MED SPORT, V6, P231, DOI 10.1016/S1440-2440(03)80259-1; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hansen Kari Schroder, 2003, Traffic Inj Prev, V4, P285, DOI 10.1080/714040486; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JENNETT B, 1975, LANCET, V1, P480; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lee Michael A, 2006, Conn Med, V70, P377; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McIntosh A, 2005, RUGBY HEADGEAR STUDY; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Peng Rui-yun, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P213; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shaw NH, 2004, CAN MED ASSOC J, V170, P15; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Theye Fred, 2004, Clin Med Res, V2, P165; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vagnozzi R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Weiss MR, 2005, RES Q EXERCISE SPORT, V76, pS71, DOI 10.1080/02701367.2005.10599291; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863; Yunoki M, 1998, ACT NEUR S, V71, P142	156	1297	1307	9	192	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	2013	47	5					250	258		10.1136/bjsports-2013-092313			12	Sport Sciences	Sport Sciences	105HZ	WOS:000316058900003	23479479	Bronze, Green Accepted	Y	N	2021-06-18	
J	FADEN, AI; DEMEDIUK, P; PANTER, SS; VINK, R				FADEN, AI; DEMEDIUK, P; PANTER, SS; VINK, R			THE ROLE OF EXCITATORY AMINO-ACIDS AND NMDA RECEPTORS IN TRAUMATIC BRAIN INJURY	SCIENCE			English	Article									VET ADM MED CTR,CTR NEURAL INJURY,SAN FRANCISCO,CA 94121; JAMES COOK UNIV N QUEENSLAND,DEPT CHEM & BIOCHEM,TOWNSVILLE,QLD 4811,AUSTRALIA	FADEN, AI (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.		Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667			CHANCE B, 1980, P NATL ACAD SCI-BIOL, V77, P7430, DOI 10.1073/pnas.77.12.7430; CHOI DW, 1987, J NEUROSCI, V7, P369; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVIES J, 1983, EXP BRAIN RES, V49, P280; DEMEDIUK P, IN PRESS J NEUROCHEM; DEMEDIUK P, 1988, T AM SOC NEUROCHEM, V19, P214; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; GEORGE CP, 1988, BRAIN RES, V440, P375, DOI 10.1016/0006-8993(88)91011-6; LODGE D, 1982, NEUROSCI LETT, V29, P281, DOI 10.1016/0304-3940(82)90330-5; MURPHY DE, 1987, J PHARMACOL EXP THER, V240, P778; OLNEY JW, 1986, NEUROSCI LETT, V68, P29, DOI 10.1016/0304-3940(86)90224-7; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P260; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Ungerstedt U, 1984, MEASUREMENT NEUROTRA, P81; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146	20	1251	1274	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 19	1989	244	4906					798	800		10.1126/science.2567056			3	Multidisciplinary Sciences	Science & Technology - Other Topics	U6396	WOS:A1989U639600023	2567056				2021-06-18	
J	Chen, JL; Li, Y; Wang, L; Zhang, ZG; Lu, DY; Lu, M; Chopp, M				Chen, JL; Li, Y; Wang, L; Zhang, ZG; Lu, DY; Lu, M; Chopp, M			Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats	STROKE			English	Article						bone marrow transplantation; middle cerebral artery occlusion; neuronal plasticity; stroke, experimental; stromal cells; rats	STIMULATING FACTOR-I; CLOSED-HEAD INJURY; ARTERY OCCLUSION; PROGENITOR CELLS; GROWTH-FACTOR; HEMATOPOIETIC CYTOKINE; STEM; TRANSPLANTATION; MOTOR; RECOVERY	Background and Purpose-We tested the hypothesis that intravenous infusion of bone marrow derived-marrow stromal cells (MSCs) enter the brain and reduce neurological functional deficits after stroke in rats. Methods-Rats (n=32) were subjected to 2 hours of middle cerebral artery occlusion (MCAO). Test groups consisted of MCAO alone (group 1, n=6); intravenous infusion of 1 x 10(6) MSCs at 24 hours after MCAO (group 2, n=6); or infusion of 3x10(6) MSCs (group 3, n=7). Rats in groups 1 to 3 were euthanized at 14 days after MCAO. Group 4 consisted of MCAO alone (n=6) and group 5, intravenous infusion of 3x10(6) MSCs at 7 days after MCAO (n=7). Rats in groups 4 and 5 were euthanized at 35 days after MCAO. For cellular identification, MSCs were prelabeled with bromodeoxyuridine. Behavioral tests (rotarod, adhesive-removal, and modified Neurological Severity Score [NSS]) were performed before and at 1, 7, 14, 21, 28, and 35 days after MCAO. Immunohistochemistry was used to identify MSCs or cells derived from MSCs in brain and other organs. Results-Significant recovery of somatosensory behavior and Neurological Severity Score (P<0.05) were found in animals infused with 3x106 MSCs at 1 day or 7 days compared with control animals. MSCs survive and are localized to the ipsilateral ischemic hemisphere, and a few cells express protein marker phenotypic neural cells. Conclusions-MSCs delivered to ischemic brain tissue through an intravenous route provide therapeutic benefit after stroke. MSCs may provide a powerful autoplastic therapy for stroke.	Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI USA; Henry Ford Hlth Sci Ctr, Dept Neurosurg, Detroit, MI USA; Henry Ford Hlth Sci Ctr, Dept Biostat & Res Epidemiol, Detroit, MI USA; Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS35504, P01-NS23393] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS023393, R01NS035504] Funding Source: NIH RePORTER		ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; BENNETT JH, 1991, J CELL SCI, V99, P131; BEREZOVSKAYA O, 1995, INT J DEV NEUROSCI, V13, P285, DOI 10.1016/0736-5748(95)00013-7; Berezovskaya O, 1996, ACTA NEUROPATHOL, V92, P479, DOI 10.1007/s004010050550; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; DUNNETT SB, 1994, J NEUROL, V242, pS43, DOI 10.1007/BF00939242; EAVES CJ, 1991, BLOOD, V78, P110; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FLEISCHMAN RA, 1995, EXP HEMATOL, V23, P1407; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Haraldsen G, 1996, J IMMUNOL, V156, P2558; HEFTI F, 1986, J NEUROSCI, V6, P2155; HUSS R, 1995, CELL TRANSPLANT, V4, P483, DOI 10.1016/0963-6897(95)00011-L; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Koc ON, 1999, EXP HEMATOL, V27, P1675, DOI 10.1016/S0301-472X(99)00101-0; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KRALL WJ, 1994, BLOOD, V83, P2737; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; LI Y, IN PRESS CELL TRANSP; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; PERKINS S, 1990, BLOOD, V75, P620; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1999, OSTEOARTHR CARTILAGE, V7, P364, DOI 10.1053/joca.1998.0213; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schallert T, 1997, ADV NEUROL, V73, P229; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Suzumura A, 1995, Tanpakushitsu Kakusan Koso, V40, P691; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi T, 1999, NAT MED, V5, P434; Unsicker Klaus, 1994, Progress in Growth Factor Research, V5, P73, DOI 10.1016/0955-2235(94)90018-3; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang ZG, 1999, J NEUROSCI, V19, P10898	50	1240	1493	2	116	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	APR	2001	32	4					1005	1011		10.1161/01.STR.32.4.1005			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	419LV	WOS:000167951300035	11283404	Bronze			2021-06-18	
J	Hootman, JM; Dick, R; Agel, J				Hootman, Jennifer M.; Dick, Randall; Agel, Julie			Epidemiology of collegiate injuries for 15 sports: Summary and recommendations for injury prevention initiatives	JOURNAL OF ATHLETIC TRAINING			English	Article						athletic injuries	ANTERIOR CRUCIATE LIGAMENT; BOARD TRAINING-PROGRAM; ANKLE SPRAINS; CONTROLLED-TRIAL; PATTERNS; FOOTBALL; PLAYERS; WOMEN; RISK; MEN	Objective: To summarize 16 years of National Collegiate Athletic Association (NCAA) injury surveillance data for 15 sports and to identify potential modifiable risk factors to target for injury prevention initiatives. Background. In 1982, the NCAA began collecting standardized injury and exposure data for collegiate sports through its Injury Surveillance System (ISS). This special issue reviews 182000 injuries and slightly more than 1 million exposure records captured over a 16-year time period (1988-1989 through 2003-2004). Game and practice injuries that required medical attention and resulted in at least 1 day of time loss were included. An exposure was defined as 1 athlete participating in 1 practice or game and is expressed as an athlete-e:KPOSure (AE). Main Results: Combining data for all sports, injury rates were statistically significantly higher in games (13.8 injuries per 1000 A-Es) than in practices (4.0 injuries per 1000 A-Es), and preseason practice injury rates (6.6 injuries per 1000 A-Es) were significantly higher than both in-season (2.3 injuries per 1000 A-Es) and postseason (1.4 injuries per 1000 A-Es) practice rates. No significant change in game or practice injury rates was noted over the 16 years. More than 50% of all injuries were to the lower extremity. Ankle ligament sprains were the most common injury over all sports, accounting for 15% of all reported injuries. Rates of concussions and anterior cruciate ligament injuries increased significantly (average annual increases of 7.0% and 1.3%, respectively) over the sample period. These trends may reflect improvements in identification of these injuries, especially for concussion, over time. Football had the highest injury rates for both practices (9.6 injuries per 1000 AEs) and games (35.9 injuries per 1000 A-Es), whereas men's baseball had the lowest rate in practice (1.9 injuries per 1000 A_Es) and women's softball had the lowest rate in games (4.3 injuries per 1000 A-Es). Recommendations: In general, participation in college athletics is safe, but these data indicate modifiable factors that, if addressed through injury prevention initiatives, may contribute to lower injury rates in collegiate sports.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Natl Coll Athlet Assoc, Indianapolis, IN USA; Univ Minnesota, Minneapolis, MN 55455 USA	Hootman, JM (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway E MSK-51, Atlanta, GA 30341 USA.	jhootman@cdc.gov					ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Bergeron MF, 2005, MED SCI SPORT EXER, V37, P1421, DOI 10.1249/01.mss.0000174891.46893.82; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cordova ML, 2005, MED SCI SPORT EXER, V37, P635, DOI 10.1249/01.MSS.0000159141.78989.9C; Dick R, 2007, J ATHL TRAINING, V42, P173; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Garrick JG, 2005, CLIN J SPORT MED, V15, P385, DOI 10.1097/01.jsm.0000181438.48892.1b; HANDOLL HH, 2001, COCHRANE DB SYST REV, V2; Marchi AG, 1999, ARCH DIS CHILD, V81, P324, DOI 10.1136/adc.81.4.324; *NAT COLL ATHL ASS, 2006NCAA FOOTB RUL I; Olmsted LC, 2004, J ATHL TRAINING, V39, P95; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Petersen W, 2005, ARCH ORTHOP TRAUM SU, V125, P614, DOI 10.1007/s00402-005-0793-7; Thelen DG, 2006, EXERC SPORT SCI REV, V34, P135, DOI 10.1249/00003677-200607000-00008; Uhorchak JM, 2003, AM J SPORT MED, V31, P831, DOI 10.1177/03635465030310061801; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031; Verhagen EALM, 2000, CLIN J SPORT MED, V10, P291, DOI 10.1097/00042752-200010000-00012	20	1192	1207	9	317	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR-JUN	2007	42	2					311	319					9	Sport Sciences	Sport Sciences	180RC	WOS:000247382300019	17710181				2021-06-18	
J	Wilson, JTL; Pettigrew, LEL; Teasdale, GM				Wilson, JTL; Pettigrew, LEL; Teasdale, GM			Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Outcome Scale; outcome assessment	SEVERE HEAD-INJURY; RATING-SCALE; RELIABILITY; DISABILITY; RECOVERY	The Glasgow Outcome Scale (GOS) is the most widely used outcome measure after traumatic brain injury, but it is increasingly recognized to have important limitations, It is proposed that shortcomings of the GOS can be addressed by adopting a standard format for the interview used to assign outcome. A set of guidelines are outlined that are directed at the main problems encountered in applying the GOS, The guidelines cover the general principles underlying the use of the GOS and common practical problems of applying the scale. Structured interview schedules are described for both the five-point GOS and an extended eight-point GOS (GOSE), An interrater reliability study of the structured interviews for the GOS and GOSE yielded weighted kappa values of 0.89 and 0.85, respectively. It is concluded that assessment of the GOS using a standard format with a written protocol is practical and reliable.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Glasgow, Dept Neurosurg, Glasgow, Lanark, Scotland	Wilson, JTL (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.		Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328			Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; GOUVIER WD, 1986, INT J CLIN NEUROPSYC, V8, P1; GRANT I, 1987, NEUROBEHAVIORAL RECO, P57; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1992, NEUROREHABILITATION, V2, DOI [10.3233/NRE-1992-2410, DOI 10.3233/NRE-1992-2410]; HORNE G, 1989, AUST NZ J SURG, V59, P465, DOI 10.1111/j.1445-2197.1989.tb01612.x; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; Livingston M G, 1985, Int Rehabil Med, V7, P145; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Marshall LF, 1987, NEUROBEHAVIORAL RECO, P206; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; SMITH RM, 1979, CLIN NEUROPSYCHOL, V1, P48; World Health Organization, 1980, INT CLASS IMP DIS HA	19	1184	1196	0	52	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1998	15	8					573	585		10.1089/neu.1998.15.573			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	111KP	WOS:000075436500002	9726257				2021-06-18	
J	Diaz, LA; Bardelli, A				Diaz, Luis A.; Bardelli, Alberto			Liquid Biopsies: Genotyping Circulating Tumor DNA	JOURNAL OF CLINICAL ONCOLOGY			English	Article							CELL-FREE DNA; ACUTE MYOCARDIAL-INFARCTION; EPITHELIAL OVARIAN-CANCER; METASTATIC BREAST-CANCER; TRAUMATIC BRAIN-INJURY; FREE PLASMA DNA; ACQUIRED-RESISTANCE; LUNG-CANCER; COLORECTAL-CANCER; MATERNAL PLASMA	Genotyping tumor tissue in search of somatic genetic alterations for actionable information has become routine practice in clinical oncology. Although these sequence alterations are highly informative, sampling tumor tissue has significant inherent limitations; tumor tissue is a single snapshot in time, is subject to selection bias resulting from tumor heterogeneity, and can be difficult to obtain. Cell-free fragments of DNA are shed into the bloodstream by cells undergoing apoptosis or necrosis, and the load of circulating cell-free DNA (cfDNA) correlates with tumor staging and prognosis. Moreover, recent advances in the sensitivity and accuracy of DNA analysis have allowed for genotyping of cfDNA for somatic genomic alterations found in tumors. The ability to detect and quantify tumor mutations has proven effective in tracking tumor dynamics in real time as well as serving as a liquid biopsy that can be used for a variety of clinical and investigational applications not previously possible. (C) 2014 by American Society of Clinical Oncology	[Diaz, Luis A.] Johns Hopkins Univ, Sch Med, Swim Amer Lab, Baltimore, MD USA; [Diaz, Luis A.] Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Bardelli, Alberto] Univ Turin, Inst Canc Res & Treatment Candiolo, Candiolo, Italy; [Bardelli, Alberto] Fdn Italiana Ric Canc, Inst Mol Oncol, Milan, Italy	Bardelli, A (corresponding author), Univ Turin, Sch Med, Mol Genet Lab, Inst Canc Res & Treatment,Dept Oncol, Str Prov 142 Km 3-95, I-10060 Turin, Italy.	a.bardelli@unito.it	; BARDELLI, Alberto/J-9721-2018	Diaz, Luis/0000-0002-7079-8914; BARDELLI, Alberto/0000-0003-1647-5070	European UnionEuropean Commission [259015]; Associazione Italiana per la Ricerca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro [12812]; AIRCFondazione AIRC per la ricerca sul cancro [9970]; Fondazione Piemontese per la Ricerca sul Cancro 5 per mille Ministero della Salute; Ministero dell'Istruzione, dell'Universita e della Ricerca (Progetti di Ricerca di Interesse Nazionale); Swim Across America; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006973] Funding Source: NIH RePORTER	Supported by the European Union Seventh Framework Programme of the Colon Therapy Research Consortium (Grant No. 259015); by the Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator Grant No. 12812; by AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille, Project No. 9970; by Fondazione Piemontese per la Ricerca sul Cancro 5 per mille 2010 Ministero della Salute; Ministero dell'Istruzione, dell'Universita e della Ricerca (Progetti di Ricerca di Interesse Nazionale), and by Swim Across America.	Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Atamaniuk J, 2012, NEPHROL DIAL TRANSPL, V27, P902, DOI 10.1093/ndt/gfr695; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bailey VJ, 2010, CLIN CHEM, V56, P1022, DOI 10.1373/clinchem.2009.140244; Bailey VJ, 2010, CHEMBIOCHEM, V11, P71, DOI 10.1002/cbic.200900630; Beck J, 2010, MOL CANCER RES, V8, P335, DOI 10.1158/1541-7786.MCR-09-0314; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Daniotti M, 2007, INT J CANCER, V120, P2439, DOI 10.1002/ijc.22598; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2013, NAT REV CLIN ONCOL, V10, P377, DOI 10.1038/nrclinonc.2013.80; Delgado PO, 2013, TUMOR BIOL, V34, P983, DOI 10.1007/s13277-012-0634-6; Destouni A, 2009, ACTA CARDIOL, V64, P51, DOI 10.2143/AC.64.1.2034362; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goncalves R, 2013, J NATL COMPR CANC NE, V11, P174, DOI 10.6004/jnccn.2013.0025; Hashad D, 2012, J CLIN LAB ANAL, V26, P467, DOI 10.1002/jcla.21548; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Holdhoff M, 2009, JNCI-J NATL CANCER I, V101, P1284, DOI 10.1093/jnci/djp240; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Ito K, 2002, JPN J CLIN ONCOL, V32, P54, DOI 10.1093/jjco/hyf011; Jahr S, 2001, CANCER RES, V61, P1659; Janne PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047; Jing RR, 2011, CLIN BIOCHEM, V44, P1074, DOI 10.1016/j.clinbiochem.2011.06.083; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Korabecna M, 2008, ANN NY ACAD SCI, V1137, P296, DOI 10.1196/annals.1448.014; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MANDEL P, 1948, C R Seances Soc Biol Fil, V142, P241; Mariani P, INT J CANCER; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Moreira VG, 2006, CLIN CHEM LAB MED, V44, P1410, DOI 10.1515/CCLM.2006.252; Morgan SR, 2012, CLIN MED INSIGHTS-PA, V5, P15, DOI 10.4137/CPath.S8798; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; No JH, 2012, ANTICANCER RES, V32, P3467; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Overman MJ, 2013, J CLIN ONCOL, V31, P17, DOI 10.1200/JCO.2012.43.1718; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Park JL, 2012, ONCOL LETT, V3, P921, DOI 10.3892/ol.2012.592; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Riedinger JM, 2006, ANN ONCOL, V17, P1234, DOI 10.1093/annonc/mdl120; Salvianti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049843; Schwarzenbach H, 2008, ANN NY ACAD SCI, V1137, P190, DOI 10.1196/annals.1448.025; Schwarzenbach H, 2011, MOL BIOSYST, V7, P2848, DOI 10.1039/c1mb05197k; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Shinozaki M, 2007, CLIN CANCER RES, V13, P2068, DOI 10.1158/1078-0432.CCR-06-2120; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Taly V, CLIN CHEM; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Weaver KD, 2006, CANCER INVEST, V24, P35, DOI 10.1080/07357900500449546; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshimasu T, 1999, INT J BIOL MARKER, V14, P99	86	1180	1210	27	395	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	FEB 20	2014	32	6					579	+		10.1200/JCO.2012.45.2011			9	Oncology	Oncology	AC8ND	WOS:000332788900018	24449238	Green Published, Green Accepted	Y	N	2021-06-18	
J	McCrory, P; Meeuwisse, W; Dvorak, J; Aubry, M; Bailes, J; Broglio, S; Cantu, RC; Cassidy, D; Echemendia, RJ; Castellani, RJ; Davis, GA; Ellenbogen, R; Emery, C; Engebretsen, L; Feddermann-Demont, N; Giza, CC; Guskiewicz, KM; Herring, S; Iverson, GL; Johnston, KM; Kissick, J; Kutcher, J; Leddy, JJ; Maddocks, D; Makdissi, M; Manley, GT; McCrea, M; Meehan, WP; Nagahiro, S; Patricios, J; Putukian, M; Schneider, KJ; Sills, A; Tator, CH; Turner, M; Vos, PE				McCrory, Paul; Meeuwisse, Willem; Dvorak, Jiri; Aubry, Mark; Bailes, Julian; Broglio, Steven; Cantu, Robert C.; Cassidy, David; Echemendia, Ruben J.; Castellani, Rudy J.; Davis, Gavin A.; Ellenbogen, Richard; Emery, Carolyn; Engebretsen, Lars; Feddermann-Demont, Nina; Giza, Christopher C.; Guskiewicz, Kevin M.; Herring, Stanley; Iverson, Grant L.; Johnston, Karen M.; Kissick, James; Kutcher, Jeffrey; Leddy, John J.; Maddocks, David; Makdissi, Michael; Manley, Geoff T.; McCrea, Michael; Meehan, William P.; Nagahiro, Shinji; Patricios, Jon; Putukian, Margot; Schneider, Kathryn J.; Sills, Allen; Tator, Charles H.; Turner, Michael; Vos, Pieter E.			Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; STANDARDIZED ASSESSMENT; AGREEMENT STATEMENT; FOOTBALL PLAYERS; GUIDELINES; MANAGEMENT; INTERVENTION; EPIDEMIOLOGY		[McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3084, Australia; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Dvorak, Jiri] Swiss Concuss Ctr, Zurich, Switzerland; [Dvorak, Jiri] Schulthess Clin, Spine Unit, Zurich, Switzerland; [Aubry, Mark] Int Ice Hockey Federat, Zurich, Switzerland; [Bailes, Julian] North Shore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Broglio, Steven] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA; [Cassidy, David] Toronto Western Res Inst, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Echemendia, Ruben J.] Univ Missouri Kansas City, Dept Psychol, State Coll, PA USA; [Echemendia, Ruben J.] Psychol & Neurobehav Assoc Inc, Miami, FL USA; [Castellani, Rudy J.] Univ Maryland, Dept Psychol, Baltimore, MD 21201 USA; [Davis, Gavin A.] Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Davis, Gavin A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Emery, Carolyn] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada; [Engebretsen, Lars] Oslo Univ Hosp, Dept Orthosurg, Oslo, Norway; [Feddermann-Demont, Nina] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Engebretsen, Lars] Schulthess Clin, Zurich, Switzerland; [Giza, Christopher C.] UCLA Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Mattel Childrens Hosp UCLA, Dept Pediat Pediat Neurol, Los Angeles, CA USA; [Guskiewicz, Kevin M.] Univ N Carolina, Sports Med Res Lab, Chapel Hill, NC USA; [Herring, Stanley] Univ Washington, Dept Rehabil Med Orthopaed & Sports Med, Seattle, WA 98195 USA; [Herring, Stanley] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Iverson, Grant L.] Red Sox Fdn & Massachusetts Gen Hosp Home Base Pr, Harvard Med Sch, Phys Med & Rehabil, Boston, MA USA; [Johnston, Karen M.] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada; [Kissick, James] Univ Ottawa, Int Paralymp Comm Med Comm, Carleton Univ, Sport Med Clin, Ottawa, ON, Canada; [Kutcher, Jeffrey] Sports Neurol Clin, Brighton, MI USA; [Leddy, John J.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY USA; [Maddocks, David] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Makdissi, Michael] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Makdissi, Michael] Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia; [Manley, Geoff T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [McCrea, Michael] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [Meehan, William P.] Childrens Hosp Boston, Sports Med, Boston, MA USA; [Meehan, William P.] Childrens Hosp Boston, Dept Emergency Med, Boston, MA USA; [Nagahiro, Shinji] Tokushima Daigaku Byoin, Tokushima, Japan; [Patricios, Jon] Univ Pretoria, Fac Hlth Sci, Sect Sports Med, Johannesburg, South Africa; [Patricios, Jon] Univ Witwatersrand, Fac Hlth Sci, Dept Emergency Med, Johannesburg, South Africa; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Sills, Allen] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Franklin, TN USA; [Sills, Allen] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Franklin, TN USA; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto, ON, Canada; [Tator, Charles H.] Canadian Sports Concuss Project, Toronto, ON, Canada; [Turner, Michael] ICHIRF, London, England; [Vos, Pieter E.] Slingeland Ziekenhuis, Dept Neurol, Doetinchem, Netherlands	McCrory, P (corresponding author), Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3084, Australia.	paulmccrory@icloud.com	McCrory, Paul/Q-8688-2019; Echemendia, Ruben/R-6939-2019; Emery, Carolyn/AAI-2761-2020	Echemendia, Ruben/0000-0001-6116-8462; Iverson, Grant/0000-0001-7348-9570; Patricios, Jon/0000-0002-6829-4098; Schneider, Kathryn/0000-0002-5951-5899; Davis, Gavin/0000-0001-8293-4496; McCrory, Paul/0000-0003-4850-0568			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg Joseph, 2005, Neurosurgery, V56, pE1166; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Davidhizar R, 2002, Accid Emerg Nurs, V10, P149, DOI 10.1054/aaen.2002.0365; Delaney J, 1997, CLIN J SPORT MED, V2000, P9; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Denke NJ, 2008, J EMERG NURS, V34, P363, DOI 10.1016/j.jen.2008.04.013; Gabbe B, 2003, J SCI MED SPORT, V6, P231, DOI 10.1016/S1440-2440(03)80259-1; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2017, BR J SPORTS IN PRESS; Manley G, 2017, BR J SPORTS IN PRESS; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meeuwisse W, 2017, BR J MED; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Theye Fred, 2004, Clin Med Res, V2, P165	46	1163	1167	9	99	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2017	51	11					838	847		10.1136/bjsports-2017-097699			10	Sport Sciences	Sport Sciences	EW3QP	WOS:000402416500003	28446457	Bronze	Y	N	2021-06-18	
J	Hemphill, JC; Bonovich, DC; Besmertis, L; Manley, GT; Johnston, SC				Hemphill, JC; Bonovich, DC; Besmertis, L; Manley, GT; Johnston, SC			The ICH score - A simple, reliable grading scale for intracerebral hemorrhage	STROKE			English	Article						intracerebral hemorrhage; medical management; outcome; prognosis; surgery	PROSPECTIVE RANDOMIZED TRIAL; SURGICAL-TREATMENT; GUIDELINES; PREDICTION; VALIDATION; MORTALITY; HEMATOMA; SURVIVAL; SURGERY; VOLUME	Background and Purpose-Intracerebral hemorrhage (ICH) constitutes 10% to 15% of all strokes and remains without a treatment of proven benefit. Despite several existing outcome prediction models for ICH, there is no standard clinical grading scale for ICH analogous to those for traumatic brain injury, subarachnoid hemorrhage, or ischemic stroke. Methods-Records of all patients with acute ICH presenting to the University of California, San Francisco during 1997-1998 were reviewed. Independent predictors of 30-day mortality were identified by logistic regression. A risk stratification scale (the ICH Score) was developed with weighting of independent predictors based on strength of association. Results-Factors independently associated with 30-day mortality were Glasgow Coma Scale score (P<0.001), age <greater than or equal to>80 years (P=0.001), infratentorial origin of ICH (P=0.03), ICH volume (P=0.047), and presence of intraventricular hemorrhage (P=0.052). The ICH Score was the sum of individual points assigned as follows: GCS score 3 to 4 (=2 points), 5 to 12 (=1), 13 to 15 (=0); age greater than or equal to 80 years yes (=1), no (=0); infratentorial origin yes (=1), no (=0); ICH volume greater than or equal to 30 cm(3) (=1), <30 cm(3) (=0); and intraventricular hemorrhage yes (=1), no (=0). All 26 patients with an ICH Score of 0 survived, and all 6 patients with an ICH Score of 5 died. Thirty-day mortality increased steadily with ICH Score (P<0.005). Conclusions-The ICH Score is a simple clinical grading scale that allows risk stratification on presentation with ICH. The use of a scale such as the ICH Score could improve standardization of clinical treatment protocols and clinical research studies in ICH.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Hemphill, JC (corresponding author), San Francisco Gen Hosp, Dept Neurol, Room 4 M62,1001 Potrero Ave, San Francisco, CA 94110 USA.			Hemphill, Claude/0000-0003-4019-7525	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-02042] Funding Source: Medline		AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BATJER HH, 1990, ARCH NEUROL-CHICAGO, V47, P1103, DOI 10.1001/archneur.1990.00530100071015; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CANDELISE L, 1988, LANCET, V1, P318; CAPLAN LR, 1992, LANCET, V339, P656, DOI 10.1016/0140-6736(92)90804-C; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DRAKE CG, 1988, J NEUROSURG, V68, P985; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Johnston SC, 2000, MUSCLE NERVE, V23, P839, DOI 10.1002/(SICI)1097-4598(200006)23:6<839::AID-MUS1>3.0.CO;2-V; Juarez V J, 1995, J Neurosci Nurs, V27, P283; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; JUVELA S, 1995, ARCH NEUROL-CHICAGO, V52, P1193, DOI 10.1001/archneur.1995.00540360071018; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LAMPL Y, 1995, STROKE, V26, P2249, DOI 10.1161/01.STR.26.12.2249; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Montes JM, 2000, STROKE, V31, P834, DOI 10.1161/01.STR.31.4.834; Morgenstern LB, 1998, NEUROLOGY, V51, P1359, DOI 10.1212/WNL.51.5.1359; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Qureshi AI, 1999, CRIT CARE MED, V27, P480, DOI 10.1097/00003246-199903000-00021; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; TEASDALE G, 1974, LANCET, V2, P81; Tellez H, 1973, STROKE, V4, P541, DOI 10.1161/01.STR.4.4.541; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; TUHRIM S, 1991, ANN NEUROL, V29, P658, DOI 10.1002/ana.410290614; TUHRIM S, 1995, CRIT CARE MED, V23, P950, DOI 10.1097/00003246-199505000-00026; YU YL, 1992, STROKE, V23, P967, DOI 10.1161/01.STR.23.7.967; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	31	1140	1174	2	32	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	APR	2001	32	4					891	896		10.1161/01.STR.32.4.891			6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	419LV	WOS:000167951300015	11283388	Bronze			2021-06-18	
J	Pandharipande, PP; Girard, TD; Jackson, JC; Morandi, A; Thompson, JL; Pun, BT; Brummel, NE; Hughes, CG; Vasilevskis, EE; Shintani, AK; Moons, KG; Geevarghese, SK; Canonico, A; Hopkins, RO; Bernard, GR; Dittus, RS; Ely, EW				Pandharipande, P. P.; Girard, T. D.; Jackson, J. C.; Morandi, A.; Thompson, J. L.; Pun, B. T.; Brummel, N. E.; Hughes, C. G.; Vasilevskis, E. E.; Shintani, A. K.; Moons, K. G.; Geevarghese, S. K.; Canonico, A.; Hopkins, R. O.; Bernard, G. R.; Dittus, R. S.; Ely, E. W.		BRAIN-ICU Study Investigators	Long-Term Cognitive Impairment after Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; FUNCTIONAL DISABILITY; REPEATABLE BATTERY; DELIRIUM DURATION; SURVIVORS; RISK; RELIABILITY; SEDATION; VALIDITY	BackgroundSurvivors of critical illness often have a prolonged and disabling form of cognitive impairment that remains inadequately characterized. MethodsWe enrolled adults with respiratory failure or shock in the medical or surgical intensive care unit (ICU), evaluated them for in-hospital delirium, and assessed global cognition and executive function 3 and 12 months after discharge with the use of the Repeatable Battery for the Assessment of Neuropsychological Status (population age-adjusted mean [SD] score, 10015, with lower values indicating worse global cognition) and the Trail Making Test, Part B (population age-, sex-, and education-adjusted mean score, 5010, with lower scores indicating worse executive function). Associations of the duration of delirium and the use of sedative or analgesic agents with the outcomes were assessed with the use of linear regression, with adjustment for potential confounders. ResultsOf the 821 patients enrolled, 6% had cognitive impairment at baseline, and delirium developed in 74% during the hospital stay. At 3 months, 40% of the patients had global cognition scores that were 1.5 SD below the population means (similar to scores for patients with moderate traumatic brain injury), and 26% had scores 2 SD below the population means (similar to scores for patients with mild Alzheimer's disease). Deficits occurred in both older and younger patients and persisted, with 34% and 24% of all patients with assessments at 12 months that were similar to scores for patients with moderate traumatic brain injury and scores for patients with mild Alzheimer's disease, respectively. A longer duration of delirium was independently associated with worse global cognition at 3 and 12 months (P=0.001 and P=0.04, respectively) and worse executive function at 3 and 12 months (P=0.004 and P=0.007, respectively). Use of sedative or analgesic medications was not consistently associated with cognitive impairment at 3 and 12 months. ConclusionsPatients in medical and surgical ICUs are at high risk for long-term cognitive impairment. A longer duration of delirium in the hospital was associated with worse global cognition and executive function scores at 3 and 12 months. (Funded by the National Institutes of Health and others; BRAIN-ICU ClinicalTrials.gov number, NCT00392795.) In this study, patients treated in ICUs were at high risk for new cognitive impairment during 12 months of follow-up, with 24% of patients having deficits similar in severity to those in Alzheimer's disease. A longer duration of delirium was associated with worse cognitive scores. Survivors of critical illness frequently have a prolonged and poorly understood form of cognitive dysfunction,(1)-(4) which is characterized by new deficits (or exacerbations of preexisting mild deficits) in global cognition or executive function. This long-term cognitive impairment after critical illness may be a growing public health problem, given the large number of acutely ill patients being treated in intensive care units (ICUs) globally.(5) Among older adults, cognitive decline is associated with institutionalization,(6) hospitalization,(7) and considerable annual societal costs.(8),(9) Yet little is known about the epidemiology of long-term cognitive impairment after critical illness. Delirium, a form of acute brain ...	[Pandharipande, P. P.; Hughes, C. G.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; [Pandharipande, P. P.; Hughes, C. G.] Tennessee Valley Healthcare Syst, Anesthesia Serv, Dept Vet Affairs, Nashville, TN USA; [Girard, T. D.; Brummel, N. E.; Bernard, G. R.; Ely, E. W.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Girard, T. D.; Pun, B. T.; Brummel, N. E.; Vasilevskis, E. E.; Dittus, R. S.; Ely, E. W.] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Girard, T. D.; Vasilevskis, E. E.; Dittus, R. S.; Ely, E. W.] Tennessee Valley Healthcare Syst, GRECC, Dept Vet Affairs, Nashville, TN USA; [Jackson, J. C.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med,Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Jackson, J. C.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jackson, J. C.] Tennessee Valley Healthcare Syst, Res Serv, Dept Vet Affairs, Nashville, TN USA; [Morandi, A.] Hosp Ancelle, Rehabil & Aged Care Unit, Cremona, Italy; [Morandi, A.] Geriatr Res Grp, Brescia, Italy; [Thompson, J. L.; Shintani, A. K.; Moons, K. G.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; [Vasilevskis, E. E.; Dittus, R. S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Moons, K. G.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Geevarghese, S. K.] Vanderbilt Univ, Sch Med, Dept Surg, Div Hepatobiliary Surg & Liver Transplantat, Nashville, TN 37212 USA; [Canonico, A.] St Thomas Hosp, Nashville, TN USA; [Hopkins, R. O.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, KY USA; [Hopkins, R. O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, R. O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	Pandharipande, PP (corresponding author), 1211 21st Ave S,MAB Ste 526, Nashville, TN 37212 USA.	pratik.pandharipande@vanderbilt.edu	Brummel, Nathan/AAB-5466-2020; Vasilevskis, Eduard/AAA-3065-2019; Ely, E. Wesley/Z-2018-2019; Girard, Timothy/I-3008-2019	Vasilevskis, Eduard/0000-0001-8165-5321; Ely, E. Wesley/0000-0003-3957-2172; Girard, Timothy/0000-0002-9833-4871; Brummel, Nathan/0000-0003-4308-0015; Pandharipande, Pratik/0000-0002-1389-8580; Thompson, Jennifer/0000-0001-8833-837X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL087738, R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG040157, R01AG027472, R01AG035117, K23AG034257, K23AG031322] Funding Source: NIH RePORTER	Funded by the National Institutes of Health and others	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chodosh J, 2004, J AM GERIATR SOC, V52, P1456, DOI 10.1111/j.1532-5415.2004.52407.x; Cunningham C, 2011, BIOCHEM SOC T, V39, P945, DOI 10.1042/BST0390945; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Harrell Frank E., 2001, REGRESSION MODELING; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Little RJA, 1987, STAT ANAL MISSING DA; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Llewellyn DJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-12; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C, 1998, REPEATABLE BATTERY A; Reitan RM., 1985, HALSTEAD REITAN NEUR; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2	40	1107	1145	7	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1306	1316		10.1056/NEJMoa1301372			11	Medicine, General & Internal	General & Internal Medicine	227KI	WOS:000325111200008	24088092	Green Accepted	Y	N	2021-06-18	
J	McKee, AC; Stein, TD; Nowinski, CJ; Stern, RA; Daneshvar, DH; Alvarez, VE; Lee, HS; Hall, G; Wojtowicz, SM; Baugh, CM; Riley, DO; Kubilus, CA; Cormier, KA; Jacobs, MA; Martin, BR; Abraham, CR; Ikezu, T; Reichard, RR; Wolozin, BL; Budson, AE; Goldstein, LE; Kowall, NW; Cantu, RC				McKee, Ann C.; Stein, Thor D.; Nowinski, Christopher J.; Stern, Robert A.; Daneshvar, Daniel H.; Alvarez, Victor E.; Lee, Hyo-Soon; Hall, Garth; Wojtowicz, Sydney M.; Baugh, Christine M.; Riley, David O.; Kubilus, Caroline A.; Cormier, Kerry A.; Jacobs, Matthew A.; Martin, Brett R.; Abraham, Carmela R.; Ikezu, Tsuneya; Reichard, Robert Ross; Wolozin, Benjamin L.; Budson, Andrew E.; Goldstein, Lee E.; Kowall, Neil W.; Cantu, Robert C.			The spectrum of disease in chronic traumatic encephalopathy	BRAIN			English	Article						axonal injury; brain trauma; frontotemporal lobar degeneration; neurodegenerative disorders; traumatic brain injury	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMER-RELATED CHANGES; REPETITIVE HEAD-INJURY; FOOTBALL-LEAGUE PLAYER; NEUROPATHOLOGIC ASSESSMENT; DEMENTIA-PUGILISTICA; NATIONAL INSTITUTE; PARKINSON-DISEASE; BRAIN TRAUMA	Chronic traumatic encephalopathy is a progressive tauopathy that occurs as a consequence of repetitive mild traumatic brain injury. We analysed post-mortem brains obtained from a cohort of 85 subjects with histories of repetitive mild traumatic brain injury and found evidence of chronic traumatic encephalopathy in 68 subjects: all males, ranging in age from 17 to 98 years (mean 59.5 years), including 64 athletes, 21 military veterans (86% of whom were also athletes) and one individual who engaged in self-injurious head banging behaviour. Eighteen age- and gender-matched individuals without a history of repetitive mild traumatic brain injury served as control subjects. In chronic traumatic encephalopathy, the spectrum of hyperphosphorylated tau pathology ranged in severity from focal perivascular epicentres of neurofibrillary tangles in the frontal neocortex to severe tauopathy affecting widespread brain regions, including the medial temporal lobe, thereby allowing a progressive staging of pathology from stages I-IV. Multifocal axonal varicosities and axonal loss were found in deep cortex and subcortical white matter at all stages of chronic traumatic encephalopathy. TAR DNA-binding protein 43 immunoreactive inclusions and neurites were also found in 85% of cases, ranging from focal pathology in stages I-III to widespread inclusions and neurites in stage IV. Symptoms in stage I chronic traumatic encephalopathy included headache and loss of attention and concentration. Additional symptoms in stage II included depression, explosivity and short-term memory loss. In stage III, executive dysfunction and cognitive impairment were found, and in stage IV, dementia, word-finding difficulty and aggression were characteristic. Data on athletic exposure were available for 34 American football players; the stage of chronic traumatic encephalopathy correlated with increased duration of football play, survival after football and age at death. Chronic traumatic encephalopathy was the sole diagnosis in 43 cases (63%); eight were also diagnosed with motor neuron disease (12%), seven with Alzheimer's disease (11%), 11 with Lewy body disease (16%) and four with frontotemporal lobar degeneration (6%). There is an ordered and predictable progression of hyperphosphorylated tau abnormalities through the nervous system in chronic traumatic encephalopathy that occurs in conjunction with widespread axonal disruption and loss. The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein.	[McKee, Ann C.; Stein, Thor D.; Wojtowicz, Sydney M.; Cormier, Kerry A.; Budson, Andrew E.; Kowall, Neil W.] VA Boston Healthcare Syst, US Dept Vet Affairs, Boston, MA 02130 USA; [McKee, Ann C.; Nowinski, Christopher J.; Stern, Robert A.; Daneshvar, Daniel H.; Alvarez, Victor E.; Wojtowicz, Sydney M.; Baugh, Christine M.; Riley, David O.; Jacobs, Matthew A.; Cantu, Robert C.] Boston Univ, Ctr Study Traumat Encephalopathy, Sch Med, Boston, MA 02118 USA; [McKee, Ann C.; Stern, Robert A.; Lee, Hyo-Soon; Kubilus, Caroline A.; Abraham, Carmela R.; Ikezu, Tsuneya; Wolozin, Benjamin L.; Budson, Andrew E.; Goldstein, Lee E.; Kowall, Neil W.] Boston Univ, Alzheimers Dis Ctr, Sch Med, Boston, MA 02118 USA; [McKee, Ann C.; Nowinski, Christopher J.; Stern, Robert A.; Daneshvar, Daniel H.; Alvarez, Victor E.; Lee, Hyo-Soon; Baugh, Christine M.; Riley, David O.; Kubilus, Caroline A.; Jacobs, Matthew A.; Ikezu, Tsuneya; Wolozin, Benjamin L.; Budson, Andrew E.; Goldstein, Lee E.; Kowall, Neil W.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.; Kowall, Neil W.] Boston Univ, Dept Pathol, Sch Med, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA 02451 USA; [Stern, Robert A.; Cantu, Robert C.] Boston Univ, Dept Neurosurg, Sch Med, Boston, MA 02118 USA; [Hall, Garth] Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA; [Martin, Brett R.] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02118 USA; [Abraham, Carmela R.] Boston Univ, Dept Biochem, Sch Med, Boston, MA 02118 USA; [Ikezu, Tsuneya; Wolozin, Benjamin L.] Boston Univ, Dept Pharmacol, Sch Med, Boston, MA 02118 USA; [Reichard, Robert Ross; Goldstein, Lee E.] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Goldstein, Lee E.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Dept Opthamol, Sch Med, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Dept Biomed Engn, Sch Med, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA	McKee, AC (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave,151-C, Boston, MA 02130 USA.	ann.mckee@va.gov	, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020; Kowall, Neil/M-5378-2019	Baugh, Christine/0000-0002-9340-6338; Kowall, Neil/0000-0002-6624-0213; Goldstein, Lee/0000-0001-8419-9800; Stein, Thor/0000-0001-6954-4477; Daneshvar, Daniel/0000-0003-3691-9513; Ikezu, Tsuneya/0000-0002-3979-8596; Abraham, Carmela/0000-0002-6649-1960; Stern, Robert/0000-0002-5008-077X	Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30 AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [AG1649]; National Institute of Neurological Disorders and Stroke, National Institute of Aging, National Institute of Child Health and Human Development [NS078337]; Sports Legacy Institute; National Operating Committee on Standards for Athletic Equipment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060872, R21NS066108, R21NS073679, R01NS078337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	The Department of Veterans Affairs; Veterans Affairs Biorepository (CSP 501); Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C to A. M.); National Institute of Aging Boston University Alzheimer's Disease Center [P30 AG13846 to N.W.K.; supplement 0572063345-5 to A. C. M., R. A. S.]; National Institute of Aging Boston University Framingham Heart Study R01 [AG1649]; National Institute of Neurological Disorders and Stroke, National Institute of Aging, National Institute of Child Health and Human Development R01 [NS078337 to R. A. S.]; Sports Legacy Institute; National Operating Committee on Standards for Athletic Equipment, and the resources and use of facilities at the Edith Nourse Rogers Memorial Veterans Hospital in Bedford, MA. This work was also supported by an unrestricted gift from the National Football League. The funding sources were not involved in the preparation, review or approval of this manuscript.	Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Brown LM, 2005, INT J GERIATR PSYCH, V20, P911, DOI 10.1002/gps.1375; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1949, HOMMAGE C VINCENT; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gandy S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004274; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hall GF, 2012, PRION, V6, P223, DOI 10.4161/pri.19912; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Lace G, 2012, DEMENT GERIATR COGN, V34, P15, DOI 10.1159/000341581; Liang ZH, 2009, J ALZHEIMERS DIS, V17, P531, DOI 10.3233/JAD-2009-1069; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lopez-Gonzalez I, 2013, BRAIN PATHOL, V23, P144, DOI 10.1111/j.1750-3639.2012.00627.x; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; McKee A, 2011, J NEUROPATH EXP NEUR, V70, P517; McKee AC, 2006, J NEUROPATH EXP NEUR, V65, P621, DOI 10.1097/00005072-200606000-00010; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKenzie JE, 1996, NEURODEGENERATION, V5, P259, DOI 10.1006/neur.1996.0034; MCNAIR DM, 1984, PSYCHOPHARMACOLOGY, V83, P134, DOI 10.1007/BF00429721; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	81	1100	1106	7	285	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2013	136		1				43	64		10.1093/brain/aws307			22	Clinical Neurology; Neurosciences	Neurosciences & Neurology	089KR	WOS:000314909900006	23208308	Green Published, Bronze	Y	N	2021-06-18	
J	Robertson, IH; Manly, T; Andrade, J; Baddeley, BT; Yiend, J				Robertson, IH; Manly, T; Andrade, J; Baddeley, BT; Yiend, J			'Oops!': Performance correlates of everyday attentional failures in traumatic brain injured and normal subjects	NEUROPSYCHOLOGIA			English	Article						attention; traumatic brain injury; attentional failures in daily life; sustained attention; brain damage	CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; DEFICITS; VIGILANCE; SYSTEM; DAMAGE	Insufficient attention to tasks can result in slips of action as automatic, unintended action sequences are triggered inappropriately. Such slips arise in part from deficits in sustained attention, which are particularly likely to happen following frontal lobe and white matter damage in traumatic brain injury (TBI). We present a reliable laboratory paradigm that elicits such slips of action and demonstrates high correlations between the severity of brain damage and relative-reported everyday attention failures in a group of 34 TBI patients. We also demonstrate significant correlations between self- and informant-reported everyday attentional failures and performance on this paradigm in a group of 75 normal controls. The paradigm (the Sustained Attention to Response Task-SART) involves the withholding of key presses to rare (one in nine) targets. Performance on the SART correlates significantly with performance on tests of sustained attention, but not other types of attention, supporting the view that this is indeed a measure of sustained attention. We also show that errors (false presses) on the SART can be predicted by a significant shortening of reaction times in the immediately preceding responses, supporting the view that these errors are a result of 'drift' of controlled processing into automatic responding consequent on impaired sustained attention to task. We also report a highly significant correlation of -0.58 between SART performance and Glasgow Coma Scale Scores in the TBI group. (C) 1997 Elsevier Science Ltd.		Robertson, IH (corresponding author), ADDENBROOKES HOSP,MRC,APPL PSYCHOL UNIT,REHABIL RES GRP,BOX 58,CAMBRIDGE CB2 2QQ,ENGLAND.		Yiend, Jenny/G-1008-2011; Andrade, Jackie/H-1215-2013; Yiend, Jenny/AAQ-8439-2020	Andrade, Jackie/0000-0002-6626-7192; Yiend, Jenny/0000-0002-1967-6292; Robertson, Ian H/0000-0001-8637-561X			Baddeley A.D., 1992, SPEED CAPACITY LANGU; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CHRONICLE EP, IN PRESS NEUROPSYCHO; COHEN RM, 1992, EXP BRAIN RES, V92, P165; COHEN RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; DEARY IJ, 1991, PERS INDIV DIFFER, V12, P983, DOI 10.1016/0191-8869(91)90027-9; FISK AD, 1981, HUM FACTORS, V23, P737; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GRONWALL D, 1974, LANCET, V2, P1452; GRONWALL D, 1975, LANCET, V2, P995; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; MACKWORTH JF, 1968, PSYCHOL REV, V75, P308, DOI 10.1037/h0025896; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Nelson H., 1982, NATIONAL ADULT READI; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RABBITT P, 1990, BRIT J PSYCHOL, V81, P1, DOI 10.1111/j.2044-8295.1990.tb02342.x; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson I. H., 1994, TEST EVERYDAY ATTENT; RUECKERT L, 1994, NEUROPSYCHOLOGIA, V32, P159, DOI 10.1016/0028-3932(94)90003-5; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHWARTZ MF, 1993, J HEAD TRAUMA REHAB, V8, P59, DOI DOI 10.1097/00001199-199303000-00007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; STUSS D, 1983, PSYCHOL BULL, V95, P3; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328	46	1099	1117	7	138	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUN	1997	35	6					747	758		10.1016/S0028-3932(97)00015-8			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	XE587	WOS:A1997XE58700001	9204482				2021-06-18	
J	Kamnitsas, K; Ledig, C; Newcombe, VFJ; Sirnpson, JP; Kane, AD; Menon, DK; Rueckert, D; Glocker, B				Kamnitsas, Konstantinos; Ledig, Christian; Newcombe, Virginia F. J.; Sirnpson, Joanna P.; Kane, Andrew D.; Menon, David K.; Rueckert, Daniel; Glocker, Ben			Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation	MEDICAL IMAGE ANALYSIS			English	Article						3D convolutional neural network; Fully connected CRF; Segmentation Brain lesions; Deep learning	HIGH-GRADE GLIOMAS; MULTIPLE-SCLEROSIS; DEFORMABLE REGISTRATION; TUMOR SEGMENTATION; INJURY; MR; NETWORKS; IMAGES	We propose a dual pathway, 11-layers deep, three-dimensional Convolutional Neural Network for the challenging task of brain lesion segmentation. The devised architecture is the result of an in-depth analysis of the limitations of current networks proposed for similar applications. To overcome the computational burden of processing 3D medical scans, we have devised an efficient and effective dense training scheme which joins the processing of adjacent image patches into one pass through the network while automatically adapting to the inherent class imbalance present in the data. Further, we analyze the development of deeper, thus more discriminative 3D CNNs. In order to incorporate both local and larger contextual information, we employ a dual pathway architecture that processes the input images at multiple scales simultaneously. For post-processing of the network's soft segmentation, we use a 3D fully connected Conditional Random Field which effectively removes false positives. Our pipeline is extensively evaluated on three challenging tasks of lesion segmentation in multi-channel MRI patient data with traumatic brain injuries, brain tumours, and ischemic stroke. We improve on the state-of-the-art for all three applications, with top ranking performance on the public benchmarks BRATS 2015 and ISLES 2015. Our method is computationally efficient, which allows its adoption in a variety of research and clinical settings. The source code of our implementation is made publicly available. (C) 2016 The Authors. Published by Elsevier B.V.	[Kamnitsas, Konstantinos; Ledig, Christian; Rueckert, Daniel; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, London, England; [Newcombe, Virginia F. J.; Sirnpson, Joanna P.; Kane, Andrew D.; Menon, David K.] Univ Cambridge, Univ Div Anaesthesia, Dept Med, Cambridge CB2 1TN, England; [Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 1TN, England	Kamnitsas, K (corresponding author), Imperial Coll London, Biomed Image Anal Grp, London, England.	konstantinos.kamnitsas12@imperial.ac.uk	Kane, Andrew D/C-5876-2013	Kane, Andrew D/0000-0001-9488-4086; Glocker, Ben/0000-0002-4897-9356; Ledig, Christian/0000-0003-4862-3138; Newcombe, Virginia/0000-0001-6044-9035	EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N023668/1]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at CambridgeNational Institute for Health Research (NIHR); UK Department of Health; Imperial College London; Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; NIHR Senior Investigator Award; NVIDIA Corporation; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N023668/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000183B, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2009-14-007, NF-SI-0512-10090] Funding Source: researchfish	This work is supported by the EPSRC First Grant scheme (grant ref no. EP/N023668/1) and partially funded under the 7th Framework Programme by the European Commission (TBIcare: http: //www.tbicare.eu/; CENTER-TBI: https://www.center-tbi.eu/). This work was further supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]), the UK National Institute of Health Research Biomedical Research Centre at Cambridge and Technology Platform funding provided by the UK Department of Health. KK is supported by the Imperial College London PhD Scholarship Programme. VFJN is supported by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship. DKM is supported by an NIHR Senior Investigator Award. We gratefully acknowledge the support of NVIDIA Corporation with the donation of two Titan X GPUs for our research.	Bakas Spyridon, 2016, Brainlesion, V9556, P144, DOI [10.1007/978-3-319-30858-6_13, 10.1007/978-3-319-30858-6_1]; Bastien F., 2012, DEEP LEARN UNS FEAT; Brosch T, 2015, LECT NOTES COMPUT SC, V9351, P3, DOI 10.1007/978-3-319-24574-4_1; Cardoso M Jorge, 2015, Inf Process Med Imaging, V24, P17, DOI 10.1007/978-3-319-19992-4_2; Carey LM, 2013, FUTUR NEUROL, V8, P507, DOI 10.2217/FNL.13.39; Chen L.-C., 2014, ARXIV14127062; Choromanska A, 2015, AISTATS; Ciresan Dan, 2012, ADV NEURAL INFORM PR, P2843, DOI DOI 10.5555/2999325.2999452; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Doyle S, 2013, P NCI MICCAI BRATS, P18; Erihov M, 2015, LECT NOTES COMPUT SC, V9351, P636, DOI 10.1007/978-3-319-24574-4_76; Feng C., 2015, INT WORKSH BRAINL GL, P233; Gal Y., 2015, ARXIV150602142; Geremia E, 2010, LECT NOTES COMPUT SC, V6361, P111; Glorot X., 2010, P 13 INT C ART INT S, P249; Gooya A, 2011, LECT NOTES COMPUT SC, V6892, P532, DOI 10.1007/978-3-642-23629-7_65; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Halme H.-L., 2015, INT WORKSH BRAINL GL, P211; Havaei M., 2015, ARXIV150503540; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton G. E., 2012, ARXIV PREPRINT ARXIV; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Ikram MA, 2010, NEUROBIOL AGING, V31, P378, DOI 10.1016/j.neurobiolaging.2008.04.008; Ioffe S, 2015, 150203167 ARXIV; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jarrett K, 2009, IEEE I CONF COMP VIS, P2146, DOI 10.1109/ICCV.2009.5459469; Kamnitsas K, 2015, P ISLES MICCAI; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Krahenbuhl P., 2011, ADV NEURAL INFORM PR, V24, P109; Krizhevsky A, 2012, NEURAL INFORM PROCES, P1097, DOI DOI 10.1145/3065386; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Li RJ, 2014, LECT NOTES COMPUT SC, V8675, P305, DOI 10.1007/978-3-319-10443-0_39; Liu XX, 2014, LECT NOTES COMPUT SC, V8675, P97, DOI 10.1007/978-3-319-10443-0_13; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lyksborg Mark, 2015, Image Analysis. 19th Scandinavian Conference, SCIA 2015. Proceedings: LNCS 9127, P201, DOI 10.1007/978-3-319-19665-7_17; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maier O, 2017, MED IMAGE ANAL, V35, P250, DOI 10.1016/j.media.2016.07.009; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mitra J, 2014, NEUROIMAGE, V98, P324, DOI 10.1016/j.neuroimage.2014.04.056; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Noh H, 2015, IEEE I CONF COMP VIS, P1520, DOI 10.1109/ICCV.2015.178; Parisot S, 2012, LECT NOTES COMPUT SC, V7511, P651, DOI 10.1007/978-3-642-33418-4_80; Pereira Sergio, 2016, Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries. First International Workshop, Brainles 2015, held in conjunction with MICCAI 2015. Revised Selected Papers: LNCS 9556, P131, DOI 10.1007/978-3-319-30858-6_12; Prasoon A, 2013, LECT NOTES COMPUT SC, V8150, P246, DOI 10.1007/978-3-642-40763-5_31; Prastawa M, 2004, MED IMAGE ANAL, V8, P275, DOI 10.1016/j.media.2004.06.007; Rao A, 2014, I S BIOMED IMAGING, P333, DOI 10.1109/ISBI.2014.6867876; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roth HR, 2014, LECT NOTES COMPUT SC, V8673, P520, DOI 10.1007/978-3-319-10404-1_65; Rovira A, 2008, EUR J RADIOL, V67, P409, DOI 10.1016/j.ejrad.2008.02.044; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sermanet Pierre, 2014, INT C LEARN REPR; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K., 2014, VERY DEEP CONVOLUTIO; Springenberg J.T., 2014, ARXIV14126806; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Sutskever I., 2013, INT C MACHINE LEARNI, V28, P1139, DOI 10.1007/s00287-015-0911-z; Tieleman T., 2012, COURSERA NEURAL NETW; Tustison N., 2013, P BRATS MICCAI; Urban G., 2014, P BRATS MIC CAI; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Weiss N, 2013, LECT NOTES COMPUT SC, V8149, P735, DOI 10.1007/978-3-642-40811-3_92; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Ye DH, 2013, LECT NOTES COMPUT SC, V8149, P606, DOI 10.1007/978-3-642-40811-3_76; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zheng S, 2015, IEEE I CONF COMP VIS, P1529, DOI 10.1109/ICCV.2015.179; Zikic D., 2014, P BRATS MICCAI; Zikic D, 2012, LECT NOTES COMPUT SC, V7512, P369, DOI 10.1007/978-3-642-33454-2_46	73	1068	1101	29	333	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	FEB	2017	36						61	78		10.1016/j.media.2016.10.004			18	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	EJ5HH	WOS:000393247900007	27865153	Green Published, Other Gold	Y	N	2021-06-18	
J	Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP				Guskiewicz, KM; McCrea, M; Marshall, SW; Cantu, RC; Randolph, C; Barr, W; Onate, JA; Kelly, JP			Cumulative effects associated with recurrent concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERIMENTAL HEAD-INJURY; LONGITUDINAL DATA-ANALYSIS; POISSON REGRESSION-MODELS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL DEFICITS; CEREBRAL CONCUSSION; SAFE RETURN; PERFORMANCE; METABOLISM	Context Approximately 300000 sport-related concussions occur annually in the United States, and the likelihood of serious sequelae may increase with repeated head injury. Objective To estimate the incidence of concussion and time to recovery after concussion in collegiate football players. Design, Setting, and Participants Prospective cohort study of 2905 football players from 25 US colleges were tested at preseason baseline in 1999, 2000, and 2001 on a variety of measures and followed up prospectively to ascertain concussion occurrence. Players injured with a concussion were monitored until their concussion symptoms resolved and were followed up for repeat concussions until completion of their collegiate football career or until the end of the 2001 football season. Main Outcome Measures Incidence of concussion and repeat concusion; type and duration of symptoms and course of recovery among players who were injured with a concussion during the seasons. Results During follow-up of 4251 player-seasons, 184 players (6.3%) had a concussion, and 12 (6.5%) of these players had a repeat concussion within the same season. There was an association between reported number of previous concussions and likelihood of incident concussion. Players reporting a history of 3 or more previous concussions were 3.0 (95% confidence interval, 1.6-5.6) times more likely to have an incident concussion than players with no concussion history. Headache was the most commonly reported symptom at the time of injury (85.2%), and mean overall symptom duration was 82 hours. Slowed recovery was associated with a history of multiple previous concussions (30.0% of those with greater than or equal to3 previous concussions had symptoms lasting >1 week compared with 14.6% of those with 1 previous concussion). Of the 12 incident within-season repeat concussions, 11 (91.7%) occurred within 10 days of the first injury, and 9 (75.0%) occurred within 7 days of the first injury. Conclusions Our study suggests that players with a history of previous concussions are more likely to have future concussive injuries than those with no history; 1 in 15 players With a concussion may have additional concussions in the same playing season; and previous concussions may be associated with slower recovery of neurological function.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthopaed, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Northwestern Univ, Feinberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Rehabil Sci, Athlet Training Program, Boston, MA 02215 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, CB 8700,211 Fetzer, Chapel Hill, NC 27599 USA.		Onate, James/E-3790-2011	Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Barr, William/0000-0001-7711-7758			ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT., 1989, MILD HEAD INJURY, P257; Bruce D A, 1982, Clin Sports Med, V1, P495; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; CANTU RC, 1991, ADOLESC MED, V2, P141; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; *COL MED SOC SPORT, 1994, P MILD BRAIN INJ SPO, P106; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; Dick R, 2002, 2001 2002 NCAA INJUR; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2001, J ATHL TRAINING, V36, P280; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2000, NEUROLOGIC ATHLETIC, P80; Greenland S., 1998, MODERN EPIDEMIOLOGY; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; MCCREA M, IN PRESS CLIN J SPOR; MCCULLOCH CE, 2001, GEN LINEAR MIXED MOD, P223; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; *NAT COLL ATHL ASS, 2002, 1981 1982 2001 2002; Nelson S, 1966, HEAD INJURY, P444; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; PRINCE DA, 1973, BRAIN RES, V50, P489, DOI 10.1016/0006-8993(73)90758-0; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	54	1042	1056	2	232	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2549	2555		10.1001/jama.290.19.2549			7	Medicine, General & Internal	General & Internal Medicine	744DQ	WOS:000186613000024	14625331	Bronze			2021-06-18	
J	Thies, W; Bleiler, L				Thies, William; Bleiler, Laura		Alzheimer's Assoc	2013 Alzheimer's disease facts and figures Alzheimer's Association	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Dementia; Diagnostic criteria; Prevalence; Incidence; Mortality; Caregivers; Family caregiver; Spouse caregiver; Health care costs; Health care expenditures; Long-term care costs; Medicare spending; Medicaid spending; Long-distance caregiver; Activities of daily living; Instrumental activities of daily living	MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; NURSING-HOME PLACEMENT; TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; NATIONAL INSTITUTE; DIAGNOSTIC GUIDELINES; LEISURE ACTIVITIES; CHRONIC STRESS; CARDIOVASCULAR-HEALTH	This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general. It also explores the roles and unique challenges of long-distance caregivers, as well as interventions that target those challenges. An estimated 5.2 million Americans have AD. Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million comprise the older onset AD population. Throughout the coming decades, the baby boom generation is projected to add about 10 million to the total number of people in the United States with AD. Today, someone in America develops AD every 68 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million. AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older. Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%. The number of deaths from AD as determined by official death certificates (83,494 in 2010) likely underrepresents the number of AD-related deaths in the United States. A projected 450,000 older Americans with AD will die in 2013, and a large proportion will die as a result of complications of AD. In 2012, more than 15 million family members and other unpaid caregivers provided an estimated 17.5 billion hours of care to people with AD and other dementias, a contribution valued at more than $216 billion. Medicare payments for services to beneficiaries age 65 years and older with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2013 for health care, long-term care, and hospice services for people age 65 years and older with dementia are expected to be $203 billion (not including the contributions of unpaid caregivers). An estimated 2.3 million caregivers of people with AD and other dementias live at least 1 hour away from the care recipient. These "long-distance caregivers" face unique challenges, including difficulty in assessing the care recipient's true health condition and needs, high rates of family disagreement regarding caregiving decisions, and high out-of-pocket expenses for costs related to caregiving. Out-of-pocket costs for long-distance caregivers are almost twice as high as for local caregivers. (C) 2013 The Alzheimer's Association. All rights reserved.			lbleiler@alz.org					Acton GJ, 2001, RES NURS HEALTH, V24, P349, DOI 10.1002/nur.1036; Aguero-Torres H, 1999, J CLIN EPIDEMIOL, V52, P737, DOI 10.1016/S0895-4356(99)00067-0; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert S. M., 2010, METLIFE STUDY WORKIN; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Alzheimer's Disease Education & Referral Center, 2011, PUBL NIH; American Association for Long-Term Care Insurance, 2011, 2011 SOURC LONG TERM; American Health Care Association, 2004, NURS FAC BEDS DED SP; American Health Care Association, 2012, LTC STATS NURS FAC O, P7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aneshensel C.S., 1995, PROFILES CAREGIVING; [Anonymous], TABULATIONS DE UNPUB; [Anonymous], DEATHS FIN DAT 2010; [Anonymous], 2011, TABULATIONS BASED DA; [Anonymous], 2011, MED FACT SHEET PRESC; [Anonymous], 2002, NAT STUD AD DAY SERV; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Barnes LL, 2003, NEUROLOGY, V60, P1777, DOI 10.1212/01.WNL.0000065892.67099.2A; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BAUMGARTEN M, 1992, J CLIN EPIDEMIOL, V45, P61, DOI 10.1016/0895-4356(92)90189-T; Beck C, 1999, INT J GERIATR PSYCH, V14, P197, DOI 10.1002/(SICI)1099-1166(199903)14:3<197::AID-GPS972>3.0.CO;2-Q; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Benefield LE, 2007, CLIN INTERV AGING, V2, P267; Bledsoe LK, 2010, AGEING INT, V35, P293, DOI 10.1007/s12126-010-9062-3; Bloudek LM, 2011, J ALZHEIMERS DIS, V26, P627, DOI 10.3233/JAD-2011-110458; Bouldin ED, CAREGIVING US CAREGI; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Buhr GT, 2006, GERONTOLOGIST, V46, P52, DOI 10.1093/geront/46.1.52; BURNS A, 1990, AGE AGEING, V19, P341, DOI 10.1093/ageing/19.5.341; Bynum J., 2011, TABULATIONS BA UNPUB; Cagle JG, 2012, J GERONTOL SOC WORK, V55, P682, DOI 10.1080/01634372.2012.703763; Caplan C, 2004, OUT OF POCKET SPENDI; Centers for Medicare and Medicaid Services, 2008, MLN MATTERS; Centers for Medicare and Medicaid Services, 2012, CMS PUBL, V11347; Centers for Medicare  Medicaid Services, HLTH EXP STAT RES 19; Chattillion EA, 2012, PSYCHOL HEALTH, V27, P1134, DOI 10.1080/08870446.2011.637559; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Clarfield AM, 2003, ARCH INTERN MED, V163, P2219, DOI 10.1001/archinte.163.18.2219; Clark PC, 2005, J AM GERIATR SOC, V53, P2012, DOI 10.1111/j.1532-5415.2005.53569.x; Cohen-Mansfield J, 2001, AM J GERIAT PSYCHIAT, V9, P361, DOI 10.1176/appi.ajgp.9.4.361; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Czaja SJ, 2002, PSYCHOSOM MED, V64, P469, DOI 10.1097/00006842-200205000-00011; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; DeNavas-Walt C., 2011, INCOME POVERTY HLTH; Dilworth-Anderson P, 2008, ALZHEIMERS DEMENT, V4, P305, DOI 10.1016/j.jalz.2008.03.001; Edwards M., 2010, DISTANCE CAREGIVERS; Eisdorfer C, 2003, GERONTOLOGIST, V43, P521, DOI 10.1093/geront/43.4.521; Eldercare Workforce Alliance, 2012, GER WORKF SHORT LOOM; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Evercare, 2007, EVERCARE STUDY FAMIL; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feinberg L., 2011, VALUING INVALUABLE 2; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Fitten LJ, 2001, J AM GERIATR SOC, V49, P1301, DOI 10.1046/j.1532-5415.2001.49257.x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fortinsky RH, 2004, GERONTOLOGIST, V44, P739, DOI 10.1093/geront/44.6.739; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fredman L, 2006, PREV MED, V43, P226, DOI 10.1016/j.ypmed.2006.04.009; Fredman L, 2010, J AM GERIATR SOC, V58, P937, DOI 10.1111/j.1532-5415.2010.02808.x; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Gaugler JE, 2002, INT J AGING HUM DEV, V54, P205, DOI 10.2190/FACK-QE61-Y2J8-5L68; Gaugler JE, 2008, DEMENTIA FAMILIES IN; Gaugler JE, 2008, J AM GERIATR SOC, V56, P421, DOI 10.1111/j.1532-5415.2007.01593.x; Gaugler JE, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-85; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Grossberg GT, 2010, PRIM CARE COMPANION, V12; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Hebert LE, 2004, NEUROLOGY, V62, P1645, DOI 10.1212/01.WNL.0000123018.01306.10; Hebert LE, 2001, AM J EPIDEMIOL, V153, P132, DOI 10.1093/aje/153.2.132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, ALZHEIMERS DIS US 20; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Hooker K, 2002, J GERONTOL B-PSYCHOL, V57, pP453, DOI 10.1093/geronb/57.5.P453; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Institute for Social Research, 2009, NAT FOOTB LEAG PLAYE; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jellinger KA, 2007, ALZHEIMERS DEMENT, V3, P40, DOI 10.1016/j.jalz.2006.09.002; Johnson R. W., 2006, PROFILE FRAIL OLDER; Joseph AE, 1998, SOC SCI MED, V46, P631, DOI 10.1016/S0277-9536(97)00181-0; Kaiser Commission on Medicaid and the Uninsured, 2012, MED LONG TERM CAR SE; Kaiser Family Foundation Program on Medicare Policy, 2011, PROJ INC ASS WHAT MI; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Koerin Beverly B., 2002, J GERONTOLOGICAL SOC, V40, P63, DOI DOI 10.1300/J083V40N01_05; Kramer NA., 2000, PROFESSIONAL PSYCHOL, P227; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LAWTON L, 1994, J MARRIAGE FAM, V56, P57, DOI 10.2307/352701; Lee CC, 2010, J GERONTOL B-PSYCHOL, V65, P185, DOI 10.1093/geronb/gbp131; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levy K, 2012, DRUG AGING, V29, P167, DOI 10.2165/11599140-000000000-00000; LIN G, 1995, RES AGING, V17, P303, DOI 10.1177/0164027595173004; Llanque SM, 2012, AM J ALZHEIMERS DIS, V27, P23, DOI 10.1177/1533317512439794; Logsdon RG, 2008, LANCET, V372, P182, DOI 10.1016/S0140-6736(08)61048-X; Logsdon RG, 2007, PSYCHOL AGING, V22, P28, DOI 10.1037/0882-7974.22.1.28; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MACERA CA, 1992, J AM GERIATR SOC, V40, P479, DOI 10.1111/j.1532-5415.1992.tb02015.x; Manly J, 2004, CRITICAL PERSPECTIVE, P95; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Marziali E, 2006, J AM MED DIR ASSOC, V7, P154, DOI 10.1016/j.jamda.2005.07.007; Mausbach BT, 2012, HEALTH PSYCHOL, V31, P433, DOI 10.1037/a0027783; Mausbach BT, 2010, J AM COLL CARDIOL, V55, P2599, DOI 10.1016/j.jacc.2009.11.093; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; McCabe MP, 2007, AGING MENT HEALTH, V11, P505, DOI 10.1080/13607860601086405; McDonald's Corporation, MCDON CORP ANN REP 2; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medicare Payment Advisory Commission (MedPAC), 2012, REP C MED PAYM POL, P257; Met Life Mature Market Institute, 2012, MARK SURV LONG TERM; MetLife Mature Market Institute, 2004, MIL AW METLIFE STUD; MetLife Mature Market Institute and LifePlans Inc, 2006, METLIFE STUD ALZH DI; Mickus MA, 2002, AGING MENT HEALTH, V6, P387, DOI 10.1080/1360786021000007009; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Mitchell G, 2006, GERONTOLOGIST, V46, P483, DOI 10.1093/geront/46.4.483; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Mittelman MS, 2003, COUNSELING ALZHEIMER; Mollica RL, 2012, ASSISTED LIVING RESI; Moody's Investors Service, 2012, SPEC COMM LONG TERM; National Alliance for Caregiving American Association of Retired Persons, 2009, CAR US DAT AN UNPUB; National Alliance for Caregiving; American Association of Retired Persons, CAR US; National Alliance for Caregiving American Association of Retired Persons, 2009, CAR US NOV 2009; National Center for Health Statistics, 2002, NATL VITAL STAT REPO; National Conference of State Legislatures, CERT NEED STAT HLTH; National Institutes of Health, TRAUM BRAIN INJ; Neuman P, 2007, HEALTH AFFAIR, V26, P1692, DOI 10.1377/hlthaff.26.6.1692; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; OKEEFFE J, 2006, ADULT DAY SERVICES K; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; OLICHNEY JM, 1995, J AM GERIATR SOC, V43, P890, DOI 10.1111/j.1532-5415.1995.tb05532.x; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PEW RW, 2004, STEER COMM WORKSH TE; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Port CL, 2005, GERONTOLOGIST, V45, P87, DOI 10.1093/geront/45.suppl_1.87; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/nrneurol.2011.2; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rocca WA, 1998, AM J EPIDEMIOL, V148, P51, DOI 10.1093/oxfordjournals.aje.a009560; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Roepke SK, 2012, STRESS, V15, P121, DOI 10.3109/10253890.2011.596866; ROFF LL, 2007, QUALITATIVE SOCIAL W, V0006, P00315, DOI DOI 10.1177/1473325007080404; ROGERSON PA, 1993, ANN ASSOC AM GEOGR, V83, P656, DOI 10.1111/j.1467-8306.1993.tb01959.x; Ronnemaa E, 2011, DEMENT GERIATR COGN, V31, P460, DOI 10.1159/000330020; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; S. Department of Labor Bureau of Labor Statistics, 2012, US DEP LAB SER; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 1998, HEALTH PSYCHOL, V17, P107, DOI 10.1037/h0092707; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SCHULZ R, 2002, GERONTECHNOLOGY, V2, P15, DOI DOI 10.4017/GT.2002.02.01.003.00; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Shaw WS, 1999, J PSYCHOSOM RES, V46, P215, DOI 10.1016/S0022-3999(98)00084-1; Shriver M, 2010, SHRIVER REPORT WOMAN; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spillman BC, 2000, MILBANK Q, V78, P347, DOI 10.1111/1468-0009.00177; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strang Vicki R, 2006, Clin Nurs Res, V15, P27, DOI 10.1177/1054773805282356; Tinetti ME, 2012, J AM GERIATR SOC, V60, P1448, DOI 10.1111/j.1532-5415.2012.04077.x; U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services, 2010, NURS HOM DAT COMP; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Vincent GK, 2010, NEXT 4 DECADES OLDER; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; von Kanel R, 2006, J GERONTOL A-BIOL, V61, P963, DOI 10.1093/gerona/61.9.963; von Kanel R, 2012, GERONTOLOGY, V58, P354, DOI 10.1159/000334219; von Kanel R, 2012, PSYCHOSOM MED, V74, P214, DOI 10.1097/PSY.0b013e3182408c14; Wagner D. L., 1997, CARING MILES FINDING; WAGNER DL, 1997, COMP ANAL CAREGIVER; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Watari K., 2006, CLIN GERONTOLOGIST, V29, P61, DOI [DOI 10.1300/J018v29n04_05, DOI 10.1300/J018V29N04_05]; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; WHO, 2004, INT STAT CLASS DIS R; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wolf DA, 2005, GERONTOLOGIST, V45, P5, DOI 10.1093/geront/45.1.5; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Zarit, 2009, AGING FAMILIES CAREG, P85; Zarit SH, 2009, AGING FAMILIES CAREG, P131	250	978	1014	8	354	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2013	9	2					208	245		10.1016/j.jalz.2013.02.003			38	Clinical Neurology	Neurosciences & Neurology	119JD	WOS:000317092700014	23507120		Y	N	2021-06-18	
J	McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP				McCrea, M; Guskiewicz, KM; Marshall, SW; Barr, W; Randolph, C; Cantu, RC; Onate, JA; Yang, JZ; Kelly, JP			Acute effects and recovery time following concussion in collegiate football players - The NCAA Concussion Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; LONGITUDINAL DATA-ANALYSIS; STANDARDIZED ASSESSMENT; POSTURAL STABILITY; AUSTRALIAN RULES; SPORTS; DEFICITS; SEVERITY	Context Lack of empirical data on recovery time following sport-related concussion hampers clinical decision making about return to play after injury. Objective To prospectively measure immediate effects and natural recovery course relating to symptoms, cognitive functioning, and postural stability following sport-related concussion. Design, Setting, and Participants Prospective cohort study of 1631 football players from 15 US colleges. All players underwent preseason baseline testing on concussion assessment measures in 1999, 2000, and 2001. Ninety-four players with concussion (based on American Academy of Neurology criteria) and 56 noninjured controls underwent assessment of symptoms, cognitive functioning, and postural stability immediately, 3 hours, and 1, 2, 3, 5, 7, and 90 days after injury. Main Outcome Measures Scores on the Graded Symptom Checklist (GSC), Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and a neuropsychological test battery. Results No player with concussion was excluded from participation; 79 players with concussion (84%) completed the protocol through day 90. Players with concussion exhibited more severe symptoms (mean GSC score 20.93 [95% confidence interval (CI), 15.65-26.21] points higher than that of controls), cognitive impairment (mean SAC score 2.94 [95% CI, 1.50-4.38] points lower than that of controls), and balance problems (mean BESS score 5.81 [95% CI, -0.67 to 12.30] points higher than that of controls) immediately after concussion. On average, symptoms gradually resolved by day 7 (GSC mean difference, 0.33; 95% CI, -1.41 to 2.06), cognitive functioning improved to baseline levels within 5 to 7 days (day 7 SAC mean difference, -0.03; 95% CI, -1.33 to 1.26), and balance deficits dissipated within 3 to 5 days after injury (day 5 BESS mean difference, -0.31; 95% CI, -3.02 to 2.40). Mild impairments in cognitive processing and verbal memory evident on neuropsychological testing 2 days after concussion resolved by day 7. There were no significant differences in symptoms or functional impairments in the concussion and control groups 90 days after concussion. Conclusions Collegiate football players may require several days for recovery of symptoms, cognitive dysfunction, and postural instability after concussion. Further research is required to determine factors that predict variability in recovery time after concussion. Standardized measurement of postconcussive symptoms, cognitive functioning, and postural stability may enhance clinical management of athletes recovering from concussion.	Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI 53188 USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; NYU, Sch Med, Dept Neurol, New York, NY USA; Northwestern Univ, Feonberg Sch Med, Chicago Neurol Inst, Chicago, IL 60611 USA; Northwestern Univ, Feonberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Athlet Training Program, Dept Rehabil Sci, Boston, MA 02215 USA	McCrea, M (corresponding author), Waukesha Mem Hosp, Ctr Neurosci, 721 Amer Ave,Suite 501, Waukesha, WI 53188 USA.	michael.mccrea@phci.org	Yang, Jingzhen/N-4786-2014; Onate, James/E-3790-2011	Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Barr, William/0000-0001-7711-7758			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benton AL, 1983, MULTILINGUAL APHASIA; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; *CO MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DICK R, 2003, NATL COLL ATHLETIC A; DIGGLE PJ, 1994, ANAL LONGITUDINAL DA, pCH11; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golden J. C., 1978, STROOP COLOR WORD TE; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead WC, 1985, HALSTEAD REITAN NEUR; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; MCCREA M, 2003, J INT NEUROPSYCH SOC, V9, P206; MCCREA M, IN PRESS CLIN J SPOR; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Smith A., 1991, SYMBOL DIGIT MODALIT; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	58	970	973	4	195	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2003	290	19					2556	2563		10.1001/jama.290.19.2556			8	Medicine, General & Internal	General & Internal Medicine	744DQ	WOS:000186613000025	14625332	Bronze			2021-06-18	
J	Meldrum, BS				Meldrum, BS			Glutamate as a neurotransmitter in the brain: Review of physiology and pathology	JOURNAL OF NUTRITION			English	Article; Proceedings Paper	International Symposium on Glutamate	OCT 12-14, 1998	BERGAMO, ITALY	Baylor Coll Med, Univ Pittsburgh Sch Med, Ctr Nutrit, Int Glutamate Tech Comm, Monell Chem Senses Ctr, Int Union Food Sci & Technol, Mario Negri Inst Pharmacol Res		glutamate; excitotoxicity; domoate; neuroprotection; cerebral ischemia	AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; D-ASPARTATE RECEPTOR; RAT HIPPOCAMPUS; NMDA RECEPTORS; NEURONAL DAMAGE; AMINO-ACIDS; NEUROPROTECTIVE STRATEGIES; SYNAPTIC TRANSMISSION; CEREBRAL-ISCHEMIA	Glutamate is the principal excitatory neurotransmitter in brain. Our knowledge of the glutamatergic synapse has advanced enormously in the last 10 years, primarily through application of molecular biological techniques to the study of glutamate receptors and transporters. There are three families of ionotropic receptors with intrinsic cation permeable channels [N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate]. There are three groups of metabotropic, G protein-coupled glutamate receptors (mGluR) that modify neuronal and glial excitability through G protein subunits acting on membrane ion channels and second messengers such as diacylglycerol and cAMP. There are also two glial glutamate transporters and three neuronal transporters in the brain. Glutamate is the most abundant amino acid in the diet. There is no evidence for brain damage in humans resulting from dietary glutamate. A kainate analog, domoate, is sometimes ingested accidentally in blue mussels; this potent toxin causes limbic seizures, which can lead to hippocampal and related pathology and amnesia. Endogenous glutamate, by activating NMDA, AMPA or mGluR1 receptors, may contribute to the brain damage occurring acutely after status epilepticus, cerebral ischemia or traumatic brain injury. It may also contribute to chronic neurodegeneration in such disorders as amyotrophic lateral sclerosis and Huntington's chorea. In animal models of cerebral ischemia and traumatic brain injury, NMDA and AMPA receptor antagonists protect against acute brain damage and delayed behavioral deficits. Such compounds are undergoing testing in humans, but therapeutic efficacy has yet to be established. Other clinical conditions that may respond to drugs acting on glutamatergic transmission include epilepsy, amnesia, anxiety, hyperalgesia and psychosis.	Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England	Meldrum, BS (corresponding author), Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England.						Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Banerjee SP, 1995, NEUROREPORT, V6, P2500, DOI 10.1097/00001756-199512150-00014; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BEAL MF, 1993, J NEUROSCI, V13, P4181; BENARI Y, 1980, BRAIN RES, V192, P399; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bordi F, 1997, EXP NEUROL, V145, P425, DOI 10.1006/exnr.1997.6442; BOSS V, 1994, MOL PHARMACOL, V45, P1177; Bristow LJ, 1996, J PHARMACOL EXP THER, V277, P578; Bruno V, 1998, NEUROSCIENCE, V85, P751, DOI 10.1016/S0306-4522(97)00531-9; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 1997, J NEUROSCI, V17, P1891; CHAPMAN AG, 1991, EPILEPSY RES, V9, P92, DOI 10.1016/0920-1211(91)90018-B; Chapman AG, 1999, EUR J PHARMACOL, V368, P17, DOI 10.1016/S0014-2999(99)00014-X; Chapman AG, 1999, EUR J PHARMACOL, V383, P23, DOI 10.1016/S0014-2999(99)00615-9; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; CURTIS DR, 1960, J NEUROCHEM, V6, P117, DOI 10.1111/j.1471-4159.1960.tb13458.x; Dingledine R, 2000, J NUTR, V130, p1039S, DOI 10.1093/jn/130.4.1039S; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; GILL R, 1994, CEREBROVAS BRAIN MET, V6, P225; Goff DC, 1997, SCHIZOPHR RES, V27, P157, DOI 10.1016/S0920-9964(97)00079-0; GOTTI B, 1990, BRAIN RES, V522, P290, DOI 10.1016/0006-8993(90)91473-T; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Gundersen V, 1998, J NEUROSCI, V18, P6059; HACK N, 1994, NEUROCHEM INT, V25, P235, DOI 10.1016/0197-0186(94)90067-1; Harata N, 1999, NEUROSCIENCE, V89, P109, DOI 10.1016/S0306-4522(98)00308-X; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HAYASHI TAKASHI, 1952, JAPANESE JOUR PHYSIOL, V3, P46; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; Hirata A, 1997, BRAIN RES, V771, P37, DOI 10.1016/S0006-8993(97)00709-9; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; JARRARD LE, 1993, NEUROPATH APPL NEURO, V19, P381, DOI 10.1111/j.1365-2990.1993.tb00458.x; JOHNSON JW, 1992, J PHYSIOL-LONDON, V455, P339, DOI 10.1113/jphysiol.1992.sp019305; Kataoka Y, 1997, J NEUROSCI, V17, P7017; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KNAPP AG, 1997, EXCITATORY AMINO ACI, P31; KRISTENSEN JD, 1992, PAIN, V51, P249, DOI 10.1016/0304-3959(92)90266-E; KRISTENSEN JD, 1997, EXCITATORY AMINO ACI, P23; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Laube B, 1998, J NEUROSCI, V18, P2954; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Leigh PN, 1996, NEUROLOGY, V47, pS221, DOI 10.1212/WNL.47.6_Suppl_4.221S; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Ludolph AC, 1998, RESTOR NEUROL NEUROS, V13, P59; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mayer ML, 1994, NMDA RECEPTOR, P132; MCDONALD JW, 1992, EUR J PHARMACOL, V215, P353, DOI 10.1016/0014-2999(92)90058-C; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MELDRUM B, 1993, BRAIN RES REV, V18, P293, DOI 10.1016/0165-0173(93)90014-Q; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; Meldrum B S, 1999, Adv Neurol, V79, P965; Meldrum BS, 1998, PROG BRAIN RES, V116, P441, DOI 10.1016/S0079-6123(08)60454-9; Mitani A, 1998, J NEUROSCI, V18, P7941; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mukhin A, 1996, J NEUROSCI, V16, P6012; O'Neill MJ, 1998, NEUROPHARMACOLOGY, V37, P1211, DOI 10.1016/S0028-3908(98)00134-8; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; OLNEY JW, 1972, J NEUROPATH EXP NEUR, V31, P464, DOI 10.1097/00005072-197207000-00006; OLNEY JW, 1983, EXCITOTOXINS, P82; Orlando LR, 1997, NEUROSCI LETT, V236, P91, DOI 10.1016/S0304-3940(97)00769-6; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Ren RF, 1996, BRAIN RES, V732, P16, DOI 10.1016/0006-8993(96)00458-1; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Roy J, 1998, J NEUROSCI, V18, P9673; SACAAN AI, 1992, NEUROSCI LETT, V139, P77, DOI 10.1016/0304-3940(92)90862-2; Sagara Y, 1998, J NEUROSCI, V18, P6662; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHMUTZ M, 1997, EXCITATORY AMINO ACI, P1; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SHORS TJ, 1995, NEUROSCI LETT, V186, P153, DOI 10.1016/0304-3940(95)11309-K; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; STEPHENS DN, 1986, PSYCHOPHARMACOLOGY, V90, P166; SVEINBJORNSDOTTIR S, 1993, EPILEPSY RES, V16, P165, DOI 10.1016/0920-1211(93)90031-2; TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505; Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6; THOMSEN C, 1993, NEUROREPORT, V4, P1099; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; VANDENPOL AN, 1994, J COMP NEUROL, V343, P428, DOI 10.1002/cne.903430307; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; WEISS JH, 1988, SCIENCE, V241, P973, DOI 10.1126/science.3136549; WILLIS CL, 1993, BRAIN RES, V627, P55, DOI 10.1016/0006-8993(93)90748-C; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	107	955	979	2	99	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-3166	1541-6100		J NUTR	J. Nutr.	APR	2000	130	4		S			1007S	1015S					9	Nutrition & Dietetics	Nutrition & Dietetics	300VQ	WOS:000086274200025	10736372	Bronze			2021-06-18	
J	Carney, N; Totten, AM; O'Reilly, C; Ullman, JS; Hawryluk, GWJ; Bell, MJ; Bratton, SL; Chesnut, R; Harris, OA; Kissoon, N; Rubiano, AM; Shutter, L; Tasker, RC; Vavilala, MS; Wilberger, J; Wright, DW; Ghajar, J				Carney, Nancy; Totten, Annette M.; O'Reilly, Cindy; Ullman, Jamie S.; Hawryluk, Gregory W. J.; Bell, Michael J.; Bratton, Susan L.; Chesnut, Randall; Harris, Odette A.; Kissoon, Niranjan; Rubiano, Andres M.; Shutter, Lori; Tasker, Robert C.; Vavilala, Monica S.; Wilberger, Jack; Wright, David W.; Ghajar, Jamshid			Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition	NEUROSURGERY			English	Article						Severe traumatic brain injury; Adults; Critical care; Evidence-based medicine; Guidelines; Systematic review	CEREBRAL PERFUSION-PRESSURE; VENOUS THROMBOEMBOLISM PROPHYLAXIS; VENTILATOR-ASSOCIATED PNEUMONIA; INTRACRANIAL-PRESSURE; CRANIECTOMY; HYPOTENSION; THRESHOLDS; REACTIVITY; NUTRITION; MORTALITY	The scope and purpose of this work is 2-fold: to synthesize the available evidence and to translate it into recommendations. This document provides recommendations only when there is evidence to support them. As such, they do not constitute a complete protocol for clinical use. Our intention is that these recommendations be used by others to develop treatment protocols, which necessarily need to incorporate consensus and clinical judgment in areas where current evidence is lacking or insufficient. We think it is important to have evidence-based recommendations to clarify what aspects of practice currently can and cannot be supported by evidence, to encourage use of evidence-based treatments that exist, and to encourage creativity in treatment and research in areas where evidence does not exist. The communities of neurosurgery and neuro-intensive care have been early pioneers and supporters of evidence-based medicine and plan to continue in this endeavor. The complete guideline document, which summarizes and evaluates the literature for each topic, and supplemental appendices (A-I) are available online at https://www.braintrauma.org/coma/guidelines.	[Carney, Nancy; Totten, Annette M.; O'Reilly, Cindy] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Ullman, Jamie S.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Hawryluk, Gregory W. J.; Bratton, Susan L.] Univ Utah, Salt Lake City, UT USA; [Bell, Michael J.; Shutter, Lori] Univ Pittsburgh, Pittsburgh, PA USA; [Chesnut, Randall; Vavilala, Monica S.] Univ Washington, Seattle, WA 98195 USA; [Harris, Odette A.; Ghajar, Jamshid] Stanford Univ, Stanford, CA 94305 USA; [Kissoon, Niranjan] Univ British Columbia, Vancouver, BC, Canada; [Rubiano, Andres M.] El Bosque Univ, Bogota, Colombia; [Rubiano, Andres M.] MEDITECH Fdn, Neiva, Colombia; [Tasker, Robert C.] Harvard Med Sch, Boston, MA USA; [Tasker, Robert C.] Boston Childrens Hosp, Boston, MA USA; [Wilberger, Jack] Drexel Univ, Pittsburgh, PA USA; [Wright, David W.] Emory Univ, Atlanta, GA 30322 USA	Ghajar, J (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,R200, Stanford, CA 94305 USA.	jghajar@stanford.edu	RUBIANO, ANDRES M/K-6704-2012; Kissoon, Niranjan/AAC-6140-2021; Totten, Annette/P-7909-2019; Shutter, Lori A/G-2957-2013; Tasker, Robert C/R-5837-2019; Ullman, Jamie/AAP-5983-2020; Viani, Rafael/V-1196-2018	RUBIANO, ANDRES M/0000-0001-8931-3254; Totten, Annette/0000-0002-9100-8678; Kissoon, Niranjan/0000-0001-8847-9973; Tasker, Robert/0000-0003-3647-8113; Chesnut, Randall/0000-0001-6377-3666	US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [W911 QY-14-C-0086]; Brain Trauma Foundation	This material is based in part upon work supported by (1) the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, through a contract awarded to Stanford University (W911 QY-14-C-0086), a subcontract awarded to the Brain Trauma Foundation, and a second-tier subcontract awarded to Oregon Health & Science University and (2) the Brain Trauma Foundation, through a contract awarded to Oregon Health & Science University. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, Stanford University, or the Brain Trauma Foundation. There are no conflicts of interest. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this publication.	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; Daley MJ, 2015, AM SURGEON, V81, P207; Dhandapani Sivashanmugam, 2012, Surg Neurol Int, V3, P31, DOI 10.4103/2152-7806.93858; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Huang SJ, 2006, SURG NEUROL, V66, pS26, DOI 10.1016/j.surneu.2006.07.007; Hutchinson P., 2005, ISRCTN66202560, DOI [10.1186/ISRCTN66202560, DOI 10.1186/ISRCTN66202560]; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liew B S, 2009, Med J Malaysia, V64, P280; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P131; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Seguin P, 2006, CRIT CARE MED, V34, P1514, DOI 10.1097/01.CCM.0000214516.73076.82; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; U. S. Food and Drug Administration, 2008, DIPR PROP INJ EM; Wang X., 2013, SPRINGER SERIES ADV, V2013, P1, DOI DOI 10.1155/2013/569161.ARTICLE; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	45	943	987	7	117	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2017	80	1					6	15		10.1227/NEU.0000000000001432			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EZ1ZT	WOS:000404510000005	27654000	Bronze	Y	N	2021-06-18	
J	Thurman, DJ; Alverson, C; Dunn, KA; Guerrero, J; Sniezek, JE				Thurman, DJ; Alverson, C; Dunn, KA; Guerrero, J; Sniezek, JE			Traumatic brain injury in the United States: A public health perspective	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; disability; epidemiology; incidence; mortality; patient care; prevalence; prevention; public health; surveillance	HEAD-INJURY; POPULATION; TRENDS; COUNTY	Traumatic brain injury (TBI) is a leading cause of death and disability among persons in the United States. Each year, an estimated 1.5 million,Americans sustain a TBI. As a result of these injuries, 50,000 people die, 230,000 people are hospitalized and sun ive, and an estimated 80,000-90,000 people experience the onset of long-term disability. Rates of TBI-related hospitalization have declined nearly 50% since 1980, a phenomenon that may be attributed, in part, to successes in injury prevention and also to changes in hospital admission practices that shift the care of persons with less severe TBI from inpatient to outpatient settings. The magnitude of TBI in the United States requires public health measures to prevent these injuries and to improve their consequences. State surveillance systems can provide reliable data on injury causes and risk factors, identify trends in TBI incidence, enable the development of cause-specific prevention strategies focused on populations at greatest risk, and monitor the effectiveness of such programs. State follow-up registries, built on surveillance systems, can provide more information regarding the frequency and nature of disabilities associated with TBI. This information can help states and communities to design, implement, and evaluate cost-effective programs for people living with TBI and for their families, addressing acute care, rehabilitation, and vocational, school, and community support.	CDC, Natl Ctr Injury Prevent & Control, Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Thurman, DJ (corresponding author), CDC, Natl Ctr Injury Prevent & Control, Ctr Dis Control & Prevent, 4770 Buford Highway NE,Mailstop F41, Atlanta, GA 30341 USA.		Fahimifar, Sepideh/M-5303-2019	Thurman, David/0000-0002-0533-7062			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; *DEP HLTH HUM FED, 1989, FED INT HEAD INJ TAS; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GUERRERO JL, 1999, UNPUB METHOD ESTIMAT; *J HOPK U SCH PUBL, 1997, ICDMAP 90 SOFTW; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kraus JF, 1993, HEAD INJURY, P1; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MacKenzie E J, 1989, Md Med J, V38, P725; *NAT CTR INJ PREV, 1998, UNPUB 1970 1995 NAT; *NAT CTR INJ PREV, 1998, UNPUB 1994 NAT HOSP; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; *STAT U NY, 1995, GUID US UN DAT SET M; Thurman DJ, 1996, WESTERN J MED, V165, P192; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US DEP HHS, 1989, INT CLASS DIS; WHITMAN S, 1984, AM J EPIDEMIOL, V4, P560; World Health Organization, 1977, INT CLASS DIS	29	926	937	0	82	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1999	14	6					602	615		10.1097/00001199-199912000-00009			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	269AV	WOS:000084454300008	10671706				2021-06-18	
J	Marion, DW; Penrod, LE; Kelsey, SF; Obrist, WD; Kochanek, PM; Palmer, AM; Wisniewski, SR; DeKosky, ST				Marion, DW; Penrod, LE; Kelsey, SF; Obrist, WD; Kochanek, PM; Palmer, AM; Wisniewski, SR; DeKosky, ST			Treatment of traumatic brain injury with moderate hypothermia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; FOREBRAIN ISCHEMIA; MILD HYPOTHERMIA; DAMAGE; RAT; ISOFLURANE; SCALE; MODEL	Background Traumatic brain injury initiates several metabolic processes that can exacerbate the injury. There is evidence that hypothermia may limit some of these deleterious metabolic responses. Methods In a randomized, controlled trial, we compared the effects of moderate hypothermia and normothermia in 82 patients with severe closed head in juries (a score of 3 to 7 on the Glasgow Coma Scale). The patients assigned to hypothermia were cooled to 33 degrees C a mean of 10 hours after injury, kept at 32 to 33 degrees C for 24 hours, and then rewarmed. A specialist in physical medicine and rehabilitation who was unaware of the treatment assignments evaluated the patients 3, 6, and 12 months later with the use of the Glasgow Outcome Scale. Results The demographic characteristics and causes and severity of injury were similar in the hypothermia and normothermia groups. At 12 months, 62 percent of the patients in the hypothermia group and 38 percent of those in the normothermia group had good outcomes (moderate, mild, or no disabilities). The adjusted risk ratio for a bad outcome in the hypothermia group was 0.5 (95 percent confidence interval, 0.2 to 1.2). Hypothermia did not improve the outcomes in the patients with coma scores of 3 or 4 on admission. Among the patients with scores of 5 to 7, hypothermia was associated with significantly improved outcomes at 3 and 6 months (adjusted risk ratio for a bad outcome, 0.2; 95 percent confidence interval, 0.1 to 0.9 at both intervals), although not at 12 months (risk ratio, 0.3; 95 percent confidence interval, 0.1 to 1.0). Conclusions Treatment with moderate hypothermia for 24 hours in patients with severe traumatic brain injury and coma scores of 5 to 7 on admission hastened neurologic recovery and may have improved the outcome. (C) 1997, Massachusetts Medical Society.	UNIV PITTSBURGH,MED CTR,BRAIN TRAUMA RES CTR,PITTSBURGH,PA			Marion, Donald/AAR-5749-2021; Palmer, Alan/AAP-8650-2020	DeKosky, Steven/0000-0003-3743-2758; Wisniewski, Stephen/0000-0002-3877-9860; Kochanek, Patrick/0000-0002-2627-913X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318] Funding Source: NIH RePORTER		BERING EA, 1961, AM J PHYSIOL, V200, P417; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; BUCHAN A, 1990, J NEUROSCI, V10, P311; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; GELB AW, 1989, ANESTHESIOLOGY, V70, P678, DOI 10.1097/00000542-198904000-00023; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Mouritzen CV, 1966, J THORAC CARDIOVASC, V51, P579; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; ROSNER B, 1984, BIOMETRICS, V40, P1025, DOI 10.2307/2531153; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; TEASDALE G, 1974, LANCET, V2, P81; THOMAS PD, 1988, J LAB CLIN MED, V111, P286; WARNER DS, 1986, ANESTHESIOLOGY, V64, P19, DOI 10.1097/00000542-198601000-00004; WORINGER E, 1954, Anesth Anal, V11, P34; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	39	925	952	0	60	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	1997	336	8					540	546		10.1056/NEJM199702203360803			7	Medicine, General & Internal	General & Internal Medicine	WJ240	WOS:A1997WJ24000003	9023090				2021-06-18	
J	Hyder, AA; Wunderlich, CA; Puvanachandra, P; Gururaj, G; Kobusingye, OC				Hyder, Adnan A.; Wunderlich, Colleen A.; Puvanachandra, Prasanthi; Gururaj, G.; Kobusingye, Olive C.			The impact of traumatic brain injuries: A global perspective	NEUROREHABILITATION			English	Article						traumatic brain injury; injury epidemiology; injuries; developing countries; brain trauma	HEAD-INJURY; NEUROSURGICAL TRAUMA; TRAFFIC ACCIDENTS; UNITED-STATES; RURAL-AREAS; EPIDEMIOLOGY; CHILDREN; MANAGEMENT; POPULATION; MORTALITY	Traumatic brain injury (TBI), according to the World Health Organization, will surpass many diseases as the major cause of death and disability by the year 2020. With an estimated 10 million people affected annually by TBI, the burden of mortality and morbidity that this condition imposes on society, makes TBI a pressing public health and medical problem. The burden of TBI is manifest throughout the world, and is especially prominent in Low and Middle Income Countries which face a higher preponderance of risk factors for causes of TBI and have inadequately prepared health systems to address the associated health outcomes. Latin America and Sub Saharan Africa demonstrate a higher TBI-related incidence rate varying from 150-170 per 100,000 respectively due to RTIs compared to a global rate of 106 per 100,000. As highlighted in this global review of TBI, there is a large gap in data on incidence, risk factors, sequelae, financial costs, and social impact of TBI. This should be addressed through planning of comprehensive TBI prevention programs in LMICs through well-established surveillance systems. Greater resources for research and prioritized interventions are critical to promote evidence-based policy for TBI.	[Hyder, Adnan A.; Puvanachandra, Prasanthi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Hyder, Adnan A.; Puvanachandra, Prasanthi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD 21205 USA; [Wunderlich, Colleen A.] Virginia Commonwealth Univ, Hlth Syst & Childrens Hosp, Med Coll Virginia, Richmond, VA 23284 USA; [Gururaj, G.] Natl Inst Mental Hlth & Neurosci, Bangalore, Karnataka, India	Hyder, AA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite E-8132, Baltimore, MD 21205 USA.	ahyder@jhsph.edu		Attwood, Prasanthi/0000-0003-3606-704X; Kobusingye, Olive/0000-0003-2413-599X			Adesunkanmi ARK, 1998, J TRAUMA, V44, P506, DOI 10.1097/00005373-199803000-00015; Adesunkanmi ARK, 2000, INJURY, V31, P225, DOI 10.1016/S0020-1383(99)00236-3; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; BRICENOLEON R, VIOLENCE RIGHT KILL; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chan H. C., 2005, SMJ Singapore Medical Journal, V46, P219; Cherpitel CJ, 2006, J STUD ALCOHOL, V67, P890, DOI 10.15288/jsa.2006.67.890; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DAVIS A, TRL REV; de Andrade AF, 2001, WORLD J SURG, V25, P1186; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Firsching R, 2001, WORLD J SURG, V25, P1221; Floret D, 2006, ARCH PEDIATRIE, V13, P528, DOI 10.1016/j.arcped.2006.03.017; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GOH KYC, 1995, INJURY, V26, P533, DOI 10.1016/0020-1383(95)00104-H; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Gururaj G, 2004, J Coll Physicians Surg Pak, V14, P713; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; GURURAJ G, 1995, NEUROL INDIA, V43, P29; GURURAJ G, 2005, NIMHANS PUBLICATION, V61, P1; Gururaj G, 2005, INJURIES INDIA NATL, P325; GURURAJ G, 1999, J ACAD HOSP ADM, V11, P9; GURURAJ G, 1994, NEUROSCIENCES; GURURAJ G, 2005, MENTAL NEUROLOGICAL, P225; Hijar-Medina MC, 1999, REV SAUDE PUBL, V33, P505, DOI 10.1590/S0034-89101999000500011; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Indrayan A, 2002, NATL MED J INDIA, V15, P7; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3; Kelly DF, 2001, WORLD J SURG, V25, P1179; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Langdon John, 1997, MEDIEVAL FARMING TEC, P1; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LANGLOIS JA, 2006, TRAUMATIC BRIAN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE MC, 1995, INJURY, V26, P467, DOI 10.1016/0020-1383(95)00071-G; Lehr E, 1990, PSYCHOL MANAGEMENT T; Leipziger DM, 2001, FINANCE DEV, V38; LEVI L, 1990, NEUROEPIDEMIOLOGY, V9, P278, DOI 10.1159/000110784; Masiira-Mukasa N, 2002, East Afr Med J, V79, P373; MATHERS C, 2006, TRACKING TBI DATA WH; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Mock C, 2007, SURG CLIN N AM, V87, P1, DOI 10.1016/j.suc.2006.09.017; Mukhida K, 2006, CHILD NERV SYST, V22, P352, DOI 10.1007/s00381-005-1235-0; MUNIU E, 1994, E AFR MED J, V71, P346; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Murgio A, 1999, J Neurosurg Sci, V43, P15; MURGIO A, 1999, J NEUROSURG SCI, V43, P23; MURRAY CJ, 1996, COMPENDIUM INCIDENCE; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Muyembe VM, 1999, E AFR MED J, V76, P200; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; *POP DIV DEP EC SO, 2003, WORLD POP PROSP 2004; Raja IA, 2001, WORLD J SURG, V25, P1230; *RES TRAIN CTR REH, 1993, PED TRAUM REG; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; Shen Christina, 2003, West Afr J Med, V22, P287; SHUKRI AA, 2006, ZH VOPR NEIROKHIR N, V2, P42; SHUKRI AA, 2006, ZH VOPR NEIROKHIR N, V2, P40; Sidhu D S, 1993, J Indian Med Assoc, V91, P16; Singer Michael S, 2004, J Coll Physicians Surg Pak, V14, P709; Solagberu Babatunde A, 2002, West Afr J Med, V21, P230; Srinath S, 2005, INDIAN J MED RES, V122, P67; Sznajder M, 2001, REV EPIDEMIOL SANTE, V49, P125; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *UNICEF INN RES CT, 2001, 2 UNICEF; *WHO, 2003, WHO REP 2003 SHAP FU; *WHO, 2002, PORJ MORT BURD DIS 2; World Health Organization, 2004, WORLD HLTH REP CHANG; World Health Organization, 2006, ICD 10 CLASS MENT BE; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Zhao YD, 2001, WORLD J SURG, V25, P1202	82	922	951	7	123	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	5					341	353					13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	258HW	WOS:000252860000002	18162698				2021-06-18	
J	McDonald, JW; Liu, XZ; Qu, Y; Liu, S; Mickey, SK; Turetsky, D; Gottlieb, DI; Choi, DW				McDonald, JW; Liu, XZ; Qu, Y; Liu, S; Mickey, SK; Turetsky, D; Gottlieb, DI; Choi, DW			Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord	NATURE MEDICINE			English	Article							ADULT-RAT; AXONAL REGENERATION; CNS NEURONS; IN-VITRO; GROWTH; GRAFTS; BRAIN	Transplantation approaches using cellular bridges(1-2), fetal central nervous system cells(3-5), fibroblasts expressing neurotrophin-3 (ref. 6), hybridoma cells expressing inhibitory protein-blocking antibodies: or olfactory nerves ensheathing glial cells(8) transplanted into the acutely injured spinal cord have produced axonal regrowth or functional benefits. Transplants of rat or cat fetal spinal cord tissue into the chronically injured cord survive and integrate with the host cord, and may be associated with some functional improvements(9). In addition, rats transplanted with fetal spinal cord cells have shown improvements in some gait parameters(10) and the delayed transplantation of fetal raphe cells can enhance reflexes(11). We transplanted neural differentiated mouse embryonic stem cells into a rat spinal cord 9 days after traumatic injury. Histological analysis 2-5 weeks later showed that transplant-derived cells survived and differentiated into astrocytes, oligodendrocytes and neurons, and migrated as far as 8 mm away from the lesion edge. Furthermore, gait analysis demonstrated that transplanted rats showed hindlimb weight support and partial hindlimb coordination not found in 'sham-operated' controls or control rats transplanted with adult mouse neocortical cells.	Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA; Washington Univ, Sch Med, Restorat Treatment & Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	McDonald, JW (corresponding author), Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37927, NS32636, NS01931] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS032636, R29NS037927] Funding Source: NIH RePORTER		ANDERSON DK, 1991, RESTOR NEUROL NEUROS, V2, P309, DOI 10.3233/RNN-1991-245621; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BERNSTEIN JJ, 1987, EXP NEUROL, V98, P633, DOI 10.1016/0014-4886(87)90271-8; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Dinsmore J, 1996, CELL TRANSPLANT, V5, P131, DOI 10.1016/0963-6897(95)02040-3; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Grill R, 1997, J NEUROSCI, V17, P5560; HOWLAND DR, 1995, EXP NEUROL, V135, P123, DOI 10.1006/exnr.1995.1072; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Liu XZ, 1997, J NEUROSCI, V17, P5395; PRIVAT A, 1989, BRAIN RES BULL, V22, P123, DOI 10.1016/0361-9230(89)90136-6; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L; WAXMAN SG, 1992, J NEUROTRAUM, V9, pS105; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113	20	922	1006	3	152	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1078-8956			NAT MED	Nat. Med.	DEC	1999	5	12					1410	1412		10.1038/70986			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	262DE	WOS:000084049700041	10581084				2021-06-18	
J	MCINTOSH, TK; VINK, R; NOBLE, L; YAMAKAMI, I; FERNYAK, S; SOARES, H; FADEN, AL				MCINTOSH, TK; VINK, R; NOBLE, L; YAMAKAMI, I; FERNYAK, S; SOARES, H; FADEN, AL			TRAUMATIC BRAIN INJURY IN THE RAT - CHARACTERIZATION OF A LATERAL FLUID-PERCUSSION MODEL	NEUROSCIENCE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; VET ADM MED CTR,CTR NEURAL INJURY,SAN FRANCISCO,CA 94121	MCINTOSH, TK (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT SURG,SURG RES CTR,FARMINGTON,CT 06032, USA.		AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R0I NS26818] Funding Source: Medline		ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; AMINOFF M, 1980, ELECTRODIAGNOSIS CLI; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P221; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CHURCH MW, 1984, ELECTROEN CLIN NEURO, V59, P328, DOI 10.1016/0168-5597(84)90050-9; CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EISENBERG H, 1983, 5TH P INT S INTR PRE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNERELLI TA, 1983, HEAD INJURY BASIC CL; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; HAYES RL, 1987, BRAIN INJURY, P93; HAYES RL, 1983, J CEREBR BLOOD FLOW, V3, P38; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KARNAZE DS, 1982, NEUROLOGY, V32, P289, DOI 10.1212/WNL.32.3.289; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OKEN BS, 1985, CENTRAL NERVOUS SYST, P177; ROSNER MJ, 1982, 5TH P INT S INTR PRE, P154; ROSNER MJ, 1985, CENTRAL NERVOUS SYST, P405; ROSNER MJ, 1982, HEAD INJURY BASIC CL, P103; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; STOCKARD JJ, 1975, HDB CLIN NEUROLOGY, V23, P317; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEASDALE G, 1976, BRIT J ANAESTH, V49, P761; TOMLINSON BE, 1970, J CLIN PATH S4, V23, P178; TSUBOKAWA T, 1980, J NEUROL NEUROSUR PS, V43, P1005, DOI 10.1136/jnnp.43.11.1005; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2	34	917	942	0	46	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-4522			NEUROSCIENCE	Neuroscience		1989	28	1					233	244		10.1016/0306-4522(89)90247-9			12	Neurosciences	Neurosciences & Neurology	R7681	WOS:A1989R768100021	2761692				2021-06-18	
J	Gustavsson, A; Svensson, M; Jacobi, F; Allgulander, C; Alonso, J; Beghi, E; Dodel, R; Ekman, M; Faravelli, C; Fratiglioni, L; Gannon, B; Jones, DH; Jennum, P; Jordanova, A; Jonsson, L; Karampampa, K; Knapp, M; Kobelt, G; Kurth, T; Lieb, R; Linde, M; Ljungcrantz, C; Maercker, A; Melin, B; Moscarelli, M; Musayev, A; Norwood, F; Preisig, M; Pugliatti, M; Rehm, J; Salvador-Carulla, L; Schlehofer, B; Simon, R; Steinhausen, HC; Stovner, LJ; Vallat, JM; Van den Bergh, P; van Os, J; Vos, P; Xu, WL; Wittchen, HU; Jonsson, B; Olesen, J				Gustavsson, Anders; Svensson, Mikael; Jacobi, Frank; Allgulander, Christer; Alonso, Jordi; Beghi, Ettore; Dodel, Richard; Ekman, Mattias; Faravelli, Carlo; Fratiglioni, Laura; Gannon, Brenda; Jones, David Hilton; Jennum, Poul; Jordanova, Albena; Jonsson, Linus; Karampampa, Korinna; Knapp, Martin; Kobelt, Gisela; Kurth, Tobias; Lieb, Roselind; Linde, Mattias; Ljungcrantz, Christina; Maercker, Andreas; Melin, Beatrice; Moscarelli, Massimo; Musayev, Amir; Norwood, Fiona; Preisig, Martin; Pugliatti, Maura; Rehm, Juergen; Salvador-Carulla, Luis; Schlehofer, Brigitte; Simon, Roland; Steinhausen, Hans-Christoph; Stovner, Lars Jacob; Vallat, Jean-Michel; Van den Bergh, Peter; van Os, Jim; Vos, Pieter; Xu, Weili; Wittchen, Hans-Ulrich; Jonsson, Bengt; Olesen, Jes		CDBE2010 Study Grp	Cost of disorders of the brain in Europe 2010	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article							QUALITY-OF-LIFE; IDIOPATHIC PARKINSONS-DISEASE; OBSTRUCTIVE SLEEP-APNEA; TREATMENT OUTCOME RESEARCH; 3 SICILIAN MUNICIPALITIES; COMMON MENTAL-DISORDERS; POPULATION-BASED SAMPLE; GUILLAIN-BARRE-SYNDROME; CENTRAL-NERVOUS-SYSTEM; SCHOOL-AGE-CHILDREN	Background: The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of 386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people. Aims: To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country. Methods: The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27 + Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010. Results: The total cost of disorders of the brain was estimated at (sic)798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between (sic)285 for headache and (sic)30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was (sic)1550 on average but varied by country. The cost (in billion (sic)PPP 2010) of the disorders of the brain included in this study was as folows: addiction: (sic)65.7; anxiety disorders: (sic)74.4; brain tumor: (sic)5.2; child/adolescent disorders: (sic)21.3; dementia: (sic)105.2; eating disorders: (sic)0.8; epilepsy: (sic)13.8; headache: (sic)43.5; mental retardation: (sic)43.3; mood disorders: (sic)113.4; multiple sclerosis: (sic)14.6; neuromuscular disorders: (sic)7.7; Parkinson's disease: (sic)13.9; personality disorders: (sic)27.3; psychotic disorders: (sic)93.9; sleep disorders: (sic)35.4; somatoform disorder: (sic)21.2; stroke: (sic)64.1; traumatic brain injury: (sic)33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted (sic)477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US. Discussion: This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges. Recommendations: Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives. (C) 2011 Published by Elsevier B.V.	[Gustavsson, Anders; Ekman, Mattias; Jonsson, Linus; Karampampa, Korinna; Ljungcrantz, Christina; Musayev, Amir] Optumlnsight, Stockholm, Sweden; [Svensson, Mikael] Karlstad Univ, Dept Econ & Stat, Karlstad, Sweden; [Jacobi, Frank; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Ctr Epidemiol & Longitudinal Studies CELOS, Dresden, Germany; [Allgulander, Christer] Karolinska Univ Hosp, Dept Clin Neurosci, Huddinge, Sweden; [Alonso, Jordi] IMIM Hosp del Mar, Hlth Serv Res Unit, Barcelona, Spain; [Beghi, Ettore] Ist Mario Negri, Lab Malattie Neurol, Milan, Italy; [Dodel, Richard] Univ Marburg, Dept Neurol Marburg, D-35032 Marburg, Germany; [Faravelli, Carlo] Univ Florence, Dept Psychol, I-50121 Florence, Italy; [Fratiglioni, Laura; Xu, Weili] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Gannon, Brenda] Leeds Inst Hlth Sci, Acad Unit Hlth Econ, Leeds, W Yorkshire, England; [Jones, David Hilton] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Jennum, Poul] Glosptup Hosp, Ctr Sleep Med, Copenhagen, Denmark; [Jordanova, Albena] VIB, Dept Mol Genet, Antwerp, Belgium; [Jordanova, Albena] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium; [Jordanova, Albena] Med Univ Sofia, Dept Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria; [Knapp, Martin] London Sch Econ, Personal Social Serv Res Unit, London, England; [Knapp, Martin] Kings Coll London, Ctr Econ Mental Hlth, Inst Psychiat, London, England; [Kobelt, Gisela] Lund Univ, S-22100 Lund, Sweden; [Kobelt, Gisela] European Hlth Econ, Mulhouse, France; [Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; [Lieb, Roselind] Univ Basel, Dept Psychol, CH-4003 Basel, Switzerland; [Linde, Mattias] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Linde, Mattias] St Olavs Hosp, Div Neurol & Neurophysiol, Trondheim, Norway; [Maercker, Andreas] Univ Zurich, Dept Psychol, CH-8006 Zurich, Switzerland; [Melin, Beatrice] Umea Univ, Dept Oncol, Umea, Sweden; [Moscarelli, Massimo] Int Ctr Mental Hlth Policy & Econ, Milan, Italy; [Moscarelli, Massimo] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Norwood, Fiona] Kings Coll London, Dept Neurol, London WC2R 2LS, England; [Preisig, Martin] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Pugliatti, Maura] Univ Sassari, Dept Neurosci, I-07100 Sassari, Italy; [Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Salvador-Carulla, Luis] Asociac Cient PSICOST, Jerez de la Frontera, Spain; [Salvador-Carulla, Luis] Univ Cadiz, Dept Neurociencias, Cadiz, Spain; [Schlehofer, Brigitte] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Simon, Roland] EMCDDA, Lisbon, Portugal; [Steinhausen, Hans-Christoph] Aalborg Psychiat Hosp, Aalborg, Denmark; [Steinhausen, Hans-Christoph] Univ Basel, Inst Psychol, CH-4003 Basel, Switzerland; [Steinhausen, Hans-Christoph] Univ Zurich, Dept Child & Adolescent Psychiat, CH-8006 Zurich, Switzerland; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol NTNU, Norwegian Natl Headache Ctr, Dept Neurosci, Trondheim, Norway; [Stovner, Lars Jacob] St Olavs Hosp, Trondheim, Norway; [Vallat, Jean-Michel] Univ Hosp, Ctr Natl Reference Neuropathies Peripher Rares, Dept Neurol, Limoges, France; [Van den Bergh, Peter] Catholic Univ Louvain, Clin Univ St Luc, Ctr Reference Neuromusculaire, B-1200 Brussels, Belgium; [van Os, Jim] Maastricht Univ Med Ctr, Dept Psychiat & Psychol, S Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Div Psychol Med, London WC2R 2LS, England; [Vos, Pieter] Radboud Univ Nijmegen, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Jonsson, Bengt] Stockholm Sch Econ, S-11383 Stockholm, Sweden; [Olesen, Jes] Glostrup Univ Hosp, Danish Headache Ctr, Dept Neurol, Glostrup, Denmark	Olesen, J (corresponding author), Glostrup Cty Hosp, Dept Neurol, Dept N39,Ndr Ringvej 57, DK-2600 Glostrup, Denmark.	jeol@glo.regionh.dk	Svensson, Mikael/P-2108-2014; Beghi, Ettore/AAA-7426-2020; Vos, Pieter/A-6043-2012; Stovner, Lars Jacob/D-5025-2014; Jordanova, Albena/H-8323-2015; Salvador-Carulla, Luis/K-6512-2013; Wittchen, Hans-Ulrich/ABA-8901-2020; Maercker, Andreas/D-2814-2017; Alonso, Jordi/A-5514-2010; van Os, Jim/V-8884-2019; Xu, Weili/AAB-6530-2020; Fahimifar, Sepideh/M-5303-2019; van Os, Jim/I-9496-2012; PRISMA, Grupo/AAI-6753-2021; Jonsson, Linus/G-2253-2017; Kurth, Tobias/A-9243-2012; Martinez-Leal, Rafael/B-4073-2009; Rehm, Jurgen/K-2147-2012; Faravelli, Carlo/B-7961-2014; Gannon, Brenda/D-2011-2017; van Os, Jim/C-2113-2014; Jacobi, Frank/O-1189-2017; Jacobi, Frank/AAA-9272-2019; Rem, Jurgen/H-1309-2011; Wittchen, Hans-Ulrich/A-8507-2014	Svensson, Mikael/0000-0003-1113-7478; Beghi, Ettore/0000-0003-2542-0469; Jordanova, Albena/0000-0002-3833-3754; Salvador-Carulla, Luis/0000-0002-5742-9866; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Maercker, Andreas/0000-0001-6925-3266; Alonso, Jordi/0000-0001-8627-9636; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Jonsson, Linus/0000-0001-5751-6292; Kurth, Tobias/0000-0001-7169-2620; Martinez-Leal, Rafael/0000-0002-1333-7951; Rehm, Jurgen/0000-0001-5665-0385; Faravelli, Carlo/0000-0002-8131-8031; Gannon, Brenda/0000-0002-3672-4030; Jacobi, Frank/0000-0001-7632-6267; Jacobi, Frank/0000-0001-7632-6267; Melin, Bo Arthur/0000-0002-8008-2215; Knapp, Martin/0000-0003-1427-0215; Preisig, Martin/0000-0001-5689-4259; Olesen, Jes/0000-0002-6712-2702	European College of Neuropsychopharmacology; European Federation of Neurological Societies; H. Lundbeck A/S	We gratefully acknowledge the unrestricted financial support from the European College of Neuropsychopharmacology, the European Federation of Neurological Societies and from H. Lundbeck A/S.	ABELA A, 2007, MALTA MED J, V19, P23; Abu-Baker A, 2007, BBA-MOL BASIS DIS, V1772, P173, DOI 10.1016/j.bbadis.2006.10.003; Acarturk C, 2009, J AFFECT DISORDERS, V115, P421, DOI 10.1016/j.jad.2008.10.008; *ACCESSECONOMICS, 2007, COST MUSC DYSTR; Adelow C, 2009, EPILEPSIA, V50, P1094, DOI 10.1111/j.1528-1167.2008.01726.x; Ancoli-Israel S, 1989, Clin Geriatr Med, V5, P347; ANCOLIISRAEL S, 1995, AM J RESP CRIT CARE, V152, P1946, DOI 10.1164/ajrccm.152.6.8520760; Andersen K, 1997, ACTA NEUROL SCAND, V96, P82; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; ANDREE C, 2011, EUROLIGHT STUD UNPUB; [Anonymous], 2010, HUMAN MORTALITY DATA; Ares B, 2007, MULT SCLER J, V13, P262, DOI 10.1177/1352458506069540; Balakrishnan R, 2009, J PUBLIC HEALTH-UK, V31, P366, DOI 10.1093/pubmed/fdp051; Balasa R, 2007, REV ROM NEUROL, VVI, P80; Baldwin CM, 2010, J CLIN SLEEP MED, V6, P176; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Barth F, 2005, FORTSCHR NEUROL PSYC, V73, P187, DOI 10.1055/s-2004-830106; Batelaan N, 2007, J AFFECT DISORDERS, V104, P127, DOI 10.1016/j.jad.2007.03.013; BAUMGAERTEL A, 1995, J AM ACAD CHILD PSY, V34, P629, DOI 10.1097/00004583-199505000-00015; Baumhackl U, 2002, NEUROEPIDEMIOLOGY, V21, P226, DOI 10.1159/000065640; Bebbington PE, 2005, SOC PSYCH PSYCH EPID, V40, P707, DOI 10.1007/s00127-005-0955-5; Beesdo K, 2010, ARCH GEN PSYCHIAT, V67, P47, DOI 10.1001/archgenpsychiatry.2009.177; Beesdo K, 2009, BIPOLAR DISORD, V11, P637, DOI 10.1111/j.1399-5618.2009.00738.x; Beghi E, 2004, EPILEPSIA, V45, P171, DOI 10.1111/j.0013-9580.2004.14103.x; BEGHI E, 1991, NEUROEPIDEMIOLOGY, V10, P33, DOI 10.1159/000110245; Behan Caragh, 2008, Irish Journal of Psychological Medicine, V25, P80, DOI 10.1017/S079096670001106X; Beilmann A, 1999, EPILEPSIA, V40, P1011, DOI 10.1111/j.1528-1157.1999.tb00811.x; Benavente I, 2009, EUR J NEUROL, V16, P1138, DOI 10.1111/j.1468-1331.2009.02659.x; Bencsik K, 1998, ACTA NEUROL SCAND, V97, P315, DOI 10.1111/j.1600-0404.1998.tb05959.x; Benedikz J, 2002, CLIN NEUROL NEUROSUR, V104, P208, DOI 10.1016/S0303-8467(02)00040-9; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Berg J, 2005, EUR J NEUROL, V12, P59, DOI 10.1111/j.1468-1331.2005.01192.x; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Berg Jenny, 2006, Eur J Health Econ, V7 Suppl 2, pS75; Bertelli M., 2009, ADV PSYCHIAT, V3, P37; Berto P, 2000, PHARMACOECONOMICS, V17, P197, DOI 10.2165/00019053-200017020-00008; Bidzan L, 2007, PSYCHIATR POL, V41, P181; Bielen I, 2007, ACTA NEUROL SCAND, V116, P361, DOI 10.1111/j.1600-0404.2007.00881.x; Bixler EO, 2009, SLEEP, V32, P731, DOI 10.1093/sleep/32.6.731; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bixler EO, 2000, ARCH INTERN MED, V160, P2289, DOI 10.1001/archinte.160.15.2289; BLIWISE DL, 1988, AM J PUBLIC HEALTH, V78, P544, DOI 10.2105/AJPH.78.5.544; Blomqvist P, 2000, J NEUROL NEUROSUR PS, V69, P792, DOI 10.1136/jnnp.69.6.792; Bluestein D, 2010, J AM BOARD FAM MED, V23, P204, DOI 10.3122/jabfm.2010.02.090179; Boada M, 1999, MED CLIN-BARCELONA, V113, P690; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Borjesson-Hanson A, 2004, NEUROLOGY, V63, P2436, DOI 10.1212/01.WNL.0000147260.52841.27; Bostrom F, 2007, INT J GERIATR PSYCH, V22, P713, DOI 10.1002/gps.1738; Bostrom I, 2009, MULT SCLER J, V15, P1253, DOI 10.1177/1352458509345909; Boyle A, 2010, J SLEEP RES, V19, P42, DOI 10.1111/j.1365-2869.2009.00788.x; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Brayne C, 2006, ALZ DIS ASSOC DIS, V20, pS47, DOI 10.1097/00002093-200607001-00006; Brodtkorb E, 2008, SEIZURE-EUR J EPILEP, V17, P646, DOI 10.1016/j.seizure.2008.03.005; Broman JE, 2008, PSYCHIAT CLIN NEUROS, V62, P472, DOI 10.1111/j.1440-1819.2008.01825.x; BRORSON LO, 1970, EPILEPSY CHILDREN AD, P1; Brower KJ, 2010, AM J ADDICTION, V19, P238, DOI 10.1111/j.1521-0391.2010.00035.x; Casado V, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-143; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cats EA, 2010, NEUROLOGY, V75, P818, DOI 10.1212/WNL.0b013e3181f0738e; Cavallo MC, 1997, ALZ DIS ASSOC DIS, V11, P184; CAVAZZUTI GB, 1980, EPILEPSIA, V21, P57, DOI 10.1111/j.1528-1157.1980.tb04044.x; Chasens ER, 2010, BEHAV SLEEP MED, V8, P157, DOI 10.1080/15402002.2010.487462; Chisholm D, 2003, BRIT J PSYCHIAT, V183, P121, DOI 10.1192/bjp.183.2.121; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; COCKERELL OC, 1994, EPILEPSY RES, V18, P249, DOI 10.1016/0920-1211(94)90045-0; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Coid J, 2006, BRIT J PSYCHIAT, V188, P423, DOI 10.1192/bjp.188.5.423; Coyle D, 1997, ADDICTION, V92, P1007, DOI 10.1111/j.1360-0443.1997.tb02980.x; Cubo E, 2005, MOVEMENT DISORD, V20, P1481, DOI 10.1002/mds.20622; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P229, DOI 10.1111/j.1600-0447.2006.00851.x; Cuijpers P, 2010, ARCH GEN PSYCHIAT, V67, P1086, DOI 10.1001/archgenpsychiatry.2010.130; Das Gupta R, 2002, BRIT J PSYCHIAT, V180, P227, DOI 10.1192/bjp.180.3.227; Dauvilliers Y, 2002, SLEEP, V25, P50, DOI 10.1093/sleep/25.1.50; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; De Ronchi D, 2005, DEMENT GERIATR COGN, V19, P97, DOI 10.1159/000082660; De Sa J, 2006, J NEUROL, V253, P914, DOI 10.1007/s00415-006-0132-0; de Zelicourt M, 2000, SEIZURE-EUR J EPILEP, V9, P88, DOI 10.1053/seiz.1999.0364; de Zelicourt M, 2003, PHARMACOECONOMICS, V21, P1081, DOI 10.2165/00019053-200321150-00002; Dean G, 2002, J NEUROL NEUROSUR PS, V73, P256, DOI 10.1136/jnnp.73.3.256; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; DEGRAAF R, 2011, SOC PSYCHIAT PS 0101; delaCourt A, 1996, EPILEPSIA, V37, P141; Dengler I, 2006, NERVENARZT, V77, P1204, DOI 10.1007/s00115-006-2150-7; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dodel RC, 1998, PHARMACOECONOMICS, V14, P299, DOI 10.2165/00019053-199814030-00006; Dodel RC, 1997, NERVENARZT, V68, P978, DOI 10.1007/s001150050226; Dopfner M, 2008, EUR CHILD ADOLES PSY, V17, P59, DOI 10.1007/s00787-008-1007-y; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dura-Trave T, 2008, J CHILD NEUROL, V23, P878, DOI 10.1177/0883073808314898; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; Edwards P, 2005, LANCET, V365, P1957; Ehret R, 2009, NERVENARZT, V80, P452, DOI 10.1007/s00115-009-2671-y; *EMCDDA, 2010, STAT B EMCDDA; Endziniene M, 1997, BRAIN DEV-JPN, V19, P379, DOI 10.1016/S0387-7604(97)00035-1; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Eriksson KJ, 1997, EPILEPSIA, V38, P1275, DOI 10.1111/j.1528-1157.1997.tb00064.x; Errea JM, 1999, MOVEMENT DISORD, V14, P596, DOI 10.1002/1531-8257(199907)14:4<596::AID-MDS1008>3.0.CO;2-U; Esperou H, 2000, INTENS CARE MED, V26, P1094, DOI 10.1007/s001340051323; ESSER G, 1990, J CHILD PSYCHOL PSYC, V31, P243, DOI 10.1111/j.1469-7610.1990.tb01565.x; *EUR, 2010, LAB COST IND NOM VAL; *EUR, 2010, POP 1 JAN AG SEX; *EUR, 2010, GDP MAIN COMP CURR P; *EUR, 2010, AV ANN GROSS EARN EC; *EUR, 2010, HARM ANN AV CONS PRI; *EUR, 2010, COMP PRIC LEV; *EUR, 2010, AV ANN GROSS EARN OC; *EUR, 2010, MONTHL LAB COSTS; *EUR, 2010, EXP SEL HLTH CAR FUC; *EUR CENTR BANK, 2010, EXCH RAT; *EUR HEART NETW, 2008, ANN REP EUR HEART NE; Eurocopter Deutschland GmbH, 2009, BRAIN RES EU FUND, P1; Evers SMAA, 2004, STROKE, V35, P1209, DOI 10.1161/01.STR.0000125860.48180.48; Fasbender P, 2008, NEUROEPIDEMIOLOGY, V30, P147, DOI 10.1159/000122331; Fenoglio P, 2003, EUR ADDICT RES, V9, P18, DOI 10.1159/000067730; Ferini-Strambi L, 1999, SLEEP, V22, P859; FERINISTRAMBI L, 1994, CHEST, V105, P1759, DOI 10.1378/chest.105.6.1759; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Florescu S, 2009, MANAGE HLTH, V13, P23; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Forsgren I, 2005, EUR J NEUROL, V12, P54, DOI 10.1111/j.1468-1331.2005.01191.x; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; FORSGREN L, 1992, EPILEPSIA, V33, P450, DOI 10.1111/j.1528-1157.1992.tb01690.x; Francois C, 2004, CLIN DRUG INVEST, V24, P373, DOI 10.2165/00044011-200424070-00001; Friemel S, 2005, PSYCHIAT PRAX, V32, P113, DOI 10.1055/s-2004-834611; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Gallitto G, 2005, EPILEPSIA, V46, P1828, DOI 10.1111/j.1528-1167.2005.00278.x; Gao S, 2008, OBESITY, V16, P2126, DOI 10.1038/oby.2008.310; Garattini LG, 2004, SCHIZOPHRENIA BULL, V30, P295, DOI 10.1093/oxfordjournals.schbul.a007079; Garcia-Altes A, 2002, ADDICTION, V97, P1145, DOI 10.1046/j.1360-0443.2002.00170.x; Gascon-Bayarri J, 2007, NEUROEPIDEMIOLOGY, V28, P224, DOI 10.1159/000108597; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Gerzeli S, 2005, NEUROL SCI, V26, P72, DOI 10.1007/s10072-005-0439-0; GESSNER U, 1993, INT J HLTH SCI, V4, P121, DOI DOI 10.1111/J.1528-1167.2006.00889.X; GISLASON T, 1988, J CLIN EPIDEMIOL, V41, P571, DOI 10.1016/0895-4356(88)90061-3; GIULIANI G, 1992, ACTA NEUROL SCAND, V85, P23; Godet-Cayre V, 2006, SLEEP, V29, P179, DOI 10.1093/sleep/29.2.179; Godfrey C, 2004, ADDICTION, V99, P697, DOI 10.1111/j.1360-0443.2004.00752.x; Goldberg LD, 2005, AM J MANAG CARE, V11, pS62; GOMEZBENEYTO M, 1994, ACTA PSYCHIAT SCAND, V89, P352, DOI 10.1111/j.1600-0447.1994.tb01528.x; Gonzalez-Pinto AM, 2010, J AFFECT DISORDERS, V121, P152, DOI 10.1016/j.jad.2009.05.010; Gostynski M, 2002, SOZ PRAVENTIV MED, V47, P330, DOI 10.1007/PL00012643; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; GRANIERI E, 1983, EPILEPSIA, V24, P502, DOI 10.1111/j.1528-1157.1983.tb04921.x; Granieri E, 2007, J NEUROL, V254, P1642, DOI 10.1007/s00415-007-0560-5; Gray OM, 2008, MULT SCLER, V14, P880, DOI 10.1177/1352458508090663; Guerrini R, 2001, EPILEPSIA, V42, P641, DOI 10.1046/j.1528-1157.2001.27300.x; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Gustavsson A, 2010, J NUTR HEALTH AGING, V14, P648, DOI 10.1007/s12603-010-0311-7; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Hagell P, 2002, MOVEMENT DISORD, V17, P1213, DOI 10.1002/mds.10262; Hakkaart-van Roijen L, 2004, ACTA PSYCHIAT SCAND, V110, P383, DOI 10.1111/j.1600-0447.2004.00403.x; Halpin David M G, 2006, Proc Am Thorac Soc, V3, P227, DOI 10.1513/pats.200507-072SF; Hamer HM, 2006, EPILEPSIA, V47, P2165, DOI 10.1111/j.1528-1167.2006.00889.x; Hamre HJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-11; Hansen ABG, 2011, SCAND J PUBLIC HEALT, V39, P128, DOI 10.1177/1403494810393556; Hausken A, 2009, EUR J CLIN PHARMACOL, V65, P295, DOI 10.1007/s00228-008-0565-8; Healey A, 1998, BRIT J PSYCHIAT, V173, P160, DOI 10.1192/bjp.173.2.160; Hedner J, 2006, EUR RESPIR J, V27, P564, DOI 10.1183/09031936.06.00042105; Heider D, 2009, EUR PSYCHIAT, V24, P216, DOI 10.1016/j.eurpsy.2008.12.013; Heier MS, 2009, ACTA NEUROL SCAND, V120, P276, DOI 10.1111/j.1600-0404.2009.01166.x; Helmer C, 2006, DEMENT GERIATR COGN, V22, P87, DOI 10.1159/000093459; Hetta J, 1999, J PSYCHOPHARMACOL, V13, pS35, DOI 10.1177/026988119901304S10; Hiller W, 2004, J PSYCHOSOM RES, V56, P437, DOI 10.1016/S0022-3999(03)00628-7; Hirst C, 2009, J NEUROL NEUROSUR PS, V80, P386, DOI 10.1136/jnnp.2008.144667; *HLTH SOC CAR INF, 2009, STAT ALC ENGL; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Hoffstein V, 2002, SLEEP, V25, P519; Hong JY, 2009, PROG NEURO-PSYCHOPH, V33, P835, DOI 10.1016/j.pnpbp.2009.03.034; Hong SC, 2002, SLEEP, V25, P440; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1055/s-2002-32322; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; HUBLIN C, 1994, SLEEP, V17, pS7, DOI 10.1093/sleep/17.suppl_8.S7; HUISMAN MH, 2011, J NEUROL NEUROS 0527; Iuliano G, 2008, EUR J NEUROL, V15, P73, DOI 10.1111/j.1468-1331.2007.02006.x; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Jacobi F, 2002, INT J METH PSYCH RES, V11, P1, DOI 10.1002/mpr.118; Jacoby A, 1998, EPILEPSIA, V39, P776, DOI 10.1111/j.1528-1157.1998.tb01164.x; Jarbrink K, 2007, AUTISM, V11, P453, DOI 10.1177/1362361307079602; Jansson-Frojmark M, 2008, SLEEP, V31, P881, DOI 10.1093/sleep/31.6.881; Jarl J, 2008, EUR J HEALTH ECON, V9, P351, DOI 10.1007/s10198-007-0082-1; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; JENNUM P, 1994, EUR NEUROL, V34, P204, DOI 10.1159/000117039; Jennum P, 2010, ACTA NEUROL SCAND, V121, P265, DOI 10.1111/j.1600-0404.2009.01227.x; Jennum P, 2009, EUR RESPIR J, V33, P907, DOI 10.1183/09031936.00180108; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Jennum P, 2009, J CLIN SLEEP MED, V5, P240; JOENSEN P, 1986, ACTA NEUROL SCAND, V74, P150, DOI 10.1111/j.1600-0404.1986.tb04642.x; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Jonsson L, 2005, EUR J NEUROL, V12, P50, DOI 10.1111/j.1468-1331.2005.01190.x; Jonsson L, 1999, CLIN THER, V21, P1230, DOI 10.1016/S0149-2918(00)80025-9; Jonsson L, 2006, INT J GERIATR PSYCH, V21, P449, DOI 10.1002/gps.1489; Kalb B, 2002, NEUROEPIDEMIOLOGY, V21, P221, DOI 10.1159/000065639; Keller S, 2003, NERVENARZT, V74, P1105, DOI 10.1007/s00115-003-1582-6; KERANEN T, 1989, EPILEPSIA, V30, P413, DOI 10.1111/j.1528-1157.1989.tb05320.x; Keranen T, 2003, PARKINSONISM RELAT D, V9, P163, DOI 10.1016/S1353-8020(02)00097-4; King B. H., 2009, KAPLAN SADOCKS COMPR, P3444; Kleinman LS, 2003, PHARMACOECONOMICS, V21, P601, DOI 10.2165/00019053-200321090-00001; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Knapp M, 2002, ACTA PSYCHIAT SCAND, V105, P42, DOI 10.1034/j.1600-0447.2002._10310.x; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Kobelt G, 2009, MULT SCLER J, V15, P741, DOI 10.1177/1352458509102771; KOBELT G, 2009, SURVEY BARRIERS TREA; Kobelt G., 2009, ACCESS INNOVATIVE TR; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS96; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS55; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS34; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS65; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS14; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS45; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS86; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Konnopka A, 2007, PHARMACOECONOMICS, V25, P605, DOI 10.2165/00019053-200725070-00006; Kotsopoulos I, 2005, SEIZURE-EUR J EPILEP, V14, P175, DOI 10.1016/j.seizure.2005.01.005; Kotsopoulos IAW, 2001, EPILEPSIA, V42, P634, DOI 10.1046/j.1528-1157.2001.18200.x; Kotsopoulos IAW, 2003, EPILEPSY RES, V54, P131, DOI 10.1016/S0920-1211(03)00062-7; Krauth C, 2002, Eur J Health Econ, V3, P244, DOI 10.1007/s10198-002-0137-2; Kroes M, 2001, J AM ACAD CHILD PSY, V40, P1401, DOI 10.1097/00004583-200112000-00010; KRONBORG AC, 1999, DEMENT GERIATR COGN, V10, P295; Kronholm E, 2008, J SLEEP RES, V17, P54, DOI 10.1111/j.1365-2869.2008.00627.x; Kryger MH, 2002, SLEEP, V25, P36, DOI 10.1093/sleep/25.1.36; Kurz X, 2001, Rev Med Liege, V56, P835; Laaban JP, 2009, DIABETES METAB, V35, P372, DOI 10.1016/j.diabet.2009.03.007; Landgren M, 1996, DEV MED CHILD NEUROL, V38, P891; Larsson K, 2006, EUR J PAEDIATR NEURO, V10, P107, DOI 10.1016/j.ejpn.2006.02.005; Latif AZ, 1998, BRIT J NEUROSURG, V12, P118; Latvala A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-73; Lauber C, 2005, INT J SOC PSYCHIATR, V51, P259, DOI 10.1177/0020764005057376; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Leger D, 1999, SLEEP, V22, pS394; Leger D, 2005, CURR MED RES OPIN, V21, P1785, DOI 10.1185/030079905X65637; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Leger D, 2006, SLEEP, V29, P171; LePen C, 1999, PHARMACOECONOMICS, V16, P59, DOI 10.2165/00019053-199916010-00006; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Li XJ, 2008, SLEEP MED, V9, P129, DOI 10.1016/j.sleep.2007.02.003; Lindberg E, 2007, RESP MED, V101, P1283, DOI 10.1016/j.rmed.2006.10.015; LINDE M, 2011, COST HEADACHE UNPUB; Lindgren P, 2005, EUR J NEUROL, V12, P68, DOI 10.1111/j.1468-1331.2005.01197.x; Lindstrom E, 2007, ACTA PSYCHIAT SCAND, V116, P33, DOI 10.1111/j.1600-0447.2007.01086.x; Linehan C, 2010, EPILEPSIA, V51, P845, DOI 10.1111/j.1528-1167.2009.02417.x; Livingston G, 2004, CURR MED RES OPIN, V20, P1007, DOI 10.1185/030079904125003980; Lofgren E, 2009, EPILEPSY BEHAV, V14, P102, DOI 10.1016/j.yebeh.2008.08.007; Lopez-Bastida J, 2006, NEUROLOGY, V67, P2186, DOI 10.1212/01.wnl.0000249311.80411.93; Loredo JS, 2010, SLEEP, V33, P962, DOI 10.1093/sleep/33.7.962; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luengo A, 2001, J NEUROL, V248, P762; Luengo-Fernandez R, 2009, STROKE, V40, pE18, DOI 10.1161/STROKEAHA.108.529776; Mahdi-Rogers M, 2009, J PERIPHER NERV SYST, V14, P118, DOI 10.1111/j.1529-8027.2009.00221.x; MAHDIROGERS M, 2008, J PERIPHER NERV S S2, V13; MAHDIROGERS M, 2008, EUR J NEUROL S3, V15; Mahler MP, 2008, SWISS MED WKLY, V138, P459, DOI 2008/31/smw-11845; Mangalore R, 2007, J MENT HEALTH POLICY, V10, P23; MAREMMANI C, 1991, EPILEPSIA, V32, P294, DOI 10.1111/j.1528-1157.1991.tb04654.x; Martikainen K, 2003, SLEEP MED, V4, P201, DOI 10.1016/S1389-9457(02)00194-6; Martinez JCA, 2004, REV CLIN ESP, V204, P64; Martinez-Leal R, 2011, J INTELL DISABIL RES, V55, P858, DOI 10.1111/j.1365-2788.2011.01439.x; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Maurel F, 2001, REV NEUROL-FRANCE, V157, P507; McCracken C, 2006, BRIT J PSYCHIAT, V189, P161, DOI 10.1192/bjp.bp.105.015081; McCrone P, 2005, EUR CHILD ADOLES PSY, V14, P407, DOI 10.1007/s00787-005-0491-6; McCrone P, 2008, PHARMACOECONOMICS, V26, P847, DOI 10.2165/00019053-200826100-00005; McCrone P, 2007, MOVEMENT DISORD, V22, P804, DOI 10.1002/mds.21360; McEvoy JP, 2007, J CLIN PSYCHIAT, V68, P4; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; MCNICHOLAS WT, 1986, LANCET, V2, P295; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Mesterton J, 2010, CURR ALZHEIMER RES, V7, P358, DOI 10.2174/156720510791162430; MORGANTE L, 1992, NEUROLOGY, V42, P1901; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Neven AK, 1998, THORAX, V53, P638, DOI 10.1136/thx.53.8.638; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Nutt David, 2011, Eur Neuropsychopharmacol, V21, P495, DOI 10.1016/j.euroneuro.2011.05.004; O'Shea E, 2000, INT J GERIATR PSYCH, V15, P208, DOI 10.1002/(SICI)1099-1166(200003)15:3<208::AID-GPS95>3.0.CO;2-X; *OECD STAT, 2010, ANN INC; *OECD STAT, 2010, NAT ACC PPPS EXCH RA; *OECD STAT, 2010, TOT HLTH EXP PER COU; *OECD STAT, 2010, TOT PHARM EXP; Ohayon MM, 1997, BRIT MED J, V314, P860; Ohayon MM, 2002, J SLEEP RES, V11, P339, DOI 10.1046/j.1365-2869.2002.00317.x; Ohayon MM, 2002, NEUROLOGY, V58, P1826, DOI 10.1212/WNL.58.12.1826; Olafsson E, 2005, LANCET NEUROL, V4, P627, DOI 10.1016/S1474-4422(05)70172-1; Olafsson E, 1999, EPILEPSIA, V40, P1529, DOI 10.1111/j.1528-1157.1999.tb02036.x; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Olie JP, 2002, EUR PSYCHIAT, V17, P278, DOI 10.1016/S0924-9338(02)00680-6; Oliva-Moreno Juan, 2006, Eur J Health Econ, V7, P182; Olivares JM, 2008, APPL HEALTH ECON HEA, V6, P41, DOI 10.2165/00148365-200806010-00004; *ONC, 2010, STAT B 2009 ANN SURV; Oopik M, 2003, J NEUROL NEUROSUR PS, V74, P1638, DOI 10.1136/jnnp.74.12.1638; Orlewska E, 2005, EUR J NEUROL, V12, P31, DOI 10.1111/j.1468-1331.2004.00950.x; Osby U, 2009, J AFFECT DISORDERS, V115, P315, DOI 10.1016/j.jad.2008.09.011; OSHEA E, 2007, ALZHEIMER SOC IRELAN; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Oun A, 2003, EPILEPSY RES, V52, P233, DOI 10.1016/S0920-1211(02)00234-6; Packer RJ, 2008, PEDIATR CLIN N AM, V55, P121, DOI 10.1016/j.pcl.2007.10.010; Pallesen S, 2001, SLEEP, V24, P771; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Papathanasopoulos P, 2008, NEUROEPIDEMIOLOGY, V30, P167, DOI 10.1159/000122334; PARTINEN M, 1994, SLEEP, V17, pS13, DOI 10.1093/sleep/17.suppl_8.S13; Partinen M, 1995, Curr Opin Pulm Med, V1, P482, DOI 10.1097/00063198-199511000-00009; Patel A, 2002, J AFFECT DISORDERS, V68, P221, DOI 10.1016/S0165-0327(00)00323-2; Pechevis M, 2005, EUR J NEUROL, V12, P956, DOI 10.1111/j.1468-1331.2005.01096.x; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; PETER JH, 1985, KLIN WOCHENSCHR, V63, P807, DOI 10.1007/BF01732285; Peterlin B, 2006, J NEUROL SCI, V247, P169, DOI 10.1016/j.jns.2006.04.002; Picot MC, 2008, EPILEPSIA, V49, P1230, DOI 10.1111/j.1528-1167.2008.01579.x; Polder JJ, 2002, J INTELL DISABIL RES, V46, P168, DOI 10.1046/j.1365-2788.2002.00384.x; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Poulas K, 2001, J NEUROL NEUROSUR PS, V71, P352, DOI 10.1136/jnnp.71.3.352; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Pradalier A, 2004, PHARMACOECONOMICS, V22, P985, DOI 10.2165/00019053-200422150-00003; Priebe S, 2010, PSYCHIAT SERV, V61, P598, DOI 10.1176/ps.2010.61.6.598; Priebe S, 2009, CROAT MED J, V50, P465, DOI 10.3325/cmj.2009.50.465; *PSSRU, 2011, UN COSTS HLTH SOC CA, P41; Puura K, 1998, SOC PSYCH PSYCH EPID, V33, P310, DOI 10.1007/s001270050060; Rahkonen T, 2003, J NEUROL NEUROSUR PS, V74, P720, DOI 10.1136/jnnp.74.6.720; Ranzato F, 2003, MULT SCLER J, V9, P387, DOI 10.1191/1352458503ms920oa; Reese JP, 2011, GESUNDHEITSWESEN, V73, P22, DOI 10.1055/s-0030-1247571; Rehm J, 2005, EUR NEUROPSYCHOPHARM, V15, P377, DOI 10.1016/j.euroneuro.2005.04.005; Reid S, 2002, BRIT J PSYCHIAT, V180, P248, DOI 10.1192/bjp.180.3.248; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Riedel-Heller SG, 2001, BRIT J PSYCHIAT, V179, P250, DOI 10.1192/bjp.179.3.250; Rigaud AS, 2003, J GERIATR PSYCH NEUR, V16, P140, DOI 10.1177/0891988703252558; Rocca WA, 2001, NEUROEPIDEMIOLOGY, V20, P237, DOI 10.1159/000054796; Romeo R, 2006, BRIT J PSYCHIAT, V188, P547, DOI 10.1192/bjp.bp.104.007625; Rossi C, 2006, INTENS CARE MED, V32, P545, DOI 10.1007/s00134-006-0080-2; Roy AN, 2010, SLEEP MED, V11, P462, DOI 10.1016/j.sleep.2009.09.012; Russo P, 2004, CLIN DRUG INVEST, V24, P409, DOI 10.2165/00044011-200424070-00004; Saar I, 2009, EUR ADDICT RES, V15, P56, DOI 10.1159/000173010; Salawu F K, 2009, Niger J Med, V18, P349; Salize HJ, 2009, SCHIZOPHR RES, V111, P70, DOI 10.1016/j.schres.2009.03.027; Salize HJ, 2004, PSYCHIAT PRAX, V31, P147; Salvador-Carulla L, 2008, PSYCHOPATHOLOGY, V41, P10, DOI 10.1159/000109950; Salvador-Carulla L, 2011, J AFFECT DISORDERS, V132, P130, DOI 10.1016/j.jad.2011.02.019; SALVADORCARULLA L, 1995, BRIT J PSYCHIAT, V166, P23, DOI 10.1192/S0007125000293367; Sancho J, 2008, EPILEPSY RES, V81, P176, DOI 10.1016/j.eplepsyres.2008.05.008; SANGRADOR CO, 1991, EPILEPSIA, V32, P791, DOI 10.1111/j.1528-1157.1991.tb05535.x; Sasai T, 2010, SLEEP MED, V11, P452, DOI 10.1016/j.sleep.2009.09.011; SCHENK M, 2010, DEUT MED WOCHENSCHR, V135, P24; Schepelmann K, 2010, J NEUROL, V257, P15, DOI 10.1007/s00415-009-5256-6; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schulenburg J, 1998, HLTH EC DEMENTIA, P217; Scuvee-Moreau J, 2002, ACTA NEUROL BELG, V102, P104; Sicras-Mainar A, 2010, GAC SANIT, V24, P13, DOI 10.1016/j.gaceta.2009.05.012; Sidenvall R, 1996, SEIZURE, V5, P139, DOI 10.1016/S1059-1311(96)80108-7; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Sillanpaa M, 1973, Acta Paediatr Scand Suppl, V237, P3; Sivertsen B, 2006, AM J EPIDEMIOL, V163, P1018, DOI 10.1093/aje/kwj145; Sivertsen B, 2010, J SLEEP RES, V19, P36, DOI 10.1111/j.1365-2869.2009.00769.x; Sivertsen B, 2009, BEHAV SLEEP MED, V7, P210, DOI 10.1080/15402000903190199; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Smestad C, 2008, J NEUROL, V255, P49, DOI 10.1007/s00415-007-0659-8; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Smith S, 2010, COST STROKE IRELAND; Sobocki P, 2006, EUR J NEUROSCI, V24, P2691, DOI 10.1111/j.1460-9568.2006.05116.x; Soeteman DI, 2008, J CLIN PSYCHIAT, V69, P259, DOI 10.4088/JCP.v69n0212; Solaro C, 2005, J NEUROL, V252, P436, DOI 10.1007/s00415-005-0670-x; SOUETRE E, 1994, J PSYCHOSOM RES, V38, P151; Souetre E J, 1995, Int Psychogeriatr, V7, P115; Spottke AE, 2005, PHARMACOECONOMICS, V23, P817, DOI 10.2165/00019053-200523080-00007; Steinhausen HC, 1998, ACTA PSYCHIAT SCAND, V98, P262, DOI 10.1111/j.1600-0447.1998.tb10082.x; Stiller C A, 1992, Br J Cancer Suppl, V18, pS50; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Stranjalis G, 2009, SEIZURE-EUR J EPILEP, V18, P206, DOI 10.1016/j.seizure.2008.09.007; Strassels SA, 2009, J MANAGE CARE PHARM, V15, P556, DOI 10.18553/jmcp.2009.15.7.556; Struijs JN, 2006, INT J TECHNOL ASSESS, V22, P518, DOI 10.1017/S0266462306051464; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sumelahti ML, 2001, ACTA NEUROL SCAND, V103, P153, DOI 10.1034/j.1600-0404.2001.103003153.x; Sveen ML, 2006, ANN NEUROL, V59, P808, DOI 10.1002/ana.20824; Svendsen T, 2007, ACTA NEUROL SCAND, V116, P307, DOI 10.1111/j.1600-0404.2007.00909.x; Swingler R J, 1994, Seizure, V3, P115, DOI 10.1016/S1059-1311(05)80201-8; Tafalla M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-31; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TAYLOR EA, 1991, EPIDEMIOLOGY CHILDHO; Teculescu D, 2001, RESPIRATION, V68, P365, DOI 10.1159/000050528; Tetto A, 2002, EPILEPSY RES, V48, P207, DOI 10.1016/S0920-1211(02)00013-X; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Tidman L, 2003, SEIZURE-EUR J EPILEP, V12, P47, DOI 10.1016/S1059131102001711; TISON F, 1994, ACTA NEUROL SCAND, V90, P111; Tognoni G, 2005, ACTA NEUROL SCAND, V112, P65, DOI 10.1111/j.1600-0404.2005.00444.x; Trabucchi M, 1999, J GERIATR PSYCH NEUR, V12, P29, DOI 10.1177/089198879901200107; Troxel WM, 2010, SLEEP, V33, P973, DOI 10.1093/sleep/33.7.973; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Tsolaki M., 1999, AM J ALZHEIMERS DIS, V14, P138, DOI DOI 10.1177/153331759901400308; UHL A, 2009, HDB ALKOHOL OSTERREI; Ursin R, 2009, SCAND J WORK ENV HEA, V35, P193, DOI 10.5271/sjweh.1325; van Asselt ADI, 2007, EUR PSYCHIAT, V22, P354, DOI 10.1016/j.eurpsy.2007.04.001; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; VANHAKKAART RL, 2007, EUR CHILD ADOLES PSY, V16, P316; vanHout B, 1997, EPILEPSIA, V38, P1221; Verhulst FC, 1997, ARCH GEN PSYCHIAT, V54, P329, DOI 10.1001/archpsyc.1997.01830160049008; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; von Campenhausen S, 2009, WIEN KLIN WOCHENSCHR, V121, P574, DOI 10.1007/s00508-009-1223-6; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Waaler PE, 2000, EPILEPSIA, V41, P802, DOI 10.1111/j.1528-1157.2000.tb00246.x; Wasserfallen JB, 2005, NEURO-ONCOLOGY, V7, P189, DOI 10.1215/S1152851704000687; Wellis G, 2003, ACTA NEUROCHIR, V145, P249, DOI 10.1007/s00701-003-0007-4; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; *WHO EUR, 2010, EUR STAT REP ALC HLT; Wilking N, 2005, PAN EUROPEAN COMP RE; Wilking N, 2009, COMPARATOR REPORT PA; Wilms HU, 2004, PSYCHIAT PRAX, V31, P177, DOI 10.1055/s-2004-812600; Wimo A, 2010, INT J GERIATR P 1028; Wing YK, 2002, ANN NEUROL, V51, P578, DOI 10.1002/ana.10162; Winter Y, 2010, NEURODEGENER DIS, V7, P365, DOI 10.1159/000302644; Winter Y, 2010, PARKINSONISM RELAT D, V16, P51, DOI 10.1016/j.parkreldis.2009.07.005; Wittchen HU, 2008, INT J METH PSYCH RES, V17, pS16, DOI 10.1002/mpr.254; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2009, INT J METH PSYCH RES, V18, P189, DOI 10.1002/mpr.298; Wittchen HU, 2009, CNS SPECTRUMS, V14, P5; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; WITTCHEN HU, 2010, MEDICOGRAPHIA, V32, P155; Wolstenholme J, 2002, BRIT J PSYCHIAT, V181, P36, DOI 10.1192/bjp.181.1.36; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1996, SLEEP, V19, P529, DOI 10.1093/sleep/19.7.529; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zambori Janos, 2002, J Ment Health Policy Econ, V5, P115; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x; 2010, THOMSON REUTERS ISI; 2009, FRAMEWORK PROGRAMME; 2010, PHARM SALES PRICES A	434	904	926	11	413	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	OCT	2011	21	10					718	779		10.1016/j.euroneuro.2011.08.008			62	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	836OA	WOS:000296119800002	21924589		Y	N	2021-06-18	
J	Clifton, GL; Miller, ER; Choi, SC; Levin, HS; McCauley, S; Smith, KR; Muizelaar, JP; Wagner, FC; Marion, DW; Luerssen, TG; Chesnut, RM; Schwartz, M				Clifton, GL; Miller, ER; Choi, SC; Levin, HS; McCauley, S; Smith, KR; Muizelaar, JP; Wagner, FC; Marion, DW; Luerssen, TG; Chesnut, RM; Schwartz, M			Lack of effect of induction of hypothermia after acute brain injury.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; PRESSURE	Background: Induction of hypothermia in patients with brain injury was shown to improve outcomes in small clinical studies, but the results were not definitive. To study this issue, we conducted a multicenter trial comparing the effects of hypothermia with those of normothermia in patients with acute brain injury. Methods: The study subjects were 392 patients 16 to 65 years of age with coma after sustaining closed head injuries who were randomly assigned to be treated with hypothermia (body temperature, 33 degreesC), which was initiated within 6 hours after injury and maintained for 48 hours by means of surface cooling, or normothermia. All patients otherwise received standard treatment. The primary outcome measure was functional status six months after the injury. Results: The mean age of the patients and the type and severity of injury in the two treatment groups were similar. The mean (+/-SD) time from injury to randomization was 4.3+/-1.1 hours in the hypothermia group and 4.1+/-1.2 hours in the normothermia group, and the mean time from injury to the achievement of the target temperature of 33 degreesC in the hypothermia group was 8.4+/-3.0 hours. The outcome was poor (defined as severe disability, a vegetative state, or death) in 57 percent of the patients in both groups. Mortality was 28 percent in the hypothermia group and 27 percent in the normothermia group (P=0.79). The patients in the hypothermia group had more hospital days with complications than the patients in the normothermia group. Fewer patients in the hypothermia group had high intracranial pressure than in the normothermia group. Conclusions: Treatment with hypothermia, with the body temperature reaching 33 degreesC within eight hours after injury, is not effective in improving outcomes in patients with severe brain injury. (N Engl J Med 2001;344:556-63.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Texas, Hlth Sci Ctr, Sch Med, Dept Neurosurg,Vivian L Smith Ctr Neurol Res, Houston, TX 77030 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA; Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA USA; Indiana Univ, Div Neurosurg, Indianapolis, IN 46204 USA; Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; Univ Toronto, Sunnybrook Med Ctr, Dept Neurosurg, Toronto, ON M4N 3M5, Canada	Clifton, GL (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Med, Dept Neurosurg,Vivian L Smith Ctr Neurol Res, 6431 Fannin,Suite 7-148, Houston, TX 77030 USA.	guy.l.clifton@uth.tmc.edu	Marion, Donald/AAR-5749-2021	Chesnut, Randall/0000-0001-6377-3666	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032786] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS32786-06] Funding Source: Medline		[Anonymous], 1996, FED REG, V61, P51531; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; DRAKE CG, 1962, CAN MED ASSOC J, V87, P887; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; JENNETT B, 1975, LANCET, V1, P480; LASKOWSKI EJ, 1960, NEUROLOGY, V10, P499, DOI 10.1212/WNL.10.5.499; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Myles G L, 1995, J Neurosci Nurs, V27, P35; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; 1995, FED REG, V60, P38353	28	896	936	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					556	563		10.1056/NEJM200102223440803			8	Medicine, General & Internal	General & Internal Medicine	403LU	WOS:000167044600003	11207351	Green Published			2021-06-18	
J	MARMAROU, A; FODA, MAA; VANDENBRINK, W; CAMPBELL, J; KITA, H; DEMETRIADOU, K				MARMAROU, A; FODA, MAA; VANDENBRINK, W; CAMPBELL, J; KITA, H; DEMETRIADOU, K			A NEW MODEL OF DIFFUSE BRAIN INJURY IN RATS .1. PATHOPHYSIOLOGY AND BIOMECHANICS	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; PATHOPHYSIOLOGY; BIOMECHANICS; EXPERIMENTAL MODEL; RAT	EXPERIMENTAL HEAD-INJURY; FLUID-PERCUSSION MODEL; CEREBRAL BLOOD-FLOW; IMPACT-ACCELERATION; AXONAL INJURY; CONCUSSION; TRAUMA; CONSUMPTION; TOMOGRAPHY; METABOLISM	This report describes the development of an experimental head injury model capable of producing diffuse brain injury in the rodent. A total of 161 anesthetized adult rats were injured utilizing a simple weight-drop device consisting of a segmented brass weight free-falling through a Plexiglas guide tube. Skull fracture was prevented by cementing a small stainless-steel disc on the calvaria. Two groups of rats were tested: Group 1, consisting of 54 rats, to establish fracture threshold; and Group 2, consisting of 107 animals, to determine the primary cause of death at severe injury levels. Data from Group 1 animals showed that a 450-gm weight falling from a 2-m height (0.9 kg-m) resulted in a mortality rate of 44% with a low incidence (12.5%) of skull fracture. Impact was followed by apnea, convulsions, and moderate hypertension. The surviving rats developed decortication flexion deformity of the forelimbs, with behavioral depression and loss of muscle tone. Data from Group 2 animals suggested that the cause of death was due to central respiratory depression; the mortality rate decreased markedly in animals mechanically ventilated during the impact. Analysis of mathematical models showed that this mass-height combination resulted in a brain acceleration of 900 G and a brain compression gradient of 0.28 mm. lt is concluded that this simple model is capable of producing a graded brain injury in the rodent without a massive hypertensive surge or excessive brain-stem damage.		MARMAROU, A (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23298, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587, NS-19235] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, R01NS019235, R56NS019235, P01NS012587] Funding Source: NIH RePORTER		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BECKMAN DL, 1969, P SOC EXP BIOL MED, V130, P5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1972, 16TH P STRAP CAR CRA, P295; GRUBB RL, 1970, J NEUROSURG, V32, P320, DOI 10.3171/jns.1970.32.3.0320; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; Nelson S, 1966, HEAD INJURY, P444; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1974, NEURAL TRAUMA, P275; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; VANDENBRINK W, 1993, INTRACRANIAL PRESSUR, V7, P221; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219	31	874	1018	0	83	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1994	80	2					291	300		10.3171/jns.1994.80.2.0291			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	MR795	WOS:A1994MR79500016	8283269				2021-06-18	
J	Lucas, SM; Rothwell, NJ; Gibson, RM				Lucas, SM; Rothwell, NJ; Gibson, RM			The role of inflammation in CNS injury and disease	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						cytokine neurodegeneration; COX; NO; interleukin; tumour necrosis factor; complement	TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; BRAIN; SEIZURES; MICE; EXPRESSION; INHIBITOR; MICROGLIA	For many years, the central nervous system (CNS) was considered to be 'immune privileged', neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflanitnatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune Cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long-term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short-term. Targeting interleukin (IL)-1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL-1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti-inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti-inflarnmatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the Outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Rothwell, NJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Nancy.Rothwell@manchester.ac.uk			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G19/24] Funding Source: Medline		Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; [Anonymous], 1999, Neurology, V53, P457; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Campbell A, 2004, ANN NY ACAD SCI, V1035, P117, DOI 10.1196/annals.1332.008; Couzin J, 2004, SCIENCE, V306, P1673, DOI 10.1126/science.306.5702.1673; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Huitinga I, 2000, J NEUROENDOCRINOL, V12, P1186, DOI 10.1046/j.1365-2826.2000.00574.x; LIAO JK, 2002, ANN REV PHARM TOXICO, V45, P89; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Mycko MP, 2003, BRAIN, V126, P1048, DOI 10.1093/brain/awg107; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Piraino PS, 2002, J NEUROIMMUNOL, V131, P147, DOI 10.1016/S0165-5728(02)00273-4; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Sayyah M, 2005, EXP NEUROL, V191, P145, DOI 10.1016/j.expneurol.2004.08.032; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Sheng JG, 1998, NEUROPATH APPL NEURO, V24, P278; Stanislaus R, 2001, J NEUROSCI RES, V66, P155, DOI 10.1002/jnr.1207; Suffredini AF, 1999, J CLIN IMMUNOL, V19, P203, DOI 10.1023/A:1020563913045; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Van Everbroeck B, 2002, NEUROBIOL AGING, V23, P59, DOI 10.1016/S0197-4580(01)00236-6; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x	37	871	914	4	177	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JAN	2006	147			1			S232	S240		10.1038/sj.bjp.0706400			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	009BZ	WOS:000235087400027	16402109	Green Published			2021-06-18	
J	Kuppermann, N; Holmes, JF; Dayan, PS; Hoyle, JD; Atabaki, SM; Holubkov, R; Nadel, FM; Monroe, D; Stanley, RM; Borgialli, DA; Badawy, MK; Schunk, JE; Quayle, KS; Mahajan, P; Lichenstein, R; Lillis, KA; Tunik, MG; Jacobs, ES; Callahan, JM; Gorelick, MH; Glass, TF; Lee, LK; Bachman, MC; Cooper, A; Powell, EC; Gerardi, MJ; Melville, KA; Muizelaar, JP; Wisner, DH; Zuspan, SJ; Dean, JM; Wootton-Gorges, SL				Kuppermann, Nathan; Holmes, James F.; Dayan, Peter S.; Hoyle, John D., Jr.; Atabaki, Shireen M.; Holubkov, Richard; Nadel, Frances M.; Monroe, David; Stanley, Rachel M.; Borgialli, Dominic A.; Badawy, Mohamed K.; Schunk, Jeff E.; Quayle, Kimberly S.; Mahajan, Prashant; Lichenstein, Richard; Lillis, Kathleen A.; Tunik, Michael G.; Jacobs, Elizabeth S.; Callahan, James M.; Gorelick, Marc H.; Glass, Todd F.; Lee, Lois K.; Bachman, Michael C.; Cooper, Arthur; Powell, Elizabeth C.; Gerardi, Michael J.; Melville, Kraig A.; Muizelaar, J. Paul; Wisner, David H.; Zuspan, Sally Jo; Dean, J. Michael; Wootton-Gorges, Sandra L.		PECARN	Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study	LANCET			English	Article							COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; DECISION RULE; EMERGENCY-DEPARTMENTS; PREDICTION RULES; SKULL FRACTURE; CONSCIOUSNESS; ABNORMALITIES; AGREEMENT; CT	Background CT imaging of head-injured children has risks of radiation-induced malignancy. Our aim was to identify children at very low risk of clinically-important traumatic brain injuries (ciTBI) for whom CT might be unnecessary. Methods We enrolled patients younger than 18 years presenting within 24 h of head trauma with Glasgow Coma Scale scores of 14-15 in 25 North American emergency departments. We derived and validated age-specific prediction rules for ciTBI (death from traumatic brain injury, neurosurgery, intubation >24 h, or hospital admission >= 2 nights). Findings We enrolled and analysed 42412 children (derivation and validation populations: 8502 and 2216 younger than 2 years, and 25 283 and 6411 aged 2 years and older). We obtained CT scans on 14969 (35.3%); ciTBIs occurred in 376 (0.9%), and 60 (0.1%) underwent neurosurgery. In the validation population, the prediction rule for children younger than 2 years (normal mental status, no scalp haematoma except frontal, no loss of consciousness or loss of consciousness for less than 5 s, non-severe injury mechanism, no palpable skull fracture, and acting normally according to the parents) had a negative predictive value for ciTBI of 1176/1176 (100.0%, 95% CI 99.7-100.0) and sensitivity of 25/25 (100%, 86.3-100.0). 167 (24.1%) of 694 CT imaged patients younger than 2 years were in this low-risk group. The prediction rule for children aged 2 years and older (normal mental status, no loss of consciousness, no vomiting, non-severe injury mechanism, no signs of basilar skull fracture, and no severe headache) had a negative predictive value of 3798/3800 (99.95%, 99.81-99.99) and sensitivity of 61/63 (96.8%, 89.0-99.6). 446 (20.1%) of 2223 CT imaged patients aged 2 years and older were in this low-risk group. Neither rule missed neurosurgery in validation populations. Interpretation These validated prediction rules identified children at very low risk of ciTBIs for whom CT can routinely be obviated. Funding The Emergency Medical Services for Children Programme of the Maternal and Child Health Bureau, and the Maternal and Child Health Bureau Research Programme, Health Resources and Services Administration, US Department of Health and Human Services.	[Kuppermann, Nathan; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Muizelaar, J. Paul] Univ Calif Davis, Sch Med, Dept Neurol Surg, Davis, CA 95616 USA; [Wisner, David H.] Univ Calif Davis, Sch Med, Dept Surg, Davis, CA 95616 USA; [Wootton-Gorges, Sandra L.] Univ Calif Davis, Sch Med, Dept Radiol, Davis, CA 95616 USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Hoyle, John D., Jr.] Michigan State Univ, Sch Med, Helen DeVos Childrens Hosp, Div Emergency Med, Grand Rapids, MI USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Holubkov, Richard; Schunk, Jeff E.; Zuspan, Sally Jo; Dean, J. Michael] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Holubkov, Richard; Zuspan, Sally Jo; Dean, J. Michael] PECARN Cent Data Management & Coordinating Ctr, Salt Lake City, UT USA; [Nadel, Frances M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Monroe, David] Howard Cty Gen Hosp, Dept Emergency Med, Columbia, MD USA; [Stanley, Rachel M.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Borgialli, Dominic A.] Univ Michigan, Sch Med, Dept Emergency Med, Flint, MI 48503 USA; [Borgialli, Dominic A.] Hudey Med Ctr, Flint, MI USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Quayle, Kimberly S.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Mahajan, Prashant] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Lichenstein, Richard] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Lillis, Kathleen A.] SUNY Buffalo, Dept Pediat & Emergency Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Pediat, New York, NY USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Jacobs, Elizabeth S.] Holy Cross Hosp, Dept Pediat, Silver Spring, MD USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY USA; [Gorelick, Marc H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Glass, Todd F.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lee, Lois K.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Pediat, Newark, NJ USA; [Cooper, Arthur] Columbia Univ, Med Ctr, Harlem Hosp, Dept Surg, New York, NY USA; [Powell, Elizabeth C.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Gerardi, Michael J.] Morristown Mem Hosp, Dept Emergency Med, Morristown, NJ USA; [Melville, Kraig A.] Calvert Mem Hosp, Dept Emergency Med, Prince Frederick, MD USA	Kuppermann, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Suite 2100, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu	Tsung, James W/I-6343-2019	Faul, Mark/0000-0002-7683-0348; Powell, Elizabeth/0000-0003-3147-9889; Tsung, James/0000-0002-4718-8325; Tunik, Michael/0000-0002-2368-5933	Emergency Medical Services for Children (EMSC) programme of the Maternal and Child Health Bureau [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]; Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); US Department of Health and Human Services; Maternal and Child Health Bureau Research Programme [1 R40MC02461-01-00]	We thank Rene Enriquez and Li Dong at the PECARN Data Center (University of Utah) for their dedicated and diligent work; the research coordinators in PECARN, without whose dedication and hard work this study would not have been possible; all the clinicians around the PECARN network who enrolled children in this study; Mark Faul from the Centers for Disease Control and Prevention for analysing the NHAMCS databases for trends in CT usage over time. PECARN is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the Emergency Medical Services for Children (EMSC) programme of the Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services. This study was also supported by grant 1 R40MC02461-01-00 from the Maternal and Child Health Bureau Research Programme.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brieman L., 1984, CLASSIFICATION REGRE; Dayan PS, 2008, PEDIATR EMERG CARE, V24, P727; Dayan PS, 2008, ACAD EMERG MED, V15, pS175; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Gausche-Hill M, 2007, PEDIATRICS, V120, P1229, DOI 10.1542/peds.2006-3780; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; Kuppermann N, 2008, ACAD EMERG MED, V15, pS82; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Marr AL., 2004, CENTRAL NERVOUS SYST; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; *NAT CTR INJ PREV, 2006, TRAUM BRAIN INJ US A; National Center for Health Statistics Centers for Disease Control and Prevention, 2005, PUBL US DAT FIL EM D; National Center for Health Statistics Centers for Disease Control and Prevention, 1995, PUBL US DAT FIL EM D; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Seidel JS, 1999, ANN EMERG MED, V33, P206, DOI 10.1016/S0196-0644(99)70395-1; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; TEASDALE G, 1974, LANCET, V2, P81	43	864	877	2	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1160	1170		10.1016/S0140-6736(09)61558-0			11	Medicine, General & Internal	General & Internal Medicine	505IZ	WOS:000270688200032	19758692				2021-06-18	
J	DIXON, CE; CLIFTON, GL; LIGHTHALL, JW; YAGHMAI, AA; HAYES, RL				DIXON, CE; CLIFTON, GL; LIGHTHALL, JW; YAGHMAI, AA; HAYES, RL			A CONTROLLED CORTICAL IMPACT MODEL OF TRAUMATIC BRAIN INJURY IN THE RAT	JOURNAL OF NEUROSCIENCE METHODS			English	Article						BRAIN INJURY; BRAIN IMPACT; CORTICAL CONTUSION; (RAT)		Controlled cortical impact models produce brain injury by using a pneumatic impactor to impact exposed brain. This study systematically examined the effects of varying magnitudes of controlled cortical impact to the rat brain on neurological, cardiovascular, and histopathological variables. As the magnitude of injury increased, the duration of suppression of somatomotor reflexes and the duration of chronic vestibular motor deficits increased. The blood pressure response was observed to depend on injury levels; a moderate injury level produced a hypotensive response while a high injury level produced an immediate brief hypertensive response followed by hypotension. Low injury levels produced no significant macroscopic or microscopic change, but higher injury levels produced cortical contusion and intraparenchymal hemorrhage which, with increasing survival time, evolved into necrotic changes and cavitation underlying the injury site. Also with high levels of injury, axonal injury was found throughout the brain-stem with the greatest concentration of injured axons occurring in the cerebellar peduncles and pontomedullary junction. These data demonstrate that controlled cortical impact in the rat reproduces many of the features observed in other experimental animal models. This model allows independent control of many mechanical loading parameters associated with traumatic brain injury. The controlled cortical impact rat model should be an effective experimental tool to investigators of traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT REHABIL MED, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT NEUROSURG, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT ANAT, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, RES LABS, DEPT BIOMED SCI, RICHMOND, VA 23298 USA					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21458] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133B80029, R49-CCR303547] Funding Source: Medline		ANDERSON TE, 1982, J NEUROSCI METH, V6, P327, DOI 10.1016/0165-0270(82)90033-4; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gennarelli T.A., 1982, HEAD INJURY BASIC CL, P129; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KEARNEY P A, 1988, Journal of Neurotrauma, V5, P187, DOI 10.1089/neu.1988.5.187; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MILLEN JE, 1983, J APPL PHYSIOL, V54, P666; MITCHELL DE, 1973, LANCET, V2, P215; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHIMA K, IN PRESS J NEUROSURG, V72, P270; SOMERSON SK, 1987, EXP NEUROL, V96, P82, DOI 10.1016/0014-4886(87)90170-1; STALHAMMAR D, 1987, BRAIN INJURY, V1, P93; Strich S J, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P166; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; WHITE D, 1990, P SOC NEUROSCI, V16, P780; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	30	857	877	1	50	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT	1991	39	3					253	262					10	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	GT306	WOS:A1991GT30600007	1787745				2021-06-18	
J	Yirmiya, R; Goshen, I				Yirmiya, Raz; Goshen, Inbal			Immune modulation of learning, memory, neural plasticity and neurogenesis	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Inflammation; Learning; Memory; Neural plasticity; Long-term potentiation (LTP); Neurogenesis; Cytokines; Microglia; Astrocytes; IL-1	LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; NERVE GROWTH-FACTOR; RAT DENTATE GYRUS; TRAUMATIC BRAIN-INJURY; AGE-RELATED IMPAIRMENT; NEURONAL CELL-DEATH; INTERLEUKIN-1-BETA GENE-EXPRESSION; ENHANCED SYNAPTIC PLASTICITY; ETHYL-EICOSAPENTAENOIC ACID	Over the past two decades it became evident that the immune system plays a central role in modulating learning, memory and neural plasticity. Under normal quiescent conditions, immune mechanisms are activated by environmental/psychological stimuli and positively regulate the remodeling of neural circuits, promoting memory consolidation, hippocampal long-term potentiation (LTP) and neurogenesis. These beneficial effects of the immune system are mediated by complex interactions among brain cells with immune functions (particularly microglia and astrocytes), peripheral immune cells (particularly T cells and macrophages), neurons, and neural precursor cells. These interactions involve the responsiveness of non-neuronal cells to classical neurotransmitters (e.g., glutamate and monoamines) and hormones (e.g., glucocorticoids), as well as the secretion and responsiveness of neurons and glia to low levels of inflammatory cytokines, such as interleukin (IL)-1, IL-6, and TNF alpha, as well as other mediators, such as prostaglandins and neurotrophins. In conditions under which the immune system is strongly activated by infection or injury, as well as by severe or chronic stressful conditions, glia and other brain immune cells change their morphology and functioning and secrete high levels of pro-inflammatory cytokines and prostaglandins. The production of these inflammatory mediators disrupts the delicate balance needed for the neurophysiological actions of immune processes and produces direct detrimental effects on memory, neural plasticity and neurogenesis. These effects are mediated by inflammation-induced neuronal hyper-excitability and adrenocortical stimulation, followed by reduced production of neurotrophins and other plasticity-related molecules, facilitating many forms of neuropathology associated with normal aging as well as neurodegenerative and neuropsychiatric diseases. (C) 2010 Elsevier Inc. All rights reserved.	[Yirmiya, Raz; Goshen, Inbal] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel	Yirmiya, R (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	razyirmiya@huji.ac.il	Yirmiya, Raz/D-1090-2014	Yirmiya, Raz/0000-0002-4009-7316; Goshen, Inbal/0000-0001-7578-2615	Israel Science FoundationIsrael Science Foundation [295/07]	The work on this paper was supported by a grant from the Israel Science Foundation (Grant No. 295/07 to RY). The authors thank Ms. Zehava Cohen for preparing all of the wonderful illustrations presented in this paper.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Ajmone-Cat MA, 2010, J NEUROCHEM, V113, P1060, DOI 10.1111/j.1471-4159.2010.06670.x; Akassoglou K, 1997, J IMMUNOL, V158, P438; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Albensi BC, 2000, SYNAPSE, V35, P151; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Aloe L, 1999, CYTOKINE, V11, P45, DOI 10.1006/cyto.1998.0397; Aloe L, 1999, BRAIN RES, V840, P125, DOI 10.1016/S0006-8993(99)01748-5; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Arnold MC, 2002, PSYCHOL MED, V32, P1075, DOI 10.1017/S0033291702006086; AUBERT A, 1995, BRAIN BEHAV IMMUN, V9, P129, DOI 10.1006/brbi.1995.1013; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Bachstetter A.D., NEUROBIOL A IN PRESS; Bains JS, 2007, TRENDS NEUROSCI, V30, P417, DOI 10.1016/j.tins.2007.06.007; Bajayo A, 2005, P NATL ACAD SCI USA, V102, P12956, DOI 10.1073/pnas.0502562102; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Balschun D, 2003, ANN NY ACAD SCI, V992, P1, DOI 10.1111/j.1749-6632.2003.tb03132.x; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Banks WA, 2001, J PHARMACOL EXP THER, V299, P536; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Baune BT, 2008, NEUROBIOL AGING, V29, P937, DOI 10.1016/j.neurobiolaging.2006.12.003; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bechtholt-Gompf A.J., 2010, NEUROPSYCHOPHARMACOL; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Ben Menachem-Zidon O., BRAIN BEHAV IN PRESS; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Besedovsky HO, 2007, BRAIN BEHAV IMMUN, V21, P34, DOI 10.1016/j.bbi.2006.09.008; Bianchi M, 1997, NEUROREPORT, V8, P1775, DOI 10.1097/00001756-199705060-00041; Bianchi M, 1998, BIOL SIGNAL RECEPT, V7, P45; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Bilbo SD, 2005, BEHAV NEUROSCI, V119, P293, DOI 10.1037/0735-7044.119.1.293; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Bilbo SD, 2007, BRAIN BEHAV IMMUN, V21, P332, DOI 10.1016/j.bbi.2006.10.005; Bjugstad KB, 1998, BRAIN RES, V795, P349, DOI 10.1016/S0006-8993(98)00351-5; Blandino P, 2006, J NEUROIMMUNOL, V173, P87, DOI 10.1016/j.jneuroim.2005.11.021; Blandino P, 2009, BRAIN BEHAV IMMUN, V23, P958, DOI 10.1016/j.bbi.2009.04.013; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1983, J PHYSIOL-LONDON, V334, P475, DOI 10.1113/jphysiol.1983.sp014507; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bodles AM, 2004, TRENDS NEUROSCI, V27, P621, DOI 10.1016/j.tins.2004.07.011; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Bracchi-Ricard V, 2008, J NEUROCHEM, V104, P611, DOI 10.1111/j.1471-4159.2007.04993.x; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; Braithwaite VA, 1998, PARASITOLOGY, V117, P145, DOI 10.1017/S003118209800290X; Brennan FX, 2004, BEHAV BRAIN RES, V153, P351, DOI 10.1016/j.bbr.2003.12.025; Brennan FX, 2003, NEUROBIOL LEARN MEM, V80, P168, DOI 10.1016/S1074-7427(03)00060-1; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Brydon L, 2005, BRAIN BEHAV IMMUN, V19, P540, DOI 10.1016/j.bbi.2004.12.003; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Bucks RS, 2008, BRAIN BEHAV IMMUN, V22, P399, DOI 10.1016/j.bbi.2007.09.005; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cakala M, 2007, PHARMACOL REP, V59, P164; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Capuron L, 1999, PSYCHOL MED, V29, P291, DOI 10.1017/S0033291798007740; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chu Y.X., 2010, BRAIN BEHAV IMMUN; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cohen O, 2003, J MOL NEUROSCI, V21, P199, DOI 10.1385/JMN:21:3:199; Conner JM, 2009, J NEUROSCI, V29, P10883, DOI 10.1523/JNEUROSCI.2594-09.2009; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; Coogan A, 1997, NEUROREPORT, V8, P2107, DOI 10.1097/00001756-199707070-00004; Coogan AN, 1999, NEUROSCIENCE, V93, P57, DOI 10.1016/S0306-4522(99)00100-1; Coogan AN, 1999, EUR J PHARMACOL, V374, P197, DOI 10.1016/S0014-2999(99)00320-9; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Cunningham C, 2008, BRAIN BEHAV IMMUN, V22, P1117, DOI 10.1016/j.bbi.2008.05.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Curran BP, 2003, NEUROSCI LETT, V344, P103, DOI 10.1016/S0304-3940(03)00440-3; D'Arcangelo G, 2000, EUR J NEUROSCI, V12, P1241, DOI 10.1046/j.1460-9568.2000.00011.x; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; del Rey A, 2006, P NATL ACAD SCI USA, V103, P16039, DOI 10.1073/pnas.0607076103; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dhir A, 2006, EUR J PHARMACOL, V535, P192, DOI 10.1016/j.ejphar.2006.01.064; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dong J, 2006, J NEUROSCI RES, V83, P489, DOI 10.1002/jnr.20745; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elkabes S, 1996, J NEUROSCI, V16, P2508; ElKhoury J, 1996, NATURE, V382, P716; Elwan O, 2003, J NEUROL SCI, V211, P15, DOI 10.1016/S0022-510X(03)00032-7; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fan LW, 2010, NEUROSCIENCE, V168, P240, DOI 10.1016/j.neuroscience.2010.03.024; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fiore M, 1996, BRAIN BEHAV IMMUN, V10, P126, DOI 10.1006/brbi.1996.0013; Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7; Forlenza OV, 2009, DEMENT GERIATR COGN, V28, P507, DOI 10.1159/000255051; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P254, DOI 10.1016/j.bbi.2009.10.005; Friedman EM, 1997, PHARMACOL THERAPEUT, V74, P27, DOI 10.1016/S0163-7258(96)00200-8; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; Gerber J, 2004, NEUROBIOL DIS, V16, P133, DOI 10.1016/j.nbd.2004.01.013; Gibbs ME, 2006, NEUROSCIENCE, V141, P9, DOI 10.1016/j.neuroscience.2006.04.038; Gibertini M, 1998, NEUROIMMUNOMODULAT, V5, P160, DOI 10.1159/000026332; GIBERTINI M, 1995, P SOC EXP BIOL MED, V210, P7, DOI 10.3181/00379727-210-43917; Gibertini M, 1996, ADV EXP MED BIOL, V402, P207; GIBERTINI M, 1995, BRAIN BEHAV IMMUN, V9, P113, DOI 10.1006/brbi.1995.1012; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Goings GE, 2006, GLIA, V54, P329, DOI 10.1002/glia.20381; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Goncalves MB, 2010, BRIT J PHARMACOL, V159, P1118, DOI 10.1111/j.1476-5381.2009.00618.x; Gong QJ, 2009, GLIA, V57, P583, DOI 10.1002/glia.20786; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Goshen I, 2003, ENDOCRINOLOGY, V144, P4453, DOI 10.1210/en.2003-0338; Goshen I, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P337; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harre EM, 2008, EUR J NEUROSCI, V27, P644, DOI 10.1111/j.1460-9568.2008.06031.x; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Hauss-Wegrzyniak B, 1999, NEUROBIOL AGING, V20, P305, DOI 10.1016/S0197-4580(99)00028-7; Hebb DO., 1949, ORG BEHAV NEUROPSYCH; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Hein AM, 2007, NEUROSCIENCE, V150, P754, DOI 10.1016/j.neuroscience.2007.10.003; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Heinz A, 2003, PSYCHOPHARMACOLOGY, V165, P111, DOI 10.1007/s00213-002-1244-6; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hilsabeck RC, 2010, J NEUROIMMUNOL, V221, P53, DOI 10.1016/j.jneuroim.2010.01.017; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hung J, 2010, BRAIN BEHAV IMMUN, V24, P31, DOI 10.1016/j.bbi.2009.06.150; Ikegaya Y, 2003, SYNAPSE, V47, P54, DOI 10.1002/syn.10154; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Iwai T, 2008, NEUROSCI RES, V61, P113, DOI 10.1016/j.neures.2008.01.018; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jain NK, 2002, BEHAV BRAIN RES, V133, P369, DOI 10.1016/S0166-4328(02)00025-6; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Jankowsky JL, 2000, LEARN MEMORY, V7, P400, DOI 10.1101/lm.32600; Jin DQ, 2008, PHARMACOL BIOCHEM BE, V89, P404, DOI 10.1016/j.pbb.2008.01.016; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Joo Y, 2006, MOL PHARMACOL, V69, P76, DOI 10.1124/mol.105.015206; Kalman J, 1997, ACTA NEUROL SCAND, V96, P236; Kamitani W, 2003, P NATL ACAD SCI USA, V100, P8969, DOI 10.1073/pnas.1531155100; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Katagiri H, 2001, EUR J NEUROSCI, V14, P547, DOI 10.1046/j.0953-816x.2001.01664.x; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelly A, 2003, J NEUROSCI, V23, P5354; Kelly A, 2001, J BIOL CHEM, V276, P45564, DOI 10.1074/jbc.M108757200; Kelly A, 1998, NEUROPHARMACOLOGY, V37, P561, DOI 10.1016/S0028-3908(98)00048-3; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kleim JA, 2007, BEHAV BRAIN RES, V178, P244, DOI 10.1016/j.bbr.2006.12.022; Kohman RA, 2007, BRAIN BEHAV IMMUN, V21, P824, DOI 10.1016/j.bbi.2007.01.009; Kohman RA, 2008, BEHAV BRAIN RES, V194, P25, DOI 10.1016/j.bbr.2008.06.018; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kozora E, 2001, J INT NEUROPSYCH SOC, V7, P745, DOI 10.1017/S1355617701766106; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Krabbe KS, 2005, BRAIN BEHAV IMMUN, V19, P453, DOI 10.1016/j.bbi.2005.04.010; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Lacosta S, 1999, BEHAV NEUROSCI, V113, P1030, DOI 10.1037/0735-7044.113.5.1030; Laflamme N, 1999, J NEUROSCI, V19, P10923; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Lee B, 2000, BRAIN RES, V856, P129, DOI 10.1016/S0006-8993(99)02381-1; LEE SC, 1993, J IMMUNOL, V150, P2659; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; Li ST, 2004, ANN NEUROL, V55, P362, DOI 10.1002/ana.10844; Li YK, 2000, J NEUROSCI, V20, P149, DOI 10.1523/JNEUROSCI.20-01-00149.2000; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Licastro F, 2005, INT J IMMUNOPATH PH, V18, P165, DOI 10.1177/039463200501800117; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Loscher CE, 2003, J NEUROIMMUNOL, V137, P117, DOI 10.1016/S0165-5728(03)00072-9; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lynch MA, 2002, VITAM HORM, V64, P185, DOI 10.1016/S0083-6729(02)64006-3; Lynch MA, 1998, REV NEUROSCIENCE, V9, P169; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Ma TC, 1997, ARZNEIMITTEL-FORSCH, V47, P595; Maher FO, 2006, J NEUROCHEM, V96, P1560, DOI 10.1111/j.1471-4159.2006.03664.x; Maier SF, 1998, PSYCHOL REV, V105, P83, DOI 10.1037/0033-295X.105.1.83; MAIER SF, 1995, BRAIN RES, V695, P279, DOI 10.1016/0006-8993(95)00930-O; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Maruta E, 1997, MOL BRAIN RES, V49, P291, DOI 10.1016/S0169-328X(97)00207-6; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Mathieu P, 2010, NEUROIMMUNOMODULAT, V17, P200, DOI 10.1159/000258723; Matsuda S, 1996, NEUROSCI LETT, V204, P109, DOI 10.1016/0304-3940(96)12340-5; Matsumoto Y, 2004, NEUROPHARMACOLOGY, V46, P1195, DOI 10.1016/j.neuropharm.2004.02.012; Matsumoto Y, 2002, J NEUROCHEM, V82, P234, DOI 10.1046/j.1471-4159.2002.00944.x; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McGahon BM, 1999, NEUROBIOL AGING, V20, P655, DOI 10.1016/S0197-4580(99)00050-0; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; McNamee EN, 2010, NEUROPHARMACOLOGY, V59, P37, DOI 10.1016/j.neuropharm.2010.03.014; McNamee EN, 2010, EUR J PHARMACOL, V626, P219, DOI 10.1016/j.ejphar.2009.09.054; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Mesches MH, 2004, NEUROBIOL AGING, V25, P315, DOI 10.1016/S0197-4580(03)00116-7; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Murray CA, 1998, J NEUROSCI, V18, P2974; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nguyen KT, 1998, J NEUROSCI, V18, P2239; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; O'Connor JJ, 1999, EXP PHYSIOL, V84, P601, DOI 10.1017/S0958067099018928; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; O'Malley A, 2000, NEUROSCIENCE, V99, P229, DOI 10.1016/S0306-4522(00)00182-2; OBanion MK, 1996, J NEUROCHEM, V66, P2532; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; OITZL MS, 1993, BRAIN RES, V613, P160, DOI 10.1016/0006-8993(93)90468-3; Olah M, 2009, GLIA, V57, P1046, DOI 10.1002/glia.20828; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Palin K, 2004, BRAIN BEHAV IMMUN, V18, P223, DOI 10.1016/j.bbi.2003.09.002; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Patanella AK, 2010, J NEUROSCI RES, V88, P1106, DOI 10.1002/jnr.22276; Pedersen L.M., 2009, EUR J PAIN; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; PLATASALAMAN CR, 1992, BRAIN RES BULL, V29, P221, DOI 10.1016/0361-9230(92)90029-W; PLATASALAMAN CR, 1994, EUR J PHARM-MOLEC PH, V266, P1, DOI 10.1016/0922-4106(94)90202-X; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Pollak Y, 2005, ANN NEUROL, V57, P741, DOI 10.1002/ana.20454; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Pugh CR, 2000, BRAIN RES, V861, P8, DOI 10.1016/S0006-8993(99)02445-2; Rall JM, 2003, BRAIN RES, V968, P273, DOI 10.1016/S0006-8993(03)02248-0; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ron-Harel N, 2008, REJUV RES, V11, P903, DOI 10.1089/rej.2008.0755; Ron-Harel N, 2009, TRENDS NEUROSCI, V32, P367, DOI 10.1016/j.tins.2009.03.003; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmid AW, 2009, HIPPOCAMPUS, V19, P670, DOI 10.1002/hipo.20542; Schmidt H, 2006, BRAIN, V129, P333, DOI 10.1093/brain/awh711; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; Schwartz M, 2010, MOL PSYCHIATR, V15, P342, DOI 10.1038/mp.2010.31; Schwartz M, 2009, NEUROSCIENCE, V158, P1133, DOI 10.1016/j.neuroscience.2008.12.013; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Servatius RJ, 2003, INTEGR PHYS BEH SCI, V38, P169, DOI 10.1007/BF02688851; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shapira-Lichter I, 2008, BRAIN BEHAV IMMUN, V22, P388, DOI 10.1016/j.bbi.2007.09.006; Sharifzadeh M, 2005, EUR J PHARMACOL, V511, P159, DOI 10.1016/j.ejphar.2005.01.041; Shaw KN, 2005, BRAIN RES, V1038, P231, DOI 10.1016/j.brainres.2005.01.035; Shaw KN, 2003, EUR J NEUROSCI, V17, P2438, DOI 10.1046/j.1460-9568.2003.02643.x; Shaw KN, 2001, BEHAV BRAIN RES, V124, P47, DOI 10.1016/S0166-4328(01)00232-7; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Singh G, 2008, EPILEPSIA, V49, P1, DOI 10.1111/j.1528-1167.2008.01748.x; Song C, 2004, MOL PSYCHIATR, V9, P630, DOI 10.1038/sj.mp.4001462; Song C, 2004, J LIPID RES, V45, P1112, DOI 10.1194/jlr.M300526-JLr200; Song C, 2004, STRESS, V7, P43, DOI 10.1080/10253890410001667188; Song C, 2003, EUR J NEUROSCI, V18, P1739, DOI 10.1046/j.1460-9568.2003.02886.x; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tanaka H, 2002, J NEUROSCI RES, V67, P11, DOI 10.1002/jnr.10004.abs; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Thomson LM, 2005, BRAIN RES BULL, V67, P24, DOI 10.1016/j.brainresbull.2005.05.024; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Tynan R.J., 2010, BRAIN BEHAV IMMUN; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Exel E, 2003, NEUROLOGY, V61, P1695, DOI 10.1212/01.WNL.0000098877.07653.7C; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vega C, 2002, GLIA, V39, P10, DOI 10.1002/glia.10080; Vereker E, 2001, EUR J NEUROSCI, V14, P1809, DOI 10.1046/j.0953-816x.2001.01809.x; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; Gonzalez PV, 2009, BRAIN BEHAV IMMUN, V23, P817, DOI 10.1016/j.bbi.2009.03.001; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Viviani B, 2003, J NEUROSCI, V23, P8692; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wilson CJ, 2003, J AM GERIATR SOC, V51, P1374, DOI 10.1046/j.1532-5415.2003.51454.x; Wolf G, 2003, PAIN, V104, P471, DOI 10.1016/S0304-3959(03)00067-8; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Woolf NJ, 2001, J NEUROSCI, V21, P1047; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yamada K, 2000, J NEUROIMMUNOL, V111, P131, DOI 10.1016/S0165-5728(00)00375-1; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103; Yirmiya R, 2009, BIOL PSYCHIAT, V66, P423, DOI 10.1016/j.biopsych.2009.03.016; Zhang JM, 2003, EXP NEUROL, V183, P469, DOI 10.1016/S0014-4886(03)00222-X; Zhong Y, 2010, BRAIN BEHAV IMMUN, V24, P874, DOI 10.1016/j.bbi.2010.01.007; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006	400	849	883	6	240	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2011	25	2					181	213		10.1016/j.bbi.2010.10.015			33	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	712XL	WOS:000286699500001	20970492		Y	N	2021-06-18	
J	Stiell, IG; Wells, GA; Vandemheen, K; Clement, C; Lesiuk, H; Laupacis, A; McKnight, RD; Verbeek, R; Brison, R; Cass, D; Eisenhauer, MA; Greenberg, GH; Worthington, J				Stiell, IG; Wells, GA; Vandemheen, K; Clement, C; Lesiuk, H; Laupacis, A; McKnight, RD; Verbeek, R; Brison, R; Cass, D; Eisenhauer, MA; Greenberg, GH; Worthington, J		CCC Study Grp	The Canadian CT head rule for patients with minor head injury	LANCET			English	Article							TRAUMATIC INTRACRANIAL HEMATOMA; CLINICAL-PREDICTION RULES; OTTAWA ANKLE RULES; COMPUTED-TOMOGRAPHY; METHODOLOGICAL STANDARDS; DECISION RULES; RADIOGRAPHY; MANAGEMENT; IMPLEMENTATION; VALIDATION	Background There is much controversy about the use of computed tomography (CT) for patients with minor head injury. We aimed to develop a highly sensitive clinical decision rule for use of CT in patients with minor head injuries. Methods We carried out this prospective cohort study in the emergency departments of ten large Canadian hospitals and included consecutive adults who presented with a Glasgow Coma Scale (GCS) score of 13-15 after head injury. We did standardised clinical assessments before the CT scan. The main outcome measures were need for neurological intervention and clinically important brain injury on CT. Findings The 3121 patients had the following characteristics: mean age 38.7 years); GCS scores of 13 (3.5%), 14 (16.7%), 15 (79.8%); 8% had clinically important brain injury; and 1% required neurological intervention. We derived a CT head rule which consists of five high-risk factors (failure to reach GCS of 15 within 2 h, suspected open skull fracture, any sign of basal skull fracture, vomiting greater than or equal to2 episodes, or age greater than or equal to 65 years) and two additional medium-risk factors (amnesia before impact greater than or equal to 30 min and dangerous mechanism of injury). The high-risk factors were 100% sensitive (95% CI 92-100%) for predicting need for neurological intervention, and would require only 32% of patients to undergo CT. The medium-risk factors were 98.4% sensitive (95% CI 96-99%) and 49.6% specific for predicting clinically important brain injury, and would require only 54% of patients to undergo CT. Interpretation We have developed the Canadian CT Head Rule, a highly sensitive decision rule for use of CT. This rule has the potential to significantly standardise and improve the emergency management of patients with minor head injury.	Univ Ottawa, Div Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Dept Epidemiol, Ottawa, ON, Canada; Univ Ottawa, Dept Community Med, Ottawa, ON, Canada; Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Clin Epidemiol Unit, Ottawa, ON, Canada; Queens Univ, Dept Emergency Med, Kingston, ON, Canada; Univ Toronto, Div Emergency Med, Toronto, ON, Canada; Univ Western Ontario, Div Emergency Med, London, ON, Canada; Univ British Columbia, Div Emergency Med, Vancouver, BC V5Z 1M9, Canada	Stiell, IG (corresponding author), Ottawa Civic Hosp, Loeb Hlth Res Inst, Clin Epidemiol Unit, F6, Ottawa, ON K1Y 4E9, Canada.			Stiell, Ian/0000-0002-2583-6408			BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; DASCEY RG, 1986, J NEUROSURG, V65, P302; DUUS BR, 1994, ANN EMERG MED, V23, P1279, DOI 10.1016/S0196-0644(94)70352-3; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEVITT MA, 1994, ANN EMERG MED, V23, P1143; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; McCaig L F, 1994, Adv Data, P1; *NAT CTR HLTH STAT, 1994, NAT HOSP AMB MED CAR; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOEY ER, 1994, ANN EMERG MED, V23, P127; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell I.G., 2000, ACAD EMERG MED, V7, P572; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.278.23.2075; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; STIELL IG, 2000, ACAD EMERG MED, V7, P533; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P28; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; 1993, ADV TRAUMA LIFE SUPP	32	849	862	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1391	1396		10.1016/S0140-6736(00)04561-X			6	Medicine, General & Internal	General & Internal Medicine	428TW	WOS:000168478200010	11356436				2021-06-18	
J	Cooper, DJ; Rosenfeld, JV; Murray, L; Arabi, YM; Davies, AR; D'Urso, P; Kossmann, T; Ponsford, J; Seppelt, I; Reilly, P; Wolfe, R				Cooper, D. James; Rosenfeld, Jeffrey V.; Murray, Lynnette; Arabi, Yaseen M.; Davies, Andrew R.; D'Urso, Paul; Kossmann, Thomas; Ponsford, Jennie; Seppelt, Ian; Reilly, Peter; Wolfe, Rory		DECRA Trial Investigators; Australian New Zealand Intensive C	Decompressive Craniectomy in Diffuse Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; AXONAL STRETCH INJURY; STRUCTURED INTERVIEWS; CLINICAL-TRIALS; CEREBRAL EDEMA; MANAGEMENT; SECONDARY; PRESSURE	BACKGROUND It is unclear whether decompressive craniectomy improves the functional outcome in patients with severe traumatic brain injury and refractory raised intracranial pressure. METHODS From December 2002 through April 2010, we randomly assigned 155 adults with severe diffuse traumatic brain injury and intracranial hypertension that was refractory to first-tier therapies to undergo either bifrontotemporoparietal decompressive craniectomy or standard care. The original primary outcome was an unfavorable outcome (a composite of death, vegetative state, or severe disability), as evaluated on the Extended Glasgow Outcome Scale 6 months after the injury. The final primary outcome was the score on the Extended Glasgow Outcome Scale at 6 months. RESULTS Patients in the craniectomy group, as compared with those in the standard-care group, had less time with intracranial pressures above the treatment threshold (P<0.001), fewer interventions for increased intracranial pressure (P<0.02 for all comparisons), and fewer days in the intensive care unit (ICU) (P<0.001). However, patients undergoing craniectomy had worse scores on the Extended Glasgow Outcome Scale than those receiving standard care (odds ratio for a worse score in the craniectomy group, 1.84; 95% confidence interval [CI], 1.05 to 3.24; P = 0.03) and a greater risk of an unfavorable outcome (odds ratio, 2.21; 95% CI, 1.14 to 4.26; P = 0.02). Rates of death at 6 months were similar in the craniectomy group (19%) and the standard-care group (18%). CONCLUSIONS In adults with severe diffuse traumatic brain injury and refractory intracranial hypertension, early bifrontotemporoparietal decompressive craniectomy decreased intracranial pressure and the length of stay in the ICU but was associated with more unfavorable outcomes.	[Cooper, D. James; Murray, Lynnette; Davies, Andrew R.] Alfred Hosp, Dept Intens Care, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Cooper, D. James; Murray, Lynnette; Davies, Andrew R.; Ponsford, Jennie; Wolfe, Rory] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [D'Urso, Paul] Epworth Healthcare, Neurosci Clin Inst, Melbourne, Vic, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Kossmann, Thomas] Epworth Med Fdn, Melbourne, Vic, Australia; [Seppelt, Ian] Univ Sydney, Dept Intens Care Med, Nepean Hosp, Sydney, NSW 2006, Australia; [Reilly, Peter] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Intens Care, Riyadh, Saudi Arabia	Cooper, DJ (corresponding author), Alfred Hosp, Dept Intens Care, Commercial Rd, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Wolfe, Rory/F-5185-2013; Venkatesh, Bala/F-4700-2010; Joyce, Christopher/B-7437-2013; Rosenfeld, Jeffrey V/B-7249-2011; Cooper, D. James/G-7961-2013; Presneill, Jeffrey J/B-4894-2012	Cooper, D. James/0000-0002-5872-9051; Presneill, Jeffrey J/0000-0001-7177-7667; Venkatesh, Bala/0000-0002-3234-5244; Wolfe, Rory/0000-0002-2126-1045; Arabi, Yaseen/0000-0001-5735-6241; Myles, Paul/0000-0002-3324-5456; Micallef, Sharon/0000-0002-8496-2324	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [NHMRC 314502]; Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative); Intensive Care Foundation (Australia); Western Australian Institute for Medical Research	Supported by grants from the National Health and Medical Research Council of Australia (NHMRC 314502), the Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative), the Intensive Care Foundation (Australia), and the Western Australian Institute for Medical Research.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Australian Bureau of Statistics, 2011, POP CLOCK; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock AR, 2006, NEUROSURGERY, V58, pVI; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	34	807	859	2	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1493	1502		10.1056/NEJMoa1102077			10	Medicine, General & Internal	General & Internal Medicine	752VH	WOS:000289722700006	21434843	Green Published	Y	N	2021-06-18	
J	Bruce, AJ; Boling, W; Kindy, MS; Peschon, J; Kraemer, PJ; Carpenter, MK; Holtsberg, FW; Mattson, MP				Bruce, AJ; Boling, W; Kindy, MS; Peschon, J; Kraemer, PJ; Carpenter, MK; Holtsberg, FW; Mattson, MP			Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; RAT-BRAIN; MESSENGER-RNA; KAINIC ACID; ASTROCYTES; PROTECTION; CYTOKINES; OLIGODENDROCYTES; MODULATION	Brain injury, as occurs in stroke or head trauma, induces a dramatic increase in levels of tumor necrosis factor-alpha (TNF), but its role in brain injury response is unknown. We generated mice genetically deficient in TNF receptors (TNFR-KO) to determine the role of TNF in brain cell injury responses. Damage to neurons caused by focal cerebral ischemia and epileptic seizures was exacerbated in TNFR-KO mice, indicating that TNF serves a neuroprotective function. Oxidative stress was increased and levels of an antioxidant enzyme reduced in brain cells of TNFR-KO mice, indicating that INF protects neurons by stimulating antioxidant pathways. Injury-induced microglial activation was suppressed in TNFR-KO mice, demonstrating a key role for TNF in injury-induced immune response. Drugs that target TNF signaling pathways may prove beneficial in treating stroke and traumatic brain injury.	UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT NEUROSURG, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT BIOCHEM, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT PSYCHOL, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT BIOL SCI, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; IMMUNEX RES & DEV CORP, SEATTLE, WA 98101 USA			Bruce-Keller, Annadora/N-1954-2017; Mattson, Mark P/F-6038-2012		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 12981] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 31220, NS 9001] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012981] Funding Source: NIH RePORTER		ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; BEUTLER B, 1994, ANN NY ACAD SCI, V730, P118, DOI 10.1111/j.1749-6632.1994.tb44244.x; BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHUNG IY, 1990, J IMMUNOL, V144, P2999; EDDY LJ, 1992, BIOCHEM BIOPH RES CO, V184, P1056, DOI 10.1016/0006-291X(92)90698-K; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LIPTON SA, 1994, MOL NEUROBIOL, V8, P181, DOI 10.1007/BF02780669; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; LYDEN PD, 1992, EXP NEUROL, V116, P122, DOI 10.1016/0014-4886(92)90160-R; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, SEMIN NEUROSCI, V5, P295; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MERRILL JE, 1991, DEV NEUROSCI-BASEL, V13, P130, DOI 10.1159/000112150; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; PANEK RB, 1995, J IMMUNOL, V154, P2846; PETERSON PK, 1994, J INFECT DIS, V170, P457, DOI 10.1093/infdis/170.2.457; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VANDERPOLL T, 1995, SHOCK, V3, P1; WARNER BB, 1991, AM J PHYSIOL, V260, pL296; WATSON BD, 1989, ANN NY ACAD SCI, V559, P269; WHITE BC, 1993, ACTA NEUROPATHOL, V86, P1, DOI 10.1007/BF00454891; WIESSNER C, 1993, ACTA NEUROPATHOL, V86, P439; WOLVERS DAW, 1993, EUR CYTOKINE NETW, V4, P377; WONG GHW, 1995, BBA-MOL BASIS DIS, V1271, P205, DOI 10.1016/0925-4439(95)00029-4; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	49	805	822	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	1996	2	7					788	794		10.1038/nm0796-788			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	WOS:A1996UU68000035	8673925				2021-06-18	
J	Taylor, CA; Bell, JM; Breiding, MJ; Xu, LK				Taylor, Christopher A.; Bell, Jeneita M.; Breiding, Matthew J.; Xu, Likang			Traumatic Brain Injury-Related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2007 and 2013	MMWR SURVEILLANCE SUMMARIES			English	Article							HEAD-INJURY; INTRACRANIAL HEMORRHAGE; SURVEILLANCE SYSTEM; PREINJURY WARFARIN; CHILDREN; PREVENTION; DISABILITY; TERM	Problem/Condition: Traumatic brain injury (TBI) has short-and long-term adverse clinical outcomes, including death and disability. TBI can be caused by a number of principal mechanisms, including motor-vehicle crashes, falls, and assaults. This report describes the estimated incidence of TBI-related emergency department (ED) visits, hospitalizations, and deaths during 2013 and makes comparisons to similar estimates from 2007. Reporting Period: 2007 and 2013. Description of System: State-based administrative health care data were used to calculate estimates of TBI-related ED visits and hospitalizations by principal mechanism of injury, age group, sex, and injury intent. Categories of injury intent included unintentional (motor-vehicle crashes, falls, being struck by or against an object, mechanism unspecified), intentional (self-harm and assault/homicide), and undetermined intent. These health records come from the Healthcare Cost and Utilization Project's Nationwide Emergency Department Sample and National Inpatient Sample. TBI-related death analyses used CDC multiplecause- of-death public-use data files, which contain death certificate data from all 50 states and the District of Columbia. Results: In 2013, a total of approximately 2.8 million TBI-related ED visits, hospitalizations, and deaths (TBI-EDHDs) occurred in the United States. This consisted of approximately 2.5 million TBI-related ED visits, approximately 282,000 TBI-related hospitalizations, and approximately 56,000 TBI-related deaths. TBIs were diagnosed in nearly 2.8 million (1.9%) of the approximately 149 million total injury-and noninjury-related EDHDs that occurred in the United States during 2013. Rates of TBI-EDHDs varied by age, with the highest rates observed among persons aged >= 75 years (2,232.2 per 100,000 population), 0-4 years (1,591.5), and 15-24 years (1,080.7). Overall, males had higher age-adjusted rates of TBI-EDHDs (959.0) compared with females (810.8) and the most common principal mechanisms of injury for all age groups included falls (413.2, age-adjusted), being struck by or against an object (142.1, age-adjusted), and motor-vehicle crashes (121.7, age-adjusted). The age-adjusted rate of ED visits was higher in 2013 (787.1) versus 2007 (534.4), with fall-related TBIs among persons aged >= 75 years accounting for 17.9% of the increase in the number of TBI-related ED visits. The number and rate of TBI-related hospitalizations also increased among persons aged >= 75 years (from 356.9 in 2007 to 454.4 in 2013), primarily because of falls. Whereas motor-vehicle crashes were the leading cause of TBI-related deaths in 2007 in both number and rate, in 2013, intentional self-harm was the leading cause in number and rate. The overall ageadjusted rate of TBI-related deaths for all ages decreased from 17.9 in 2007 to 17.0 in 2013; however, age-adjusted TBI-related death rates attributable to falls increased from 3.8 in 2007 to 4.5 in 2013, primarily among older adults. Although the age-adjusted rate of TBI-related deaths attributable to motor-vehicle crashes decreased from 5.0 in 2007 to 3.4 in 2013, the age-adjusted rate of TBI-related ED visits attributable to motor-vehicle crashes increased from 83.8 in 2007 to 99.5 in 2013. The age-adjusted rate of TBI-related hospitalizations attributable to motor-vehicle crashes decreased from 23.5 in 2007 to 18.8 in 2013. Interpretation: Progress has been made to prevent motor-vehicle crashes, resulting in a decrease in the number of TBI-related hospitalizations and deaths from 2007 to 2013. However, during the same time, the number and rate of older adult fall-related TBIs have increased substantially. Although considerable public interest has focused on sports-related concussion in youth, the findings in this report suggest that TBIs attributable to older adult falls, many of which result in hospitalization and death, should receive public health attention. Public Health Actions: The increase in the number of fall-related TBIs in older adults suggests an urgent need to enhance fall-prevention efforts in that population. Multiple effective interventions have been identified, and CDC has developed the STEADI initiative (Stopping Elderly Accidents Deaths and Injuries) as a comprehensive strategy that incorporates empirically supported clinical guidelines and scientifically tested interventions to help primary care providers address their patients' fall risk through the identification of modifiable risk factors and implementation of effective interventions (e.g., exercise, medication management, and Vitamin D supplementation).	[Taylor, Christopher A.; Bell, Jeneita M.; Breiding, Matthew J.] Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30329 USA; [Xu, Likang] Natl Ctr Injury Prevent & Control, Div Anal Res & Practice Integrat, Atlanta, GA USA	Breiding, MJ (corresponding author), Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30329 USA.	dvi8@cdc.gov	Lang, Steven/AAE-8102-2021; Taylor, Christopher A/D-2067-2013	Lang, Steven/0000-0003-1669-9146; Taylor, Christopher A/0000-0002-0937-5461			Agency for Healthcare Research and Quality, 2016, OV NAT EM DEP SAMPL; Agency for Healthcare Research and Quality, 2016, OV NAT NAT INP SAMPL; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Bull MJ, 2001, PEDIATRICS, V108, P1030; CDC, 2016, NAT VIT STAT SYST; CDC, 2014, MATR E COD GROUP; CDC, 2016, US CENS POP BRIDG RA; Centers for Disease Control, 2016, TRAUM BRAIN INJ US F; Centers for Disease Control National Center for Health Statistics, 2016, HLTH US 2015 SPEC FE; Centre for Disease Control, 2011, ICD 9 CM OFF GUID CO; Committee on Injury and Poison Prevention American Academy of Pediatrics, 1997, INJ PREV CONTR CHILD; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2011, SURVEILLANCE TRAUMAT, V60; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Curtin Sally C, 2016, NCHS Data Brief, P1; Dawson, 1987, ALCOHOL DRUGS DRIV, V3, P13; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson Susan A, 2007, Traffic Inj Prev, V8, P329, DOI 10.1080/15389580701588949; Fortson B. L., 2016, PREVENTING CHILD ABU; Gillespie LD, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Houchens R, 2016, USING HCUP NATL INPA; Insurance Institute for Highway Safety (IIHS), 2014, TEEN 2014; Marr AL., 2004, CENTRAL NERVOUS SYST; Nance ML, 2010, TRAFFIC INJ PREV, V11, P600, DOI 10.1080/15389588.2010.513072; National Center for Statistics and Analysis, 2014, 812102 DOT HIS NAT C; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Parks SE, 2012, PEDIAT ABUSIVE HEAD; Pfeffer CR, 2000, REV SUICIDOL, P159; Pickrell TM, 2016, 812244 DOT HS NAT HI; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Sauber-Schatz EK, 2016, MMWR-MORBID MORTAL W, V65, P672, DOI 10.15585/mmwr.mm6526e1; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shults RA, 2002, AM J PREV MED, V23, P72; Smith GA, 2006, PEDIATRICS, V118, P825, DOI 10.1542/peds.2006-1215; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; Stone DM., 2017, PREVENTING SUICIDE T; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Taylor HG., 2006, EXCEPTIONALITY, V14, P141, DOI [10.1207/s15327035ex1403_3, DOI 10.1207/S15327035EX1403_3, DOI 10.1207/S15327035EX1403_]; Williams AF, 2016, J SAFETY RES, V56, P9, DOI 10.1016/j.jsr.2015.11.006; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	44	792	806	13	95	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1545-8636			MMWR SURVEILL SUMM	MMWR Surv. Summ.	MAR 17	2017	66	9					1	18		10.15585/mmwr.ss6609a1			18	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	EU0CO	WOS:000400676900001	28301451	Bronze, Green Published	Y	N	2021-06-18	
J	Olesen, J; Gustavsson, A; Svensson, M; Wittchen, HU; Jonsson, B				Olesen, J.; Gustavsson, A.; Svensson, M.; Wittchen, H. -U; Jonsson, B.		CDBE2010 Study Grp; European Brain Council	The economic cost of brain disorders in Europe	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						brain disorder; cost; Europe	BURDEN; DISEASE; IMPACT	Background and purpose: In 2005, we presented for the first time overall estimates of annual costs for brain disorders (mental and neurologic disorders) in Europe. This new report presents updated, more accurate, and comprehensive 2010 estimates for 30 European countries. Methods: One-year prevalence and annual cost per person of 19 major groups of disorders are based on 'best estimates' derived from systematic literature reviews by panels of experts in epidemiology and health economics. Our cost estimation model was populated with national statistics from Eurostat to adjust to 2010 values, converting all local currencies to Euros (sic), imputing cost for countries where no data were available, and aggregating country estimates to purchasing power parityadjusted estimates of the total cost of brain disorders in Europe in 2010. Results: Total European 2010 cost of brain disorders was sic 798 billion, of which direct health care cost 37%, direct non-medical cost 23%, and indirect cost 40%. Average cost per inhabitant was sic 5.550. The European average cost per person with a disorder of the brain ranged between sic 285 for headache and sic 30 000 for neuromuscular disorders. Total annual cost per disorder (in billion sic 2010) was as follows: addiction 65.7; anxiety disorders 74.4; brain tumor 5.2; child/adolescent disorders 21.3; dementia 105.2; eating disorders 0.8; epilepsy 13.8; headache 43.5; mental retardation 43.3; mood disorders 113.4; multiple sclerosis 14.6; neuromuscular disorders 7.7; Parkinson's disease 13.9; personality disorders 27.3; psychotic disorders 93.9; sleep disorders 35.4; somatoform disorder 21.2; stroke 64.1; and traumatic brain injury 33.0. Conclusion: Our cost model revealed that brain disorders overall are much more costly than previously estimated constituting a major health economic challenge for Europe. Our estimate should be regarded as conservative because many disorders or cost items could not be included because of lack of data.	[Olesen, J.] Univ Copenhagen, Dept Neurol, Glostrup Hosp, Copenhagen, Denmark; [Gustavsson, A.] i3 Innovus, Stockholm, Sweden; [Gustavsson, A.] Karolinska Inst, KI Alzheimers Dis Res Ctr, Stockholm, Sweden; [Svensson, M.] Karlstad Univ, Dept Econ & Stat, Karlstad, Sweden; [Wittchen, H. -U] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Ctr Clin & Epidemiol & Longitudinal Studies, D-01062 Dresden, Germany; [Jonsson, B.] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden	Olesen, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.	jeol@glo.regionh.dk	Vecsei, Laszlo/B-2066-2010; Martinez-Leal, Rafael/B-4073-2009; Stoyanova, Maria/AAF-6320-2019; Wittchen, Hans-Ulrich/A-8507-2014; Rehm, Jurgen/K-2147-2012; Beghi, Ettore/AAA-7426-2020; Jonsson, Linus/G-2253-2017; Svensson, Mikael/P-2108-2014; Kurth, Tobias/A-9243-2012; Jacobi, Frank/O-1189-2017; Wittchen, Hans-Ulrich/ABA-8901-2020; Salvador-Carulla, Luis/K-6512-2013; Stovner, Lars Jacob/D-5025-2014; Glaus, Jennifer/C-7887-2017; PRISMA, Grupo/AAI-6753-2021; van Os, Jim/C-2113-2014; Gannon, Brenda/D-2011-2017	Vecsei, Laszlo/0000-0001-8037-3672; Martinez-Leal, Rafael/0000-0002-1333-7951; Rehm, Jurgen/0000-0001-5665-0385; Beghi, Ettore/0000-0003-2542-0469; Jonsson, Linus/0000-0001-5751-6292; Svensson, Mikael/0000-0003-1113-7478; Kurth, Tobias/0000-0001-7169-2620; Jacobi, Frank/0000-0001-7632-6267; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Salvador-Carulla, Luis/0000-0002-5742-9866; Glaus, Jennifer/0000-0001-8883-9473; Olesen, Jes/0000-0002-6712-2702; Gannon, Brenda/0000-0002-3672-4030; Knapp, Martin/0000-0003-1427-0215; Verschuuren, Jan/0000-0002-4572-1501	European Federation of Neurological Societies; European College of Neuropsychopharmacology; H. Lundbeck A/S	The study was funded by grants from the European Federation of Neurological Societies, the European College of Neuropsychopharmacology and H. Lundbeck A/S.	American Psychiatric Association, 1994, DIAGN STAT MAN, V4th; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Evers SMAA, 2004, STROKE, V35, P1209, DOI 10.1161/01.STR.0000125860.48180.48; Goldberg LD, 2005, AM J MANAG CARE, V11, pS62; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Halpin David M G, 2006, Proc Am Thorac Soc, V3, P619, DOI 10.1513/pats.200603-093SS; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1055/s-2002-32322; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kleinman LS, 2003, PHARMACOECONOMICS, V21, P601, DOI 10.2165/00019053-200321090-00001; Kobelt G, 2009, MULT SCLER J, V15, P741, DOI 10.1177/1352458509102771; Kotsopoulos IAW, 2001, EPILEPSIA, V42, P634, DOI 10.1046/j.1528-1157.2001.18200.x; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Nutt David, 2011, Eur Neuropsychopharmacol, V21, P495, DOI 10.1016/j.euroneuro.2011.05.004; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; OLESEN J, 2006, J NEUROL NEUROSUR S1, V77, P1; Olesen J, 2006, TRENDS NEUROSCI, V29, P493, DOI 10.1016/j.tins.2006.07.008; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Strassels SA, 2009, J MANAGE CARE PHARM, V15, P556, DOI 10.18553/jmcp.2009.15.7.556; Wilking Nils, 2006, Tidsskr Nor Laegeforen, V126, P2828; Wimo A, 2011, INT J GERIATR PSYCH, V26, P825, DOI 10.1002/gps.2610; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	21	789	816	5	175	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1351-5101			EUR J NEUROL	Eur. J. Neurol.	JAN	2012	19	1					155	162		10.1111/j.1468-1331.2011.03590.x			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	878JW	WOS:000299254100026	22175760		Y	N	2021-06-18	
J	Asahi, M; Wang, XY; Mori, T; Sumii, T; Jung, JC; Moskowitz, MA; Fini, ME; Lo, EH				Asahi, M; Wang, XY; Mori, T; Sumii, T; Jung, JC; Moskowitz, MA; Fini, ME; Lo, EH			Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia	JOURNAL OF NEUROSCIENCE			English	Article						stroke; extracellular proteolysis; blood-brain barrier; myelin; neuroprotection; mouse	MATRIX-METALLOPROTEINASE EXPRESSION; ENDOTHELIAL-CELLS; SERINE PROTEASES; NEURONAL DEATH; KEY REGULATOR; GELATINASE B; INHIBITION; DAMAGE; HEMORRHAGE; INCREASE	Deleterious processes of extracellular proteolysis may contribute to the progression of tissue damage after acute brain injury. We recently showed that matrix metalloproteinase-9 (MMP-9) knock-out mice were protected against ischemic, and traumatic brain! injury. In this study, we examined the mechanisms involved! by focusing. on relevant MMP-9 substrates in blood-brain barrier, matrix, and white matter. MMP-9 knock-out and wild-type mice were subjected to transient focal ischemia. MMP-9 levels increased after ischemia in wild-type brain, with expression primarily present in vascular endothelium. Western blots showed that the blood-brain: barrier-associated protein and MMP-9 substrate zonae occludens-1 was degraded after ischemia, but this was reduced in knock-out mice. There were no detectable changes in another blood-brain barrier-associated protein, occludin. Correspondingly, blood-brain barrier disruption assessed via Evans Blue, leakage was significantly attenuated in MMP-9 knock-out mice compared with wild types. In white matter, ischemic degradation: of the MMP-9 substrate myelin basic protein was significantly reduced in knock-out mice compared with wild types, whereas there was no degradation of other myelin proteins that are not MMP substrates (proteolipid protein and DM20). There were no detectable changes in the ubiquitous structural protein actin or the extracellular matrix protein laminin. Finally, 24 hr lesion volumes were significantly reduced in knock-out mice compared with wild types. These data demonstrate that the protective effects of MMP-9 gene knock-out after transient focal ischemia may be mediated by reduced proteolytic degradation of critical blood-brain barrier and white matter components.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,Neuroprotect Res Lab, Charlestown, MA 02139 USA; Harvard Univ, Sch Med, Program Neurosci, Charlestown, MA 02139 USA; Tufts Univ, New England Eye Ctr, Vis Res Labs, Boston, MA 02111 USA; Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,Neuroprotect Res Lab, Charlestown, MA 02129 USA	Lo, EH (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp E 149 2322, Dept Neurol,Neuroprotect Res Lab, Charlestown, MA 02139 USA.	Lo@helix.mgh.harvard.edu	Moskowitz, Michael A/D-9916-2011		NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01-EY12651] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS38731, P50-NS10828, R01-NS37074, R01-NS40529] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037074, R01NS040529, R01NS038731, P50NS010828] Funding Source: NIH RePORTER		Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Betsuyaku T, 2000, AM J PATHOL, V157, P525, DOI 10.1016/S0002-9440(10)64563-4; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; Chandler S, 1995, NEUROSCI LETT, V201, P223, DOI 10.1016/0304-3940(95)12173-0; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; COYLE P, 1982, ANAT REC, V203, P397, DOI 10.1002/ar.1092030309; Cuzner ML, 1999, J NEUROIMMUNOL, V94, P1, DOI 10.1016/S0165-5728(98)00241-0; CUZNER ML, 2001, NEUROPROTECTION; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1; Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859; Fini ME, 1998, BIOL EXTRAC, P299; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; HERRON GS, 1986, J BIOL CHEM, V261, P2814; Imper V, 1998, BIOL EXTRAC, P219; Kieseier BC, 1999, BRAIN, V122, P1579, DOI 10.1093/brain/122.8.1579; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Maeda K, 1999, NEUROBIOL DIS, V6, P101, DOI 10.1006/nbdi.1998.0235; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Nico B, 1999, DEV BRAIN RES, V114, P161, DOI 10.1016/S0165-3806(99)00008-5; Oh LYS, 1999, J NEUROSCI, V19, P8464; Petty MA, 1999, BRAIN RES REV, V31, P58, DOI 10.1016/S0165-0173(99)00025-9; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Valeriani V, 2000, J CEREBR BLOOD F MET, V20, P765, DOI 10.1097/00004647-200005000-00002; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wachtel M, 1999, J CELL SCI, V112, P4347; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Westermarck J, 1999, FASEB J, V13, P781; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Zhang JWJ, 2000, NEUROSCI LETT, V295, P9, DOI 10.1016/S0304-3940(00)01582-2	55	758	810	1	48	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	OCT 1	2001	21	19					7724	7732					9	Neurosciences	Neurosciences & Neurology	475GL	WOS:000171154000034	11567062				2021-06-18	
J	McCrea, M; Hammeke, T; Olsen, G; Leo, P; Guskiewicz, K				McCrea, M; Hammeke, T; Olsen, G; Leo, P; Guskiewicz, K			Unreported concussion in high school football players - Implications for prevention	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; head injury; athletic injuries	TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; EPIDEMIOLOGY; RETURN	Objective: To investigate the frequency of unreported concussion and estimate more accurately the overall rate of concussion in high school football players. Design: Retrospective, confidential survey completed by all subjects at the end of the football season. Setting and Participants: A total of 1,532 varsity football players from 20 high schools in the Milwaukee, Wisconsin, area were surveyed. Main Outcome Measurements: The structured survey assessed (1) number of concussions before the current season, (2) number of concussions sustained during the current season, (3) whether concussion during the current season was reported, (4) to whom concussion was reported, and (5) reasons for not reporting concussion. Results: Of respondents, 29.9% reported a previous history of concussion, and 15.3% reported sustaining a concussion during the current football season; of those, 47.3% reported their injury. Concussions were reported most frequently to a certified athletic trainer (76.7% of reported injuries). The most common reasons for concussion not being reported included a player not thinking the injury was serious enough to warrant medical attention (66.4% of unreported injuries), motivation not to be withheld from competition (41.0%), and lack of awareness of probable concussion (36.1%). Conclusions: These findings reflect a higher prevalence of concussion in high school football players than previously reported in the literature. The ultimate concern associated with unreported concussion is an athlete's increased risk of cumulative or catastrophic effects from recurrent injury. Future prevention initiatives should focus on education to improve athlete awareness of the signs of concussion and potential risks of unreported injury.	Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI 53188 USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC USA	McCrea, M (corresponding author), Waukesha Mem Hosp, Ctr Neurosci, 721 Amer Ave,Suite 501, Waukesha, WI 53188 USA.	michael.mccrea@phci.org	Fahimifar, Sepideh/M-5303-2019	Guskiewicz, Kevin/0000-0002-8682-2130	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00058] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000058] Funding Source: NIH RePORTER		Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; *COL MED SOC, 1991, REP SPORTS MED COMM; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	20	745	746	1	133	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2004	14	1					13	17		10.1097/00042752-200401000-00003			5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	943BM	WOS:000230326800003	14712161				2021-06-18	
J	KING, NS; CRAWFORD, S; WENDEN, FJ; MOSS, NEG; WADE, DT				KING, NS; CRAWFORD, S; WENDEN, FJ; MOSS, NEG; WADE, DT			THE RIVERMEAD POST CONCUSSION SYMPTOMS QUESTIONNAIRE - A MEASURE OF SYMPTOMS COMMONLY EXPERIENCED AFTER HEAD-INJURY AND ITS RELIABILITY	JOURNAL OF NEUROLOGY			English	Article						HEAD INJURY; POSTCONCUSSION SYMPTOMS; RIVERMEAD POST CONCUSSION SYMPTOMS QUESTIONNAIRE	SEQUELAE; TIME	After head injuries, particularly mild or moderate ones, a range of post-concussion symptoms (PCS) are often reported by patients. Such symptoms may significantly affect patients' psychosocial functioning. To date, no measure of the severity of PCS has been developed. This study presents the Rivermead Post Concussion Symptoms Questionnaire (RPQ) as such a measure, derived from published material, and investigates its reliability. The RPQ's reliability was investigated under two experimental conditions. Study 1 examined its test-retest reliability when used as a self-report questionnaire at 7-10 days after injury. Forty-one head-injured patients completed an RPQ at 7-10 days following their head injury and again approximately 24 h later. Study 2 examined the questionnaire's inter-rater reliability when used as a measure administered by two separate investigators. Forty-six head-injured patients had an RPQ administered by an investigator at 6 months after injury. A second investigator readministered the questionnaire approximately 7 days later. Spearman rank correlation coefficients were calculated for ratings on the total symptom scores, and for individual items. High reliability was found for the total PCS scores under both experimental conditions (R(s) = +0.91 in study 1 and R(s) = +0.87 in study 2). Good reliability was also found for individual PCS items,generally, although with some variation between different symptoms. The results are discussed in relation to the major difficulties involved when looking for appropriate experimental criteria against which measures of PCS can be validated.		KING, NS (corresponding author), RIVERMEAD REHABIL CTR,OXFORD HEAD INJURY SERV,ABINGTON RD,OXFORD OX1 4XD,ENGLAND.			Wade, Derick/0000-0002-1188-8442			Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BOHNEN N, 1992, NEUROSURGERY, V30, P692; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1989, MILD HEAD INJURY, P229; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; EVANS RW, 1992, NEUROL CLIN, V10, P815; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; JENNETT B, 1975, LANCET, V1, P480; LISHMAN WA, 1988, BRIT J PSYCHIAT, V155, P460; MCLEAN A, 1986, J CLIN NEUROPSYCHOL, V5, P361; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOSS NEG, 1994, CLIN REHABIL, V8, P149; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTHERFORD WH, 1977, INJURY, V10, P225; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; 1978, MENTAL DISORDERS GLO; 1988, MANAGEMENT TRAUMATIC	29	740	746	2	36	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-5354			J NEUROL	J. Neurol.	SEP	1995	242	9					587	592		10.1007/BF00868811			6	Clinical Neurology	Neurosciences & Neurology	RW082	WOS:A1995RW08200006	8551320				2021-06-18	
J	Guskiewicz, KM; Marshall, SW; Bailes, J; McCrea, M; Cantu, RC; Randolph, C; Jordan, BD				Guskiewicz, KM; Marshall, SW; Bailes, J; McCrea, M; Cantu, RC; Randolph, C; Jordan, BD			Association between recurrent concussion and late-life cognitive impairment in retired professional football players	NEUROSURGERY			English	Article						Alzheimer; concussion; mild cognitive impairment; retired professional football players	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTORS; BRAIN-INJURY; UNITED-STATES; DEMENTIA; TRAUMA; EPIDEMIOLOGY; COLLEGIATE; PREDICTION	OBJECTIVE: Cerebral concussion is common in collision sports such as football, yet the chronic neurological effects of recurrent concussion are not well understood. The purpose of our study was to investigate the association between previous head injury and the likelihood of developing mild cognitive impairment (MCI) and Alzheimer's disease in a unique group of retired professional football players with previous head injury exposure. METHODS: A general health questionnaire was completed by 2552 retired professional football players with an average age of 53.8 (13.4) years and an average professional football playing career of 6.6 ( +/- 3.6) years. A second questionnaire focusing on memory and issues related to MCI was then completed by a subset of 758 retired professional football players ( >= 50 yr of age). Results on MCI were then cross-tabulated with results from the original health questionnaire for this subset of older retirees. RESULTS: Of the former players, 61% sustained at least one concussion during their professional football career, and 24% sustained three or more concussions. Statistical analysis of the data identified an association between recurrent concussion and clinically diagnosed MCI (chi(2) = 7.82, df = 2, P = 0.02) and self-reported significant memory impairments (chi(2) = 19.75, df = 2, P = 0.001). Retired players with three or more reported concussions had a fivefold prevalence of MCI diagnosis and a threefold prevalence of reported significant memory problems compared with retirees without a history of concussion. Although there was not an association between recurrent concussion and Alzheimer's disease, we observed an earlier onset of Alzheimer's disease in the retirees than in the general American male population. CONCLUSION: Our findings suggest that the onset of dementia-related syndromes may be initiated by repetitive cerebral concussions in professional football players.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol & Orthoped, Chapel Hill, NC 27599 USA; W Virginia Univ, Dept Neurosurg, Sch Med, Morgantown, WV 26506 USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI USA; Brigham & Womens Hosp, Neurol Sports Injury Ctr, Boston, MA 02115 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Loyola Univ, Sch Med, Dept Neurol, Maywood, IL 60153 USA; Chicago Neurol Inst, Chicago, IL USA; Burke Rehabil Hosp, Memory Evaluat & Treatment Serv, White Plains, NY USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, 211 Fetzer CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130			BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; FERINISTRAMBI L, 1990, NEUROEPIDEMIOLOGY, V9, P39, DOI 10.1159/000110750; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; Meyer JS, 2002, J NEUROL SCI, V201, P19, DOI 10.1016/S0022-510X(02)00159-4; Meyer JS, 2002, STROKE, V33, P1981, DOI 10.1161/01.STR.0000024432.34557.10; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; RYAN DH, 1994, DEMENTIA, V5, P339, DOI 10.1159/000106744; Sadek JR, 2004, NEUROPSYCHOLOGY, V18, P692, DOI 10.1037/0894-4105.18.4.692; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	41	739	744	1	167	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2005	57	4					719	724		10.1227/01.NEU.0000175725.75780.DD			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	031CK	WOS:000236681500032	16239884				2021-06-18	
J	Teng, YD; Lavik, EB; Qu, XL; Park, KI; Ourednik, J; Zurakowski, D; Langer, R; Snyder, EY				Teng, YD; Lavik, EB; Qu, XL; Park, KI; Ourednik, J; Zurakowski, D; Langer, R; Snyder, EY			Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							OLFACTORY ENSHEATHING CELLS; AXONAL REGENERATION; CORTICOSPINAL TRACT; NEURITE OUTGROWTH; PARAPLEGIC RATS; GROWTH; BRAIN; TRANSPLANTATION; DIFFERENTIATE; INFLAMMATION	To better direct repair following spinal cord injury (SCI), we designed an implant modeled after the intact spinal cord consisting of a multicomponent polymer scaffold seeded with neural stem cells. Implantation of the scaffold-neural stem cells unit into an adult rat hemisection model of SCI promoted long-term improvement in function (persistent for 1 year in some animals) relative to a lesion-control group. At 70 days postinjury, animals implanted with scaffold-plus-cells exhibited coordinated, weight-bearing hindlimb stepping. Histology and immunocytochemical analysis suggested that this recovery might be attributable partly to a reduction in tissue loss from secondary injury processes as well as in diminished glial scarring. Tract tracing demonstrated corticospinal tract fibers passing through the injury epicenter to the caudal cord, a phenomenon not present in untreated groups. Together with evidence of enhanced local GAP-43 expression not seen in controls, these findings suggest a possible regeneration component. These results may suggest a new approach to SCI and, more broadly, may serve as a prototype for multidisciplinary strategies against complex neurological problems.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; Childrens Hosp, Dept Biostat, Boston, MA 02115 USA	Langer, R (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.			Lavik, Erin/0000-0002-0644-744X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1-R21-NS41999-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS041999] Funding Source: NIH RePORTER		BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Davies SJA, 1997, NATURE, V390, P680; Diener PS, 1998, J NEUROSCI, V18, P763; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K; Grill R, 1997, J NEUROSCI, V17, P5560; Guo X, 2001, ANN NEUROL, V50, P6, DOI 10.1002/ana.1030; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9; Teng YD, 1999, J NEUROSCI, V19, P7037, DOI 10.1523/JNEUROSCI.19-16-07037.1999; Vacanti MP, 2001, TRANSPLANT P, V33, P592, DOI 10.1016/S0041-1345(00)02158-8; Weidner N, 1999, EXP NEUROL, V160, P40, DOI 10.1006/exnr.1999.7200; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029	34	737	793	0	109	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 5	2002	99	5					3024	3029		10.1073/pnas.052678899			6	Multidisciplinary Sciences	Science & Technology - Other Topics	529DK	WOS:000174284600078	11867737	Bronze, Green Published			2021-06-18	
J	Liu, XZ; Xu, XM; Hu, R; Du, C; Zhang, SX; McDonald, JW; Dong, HX; Wu, YJ; Fan, GS; Jacquin, MF; Hsu, CY; Choi, DW				Liu, XZ; Xu, XM; Hu, R; Du, C; Zhang, SX; McDonald, JW; Dong, HX; Wu, YJ; Fan, GS; Jacquin, MF; Hsu, CY; Choi, DW			Neuronal and glial apoptosis after traumatic spinal cord injury	JOURNAL OF NEUROSCIENCE			English	Article						acute SCI; apoptosis; cell death; contusion injury; spinal cord; rat; cycloheximide; motor function	PROGRAMMED CELL-DEATH; FOCAL CEREBRAL-ISCHEMIA; PROTEIN-SYNTHESIS; GLUCOSE DEPRIVATION; TRANSIENT ISCHEMIA; POTENTIAL ROLE; CHICK-EMBRYO; BRAIN INJURY; RAT-BRAIN; CYCLOHEXIMIDE	Cell death was examined by studying the spinal cords of rats subjected to traumatic insults of mild to moderate severity. Within minutes after mild weight drop impact (a 10 gm weight falling 6.25 mm), neurons in the immediate impact area showed toss of cytoplasmic Nissl substances. Over the next 7 d, this lesion area expanded and cavitated. Terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive neurons were noted primarily restricted to the gross lesion area 4-24 hr after injury, with. a maximum presence at 8 hr after injury. TUNEL-positive glia were present at all stages studied between 4 hr and 14 d, with a maximum presence within the lesion area 24 hr after injury. However 7 d after injury, a second wave of TUNEL-positive glial cells was noted in the white matter peripheral to the lesion and extending at least several millimeters away from the lesion center. nle suggestion of apoptosis was supported by electron microscopy, as well as by nuclear staining with Hoechst 33342 dye, and by examination of DNA prepared from the lesion site. Furthermore, repeated intraperitoneal injections of cycloheximide, beginning immediately after a 12.5 mm weight drop insult, produced a substantial reduction in histological evidence of cord damage and in motor dysfunction assessed 4 weeks later. Present data support the hypothesis that apoptosis dependent on active protein synthesis contributes to the neuronal and glial cell death, as well as to the neurological dysfunction, induced by mild-to-moderate severity traumatic insults to the rat spinal cord.	WASHINGTON UNIV, SCH MED, CTR STUDY NERVOUS SYST INJURY, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT NEUROL, ST LOUIS, MO 63110 USA; ST LOUIS UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63104 USA					PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [32626] Funding Source: Medline		Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; BALENTINE JD, 1978, LAB INVEST, V39, P236; BALENTINE JD, 1978, LAB INVEST, V39, P254; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BEATTIE MS, 1988, PHARM APPROACHES TRE, P43; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Bresnahan J. C., 1996, Society for Neuroscience Abstracts, V22, P1185; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; BUNGE RP, 1993, ADV NEUROL, V59, P75; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; CHARRIAUTMARLANGUE C, 1995, J CEREBR BLOOD F MET, V15, P385, DOI 10.1038/jcbfm.1995.48; Ciutat D, 1996, J NEUROSCI, V16, P3979; COYLE JT, 1981, NEUROSCI RES PROG B, V19, pU335; Crowe M. J., 1995, Society for Neuroscience Abstracts, V21, P232; CSERNANSKY CA, 1994, J NEUROSCI RES, V38, P101, DOI 10.1002/jnr.490380113; Du C, 1996, BRAIN RES, V718, P233, DOI 10.1016/0006-8993(96)00162-X; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FAIRHOLM DJ, 1971, J NEUROSURG, V35, P277, DOI 10.3171/jns.1971.35.3.0277; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Furukawa K, 1997, J CELL BIOL, V136, P1137, DOI 10.1083/jcb.136.5.1137; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; GOODKIN R, 1969, Surgical Forum (Chicago), V20, P430; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Green B A, 1973, Surg Neurol, V1, P98; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; HERON A, 1993, J NEUROCHEM, V61, P1973, DOI 10.1111/j.1471-4159.1993.tb09843.x; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; KAO CC, 1983, SPINAL CORD RECONSTR, P41; Katoh K, 1996, NEUROSCI LETT, V216, P9; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1991, APOPTOSIS MOL BASIS, P5; KIHARA S, 1994, NEUROSCI LETT, V175, P133, DOI 10.1016/0304-3940(94)91097-9; Kondo S, 1996, FASEB J, V10, P1192; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; LI Y, 1995, AM J PATHOL, V146, P1045; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu X. Z., 1996, Society for Neuroscience Abstracts, V22, P1185; MACMANUS JP, 1994, NEUROREPORT, V5, P493, DOI 10.1097/00001756-199401120-00031; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN DP, 1992, J NEUROBIOL, V23, P1205, DOI 10.1002/neu.480230911; NITATORI T, 1995, J NEUROSCI, V15, P1001; OKAMOTO M, 1993, BIOCHEM BIOPH RES CO, V196, P1356, DOI 10.1006/bbrc.1993.2402; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PAPAS S, 1992, EUR J NEUROSCI, V4, P758, DOI 10.1111/j.1460-9568.1992.tb00185.x; PAVLIK A, 1980, BRAIN RES, V192, P531, DOI 10.1016/0006-8993(80)90903-8; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; RATAN RR, 1994, J NEUROSCI, V14, P4385; RINK A, 1995, AM J PATHOL, V147, P1575; ROBERTSLEWIS JM, 1993, J NEUROCHEM, V61, P378, DOI 10.1111/j.1471-4159.1993.tb03583.x; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, P16; SELINA CC, 1989, BRAIN RES, V482, P271; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; SHIGENO T, 1990, NEUROSCI LETT, V120, P117, DOI 10.1016/0304-3940(90)90182-9; Shuman S. L., 1996, Society for Neuroscience Abstracts, V22, P1185; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Swoboda T. K., 1996, Society for Neuroscience Abstracts, V22, P20; TANABE J, 1994, BRIT J PHARMACOL, V113, P1480, DOI 10.1111/j.1476-5381.1994.tb17163.x; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOMINAGA T, 1993, BRAIN RES, V608, P21, DOI 10.1016/0006-8993(93)90768-I; WHITE RJ, 1975, CLIN ORTHOP RELAT R, V112, P16; WRATHALL JR, 1992, BRAIN RES, V586, P140, DOI 10.1016/0006-8993(92)91384-Q; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yaginuma H, 1996, J NEUROSCI, V16, P3685; Yong C., 1996, Society for Neuroscience Abstracts, V22, P20; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	79	718	766	2	38	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 15	1997	17	14					5395	5406					12	Neurosciences	Neurosciences & Neurology	XV075	WOS:A1997XV07500016	9204923				2021-06-18	
J	OMMAYA, AK; GENNARELLI, TA				OMMAYA, AK; GENNARELLI, TA			CEREBRAL CONCUSSION AND TRAUMATIC UNCONSCIOUSNESS - CORRELATION OF EXPERIMENTAL AND CLINICAL OBSERVATIONS ON BLUNT HEAD-INJURIES	BRAIN			English	Article									DEPT HEW, NINDS, SECT APPL RES, BETHESDA, MD 20014 USA; GEORGETOWN UNIV, SCH MED,DEPT SURG,DIV NEUROSURG,3800 RESERVOIR RD, WASHINGTON, DC 20007 USA							ADVANI SH, 1972, SHOCK VIBRATION DIGE, V4, P3; AMBROSE J, 1973, BRIT J RADIOL, V46, P148; BRACKETT CE, 1971, HEAD INJURIES, P255; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BYCROFT GN, 1973, J BIOMECH, V6, P487, DOI 10.1016/0021-9290(73)90007-9; COHEN LB, 1973, PHYSIOL REV, V53, P373; Congress of Neurological Surgeon, 1966, CLIN NEUROSURG, V12, P386; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Gennarelli T. A., 1972, 16 STAPP CAR CRASH C, P296; GENNARELLI TA, 1975, EXPTL HEAD TRAUMA; GENNARELLI TA, 1971, 15TH P STAPP CAR CRA, P797; GENNARELLI TA, IN PRESS; GOLDSMITH W, 1970, BIOMECHANICS ITS FDN, P585; GRAY JAB, 1954, J PHYSIOL-LONDON, V124, P84, DOI 10.1113/jphysiol.1954.sp005087; GRCEVIC N, 1965, LATE SEQUELAE HEAD I, P369; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; HAYASHI T, 1970, J FAC ENGNG TOKYO U, V30, P4; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1969, LATE EFFECTS HEAD IN, P509; HOOPER RS, 1969, PATTERNS ACUTE HEAD; JENNETT B, 1972, LANCET, V1, P734; JOSEPH PD, 1971, BRAIN RES, V26, P15; LETCHER FS, 1973, J NEUROSURG, V39, P167, DOI 10.3171/jns.1973.39.2.0167; LEWIN W, 1966, MANAGEMENT HEAD INJU; LINDGREN SO, 1966, ACTA CHIR SCAND S360; MEINIG G, 1973, INTRACRANIAL PRESSUR, P79; MITCHELL DE, 1973, LANCET, V2, P215; NAKATANI S, 1973, INTRACRANIAL PRESSUR, P144; Ommaya A, 1967, 11 P STAPP CAR CRASH, P47; Ommaya A, 1966, 10 P STAPP CAR CRASH, P197; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA A K, 1963, Med Ann Dist Columbia, V32, P18; Ommaya A K, 1973, Surg Neurol, V1, P217; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1972, CONFIN NEUROL, V34, P398; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Ommaya AK, 1968, J BIOMECH; OMMAYA AK, 1970, ACCIDENT PATHOLOGY, P160; OMMAYA AK, 1973, P AM ASSOCIATION NEU; OMMAYA AK, 1972, CISTERNOGRAPHY HYDRO, P57; OVERGAARD J, 1973, LANCET, V2, P631; PARSONS LC, 1969, EXCERPTA MEDICA  193, P70; PETIT JL, 1944, MALADIE OS MALADIES; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; STRICH SJ, 1969, LATE EFFECTS HEAD IN, P501; SYMONDS C, 1962, LANCET, V1, P1; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; UNTERHARNSCHEID.F, 1969, LATE EFFECTS HEAD IN, P158; UNTERHARNSCHEID.F, 1966, HEAD INJURY C P, P321; WALKER AE, 1973, NEUROLOGICAL SURGERY, V2, P936; WARD AA, 1966, CLIN NEUROSURG, V12, P95; Wiener N., 1971, CYBERNETICS CONTROL; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863; ZULCH KJ, 1969, B SOC SCI MED LUX, V106, P153	65	710	714	0	41	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain		1974	97	DEC					633	+		10.1093/brain/97.1.633			1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V1494	WOS:A1974V149400002	4215541				2021-06-18	
J	MUIZELAAR, JP; MARMAROU, A; WARD, JD; KONTOS, HA; CHOI, SC; BECKER, DP; GRUEMER, H; YOUNG, HF				MUIZELAAR, JP; MARMAROU, A; WARD, JD; KONTOS, HA; CHOI, SC; BECKER, DP; GRUEMER, H; YOUNG, HF			ADVERSE-EFFECTS OF PROLONGED HYPERVENTILATION IN PATIENTS WITH SEVERE HEAD-INJURY - A RANDOMIZED CLINICAL-TRIAL	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; HYPERVENTILATION; TROMETHAMINE; OUTCOME; CEREBRAL BLOOD FLOW; INTRACRANIAL PRESSURE	CEREBRAL BLOOD-FLOW; LACTIC-ACIDOSIS; RABBIT	There is still controversy over whether or not patients should be hyperventilated after traumatic brain injury, and a randomized trial has never been conducted. The theoretical advantages of hyperventilation are cerebral vasoconstriction for intracranial pressure (ICP) control and reversal of brain and cerebrospinal fluid (CSF) acidosis. Possible disadvantages include cerebral vasoconstriction to such an extent that cerebral ischemia ensues, and only a short-lived effect on CSF pH with a loss of HCO3- buffer from CSF. The latter disadvantage might be overcome by the addition of the buffer tromethamine (THAM), which has shown some promise in experimental and clinical use. Accordingly, a trial was performed with patients randomly assigned to receive normal ventilation (PaCO2 35 +/- 2 mm Hg (mean +/- standard deviation): control group), hyperventilation (PaCO2 25 +/- 2 mm Hg: HV group), or hyperventilation plus THAM (PaCO2 25 +/- 2 mm Hg: HV + THAM group). Stratification into subgroups of patients with motor scores of 1-3 and 4-5 took place. Outcome was assessed according to the Glasgow Outcome Scale at 3, 6, and 12 months. There were 41 patients in the control group, 36 in the HV group, and 36 in the HV + THAM group. The mean Glasgow Coma Scale score for each group was 5.7 +/- 1.7, 5.6 +/- 1.7, and 5.9 +/- 1.7, respectively; this score and other indicators of severity of injury were not significantly different. A 100% follow-up review was obtained. At 3 and 6 months after injury the number of patients with a favorable outcome (good or moderately disabled) was significantly (p < 0.05) lower in the hyperventilated patients than in the control and HV + THAM groups. This occurred only in patients with a motor score of 4-5. At 12 months posttrauma this difference was not significant (p = 0. 13). Biochemical data indicated that hyperventilation could not sustain alkalinization in the CSF, although THAM could. Accordingly, cerebral blood flow (CBF) was lower in the HV + THAM group than in the control and HV groups, but neither CBF nor arteriovenous difference of oxygen data indicated the occurrence of cerebral ischemia in any of the three groups. Although mean ICP could be kept well below 25 mm Hg in all three groups, the course of ICP was most stable in the HV + THAM group. It is concluded that prophylactic hyperventilation is deleterious in head-injured patients with motor scores of 4-5. When sustained hyperventilation becomes necessary for ICP control, its deleterious effect may be overcome by the addition of THAM.		MUIZELAAR, JP (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROL SURG,MCV STN,BOX 631,RICHMOND,VA 23298, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587] Funding Source: Medline		AKIOKA T, 1976, INTRACRANIAL PRESSUR, V3, P219; Becker DP, 1985, NEUROSURGERY, V2, P1593; BRUCE D, 1983, PEDIAT HEAD TRAUMA, P31; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHRISTENSEN M S, 1976, Acta Anaesthesiologica Scandinavica Supplementum, V62, P7; COLD G, 1975, ACTA NEUROL SCAND, V52, P187, DOI 10.1111/j.1600-0404.1975.tb05773.x; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; GAAB M, 1980, INTRACRANIAL PRESSUR, V4, P664; GORDON E, 1970, ACTA ANAESTH SCAND, V14, P97, DOI 10.1111/j.1399-6576.1970.tb00763.x; Gordon E, 1979, Int Anesthesiol Clin, V17, P181, DOI 10.1097/00004311-197917020-00008; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HINDS CJ, 1987, INTENSIVE CARE CONCI, P284; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, MANAGEMENT HEAD INJU, P255; LEVASSEUR JE, 1979, J APPL PHYSIOL, V46, P89; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1989, INTRACRANIAL PRESSUR, V7, P549; Marshall LF, 1987, HEAD INJURY, P177; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; ROSSANDA M, 1973, J NEUROL SCI, V17, P265; SAUL TG, 1987, CONNS CURRENT THERAP, P776; SCHINDLER U, 1971, EUR NEUROL, V6, P83, DOI 10.1159/000114471; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087	31	692	711	0	20	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1991	75	5					731	739		10.3171/jns.1991.75.5.0731			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GM092	WOS:A1991GM09200008	1919695				2021-06-18	
J	Gaugler, J; James, B; Johnson, T; Marin, A; Weuve, J				Gaugler, Joseph; James, Bryan; Johnson, Tricia; Marin, Allison; Weuve, Jennifer		Alzheimer's Assoc	2019 Alzheimer's disease facts and figures	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Alzheimer's dementia; Dementia; Diagnostic criteria; Risk factors; Prevalence; Incidence; Mortality; Morbidity; Caregivers; Family caregiver; Spouse caregiver; Health care professional; Health care costs; Health care expenditures; Long-term care costs; Medicare spending; Medicaid spending; Brief cognitive assessment; Primary care physician; Medicare Annual Wellness Visit; Early detection	MILD COGNITIVE IMPAIRMENT; NURSING-HOME RESIDENTS; VASCULAR RISK-FACTORS; APOLIPOPROTEIN-E GENOTYPE; HEALTH-CARE USE; OF-LIFE CARE; DEMENTIA CAREGIVER INTERVENTION; TRAUMATIC BRAIN-INJURY; ANNUAL WELLNESS VISIT; C-REACTIVE PROTEIN	This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report examines the use of brief cognitive assessments by primary care physicians as a tool for improving early detection of dementia. An estimated 5.8 million Americans have Alzheimer's dementia. By mid-century, the number of people living with Alzheimer's dementia in the United States may grow to 13.8 million, fueled in large part by the aging baby boom generation. In 2017, official death certificates recorded 121,404 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age >= 65 years. Between 2000 and 2017, deaths resulting from stroke, heart disease, and prostate cancer decreased, whereas reported deaths from AD increased 145%. In 2018, more than 16 million family members and other unpaid caregivers provided an estimated 18.5 billion hours of care to people with Alzheimer's or other dementias. This care is valued at nearly $234 billion, but its costs extend to family caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Average per-person Medicare payments for services to beneficiaries age >= 65 years with Alzheimer's or other dementias are more than three times as great as payments for beneficiaries without these conditions. Total payments in 2019 for health care, long-term care and hospice services for people age >= 65 years with dementia are estimated to be $290 billion. Early detection of Alzheimer's offers numerous medical, emotional and financial benefits-benefits that accrue to affected individuals and their families as well as to society at large. Alzheimer's Association surveys regarding brief cognitive assessments for detection of dementia found that while a large majority of seniors and primary care physicians say the assessments are important, only half of seniors have received an assessment, and only 16 percent of seniors receive regular cognitive assessments. Many educational opportunities exist to facilitate increased use of brief cognitive assessments in the primary care setting.								AARP, FAM CAR OUT OF POCK; Abell JG, 2018, EUR HEART J, V39, P3119, DOI 10.1093/eurheartj/ehy288; Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Administration on Aging Administration for Community Living U. S. Department of Health and Human Services, 2016, PROF OLD AM; Aguirre E, 2013, AGEING RES REV, V12, P253, DOI 10.1016/j.arr.2012.07.001; Ahmadi-Abhari S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2856; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert S. M., 2010, METLIFE STUDY WORKIN; Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Alsaeed D, 2016, INT J PHARMACEUT, V512, P396, DOI 10.1016/j.ijpharm.2015.12.050; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Alzheimer's Association, 2015, ALZH DIS FACTS FIG S; Alzheimer's Association, 2014, 2014 ALZH DIS FACTS; Alzheimer's Association, ISS BRIEF LGBT DEM; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Alzheimer's Association, CHANG TRAJ ALZH DIS; Alzheimer's Association and the Centers for Disease Control and Prevention, HLTH BRAIN IN STAT L; American Academy of Family Physicians, COGN CAR KIT; American Health Care Association, 2011, STAFF SURV REP; American Health Care Association, 2014, LTC STATS NURS FAC O; American Society on Aging Metlife Foundation, 2006, ATT AW BRAIN HLTH PO; Amjad H, 2016, JAMA INTERN MED, V176, P1371, DOI 10.1001/jamainternmed.2016.3553; Amjad H, 2016, J AM GERIATR SOC, V64, P1223, DOI 10.1111/jgs.14164; [Anonymous], DAT 2015 2016 UNPUB; [Anonymous], 2016, 2016 ALZH DIS FACTS; [Anonymous], COGN ASS TOOLK; [Anonymous], MCDONALDS CORPORATIO; [Anonymous], 2016, TAB BAS DAT NA UNPUB; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; Arthur PB, 2018, INT PSYCHOGERIATR, V30, P1099, DOI 10.1017/S104161021700237X; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Aston L, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0638-6; Atteih S, 2015, INT J STROKE, V10, P918, DOI 10.1111/ijs.12535; Austrom MG, 2016, AGING MENT HEALTH, V20, P781, DOI 10.1080/13607863.2015.1119802; Avalere Health, 2016, TAB BAS DAT ME UNPUB; Badana ANS, 2019, J AGING HEALTH, V31, P925, DOI 10.1177/0898264317743611; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barrett AM, 2006, J AM GERIATR SOC, V54, P1968, DOI 10.1111/j.1532-5415.2006.00992.x; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; BAUMGARTEN M, 1992, J CLIN EPIDEMIOL, V45, P61, DOI 10.1016/0895-4356(92)90189-T; Beck C, 1999, INT J GERIATR PSYCH, V14, P197, DOI 10.1002/(SICI)1099-1166(199903)14:3<197::AID-GPS972>3.0.CO;2-Q; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Beydoun MA, 2015, J ALZHEIMERS DIS, V48, P361, DOI 10.3233/JAD-150228; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bloudek LM, 2011, J ALZHEIMERS DIS, V26, P627, DOI 10.3233/JAD-2011-110458; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Boise L, 2010, J AM BOARD FAM MED, V23, P486, DOI 10.3122/jabfm.2010.04.090225; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Borson S, 2016, ALZHEIMERS DEMENT, V12, P334, DOI 10.1016/j.jalz.2016.01.005; Borson S, 2014, CLIN GERIATR MED, V30, P395, DOI 10.1016/j.cger.2014.05.001; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Boustani M, 2006, INT J GERIATR PSYCH, V21, P556, DOI 10.1002/gps.1524; Boustani M, 2018, J AM GERIATR SOC, V66, P1372, DOI 10.1111/jgs.15283; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Brasure M, 2018, ANN INTERN MED, V168, P30, DOI 10.7326/M17-1528; Bray Jennifer, 2015, Nurs Older People, V27, P29, DOI 10.7748/nop.27.10.29.s21; Bremer P, 2015, HEALTH POLICY, V119, P1459, DOI 10.1016/j.healthpol.2015.09.014; Brenowitz WD, 2017, ALZHEIMERS DEMENT, V13, P654, DOI 10.1016/j.jalz.2016.09.015; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Brody AA, 2013, GERONTOL GERIATR EDU, V34, P225, DOI 10.1080/02701960.2013.801342; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brown EL, 2019, J APPL GERONTOL, V38, P73, DOI 10.1177/0733464817723088; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Buckley RF, 2016, ALZHEIMERS DEMENT, V12, P796, DOI 10.1016/j.jalz.2015.12.013; Burgio LD, 2009, GERONTOLOGIST, V49, P103, DOI 10.1093/geront/gnp012; BURNS A, 1990, AGE AGEING, V19, P341, DOI 10.1093/ageing/19.5.341; Butler M, 2018, ANN INTERN MED, V168, P52, DOI 10.7326/M17-1530; Butler M, 2018, ANN INTERN MED, V168, P63, DOI 10.7326/M17-1531; Bynum J., 2009, CHARACTERISTIC UNPUB; Caffrey C, VARIATION RESIDENTIA, P1; Caffrey C, VARIATION OPERATING; Callahan CM, 2017, J AM GERIATR SOC, V65, P892, DOI 10.1111/jgs.14808; Callahan CM, 2014, HEALTH AFFAIR, V33, P626, DOI 10.1377/hlthaff.2013.1260; Callahan CM, 2012, J AM GERIATR SOC, V60, P813, DOI 10.1111/j.1532-5415.2012.03905.x; Cannon P, 2016, NEURODEGENER DIS MAN, V6, P271, DOI 10.2217/nmt-2016-0004; Carter CL, 2012, J WOMENS HEALTH, V21, P1018, DOI 10.1089/jwh.2012.3789; Centers for Disease Control and Prevention, TABL SUMM HLTH STAT; Centers for Disease Control and Prevention, NAT AMB CAR SURV 201; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Cerasuolo JO, 2017, ALZHEIMERS DEMENT, V13, P1081, DOI 10.1016/j.jalz.2017.02.010; Chattillion EA, 2012, PSYCHOL HEALTH, V27, P1134, DOI 10.1080/08870446.2011.637559; Chene G, 2015, ALZHEIMERS DEMENT, V11, P310, DOI 10.1016/j.jalz.2013.10.005; Cheng ST, 2016, GERONTOLOGIST, V56, P451, DOI 10.1093/geront/gnu118; Cherubini M, 2018, CELL TISSUE RES, V373, P79, DOI 10.1007/s00441-017-2700-2; Cheung KSL, 2015, INT J GERIATR PSYCH, V30, P460, DOI 10.1002/gps.4160; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Choi D, 2018, ANN CLIN TRANSL NEUR, V5, P1192, DOI 10.1002/acn3.633; Choi H, 2018, J GERONTOL B-PSYCHOL, V73, pS29, DOI 10.1093/geronb/gbx155; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Clark PC, 2005, J AM GERIATR SOC, V53, P2012, DOI 10.1111/j.1532-5415.2005.53569.x; Clarkson P, 2017, VALUE HEALTH, V20, P1198, DOI 10.1016/j.jval.2017.04.004; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; Corrada MM, 2017, ALZHEIMERS DEMENT, V13, P103, DOI 10.1016/j.jalz.2016.09.007; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740; Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2; Crimmins EM, 2018, J GERONTOL B-PSYCHOL, V73, pS20, DOI 10.1093/geronb/gbx135; Cross AJ, 2018, PSYCHOL HEALTH, V27, P1; Czaja SJ, 2018, GERONTOLOGIST, V58, pE130, DOI 10.1093/geront/gny001; Czaja SJ, 2013, AM J GERIAT PSYCHIAT, V21, P1071, DOI 10.1016/j.jagp.2013.02.019; Dassel KB, 2016, GERONTOLOGIST, V56, P444, DOI 10.1093/geront/gnu078; Dassel KB, 2017, GERONTOLOGIST, V57, P319, DOI 10.1093/geront/gnv148; Davydow DS, 2014, J GEN INTERN MED, V29, P1362, DOI 10.1007/s11606-014-2916-8; Day KL, 2012, J APPL GERONTOL, V31, P743, DOI 10.1177/0733464811401354; De Reuck J, 2018, FOLIA NEUROPATHOL, V56, P81, DOI 10.5114/fn.2018.76610; De Vleminck A, 2018, J AM MED DIR ASSOC, V19, P633, DOI 10.1016/j.jamda.2017.10.003; Deb A, 2017, EXPERT REV PHARM OUT, V17, P189, DOI 10.1080/14737167.2017.1313118; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Demirovic J, 2003, ANN EPIDEMIOL, V13, P472, DOI 10.1016/S1047-2797(02)00437-4; Derby CA, 2017, JAMA NEUROL, V74, P1345, DOI 10.1001/jamaneurol.2017.1964; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Dilworth-Anderson P, 2008, ALZHEIMERS DEMENT, V4, P305, DOI 10.1016/j.jalz.2008.03.001; Dreier-Wolfgramm A, 2017, Z GERONTOL GERIATR, V50, pS68, DOI 10.1007/s00391-017-1220-8; Dubois B, 2016, J ALZHEIMERS DIS, V49, P617, DOI 10.3233/JAD-150692; Dwibedi N, 2018, MED CARE, V56, P240, DOI 10.1097/MLR.0000000000000869; Eiken S., 2018, MEDICAID EXPENDITURE; Eldercare Workforce Alliance, 2012, GER WORKF SHORT LOOM; Elvish R, 2018, DEMENTIA-LONDON, V17, P96, DOI 10.1177/1471301216634926; Epstein-Lubow G, 2012, AM J GERIAT PSYCHIAT, V20, P815, DOI 10.1097/JGP.0b013e318235b62f; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Farina N, 2014, INT PSYCHOGERIATR, V26, P9, DOI 10.1017/S1041610213001385; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fauth EB, 2019, J APPL GERONTOL, V38, P1253, DOI 10.1177/0733464817714564; Feast A, 2016, INT PSYCHOGERIATR, V28, P1761, DOI 10.1017/S1041610216000922; Feng ZL, 2014, HEALTH AFFAIR, V33, P683, DOI 10.1377/hlthaff.2013.1179; Fernandez-Blazquez MA, 2016, J ALZHEIMERS DIS, V52, P271, DOI 10.3233/JAD-150956; Fields NL, 2016, DEMENTIA-LONDON, DOI [10.1177/1471301216685626.1471301216685626, DOI 10.1177/1471301216685626.1471301216685626]; Fisher GG, 2014, J OCCUP HEALTH PSYCH, V19, P231, DOI 10.1037/a0035724; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Fitten LJ, 2001, J AM GERIATR SOC, V49, P1301, DOI 10.1046/j.1532-5415.2001.49257.x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fonareva I, 2014, INT PSYCHOGERIATR, V26, P725, DOI 10.1017/S1041610214000039; Fortinsky RH, 2016, CONTEMP CLIN TRIALS, V49, P155, DOI 10.1016/j.cct.2016.07.006; Fowler Nicole R, 2015, Alzheimers Dement (Amst), V1, P349; Fowler Nicole R, 2015, Alzheimers Dement (Amst), V1, P236; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fredman L, 2006, PREV MED, V43, P226, DOI 10.1016/j.ypmed.2006.04.009; Fredriksen-Goldsen KI, 2018, J APPL GERONTOL, V37, P545, DOI 10.1177/0733464816672047; Freedman VA, 2018, J GERONTOL B-PSYCHOL, V73, pS48, DOI 10.1093/geronb/gbx144; French DD, 2014, HEALTH AFFAIR, V33, P613, DOI 10.1377/hlthaff.2013.1221; Friedman EM, 2015, HEALTH AFFAIR, V34, P1637, DOI 10.1377/hlthaff.2015.0510; Froehlich TE, 2001, J AM GERIATR SOC, V49, P477, DOI 10.1046/j.1532-5415.2001.49096.x; Fukushima Raiana Lídice Mór, 2016, Dement. neuropsychol., V10, P178, DOI 10.1590/S1980-5764-2016DN1003003; Ganguli I, 2017, JAMA-J AM MED ASSOC, V317, P2233, DOI 10.1001/jama.2017.4342; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Gaugler J.E., 2015, FAMILY CAREGIVING NE; Gaugler JE, 2002, INT J AGING HUM DEV, V54, P205, DOI 10.2190/FACK-QE61-Y2J8-5L68; Gaugler JE, 2019, GERONTOLOGIST, V59, P78, DOI 10.1093/geront/gny078; Gaugler JE, 2017, INT PSYCHOGERIATR, V29, P19, DOI 10.1017/S1041610216001514; Gaugler JE, 2016, GERONTOLOGIST, V56, P1161, DOI 10.1093/geront/gnv150; Gaugler JE, 2016, INT PSYCHOGERIATR, V28, P1029, DOI 10.1017/S1041610215002318; Gaugler JE, 2014, CLIN GERIATR MED, V30, P493, DOI 10.1016/j.cger.2014.04.003; Gaugler JE, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-85; Geldmacher DS, 2013, APPL HEALTH ECON HEA, V11, P407, DOI 10.1007/s40258-013-0038-9; Genworth, COST CAR SURV 2018 M; Genworth, 2017 COST CAR ANN CO; Gerontological Society of America, 2015, KAERTOOLKIT 4 STEP P; Gifford KA, 2014, ALZHEIMERS DEMENT, V10, P319, DOI 10.1016/j.jalz.2013.02.007; Gillespie R, 2014, J CLIN NURS, V23, P3296, DOI 10.1111/jocn.12519; Gilligan AM, 2013, AM J ALZHEIMERS DIS, V28, P84, DOI 10.1177/1533317512467679; Gilmore-Bykovskyi A, 2018, AM J ALZHEIMERS DIS, V33, P145, DOI 10.1177/1533317517749465; Gitlin LN, 2015, GERONTOLOGIST, V55, P210, DOI 10.1093/geront/gnu123; Gitlin LN, 2010, GERONTOLOGIST, V50, P847, DOI 10.1093/geront/gnq057; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Gonyea JG, 2016, GERONTOLOGIST, V56, P292, DOI 10.1093/geront/gnu045; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Goren A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0298-y; Gottesman RF, 2017, JAMA NEUROL, V74, P1246, DOI 10.1001/jamaneurol.2017.1658; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Gozalo P, 2015, NEW ENGL J MED, V372, P1823, DOI 10.1056/NEJMsa1408705; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Graham-Phillips A, 2016, J AM GERIATR SOC, V64, P1662, DOI 10.1111/jgs.14204; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Griffiths PC, 2016, GERONTOLOGIST, V56, P145, DOI 10.1093/geront/gnv123; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Grossberg GT, 2010, PRIM CARE COMPANION, V12; Grossman MR, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9345; Grzywacz JG, 2016, J OCCUP ENVIRON MED, V58, P535, DOI 10.1097/JOM.0000000000000727; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Guure CB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9016924; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hall KS, 2009, ALZHEIMERS DEMENT, V5, P227, DOI 10.1016/j.jalz.2009.01.026; Hardman RJ, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00022; Harrington M, PHYS ACTIVITY ALZRIS; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Harris-Kojetin L, 2016, VITAL HLTH STAT, V3, P1; Harwood D G, 2000, Curr Psychiatry Rep, V2, P40, DOI 10.1007/s11920-000-0040-4; He W., 2016, P95161 US CENS BUR; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Hebert LE, 2001, AM J EPIDEMIOL, V153, P132, DOI 10.1093/aje/153.2.132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Hendrie HC, 2018, J GERONTOL B-PSYCHOL, V73, pS82, DOI 10.1093/geronb/gbx143; Hendrie HC, 2014, INT PSYCHOGERIATR, V26, P977, DOI 10.1017/S1041610214000167; Henry J, PERC WOM WHO REP HAV; Henry J, PERC MEN WHO REP HAV; Heron M, 2018, NATL VITAL STAT REPO, V67; Hicken BL, 2017, J RURAL HEALTH, V33, P305, DOI 10.1111/jrh.12195; Hoffman D, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160233; Hohman TJ, 2018, JAMA NEUROL, V75, P989, DOI 10.1001/jamaneurol.2018.0821; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Honea RA, 2012, J ALZHEIMERS DIS, V31, P659, DOI 10.3233/JAD-2012-120676; Hopwood J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9548; Hudomiet P, 2018, J GERONTOL B-PSYCHOL, V73, pS10, DOI 10.1093/geronb/gbx169; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Institute of Medicine, 2015, COGN AG PROGR UND OP; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jacobson G., 2017, Income and assets of Medicare beneficiaries, 2016-2035; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jellinger KA, 2007, ALZHEIMERS DEMENT, V3, P40, DOI 10.1016/j.jalz.2006.09.002; Jennings LA, 2018, J AM GERIATR SOC, V66, P2120, DOI 10.1111/jgs.15541; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; John A. Hartford Foundation, 2012, DOES IT FEEL OLD AD; Jones Adrienne L, 2009, Vital Health Stat 13, P1; Jones RW, 2017, DEMENT GER COGN D EX, V7, P87, DOI 10.1159/000461577; Jutkowitz E, 2017, J AM GERIATR SOC, V65, P2169, DOI 10.1111/jgs.15043; Kally Z, 2014, J GERONTOL SOC WORK, V57, P681, DOI 10.1080/01634372.2013.850584; Kally Z, 2014, J GERONTOL SOC WORK, V57, P710, DOI 10.1080/01634372.2013.854856; Kane, 2015, FAMILY CAREGIVING NE, P305, DOI DOI 10.1016/B978-0-12-417046-9.00017-9; Kane RL., 2015, FAMILY CAREGIVING NE, P57, DOI DOI 10.1016/B978-0-12-417046-9.00006-4; Kang JH, 2012, NEUROBIOL AGING, V33, P1129, DOI 10.1016/j.neurobiolaging.2010.10.007; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Kapasi A, 2017, ACTA NEUROPATHOL, V134, P171, DOI 10.1007/s00401-017-1717-7; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kasper JD., 2014, DISABILITY CARE NEED; Kasper JD, 2015, HEALTH AFFAIR, V34, P1642, DOI 10.1377/hlthaff.2015.0536; Kaup AR, 2015, NEUROLOGY, V85, P1852, DOI 10.1212/WNL.0000000000002153; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kiely DK, 2010, J AM GERIATR SOC, V58, P2284, DOI 10.1111/j.1532-5415.2010.03185.x; Kirson NY, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0303-5; Kivimaki M, 2018, ALZHEIMERS DEMENT, V14, P601, DOI 10.1016/j.jalz.2017.09.016; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Kohler L, 2014, CURR ALZHEIMER RES, V11, P538, DOI 10.2174/1567205011666140618100727; Kotagal V, 2015, NEUROLOGY, V84, P64, DOI 10.1212/WNL.0000000000001096; Kramer NA., 2000, PROFESSIONAL PSYCHOL, P227; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kulmala J, 2018, J ALZHEIMERS DIS, V64, pS191, DOI 10.3233/JAD-179919; LaMantia MA, 2015, J AM GERIATR SOC, V63, P1209, DOI 10.1111/jgs.13447; Landon BE, 2018, JAMA INTERN MED, V178, P66, DOI 10.1001/jamainternmed.2017.5034; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Langa KM, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0118-1; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lathren CR, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-134; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Leibson CL, 2015, ALZHEIMERS DEMENT, V11, P917, DOI 10.1016/j.jalz.2015.01.007; Liew TM, 2019, GERONTOLOGIST, V59, pE380, DOI 10.1093/geront/gny061; Lin PJ, 2017, ALZHEIMERS DEMENT, V13, P1174, DOI 10.1016/j.jalz.2017.08.010; Lin PJ, 2016, J AM GERIATR SOC, V64, P1549, DOI 10.1111/jgs.14227; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Lines L.M, 2014, RACIAL ETHNIC DISPAR; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Llanque SM, 2012, AM J ALZHEIMERS DIS, V27, P23, DOI 10.1177/1533317512439794; Lloyd J, 2016, DEMENTIA-LONDON, V15, P1534, DOI 10.1177/1471301214564792; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Luchsinger JA, 2018, J AM GERIATR SOC, V66, P1708, DOI 10.1111/jgs.15450; Lykens K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089290; Maarsingh OR, 2016, BRIT J GEN PRACT, V66, pE531, DOI 10.3399/bjgp16X686101; Manly J, 2004, CRITICAL PERSPECTIVE, P95; Martindale-Adams J, 2017, TRANSL BEHAV MED, V7, P427, DOI 10.1007/s13142-017-0505-1; Maslow K., 2012, TRANSLATING INNOVATI; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; Mattke S., 2017, ASSESSING PREPAREDNE; Mausbach BT, 2017, PSYCHOSOM MED, V79, P735, DOI 10.1097/PSY.0000000000000497; Mausbach BT, 2014, PSYCHOL AGING, V29, P776, DOI 10.1037/a0037626; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; Mausbach BT, 2012, HEALTH PSYCHOL, V31, P433, DOI 10.1037/a0027783; Mausbach BT, 2010, J AM COLL CARDIOL, V55, P2599, DOI 10.1016/j.jacc.2009.11.093; Maye JE, 2016, NEUROBIOL AGING, V40, P61, DOI 10.1016/j.neurobiolaging.2015.12.013; Mayeda ER, 2017, ALZ DIS ASSOC DIS, V31, P181, DOI 10.1097/WAD.0000000000000189; Mayeda ER, 2016, ALZHEIMERS DEMENT, V12, P216, DOI 10.1016/j.jalz.2015.12.007; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; McCabe MP, 2007, AGING MENT HEALTH, V11, P505, DOI 10.1080/13607860601086405; McCaffrey R, 2013, J INTERPROF CARE, V27, P534, DOI 10.3109/13561820.2013.817384; McCurry SM, 2018, J GERONTOL SOC WORK, V61, P45, DOI 10.1080/01634372.2017.1400486; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKhann GM, 2012, ADV BIOL PSYCH-KARG, V28, P115; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medicare, GLOSS MED OFF US GOV; Mehta KM, 2017, ALZHEIMERS DEMENT, V13, P72, DOI 10.1016/j.jalz.2016.06.2360; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Menne HL, 2017, J APPL GERONTOL, V36, P537, DOI 10.1177/0733464815591212; Menne HL, 2014, J GERONTOL SOC WORK, V57, P626, DOI 10.1080/01634372.2013.870276; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; MetLife Mature Market Institute, METLIFE STUD ALZH DI; Meyer OL, 2017, AGING MENT HEALTH, V24, P1; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2012, J PALLIAT MED, V15, P43, DOI 10.1089/jpm.2011.0210; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2016, JAMA-J AM MED ASSOC, V316, P769, DOI 10.1001/jama.2016.9374; Mittelman MS, 2014, HEALTH AFFAIR, V33, P587, DOI 10.1377/hlthaff.2013.1334; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Monin JK, 2015, GERONTOLOGIST, V55, P981, DOI 10.1093/geront/gnu001; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1007, DOI 10.1016/j.jalz.2014.11.009; Murman DL, 2002, NEUROLOGY, V59, P1721, DOI 10.1212/01.WNL.0000036904.73393.E4; Napoles AM, 2010, AM J ALZHEIMERS DIS, V25, P389, DOI 10.1177/1533317510370957; National Academies of Sciences, 2016, FAM CAR AG AM 2016; National Alliance for Caregiving and AARP, 2009, CAR US; National Alliance for Caregiving and AARP, 2009, CAR US UNP DAT AN CO; National Alliance for Caregiving in Partnership with the Alzheimer's Association, DEM CAR US; National Association of Insurance Commissioners and the Center for Insurance Policy and Research, 2016, CIPR STUD SER; National Down Syndrome Society, AG SYNDR HLTH WELL B; National Institute on Aging, WHAT AR FRONT DIS; National Institute on Aging, ALZH DEM RES PROF; National Institutes of Health. National Institute on Aging, WHAT HAPP BRAIN ALZH; National Poll on Healthy Aging, DEM CAR JUGGL DEL LO; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Nichols LO, 2016, GERONTOLOGIST, V56, P135, DOI 10.1093/geront/gnu112; Nickel F, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0751-1; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Noel MA, 2017, J APPL GERONTOL, V36, P195, DOI 10.1177/0733464815589986; Odenheimer G, 2013, AM J OCCUP THER, V67, P704, DOI 10.5014/ajot.2013.676004; Official Data Foundation, CPI INFL CALC; Ohara T, 2015, J AM GERIATR SOC, V63, P2332, DOI 10.1111/jgs.13794; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Ortman J.M., 2014, CURRENT POPULATION R; Romero JP, 2014, J ALZHEIMERS DIS, V39, P741, DOI 10.3233/JAD-131622; Palmer JL, 2014, J CONTIN EDUC NURS, V45, P416, DOI 10.3928/00220124-20140825-20; Patel A, 2015, CIRC-HEART FAIL, V8, P8, DOI 10.1161/CIRCHEARTFAILURE.114.001438; Peacock SC, 2013, PALLIAT SUPPORT CARE, V11, P155, DOI 10.1017/S1478951512000831; Peng HL, 2013, PERSPECT PSYCHIATR C, V49, P135, DOI 10.1111/ppc.12005; Perkins M, 2013, J GERONTOL B-PSYCHOL, V68, P504, DOI 10.1093/geronb/gbs084; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polenick CA, 2020, GERONTOLOGIST, V60, P165, DOI 10.1093/geront/gny130; Pond D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021125; Pool LR, 2016, NEUROLOGY, V86, P1386, DOI 10.1212/WNL.0000000000002569; Port CL, 2005, GERONTOLOGIST, V45, P87, DOI 10.1093/geront/45.suppl_1.87; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Prentice, 2017, AGING MENT HEALTH, V5, P1; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Primetica B, 2015, J APPL GERONTOL, V34, P652, DOI 10.1177/0733464813508888; Prince M., 2015, WORLD ALZHEIMER REPO; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rabarison KM, 2018, AM J PUBLIC HEALTH, V108, P1370, DOI 10.2105/AJPH.2018.304573; Rabinovici GD, 2017, ALZHEIMERS DEMENT, V13, pP1474; Rajan KB, 2019, ALZHEIMERS DEMENT, V15, P1, DOI 10.1016/j.jalz.2018.07.216; Rajan KB, 2017, J AM GERIATR SOC, V65, P2425, DOI 10.1111/jgs.15059; Ranson JM, 2018, NEUROL CLIN PRACT; Rattinger GB, 2016, ALZHEIMERS DEMENT, V12, P917, DOI 10.1016/j.jalz.2016.03.008; Rattinger GB, 2015, ALZHEIMERS DEMENT, V11, P946, DOI 10.1016/j.jalz.2014.11.004; Reaves EL, 2015, USITC PUBL, V#8617-02; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/nrneurol.2011.2; Reuben DB, 2013, J AM GERIATR SOC, V61, P2214, DOI 10.1111/jgs.12562; Rhoads JM., 2016, OUR PARENTS OURSELVE; Riedel O, 2016, RES GERONTOL NURS, V9, P167, DOI 10.3928/19404921-20160531-02; Riffin C, 2017, J AM GERIATR SOC, V65, P1821, DOI 10.1111/jgs.14910; Roberts R, 2013, CLIN GERIATR MED, V29, P753, DOI 10.1016/j.cger.2013.07.003; Rocca WA, 2014, MATURITAS, V79, P196, DOI 10.1016/j.maturitas.2014.05.008; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Roepke SK, 2012, STRESS, V15, P121, DOI 10.3109/10253890.2011.596866; Rome V., VARIATION ADULT DAY; Rome V, VARIATION OPERATING, P1; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Ronnemaa E, 2011, DEMENT GERIATR COGN, V31, P460, DOI 10.1159/000330020; Rosalynn Carter Institute for Caregiving, CAR INT DAT; Rosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006; Roth DL, 2015, J GERONTOL B-PSYCHOL, V70, P813, DOI 10.1093/geronb/gbv034; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Sadak T, 2018, J APPL GERONTOL, V37, P620, DOI 10.1177/0733464816657472; Sajeev G., DIABETES ALZRISK DAT; Samia LW, 2014, J GERONTOL SOC WORK, V57, P640, DOI 10.1080/01634372.2013.859201; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Samper-Ternent R, 2012, J AM MED DIR ASSOC, V13, P254, DOI 10.1016/j.jamda.2010.07.010; Sando SB, 2008, INT J GERIATR PSYCH, V23, P1156, DOI 10.1002/gps.2043; Sanjeev G, 2016, EPIDEMIOLOGY, V27, P732; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1998, HEALTH PSYCHOL, V17, P107, DOI 10.1037/h0092707; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Shaw WS, 1999, J PSYCHOSOM RES, V46, P215, DOI 10.1016/S0022-3999(98)00084-1; Sheffield KM, 2011, AM J EPIDEMIOL, V174, P274, DOI 10.1093/aje/kwr074; Shega JW, 2008, J PAIN SYMPTOM MANAG, V35, P499, DOI 10.1016/j.jpainsymman.2007.06.011; Shriver M, 2010, SHRIVER REPORT WOMAN; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Soni M, 2019, AGING MENT HEALTH, V23, P15, DOI 10.1080/13607863.2017.1390731; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Spector A, 2013, AGEING RES REV, V12, P354, DOI 10.1016/j.arr.2012.06.005; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spillman B., INFORMAL CAREGIVING; Spinney L, 2014, NATURE, V510, P26, DOI 10.1038/510026a; Squillace MR., 2011, UNDERSTANDING DIRECT; Starfield B., 1998, PRIMARY CARE BALANCI; Steenland K, 2016, J ALZHEIMERS DIS, V50, P71, DOI 10.3233/JAD-150778; Stephen R, 2017, J GERONTOL A-BIOL, V72, P733, DOI 10.1093/gerona/glw251; Steptoe A, 2005, AGING HLTH PUBLIC PO; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stojkovska I, 2018, CELL TISSUE RES, V373, P51, DOI 10.1007/s00441-017-2704-y; Stone R.I., 2012, UNIVERSAL COVERAGE L, P155; Suehs BT, 2013, AM J ALZHEIMERS DIS, V28, P384, DOI 10.1177/1533317513488911; Sullivan KJ, 2019, J GERONTOL A-BIOL, V74, P1439, DOI 10.1093/gerona/gly236; Surr CA, 2016, INT J NURS STUD, V53, P144, DOI 10.1016/j.ijnurstu.2015.09.009; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Tan ZS, 2014, HEALTH AFFAIR, V33, P619, DOI 10.1377/hlthaff.2013.1294; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Taylor CA, 2018, MMWR-MORBID MORTAL W, V67, P753, DOI 10.15585/mmwr.mm6727a1; Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor DH, 2018, J PALLIAT MED, V21, P645, DOI 10.1089/jpm.2017.0485; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; The American Geriatrics Society, CURR GER SHORTF; The Lewin Group, 2016, PROC EV OLD AM ACT T; The National Alliance for Caregiving and the AARP Public Policy Institute, 2015, CAR US; The Robert Graham Center, STAT PRIM CAR US CHA; U.S. Census Bureau, 2014, NAT POP PROJ DOWNL F; U. S. Centers for Medicare & Medicaid Services, 2018, MED LEARN NETW ANN W; U.S. Centers for Medicare & Medicaid Services, MED PROV UT PAYM DAT; U. S. Centers for Medicare & Medicaid Services, HLTH EXP STAT RES 19; U.S. Centers for Medicare & Medicaid Services, NURS HOM DAT COMP 20; U.S. Centers for Medicare & Medicaid Services, YOUR MED COV LONG TE; U. S. Centers for Medicare & Medicaid Services, 2015, STAT LEV CHRON COND; U. S. Centers for Medicare & Medicaid Services Enterprise Portal, 2016, BEN UT FREE PREV SER; U. S. Centers for Medicare & Medicaid Services Enterprise Portal, 2015, BEN UT FREE PREV SER; U. S. Centers for Medicare & Medicaid Services Medicare Learning Network, MED LEARN NETW UPD H; U.S. Department of Health and Human Services, NAT RES SUMM CAR SER; U.S. Department of Health and Human Services, WHAT IS LONG TERM CA; U. S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, CDC WONDER ONL DAT U; U.S. Department of Labor Bureau of Labor Statistics, 2018, US DEP LAB SER; Urban Institute Health Policy Center Health Reform Monitoring Survey, 2017, PAT FEEL COMF TALK T; Urban Institute Health Policy Center Health Reform Monitoring Survey., 2017, DO PAT TRUST THEIR P; Walmart, 2018 ANN REP; WHO, 2004, INT STAT CLASS DIS R; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Zarit, 2009, AGING FAMILIES CAREG, P85; Kane RL., 2015, FAMILY CAREGIVING NE, P193; TEASDALE G, 1974, LANCET, V2, P81; Teno J, 2014, HEALTH AFFAIR, V33, P675, DOI 10.1377/hlthaff.2013.1248; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Teri L, 2020, GERONTOLOGIST, V60, P548, DOI 10.1093/geront/gny122; Teri L, 2012, GERONTOLOGIST, V52, P452, DOI 10.1093/geront/gnr132; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Thunyadee C, 2015, NURS HEALTH SCI, V17, P412, DOI 10.1111/nhs.12205; Thyrian JR, 2017, JAMA PSYCHIAT, V74, P996, DOI 10.1001/jamapsychiatry.2017.2124; Tierney MC, 2014, ALZ DIS ASSOC DIS, V28, P320, DOI 10.1097/WAD.0000000000000039; Tivadar BK, 2017, BIOGERONTOLOGY, V18, P477, DOI 10.1007/s10522-017-9708-6; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Tom SE, 2015, AM J PUBLIC HEALTH, V105, P408, DOI 10.2105/AJPH.2014.301935; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; Vaingankar JA, 2016, COMPR PSYCHIAT, V68, P178, DOI 10.1016/j.comppsych.2016.04.017; Valimaki TH, 2016, QUAL LIFE RES, V25, P687, DOI 10.1007/s11136-015-1100-x; van den Kommer TN, 2018, J GERONTOL B-PSYCHOL, V73, pS57, DOI 10.1093/geronb/gbx151; Van Mierlo LD, 2016, INT PSYCHOGERIATR, V28, P801, DOI 10.1017/S1041610215001817; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Vitaliano PP, 2017, GERONTOLOGIST, V57, P637, DOI 10.1093/geront/gnv690; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; von Kanel R, 2006, J GERONTOL A-BIOL, V61, P963, DOI 10.1093/gerona/61.9.963; von Kanel R, 2014, BEHAV SLEEP MED, V12, P358, DOI 10.1080/15402002.2013.819470; von Kanel R, 2012, GERONTOLOGY, V58, P354, DOI 10.1159/000334219; von Kanel R, 2012, PSYCHOSOM MED, V74, P214, DOI 10.1097/PSY.0b013e3182408c14; Waller A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0654-6; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Ward A, 2013, DEMENT GER COGN D EX, V3, P320, DOI 10.1159/000354370; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Warren-Findlow J, 2010, HEALTH PROMOT INT, V25, P464, DOI 10.1093/heapro/daq043; Warshaw GA, 2014, HEALTH AFFAIR, V33, P633, DOI 10.1377/hlthaff.2013.1232; Weuve J, 2018, J GERONTOL B-PSYCHOL, V73, pS73, DOI 10.1093/geronb/gbx167; Weuve J, 2018, EPIDEMIOLOGY, V29, P151, DOI [10.1097/EDE.0000000000000747, 10.1097/ede.0000000000000747]; Weuve J, 2015, EPIDEMIOLOGY, V26, pE4, DOI 10.1097/EDE.0000000000000199; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; Whitlatch CJ, 2018, GERONTOLOGIST, V58, pS58, DOI 10.1093/geront/gnx162; Wiberg P, 2013, PSYCHOL MED, V43, P2627, DOI 10.1017/S0033291713000299; Willey JZ, 2016, NEUROLOGY, V86, P1897, DOI 10.1212/WNL.0000000000002582; Wilson RS, 2012, PSYCHOL AGING, V27, P1008, DOI 10.1037/a0029857; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wimo A, 2016, J ALZHEIMERS DIS, V50, P387, DOI 10.3233/JAD-150708; Wojtowicz A, 2015, NEURODEGENER DIS MAN, V5, P505, DOI 10.2217/nmt.15.43; Wolff JL, 2018, GERONTOLOGIST, V58, P1021, DOI 10.1093/geront/gnx093; Wolfsgruber S, 2016, J ALZHEIMERS DIS, V54, P1135, DOI 10.3233/JAD-160407; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188; Wolters FJ, 2017, NEUROLOGY, V88, P1642, DOI 10.1212/WNL.0000000000003871; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051; Yang Z, 2015, WOMEN HEALTH ISS, V25, P436, DOI 10.1016/j.whi.2015.06.001; Yang Z, 2012, HEALTH SERV RES, V47, P1660, DOI 10.1111/j.1475-6773.2011.01365.x; Yarnall KSH, 2009, PREV CHRONIC DIS, V6; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Yates LA, 2016, INT PSYCHOGERIATR, V9, P1; Yu DSF, 2018, INT J NURS STUD, V79, P1, DOI 10.1016/j.ijnurstu.2017.10.008; Zaleta AK, 2012, ALZ DIS ASSOC DIS, V26, P232, DOI 10.1097/WAD.0b013e3182351c04; Zarit SH, 2017, AGING MENT HEALTH, V16, P1; Zarit SH, 2009, AGING FAMILIES CAREG, P131; Zarit SH, 2013, AGING MENT HEALTH, V17, P197, DOI 10.1080/13607863.2012.717252; Zarit SH, 2012, AGING MENT HEALTH, V16, P673, DOI 10.1080/13607863.2012.692768; Zhang ZM, 2016, J HEALTH SOC BEHAV, V57, P184, DOI 10.1177/0022146516645925; Zhu CW, 2015, J GERONTOL A-BIOL, V70, P1448, DOI 10.1093/gerona/glv124; Zhu CW, 2015, ALZHEIMERS DEMENT, V11, P444, DOI 10.1016/j.jalz.2013.12.018; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25	576	684	689	85	371	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2019	15	3					321	387		10.1016/j.jalz.2019.01.010			67	Clinical Neurology	Neurosciences & Neurology	HN5OH	WOS:000460233800001			Y	Y	2021-06-18	
J	Winblad, B; Amouyel, P; Andrieu, S; Ballard, C; Brayne, C; Brodaty, H; Cedazo-Minguez, A; Dubois, B; Edvardsson, D; Feldman, H; Fratiglioni, L; Frisoni, GB; Gauthier, S; Georges, J; Graff, C; Iqbal, K; Jessen, F; Johansson, G; Jonsson, L; Kivipelto, M; Knapp, M; Mangialasche, F; Melis, R; Nordberg, A; Rikkert, MO; Qiu, CX; Sakmar, TP; Scheltens, P; Schneider, LS; Sperling, R; Tjernberg, LO; Waldemar, G; Wimo, A; Zetterberg, H				Winblad, Bengt; Amouyel, Philippe; Andrieu, Sandrine; Ballard, Clive; Brayne, Carol; Brodaty, Henry; Cedazo-Minguez, Angel; Dubois, Bruno; Edvardsson, David; Feldman, Howard; Fratiglioni, Laura; Frisoni, Giovanni B.; Gauthier, Serge; Georges, Jean; Graff, Caroline; Iqbal, Khalid; Jessen, Frank; Johansson, Gunilla; Jonsson, Linus; Kivipelto, Miia; Knapp, Martin; Mangialasche, Francesca; Melis, Rene; Nordberg, Agneta; Rikkert, Marcel Olde; Qiu, Chengxuan; Sakmar, Thomas P.; Scheltens, Philip; Schneider, Lon S.; Sperling, Reisa; Tjernberg, Lars O.; Waldemar, Gunhild; Wimo, Anders; Zetterberg, Henrik			Defeating Alzheimer's disease and other dementias: a priority for European science and society	LANCET NEUROLOGY			English	Article							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; NURSING-HOME RESIDENTS; GENOME-WIDE ASSOCIATION; VASCULAR RISK-FACTORS; COMPREHENSIVE GERIATRIC ASSESSMENT; APOLIPOPROTEIN-E GENOTYPE; COPING STRATEGY PROGRAM		[Winblad, Bengt; Cedazo-Minguez, Angel; Graff, Caroline; Johansson, Gunilla; Jonsson, Linus; Kivipelto, Miia; Sakmar, Thomas P.; Tjernberg, Lars O.; Wimo, Anders] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, SE-14157 Huddinge, Sweden; [Nordberg, Agneta] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Translat Alzheimer Biol, SE-14157 Huddinge, Sweden; [Winblad, Bengt; Graff, Caroline; Kivipelto, Miia; Nordberg, Agneta] Karolinska Univ Hosp, Dept Geriatr Med, Huddinge, Sweden; [Amouyel, Philippe] Ctr Hosp Reg & Univ Lille, Inst Pasteur Lille, INSERM RID AGE U1167, Unite Epidemiol & Sante Publ,Labex DISTALZ, Pl Verdun, F-59037 Lille, France; [Andrieu, Sandrine] Toulouse Univ Hosp, Fac Med, Dept Epidemiol & Publ Hlth, Toulouse, France; [Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Brodaty, Henry] Univ New S Wales, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Dubois, Bruno] Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, IM2A,INSERM,UMR S975, Paris, France; [Edvardsson, David] La Trobe Univ, Sch Nursing & Midwifery, Melbourne, Vic, Australia; [Edvardsson, David] Umea Univ, Dept Nursing, Umea, Sweden; [Feldman, Howard] Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC, Canada; [Fratiglioni, Laura; Kivipelto, Miia; Mangialasche, Francesca; Qiu, Chengxuan] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Frisoni, Giovanni B.] Univ Hosp Geneva, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Geneva, Geneva, Switzerland; [Frisoni, Giovanni B.] IRCCS Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy; [Gauthier, Serge] McGill Ctr Studies Aging, Alzheimers Dis Res Unit, Montreal, PQ, Canada; [Gauthier, Serge] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Georges, Jean] Alzheimer Europe, Luxembourg, Luxembourg; [Iqbal, Khalid] New York State Inst Basic Res, Dept Neurochem, Staten Isl, NY USA; [Jessen, Frank] Univ Cologne, Dept Psychiat, D-50931 Cologne, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Knapp, Martin] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, Houghton St, London WC2A 2AE, England; [Melis, Rene; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Radboudumc Alzheimer Ctr, NL-6525 ED Nijmegen, Netherlands; [Melis, Rene; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, NL-6525 ED Nijmegen, Netherlands; [Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Leonard Davis Sch Gerontol, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Leonard Davis Sch Gerontol, Dept Neurol, Los Angeles, CA 90033 USA; [Sperling, Reisa] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Alzheimer Res & Treatment,Dept Neurol, Boston, MA 02115 USA; [Sperling, Reisa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Waldemar, Gunhild] Univ Copenhagen, Rigshosp, Dept Neurol, Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	Winblad, B (corresponding author), Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, SE-14157 Huddinge, Sweden.	bengt-winblad-swedishbrainpower@ki.se	graff, caroline/A-2545-2009; Frisoni, Giovanni B/K-1360-2016; Jessen, Frank/AAK-6170-2020; Jonsson, Linus/G-2253-2017; Cedazo-Minguez, Angel/C-6707-2012; Rikkert, M.G.M. Olde/H-8078-2014; Sakmar, Thomas P/D-1833-2015; Brayne, Carol/AAA-4285-2020; Melis, Rene/J-5943-2012; Scheltens, Philip/AAL-9631-2020	Frisoni, Giovanni B/0000-0002-6419-1753; Jonsson, Linus/0000-0001-5751-6292; Cedazo-Minguez, Angel/0000-0003-4626-4864; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Sakmar, Thomas P/0000-0002-2836-8953; Brayne, Carol/0000-0001-5307-663X; Melis, Rene/0000-0002-7863-4738; Scheltens, Philip/0000-0002-1046-6408; Georges, Jean/0000-0003-4862-3031; Nordberg, Agneta/0000-0001-7345-5151; Amouyel, Philippe/0000-0001-9088-234X; Ballard, Clive/0000-0003-0022-5632; Graff, Caroline/0000-0002-9949-2951; Feldman, Howard/0000-0002-9258-4538; Knapp, Martin/0000-0003-1427-0215	AlzProtect; Genoscreen; Hoffmann-La RocheHoffmann-La Roche; ServierServier; TakedaTakeda Pharmaceutical Company Ltd; Acadia; LundbeckLundbeck Corporation; GlaxoSmithKlineGlaxoSmithKline; Heptares; LillyEli Lilly; Orion; Otusaka; RocheRoche Holding; Tau Therapeutics; Nutricia; Eli LillyEli Lilly; Brain Canada Multi-Investigator Research Initiative; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Pacific Alzheimer Research Foundation; TauRx Therapeutics; Alzheimer Society of Canada; Arena Pharmaceuticals; BiogenBiogen; General Electric; Hakko Kyowa Kirin Pharmaceuticals; Isis Pharmaceuticals; Swedish Alzheimer Foundation; Gun and Bertil Stohne Foundation; Karolinska InstitutetKarolinska Institutet; King Gustaf V and Queen Victoria's Foundation of Freemasons; Swedish Brain Power; Swedish Research CouncilSwedish Research CouncilEuropean Commission; NovartisNovartis; Piramal; Schwabe; Pfizer Centers for Therapeutic Innovation; GE HealthcareGE Healthcare; Stichting VUMC Fonds; Janssen Research FoundationJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; Takeda PharmaceuticalsTakeda Pharmaceutical Company Ltd; Baxter; Forum; MerckMerck & Company; US National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); University of Southern California; AC Immune; vTv Therapeutics; Boehringer IngelheimBoehringer Ingelheim; Sanofi; Brain Biomarker Solutions; GU-Venture-based platform company at the University of Gothenburg, Sweden; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10084] Funding Source: researchfish	No funding was provided specifically for this Commission paper. PA has received personal fees from AlzProtect, Genoscreen, Hoffmann-La Roche, Servier, Takeda, and Total. CBa has received grants from Acadia and Lundbeck, and personal fees from Acadia, GlaxoSmithKline, Heptares, Lilly, Lundbeck, Orion, Otusaka, and Roche. HB has received grants from Servier and Tau Therapeutics, and fees for advisory board activities from Nutricia. BD has received personal fees from Eli Lilly. HF has received grants and research funds from the Brain Canada Multi-Investigator Research Initiative, the Canadian Institutes of Health Research, Hoffmann-La Roche, Lilly, the US National Institutes of Health, the Pacific Alzheimer Research Foundation, and TauRx Therapeutics; expenses for research policy committee activities from the Alzheimer Society of Canada; consulting fees (paid to the University of British Columbia [UBC]) from Arena Pharmaceuticals, Biogen, General Electric, Hakko Kyowa Kirin Pharmaceuticals, Isis Pharmaceuticals, and Lilly; fees for diagnostic outcome monitoring board activities (paid to UBC) from the Banner Alzheimer's Institute and Genentech; fees for safety monitoring board activities (paid to UBC) from Eisai; travel expenses and consultancy fees for health outcomes research advisory board activities (paid to UBC) from Merck; and personal fees from the Bluefield Project to Cure Frontotemporal Dementia, Danone Nutricia, and the Rainwater Foundation Tau Consortium. HF is the recipient of the Ralph Fisher Family and Alzheimer Society of British Columbia Endowed Professorship in Alzheimer's Disease Research. He has a patent issued: detecting and treating dementia (application number US 12/302691; US patent PCT/US2007/070008). GBF has received grants from the Alzheimer's Association, Avid/Lilly, General Electric, Lilly, Lundbeck, Piramal, Roche, and Wyeth; personal fees from AstraZeneca, Bayer, Baxter, BMS, Elan, General Electric, Lilly, Lundbeck, Piramal, Pfizer, TauRx, and Wyeth; and non -financial support from Avid/Lilly, General Electric, Lilly, and Piramal. CG has received grants and research funding from the Swedish Alzheimer Foundation, the Gun and Bertil Stohne Foundation, the Karolinska Institutet, the King Gustaf V and Queen Victoria's Foundation of Freemasons, Swedish Brain Power, and the Swedish Research Council. KI has six patents issued (US patents 7256003, 8338378, 8349577, 8592374, 8796214, and 8796215) and six patents pending on the treatment of AD and related conditions; he is chairman of the scientific advisory committee of Axon Neuroscience. FJ has received personal fees from AstraZeneca, Boehringer Ingelheim, Lilly, Novartis, Nutricia, Piramal, and Schwabe. H has received personal fees from Lundbeck. MKn has received grants from Lundbeck, and personal fees from Lundbeck and Takeda. TPS has received grants through the Pfizer Centers for Therapeutic Innovation; he has a patent issued: nucleobindin I variant protein compositions and methods of use (US patent 8703707). PS has received grants from Alzheimer Nederland, GE Healthcare, Merck, Piramal, Stichting Dioraphte, and Stichting VUMC Fonds; and consultancy fees (paid to his institution) from AbbVie, Avraham Pharmaceuticals, EIP Pharma, the Janssen Research Foundation, MD Start, Nutricia, Probiodrug AG, and Takeda Pharmaceuticals.; LSS has received grants and other research support from Baxter, Eli Lilly, Forum, Lundbeck, Merck, the US National Institute on Aging, Novartis, Roche/Genentech, the state of California, TauRx, and the University of Southern California, and personal fees from AC Immune, Accera, Avraham, Boehringer Ingelheim, Cerespir, Cognition, Forum, Merck, Neurim, Roche, Stemedica, Takeda, TauRx, Toyama/FujiFilm, Transition, and vTv Therapeutics. RS has received grants from Eli Lilly, Janssen, and the US National Institute on Aging; and personal fees from Boehringer Ingelheim, Biogen, Bracket, Genentech, Isis Pharmaceuticals, Lundbeck, Roche, and Sanofi. GW is a board member of the Lundbeck Foundation. HZ is cofounder of Brain Biomarker Solutions, a GU-Venture-based platform company at the University of Gothenburg, Sweden. BW, SA, CBr, AC-M, DE, LF, SG, JG, GJ, MKi, FM, RM, AN, MOR, CQ, LOT, and AW declare no competing interests.	Aguero-Torres H, 2002, ALZ DIS ASSOC DIS, V16, P221, DOI 10.1097/00002093-200210000-00003; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALCOVE, 2013, ALCOVE SYNTH REP 201; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; AlzForum, 2014, THER TAK AIM TAU; AlzForum, THER ACI 35; Alzheimer Europe, DEM EUR YB 2013; Alzheimer Europe, 2012, DEM EUR YB 2012 NAT; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Andersen F, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-58; Andres-Pretel F, 2012, GAC SANIT, V26, P570, DOI 10.1016/j.gaceta.2011.12.007; [Anonymous], 2014, DISC PAP CLIN INV ME; [Anonymous], NAT PLAN ADDR ALZH D; Anstey KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086141; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Arif M, 2014, P NATL ACAD SCI USA, V111, P1144, DOI 10.1073/pnas.1322614111; Artero S, 2001, INT J GERIATR PSYCH, V16, P1092, DOI 10.1002/gps.477; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Ayalon L, 2006, ARCH INTERN MED, V166, P2182, DOI 10.1001/archinte.166.20.2182; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Balasubramanian AB, 2012, NEUROLOGY, V79, P915, DOI 10.1212/WNL.0b013e318266fc77; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Ballard C, 2001, BRIT MED J, V323, P426, DOI 10.1136/bmj.323.7310.426; Ballard C, 2016, AM J PSYCHIAT, V173, P252, DOI 10.1176/appi.ajp.2015.15010130; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Banningh LJW, 2008, INT J GERIATR PSYCH, V23, P148, DOI 10.1002/gps.1855; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2010, AM J EPIDEMIOL, V171, P292, DOI 10.1093/aje/kwp376; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beauchamp TL., 2009, PRINCIPLES BIOMEDICA, V7; Beecham J., 1992, MEASURING MENTAL HLT, P163; Beekes M, 2014, ACTA NEUROPATHOL, V128, P463, DOI 10.1007/s00401-014-1324-9; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 2014, ACTA NEUROPATHOL, V127, P137, DOI 10.1007/s00401-013-1226-2; Bennett DA, 2013, J ALZHEIMERS DIS, V33, pS397, DOI 10.3233/JAD-2012-129007; Bentham P., 2005, PSYCHIAT, V4, P100, DOI [10.1016/j.mppsy.2007.12.008, DOI 10.1016/J.MPPSY.2007.12.008, DOI 10.1383/psyt.4.2.100.59105]; Bergland A, 2006, INT J NURS STUD, V43, P681, DOI 10.1016/j.ijnurstu.2005.09.006; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Birks J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003120.pub3; Bittner T, 2016, ALZHEIMERS DEMENT, V12, P517, DOI 10.1016/j.jalz.2015.09.009; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Black SA, 2002, J AM GERIATR SOC, V50, P1978, DOI 10.1046/j.1532-5415.2002.50609.x; Blaum CS, 2002, J GERONTOL A-BIOL, V57, pM523, DOI 10.1093/gerona/57.8.M523; Blennow K, 2015, NAT MED, V21, P217, DOI 10.1038/nm.3810; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Boenink M, 2011, INT J ALZHEIMERS DIS, V2011; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bond M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16210; Borjesson-Hanson A, 2004, NEUROLOGY, V63, P2436, DOI 10.1212/01.WNL.0000147260.52841.27; Boustani M, 2008, INT J GERIATR PSYCH, V23, P812, DOI 10.1002/gps.1983; Braskie MN, 2014, BIOL PSYCHIAT, V75, P527, DOI 10.1016/j.biopsych.2013.11.020; Bravo G, 2008, SOC SCI MED, V67, P1122, DOI 10.1016/j.socscimed.2008.06.006; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Brayne C, 2011, ALZHEIMERS DEMENT, V7, P3, DOI 10.1016/j.jalz.2010.12.003; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Brodaty H, 2014, J ALZHEIMERS DIS, V40, P221, DOI 10.3233/JAD-131850; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Brodaty H, 2011, J AM GERIATR SOC, V59, P923, DOI 10.1111/j.1532-5415.2011.03365.x; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Brunner-La Rocca HP, 2012, EUR HEART J, V33, P752, DOI 10.1093/eurheartj/ehr404; Brunnstrom H, 2009, AM J GERIAT PSYCHIAT, V17, P664, DOI 10.1097/JGP.0b013e3181a6516e; Buckles VD, 2003, NEUROLOGY, V61, P1662, DOI 10.1212/01.WNL.0000098933.34804.FC; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; Carrie I, 2012, J NUTR HEALTH AGING, V16, P355, DOI 10.1007/s12603-012-0046-8; Carrillo MC, 2013, ALZHEIMERS DEMENT, V9, P137, DOI 10.1016/j.jalz.2012.11.003; Carrillo MC, 2013, ALZHEIMERS DEMENT, V9, P160, DOI 10.1016/j.jalz.2012.10.006; Casanova R, 2016, ALZHEIMERS DEMENT, V12, P815, DOI 10.1016/j.jalz.2015.12.008; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Cedazo-Minguez A, 2001, FEBS LETT, V504, P45, DOI 10.1016/S0014-5793(01)02761-2; Cedazo-Minguez A, 2001, NEUROREPORT, V12, P201, DOI 10.1097/00001756-200102120-00006; Challis D, 2002, INT J GERIATR PSYCH, V17, P315, DOI 10.1002/gps.595; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; Chen RL, 2012, ALZHEIMERS DEMENT, V8, P590, DOI 10.1016/j.jalz.2011.09.231; Chen SL, 2014, INT PSYCHOGERIATR, V26, P1059, DOI 10.1017/S1041610214000854; Cheng ST, 2012, AM J GERIAT PSYCHIAT, V20, P904, DOI 10.1097/JGP.0b013e3182423988; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; CLIPP EC, 1995, CLIN PHARMACOL THER, V58, P228, DOI 10.1016/0009-9236(95)90201-5; Cohen-Mansfield J, 2005, ALZ DIS ASSOC DIS, V19, P37, DOI 10.1097/01.wad.0000155066.39184.61; Cohen-Mansfield J., 2005, ALZHEIMERS CARE Q, V6, P129; Cohen-Mansfield J, 2007, J GERONTOL A-BIOL, V62, P908, DOI 10.1093/gerona/62.8.908; Cohen-Mansfield J, 2010, PSYCHIAT RES, V177, P216, DOI 10.1016/j.psychres.2009.02.010; Cohen-Mansfield J, 2010, AGING MENT HEALTH, V14, P67, DOI 10.1080/13607860902845574; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Comas-Herrera A, 2007, INT J GERIATR PSYCH, V22, P1037, DOI 10.1002/gps.1830; Cooney A, 2009, J ADV NURS, V65, P1029, DOI 10.1111/j.1365-2648.2008.04960.x; Corbett A, 2015, J AM MED DIR ASSOC, V16, P990, DOI 10.1016/j.jamda.2015.06.014; Corbett A, 2012, INT J GERIATR PSYCH, V27, P628, DOI 10.1002/gps.2762; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Corrada MM, 2008, NEUROLOGY, V71, P337, DOI 10.1212/01.wnl.0000310773.65918.cd; Corrada MM, 2012, CURR ALZHEIMER RES, V9, P709, DOI 10.2174/156720512801322537; Cowburn RF, 2007, PHYSIOL BEHAV, V92, P93, DOI 10.1016/j.physbeh.2007.05.053; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Davis KL, 1997, INT J GERIATR PSYCH, V12, P978, DOI 10.1002/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; Department of Health, 2013, G8 DEM SUMM AGR; Derksen E, 2006, AGING MENT HEALTH, V10, P525, DOI 10.1080/13607860600638024; Devons CAJ, 2002, CURR OPIN CLIN NUTR, V5, P19, DOI 10.1097/00075197-200201000-00004; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dixon WG, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1294; Dodge HH, 2005, GERONTOLOGIST, V45, P222, DOI 10.1093/geront/45.2.222; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Drageset J, 2008, J CLIN NURS, V17, P1227, DOI 10.1111/j.1365-2702.2007.02132.x; Draper B, 2010, ALZHEIMERS DEMENT, V6, P75, DOI 10.1016/j.jalz.2009.04.1229; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Edvardsson D, 2008, LANCET NEUROL, V7, P362, DOI 10.1016/S1474-4422(08)70063-2; Edvardsson D, 2014, INT J OLDER PEOPLE N, V9, P269, DOI 10.1111/opn.12030; Elwyn G, 2013, PATIENT EDUC COUNS, V90, P207, DOI 10.1016/j.pec.2012.06.036; Erlangsen A, 2008, AM J GERIAT PSYCHIAT, V16, P220, DOI 10.1097/JGP.0b013e3181602a12; Ersek K, 2010, J NUTR HEALTH AGING, V14, P633, DOI 10.1007/s12603-010-0309-1; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FDA, 2014, GUID IND EXP PROGR S; [FDA CDER], 2013, GUID IND ALZH DIS DE; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Ferrari C, 2013, NEUROBIOL AGING, V34, P13, DOI 10.1016/j.neurobiolaging.2012.03.003; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finucane TE, 2007, J AM MED DIR ASSOC, V8, P205, DOI 10.1016/j.jamda.2007.01.007; Fitzpatrick AL, 2005, J NEUROL SCI, V229, P43, DOI 10.1016/j.jns.2004.11.022; Food Drug Administration, 2006, GUID IND INV REV EXP; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Forrest LE, 2007, EUR J HUM GENET, V15, P612, DOI 10.1038/sj.ejhg.5201822; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Fossey J, 2014, INT J GERIATR PSYCH, V29, P797, DOI 10.1002/gps.4072; Fox C, 2013, INT J CLIN PRACT, V67, P1076, DOI 10.1111/ijcp.12239; Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185; Franco R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00146; FRATIGLIONI L, 1994, NEUROEPIDEMIOLOGY, V13, P79, DOI 10.1159/000110363; Fratiglioni L., 2013, OXFORD TXB OLD AGE P, P389; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Frisoni GB, 2011, ALZHEIMERS DEMENT, V7, P171, DOI 10.1016/j.jalz.2010.06.007; Funaki Yuuka, 2005, Scand J Occup Ther, V12, P4, DOI 10.1080/11038120510031725; G8 Health and Science Ministers, 2013, G8 DEM SUMM DECL; Galasko D, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt164; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Gao SJ, 2016, ALZHEIMERS DEMENT, V12, P244, DOI 10.1016/j.jalz.2015.06.1894; Garcia-Alloza M, 2011, BRAIN, V134, P3694, DOI 10.1093/brain/awr300; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gaugler JE, 2003, INT PSYCHOGERIATR, V15, P37, DOI 10.1017/S1041610203008743; Gaugler JE, 2013, AM J ALZHEIMERS DIS, V28, P337, DOI 10.1177/1533317513488910; Gauthier S, 2013, PROG NEUROBIOL, V110, P102, DOI 10.1016/j.pneurobio.2013.01.003; Gauthier S, 2015, DEMENT GERIATR COGN, V39, P332, DOI 10.1159/000377672; Gavett R, 2011, ALZ DIS ASSOC DIS, V25, P305, DOI 10.1097/WAD.0b013e31820d8652; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Gersbacher MT, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-61; Gifford KA, 2014, ALZHEIMERS DEMENT, V10, P319, DOI 10.1016/j.jalz.2013.02.007; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Golden AG, 2009, AM J HOSP PALLIAT ME, V26, P13, DOI 10.1177/1049909108324359; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gong CX, 2006, J ALZHEIMERS DIS, V9, P1; Gooblar J, 2015, JAMA NEUROL, V72, P1484, DOI 10.1001/jamaneurol.2015.2875; Groenewoud JH, 2000, ARCH INTERN MED, V160, P357, DOI 10.1001/archinte.160.3.357; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guehne U, 2005, NEUROEPIDEMIOLOGY, V25, P153, DOI 10.1159/000086680; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gustavsson A, 2010, J NUTR HEALTH AGING, V14, P648, DOI 10.1007/s12603-010-0311-7; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Gustavsson A, 2010, INT J GERIATR PSYCH, V25, P622, DOI 10.1002/gps.2385; Haas M, 2015, NAT REV DRUG DISCOV, V14, P221, DOI 10.1038/nrd4585; Hall KS, 2009, ALZHEIMERS DEMENT, V5, P227, DOI 10.1016/j.jalz.2009.01.026; Handels RLH, 2013, ALZ DIS ASSOC DIS, V27, P30, DOI 10.1097/WAD.0b013e318242da1d; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harms M, 2013, JAMA NEUROL, V70, P736, DOI 10.1001/2013.jamaneurol.537; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hausner L, 2010, J ALZHEIMERS DIS, V21, P155, DOI 10.3233/JAD-2010-091489; Hazrati LN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.001; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Helgesen AK, 2014, NURS ETHICS, V21, P108, DOI 10.1177/0969733013486796; Helgesen AK, 2010, INT J OLDER PEOPLE N, V5, P169, DOI 10.1111/j.1748-3743.2010.00223.x; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; Helmer C, 2006, DEMENT GERIATR COGN, V22, P87, DOI 10.1159/000093459; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hickman SE, 2011, J AM GERIATR SOC, V59, P2091, DOI 10.1111/j.1532-5415.2011.03656.x; Hill JW, 2002, NEUROLOGY, V58, P62, DOI 10.1212/WNL.58.1.62; Hoedemaekers R, 2006, HEC FORUM, V18, P18, DOI 10.1007/s10730-006-7985-6; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ilomaki J, 2015, CURR CLIN PHARMACOL, V10, P204, DOI 10.2174/157488471003150820145539; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; International Diabetes Federation, 2013, IDF DIABETES ATLAS, V6th; Iqbal K, 2013, J ALZHEIMERS DIS, V37, P469, DOI 10.3233/JAD-130827; Iqbal K, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P219; Ishizaki T, 2006, ARCH GERONTOL GERIAT, V42, P47, DOI 10.1016/j.archger.2005.06.001; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2014, EUR ARCH PSY CLIN N, V264, pS3, DOI 10.1007/s00406-014-0539-z; Jessen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016852; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P1, DOI 10.1016/j.jalz.2013.01.012; Jiang T, 2013, MOL NEUROBIOL, V48, P180, DOI 10.1007/s12035-013-8424-8; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Joas E, 2012, HYPERTENSION, V59, P796, DOI 10.1161/HYPERTENSIONAHA.111.182204; Johnell K, 2008, DRUG AGING, V25, P871, DOI 10.2165/00002512-200825100-00006; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Jonsson L., 2003, THESIS KAROLINSKA I; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jorm AF, 2005, AUST NZ J PSYCHIAT, V39, P959, DOI 10.1111/j.1440-1614.2005.01713.x; Joshi A, 2012, J NEUROL, V259, P2182, DOI 10.1007/s00415-012-6481-y; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Karlawish J, 2008, AM J GERIAT PSYCHIAT, V16, P568, DOI 10.1097/JGP.0b013e318172b406; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; Kendall J., 2006, NONPROFIT SECTOR RES, P415; Kiejna A, 2011, INT J GERIATR PSYCH, V26, P111, DOI 10.1002/gps.2511; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kivipelto M, 2013, ALZHEIMERS DEMENT, V9, P657, DOI 10.1016/j.jalz.2012.09.012; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Knapp M, 1999, POLICY POLIT, V27, P25, DOI 10.1332/030557399782019589; Knapp M, 2006, BRIT J PSYCHIAT, V188, P574, DOI 10.1192/bjp.bp.105.010561; Knapp M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6342; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Knowles J, 2006, CORE EVID, V1, P195; Konig HH, 2014, J AM MED DIR ASSOC, V15, P117, DOI 10.1016/j.jamda.2013.10.003; Kolanowski A, 2011, J AM GERIATR SOC, V59, P1032, DOI 10.1111/j.1532-5415.2011.03449.x; Kolanowski Ann, 2006, Am J Alzheimers Dis Other Demen, V21, P15, DOI 10.1177/153331750602100109; Kovacs GG, 2008, DEMENT GERIATR COGN, V26, P343, DOI 10.1159/000161560; Krafts K, 2012, PARASITOL RES, V111, P1, DOI 10.1007/s00436-012-2886-x; Kryscio RJ, 2014, JAMA NEUROL, V71, P947, DOI 10.1001/jamaneurol.2014.1120; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Lambert JC, 2015, NATURE, V520, pE1, DOI 10.1038/nature14036; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lambert MA, 2014, EUR J NEUROL, V21, P563, DOI 10.1111/ene.12325; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Launer LJ, 2010, HYPERTENSION, V55, P1352, DOI 10.1161/HYPERTENSIONAHA.109.147389; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Leinenbach A, 2014, CLIN CHEM, V60, P987, DOI 10.1373/clinchem.2013.220392; Lerner AJ, 2013, NEUROLOGY, V81, P1108, DOI 10.1212/WNL.0b013e3182a55fe3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li S, 2007, ACTA PSYCHIAT SCAND, V115, P73, DOI 10.1111/j.1600-0447.2006.00859.x; Teixeira CVL, 2012, ARCH GERONTOL GERIAT, V54, P175, DOI 10.1016/j.archger.2011.02.014; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Llibre R., 2008, LANCET, V372, P464, DOI DOI 10.1016/S0140-6736(08)61002-8; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; Logsdon Rebecca G, 2007, Alzheimers care today, V8, P309; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; LUC G, 1994, ARTERIOSCLER THROMB, V14, P1412, DOI 10.1161/01.ATV.14.9.1412; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Malinowsky C, 2014, SCAND J OCCUP THER, V21, P199, DOI 10.3109/11038128.2013.847119; Manelli AM, 2007, NEUROBIOL AGING, V28, P1139, DOI 10.1016/j.neurobiolaging.2006.05.024; Manton K C, 2005, Adv Gerontol, V16, P30; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mariani E, 2008, INT J GERIATR PSYCH, V23, P523, DOI 10.1002/gps.1932; Marin D, 2003, INT PSYCHOGERIATR, V15, P385, DOI 10.1017/S1041610203009633; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Matsuda O, 2010, PSYCHOGERIATRICS, V10, P167, DOI 10.1111/j.1479-8301.2010.00335.x; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGough EL, 2011, PHYS THER, V91, P1198, DOI 10.2522/ptj.20100372; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Medina M, 2014, BIOCHEM PHARMACOL, V88, P540, DOI 10.1016/j.bcp.2014.01.013; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Melis RJF, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61870-9; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Menne HL, 2014, J GERONTOL SOC WORK, V57, P626, DOI 10.1080/01634372.2013.870276; Menzel PT, 2013, J LAW MED ETHICS, V41, P484, DOI 10.1111/jlme.12057; Middleton LE, 2011, NEUROLOGY, V77, P1737, DOI 10.1212/WNL.0b013e318236f0cf; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Millan-Calenti JC, 2012, ARCH GERONTOL GERIAT, V54, P197, DOI 10.1016/j.archger.2011.02.010; Miller G, 2012, SCIENCE, V337, P790, DOI 10.1126/science.337.6096.790; Misiak B, 2013, INT J GERIATR PSYCH, V28, P1211, DOI 10.1002/gps.3948; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Molinuevo D, 2008, SERV OLD PEOPL EUR F; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Mordor Intelligence, GLOB ALZH DIAGN DRUG; Morimoto BH, 2013, DEMENT GERIATR COGN, V35, P325, DOI 10.1159/000348347; Mormont E, 2014, J GERIATR PSYCH NEUR, V27, P231, DOI 10.1177/0891988714532021; Morris JC, 2014, J INTERN MED, V275, P204, DOI 10.1111/joim.12199; Morris John C, 2012, Clin Investig (Lond), V2, P975; Mulhern B, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17050; Murphy K, 2007, J CLIN NURS, V16, P2167, DOI 10.1111/j.1365-2702.2006.01865.x; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Nagamatsu Lindsay S, 2013, J Aging Res, V2013, P861893, DOI 10.1155/2013/861893; Naisbitt J, 1982, MEGATRENDS 10 NEW DI, P123; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Neumann PJ, 1999, MED CARE, V37, P27, DOI 10.1097/00005650-199901000-00005; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nordstrom P, 2013, JAMA INTERN MED, V173, P1612, DOI 10.1001/jamainternmed.2013.9079; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Octave JN, 2013, J NEUROCHEM, V126, P183, DOI 10.1111/jnc.12239; OECD, 2015, GLOB ACT DRIV INN AL; OECD, 2015, DEM RES CAR CAN BIG; OECD, 2015, ENH TRANSL RES CLIN; Olafsdottir M, 2001, SCAND J PRIM HEALTH, V19, P194, DOI 10.1080/028134301316982469; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Orrell M, 2005, INT J GERIATR PSYCH, V20, P446, DOI 10.1002/gps.1304; Ossenkoppele R, 2015, JAMA-J AM MED ASSOC, V313, P1939, DOI 10.1001/jama.2015.4669; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Panegyres Peter K, 2007, Am J Alzheimers Dis Other Demen, V22, P48, DOI 10.1177/1533317506295887; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Panza F, 2012, IMMUNOTHERAPY-UK, V4, P213, DOI [10.2217/IMT.11.170, 10.2217/imt.11.170]; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pennisi E, 2007, SCIENCE, V318, P1842, DOI 10.1126/science.318.5858.1842; Pepersack T, 2008, Rev Med Brux, V29, P89; Perales J, 2013, INT PSYCHOGERIATR, V25, P691, DOI 10.1017/S1041610212002293; Peskind ER, 2005, ALZ DIS ASSOC DIS, V19, P220, DOI 10.1097/01.wad.0000194014.43575.fd; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Prince, 2011, WORLD ALZHEIMER REPO; Prince M., 2015, WORLD ALZHEIMER REPO; Prince M., 2013, WORLD ALZHEIMER REPO; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Prince MJ, 2013, LANCET, V381, P1967, DOI 10.1016/S0140-6736(13)60770-9; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Qiu CX, 2012, J ALZHEIMERS DIS, V32, P721, DOI 10.3233/JAD-2012-120922; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Rabins PV, 2014, GUID WATCH OCTOBER 2; Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; Richard E, 2012, J NEUROL SCI, V322, P64, DOI 10.1016/j.jns.2012.06.012; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Ringman JM, 2005, J GERIATR PSYCH NEUR, V18, P228, DOI 10.1177/0891988705281878; Rizzuto D, 2012, CURR ALZHEIMER RES, V9, P795, DOI 10.2174/156720512802455421; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Roberts JS, 2011, CLIN GENET, V80, P407, DOI 10.1111/j.1399-0004.2011.01739.x; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Rockwood K, 2006, CAN MED ASSOC J, V174, P1099, DOI 10.1503/cmaj.051432; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Rodriguez-Vieitez E, 2016, BRAIN, V139, P922, DOI 10.1093/brain/awv404; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rurup ML, 2006, SOC SCI MED, V62, P1552, DOI 10.1016/j.socscimed.2005.08.010; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Sano M, 2006, ALZ DIS ASSOC DIS, V20, pS191; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheef L, 2012, NEUROLOGY, V79, P1332, DOI 10.1212/WNL.0b013e31826c1a8d; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Scholl M, 2011, NEUROBIOL AGING, V32, P1388, DOI 10.1016/j.neurobiolaging.2009.08.016; Scholzel-Dorenbos CJM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-118; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schurks M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5702; Schwarzkopf L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-2; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheffield KM, 2011, AM J EPIDEMIOL, V174, P274, DOI 10.1093/aje/kwr074; Shen Y, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-21; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Sikkes SAM, 2013, NEUROEPIDEMIOLOGY, V41, P35, DOI 10.1159/000346277; Sikkes SAM, 2012, ALZHEIMERS DEMENT, V8, P536, DOI 10.1016/j.jalz.2011.08.006; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Skoldunger A, 2013, CURR ALZHEIMER RES, V10, P207, DOI 10.2174/1567205011310020011; Smit D, 2014, INT PSYCHOGERIATR, V26, P69, DOI 10.1017/S1041610213001397; Smith AD, 2014, J ALZHEIMERS DIS, V38, P699, DOI 10.3233/JAD-132372; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Spector A., 2006, MAKING DIFFERENCE EV; Spector A, 2012, DEMENT GERIATR COGN, V34, P244, DOI 10.1159/000343931; Spector A, 2011, AGING MENT HEALTH, V15, P945, DOI 10.1080/13607863.2011.586622; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stephan BCM, 2012, ALZ DIS ASSOC DIS, V26, P205, DOI 10.1097/WAD.0b013e31822fc24d; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Stewart R, 2007, ARCH NEUROL-CHICAGO, V64, P103, DOI 10.1001/archneur.64.1.103; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Stolt R, 2011, SOC SCI MED, V72, P560, DOI 10.1016/j.socscimed.2010.11.012; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Strozyk D, 2010, NEUROBIOL AGING, V31, P1710, DOI 10.1016/j.neurobiolaging.2008.09.011; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Suh GH, 2009, INT PSYCHOGERIATR, V21, P1116, DOI 10.1017/S104161020999086X; Swedish Agency for Health Technology Assessment and Assessment of Social Services, 2008, DEM SYST REV; Tabaton M, 2010, EXP NEUROL, V221, P18, DOI 10.1016/j.expneurol.2009.09.002; Terai K, 1997, BRAIN RES, V769, P385, DOI 10.1016/S0006-8993(97)00849-4; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Testad I, 2014, INT PSYCHOGERIATR, V26, P1083, DOI 10.1017/S1041610214000131; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tschanz JT, 2011, AM J GERIAT PSYCHIAT, V19, P532, DOI 10.1097/JGP.0b013e3181faec23; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; WHO, WHO METH DAT SOURC G; WHO, 2015, 1 WHO MIN C GLOB ACT; World Economic Forum, 2011, GLOBAL EC BURDEN NON; World Health Organization, 2012, DEM PUBL HLTH PRIOR; World Health Organization, 1992, ICD 10 INT STAT CLAS; World Health Organization, WHO HLTH STAT INF SY; van den Berg B, 2006, HEALTH ECON, V15, P447, DOI 10.1002/hec.1075; van Harten AC, 2013, ALZHEIMERS DEMENT, V9, P481, DOI 10.1016/j.jalz.2012.08.004; Varela S, 2012, CLIN REHABIL, V26, P442, DOI 10.1177/0269215511425835; Verbeek H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-68; Vestling M, 1999, BBA-MOL BASIS DIS, V1453, P341, DOI 10.1016/S0925-4439(99)00003-4; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Vogel A, 2012, INT PSYCHOGERIATR, V24, P82, DOI 10.1017/S1041610211001128; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang J, 2013, AGEING RES REV, V12, P1024, DOI 10.1016/j.arr.2013.05.003; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Watson R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g223; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; Whalley LJ, 2012, NEUROIMAG CLIN N AM, V22, P1, DOI 10.1016/j.nic.2011.11.002; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Wiberg P, 2013, PSYCHOL MED, V43, P2627, DOI 10.1017/S0033291713000299; Wilberforce M, 2011, SOC POLICY ADMIN, V45, P593, DOI 10.1111/j.1467-9515.2011.00788.x; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Wilhelm EE, 2014, JAMA-J AM MED ASSOC, V311, P1201, DOI 10.1001/jama.2014.850; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; WIMO A, 1994, HEALTH ECON, V3, P395, DOI 10.1002/hec.4730030607; Wimo A, 2014, J INTERN MED, V275, P304, DOI 10.1111/joim.12167; Wimo A, 2011, INT J GERIATR PSYCH, V26, P825, DOI 10.1002/gps.2610; Wimo A, 2004, CURR MED RES OPIN, V20, P1221, DOI 10.1185/030079902125004349; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2000, INT J GERIATR PSYCH, V15, P969, DOI 10.1002/1099-1166(200010)15:10<969::AID-GPS272>3.0.CO;2-9; Wimo A, 2010, WORLD ALZHEIMER REPO; Wimo A, 2014, DEMENSSJUKDOMARNAS S; Wimo A, 1998, HLTH EC DEMENTIA, P465; Wimo Anders, 1993, Scandinavian Journal of Primary Health Care, V11, P117, DOI 10.3109/02813439308994913; Wimo A, 2013, INT J GERIATR PSYCH, V28, P1039, DOI 10.1002/gps.3925; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P429, DOI 10.1016/j.jalz.2012.06.008; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wisniewski T, 2015, NEURON, V85, P1162, DOI 10.1016/j.neuron.2014.12.064; Wright CF, 2010, HUM GENET, V127, P125, DOI 10.1007/s00439-009-0767-x; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7; Wu YT, 2014, INT J GERIATR PSYCH, V29, P1212, DOI 10.1002/gps.4148; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yao ZX, 2002, FASEB J, V16, P1677, DOI 10.1096/fj.02-0285fje; Yu Ruby, 2012, Int J Alzheimers Dis, V2012, P406852, DOI 10.1155/2012/406852; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033; Zhang YL, 2011, J ALZHEIMERS DIS, V26, P735, DOI 10.3233/JAD-2011-110065; Zimmerman S, 2005, GERONTOLOGIST, V45, P133, DOI 10.1093/geront/45.suppl_1.133; Zingmark K, 2002, J ADV NURS, V38, P50, DOI 10.1046/j.1365-2648.2002.02145.x; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	554	679	698	13	215	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2016	15	5					455	532		10.1016/S1474-4422(16)00062-4			78	Clinical Neurology	Neurosciences & Neurology	DG8IU	WOS:000372328100003	26987701		Y	N	2021-06-18	
J	Kraus, MF; Susmaras, T; Caughlin, BP; Walker, CJ; Sweeney, JA; Little, DM				Kraus, Marilyn F.; Susmaras, Teresa; Caughlin, Benjamin P.; Walker, Corey J.; Sweeney, John A.; Little, Deborah M.			White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study	BRAIN			English	Article						traumatic brain injury; diffusion tensor imaging; white matter fibre tracts; fractional anisotropy; diffuse axonal injury; MRI	MILD HEAD-INJURY; AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; CONCUSSION; RECOVERY; DAMAGE; MRI; DYSMYELINATION; ABNORMALITIES; EPIDEMIOLOGY	Traumatic brain injury (TBI) is a serious public health problem. Even injuries classified as mild, the most common, can result in persistent neurobehavioural impairment. Diffuse axonal injury is a common finding after TBI, and is presumed to contribute to outcomes, but may not always be apparent using standard neuroimaging. Diffusion tensor imaging (DTI) is a more recent method of assessing axonal integrity in vivo. The primary objective of the current investigation was to characterize white matter integrity utilizing DTI across the spectrum of chronic TBI of all severities. A secondary objective was to examine the relationship between white matter integrity and cognition. Twenty mild, 17 moderate to severe TBI and 18 controls underwent DTI and neuropsychological testing. Fractional anisotropy, axial diffusivity and radial diffusivity were calculated from the DTI data. Fractional anisotropy was the primary measure of white matter integrity. Region of interest analysis included anterior and posterior corona radiata, cortico-spinal tracts, cingulum fibre bundles, external capsule, forceps minor and major, genu, body and splenium of the corpus callosum, inferior fronto-occipital fasciculus, superior longitudinal fasciculus and sagittal stratum. Cognitive domain scores were calculated from executive, attention and memory testing. Decreased fractional anisotropy was found in all 13 regions of interest for the moderate to severe TBI group, but only in the cortico-spinal tract, sagittal stratum and superior longitudinal fasciculus for the mild TBI group. White Matter Load (a measure of the total number of regions with reduced FA) was negatively correlated with all cognitive domains. Analysis of radial and axial diffusivity values suggested that all severities of TBI can result in a degree of axonal damage, while irreversible myelin damage was only apparent for moderate to severe TBI. The present data emphasize that white matter changes exist on a spectrum, including mild TBI. An index of global white matter neuropathology (White Matter Load) was related to cognitive function, such that greater white matter pathology predicted greater cognitive deficits. Mechanistically, mild TBI white matter changes may be primarily due to axonal damage as opposed to myelin damage. The more severe injuries impact both. DTI provides an objective means for determining the relationship of cognitive deficits to TBI, even in cases where the injury was sustained years prior to the evaluation.	Univ Illinois, Coll Med, Ctr Cognit Med, Dept Psychiat, Chicago, IL 60607 USA; Univ Illinois, Med Ctr, Dept Psychiat, Chicago, IL USA; Univ Illinois, Med Ctr, Dept Neurol, Chicago, IL USA; Univ Illinois, Med Ctr, Dept Psychol, Chicago, IL USA; Univ Illinois, Med Ctr, Dept Bioengn, Chicago, IL USA; Univ Illinois, Dept Anat, Chicago, IL USA; Univ Illinois, Med Ctr, Dept Ophthalmol, Chicago, IL USA; Univ Illinois, Med Ctr, Ctr Cognit Med, Chicago, IL USA; Univ Illinois, Med Ctr, Ctr Stroke Res, Chicago, IL USA; Wayne State Univ, Sch Med, Detroit, MI USA	Kraus, MF (corresponding author), Univ Illinois, Coll Med, Ctr Cognit Med, Dept Psychiat, 912 S Wood St, Chicago, IL 60607 USA.	mkraus@psych.uic.edu	Kennedy, Kristen M/B-4699-2008; Lang, Steven/AAE-8102-2021	Kennedy, Kristen M/0000-0001-5373-9026; Lang, Steven/0000-0003-1669-9146	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH068787] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH068787] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A, 1989, MULTILINGUAL APHASIA; BENTON A, 1976, MULTILIGUAL APHASIA; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control, 2001, TRAUM BRAIN INJ US R; CONNERS D, 2000, CONNERS CONTINOUS PE; Culbertson W. C., 2001, TOWER LONDON DREXEL; Delis DC, 2000, ADULT VERSION MANUAL; GEDDES J, 1997, NEUROPATHOL APPL NEU, P50; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Golden CJ, 2002, STROOP COLOR WORD TE; GOODMAN JC, 1994, SEMIN NEUROL, V14, P19, DOI 10.1055/s-2008-1041054; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 1989, MILD MODERATE HEAD I, P63; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; KLOVE H, 1964, CLIN NEUROPSYCHOLOGY; KURCA E, 2006, NEURORADIOLOGY, P48; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MATTEWS C, 1964, INSTRUCTION MANUAL A; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MIRANDA M, IN PRESS J ATTEN DIS; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; POVLISHOCK J, 1983, J NEUROPATHOL EXPER, P42; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PSYCHOLOGICAL C, 2001, WECHSLER TEST ADULT; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RUFF R, 1988, PROFESSIONAL MANUAL; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tisserand DJ, 2006, BRAIN COGNITION, V60, P216; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wechsler D, 1997, WMS 3 ADM SCORING MA; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	72	671	686	3	127	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2007	130		10				2508	2519		10.1093/brain/awm216			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	218UC	WOS:000250039500005	17872928	Bronze			2021-06-18	
J							Alzheimers Assoc	2012 Alzheimer's disease facts and figures	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease Dementia; Diagnostic criteria; Prevalence; Incidence; Mortality; Caregivers; Family caregiver; Spouse caregiver; Health care costs; Health care expenditures; Long-term care costs; Hospice care costs; Medicare spending; Medicaid spending; Live alone; Living arrangements; Unmet needs	MILD COGNITIVE IMPAIRMENT; NURSING-HOME PLACEMENT; TRAUMATIC BRAIN-INJURY; VASCULAR RISK-FACTORS; NEUROPSYCHIATRIC SYMPTOMS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PRIMARY-CARE; DEPRESSIVE SYMPTOMS	This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD). Topics addressed include incidence, prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society. The report also explores issues that arise when people with AD and other dementias live alone. The characteristics, risks, and unmet needs of this population are described. An estimated 5.4 million Americans have AD, including approximately 200,000 age <65 years who comprise the younger-onset AD population. Over the coming decades, the aging of the baby boom generation is projected to result in an additional 10 million people with AD. Today, someone in America develops AD every 68 seconds. By 2050, there is expected to be one new case of AD every 33 seconds, or nearly a million new cases per year, and AD prevalence is projected to be 11 million to 16 million. Dramatic increases in the number of "oldest-old" (those age >= 85 years) across all racial and ethnic groups are expected to contribute to the increased prevalence of AD. AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age >= 65 years. Although the proportions of deaths due to other major causes of death have decreased in the last several years, the proportion due to AD has risen significantly. Between 2000 and 2008, the proportion of deaths due to heart disease, stroke, and prostate cancer decreased by 13%, 20%, and 8%, respectively, whereas the proportion due to AD increased by 66%. In 2011, more than 15 million family members and other unpaid caregivers provided an estimated 17.4 billion hours of care to people with AD and other dementias, a contribution valued at more than $210 billion. Medicare payments for services to beneficiaries age >= 65 years with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great. In 2012, payments for health care, long-term care, and hospice services for people age >= 65 years with AD and other dementias are expected to be $200 billion (not including the contributions of unpaid caregivers). An estimated 800,000 people with AD (one in seven) live alone, and up to half of them do not have an identifiable caregiver. People with dementia who live alone are exposed to risks that exceed the risks encountered by people with dementia who live with others, including inadequate self-care, malnutrition, untreated medical conditions, falls, wandering from home unattended, and accidental deaths. (C) 2012 The Alzheimer's Association. All rights reserved.				MUNOZ, ROSA ANA/H-3964-2018	MUNOZ, ROSA ANA/0000-0002-7504-2163			Aguero-Torres H, 1999, J CLIN EPIDEMIOL, V52, P737, DOI 10.1016/S0895-4356(99)00067-0; Al-Aama T, 2011, CAN FAM PHYSICIAN, V57, P771; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, STAG ALZH DIS; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; American Association for Long-Term Care Insurance, 2011, SOURC LONG TERM CAR; American Health Care Association, 2011, LTC STATS NURS FAC O; American Health Care Association, 2004, NURS FAC BEDS DED SP; American Health Care Association, 2011, NURS FAC PAT CHAR RE; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2000, TABULATIONS DE UNPUB; [Anonymous], 1998, NAT CTR ELD AB AM PU; [Anonymous], 2002, NAT STUD AD DAY SERV; [Anonymous], 2010, MED FACT SHEET PRESC; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Barnes LL, 2003, NEUROLOGY, V60, P1777, DOI 10.1212/01.WNL.0000065892.67099.2A; Bouldin ED, 2010, CAREGIVING US CAREGI; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Brayne C, 2007, JAMA-J AM MED ASSOC, V298, P2409, DOI 10.1001/jama.298.20.2409; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Buhr GT, 2006, GERONTOLOGIST, V46, P52, DOI 10.1093/geront/46.1.52; BURNS A, 1990, AGE AGEING, V19, P341, DOI 10.1093/ageing/19.5.341; BUTLER R, 1995, ADAPTATIONS AGING, P289; Bynum J., 2011, TABULATIONS BA UNPUB; Caplan C, 2004, OUT OF POCKET SPENDI; *CDCP MERCK CO FDN, 2007, STAT AG HLTH AM 2007; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SUURV; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Clark PC, 2005, J AM GERIATR SOC, V53, P2012, DOI 10.1111/j.1532-5415.2005.53569.x; Cooney LM, 2004, ARCH INTERN MED, V164, P357, DOI 10.1001/archinte.164.4.357; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dilworth-Anderson P, 2008, ALZHEIMERS DEMENT, V4, P305, DOI 10.1016/j.jalz.2008.03.001; Ebly EM, 1999, DEMENT GERIATR COGN, V10, P541, DOI 10.1159/000017202; Edwards D. F, 2007, DEMENTIA, V6, P489, DOI [10.1177/1471301207084367, DOI 10.1177/1471301207084367]; Elder AT, 1996, AGE AGEING, V25, P214, DOI 10.1093/ageing/25.3.214; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Federal Interagency Forum on Aging Related Statistics, 2010, OLD AM 2010 KEY IND; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Fitten LJ, 2001, J AM GERIATR SOC, V49, P1301, DOI 10.1046/j.1532-5415.2001.49257.x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fortinsky RH, 2004, GERONTOLOGIST, V44, P739, DOI 10.1093/geront/44.6.739; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fredman L, 2006, PREV MED, V43, P226, DOI 10.1016/j.ypmed.2006.04.009; Fredman L, 2010, J AM GERIATR SOC, V58, P937, DOI 10.1111/j.1532-5415.2010.02808.x; Fredman L, 2010, J GERONTOL A-BIOL, V65, P565, DOI 10.1093/gerona/glq025; Freedman VA, 1996, J GERONTOL B-PSYCHOL, V51, pS61, DOI 10.1093/geronb/51B.2.S61; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Gaugler JE, 2008, J AM GERIATR SOC, V56, P421, DOI 10.1111/j.1532-5415.2007.01593.x; Geda YE, 2008, ARCH GEN PSYCHIAT, V65, P1193, DOI 10.1001/archpsyc.65.10.1193; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Gould E, 2010, PROVIDING SERVICES P; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Grossberg GT, 2010, PRIM CARE COMPANION, V12; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Harris P. B., 2006, ALZHEIMERS CARE Q, V7, P84; Hebert LE, 2004, NEUROLOGY, V62, P1645, DOI 10.1212/01.WNL.0000123018.01306.10; Hebert LE, 2001, AM J EPIDEMIOL, V153, P132, DOI 10.1093/aje/153.2.132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Hooker K, 2002, J GERONTOL B-PSYCHOL, V57, pP453, DOI 10.1093/geronb/57.5.P453; Institute for Social Research, 2009, NAT FOOTB LEAG PLAYE; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jellinger KA, 2007, ALZHEIMERS DEMENT, V3, P40, DOI 10.1016/j.jalz.2006.09.002; Johnson R. W., 2006, PROFILE FRAIL OLDER; Juster FT, 1995, J HUM RESOUR, V30, pS135; Kaiser Commission on Medicaid and the Uninsured, 2010, MED LONG TERM CAR SE; Kaiser Family Foundation Program on Medicare Policy, 2011, PROJ INC ASS WHAT MI; Katzman R, 1996, NEUROLOGY, V46, P889; Kibayashi K, 2007, AM J FOREN MED PATH, V28, P73, DOI 10.1097/01.paf.0000257428.80088.94; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Knight Alzheimer's Disease Research Center, CLIN DEM RAT CDR TAB; Knight Alzheimer's Disease Research Center, ASS CDR RAT; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Larsson K, 2004, J AGING HEALTH, V16, P641, DOI 10.1177/0898264304268586; Lauder W, 1999, J CLIN NURS, V8, P95, DOI 10.1046/j.1365-2702.1999.00231.x; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lee CC, 2010, J GERONTOL B-PSYCHOL, V65, P185, DOI 10.1093/geronb/gbp131; Lehmann SW, 2010, INT PSYCHOGERIATR, V22, P778, DOI 10.1017/S1041610209991529; Livingston G, 1997, BRIT J PSYCHIAT, V171, P56, DOI 10.1192/bjp.171.1.56; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; MACERA CA, 1992, J AM GERIATR SOC, V40, P479, DOI 10.1111/j.1532-5415.1992.tb02015.x; Mahoney Diane Feeney, 2003, J Gerontol Nurs, V29, P24; Manly J, 2004, CRITICAL PERSPECTIVE, P95; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Mausbach BT, 2010, J AM COLL CARDIOL, V55, P2599, DOI 10.1016/j.jacc.2009.11.093; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meaney AM, 2005, INT J GERIATR PSYCH, V20, P322, DOI 10.1002/gps.1284; MetLife Mature Market Institute, 2011, MARK SURV LONG TERM; MetLife Mature Market Institute and LifePlans Inc, 2006, METLIFE STUD ALZH DI; Michel JP, 2001, AGING CLIN EXP RES, V13, P255, DOI 10.1007/BF03351484; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Minino AM, 2011, DEATHS FINAL DATA 20; Miranda-Castillo C, 2010, INT PSYCHOGERIATR, V22, P607, DOI 10.1017/S104161021000013X; Mitchell G, 2006, GERONTOLOGIST, V46, P483, DOI 10.1093/geront/46.4.483; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Monin JK, 2009, PSYCHOL AGING, V24, P681, DOI 10.1037/a0016355; *NAT CTR HLTH STAT, 2002, NAT VIT STAT REP; National Alliance for Caregiving, 2011, WHAT MAD YOU THINK M; National Alliance for Caregiving and AARP, 2009, CAR US UNPUB; National Association of Area Agencies on Aging, 2011, MAT AM COMM MOV FORW; Nelson T, 2004, PSYCHOL MED, V34, P147, DOI 10.1017/S0033291703008808; Nelson T, 2002, AGE AGEING, V31, P445, DOI 10.1093/ageing/31.6.445; Neuman P, 2007, HEALTH AFFAIR, V26, P1692, DOI 10.1377/hlthaff.26.6.1692; Newhouse B. J., 2001, ALZHEIMERS CARE Q, V2, P53; Nourhashemi F, 2005, J NUTR HEALTH AGING, V9, P117; OKEEFFE J, 2006, ADULT DAY SERVICES K; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; OLICHNEY JM, 1995, J AM GERIATR SOC, V43, P890, DOI 10.1111/j.1532-5415.1995.tb05532.x; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polidori MC, 2009, J ALZHEIMERS DIS, V17, P921, DOI 10.3233/JAD-2009-1114; Porell F., 2009, ANAL MEDICARE DATA U; Port CL, 2005, GERONTOLOGIST, V45, P87, DOI 10.1093/geront/45.suppl_1.87; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Prescop K L, 1999, Int Psychogeriatr, V11, P235, DOI 10.1017/S1041610299005803; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rocca WA, 1998, AM J EPIDEMIOL, V148, P51, DOI 10.1093/oxfordjournals.aje.a009560; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Rowe M A, 2001, Am J Alzheimers Dis Other Demen, V16, P344, DOI 10.1177/153331750101600610; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schneider J, 2002, AGING MENT HEALTH, V6, P255, DOI 10.1080/13607860220142486; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; SCHULZ R, 2002, GERONTECHNOLOGY, V2, P15, DOI DOI 10.4017/GT.2002.02.01.003.00; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shaw FE, 1998, AGE AGEING, V27, P7, DOI 10.1093/ageing/27.1.7; Shaw WS, 1999, J PSYCHOSOM RES, V46, P215, DOI 10.1016/S0022-3999(98)00084-1; Shriver M, 2010, SHRIVER REPORT WOMAN; Sibley A, 2002, DEMENT GERIATR COGN, V13, P40, DOI 10.1159/000048632; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Soniat BA, 2004, J AM GERIATR SOC, V52, P1576, DOI 10.1111/j.1532-5415.2004.52427.x; Soniat BA, 1993, DIN GERONTOL, V14, P33; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Steinberg M, 2003, J NEUROPSYCH CLIN N, V15, P340, DOI 10.1176/appi.neuropsych.15.3.340; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Taylor DH, 2008, J AM GERIATR SOC, V56, P322, DOI 10.1111/j.1532-5415.2007.01558.x; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tierney MC, 2007, AM J GERIAT PSYCHIAT, V15, P140, DOI 10.1097/01.JGP.0000230661.32735.c0; Tierney MC, 2004, J AM GERIATR SOC, V52, P1435, DOI 10.1111/j.0002-8614.2004.52404.x; Tuokko H, 1999, AGING MENT HEALTH, V3, P21, DOI 10.1080/13607869956406; U.S. Census Bureau, 2011, TABL A2 FAM STAT HOU; U.S. Census Bureau, 2010, US POP PROJ NAT POP; U.S. Congressional Office of Technology Assessment, 1990, OTA13A403; U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services, 2010, NURS HOM DAT COMP; US Census Bureau, 2005, CURR POP REP SPEC ST; US Department of Health & Human Services, 2011 HHS POV GUID ON; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; von Kanel R, 2006, J GERONTOL A-BIOL, V61, P963, DOI 10.1093/gerona/61.9.963; Wachterman M, 2008, JAMA-J AM MED ASSOC, V300, P2608, DOI 10.1001/jama.2008.768; WEBBER PA, 1994, GERONTOLOGIST, V34, P8, DOI 10.1093/geront/34.1.8; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Wilkins CH, 2007, J AM GERIATR SOC, V55, P1771, DOI 10.1111/j.1532-5415.2007.01417.x; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yaffe K, 2011, NEUROLOGY, V77, P1351, DOI 10.1212/WNL.0b013e3182315a56; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/156720507780362191; Zhu CW, 2006, J AM GERIATR SOC, V54, P1596, DOI 10.1111/j.1532-5415.2006.00871.x	214	669	686	5	109	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2012	8	2					131	168		10.1016/j.jalz.2012.02.001			38	Clinical Neurology	Neurosciences & Neurology	914ZE	WOS:000301991600006	22404854		Y	N	2021-06-18	
J	Bell, RD; Winkler, EA; Singh, I; Sagare, AP; Deane, R; Wu, ZH; Holtzman, DM; Betsholtz, C; Armulik, A; Sallstrom, J; Berk, BC; Zlokovic, BV				Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Holtzman, David M.; Betsholtz, Christer; Armulik, Annika; Sallstrom, Jan; Berk, Bradford C.; Zlokovic, Berislav V.			Apolipoprotein E controls cerebrovascular integrity via cyclophilin A	NATURE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; APOE; DEMENTIA; PROTEIN; MICE; NEURODEGENERATION; EXPRESSION	Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4(1). APOE4 is a major genetic risk factor for Alzheimer's disease(2,3) and is associated with Down's syndrome dementia and poor neurological outcome after traumatic brain injury and haemorrhage(3). Neurovascular dysfunction is present in normal APOE4 carriers(4-6) and individuals with APOE4-associated disorders(3,7-10). In mice, lack of Apoe leads to blood-brain barrier (BBB) breakdown(11,12), whereas APOE4 increases BBB susceptibility to injury(13). How APOE genotype affects brain microcirculation remains elusive. Using different APOE transgenic mice, including mice with ablation and/or inhibition of cyclophilin A (CypA), here we show that expression of APOE4 and lack of murine Apoe, but not APOE2 and APOE3, leads to BBB breakdown by activating a proinflammatory CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes. This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic proteins, and microvascular and cerebral blood flow reductions. We show that the vascular defects in Apoe-deficient and APOE4-expressing mice precede neuronal dysfunction and can initiate neurodegenerative changes. Astrocyte-secreted APOE3, but not APOE4, suppressed the CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes through a lipoprotein receptor. Our data suggest that CypA is a key target for treating APOE4-mediated neurovascular injury and the resulting neuronal dysfunction and degeneration.	[Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Sallstrom, Jan; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Bell, Robert D.; Berk, Bradford C.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, St Louis, MO 63110 USA; [Betsholtz, Christer; Armulik, Annika] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Armulik, Annika] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Ctr Neurodegenerat & Regenerat, Los Angeles, CA 90089 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	zlokovic@usc.edu	Sagare, Abhay/Y-3273-2019	Sagare, Abhay/0000-0002-8178-3785; Keller, Annika/0000-0003-1466-3633; Berk, Bradford/0000-0002-2767-4115	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37NS34467, R37AG23084, RO1AG039452, R37AG13956]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG023084, R01AG039452, R37AG013956, RF1AG039452] Funding Source: NIH RePORTER	We would like to thank the National Institute of Health for grants R37NS34467 (B.V.Z.); R37AG23084 (B.V.Z.); RO1AG039452 (B.V.Z.); and R37AG13956 (D. M. H.) used to support this study.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Garcia-Alloza M, 2009, J NEUROCHEM, V109, P1636, DOI 10.1111/j.1471-4159.2009.06096.x; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	30	663	685	5	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					512	516		10.1038/nature11087			5	Multidisciplinary Sciences	Science & Technology - Other Topics	946IH	WOS:000304344500045	22622580	Green Accepted	Y	N	2021-06-18	
J	Narayan, RK; Michel, ME				Narayan, RK; Michel, ME		The Clin Trials Head Injury Study	Clinical trials in head injury	JOURNAL OF NEUROTRAUMA			English	Article						clinical trials; head injury; intracranial pressure; outcome measures; traumatic brain injury; trial design; uniformed consent	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; RANDOMIZED CONTROLLED-TRIALS; ACUTE ISCHEMIC STROKE; MULTICENTER TRIAL; ANTAGONIST; DEXAMETHASONE; HU-211; NEUROPROTECTANT; HYDROPEROXIDES	Traumatic brain injury (TBI) remains a major public health problem globally. In the United States the incidence of closed head injuries admitted to hospitals is conservatively estimated to be 200 per 100,000 population, and the incidence of penetrating head injury is estimated to be 12 per 100,000, the highest of any developed country in the world. This yields an approximate number of 500,000 new cases each year, a sizeable proportion of which demonstrate signficant long-term disabilities. Unfortunately, there is a paucity of proven therapies for this disease. For a variety of reasons, clinical trials for this condition have been difficult to design and perform. Despite promising pre-clinical data, most of the trials that have been performed in recent years have failed to demonstrate any significant improvement in outcomes. The reasons for these failures have not always been apparent and any insights gained were not always shared. It was therefore feared that we were running the risk of repeating our mistakes. Recognizing the importance of TBI, the National Institute of Neurological Disorders and Stroke (NINDS) sponsored a workshop that brought together experts from clinical,, research, and pharmaceutical backgrounds. This workshop proved to be very informative and yielded many insights into previous and future TBI trials. This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research.	Temple Univ Hosp & Med Sch, Dept Neurosurg, Philadelphia, PA 19140 USA; Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; NIH NCMRR, Bethesda, MD USA; Univ Munich, Munich, Germany; Lawrence Berkeley Natl Lab, Berkeley, CA USA; Yale Univ, Sch Med, New Haven, CT USA; Virginia Commonwealth Univ, Richmond, VA USA; Univ Texas HSC, Houston, TX USA; Baylor Coll Med, Houston, TX USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Miami, Sch Med, Miami, FL USA; Brain Trauma Fdn, New York, NY USA; Hosp Univ Penn, Philadelphia, PA USA; Pfizer Global R&D, Ann Arbor, MI USA; NIH, NINDS, Bethesda, MD USA; Univ Calif Los Angeles, Los Angeles, CA USA; Temple Univ, Sch Med, Philadelphia, PA USA; Food & Drug Adv, Rockville, MD USA; Sheba Med Ctr, Tel Hashomer, Israel; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Acad Hosp, Rotterdam, Netherlands; Off Naval Res, Arlington, VA USA; Univ Calif San Diego, La Jolla, CA USA; Parke Davis Pharmaceut Res, Ann Arbor, MI USA; Univ Calif Davis, Med Ctr, Sacramento, CA USA; Univ Calif San Francisco, San Francisco, CA USA; Pharmos Corp, Iselin, NJ USA; Temple Univ, Sch Med, Philadelphia, PA USA; So Gen Hosp, Glasgow, Lanark, Scotland; Univ Washington, Seattle, WA USA; Allegheny Gen Hosp, Pittsburgh, PA USA; Univ Kentucky, Chandler Med Ctr, Lexington, KY USA; Pfizer Pharmaceut Inc, Groton, CT USA	Narayan, RK (corresponding author), Temple Univ Hosp & Med Sch, Dept Neurosurg, 3401 N Broad St, Philadelphia, PA 19140 USA.	Narayan@nimbus.temple.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Jallo, Jack/0000-0002-5512-1729; Whyte, John/0000-0002-4381-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS038654, R01 NS038654-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038654] Funding Source: NIH RePORTER		Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Choi SC, 2001, NEUROL RES, V23, P190, DOI 10.1179/016164101101198325; Choi SC, 1998, J NEUROTRAUM, V15, P771, DOI 10.1089/neu.1998.15.771; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; FAUPEL G, 1976, DYNAMICS BRAIN EDEMA, P337; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GIANNOTTA SL, 1984, NEUROSURGERY, V15, P497, DOI 10.1227/00006123-198410000-00004; Gobiet W, 1976, INTRACRANIAL PRESSUR, P231; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; GUDEMAN SK, 1979, J NEUROSURG, V51, P301, DOI 10.3171/jns.1979.51.3.0301; *GUID AUTH, 2000, J NEUROTRAUM, V17, P451; HALL ED, 1993, RES P ARNMD, V71, P81; Kontos H A, 1983, Physiologist, V26, P165; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; LAVIE G, 2000, AM SOC NEUR ABST, V30, P771; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Piantadosi S., 1997, CLIN TRIALS METHODOL; Polidori MC, 1998, FREE RADICAL BIO MED, V25, P561, DOI 10.1016/S0891-5849(98)00085-9; Polidori MC, 1997, FREE RADICAL BIO MED, V23, P762, DOI 10.1016/S0891-5849(97)00053-1; Sandercock P, 1997, LANCET, V349, P1569; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Whitehead J., 1997, DESIGN ANAL SEQUENTI; Whyte J, 1998, REHABILITATION MED P, P1191; Whyte J., 1997, PROMISE OUTCOMES RES, P43; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	50	648	663	1	32	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2002	19	5					503	557		10.1089/089771502753754037			55	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	557PA	WOS:000175915900001	12042091	Green Accepted			2021-06-18	
J	ALEXANDER, MP				ALEXANDER, MP			MILD TRAUMATIC BRAIN INJURY - PATHOPHYSIOLOGY, NATURAL-HISTORY, AND CLINICAL MANAGEMENT	NEUROLOGY			English	Article; Proceedings Paper	46th Annual Meeting of the American-Academy-of-Neurology	MAY 01-07, 1994	WASHINGTON, D.C.	Amer Acad Neurol			CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; CEREBRAL BLOOD-FLOW; BASAL GANGLIA HEMORRHAGE; COMPUTED-TOMOGRAPHY; FOLLOW-UP; TECHNETIUM-99M-HMPAO SPECT; BEHAVIORAL SEQUELAE; DEPRESSION; RECOVERY		BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA	ALEXANDER, MP (corresponding author), BRAINTREE REHABIL HOSP, STROKE REHABIL PROGRAM, 250 POND ST, BRAINTREE, MA 02185 USA.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Barth JT., 1989, MILD HEAD INJURY, P257; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Cicerone K. D., 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1989, MILD HEAD INJURY, P229; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; EAGGER S, 1992, J NEUROL NEUROSUR PS, V55, P383, DOI 10.1136/jnnp.55.5.383; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; EVANS RW, 1992, PHYSICAL MED REHAB C, V3, P427; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FUMEYA H, 1990, ACT NEUR S, V51, P283; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOETZ CG, 1991, ANN NEUROL, V29, P191, DOI 10.1002/ana.410290213; GRAY BG, 1992, J NUCL MED, V33, P52; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; HOLLNAGEL H, 1980, Ugeskrift for Laeger, V142, P3071; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; KELLY R, 1981, J ROY SOC MED, V74, P275; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRUPNICK JL, 1981, ARCH GEN PSYCHIAT, V38, P428; Kurtzke J. F., 1993, CLIN NEUROLOGY; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LIPSEY JR, 1984, LANCET, V1, P297; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Marshall LF, 1989, MILD HEAD INJURY, P276; MATHEW NT, 1993, NEUROLOGY S3, V43, pS6; MAZZUCCHI A, 1992, J NEUROL, V239, P256; McKinlay W W, 1992, Brain Inj, V6, P387, DOI 10.3109/02699059209008134; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PACKARD RC, 1994, SEMIN NEUROL, V14, P40, DOI 10.1055/s-2008-1041057; PARODI CI, 1992, J NEUROL NEUROSUR PS, V55, P72, DOI 10.1136/jnnp.55.1.72; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOK JT, 1986, J NEUROPATHOL EXP NE, V42, P225; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROPER SN, 1991, J NUCL MED, V32, P1684; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SCHOENHUBER R, 1988, J NEUROSURG, V68, P742, DOI 10.3171/jns.1988.68.5.0742; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TARSH MJ, 1985, BRIT J PSYCHIAT, V146, P18, DOI 10.1192/bjp.146.1.18; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WELLS CE, 1979, AM J PSYCHIAT, V136, P895; WHITLOCK FA, 1977, AUST NZ J PSYCHIAT, V11, P127, DOI 10.3109/00048677709159549; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	86	647	652	0	63	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL	1995	45	7					1253	1260		10.1212/WNL.45.7.1253			8	Clinical Neurology	Neurosciences & Neurology	RJ279	WOS:A1995RJ27900004	7617178				2021-06-18	
J	Roozenbeek, B; Maas, AIR; Menon, DK				Roozenbeek, Bob; Maas, Andrew I. R.; Menon, David K.			Changing patterns in the epidemiology of traumatic brain injury	NATURE REVIEWS NEUROLOGY			English	Article							NEUROSURGICAL TRAUMA; HEAD-INJURY; RECOMMENDATIONS; POPULATION; CONCUSSION; RECOVERY; MODERATE	Traumatic brain injury (TBI) is a critical public health and socio-economic problem throughout the world. Reliable quantification of the burden caused by TBI is difficult owing to inadequate standardization and incomplete capture of data on the incidence and outcome of brain injury, with variability in the definition of TBI being partly to blame. Reports show changes in epidemiological patterns of TBI: the median age of individuals who experience TBI is increasing, and falls have now surpassed road traffic incidents as the leading cause of this injury. Despite claims to the contrary, no clear decrease in TBI-related mortality or improvement of overall outcome has been observed over the past two decades. In this Perspectives article, we discuss the strengths and limitations of epidemiological studies, address the variability in its definition, and highlight changing epidemiological patterns. Taken together, these analyses identify a great need for standardized epidemiological monitoring in TBI. Roozenbeek, B. et al. Nat. Rev. Neurol. 9, 231-236 (2013); published online 26 February 2013; doi:10.1038/nrneurol.2013.22	[Roozenbeek, Bob] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp, Dept Neurosurg, Univ Antwerp Hosp, B-2650 Edegem, Belgium; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge CD2 2QQ, England	Maas, AIR (corresponding author), Univ Antwerp, Dept Neurosurg, Univ Antwerp Hosp, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS042691]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354, G1000183B, G0001354B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER	Part of this work was funded by NIH grant NS042691. The authors acknowledge with gratitude the input of V. De Keyser in preparing the manuscript.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Carroll C. P., 2012, NEUROSURGERY, V71, P164; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chesnut R, 2011, J NEUROTRAUM, V28, pA111; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Darnoux E., 2011, ANN PHYS REHABIL MED, V54, pe22; Dowling S., 2010, CJEM, V12, pa59; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Firsching R, 2001, WORLD J SURG, V25, P1221; Fleminger S, 2012, J NEUROL NEUROSUR PS, V83, P1036, DOI 10.1136/jnnp-2012-303015; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harrison D. A., HLTH TECHNO IN PRESS; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan B. D., NAT REV NEU IN PRESS; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maset A, 1993, ARQ BRAS NEUROCIRURG, V12, P293; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prichep L. S., J HEAD TRAUMA REHABI; Raja IA, 2001, WORLD J SURG, V25, P1230; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Servadei F, 2002, J Neurosurg Sci, V46, P111; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Yuh E., ANN NEUROL; Zetterberg H., NAT REV NEUROL; Zhao YD, 2001, WORLD J SURG, V25, P1202	55	646	671	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	APR	2013	9	4					231	236		10.1038/nrneurol.2013.22			6	Clinical Neurology	Neurosciences & Neurology	121TV	WOS:000317268100011	23443846		Y	N	2021-06-18	
J	Johnson, SC; Baxter, LC; Wilder, LS; Pipe, JG; Heiserman, JE; Prigatano, GP				Johnson, Sterling C.; Baxter, Leslie C.; Wilder, Lana S.; Pipe, James G.; Heiserman, Joseph E.; Prigatano, George P.			Neural correlates of self-reflection	BRAIN			English	Article						fMRI; medial prefrontal cortex; posterior cingulate; self-awareness; self-reflection	POSTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; MEMORY RETRIEVAL; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; MINDS; ACTIVATION; PEOPLE; DAMAGE; LOBE	The capacity to reflect on one's sense of self is an important component of self-awareness. In this paper, we investigate some of the neurocognitive processes underlying reflection on the self using functional MRI. Eleven healthy volunteers were scanned with echoplanar imaging using the blood oxygen level-dependent contrast method. The task consisted of aurally delivered statements requiring a yes-no decision. In the,:experimental condition, participants responded to a variety of statements requiring knowledge of and reflection on their own abilities, traits and attitudes (e.g. 'I forget important things', 'I'm a good friend', 'I have a quick temper'). In the control condition, participants responded to statements requiring a basic level of semantic knowledge (e.g. 'Ten seconds is more than a minute', 'You need water to live'). The latter condition was intended to control for auditory comprehension, attentional demands, decision-making, the motoric response, and any common retrieval processes. Individual analyses revealed consistent anterior medial prefrontal and posterior cingulate activation for all participants. The overall activity for the group, using a random-effects model, occurred in anterior medial prefrontal cortex (t = 13.0, corrected P = 0.05; x, y, z, 0, 54, 8, respectively) and the posterior cingulate (t = 14.7, P = 0.02; x, y, z, -2, -62, 32, respectively; 967 voxel extent). These data are consistent with lesion studies of impaired awareness, and suggest that the medial prefrontal and posterior cingulate cortex are part of a neural system subserving self-reflective thought.	St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ 85013 USA; St Josephs Hosp, Barrow Neurol Inst, Dept Magnet Resonance Imaging, Phoenix, AZ 85013 USA	Johnson, SC (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, 222 W Thomas Rd 315, Phoenix, AZ 85013 USA.	s2johns@chw.edu	Bruehl, Annette Beatrix/A-5272-2013	Bruehl, Annette Beatrix/0000-0003-4704-4986	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH065723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG018540] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG18540] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH65723] Funding Source: Medline		ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Cahill L, 2000, PROG BRAIN RES, V126, P29; Cahill L, 1997, ANN NY ACAD SCI, V821, P238, DOI 10.1111/j.1749-6632.1997.tb48283.x; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Duvernoy H, 1998, HUMAN HIPPOCAMPUS; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; KAGAN J, 1982, J CHILD PSYCHOL PSYC, V23, P363, DOI 10.1111/j.1469-7610.1982.tb00084.x; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; McGuire PK, 1996, NEUROREPORT, V7, P2095; Meares R, 1999, AM J PSYCHIAT, V156, P1850; Mesulam MM, 2000, PRINCIPLES BEHAV COG, P1; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Pihlajamaki M, 2000, ANN NEUROL, V47, P470, DOI 10.1002/1531-8249(200004)47:4<470::AID-ANA10>3.3.CO;2-D; Prigatano G., 1999, PRINCIPLES NEUROPSYC, P265; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1991, AWARENESS DEFICT BRA; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Ryan L, 2001, HIPPOCAMPUS, V11, P707, DOI 10.1002/hipo.1086; RYCHLAK J, 1981, PERS PSYCHOTHER, P664; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	39	643	657	0	49	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG	2002	125		8				1808	1814		10.1093/brain/awf181			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42NS	WOS:000202874800012	12135971	Bronze			2021-06-18	
J	Slick, DJ; Sherman, EMS; Iverson, GL				Slick, DJ; Sherman, EMS; Iverson, GL			Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; MMPI-2 VALIDITY SCALES; MEMORY DEFICITS; NEUROPSYCHOLOGICAL TESTS; HEAD-INJURY; BELIEVABLE DEFICITS; IMPAIRMENT; FAKING; TASK; PROSPECTS	Over the past 10 years, widespread and concerted research efforts have led to increasingly sophisticated and efficient methods and instruments for detecting exaggeration or fabrication of cognitive dysfunction. Despite these psychometric advances, the process of diagnosing malingering remains difficult and largely idiosyncratic. This article presents a proposed set of diagnostic criteria that define psychometric, behavioral, and collateral data indicative of possible, probable, and definite malingering of cognitive dysfunction, for use in clinical practice and for defining populations for clinical research. Relevant literature is reviewed, and limitations and benefits of the proposed criteria are discussed.	British Columbia Childrens Hosp, Dept Psychol, Vancouver, BC V6H 3V4, Canada; Riverview Hosp, Vancouver, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Sherman, EMS (corresponding author), British Columbia Childrens Hosp, Dept Psychol, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.			Iverson, Grant/0000-0001-7348-9570			*AM PSYCH ASS, 1992, ETH PRINC PSYCH COD; *AM PSYCH ASS, 1986, GUID COMP BAS TESTS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychological Association American Educational Research Association & National Council on Measurement in Education, 1985, STAND ED PSYCH TEST; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BAKER GA, 1993, J CLIN EXP NEUROPSYC, V15, P668, DOI 10.1080/01688639308402588; BARTON PW, 1995, CLIN NEUROPSYCHOL, V9, P68; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BERNEDE JC, 1993, VIDE, V49, P1; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1993, PORTLAND DIGIT RECOG; BINDER LM, 1994, ARCH CLIN NEUROPSYCH, V10, P27; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Derogatis LR, 1994, USE PSYCHOL TESTING; ELWOOD RW, 1993, CLIN NEUROPSYCHOL, V7, P224, DOI 10.1080/13854049308401527; FAUST D, 1990, J CONSULT CLIN PSYCH, V58, P248, DOI 10.1037/0022-006X.58.2.248; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FAUST D, 1998, DETECTOIN MALINGERIN, P261; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Gouvier WD, 1998, CRIT ISS NE, P55; GRANT L, 1994, NEUROPSYCHOLOGY HIV; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson G.L., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401, DOI 10.1177/107319119400100401]; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; KNIGHT J, 1995, 23 ANN M INT NEUR SO; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LINDEBOOM J, 1989, J CLIN PSYCHOL, V45, P679, DOI 10.1002/1097-4679(198907)45:4<679::AID-JCLP2270450427>3.0.CO;2-L; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MARTIN RC, 1996, CLIN NEUROPSYCHOL, V12, P84; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Pankratz, 1997, CLIN ASSESSMENT MALI, P223; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Pankratz L., 1990, CLIN NEUROPSYCHOL, V4, P379; Reynolds CR, 1998, CRIT ISS NE, P261; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; ROGERS R, 1983, J PSYCHIAT LAW, V11, P443; Rogers R, 1997, CLIN ASSESSMENT MALI, P373; RUSSELL ML, 1993, 21 ANN M INT NEUR SO; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh TN, 1996, TEST MEMORY MALINGER	67	639	646	1	38	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		1999	13	4					545	561		10.1076/1385-4046(199911)13:04;1-Y;FT545			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	310PP	WOS:000086836800020	10806468				2021-06-18	
J	ROSNER, MJ; ROSNER, SD; JOHNSON, AH				ROSNER, MJ; ROSNER, SD; JOHNSON, AH			CEREBRAL PERFUSION-PRESSURE - MANAGEMENT PROTOCOL AND CLINICAL RESULTS	JOURNAL OF NEUROSURGERY			English	Article						CEREBRAL PERFUSION PRESSURE; INTRACRANIAL PRESSURE; TRAUMATIC BRAIN INJURY; THERAPY	SEVERE HEAD-INJURY; PHENYLEPHRINE-INDUCED HYPERTENSION; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; AUTO-REGULATION; EXPANDING MASS; PLATEAU WAVES; MANNITOL	Early results using cerebral perfusion pressure (CPP) management techniques in persons with traumatic brain injury indicate that treatment directed at CPP is superior to traditional techniques focused on intracranial pressure (ICP) management. The authors have continued to refine management techniques directed at CPP maintenance. One hundred fifty-eight patients with Glasgow Coma Scale (GCS) scores of 7 or lower were managed using vascular volume expansion, cerebrospinal fluid drainage via ventriculostomy, systemic vasopressors (phenylephrine or norepinephrine), and mannitol to maintain a minimum CPP of at least 70 mm Hg. Detailed outcomes and follow-up data bases were maintained. Barbiturates', hyperventilation, and hypothermia were not used. Cerebral perfusion pressure averaged 83 +/- 14 mm Hg; ICP averaged 27 +/- 12 mm Hg; and mean systemic arterial blood pressure averaged 109 +/- 14 mm Hg. Cerebrospinal fluid drainage averaged 100 +/- 98 cc per day. Intake (6040 +/- 4150 cc per day) was carefully titrated to output (5460 +/- 4000 cc per day); mannitol averaged 188 +/- 247 g per day. Approximately 40% of these patients required vasopressor support. Patients requiring vasopressor support had lower GCS scores than those not requiring vasopressors (4.7 +/- 1.3 vs. 5.4 +/- 1.2, respectively). Patients with vasopressor support required larger amounts of mannitol, and their admission ICP was 28.7 +/- 20.7 versus 17.5 +/- 8.6 mm Hg for the nonvasopressor group. Although the death rate in the former group was higher, the outcome quality of the survivors was the same (Glasgow Outcome Scale scores 4.3 +/- 0.9 vs. 4.5 +/- 0.7). Surgical mass lesion patients had outcomes equal to those of the closed head-injury group. Mortality ranged from 52% of patients with a GCS score of 3 to 12% of those with a GCS score of 7; overall mortality was 29% across GCS categories. Favorable outcomes ranged from 35% of patients with a GCS score of 3 to 75% of those with a GCS score of 7. Only 2% of the patients in the series remained vegetative and if patients survived, the likelihood of their having a favorable recovery was approximately 80%. These results are significantly better than other reported series across GCS categories in comparisons of death rates, survival versus dead or vegetative, or favorable versus nonfavorable outcome classifications (Mantel-Haenszel chi(2), p < 0.001). Better management could have improved outcome in as many as 35% to 50% of the deaths.		ROSNER, MJ (corresponding author), UNIV ALABAMA,DEPT SURG,DIV NEUROL SURG,516 MED EDUC BLDG,1813 6TH AVE S,BIRMINGHAM,AL 35294, USA.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BISHOP R, 1994, INTRACRANIAL PRESSUR, V9, P189; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; DRUMMOND JC, 1991, J NEUROSURG ANESTH, V3, P4, DOI 10.1097/00008506-199103000-00002; DRUMMOND JC, 1989, STROKE, V20, P1538, DOI 10.1161/01.STR.20.11.1538; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ELADAWY Y, 1989, INTRACRANIAL PRESSUR, V7, P829; FEIN JM, 1983, J NEUROSURG, V59, P51, DOI 10.3171/jns.1983.59.1.0051; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jennett B, 1991, J Neurotrauma, V8 Suppl 1, pS15; JENNETT B, 1975, LANCET, V1, P480; JONES MD, 1981, AM J PHYSIOL, V240, pH209; KAJITA Y, 1994, J NEUROSURG, V80, P476, DOI 10.3171/jns.1994.80.3.0476; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KAUFMANN GE, 1970, J NEUROSURG, V33, P145, DOI 10.3171/jns.1970.33.2.0145; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Langfitt T W, 1969, Clin Neurosurg, V16, P436; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LANGFITT TW, 1964, J NEUROSURG, V21, P998, DOI 10.3171/jns.1964.21.11.0998; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LUNDBERG N, 1960, ACTA PSYCHIATRICA  S, V149, P1; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; MATSUDA M, 1979, J NEUROSURG, V50, P483, DOI 10.3171/jns.1979.50.4.0483; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; MOORE FD, 1975, MANUAL SURGICAL NUTR, P169; MUIZELAAR JP, 1986, STROKE, V17, P44, DOI 10.1161/01.STR.17.1.44; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1992, AM J PHYSIOL, V262, pH949; NAKATANI S, 1983, INTRACRANIAL PRESSUR, V5, P784; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PIEK J, 1988, ACTA NEUROCHIR, V93, P129, DOI 10.1007/BF01402894; PROCTOR HJ, 1984, SURGERY, V96, P273; ROSENWASSER RH, 1989, J NEUROSURG, V71, P503, DOI 10.3171/jns.1989.71.4.0503; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; Rosner M., 1987, CEREBRAL BLOOD FLOW, P425; Rosner Michael J., 1993, P57; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; ROSNER MJ, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P313; ROSNER MJ, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P293; Rosner MJ, 1993, INTRACRANIAL PRESSUR, P540; ROSNER MJ, 1994, INTRACRANIAL PRESSUR, V9, P222; ROSNER MJ, 1993, INTRACRANIAL PRESSUR, P686; ROSNER MJ, 1993, INTRACRANIAL PRESSUR, V8, P414; SCHETTINI A, 1972, ANESTHESIOLOGY, V36, P4, DOI 10.1097/00000542-197201000-00002; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P453; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P114; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHALMON E, 1994, INTRACRANIAL PRESSUR, V9, P357; SHALMON E, 1994, INTRACRANIAL PRESSUR, V9, P348; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; TAKAGI H, 1983, INTRACRANIAL PRESSUR, V5, P729; TEASDALE G, 1974, LANCET, V2, P81; WEAVER DD, 1982, J NEUROSURG, V56, P660, DOI 10.3171/jns.1982.56.5.0660; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; YOSHIDA A, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P309; ZEMAN FJ, 1983, CLIN NUTRITION DIETE, P555	83	636	660	0	17	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	1995	83	6					949	962		10.3171/jns.1995.83.6.0949			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	TG914	WOS:A1995TG91400001	7490638				2021-06-18	
J	Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Johnston, KM; Kelly, J; Lovell, M; McCrory, P; Meeuwisse, WH; Schamasch, P				Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Johnston, KM; Kelly, J; Lovell, M; McCrory, P; Meeuwisse, WH; Schamasch, P		Concussion Sport Grp	Summary and agreement statement of the 1st International Symposium on Concussion in Sport, Vienna 2001	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article							STANDARDIZED ASSESSMENT; SAFE RETURN; PATHOPHYSIOLOGY; CONSCIOUSNESS; INJURY		Int Ice Hockey Federat, Zurich, Switzerland; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Emerson Hosp, Sports Med Serv, Concord, MA USA; Natl Ctr Catastroph Sports Injury Res, Chapel Hill, NC USA; FIFA, Med Res & Assessment Ctr, FMARC, Zurich, Switzerland; Schulthess Clin, Zurich, Switzerland; FIFA, Med Res & Assessment Ctr, FMARC, Tenningen, Germany; McGill Univ, Div Neurosurg, Ctr Hlth, Montreal, PQ, Canada; McGill Sport Med Ctr, Montreal, PQ, Canada; Northwestern Univ, Sch Med, Chicago Neurol Inst, Chicago, IL USA; Univ Pittsburgh, Sports Med Concuss Program, Pittsburgh, PA 15260 USA; Natl Hockey League Neuropsychol Program, Pittsburgh, PA USA; Univ Melbourne, Brain Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia; Univ Calgary, Ctr Sports Med, Calgary, AB T2N 1N4, Canada; Natl Hockey League, Calgary, AB, Canada; Int Olymp Comm Med Commiss, Lausanne, Switzerland	Johnston, KM (corresponding author), Montreal Gen Hosp, Div Neurosurg, 1650 Cedar Ave,Room L7-524, Montreal, PQ H3G 1A4, Canada.		McCrory, Paul/Q-8688-2019				*C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu RC, 2001, J ATHL TRAINING, V36, P244; COLLIE A, IN PRESS BR J SPORTS; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; LENINGER B, 2000, J NEUROL NEUROSUR PS, V53, P293; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3	25	633	637	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2002	12	1					6	11		10.1097/00042752-200201000-00005			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	521CA	WOS:000173820100004	11867482				2021-06-18	
J	Chesnut, RM; Temkin, N; Carney, N; Dikmen, S; Rondina, C; Videtta, W; Petroni, G; Lujan, S; Pridgeon, J; Barber, J; Machamer, J; Chaddock, K; Celix, JM; Cherner, M; Hendrix, T				Chesnut, Randall M.; Temkin, Nancy; Carney, Nancy; Dikmen, Sureyya; Rondina, Carlos; Videtta, Walter; Petroni, Gustavo; Lujan, Silvia; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley; Celix, Juanita M.; Cherner, Marianna; Hendrix, Terence			A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE; HEAD-INJURY; MANAGEMENT	Background Intracranial-pressure monitoring is considered the standard of care for severe traumatic brain injury and is used frequently, but the efficacy of treatment based on monitoring in improving the outcome has not been rigorously assessed. Methods We conducted a multicenter, controlled trial in which 324 patients 13 years of age or older who had severe traumatic brain injury and were being treated in intensive care units (ICUs) in Bolivia or Ecuador were randomly assigned to one of two specific protocols: guidelines-based management in which a protocol for monitoring intra-parenchymal intracranial pressure was used (pressure-monitoring group) or a protocol in which treatment was based on imaging and clinical examination (imaging-clinical examination group). The primary outcome was a composite of survival time, impaired consciousness, and functional status at 3 months and 6 months and neuropsychological status at 6 months; neuropsychological status was assessed by an examiner who was unaware of protocol assignment. This composite measure was based on performance across 21 measures of functional and cognitive status and calculated as a percentile (with 0 indicating the worst performance, and 100 the best performance). Results There was no significant between-group difference in the primary outcome, a composite measure based on percentile performance across 21 measures of functional and cognitive status (score, 56 in the pressure-monitoring group vs. 53 in the imaging-clinical examination group; P = 0.49). Six-month mortality was 39% in the pressure-monitoring group and 41% in the imaging-clinical examination group (P = 0.60). The median length of stay in the ICU was similar in the two groups (12 days in the pressure-monitoring group and 9 days in the imaging-clinical examination group; P = 0.25), although the number of days of brain-specific treatments (e.g., administration of hyperosmolar fluids and the use of hyperventilation) in the ICU was higher in the imaging-clinical examination group than in the pressure-monitoring group (4.8 vs. 3.4, P = 0.002). The distribution of serious adverse events was similar in the two groups. Conclusions For patients with severe traumatic brain injury, care focused on maintaining monitored intracranial pressure at 20 mm Hg or less was not shown to be superior to care based on imaging and clinical examination. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01068522.)	[Chesnut, Randall M.; Temkin, Nancy; Dikmen, Sureyya; Pridgeon, Jim; Barber, Jason; Chaddock, Kelley; Celix, Juanita M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Harborview Med Ctr, Dept Biostat, Seattle, WA 98104 USA; [Dikmen, Sureyya; Machamer, Joan] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Rondina, Carlos; Petroni, Gustavo; Lujan, Silvia] Hosp Emergencias Dr Clemente Alvarez, Santa Fe, Argentina; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Hendrix, Terence] Univ Calif San Diego, HIV Neurobehav Res Programs, La Jolla, CA 92093 USA; [Cherner, Marianna] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9th Ave,Box 359766, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666	National Institutes of Health and the Fogarty International Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ROINS058302]; Integra Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS080648, R01NS058302] Funding Source: NIH RePORTER	Supported by the National Institutes of Health and the Fogarty International Center, the National Institute of Neurological Disorders and Stroke (ROINS058302), and Integra Life Sciences.	[Anonymous], 1996, J NEUROTRAUM, V13, P639; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL AIS; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, GUIDELINES MANAGEMEN; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Kerr M E, 2001, Neurosurg Focus, V11, pE1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; 2000, J NEUROTRAUMA, V17, P457	20	628	663	0	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2471	2481		10.1056/NEJMoa1207363			11	Medicine, General & Internal	General & Internal Medicine	059OG	WOS:000312714200005	23234472	Green Accepted	Y	N	2021-06-18	
J	Steyerberg, EW; Mushkudiani, N; Perel, P; Butcher, I; Lu, J; McHugh, GS; Murray, GD; Marmarou, A; Roberts, I; Habbema, JDF; Maas, AIR				Steyerberg, Ewout W.; Mushkudiani, Nino; Perel, Pablo; Butcher, Isabella; Lu, Juan; McHugh, Gillian S.; Murray, Gordon D.; Marmarou, Anthony; Roberts, Ian; Habbema, J. Dik F.; Maas, Andrew I. R.			Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics	PLOS MEDICINE			English	Article							LOGISTIC-REGRESSION MODELS; HEAD-INJURY; IMPACT DATABASE; CLINICAL-TRIALS; PRACTICAL SCALE; MISSING-DATA; SAMPLE-SIZE; DESIGN; CLASSIFICATION; ADJUSTMENT	Background Traumatic brain injury (TBI) is a leading cause of death and disability. A reliable prediction of outcome on admission is of great clinical relevance. We aimed to develop prognostic models with readily available traditional and novel predictors. Methods and Findings Prospectively collected individual patient data were analyzed from 11 studies. We considered predictors available at admission in logistic regression models to predict mortality and unfavorable outcome according to the Glasgow Outcome Scale at 6 mo after injury. Prognostic models were developed in 8,509 patients with severe or moderate TBI, with cross-validation by omission of each of the 11 studies in turn. External validation was on 6,681 patients from the recent Medical Research Council Corticosteroid Randomisation after Significant Head Injury (MRC CRASH) trial. We found that the strongest predictors of outcome were age, motor score, pupillary reactivity, and CT characteristics, including the presence of traumatic subarachnoid hemorrhage. A prognostic model that combined age, motor score, and pupillary reactivity had an area under the receiver operating characteristic curve (AUC) between 0.66 and 0.84 at cross-validation. This performance could be improved (AUC increased by approximately 0.05) by considering CT characteristics, secondary insults (hypotension and hypoxia), and laboratory parameters (glucose and hemoglobin). External validation confirmed that the discriminative ability of the model was adequate (AUC 0.80). Outcomes were systematically worse than predicted, but less so in 1,588 patients who were from high-income countries in the CRASH trial. Conclusions Prognostic models using baseline characteristics provide adequate discrimination between patients with good and poor 6 mo outcomes after TBI, especially if CT and laboratory findings are considered in addition to traditional predictors. The model predictions may support clinical practice and research, including the design and analysis of randomized controlled trials.	[Steyerberg, Ewout W.; Mushkudiani, Nino; Habbema, J. Dik F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands; [Perel, Pablo; Roberts, Ian] London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1, England; [Butcher, Isabella; McHugh, Gillian S.; Murray, Gordon D.] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9YL, Midlothian, Scotland; [Lu, Juan; Marmarou, Anthony] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Maas, Andrew I. R.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	Steyerberg, EW (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands.	E.Steyerberg@ErasmusMC.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; /0000-0002-2342-301X; Murray, Gordon/0000-0001-9866-4734; Lu, Juan/0000-0002-5389-7603; Steyerberg, Ewout/0000-0002-7787-0122	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 42691]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER	Grant support was provided by NIH NS 42691 of which Andrew Maas is PI. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; nor in the preparation, review, decision to publish, or approval of the manuscript.	Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Choi S C, 1998, J Biopharm Stat, V8, P367, DOI 10.1080/10543409808835246; Edwards P, 2005, LANCET, V365, P1957; Enders CK, 2006, PSYCHOSOM MED, V68, P427, DOI 10.1097/01.psy.0000221275.75056.d8; HARRELL FE, 2001, REGRESSION MODELING; HARRELL FE, 2006, DESIGN DESIGN PACKAG; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Development Core Team, 2006, R LANG ENV STAT COMP; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2005, MED DECIS MAKING, V25, P678, DOI 10.1177/0272989X05282645; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; TEASDALE G, 1974, LANCET, V2, P81; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VANBUUREN S, 2006, MICE MULTIVARIATE IM; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017	43	625	632	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1549-1277			PLOS MED	PLos Med.	AUG	2008	5	8					1251	1261	e165	10.1371/journal.pmed.0050165			11	Medicine, General & Internal	General & Internal Medicine	341TY	WOS:000258739200015	18684008	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Thomas, JL; Wilk, JE; Riviere, LA; McGurk, D; Castro, CA; Hoge, CW				Thomas, Jeffrey L.; Wilk, Joshua E.; Riviere, Lyndon A.; McGurk, Dennis; Castro, Carl A.; Hoge, Charles W.			Prevalence of Mental Health Problems and Functional Impairment Among Active Component and National Guard Soldiers 3 and 12 Months Following Combat in Iraq	ARCHIVES OF GENERAL PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; US MILITARY COHORT; PRIMARY-CARE; DEPLOYMENT; AFGHANISTAN; CHECKLIST; SYMPTOMS; PTSD; WAR	Context: A growing body of literature has demonstrated the association of combat in Iraq and Afghanistan with postdeployment mental health problems, particularly posttraumatic stress disorder (PTSD) and depression. However, studies have shown varying prevalence rates of these disorders based on different case definitions and have not assessed functional impairment, alcohol misuse, or aggressive behavior as comorbid factors occurring with PTSD and depression. Objectives: To (1) examine the prevalence rates of depression and PTSD using several case definitions including functional impairment, (2) determine the comorbidity of alcohol misuse or aggressive behaviors with depression or PTSD, and (3) compare rates between Active Component and National Guard soldiers at the 3- and 12-month time points following their deployment to Iraq. Design: Population-based, cross-sectional study. Setting: United States Army posts and National Guard armories. Participants: A total of 18 305 US Army soldiers from 4 Active Component and 2 National Guard infantry brigade combat teams. Interventions: Between 2004 and 2007, anonymous mental health surveys were collected at 3 and 12 months following deployment. Main Outcome Measures: Current PTSD, depression, functional impairment, alcohol misuse, and aggressive behavior. Results: Prevalence rates for PTSD or depression with serious functional impairment ranged between 8.5% and 14.0%, with some impairment between 23.2% and 31.1%. Alcohol misuse or aggressive behavior comorbidity was present in approximately half of the cases. Rates remained stable for the Active Component soldiers but increased across all case definitions from the 3- to 12-month time point for National Guard soldiers. Conclusions: The prevalence rates of PTSD and depression after returning from combat ranged from 9% to 31% depending on the level of functional impairment reported. The high comorbidity with alcohol misuse and aggression highlights the need for comprehensive postdeployment screening. Persistent or increased prevalence rates at 12 months compared with 3 months postdeployment illustrate the persistent effects of war zone service and provide important data to guide postdeployment care.	[Thomas, Jeffrey L.] USA, Med Res & Mat Command, Walter Reed Army Inst Res, Dept Mil Psychiat,Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [McGurk, Dennis] USA, Med Res & Mat Command, Walter Reed Army Inst Res, USA Med Res Unit Europe, Heidelberg, Germany; [Castro, Carl A.] USA, Med Res & Mat Command, Mil Operat Med Res Program, Ft Detrick, MD USA	Thomas, JL (corresponding author), USA, Med Res & Mat Command, Walter Reed Army Inst Res, Dept Mil Psychiat,Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jeffrey.l.thomas@us.army.mil		McGurk, Dennis/0000-0003-4126-5980	Military Operational Medicine Research Area Directorate, US Army Medical Research and Materiel Command, Fort Detrick, MarylandU.S. Army Medical Research & Materiel Command (USAMRMC)	This study was supported by the Military Operational Medicine Research Area Directorate, US Army Medical Research and Materiel Command, Fort Detrick, Maryland.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BLIESE PD, POSTDEPLOYMENT PSYCH; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; *MACARTHUR IN DEPR, DEPR TOOL KIT; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *OFF SURG MULT FOC, 0608 OFF SURG MULT F; Ramchand R., 2008, INVISIBLE WOUNDS WAR, P35; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; SANTIAGO PN, PSYCHIAT SE IN PRESS; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sollinger J. M., 2008, INVISIBLE WOUNDS WAR, P19; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; *TRICARE, TRICARE MAN ACT FACT; WEATHERS FW, 2003, ANN M INT SOC TRAUM; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	26	622	627	1	67	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0003-990X			ARCH GEN PSYCHIAT	Arch. Gen. Psychiatry	JUN	2010	67	6					614	623		10.1001/archgenpsychiatry.2010.54			10	Psychiatry	Psychiatry	605CD	WOS:000278324000010	20530011	Bronze			2021-06-18	
J	Menon, DK; Schwab, K; Wright, DW; Maas, AI				Menon, David K.; Schwab, Karen; Wright, David W.; Maas, Andrew I.		Int Interagency Initiative Common	Position Statement: Definition of Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Diagnosis; differential; Stress disorder; posttraumatic; Rehabilitation	VOLUME	A clear, concise definition of traumatic brain injury (TBI) is fundamental for reporting, comparison, and interpretation of studies on TBI. Changing epidemiologic patterns, an increasing recognition of significance of mild TBI, and a better understanding of the subtler neurocognitive neuroaffective deficits that may result from these injuries make this need even more critical. The Demographics and Clinical Assessment Working Group of the International and Interagency Initiative toward Common Data Elements for Research on Traumatic Brain Injury and Psychological Health has therefore formed an expert group that proposes the following definition: TBI is defined as an alteration in brain function, or other evidence of brain pathology, caused by an external force. In this article, we discuss criteria for considering or establishing a diagnosis of TBI, with a particular focus on the problems how a diagnosis of TBI can be made when patients present late after injury and how mild TBI may be differentiated from non-TBI causes with similar symptoms. Technologic advances in magnetic resonance imaging and the development of biomarkers offer potential for improving diagnostic accuracy in these situations.	[Schwab, Karen] Def & Vet Brain Injury Ctr, Washington, DC USA; [Wright, David W.] Emory Univ, Sch Med, Atlanta, GA USA; [Maas, Andrew I.] Univ Antwerp Hosp, Antwerp, Belgium	Menon, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk; andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013; Wright, David/F-1209-2013	Maas, Andrew IR/0000-0003-1612-1264; Wright, David/0000-0002-7145-9105	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute on Disability and Rehabilitation Research; Department of Veterans AffairsUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Defense Centers of Excellence; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [RG46503]; National Institute for Health Research, United KingdomNational Institute for Health Research (NIHR) [RG53668]; Royal College of Anaesthetists [RG42458]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 062778A, NS 059032-01, TW 007262-01, NS 42691]; Wallace H. Coulter Foundation; Division of Emergency Neurosciences, Department of Emergency Medicine at Emory University; Flemish Institute for promoting Innovation in Science and Technology; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032, R56NS006277, R01NS042691, R01NS006277] Funding Source: NIH RePORTER	Supported by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Disability and Rehabilitation Research, the Department of Veterans Affairs, the Defense and Veterans Brain Injury Center, and the Defense Centers of Excellence, the Medical Research Council (RG46503), the National Institute for Health Research, United Kingdom (RG53668), the BOC Professorship of the Royal College of Anaesthetists (RG42458), the NIH-NINDS (NS 062778A, NS 059032-01, TW 007262-01), the Wallace H. Coulter Foundation, the Division of Emergency Neurosciences, Department of Emergency Medicine at Emory University, the NIH-NINDS (NS 42691), and the Flemish Institute for promoting Innovation in Science and Technology.	Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; *DEP VET DOD, 2009, CLIN PRACT GUID MAN; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kochanek PM, 2009, J NEUROTRAUM, V26, P813, DOI 10.1089/neu.2008.0893; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; *NINDS CDE PROJ, 2010, NINDS COMM DAT EL; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604	16	618	628	1	83	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2010	91	11					1637	1640		10.1016/j.apmr.2010.05.017			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	681UQ	WOS:000284346400002	21044706				2021-06-18	
J	Gessel, LM; Fields, SK; Collins, CL; Dick, RW; Comstock, RD				Gessel, Luke M.; Fields, Sarah K.; Collins, Christy L.; Dick, Randall W.; Comstock, R. Dawn			Concussions among united states high school and collegiate athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; injury surveillance; sex differences; traumatic brain injury	SEGMENT DYNAMIC STABILIZATION; SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; SEX-DIFFERENCES; SOCCER PLAYERS; BRAIN-INJURY; HEAD; EPIDEMIOLOGY; RECOVERY	Context: An estimated 300000 sport-related traumatic brain injuries, predominantly concussions, occur annually in the United States. Sports are second only to motor vehicle crashes as the leading cause of traumatic brain injury among people aged 15 to 24 years. Objective: To investigate the epidemiology of concussions in a nationally representative sample of high school athletes and to compare rates of concussion among high school and collegiate athletes. Design: Descriptive epidemiologic study Setting: 100 United States high schools and 180 US colleges. Patients or Other Participants: United States high school and collegiate athletes. Main Outcome Measure(s): Data from 2 injury surveillance systems, High School Reporting Information Online (RIO) and the National Collegiate Athletic Association Injury Surveillance System, were analyzed to calculate rates, describe patterns, and evaluate potential risk factors for sport-related concussion. Results: Concussions represented 8.9% (n = 396) of all high school athletic injuries and 5.8% (n = 482) of all collegiate athletic injuries. Among both groups, rates of concussions were highest in the sports of football and soccer. In high school sports played by both sexes, girls sustained a higher rate of concussions, and concussions represented a greater proportion of total injuries than in boys. In all sports, collegiate athletes had higher rates of concussion than high school athletes, but concussions represented a greater proportion of all injuries among high school athletes. Conclusions: Sport-related injury surveillance systems can provide scientific data to drive targeted injury-prevention projects. Developing effective sport-related concussion preventive measures depends upon increasing our knowledge of concussion rates, patterns, and risk factors.	[Collins, Christy L.; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Gessel, Luke M.; Fields, Sarah K.; Comstock, R. Dawn] Ohio State Univ, Columbus, OH 43210 USA; [Dick, Randall W.] Natl Coll Athlet Assoc, Indianapolis, IN USA	Collins, CL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	Christy.Collins@nationwidechildrens.org			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CEOOO674-01] Funding Source: Medline		*AM ORTH SOC SPORT, HIGH SCHOOL FOOTB PL; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; *CDC, FREE CDC TOOL KIT CO; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2003, J ATHL TRAINING, V38, P238; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Mansell J, 2005, J ATHL TRAINING, V40, P310; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; National Collegiate Athletic Association, NCAA INJ SURV SYST I; NCAA, NCAA SPORTS SPONS PA; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; *NFHS, PART HIGH SCHOOL SPO; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Sosin DM, 1996, BRAIN INJURY, V10, P47; Theye Fred, 2004, Clin Med Res, V2, P165; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; United States Census Bureau, CENS REG US; Vertinsky Patricia, 1994, ETERNALLY WOUNDED WO, P1	33	609	613	0	101	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	OCT-DEC	2007	42	4					495	503					9	Sport Sciences	Sport Sciences	251AQ	WOS:000252343100009	18174937				2021-06-18	
J	Harmon, KG; Drezner, JA; Gammons, M; Guskiewicz, KM; Halstead, M; Herring, SA; Kutcher, JS; Pana, A; Putukian, M; Roberts, W				Harmon, Kimberly G.; Drezner, Jonathan A.; Gammons, Matthew; Guskiewicz, Kevin M.; Halstead, Mark; Herring, Stanley A.; Kutcher, Jeffrey S.; Pana, Andrea; Putukian, Margot; Roberts, William			American Medical Society for Sports Medicine position statement: concussion in sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Purpose of the statement To provide an evidence-based, best practises summary to assist physicians with the evaluation and management of sports concussion. To establish the level of evidence, knowledge gaps and areas requiring additional research. Importance of an AMSSM statement Sports medicine physicians are frequently involved in the care of patients with sports concussion. Sports medicine physicians are specifically trained to provide care along the continuum of sports concussion from the acute injury to return-to-play (RTP) decisions. The care of athletes with sports concussion is ideally performed by healthcare professionals with specific training and experience in the assessment and management of concussion. Competence should be determined by training and experience, not dictated by specialty. While this statement is directed towards sports medicine physicians, it may also assist other physicians and healthcare professionals in the care of patients with sports concussion. Definition Concussion is defined as a traumatically induced transient disturbance of brain function and involves a complex pathophysiological process. Concussion is a subset of mild traumatic brain injury (MTBI) which is generally self-limited and at the less-severe end of the brain injury spectrum. Pathophysiology Animal and human studies support the concept of postconcussive vulnerability, showing that a second blow before the brain has recovered results in worsening metabolic changes within the cell. Experimental evidence suggests the concussed brain is less responsive to usual neural activation and when premature cognitive or physical activity occurs before complete recovery the brain may be vulnerable to prolonged dysfunction. Incidence It is estimated that as many as 3.8 million concussions occur in the USA per year during competitive sports and recreational activities; however, as many as 50% of the concussions may go unreported. Concussions occur in all sports with the highest incidence in football, hockey, rugby, soccer and basketball. Risk factors for sport-related concussion A history of concussion is associated with a higher risk of sustaining another concussion. A greater number, severity and duration of symptoms after a concussion are predictors of a prolonged recovery. D In sports with similar playing rules, the reported incidence of concussion is higher in female athletes than in male athletes. Certain sports, positions and individual playing styles have a greater risk of concussion. Youth athletes may have a more prolonged recovery and are more susceptible to a concussion accompanied by a catastrophic injury. Preinjury mood disorders, learning disorders, attention-deficit disorders (ADD/ADHD) and migraine headaches complicate diagnosis and management of a concussion. Diagnosis of concussion Concussion remains a clinical diagnosis ideally made by a healthcare provider familiar with the athlete and knowledgeable in the recognition and evaluation of concussion. Graded symptom checklists provide an objective tool for assessing a variety of symptoms related to concussions, while also tracking the severity of those symptoms over serial evaluations. Standardised assessment tools provide a helpful structure for the evaluation of concussion, although limited validation of these assessment tools is available. 'Sideline' evaluation and management Any athlete suspected of having a concussion should be stopped from playing and assessed by a licenced healthcare provider trained in the evaluation and management of concussions. Recognition and initial assessment of a concussion should be guided by a symptoms checklist, cognitive evaluation (including orientation, past and immediate memory, new learning and concentration), balance tests and further neurological physical examination. While standardised sideline tests are a useful framework for examination, the sensitivity, specificity, validity and reliability of these tests among different age groups, cultural groups and settings is largely undefined. Their practical usefulness with or without an individual baseline test is also largely unknown. Balance disturbance is a specific indicator of a concussion, but not very sensitive. Balance testing on the sideline may be substantially different than baseline tests because of differences in shoe/cleat-type or surface, use of ankle tape or braces, or the presence of other lower extremity injury. Imaging is reserved for athletes where intracerebral bleeding is suspected. There is no same day RTP for an athlete diagnosed with a concussion. Athletes suspected or diagnosed with a concussion should be monitored for deteriorating physical or mental status. Neuropsychological testing Neuropsychological (NP) tests are an objective measure of brain behaviour relationships and are more sensitive for subtle cognitive impairment than clinical exam. Most concussions can be managed appropriately without the use of NP testing. D. Computerised neuropsychological (CNP) testing should be interpreted by healthcare professionals trained and familiar with the type of test and the individual test limitations, including a knowledgeable assessment of the reliable change index, baseline variability and false-positive and false-negative rates. Paper and pencil NP tests can be more comprehensive, test different domains and assess for other conditions which may masquerade as or complicate assessment of concussion. NP testing should be used only as part of a comprehensive concussion management strategy and should not be used in isolation. The ideal timing, frequency and type of NP testing have not been determined. In some cases, properly administered and interpreted NP testing provides an added value to assess cognitive function and recovery in the management of sports concussions. It is unknown if use of NP testing in the management of sports concussion helps prevent recurrent concussion, catastrophic injury or long-term complications. Comprehensive NP evaluation is helpful in the post-concussion management of athletes with persistent symptoms or complicated courses. Return to class Students will require cognitive rest and may require academic accommodations such as reduced workload and extended time for tests while recovering from a concussion. Return to play Concussion symptoms should be resolved before returning to exercise. A RTP progression involves a gradual, step-wise increase in physical demands, sports-specific activities and the risk for contact. If symptoms occur with activity, the progression should be halted and restarted at the preceding symptom-free step. RTP after concussion should occur only with medical clearance from a licenced healthcare provider trained in the evaluation and management of concussions. Short-term risks of premature RTP The primary concern with early RTP is decreased reaction time leading to an increased risk of a repeat concussion or other injury and prolongation of symptoms. Long-term effects There is an increasing concern that head impact exposure and recurrent concussions contribute to long-term neurological sequelae. Some studies have suggested an association between prior concussions and chronic cognitive dysfunction. Large-scale epidemiological studies are needed to more clearly define risk factors and causation of any long-term neurological impairment. Disqualification from sport There are no evidence-based guidelines for disqualifying/retiring an athlete from a sport after a concussion. Each case should be carefully deliberated and an individualised approach to determining disqualification taken. Education Greater efforts are needed to educate involved parties, including athletes, parents, coaches, officials, school administrators and healthcare providers to improve concussion recognition, management and prevention. Physicians should be prepared to provide counselling regarding potential long-term consequences of a concussion and recurrent concussions. Prevention Primary prevention of some injuries may be possible with modification and enforcement of the rules and fair play. Helmets, both hard (football, lacrosse and hockey) and soft (soccer, rugby) are best suited to prevent impact injuries (fracture, bleeding, laceration, etc.) but have not been shown to reduce the incidence and severity of concussions. There is no current evidence that mouth guards can reduce the severity of or prevent concussions. Secondary prevention may be possible by appropriate RTP management. Legislation Legislative efforts provide a uniform standard for scholastic and non-scholastic sports organisations regarding concussion safety and management. Future directions Additional research is needed to validate current assessment tools, delineate the role of NP testing and improve identification of those at risk of prolonged post-concussive symptoms or other long-term complications. Evolving technologies for the diagnosis of concussion, such as newer neuroimaging techniques or biological markers, may provide new insights into the evaluation and management of sports concussion.	[Harmon, Kimberly G.; Drezner, Jonathan A.; Herring, Stanley A.] Univ Washington, Stanley Herring Dept Phys Med & Rehabil, Dept Family Med, Seattle, WA 98195 USA; [Gammons, Matthew] Vermont Orthopaed Clin, Rutland, VT USA; [Guskiewicz, Kevin M.] Univ N Carolina, Sports Med Res Lab, Chapel Hill, NC USA; [Halstead, Mark] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurosport, Ann Arbor, MI USA; [Pana, Andrea] Univ Texas Austin, Austin, TX 78712 USA; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Roberts, William] Univ Minnesota, Dept Family Med & Community Hlth, St Paul, MN 55108 USA	Harmon, KG (corresponding author), Univ Washington, Stanley Herring Dept Phys Med & Rehabil, Dept Family Med, Box 354410, Seattle, WA 98195 USA.	kharmon@u.washington.edu		Roberts, William O/0000-0003-4517-4330; Guskiewicz, Kevin/0000-0002-8682-2130				0	598	601	18	564	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JAN	2013	47	1					15	26		10.1136/bjsports-2012-091941			12	Sport Sciences	Sport Sciences	073SF	WOS:000313762100008	23243113	Bronze	Y	N	2021-06-18	
J	Annegers, JF; Hauser, WA; Coan, SP; Rocca, WA				Annegers, JF; Hauser, WA; Coan, SP; Rocca, WA			A population-based study of seizures after traumatic brain injuries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPILEPSY	Background The risk of seizures is increased after traumatic brain injury, but the extent and duration of the increase in risk are unknown. The purpose of this study was to identify the characteristics of brain injuries that are associated with the development of seizures. Methods We identified 4541 children and adults with traumatic brain injury (characterized by loss of consciousness, post-traumatic amnesia, or skull fracture) in Olmsted County, Minnesota, during the period from 1935 through 1984. Injuries were classified as mild (loss of consciousness or amnesia lasting less than 30 minutes), moderate (loss of consciousness for 30 minutes to 24 hours or a skull fracture), or severe (loss of consciousness or amnesia for more than 24 hours, subdural hematoma, or brain contusion). We compared the incidence of new unprovoked seizures in this cohort with population rates, using standardized incidence ratios and Cox proportional-hazards analysis. Results The overall standardized incidence ratio was 3.1 (95 percent confidence interval, 2.5 to 3.8). The standardized incidence ratio was 1.5 (95 percent confidence interval, 1.0 to 2.2) after mild injuries but with no increase over the expected number after five years, 2.9 (95 percent confidence interval, 1.9 to 4.1) after moderate injuries, and 17.0 (95 percent confidence interval, 12.3 to 23.6) after severe injuries, In the multivariate analysis, significant risk factors for later seizures were brain contusion with subdural hematoma, skull fracture, loss of consciousness or amnesia for more than one day, and an age of 65 years or older. Conclusions The increased risk of seizures after traumatic brain injury varies greatly according to the severity of the injury and the time since the injury. (C) 1998, Massachusetts Medical Society.	Univ Texas, Sch Publ Hlth, Houston, TX 77225 USA; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Annegers, JF (corresponding author), Univ Texas, Sch Publ Hlth, POB 20186, Houston, TX 77225 USA.		Ritter, Stefanie L/D-9312-2012; Hauser, W Allen/AAB-5277-2020; Rocca, Walter/Z-5335-2019		NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR30582] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS16308] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR030582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS016308] Funding Source: NIH RePORTER		ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1976, EPILEPSIA, V17, P1, DOI 10.1111/j.1528-1157.1976.tb03375.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Jennett B, 1975, EPILEPSY NONMISSILE; KLEINBAUM DG, 1986, EPIDEMIOLOGIC RES PR, P103; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; PENFIELD W, 1945, RES PUBL ASSOC RES N, V24, P620; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; *STATACORP, 1997, STATA REF MAN REL 5, V1; WALKER AE, 1989, SURG NEUROL, V32, P235, DOI 10.1016/0090-3019(89)90185-7; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	12	588	610	1	30	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	1998	338	1					20	24		10.1056/NEJM199801013380104			5	Medicine, General & Internal	General & Internal Medicine	YN801	WOS:000071209200004	9414327				2021-06-18	
J	Perel, P; Arango, M; Clayton, T; Edwards, P; Komolafe, E; Pocock, S; Roberts, I; Shakur, H; Steyerberg, E; Yutthakasemsunt, S				Perel, Pablo; Arango, Miguel; Clayton, Tim; Edwards, Phil; Komolafe, Edward; Pocock, Stuart; Roberts, Ian; Shakur, Haleema; Steyerberg, Ewout; Yutthakasemsunt, Surakrant		MRC CRASH Trial Collaborators	Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; MRC CRASH; MANAGEMENT; COUNTRIES; VARIABLES; ADULTS	Objective To develop and validate practical prognostic models for death at 14 days and for death or severe disability six months after traumatic brain injury. Design Multivariable logistic regression to select variables that were independently associated with two patient outcomes. Two models designed: "basic" model (demographic and clinical variables only) and "CT" model (basic model plus results of computed tomography). The models were subsequently developed for high and low-middle income countries separately. Setting Medical Research Council (MRC) CRASH Trial. Subjects 10 008 patients with traumatic brain injury. Models externally validated in a cohort of 8509. Results The basic model included four predictors: age, Glasgow coma scale, pupil reactivity, and the presence of major extracranial injury. The CT model also included the presence of petechial haemorrhages, obliteration of the third ventricle or basal cisterns, subarachnoid bleeding, midline shift, and non-evacuated haematoma. In the derivation sample the models showed excellent discrimination (C statistic above 0.80). The models showed good calibration graphically. The Hosmer-Lemeshow test also indicated good calibration, except for the CT model in low-middle income countries. External validation for unfavourable outcome at six months in high income countries showed that basic and CT models had good discrimination (C statistic 0.77 for both models) but poorer calibration. Conclusion Simple prognostic models can be used to obtain valid predictions of relevant outcomes in patients with traumatic brain injury.	[Perel, Pablo] London Sch Hyg & Trop Med, London WC1B 3DP, England	Perel, P (corresponding author), London Sch Hyg & Trop Med, London WC1B 3DP, England.	Pablo.perel@lshtm.ac.uk	Nabil H, khalil/A-9528-2015; Abdullah, J/C-2828-2011; LORIA-CASTELLANOS, JORGE/N-2363-2019; LORIA-CASTELLANOS, JORGE/J-2410-2016; Gallardo, Angel Jesus Lacerda/AAZ-9478-2020; Chytra, Ivan/B-2075-2008	Nabil H, khalil/0000-0001-6293-7972; Abdullah, J/0000-0002-0258-7410; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000; Maliawan, Prof. Sri/0000-0002-6151-3155; Chytra, Ivan/0000-0001-5342-5537; /0000-0002-2342-301X; Maliawan, Sri/0000-0003-2389-3481; Ochoa-Parra, Marcelo/0000-0003-0432-8962; Clayton, Tim/0000-0002-1266-3288; Cakar, Nahit/0000-0002-1302-9596; Kramar, Filip/0000-0003-0833-2360; Edwards, Phil/0000-0003-4431-8822; Shakur-Still, Haleema/0000-0002-6511-109X			Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; *BRAIN TRAUM FDN U, 2000, MAN PROGN SEV TRAUM; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Edwards P, 2005, LANCET, V365, P1957; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JENNETT B, 1975, LANCET, V1, P480; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; World Bank, 2006, WORLD DEV IND	22	582	589	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					425	429		10.1136/bmj.39461.643438.25			9	Medicine, General & Internal	General & Internal Medicine	269QM	WOS:000253664000037	18270239	Green Published, Bronze, Green Accepted			2021-06-18	
J	Taub, E; Uswatte, G; Pidikiti, R				Taub, E; Uswatte, G; Pidikiti, R			Constraint-Induced Movement Therapy: A new family of techniques with broad application to physical rehabilitation - A clinical review	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cerebrovascular accident; CVA; focal hand dystonia; fractured hip; phantom limb pain; physical therapy; rehabilitation; spinal cord injury; traumatic brain injury	MYOGRAPHIC BIOFEEDBACK APPLICATIONS; NONAMBULATORY HEMIPARETIC PATIENTS; FREQUENCY-DISCRIMINATION TASK; BODY-WEIGHT SUPPORT; PHANTOM-LIMB PAIN; ADULT OWL MONKEYS; CORTICAL REORGANIZATION; SOMATOSENSORY CORTEX; UPPER-EXTREMITY; STROKE REHABILITATION	A new family of rehabilitation techniques, termed Constraint-Induced Movement Therapy or CI Therapy, has been developed that controlled experiments have shown is effective in producing large improvements in limb use in the real-world environment after cerebrovascular accident (CVA). The signature therapy involves constraining movements of the less-affected arm with a sling for 90% of waking hours for 2 weeks, while intensively training use of the more-affected arm. The common therapeutic factor in all CI Therapy techniques would appear to be inducing concentrated, repetitive practice of use of the more-affected limb. A number of neuroimaging and transcranial magnetic stimulation studies have shown that the massed practice of CI Therapy produces a massive use-dependent cortical reorganization that increases the area of cortex involved in the innervation of movement of the more-affected limb. The CI Therapy approach has been used successfully to date for the upper limb of patients with chronic and subacute CVA and patients with chronic traumatic brain injury and for the lower limb of patients with CVA, incomplete spinal cord injury, and fractured hip. The approach has recently been extended to focal hand dystonia of musicians and possibly phantom limb pain.	Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; Birmingham Dept Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Birmingham, AL 35233 USA	Taub, E (corresponding author), Univ Alabama Birmingham, Dept Psychol, CH415,1530 3rd Ave S, Birmingham, AL 35294 USA.	etaub@uab.edu	Uswatte, Gitendra/C-4913-2009				ANDREWS K, 1979, RHEUMATOL REHABIL, V18, P43, DOI 10.1093/rheumatology/18.1.43; Azrin N. H., 1966, OPERANT BEHAVIOR ARE, P380; Bach-y-Rita P, 1992, J NEUROL REHABIL, V6, P191, DOI [10.1177/136140969200600404, DOI 10.1177/136140969200600404]; BACHYRITA P, 1990, CAN J PSYCHOL, V44, P148, DOI 10.1037/h0084247; BALLIET R, 1986, ARCH PHYS MED REHAB, V67, P304; BASMAJIAN JV, 1975, ARCH PHYS MED REHAB, V56, P231; BASMAJIAN JV, 1977, GERIATRICS, V32, P85; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Candia V, 1999, LANCET, V353, P42, DOI 10.1016/S0140-6736(05)74865-0; Catania A.C., 1998, LEARNING, Vinterim 4th; CHAMBERS W W, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P721; Cohen J., 1997, STAT POWER ANAL BEHA; Crocker MD, 1997, AM J OCCUP THER, V51, P824, DOI 10.5014/ajot.51.10.824; DAVIS P, 1998, AM HEART ASS 23 INT; DEPEDROCUESTA J, 1992, ACTA NEUROL SCAND, V86, P433; DESAI V, 1991, S COND M ASS APPL PS; DOBKIN B, 1995, NEUROLOGY, V45, pS6; Duncan P W, 1997, Top Stroke Rehabil, V3, P1, DOI 10.1080/10749357.1997.11754126; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Elbert T, 1995, SCIENCE, V220, P21; ERNST E, 1990, STROKE, V21, P1081, DOI 10.1161/01.STR.21.7.1081; Estes WK, 1944, PSYCHOL MONOGR, V57, P1; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Franz S. I., 1915, JAMA-J AM MED ASSOC, V65, P2150, DOI [DOI 10.1001/JAMA.1915.02580250022007, 10.1001/jama.1915.02580250022007]; HALBERSTAM J L, 1971, Archives of Physical Medicine and Rehabilitation, V52, P318; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; INCE LP, 1969, PSYCHON SCI, V16, P49; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82; KNAPP HD, 1963, EXP NEUROL, V7, P305, DOI 10.1016/0014-4886(63)90077-3; KNAPP HD, 1958, SCIENCE, V128, P842, DOI 10.1126/science.128.3328.842; Kopp B, 1997, ARCH PHYS MED REHAB, V78, P615, DOI 10.1016/S0003-9993(97)90427-5; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Lashley KS, 1924, ARCH NEURO PSYCHIATR, V12, P249, DOI 10.1001/archneurpsyc.1924.02200030002001; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; MCCULLOCH K, 1988, ARCH PHYS MED REHAB, V69, P755; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; MORGAN WG, 1974, BEHAV THER, V5, P271, DOI 10.1016/S0005-7894(74)80144-9; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ogden R, 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; OSTENDORF CG, 1981, PHYS THER, V61, P1022, DOI 10.1093/ptj/61.7.1022; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Panyan M.V., 1980, USE SHAPING; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Sherrington CS., 1894, P ROY SOC LONDON, V57, P481, DOI DOI 10.1098/RSP1.1894.0179; Skinner B. F., 1968, TECHNOLOGY TEACHING; SKINNER BF, 1938, BEHAV ORGANIMS; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Stineman MG, 1997, STROKE, V28, P550, DOI 10.1161/01.STR.28.3.550; TAUB E, 1975, EXP NEUROL, V46, P178, DOI 10.1016/0014-4886(75)90040-0; TAUB E, 1965, J COMP PHYSIOL PSYCH, V59, P275, DOI 10.1037/h0021817; Taub E, 1997, Top Stroke Rehabil, V3, P38, DOI 10.1080/10749357.1997.11754128; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; TAUB E, 1995, BIOBEHAVIORAL SELF-REGULATION, P2; TAUB E, 1973, SCIENCE, V181, P959, DOI 10.1126/science.181.4103.959; TAUB E, 1975, BIOL PSYCHIAT, V10, P609; TAUB E, 1963, J COMP PHYSIOL PSYCH, V56, P1012, DOI 10.1037/h0048315; TAUB E, 1994, PL S BEHAV, P185; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; Taub E, 1996, COMP NEUR R, V9, P133; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; TAUB E, 1995, SFI STUDIES SCI COMP, P201; TAUB E, IN PRESS HDB REHABIL; TAUB E, 1977, BIOMECHANICS, V6, P125; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub E, 1968, NEUROPSYCHOL SPATIAL, P173; TAUB E, 1976, NEURAL CONTROL LOCOM, P675; TAUB E, 1966, PSYCHON SCI, V4, P323; Tower SS, 1940, BRAIN, V63, P36, DOI 10.1093/brain/63.1.36; TRIES J, 1989, BIOFEEDBACK SELF-REG, V14, P21, DOI 10.1007/BF00999339; TWITCHELL TE, 1954, J NEUROPHYSIOL, V17, P239; *US DEP VET AFF, 1998, ANN REP SECR VET AFF; USWATTE G, IN PRESS COGNITIVE N; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEISS T, IN PRESS NEUROSCI LE; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; WOLF SL, 1983, PHYS THER, V63, P1448, DOI 10.1093/ptj/63.9.1448; WOLF SL, 1983, PHYS THER, V63, P1393, DOI 10.1093/ptj/63.9.1393; YANG TT, 1994, NATURE, V368, P592, DOI 10.1038/368592b0	91	579	618	5	117	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	JUL	1999	36	3					237	251					15	Rehabilitation	Rehabilitation	288VJ	WOS:000085584900011	10659807				2021-06-18	
J	Unterberg, AW; Stover, J; Kress, B; Kiening, KL				Unterberg, AW; Stover, J; Kress, B; Kiening, KL			Edema and brain trauma	NEUROSCIENCE			English	Article						blood brain barrier; brain edema; traumatic brain injury; cerebral perfusion pressure; intracranial pressure; aquaporin	CORTICAL IMPACT INJURY; BLOOD-BRAIN; CEREBRAL CONTUSION; WATER TRANSPORT; AQUAPORIN-4 EXPRESSION; ARTERIAL HYPERTENSION; RAT ASTROCYTES; DIFFUSION MRI; HEAD-INJURY; GLUTAMATE	Brain edema leading to an expansion of brain volume has a crucial impact on morbidity and mortality following traumatic brain injury (TBI) as it increases intracranial pressure, impairs cerebral perfusion and oxygenation, and contributes to additional ischemic injuries. Classically, two major types of traumatic brain edema exist: "vasogenic" due to blood-brain barrier (BBB) disruption resulting in extracellular water accumulation and "cytotoxic/cellular" due to sustained intracellular water collection. A third type, "osmotic" brain edema is caused by osmotic imbalances between blood and tissue. Rarely after TBI do we encounter a "hydrocephalic edema/interstitial" brain edema related to an obstruction of cerebrospinal fluid outflow. Following TBI, various mediators are released which enhance vasogenic and/or cytotoxic brain edema. These include glutamate, lactate, H+, K+, Ca2+, nitric oxide, arachidonic acid and its metabolites, free oxygen radicals, histamine, and kinins. Thus, avoiding cerebral anaerobic metabolism and acidosis is beneficial to control lactate and H+, but no compound inhibiting mediators/mediator channels showed beneficial results in conducted clinical trials, despite successful experimental studies. Hence, antiedematous therapy in TBI patients is still symptomatic and rather non-specific (e.g. mannitol infusion, controlled hyperventilation). For many years, vasogenic brain edema was accepted as the prevalent edema type following TBI. The development of mechanical TBI models ("weight drop," "fluid percussion injury," and "controlled cortical impact injury") and the use of magnetic resonance imaging, however, revealed that "cytotoxic" edema is of decisive pathophysiological importance following TBI as it develops early and persists while BBB integrity is gradually restored. These findings suggest that cytotoxic and vasogenic brain edema are two entities which can be targeted simultaneously or according to their temporal prevalence. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.	Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; Univ Zurich Hosp, Dept Surg, Div Surg Intens Care Med, CH-8091 Zurich, Switzerland; Heidelberg Univ, Div Neuroradiol, Heidelberg, Germany	Unterberg, AW (corresponding author), Heidelberg Univ, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	andreas.unterberg@med.uni-heidelberg.de					Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Amorini AM, 2003, ACT NEUR S, V86, P261; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; AVERY S, 1984, J NEUROL NEUROSUR PS, V47, P604, DOI 10.1136/jnnp.47.6.604; Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P119; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Beaumont A, 2000, ACT NEUR S, V76, P147; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P453; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; BULLOCK R, 1990, ACT NEUR S, V51, P286; Cheney JA, 2001, J CEREBR BLOOD F MET, V21, P396, DOI 10.1097/00004647-200104000-00008; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fukui S, 2003, ACT NEUR S, V86, P301; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HOSSMANN KA, 1980, STROKE, V11, P583, DOI 10.1161/01.STR.11.6.583; Ikeda Y, 2000, ACT NEUR S, V76, P343; Ikeda Y, 2000, ACT NEUR S, V76, P195; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Maeda T, 2003, ACT NEUR S, V86, P329; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nakahama K, 1999, GLIA, V25, P240, DOI 10.1002/(SICI)1098-1136(19990201)25:3<240::AID-GLIA4>3.3.CO;2-3; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pappius H.M., 1974, HDB CLIN NEUROLOGY 1, V16, P167; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Reichardt M, 1905, DTSCH Z NERVENHEILK, V28, P306; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Saadoun S, 2003, J CLIN PATHOL, V56, P972, DOI 10.1136/jcp.56.12.972; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Sato S, 2000, ACTA NEUROCHIR SUPPL, V76, P239; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; SCHUIER FJ, 1980, STROKE, V11, P593, DOI 10.1161/01.STR.11.6.593; SCHUTTA HS, 1968, J NEUROPATH EXP NEUR, V27, P130; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; STAUB F, 1993, BRAIN RES, V610, P69, DOI 10.1016/0006-8993(93)91218-H; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Stover John F, 2003, Med Sci Monit, V9, pBR382; Stoves J, 2001, NEPHROL DIAL TRANSPL, V16, P171, DOI 10.1093/ndt/16.1.171; Stroop R, 1998, ACT NEUR S, V71, P303; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2000, NEUROSURGERY SCI BAS, P410; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Yamamoto N, 2002, MOL BRAIN RES, V104, P96, DOI 10.1016/S0169-328X(02)00322-4; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X	81	578	605	2	76	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2004	129	4					1021	1029		10.1016/j.neuroscience.2004.06.046			9	Neurosciences	Neurosciences & Neurology	879OB	WOS:000225726000016	15561417				2021-06-18	
J	Omalu, BI; DeKosky, ST; Minster, RL; Kamboh, MI; Hamilton, RL; Wecht, CH				Omalu, BI; DeKosky, ST; Minster, RL; Kamboh, MI; Hamilton, RL; Wecht, CH			Chronic traumatic encephalopathy in a National Football League player	NEUROSURGERY			English	Article						chronic traumatic encephalopathy; National Football League; retired professional football players	APOLIPOPROTEIN-E EPSILON-4; POST CONCUSSION SYNDROME; AMYLOID BETA-PROTEIN; BRAIN-INJURY; HEAD-INJURY; PROFESSIONAL FOOTBALL; NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; SOCCER INJURIES; POLYMORPHISM	OBJECTIVE: We present the results of the autopsy of a retired professional football player that revealed neuropathological changes consistent with long-term repetitive concussive brain injury. This case draws attention to the need for further studies in the cohort of retired National Football League players to elucidate the neuropathological sequelae of repeated mild traumatic brain injury in professional football. METHODS: The patient's premortern medical history included symptoms of cognitive impairment, a mood disorder, and parkinsonian symptoms. There was no family history of Alzheimer's disease or any other head trauma outside football. A complete autopsy with a comprehensive neuropathological examination was performed on the retired National Football League player approximately 12 years after retirement. He died suddenly as a result of coronary atherosclerotic disease. Studies included determination of apolipoprotein E genotype. RESULTS: Autopsy confirmed the presence of coronary atherosclerotic disease with dilated cardiomyopathy. The brain demonstrated no cortical atrophy, cortical contusion, hemorrhage, or infarcts. The substantia nigra revealed mild pallor with mild dropout of pigmented neurons. There was mild neuronal dropout in the frontal, parietal, and temporal neocortex. Chronic traumatic encephalopathy was evident with many diffuse amyloid plaques as well as sparse neurofibrillary tangles and T-positive neuritic threads in neocortical areas. There were no neurofibrillary tangles or neuropil threads in the hippocampus or entorhinal cortex. Lewy bodies were absent. The apolipoprotein E genotype was E3/E3. CONCLUSION: This case highlights potential long-term neurodegenerative outcomes in retired professional National Football League players subjected to repeated mild traumatic brain injury. The prevalence and pathoetiological mechanisms of these possible adverse long-term outcomes and their relation to duration of years of playing football have not been sufficiently studied. We recommend comprehensive clinical and forensic approaches to understand and further elucidate this emergent professional sport hazard.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15221 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15221 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15221 USA	Omalu, BI (corresponding author), Univ Pittsburgh, Dept Pathol, 7520 Penn Bridge Court, Pittsburgh, PA 15221 USA.	bennet.omalu@verizon.net		Minster, Ryan/0000-0001-7382-6717; Kamboh, M. Ilyas/0000-0002-3453-1438; DeKosky, Steven/0000-0003-3743-2758			Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aotsuka A, 1990, Rinsho Shinkeigaku, V30, P1243; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Jin ZQ, 2004, ACTA PHARMACOL SIN, V25, P352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Mathis CA, 2004, CURR PHARM DESIGN, V10, P1469, DOI 10.2174/1381612043384772; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; ROBERTS GW, 1988, LANCET, V2, P1456; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Tagliabue P, 2003, NEUROSURGERY, V53, P796, DOI 10.1227/01.NEU.0000083559.68424.3F; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; 1976, LANCET, V1, P401	42	573	576	3	225	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUL	2005	57	1					128	133		10.1227/01.NEU.0000163407.92769.ED			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	942ZQ	WOS:000230321800036	15987548				2021-06-18	
J	McCrory, P; Johnston, K; Meeuwisse, W; Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Kelly, J; Lovell, M; Schamasch, P				McCrory, P; Johnston, K; Meeuwisse, W; Aubry, M; Cantu, R; Dvorak, J; Graf-Baumann, T; Kelly, J; Lovell, M; Schamasch, P			Summary and agreement statement of the 2nd International Conference on Concussion in Sport, Prague 2004	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E EPSILON-4; AMYLOID BETA-PROTEIN; HEAD-INJURY; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; SEVERITY; SYMPTOMS; ORIENTATION; PERFORMANCE	In November 2001, the 1st International Symposium on Concussion in Sport was held in Vienna, Austria to provide recommendations for the improvement of safety and health of athletes who suffer concussive injuries in ice hockey, football (soccer), and other sports. The 2nd International Symposium on Concussion in Sport was organised by the same group and held in Prague, Czech Republic in November 2004. It resulted in a revision and update of the Vienna consensus recommendations, which are presented here.	Emerson Hosp, Dept Surg, Concord, MA USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Emerson Hosp, Sports Med Serv, Concord, MA USA; Natl Ctr Catastroph Sports Injury Res, Chapel Hill, NC USA; Schulthess Clin, Dept Neurol, Zurich, Switzerland; FIFA Med Res & Assessment Ctr, Zurich, Switzerland; German Soc Musculoskeletal Med & Pain Therapy, FIFA Med Res & Assessment Ctr, Off Sci Management, Teningen, Germany; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H3A 2T5, Canada; McGill Sport Med Ctr, Concuss Program, Montreal, PQ, Canada; Univ Colorado, Sch Med, Denver, CO USA; Univ Pittsburgh, Sports Med Concuss Program, Pittsburgh, PA USA; Natl Hockey League Neuropsychol Program, Pittsburgh, PA USA; Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; Univ Melbourne, Brain Res Inst, Melbourne, Vic, Australia; Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; Natl Hockey League, Calgary, AB, Canada; Int Olymp Comm, Lausanne, Switzerland	McCrory, P (corresponding author), POB 93, Shoreham, Vic 3916, Australia.	paulmccr@bigpond.net.au					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; AUBRY M, 2002, PHYSICIAN SPORTSMED, V36, P3; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu R, 2004, LANCET NEUROL, V3, P437; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; COLLIE A, 2001, IN PRESS BR J SPORTS, V35; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; CREMONAMEYTARD SL, 1993, LIFE CYCLE DEV MATUR, P137; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DUPUIS F, 2005, IN PRESS CLIN J SPOR; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Gross R, 1997, JAMA-J AM MED ASSOC, V278, P2143, DOI 10.1001/jama.1997.03550240033025; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; IGEBRIGTSEN T, 1997, J CLIN NEUROSCI, V4, P29; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katzman R, 1996, NEUROLOGY, V46, P889; KELLY J, 2004, AM J NEURORADIOL, V25, P738; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MCCRORY P, 1996, SMA ACSP ANN SCI C 1, P214; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McIntosh TK, 1996, LAB INVEST, V74, P315; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Turner M., 1998, JOCK CLUB C HEAD INJ; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863	65	571	573	0	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2005	39			1			I78	I86		10.1136/bjsm.2005.018614			9	Sport Sciences	Sport Sciences	954KI	WOS:000231153600011	15793085	Green Published, Bronze			2021-06-18	
J	Goldstein, LE; Fisher, AM; Tagge, CA; Zhang, XL; Velisek, L; Sullivan, JA; Upreti, C; Kracht, JM; Ericsson, M; Wojnarowicz, MW; Goletiani, CJ; Maglakelidze, GM; Casey, N; Moncaster, JA; Minaeva, O; Moir, RD; Nowinski, CJ; Stern, RA; Cantu, RC; Geiling, J; Blusztajn, JK; Wolozin, BL; Ikezu, T; Stein, TD; Budson, AE; Kowall, NW; Chargin, D; Sharon, A; Saman, S; Hall, GF; Moss, WC; Cleveland, RO; Tanzi, RE; Stanton, PK; McKee, AC				Goldstein, Lee E.; Fisher, Andrew M.; Tagge, Chad A.; Zhang, Xiao-Lei; Velisek, Libor; Sullivan, John A.; Upreti, Chirag; Kracht, Jonathan M.; Ericsson, Maria; Wojnarowicz, Mark W.; Goletiani, Cezar J.; Maglakelidze, Giorgi M.; Casey, Noel; Moncaster, Juliet A.; Minaeva, Olga; Moir, Robert D.; Nowinski, Christopher J.; Stern, Robert A.; Cantu, Robert C.; Geiling, James; Blusztajn, Jan K.; Wolozin, Benjamin L.; Ikezu, Tsuneya; Stein, Thor D.; Budson, Andrew E.; Kowall, Neil W.; Chargin, David; Sharon, Andre; Saman, Sudad; Hall, Garth F.; Moss, William C.; Cleveland, Robin O.; Tanzi, Rudolph E.; Stanton, Patric K.; McKee, Ann C.			Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model	SCIENCE TRANSLATIONAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; LOCAL PROTEIN-SYNTHESIS; DIFFUSE AXONAL INJURY; BRAIN-INJURY; HEAD-INJURY; EXPLOSIVE BLAST; SHOCK-WAVE; RAT-BRAIN; IRAQ-WAR; FOOTBALL	Blast exposure is associated with traumatic brain injury (TBI), neuropsychiatric symptoms, and long-term cognitive disability. We examined a case series of postmortem brains from U. S. military veterans exposed to blast and/or concussive injury. We found evidence of chronic traumatic encephalopathy (CTE), a tau protein-linked neuro-degenerative disease, that was similar to the CTE neuropathology observed in young amateur American football players and a professional wrestler with histories of concussive injuries. We developed a blast neurotrauma mouse model that recapitulated CTE-linked neuropathology in wild-type C57BL/6 mice 2 weeks after exposure to a single blast. Blast-exposed mice demonstrated phosphorylated tauopathy, myelinated axonopathy, microvasculopathy, chronic neuroinflammation, and neurodegeneration in the absence of macroscopic tissue damage or hemorrhage. Blast exposure induced persistent hippocampal-dependent learning and memory deficits that persisted for at least 1 month and correlated with impaired axonal conduction and defective activity-dependent long-term potentiation of synaptic transmission. Intracerebral pressure recordings demonstrated that shock waves traversed the mouse brain with minimal change and without thoracic contributions. Kinematic analysis revealed blast-induced head oscillation at accelerations sufficient to cause brain injury. Head immobilization during blast exposure prevented blast-induced learning and memory deficits. The contribution of blast wind to injurious head acceleration may be a primary injury mechanism leading to blast-related TBI and CTE. These results identify common pathogenic determinants leading to CTE in blast-exposed military veterans and head-injured athletes and additionally provide mechanistic evidence linking blast exposure to persistent impairments in neurophysiological function, learning, and memory.	[Goldstein, Lee E.; Fisher, Andrew M.; Tagge, Chad A.; Wojnarowicz, Mark W.; Casey, Noel; Moncaster, Juliet A.; Minaeva, Olga] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Goldstein, Lee E.; Stern, Robert A.; Blusztajn, Jan K.; Wolozin, Benjamin L.; Ikezu, Tsuneya; Stein, Thor D.; Budson, Andrew E.; Kowall, Neil W.; McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Goldstein, Lee E.; Casey, Noel; Moncaster, Juliet A.; Minaeva, Olga] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Goldstein, Lee E.; Fisher, Andrew M.; Tagge, Chad A.; Kracht, Jonathan M.; Minaeva, Olga; Sharon, Andre] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Zhang, Xiao-Lei; Velisek, Libor; Sullivan, John A.; Upreti, Chirag; Goletiani, Cezar J.; Maglakelidze, Giorgi M.; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Ericsson, Maria] Harvard Univ, Sch Med, Electron Microscope Facil, Boston, MA 02115 USA; [Moir, Robert D.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Nowinski, Christopher J.; Stern, Robert A.; Cantu, Robert C.; McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA; [Geiling, James] Vet Affairs Med Ctr, Dept Med, White River Jct, VT 05009 USA; [Stein, Thor D.; Budson, Andrew E.; Kowall, Neil W.; McKee, Ann C.] Vet Affairs Boston Healthcare Syst, Neurol Serv, Boston, MA 02130 USA; [Chargin, David; Sharon, Andre] Boston Univ, Fraunhofer Ctr Mfg Innovat, Brookline, MA 02446 USA; [Saman, Sudad; Hall, Garth F.] Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA; [Cleveland, Robin O.] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX3 7DQ, England; [Moss, William C.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA	Goldstein, LE (corresponding author), Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA.	lgold@bu.edu; amckee@bu.edu	Velisek, Libor/AAA-1151-2020; Tanzi, Rudolph/AAE-9622-2019; Ritter, Stefanie L/D-9312-2012; Moir, Robert D./M-7612-2017; , Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019; Cleveland, Robin/G-9468-2013	Velisek, Libor/0000-0003-2805-349X; Tanzi, Rudolph/0000-0002-7032-1454; Moir, Robert D./0000-0001-5431-3553; Kowall, Neil/0000-0002-6624-0213; Moncaster, Juliet/0000-0002-7849-4325; Goldstein, Lee/0000-0001-8419-9800; Stern, Robert/0000-0002-5008-077X; /0000-0001-8438-3122; Stein, Thor/0000-0001-6954-4477; Ikezu, Tsuneya/0000-0002-3979-8596	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM75986]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026599]; NSFNational Science Foundation (NSF) [0901760, 0821304]; Cure Alzheimer's Fund; Office of the Dean, Boston University School of Medicine; Office of the Provost, Boston University; Boston University Photonics Center Neurophotonics; U.S. Army and Boston University Photonics Center [W911NG-06-2-0040]; Department of Veterans AffairsUS Department of Veterans Affairs [W911NG-06-2-0040]; Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Center [P30AG13846, 0572063345-5]; NIH/National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5T32EB006359]; NIH/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS077796]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK043881]; National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS044421, NS072966, R01NS078337]; Department of DefenseUnited States Department of Defense [W81XWH]; Migraine Research Foundation; March of Dimes FoundationMarch of Dimes [6FY08591]; National Operating Committee on Standards for Athletic Equipment; Department of EnergyUnited States Department of Energy (DOE) [DE-AC52-07NA27344]; agency of the U.S. government; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI081990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB006359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK043881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS066108, R01NS060872, R56NS044421, RC4NS072966, R01NS078337, F31NS077796, R21NS073679, R01NS044421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [0901503] Funding Source: National Science Foundation	Supported by National Institute of General Medical Sciences grant GM75986 (L.E.G.); National Center for Research Resources grant S10RR026599 (L.E.G.); NSF grants 0901760 and 0821304 (L.E.G.); Cure Alzheimer's Fund (L.E.G., R.D.M., and R.E.T.), Office of the Dean, Boston University School of Medicine; Office of the Provost, Boston University (L.E.G.); Boston University Photonics Center Neurophotonics Pilot Project Grant (L.E.G.); Cooperative Agreement W911NG-06-2-0040 between the U.S. Army and Boston University Photonics Center (L.E.G.); Department of Veterans Affairs (A.C.M.); Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C; A.C.M., L.E.G.); National Institute of Aging Center grant P30AG13846 (N.W.K.), Supplement 0572063345-5 (N.W.K.), and Pilot Project Grant (N.C.); NIH/National Institute of Biomedical Imaging and Bioengineering T32 Training Grant Award 5T32EB006359 and NIH/National Institute of Neurological Disorders and Stroke Pre-Doctoral Fellowship Research grant F31NS077796 (C.A.T.); National Institute of Diabetes and Digestive and Kidney Diseases grant P01DK043881 (R.O. C.); National Institute of Neurological Diseases and Stroke grants NS044421 (P.K.S.), NS072966 (L.V.), and R01NS078337 (R.A.S.); Department of Defense grant W81XWH (P.K.S.); Migraine Research Foundation (P.K.S.); March of Dimes Foundation grant 6FY08591 (L.V.); National Operating Committee on Standards for Athletic Equipment (A.C.M.); an unrestricted gift from the National Football League (A.C.M.); and Department of Energy Contract DE-AC52-07NA27344 to the Lawrence Livermore National Laboratory (W.C.M.).; F.H. is a Science Advisory Board member of Immunotrex Biologics Inc. The other authors declare that they have no competing interests. The views expressed in this article are those of authors J.G., A. E. B., N.W.K., and A.C.M. and should not to be construed as official positions of the Department of Veterans Affairs or the U.S. government. Portions of this document were prepared, in part, as an account of work by W.C.M. sponsored by an agency of the U.S. government. Neither the U.S. government nor Lawrence Livermore National Security, LLC, nor any of their employees makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the U.S. government or Lawrence Livermore National Security, LLC. The views and opinions of author W.C.M. expressed herein do not necessarily state or reflect those of the U.S. government or Lawrence Livermore National Security, LLC, and shall not be used for advertising or product endorsement purposes.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; [Anonymous], 2011, TRITON REP; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; Blackstock D. T., 2000, FUNDAMENTALS PHYS AC, P146; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; COHEN H, 1946, ARCH PATHOL, V42, P12; Crum LA, 1996, J ACOUST SOC AM, V99, P2898, DOI 10.1121/1.414859; Cullis I G, 2001, J R Army Med Corps, V147, P16; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; Department of Veterans Affairs and Department of Defense, CLIN PRACT GUID MAN; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Evan AP, 2002, J UROLOGY, V168, P1556, DOI 10.1016/S0022-5347(05)64520-X; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Formby SA, 1996, J HAZARD MATER, V50, P183, DOI 10.1016/0304-3894(96)01791-8; Fulton J. F., 1942, NEW ENGL J MED, V226, P1; Gennarelli T. A., 1993, BIOMECHANICS IMPACT; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; Hyde D. W., 2004, CONWEP 2 1 0 8 CONV; Hynynen K, 2003, ULTRASOUND MED BIOL, V29, P473, DOI 10.1016/S0301-5629(02)00741-X; Ito U, 2011, J CEREBR BLOOD F MET, V31, P328, DOI 10.1038/jcbfm.2010.97; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott F. W., 1916, LANCET, V187, P331; Mott F. W., 1916, LANCET, V187, P545; Mott F. W., 1916, LANCET, V187, P441; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nelson TJ, 2008, J TRAUMA, V65, P212, DOI 10.1097/01.ta.0000196010.50246.9a; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Phillips Y., 1990, TXB MILITARY MED 1, V5, P221; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Richmond D. R., 1967, 1854 DASA FISS PROD, P1; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STRICH SJ, 1961, LANCET, V2, P443; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Jackson Laboratory, MPD JAXPHENO1 MOUS P; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	87	567	568	24	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	MAY 16	2012	4	134							134ra60	10.1126/scitranslmed.3003716			16	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	943KY	WOS:000304121500003	22593173	Green Accepted	Y	N	2021-06-18	
J	Baumgart, M; Snyder, HM; Carrillo, MC; Fazio, S; Kim, H; Johns, H				Baumgart, Matthew; Snyder, Heather M.; Carrillo, Maria C.; Fazio, Sam; Kim, Hye; Johns, Harry			Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective	ALZHEIMERS & DEMENTIA			English	Article						World Dementia Council; Alzheimer's Association; Alzheimer's disease; Cognitive decline; Dementia; Risk factors; Modifiable risk factors; Cardiovascular disease risk factors; Lifestyle risk factors; Physical activity; Diabetes; Obesity; Smolcing; Hypertension; Diet; Lifelong learning; Cognitive training	TRAUMATIC BRAIN-INJURY; INCIDENT ALZHEIMER-DISEASE; LATE-LIFE; PHYSICAL-ACTIVITY; OLDER-ADULTS; ALCOHOL-CONSUMPTION; HEAD-INJURY; ANTIHYPERTENSIVE DRUGS; SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS	An estimated 47 million people worldwide are living with dementia in 2015, and this number is projected to triple by 2050. In the absence of a disease-modifying treatment or cure, reducing the risk of developing dementia takes on added importance. In 2014, the World Dementia Council (WDC) requested the Alzheimer's Association evaluate and report on the state of the evidence on modifiable risk factors for cognitive decline and dementia. This report is a summary of the Association's evaluation, which was presented at the October 2014 WDC meeting. The Association believes there is sufficient evidence to support the link between several modifiable risk factors and a reduced risk for cognitive decline, and sufficient evidence to suggest that some modifiable risk factors may be associated with reduced risk of dementia. Specifically, the Association believes there is sufficiently strong evidence, from a population-based perspective, to conclude that regular physical activity and management of cardiovascular risk factors (diabetes, obesity, smoking, and hypertension) reduce the risk of cognitive decline and may reduce the risk of dementia. The Association also believes there is sufficiently strong evidence to conclude that a healthy diet and lifelong learning/cognitive training may also reduce the risk of cognitive decline. (C) 2015. The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Baumgart, Matthew; Kim, Hye] Alzheimers Assoc, Div Publ Policy, Washington, DC USA; [Snyder, Heather M.; Carrillo, Maria C.] Alzheimers Assoc, Div Med & Sci Relat, Chicago, IL 60631 USA; [Fazio, Sam] Alzheimers Assoc, Div Constituent Relat, Chicago, IL USA; [Johns, Harry] Alzheimers Assoc, Chicago, IL USA	Snyder, HM (corresponding author), Alzheimers Assoc, Div Med & Sci Relat, Chicago, IL 60631 USA.	hsnyder@alz.org					Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; Angevaren M., 2008, COCHRANE DATABASE SY; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Beri A, 2009, AM J CARDIOVASC DRUG, V9, P361, DOI 10.2165/11315710-000000000-00000; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI 10.1155/2013/197326; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Brown C.L., 2012, J AGING RES, V2012, DOI [10.1155/2012/287438, DOI 10.1155/2012/287438]; Caamano-Isorna F, 2006, NEUROEPIDEMIOLOGY, V26, P226, DOI 10.1159/000093378; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Chang-Quan H, 2011, INT J CLIN PRACT, V65, P1295, DOI 10.1111/j.1742-1241.2011.02810.x; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Corrada M, 2014, ALZHEIMERS DEMENT, V10, pP501, DOI DOI 10.1016/J.JALZ.2014.05.757; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Dahl AK, 2008, J AM GERIATR SOC, V56, P2261, DOI 10.1111/j.1532-5415.2008.01958.x; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Doblhammer G, 2015, ALZHEIMERS DEMENT, V11, P291, DOI 10.1016/j.jalz.2014.02.006; Dodge HH, 2014, J GERONTOL A-BIOL, V69, P687, DOI 10.1093/gerona/glt181; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrow M, 2012, 29 ALZH AUSTR; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Guan JW, 2011, J ALZHEIMERS DIS, V27, P799, DOI 10.3233/JAD-2011-111160; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gustafson DR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt221; Gustafson DR, 2012, J ALZHEIMERS DIS, V28, P162, DOI 10.3233/JAD-2011-110917; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Holtzman RE, 2004, J GERONTOL B-PSYCHOL, V59, pP278, DOI 10.1093/geronb/59.6.P278; Institute for Social Research, 2009, NAT FOOTB LEAG PLAYE; Institute of Medicine, 2015, COGN AG PROGR UND OP; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Jefferson AL, 2011, J AM GERIATR SOC, V59, P1403, DOI 10.1111/j.1532-5415.2011.03499.x; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kennelly SP, 2009, AGEING RES REV, V8, P61, DOI 10.1016/j.arr.2008.11.001; Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mangialasche F, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt104; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; McGuinness B, 2009, COCHRANE DB SYST REV; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; McKenzie J, 2014, WHO TOBACCO KNOWLEDG; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Middleton LE, 2010, J ALZHEIMERS DIS, V20, P915, DOI 10.3233/JAD-2010-091657; Monsuez JJ, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/250970; Morris M. C., 2015, ALZHEIMERS DEMENT; Muangpaisan W, 2010, GERIATR GERONTOL INT, V10, P199, DOI 10.1111/j.1447-0594.2009.00579.x; Mukamal KJ, 2004, J AM GERIATR SOC, V52, P1174, DOI 10.1111/j.1532-5415.2004.52318.x; Mushtaq G, 2014, CNS NEUROL DISORD-DR, V13, P1192, DOI 10.2174/1871527313666140917114537; National Institutes of Health, 2010, NIH CONS DEV C STAT; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Ngandu T., 2015, LANCET; Noice T, 2014, GERONTOLOGIST, V54, P741, DOI 10.1093/geront/gnt138; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Peters R, 2008, AGE AGEING, V37, P505, DOI 10.1093/ageing/afn095; Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI 10.1186/1471-2318-8-36; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Power MC, 2011, EPIDEMIOLOGY, V22, P646, DOI 10.1097/EDE.0b013e31822708b5; Prince M, 2013, POLICY BRIEF HEADS G; Prince MAE., 2014, DEMENTIA RISK REDUCT; Prince MJ., 2015, EPIDEMIOLOGY IMPACT; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Psaltopoulou T, 2013, ANN NEUROL, V74, P580, DOI 10.1002/ana.23944; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Qizilbash N, 2015, LANCET DIABETES ENDO; Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Roberts RO, 2015, NEUROLOGY, V84, P1854, DOI 10.1212/WNL.0000000000001537; Roberts RO, 2014, J NUCL MED, V55, P759, DOI 10.2967/jnumed.113.132647; Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007; Rouch L, 2015, CNS DRUGS, V29, P113, DOI 10.1007/s40263-015-0230-6; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sando SB, 2008, INT J GERIATR PSYCH, V23, P1156, DOI 10.1002/gps.2043; Satizabal CL, 2014, ALZHEIMERS DEMENT S, V10, pP296; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seeman TE, 2011, J GERONTOL B-PSYCHOL, V66, P141, DOI 10.1093/geronb/gbq091; Sellbom KS, 2012, J ALZHEIMERS DIS, V30, pS89, DOI 10.3233/JAD-2011-111073; Shah K, 2009, AM J GERIATR PHARMAC, V7, P250, DOI 10.1016/j.amjopharm.2009.11.001; Sharp SI, 2011, INT J GERIATR PSYCH, V26, P661, DOI 10.1002/gps.2572; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Stern C, 2010, INT J EVID-BASED HEA, V8, P2, DOI 10.1111/j.1744-1609.2010.00150.x; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Sterniczuk R, 2013, CURR ALZHEIMER RES, V10, P767, DOI 10.2174/15672050113109990134; Stine-Morrow EAL, 2008, PSYCHOL AGING, V23, P778, DOI 10.1037/a0014341; UK Health Forum, 2014, PROM BRAIN HLTH DEV; USDA, 2010, DIET GUID AM; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Wilson RS, 2014, NEUROLOGY, V83, P702, DOI 10.1212/WNL.0000000000000715; Woodward M, 2007, 13 ALZH AUSTR; Yaffe K, 2014, LANCET NEUROL, V13, P1017, DOI 10.1016/S1474-4422(14)70172-3; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Zhong GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118333	149	565	577	8	110	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2015	11	6					718	726		10.1016/j.jalz.2015.05.016			9	Clinical Neurology	Neurosciences & Neurology	CL8NR	WOS:000357231900014	26045020	Other Gold	Y	N	2021-06-18	
J	Collins, MW; Grindel, SH; Lovell, MR; Dede, DE; Moser, DJ; Phalin, BR; Nogle, S; Wasik, M; Cordry, D; Daugherty, MK; Sears, SF; Nicolette, G; Indelicato, P; McKeag, DB				Collins, MW; Grindel, SH; Lovell, MR; Dede, DE; Moser, DJ; Phalin, BR; Nogle, S; Wasik, M; Cordry, D; Daugherty, MK; Sears, SF; Nicolette, G; Indelicato, P; McKeag, DB			Relationship between concussion and neuropsychological performance in college football players	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINOR HEAD-INJURY	Context Despite the high prevalence and potentially serious outcomes associated with concussion in athletes, there is little systematic research examining risk factors and short- and long-term outcomes. Objectives To assess the relationship between concussion history and learning disability (LD) and the association of these variables with neuropsychological performance and to evaluate postconcussion recovery in a sample of college football players. Design, Setting, and Participants A total of 393 athletes from 4 university football programs across the United States received preseason baseline evaluations between May 1997 and February 1999. Subjects who had subsequent football-related acute concussions (n = 16) underwent neuropsychological comparison with matched control athletes from within the sample (n = 10). Main Outcome Measures Clinical interview, 8 neuropsychological measures, and concussion symptom scale ratings at baseline and after concussion. Results Of the 393 players, 129 (34%) had experienced 1 previous concussion and 79 (20%) had experienced 2 or more concussions. Multivariate analysis of variance yielded significant main effects for both LD (P<.001) and concussion history (P = .009), resulting in lowered baseline neuropsychological performance. A significant interaction was found between LD and history of multiple concussions and LD on 2 neurol psychological measures (Trail-Making Test, Form B [P = .007] and Symbol Digit Modalities Test [P = .009]), indicating poorer performance for the group with LD and multiple concussions compared with other groups. A discriminant function analysis using neuropsychological testing of athletes 24 hours after acute in-season concussion compared with controls resulted in an overall 89.5% correct classification rate. Conclusions Our study suggests that neuropsychological assessment is a useful indicator of cognitive functioning in athletes and that bath history of multiple concussions and LD are associated with reduced cognitive performance. These variables may be detrimentally synergistic and should receive further study.	Henry Ford Hlth Syst, Div Neuropsychol, Dept Behav Hlth, Detroit, MI 48202 USA; Univ Pittsburgh, Dept Family Practice, Pittsburgh, PA USA; Univ Pittsburgh, Dept Family Med Sports Med, Pittsburgh, PA USA; Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; Univ Florida, Coll Med, Dept Orthoped & Rehabil, Gainesville, FL USA; Univ Florida, Dept Community & Family Hlth, Gainesville, FL USA; Univ Florida, Dept Sports Hlth, Gainesville, FL USA; Michigan State Univ, Dept Athlet Training, E Lansing, MI 48824 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; St Vincents Med Ctr, Dept Sports Med, Erie, PA USA	Collins, MW (corresponding author), Henry Ford Hlth Syst, Div Neuropsychol, Dept Behav Hlth, 1 Ford Pl 1E, Detroit, MI 48202 USA.			sears, samuel/0000-0002-7863-3591; Moser, David/0000-0003-4102-5266			Barth JT., 1989, MILD HEAD INJURY, P257; BEARS SR, 1995, J LEARN DISABIL, V27, P315; Bream H., 1996, ATHLETIC THERAPY TOD, V1, P7; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Donders J, 1997, Pediatr Rehabil, V1, P179; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HENDERSON C, 1994, COLL FRESHMEN DISABI; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; HURBERT RT, 1994, COMPREHENDING BEHAV; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; JORDAN BD, 1994, MILD BRAIN INJURY SP; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Powell JW, 1999, SPORTS-RELATED CONCUSSION, P75; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P976; Spreen O., 1998, COMPENDIUM NEUROPSYC; Spreen O., 1995, DEV NEUROPSYCHOLOGY; *STATS, 1995, STAT WIND COMP PROGR; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Torg JS, 1982, ATHLETIC INJURIES HE	29	565	574	1	77	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1999	282	10					964	970		10.1001/jama.282.10.964			7	Medicine, General & Internal	General & Internal Medicine	231XD	WOS:000082335900035	10485682	Bronze			2021-06-18	
J	Marar, M; McIlvain, NM; Fields, SK; Comstock, RD				Marar, Mallika; McIlvain, Natalie M.; Fields, Sarah K.; Comstock, R. Dawn			Epidemiology of Concussions Among United States High School Athletes in 20 Sports	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; high school; injury; surveillance	SEX-DIFFERENCES; SOCCER PLAYERS; YOUNG ATHLETE; COLLEGIATE; MANAGEMENT; INJURIES; GUIDELINES; RECOVERY	Background: In the United States (US), an estimated 300,000 sports-related concussions occur annually. Among individuals 15 to 24 years of age, sports are second only to motor vehicle crashes as the leading cause of concussions. Purpose: To investigate the epidemiology of concussions in high school athletes by comparing rates and patterns of concussion among 20 sports. Study Design: Descriptive epidemiology study. Methods: Using an Internet-based data collection tool, RIO, certified athletic trainers from a large, nationally disperse sample of US high schools reported athlete exposure and injury data for 20 sports during the 2008-2010 academic years. Results: During the study period, 1936 concussions were reported during 7,780,064 athlete-exposures (AEs) for an overall injury rate of 2.5 per 10,000 AEs. The injury rate was higher in competition (6.4) than practice (1.1) (rate ratio [RR], 5.7; 95% confidence interval [CI], 5.2-6.3). The majority of concussions resulted from participation in football (47.1%, n = 912), followed by girls' soccer (8.2%, n = 159), boys' wrestling (5.8%, n = 112), and girls' basketball (5.5%, n = 107). Football had the highest concussion rate (6.4), followed by boys' ice hockey (5.4) and boys' lacrosse (4.0). Concussions represented a greater proportion of total injuries among boys' ice hockey (22.2%) than all other sports studied (13.0%) (injury proportion ratio [IPR], 1.7; 95% CI, 1.4-2.1; P < .01). In gender-comparable sports, girls had a higher concussion rate (1.7) than boys (1.0) (RR, 1.7; 95% CI, 1.4-2.0). The most common mechanisms of injury were player-player contact (70.3%) and player-playing surface contact (17.2%). In more than 40% of athletes in sports other than girls' swimming and girls' track, concussion symptoms resolved in 3 days or less. Athletes most commonly returned to play in 1 to 3 weeks (55.3%), with 22.8% returning in less than 1 week and 2.0% returning in less than 1 day. Conclusion: Although interest in sports-related concussions is usually focused on full-contact sports like football and ice hockey, concussions occur across a wide variety of high school sports. Concussion rates vary by sport, gender, and type of exposure. An understanding of concussion rates, patterns of injury, and risk factors can drive targeted preventive measures and help reduce the risk for concussion among high school athletes in all sports.	[Marar, Mallika; McIlvain, Natalie M.; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA	McIlvain, NM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	natalie.mcilvain@nationwidechildrens.org			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations (NFHS); DonJoy Orthotics; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: The content of this report was funded in part by the Centers for Disease Control and Prevention (CDC) grants #R49/CE000674-01 and #R49/CE001172-01. The authors also acknowledge the generous research funding contributions of the National Federation of State High School Associations (NFHS) and DonJoy Orthotics.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; [Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P733; [Anonymous], 1997, NEUROLOGY, V48, P581; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Mansell J, 2005, J ATHL TRAINING, V40, P310; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; National Federation of State High School Associations, 2009, 2009 10 HIGH SCH ATH; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; US Census Bureau, CENS REG US; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	28	560	560	5	158	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	APR	2012	40	4					747	755		10.1177/0363546511435626			9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	918XO	WOS:000302285100002	22287642		Y	N	2021-06-18	
J	Warden, D				Warden, Deborab			Military TBI during the Iraq and Afghanistan wars	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	2nd Federal Interagency Conference on Traumatic Brain Injury	MAR 10, 2006	Bethesda, MD			blast injury; brain injury; concussion; Iraq war; mild TBI; military; TBI	TRAUMATIC BRAIN-INJURY; BLAST INJURY; HEAD-INJURY; CONCUSSION; VETERANS; WOUNDS; PTSD	Traumatic brain injury (TBI) is an important source of morbidity in the Iraq and Afghanistan wars. Although penetrating brain injuries are more readily identified, closed brain injuries occur more commonly. Explosion or blast injury is the most common cause of war injuries. The contribution of the primary blast wave (primary blast injury) in brain injury is an area of active research. Lessons learned from the sports concussion and civilian mild TBI literature are useful. Individuals with TBI and posttraumatic stress disorder require treatment of both conditions. Families and communities need to be cognizant of the needs of these returning veterans.	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA	Warden, D (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA.	Deborah.Warden@na.amedd.army.mil					*AMEDD, ARM MED EV STAT OP I; BYNUM R, 2006, GRENADE BLAST CRIPPL; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GRADY D, 2006, NY TIMES        0122; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; KING D, 1997, EVERY MAN WILL DO HI; Klein E, 2003, CAN J PSYCHIAT, V48, P28; LEEDHAM CS, 1993, MIL MED, V158, P508; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; WALLACE M, 2006, CBS NEWS        0212; Warden DL, 2005, J NEUROTRAUM, V22, P1178	25	552	554	1	50	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2006	21	5					398	402		10.1097/00001199-200609000-00004			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	084JM	WOS:000240529200004	16983225				2021-06-18	
J	Guskiewicz, KM; Marshall, SW; Bailes, J; McCrea, M; Harding, HP; Matthews, A; Mihalik, JR; Cantu, RC				Guskiewicz, Kevin M.; Marshall, Stephen W.; Bailes, Julian; McCrea, Michael; Harding, Herndon P., Jr.; Matthews, Amy; Mihalik, Johna Register; Cantu, Robert C.			Recurrent concussion and risk of depression in retired professional football players	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						concussion; head injury; neurologic; dementia; psychiatric; neurological risk factors	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; HEAD-INJURY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PREVALENCE; SYMPTOMS; DEMENTIA; DISORDERS; DIAGNOSIS	Guskiewicz, K. M., S. W. Marshall, J. Bailes, M. McCrea, H. P. Harding JR, A. Matthews, J. R. Mihalik, and R. C. Cantu. Recurrent Concussion and Risk of Depression in Retired Professional Football Players. Med. Sci. Sports Exerc., Vol. 39, No. 6, pp. 903-909, 2007. Purpose: The purpose of our study was to investigate the association between prior head injury and the likelihood of being diagnosed with clinical depression among retired professional football players with prior head injury exposure..-Niethods: A general health questionnaire, including information about prior injuries, the SF-36 (Short Form 36), and other markers for depression, was completed by 2552 retired professional football players with an average age of 53.8 (+/- 13.4) yr and an average professional football-playing career of 6.6 (+/- 3.6) yr. A second questionnaire focusing on mild cognitive impairment (MCI)-related issues was completed by a subset of 758 retired professional football players (50 yr and older). Results: Two hundred sixty-nine (11. 1%) of all respondents reported having prior or current diagnosis of clinical depression. There was an association between recurrent concussion and diagnosis of lifetime depression (x(2) = 71.21, df = 2, P < 0.005), suggesting that the prevalence increases with increasing concussion history. Compared with retired players with no history of concussion, retired players reporting three or more previous concussions (24.4%) were three times more likely to be diagnosed with depression; those with a history of one or two previous concussions (36.3%) were 1.5 times more likely to be diagnosed with depression. The analyses controlled for age, number of years since retirement, number of years played, physical component score on the SF-36, and diagnosed comorbidities such as osteoarthritis, coronary heart disease, stroke, cancer, and diabetes. Conclusion: Our findings suggest a possible link between recurrent sport-related concussion and increased risk of clinical depression. The findings emphasize the importance of understanding potential neurological consequences of recurrent concussion.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; W Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; Waukesha Mem Hosp, Ctr Neurosci, Waukesha, WI USA; Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Florida State Univ, Coll Med, Dept Psychiat, Tallahassee, FL 32306 USA; Emerson Hosp, Neurosurg Serv, Concord, MA USA; Brigham & Womens Hosp, Neurol Sports Injury Ctr, Boston, MA 02115 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, 209 Fetzer CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233; Register-Mihalik, Johna/0000-0002-4229-4743			Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Baumann B, 1999, J NEUROPSYCH CLIN N, V11, P71, DOI 10.1176/jnp.11.1.71; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Dodel RC, 2001, PHARMACOECONOMICS, V19, P1013, DOI 10.2165/00019053-200119100-00004; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heilbronner RL, 1993, TRIAL DIPLOMACY J, V16, P161; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 1998, J INT NEUROPSYCH SOC, V4, P75; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NAUTA W J H, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P125; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Rush AJ., 2000, DIAGN STAT MAN MENT, V4th, P345; RUTHERFORD WH, 1977, LANCET, V1, P1; Sadek JR, 2004, NEUROPSYCHOLOGY, V18, P692, DOI 10.1037/0894-4105.18.4.692; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034; Tsai CH, 2002, CLIN NEUROL NEUROSUR, V104, P328, DOI 10.1016/S0303-8467(02)00027-6; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Vaidya VA, 1999, NEUROSCI LETT, V262, P1, DOI 10.1016/S0304-3940(99)00006-3; Weiner MF, 2002, DEMENT GERIATR COGN, V13, P8, DOI 10.1159/000048627; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	40	551	553	0	143	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2007	39	6					903	909		10.1249/mss.0b013e3180383da5			7	Sport Sciences	Sport Sciences	175UI	WOS:000247039100002	17545878				2021-06-18	
J	Schneiderman, AI; Braver, ER; Kang, HK				Schneiderman, Aaron I.; Braver, Elisa R.; Kang, Han K.			Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: Persistent postconcussive symptoms and posttraumatic stress disorder	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						Afghanistan; brain injuries; Iraq; post-concussion syndrome; stress disorders; post-traumatic; veterans; war; wounds and injuries	MOTOR-VEHICLE ACCIDENTS; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; WAR VETERANS; DEPLOYMENT; RISK; CARE	A cross-sectional study of military personnel following deployment to conflicts in Iraq or Afghanistan ascertained histories of combat theater injury mechanisms and mild traumatic brain injury (TBI) and current prevalence of posttraumatic stress disorder (PTSD) and postconcussive symptoms. Associations among injuries, PTSD, and postconcussive symptoms were explored. In February 2005, a postal survey was sent to Iraq/Afghanistan veterans who had left combat theaters by September 2004 and lived in Maryland; Washington, DC; northern Virginia; and eastern West Virginia. Immediate neurologic symptoms postinjury were used to identify mild TBI. Adjusted prevalence ratios and 95% confidence intervals were computed by using Poisson regression. About 12% of 2,235 respondents reported a history consistent with mild TBI, and 11% screened positive for PTSD. Mild TBI history was common among veterans injured by bullets/shrapnel, blasts, motor vehicle crashes, air/water transport, and falls. Factors associated with PTSD included reporting multiple injury mechanisms (prevalence ratio = 3.71 for three or more mechanisms, 95% confidence interval: 2.23, 6.19) and combat mild TBI (prevalence ratio = 2.37, 95% confidence interval: 1.72, 3.28). The strongest factor associated with postconcussive symptoms was PTSD, even after overlapping symptoms were removed from the PTSD score (prevalence ratio = 3.79, 95% confidence interval: 2.57, 5.59).	[Schneiderman, Aaron I.; Braver, Elisa R.; Kang, Han K.] Washington DC VA Med Ctr, War Related Illness & Injury Study Ctr, Washington, DC 20422 USA; [Braver, Elisa R.] Univ Maryland, Sch Med, Natl Study Ctr Trauma & Emergency Med Syst, Baltimore, MD 21201 USA; [Kang, Han K.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA	Schneiderman, AI (corresponding author), Washington DC VA Med Ctr, War Related Illness & Injury Study Ctr, 50 Irving St NW,127, Washington, DC 20422 USA.	aaron.schneiderman@va.gov	Braver, Elisa/AAT-4631-2020				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breslau N, 2007, J ABNORM PSYCHOL, V116, P607, DOI 10.1037/0021-843X.116.3.607; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bullman T A, 1991, Ann Epidemiol, V1, P505, DOI 10.1016/1047-2797(91)90022-5; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; *DEF MANP DAT CTR, 2007, CONT TRACK SYST DEPL; *DEP DEF, CAS COUNT OP END FRE; *DEP DEF, CAS COUNT OP IR FREE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Defence Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Dirkzwager AJE, 2007, PSYCHOSOM MED, V69, P435, DOI 10.1097/PSY.0b013e318052e20a; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; *GLOB SEC, EN IN ATT AG COAL IT; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2006, ANN EPIDEMIOL, V16, P381, DOI 10.1016/j.annepidem.2005.03.004; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; LANDIS JR, 1978, INT STAT REV, V46, P237, DOI 10.2307/1402373; LEGOME E, 2006, EMED EMERGENCY  0906; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; *SAS I INC, 2003, SAS 9 1; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; *US DEP VET AFF, 2005, IMPL NAT CLIN REM AF, P1; US Department of Health and Human Services, 2007, SCREEN EV POSS TRAUM, P1; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Weathers F. W., 1993, 9 ANN C INT SOC TRAU; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	42	549	550	0	47	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUN 15	2008	167	12					1446	1452		10.1093/aje/kwn068			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	313QU	WOS:000256755900007	18424429				2021-06-18	
J	Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E				Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E			An endogenous cannabinoid (2-AG) is neuroprotective after brain injury	NATURE			English	Article							CLOSED-HEAD-INJURY; NECROSIS-FACTOR-ALPHA; RECEPTOR-LIGAND; RAT-BRAIN; ANANDAMIDE; MICE; SYSTEM; 2-ARACHIDONOYLGLYCEROL; ENDOCANNABINOIDS; AMIDOHYDROLASE	Traumatic brain injury triggers the accumulation of harmful mediators that may lead to secondary damage(1,2). Protective mechanisms to attenuate damage are also set in motion(2). 2-Arachidonoyl glycerol (2-AG) is an endogenous cannabinoid, identified both in the periphery(3) and in the brain(4), but its physiological roles have been only partially clarified(5-7). Here we show that, after injury to the mouse brain, 2-AG may have a neuroprotective role in which the cannabinoid system is involved. After closed head injury (CHI) in mice, the level of endogenous 2-AG was significantly elevated. We administered synthetic 2-AG to mice after CHI and found significant reduction of brain oedema, better clinical recovery, reduced infarct volume and reduced hippocampal cell death compared with controls. When 2-AG was administered together with additional inactive 2-acyl-glycerols that are normally present in the brain, functional recovery was significantly enhanced. The beneficial effect of 2-AG was dose-dependently attenuated by SR-141761A, an antagonist of the CB1 cannabinoid receptor.	Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel.						Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209; Axelrod J, 1998, NEUROCHEM RES, V23, P575, DOI 10.1023/A:1022418217479; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEN DS, 1987, J GASTROEN HEPATOL, V2, P1, DOI 10.1111/j.1440-1746.1987.tb00142.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Klein TW, 2000, P SOC EXP BIOL MED, V225, P1, DOI 10.1046/j.1525-1373.2000.22501.x; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Mathews KS, 2000, J NEUROSCI METH, V102, P43, DOI 10.1016/S0165-0270(00)00277-6; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nagayama T, 1999, J NEUROSCI, V19, P2987; OVADIA H, 1995, NEUROPHARMACOLOGY, V34, P175, DOI 10.1016/0028-3908(94)00133-D; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reggio PH, 2000, CHEM PHYS LIPIDS, V108, P15, DOI 10.1016/S0009-3084(00)00185-7; Shen MX, 1998, MOL PHARMACOL, V54, P459; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Sugiura T, 2000, BIOCHEM BIOPH RES CO, V271, P654, DOI 10.1006/bbrc.2000.2686; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; van der Stelt M, 2001, J NEUROSCI, V21, P6475	31	547	569	2	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					527	531		10.1038/35097089			5	Multidisciplinary Sciences	Science & Technology - Other Topics	478HG	WOS:000171340500048	11586361				2021-06-18	
J	Field, M; Collins, MW; Lovell, MR; Maroon, J				Field, M; Collins, MW; Lovell, MR; Maroon, J			Does age play a role in recovery from sports-related concussion? A comparison of high school and collegiate athletes	JOURNAL OF PEDIATRICS			English	Article							CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; CENTRAL-NERVOUS-SYSTEM; COMA DATA-BANK; INTRAVENTRICULAR PRESSURE; GLUCOSE-UTILIZATION; DYNAMIC CHANGES; CHILDREN; RATS	Objective To evaluate symptoms and neurocognitive recovery patterns after sports-related concussion in high school and college athletes. Study design College athletes (n = 371) and high school athletes (n = 183) underwent baseline neuropsychological evaluation between 1997 and 2000. Individuals who received a concussion during athletic competition (n = 54) underwent serial neuropsychologic evaluation after injury and were compared with a noninjured within-sample control group (n = 38). Main outcome measures included structured interview, four memory measures, and Concussion Symptom Scale ratings. Baseline to postinjury change scores and multiple analyses of variance were used to compare recovery curves within and between groups. Results High school athletes with concussion had prolonged memory dysfunction compared with college athletes with concussion. High school athletes performed significantly worse than age-matched control subjects at 7 days after injury (F = 2.90; P <.005). College athletes, despite having more severe in-season concussions, displayed commensurate performance with matched control subjects by day 3 after concussion. Self-report of postconcussion symptoms by student athletes was not predictive of poor performance on neuropsychologic testing. Conclusions Caution and systematic evaluation should be undertaken before returning athletes with concussion to competition. Sole reliance on the self-report of the athlete may be inadequate. Preliminary data may suggest a more protracted recovery from concussion in high school athletes.	Univ Pittsburgh, Sch Med, Dept Neurol Surg, Ctr Sports Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Orthoped Surg, Ctr Sports Med, Pittsburgh, PA 15213 USA	Field, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol Surg, Ctr Sports Med, PUH Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	fieldm@msx.upmc.edu					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; *COMM QUAL IMPR, 1999, PEDIATRICS, V6, P1407; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIFSHITZ J, 1995, J NEUROTRAUM, V12, P129; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SCHEINKER IM, 1949, J PEDIAT, V35, P557; Scheinker M, 1944, ARCH NEURO PSYCHIATR, V52, P43; SUTTON RL, 1994, ACTA NEUROCHIR, P446; VILLABLANCA JR, 1986, BEHAV BRAIN RES, V19, P205, DOI 10.1016/0166-4328(86)90021-5; WILBERGER JE, 1999, TRAUMATIC BRAIN INJU, P165; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	35	546	548	1	91	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2003	142	5					546	553		10.1067/mpd.2003.190			8	Pediatrics	Pediatrics	682AR	WOS:000183068400018	12756388				2021-06-18	
J	Chung, H; Dai, TH; Sharma, SK; Huang, YY; Carroll, JD; Hamblin, MR				Chung, Hoon; Dai, Tianhong; Sharma, Sulbha K.; Huang, Ying-Ying; Carroll, James D.; Hamblin, Michael R.			The Nuts and Bolts of Low-level Laser (Light) Therapy	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Low level laser therapy; Photobiomodulation; Mitochondria; Tissue optics; Wound healing; Hair regrowth; Laser acupuncture	LOW-POWER LASER; HELIUM-NEON LASER; NEAR-INFRARED LIGHT; OPEN SKIN WOUNDS; DOUBLE-BLIND; NITRIC-OXIDE; LATERAL EPICONDYLITIS; CYTOCHROME-OXIDASE; DIODE-LASER; C-OXIDASE	Soon after the discovery of lasers in the 1960s it was realized that laser therapy had the potential to improve wound healing and reduce pain, inflammation and swelling. In recent years the field sometimes known as photobiomodulation has broadened to include light-emitting diodes and other light sources, and the range of wavelengths used now includes many in the red and near infrared. The term "low level laser therapy" or LLLT has become widely recognized and implies the existence of the biphasic dose response or the Arndt-Schulz curve. This review will cover the mechanisms of action of LLLT at a cellular and at a tissular level and will summarize the various light sources and principles of dosimetry that are employed in clinical practice. The range of diseases, injuries, and conditions that can be benefited by LLLT will be summarized with an emphasis on those that have reported randomized controlled clinical trials. Serious life-threatening diseases such as stroke, heart attack, spinal cord injury, and traumatic brain injury may soon be amenable to LLLT therapy.	[Chung, Hoon; Dai, Tianhong; Sharma, Sulbha K.; Huang, Ying-Ying; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Chung, Hoon; Dai, Tianhong; Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Carroll, James D.] Thor Photomed Ltd, Chesham HP5 1HQ, England; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Huang, Ying-ying/G-3153-2011; Huang, yingying/J-7329-2012; Carroll, James/AAL-1739-2021; Dai, Tianhong/P-5961-2018; Hamblin, Michael R/H-2758-2019	Huang, Ying-ying/0000-0003-3066-6981; Huang, yingying/0000-0002-4038-0277; Carroll, James/0000-0002-9205-1061; Dai, Tianhong/0000-0001-8960-8896; Hamblin, Michael R/0000-0001-6431-4605	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRPUnited States Department of Defense [W81XWH-09-1-0514]; Air Force Office of Scientific ResearchUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9950-04-1-0079]; Airlift Research Foundation [109421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875] Funding Source: NIH RePORTER	Funding: Research in the Hamblin laboratory is supported by NIH grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research (FA9950-04-1-0079). Tianhong Dai was supported by an Airlift Research Foundation Extremity Trauma Research Grant (grant 109421).	ABERGEL RP, 1987, J DERMATOL SURG ONC, V13, P127, DOI 10.1111/j.1524-4725.1987.tb00510.x; Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Almeida-Lopes L, 2001, LASER SURG MED, V29, P179, DOI 10.1002/lsm.1107; ANNEROTH G, 1988, BRIT J ORAL MAX SURG, V26, P12, DOI 10.1016/0266-4356(88)90144-1; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; BISHT D, 1994, INDIAN J MED RES, V100, P43; Bisht Dipti, 1999, Indian Journal of Experimental Biology, V37, P187; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; CAPALDI RA, 1983, BIOCHIM BIOPHYS ACTA, V726, P135, DOI 10.1016/0304-4173(83)90003-4; Castano AP, 2007, LASER SURG MED, V39, P543, DOI 10.1002/lsm.20516; Cauwels RGEC, 2011, EUR ARCH PAEDIATR DE, V12, P118, DOI 10.1007/BF03262791; Chandrasekhar S., 1960, RAD TRANSFER; Chang WD, 2008, PHOTOMED LASER SURG, V26, P551, DOI 10.1089/pho.2007.2234; Chen A. C.-H., 2009, P SOC PHOTO-OPT INS, V7165, P71650; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Christie A, 2007, PHYS THER, V87, P1697, DOI 10.2522/ptj.20070039; de Lima AG, 2012, INT J RADIAT ONCOL, V82, P270, DOI 10.1016/j.ijrobp.2010.10.012; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; ElSayed SO, 1996, LASER SURG MED, V19, P433, DOI 10.1002/(SICI)1096-9101(1996)19:4<433::AID-LSM8>3.0.CO;2-T; Emanet SK, 2010, PHOTOMED LASER SURG, V28, P397, DOI 10.1089/pho.2009.2555; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; GOODSON WH, 1979, SURG GYNECOL OBSTET, V149, P600; GRECO M, 1989, BIOCHEM BIOPH RES CO, V163, P1428, DOI 10.1016/0006-291X(89)91138-8; Gur A, 2003, LASER SURG MED, V33, P330, DOI 10.1002/lsm.10236; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Hawkins D, 2005, ANN NY ACAD SCI, V1056, P486, DOI 10.1196/annals.1352.040; Hawkins D, 2005, PHOTOMED LASER SURG, V23, P251, DOI 10.1089/pho.2005.23.251; Haxsen V, 2008, LASER MED SCI, V23, P381, DOI 10.1007/s10103-007-0511-5; Hayworth CR, 2010, PHOTOCHEM PHOTOBIOL, V86, P673, DOI 10.1111/j.1751-1097.2010.00732.x; Hegedus B, 2009, PHOTOMED LASER SURG, V27, P577, DOI 10.1089/pho.2008.2297; Hoffmann G, 2007, GMS HYG INFECT CONTR, V2; Huang CY, 2009, IEEE ENG MED BIO, P1589, DOI 10.1109/IEMBS.2009.5334124; Huang Y. Y., 2011, DOSE RESPON IN PRESS; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; KANA JS, 1981, ARCH SURG-CHICAGO, V116, P293; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; KARU TI, 1987, IEEE J QUANTUM ELECT, V23, P1703, DOI 10.1109/JQE.1987.1073236; Kaviani A, 2011, PHOTOMED LASER SURG, V29, P109, DOI 10.1089/pho.2009.2680; Kokol R, 2005, HAUTARZT, V56, P570, DOI 10.1007/s00105-004-0864-7; Lam LKY, 2007, PHOTOMED LASER SURG, V25, P65, DOI 10.1089/pho.2006.2047; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lanzafame RJ, 2007, LASER SURG MED, V39, P534, DOI 10.1002/lsm.20519; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Leavitt M, 2009, CLIN DRUG INVEST, V29, P283, DOI 10.2165/00044011-200929050-00001; Lebed'kov E V, 1998, Voen Med Zh, V319, P37; Lebed'kov E. V., 1998, VOEN MED ZH, V319, P95; LEE G, 1982, AM HEART J, V103, P1076, DOI 10.1016/0002-8703(82)90576-2; Lima Aline Gouvêa de, 2010, Braz. Dent. J., V21, P186, DOI 10.1590/S0103-64402010000300002; Lin YS, 2006, OSTEOARTHR CARTILAGE, V14, P377, DOI 10.1016/j.joca.2005.10.010; LOEVSCHALL H, 1994, LASER SURG MED, V14, P347, DOI 10.1002/lsm.1900140407; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; LUNDEBERG T, 1991, ANN PLAS SURG, V27, P537, DOI 10.1097/00000637-199112000-00004; Martius F, 1923, MUNCH MED WSCHR, V70, P1005; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; MCGUFF P E, 1963, Surg Forum, V14, P143; Medalha CC, 2010, PHOTOMED LASER SURG, V28, P669, DOI 10.1089/pho.2009.2691; Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126; MESTER E, 1985, LASER SURG MED, V5, P31, DOI 10.1002/lsm.1900050105; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; MESTER E, 1972, ACTA CHIR HUNG, V13, P315; MESTER E, 1976, ACTA CHIR HUNG, V17, P49; Mester E, 1967, KISERL ORVOSTUD, V19, P628; MEYERS AD, 1990, ARCH OTOLARYNGOL, V116, P1128; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Moore P, 2005, LASER SURG MED, V36, P8, DOI 10.1002/lsm.20117; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Moreno I, 2008, OPT EXPRESS, V16, P1808, DOI 10.1364/OE.16.001808; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; NOBLE PB, 1992, LASER SURG MED, V12, P669, DOI 10.1002/lsm.1900120617; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; PASTORE D, 1994, BIOCHEM MOL BIOL INT, V34, P817; Pereira AN, 2002, LASER SURG MED, V31, P263, DOI 10.1002/lsm.10107; Pinheiro ALB, 2005, PHOTOMED LASER SURG, V23, P485, DOI 10.1089/pho.2005.23.485; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; Poyton RO, 2011, DISCOV MED, V11, P154; RASKIN P, 1975, AM J MED, V58, P365, DOI 10.1016/0002-9343(75)90602-6; Reddy GK, 2001, WOUND REPAIR REGEN, V9, P248, DOI 10.1046/j.1524-475x.2001.00248.x; Rubio CR, 2010, PHOTOMED LASER SURG, V28, P125, DOI 10.1089/pho.2008.2472; Ribeiro MS, 2004, J CLIN LASER MED SUR, V22, P59, DOI 10.1089/104454704773660994; Sandford M. A., 1994, PERIODONTOLOGY, V15, P25; Santana-Blank L, 2010, PHOTOMED LASER SURG, V28, pS41, DOI 10.1089/pho.2009.2647; Santana-Blank L, 2010, PHOTOMED LASER SURG, V28, pS173, DOI 10.1089/pho.2009.2745; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Schikora D, 2008, MED ACUPUNCT, V20, P37, DOI 10.1089/acu.2007.0606; Schindl A, 1998, DIABETES CARE, V21, P580, DOI 10.2337/diacare.21.4.580; Schindl A, 2000, PHOTODERMATOL PHOTO, V16, P34, DOI 10.1034/j.1600-0781.2000.160109.x; Schindl A, 2002, MICROVASC RES, V64, P240, DOI 10.1006/mvre.2002.2429; Shen JF, 2008, J CEREBR BLOOD F MET, V28, P1460, DOI 10.1038/jcbfm.2008.37; Shooshtari S M J, 2008, Electromyogr Clin Neurophysiol, V48, P229; Silva DFT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187418; Simunovic Z, 1998, J CLIN LASER MED SUR, V16, P145, DOI 10.1089/clm.1998.16.145; Skinner SM, 1996, AUST DENT J, V41, P188, DOI 10.1111/j.1834-7819.1996.tb04854.x; Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910; SPANHEIMER RG, 1988, DIABETES, V37, P371, DOI 10.2337/diabetes.37.4.371; STEBLYUKOVA IA, 1989, SOV MEDITISINA, P77; Sutherland JC, 2002, PHOTOCHEM PHOTOBIOL, V76, P164, DOI 10.1562/0031-8655(2002)076<0164:BEOPL>2.0.CO;2; Tadakuma Takushi, 1993, Keio Journal of Medicine, V42, P180; Tascioglu F, 2012, RHEUMATOL INT, V32, P409, DOI 10.1007/s00296-010-1652-6; THOMAS DW, 1995, J ORAL MAXIL SURG, V53, P442, DOI 10.1016/0278-2391(95)90721-1; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377; WAHL G, 1991, ZWR (Heidelberg), V100, P512; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Webb C, 1998, LASER SURG MED, V22, P294, DOI 10.1002/(SICI)1096-9101(1998)22:5<294::AID-LSM6>3.0.CO;2-K; WELCH AJ, 1989, TEX HEART I J, V16, P141; Whittaker P, 2004, LASER MED SCI, V19, P69, DOI 10.1007/s10103-004-0296-8; Wolf T., 2007, GER J ACUPUNCTURE RE, V50, P12; Wu Q., 2010, P SOC PHOTO-OPT INS, V7552, P755201; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Xiao LX, 2011, ADV MATER, V23, P926, DOI 10.1002/adma.201003128; Yang ZK, 2011, PHOTOMED LASER SURG, V29, P391, DOI 10.1089/pho.2010.2866; Yu HS, 2003, J INVEST DERMATOL, V120, P56, DOI 10.1046/j.1523-1747.2003.12011.x; Yu W, 1997, LASER SURG MED, V20, P56, DOI 10.1002/(SICI)1096-9101(1997)20:1<56::AID-LSM9>3.0.CO;2-Y; Zand N, 2009, LASER MED SCI, V24, P515, DOI 10.1007/s10103-008-0555-1; Zhang L, 2008, CELL PHYSIOL BIOCHEM, V22, P215, DOI 10.1159/000149799; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547; Zycinski P, 2007, KARDIOL POL, V65, P13	132	543	561	21	209	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2012	40	2					516	533		10.1007/s10439-011-0454-7			18	Engineering, Biomedical	Engineering	895GV	WOS:000300485100019	22045511	Green Accepted	Y	N	2021-06-18	
J	Giza, CC; Kutcher, JS; Ashwal, S; Barth, J; Getchius, TSD; Gioia, GA; Gronseth, GS; Guskiewicz, K; Mandel, S; Manley, G; McKeag, DB; Thurman, DJ; Zafonte, R				Giza, Christopher C.; Kutcher, Jeffrey S.; Ashwal, Stephen; Barth, Jeffrey; Getchius, Thomas S. D.; Gioia, Gerard A.; Gronseth, Gary S.; Guskiewicz, Kevin; Mandel, Steven; Manley, Geoffrey; McKeag, Douglas B.; Thurman, David J.; Zafonte, Ross			Summary of evidence-based guideline update: Evaluation and management of concussion in sports Report of the Guideline Development Subcommittee of the American Academy of Neurology	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; NCAA CONCUSSION; RUGBY PLAYERS; EPIDEMIOLOGY; RECOVERY; RISK; PREDICTORS	Objective: To update the 1997 American Academy of Neurology (AAN) practice parameter regarding sports concussion, focusing on 4 questions: 1) What factors increase/decrease concussion risk? 2) What diagnostic tools identify those with concussion and those at increased risk for severe/prolonged early impairments, neurologic catastrophe, or chronic neurobehavioral impairment? 3) What clinical factors identify those at increased risk for severe/prolonged early postconcussion impairments, neurologic catastrophe, recurrent concussions, or chronic neurobehavioral impairment? 4) What interventions enhance recovery, reduce recurrent concussion risk, or diminish long-term sequelae? The complete guideline on which this summary is based is available as an online data supplement to this article. Methods: We systematically reviewed the literature from 1955 to June 2012 for pertinent evidence. We assessed evidence for quality and synthesized into conclusions using a modified Grading of Recommendations Assessment, Development and Evaluation process. We used a modified Delphi process to develop recommendations. Results: Specific risk factors can increase or decrease concussion risk. Diagnostic tools to help identify individuals with concussion include graded symptom checklists, the Standardized Assessment of Concussion, neuropsychological assessments, and the Balance Error Scoring System. Ongoing clinical symptoms, concussion history, and younger age identify those at risk for postconcussion impairments. Risk factors for recurrent concussion include history of multiple concussions, particularly within 10 days after initial concussion. Risk factors for chronic neurobehavioral impairment include concussion exposure and APOE epsilon 4 genotype. Data are insufficient to show that any intervention enhances recovery or diminishes long-term sequelae postconcussion. Practice recommendations are presented for preparticipation counseling, management of suspected concussion, and management of diagnosed concussion.	[Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Kutcher, Jeffrey S.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Ashwal, Stephen] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA; [Ashwal, Stephen] Loma Linda Univ, Dept Neurol, Loma Linda, CA 92350 USA; [Barth, Jeffrey] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Getchius, Thomas S. D.] Amer Acad Neurol, Ctr Hlth Policy, Minneapolis, MN USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Dept Pediat & Psychiat, Washington, DC USA; [Gronseth, Gary S.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA; [Guskiewicz, Kevin] Univ N Carolina, Matthew Geller Sport Related Traumat Brain Injury, Chapel Hill, NC USA; [Mandel, Steven] Neurol & Neurophysiol Associates PC, Philadelphia, PA USA; [Manley, Geoffrey] UCSF Med Ctr, San Francisco, CA USA; [McKeag, Douglas B.] Indiana Univ, Ctr Sports Med, Dept Family Med, Indianapolis, IN 46204 USA; [Thurman, David J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Cambridge, MA 02138 USA	Giza, CC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA.			Guskiewicz, Kevin/0000-0002-8682-2130; Thurman, David/0000-0002-0533-7062	American Academy of Neurology	This evidence-based guideline was funded by the American Academy of Neurology. No author received honoraria or financial support to develop this document.	American Academy of Neurology, 2011, CLIN PRACTICE GUIDEL; American Academy of Neurology, 2004, CLIN PRACTICE GUIDEL; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Blignaut J B, 1987, Br J Sports Med, V21, P5; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2003, J ATHL TRAINING, V38, P238; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; Nassiri JD, 2002, MIL MED, V167, P873; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2003, J ATHL TRAINING, V38, P104; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	40	540	543	2	98	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 11	2013	80	24					2250	2257		10.1212/WNL.0b013e31828d57dd			8	Clinical Neurology	Neurosciences & Neurology	304FW	WOS:000330733500019	23508730	Bronze, Green Published	Y	N	2021-06-18	
J	Terrio, H; Brenner, LA; Ivins, BJ; Cho, JM; Helmick, K; Schwab, K; Scally, K; Bretthauer, R; Warden, D				Terrio, Heidi; Brenner, Lisa A.; Ivins, Brian J.; Cho, John M.; Helmick, Katherine; Schwab, Karen; Scally, Katherine; Bretthauer, Rick; Warden, Deborah			Traumatic Brain Injury Screening: Preliminary Findings in a US Army Brigade Combat Team	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; blast; combat; deployment; Iraq; sequelae; symptoms; traumatic brain injury	BLAST INJURY; IRAQ; AFGHANISTAN; TBI; IDENTIFICATION; RELIABILITY; NEUROTRAUMA; DEPLOYMENT; VALIDITY	Objectives: The objective of this article is to report the proportion of soldiers in a Brigade Combat Team (BCT) with at least 1 clinician-confirmed deployment-acquired traumatic brain injury (TBI) and to describe the nature of sequelae associated with such injuries. Participants: Members of an Army unit (n = 3973) that served in Iraq were screened for history of TBI. Those reporting an injury (n = 1292) were further evaluated regarding sequelae. Of the injuries suffered, 907 were TBIs and 385 were other types of injury. The majority of TBIs sustained were mild. Methods: Postdeployment, responses to the Warrior Administered Retrospective Casualty Assessment Tool (WARCAT) facilitated clinical interviews regarding injury history and associated somatic (ie, headache, dizziness, balance) and neuropsychiatric symptoms (le, irritability, memory). Traumatic brain injury diagnosis was based on the American Congress of Rehabilitation Medicine mild TBI criteria, which requires an injury event followed by an alteration in consciousness. Results:A total of 22.8% of soldiers in a BCT returning from Iraq had clinician-confirmed TBI. Those with TBI were significantly more likely to recall somatic and/or neuropsychiatric symptoms immediately postinjury and endorse symptoms at follow-up than were soldiers without a history of deployment-related TBI. A total of 33.4% of soldiers with TBI reported 3 or more symptoms immediately postinjury compared with 7.5% at postdeployment. For soldiers injured without TBI, rates of 3 or more symptoms postinjury and postdeployment were 2.9% and 2.3%, respectively. In those with TBI, headache and dizziness were most frequently reported postinjury, with irritability and memory problems persisting and presenting over time. Conclusion: Following deployment to Iraq, a clinician-confirmed TBI history was identified in 22.8% of soldiers from a BCT Those with TBI were significantly more likely to report postinjury and postdeployment somatic and/or neuropsychiatric symptoms than those without this injury history. Overall, symptom endorsement decreased over time.	[Terrio, Heidi; Cho, John M.; Scally, Katherine; Bretthauer, Rick] Evans Army Community Hosp, Dept Deployment Hlth & Headquarters, Ft Carson, CO USA; [Brenner, Lisa A.] VA VISN 19 Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Psychiat, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Denver, CO USA; [Terrio, Heidi; Ivins, Brian J.; Helmick, Katherine; Schwab, Karen; Warden, Deborah] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA	Terrio, H (corresponding author), 1853 Oconnell Blvd,Bldg 1042,Room 107, Ft Carson, CO 80913 USA.	heidi.terrio@amedd.army.mil	Brenner, Lisa A./AAG-2442-2019		Fort Carson Leadership; Evans Community Hospital staff; Great Plains Regional Medical Command; Office of the Army Surgeon General; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; TBI Task Force	This project could not have been completed without the tremendous effort put forth by the Fort Carson Soldier Readiness Center Staff. The authors also acknowledge the support provided by the Fort Carson Leadership, Evans Community Hospital staff, Great Plains Regional Medical Command, Office of the Army Surgeon General, Defense and Veterans Brain Injury Center, and TBI Task Force. In addition, the editorial assistance of Dr Sheila Saliman and Lisa Betthauser is greatly appreciated.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM PSYCH ASS, 2005, DIAGN STAT MAN MENT; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; *DEF VET BRAIN INJ, BLAST INJ; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; DOLE B, 2007, SERVE SUPPORT SIMPLI; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; SCOTT BA, 1986, NEUROSURGERY, V18, P107, DOI 10.1227/00006123-198601000-00020; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; SOLDIER READINESS PR	32	536	540	1	45	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					14	23		10.1097/HTR.0b013e31819581d8			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500004	19158592				2021-06-18	
J	Zhang, LY; Yang, KH; King, AI				Zhang, LY; Yang, KH; King, AI			A proposed injury threshold for introduction mild traumatic brain injury	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							DIFFUSE AXONAL INJURY; WHITE-MATTER; HEAD-INJURY; ACCELERATION; DEGENERATION; PRESSURE; SHEARING; DAMAGE	Traumatic brain injuries constitute a significant portion of injury, resulting from automotive collisions, motorcycle crashes, and sports collisions. Brain injuries not only represent a serious trauma for those involved but also place an enormous burden on society, often exacting a heavy economical, social, and emotional price. Development of intervention strategies to prevent or minimize these injuries requires a complete understanding of injury mechanisms, response and tolerance level. In this study, an attempt is made to delineate actual injury causation and establish a meaningful injury, criterion through the use of the actual field accident data. Twenty-four head-to-head field collisions that occurred in professional football games were duplicated using a validated finite element human head model. The injury predictors and injury levels were analyzed based on resulting brain tissue responses and were correlated with the site and occurrence of mild traumatic brain injury (MTBI). Predictions indicated that the shear stress around the brainstem region could be an injury predictor for concussion. Statistical analyses were performed to establish the new brain injury tolerance level.	Wayne State Univ, Ctr Bioengn, Detroit, MI 48202 USA	Zhang, LY (corresponding author), Wayne State Univ, Ctr Bioengn, 818 W Hancock, Detroit, MI 48202 USA.	lzhang@wayne.edu			ODCDC CDC HHS [R49/CCR 503534-10] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Al-Bsharat AS, 1999, P 43 STAPP CAR CRASH; Altman D, 1991, PRACTICAL STAT MED R; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Arbogast K., 1997, P 41 STAPP CAR CRASH; ARBOGAST KB, 1997, PREVENTION BIOMECHAN, P33; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, P 38 STAPP CAR CRASH; DENNEYBROWN D, 1943, BRAIN, V64, P93; EDBERG S, 1963, LAB INVEST, V12, P1305; EWING CL, 1975, AIRCRAFT CRASHWORTHI; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; GALFORD JE, 1969, 69BHF6 ASME; Gennarelli T, 1987, P 31 STAPP CAR CRASH; Gennarelli T. A., 1987, HEAD INJURY, P137; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GROSS A G, 1958, J Aviat Med, V29, P725; Gurdjian E S, 1964, Clin Neurosurg, V12, P112; GURDJIAN ES, 1963, P 7 STAPP CAR CRASH, P470; Hodgson V. R., 1972, P 16 STAPP CAR CRASH; HODGSON VR, 1983, P 27 STAPP CAR CRASH; Holbourn AHS, 1943, LANCET, V2, P438; Hosmer D, 1989, APPL LOGISTIC REGRES; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kang HS, 1997, P 41 STAPP CAR CRASH; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; MAGOUN HM, 1958, WALKING BRAIN; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Mertz HJ, 1994, 941056 SAE; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J. A., 1999, P INT RESEAR C BIOME, P17; NEWMAN JA, 2004, IN PRESS J BIOMECH; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; ONO K, 1980, P 24 STAPP CAR CRASH, P101; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; PRASAD P, 1985, 851246 SAE; PRINCEMAILLE Y, 1989, P 33 STAPP CAR CRASH; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1993, P 37 STAPP CAR CRASH; SHOCK LZ, 1972, BAS ENG T AM SOC MEC, P905; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Tarriere C, 1987, HEAD INJURY MECHANIS, P47; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Trosseille X., 1992, P 36 STAPP CAR CRASH; VERSAC J, 1971, P 15 STAPP CAR CRASH; Ward C, 1980, P 24 STAPP CAR CRASH; ZHANG L, 1999, P AMERI PAM N AM C, P531; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P 39 STAPP CAR CRASH; ZHOU C, 1994, P 38 STAPP CAR CRASH	63	536	546	0	92	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2004	126	2					226	236		10.1115/1.1691446			11	Biophysics; Engineering, Biomedical	Biophysics; Engineering	819XN	WOS:000221349700012	15179853				2021-06-18	
J	Plassman, BL; Havlik, RJ; Steffens, DC; Helms, MJ; Newman, TN; Drosdick, D; Phillips, C; Gau, BA; Welsh-Bohmer, KA; Burke, JR; Guralnik, JM; Breitner, JCS				Plassman, BL; Havlik, RJ; Steffens, DC; Helms, MJ; Newman, TN; Drosdick, D; Phillips, C; Gau, BA; Welsh-Bohmer, KA; Burke, JR; Guralnik, JM; Breitner, JCS			Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias	NEUROLOGY			English	Article							APOLIPOPROTEIN-E GENOTYPE; TRAUMATIC BRAIN INJURY; AGING TWIN VETERANS; DIAGNOSIS; ONSET; QUESTIONNAIRE; ASSOCIATION; RELIABILITY; REGISTRY; SEQUELAE	Background: The association between antecedent head injury and AD is inconsistent. Objective: To examine the association between early adult head injury, as documented by military hospital records, and dementia in late life; and to evaluate the interaction between head injury and APOE epsilon4 as risk factors for dementia. Methods: The study had a population-based prospective historical cohort design. It included men who were World War II Navy and Marine veterans, and were hospitalized during their military service with a diagnosis of either a nonpenetrating head injury or another unrelated condition. In 1996 to 1997, military medical records were abstracted to document; the occurrence and details of closed head injury. The entire sample was then evaluated for dementia and AD using a multistage procedure. There were 548 veterans with head injury and 1228 without head injury who completed all assigned stages of the study. The authors estimated risk of dementia, specifically AD, using proportional hazards models. Results: Both moderate head injury (hazard ratio [HR] = 2.32; CI = 1.04 to 5.17) and severe head injury (HR = 4.51; CI = 1.77 to 11.47) were associated with increased risk of AD. Results mere similar for dementia in general. The results for mild head injury were inconclusive. When the authors stratified by the number of APOE epsilon4 alleles, they observed a nonsignificant trend toward a stronger association between AD and head injury in men with more epsilon4 alleles. Conclusions: Moderate and severe head injuries in young men may be associated with increased risk of AD and other dementias in late life. However, the authors cannot exclude the possibility that other unmeasured factors may be influencing this association.	Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; Duke Univ, Med Ctr, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC 27706 USA; Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27706 USA; NIA, Epidemiol Demog & Biometry Program, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21218 USA	Plassman, BL (corresponding author), Box 41,905 W Main St,Suite 25D, Durham, NC 27701 USA.	brenda.plassman@duke.edu	Plassman, Brenda L/K-2620-2015; Burke, James R/E-4245-2016; Welsh-Bohmer, Kathleen/AAA-3178-2020	Burke, James R/0000-0002-3408-7787; 	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [N01-AG-4-2142] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [N01AG042142] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Breitner JCS, 1999, INT J GERIATR PSYCH, V14, P577, DOI 10.1002/(SICI)1099-1166(199907)14:7<577::AID-GPS32>3.0.CO;2-M; BREITNER JCS, 1995, ARCH NEUROL-CHICAGO, V52, P763, DOI 10.1001/archneur.1995.00540320035011; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; GALLO JJ, 1995, PSYCHOL MED, V25, P1211, DOI 10.1017/S0033291700033183; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Katzman R, 1996, NEUROLOGY, V46, P889; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; KHACHTURIAN AS, 2000, IN PRESS J CLIN EPID; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Mayeux R, 1996, NEUROLOGY, V46, P891; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; Tatemichi Thomas K., 1994, P123; Tsuang D, 1999, ARCH NEUROL-CHICAGO, V56, P1489, DOI 10.1001/archneur.56.12.1489; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	40	536	548	0	36	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 24	2000	55	8					1158	1166		10.1212/WNL.55.8.1158			9	Clinical Neurology	Neurosciences & Neurology	366PB	WOS:000090012800016	11071494				2021-06-18	
J	Guskiewicz, KM; Weaver, NL; Padua, DA; Garrett, WE				Guskiewicz, KM; Weaver, NL; Padua, DA; Garrett, WE			Epidemiology of concussion in collegiate and high school football players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							MINOR HEAD-INJURY; SPORTS; MANAGEMENT; PREVENTION; SEQUELAE	Despite evolutionary changes in protective equipment, head injury remains common in football. We investigated concussion in football and associated epidemiologic issues such as 1) incidence of injury, 2) common signs and symptoms, and 3) patterns in making return-to-play decisions. We received 242 of 392 surveys (62%) that were sent to high school and collegiate certified athletic trainers at the beginning of three football seasons, Of the 17,549 football players represented, 888 (5.1%) sustained at least one concussion, and 131 (14.7% of the 888) sustained a second injury during the same season. The greatest incidence of concussion was found at the high school (5.6%) and collegiate division III (5.5%) levels, suggesting that there is an association between level of play and the proportion of players injured. Players who sustained one concussion in a season were three times more likely to sustain a second concussion in the same season compared with uninjured players. Contact with artificial turf appears to be associated with a more serious concussion than contact with natural grass. Only 8.9% of all injuries involved loss of consciousness, while 86% involved a headache, Overall, 30.8% of all players sustaining a concussion returned to participation on the same day of injury.	Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthopaed Surg, Chapel Hill, NC 27599 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Sports Med Res Lab, Dept Exercise & Sport Sci, CB 8700, Chapel Hill, NC 27599 USA.			Padua, Darin/0000-0002-9383-4236; Guskiewicz, Kevin/0000-0002-8682-2130			ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT., 1989, MILD HEAD INJURY, P257; Bruce D A, 1982, Clin Sports Med, V1, P495; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P10; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Colorado Medical Society Sports Medicine Committee, 1994, P MILD BRAIN INJ SPO, P106; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; DICK RW, 1998, 1997 98 NCAA INJURY; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MCSHANE J, 1998, SPORTS RELATED CONCU; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; POWELL JW, 1998, SPORTS RELATED CONCU; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005	30	534	539	0	64	AMER ORTHOPAEDIC SOC SPORT MED	WALTHAM	230 CALVARY STREET, WALTHAM, MA 02154 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	SEP-OCT	2000	28	5					643	650		10.1177/03635465000280050401			8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	365JU	WOS:000089948800004	11032218				2021-06-18	
J	Ghajar, J				Ghajar, J			Traumatic brain injury	LANCET			English	Article							SEVERE HEAD-INJURY; CARE MANAGEMENT; INTENSIVE-CARE; UNITED-STATES; MAJOR TRAUMA; MORTALITY; PRESSURE; EMERGENCY; COMATOSE; CENTERS	The decrease in mortality and improved outcome for patients with severe traumatic brain injury over the past 25 years can be attributed to the approach of "squeezing oxygenated blood through a swollen brain". Quantification of cerebral perfusion by monitoring of Intracranial pressure and treatment of cerebral hypoperfusion decrease secondary injury. Before the patient reaches hospital, an oganised trauma system that allows rapid resuscitation and transport directly to an experienced trauma centre significantly lowers mortality and morbidity. Only the education of medical personnel and the institution of trauma hospital systems can achieve further improvements in outcome for patients with traumatic brain injuries.	Cornell Univ, Brain Trauma Fdn, New York, NY 10021 USA	Ghajar, J (corresponding author), Cornell Univ, Brain Trauma Fdn, New York, NY 10021 USA.						*AM COLL SURG, 1996, ADV TRAUM LIF SUPP I; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; *BRAIN TRAUM TASK, 2000, J NEUROTRAUM, V17, P557; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; BULLOCK R, 2000, ABC MAJOR TRAUMA, P34; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DeWitt D S, 1995, New Horiz, V3, P376; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gruen P, 1998, EMERG MED CLIN N AM, V16, P63, DOI 10.1016/S0733-8627(05)70349-7; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hsiao A K, 1993, Prehosp Disaster Med, V8, P229; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1988, J NEUROSURG, V69, P15; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1999, BRIT J NEUROSURG, V13, P546; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; *NAT CTR INJ PREV, 1999, EP TRAUM BRAIN INJ U; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROY PD, 1987, CAN J SURG, V30, P17; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; SCHIERHOUT G, 1999, COCHRANE LIB; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Silvestri S, 1997, MT SINAI J MED, V64, P329; Sosin DM, 1996, BRAIN INJURY, V10, P47; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Woodman R, 1999, BRIT MED J, V318, P1577, DOI 10.1136/bmj.318.7198.1577	51	532	552	0	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					923	929		10.1016/S0140-6736(00)02689-1			7	Medicine, General & Internal	General & Internal Medicine	353DP	WOS:000089259800038	11036909				2021-06-18	
J	Arfanakis, K; Haughton, VM; Carew, JD; Rogers, BP; Dempsey, RJ; Meyerand, ME				Arfanakis, K; Haughton, VM; Carew, JD; Rogers, BP; Dempsey, RJ; Meyerand, ME			Diffusion tensor MR imaging in diffuse axonal injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							WHITE-MATTER; HEAD-INJURY; BRAIN; TISSUES; CT; ANISOTROPY; FEATURES; TRAUMA; IMAGES; NERVE	BACKGROUND AND PURPOSE: Disruption of the cytoskeletal network and axonal membranes characterizes diffuse axonal injury (DAI) in the first few hours after traumatic brain injury. Histologic abnormalities seen in DAI hypothetically decrease the diffusion along axons and increase the diffusion in directions perpendicular to them. DAI therefore is hypothetically associated in the short term with decreased diffusion anisotropy. We tested this hypothesis by measuring the diffusion characteristics of traumatized brain tissue with use of diffusion tensor MR imaging. METHODS. Five patients with mild traumatic brain injuries and 10 control subjects were studied with CT, conventional MR imaging, and diffusion tensor imaging. All patients were examined within 24 hours of injury. In each participant, diffusion tensor indices from homologous normal-appearing white matter regions of both hemispheres were compared. These indices were also compared between homologous regions of each patient and the control group. In two patients, diffusion tensor images from the immediate posttrauma period were compared with those at 1 month follow-up. RESULTS: Patients displayed significant reduction of diffusion anisotropy in several regions compared with the homologous ones in the contralateral hemisphere. Such differences were not observed in the control subjects. Significant reduction of diffusion anisotropy was also detected when diffusion tensor results from the patients were compared with those of the controls. This reduction was often less evident 1 month after injury. CONCLUSION. White matter regions with reduced anisotropy are detected in the first 24 hours after traumatic brain injury. Therefore, diffusion tensor imaging may be a powerful technique for in vivo detection of DAI.	Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; Univ Wisconsin, Dept Neurosurg, Madison, WI USA	Arfanakis, K (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.		Arfanakis, Konstantinos/AAN-3148-2021; Rogers, Baxter P/B-7897-2010	Arfanakis, Konstantinos/0000-0001-9705-597X; Rogers, Baxter/0000-0002-5666-2797			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; EVANS RW, 1992, NEUROL CLIN, V10, P815; Fenyes DA, 1999, MAGNET RESON MED, V42, P300, DOI 10.1002/(SICI)1522-2594(199908)42:2<300::AID-MRM12>3.0.CO;2-9; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hofman PAM, 1999, MAGN RESON MED, V42, P803, DOI 10.1002/(SICI)1522-2594(199910)42:4<803::AID-MRM24>3.3.CO;2-6; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holmes AA, 2000, MAGNET RESON MED, V44, P157, DOI 10.1002/1522-2594(200007)44:1<157::AID-MRM22>3.3.CO;2-6; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KRAUS JF, 1989, MILD HEAD INJURY, P8; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 1991, Magn Reson Q, V7, P1; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Lythgoe MF, 1997, MAGN RESON MED, V38, P662, DOI 10.1002/mrm.1910380421; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; VANGELDEREN P, 1994, MAGNET RESON MED, V31, P154, DOI 10.1002/mrm.1910310209; Virta A, 1999, MAGN RESON IMAGING, V17, P1121, DOI 10.1016/S0730-725X(99)00048-X; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; WOODS RP, 1998, J COMPUT ASSIST TOMO, V22, P141	44	529	552	0	32	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2002	23	5					794	802					9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	552BW	WOS:000175599300012	12006280				2021-06-18	
J	Jessen, NA; Munk, ASF; Lundgaard, I; Nedergaard, M				Jessen, Nadia Aalling; Munk, Anne Sofie Finmann; Lundgaard, Iben; Nedergaard, Maiken			The Glymphatic System: A Beginner's Guide	NEUROCHEMICAL RESEARCH			English	Article						The glymphatic system; Astrocytes; Perivascular spaces; Virchow-Robin spaces; Cerebrospinal fluid secretion; Sleep; Aging; Neurodegenerative diseases; Traumatic brain injury	CEREBROSPINAL-FLUID FLOW; VIRCHOW-ROBIN SPACES; CEREBRAL AMYLOID ANGIOPATHY; CENTRAL NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CHOROID-PLEXUS; ALZHEIMERS-DISEASE; INTERSTITIAL FLUID; APOLIPOPROTEIN-E; ARTERIAL PULSATION	The glymphatic system is a recently discovered macroscopic waste clearance system that utilizes a unique system of perivascular tunnels, formed by astroglial cells, to promote efficient elimination of soluble proteins and metabolites from the central nervous system. Besides waste elimination, the glymphatic system also facilitates brain-wide distribution of several compounds, including glucose, lipids, amino acids, growth factors, and neuromodulators. Intriguingly, the glymphatic system function mainly during sleep and is largely disengaged during wakefulness. The biological need for sleep across all species may therefore reflect that the brain must enter a state of activity that enables elimination of potentially neurotoxic waste products, including beta-amyloid. Since the concept of the glymphatic system is relatively new, we will here review its basic structural elements, organization, regulation, and functions. We will also discuss recent studies indicating that glymphatic function is suppressed in various diseases and that failure of glymphatic function in turn might contribute to pathology in neurodegenerative disorders, traumatic brain injury and stroke.	[Jessen, Nadia Aalling; Munk, Anne Sofie Finmann; Lundgaard, Iben; Nedergaard, Maiken] Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA	Jessen, NA (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	Nadia_Aalling@urmc.rochester.edu	Aalling, Nadia/AAG-5669-2020	Aalling, Nadia/0000-0001-6995-1590	NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS075177, NS078304]; Novo Nordisk FondenNovo Nordisk Foundation [NNF13OC0004258] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD080573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075177, R01NS078167, R01NS078304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG048769] Funding Source: NIH RePORTER	This study was supported by NIH (NINDS NS075177 and NS078304). We thank Gerry Dienel, Ben Kress, and Rashid Deane for comments on the manuscript and Takahiro Takano for illustrations.	AMES A, 1965, J PHYSIOL-LONDON, V181, P516, DOI 10.1113/jphysiol.1965.sp007780; AXELROD J, 1974, SCIENCE, V184, P1341, DOI 10.1126/science.184.4144.1341; Aydin K, 2008, NEUROSURGERY, V62, P584, DOI 10.1227/01.neu.0000317306.39203.24; Ball KK, 2010, J CEREBR BLOOD F MET, V30, P162, DOI 10.1038/jcbfm.2009.206; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Biceroglu H, 2012, J NEUROSURG-SPINE, V16, P394, DOI 10.3171/2011.12.SPINE11108; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1998, J LIPID RES, V39, P1594; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BRADBURY MWB, 1981, AM J PHYSIOL, V240, pF329; Bradbury MWB, 1985, EXPT BIOL LYMPHATIC, P355; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Buerge C, 2011, CASE REP NEUROL, V3, P136, DOI 10.1159/000329267; Buishas J, 2014, CROAT MED J, V55, P481, DOI 10.3325/cmj.2014.55.481; Bulat M, 2008, COLLEGIUM ANTROPOL, V32, P43; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Chen RL, 2009, EXP GERONTOL, V44, P289, DOI 10.1016/j.exger.2008.12.004; Christensen HL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00304; Cipolla M, 2010, ANATOMY ULTRASTRUCTU; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2012, AM J PHYSIOL-CELL PH, V302, pC1452, DOI 10.1152/ajpcell.00285.2011; DAVSON H, 1970, J PHYSIOL-LONDON, V209, P131, DOI 10.1113/jphysiol.1970.sp009159; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; del Zoppo GJ, 2015, STROKE PATHOPHYSIOLO; DENG QS, 1989, BRAIN RES, V501, P183, DOI 10.1016/0006-8993(89)91041-X; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Ferrer I, 2010, J NEUROL SCI, V299, P139, DOI 10.1016/j.jns.2010.08.039; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gaberel T, 2014, STROKE, V45, P3092, DOI 10.1161/STROKEAHA.114.006617; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Groeschel S, 2006, NEURORADIOLOGY, V48, P745, DOI 10.1007/s00234-006-0112-1; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; HUSTED RF, 1976, J PHYSIOL-LONDON, V259, P213, DOI 10.1113/jphysiol.1976.sp011462; ICHIMURA T, 1991, BRAIN RES, V545, P103, DOI 10.1016/0006-8993(91)91275-6; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Johanson CE, 2008, NEUROSCI MED; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Klose U, 2000, JMRI-J MAGN RESON IM, V11, P438, DOI 10.1002/(SICI)1522-2586(200004)11:4<438::AID-JMRI12>3.0.CO;2-O; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kulik T, 2008, NEUROPHARMACOLOGY, V55, P281, DOI 10.1016/j.neuropharm.2008.04.017; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liao S, 2013, LYMPHAT RES BIOL, V11, P136, DOI 10.1089/lrb.2013.0012; LINDVALL M, 1981, J CEREBR BLOOD F MET, V1, P245, DOI 10.1038/jcbfm.1981.30; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MADSEN PL, 1991, J APPL PHYSIOL, V70, P2597; MAURIZI CP, 1991, MED HYPOTHESES, V35, P154, DOI 10.1016/0306-9877(91)90041-V; MAYER SE, 1993, J NEUROCHEM, V60, P1308, DOI 10.1111/j.1471-4159.1993.tb03291.x; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Murtha LA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-12; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; NILSSON C, 1992, BRAIN RES REV, V17, P109, DOI 10.1016/0165-0173(92)90011-A; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Oreskovic D, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-16; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2003, ACT NEUR S, V86, P525; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Praetorius J, 2007, PFLUG ARCH EUR J PHY, V454, P1, DOI 10.1007/s00424-006-0170-6; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Prince EA, 2013, SEMIN INTERVENT RAD, V30, P234, DOI 10.1055/s-0033-1353475; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Rennels M L, 1990, Adv Neurol, V52, P431; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sabbatini A, 1999, MECH AGEING DEV, V108, P165, DOI 10.1016/S0047-6374(99)00008-1; Sagare AP, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011452; SAITO Y, 1983, J PHYSIOL-LONDON, V336, P635, DOI 10.1113/jphysiol.1983.sp014602; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; Schick U, 2010, MINIM INVAS NEUROSUR, V53, P15, DOI 10.1055/s-0030-1247552; Schlesinger B, 1939, BRAIN, V62, P274, DOI 10.1093/brain/62.3.274; SCHROTH G, 1992, NEURORADIOLOGY, V35, P1, DOI 10.1007/BF00588270; SEGAL MB, 1974, J CELL SCI, V14, P339; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Silverberg GD, 2002, J NEUROSURG, V97, P1271, DOI 10.3171/jns.2002.97.6.1271; Skaper SD, 2009, NEUROCHEM RES, V34, P2243, DOI 10.1007/s11064-009-0022-9; Stoodley MA, 1997, J NEUROSURG, V86, P686, DOI 10.3171/jns.1997.86.4.0686; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Thal DR, 2012, EXP GERONTOL, V47, P816, DOI 10.1016/j.exger.2012.05.023; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Thrane VR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02582; Tonsfeldt KJ, 2012, MOL CELL ENDOCRINOL, V349, P3, DOI 10.1016/j.mce.2011.07.003; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Wang ZM, 2012, OBESITY, V20, P95, DOI 10.1038/oby.2011.256; Weed LH, 1917, ANAT REC, V12, P461, DOI 10.1002/ar.1090120405; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yamada S, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-36; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; ZHANG ET, 1990, J ANAT, V170, P111; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	139	525	543	10	161	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2015	40	12			SI		2583	2599		10.1007/s11064-015-1581-6			17	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DB3KZ	WOS:000368411500019	25947369	Green Accepted	Y	N	2021-06-18	
J	Ramlackhansingh, AF; Brooks, DJ; Greenwood, RJ; Bose, SK; Turkheimer, FE; Kinnunen, KM; Gentleman, S; Heckemann, RA; Gunanayagam, K; Gelosa, G; Sharp, DJ				Ramlackhansingh, Anil F.; Brooks, David J.; Greenwood, Richard J.; Bose, Subrata K.; Turkheimer, Federico E.; Kinnunen, Kirsi M.; Gentleman, Steve; Heckemann, Rolf A.; Gunanayagam, Karen; Gelosa, Giorgio; Sharp, David J.			Inflammation after Trauma: Microglial Activation and Traumatic Brain Injury	ANNALS OF NEUROLOGY			English	Article							HEAD-INJURY; NERVOUS-SYSTEM; RHESUS-MONKEY; RAT-BRAIN; NEURODEGENERATION; ASTROCYTES; STROKE; DEATH; TIME; PET	Objective: Patient outcome after traumatic brain injury (TBI) is highly variable. The underlying pathophysiology of this is poorly understood, but inflammation is potentially an important factor. Microglia orchestrate many aspects of this response. Their activation can be studied in vivo using the positron emission tomography (PET) ligand [11C](R)PK11195 (PK). In this study, we investigate whether an inflammatory response to TBI persists, and whether this response relates to structural brain abnormalities and cognitive function. Methods: Ten patients, studied at least 11 months after moderate to severe TBI, underwent PK PET and structural magnetic resonance imaging (including diffusion tensor imaging). PK binding potentials were calculated in and around the site of focal brain damage, and in selected distant and subcortical brain regions. Standardized neuropsychological tests were administered. Results: PK binding was significantly raised in the thalami, putamen, occipital cortices, and posterior limb of the internal capsules after TBI. There was no increase in PK binding at the original site of focal brain injury. High PK binding in the thalamus was associated with more severe cognitive impairment, although binding was not correlated with either the time since the injury or the extent of structural brain damage. Interpretation: We demonstrate that increased microglial activation can be present up to 17 years after TBI. This suggests that TBI triggers a chronic inflammatory response particularly in subcortical regions. This highlights the importance of considering the response to TBI as evolving over time and suggests interventions may be beneficial for longer intervals after trauma than previously assumed. ANN NEUROL 2011;70:374-383	[Ramlackhansingh, Anil F.; Brooks, David J.; Turkheimer, Federico E.; Gentleman, Steve; Heckemann, Rolf A.; Gunanayagam, Karen; Gelosa, Giorgio; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neurosci, London, England; [Greenwood, Richard J.] UCL, Dept Neurol, London, England; [Bose, Subrata K.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London, England; [Kinnunen, Kirsi M.] Univ London, London, England; [Heckemann, Rolf A.] Neurodis Fdn, Ctr Med Res Positron Emiss Tomog Vivo Imaging, Lyon, France	Sharp, DJ (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	david.sharp@imperial.ac.uk	Turkheimer, Federico E/B-9485-2012; Kinnunen, Kirsi/P-6402-2019; Heckemann, Rolf Andreas/H-9022-2019; Kinnunen, Kirsi M/D-6061-2011; Sharp, David J/A-2119-2013	Turkheimer, Federico E/0000-0002-3766-3815; Heckemann, Rolf Andreas/0000-0003-3582-3683; Brooks, David/0000-0003-2602-2518; Kinnunen, Kirsi M./0000-0002-8562-2866	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial College Healthcare Charity; Dunhill Medical TrustDunhill Medical Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951, MC_U120036861, MC_U120085814] Funding Source: researchfish	This work was supported by grants from the Medical Research Council (UK) to D.J.S., the Imperial College Healthcare Charity to D.J.S., and the Dunhill Medical Trust to R.A.H.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hashimoto K, 1989, Ann Nucl Med, V3, P63; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; MORIOKA T, 1993, J COMP NEUROL, V327, P123, DOI 10.1002/cne.903270110; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Turkheimer FE, 2007, J NUCL MED, V48, P158; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031	30	524	530	3	82	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0364-5134			ANN NEUROL	Ann. Neurol.	SEP	2011	70	3					374	383		10.1002/ana.22455			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	819HU	WOS:000294816800011	21710619		Y	N	2021-06-18	
J	Schiff, ND; Giacino, JT; Kalmar, K; Victor, JD; Baker, K; Gerber, M; Fritz, B; Eisenberg, B; O'Connor, J; Kobylarz, EJ; Farris, S; Machado, A; McCagg, C; Plum, F; Fins, JJ; Rezai, AR				Schiff, N. D.; Giacino, J. T.; Kalmar, K.; Victor, J. D.; Baker, K.; Gerber, M.; Fritz, B.; Eisenberg, B.; O'Connor, J.; Kobylarz, E. J.; Farris, S.; Machado, A.; McCagg, C.; Plum, F.; Fins, J. J.; Rezai, A. R.			Behavioural improvements with thalamic stimulation after severe traumatic brain injury	NATURE			English	Article							MINIMALLY CONSCIOUS STATE; INTRALAMINAR; PROJECTIONS; ACTIVATION; ATTENTION; RECOVERY; AROUSAL	Widespread loss of cerebral connectivity is assumed to underlie the failure of brain mechanisms that support communication and goal-directed behaviour following severe traumatic brain injury. Disorders of consciousness that persist for longer than 12 months after severe traumatic brain injury are generally considered to be immutable; no treatment has been shown to accelerate recovery or improve functional outcome in such cases(1,2). Recent studies have shown unexpected preservation of large-scale cerebral networks in patients in the minimally conscious state (MCS)(3,4), a condition that is characterized by intermittent evidence of awareness of self or the environment(5). These findings indicate that there might be residual functional capacity in some patients that could be supported by therapeutic interventions. We hypothesize that further recovery in some patients in the MCS is limited by chronic underactivation of potentially recruitable large-scale networks. Here, in a 6-month double-blind alternating crossover study, we show that bilateral deep brain electrical stimulation (DBS) of the central thalamus modulates behavioural responsiveness in a patient who remained in MCS for 6 yr following traumatic brain injury before the intervention. The frequency of specific cognitively mediated behaviours (primary outcome measures) and functional limb control and oral feeding (secondary outcome measures) increased during periods in which DBS was on as compared with periods in which it was off. Logistic regression modelling shows a statistical linkage between the observed functional improvements and recent stimulation history. We interpret the DBS effects as compensating for a loss of arousal regulation that is normally controlled by the frontal lobe in the intact brain. These findings provide evidence that DBS can promote significant late functional recovery from severe traumatic brain injury. Our observations, years after the injury occurred, challenge the existing practice of early treatment discontinuation for patients with only inconsistent interactive behaviours and motivate further research to develop therapeutic interventions.	Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; JFK Rehabil Inst, Edison, NJ 08818 USA; New Jersey Neurosci Inst, Edison, NJ 08818 USA; Cleveland Clin Fdn, Ctr Neurol Restorat, Cleveland, OH 44195 USA; Weill Cornell Med Coll, Div Med Eth, New York, NY 10021 USA	Schiff, ND (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.	nds2001@mail.med.cornell.edu	Victor, Jonathan D./D-2931-2009; Machado, Andre GG/B-7572-2014	Victor, Jonathan D./0000-0002-9293-0111; Machado, Andre GG/0000-0002-8132-5610			Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2000, NEUROL RES, V22, P273; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Morel A, 2005, EUR J NEUROSCI, V21, P1007, DOI 10.1111/j.1460-9568.2005.03921.x; Munkle MC, 2000, J CHEM NEUROANAT, V19, P155, DOI 10.1016/S0891-0618(00)00060-0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; PFAFF DW, 2005, BRAIN AROUSAL INFORM; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; SCHIFF ND, 2002, SOC NEUR 31 ANN M; Schiff Nicholas D., 2002, Thalamus & Related Systems, V2, P55, DOI 10.1017/S1472928802000286; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wyder MT, 2004, J NEUROPHYSIOL, V91, P2628, DOI 10.1152/jn.01221.2003	23	523	550	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					600	U10		10.1038/nature06041			5	Multidisciplinary Sciences	Science & Technology - Other Topics	195XV	WOS:000248446700045	17671503				2021-06-18	
J	del Zoppo, G; Ginis, I; Hallenbeck, JM; Iadecola, C; Wang, XK; Feuerstein, GZ				del Zoppo, G; Ginis, I; Hallenbeck, JM; Iadecola, C; Wang, XK; Feuerstein, GZ			Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia	BRAIN PATHOLOGY			English	Article; Proceedings Paper	5th Altschul Symposium	AUG 19-21, 1999	UNIV SASKATCHEWAN, SASKATOON, CANADA	Hlth Canada, Div Adult Hlth, AstraZeneca, Univ Saskatchewan, Coll Med, DuPont Pharma, DuPont Pharmaceut Co, GlaxoWelcome Inc, Heart & Stroke Fdn, Hoffman La Roche Ltd, Merck Frosst Canada Inc, Hlth Canada, Lab Ctr Dis Control, Sanofi Canada Inc, Bristol Myers Squibb, Saskatchewan Nutraceut Networks, WHO	UNIV SASKATCHEWAN		TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; TRANSIENT FOREBRAIN ISCHEMIA; MESSENGER-RNA EXPRESSION; CLOSED-HEAD INJURY; FACTOR-ALPHA	Ischemic stroke is a leading cause of death and disability in developed countries, Yet, in spite of substantial research and development efforts, no specific therapy for stroke is available, Several mechnism for neuroprotection have been explored including ionchannels, excitatory amino acids and oxygen raicals yet none has culminated in an effective therapeutic effect, The review article on "inflammation and stroke" summarizes key data in support for the possibility that inflammatory cells and mediators are important contributing and confounding factors in ischemic brain injury. In particular, the role of cytokines, endothelial cells and leukocyte adhesion molecules, nitric oxide and cyclooxygenase (COX-2) products are discussed. Furthermore, the potential role for certain cytokines in modulation of brain vulnerability to ischemia is also reviewed,The data suggest that novel therapeutic strategies may evolve from detailed research on some specific inflammatory factors that act in spatial and temporal relationships with traditionally recognized neurotoxic factors, The dual nature of some mediators in reformatting of brain cells for resistance or sensitivity to injury demonstrate the delicate balance needed in interventions based on anti-inflammatory strategies.	DuPont Pharmaceut Co, Cardiovasc Dis Res, Expt Stn E400 3257, Wilmington, DE 19880 USA; Scripps Res Inst, La Jolla, CA USA; NIH, Bethesda, MD 20892 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	Feuerstein, GZ (corresponding author), DuPont Pharmaceut Co, Cardiovasc Dis Res, Expt Stn E400 3257, Rt 141 & Henry Clay Rd, Wilmington, DE 19880 USA.		Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035806, R37NS034179, R01NS034179, Z01NS002924, ZIANS002924] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34179, NS35806] Funding Source: Medline		Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Auge N, 1998, J BIOL CHEM, V273, P12893, DOI 10.1074/jbc.273.21.12893; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Barnes DA, 1998, J NEUROIMMUNOL, V87, P17, DOI 10.1016/S0165-5728(98)00041-1; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; Botchkina GI, 1999, MOL MED, V5, P372, DOI 10.1007/BF03402126; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Burda J, 1998, J CEREBR BLOOD F MET, V18, P59, DOI 10.1097/00004647-199801000-00006; BUTTINI M, 1995, NEUROSCIENCE, V65, P523, DOI 10.1016/0306-4522(94)00525-A; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Carroll JE, 1998, MOL BRAIN RES, V56, P186, DOI 10.1016/S0169-328X(98)00045-X; CHEN H, 1992, NEUROSCI RES COMMUN, V11, P93; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; CLARK RK, 1994, BRAIN RES BULL, V35, P387, DOI 10.1016/0361-9230(94)90119-8; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; CROW JP, 1995, NITRIC OXIDE BIOCH M, P17; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/0304-3940(96)13116-5; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; DELZOPPO GJ, 1996, CEREBROVASC DIS, V6, P9; Di Loreto S, 1997, NEUROIMMUNOMODULAT, V4, P195, DOI 10.1159/000097338; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DSOUZA S, 1995, J NEUROSCI, V15, P7293; DUTKA AJ, 1989, STROKE, V20, P390, DOI 10.1161/01.STR.20.3.390; ENG LF, 1988, BIOCH PATHOLOGY ASTR, P79; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FEUERSTEIN GZ, 1998, CEREBROVASC DIS, P507; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; Garcia JH, 1997, BRAIN PATHOL, V7, P1151, DOI 10.1111/j.1750-3639.1997.tb00998.x; GARCIA JH, 1994, AM J PATHOL, V144, P188; GARCIA JH, 1974, J NEUROPATH EXP NEUR, V33, P408, DOI 10.1097/00005072-197407000-00007; Ghosh S, 1997, FASEB J, V11, P45; Ginis I, 1999, AM J PHYSIOL-CELL PH, V276, pC1171; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GOLDBLUM SE, 1990, AM J PHYSIOL, V258, pL57; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; Grandati M, 1997, BRIT J PHARMACOL, V122, P625, DOI 10.1038/sj.bjp.0701427; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; HALLENBECK JM, 1991, BRAIN RES, V541, P115, DOI 10.1016/0006-8993(91)91083-D; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Haring HP, 1996, STROKE, V27, P1386, DOI 10.1161/01.STR.27.8.1386; Haring HP, 1996, J NEUROPATH EXP NEUR, V55, P236, DOI 10.1097/00005072-199602000-00012; Hayward NJ, 1996, EXP NEUROL, V139, P188, DOI 10.1006/exnr.1996.0093; Heidenreich KA, 1996, J BIOL CHEM, V271, P9891, DOI 10.1074/jbc.271.17.9891; HEINEL LA, 1994, BRAIN RES BULL, V34, P137, DOI 10.1016/0361-9230(94)90010-8; HEO J, 1969, J CEREB BLOOD FLOW M, V19, P624; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Huwiler A, 1999, BIOCHEM BIOPH RES CO, V258, P60, DOI 10.1006/bbrc.1999.0582; Iadecola C, 1999, J EXP MED, V189, P719, DOI 10.1084/jem.189.4.719; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; ITO A, 1995, J NEUROCHEM, V65, P463; Jiang N, 1995, ANN NEUROL, V38, P935, DOI 10.1002/ana.410380615; Karsan A, 1996, J Atheroscler Thromb, V3, P75; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Khayyam N, 1999, NEUROREPORT, V10, P371, DOI 10.1097/00001756-199902050-00029; KOBAYASHI E, 1990, BIOCHEM BIOPH RES CO, V172, P993; Kogure K, 1996, ACT NEUR S, V66, P40; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234; Lee JY, 1998, BIOCHEM J, V334, P457, DOI 10.1042/bj3340457; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; LIU T, 1993, STROKE, V24, P1746, DOI 10.1161/01.STR.24.11.1746; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; LIU T, 2000, IN PRESS AM J PHYSL; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mattson MP, 1997, NEUROSCI BIOBEHAV R, V21, P193, DOI 10.1016/S0149-7634(96)00010-3; Melillo G, 1996, J IMMUNOL, V157, P2638; Miettinen S, 1997, P NATL ACAD SCI USA, V94, P6500, DOI 10.1073/pnas.94.12.6500; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; MORI E, 1991, FIBRINOLYTIC RECANAL, P137; Mori T, 1999, BRAIN RES, V816, P350, DOI 10.1016/S0006-8993(98)01124-X; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P661, DOI 10.1097/00004647-199906000-00009; Nagayama M, 1998, J CEREBR BLOOD F MET, V18, P1107, DOI 10.1097/00004647-199810000-00007; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Nogawa S, 1997, J NEUROSCI, V17, P2746; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; O'CALLAGHAN J P, 1991, Biomedical and Environmental Sciences, V4, P197; Okada Y, 1996, AM J PATHOL, V149, P37; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; Parmentier S, 1999, BRIT J PHARMACOL, V127, P546, DOI 10.1038/sj.bjp.0702549; Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9; PERRY VH, 1991, INT REV CYTOL, V125, P203, DOI 10.1016/S0074-7696(08)61220-6; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Planas AM, 1995, NEUROSCI LETT, V200, P187, DOI 10.1016/0304-3940(95)12108-G; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; ROBBINS DS, 1987, J IMMUNOL, V139, P2593; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; ROTHWELL NJ, 1993, CEREBROVAS BRAIN MET, V5, P178; Salvemini D, 1996, METHOD ENZYMOL, V269, P12; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; SEMMLER J, 1993, INT J IMMUNOPHARMACO, V15, P409, DOI 10.1016/0192-0561(93)90052-Z; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SIREN AL, 1992, STROKE, V23, P1643, DOI 10.1161/01.STR.23.11.1643; SMITH RA, 1992, IMMUNOL SER, V56, P149; SMITH WL, 1995, SEMIN NEPHROL, V15, P179; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; SUEMATSU M, 1992, ADV EXP MED BIOL, V316, P211; Tagaya M, 1997, STROKE, V28, P1245, DOI 10.1161/01.STR.28.6.1245; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Tepper AD, 1997, J BIOL CHEM, V272, P24308, DOI 10.1074/jbc.272.39.24308; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Uno H, 1997, J CEREBR BLOOD F MET, V17, P491, DOI 10.1097/00004647-199705000-00002; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VODOVOTZ Y, 1994, J IMMUNOL, V152, P4110; Vuorte J, 1999, J IMMUNOL, V162, P2353; Wagner S, 1997, STROKE, V28, P858, DOI 10.1161/01.STR.28.4.858; WANG XK, 1995, STROKE, V26, P1665, DOI 10.1161/01.STR.26.9.1665; WANG XK, 1994, MOL BRAIN RES, V26, P61, DOI 10.1016/0169-328X(94)90074-4; Wang XK, 1997, STROKE, V28, P155, DOI 10.1161/01.STR.28.1.155; WANG XK, 1994, MOL CHEM NEUROPATHOL, V23, P103, DOI 10.1007/BF02815404; WANG XK, 2000, IN PRESS J CEREB BLO; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu J, 1998, J BIOL CHEM, V273, P16521, DOI 10.1074/jbc.273.26.16521; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Young AR, 1997, STROKE, V28, P632, DOI 10.1161/01.STR.28.3.632; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; Zhang RL, 1999, NEUROLOGY, V52, P273, DOI 10.1212/WNL.52.2.273; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; Zhao X., 1999, Society for Neuroscience Abstracts, V25, P793	163	514	519	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JAN	2000	10	1					95	112					18	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	276PV	WOS:000084887300010	10668900				2021-06-18	
J	BOUMA, GJ; MUIZELAAR, JP; CHOI, SC; NEWLON, PG; YOUNG, HF				BOUMA, GJ; MUIZELAAR, JP; CHOI, SC; NEWLON, PG; YOUNG, HF			CEREBRAL-CIRCULATION AND METABOLISM AFTER SEVERE TRAUMATIC BRAIN INJURY - THE ELUSIVE ROLE OF ISCHEMIA	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; CEREBRAL BLOOD FLOW; ARTERIOVENOUS OXYGEN DIFFERENCE; OUTCOME	SEVERE HEAD-INJURY; BLOOD-FLOW; INTRAVENTRICULAR PRESSURE; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; CHILDREN; EDEMA; HYPERTENSION; THRESHOLDS; ICP	Although experimental and pathological studies suggest an important role for ischemia in the majority of fatal cases of traumatic brain injury, ischemia has been a rare finding in most clinical studies of cerebral blood flow (CBF) in head-injured patients. The hypothesis of the present study was that cerebral ischemia occurs in the first few hours after injury, but that CBF measurements have not been performed early enough. Early measurements of CBF (by the Xe-133 intravenous method) and arteriovenous oxygen difference (AVDO2) were obtained in 186 adult head-injured patients with a Glasgow Coma Scale score of 8 or less, and were correlated with neurological status and outcome. During the first 6 hours after injury, CBF was low (22.5 +/- 5.2 ml/100 gm/min) but increased significantly during the first 24 hours. The AVDO2 followed the opposite course; the decline of AVDO2 was most profound in patients with low motor scores, suggesting relative hyperemia after 24 hours. A significant correlation between motor score and CBF was found in the first 8 hours after injury (Spearman coefficient = 0.69, p < 0.001), but as early as 12 hours postinjury this correlation was lost. A similar pattern was found for the relationship between CBF and outcome. Cerebral blood flow below the threshold for infarction (CBF less-than-or-equal-to 18 ml/100 gm/min) was found in one-third of the studies obtained within 6 hours, the incidence rapidly decreasing thereafter. A low CBF after 24 hours was not generally associated with a high AVDO2, and was probably a reflection of low oxidative metabolism rather than frank ischemia. In 24 patients, a CBF of 18 ml/100 gm/min or less was found at some point after injury; the mortality rate was significantly higher in this subgroup, and survivors did worse. In some cases, ischemia was successfully treated by reducing hyperventilation or inducing arterial hypertension. These results support the above hypothesis, and suggest that early ischemia after traumatic brain injury may be an important factor determining neurological outcome. Moreover, these data indicate that early hyperventilation or lowering of blood pressure to prevent brain edema may be harmful.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, MCV STN, BOX 631, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT BIOSTAT, RICHMOND, VA 23298 USA				Bouma, Gerrit/0000-0002-2772-7475	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER		ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; AUSTIN G, 1975, CEREBRAL CIRCULATION, P391; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DICKMAN CA, 1991, NEUROSURGERY, V28, P467, DOI 10.1227/00006123-199103000-00026; ENEVOLDSEN EM, 1977, J NEUROSURG, V47, P699, DOI 10.3171/jns.1977.47.5.0699; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1972, SCI F NEUROLOGY, P478; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; HANSON EJ, 1975, CIRC RES, V36, P18, DOI 10.1161/01.RES.36.1.18; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1973, CEREBROVASC DIS, P163; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KASOFF SS, 1972, J NEUROSURG, V36, P463, DOI 10.3171/jns.1972.36.4.0463; KONTOS HA, 1989, INTRACRANIAL PRESSUR, V7, P787; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL LF, 1990, CURR OPIN NEUROL NEU, V3, P4; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1986, SURG NEUROL, V25, P317, DOI 10.1016/0090-3019(86)90205-3; MUIZELAAR JP, 1984, ADV NEUROTRAUMATOLOG, P92; Nilsson B, 1980, CEREBRAL ARTERIAL SP, V488-95; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OBRIST WD, 1980, CEREBRAL CIRCULATION, P119; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; SUTTON LN, 1990, J NEUROSURG, V73, P927, DOI 10.3171/jns.1990.73.6.0927; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	47	511	522	0	22	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1991	75	5					685	693		10.3171/jns.1991.75.5.0685			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GM092	WOS:A1991GM09200002	1919689				2021-06-18	
J	Johnson, VE; Stewart, JE; Begbie, FD; Trojanowski, JQ; Smith, DH; Stewart, W				Johnson, Victoria E.; Stewart, Janice E.; Begbie, Finn D.; Trojanowski, John Q.; Smith, Douglas H.; Stewart, William			Inflammation and white matter degeneration persist for years after a single traumatic brain injury	BRAIN			English	Article						inflammation; diffuse axonal injury; traumatic brain injury; axonal pathology; microglia	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; LONG-TERM ACCUMULATION; HEAD-INJURY; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; RISK-FACTOR; BETA ACCUMULATION; NEUROINFLAMMATION; DIAGNOSIS	A single traumatic brain injury is associated with an increased risk of dementia and, in a proportion of patients surviving a year or more from injury, the development of hallmark Alzheimer's disease-like pathologies. However, the pathological processes linking traumatic brain injury and neurodegenerative disease remain poorly understood. Growing evidence supports a role for neuroinflammation in the development of Alzheimer's disease. In contrast, little is known about the neuroinflammatory response to brain injury and, in particular, its temporal dynamics and any potential role in neurodegeneration. Cases of traumatic brain injury with survivals ranging from 10 h to 47 years post injury (n = 52) and age-matched, uninjured control subjects (n = 44) were selected from the Glasgow Traumatic Brain Injury archive. From these, sections of the corpus callosum and adjacent parasaggital cortex were examined for microglial density and morphology, and for indices of white matter pathology and integrity. With survival of epsilon 3 months from injury, cases with traumatic brain injury frequently displayed extensive, densely packed, reactive microglia (CR3/43- and/or CD68-immunoreactive), a pathology not seen in control subjects or acutely injured cases. Of particular note, these reactive microglia were present in 28% of cases with survival of > 1 year and up to 18 years post-trauma. In cases displaying this inflammatory pathology, evidence of ongoing white matter degradation could also be observed. Moreover, there was a 25% reduction in the corpus callosum thickness with survival > 1 year post-injury. These data present striking evidence of persistent inflammation and ongoing white matter degeneration for many years after just a single traumatic brain injury in humans. Future studies to determine whether inflammation occurs in response to or, conversely, promotes white matter degeneration will be important. These findings may provide parallels for studying neurodegenerative disease, with traumatic brain injury patients serving as a model for longitudinal investigations, in particular with a view to identifying potential therapeutic interventions.	[Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stewart, Janice E.; Begbie, Finn D.; Stewart, William] Univ Glasgow, Div Clin Neurosci, Glasgow G51 4TF, Lanark, Scotland; [Stewart, Janice E.; Stewart, William] So Gen Hosp, Dept Lab Med, Glasgow G51 4TF, Lanark, Scotland; [Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Inst Ageing, Perelman Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Stewart, W (corresponding author), So Gen Hosp, Dept Lab Med, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	William.Stewart@glasgow.ac.uk		Stewart, William/0000-0003-2199-2582	Think Pink Charity; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, AG038911]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG038911] Funding Source: NIH RePORTER	The authors would like to thank Ms Clare Orange, Pathology Unit, University of Glasgow who kindly assisted with digital slide scanning and the Think Pink Charity for providing financial support for the slide scanner.; National Institutes of Health grants NS038104 (to D.H.S. and W.S.), AG038911 (to D.H.S.).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRAEBER MB, 1994, NEUROPATH APPL NEURO, V20, P406, DOI 10.1111/j.1365-2990.1994.tb00987.x; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Greaves DR, 1998, GENOMICS, V54, P165, DOI 10.1006/geno.1998.5546; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, EXP NEUROL IN PRESS; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pratico D, 2000, NEUROBIOL AGING, V21, P441, DOI 10.1016/S0197-4580(00)00141-X; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	71	510	515	1	70	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2013	136		1				28	42		10.1093/brain/aws322			15	Clinical Neurology; Neurosciences	Neurosciences & Neurology	089KR	WOS:000314909900005	23365092	Green Published, Bronze	Y	N	2021-06-18	
J	Rutland-Brown, W; Langlois, JA; Thomas, KE; Lily, YL				Rutland-Brown, Wesley; Langlois, Jean A.; Thomas, Karen E.; Lily, Yongli			Incidence of traumatic brain injury in the United States, 2003	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						closed head injury; craniocerebral trauma; epidemiology; traumatic brain injury		Traumatic brain injury (TBI) is an important public health problem in the United States. In 2003, there were an estimated 1,565,000 TBIs in the United States: 1,224,000 emergency department visits, 290,000 hospitalizations, and 51,000 deaths. Findings were similar to those from previous years in which rates of TBI were highest for young children (aged 0-4) and men, and the leading causes of TBI were falls and motor vehicle traffic.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, Atlanta, GA 30341 USA	Langlois, JA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, Atlanta, GA 30341 USA.	jal7@cdc.gov					[Anonymous], 2002, EXT CAUS INJ MORT MA; *CDCP, 2003, US CENS POP BRIDG RA; *CDCP, 2001, REC FRAM E COD GROUP; CHESNUT RM, 1999, 2 AG HLTH CAR POL RE; DENNISON C, 2000, VITAL HLTH STAT, V1, P39; HOYET DL, 2006, DEATHS FINAL DATA 20, V54; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marr AL., 2004, CENTRAL NERVOUS SYST; McCaig L F, 1994, Vital Health Stat 1, P1; *RES TRIANGL I, 2004, SUDAAN SOFTW STAT AN; *US DEP HLTH HUM S, 1989, INT CLASS DIS 9 REV; *WHO, 2001, INT CLASS DIS 10 REV	13	510	516	0	44	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2006	21	6					544	548		10.1097/00001199-200611000-00009			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	109UC	WOS:000242333400009	17122685				2021-06-18	
J	LOWENSTEIN, DH; THOMAS, MJ; SMITH, DH; MCINTOSH, TK				LOWENSTEIN, DH; THOMAS, MJ; SMITH, DH; MCINTOSH, TK			SELECTIVE VULNERABILITY OF DENTATE HILAR NEURONS FOLLOWING TRAUMATIC BRAIN INJURY - A POTENTIAL MECHANISTIC LINK BETWEEN HEAD TRAUMA AND DISORDERS OF THE HIPPOCAMPUS	JOURNAL OF NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; SUSTAINED ELECTRICAL-STIMULATION; PERFORANT PATH; FOREBRAIN ISCHEMIA; MEMORY IMPAIRMENT; TEMPORAL PROFILE; GRANULE CELLS; RAT; SOMATOSTATIN; DAMAGE	Despite intensive study, the neurobiological basis of epilepsy and persistent memory impairment following traumatic head injury remains unknown. Since abnormalities of the hippocampus are known to be associated with temporal lobe seizures and memory dysfunction, we investigated the effects of experimental traumatic brain injury on hippocampal structure and function in the rat. Using a model of fluid-percussion injury, we have discovered that neurons of the dentate hilus are vulnerable to a brief, unilateral impact to the extradural surface of the brain. One week after trauma, there was a dramatic reduction in hilar neurons ipsilateral to the impact, and a milder but significant decrease in neurons on the contralateral side as well. This neuronal loss was highly selective since adjacent dentate granule and pyramidal neurons appeared relatively unaffected. Immunocytochemistry showed that the hilar cell loss included a loss of somatostatin-immunoreactive neurons, and degeneration stains provided evidence that irreversible hilar injury occurred within 4 hr of impact. To assess the functional effects of the hilar damage, dentate granule cell field potentials were measured in response to perforant path stimulation. This revealed abnormal dentate granule cell hyperexcitability at 2.0 Hz stimulation in many of the injured animals. The presence of abnormal hyperexcitability correlated with the loss of hilar neurons. Thus, a momentary impact to the surface of the brain can cause selective, bilateral hippocampal injury with associated abnormalities in dentate gyrus physiology. Furthermore, the pattern of cell loss is similar to that observed in some patients with temporal lobe epilepsy. These findings provide a potential mechanistic link between human head trauma and the subsequent development of disorders of the hippocampus such as epilepsy and memory loss.	UNIV CALIF SAN FRANCISCO,DEPT NEUROL,EPILEPSY RES LAB,SAN FRANCISCO,CA 94143; UNIV PENN,DEPT NEUROSURG,PHILADELPHIA,PA 19104	LOWENSTEIN, DH (corresponding author), SAN FRANCISCO GEN HOSP,DEPT NEUROL,4M62,1001 POTRERO AVE,SAN FRANCISCO,CA 94110, USA.		smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, K08NS001424, R55NS026818] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26818, NS01424] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Amaral DG, 1987, HDB PHYSL NERVOUS SY, P211; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROWN A, 1968, BR J EXP PATHOL, V44, P87; Bruton CJ, 1988, NEUROPATHOLOGY TEMPO; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Engel J, 1989, SEIZURES EPILEPSY CO; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRAHAM DI, 1989, MILD MODERATE HEAD I, P63; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HAUSER WA, 1967, EPILEPSIA, V16, P1; Hayes RL, 1989, MILD HEAD INJURY, P54; Jennett B, 1975, EPILEPSY NONMISSILE; JOHANSEN FF, 1987, ACTA NEUROPATHOL, V73, P110, DOI 10.1007/BF00693775; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; KRAUS J, 1987, EPIDEMIOLOGY HEAD IN; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1989, MILD MODERATE HEAD I, P153; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LOWENSTEIN DH, 1991, NEURON, V6, P627, DOI 10.1016/0896-6273(91)90065-8; LOWENSTEIN DH, 1991, NEURON, V7, P1053, DOI 10.1016/0896-6273(91)90349-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK J, 1985, CENTRAL NERVOUS SYST; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; SAGAR SM, 1985, BRAIN RES, V336, P235, DOI 10.1016/0006-8993(85)90650-X; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SIMON RP, 1991, J NEUROSCI, V11, P881; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SLOVITER RS, 1981, NEUROSCI LETT, V24, P279, DOI 10.1016/0304-3940(81)90171-3; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRUASS I, 1934, ARCH NEUROL PSYCHIAT, V31, P893; WILLIAMSON A, 1990, EPILEPSIA, V31, P625; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	52	510	517	0	28	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036	0270-6474			J NEUROSCI	J. Neurosci.	DEC	1992	12	12					4846	4853					8	Neurosciences	Neurosciences & Neurology	KC840	WOS:A1992KC84000025	1464770				2021-06-18	
J	Corrigan, JD; Selassie, AW; Orman, JA				Corrigan, John D.; Selassie, Anbesaw W.; Orman, Jean A. (Langlois)			The Epidemiology of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						craniocerebral trauma; epidemiology; traumatic brain injury	LONG-TERM DISABILITY; UNITED-STATES; HEAD-INJURY; YOUNG-ADULTS; IDENTIFICATION; ASSOCIATION; RELIABILITY; POPULATION; PREVALENCE; VALIDITY	Objective: To describe the most recent estimates of the incidence and prevalence of traumatic brain injury (TBI) and review current issues related to measurement and use of these data. Design: State of the science literature for the United States and abroad was analyzed and issues were identified for (1) incidence of TBI, (2) prevalence of lifetime history of TBI, and (3) incidence and prevalence of disability associated with TBI. Results: The most recent estimates indicate that each year 235 000 Americans are hospitalized for nonfatal TBI, 1.1 million are treated in emergency departments, and 50 000 die. The northern Finland birth cohort found that 3.8% of the population had experienced at least 1 hospitalization due to TBI by 35 years of age. The Christchurch New Zealand birth cohort found that by 25 years of age 31.6% of the population had experienced at least 1 TBI, requiring medical attention (hospitalization, emergency department, or physician office). An estimated 43.3% of Americans have residual disability 1 year after injury. The most recent estimate of the prevalence of US civilian residents living with disability following hospitalization with TBI is 3.2 million. Conclusion: Estimates of the incidence and prevalence of TBI are based on varying sources of data, methods of calculation, and assumptions. Informed users should be cognizant of the limitations of these estimates when determining their applicability.	[Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Selassie, Anbesaw W.] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; [Orman, Jean A. (Langlois)] Res & Dev Serv, US Dept Vet Affairs, Washington, DC USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011		Department of Education, National Institute on Disability and Rehabilitation Research [H133A070029]	The contents of this article were developed under the grant from the Department of Education, National Institute on Disability and Rehabilitation Research (grant H133A070029 [Corrigan]).	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; CORRIGAN JD, 2006, BRAIN INJURY MED PRI, P1105; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Granacher RP, 2008, J AM ACAD PSYCHIATRY, V36, P323; GUERRERO JL, 2001, STAT MED, V20, P1307; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; *J HOPK U SCH PUBL, 1997, ICDMAP 90 SOFTW; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LANGLOIS JA, 1997, MMWR-MORBID MORTAL W, V52, P1; LARNER SF, 2008, BIOMARKERS FUTURE DI; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, CHILD CARE HLTH DEV; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Murray CJL., 1996, GLOBAL HLTH STAT COM; *NAT CHILDR STUD I, 2003, ENV HLTH PERSPECT, V111, P642; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; SHIROMA EJ, 2009, J CORRECTIO IN PRESS, V16; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; TEASDALE G, 1974, LANCET, V2, P81; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; WINQVIST S, 2006, J ADOLESC HLTH, V39; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	51	509	524	2	85	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2010	25	2					72	80		10.1097/HTR.0b013e3181ccc8b4			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	578EJ	WOS:000276276000002	20234226				2021-06-18	
J	Brines, M; Grasso, G; Fiordaliso, F; Sfacteria, A; Ghezzi, P; Fratelli, M; Latini, R; Xie, QW; Smart, J; Su-Rick, CJ; Pobre, E; Diaz, D; Gomez, D; Hand, C; Coleman, T; Cerami, A				Brines, M; Grasso, G; Fiordaliso, F; Sfacteria, A; Ghezzi, P; Fratelli, M; Latini, R; Xie, QW; Smart, J; Su-Rick, CJ; Pobre, E; Diaz, D; Gomez, D; Hand, C; Coleman, T; Cerami, A			Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							COLONY-STIMULATING FACTOR; GM-CSF; RECEPTOR; INTERLEUKIN-3; CHAIN; INJURY; CELLS; ACTIVATION; DEFICIENT; APOPTOSIS	The cytokine erythropoietin (Epo) is tissue-protective in preclinical models of ischemic, traumatic, toxic, and inflammatory injuries. We have recently characterized Epo derivatives that do not bind to the Epo receptor (EpoR) yet are tissue-protective. For example, carbarrylated Epo (CEpo) does not stimulate erythropoiesis, yet it prevents tissue injury in a wide variety of in vivo and in vitro models. These observations suggest that another receptor is responsible for the tissue-protective actions of Epo. Notably, prior investigation suggests that EpoR physically interacts with the common beta receptor (betacR), the signal-transducing subunit shared by the granulocyte-macrophage colony stimulating factor, and the IL-3 and IL-5 receptors. However, because betacR knockout mice exhibit normal erythrocyte maturation, betacR is not required for erythropoiesis. We hypothesized that betacR in combination with the EpoR expressed by nonhematopoietic cells constitutes a tissue-protective receptor. In support of this hypothesis, membrane proteins prepared from rat brain, heart, liver, or kidney were greatly enriched in EpoR after passage over either Epo or CEpo columns but covalently bound in a complex with betacR. Further, antibodies against EpoR coimmunoprecipitated betacR from membranes prepared from neuronal-like P-19 cells that respond to Epo-induced tissue protection. Immunocytochemical studies of spinal cord neurons and cardiomyocytes protected by Epo demonstrated cellular colocalization of Epo betacR and EpoR. Finally, as predicted by the hypothesis, neither Epo nor CEpo was active in cardiomyocyte or spinal cord injury models performed in the betacR knockout mouse. These data support the concept that EpoR and betacR comprise a tissue-protective heteroreceptor.	Kenneth S Warren Inst, Kitchawan, NY 10562 USA; Warren Pharmaceut Inc, Ossining, NY 10563 USA; Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Univ Messina, I-98122 Messina, Italy	Brines, M (corresponding author), Kenneth S Warren Inst, 712 Kitchawan Rd, Kitchawan, NY 10562 USA.	mbrines@kswi.org	Brinesd, Michael/AAE-6072-2020; Ghezzi, Pietro/A-4995-2010; Fratelli, Maddalena/AAA-6446-2020; Fiordaliso, Fabio/AAA-7161-2020; Sfacteria, Alessandra/AAK-1839-2020; grasso, giovanni/K-3774-2018; Latini, Roberto/AAB-1410-2020	Fratelli, Maddalena/0000-0002-1769-3427; Fiordaliso, Fabio/0000-0002-0172-4030; grasso, giovanni/0000-0001-5362-0092; Latini, Roberto/0000-0002-3729-4650; Brines, Michael/0000-0003-4151-4449; Cerami, Carla/0000-0002-7634-0955; Ghezzi, Pietro/0000-0003-0911-8358			BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Blake TJ, 2002, J LEUKOCYTE BIOL, V72, P1246; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Campana WM, 1998, INT J MOL MED, V1, P235; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Farooque M, 2000, ACTA NEUROPATHOL, V100, P13, DOI 10.1007/s004010051187; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Iwasaki Y, 2002, NEUROL RES, V24, P643, DOI 10.1179/016164102101200681; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; KAMEGAI M, 1990, NEURON, V4, P429, DOI 10.1016/0896-6273(90)90055-K; Klampfer L, 1999, CYTOKINE, V11, P849, DOI 10.1006/cyto.1999.0514; KONISHI Y, 1994, NEUROSCI LETT, V182, P271, DOI 10.1016/0304-3940(94)90814-1; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MASUDA S, 1993, J BIOL CHEM, V268, P11208; McClure BJ, 2003, BLOOD, V101, P1308, DOI 10.1182/blood-2002-06-1903; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Reed JA, 2000, AM J PHYSIOL-LUNG C, V278, pL1164; Rossjohn J, 2000, BLOOD, V95, P2491; Scott CL, 2000, BLOOD, V96, P1588, DOI 10.1182/blood.V96.4.1588.h8001588_1588_1590; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Tabira T, 1998, ANN NY ACAD SCI, V840, P107, DOI 10.1111/j.1749-6632.1998.tb09554.x; TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Yu XB, 2002, DEVELOPMENT, V129, P505	33	501	537	1	24	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 12	2004	101	41					14907	14912		10.1073/pnas.0406491101			6	Multidisciplinary Sciences	Science & Technology - Other Topics	862JX	WOS:000224488000041	15456912	Green Published, Bronze			2021-06-18	
J	Yakovlev, AG; Knoblach, SM; Fan, L; Fox, GB; Goodnight, R; Faden, AI				Yakovlev, AG; Knoblach, SM; Fan, L; Fox, GB; Goodnight, R; Faden, AI			Activation of CPP32-Like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury	JOURNAL OF NEUROSCIENCE			English	Article						brain trauma; apoptosis; caspase-3; mRNA; PCR; neuron; immunofluorescence	INTERLEUKIN-1-BETA CONVERTING-ENZYME; FOCAL CEREBRAL-ISCHEMIA; PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; DEPENDENT PROTEIN-KINASE; ICE-LIKE PROTEASE; DNA FRAGMENTATION; ICE/CED-3 PROTEASE; CYSTEINE PROTEASE; GENE CED-3	We examined the temporal profile of apoptosis after fluid percussion-induced traumatic brain injury (TBI) in rats and investigated the potential pathophysiological role of caspase-3-like proteases in this process. DNA fragmentation was observed in samples from injured cortex and hippocampus, but not from contralateral tissue, beginning 4 hr after TBI and continuing for at least 3 d. Double labeling of brain with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) and an antibody directed to neuronal nuclear protein identified apoptotic neurons with high frequency in both traumatized rat cortex and hippocampus. Cytosolic extracts from injured cortex and hippocampus, but not from contralateral or control tissue, induced internucleosomal DNA fragmentation in isolated nuclei with temporal profiles consistent with those of DNA fragmentation observed in vivo. Caspase-3 mRNA levels, estimated by semiquantitative RT-PCR, were elevated fivefold in ipsilateral cortex and twofold in hippocampus by 24 hr after TBI. Caspase-1 mRNA content also was increased after trauma, but to a lesser extent in cortex. Increased caspase-3-like, but not caspase-1-like, enzymatic activity was found in cytosolic extracts from injured cortex. Intracerebroventricular administration of z-DEVD-fmk-a specific tetrapeptide inhibitor of caspase-3-before and after injury markedly reduced post-traumatic apoptosis, as demonstrated by DNA electrophoresis and TUNEL staining, and significantly improved neurological recovery. Together, these results implicate caspase-3-like proteases in neuronal apoptosis induced by TBI and suggest that the blockade of such caspases can reduce post-traumatic apoptosis and associated neurological dysfunction.	GEORGETOWN UNIV, DEPT NEUROL, WASHINGTON, DC 20007 USA	Yakovlev, AG (corresponding author), GEORGETOWN UNIV, MED CTR, GEORGETOWN INST COGNIT & COMPUTAT SCI, RES BLDG, EP-20, WASHINGTON, DC 20007 USA.						Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Duffey DC, 1996, LARYNGOSCOPE, V106, P889, DOI 10.1097/00005537-199607000-00020; Eldadah BA, 1997, J NEUROSCI, V17, P6105; Eldadah BA, 1996, NUCLEIC ACIDS RES, V24, P4092, DOI 10.1093/nar/24.20.4092; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FAUCHEU C, 1995, EMBO J, V14, P1914, DOI 10.1002/j.1460-2075.1995.tb07183.x; Faucheu C, 1996, EUR J BIOCHEM, V236, P207, DOI 10.1111/j.1432-1033.1996.t01-1-00207.x; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; HILL IE, 1995, BRAIN RES, V676, P398, DOI 10.1016/0006-8993(95)00145-G; ISLAM N, 1995, NEUROSCI LETT, V188, P159, DOI 10.1016/0304-3940(95)11419-W; IWAI T, 1995, BRAIN RES, V671, P305, DOI 10.1016/0006-8993(94)01363-M; KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/jbc.270.25.15250; KEANE KM, 1995, CYTOKINE, V7, P105, DOI 10.1006/cyto.1995.1014; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kharlamov A, 1996, BRAIN RES, V734, P1; KIHARA S, 1994, NEUROSCI LETT, V175, P133, DOI 10.1016/0304-3940(94)91097-9; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; LI Y, 1995, MOL BRAIN RES, V28, P164, DOI 10.1016/0169-328X(94)00220-9; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MARTIN SJ, 1995, EMBO J, V14, P5191, DOI 10.1002/j.1460-2075.1995.tb00203.x; Mashima T, 1995, BIOCHEM BIOPH RES CO, V217, P1185, DOI 10.1006/bbrc.1995.2894; MASSON M, 1995, BIOCHIMIE, V77, P456, DOI 10.1016/0300-9084(96)88160-0; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miller TM, 1996, J NEUROSCI, V16, P7487; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MOGIL RJ, 1994, J IMMUNOL, V152, P1674; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; MUNDAY NA, 1995, J BIOL CHEM, V270, P15870, DOI 10.1074/jbc.270.26.15870; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; RINK A, 1995, AM J PATHOL, V147, P1575; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schulz JB, 1996, J NEUROSCI, V16, P4696; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SEI Y, 1994, NEUROSCI LETT, V171, P179, DOI 10.1016/0304-3940(94)90634-3; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Srinivasan A, 1996, J NEUROSCI, V16, P5654; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRUMP BF, 1967, LAB INVEST, V16, P453; TRUMP BF, 1982, PATHOPHYSIOLOGY SHOC, P6; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	81	493	519	2	12	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 1	1997	17	19					7415	7424					10	Neurosciences	Neurosciences & Neurology	XX358	WOS:A1997XX35800024	9295387				2021-06-18	
J	Fazel, S; Geddes, JR; Kushel, M				Fazel, Seena; Geddes, John R.; Kushel, Margot			The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations	LANCET			English	Article							TRAUMATIC BRAIN-INJURY; ADVERSE CHILDHOOD EXPERIENCES; CARE UTILIZATION PATTERNS; NEW-YORK-CITY; MENTAL-HEALTH; RISK-FACTORS; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; SMOKING-CESSATION; SUBSTANCE-USE	In the European Union, more than 400 000 individuals are homeless on any one night and more than 600 000 are homeless in the USA. The causes of homelessness are an interaction between individual and structural factors. Individual factors include poverty, family problems, and mental health and substance misuse problems. The availability of low-cost housing is thought to be the most important structural determinant for homelessness. Homeless people have higher rates of premature mortality than the rest of the population, especially from suicide and unintentional injuries, and an increased prevalence of a range of infectious diseases, mental disorders, and substance misuse. High rates of non-communicable diseases have also been described with evidence of accelerated ageing. Although engagement with health services and adherence to treatments is often compromised, homeless people typically attend the emergency department more often than non-homeless people. We discuss several recommendations to improve the surveillance of morbidity and mortality in homeless people. Programmes focused on high-risk groups, such as individuals leaving prisons, psychiatric hospitals, and the child welfare system, and the introduction of national and state-wide plans that target homeless people are likely to improve outcomes.	[Fazel, Seena; Geddes, John R.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Kushel, Margot] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA	Fazel, S (corresponding author), Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Lorente, Rosa/AAL-5850-2021; Fazel, Seena/B-5307-2008; Geddes, John/B-8240-2011	Fazel, Seena/0000-0002-5383-5365; Geddes, John/0000-0002-5281-5960; Kushel, Margot/0000-0002-1361-6889	Wellcome TrustWellcome TrustEuropean Commission; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10150] Funding Source: researchfish	SF is supported by a Wellcome Trust Senior Research Fellowship in clinical science. JRG is an NIHR Senior Investigator. We are grateful to Achim Wolf for assistance with the literature searches.	Adams J, 2007, J HEALTH CARE POOR U, V18, P173, DOI 10.1353/hpu.2007.0000; Apollonio DE, 2005, TOB CONTROL, V14, P409, DOI 10.1136/tc.2005.011890; Arangua L, 2007, TOB CONTROL, V16, P143, DOI 10.1136/tc.2006.018697; Argintaru N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-577; Arnaud A, 2010, EUR J PUBLIC HEALTH, V20, P601, DOI 10.1093/eurpub/ckp197; Arnsten JH, 2004, ADDICT BEHAV, V29, P1155, DOI 10.1016/j.addbeh.2004.03.010; Badiaga S, 2008, EMERG INFECT DIS, V14, P1353, DOI 10.3201/eid1409.080204; Baggett TP, 2013, ADDICTION, V108, P2009, DOI 10.1111/add.12292; Baggett TP, 2013, NEW ENGL J MED, V369, P201, DOI 10.1056/NEJMp1301935; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baggett TP, 2011, J GEN INTERN MED, V26, P627, DOI 10.1007/s11606-011-1638-4; Baggett TP, 2010, AM J PREV MED, V39, P164, DOI 10.1016/j.amepre.2010.03.024; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Beijer U, 2009, THESIS, P1; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beijer U, 2010, EUR J PUBLIC HEALTH, V20, P511, DOI 10.1093/eurpub/ckq033; Bharel M, 2013, AM J PUBLIC HEALTH, V103, pS311, DOI 10.2105/AJPH.2013.301421; Brown RT, 2013, JAMA INTERN MED, V173, P1831, DOI 10.1001/jamainternmed.2013.6627; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burt MarthaR., 2001, HELPING AMERICAS HOM; Busch-Geertsema V, 2010, EUROPEAN CONSENSUS C; Canavan R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-222; Capp R, 2013, AM J EMERG MED, V31, P1333, DOI 10.1016/j.ajem.2013.05.050; Caton CLM, 2013, AIDS BEHAV, V17, P856, DOI 10.1007/s10461-012-0198-x; Caton CLM, 2005, AM J PUBLIC HEALTH, V95, P1753, DOI 10.2105/AJPH.2005.063321; Centers for Disease Control and Prevention, 2013, TRAUMATIC BRAIN INJU; Chambers C, 2014, COMMUNITY MENT HLT J, V50, P553, DOI 10.1007/s10597-013-9605-7; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Coe AB, 2015, RES SOC ADMIN PHARM, V11, pE110, DOI 10.1016/j.sapharm.2012.11.004; Corliss HL, 2011, AM J PUBLIC HEALTH, V101, P1683, DOI 10.2105/AJPH.2011.300155; Crane M, 2005, J GERONTOL B-PSYCHOL, V60, pS152, DOI 10.1093/geronb/60.3.S152; Culhane DP, 2010, PENN SCHOOL OF SOCIA; Dworsky A, 2013, AM J PUBLIC HEALTH, V103, pS318, DOI 10.2105/AJPH.2013.301455; Dworsky A, 2009, CHILD WELFARE, V88, P23; Edens EL, 2011, WOMEN HEALTH ISS, V21, P383, DOI 10.1016/j.whi.2011.03.004; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; European Comission, 2013, COMMISSION STAFF WOR; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2012, BRIT J PSYCHIAT, V200, P364, DOI 10.1192/bjp.bp.111.096370; Federation of National Organisations Working with the Homeless, 2012, ON THE WAY HOME FEAN; Fichter MM, 2005, EUR ARCH PSY CLIN N, V255, P111, DOI 10.1007/s00406-004-0543-9; Frances Pierre, 2013, Rev Prat, V63, P29; Frencher SK, 2010, J TRAUMA, V69, pS191, DOI 10.1097/TA.0b013e3181f1d31e; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; Garner L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-951; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Greenberg GA, 2010, J HEALTH CARE POOR U, V21, P1234, DOI 10.1353/hpu.2010.0926; Guyavarch E, 2010, CHANGING FACES HOMEL; Henry M, 2013, THE 2013 ANNUAL HOME; Homelessness Taskforce Department of Families Housing Community Services and Indigenous Affairs Commonwealth of Australia, 2008, THE ROAD HOME A NATI; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Hwang SW, 2013, AM J PUBLIC HEALTH, V103, pS294, DOI 10.2105/AJPH.2013.301369; Hwang SW, 2011, MED CARE, V49, P350, DOI 10.1097/MLR.0b013e318206c50d; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Jones CA, 2009, CURR CARDIOL REV, V5, P69, DOI 10.2174/157340309787048086; Kaba M, 2010, EMERG INFECT DIS, V16, P1761, DOI 10.3201/eid1611.091890; Kerker BD, 2011, AM J PUBLIC HEALTH, V101, P546, DOI 10.2105/AJPH.2010.193102; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kim DH, 2008, FAM COMMUNITY HEALTH, V31, P269, DOI 10.1097/01.FCH.0000336090.37280.2e; Kramer CB, 2008, J BURN CARE RES, V29, P461, DOI 10.1097/BCR.0b013e31817112b0; Ku BS, 2010, PUBLIC HEALTH REP, V125, P398, DOI 10.1177/003335491012500308; Kubisova D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-51; Kuhn R, 1998, AM J COMMUN PSYCHOL, V26, P207, DOI 10.1023/A:1022176402357; Kushel MB, 2007, ARCH PEDIAT ADOL MED, V161, P986, DOI 10.1001/archpedi.161.10.986; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Laporte A, 2010, LA LETTRE DE LOBSERV, V5, P1; Larney S, 2009, AUST NZ J PUBL HEAL, V33, P347, DOI 10.1111/j.1753-6405.2009.00406.x; Lebrun-Harris LA, 2013, HEALTH SERV RES, V48, P992, DOI 10.1111/1475-6773.12009; Lee CH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-720; Lee TC, 2005, CIRCULATION, V111, P2629, DOI 10.1161/CIRCULATIONAHA.104.510826; Lindamer LA, 2012, ADM POLICY MENT HLTH, V39, P200, DOI 10.1007/s10488-011-0350-3; Lyles CR, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120301; Mackelprang JL, 2014, INT J INJ CONTROL SA, V21, P289, DOI 10.1080/17457300.2013.825631; McDonald L, 2007, J GERONTOL SOC WORK, V49, P19, DOI 10.1300/J083v49n01_02; Meinbresse M, 2014, VIOLENCE VICTIMS, V29, P122, DOI 10.1891/0886-6708.VV-D-12-00069; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Minnery J, 2007, J SOC ISSUES, V63, P641, DOI 10.1111/j.1540-4560.2007.00528.x; Moniruzzaman A., 2012, MENTAL HLTH SUBSTANC, V5, DOI [DOI 10.1080/17523281.2011.618143, 10.1080/17523281.2011.618143]; Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS262, DOI 10.2105/AJPH.2013.301474; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Newburn T, 2005, LIVING IN FEAR VIOLE; NICE, 2012, TUBERCULOSIS HARD TO; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Nusselder WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073979; O'Carroll A, 2008, EUR J PUBLIC HEALTH, V18, P448, DOI 10.1093/eurpub/ckn038; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Ohsaka Takako, 2003, Nihon Koshu Eisei Zasshi, V50, P686; Okuyemi KS, 2006, NICOTINE TOB RES, V8, P689, DOI 10.1080/14622200600789841; Okuyemi KS, 2006, NICOTINE TOB RES, V8, P287, DOI 10.1080/14622200500494971; Okuyemi KS, 2013, NICOTINE TOB RES, V15, P22, DOI 10.1093/ntr/nts030; Oliveira LD, 2012, CAD SAUDE PUBLICA, V28, P1517; Pascual JC, 2008, GEN HOSP PSYCHIAT, V30, P14, DOI 10.1016/j.genhosppsych.2007.08.006; Pleace N, 2000, HOUSING STUD, V15, P581, DOI 10.1080/02673030050081113; Porter J, 2011, HEALTH PROMOT PRACT, V12, p144S, DOI 10.1177/1524839911414412; Raoult D, 2001, Lancet Infect Dis, V1, P77, DOI 10.1016/S1473-3099(01)00062-7; Riley AJ, 2003, BRIT J GEN PRACT, V53, P473; Romaszko J, 2013, CENT EUR J MED, V8, P283, DOI 10.2478/s11536-012-0114-9; Roos LE, 2013, AM J PUBLIC HEALTH, V103, pS275, DOI 10.2105/AJPH.2013.301323; Rosario M, 2012, CHILD YOUTH SERV REV, V34, P186, DOI 10.1016/j.childyouth.2011.09.016; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Schanzer B, 2007, AM J PUBLIC HEALTH, V97, P464, DOI 10.2105/AJPH.2005.076190; Scott J, 2013, QJM-INT J MED, V106, P547, DOI 10.1093/qjmed/hct063; Shelley D, 2010, AM J HEALTH BEHAV, V34, P544; Shinn M, 2007, J HEALTH PSYCHOL, V12, P696, DOI 10.1177/1359105307080581; Shinn M, 2007, J SOC ISSUES, V63, P657, DOI 10.1111/j.1540-4560.2007.00529.x; Snyder LD, 2004, CHEST, V125, P1719, DOI 10.1378/chest.125.5.1719; Song J, 2008, J GEN INTERN MED, V23, P2031, DOI 10.1007/s11606-008-0771-1; Sprake EF, 2014, J HUM NUTR DIET, V27, P242, DOI 10.1111/jhn.12130; Strehlau V, 2012, J PSYCHIATR PRACT, V18, P349, DOI 10.1097/01.pra.0000419819.60505.dc; Sun S, 2012, SCAND J PUBLIC HEALT, V40, P115, DOI 10.1177/1403494811435493; Thompson RG, 2013, AM J PUBLIC HEALTH, V103, pS282, DOI 10.2105/AJPH.2013.301302; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Torchalla I, 2012, CHILD MALTREATMENT, V17, P132, DOI 10.1177/1077559512439350; Torchalla I, 2011, DRUG ALCOHOL DEPEN, V118, P173, DOI 10.1016/j.drugalcdep.2011.03.016; Torchalla I, 2011, NICOTINE TOB RES, V13, P934, DOI 10.1093/ntr/ntr101; Tsai J, 2013, AM J PUBLIC HEALTH, V103, pS225, DOI 10.2105/AJPH.2013.301307; Tsai J, 2013, AM J EMERG MED, V31, P855, DOI 10.1016/j.ajem.2013.02.046; Tyler KA, 2010, VIOLENCE VICTIMS, V25, P101, DOI 10.1891/0886-6708.25.1.101; United Kingdom Department for Communities and Local Government, 2013, STATISTICAL DATA SET; United Kingdom Department for Communities and Local Government, 2013, ROUGH SLEEPING STATI; United States Interagency Council on Homelessness, 2010, OPENING DOORS FEDERA; van den Bree MBM, 2009, J ADOLESCENT HEALTH, V45, P571, DOI 10.1016/j.jadohealth.2009.03.027; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Verlinde E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-242	132	492	494	10	177	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1529	1540		10.1016/S0140-6736(14)61132-6			12	Medicine, General & Internal	General & Internal Medicine	AR9MO	WOS:000343899600027	25390578	Green Accepted	Y	N	2021-06-18	
J	Jordan, BD; Relkin, NR; Ravdin, LD; Jacobs, AR; Bennett, A; Gandy, S				Jordan, BD; Relkin, NR; Ravdin, LD; Jacobs, AR; Bennett, A; Gandy, S			Apolipoprotein E epsilon 4 associated with chronic traumatic brain injury in boxing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID PROTEIN DEPOSITION; SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; DEMENTIA-PUGILISTICA; PRECURSOR PROTEIN; TYPE-4 ALLELE; BETA-PROTEIN; BOXERS; AFTERMATH; DAMAGE	Context.-Given the similarities between Alzheimer disease and dementia pugilistica, we evaluated the relationship between apolipoprotein E (APOE) genotype and chronic traumatic brain injury (CTBI) in boxers to determine whether there is a genetic susceptibility to the effects of head trauma. Objective.-To assess the relationship between CTBI and APOE genotype in boxers. Design and Setting.-Clinical characterization of 24 volunteer and 6 referred boxers in an outpatient setting. Participants.-Thirty professional boxers aged 23 to 76 years underwent neurologic and behavioral assessment in conjunction with APOE genotyping. Main Outcome Measures.-Apolipoprotein E genotype was examined in relationship to measures of CTBI. A 10-point clinical rating scale (0-9), the Chronic Brain Injury (CBI) scale, was devised to assess the severity of traumatic encephalopathy associated with boxing, Boxers with abnormal CTBI scores were further classified on the basis of whether their impairments were possibly or probably related to boxing. Scores were analyzed in relation to boxing exposure (number of bouts) and APOE genotype. Results.-Among the 30 boxers, 11 were found to be normal (CBI score=0), 12 showed mild deficits (CBI score=1-2), 4 were moderately impaired (CBI score=3-4), and 3 showed signs of severe impairment (CBI score >4). High-exposure boxers tie, those with greater than or equal to 12 professional bouts) had significantly higher CBI scores (mean [SD], 2.6 [1.9]) than low-exposure boxers (mean [SD], 0.3 [0.7]) (P<.001), indicating that neurologic impairment as measured by the CBI scale seems related to boxing exposure. The APOE genotype frequencies of the study population were approximately the same as those found in the general population. Boxers with low exposure had mean CBI scores of 0.33, irrespective of APOE genotype. However, high-exposure boxers with an APOE epsilon 4 allele had significantly greater CBI scores (mean [SD], 3.9 [2.3]) than high-exposure boxers without APOE epsilon 4 (mean [SD], 1.8 [1.2]) (P=.04), All boxers with severe impairment possessed at least 1 APOE epsilon 4 allele. The tendency for greater CTBI among those with both high exposure and an epsilon 4 allele was statistically significant at the P<.001 level. ConcIusions.-These preliminary findings suggest that possession or an APOE epsilon 4 allele may be associated with increased severity of chronic neurologic deficits in high-exposure boxers.	CORNELL UNIV MED COLL,NEW YORK HOSP,DEPT NEUROL & NEUROSCI,NEW YORK,NY; CORNELL UNIV MED COLL,HOSP SPECIAL SURG,SPORTS NEUROL PROGRAM,NEW YORK,NY							BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; JORDAN BD, 1993, MED ASPECTS BOXING, P147; JORDAN BD, 1993, MED ASPECTS BOXING, P177; Katzman R, 1996, NEUROLOGY, V46, P889; Lehmann EL, 1975, NONPARAMETRICS; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; *NAT I AG ALZH ASS, 1996, LANCET, V347, P1091; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; UHL GR, 1982, ANN NEUROL, V12, P99; vanDuijn CM, 1996, J NEUROL NEUROSUR PS, V60, P478, DOI 10.1136/jnnp.60.5.478; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	37	487	498	1	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	1997	278	2					136	140		10.1001/jama.278.2.136			5	Medicine, General & Internal	General & Internal Medicine	XH667	WOS:A1997XH66700034	9214529				2021-06-18	
J	Masel, BE; DeWitt, DS				Masel, Brent E.; DeWitt, Douglas S.			Traumatic Brain Injury: A Disease Process, Not an Event	JOURNAL OF NEUROTRAUMA			English	Article						brain injury morbidity; chronic disease; head injury; head trauma; rehabilitation; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; OBSTRUCTIVE SLEEP-APNEA; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; LATE POSTTRAUMATIC SEIZURES; LONG-TERM ACCUMULATION; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; NEURODEGENERATIVE DISEASES	Traumatic brain injury (TBI) is seen by the insurance industry and many health care providers as an "event." Once treated and provided with a brief period of rehabilitation, the perception exists that patients with a TBI require little further treatment and face no lasting effects on the central nervous system or other organ systems. In fact, TBI is a chronic disease process, one that fits the World Health Organization definition as having one or more of the following characteristics: it is permanent, caused by non-reversible pathological alterations, requires special training of the patient for rehabilitation, and/or may require a long period of observation, supervision, or care. TBI increases long-term mortality and reduces life expectancy. It is associated with increased incidences of seizures, sleep disorders, neurodegenerative diseases, neuroendocrine dysregulation, and psychiatric diseases, as well as non-neurological disorders such as sexual dysfunction, bladder and bowel incontinence, and systemic metabolic dysregulation that may arise and/or persist for months to years post-injury. The purpose of this article is to encourage the classification of TBI as the beginning of an ongoing, perhaps lifelong process, that impacts multiple organ systems and may be disease causative and accelerative. Our intent is not to discourage patients with TBI or their families and caregivers, but rather to emphasize that TBI should be managed as a chronic disease and defined as such by health care and insurance providers. Furthermore, if the chronic nature of TBI is recognized by government and private funding agencies, research can be directed at discovering therapies that may interrupt the disease processes months or even years after the initiating event.	[Masel, Brent E.] Univ Texas Med Branch, Transit Learning Ctr Galveston, Galveston, TX 77550 USA; [Masel, Brent E.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77550 USA; [DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Moody Ctr Traumat Brain & Spinal Cord Injury Res, Galveston, TX 77550 USA	Masel, BE (corresponding author), Univ Texas Med Branch, Transit Learning Ctr Galveston, 1528 Post Off St, Galveston, TX 77550 USA.	bmasel@tlc-galveston.org		DeWitt, Douglas/0000-0001-9810-8156	Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect; Pharmacial Pfizer	The authors are grateful for support from the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect, and for editorial assistance from Andrew Hall and Patrick Enos in the Office of Grants & Manuscript Preparation in the Department of Anesthesiology of The University of Texas Medical Branch.; B.E.M. has received grant support from Pharmacial Pfizer and has been a consultant to Pfizer and NovoNordisk.	Aarabi B, 2000, Neurosurg Focus, V8, pe1; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Aquilani R, 2000, ARCH PHYS MED REHAB, V81, P176, DOI 10.1016/S0003-9993(00)90137-0; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Borsheim E, 2007, ARCH PHYS MED REHAB, V88, P234, DOI 10.1016/j.apmr.2006.11.003; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 2003, EXP NEUROL, V184, P27, DOI 10.1016/S0014-4886(03)00401-1; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Cribbs DH, 1996, NEUROREPORT, V7, P1773, DOI 10.1097/00001756-199607290-00016; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; DALAKAS MC, 1995, ANN NY ACAD SCI, V753, P167, DOI 10.1111/j.1749-6632.1995.tb27543.x; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; EDWARDS OM, 1986, MEDICINE, V65, P281; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; FRANCIS PT, 1993, J NEUROCHEM, V60, P1589, DOI 10.1111/j.1471-4159.1993.tb13381.x; Franz G, 1999, J NEUROCHEM, V73, P1615, DOI 10.1046/j.1471-4159.1999.0731615.x; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; FUNK P, 1980, FUNK WAGNALLS STANDA; GARBER JR, 2009, REV ENDROCRINOL, V3, P20; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Institute of Medicine, 2009, GULF WAR HLTH, V7; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jubelt B, 2000, JAMA-J AM MED ASSOC, V284, P412, DOI 10.1001/jama.284.4.412; Jubelt B, 1999, MOTOR DISORDERS, P381; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; O'Connor MM, 2000, NEUROSURGERY, V46, P138; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; PAPALIAGKAS VT, 2008, J NEURODEGENERATION, V1, P35; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rango M, 2006, J CEREBR BLOOD F MET, V26, P283, DOI 10.1038/sj.jcbfm.9600192; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; *STAT COL DEP LAB, 2006, TRAUM BRAIN INJ MED; Tan ZS, 2008, ARCH INTERN MED, V168, P1514, DOI 10.1001/archinte.168.14.1514; Tattersall R, 2002, CLIN MED, V2, P227, DOI 10.7861/clinmedicine.2-3-227; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Voshol H, 2003, CURR MOL MED, V3, P447, DOI 10.2174/1566524033479645; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Weiss JW, 1999, PROG CARDIOVASC DIS, V41, P367, DOI 10.1053/pcad.1999.0410367; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; World Health Organization, 2002, INN CAR CHRON COND B; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132; Zafonte R, 2004, J HEAD TRAUMA REHAB, V19, P89, DOI 10.1097/00001199-200403000-00002; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zasler N, 2007, BRAIN INJURY MED PRI; Zazryn T, 2007, SPORTS MED, V37, P467; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	128	485	490	1	72	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2010	27	8					1529	1540		10.1089/neu.2010.1358			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	639OU	WOS:000280984900016	20504161				2021-06-18	
J	Singer, P; Blaser, AR; Berger, MM; Alhazzani, W; Calder, PC; Casaer, MP; Hiesmayr, M; Mayer, K; Montejo, JC; Pichard, C; Preiser, JC; van Zanten, ARH; Oczkowski, S; Szczeklik, W; Bischoff, SC				Singer, Pierre; Blaser, Annika Reintam; Berger, Mette M.; Alhazzani, Waleed; Calder, Philip C.; Casaer, Michael P.; Hiesmayr, Michael; Mayer, Konstantin; Carlos Montejo, Juan; Pichard, Claude; Preiser, Jean-Charles; van Zanten, Arthur R. H.; Oczkowski, Simon; Szczeklik, Wojciech; Bischoff, Stephan C.			ESPEN guideline on clinical nutrition in the intensive care unit	CLINICAL NUTRITION			English	Article						Intensive care; Nutrition; Enteral; Parenteral; Guidelines; ESPEN	CRITICALLY-ILL PATIENTS; EARLY ENTERAL NUTRITION; GAMMA-LINOLENIC ACID; RANDOMIZED CONTROLLED-TRIAL; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; SUPPLEMENTAL PARENTERAL-NUTRITION; MECHANICALLY VENTILATED PATIENTS; VITAMIN-D DEFICIENCY; ACUTE LUNG INJURY	Following the new ESPEN Standard Operating Procedures, the previous guidelines to provide best medical nutritional therapy to critically ill patients have been updated. These guidelines define who are the patients at risk, how to assess nutritional status of an ICU patient, how to define the amount of energy to provide, the route to choose and how to adapt according to various clinical conditions. When to start and how to progress in the administration of adequate provision of nutrients is also described. The best determination of amount and nature of carbohydrates, fat and protein are suggested. Special attention is given to glutamine and omega-3 fatty acids. Particular conditions frequently observed in intensive care such as patients with dysphagia, frail patients, multiple trauma patients, abdominal surgery, sepsis, and obesity are discussed to guide the practitioner toward the best evidence based therapy. Monitoring of this nutritional therapy is discussed in a separate document. (C) 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.	[Singer, Pierre] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Dept Gen Intens Care,Rabin Med Ctr, Tel Aviv, Israel; [Singer, Pierre] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Inst Nutr Res,Rabin Med Ctr, Tel Aviv, Israel; [Blaser, Annika Reintam] Univ Tartu, Dept Anaesthesiol & Intens Care, Tartu, Estonia; [Blaser, Annika Reintam] Lucerne Cantonal Hosp, Dept Intens Care Med, Luzern, Switzerland; [Berger, Mette M.] Lausanne Univ Hosp, Serv Adult Intens Care & Burns, Lausanne, Switzerland; [Alhazzani, Waleed; Oczkowski, Simon] McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada; [Alhazzani, Waleed; Oczkowski, Simon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Calder, Philip C.] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Casaer, Michael P.] Catholic Univ Hosp UZLeuven, Clin Dept, Leuven, Belgium; [Casaer, Michael P.] Catholic Univ Hosp UZLeuven, Lab Intens Care Med, Leuven, Belgium; [Casaer, Michael P.] Katholieke Univ Leuven, Leuven, Belgium; [Hiesmayr, Michael] Med Univ Vienna, Div Cardiac Thorac Vasc Anaesthesia & Intens Care, Vienna, Austria; [Mayer, Konstantin] Univ Klinikum Giessen Med, Giessen, Germany; [Carlos Montejo, Juan] Hosp Univ 12 Octobre, Serv Med Intens, Madrid, Spain; [Pichard, Claude] Geneva Univ Hosp, Clin Nutr, Geneva, Switzerland; [Preiser, Jean-Charles] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium; [van Zanten, Arthur R. H.] Gelderse Vallei Hosp, Dept Intens Care, Ede, Netherlands; [Szczeklik, Wojciech] Jagiellonian Univ, Med Coll, Dept Intens Care & Perioperat Med, Krakow, Poland; [Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med Prevent, Stuttgart, Germany	Singer, P (corresponding author), Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Dept Gen Intens Care,Rabin Med Ctr, Tel Aviv, Israel.; Singer, P (corresponding author), Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Inst Nutr Res,Rabin Med Ctr, Tel Aviv, Israel.	psinger@clalit.org.il	BERGER, Mette/AAF-1284-2020; Blaser, Annika Reintam/M-1573-2013; Szczeklik, Wojciech/N-8096-2014; Preiser, Jean-Charles/AAL-2355-2021; Calder, Philip C/E-9739-2013; Hiesmayr, Michael Joerg/AAR-1969-2020; casaer, michael P/Y-7131-2019	BERGER, Mette/0000-0001-5427-1648; Blaser, Annika Reintam/0000-0003-1211-7372; Szczeklik, Wojciech/0000-0002-1349-1123; Preiser, Jean-Charles/0000-0003-3163-0390; Calder, Philip C/0000-0002-6038-710X; casaer, michael P/0000-0002-7087-0795; Montejo, Juan/0000-0002-1271-9974; van Zanten, Arthur/0000-0001-6276-7192			Abbasoglu O, 2019, JPEN-PARENTER ENTER, V43, P458, DOI 10.1177/0148607117721907; Abdelhamid YA, 2015, JPEN-PARENTER ENTER, V39, P966, DOI 10.1177/0148607114540214; Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Adam MD, 2013, CRIT CARE, V17, DOI [10.1186/cc12800, 10.1186/cc12758]; Aguilera-Martinez R, 2014, JBI DATABASE SYST RE, V12, P281; Aiko S, 2001, SURG TODAY, V31, P971, DOI 10.1007/s005950170005; Al-Dorzi HM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1539-3; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Alhazzani W, 2013, CRIT CARE, V17, DOI 10.1186/cc12806; Alhazzani W, 2013, CRIT CARE MED, V41, P1555, DOI 10.1097/CCM.0b013e31828a24c6; Alkhawaja S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008875.pub2; Allingstrup MJ, 2017, INTENS CARE MED, V43, P1637, DOI 10.1007/s00134-017-4880-3; Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Altintas ND, 2011, NUTR CLIN PRACT, V26, P322, DOI 10.1177/0884533611405790; Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; [Anonymous], 2014, REV MAN REVMAN, P11; Arabi YM, 2017, INTENS CARE MED, V43, P1875, DOI 10.1007/s00134-017-4894-x; Arabi YM, 2017, AM J RESP CRIT CARE, V195, P652, DOI 10.1164/rccm.201605-1012OC; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Arrazcaeta J, 2014, J PARENTER ENTERAL N, V29, P255; Azman M, 2015, HEAD NECK-J SCI SPEC, V37, P1799, DOI 10.1002/hed.23839; Bakker OJ, 2014, NEW ENGL J MED, V371, P1983, DOI 10.1056/NEJMoa1404393; Barazzoni R, 2017, CLIN NUTR, V36, P355, DOI 10.1016/j.clnu.2016.09.010; Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844; Barlow R, 2011, CLIN NUTR, V30, P560, DOI 10.1016/j.clnu.2011.02.006; BARTLETT RH, 1982, SURGERY, V92, P771; Bauer P, 2000, INTENS CARE MED, V26, P893, DOI 10.1007/s001340051278; Bellomo R, 2014, CRIT CARE, V18, DOI 10.1186/cc13767; Ben-Hamouda N, 2017, NUTRITION, V34, P71, DOI 10.1016/j.nut.2016.09.012; Bendavid I, 2017, CLIN NUTR, V36, P1122, DOI 10.1016/j.clnu.2016.07.012; Berger MM, 2008, EUR J CLIN NUTR, V62, P1116, DOI 10.1038/sj.ejcn.1602817; Berger MM, 2015, CURR OPIN CLIN NUTR, V18, P193, DOI 10.1097/MCO.0000000000000148; Berger MM, 2015, JPEN-PARENTER ENTER, V39, P144, DOI 10.1177/0148607114542831; Berger MM, 2014, CLIN NUTR, V33, P563, DOI 10.1016/j.clnu.2014.03.005; Berger MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6981; Berger MM, 2018, CLIN NUTR, DOI [10.1016/j.clnu.2018.07.009, DOI 10.1011/J.CLNU.2018.07.009]; Berne JD, 2002, J TRAUMA, V53, P422, DOI 10.1097/00005373-200209000-00004; Bier DM, 1999, EUR J CLIN NUTR, V53, pS177, DOI 10.1038/sj.ejcn.1600759; Biolo G, 1997, AM J PHYSIOL-ENDOC M, V273, pE122; Biolo G, 2013, WORLD REV NUTR DIET, V105, P12, DOI 10.1159/000341545; Bischoff SC, 2015, CLIN NUTR, V34, P1043, DOI 10.1016/j.clnu.2015.07.008; Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0; Blass SC, 2012, CLIN NUTR, V31, P469, DOI 10.1016/j.clnu.2012.01.002; Bloos F, 2016, JAMA INTERN MED, V176, P1266, DOI 10.1001/jamainternmed.2016.2514; Boelens PG, 2014, ANN SURG, V259, P649, DOI 10.1097/SLA.0000000000000288; Boivin MA, 2001, CRIT CARE MED, V29, P1916, DOI 10.1097/00003246-200110000-00011; Bollhalder L, 2013, CLIN NUTR, V32, P213, DOI 10.1016/j.clnu.2012.11.003; Bouletreau P, 2005, INTENS CARE MED, V31, P1394, DOI 10.1007/s00134-005-2771-5; Bousie E, 2016, EUR J CLIN NUTR, V70, P1443, DOI 10.1038/ejcn.2016.167; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; Braunschweig CA, 2015, JPEN-PARENTER ENTER, V39, P13, DOI 10.1177/0148607114528541; Braunschweig CA, 2014, JPEN-PARENTER ENTER, V38, P880, DOI 10.1177/0148607113500505; Broman M, 2018, CLIN NUTR, V37, P1399, DOI 10.1016/j.clnu.2017.06.014; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; BURKE JF, 1979, ANN SURG, V190, P274, DOI 10.1097/00000658-197909000-00002; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Calder PC, 2018, CLIN NUTR, V37, P1, DOI 10.1016/j.clnu.2017.08.032; Canales C, 2019, JPEN-PARENTER ENTER, V43, P81, DOI 10.1002/jpen.1181; Casaer MP, 2014, CRIT CARE, V18, DOI 10.1186/cc13861; Casaer MP, 2013, AM J RESP CRIT CARE, V187, P247, DOI 10.1164/rccm.201206-0999OC; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Cederholm T, 2019, CLIN NUTR, V38, P1, DOI 10.1016/j.clnu.2018.08.002; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Chapman MJ, 2000, CRIT CARE MED, V28, P2334, DOI 10.1097/00003246-200007000-00026; Chapple LAS, 2017, CRIT CARE RESUSC, V19, P29; Charles EJ, 2014, AM J CLIN NUTR, V100, P1337, DOI 10.3945/ajcn.114.088609; Chatellier G, 1996, BRIT MED J, V312, P426; Chen B, 2010, JPEN-PARENTER ENTER, V34, P387, DOI 10.1177/0148607110362532; Chen W, 2014, NUTRIENTS, V6, P2148, DOI 10.3390/nu6062148; Choi EY, 2015, JPEN-PARENTER ENTER, V39, P291, DOI 10.1177/0148607114544322; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Chowdhury AH, 2016, ANN SURG, V263, P450, DOI 10.1097/SLA.0000000000001110; Chua HR, 2012, BLOOD PURIFICAT, V33, P292, DOI 10.1159/000335607; Chuntrasakul Chomchark, 1996, Journal of the Medical Association of Thailand, V79, P21; Coltman A, 2015, JPEN-PARENTER ENTER, V39, P28, DOI 10.1177/0148607114532135; Compher C, 2017, CRIT CARE MED, V45, P156, DOI [10.1097/ccm.0000000000002083, 10.1097/CCM.0000000000002083]; Crosara ICR, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0079-3; CUTHBERTSON BH, 2009, BMJ BRIT MED J, V0339, DOI [DOI 10.1136/bmj.b3723, DOI 10.1136/BMJ.B3723]; da Silva TK, 2015, NUTR CLIN PRACT, V30, P261, DOI 10.1177/0884533615572150; Dai YJ, 2016, ADV NUTR, V7, P279, DOI 10.3945/an.114.007427; Dallas MJ, 1998, JPEN-PARENTER ENTER, V22, P352, DOI 10.1177/0148607198022006352; Davies AR, 2012, CRIT CARE MED, V40, P2342, DOI 10.1097/CCM.0b013e318255d87e; Davies AR, 2002, CRIT CARE MED, V30, P586, DOI 10.1097/00003246-200203000-00016; Day I, 2001, J NEUROSCI NURS, V33, P155; Silva RRDE, 2015, NUTR HOSP, V31, P1278, DOI 10.3305/nh.2015.31.3.8014; Deane AM, 2014, CRIT CARE MED, V42, P57, DOI 10.1097/CCM.0b013e318298a8af; Denehy L, 2013, PHYS THER, V93, P1636, DOI 10.2522/ptj.20120310; Desachy A, 2008, INTENS CARE MED, V34, P1054, DOI 10.1007/s00134-007-0983-6; DETSKY AS, 1984, JPEN-PARENTER ENTER, V8, P153, DOI 10.1177/0148607184008002153; Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007; Devaud JC, 2012, INTENS CARE MED, V38, P1990, DOI 10.1007/s00134-012-2688-8; Dhaliwal R, 2014, NUTR CLIN PRACT, V29, P29, DOI 10.1177/0884533613510948; Dickerson RN, 2017, NUTR CLIN PRACT, V32, p86S, DOI 10.1177/0884533617691745; Dickerson RN, 2014, NUTR CLIN PRACT, V29, P786, DOI 10.1177/0884533614542439; Doig GS, 2015, LANCET RESP MED, V3, P943, DOI 10.1016/S2213-2600(15)00418-X; Doig GS, 2015, INTENS CARE MED, V41, P1197, DOI 10.1007/s00134-015-3827-9; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Doig GS, 2011, INJURY, V42, P50, DOI 10.1016/j.injury.2010.06.008; Doiron KA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010754.pub2; Dossett LA, 2008, AM SURGEON, V74, P679; Dubick MA, 2005, SHOCK, V24, P139, DOI 10.1097/01.shk.0000170355.26060.e6; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Eckerwall GE, 2006, ANN SURG, V244, P959, DOI 10.1097/01.sla.0000246866.01930.58; Egi M, 2016, INTENS CARE MED, V42, P562, DOI 10.1007/s00134-016-4216-8; Elamim EM, 2014, J NUTR DISORD THER, V2, P109; Elia M., 2003, MUST REPORT NUTR SCR; Elke G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1298-1; Elke G, 2014, CRIT CARE, V18, DOI 10.1186/cc13720; ELWYN DH, 1993, NUTRITION, V9, P50; Esparza J, 2001, INTENS CARE MED, V27, P660, DOI 10.1007/s001340100880; Evans David C, 2016, Int J Crit Illn Inj Sci, V6, P9, DOI 10.4103/2229-5151.177357; Fan E, 2010, INTENS CARE MED, V36, P1038, DOI 10.1007/s00134-010-1796-6; Fan Ming-chao, 2016, Chinese Medical Sciences Journal, V31, P213; Ferrie S, 2016, JPEN-PARENTER ENTER, V40, P795, DOI 10.1177/0148607115618449; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Forbes R, 2013, J AM COLL SURGEONS, V217, pS57, DOI 10.1016/j.jamcollsurg.2013.07.119; Fowler AA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-32; Frankenfield DC, 2009, JPEN-PARENTER ENTER, V33, P27, DOI 10.1177/0148607108322399; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Friedman G, 2015, INDIAN J CRIT CARE M, V19, P71, DOI 10.4103/0972-5229.151013; Friesecke S, 2008, INTENS CARE MED, V34, P1411, DOI 10.1007/s00134-008-1072-1; Fujita T, 2012, EUR SURG RES, V48, P79, DOI 10.1159/000336574; FURST P, 1989, KIDNEY INT, V36, pS287; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Glenn JO, 2014, CURR OPIN CLIN NUTR, V17, P116, DOI 10.1097/MCO.0000000000000039; Goiburu ME, 2006, NUTR HOSP, V21, P604; Gonzalez MR, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00111-15; Gottschalk A, 2013, CLIN NUTR, V32, P668, DOI 10.1016/j.clnu.2012.12.004; Graf S, 2017, CLIN NUTR, V36, P224, DOI 10.1016/j.clnu.2015.11.007; Grau T, 2011, CRIT CARE MED, V39, P1263, DOI 10.1097/CCM.0b013e31820eb774; Grau-Carmona T, 2015, CRIT CARE MED, V43, P31, DOI 10.1097/CCM.0000000000000612; Grau-Carmona T, 2011, CLIN NUTR, V30, P578, DOI 10.1016/j.clnu.2011.03.004; Green P, 2016, CURR OPIN CLIN NUTR, V19, P111, DOI 10.1097/MCO.0000000000000253; Griffiths RD, 1997, NUTRITION, V13, P295; Gupta R, 2003, PANCREATOLOGY, V3, P406, DOI 10.1159/000073657; Han YY, 2017, CLIN NUTR, V36, P1567, DOI 10.1016/j.clnu.2016.09.027; Han YY, 2012, NUTR CLIN PRACT, V27, P91, DOI 10.1177/0884533611429796; Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; Hermans G, 2013, LANCET RESP MED, V1, P621, DOI 10.1016/S2213-2600(13)70183-8; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Heyland DK, 2015, JPEN-PARENTER ENTER, V39, P401, DOI 10.1177/0148607114529994; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; Heyland DK, 2001, CRIT CARE MED, V29, P1495, DOI 10.1097/00003246-200108000-00001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoeger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176069; Hoffer LJ, 2017, NUTR CLIN PRACT, V32, p94S, DOI 10.1177/0884533617694613; Hoffer LJ, 2016, JPEN-PARENTER ENTER, V40, P460, DOI 10.1177/0148607115624084; Hofman Z, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0220-y; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Howe KP, 2015, AM J CRIT CARE, V24, P440, DOI 10.4037/ajcc2015335; Hsu CW, 2009, CRIT CARE MED, V37, P1866, DOI 10.1097/CCM.0b013e31819ffcda; Huang HH, 2012, J ACAD NUTR DIET, V112, P1138, DOI 10.1016/j.jand.2012.04.013; Huschak G, 2005, INTENS CARE MED, V31, P1202, DOI 10.1007/s00134-005-2727-9; Iapichino G, 2006, MINERVA ANESTESIOL, V72, P533; Ichai C, 2010, CRIT CARE, V14, DOI 10.1186/cc9258; Ishibashi N, 1998, CRIT CARE MED, V26, P1529, DOI 10.1097/00003246-199809000-00020; Janice Pan, 2017, C P IEEE ENG MED BIO, P3360; Jia ZY, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0100-6; Jolliet P, 1999, CLIN NUTR, V18, P47, DOI 10.1016/S0261-5614(99)80049-1; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.3305/nh.2011.26.5.5133, 10.1590/S0212-16112011000500030]; Kagan I, 2015, INTENS CARE MED, V41, P460, DOI 10.1007/s00134-015-3646-z; Kaur N, 2005, WORLD J SURG, V29, P1023, DOI 10.1007/s00268-005-7491-z; Kearns PJ, 2000, CRIT CARE MED, V28, P1742, DOI 10.1097/00003246-200006000-00007; Khalid I, 2010, AM J CRIT CARE, V19, P261, DOI 10.4037/ajcc2010197; Kibor D K, 2014, East Afr Med J, V91, P33; Koekkoek KWAC, 2018, CURR OPIN ANESTHESIO, V31, P136, DOI 10.1097/ACO.0000000000000571; Koekkoek WAC, 2019, CLIN NUTR, V38, P883, DOI 10.1016/j.clnu.2018.02.012; Koekkoek WAC, 2016, NUTR CLIN PRACT, V31, P457, DOI 10.1177/0884533616653832; Kogo M, 2017, RESP CARE, V62, P459, DOI 10.4187/respcare.05003; Kompan L, 2004, CLIN NUTR, V23, P527, DOI 10.1016/j.clnu.2003.09.013; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kremer T, 2010, J BURN CARE RES, V31, P470, DOI 10.1097/BCR.0b013e3181db5199; Kreymann KG, 2018, CLIN NUTR, V37, P1075, DOI 10.1016/j.clnu.2017.07.006; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Krinsley JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0908-7; Kruser JM, 2017, ANN AM THORAC SOC, V14, P307, DOI 10.1513/AnnalsATS.201612-1040ED; Kuchnia A, 2017, JPEN-PARENTER ENTER, V41, P1131, DOI 10.1177/0148607116651063; Kutsogiannis J, 2011, CRIT CARE MED, V39, P2691, DOI 10.1097/CCM.0b013e3182282a83; Lad UP, 2013, J CLIN DIAGN RES, V7, P51, DOI [10.7860/JCDR/2012/5026.2666, 10.7860/JCDR/2012/5026.2668]; Lam NN, 2008, BURNS, V34, P192, DOI 10.1016/j.burns.2007.03.010; Lammert O, 2000, BRIT J NUTR, V84, P233; LARSSON J, 1981, ACTA CHIR SCAND, V147, P317; Leder SB, 2016, DYSPHAGIA, V31, P154, DOI 10.1007/s00455-015-9669-3; Lee Yoojin, 2015, Clin Nutr Res, V4, P32, DOI 10.7762/cnr.2015.4.1.32; LEVERVE X, 1984, METABOLISM, V33, P471, DOI 10.1016/0026-0495(84)90150-1; Lew CCH, 2017, JPEN-PARENTER ENTER, V41, P744, DOI 10.1177/0148607115625638; Lewis K, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1441-z; Lin JJ, 2013, BURNS, V39, P565, DOI 10.1016/j.burns.2012.11.008; Looijaard WGPM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1563-3; Lu C, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0282-5; Macht M, 2014, CHEST, V146, P1681, DOI 10.1378/chest.14-1133; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; MacLeod JBA, 2007, J TRAUMA, V63, P57, DOI 10.1097/01.ta.0000249294.58703.11; Mahadeva S, 2008, NUTR CLIN PRACT, V23, P176, DOI 10.1177/0884533608314535; Malhotra Amber, 2004, J Postgrad Med, V50, P102; Mancl EE, 2013, JPEN-PARENTER ENTER, V37, P641, DOI 10.1177/0148607112470460; MANTEL N, 1959, J NATL CANCER I, V22, P719; Manzanares W, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1618-0; Manzanares W, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1529-5; Manzanares W, 2016, CURR OPIN CRIT CARE, V22, P308, DOI 10.1097/MCC.0000000000000314; Manzanares W, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0888-7; Manzanares W, 2013, INTENS CARE MED, V39, P1683, DOI 10.1007/s00134-013-2999-4; Manzanares W, 2012, CRIT CARE, V16, DOI 10.1186/cc11316; Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036; Marik PE, 2016, INTENS CARE MED, V42, P316, DOI 10.1007/s00134-015-4131-4; Torrinhas RSMD, 2013, CLIN NUTR, V32, P503, DOI 10.1016/j.clnu.2012.12.008; Mayer K, 2003, AM J RESP CRIT CARE, V167, P1321, DOI 10.1164/rccm.200207-674OC; McDermid RC, 2011, CRIT CARE, V15, DOI 10.1186/cc9297; McNally JD, 2015, PEDIATRICS, V135, pE152, DOI 10.1542/peds.2014-1703; McNally JD, 2014, J PEDIAT-BRAZIL, V90, P99, DOI 10.1016/j.jped.2013.12.002; McRae MP, 2017, BIOMED REP, V6, P576, DOI 10.3892/br.2017.885; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Melis M, 2006, ARCH SURG-CHICAGO, V141, P701, DOI 10.1001/archsurg.141.7.701; Mertens K, 2015, BRIT J ANAESTH, V114, P990, DOI 10.1093/bja/aev073; Mesejo A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1108-1; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Mogensen KM, 2015, CRIT CARE MED, V43, P2605, DOI 10.1097/CCM.0000000000001306; Montejo JC, 2002, CRIT CARE MED, V30, P796, DOI 10.1097/00003246-200204000-00013; Moritoki E, 2006, ANESTHESIOLOGY, V105, P244; Mortensen A, 2014, NITRIC OXIDE-BIOL CH, V36, P51, DOI 10.1016/j.niox.2013.12.001; Moses V, 2009, CLIN TOXICOL, V47, P419, DOI 10.1080/15563650902936664; Mottaghi A, 2016, ASIA PAC J CLIN NUTR, V25, P504, DOI 10.6133/apjcn.092015.24; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; Nandivada P, 2016, AM J CLIN NUTR, V104, P663, DOI 10.3945/ajcn.116.137083; Nassaji M., 2010, Eastern Mediterranean Health Journal, V16, P371; National Institute for Health and Clinical Excellence, 2012, GUID MAN; National Institute of Clinical Excellence, 2006, NUTR SUPP AD OR ENT; Neumann DA, 2002, CRIT CARE MED, V30, P1436, DOI 10.1097/00003246-200207000-00006; Nguyen NQ, 2008, CRIT CARE MED, V36, P1469, DOI 10.1097/CCM.0b013e31816fc457; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Nursal TZ, 2007, J CLIN NEUROSCI, V14, P344, DOI 10.1016/j.jocn.2005.11.011; Olthof LE, 2018, CLIN NUTR, V37, P1609, DOI 10.1016/j.clnu.2017.08.001; Oshima T, 2017, CLIN NUTR, V36, P651, DOI 10.1016/j.clnu.2016.06.010; Oshima T, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1595-8; Oudemans-van Straaten HM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0460-x; Palmer AJ, 2013, CRIT CARE MED, V41, P307, DOI 10.1097/CCM.0b013e3182657578; Parikh HG, 2016, CRIT CARE RESUSC, V18, P17; Parish M, 2014, ADV PHARM BULL, V4, P555, DOI 10.5681/apb.2014.082; Pasin L, 2013, NEW ENGL J MED, V369, P482, DOI 10.1056/NEJMc1306658; Patel JJ, 2018, CURR OPIN CLIN NUTR, V21, P116, DOI 10.1097/MCO.0000000000000447; Peake SL, 2014, AM J CLIN NUTR, V100, P616, DOI 10.3945/ajcn.114.086322; Peck MD, 2004, J TRAUMA, V57, P1143, DOI 10.1097/01.TA.0000145826.84657.38; Peterson CM, 2016, AM J CLIN NUTR, V103, P1197, DOI 10.3945/ajcn.115.121178; Peterson SJ, 2010, J AM DIET ASSOC, V110, P427, DOI 10.1016/j.jada.2009.11.020; Petros S, 2016, JPEN-PARENTER ENTER, V40, P242, DOI 10.1177/0148607114528980; Petrov MS, 2006, DIGEST SURG, V23, P336, DOI 10.1159/000097949; Pettersson L, 2017, CLIN NUTR, V36, P186, DOI 10.1016/j.clnu.2015.10.008; Picot D, 2017, CLIN NUTR, V36, P593, DOI 10.1016/j.clnu.2016.04.020; Pollack LR, 2017, J AM GERIATR SOC, V65, P1168, DOI 10.1111/jgs.14799; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Pradelli L, 2015, EUR J CLIN NUTR, V69, P546, DOI 10.1038/ejcn.2014.255; Pradelli L, 2012, CRIT CARE, V16, DOI 10.1186/cc11668; Pradelli L, 2012, INT J TECHNOL ASSESS, V28, P22, DOI 10.1017/S0266462311000705; Preiser JC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0737-8; Preiser JC, 2012, JPEN-PARENTER ENTER, V36, P147, DOI 10.1177/0148607111434963; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Pryor L, 2016, INT J LANG COMM DIS, V51, P556, DOI 10.1111/1460-6984.12231; Pupelis G, 2001, NUTRITION, V17, P91, DOI 10.1016/S0899-9007(00)00508-6; Pupelis G, 2000, EUR J SURG, V166, P383; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Putzu A, 2017, J CRIT CARE, V38, P109, DOI 10.1016/j.jcrc.2016.10.029; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Reeves A, 2014, CLIN NUTR, V33, P1068, DOI 10.1016/j.clnu.2013.11.012; Reigner Mercier E, 2013, JAMA-J AM MED ASSOC, V209, P249, DOI DOI 10.1001/jama.2012.196377; Reignier J, 2002, CRIT CARE MED, V30, P1237, DOI 10.1097/00003246-200206000-00012; Reignier J, 2018, LANCET, V391, P133, DOI [10.1016/s0140-6736(17)32146-3, 10.1016/S0140-6736(17)32146-3]; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, CRIT CARE MED, V39, P967, DOI 10.1097/CCM.0b013e31820a905a; Rice TW, 2012, JAMA-J AM MED ASSOC, V306, P1574; Ridley EJ, 2011, NUTRITION, V27, P509, DOI 10.1016/j.nut.2010.10.010; Ringaitiene D, 2016, CLIN NUTR, V35, P1328, DOI 10.1016/j.clnu.2016.02.010; Rio A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002173; Rockwood K., 2005, CANADIAN MED ASS J, V173, P489; Rodas PC, 2012, CLIN SCI, V122, P591, DOI 10.1042/CS20110520; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rooyackers O, 2015, CLIN NUTR, V34, P95, DOI 10.1016/j.clnu.2014.01.020; Rousseau AF, 2013, CLIN NUTR, V32, P497, DOI 10.1016/j.clnu.2013.02.012; Rugeles S, 2016, J CRIT CARE, V35, P110, DOI 10.1016/j.jcrc.2016.05.004; Rugeles SJ, 2013, INDIAN J CRIT CARE M, V17, P343, DOI 10.4103/0972-5229.123438; Santacruz CA, 2015, JPEN-PARENTER ENTER, V39, P837, DOI 10.1177/0148607114562913; Sarap AN, 2010, JAAPA-J AM ACAD PHYS, V23, p[28, 30]; Savalle M, 2012, AM J PHYSIOL-ENDOC M, V303, pE389, DOI 10.1152/ajpendo.00502.2011; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Scheinkestel CD, 2003, NUTRITION, V19, P909, DOI 10.1016/S0899-9007(03)00175-8; Schindler K, 2016, AM J CLIN NUTR, V104, P1393, DOI 10.3945/ajcn.116.137125; Schultz MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8966; Serpa Letícia Faria, 2003, Rev. Hosp. Clin., V58, P9, DOI 10.1590/S0041-87812003000100003; SHAW JHF, 1987, ANN SURG, V205, P288, DOI 10.1097/00000658-198703000-00012; Sheean PM, 2013, CLIN NUTR, V32, P752, DOI 10.1016/j.clnu.2012.12.012; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Singer P, 2009, CLIN NUTR, V33, P246; Singer P, 2007, WIEN KLIN WOCHENSCHR, V119, P218, DOI 10.1007/s00508-007-0794-3; Singer P, 2015, WORLD REV NUTR DIET, V112, P163, DOI 10.1159/000365610; Singer P, 2014, CLIN NUTR, V33, P246, DOI 10.1016/j.clnu.2013.12.004; Singer P, 2013, WORLD REV NUTR DIET, V105, P169, DOI 10.1159/000341294; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Singh N, 2012, PANCREAS, V41, P153, DOI 10.1097/MPA.0b013e318221c4a8; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Song JH, 2017, ASIA PAC J CLIN NUTR, V26, P234, DOI 10.6133/apjcn.032016.01; Stapel SN, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1087-2; Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d; Stehle P, 2017, CLIN NUTR ESPEN, V17, P75, DOI 10.1016/j.clnesp.2016.09.007; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Sun JK, 2013, WORLD J GASTROENTERO, V19, P917, DOI 10.3748/wjg.v19.i6.917; Supinski GS, 2010, CRIT CARE, V14, DOI 10.1186/cc8913; Tanaka H, 2000, ARCH SURG-CHICAGO, V135, P326, DOI 10.1001/archsurg.135.3.326; Tao W, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0200-7; Tappy L, 1998, CRIT CARE MED, V26, P860, DOI 10.1097/00003246-199805000-00018; Tatucu-Babet OA, 2015, PARENTER ENTERAL NUT, V40, P212, DOI DOI 10.1177/0148607114567898; de Araujo VMT, 2014, NUTR HOSP, V29, P563, DOI [10.3305/NH.2014.29.3.7169, 10.3305/nh.2014.29.3.7169]; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI 10.1097/CCM.0000000000001525; Thibault R, 2016, INTENS CARE MED, V42, P1445, DOI 10.1007/s00134-016-4468-3; Thorell A, 2014, J CLIN ENDOCR METAB, V89, P5382; Tsai MH, 2016, MEDICINE, V95, P24; Tyml K, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030049; Umpierrez GE, 2012, CRIT CARE MED, V40, P1792, DOI 10.1097/CCM.0b013e3182474bf9; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van Zanten ARH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1002-x; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Verlaan S, 2017, J AM MED DIR ASSOC, pS1525; Verlaan S, 2017, J AM MED DIR ASSOC, P1525; Viana MV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-50; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vincent JL, 2013, CURR OPIN CLIN NUTR, V16, P182, DOI 10.1097/MCO.0b013e32835d803e; Wan B, 2015, ASIA PAC J CLIN NUTR, V24, P51, DOI 10.6133/apjcn.2015.24.1.03; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539; Wei XJ, 2015, CRIT CARE MED, V43, P1569, DOI 10.1097/CCM.0000000000001000; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0701-z; Weijs PJM, 2014, CURR OPIN CLIN NUTR, V17, P183, DOI 10.1097/MCO.0000000000000029; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x; Wernerman J, 2014, CRIT CARE, V18, DOI 10.1186/cc13781; White H, 2009, CRIT CARE, V13, DOI 10.1186/cc8181; Wischmeyer PE, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1736-8; Wischmeyer PE, 2015, CRIT CARE, V19, DOI 10.1186/cc14724; Wischmeyer PE, 2014, CRIT CARE, V18, DOI 10.1186/cc13836; Yatahe T, 2017, JAMA-J AM MED ASSOC, V42, P16; Yavagal DR, 2000, CRIT CARE MED, V28, P1408, DOI 10.1097/00003246-200005000-00025; Zajic P, 2014, MINERVA ENDOCRINOL, V39, P275; Zhu DJ, 2014, INTENS CARE MED, V40, P504, DOI 10.1007/s00134-014-3244-5; Zusman O, 2018, ANN INTENSIVE UNPUB; Zusman O, 2019, CLIN NUTR, V38, P1206, DOI 10.1016/j.clnu.2018.04.020; Zusman O, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1538-4	352	481	563	7	84	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	FEB	2019	38	1					48	79		10.1016/j.clnu.2018.08.037			32	Nutrition & Dietetics	Nutrition & Dietetics	HR9EQ	WOS:000463462400003	30348463	Green Accepted, Bronze	Y	N	2021-06-18	
J	Fujimura, H; Altar, CA; Chen, RY; Nakamura, T; Nakahashi, T; Kambayashi, J; Sun, B; Tandon, NN				Fujimura, H; Altar, CA; Chen, RY; Nakamura, T; Nakahashi, T; Kambayashi, J; Sun, B; Tandon, NN			Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation	THROMBOSIS AND HAEMOSTASIS			English	Article						BDNF; platelets; aggregation; secretion; shear stress	NERVE GROWTH-FACTOR; TRK PROTOONCOGENE PRODUCT; MOLECULAR-CLONING; FACTOR FAMILY; MESSENGER-RNAS; RAT-BRAIN; IN-VITRO; EXPRESSION; RECEPTORS; CELLS	Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family. plays critical roles in the survival. growth, and maintenance of brain and peripheral neurons, We report the presence of BDNF protein in human platelets and its release upon agonist stimulation. The BDNF content of washed platelets varied widely. from 3.5 to 67 ng/ 4 X 10(8) platelets. averaging 25.2+/-21.2 ng/4 X 10(8) platelets (mean +/- SD). The BDNF concentration in platelet-poor plasma was low (1.7 +/- 1.7 ng/ml, n = 11), Thrombin, collagen, the Ca++ ionophore A23187. and shear stress each induced a rapid release of BDNF from platelets. tip to only half of platelet BDNF was secreted upon agonist stimulation. suggesting that platelets may have a non-re leasable pool of BDNF, or that the released BDNF binds to a recognition site on the platelet surface and is internalized. as occurs with serotonin. However. the cognate BDNF receptor. TrkB. was not detected in platelets, Nevertheless. the ability of BDNF to bind washed platelets was shown by FACS analysis confocal microscopy and by the binding and apparent internalization of [I-125]-BDNF by platelets. A very high affinity, site (K-d = 130 X 10(-15) M, similar to80 sites/platelet) and a moderately high affinity site (K-d = 20 nM, similar to3750 sites/platelet) were identified. The BDNF content in two megakryocytic cell lines, DAMI and Meg-01. was only 0.1% of the content measured in platelets. No BDNF mRNA was detected by Northern blotting in these cell lines or in platelets. The Pituitary gland was also ruled out as a source for platelet BDNF. since the BDNF content of rat platelets did not decrease 2 weeks after hypophysectomy. Thus. platelet BDNF is not acquired from he megakaryocyte or pituitary gland. but is probably acquired front other sources via the blood circulation, Platelets appear to bind. store and release BDNF upon activation at the si,,e of traumatic injury to facilitate the repair of peripheral nerves or other tissues that contain TrkB.	Otsuka Maryland Res Inst, Detp Thrombosis Res, LLC, Rockville, MD 20850 USA	Tandon, NN (corresponding author), Otsuka Maryland Res Inst, Detp Thrombosis Res, LLC, 9900 Med Ctr Dr, Rockville, MD 20850 USA.						Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; ANTONIADES HN, 1979, P NATL ACAD SCI USA, V76, P1809, DOI 10.1073/pnas.76.4.1809; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Besser M, 1999, J IMMUNOL, V162, P6303; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; Conner JM, 1996, NEUROREPORT, V7, P1937, DOI 10.1097/00001756-199608120-00014; D'Onofrio M, 2000, EUR CYTOKINE NETW, V11, P283; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ESTEBAN I, 1995, BRAIN RES BULL, V38, P539, DOI 10.1016/0361-9230(95)02025-9; FUKUYAMA M, 1989, THROMB RES, V54, P253, DOI 10.1016/0049-3848(89)90233-8; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P915, DOI 10.1021/bi951504q; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; Hiltunen JO, 1996, CIRC RES, V79, P930, DOI 10.1161/01.RES.79.5.930; Hoehner JC, 1996, GASTROENTEROLOGY, V110, P756, DOI 10.1053/gast.1996.v110.pm8608885; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KINLOUGHRATHBONE RL, 1991, THROMB HAEMOSTASIS, V65, P403; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Maroder M, 1996, J IMMUNOL, V157, P2864; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; Nemoto E, 1998, BIOCHEM BIOPH RES CO, V245, P284, DOI 10.1006/bbrc.1998.8418; OMENN GS, 1978, J CLIN INVEST, V62, P235, DOI 10.1172/JCI109121; Perez-Perez M, 1999, CELL TISSUE RES, V298, P75, DOI 10.1007/s004419900089; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; ROSENFELD RD, 1995, PROTEIN EXPRES PURIF, V6, P465, DOI 10.1006/prep.1995.1062; Rubio N, 1997, EUR J NEUROSCI, V9, P1847, DOI 10.1111/j.1460-9568.1997.tb00751.x; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; TANDON NN, 1991, BLOOD, V78, P2809; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469	44	479	494	0	17	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0340-6245			THROMB HAEMOSTASIS	Thromb. Haemost.	APR	2002	87	4					728	734					7	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	541JK	WOS:000174981300025	12008958				2021-06-18	
J	Schwab, S; Schwarz, S; Spranger, M; Keller, E; Bertram, M; Hacke, W				Schwab, S; Schwarz, S; Spranger, M; Keller, E; Bertram, M; Hacke, W			Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction	STROKE			English	Article						hypothermia; intracranial pressure; neuroprotection; outcome; stroke, ischemic; treatment	SEVERE HEAD-INJURY; ISCHEMIC NEURONAL INJURY; TRAUMATIC BRAIN INJURY; MILD HYPOTHERMIA; ACUTE STROKE; TEMPERATURE; RATS; HYPERTHERMIA; HYPERTENSION; MODULATION	Background and Purpose-Animal research and clinical studies in head trauma patients suggest that moderate hypothermia may improve outcome by attenuating the deleterious metabolic processes in neuronal injury. Clinical studies on moderate hypothermia in the treatment of acute ischemic stroke patients are still lacking. Methods-Moderate hypothermia was induced in 25 patients with severe ischemic stroke in the middle cerebral artery (MCA) territory for therapy of postischemic brain edema. Hypothermia was induced within 14+/-7 hours after stroke onset and achieved by external cooling with cooling blankets, cold infusions, and cold washing. Patients were kept at 33 degrees C body-core temperature for 48 to 72 hours, and intracranial pressure (ICP), cerebral perfusion pressure, and brain temperature were monitored continuously. Outcome at 4 weeks and 3 months after the stroke was analyzed with the Scandinavian Stroke Scale (SSS) and Barthel index. The side effects of induced moderate hypothermia were analyzed. Results-Fourteen patients survived the hemispheric stroke (56%). Neurological outcome according to the SSS score was 29 (range, 25 to 37) 4 weeks after stroke and 38 (range 28 to 48) 3 months after stroke. During hypothermia, elevated ICP values could be significantly reduced. Herniation caused by a secondary rise in ICP after rewarming was the cause of death in all remaining patients. The most frequent complication of moderate hypothermia was pneumonia in 10 of the 25 patients (40%). Other severe side effects of hypothermia could not be detected. Conclusions-Moderate hypothermia in the treatment of severe cerebral ischemia is not associated with severe side effects. Moderate hypothermia can help to control critically elevated ICP values in severe space-occupying edema after MCA stroke and may improve clinical outcome in these patients.	Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany	Schwab, S (corresponding author), Univ Heidelberg, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	Stefan_Schwab@ukl.uni_heidelberg.de	Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261			ASPLUND K, 1985, STROKE, V16, P885; AUSMAN JI, 1993, J NEUROSURG, V79, P810, DOI 10.3171/jns.1993.79.6.0810; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BOUNDS JV, 1981, STROKE, V12, P474, DOI 10.1161/01.STR.12.4.474; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; CHIARA O, 1987, CRIT CARE MED, V15, P995, DOI 10.1097/00003246-198711000-00001; CHOPP M, 1988, STROKE, V19, P1521, DOI 10.1161/01.STR.19.12.1521; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COIMBRA C, 1994, ACTA NEUROPATHOL, V87, P325, DOI 10.1007/bf00313599; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; FOULIS AK, 1982, J CLIN PATHOL, V35, P1244, DOI 10.1136/jcp.35.11.1244; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HAYWARD JN, 1968, AM J PHYSIOL, V215, P389; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; KARIBE H, 1994, J NEUROSURG, V80, P112, DOI 10.3171/jns.1994.80.1.0112; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; MAHER J, 1993, CEREBROVAS BRAIN MET, V5, P277; MAHONEY F I, 1965, Md State Med J, V14, P61; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markarian GZ, 1996, NEUROSURGERY, V38, P542; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; RANKIN J, 1957, Scott Med J, V2, P200; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Safar P, 1996, CRIT CARE MED, V24, P911, DOI 10.1097/00003246-199606000-00004; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; TEASDALE G, 1975, LANCET, V1, P480; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; XUE D, 1992, BRAIN RES, V587, P66, DOI 10.1016/0006-8993(92)91428-H	46	471	480	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0039-2499			STROKE	Stroke	DEC	1998	29	12					2461	2466		10.1161/01.STR.29.12.2461			6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	142PA	WOS:000077207900002	9836751	Bronze			2021-06-18	
J	Guskiewicz, KM; Ross, SE; Marshall, SW				Guskiewicz, KM; Ross, SE; Marshall, SW			Postural stability and neuropsychological deficits after concussion in collegiate athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						mild head injury; balance; neurocognitive function	MILD HEAD-INJURY; TRAUMATIC BRAIN INJURY; FOOTBALL PLAYERS; SOCCER PLAYERS; STANDARDIZED ASSESSMENT; SENSORY INTERACTION; 2ND IMPACT; PERFORMANCE; BALANCE; SPORTS	Objective: Postural stability and neuropsychological testing are gradually becoming integral parts of postconcussion assessment in athletes. Clinicians, however, sometimes question the viability of instituting preseason baseline testing and the value of these results in making return-to-play decisions. Our purpose was to examine the course of recovery on various postural stability and neuropsychological measures after sport-related concussion. A secondary goal was to determine if loss of consciousness and amnesia, both of which are heavily weighted in most of the concussion classification systems, affect the rate of recovery. Design and Setting: All subjects underwent a battery of baseline postural stability and neuropsychological tests before the start of their respective seasons. Any athletes subsequently injured were followed up at postinjury days 1, 3, and 5. Matched control subjects were assessed using the same test battery at the same time intervals. Subjects: We studied 36 Division I collegiate athletes who sustained a concussion and 36 matched control subjects. Measurements: We assessed postural stability using the Sensory Organization Test on the NeuroCom Smart Balance Master System and the Balance Error Scoring System. Neurocognitive functioning was measured with several neuropsychological tests: Trail-Making Test, Wechsler Digit Span Test, Stroop Color Word Test, and Hopkins Verbal Learning Test. Results: Injured subjects demonstrated postural stability deficits, as measured on both the Sensory Organization Test and Balance Error Scoring System. These deficits were significantly worse than both preseason scores and matched control subjects' scores on postinjury day 1. Only the results on the Trail-Making Test B and Wechsler Digit Span Test Backward resulted in a logical recovery curve that could explain lowered neuropsychological performance due to concussive injury. Significant differences were revealed between the control and injured groups at day 1 postinjury, but a significant decline between baseline and postinjury scores was not demonstrated. Loss of consciousness and amnesia were not associated with increased deficits or slowed recovery on measures of postural stability or neurocognitive functioning. Conclusions: Athletes with cerebral concussion demonstrated acute balance deficits, which are likely the result of not using information from the vestibular and visual systems effectively. Neurocognitive deficits are more difficult to identify in the acute stages of concussion, although concentration, working memory, immediate memory recall, and rapid visual processing appear to be mildly affected. More research is necessary to determine the best neuropsychological test battery for assessing sport-related concussion.	Univ N Carolina, Chapel Hill, NC 27599 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, 209 Fetzer,CB8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Marshall, Stephen/0000-0002-2664-9233			ADAMS JH, 1975, HDB CLINICAL NEUROLO, V23, P35; ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ARCAN M, 1977, SCAND J REHABIL MED, V9, P165; Barth JT., 1989, MILD HEAD INJURY, P257; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BROWN JJ, 1990, NEUROL CLIN, V8, P209, DOI 10.1016/S0733-8619(18)30351-7; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DICK RW, 1998, 1997 98 NCAA INJURY; DROULEZ J, 1985, VESTIBULAR VISUAL CO, P14; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HORSTMANN GA, 1988, NEUROSCI LETT, V95, P179, DOI 10.1016/0304-3940(88)90653-2; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Mallinson AI, 1998, AM J OTOL, V19, P814; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MCINTOSH T, 1989, MILD MODERATE HEAD I, P135; MITCHELL DE, 1973, LANCET, V2, P215; NASHNER LM, 1982, J NEUROSCI, V2, P536; NASHNER LM, 1982, TRENDS NEUROSCI, V5, P358, DOI 10.1016/0166-2236(82)90204-1; NORRE ME, 1993, J LARYNGOL OTOL, V107, P496, DOI 10.1017/S0022215100123564; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSS S, 2000, J ATHL TRAINING, V35, pS53; RUBIN AM, 1995, AM J OTOL, V16, P216; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	58	470	471	5	80	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					263	273					11	Sport Sciences	Sport Sciences	557NC	WOS:000175913800009					2021-06-18	
J	GIULIAN, D; CHEN, J; INGEMAN, JE; GEORGE, JK; NOPONEN, M				GIULIAN, D; CHEN, J; INGEMAN, JE; GEORGE, JK; NOPONEN, M			THE ROLE OF MONONUCLEAR PHAGOCYTES IN WOUND-HEALING AFTER TRAUMATIC INJURY TO ADULT MAMMALIAN BRAIN	JOURNAL OF NEUROSCIENCE			English	Article										GIULIAN, D (corresponding author), BAYLOR UNIV,DEPT NEUROL,HOUSTON,TX 77030, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025637] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS25637] Funding Source: Medline		Ahn Y S, 1980, Adv Intern Med, V25, P453; ANDERSON DC, 1979, STROKE, V10, P68, DOI 10.1161/01.STR.10.1.68; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BLAKEMORE WF, 1986, ACTA NEUROPATHOL, V71, P295, DOI 10.1007/BF00688052; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CHEN ST, 1986, NEUROLOGY, V36, P466, DOI 10.1212/WNL.36.4.466; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; DAEMS WT, 1980, RETICULOENDOTHELIAL, P57; DINARELLO CA, 1988, FASEB J, V2, P108; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1985, J CELL BIOL, V101, P2411, DOI 10.1083/jcb.101.6.2411; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Giulian D., 1988, CURRENT ISSUES NEURA, P281; GIULIAN D, 1989, IN PRESS ANN NEUROL; GODFREY K, 1985, NEW ENGL J MED, V313, P1452; Gomori G, 1937, AM J PATHOL, V13, P993; HEITER E, 1988, J NEUROSCI RES, V21, P391; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; KAYE J, 1984, J IMMUNOL, V133, P1339; KONIGSMARK BW, 1963, J NEUROPATH EXP NEUR, V22, P643; KOSKI IR, 1976, IN VITRO METHODS CEL, P359; KREUTZBERG GW, 1978, J NEUROCYTOL, V7, P601, DOI 10.1007/BF01260892; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; LEVINE S, 1977, EXP MOL PATHOL, V26, P103, DOI 10.1016/0014-4800(77)90070-3; LING EA, 1979, J ANAT, V128, P143; LING EA, 1981, ADV CELL NEUROBIOL, V2, P33; MACKENZIE AH, 1983, AM J MED, V75, P5, DOI 10.1016/0002-9343(83)91264-0; NATHAN CF, 1980, NEW ENGL J MED, V303, P622, DOI 10.1056/NEJM198009113031106; NORRIS DA, 1977, J LAB CLIN MED, V90, P569; NORRIS JW, 1986, BMJ-BRIT MED J, V292, P21, DOI 10.1136/bmj.292.6512.21; NORTH RJ, 1978, J IMMUNOL, V121, P806; OEHMICHEN M, 1983, PROG NEUROPATH, V5, P277; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; POPE A, 1984, NEUROCHEM RES, V9, P291, DOI 10.1007/BF00963980; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; Reier PJ, 1983, SPINAL CORD RECONSTR, P163; RIOHORTEGA P, 1932, CYTOLOGY CELLULAR PA, P481; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; WILDFEUER A, 1983, ARZNEIMITTELFORSCH, V33-1, P780; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206	47	468	472	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513	0270-6474			J NEUROSCI	J. Neurosci.	DEC	1989	9	12					4416	4429					14	Neurosciences	Neurosciences & Neurology	CE145	WOS:A1989CE14500025	2480402				2021-06-18	
J	Feigin, VL; Nichols, E; Alam, T; Bannick, MS; Beghi, E; Blake, N; Culpepper, WJ; Dorsey, ER; Elbaz, A; Ellenbogen, RG; Fisher, JL; Fitzmaurice, C; Giussani, G; Glennie, L; James, SL; Johnson, CO; Kassebaum, NJ; Logroscino, G; Marin, B; Mountjoy-Venning, WC; Nguyen, M; Ofori-Asenso, R; Patel, AP; Piccininni, M; Roth, GA; Steiner, TJ; Stovner, LJ; Szoeke, CEI; Theadom, A; Vollset, SE; Wallin, MT; Wright, C; Zunt, JR; Abbasi, N; Abd-Allah, F; Abdelalim, A; Abdollahpour, I; Aboyans, V; Abraha, HN; Acharya, D; Adamu, AA; Adebayo, OM; Adeoye, AM; Adsuar, JC; Afarideh, M; Agrawal, S; Ahmadi, A; Ahmed, MB; Aichour, AN; Aichour, I; Aichour, MTE; Akinyemi, RO; Akseer, N; Al-Eyadhy, A; Salman, RA; Alahdab, F; Alene, KA; Aljunid, SM; Altirkawi, K; Alvis-Guzman, N; Anber, NH; Antonio, CAT; Arabloo, J; Aremu, O; Arnlov, J; Asayesh, H; Asghar, RJ; Atalay, HT; Awasthi, A; Quintanilla, BPA; Ayuk, TB; Badawi, A; Banach, M; Banoub, JAM; Barboza, MA; Barker-Collo, SL; Barnighausen, TW; Baune, BT; Bedi, N; Behzadifar, M; Behzadifar, M; Bejot, Y; Bekele, BB; Belachew, AB; Bennett, DA; Bensenor, IM; Berhane, A; Beuran, M; Bhattacharyya, K; Bhutta, ZA; Biadgo, B; Bijani, A; Bililign, N; Bin Sayeed, MS; Blazes, CK; Brayne, C; Butt, ZA; Campos-Nonato, IR; Cantu-Brito, C; Car, M; Cardenas, R; Carrero, JJ; Carvalho, F; Castaneda-Orjuela, CA; Castro, F; Catala-Lopez, F; Cerin, E; Chaiah, Y; Chang, JC; Chatziralli, I; Chiang, PPC; Christensen, H; Christopher, DJ; Cooper, C; Cortesi, PA; Costa, VM; Criqui, MH; Crowe, CS; Damasceno, AAM; Daryani, A; De la Cruz-Gongora, V; De la Hoz, FP; De Leo, D; Degefa, MG; Demoz, GT; Deribe, K; Dharmaratne, SD; Diaz, D; Dinberu, MT; Djalalinia, S; Doku, DT; Dubey, M; Dubljanin, E; Duken, EE; Edvardsson, D; El-Khatib, Z; Endres, M; Endries, AY; Eskandarieh, S; Esteghamati, A; Esteghamati, S; Farhadi, F; Faro, A; Farzadfar, F; Farzaei, MH; Fatima, B; Fereshtehnejad, SM; Fernandes, E; Feyissa, GT; Filip, I; Fischer, F; Fukumoto, T; Ganji, M; Gankpe, FG; Garcia-Gordillo, MA; Gebre, AK; Gebremichael, TG; Gelaw, BK; Geleijnse, JM; Geremew, D; Gezae, KE; Ghasemi-Kasman, M; Gidey, MY; Gill, PS; Gill, TK; Gnedovskaya, EV; Goulart, AC; Grada, A; Grosso, G; Guo, YM; Gupta, R; Gupta, R; Haagsma, JA; Hagos, TB; Haj-Mirzaian, A; Haj-Mirzaian, A; Hamadeh, RR; Hamidi, S; Hankey, GJ; Hao, Y; Haro, JM; Hassankhani, H; Hassen, HY; Havmoeller, R; Hay, SI; Hegazy, MI; Heidari, B; Henok, A; Heydarpour, F; Hoang, CL; Hole, MK; Rad, EH; Hosseini, SM; Hu, GQ; Igumbor, EU; Ilesanmi, OS; Irvani, SSN; Islam, SMS; Jakovljevic, M; Javanbakht, M; Jha, RP; Jobanputra, YB; Jonas, JB; Jozwiak, JJ; Jurisson, M; Kahsay, A; Kalani, R; Kalkonde, Y; Kamil, TA; Kanchan, T; Karami, M; Karch, A; Karimi, N; Kasaeian, A; Kassa, TD; Kassa, ZY; Kaul, A; Kefale, AT; Keiyoro, PN; Khader, YS; Khafaie, MA; Khalil, IA; Khan, EA; Khang, YH; Khazaie, H; Kiadaliri, AA; Kiirithio, DN; Kim, AS; Kim, D; Kim, YE; Kim, YJ; Kisa, A; Kokubo, Y; Koyanagi, A; Krishnamurthi, RV; Defo, BK; Bicer, BK; Kumar, M; Lacey, B; Lafranconi, A; Lansingh, VC; Latifi, A; Leshargie, CT; Li, SS; Liao, Y; Linn, S; Lo, WD; Lopez, JCF; Lorkowski, S; Lotufo, PA; Lucas, RM; Lunevicius, R; Mackay, MT; Mahotra, NB; Majdan, M; Majdzadeh, R; Majeed, A; Malekzadeh, R; Malta, DC; Manafi, N; Mansournia, MA; Mantovani, LG; Marz, W; Mashamba-Thompson, TP; Massenburg, BB; Mate, KKV; McAlinden, C; McGrath, JJ; Mehta, V; Meier, T; Meles, HG; Melese, A; Memiah, PTN; Memish, ZA; Mendoza, W; Mengistu, DT; Mengistu, G; Meretoja, A; Meretoja, TJ; Mestrovic, T; Miazgowski, B; Miazgowski, T; Miller, TR; Mini, GK; Mirrakhimov, EM; Moazen, B; Mohajer, B; Mezerji, NMG; Mohammadi, M; Mohammadi-Khanaposhtani, M; Mohammadibakhsh, R; Mohammadnia-Afrouzi, M; Mohammed, S; Mohebi, F; Mokdad, AH; Monasta, L; Mondello, S; Moodley, Y; Moosazadeh, M; Moradi, G; Moradi-Lakeh, M; Moradinazar, M; Moraga, P; Velasquez, IM; Morrison, SD; Mousavi, SM; Muhammed, OS; Muruet, W; Musa, KI; Mustafa, G; Naderi, M; Nagel, G; Naheed, A; Naik, G; Najafi, F; Nangia, V; Negoi, I; Negoi, RI; Newton, CRJ; Ngunjiri, JW; Nguyen, CT; Nguyen, LH; Ningrum, DNA; Nirayo, YL; Nixon, MR; Norrving, B; Noubiap, JJ; Shiadeh, MN; Nyasulu, PS; Ogbo, FA; Oh, IH; Olagunju, AT; Olagunju, TO; Olivares, PR; Onwujekwe, OE; Oren, E; Owolabi, MO; Mahesh, PA; Pakpour, AH; Pan, WH; Panda-Jonas, S; Pandian, JD; Patel, SK; Pereira, DM; Petzold, M; Pillay, JD; Piradov, MA; Polanczyk, GV; Polinder, S; Postma, MJ; Poulton, R; Poustchi, H; Prakash, S; Prakash, V; Qorbani, M; Radfar, A; Rafay, A; Rafiei, A; Rahim, F; Rahimi-Movaghar, V; Rahman, M; Rahman, MHU; Rahman, MA; Rajati, F; Ram, U; Ranta, A; Rawaf, DL; Rawaf, S; Reinig, N; Reis, C; Renzaho, AMN; Resnikoff, S; Rezaeian, S; Rezai, MS; Gonzalez, CMR; Roberts, NLS; Roever, L; Ronfani, L; Roro, EM; Roshandel, G; Rostami, A; Sabbagh, P; Sacco, RL; Sachdev, PS; Saddik, B; Safari, H; Safari-Faramani, R; Safi, S; Safiri, S; Sagar, R; Sahathevan, R; Sahebkar, A; Sahraian, MA; Salamati, P; Zahabi, SS; Salimi, Y; Samy, AM; Sanabria, J; Santos, IS; Milicevic, MMS; Sarrafzadegan, N; Sartorius, B; Sarvi, S; Sathian, B; Satpathy, M; Sawant, AR; Sawhney, M; Schneider, IJC; Schottker, B; Schwebel, DC; Seedat, S; Sepanlou, SG; Shabaninejad, H; Shafieesabet, A; Shaikh, MA; Shakir, RA; Shams-Beyranvand, M; Shamsizadeh, M; Sharif, M; Sharif-Alhoseini, M; She, J; Sheikh, A; Sheth, KN; Shigematsu, M; Shiri, R; Shirkoohi, R; Shiue, I; Siabani, S; Siddiqi, TJ; Sigfusdottir, ID; Sigurvinsdottir, R; Silberberg, DH; Silva, JP; Silveira, DGA; Singh, JA; Sinha, DN; Skiadaresi, E; Smith, M; Sobaih, BH; Sobhani, S; Soofi, M; Soyiri, IN; Sposato, LA; Stein, DJ; Stein, MB; Stokes, MA; Sufiyan, MB; Sykes, BL; Sylaja, P; Tabares-Seisdedos, R; Ao, BJT; Tehrani-Banihashemi, A; Temsah, MH; Temsah, O; Thakur, JS; Thrift, AG; Topor-Madry, R; Tortajada-Girbes, M; Tovani-Palone, MR; Tran, BX; Tran, KB; Truelsen, TC; Tsadik, AG; Car, LT; Ukwaja, KN; Ullah, I; Usman, MS; Uthman, OA; Valdez, PR; Vasankari, TJ; Vasanthan, R; Veisani, Y; Venketasubramanian, N; Violante, FS; Vlassov, V; Vosoughi, K; Vu, GT; Vujcic, IS; Wagnew, FS; Waheed, Y; Wang, YP; Weiderpass, E; Weiss, J; Whiteford, HA; Wijeratne, T; Winkler, AS; Wiysonge, CS; Wolfe, CDA; Xu, G; Yadollahpour, A; Yamada, T; Yano, Y; Yaseri, M; Yatsuya, H; Yimer, EM; Yip, P; Yisma, E; Yonemoto, N; Yousefifard, M; Yu, CH; Zaidi, Z; Bin Zaman, S; Zamani, M; Zandian, H; Zare, Z; Zhang, YQ; Zodpey, S; Naghavi, M; Murray, CJL; Vos, T				Feigin, Valery L.; Nichols, Emma; Alam, Tahiya; Bannick, Marlena S.; Beghi, Ettore; Blake, Natacha; Culpepper, William J.; Dorsey, E. Ray; Elbaz, Alexis; Ellenbogen, Richard G.; Fisher, James L.; Fitzmaurice, Christina; Giussani, Giorgia; Glennie, Linda; James, Spencer L.; Johnson, Catherine Owens; Kassebaum, Nicholas J.; Logroscino, Giancarlo; Marin, Benoit; Mountjoy-Venning, W. Cliff; Minh Nguyen; Ofori-Asenso, Richard; Patel, Anoop P.; Piccininni, Marco; Roth, Gregory A.; Steiner, Timothy J.; Stovner, Lars Jacob; Szoeke, Cassandra E. I.; Theadom, Alice; Vollset, Stein Emil; Wallin, Mitchell Taylor; Wright, Claire; Zunt, Joseph Raymond; Abbasi, Nooshin; Abd-Allah, Foad; Abdelalim, Ahmed; Abdollahpour, Ibrahim; Aboyans, Victor; Abraha, Haftom Niguse; Acharya, Dilaram; Adamu, Abdu A.; Adebayo, Oladimeji M.; Adeoye, Abiodun Moshood; Adsuar, Jose C.; Afarideh, Mohsen; Agrawal, Sutapa; Ahmadi, Alireza; Ahmed, Muktar Beshir; Aichour, Amani Nidhal; Aichour, Ibtihel; Aichour, Miloud Taki Eddine; Akinyemi, Rufus Olusola; Akseer, Nadia; Al-Eyadhy, Ayman; Salman, Rustam Al-Shahi; Alahdab, Fares; Alene, Kefyalew Addis; Aljunid, Syed Mohamed; Altirkawi, Khalid; Alvis-Guzman, Nelson; Anber, Nahla Hamed; Antonio, Carl Abelardo T.; Arabloo, Jalal; Aremu, Olatunde; Arnlov, Johan; Asayesh, Hamid; Asghar, Rana Jawad; Atalay, Hagos Tasew; Awasthi, Ashish; Ayala Quintanilla, Beatriz Paulina; Ayuk, Tambe B.; Badawi, Alaa; Banach, Maciej; Banoub, Joseph Adel Mattar; Barboza, Miguel A.; Barker-Collo, Suzanne Lyn; Barnighausen, Till Winfried; Baune, Bernhard T.; Bedi, Neeraj; Behzadifar, Masoud; Behzadifar, Meysam; Bejot, Yannick; Bekele, Bayu Begashaw; Belachew, Abate Bekele; Bennett, Derrick A.; Bensenor, Isabela M.; Berhane, Adugnaw; Beuran, Mircea; Bhattacharyya, Krittika; Bhutta, Zulfiqar A.; Biadgo, Belete; Bijani, Ali; Bililign, Nigus; Bin Sayeed, Muhammad Shahdaat; Blazes, Christopher Kynrint; Brayne, Carol; Butt, Zahid A.; Campos-Nonato, Ismael R.; Cantu-Brito, Carlos; Car, Mate; Cardenas, Rosario; Carrero, Juan J.; Carvalho, Felix; Castaneda-Orjuela, Carlos A.; Castro, Franz; Catala-Lopez, Ferran; Cerin, Ester; Chaiah, Yazan; Chang, Jung-Chen; Chatziralli, Irini; Chiang, Peggy Pei-Chia; Christensen, Hanne; Christopher, Devasahayam J.; Cooper, Cyrus; Cortesi, Paolo Angelo; Costa, Vera M.; Criqui, Michael H.; Crowe, Christopher Stephen; Damasceno, Albertino Antonio Moura; Daryani, Ahmad; De la Cruz-Gongora, Vanessa; Pio De la Hoz, Fernando; De Leo, Diego; Degefa, Meaza Girma; Demoz, Gebre Teklemariam; Deribe, Kebede; Dharmaratne, Samath Dhamminda; Diaz, Daniel; Dinberu, Mesfin Tadese; Djalalinia, Shirin; Doku, David Teye; Dubey, Manisha; Dubljanin, Eleonora; Duken, Eyasu Ejeta; Edvardsson, David; El-Khatib, Ziad; Endres, Matthias; Endries, Aman Yesuf; Eskandarieh, Sharareh; Esteghamati, Alireza; Esteghamati, Sadaf; Farhadi, Farzaneh; Faro, Andre; Farzadfar, Farshad; Farzaei, Mohammad Hosein; Fatima, Batool; Fereshtehnejad, Seyed-Mohammad; Fernandes, Eduarda; Feyissa, Garumma Tolu; Filip, Irina; Fischer, Florian; Fukumoto, Takeshi; Ganji, Morsaleh; Gankpe, Fortune Gbetoho; Garcia-Gordillo, Miguel A.; Gebre, Abadi Kahsu; Gebremichael, Teklu Gebrehiwo; Gelaw, Belayneh K.; Geleijnse, Johanna M.; Geremew, Demeke; Gezae, Kebede Embaye; Ghasemi-Kasman, Maryam; Gidey, Mahari Y.; Gill, Paramjit Singh; Gill, Tiffany K.; Gnedovskaya, Elena V.; Goulart, Alessandra C.; Grada, Ayman; Grosso, Giuseppe; Guo, Yuming; Gupta, Rahul; Gupta, Rajeev; Haagsma, Juanita A.; Hagos, Tekleberhan B.; Haj-Mirzaian, Arvin; Haj-Mirzaian, Arya; Hamadeh, Randah R.; Hamidi, Samer; Hankey, Graeme J.; Hao, Yuantao; Haro, Josep Maria; Hassankhani, Hadi; Hassen, Hamid Yimam; Havmoeller, Rasmus; Hay, Simon I.; Hegazy, Mohamed I.; Heidari, Behnam; Henok, Andualem; Heydarpour, Fatemeh; Hoang, Chi Linh; Hole, Michael K.; Rad, Enayatollah Homaie; Hosseini, Seyed Mostafa; Hu, Guoqing; Igumbor, Ehimario U.; Ilesanmi, Olayinka Stephen; Irvani, Seyed Sina Naghibi; Islam, Sheikh Mohammed Shariful; Jakovljevic, Mihajlo; Javanbakht, Mehdi; Jha, Ravi Prakash; Jobanputra, Yash B.; Jonas, Jost B.; Jozwiak, Jacek Jerzy; Jurisson, Mikk; Kahsay, Amaha; Kalani, Rizwan; Kalkonde, Yogeshwar; Kamil, Teshome Abegaz; Kanchan, Tanuj; Karami, Manoochehr; Karch, Andre; Karimi, Narges; Kasaeian, Amir; Kassa, Tesfaye Dessale; Kassa, Zemenu Yohannes; Kaul, Anil; Kefale, Adane Teshome; Keiyoro, Peter Njenga; Khader, Yousef Saleh; Khafaie, Morteza Abdullatif; Khalil, Ibrahim A.; Khan, Ejaz Ahmad; Khang, Young-Ho; Khazaie, Habibolah; Kiadaliri, Aliasghar A.; Kiirithio, Daniel N.; Kim, Anthony S.; Kim, Daniel; Kim, Young-Eun; Kim, Yun Jin; Kisa, Adnan; Kokubo, Yoshihiro; Koyanagi, Ai; Krishnamurthi, Rita V.; Defo, Barthelemy Kuate; Bicer, Burcu Kucuk; Kumar, Manasi; Lacey, Ben; Lafranconi, Alessandra; Lansingh, Van C.; Latifi, Arman; Leshargie, Cheru Tesema; Li, Shanshan; Liao, Yu; Linn, Shai; Lo, Warren David; Lopez, Jaifred Christian F.; Lorkowski, Stefan; Lotufo, Paulo A.; Lucas, Robyn M.; Lunevicius, Raimundas; Mackay, Mark T.; Mahotra, Narayan Bahadur; Majdan, Marek; Majdzadeh, Reza; Majeed, Azeem; Malekzadeh, Reza; Malta, Deborah Carvalho; Manafi, Navid; Mansournia, Mohammad Ali; Mantovani, Lorenzo Giovanni; Marz, Winfried; Mashamba-Thompson, Tivani Phosa; Massenburg, Benjamin Ballard; Mate, Kedar K. V.; McAlinden, Colm; McGrath, John J.; Mehta, Varshil; Meier, Toni; Meles, Hagazi Gebre; Melese, Addisu; Memiah, Peter T. N.; Memish, Ziad A.; Mendoza, Walter; Mengistu, Desalegn Tadese; Mengistu, Getnet; Meretoja, Atte; Meretoja, Tuomo J.; Mestrovic, Tomislav; Miazgowski, Bartosz; Miazgowski, Tomasz; Miller, Ted R.; Mini, G. K.; Mirrakhimov, Erkin M.; Moazen, Babak; Mohajer, Bahram; Mezerji, Naser Mohammad Gholi; Mohammadi, Moslem; Mohammadi-Khanaposhtani, Maryam; Mohammadibakhsh, Roghayeh; Mohammadnia-Afrouzi, Mousa; Mohammed, Shafiu; Mohebi, Farnam; Mokdad, Ali H.; Monasta, Lorenzo; Mondello, Stefania; Moodley, Yoshan; Moosazadeh, Mahmood; Moradi, Ghobad; Moradi-Lakeh, Maziar; Moradinazar, Mehdi; Moraga, Paula; Velasquez, Ilais Moreno; Morrison, Shane Douglas; Mousavi, Seyyed Meysam; Muhammed, Oumer Sada; Muruet, Walter; Musa, Kamarul Imran; Mustafa, Ghulam; Naderi, Mehdi; Nagel, Gabriele; Naheed, Aliya; Naik, Gurudatta; Najafi, Farid; Nangia, Vinay; Negoi, Ionut; Negoi, Ruxandra Irina; Newton, Charles Richard James; Ngunjiri, Josephine W.; Nguyen, Cuong Tat; Nguyen, Long Hoang; Ningrum, Dina Nur Anggraini; Nirayo, Yirga Legesse; Nixon, Molly R.; Norrving, Bo; Noubiap, Jean Jacques; Shiadeh, Malihe Nourollahpour; Nyasulu, Peter S.; Ogbo, Felix Akpojene; Oh, In-Hwan; Olagunju, Andrew T.; Olagunju, Tinuke O.; Olivares, Pedro R.; Onwujekwe, Obinna E.; Oren, Eyal; Owolabi, Mayowa Ojo; Mahesh, P. A.; Pakpour, Amir H.; Pan, Wen-Harn; Panda-Jonas, Songhomitra; Pandian, Jeyaraj Durai; Patel, Sangram Kishor; Pereira, David M.; Petzold, Max; Pillay, Julian David; Piradov, Michael A.; Polanczyk, Guilherme V.; Polinder, Suzanne; Postma, Maarten J.; Poulton, Richie; Poustchi, Hossein; Prakash, Swayam; Prakash, V.; Qorbani, Mostafa; Radfar, Amir; Rafay, Anwar; Rafiei, Alireza; Rahim, Fakher; Rahimi-Movaghar, Vafa; Rahman, Mahfuzar; Rahman, Mohammad Hifz Ur; Rahman, Muhammad Aziz; Rajati, Fatemeh; Ram, Usha; Ranta, Anna; Rawaf, David Laith; Rawaf, Salman; Reinig, Nickolas; Reis, Cesar; Renzaho, Andre M. N.; Resnikoff, Serge; Rezaeian, Shahab; Rezai, Mohammad Sadegh; Gonzalez, Carlos Miguel Rios; Roberts, Nicholas L. S.; Roever, Leonardo; Ronfani, Luca; Roro, Elias Merdassa; Roshandel, Gholamreza; Rostami, Ali; Sabbagh, Parisa; Sacco, Ralph L.; Sachdev, Perminder S.; Saddik, Basema; Safari, Hosein; Safari-Faramani, Roya; Safi, Sare; Safiri, Saeid; Sagar, Rajesh; Sahathevan, Ramesh; Sahebkar, Amirhossein; Sahraian, Mohammad Ali; Salamati, Payman; Zahabi, Saleh Salehi; Salimi, Yahya; Samy, Abdallah M.; Sanabria, Juan; Santos, Itamar S.; Milicevic, Milena M. Santric; Sarrafzadegan, Nizal; Sartorius, Benn; Sarvi, Shahabeddin; Sathian, Brijesh; Satpathy, Maheswar; Sawant, Arundhati R.; Sawhney, Monika; Schneider, Ione J. C.; Schottker, Ben; Schwebel, David C.; Seedat, Soraya; Sepanlou, Sadaf G.; Shabaninejad, Hosein; Shafieesabet, Azadeh; Shaikh, Masood Ali; Shakir, Raad A.; Shams-Beyranvand, Mehran; Shamsizadeh, Morteza; Sharif, Mehdi; Sharif-Alhoseini, Mahdi; She, Jun; Sheikh, Aziz; Sheth, Kevin N.; Shigematsu, Mika; Shiri, Rahman; Shirkoohi, Reza; Shiue, Ivy; Siabani, Soraya; Siddiqi, Tariq J.; Sigfusdottir, Inga Dora; Sigurvinsdottir, Rannveig; Silberberg, Donald H.; Silva, Joao Pedro; Silveira, Dayane Gabriele Alves; Singh, Jasvinder A.; Sinha, Dhirendra Narain; Skiadaresi, Eirini; Smith, Mari; Sobaih, Badr Hasan; Sobhani, Soheila; Soofi, Moslem; Soyiri, Ireneous N.; Sposato, Luciano A.; Stein, Dan J.; Stein, Murray B.; Stokes, Mark A.; Sufiyan, Mu'awiyyah Babale; Sykes, Bryan L.; Sylaja, Pn; Tabares-Seisdedos, Rafael; Ao, Braden James Te; Tehrani-Banihashemi, Arash; Temsah, Mohamad-Hani; Temsah, Omar; Thakur, Jarnail Singh; Thrift, Amanda G.; Topor-Madry, Roman; Tortajada-Girbes, Miguel; Tovani-Palone, Marcos Roberto; Tran, Bach Xuan; Tran, Khanh Bao; Truelsen, Thomas Clement; Tsadik, Afewerki Gebremeskel; Car, Lorainne Tudor; Ukwaja, Kingsley Nnanna; Ullah, Irfan; Usman, Muhammad Shariq; Uthman, Olalekan A.; Valdez, Pascual R.; Vasankari, Tommi Juhani; Vasanthan, Rajagopalan; Veisani, Yousef; Venketasubramanian, Narayanaswamy; Violante, Francesco S.; Vlassov, Vasily; Vosoughi, Kia; Vu, Giang Thu; Vujcic, Isidora S.; Wagnew, Fasil Shiferaw; Waheed, Yasir; Wang, Yuan-Pang; Weiderpass, Elisabete; Weiss, Jordan; Whiteford, Harvey A.; Wijeratne, Tissa; Winkler, Andrea Sylvia; Wiysonge, Charles Shey; Wolfe, Charles D. A.; Xu, Gelin; Yadollahpour, Ali; Yamada, Tomohide; Yano, Yuichiro; Yaseri, Mehdi; Yatsuya, Hiroshi; Yimer, Ebrahim M.; Yip, Paul; Yisma, Engida; Yonemoto, Naohiro; Yousefifard, Mahmoud; Yu, Chuanhua; Zaidi, Zoubida; Bin Zaman, Sojib; Zamani, Mohammad; Zandian, Hamed; Zare, Zohreh; Zhang, Yunquan; Zodpey, Sanjay; Naghavi, Mohsen; Murray, Christopher J. L.; Vos, Theo		GBD 2016 Neurology Collaborators	Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016	LANCET NEUROLOGY			English	Article								Background Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. Methods We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs; the sum of years of life lost [YLLs] and years lived with disability [YLDs]) by age and sex for 15 neurological disorder categories (tetanus, meningitis, encephalitis, stroke, brain and other CNS cancers, traumatic brain injury, spinal cord injury, Alzheimer's disease and other dementias, Parkinson's disease, multiple sclerosis, motor neuron diseases, idiopathic epilepsy, migraine, tension-type headache, and a residual category for other less common neurological disorders) in 195 countries from 1990 to 2016. DisMod-MR 2.1, a Bayesian meta-regression tool, was the main method of estimation of prevalence and incidence, and the Cause of Death Ensemble model (CODEm) was used for mortality estimation. We quantified the contribution of 84 risks and combinations of risk to the disease estimates for the 15 neurological disorder categories using the GBD comparative risk assessment approach. Findings Globally, in 2016, neurological disorders were the leading cause of DALYs (276 million [95% UI 247-308]) and second leading cause of deaths (9.0 million [8.8-9.4]). The absolute number of deaths and DALYs from all neurological disorders combined increased (deaths by 39% [34-44] and DALYs by 15% [9-21]) whereas their age-standardised rates decreased (deaths by 28% [26-30] and DALYs by 27% [24-31]) between 1990 and 2016. The only neurological disorders that had a decrease in rates and absolute numbers of deaths and DALYs were tetanus, meningitis, and encephalitis. The four largest contributors of neurological DALYs were stroke (42.2% [38.6-46.1]), migraine (16.3% [11.7-20.8]), Alzheimer's and other dementias (10.4% [9.0-124]), and meningitis (7.9% [6.6-10.4]). For the combined neurological disorders, age-standardised DALY rates were significantly higher in males than in females (male-to-female ratio 1.12 [1.05-1.20]), but migraine, multiple sclerosis, and tension-type headache were more common and caused more burden in females, with male-to-female ratios of less than 0.7. The 84 risks quantified in GBD explain less than 10% of neurological disorder DALY burdens, except stroke, for which 88.8% (86.5-90.9) of DALYs are attributable to risk factors, and to a lesser extent Alzheimer's disease and other dementias (22.3% [11.8-35.1] of DALYs are risk attributable) and idiopathic epilepsy (14.1% [10.8-17.5] of DALYs are risk attributable). Interpretation Globally, the burden of neurological disorders, as measured by the absolute number of DALYs, continues to increase. As populations are growing and ageing, and the prevalence of major disabling neurological disorders steeply increases with age, governments will face increasing demand for treatment, rehabilitation, and support services for neurological disorders. The scarcity of established modifiable risks for most of the neurological burden demonstrates that new knowledge is required to develop effective prevention and treatment strategies. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Feigin, Valery L.; Theadom, Alice] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Krishnamurthi, Rita V.] Auckland Univ Technol, Sch Publ Hlth, Auckland, New Zealand; [Ao, Braden James Te] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Feigin, Valery L.; Nichols, Emma; Alam, Tahiya; Bannick, Marlena S.; Fitzmaurice, Christina; James, Spencer L.; Johnson, Catherine Owens; Kassebaum, Nicholas J.; Mountjoy-Venning, W. Cliff; Minh Nguyen; Roth, Gregory A.; Vollset, Stein Emil; Dharmaratne, Samath Dhamminda; Hay, Simon I.; Khalil, Ibrahim A.; Mokdad, Ali H.; Nixon, Molly R.; Reinig, Nickolas; Roberts, Nicholas L. S.; Smith, Mari; Whiteford, Harvey A.; Naghavi, Mohsen; Murray, Christopher J. L.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ellenbogen, Richard G.; Zunt, Joseph Raymond; Kalani, Rizwan] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Fitzmaurice, Christina] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Vollset, Stein Emil; Hay, Simon I.; Khalil, Ibrahim A.; Mokdad, Ali H.; Naghavi, Mohsen; Murray, Christopher J. L.; Vos, Theo] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Crowe, Christopher Stephen; Massenburg, Benjamin Ballard] Univ Washington, Div Plast Surg, Seattle, WA 98195 USA; [Morrison, Shane Douglas] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Oren, Eyal] Univ Washington, Seattle, WA 98195 USA; [Beghi, Ettore; Giussani, Giorgia] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy; [Blake, Natacha; Glennie, Linda; Wright, Claire] Meningitis Res Fdn, Res Evidence & Policy Dept, Bristol, Avon, England; [Culpepper, William J.] US Dept Vet Affairs, Multiple Sclerosis Ctr Excellence, Baltimore, MD USA; [Culpepper, William J.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Wallin, Mitchell Taylor] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Dorsey, E. Ray] Univ Rochester, Rochester, NY USA; [Elbaz, Alexis] Natl Inst Hlth & Med Res, Ctr Res Epidemiol & Populat Hlth, Paris, France; [Ellenbogen, Richard G.] Seattle Childrens Hosp, Dept Surg, Seattle, WA USA; [Kassebaum, Nicholas J.] Seattle Childrens Hosp, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Fisher, James L.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Lo, Warren David] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Piccininni, Marco] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Piccininni, Marco] Univ Bari Aldo Moro, Unit Neurodegenerat Dis, Dept Clin Res Neurol, Bari, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Bari, Italy; [Logroscino, Giancarlo] Fdn Cardinale Giovanni Panico Hosp, Dept Clin Res Neurol, Tricase, Italy; [Marin, Benoit] Univ Limoges, Inst Neurol Epidemiol & Trop Neurol, Limoges, France; [Ofori-Asenso, Richard] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia; [Guo, Yuming; Li, Shanshan] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Thrift, Amanda G.] Monash Univ, Melbourne, Vic, Australia; [Patel, Anoop P.] Univ Washington, Med Ctr, Neurosurg, Seattle, WA 98195 USA; [Steiner, Timothy J.; Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway; [Steiner, Timothy J.; Shakir, Raad A.] Imperial Coll London, Div Brain Sci, London, England; [Car, Mate; Majeed, Azeem; Rawaf, Salman] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Rawaf, David Laith] Imperial Coll London, WHO Collaborating Ctr Publ Hlth Educ & Training, London, England; [Stovner, Lars Jacob] St Olavs Hosp, Neuro Ctr, Trondheim, Norway; [Szoeke, Cassandra E. I.; Meretoja, Atte; Sahathevan, Ramesh] Univ Melbourne, Sch Hlth Sci, Melbourne, Vic, Australia; [Mackay, Mark T.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Szoeke, Cassandra E. I.] Australian Catholic Univ, Inst Brain, Melbourne, Vic, Australia; [Cerin, Ester] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Wallin, Mitchell Taylor] George Washington Univ, Dept Neurol, Washington, DC USA; [Abbasi, Nooshin; Farzadfar, Farshad; Irvani, Seyed Sina Naghibi; Mohajer, Bahram; Mohebi, Farnam; Shams-Beyranvand, Mehran] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Afarideh, Mohsen; Esteghamati, Alireza; Esteghamati, Sadaf; Ganji, Morsaleh] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Eskandarieh, Sharareh; Mohajer, Bahram; Sahraian, Mohammad Ali] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Tehran, Iran; [Haj-Mirzaian, Arvin; Haj-Mirzaian, Arya] Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran; [Hosseini, Seyed Mostafa; Mansournia, Mohammad Ali; Yaseri, Mehdi] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran; [Malekzadeh, Reza; Poustchi, Hossein; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Mohebi, Farnam] Univ Tehran Med Sci, Iran Natl Inst Hlth Res, Tehran, Iran; [Mousavi, Seyyed Meysam] Univ Tehran Med Sci, Dept Hlth Management & Econ, Tehran, Iran; [Rahimi-Movaghar, Vafa; Salamati, Payman; Sharif-Alhoseini, Mahdi] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Shirkoohi, Reza] Univ Tehran Med Sci, Canc Biol Res Ctr, Tehran, Iran; [Sobhani, Soheila] Univ Tehran Med Sci, Dept Anat, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, Community Based Participatory Res Ctr CBPR, Tehran, Iran; [Shirkoohi, Reza] Univ Tehran Med Sci, Canc Res Ctr, Tehran, Iran; [Abbasi, Nooshin] McGill Univ, Montreal Neuroimaging Ctr, Montreal, PQ, Canada; [Mate, Kedar K. V.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Abd-Allah, Foad; Abdelalim, Ahmed; Hegazy, Mohamed I.] Cairo Univ, Dept Neurol, Cairo, Egypt; [Abdollahpour, Ibrahim] Arak Univ Med Sci, Dept Epidemiol, Arak, Iran; [Abdollahpour, Ibrahim] Multiple Sclerosis Res Ctr, Tehran, Iran; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Aboyans, Victor] Univ Limoges, Inst Epidemiol, Limoges, France; [Abraha, Haftom Niguse; Kassa, Tesfaye Dessale; Nirayo, Yirga Legesse] Mekelle Univ, Clin Pharm Unit, Mekelle, Ethiopia; [Belachew, Abate Bekele] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia; [Gebre, Abadi Kahsu; Gebremichael, Teklu Gebrehiwo; Tsadik, Afewerki Gebremeskel; Yimer, Ebrahim M.] Mekelle Univ, Sch Pharm, Mekelle, Ethiopia; [Gezae, Kebede Embaye] Mekelle Univ, Dept Biostat, Mekelle, Ethiopia; [Hagos, Tekleberhan B.] Mekelle Univ, Anat Unit, Mekelle, Ethiopia; [Degefa, Meaza Girma; Kahsay, Amaha] Mekelle Univ, Dept Nutr & Dietet, Mekelle, Ethiopia; [Mengistu, Getnet] Mekelle Univ, Sch Med, Mekelle, Ethiopia; [Meles, Hagazi Gebre] Mekelle Univ, Mekelle, Ethiopia; [Acharya, Dilaram] Dongguk Univ, Dept Prevent Med, Gyeongju, South Korea; [Acharya, Dilaram] Kathmandu Univ, Dept Community Med, Kathmandu, Nepal; [Adamu, Abdu A.; Wiysonge, Charles Shey] Stellenbosch Univ, Dept Global Hlth, Cape Town, South Africa; [Nyasulu, Peter S.] Stellenbosch Univ, Fac Med & Hlth Sci, Cape Town, South Africa; [Seedat, Soraya] Stellenbosch Univ, Dept Psychiat, Cape Town, South Africa; [Adamu, Abdu A.] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Stein, Dan J.] South African Med Res Council, Cape Town, South Africa; [Adebayo, Oladimeji M.] Univ Coll Hosp, Dept Med, Ibadan, Nigeria; [Adeoye, Abiodun Moshood] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Akinyemi, Rufus Olusola; Owolabi, Mayowa Ojo] Univ Ibadan, Inst Adv Med Res & Training, Ibadan, Nigeria; [Adeoye, Abiodun Moshood] Elyon Heart Rehabil Ctr, Community Cardiovasc Res Unit, Ibadan, Nigeria; [Adsuar, Jose C.] Univ Extremadura, Sport Sci Dept, Badajoz, Spain; [Zodpey, Sanjay] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurugram, India; [Agrawal, Sutapa] Vital Strategies, Gurugram, India; [Ahmadi, Alireza] Kermanshah Univ Med Sci, Dept Anesthesiol, Kermanshah, Iran; [Farzaei, Mohammad Hosein] Kermanshah Univ Med Sci, Dept Tradit & Complementary Med, Kermanshah, Iran; [Heydarpour, Fatemeh] Kermanshah Univ Med Sci, Fac Nutr & Food Sci, Kermanshah, Iran; [Khazaie, Habibolah] Kermanshah Univ Med Sci, Dept Psychiat, Kermanshah, Iran; [Moradinazar, Mehdi] Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran; [Naderi, Mehdi] Kermanshah Univ Med Sci, Dept Operating Room, Sch Paramed, Kermanshah, Iran; [Najafi, Farid; Salimi, Yahya] Kermanshah Univ Med Sci, Dept Epidemiol & Biostat, Kermanshah, Iran; [Rajati, Fatemeh] Kermanshah Univ Med Sci, Dept Hlth Educ & Promot, Kermanshah, Iran; [Safari-Faramani, Roya] Kermanshah Univ Med Sci, Fac Publ Hlth, Kermanshah, Iran; [Zahabi, Saleh Salehi] Kermanshah Univ Med Sci, Radiol & Nucl Med, Kermanshah, Iran; [Siabani, Soraya] Kermanshah Univ Med Sci, Imam Ali Cardiovasc Res Ctr, Kermanshah, Iran; [Soofi, Moslem] Kermanshah Univ Med Sci, Environm Determinants Hlth Res Ctr, Kermanshah, Iran; [Farzaei, Mohammad Hosein] Kermanshah Univ Med Sci, Pharmaceut Sci Res Ctr, Kermanshah, Iran; [Rezaeian, Shahab] Kermanshah Univ Med Sci, Kermanshah, Iran; [Ahmed, Muktar Beshir] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Duken, Eyasu Ejeta] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Aichour, Amani Nidhal; Aichour, Ibtihel] Univ Ferhat Abbas Setif, Setif, Algeria; [Aichour, Miloud Taki Eddine] Higher Natl Sch Vet Med, Algiers, Algeria; [Akseer, Nadia] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Badawi, Alaa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Univ Toronto, Ctr Global Child Hlth, Hosp Sick Children, Toronto, ON, Canada; [Al-Eyadhy, Ayman] King Saud Univ, Pediat Intens Care Unit, Riyadh, Saudi Arabia; [Sobaih, Badr Hasan; Temsah, Omar] King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; [Altirkawi, Khalid] King Saud Univ, Riyadh, Saudi Arabia; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz; Soyiri, Ireneous N.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Alahdab, Fares] Mayo Clin, Fdn Med Educ & Res, Evidence Based Practice Ctr, Rochester, MN USA; [Alene, Kefyalew Addis; Bekele, Bayu Begashaw] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Biadgo, Belete] Univ Gondar, Dept Clin Chem, Gondar, Ethiopia; [Geremew, Demeke] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia; [Alene, Kefyalew Addis] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Bin Sayeed, Muhammad Shahdaat; Lucas, Robyn M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Aljunid, Syed Mohamed] Kuwait Univ, Dept Hlth Policy & Management, Safat, Kuwait; [Aljunid, Syed Mohamed] Natl Univ Malaysia, Int Ctr Casemix & Clin Coding, Bandar Tun Razak, Malaysia; [Alvis-Guzman, Nelson] Univ Cartagena, Hlth Econ Res Grp, Cartagena, Colombia; [Alvis-Guzman, Nelson] Univ Coast, Res Grp Hosp Management & Hlth Policies, Barranquilla, Colombia; [Anber, Nahla Hamed] Mansoura Univ, Fac Med, Mansoura, Egypt; [Anber, Nahla Hamed] Mansoura Univ, Mansoura, Egypt; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines; [Lopez, Jaifred Christian F.] Univ Philippines Manila, Dept Epidemiol & Biostat, Manila, Philippines; [Antonio, Carl Abelardo T.] Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Peoples R China; [Arabloo, Jalal] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran; [Moradi-Lakeh, Maziar; Tehrani-Banihashemi, Arash; Vosoughi, Kia] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Shabaninejad, Hosein] Iran Univ Med Sci, Dept Hlth Policy, Tehran, Iran; [Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Dept Community Med, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Physiol Res Ctr, Tehran, Iran; [Farhadi, Farzaneh] Iran Univ Med Sci, Tehran, Iran; [Aremu, Olatunde] Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England; [Arnlov, Johan] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Carrero, Juan J.; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [El-Khatib, Ziad] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Asghar, Rana Jawad] Qom Univ Med Sci, Qom, Iran; [Asghar, Rana Jawad] South Asian Publ Hlth Forum, Lahore, Pakistan; [Atalay, Hagos Tasew] Aksum Univ, Dept Nursing, Aksum, Ethiopia; [Demoz, Gebre Teklemariam] Aksum Univ, Dept Clin Pharm, Aksum, Ethiopia; [Awasthi, Ashish] Indian Inst Publ Hlth, Gandhinagar, India; [Ayala Quintanilla, Beatriz Paulina] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Edvardsson, David] La Trobe Univ, Sch Nursing & Midwifery, Melbourne, Vic, Australia; [Rahman, Mahfuzar] La Trobe Univ, Austin Clin Sch Nursing, Melbourne, Vic, Australia; [Wijeratne, Tissa] La Trobe Univ, Dept Psychol, Melbourne, Vic, Australia; [Ayala Quintanilla, Beatriz Paulina] Peruvian Natl Inst Hlth, Gen Off Res & Technol Transfer, Lima, Peru; [Ayuk, Tambe B.] Inst Med Res & Med Plant Studies, Ctr Food & Nutr Res, Yaounde, Cameroon; [Ayuk, Tambe B.] Univ South Africa, Dept Hlth Studies, Pretoria, South Africa; [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banach, Maciej] Polish Mothers Mem Hosp Res Inst, Lodz, Poland; [Banoub, Joseph Adel Mattar] Alexandria Univ, Fac Med, Alexandria, Egypt; [Banoub, Joseph Adel Mattar] Univ Hosp Fdn Santa Fe Bogota, Dept Transplant Serv, Bogota, Colombia; [Barboza, Miguel A.] Costa Rican Dept Social Secur, Dept Neurosci, San Jose, Costa Rica; [Barboza, Miguel A.] Univ Costa Rica, Sch Med, San Pedro, Costa Rica; [Barker-Collo, Suzanne Lyn] Univ Auckland, Sch Psychol, Fac Med & Hlth Sci, Auckland, New Zealand; [Ao, Braden James Te] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand; [Tran, Khanh Bao] Univ Auckland, Mol Med & Pathol, Auckland, New Zealand; [Barnighausen, Till Winfried] Heidelberg Univ Hosp, Inst Publ Hlth, Heidelberg, Germany; [Barnighausen, Till Winfried] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Sheikh, Aziz] Harvard Univ, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Baune, Bernhard T.] Melbourne Med Sch, Melbourne, Vic, Australia; [Bedi, Neeraj] Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India; [Bedi, Neeraj] Jazan Univ, Jazan, Saudi Arabia; Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran; Lorestan Univ Med Sci, Khorramabad, Iran; [Bejot, Yannick] Univ Hosp Dijon, Dept Neurol, Dijon, France; [Bejot, Yannick] Univ Burgundy, Dijon Stroke Registry, UFR Sci Sante, Dijon, France; [Bekele, Bayu Begashaw; Hassen, Hamid Yimam] Mizan Tepi Univ, Dept Publ Hlth, Teppi, Ethiopia; [Kefale, Adane Teshome] Mizan Tepi Univ, Dept Pharm, Teppi, Ethiopia; [Henok, Andualem] Mizan Tepi Univ, Teppi, Ethiopia; [Bennett, Derrick A.; Lacey, Ben] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Newton, Charles Richard James] Univ Oxford, Dept Psychiat, Oxford, England; [Bensenor, Isabela M.; Santos, Itamar S.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Univ Hosp, Dept Internal Med, Sao Paulo, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; [Polanczyk, Guilherme V.; Wang, Yuan-Pang] Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Tovani-Palone, Marcos Roberto] Univ Sao Paulo, Dept Pathol & Legal Med, Sao Paulo, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil; [Berhane, Adugnaw; Deribe, Kebede; Gidey, Mahari Y.; Goulart, Alessandra C.] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Muhammed, Oumer Sada] Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia; [Roro, Elias Merdassa] Addis Ababa Univ, Publ Hlth, Addis Ababa, Ethiopia; [Yisma, Engida] Addis Ababa Univ, Sch Allied Hlth Sci, Addis Ababa, Ethiopia; [Demoz, Gebre Teklemariam] Addis Ababa Univ, Addis Ababa, Ethiopia; [Beuran, Mircea; Negoi, Ionut] Carol Davila Univ Med & Pharm, Emergency Hosp Bucharest, Bucharest, Romania; [Negoi, Ionut] Carol Davila Univ Med & Pharm, Dept Anat & Embryol, Bucharest, Romania; [Bhattacharyya, Krittika] Natl Inst Biomed Genom, Biostat & Bioinformat, Kalyani, W Bengal, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Fatima, Batool] Aga Khan Univ, Human Dev Programme, Karachi, Pakistan; [Bijani, Ali] Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol Sar, Iran; [Ghasemi-Kasman, Maryam] Babol Univ Med Sci, Hlth Res Inst, Babol Sar, Iran; [Mohammadi-Khanaposhtani, Maryam] Babol Univ Med Sci, Dept Pharmacol, Babol Sar, Iran; [Mohammadnia-Afrouzi, Mousa] Babol Univ Med Sci, Dept Immunol, Babol Sar, Iran; [Rostami, Ali; Sabbagh, Parisa] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran; [Zamani, Mohammad] Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran; [Bililign, Nigus] Woldia Univ, Woldia, Ethiopia; [Bin Sayeed, Muhammad Shahdaat] Univ Dhaka, Dept Clin Pharm & Pharmacol, Ramna, Bangladesh; [Blazes, Christopher Kynrint] Univ Michigan, Med Ctr, Sch Med, Ann Arbor, MI 48109 USA; [Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Butt, Zahid A.; Sarrafzadegan, Nizal] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Butt, Zahid A.] Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan; [De la Cruz-Gongora, Vanessa] Natl Inst Publ Hlth, Ctr Evaluat & Surveys Res, Cuernavaca, Morelos, Mexico; [Campos-Nonato, Ismael R.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Campos-Nonato, Ismael R.; Cantu-Brito, Carlos] Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Neurol, Mexico City, DF, Mexico; [Car, Mate] Minist Hlth, Zagreb, Croatia; [Cardenas, Rosario] Metropolitan Autonomous Univ, Dept Populat & Hlth, Mexico City, DF, Mexico; [Carvalho, Felix] Univ Porto, Inst Publ Hlth, Porto, Portugal; [Costa, Vera M.] Univ Porto, UCIBIO, REQUIMTE, Lab Toxicol,Fac Pharm, Porto, Portugal; [Fernandes, Eduarda; Pereira, David M.] Univ Porto, REQUIMTE, LAQV, Porto, Portugal; [Silva, Joao Pedro] Univ Porto, UCIBIO, Porto, Portugal; [Carvalho, Felix] Univ Porto, Appl Mol Biosci Unit, Porto, Portugal; [Castaneda-Orjuela, Carlos A.] Natl Inst Hlth, Colombian Natl Hlth Observ, Bogota, Colombia; [Gonzalez, Carlos Miguel Rios] Natl Inst Hlth, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Pio De la Hoz, Fernando] Univ Nacl Colombia, Dept Publ Hlth, Bogota, Colombia; [Castro, Franz] Gorgas Mem Inst Hlth Studies, Dept Res & Hlth Technol Assessment, Panama City, Panama; [Velasquez, Ilais Moreno] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Catala-Lopez, Ferran] Inst Hlth Carlos III, Dept Hlth Planning & Econ, Madrid, Spain; [Cerin, Ester] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Peoples R China; [Chaiah, Yazan; Memish, Ziad A.; Temsah, Mohamad-Hani; Temsah, Omar] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Chang, Jung-Chen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chatziralli, Irini] Univ Athens, Dept Ophthalmol 2, Haidari, Greece; [Chiang, Peggy Pei-Chia] Clin Governance, Gold Coast Hlth, Gold Coast, Qld, Australia; [Christensen, Hanne] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Christensen, Hanne] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark; [Truelsen, Thomas Clement] Univ Copenhagen, Dept Neurol, Copenhagen, Denmark; [Christopher, Devasahayam J.] Christian Med Coll & Hosp CMC, Dept Pulm Med, Vellore, Tamil Nadu, India; [Pandian, Jeyaraj Durai] Christian Med Coll & Hosp CMC, Dept Neurol, Vellore, Tamil Nadu, India; [Cooper, Cyrus] Univ Southampton, NIHR Oxford Biomed Res Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Southampton, Southampton, Hants, England; [Cortesi, Paolo Angelo; Lafranconi, Alessandra; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Damasceno, Albertino Antonio Moura] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Daryani, Ahmad; Sarvi, Shahabeddin] Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran; [Karimi, Narges] Mazandaran Univ Med Sci, Dept Neurol, Sari, Iran; [Mohammadi, Moslem] Mazandaran Univ Med Sci, Dept Physiol & Pharmacol, Sari, Iran; [Moosazadeh, Mahmood] Mazandaran Univ Med Sci, Hlth Sci Res Ctr, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Mol & Cell Biol Res Ctr, Sari, Iran; [Rezai, Mohammad Sadegh] Mazandaran Univ Med Sci, Dept Pediat, Sari, Iran; [Karimi, Narges] Mazandaran Univ Med Sci, Immunogenet Res Ctr, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran; [Shiadeh, Malihe Nourollahpour; Zare, Zohreh] Mazandaran Univ Med Sci, Sari, Iran; [De Leo, Diego] Griffith Univ, Australian Inst Suicide Res & Prevent, Mt Gravatt, Qld, Australia; [Deribe, Kebede] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Dharmaratne, Samath Dhamminda] Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka; [Diaz, Daniel] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico; [Diaz, Daniel] Autonomous Univ Sinaloa, Fac Vet Med & Zootech, Culiacan, Mexico; [Dinberu, Mesfin Tadese] Debre Berhan Univ, Dept Midwifery, Debre Berhan, Ethiopia; [Djalalinia, Shirin] Minist Hlth & Med Educ, Res & Technol, Tehran, Iran; [Doku, David Teye] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Doku, David Teye] Univ Tampere, Fac Social Sci, Hlth Sci, Tampere, Finland; [Dubey, Manisha] United Nations World Food Programme, New Delhi, India; [Dubljanin, Eleonora] Univ Belgrade, Fac Med, Belgrade, Serbia; [Milicevic, Milena M. Santric] Univ Belgrade, Ctr Sch Publ Hlth & Hlth Management, Belgrade, Serbia; [Vujcic, Isidora S.] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Duken, Eyasu Ejeta] Wollega Univ, Dept Hlth Sci, Nekemte, Ethiopia; [Roro, Elias Merdassa] Wollega Univ, Dept Publ Hlth, Nekemte, Ethiopia; [Edvardsson, David] Umea Univ, Dept Nursing, Umea, Sweden; [Endres, Matthias] Charite Univ Med Ctr Berlin, Dept Neurol, Berlin, Germany; [Endries, Aman Yesuf] St Pauls Hosp, Millennium Med Coll, Dept Publ Hlth, Addis Ababa, Ethiopia; [Faro, Andre] Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil; [Fereshtehnejad, Seyed-Mohammad] Univ Ottawa, Div Neurol, Ottawa, ON, Canada; [Filip, Irina] Kaiser Permanente, Psychiat, Fontana, CA USA; [Filip, Irina] AT Still Univ, Dept Hlth Sci, Mesa, AZ USA; [Radfar, Amir] AT Still Univ, Mesa, AZ USA; [Fischer, Florian] Bielefeld Univ, Dept Publ Hlth Med, Bielefeld, Germany; [Fukumoto, Takeshi] Canc Inst WIA, Gene Express & Regulat Program, Philadelphia, PA USA; [Fukumoto, Takeshi] Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan; [Gankpe, Fortune Gbetoho] Univ Sidi Mohammed Ben Abdellah, Fac Med & Pharm Fez, Fes, Morocco; [Gankpe, Fortune Gbetoho] Noncommunicable Dis Dept, Lab Studies & Res Act Hlth, Porto Novo, Benin; [Garcia-Gordillo, Miguel A.] Autonomous Univ Chile, Fac Business & Management, Talca, Chile; [Olivares, Pedro R.] Autonomous Univ Chile, Inst Phys Act & Hlth, Talca, Chile; [Gelaw, Belayneh K.] Ambo Univ, Sch Pharm, Ambo, Ethiopia; [Geleijnse, Johanna M.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Gidey, Mahari Y.] Res Performance Monitoring & Accountabil 2020 Eth, Addis Ababa, Ethiopia; [Gill, Paramjit Singh] Univ Warwick, Unit Acad Primary Care, Coventry, W Midlands, England; [Uthman, Olalekan A.] Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England; [Gill, Tiffany K.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Olagunju, Andrew T.] Univ Adelaide, Adelaide, SA, Australia; [Gnedovskaya, Elena V.; Piradov, Michael A.] Res Ctr Neurol, Moscow, Russia; [Grada, Ayman] Boston Univ, Sch Med, Boston, MA USA; [Grosso, Giuseppe] Vittorio Emanuele Univ Hosp Polyclin, Registro Tumori Integrato, Catania, Italy; West Virginia Bur Publ Hlth, Publ Hlth, Charleston, WV USA; West Virginia Univ, Sch Publ Hlth, Dept Hlth Policy Management & Leadership, Morgantown, WV 26506 USA; Rajasthan Univ Hlth Sci, Acad & Res, Jaipur, Rajasthan, India; Eternal Heart Care Ctr & Res Inst, Dept Prevent Cardiol, Jaipur, Rajasthan, India; [Haagsma, Juanita A.; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Haj-Mirzaian, Arvin; Irvani, Seyed Sina Naghibi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran; [Safi, Sare] Shahid Beheshti Univ Med Sci, Ophthalm Epidemiol Res Ctr, Tehran, Iran; [Safi, Sare; Yaseri, Mehdi] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran; [Haj-Mirzaian, Arya] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Vosoughi, Kia] Johns Hopkins Univ, Dept Gastroenterol & Hepatol, Baltimore, MD USA; [Hamadeh, Randah R.] Arabian Gulf Univ, Dept Family & Community Med, Manama, Bahrain; [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Sch Hlth & Environm Studies, Dubai, U Arab Emirates; [Hankey, Graeme J.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Lucas, Robyn M.] Univ Western Australia, Lions Eye Inst, Perth, WA, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Hao, Yuantao] Sun Yat Sen Univ, Sun Yat Sen Global Hlth Inst, Guangzhou, Guangdong, Peoples R China; [Hao, Yuantao; Liao, Yu] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Haro, Josep Maria; Koyanagi, Ai] San Juan Dios Sanitary Pk, Res & Dev Unit, St Boi De Llobregat, Spain; [Haro, Josep Maria] Univ Barcelona, Dept Med, Barcelona, Spain; [Hassankhani, Hadi] Tabriz Univ Med Sci, Tabriz, Iran; [Hassen, Hamid Yimam] Univ Hosp Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium; [Havmoeller, Rasmus] Karolinska Univ Hosp, Clin Sci, Stockholm, Sweden; [Heidari, Behnam] Teikyo Univ, Sch Med, Endocrinol & Metab Res Ctr, Tehran, Iran; [Hoang, Chi Linh; Vu, Giang Thu] Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh, Vietnam; [Nguyen, Long Hoang] Nguyen Tat Thanh Univ, Ctr Excellence Behav Hlth, Ho Chi Minh, Vietnam; [Hole, Michael K.] Univ Texas Austin, Austin, TX 78712 USA; [Rad, Enayatollah Homaie] Guilan Univ Med Sci, Sch Hlth, Rasht, Iran; [Rad, Enayatollah Homaie] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Hu, Guoqing] Cent South Univ, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Igumbor, Ehimario U.] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Igumbor, Ehimario U.] Walter Sisulu Univ, Dept Publ Hlth, Mthatha, South Africa; [Ilesanmi, Olayinka Stephen] Univ Liberia, Dept Publ Hlth & Community Med, Monrovia, CA, Liberia; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia; [Rahman, Mahfuzar] Deakin Univ, Natl Ctr Farmer Hlth, Burwood, Vic, Australia; [Stokes, Mark A.] Deakin Univ, Dept Psychol, Burwood, Vic, Australia; [Islam, Sheikh Mohammed Shariful] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Jakovljevic, Mihajlo] Univ Kragujevac, Dept Med Sci, Kragujevac, Serbia; [Javanbakht, Mehdi] Newcastle Univ, Tyne, England; [Jha, Ravi Prakash] Banaras Hindu Univ, Dept Community Med, Varanasi, Uttar Pradesh, India; [Jobanputra, Yash B.] Univ Miami, Dept Med, Atlantis, FL USA; [Sacco, Ralph L.] Univ Miami, Dept Neurol, Atlantis, FL USA; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Mannheim, Germany; [Marz, Winfried] Heidelberg Univ, Med Clin 5, Mannheim, Germany; [Moazen, Babak; Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Mannheim, Germany; [Panda-Jonas, Songhomitra] Heidelberg Univ, Augenpraxis Jonas, Mannheim, Germany; [Jonas, Jost B.] Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jozwiak, Jacek Jerzy] Univ Opole, Fac Med & Hlth Sci, Opole, Poland; [Jozwiak, Jacek Jerzy] Univ Opole, Dept Family Med & Publ Hlth, Opole, Poland; [Jurisson, Mikk] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia; [Kalkonde, Yogeshwar] Publ Hlth Soc Educ Act & Res Community Hlth, Mumbai, Maharashtra, India; [Kamil, Teshome Abegaz] ACS Med Coll & Hosp, Sch Publ Hlth, Dept Hlth Informat & Hlth Innovat, Mekelle, Ethiopia; [Zaidi, Zoubida] ACS Med Coll & Hosp, Mekelle, Ethiopia; [Kanchan, Tanuj] All India Inst Med Sci, Dept Forens Med & Toxicol, Jodhpur, Rajasthan, India; [Sagar, Rajesh] All India Inst Med Sci, Dept Psychiat, Jodhpur, Rajasthan, India; [Karami, Manoochehr] Hamadan Univ Med Sci, Dept Epidemiol, Hamadan, Iran; [Mezerji, Naser Mohammad Gholi] Hamadan Univ Med Sci, Biostat, Hamadan, Iran; [Mohammadibakhsh, Roghayeh] Hamadan Univ Med Sci, Hlth, Hamadan, Iran; [Shamsizadeh, Morteza] Hamadan Univ Med Sci, Chron Dis Home Care Res Ctr, Hamadan, Iran; [Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [Kassa, Zemenu Yohannes] Hawassa Univ, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Kaul, Anil] Oklahoma State Univ, Sch Hlth Care Adm, Tulsa, OK USA; [Kaul, Anil] Univ Tulsa, Hlth Care Delivery Sci, Tulsa, OK 74104 USA; [Keiyoro, Peter Njenga] Univ Nairobi, ODeL Campus, Nairobi, Kenya; [Kumar, Manasi] Univ Nairobi, Dept Psychiat, Nairobi, Kenya; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Dept Publ Hlth & Community Med, Ramtha, Jordan; [Khafaie, Morteza Abdullatif] Ahvaz Jundishapur Univ Med Sci, Dept Publ Hlth, Ahwaz, Iran; [Rahim, Fakher] Ahvaz Jundishapur Univ Med Sci, Thalassemia & Hemoglobinopathy Res Ctr, Ahwaz, Iran; [Safari, Hosein] Ahvaz Jundishapur Univ Med Sci, Dept Neurosurg, Ahwaz, Iran; [Yadollahpour, Ali] Ahvaz Jundishapur Univ Med Sci, Dept Med Phys, Ahwaz, Iran; [Khan, Ejaz Ahmad] Hlth Serv Acad, Epidemiol & Biostat Dept, Islamabad, Pakistan; [Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Seoul, South Korea; [Kiadaliri, Aliasghar A.] Lund Univ, Clin Epidemiol Unit, Lund, Sweden; [Norrving, Bo] Lund Univ, Dept Clin Sci, Lund, Sweden; [Kiirithio, Daniel N.] Kenya Revenue Author, Res Dept, Nairobi, Kenya; [Kiirithio, Daniel N.] Synotech Consultant, Res & Data Solut, Nairobi, Kenya; [Kim, Anthony S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Kim, Daniel] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA; Korea Univ, Dept Prevent Med, Seoul, South Korea; Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia; [Kisa, Adnan] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Winkler, Andrea Sylvia] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Kisa, Adnan] Tulane Univ, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Defo, Barthelemy Kuate] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Defo, Barthelemy Kuate] Univ Montreal, Dept Demog, Montreal, PQ, Canada; [Bicer, Burcu Kucuk] Yuksek Ihtisas Univ, Dept Publ Hlth, Ankara, Turkey; [Bicer, Burcu Kucuk] Hacettepe Univ, Dept Publ Hlth, Ankara, Turkey; [Kumar, Manasi] UCL, Dept Psychol, London, England; [Lacey, Ben] NIHR Oxford Biomed Res Ctr, Oxford, England; [Lansingh, Van C.] Helpmesee, New York, NY USA; [Lansingh, Van C.] Mexican Inst Ophthalmol, Int Relat, Queretaro, Mexico; [Latifi, Arman] Maragheh Univ Med Sci, Dept Publ Hlth, Maragheh, Iran; [Safiri, Saeid] Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Maragheh, Iran; [Leshargie, Cheru Tesema] Debre Markos Univ, Dept Publ Hlth, Debre Markos, Ethiopia; [Wagnew, Fasil Shiferaw] Debre Markos Univ, Dept Nursing, Debre Markos, Ethiopia; [Liao, Yu] Alliance Improving Hlth Outcomes Inc, Quezon City, Philippines; [Linn, Shai] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Lo, Warren David] Nationwide Childrens Hosp, Dept Pediat Neurol, Columbus, OH USA; [Lorkowski, Stefan] Friedrich Schiller Univ Jena, Inst Nutr, Jena, Germany; [Meier, Toni] Competence Cluster Nutr & Cardiovasc Hlth NUTRICA, Innovat Off, Jena, Germany; [Lorkowski, Stefan] Competence Cluster Nutr & Cardiovasc Hlth NUTRICA, Jena, Germany; [Lunevicius, Raimundas] Aintree Univ Hosp Natl Hlth Serv Fdn Trust NHS, Dept Gen Surg, Liverpool, Merseyside, England; [Lunevicius, Raimundas] Univ Liverpool, Dept Surg, Liverpool, Merseyside, England; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Mahotra, Narayan Bahadur] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Majdan, Marek] Trnava Univ, Dept Publ Hlth, Trnava, Slovakia; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil; [Manafi, Navid] IUMS, Ophthalmol, Tehran, Iran; [Manafi, Navid] Univ Manitoba, Ophthalmol, Winnipeg, MB, Canada; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Mashamba-Thompson, Tivani Phosa; Moodley, Yoshan; Sartorius, Benn] Univ Kwazulu Natal, Dept Publ Hlth Med, Durban, South Africa; [McAlinden, Colm; Skiadaresi, Eirini] Hywel Dda Univ Hlth Board, Dept Ophthalmol, Carmarthen, Dyfed, Wales; [McGrath, John J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia; [McGrath, John J.] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Mehta, Varshil] Sevenhills Hosp, Dept Internal Med, Mumbai, Maharashtra, India; [Meier, Toni] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Germany; [Shiue, Ivy] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol, Halle, Germany; [Melese, Addisu] Debre Tabor Univ, Coll Hlth Sci, Debre Tabor, Ethiopia; [Memiah, Peter T. N.] Univ West Florida, Dept Publ Hlth, Pensacola, FL USA; [Memish, Ziad A.] Prince Mohammed Bin Abdulaziz Hosp, Res Dept, Minist Hlth, Riyadh, Saudi Arabia; [Mendoza, Walter] United Nations Populat Fund UNFPA, Peru Country Off, Lima, Peru; [Mengistu, Getnet] Haramaya Univ, Sch Pharm, Harar, Ethiopia; [Mengistu, Getnet] Wollo Univ, Dept Pharm, Dessie, Ethiopia; [Meretoja, Atte] Helsinki Univ Hosp, Neuroctr, Helsinki, Finland; [Meretoja, Tuomo J.] Helsinki Univ Hosp, Breast Surg Unit, Helsinki, Finland; [Meretoja, Tuomo J.] Univ Helsinki, Helsinki, Finland; [Mestrovic, Tomislav] Dr Zora Profoz Polyclin, Clin Microbiol & Parasitol Unit, Zagreb, Croatia; [Mestrovic, Tomislav] Univ Ctr Varazdin, Varazhdin, Croatia; [Miazgowski, Tomasz] Pomeranian Med Univ, Dept Hypertens, Szczecin, Poland; [Miazgowski, Bartosz] Pomeranian Med Univ, Emergency Dept, Szczecin, Poland; [Miazgowski, Bartosz] Pomeranian Med Univ, Szczecin, Poland; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Mini, G. K.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Sylaja, Pn] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India; [Sylaja, Pn] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [Mini, G. K.] Amrita Inst Med Sci, Dept Publ Hlth, Kochi, India; [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Fac Gen Med, Bishkek, Kyrgyzstan; [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Dept Atherosclerosis & Coronary Heart Dis, Bishkek, Kyrgyzstan; [Moazen, Babak] Frankfurt Univ Appl Sci, Inst Addict Res ISFF, Frankfurt, Germany; [Mohammadibakhsh, Roghayeh] Hamedan Univ Med Sci, Hamadan, Iran; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Sufiyan, Mu'awiyyah Babale] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria; [Monasta, Lorenzo; Ronfani, Luca] Burlo Garofolo Inst Maternal & Child Hlth, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Mondello, Stefania] Oasi Res Inst, Dept Neurol, Troina, Italy; [Moradi, Ghobad] Kurdistan Univ Med Sci, Dept Epidemiol & Biostat, Sanandaj, Iran; [Moradi, Ghobad] Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Sanandaj, Iran; [Moraga, Paula] Univ Lancaster, Lancaster, England; [Muruet, Walter; Wolfe, Charles D. A.] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Musa, Kamarul Imran] Univ Sci Malaysia, Sch Med Sci, Kubang Kerian, Malaysia; [Mustafa, Ghulam] Nishtar Med Univ, Dept Pediat, Multan, Pakistan; [Mustafa, Ghulam] Inst Mother & Child Care, Pediat & Pediat Pulmonol, Multan, Pakistan; [Nagel, Gabriele] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Initiat Non Communicable Dis, Dhaka, Bangladesh; [Bin Zaman, Sojib] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Naik, Gurudatta; Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Sawant, Arundhati R.] Univ Alabama Birmingham, Birmingham, AL USA; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Negoi, Ionut] Cardio Aid, Dept Cardiol, Bucharest, Romania; [Newton, Charles Richard James] Wellcome Trust Res Programme, Kenya Med Res Inst, Neurosci, Kilifi, Kenya; [Ngunjiri, Josephine W.] Univ Embu, Dept Biol Sci, Embu, Kenya; [Nguyen, Cuong Tat] Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam; [Ningrum, Dina Nur Anggraini] State Univ Semarang, Dept Publ Hlth Sci, Kota Semarang, Indonesia; [Ningrum, Dina Nur Anggraini] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Noubiap, Jean Jacques] Univ Cape Town, Dept Med, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Ogbo, Felix Akpojene] Western Sydney Univ, Penrith, NSW, Australia; [Oh, In-Hwan] Kyung Hee Univ, Dept Prevent Med, Seoul, South Korea; [Olagunju, Andrew T.] Univ Lagos, Dept Psychiat, Lagos, Nigeria; [Olagunju, Tinuke O.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Onwujekwe, Obinna E.] Univ Nigeria Nsukka, Dept Pharmacol & Therapeut, Enugu, Nigeria; [Oren, Eyal] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Mahesh, P. A.] Jagadguru Sri Shivarathreeswara Univ, Dept TB & Resp Med, Mysore, Karnataka, India; [Pakpour, Amir H.] Qazvin Univ Med Sci, Dept Publ Hlth, Qazvin, Iran; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Patel, Sangram Kishor] Populat Council, Res & Evaluat, New Delhi, India; [Patel, Sangram Kishor] Indian Inst Hlth Management Res Univ, Jaipur, Rajasthan, India; [Pereira, David M.] Cartagena Univ, Cartagena, Colombia; [Petzold, Max] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Petzold, Max] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Pillay, Julian David] Durban Univ Technol, Basic Med Sci Dept, Durban, South Africa; [Postma, Maarten J.] Univ Groningen, Dept Econ & Business, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Poulton, Richie] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Ranta, Anna] Univ Otago, Dept Med, Dunedin, New Zealand; [Prakash, Swayam] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nephrol, Lucknow, Uttar Pradesh, India; [Prakash, V.] Charotar Univ Sci & Technol, Askok & Rita Patel Inst Physiotherapy, Anand, Gujarat, India; [Qorbani, Mostafa] Alborz Univ Med Sci, Non Communicable Dis Res Ctr, Karaj, Iran; [Radfar, Amir] Medichem, Barcelona, Spain; [Rafay, Anwar] Contech Sch Publ Hlth, Dept Epidemiol & Biostat, Lahore, Pakistan; [Rahman, Mahfuzar] Brac Univ, Res & Evaluat Div, Dhaka, Bangladesh; [Rahman, Mahfuzar; Ram, Usha] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Ranta, Anna] Capital & Coast Dist Hlth Board, Dept Neurol, Wellington, New Zealand; [Rawaf, David Laith] Univ Coll London Hosp, London, England; [Rawaf, Salman] Publ Hlth England, London, England; [Reis, Cesar] Loma Linda Univ, Med Ctr, Dept Prevent Med & Occupat Med, Loma Linda, CA USA; [Renzaho, Andre M. N.] Univ Western Sydney, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Resnikoff, Serge] Brien Holden Vision Inst, Sydney, NSW, Australia; [Resnikoff, Serge] Org Prevent Blindness, Paris, France; [Gonzalez, Carlos Miguel Rios] Nihon Gakko Univ, Res Directorate, Fernando De La Mora, Paraguay; [Roever, Leonardo] Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil; [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Golestan, Iran; [Sachdev, Perminder S.] Univ New South Wales, Sch Psychiat, Kensington, NSW, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Saddik, Basema] Univ Sharjah, Dept Med, Sharjah, U Arab Emirates; [Sahathevan, Ramesh] Ballarat Hlth Serv, Internal Med Serv, Ballarat, Vic, Australia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran; [Salamati, Payman] York Univ, Sch Hlth & Policy Management, Fac Hlth, Toronto, ON, Canada; [Zahabi, Saleh Salehi] Taleghani Hosp, Kermanshah, Iran; [Samy, Abdallah M.] Ain Shams Univ, Dept Entomol, Cairo, Egypt; [Sanabria, Juan] Marshall Univ, Dept Surg, Huntington, WV USA; [Sanabria, Juan] Case Western Reserve Univ, Dept Nutr & Prevent Med, Cleveland, OH 44106 USA; [Sarrafzadegan, Nizal] Isfahan Univ Med Sci, Cardiovasc Res Inst, Esfahan, Iran; [Sathian, Brijesh] Hamad Med Corp, Dept Surg, Doha, Qatar; [Sathian, Brijesh] Bournemouth Univ, Fac Hlth & Social Sci, Bournemouth, Dorset, England; [Satpathy, Maheswar] Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, Odisha, India; [Satpathy, Maheswar] Udyam Global Assoc Sustainable Dev, Bhubaneswar, Odisha, India; [Sawant, Arundhati R.] Dr DY Patil Vidyapeeth, Pune, Maharashtra, India; [Sawhney, Monika] Univ N Carolina, Dept Publ Hlth Sci, Charlotte, NC USA; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Sch Hlth Sci, Ararangua, Brazil; [Schottker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Shafieesabet, Azadeh] NYU, Langone Med Ctr, New York, NY USA; [Shams-Beyranvand, Mehran] Dezful Univ Med Sci, Sch Med, Dezful, Iran; [Sharif, Mehdi] Islamic Azad Univ, Dept Lab Sci, Sari, Iran; [Sharif, Mehdi] Islamic Azad Univ, Dept Basic Sci, Sari, Iran; [She, Jun] Fudan Univ, Dept Pulm Med, Shanghai, Peoples R China; [Sheth, Kevin N.] Yale Univ, Dept Neurol, New Haven, CT USA; [Shigematsu, Mika] Natl Inst Infect Dis, Tokyo, Japan; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Siabani, Soraya] Univ Technol Sydney, Sch Hlth, Sydney, NSW, Australia; [Siddiqi, Tariq J.; Usman, Muhammad Shariq] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan; [Sigfusdottir, Inga Dora; Sigurvinsdottir, Rannveig] Reykjavik Univ, Dept Psychol, Reykjavik, Iceland; [Sigfusdottir, Inga Dora] Columbia Univ, Dept Hlth & Behav Studies, New York, NY USA; [Silberberg, Donald H.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Weiss, Jordan] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Silveira, Dayane Gabriele Alves] Brasilia Univ, Brasilia, DF, Brazil; [Silveira, Dayane Gabriele Alves] Fed Minist Hlth, Dept Hlth Ind Complex & Innovat Hlth, Brasilia, DF, Brazil; [Sinha, Dhirendra Narain] Sch Prevent Oncol, Dept Epidemiol, Patna, Bihar, India; [Sinha, Dhirendra Narain] Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India; [Sobhani, Soheila] King Khalid Univ Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Soyiri, Ireneous N.] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Sposato, Luciano A.] Univ Western Ontario, Clin Neurol Sci, London, ON, Canada; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Valencia, Spain; [Tortajada-Girbes, Miguel] Univ Valencia, Dept Pediat Obstet & Gynecol, Valencia, Spain; [Tabares-Seisdedos, Rafael] Carlos III Hlth Inst, Biomed Res Networking Ctr Mental Hlth Network CIB, Madrid, Spain; [Thakur, Jarnail Singh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Topor-Madry, Roman] Jagiellonian Univ, Inst Publ Hlth, Coll Med, Krakow, Poland; [Topor-Madry, Roman] Agcy Hlth Technol Assessment & Tariff Syst, Warsaw, Poland; [Tortajada-Girbes, Miguel] Univ Hosp Doctor Peset, Dept Pediat, Valencia, Spain; [Tran, Bach Xuan] Hanoi Med Univ, Dept Hlth Econ, Hanoi, Vietnam; [Tran, Khanh Bao] Mil Med Univ, Clin Hematol & Toxicol, Hanoi, Vietnam; [Car, Lorainne Tudor] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Ullah, Irfan] Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan, Pakistan; [Ullah, Irfan] Mufti Mehmood Mem Teaching Hosp, TB Culture Lab, Dera Ismail Khan, Pakistan; [Valdez, Pascual R.] Argentine Soc Med, Buenos Aires, DF, Argentina; [Valdez, Pascual R.] Velez Sarsfield Hosp, Buenos Aires, DF, Argentina; [Vasankari, Tommi Juhani] UKK Inst, Tampere, Finland; [Vasanthan, Rajagopalan] Oxford Coll Physiotherapy, Dept Neurophysiotherapy, Bangalore, Karnataka, India; [Veisani, Yousef] Ilam Univ Med Sci, Psychosocial Injuries Res Ctr, Ilam, Iran; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Venketasubramanian, Narayanaswamy] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Violante, Francesco S.] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Violante, Francesco S.] Santorsola Malpighi Hosp, Occupat Hlth Unit, Bologna, Italy; [Vlassov, Vasily] Natl Res Univ Higher Sch Econ, Dept Hlth Care Adm & Econ, Moscow, Russia; [Waheed, Yasir] Fdn Univ Med Coll, Fdn Univ, Rawalpindi, Pakistan; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Winkler, Andrea Sylvia] Tech Univ Munich, Dept Neurol, Munich, Germany; [Wiysonge, Charles Shey] Med Res Council South Africa, Cochrane South Africa, Cape Town, South Africa; [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Biomed Res Council, London, England; [Xu, Gelin] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yamada, Tomohide] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan; [Yano, Yuichiro] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Yatsuya, Hiroshi] Fujita Hlth Univ, Dept Publ Hlth, Toyoake, Aichi, Japan; [Yatsuya, Hiroshi] Nagoya Univ, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Psychopharmacol, Tokyo, Japan; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Hubei, Peoples R China; [Zhang, Yunquan] Wuhan Univ, Dept Prevent Med, Wuhan, Hubei, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Zaidi, Zoubida] Univ Hosp Setif, Dept Epidemiol, Setif, Algeria; [Zandian, Hamed] Ardebil Univ Med Sci, Social Determinants Hlth Res Ctr, Ardebil, Iran	Feigin, VL (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland 0627, New Zealand.	valery.feigin@aut.ac.nz	Igumbor, Ehimario U/B-2652-2012; Sachdev, Perminder/ABC-1137-2020; Truelsen, Thomas/AAY-1549-2020; Alahdab, Fares/N-6680-2013; Lorkowski, Stefan/B-9689-2008; Car, Mate/F-2184-2017; Al-Eyadhy, Ayman/AAQ-1411-2021; Musa, Kamarul Imran/N-3198-2015; Barboza, Miguel/AAU-2368-2020; Kisa, Adnan/AAA-6824-2021; Grosso, Giuseppe/K-6730-2016; Tehrani-Banihashemi, Arash/L-5964-2018; Ahmed, Muktar/AAY-6783-2020; Defo, Barthelemy Kuate/I-4818-2017; Temsah, Mohamad-Hani/AAJ-9703-2020; Endries, Aman Yesuf/AAN-6871-2021; Acharya, Dilaram/AAD-9825-2020; KIM, YUN JIN/AAE-8281-2019; Catala-Lopez, Ferran/N-6018-2018; aleyadhy, ayman/AAP-8396-2021; shirkoohi, reza/AAD-8261-2020; Hamadeh, Randah R./AAE-9720-2020; Shafieesabet, Azadeh/AAE-6860-2019; Ullah, Irfan/L-5150-2017; Naderi, Mehdi/K-2681-2019; Akinyemi, Rufus/X-2370-2019; Nagel, Gabriele/C-3635-2012; Altirkawi, Khalid A/D-7302-2017; Zhang, Yunquan/M-9828-2017; Feigin, Valery/AAF-2313-2019; Koyanagi, Ai/D-3833-2018; Samy, Abdallah/B-4375-2010; Yisma, Engida/ABA-4170-2020; Lopez, Jaifred Christian/P-2746-2019; Mondello, Stefania/A-1813-2012; Wiysonge, Charles/AAF-2845-2019; Roshandel, Gholamreza/AAJ-9562-2021; Bhattacharyya, Krittika/AAA-8258-2021; Banach, Maciej/A-1271-2009; Rad, Enayatollah Homaie/G-5567-2015; Mousavi, Seyyed Meysam/P-7797-2015; Sahebkar, Amirhossein/B-5124-2018; Tran, Khanh/A-2437-2019; Feyissa, Garumma/AAP-9097-2020; Aljunid, Syed/J-6009-2014; Butt, Zahid Ahmad/W-4292-2017; Manafi, Navid/AAM-7393-2020; Hassen, Hamid Y./K-6445-2019; Mohammadnia-Afrouzi, Mousa/I-6160-2015; Vaidhiyalingam, Prakash/AAF-4372-2020; Ilesanmi, Olayinka/AAF-8628-2021; Pakpour, Amir/C-6160-2014; Jakovljevic, Mihajlo B/B-3002-2014; Bijani, Ali/B-1718-2017; Szoeke, CAssandra/AAE-8715-2019; Gill, Tiffany/F-9042-2010; Adebayo, Oladimeji/Y-5260-2019; T., Olagunju Andrew/B-4746-2017; Sposato, Luciano A/D-7782-2012; Sagar, Rajesh/L-7775-2016; Kasaeian, Amir/C-8290-2017; Weiderpass, Elisabete/AAP-2747-2021; Khader, Yousef/AAE-9620-2019; Meier, Toni/AAB-1704-2021; Topor-Madry, Roman/ABF-5449-2020; Rajagopalan, Vasanthan/G-8733-2015; Singh, Jasvinder/R-6172-2019; Sawant, Arundhati/ABE-1360-2020; Negoi, Ionut/A-9039-2012; Mohammed, Shafiu/P-2016-2014; Gnedovskaya, Elena V/C-1891-2012; moradinazar, mehdi/N-2129-2017; Linn, Shai/N-3079-2019; MHS, Leonardo Roever/F-5315-2012; Hankey, Graeme J/H-4968-2014; Radfar, Amir/I-8057-2019; Mantovani, Lorenzo Giovanni/AAC-4263-2021; Oren, Eyal/AAD-5561-2019; Olivares, Pedro R/C-6287-2008; Giussani, Giorgia/E-8057-2017; Rahman, Muhammad Aziz/B-3380-2009; Meles, Hagazi Gebre/AAM-5772-2020; Brayne, Carol/AAA-4285-2020; Bin Sayeed, Muhammad Shahdaat/M-7055-2014; Prakash, Swayam/ABB-6036-2020; Antonio, Carl Abelardo/AAP-4280-2020; Cerin, Ester/L-1271-2015; Carvalho, Felix/D-4914-2013; Naohiro, Yonemoto/Y-3761-2019; Geremew, Demeke/ABE-5034-2020; Yimer, Ebrahim M./N-4597-2018; Goulart, Alessandra C/J-2845-2014; Stein, Dan J/A-1752-2008; Oh, In Hwan/AAI-9070-2020; Giussani, Giorgia/AAA-8029-2020; Polanczyk, Guilherme V/C-2345-2012; Salamati, Payman/AAK-7086-2020; Szoeke, Cassandra/AAI-8631-2021; Beghi, Ettore/AAA-7426-2020; Jozwiak, Jacek/AAN-6351-2020; El-Baz, Ayman/AAC-6689-2019; Salimi, Yahya/V-2626-2017; Kefale, Belayneh/AAK-7367-2020; Kefale, Adane Teshome/AAP-6928-2020; Usman, Muhammad/AAH-1076-2020; Safiri, Saeid/A-1678-2017; Safi, Sare/AAW-4651-2020; Haro, Josep Maria/D-1423-2011; KISA, ADNAN/Q-2081-2019; Polanczyk, Guilherme V./AAF-6142-2021; de la cruz, vanessa/AAH-5999-2020; Arnlov, Johan/AAF-2746-2019; Anber, Nahla/AAM-9830-2021; Abdelalim, Ahmed/A-6051-2015; Grosso, Giuseppe/ABA-1587-2020; Rajati, Fatemeh/S-1041-2017; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Onwujekwe, Obinna/O-6232-2014; Dubljanin, Eleonora/AAW-6278-2020; Waheed, Yasir/AAC-3896-2019; Sathian, Brijesh/G-7576-2014; Afarideh, Mohsen/H-8945-2019; Roberts, Nicholas/AAL-2040-2021; Massenburg, Benjamin B./AAB-9349-2019; Mirrakhimov, Erkin/E-6900-2017; Arabloo, Jalal/K-1829-2019; Cerin, Ester/Z-2011-2019; Adsuar, Jose C/R-1333-2019; Mohammed, Shafiu/AAR-7889-2020; Costa, Vera Marisa/D-6284-2013; Chatziralli, Irini/AAG-4779-2020; Newton, Charles RJC/B-7578-2014; MARIN, Benoit/E-2356-2015; Pandian, Jeyaraj Durai/AAV-5591-2020; KANCHAN, TANUJ/L-8547-2015; Miazgowski, Tomasz/H-9448-2014; Diaz, Daniel/P-1916-2018; Siddiqi, Tariq/AAH-1034-2020; Shams, Mehran/S-2695-2017; Alvis-Guzman, Nelson/D-4913-2013; Silva, Joao P/E-8444-2012; Hay, Simon I/F-8967-2015; Safari, Hosein/AAA-4970-2019; moosazadeh, mahmood/F-3730-2017; Moradi, Ghobad/R-1267-2016; Violante, Francesco S/A-6934-2009; Monasta, Lorenzo/B-1388-2012; Gonzalez, Carlos Miguel Rios/AAD-4669-2019; Jha, Ravi Prakash/ABC-6588-2020; Sacco, Ralph/Y-9278-2019; Kamyari, Naser/AAP-1999-2021; Fisher, James L./N-3935-2019; نِیسی, محمود عُبِیدی/AAL-4864-2020; Cortesi, Paolo Angelo/AAD-7926-2020; Niguse, Haftom/AAF-8975-2020; Irvani, Seyed Sina Naghibi/O-2413-2018; Haj-Mirzaian, Arvin/W-6013-2019; Barnighausen, Till/Y-2388-2019; Daryani, Ahmad/E-2186-2017; Geleijnse, Johanna Marianna M/B-5749-2012; Karami, Manoochehr/E-5030-2012; Car, Lorainne Tudor/E-1205-2017; Schneider, Ione J.C./J-8762-2013; Saddik, Basema/H-5679-2019; Piradov, Michael A/B-4407-2012; McGrath, John J/G-5493-2010; Aboyans, Victor/AAN-8308-2020; Ram, Usha/AAS-4140-2020; Wang, Yuan Pang/A-4863-2008; Ningrum, Dina Nur Anggraini/ABA-1698-2020; Palone, Marcos Roberto Tovani/J-6491-2014; Bekele, Bayu Begashaw/R-9348-2017; Kumar, Manasi/AAI-9488-2020; rahim, fakher/AAC-3905-2019; Atalay, Hagos Tasew/O-2286-2016; Elbaz, Alexis/F-8952-2017; Asghar, Rana Jawad/AAF-7634-2021; Renzaho, Andre M.N./AAH-7679-2021; Schottker, Ben/F-8183-2014; Stokes, Mark A/P-8937-2017; Faro, Andre/J-1696-2014; Aremu, Olatunde/AAD-1995-2019; Awasthi, Ashish/Y-5915-2019; Wijeratne, Tissa/I-2086-2019; Safari-Faramani, Roya/C-7344-2018; Soofi, Moslem/E-7665-2019; Grada, Ayman/N-3691-2013; Fatima, Batool/P-9987-2015; Uthman, Olalekan/P-7916-2014; Yaseri, Mehdi/I-1645-2018; Satpathy, Maheswar/J-3135-2017; Fernandes, Eduarda/D-4943-2013; Alene, Kefyalew Addis/V-8240-2018; Rezaeian, Shahab/G-7482-2011; Behzadifar, Masoud/H-1433-2016; Jurisson, Mikk/M-1360-2017; Khafaie, Morteza Abdullatif/J-5659-2016; El-Khatib, Ziad/B-5161-2017; Demoz, Gebre Teklemariam/K-6986-2019; Lunevicius, Raimundas/B-2528-2018; yadollahpour, ali/K-9098-2015; Shamsizadeh, Morteza/C-6000-2014; Naderi, Mehdi/R-4325-2017; Abdollapour, Ibrahim/M-9329-2017; Zamani, Mohammad/A-7733-2016; Pereira, David/M-9286-2013; Thrift, Amanda/I-6251-2012; Zandian, Hamed/J-9351-2017; Soyiri, Ireneous/H-4594-2011; Ukwaja, Kingsley N./A-7794-2013; Karch, Andre/D-6973-2017; Carvalho Malta, Deborah/H-7880-2012	Igumbor, Ehimario U/0000-0002-6313-6031; Sachdev, Perminder/0000-0002-9595-3220; Alahdab, Fares/0000-0001-5481-696X; Lorkowski, Stefan/0000-0002-9649-840X; Car, Mate/0000-0002-7005-0500; Al-Eyadhy, Ayman/0000-0002-6051-9125; Musa, Kamarul Imran/0000-0002-3708-0628; Barboza, Miguel/0000-0002-1037-962X; Kisa, Adnan/0000-0001-7825-3436; Grosso, Giuseppe/0000-0003-3930-5285; Ahmed, Muktar/0000-0002-9524-7027; Defo, Barthelemy Kuate/0000-0002-6589-0564; KIM, YUN JIN/0000-0001-8853-6587; Catala-Lopez, Ferran/0000-0002-3833-9312; Hamadeh, Randah R./0000-0002-4205-1354; Nagel, Gabriele/0000-0001-6185-8535; Altirkawi, Khalid A/0000-0002-7331-4196; Zhang, Yunquan/0000-0002-2618-5088; Koyanagi, Ai/0000-0002-9565-5004; Samy, Abdallah/0000-0003-3978-1134; Yisma, Engida/0000-0003-0703-1515; Lopez, Jaifred Christian/0000-0002-8273-992X; Mondello, Stefania/0000-0002-8587-3614; Wiysonge, Charles/0000-0002-1273-4779; Roshandel, Gholamreza/0000-0002-5494-0722; Bhattacharyya, Krittika/0000-0002-9914-7031; Banach, Maciej/0000-0001-6690-6874; Rad, Enayatollah Homaie/0000-0002-9064-0380; Mousavi, Seyyed Meysam/0000-0002-6795-7224; Tran, Khanh/0000-0002-8730-3340; Feyissa, Garumma/0000-0001-6179-0024; Aljunid, Syed/0000-0002-0380-1335; Butt, Zahid Ahmad/0000-0002-2486-4781; Manafi, Navid/0000-0002-4610-402X; Hassen, Hamid Y./0000-0001-6485-4193; Mohammadnia-Afrouzi, Mousa/0000-0003-2083-7425; Ilesanmi, Olayinka/0000-0003-0827-6442; Pakpour, Amir/0000-0002-8798-5345; Jakovljevic, Mihajlo B/0000-0002-9160-6846; Bijani, Ali/0000-0003-2233-8726; Gill, Tiffany/0000-0002-2822-2436; Adebayo, Oladimeji/0000-0001-7096-4460; T., Olagunju Andrew/0000-0003-1736-9886; Sposato, Luciano A/0000-0001-6425-9343; Kasaeian, Amir/0000-0003-2018-9368; Weiderpass, Elisabete/0000-0003-2237-0128; Khader, Yousef/0000-0002-7830-6857; Meier, Toni/0000-0001-6056-0665; Rajagopalan, Vasanthan/0000-0002-7524-8487; Singh, Jasvinder/0000-0003-3485-0006; Negoi, Ionut/0000-0002-6950-9599; Mohammed, Shafiu/0000-0001-5715-966X; moradinazar, mehdi/0000-0001-7033-6755; Linn, Shai/0000-0002-0867-2958; MHS, Leonardo Roever/0000-0002-7517-5548; Hankey, Graeme J/0000-0002-6044-7328; Radfar, Amir/0000-0001-6177-3048; Olivares, Pedro R/0000-0001-7371-343X; Giussani, Giorgia/0000-0003-2460-3095; Rahman, Muhammad Aziz/0000-0003-1665-7966; Meles, Hagazi Gebre/0000-0001-5773-4011; Brayne, Carol/0000-0001-5307-663X; Bin Sayeed, Muhammad Shahdaat/0000-0003-0027-9614; Antonio, Carl Abelardo/0000-0001-7476-0553; Cerin, Ester/0000-0002-7599-165X; Carvalho, Felix/0000-0003-3858-3494; Geremew, Demeke/0000-0001-8493-1512; Yimer, Ebrahim M./0000-0003-3140-4967; Goulart, Alessandra C/0000-0003-1076-5210; Stein, Dan J/0000-0001-7218-7810; Oh, In Hwan/0000-0002-5450-9887; Giussani, Giorgia/0000-0003-2460-3095; Polanczyk, Guilherme V/0000-0003-2311-3289; Salamati, Payman/0000-0001-9313-3977; Szoeke, Cassandra/0000-0002-3698-2590; Beghi, Ettore/0000-0003-2542-0469; Jozwiak, Jacek/0000-0002-2645-7274; El-Baz, Ayman/0000-0001-7264-1323; Salimi, Yahya/0000-0001-9351-3208; Kefale, Adane Teshome/0000-0001-7254-4435; Usman, Muhammad/0000-0001-9747-8892; Safiri, Saeid/0000-0001-7986-9072; Haro, Josep Maria/0000-0002-3984-277X; Polanczyk, Guilherme V./0000-0003-2311-3289; Arnlov, Johan/0000-0002-6933-4637; Anber, Nahla/0000-0001-5684-9298; Abdelalim, Ahmed/0000-0001-6445-5539; Grosso, Giuseppe/0000-0003-3930-5285; Rajati, Fatemeh/0000-0001-6426-664X; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Onwujekwe, Obinna/0000-0002-1214-4285; Waheed, Yasir/0000-0002-5789-4215; Sathian, Brijesh/0000-0003-0851-4762; Afarideh, Mohsen/0000-0002-3578-5640; Roberts, Nicholas/0000-0001-7238-8559; Massenburg, Benjamin B./0000-0002-8570-5178; Mirrakhimov, Erkin/0000-0003-2982-6108; Arabloo, Jalal/0000-0003-1223-4528; Cerin, Ester/0000-0002-7599-165X; Adsuar, Jose C/0000-0001-7203-3168; Mohammed, Shafiu/0000-0001-5715-966X; Costa, Vera Marisa/0000-0002-0471-2756; Chatziralli, Irini/0000-0001-8523-1024; Newton, Charles RJC/0000-0002-6999-5507; KANCHAN, TANUJ/0000-0003-0346-1075; Miazgowski, Tomasz/0000-0002-4819-9376; Diaz, Daniel/0000-0003-2302-1982; Shams, Mehran/0000-0001-9474-0955; Alvis-Guzman, Nelson/0000-0001-9458-864X; Silva, Joao P/0000-0002-5656-0897; Hay, Simon I/0000-0002-0611-7272; Safari, Hosein/0000-0003-3477-6344; moosazadeh, mahmood/0000-0002-5452-514X; Moradi, Ghobad/0000-0003-2612-6528; Violante, Francesco S/0000-0003-4084-2782; Monasta, Lorenzo/0000-0001-7774-548X; Gonzalez, Carlos Miguel Rios/0000-0001-7558-8206; Jha, Ravi Prakash/0000-0001-5230-1436; Kamyari, Naser/0000-0002-5209-8324; Fisher, James L./0000-0003-3211-2691; نِیسی, محمود عُبِیدی/0000-0002-6030-4124; Irvani, Seyed Sina Naghibi/0000-0002-4566-7402; Haj-Mirzaian, Arvin/0000-0001-8977-6865; Daryani, Ahmad/0000-0001-8571-5803; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Karami, Manoochehr/0000-0002-9026-3757; Car, Lorainne Tudor/0000-0001-8414-7664; Schneider, Ione J.C./0000-0001-6339-7832; Piradov, Michael A/0000-0002-6338-0392; McGrath, John J/0000-0002-4792-6068; Ram, Usha/0000-0001-6722-7347; Wang, Yuan Pang/0000-0001-7076-8312; Palone, Marcos Roberto Tovani/0000-0003-1149-2437; Bekele, Bayu Begashaw/0000-0001-8590-4874; rahim, fakher/0000-0002-2857-4562; Atalay, Hagos Tasew/0000-0002-0886-815X; Elbaz, Alexis/0000-0001-9724-5490; Schottker, Ben/0000-0002-1217-4521; Stokes, Mark A/0000-0001-6488-4544; Faro, Andre/0000-0002-7348-6297; Aremu, Olatunde/0000-0002-5832-2403; Awasthi, Ashish/0000-0002-9308-9782; Wijeratne, Tissa/0000-0002-1701-7111; Te Ao, Braden/0000-0002-1050-200X; Safari-Faramani, Roya/0000-0002-5379-572X; Bejot, Yannick/0000-0001-7848-7072; Degefa, Meaza/0000-0003-0175-6937; Soofi, Moslem/0000-0003-4922-8412; Grada, Ayman/0000-0002-5321-0584; Fatima, Batool/0000-0002-7079-8121; Saddik, Basema/0000-0002-4682-5927; /0000-0001-5266-0201; Sufiyan, Muawiyyah Babale/0000-0003-3630-6995; Kumar, Manasi/0000-0002-9773-8014; Farzadfar, Farshad/0000-0001-8288-4046; Olagunju, Tinuke/0000-0003-4019-8755; Meretoja, Tuomo/0000-0002-2691-0710; Feigin, Valery L./0000-0002-6372-1740; Uthman, Olalekan/0000-0002-8567-3081; Yaseri, Mehdi/0000-0002-4066-873X; Satpathy, Maheswar/0000-0003-3521-4781; Fernandes, Eduarda/0000-0001-6424-0976; Postma, Maarten/0000-0002-6306-3653; /0000-0002-4565-5364; Campos, Ismael/0000-0001-5939-3396; Alene, Kefyalew Addis/0000-0002-1904-4682; siabani, soraya/0000-0003-2856-0205; Piccininni, Marco/0000-0002-1397-0060; Moazen, Babak/0000-0002-2552-0438; Rezaeian, Shahab/0000-0002-5094-5315; Hamidi, Samer/0000-0002-6766-3728; Behzadifar, Masoud/0000-0002-0271-4360; Jurisson, Mikk/0000-0002-4487-7045; Shiri, Rahman/0000-0002-9312-3100; Deribe, Kebede/0000-0002-8526-6996; Ranta, Annemarei/0000-0002-3223-3330; Khafaie, Morteza Abdullatif/0000-0002-1651-3017; Dubljanin, Eleonora/0000-0002-6484-3192; El-Khatib, Ziad/0000-0003-0756-7280; RENZAHO, ANDRE/0000-0002-6844-0833; Moodley, Yoshan/0000-0002-4119-1734; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Kim, Young-Eun/0000-0003-0694-6844; Filip, Irina/0000-0002-2466-2346; Mohajer, Bahram/0000-0001-6398-8448; Noubiap, Jean Jacques/0000-0002-7722-9757; Prakash, Swayam/0000-0003-3986-890X; De la Cruz-Gongora, Vanessa/0000-0002-0408-6580; Kim, Daniel/0000-0001-8907-6420; Berhane, Adugnaw/0000-0003-2160-958X; Cooper, Cyrus/0000-0003-3510-0709; Demoz, Gebre Teklemariam/0000-0002-2534-821X; Lunevicius, Raimundas/0000-0003-3295-0142; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Oren, Eyal/0000-0001-7817-3516; yadollahpour, ali/0000-0002-1216-2109; Shamsizadeh, Morteza/0000-0002-8153-5482; Naderi, Mehdi/0000-0002-5608-6582; Abdollapour, Ibrahim/0000-0002-8607-4507; Kalkonde, Yogeshwar/0000-0003-3543-3618; Zamani, Mohammad/0000-0003-1916-3873; Pereira, David/0000-0003-0384-7592; Zaman, Sojib Bin/0000-0002-3043-7954; Esteghamati, Alireza/0000-0001-5114-3982; Thrift, Amanda/0000-0001-8533-4170; Sheikh, Aziz/0000-0001-7022-3056; Li, Shanshan/0000-0002-9021-8470; Akinyemi, Rufus/0000-0001-5286-428X; Majeed, Azeem/0000-0002-2357-9858; Gebremeskel, Afewerki/0000-0001-5818-3434; Ayala Quintanilla, Beatriz Paulina/0000-0002-2630-4569; Zandian, Hamed/0000-0002-1284-5823; Soyiri, Ireneous/0000-0003-4697-5156; Miller, Ted/0000-0002-0958-2639; Ukwaja, Kingsley N./0000-0002-1974-8735; Naheed, Aliya/0000-0002-6016-5603; Karch, Andre/0000-0003-3014-8543; Cortesi, Paolo Angelo/0000-0001-5241-4473; Carvalho Malta, Deborah/0000-0002-8214-5734; Mashamba-Thompson, Tivani/0000-0002-4193-2416; , Tariq/0000-0002-9672-6628; Mohebi, Farnam/0000-0002-6181-2008; Tabares-Seisdedos, Rafael/0000-0002-1089-2204; Bekele, Abate/0000-0003-2583-9913; CHANG, JUNG-CHEN/0000-0001-8651-2602	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HG010273]; International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia; Department of Health Policy and Management, Faculty of Public Health, Kuwait University; Department of Science and Technology, Government of India, New Delhi, through INSPIRE Faculty scheme; Institute of Medical Research and Medicinal Plant Studies; Public Health Agency of Canada; Alexander von Humboldt Foundation through the Alexander von Humboldt Professor Award - Federal Ministry of Education and ResearchAlexander von Humboldt Foundation; Australian GovernmentAustralian GovernmentCGIAR; Swedish Heart and Lung FoundationSwedish Heart-Lung Foundation; European Union (FEDER funds)European Commission [POCI/01/0145/FEDER/007728, POCI/01/0145/FEDER/007265]; National Funds (FCT/MEC, Fundacao para a Ciencia e a Tecnologia and Ministerio da Educacao e Ciencia) [PT2020 UID/MULTI/04378/2013, PT2020UID/QUI/50006/2013]; Australian Research CouncilAustralian Research Council [FT3 140100085]; Wellcome TrustWellcome TrustEuropean Commission [201900]; Institute for Physical Activity and Nutrition (IPAN), Deakin University; High Blood Pressure Research Council of Australia; Office of Research and Innovation at Xiamen University Malaysia; National Institute for Health Research (NIHR) Oxford Biomedical Research CentreNational Institute for Health Research (NIHR); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS086484]; German Federal Ministry of Education and Research (nutriCARD) [01EA1411A]; National Health and Medical Research Council (NHMRC) of Australia Senior Research FellowshipNational Health and Medical Research Council of Australia; NW London NIHR Collaboration for Leadership in Applied Health Research and Care; Danish National Research FoundationDanmarks Grundforskningsfond; NHMRCNational Health and Medical Research Council of Australia [APP1056929]; Sistema Nacional de Investigacion (Panama); SIREN grant [U54 U54HG007479]; SIBS Genomics grant [R01NS107900]; Egyptian Fulbright Mission Program; Ministry of Education, Science and Technological Development, Republic of Serbia [175087]; Health Data Research UK; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH U01 NS086090]; United States Department of DefenseUnited States Department of Defense [DoD W81XWH-14-2-0176]; Generalitat ValencianaGeneralitat ValencianaEuropean Commission [PROMETEOII/2015/021]; ISCIIIFEDER [PI17/00719]; NHMRC (Australia)National Health and Medical Research Council of Australia [1042600]; Maurice Wilkins Centre for Biodiscovery; Cancer Society of New Zealand; Health Research Council; Gut Cancer Foundation; University of Auckland; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81773552]; Chinese NSFC International Cooperation and Exchange Program [71661167007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007242] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K43TW010716] Funding Source: NIH RePORTER	ROA is funded by the National Institutes of Health (U01HG010273). SMA acknowledges the International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia and Department of Health Policy and Management, Faculty of Public Health, Kuwait University for the approval and support to participate in this research project. AAw acknowledges funding support from Department of Science and Technology, Government of India, New Delhi, through INSPIRE Faculty scheme. TBA acknowledges partial funding from the Institute of Medical Research and Medicinal Plant Studies. ABa is supported by the Public Health Agency of Canada. TWB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor Award, funded by the Federal Ministry of Education and Research. MSBS acknowledges support from the Australian Government Research and Training Program scholarship for a PhD degree at the Australian National University, Australia. JJC is supported by the Swedish Heart and Lung Foundation. FCar is supported by the European Union (FEDER funds POCI/01/0145/FEDER/007728 and POCI/01/0145/FEDER/007265) and National Funds (FCT/MEC, Fundacao para a Ciencia e a Tecnologia and Ministerio da Educacao e Ciencia) under the Partnership Agreements PT2020 UID/MULTI/04378/2013 and PT2020UID/QUI/50006/2013. EC is supported by an Australian Research Council Future Fellowship (FT3 140100085). KD is supported by a Wellcome Trust [Grant Number 201900] as part of his International Intermediate Fellowship. EF is supported by the European Union (FEDER funds POCI/01/0145/FEDER/007728 and POCI/01/0145/FEDER/007265) and National Funds (FCT/MEC, Fundacao para a Ciencia e a Tecnologia and Ministerio da Educacao e Ciencia) under the Partnership Agreements PT2020 UID/MULTI/04378/2013 and PT2020UID/QUI/50006/2013. SMSI is funded by the Institute for Physical Activity and Nutrition (IPAN), Deakin University and received funding from High Blood Pressure Research Council of Australia. YKa is a DBT/Wellcome Trust India Alliance Fellow in Public Health. YJK is supported by the Office of Research and Innovation at Xiamen University Malaysia. BL acknowledges funding from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. WDL is supported in part by U10NS086484 NINDS. SLo is funded by the German Federal Ministry of Education and Research (nutriCARD, grant agreement number 01EA1411A). RML is supported by a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship. AMa and the Imperial College London are grateful for support from the NW London NIHR Collaboration for Leadership in Applied Health Research and Care. JJM is supported by the Danish National Research Foundation (Niels Bohr Professorship), and the John Cade Fellowship (APP1056929) from NHMRC. TMei acknowledges additional institutional support from the Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD), Jena-Halle-Leipzig. IMV is supported by the Sistema Nacional de Investigacion (Panama). MOO is supported by SIREN U54 U54HG007479 and SIBS Genomics R01NS107900 grants. AMS was supported by a fellowship from the Egyptian Fulbright Mission Program. MMSM acknowledges the support from the Ministry of Education, Science and Technological Development, Republic of Serbia (contract no 175087). AShe is supported by Health Data Research UK.; MBS' work on traumatic brain injury is supported by grants NIH U01 NS086090 (PI G Manley) from the National Institutes of Health (NIH) and DoD W81XWH-14-2-0176 (PI G Manley) from the United States Department of Defense. RTS is supported in part by grant number PROMETEOII/2015/021 from Generalitat Valenciana and the national grant PI17/00719 from ISCIIIFEDER. AGT was supported by a Fellowship from the NHMRC (Australia; 1042600. KBT acknowledges funding supports from the Maurice Wilkins Centre for Biodiscovery, Cancer Society of New Zealand, Health Research Council, Gut Cancer Foundation, and the University of Auckland. CY acknowledges support from the National Natural Science Foundation of China (grant number 81773552) and the Chinese NSFC International Cooperation and Exchange Program (grant number 71661167007).	Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Feigin VL, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000306; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Irimia P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-94; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson CO, 2019, LANCET NEUROL, V18, P439, DOI 10.1016/S1474-4422(19)30034-1; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Narain Jai Prakash, 2016, Indian J Community Med, V41, P85, DOI 10.4103/0970-0218.177507; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Nyaaba GN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4199-6; Patel AP, 2019, LANCET NEUROL, V18, P376, DOI 10.1016/S1474-4422(18)30468-X; Ranta A, 2015, NEW ZEAL MED J, V128, P35; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30322-3; United Nations General Assembly, 2017, REPORT SECRETARY GEN; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	24	467	479	60	229	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2019	18	5					459	480		10.1016/S1474-4422(18)30499-X			22	Clinical Neurology	Neurosciences & Neurology	HS8SW	WOS:000464140400014	30879893	Green Published, Green Accepted, Other Gold	Y	Y	2021-06-18	
J	Bowie, CR; Harvey, PD				Bowie, Christopher R.; Harvey, Philip D.			Administration and interpretation of the trail making test	NATURE PROTOCOLS			English	Article							TRAUMATIC BRAIN-INJURY; TEST-B PERFORMANCE; EXECUTIVE FUNCTION; NEUROPSYCHOLOGICAL IMPAIRMENT; SCHIZOAFFECTIVE DISORDER; SCHIZOPHRENIC-PATIENTS; BIPOLAR DISORDER; VISUAL-SEARCH; PART-B; AGE	Measurement of cognitive functions is an increasingly important goal for clinicians and researchers. Many neuropsychological test batteries are comprehensive and require specialized training to administer and interpret. The Trail Making Test is an accessible neuropsychological instrument that provides the examiner with information on a wide range of cognitive skills and can be completed in 5 - 10 min. Its background, psychometric properties, administration procedures and interpretive guidelines are provided in this protocol.	Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Harvey, PD (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1425 Madison Ave, Box 1230, New York, NY 10029 USA.	philipdharvey1@cs.com					Abe Mitsuyo, 2004, No To Shinkei, V56, P567; Amieva H, 1998, J CLIN EXP NEUROPSYC, V20, P280, DOI 10.1076/jcen.20.2.280.1161; Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Borkowska A, 2002, PROG NEURO-PSYCHOPH, V26, P1349, DOI 10.1016/S0278-5846(02)00300-7; Borkowska A, 2001, BIPOLAR DISORD, V3, P88, DOI 10.1034/j.1399-5618.2001.030207.x; CHARTER RA, 1987, INT J CLIN NEUROPSYC, V9, P28; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.0.CO;2-K; DELIA L, 1989, TRAILS; DICKINSON D, IN PRESS ARCH GEN PS; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dugbartey AT, 2000, ARCH CLIN NEUROPSYCH, V15, P425, DOI 10.1016/S0887-6177(99)00034-7; Frazen MD, 1996, CLIN NEUROPSYCHOL, V10, P125; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gold JM, 2002, AM J PSYCHIAT, V159, P1395, DOI 10.1176/appi.ajp.159.8.1395; Harvey PD, 2003, INT J GERIATR PSYCH, V18, P820, DOI 10.1002/gps.929; Harvey PD, 2004, PSYCHOPHARMACOLOGY, V172, P324, DOI 10.1007/s00213-003-1652-2; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Keefe RSE, 2006, NEUROPSYCHOPHARMACOL, V31, P2033, DOI 10.1038/sj.npp.1301072; KLUSMAN LE, 1989, PERCEPT MOTOR SKILL, V68, P1199, DOI 10.2466/pms.1989.68.3c.1199; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; LoSasso GL, 1998, J CLIN EXP NEUROPSYC, V20, P107, DOI 10.1076/jcen.20.1.107.1487; Marshall GA, 2006, INT J GERIATR PSYCH, V21, P32, DOI 10.1002/gps.1419; Martinez-Aran A, 2002, PSYCHOTHER PSYCHOSOM, V71, P39, DOI 10.1159/000049342; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reitan RM, 1996, CLIN NEUROPSYCHOL, V10, P37, DOI 10.1080/13854049608406661; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Rybakowski JK, 2002, SCHIZOPHR RES, V54, P105, DOI 10.1016/S0920-9964(01)00357-7; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SPREEN O, 1998, COMPENDIUM NEUROSYPC; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Thompson MD, 1999, CLIN NEUROPSYCHOL, V13, P450, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT450; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Torrent C, 2006, BRIT J PSYCHIAT, V189, P254, DOI 10.1192/bjp.bp.105.017269; Uc EY, 2006, ANN NEUROL, V60, P407, DOI 10.1002/ana.20958; Wahlin TBR, 1996, ARCH GERONTOL GERIAT, V22, P87, DOI 10.1016/0167-4943(95)00681-8; WALDMANN BW, 1992, J CLIN PSYCHOL, V48, P360, DOI 10.1002/1097-4679(199205)48:3<360::AID-JCLP2270480314>3.0.CO;2-P; Warner TD, 2006, PEDIATRICS, V118, P2014, DOI 10.1542/peds.2006-0003; Wolfson D., 1993, HALSTEAD REITAN NEUR; Wolwer W, 2003, NEUROPSYCHOBIOLOGY, V48, P59, DOI 10.1159/000072878; Wolwer W, 2002, J PSYCHIATR RES, V36, P407, DOI 10.1016/S0022-3956(02)00050-X; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zimmerman ME, 2006, BIPOLAR DISORD, V8, P281, DOI 10.1111/j.1399-5618.2006.00298.x; 1994, AMRY INDIVIDUAL TEST	61	467	475	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.		2006	1	5					2277	2281		10.1038/nprot.2006.390			5	Biochemical Research Methods	Biochemistry & Molecular Biology	234IV	WOS:000251155600013	17406468				2021-06-18	
J	Rabin, LA; Barr, WB; Burton, LA				Rabin, LA; Barr, WB; Burton, LA			Assessment practices of clinical neuropsychologists in the United States and Canada: A survey of INS, NAN, and APA Division 40 members	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						test usage; current assessment practices; neuropsychology survey	PSYCHOLOGICAL TEST USAGE; FOLLOW-UP SURVEY; EDUCATIONAL BACKGROUNDS; PROFESSIONAL ACTIVITIES; PART I; INSTRUCTORS; CENTERS; TESTS	The present study surveyed assessment practices and test usage patterns among clinical neuropsychologists. Respondents were 747 North American, doctorate-level psychologists (40% usable response rate) affiliated with Division 40 of the American Psychological Association (APA), the National Academy of Neuropsychology (NAN), or the International Neuropsychological Society (INS). Respondents first provided basic demographic and practice-related information and reported their most frequently utilized instruments. Overall, the Wechsler Adult Intelligence Scales and Wechsler Memory Scales were most frequently used, followed by the Trail Making Test, California Verbal Learning Test, and Wechsler Intelligence Scale for Children. Respondents also reviewed a vignette about a traumatic brain injury patient, and then reported the instruments they would use to assess this patient's specific cognitive symptomatology, general cognitive ability, and capacity to return to work. Particular attention was paid to the areas of memory, attention, and executive functioning. The current study represents the largest and most comprehensive test usage survey conducted to date within the field of clinical neuropsychology. Survey results update and greatly expand knowledge about neuropsychologists' assessment practices. Following a review of findings, results are compared to those obtained in prior surveys and implications for the field of neuropsychology are discussed. (C) 2004 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, Dartmouth Med Sch, Lebanon, NH 03756 USA; NYU, Sch Med, Comprehens Epilepsy Ctr, New York, NY 10003 USA; Fordham Univ, Dept Psychol, Bronx, NY 10458 USA	Rabin, LA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, Dartmouth Med Sch, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Iaura.a.rabin@dartmouth.edu		Barr, William/0000-0001-7711-7758			*AM BOARD PROF PSY, 2001, CLIN NEUR DIPL DIR; Beck A.T., 1987, BECK DEPRESSION INVE; BECK AT, 1944, RORSCHACHS TEST, V1; BENDER L, 1946, INSTRUCTIONS USE VIS; Benton A, 1989, MULTILINGUAL APHASIA; BENTON AL, 1946, VISUAL RETENTION TES; Boyd T. A., 1988, ASSESSMENT ISSUES CH, P177; BROWN LB, 1999, THESIS SAINT LOUIS U, V60; BROWN WR, 1976, PROF PSYCHOL, V7, P475; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; *COMM CLIN SECT AM, 1935, PSYCHOL CLIN, V23, P23; Conners C. K., 1995, CONNERS CONTINUOUS P; CUBIC BA, 1996, ECOLOGICAL VALIDITY, P203; Darley JG, 1946, J CLIN PSYCHOL, V2, P109, DOI 10.1002/1097-4679(194604)2:2<109::AID-JCLP2270020204>3.0.CO;2-K; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J. W., 1989, CLIN NEUROPSYCHOL, V3, P3; DELUCA JW, 1993, PROF PSYCHOL-RES PR, V24, P100, DOI 10.1037/0735-7028.24.1.100; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; GOLDEN CJ, 1985, LURIANEBRASKA NEUROP; Graham FK, 1960, PERCEPT MOTOR SKILL, V11, P147, DOI DOI 10.2466/PMS.11.6.147-188; GRAHAM JR, 1990, MMPI2 ASSESSING PERS; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; Guilmette T. J., 1996, ECOLOGICAL VALIDITY, P387; GUILMETTE TJ, 1991, PROF PSYCHOL-RES PR, V22, P80, DOI 10.1037/0735-7028.22.1.80; Halstead WC, 1947, BRAIN INTELLIGENCE; HARTLAGE LC, 1980, INT J CLIN NEUROPSYC, V2, P200; Hathaway SR, 1951, MINNESOTA MULTIPHASI; Heaton R., 1993, WISCONSIN CARD SORTI; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Jastak S., 1941, WIDE RANGE ACHIEVEME; Jastak S, 1984, WIDE RANGE ACHIEVEME; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kaplan E, 1978, BOSTON NAMING TEST; Kerlinger F., 1973, FDN BEHAV RES; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; Lewis RF., 1979, MANUAL REPEATABLE CO; LOUTTIT CM, 1947, J CONSULT PSYCHOL, V11, P49, DOI 10.1037/h0056136; LUBIN B, 1971, PROF PSYCHOL, V2, P70, DOI 10.1037/h0031544; Matthews C, 1964, INSTRUCTION MANUAL A; MCCAFFREY RJ, 1985, PROF PSYCHOL-RES PR, V16, P236, DOI 10.1037/0735-7028.16.2.236; MCCAFFREY RJ, 1984, PROF PSYCHOL-RES PR, V15, P26, DOI 10.1037/0735-7028.15.1.26; McCaffrey RJ, 1996, ARCH CLIN NEUROPSYCH, V11, P11; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; Morgan CD, 1935, ARCH NEURO PSYCHIATR, V34, P289, DOI 10.1001/archneurpsyc.1935.02250200049005; *NAT SCI FDN, 1999, WOM MIN PERS DIS SCI; PIOTROWSKI C, 1978, PROF PSYCHOL, V9, P63, DOI 10.1037/0735-7028.9.1.63; Putnam S, 1990, CLIN NEUROPSYCHOL, V4, P199, DOI DOI 10.1080/13854049008401906; Putnam S., 1989, CLIN NEUROPSYCHOL, V3, P97; Putnam S. H., 1991, CLIN NEUROPSYCHOL, V5, P103, DOI [10.1080/13854049108403296, DOI 10.1080/13854049108403296]; PUTNAM SH, 1994, CLIN NEUROPSYCHOL, V8, P245; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ryan J J, 1990, Arch Clin Neuropsychol, V5, P69; SELL JM, 1979, PROF PSYCHOL, V10, P774; Seretny M L, 1986, Arch Clin Neuropsychol, V1, P5, DOI 10.1016/0887-6177(86)90021-1; SLAY DK, 1988, PROF PSYCHOL-RES PR, V19, P323; Strub RL, 1977, MENTAL STATUS EXAMIN; SUNDBERG ND, 1961, AM PSYCHOL, V16, P79, DOI 10.1037/h0040647; Sweet J., 1990, CLIN NEUROPSYCHOL, V4, P101, DOI DOI 10.1080/13854049008401504; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Sweet JJ, 1996, CLIN NEUROPSYCHOL, V10, P202, DOI 10.1080/13854049608406681; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Swenson WM, 1952, PERS PSYCHOL, V5, P19, DOI 10.1111/j.1744-6570.1952.tb00988.x; VANHUTTON V, 1993, THESOS U CALIFORNIA, V52; WADE TC, 1977, AM PSYCHOL, V32, P874, DOI 10.1037/0003-066X.32.10.874; WADE TC, 1978, J PERS ASSESS, V42, P3, DOI 10.1207/s15327752jpa4201_1; WADE TC, 1979, BEHAV THERAPIST, V2, P3; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D., 1991, WECHSLER INTELLIGENC; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WIENS AN, 1988, CLIN NEUROPSYCHOL, V2, P67, DOI DOI 10.1080/13854048808520087; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS	84	467	472	0	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2005	20	1					33	65		10.1016/j.acn.2004.02.005			33	Psychology, Clinical; Psychology	Psychology	886WI	WOS:000226263200003	15620813	Bronze			2021-06-18	
J	Robertson, CS; Valadka, AB; Hannay, J; Contant, CF; Gopinath, SP; Cormio, M; Uzura, M; Grossman, RG				Robertson, CS; Valadka, AB; Hannay, J; Contant, CF; Gopinath, SP; Cormio, M; Uzura, M; Grossman, RG			Prevention of secondary ischemic insults after severe head injury	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; severe head injury; secondary ischemic insults; jugular venous oxygen saturation monitoring; jugular venous desaturation; intracranial hypertension; cerebral perfusion pressure	CEREBRAL PERFUSION-PRESSURE; VENOUS OXYGEN-SATURATION; RESPIRATORY-DISTRESS-SYNDROME; BRAIN INJURY; JUGULAR BULB; BLOOD-FLOW; AUTOREGULATION; METABOLISM; MANAGEMENT; TRAUMA	Objective: The purpose of this study was to compare the effects of two acute-care management strategies on the frequency of jugular venous desaturation and refractory intracranial hypertension and on long-term neurologic outcome in patients with severe head injury. Design: Randomized clinical trial. Setting: Level I trauma hospital. Patients: One hundred eighty-nine adults admitted in coma because of severe head injury. Interventions: Patients were assigned to either cerebral blood Row (CBF)-targeted or intracranial pressure (ICP)-targeted management protocols during randomly assigned time blacks. In the CBF-targeted protocol, cerebral perfusion pressure was kept at >70 mm Hg and PaCO2 was kept at approximately 35 torr (4.67 kPa). In the ICP-targeted protocol, cerebral perfusion pressure was kept at >50 mm Hg and hyperventilation to a PaCO2 of 25-30 torr (3.33-4.00 kPa) was used to treat intracranial hypertension, Measurements and Main Results: The CBF-targeted protocol reduced the frequency of jugular desaturation from 50.6% to 30% (p = .006). Even when the frequency of jugular desaturation was adjusted for all confounding factors that were significant, the risk of cerebral ischemia was 2.4-fold greater with the ICP-targeted protocol. Despite the reduction in secondary ischemic insults, there was no difference in neurologic outcome. Failure to alter long-term neurologic outcome was probably attributable to two major factors. A law jugular venous oxygen saturation was treated in both groups, minimizing the injury that occurred in the ICP-targeted group, The beneficial effects of the CBF-targeted protocol may have been offset by a five-fold increase in the frequency of adult respiratory distress syndrome. Conclusions: Secondary ischemic insults caused by systemic factors after severe head injury can be prevented with a targeted management protocol. However, potential adverse effects of this management strategy may offset these beneficial effects.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX USA	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu		Hannay, H. Julia/0000-0001-7023-912X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616, P50NS027616] Funding Source: NIH RePORTER		BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CONTANT CF, 1993, J NEUROTRAUMA S1, V10, pS57; DeWitt D S, 1995, New Horiz, V3, P376; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Lam JMK, 1996, BRIT J NEUROSURG, V10, P357; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Marion D W, 1991, Neurosurg Clin N Am, V2, P411; MARION DW, 1993, J NEUROTRAUM, V10, pS102; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38	30	465	484	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	1999	27	10					2086	2095		10.1097/00003246-199910000-00002			10	Critical Care Medicine	General & Internal Medicine	250DT	WOS:000083374300002	10548187				2021-06-18	
J	MARMAROU, A; ANDERSON, RL; WARD, JD; CHOI, SC; YOUNG, HF; EISENBERG, HM; FOULKES, MA; MARSHALL, LF; JANE, JA				MARMAROU, A; ANDERSON, RL; WARD, JD; CHOI, SC; YOUNG, HF; EISENBERG, HM; FOULKES, MA; MARSHALL, LF; JANE, JA			IMPACT OF ICP INSTABILITY AND HYPOTENSION ON OUTCOME IN PATIENTS WITH SEVERE HEAD TRAUMA	JOURNAL OF NEUROSURGERY			English	Article						TRAUMATIC COMA DATA BANK; HEAD INJURY; COMA; OUTCOME; INTRACRANIAL PRESSURE; BLOOD PRESSURE	INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; AGGRESSIVE TREATMENT; INJURY; MANAGEMENT; PREDICTION; BRAIN	This study describes the relationship between raised intracranial pressure (ICP), hypotension, and outcome from severe head injury. The study is based on information derived from the Traumatic Coma Data Bank where ICP records from a relatively large number of patients were available to help delineate the major factors influencing outcome. From the total data base of 1030 patients, 428 met minimum monitoring duration criteria for inclusion in the present analysis. Outcome was classified according to the Glasgow Outcome Scale score determined at 6 months postinjury. Arrays of comparably defined summary measures describing the patient's course were considered for ICP, blood pressure (BP), central perfusion pressure, and therapy intensity level. For instance, the array of ICP summary descriptors included the proportion of ICP readings greater than x, for x = 0 to 80 mm Hg by increments of 5 mm Hg. A total of 187 candidate summary descriptors were considered. A stepwise ordinal logistic regression was used to select the subset of candidate summary descriptors that best explained the 6-month outcome. As established previously, age, admission motor score, and abnormal pupils were each highly significant in explaining outcome. Beyond these factors, the proportion of hourly ICP readings greater than 20 mm Hg was next selected and was also highly significant in explaining outcome (p < 0.0001). In addition to the ICP factor, the cutoff point of 20 mm Hg was selected by the procedure as most indicative of outcome. With these four factors modeled, the next selected factor was the proportion of hourly BP readings less than 80 mm Hg. Again, the BP factor was highly significant in explaining outcome (p < 0.0001). As with the ICP factor, the BP cutoff point of 80 mm Hg was objectively selected as most indicative of outcome. In summary, the incidence of mortality and morbidity resulting from severe head trauma is strongly related to raised ICP and hypotension measured during the course of ICP management. Moreover, these ICP and BP factors provide a better indication of outcome than the similarly defined factors of central perfusion pressure or therapy intensity level.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT BIOSTAT, RICHMOND, VA 23298 USA; UNIV TEXAS, MED BRANCH, DIV NEUROSURG, GALVESTON, TX 77550 USA; NINCDS, BIOMETRY & FIELD STUDIES BRANCH, BETHESDA, MD 20892 USA; UNIV CALIF SAN DIEGO, DIV NEUROL SURG, LA JOLLA, CA 92093 USA; UNIV VIRGINIA, MED CTR, SCH MED, DEPT NEUROSURG, CHARLOTTESVILLE, VA 22901 USA	MARMAROU, A (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, POB 508, MCV STN, RICHMOND, VA 23298 USA.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARTOLUCCI A A, 1977, Biometrical Journal, V19, P437, DOI 10.1002/bimj.4710190607; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHESTNUT RM, 1990, J NEUROSURG, V72, pA360; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GAAB MR, 1983, INTRACRANIAL PRESSUR, V5, P501; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1985, 10TH P ANN SAS US GR, P1031; JANNY P, 1972, INTRACRANIAL PRESSUR, P59; JENNETT B, 1975, LANCET, V1, P480; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MCGRAW CP, 1983, INTRACRANIAL PRESSUR, V5, P558; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NORDBY HK, 1985, ACTA NEUROCHIR, V74, P21, DOI 10.1007/BF01413271; PITTS LH, 1980, INTRACRANIAL PRESSUR, V4, P5; PRICE JE, 1972, BR J ACCID SURG, V3, P218; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; TEASDALE G, 1974, LANCET, V2, P81; TSUTSUMI H, 1986, INTRACRANIAL PRESSUR, V6, P661	30	463	477	1	28	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1991	75			S			S59	S66		10.3171/sup.1991.75.1s.0s59			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GN584	WOS:A1991GN58400009					2021-06-18	
J	Stergiou, N; Decker, LM				Stergiou, Nicholas; Decker, Leslie M.			Human movement variability, nonlinear dynamics, and pathology: Is there a connection?	HUMAN MOVEMENT SCIENCE			English	Article						Chaos; Stability; Anterior cruciate ligament; Cerebral concussion; Passive dynamic walker; Infant motor development	ANTERIOR CRUCIATE LIGAMENT; SITTING POSTURAL CONTROL; LONG-RANGE CORRELATIONS; TIME-SERIES ANALYSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; SIMPLEST WALKING MODEL; TO-STRIDE VARIABILITY; MILD HEAD-INJURY; FRACTAL DYNAMICS; CEREBRAL CONCUSSION	Fields studying movement generation, including robotics, psychology, cognitive science, and neuroscience utilize concepts and tools related to the pervasiveness of variability in biological systems. The concept of variability and the measures for nonlinear dynamics used to evaluate this concept open new vistas for research in movement dysfunction of many types. This review describes innovations in the exploration of variability and their potential importance in understanding human movement. Far from being a source of error, evidence supports the presence of an optimal state of variability for healthy and functional movement. This variability has a particular organization and is characterized by a chaotic structure. Deviations from this state can lead to biological systems that are either overly rigid and robotic or noisy and unstable. Both situations result in systems that are less adaptable to perturbations, such as those associated with unhealthy pathological states or absence of skillfulness. (C) 2011 Elsevier B.V. All rights reserved.	[Stergiou, Nicholas; Decker, Leslie M.] Univ Nebraska, Nebraska Biomech Core Facil, Omaha, NE 68182 USA; [Stergiou, Nicholas] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth Sci, Coll Publ Hlth, Omaha, NE 68198 USA	Stergiou, N (corresponding author), Univ Nebraska, Nebraska Biomech Core Facil, 6001 Dodge St, Omaha, NE 68182 USA.	nstergiou@unomaha.edu	Decker, Leslie M/N-8923-2015	Decker, Leslie M/0000-0003-2929-0761	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K25HD047194]; NIDRR [H133G040118, H133G080023]; Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD047194] Funding Source: NIH RePORTER	This work is supported by the NIH (K25HD047194), the NIDRR (H133G040118 and HI 33G080023) and the Nebraska Research Initiative.	Abarbanel H., 1996, ANAL OBSERVED CHAOTI; Alligood K., 1997, CHAOS INTRO DYNAMICA; AMATO I, 1992, SCIENCE, V256, P1763, DOI 10.1126/science.1615321; ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011; Bassingthwaighte J. B., 1994, FRACTAL PHYSL, P63; Bates BT, 1996, MED SCI SPORT EXER, V28, P631, DOI 10.1097/00005768-199605000-00016; Beauchet O, 2007, GAIT POSTURE, V26, P327, DOI 10.1016/j.gaitpost.2007.02.001; Bernstein N., 1967, COORDINATION REGULAT; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Buchman TG, 2001, SHOCK, V16, P248, DOI 10.1097/00024382-200116040-00002; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cai LL, 2006, J NEUROSCI, V26, P10564, DOI 10.1523/JNEUROSCI.2266-06.2006; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chmielewski TL, 2002, J ELECTROMYOGR KINES, V12, P267, DOI 10.1016/S1050-6411(02)00013-5; Cignetti F, 2009, J BIOMECH, V42, P1452, DOI 10.1016/j.jbiomech.2009.04.012; CLARK JE, 1993, CHILD DEV, V64, P1143, DOI 10.1111/j.1467-8624.1993.tb04192.x; Courtney C, 2005, GAIT POSTURE, V22, P69, DOI 10.1016/j.gaitpost.2004.07.002; Deffeyes JE, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-34; Deffeyes JE, 2009, CLIN BIOMECH, V24, P564, DOI 10.1016/j.clinbiomech.2009.05.004; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Demura S, 2008, GERIATR GERONTOL INT, V8, P188, DOI 10.1111/j.1447-0594.2008.00469.x; DENTON TA, 1990, AM HEART J, V120, P1419, DOI 10.1016/0002-8703(90)90258-Y; DIFABIO RP, 1992, EXP BRAIN RES, V90, P189, DOI 10.1007/BF00229271; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Dyhre-Poulsen P, 2000, J APPL PHYSIOL, V89, P2191; Faure P, 2001, CR ACAD SCI III-VIE, V324, P773, DOI 10.1016/S0764-4469(01)01377-4; Fedrizzi E, 2000, J CHILD NEUROL, V15, P228, DOI 10.1177/088307380001500405; Fithian DC, 2002, ORTHOP CLIN N AM, V33, P621, DOI 10.1016/S0030-5898(02)00015-9; Fujita I, 2000, J ORTHOPAED RES, V18, P183, DOI 10.1002/jor.1100180204; Full RJ, 1999, J EXP BIOL, V202, P3325; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gates DH, 2008, EXP BRAIN RES, V187, P573, DOI 10.1007/s00221-008-1326-8; Gates DH, 2007, J APPL PHYSIOL, V102, P965, DOI 10.1152/japplphysiol.00413.2006; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GOLDBERGER AL, 1988, EXPERIENTIA, V44, P983, DOI 10.1007/BF01939894; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; Goswami A, 1998, INT J ROBOT RES, V17, P1282, DOI 10.1177/027836499801701202; Granata KP, 2007, GAIT POSTURE, V26, P329, DOI 10.1016/j.gaitpost.2007.02.002; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2002, ORTHOP PHYS THER CLI, V11, P143; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Harbourne RT, 2009, NONLIN DYNAM PSYCHOL, V13, P123; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045; Hurmuzlu Y, 1996, J BIOMECH ENG-T ASME, V118, P405, DOI 10.1115/1.2796024; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; JOHANSSON H, 1991, CRIT REV BIOMED ENG, V18, P341; JOHANSSON H, 1990, NEUROSCI RES, V8, P54, DOI 10.1016/0168-0102(90)90057-L; Jordan K, 2006, GAIT POSTURE, V24, P120, DOI 10.1016/j.gaitpost.2005.08.003; KAMM K, 1990, PHYS THER, V70, P763, DOI 10.1093/ptj/70.12.763; Kang HG, 2006, GAIT POSTURE, V24, P386, DOI 10.1016/j.gaitpost.2005.11.004; Kang HG, 2006, EXP BRAIN RES, V172, P35, DOI 10.1007/s00221-005-0224-6; Kapreli E, 2006, MED HYPOTHESES, V67, P645, DOI 10.1016/j.mehy.2006.01.063; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelso JAS., 1995, DYNAMIC PATTERNS SEL; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Kurz MJ, 2007, J BIOMECH ENG-T ASME, V129, P216, DOI 10.1115/1.2486008; Kurz MJ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-30; Kurz MJ, 2010, NONLIN DYNAM PSYCHOL, V14, P151; Kurz MJ, 2010, J COMPUT NEUROSCI, V28, P131, DOI 10.1007/s10827-009-0192-0; Kurz MJ, 2005, BIOL CYBERN, V93, P213, DOI 10.1007/s00422-005-0579-6; Kurz MJ, 2005, CHAOS SOLITON FRACT, V23, P485, DOI 10.1016/j.chaos.2004.04.034; Kyvelidou A, 2010, ARCH PHYS MED REHAB, V91, P1593, DOI 10.1016/j.apmr.2010.06.027; Kyvelidou A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-22; Kyvelidou A, 2009, ARCH PHYS MED REHAB, V90, P1176, DOI 10.1016/j.apmr.2009.01.031; Lanza GA, 1998, AM J CARDIOL, V82, P1323, DOI 10.1016/S0002-9149(98)00635-3; Latash M. L., 2008, PART 4 MOTOR VARIABI, P119; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Latash ML, 2001, EXP BRAIN RES, V141, P153, DOI 10.1007/s002210100861; Li L, 2005, HUM MOVEMENT SCI, V24, P257, DOI 10.1016/j.humov.2005.03.003; Liao FY, 2008, MED ENG PHYS, V30, P299, DOI 10.1016/j.medengphy.2007.04.014; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lomax R.G., 2007, STAT CONCEPTS 2 COUR; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MCDANIEL WJ, 1983, CLIN ORTHOP RELAT R, P158; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Miller DJ, 2006, J BIOMECH, V39, P2873, DOI 10.1016/j.jbiomech.2005.10.019; Mitra S, 1997, J MOTOR BEHAV, V29, P195, DOI 10.1080/00222899709600834; Moraiti C, 2007, KNEE SURG SPORT TR A, V15, P1406, DOI 10.1007/s00167-007-0373-1; Moraiti CO, 2010, GAIT POSTURE, V32, P169, DOI 10.1016/j.gaitpost.2010.04.008; NEWELL KM, 1993, VARIABILITY AND MOTOR CONTROL, P475; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Newell KM, 1998, APPLICATIONS OF NONLINEAR DYNAMICS TO DEVELOPMENTAL PROCESS MODELING, P63; NEWELL KM, 1993, VARIABILITY AND MOTOR CONTROL, P1; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P163, DOI 10.2106/00004623-198365020-00004; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003; Orsucci FF, 2006, NEUROSCIENTIST, V12, P390, DOI 10.1177/1073858406290266; Peng C. K., 2000, NONLINEAR DYNAMICS S, P66; PINCUS SM, 1994, MATH BIOSCI, V122, P161, DOI 10.1016/0025-5564(94)90056-6; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1992, AM J PHYSIOL, V262, pE741; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Pincus Steven M., 1995, QUANT NEUROENDOCRINO, V28, P336; Pinczewski LA, 2007, AM J SPORT MED, V35, P564, DOI 10.1177/0363546506296042; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Rosano C, 2007, NEUROEPIDEMIOLOGY, V29, P193, DOI 10.1159/000111582; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4, 89-122; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Scholz JP, 2003, EXP BRAIN RES, V153, P45, DOI 10.1007/s00221-003-1580-8; Slutzky MW, 2001, ANN BIOMED ENG, V29, P607, DOI 10.1114/1.1380419; SOLOMONOW M, 1987, AM J SPORT MED, V15, P207, DOI 10.1177/036354658701500302; Solomonow M, 2001, SCAND J MED SCI SPOR, V11, P64, DOI 10.1034/j.1600-0838.2001.011002064.x; Sosnoff JJ, 2009, J MOTOR BEHAV, V41, P137, DOI 10.3200/JMBR.41.2.137-146; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Stergiou N, 2004, CLIN BIOMECH, V19, P957, DOI 10.1016/j.clinbiomech.2004.06.008; Stergiou N, 2004, INNOVATIVE ANAL HUMA, P63; Stergiou N., 2009, PHYS THER, V89, P1, DOI DOI 10.2522/PTJ.20080130; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Summers JJ, 2009, HUM MOVEMENT SCI, V28, P566, DOI 10.1016/j.humov.2009.01.002; THELEN E, 1995, AM PSYCHOL, V50, P79, DOI 10.1037/0003-066X.50.2.79; THELEN E, 1991, MONOGR SOC RES CHILD, V56, pR1, DOI 10.2307/1166099; Toweill DL, 1998, NEW HORIZ-SCI PRACT, V6, P155; Tsuda E, 2001, AM J SPORT MED, V29, P83, DOI 10.1177/03635465010290011801; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2004, J APPL PHYSIOL, V97, P454, DOI 10.1152/japplphysiol.00244.2004; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Valeriani M, 1996, BRAIN, V119, P1751, DOI 10.1093/brain/119.5.1751; Wagner CD, 1996, CARDIOVASC RES, V31, P380; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wu YW, 2004, PEDIATRICS, V114, P1264, DOI 10.1542/peds.2004-0114; Yang CX, 2011, NONLINEAR DYNAM, V64, P279, DOI 10.1007/s11071-010-9860-x; ZARINS B, 1988, NEW ENGL J MED, V318, P950, DOI 10.1056/NEJM198804143181504	147	458	460	15	151	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	OCT	2011	30	5					869	888		10.1016/j.humov.2011.06.002			20	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	834WV	WOS:000295996100004	21802756	Green Accepted	Y	N	2021-06-18	
J	Fregni, F; Boggio, PS; Lima, MC; Ferreira, MJL; Wagner, T; Rigonatti, SP; Castro, AW; Souza, DR; Riberto, M; Freedman, SD; Nitsche, MA; Pascual-Leone, A				Fregni, Felipe; Boggio, Paulo S.; Lima, Moises C.; Ferreira, Merari J. L.; Wagner, Tim; Rigonatti, Sergio P.; Castro, Anita W.; Souza, Daniel R.; Riberto, Marcelo; Freedman, Steven D.; Nitsche, Michael A.; Pascual-Leone, Alvaro			A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury	PAIN			English	Article						transcranial direct current stimulation; brain polarization; central pain; spinal cord injury	MOTOR CORTEX STIMULATION; UPPER-EXTREMITY AMPUTEES; MAGNETIC STIMULATION; NEUROPATHIC PAIN; CORTICAL STIMULATION; ELECTRICAL-STIMULATION; NEURONAL-ACTIVITY; DC-STIMULATION; CLINICAL-TRIAL; HUMAN BRAIN	Past evidence has shown that motor cortical stimulation with invasive and non-invasive brain stimulation is effective to relieve central pain. Here we aimed to study the effects of another, very safe technique of non-invasive brain stimulation-transcranial direct current stimulation (tDCS)-on pain control in patients with central pain due to traumatic spinal cord injury. Patients were randomized to receive sham or active motor tDCS (2 mA, 20 min for 5 consecutive days). A blinded evaluator rated the pain using the visual analogue scale for pain, Clinician Global Impression and Patient Global Assessment. Safety was assessed with a neuropsychological battery and confounders with the evaluation of depression and anxiety changes. There was a significant pain improvement after active anodal stimulation of the motor cortex, but not after sham stimulation. These results were not confounded by depression or anxiety changes. Furthermore, cognitive performance was not significantly changed throughout the trial in both treatment groups. The results of our study suggest that this new approach of cortical stimulation can be effective to control pain in patients with spinal cord lesion. We discuss potential mechanisms for pain amelioration after tDCS, such as a secondary modulation of thalamic nuclei activity. (c) 2006 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Noninvasc Brain Stimulat, Boston, MA 02215 USA; Univ Sao Paulo, Dept Expt Psychol, BR-05508 Sao Paulo, Brazil; Univ Sao Paulo, Dept Psychiat, BR-05508 Sao Paulo, Brazil; Univ Prebiteriana Mackenzie, Dept Neurosci, Sao Paulo, Brazil; Univ Sao Paulo, Dept Orthopaed Surg, Div Phys Med & Rehabil, BR-05508 Sao Paulo, Brazil; Inst Guttman, Hosp Neurorehabil, Barcelona, Spain; Univ Gottingen, Dept Clin Neurophysiol, D-3400 Gottingen, Germany	Fregni, F (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Noninvasc Brain Stimulat, Boston, MA 02215 USA.	ffregni@bidmc.harvard.edu	Boggio, Paulo S/K-6272-2012; Riberto, Marcelo/C-3141-2012; Boggio, Paulo/B-9870-2008; Nitsche, Michael A/B-6755-2012; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Boggio, Paulo S/0000-0002-6109-0447; Riberto, Marcelo/0000-0001-9549-8830; Pascual-Leone, Alvaro/0000-0001-8975-0382; Lima, Moises/0000-0002-7600-6391; Fregni, Felipe/0000-0001-9359-8643	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K24 RR018875] Funding Source: Medline; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01-EY12091] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K30 HL04095] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01-EB 005047] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01-DC05672] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS 47754, R01-NS 20068] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012091] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K30HL004095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC005672] Funding Source: NIH RePORTER		Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Barros F, 1990, REV HOSP CLIN FM SAO, V45, P123; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; BONICA JJ, 1991, PAIN CENTRAL NERVOUS; Brown JA, 2005, NEUROSURGERY, V56, P290, DOI 10.1227/01.neu.0000148905.75845.98; Canavero S, 2002, STEREOT FUNCT NEUROS, V78, P192, DOI 10.1159/000068965; Carroll D, 2000, PAIN, V84, P431, DOI 10.1016/S0304-3959(99)00245-6; Drouot X, 2002, BRAIN, V125, P1660, DOI 10.1093/brain/awf161; Ebel H, 1996, ACTA NEUROCHIR, V138, P1300, DOI 10.1007/BF01411059; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Fregni F, 2006, EPILEPSIA, V47, P335, DOI 10.1111/j.1528-1167.2006.00426.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; FREGNI F, IN PRESS BIPOLAR DIS; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; Herregodts P, 1995, ADV STER F, V11, P132; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lefaucheur JP, 2001, NEUROREPORT, V12, P2963, DOI 10.1097/00001756-200109170-00041; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; MIGITA K, 1995, NEUROSURGERY, V36, P1037, DOI 10.1227/00006123-199505000-00025; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nicholson BD, 2004, NEUROLOGY, V62, pS30, DOI 10.1212/WNL.62.5_suppl_2.S30; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2004, CLIN NEUROPHYSIOL, V115, P2419, DOI 10.1016/j.clinph.2004.05.001; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nuti C, 2005, PAIN, V118, P43, DOI 10.1016/j.pain.2005.07.020; PETO R, 1978, BIOMEDICINE, V28, P24; PEYRON R, 1995, PAIN, V62, P275, DOI 10.1016/0304-3959(94)00211-V; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; POCOCK SJ, 1979, BIOMETRICS, V35, P183, DOI 10.2307/2529944; Romero JR, 2002, CLIN NEUROPHYSIOL, V113, P101, DOI 10.1016/S1388-2457(01)00693-9; Ruck A, 2006, AM J CARDIOL, V97, P152, DOI 10.1016/j.amjcard.2005.08.015; Strafella AP, 2004, EUR J NEUROSCI, V20, P2245, DOI 10.1111/j.1460-9568.2004.03669.x; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; VANBELLE G, 1990, J CLIN EPIDEMIOL, V43, P589, DOI 10.1016/0895-4356(90)90163-J; Wallace BA, 2004, NEUROSURG CLIN N AM, V15, P343, DOI 10.1016/j.nec.2004.03.004	45	458	472	1	39	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	MAY	2006	122	1-2					197	209		10.1016/j.pain.2006.02.023			13	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	042SG	WOS:000237549100029	16564618				2021-06-18	
J	Crigler, L; Robey, RC; Asawachaicharn, A; Gaupp, D; Phinney, DG				Crigler, L; Robey, RC; Asawachaicharn, A; Gaupp, D; Phinney, DG			Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis	EXPERIMENTAL NEUROLOGY			English	Article						mesenchymal stem cells; marrow stromal cells; neurotrophins; serial analysis of gene expression; neuritogenesis; SH-SY5Y	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; SPINAL-CORD; NEUROTROPHIC FACTORS; ADHESION MOLECULE; ISCHEMIC BRAIN; RAT; MIGRATION; DIFFERENTIATION	Mesenchymal stem cells (MSCs) transplanted at sites of nerve injury are thought to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons. To evaluate this phenomenon further, we quantified in human MSCs neurotrophin expression levels and their effects on neuronal cell survival and neuritogenesis. Screening a human MSC cDNA library revealed expressed transcripts encoding BDNF and beta-NGF but not NT-3 and NT-4. Immunostaining demonstrated that BDNF and beta-NGF proteins were restricted to specific MSC subpopulations, which was confirmed by ELISA analysis of 56 separate subelones. Using a co-culture assay, we also demonstrated that BDNF expression levels correlated with the ability of MSC populations or subelones to induce survival and neurite outgrowth in the SH-SY5Y neuroblastoma cell line. However, these MSC-induced effects were only partially inhibited by a neutralizing anti-BDNF antibody. MSCs were also shown to promote neurite outgrowth within dorsal root ganglion explants despite secreting 25-fold lower level of beta-NGF required exogenously to produce a similar effect. Interrogation of the human MSC transcriptome identified expressed mRNAs encoding various neurite-inducing factors, axon guidance and neural cell adhesion molecules. Moreover, a subset of these transcripts was shown to correlate with BDNF expression in MSC subelones. Collectively, these studies reveal the existence of MSC subpopulations that co-express neurotrophins and other potent neuro-regulatory molecules, which contribute to MSC-induced effects on neuronal cell survival and nerve regeneration. These subpopulations may represent more potent vectors for treating a variety of neurological disorders. (c) 2005 Elsevier Inc. All rights reserved.	Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA	Phinney, DG (corresponding author), Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, 1430 Tulane Ave, New Orleans, LA 70112 USA.	dphinne@tulane.edu	Phinney, Donald G/D-2155-2014; 谭, 德华 德/D-1910-2009	Phinney, Donald/0000-0002-8688-2619	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39033-01A2, NS39033-02S1] Funding Source: Medline		Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Auffray I, 1996, BLOOD, V88, P1608, DOI 10.1182/blood.V88.5.1608.bloodjournal8851608; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Gil OD, 1998, J NEUROSCI, V18, P9312; Guan HB, 2003, J IMMUNOL, V171, P6519, DOI 10.4049/jimmunol.171.12.6519; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Moreno-Flores MT, 2003, J NEUROCHEM, V87, P879, DOI 10.1046/j.1471-4159.2003.02051.x; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Simone MD, 1999, HEMATOL ONCOL, V17, P1; Soeda S, 2004, NEUROREPORT, V15, P855, DOI 10.1097/00001756-200404090-00024; Stollberg J, 2000, GENOME RES, V10, P1241, DOI 10.1101/gr.10.8.1241; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	45	458	505	0	49	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2006	198	1					54	64		10.1016/j.expneurol.2005.10.029			11	Neurosciences	Neurosciences & Neurology	018EO	WOS:000235747000007	16336965				2021-06-18	
J	HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG; JENKINS, LW				HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG; JENKINS, LW			THE ROTAROD TEST - AN EVALUATION OF ITS EFFECTIVENESS IN ASSESSING MOTOR DEFICITS FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							RAT; MODEL; MICE	The purpose of the present experiment was to examine the effectiveness of a modified rotarod test in detecting motor deficits following mild and moderate central fluid percussion brain injury. In addition, this investigation compared the performance of the rotarod task with two other commonly used measures of motor function after brain injury (beam-balance and beam-walking latencies). Rats were either injured with a mild (n = 14) or moderate (n = 8) level of fluid percussion injury or were surgically prepared but not injured (n = 8). All rats were assessed on all tasks for 5 days following their respective treatments. Results revealed that both the mild and moderate injury levels produced significant deficits in the ability of the animals to perform the rotarod task. Performance on the beam-balance and beam-walking tasks were not significantly impaired at the mild injury level. It was only at the moderate injury level that the beam-balance and beam-walking tasks detected deficits in motor performance. This result demonstrated that the rotarod task was a sensitive index of injury-induced motor dysfunction following even mild fluid percussion injury. A power analysis of the three tasks indicated that statistically significant group differences could be obtained with the rotarod task with much smaller sample sizes than with the beam-balance and beam-walking tasks. Performance on the rotarod, beam-walk, and beam-balance tasks were compared and evaluated by a multivariate stepdown analysis (multiple analysis of variance followed by univariate analyses of covariance). This analysis indicated that the rotarod task measures aspects of motor impairment that are not assessed by either the beam-balance or beam-walking latency. These findings suggest that compared to the beam-balance and beam-walking tasks, the rotarod task is a more sensitive and efficient index for assessing motor impairment produced by brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23284	HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,BOX 2018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [NIDRR H133B80029] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12857] Funding Source: Medline		BROCK RD, 1968, HDB MEASUREMENT ASSE; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAYES RL, 1988, J NEUROTRAUM, V5, P287; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; KURIBARA H, 1977, JPN J PHARMACOL, V27, P117, DOI 10.1254/jjp.27.117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A	10	458	471	1	37	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1994	11	2					187	196		10.1089/neu.1994.11.187			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	NR684	WOS:A1994NR68400005	7932797				2021-06-18	
J	TAUPIN, V; TOULMOND, S; SERRANO, A; BENAVIDES, J; ZAVALA, F				TAUPIN, V; TOULMOND, S; SERRANO, A; BENAVIDES, J; ZAVALA, F			INCREASE IN IL-6, IL-1 AND TNF LEVELS IN RAT-BRAIN FOLLOWING TRAUMATIC LESION - INFLUENCE OF PRE-TRAUMATIC AND POSTTRAUMATIC TREATMENT WITH RO5 4864, A PERIPHERAL-TYPE (P-SITE) BENZODIAZEPINE LIGAND	JOURNAL OF NEUROIMMUNOLOGY			English	Article						CYTOKINES; BRAIN; TRAUMA; BENZODIAZEPINE; PERIPHERAL-TYPE BENZODIAZEPINE BINDING SITES	TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; FACTOR-ALPHA; CELLULAR SOURCE; MESSENGER-RNA; INTERLEUKIN-1; INJURY; INVIVO; ASTROCYTES	The effects of fluid percussion trauma on brain interleukin (IL)-6, IL-1 and tumor necrosis factor-alpha (TNF-alpha) levels have been studied. In the cortex and hippocampus of control and sham-operated rats, the levels of these cytokines were very low (below 4 units/mg protein) and constant. IL-6 and IL-1 levels in the ipsilateral cortex increased rapidly following trauma to reach a maximum of 350 and 16 units/mg protein, respectively, 8 h after the lesion, remained elevated until 18 h and decreased thereafter to basal values. TNF-alpha levels were maximally elevated (12 units/mg protein) at 3 h and 8 h and returned to basal values by 18 h. Qualitatively similar changes, but with 25-80-fold smaller amplitude, were seen in the contralateral cortex and in the ipsi- and contralateral hippocampus. The levels of IL-6 in the plasma of sham-operated and lesioned rats were only slightly elevated, whereas IL-1 and TNF-alpha were undetectable. Histological studies of brain tissue at early stages after trauma demonstrated an acute hemorrhage associated with neutrophil invasion. The administration of Ro5 4864 (0.5 mg/kg i.p.), a specific ligand of p (peripheral-type benzodiazepine) binding sites, did not result in any significant effect on the levels of IL-6, IL-1 or TNF-alpha in the brain of control or sham-operated animals. However, when administered 24 h before or 15 min after trauma, this benzodiazepine enhanced the increase of these cytokines by 2-4-fold in the ipsilateral cortex. The global effect of Ro5 4864 on IL-6 levels was of greater amplitude than those on IL-1 or TNF-alpha. Ro5 4864 had no effect on IL-6 levels in the plasma of lesioned rats. The activation of p sites by specific benzodiazepine ligands might, by increasing the trauma-induced production of these cytokines, modulate the inflammatory reaction at the site of brain injury.	HOP NECKER ENFANTS MALAD, INSERM, U25, 161 RUE SEVRES, F-75743 PARIS 15, FRANCE; SYNTHELABO RECH, BAGNEUX, FRANCE			ZAvALA, Flora/E-7973-2017	ZAvALA, Flora/0000-0002-2338-6802			AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; Adams J. H., 1982, HEAD INJURY BASIC CL, P141; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; BENAVIDES J, 1990, BRAIN RES, V522, P275, DOI 10.1016/0006-8993(90)91472-S; BENAVIDES J, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P39; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; BOURDIOL F, 1991, BRAIN RES, V543, P194, DOI 10.1016/0006-8993(91)90028-T; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CROCKARD A, 1982, J NEUROTRAUM, V5, P115; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; Dinarello C A, 1992, Eur Cytokine Netw, V3, P7; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; DOLLMAN CL, 1986, TXB NEUROPATHOLOGY, P117; DUBRAVEC DB, 1990, P NATL ACAD SCI USA, V87, P6758, DOI 10.1073/pnas.87.17.6758; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; FERRAN C, 1990, EUR J IMMUNOL, V20, P509, DOI 10.1002/eji.1830200308; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; GERY I, 1972, J EXP MED, V136, P143, DOI 10.1084/jem.136.1.143; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HOPKINS SJ, 1990, J IMMUNOL METHODS, V133, P127, DOI 10.1016/0022-1759(90)90326-Q; LACHMAN LB, 1987, J IMMUNOL, V138, P2913; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; MARUCHA PT, 1990, J IMMUNOL, V145, P2932; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; MINAMI M, 1990, BIOCHEM BIOPH RES CO, V171, P832, DOI 10.1016/0006-291X(90)91221-D; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; MORGANTIKOSSMANN MC, 1992, J NEUROIMMUNOL, V39, P163, DOI 10.1016/0165-5728(92)90185-N; NELSON LR, 1982, HEAD INJURY BASIC CL, P117; NIETOSAMPEDRO M, 1987, J NEUROSCI RES, V17, P214, DOI 10.1002/jnr.490170303; NISHIMOTO N, 1989, CLIN IMMUNOL IMMUNOP, V50, P399, DOI 10.1016/0090-1229(89)90147-5; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Ruff M. R., 1981, LYMPHOKINES, P235; SCHOBITZ B, 1992, NEUROSCI LETT, V136, P189, DOI 10.1016/0304-3940(92)90046-A; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SHENKIN A, 1989, LYMPHOKINE RES, V8, P123; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; TAUPIN V, 1991, LYMPHOKINE CYTOK RES, V10, P7; TAUPIN V, 1991, J NEUROIMMUNOL, V35, P13, DOI 10.1016/0165-5728(91)90157-3; TEREBUH PD, 1992, AM J PATHOL, V140, P649; VOLL CL, 1991, NEUROLOGY, V41, P423, DOI 10.1212/WNL.41.3.423; WEISSMAN BA, 1983, BENZODIAZEPINE RECOG, P139; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; ZAVALA F, 1990, J PHARMACOL EXP THER, V255, P442	51	458	465	2	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	FEB	1993	42	2					177	185		10.1016/0165-5728(93)90008-M			9	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	KM856	WOS:A1993KM85600008	8429103				2021-06-18	
J	CICERONE, KD; KALMAR, K				CICERONE, KD; KALMAR, K			PERSISTENT POSTCONCUSSION SYNDROME - THE STRUCTURE OF SUBJECTIVE COMPLAINTS AFTER MILD TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MINOR HEAD-INJURY; CHRONIC FATIGUE SYNDROME; WHIPLASH INJURY; NEUROPSYCHOLOGICAL EVALUATION; CEREBRAL SYMPTOMS; CONCUSSION; DEFICITS	Objective: To examine the structure of persistent postconcussive symptoms in a sample of patients with mild traumatic brain injury. Design: Multivariate discriminant analysis in a series of 50 consecutive clinical referrals evaluated for postconcussive symptoms, neuropsychological functioning, and personality and emotional functioning at least 3 months after injury; follow-up information regarding level of disability was obtained for 37 patients at least 1 year after injury. Setting: Neuropsychology clinic affiliated with a comprehensive brain trauma rehabilitation center. Patients: 50 consecutively referred patients with a diagnosis of mild traumatic brain injury referred by physicians, rehabilitation nurses, or attorneys because of persistent deficits or subjective complaints consistent with a postconcussion syndrome. Main Outcome Measure: Postconcussive symptoms endorsed on the Post Mild Traumatic Brain Injury Symptom Checklist. Results: Pour factors consisting of multiple symptoms were identified: cognitive factor, affective factor, somatic factor, and sensory factor. Using these four factors, K-means cluster analysis of subjects was applied to classify patients. Patient clusters consisted of those with minimal symptoms, those with primarily cognitive-affective symptoms, those with prominent somatic symptoms, and those with severe global symptoms (P = .000). Patient symptom clusters were largely unrelated to neurological or neuropsychological functioning. The presence of chronic disability and resumption of productive functioning differed significantly among groups (P = .003). Conclusions: Subjective complaints provide clinically meaningful information and are strongly related to the nature and extent of disability after mild traumatic brain injury. Characterization of a single postconcussive syndrome may be misleading, and it may be more meaningful to define a number of postconcussive syndromes with differing symptom profiles and recovery.	SETON HALL UNIV,GRAD SCH MED EDUC,DEPT NEUROSCI,S ORANGE,NJ 07079	CICERONE, KD (corresponding author), JFK JOHNSON REHABIL INST,NEUROPSYCHOL SERV,EDISON,NJ, USA.						ABBEY SE, 1991, AM J PSYCHIAT, V148, P1638; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Barontini F, 1992, Acta Neurol (Napoli), V14, P90; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1992, NEUROSURGERY, V30, P692; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; BRUNO RL, 1994, ARCH PHYS MED REHAB, V75, P498; BRUNO RL, 1993, ARCH PHYS MED REHAB, V74, P1061, DOI 10.1016/0003-9993(93)90062-F; CHELUNE GJ, 1986, ADV CLIN NEUROPSYCHO, P3; Cicerone K, 1994, ARCH PHYS MED REHAB, V75, P723; Cicerone K. D., 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; COWELL LC, 1990, 9TH ANN S NAT HEAD I; DIKMEN S, 1989, MILD HEAD INJURY; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Farber S. D., 1989, J HEAD TRAUMA REHAB, V4, P9; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; GEFFENSTEIN MF, 1994, PSYCHOL ASSESSMENT, V6, P218; GENNARELLI TA, 1982, SEMINARS NEUROLOGICA; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GRAFMAN J, 1993, J NEUROL NEUROSUR PS, V56, P684, DOI 10.1136/jnnp.56.6.684; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; GROMWALL D, 1974, LANCET, V2, P605; JACOBS A, 1994, J NUCL MED, V35, P942; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENNUM P, 1994, ARCH NEUROL-CHICAGO, V51, P937, DOI 10.1001/archneur.1994.00540210111020; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; KRAUSS JF, 1989, MILD HEAD INJURY; KRUPP LB, 1991, ARCH NEUROL-CHICAGO, V48, P1125, DOI 10.1001/archneur.1991.00530230033017; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIDVALL H F, 1974, Acta Neurologica Scandinavica Supplementum, V50, P1; MCEVOY JP, 1979, J CLIN PSYCHIAT, V40, P447; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1048; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1986, JAMA-J AM MED ASSOC, V204, P285; PEARCE JMS, 1993, J NEUROL NEUROSUR PS, V56, P1328, DOI 10.1136/jnnp.56.12.1328-a; RADANOV BP, 1994, J NEUROL NEUROSUR PS, V57, P486, DOI 10.1136/jnnp.57.4.486; RADANOV BP, 1992, ACTA NEUROL SCAND, V85, P358; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1989, MILD HEAD INJURY; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; TOGLIA JU, 1976, NEUROLOGY, V26, P808, DOI 10.1212/WNL.26.9.808; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; WESSELY S, 1989, J NEUROL NEUROSUR PS, V45, P940; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	59	457	458	0	43	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1995	10	3					1	17		10.1097/00001199-199510030-00002			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RC717	WOS:A1995RC71700002					2021-06-18	
J	Bryant, RA; O'Donnell, ML; Creamer, M; McFarlane, AC; Clark, CR; Silove, D				Bryant, Richard A.; O'Donnell, Meaghan L.; Creamer, Mark; McFarlane, Alexander C.; Clark, C. Richard; Silove, Derrick			The Psychiatric Sequelae of Traumatic Injury	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; NEUROCIRCUITRY MODELS; WHOQOL-BREF; DEPRESSION; HEALTH; PREDICTORS; SYMPTOMS; DISASTER; OUTCOMES	Objective: Traumatic injury affects millions of people each year. There is little understanding of the extent of psychiatric illness that develops after traumatic injury or of the impact of mild traumatic brain injury (TBI) on psychiatric illness. The authors sought to determine the range of new psychiatric disorders occurring after traumatic injury and the influence of mild TBI on psychiatric status. Method: In this prospective cohort study, patients were drawn from recent admissions to four major trauma hospitals across Australia. A total of 1,084 traumatically injured patients were initially assessed during hospital admission and followed up 3 months (N=932, 86%) and 12 months (N=817, 75%) after injury. Lifetime psychiatric diagnoses were assessed in hospital. The prevalence of psychiatric disorders, levels of quality of life, and mental health service use were assessed at the follow-ups. The main outcome measures were 3- and 12-month prevalence of axis I psychiatric disorders, levels of quality of life, and mental health service use and lifetime axis I psychiatric disorders. Results: Twelve months after injury, 31% of patients reported a psychiatric disorder, and 22% developed a psychiatric disorder that they had never experienced before. The most common new psychiatric disorders were depression (9%), generalized anxiety disorder (9%), posttraumatic stress disorder (6%), and agoraphobia (6%). Patients were more likely to develop posttraumatic stress disorder (odds ratio=1.92, 95% CI=1.08-3.40), panic disorder (odds ratio=2.01, 95% CI=1.03-4.14), social phobia (odds ratio=2.07, 95% CI=1.03-4.16), and agoraphobia (odds ratio=1.94, 95% CI=1.11-3.39) if they had sustained a mild TBI. Functional impairment, rather than mild TBI, was associated with psychiatric illness. Conclusions: A significant range of psychiatric disorders occur after traumatic injury. The identification and treatment of a range of psychiatric disorders are important for optimal adaptation after traumatic injury.	[Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia; Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia; Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic, Australia; Natl Trauma Res Inst, Melbourne, Vic, Australia; Univ Adelaide, Ctr Mil & Vet Hlth, Adelaide, SA 5005, Australia; Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia; Flinders Univ S Australia, Cognit Neurosci Lab, Adelaide, SA 5001, Australia	Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au	clark, christopher richard/B-3525-2012; Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022	National Health and Medical Research Council ProgramNational Health and Medical Research Council of Australia [300403]; Victorian Trauma Foundation [V-11]; National Health and Medical Research Council Australian Clinical Research FellowshipNational Health and Medical Research Council of Australia [359284]	Supported by National Health and Medical Research Council Program grant 300403, Victorian Trauma Foundation grant V-11, and National Health and Medical Research Council Australian Clinical Research Fellowship 359284.	Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; *AM ASS AUT MED, 1990, ABBR INJ SCAL 1990 R; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Aziz Mohamed A, 2004, J Psychiatr Pract, V10, P307, DOI 10.1097/00131746-200409000-00004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Boscarino Joseph A, 2002, Int J Emerg Ment Health, V4, P143; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; BRYANT RA, J INT NEURO IN PRESS; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Levin HS, 1996, NEUROTRAUMA, P749; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; *NAT CTR INJ PREV, 2006, NONF INJ REP; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROSURG CLIN N AM, V14, P213, DOI 10.1016/S1042-3680(02)00114-6; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; The WHOQOL Group, 1996, WHOQOL BREF INTR ADM; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200	44	454	455	2	77	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0002-953X	1535-7228		AM J PSYCHIAT	Am. J. Psychiat.	MAR	2010	167	3					312	320		10.1176/appi.ajp.2009.09050617			9	Psychiatry	Psychiatry	562MR	WOS:000275056300013	20048022				2021-06-18	
J	Platz, T; Pinkowski, C; van Wijck, F; Kim, IH; di Bella, P; Johnson, G				Platz, T; Pinkowski, C; van Wijck, F; Kim, IH; di Bella, P; Johnson, G			Reliability and validity of arm function assessment with standardized guidelines for the Fugl-Meyer Test, Action Research Arm Test and Box and Block Test: a multicentre study	CLINICAL REHABILITATION			English	Article							UPPER EXTREMITY FUNCTION; INTERRATER RELIABILITY; MULTIPLE-SCLEROSIS; STROKE; PERFORMANCE; SCALE; REHABILITATION; DEXTERITY; NORMS	Objectives: To establish: (1) inter-rater and test-retest reliability of standardized guidelines for the Fugl-Meyer upper limb section, Action Research Arm Test and Box and Block Test in patients with paresis secondary to stroke, multiple sclerosis or traumatic brain injury and (2) correlation between these arm motor scales and more general measures of impairment and activity limitation. Design: Multicentre cohort study. Setting: Three European referral centres for neurorehabilitation. Subjects: Thirty-seven stroke, 14 multiple sclerosis and five traumatic brain injury patients. Main measures: Scores of the Fugl-Meyer Test (arm section), Action Research Arm Test, and Box and Block Test derived from video information. Results: All three motor tests showed very high inter-rater and test-retest reliability (ICC and rho for main variables > 0.95). Correlation between the motor scales was very high (rho > 0.92). Motor scales correlated moderately highly with the Hemispheric Stroke Scale, a measure of impairment (rho = 0.660-0.689), but not with the Modified Barthel Index, a measure of the ability to cope with basic activities of daily living (rho = 0.044-0.086). Conclusions: The standardized guidelines assured comparability of test administration and scoring across clinical facilities. The arm motor scales provided information that was not identical to information from the Hemispheric Stroke Scale or the Modified Barthel Index.	Univ Newcastle Upon Tyne, Ctr Rehabil & Engn Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Ctr Studiop & Trattamento Neurolesi Lungodegenti, Messina, Italy	Platz, T (corresponding author), Charite Univ Med Berlin, Klin Berlin, Abt Neurol Rehabil, Kladower Damm 223, D-14089 Berlin, Germany.	tplatz@zedat.fu-berlin.de		Platz, Thomas/0000-0003-2629-9744			ADAMS RJ, 1987, STROKE, V18, P665, DOI 10.1161/01.STR.18.3.665; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; CARROLL D, 1965, J CHRON DIS, V18, P479, DOI 10.1016/0021-9681(65)90030-5; Cromwell F.S., 1976, OCCUPATIONAL THERAPI, P29; De Weerdt W, 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; DEYO RA, 1991, CONTROL CLIN TRIALS, V12, P412; DUNCAN PW, 1983, PHYS THER, V63, P1607; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Svensson E, 2001, J REHABIL MED, V33, P47, DOI 10.1080/165019701300006542; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; World Health Organization, 2001, INT CLASS FUNCT DIS	24	451	479	3	48	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	JUN	2005	19	4					404	411		10.1191/0269215505cr832oa			8	Rehabilitation	Rehabilitation	929UT	WOS:000229372800008	15929509				2021-06-18	
J	Atkins, L; Francis, J; Islam, R; O'Connor, D; Patey, A; Ivers, N; Foy, R; Duncan, EM; Colquhoun, H; Grimshaw, JM; Lawton, R; Michie, S				Atkins, Lou; Francis, Jill; Islam, Rafat; O'Connor, Denise; Patey, Andrea; Ivers, Noah; Foy, Robbie; Duncan, Eilidh M.; Colquhoun, Heather; Grimshaw, Jeremy M.; Lawton, Rebecca; Michie, Susan			A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems	IMPLEMENTATION SCIENCE			English	Article						Theoretical Domains Framework; Guide; Methods	HEALTH-CARE PROFESSIONALS; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; DIGESTIVE-TRACT; SELECTIVE DECONTAMINATION; CHANGE INTERVENTIONS; UNDERSTANDING PRACTICE; GENERAL-PRACTICE; MANAGEMENT	Background: Implementing new practices requires changes in the behaviour of relevant actors, and this is facilitated by understanding of the determinants of current and desired behaviours. The Theoretical Domains Framework (TDF) was developed by a collaboration of behavioural scientists and implementation researchers who identified theories relevant to implementation and grouped constructs from these theories into domains. The collaboration aimed to provide a comprehensive, theory-informed approach to identify determinants of behaviour. The first version was published in 2005, and a subsequent version following a validation exercise was published in 2012. This guide offers practical guidance for those who wish to apply the TDF to assess implementation problems and support intervention design. It presents a brief rationale for using a theoretical approach to investigate and address implementation problems, summarises the TDF and its development, and describes how to apply the TDF to achieve implementation objectives. Examples from the implementation research literature are presented to illustrate relevant methods and practical considerations. Methods: Researchers from Canada, the UK and Australia attended a 3-day meeting in December 2012 to build an international collaboration among researchers and decision-makers interested in the advancing use of the TDF. The participants were experienced in using the TDF to assess implementation problems, design interventions, and/or understand change processes. This guide is an output of the meeting and also draws on the authors' collective experience. Examples from the implementation research literature judged by authors to be representative of specific applications of the TDF are included in this guide. Results: We explain and illustrate methods, with a focus on qualitative approaches, for selecting and specifying target behaviours key to implementation, selecting the study design, deciding the sampling strategy, developing study materials, collecting and analysing data, and reporting findings of TDF-based studies. Areas for development include methods for triangulating data, e.g. from interviews, questionnaires and observation and methods for designing interventions based on TDF-based problem analysis. Conclusions: We offer this guide to the implementation community to assist in the application of the TDF to achieve implementation objectives. Benefits of using the TDF include the provision of a theoretical basis for implementation studies, good coverage of potential reasons for slow diffusion of evidence into practice and a method for progressing from theory-based investigation to intervention.	[Atkins, Lou; Michie, Susan] UCL, Ctr Behav Change, London, England; [Francis, Jill] Univ London, Sch Hlth Sci City, London, England; [Francis, Jill; Islam, Rafat; Patey, Andrea; Grimshaw, Jeremy M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [O'Connor, Denise] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia; [Ivers, Noah] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Ivers, Noah] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Foy, Robbie] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Duncan, Eilidh M.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Lawton, Rebecca] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England	Atkins, L (corresponding author), UCL, Ctr Behav Change, London, England.	atkins@ucl.ac.uk	Patey, Andrea M./J-9277-2019; Atkins, Louise/C-7740-2011; O'Connor, Denise/ABC-6655-2020	Patey, Andrea M./0000-0002-8770-4494; O'Connor, Denise/0000-0002-6836-122X; Francis, Jill/0000-0001-5784-8895; Lawton, Rebecca/0000-0002-5832-402X; Foy, Robbie/0000-0003-0605-7713; Duncan, Eilidh/0000-0002-1009-9732	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [UD99999938] Funding Source: researchfish; Chief Scientist Office [HSRU2] Funding Source: researchfish	The collaborative meeting in December 2012 in Ottawa described in the methods which lead to the writing of this guide was funded by the Canadian Institutes of Health Research (planning grant).	Amemori M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-50; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Atkins L, 2016, GASTROINTEST ENDOSC, V83, P617, DOI 10.1016/j.gie.2015.08.075; Backman R, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0224-2; Baker R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub3; Beenstock J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-36; BIRKIMER JC, 1979, J APPL BEHAV ANAL, V12, P535, DOI 10.1901/jaba.1979.12-535; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Bussieres AE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-82; Cane J, 2015, BRIT J HEALTH PSYCH, V20, P130, DOI 10.1111/bjhp.12102; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Charmaz K, 2006, CONSTRUCTING GROUNDE; Colquhoun HL, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-66; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc13096; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davies P, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-14; Davis R, 2015, HEALTH PSYCHOL REV, V9, P323, DOI 10.1080/17437199.2014.941722; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Dombrowski SU, 2013, AUST CRIT CARE, V26, P173, DOI 10.1016/j.aucc.2013.04.002; Duncan EM, 2014, J CRIT CARE, V29, P634, DOI 10.1016/j.jcrc.2014.03.013; Duncan EM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-86; Dyson J., 2011, Journal of Infection Prevention, V12, P17, DOI 10.1177/1757177410384300; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-99; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; FISHBEIN M., 1967, READINGS ATTITUDE TH; Foy R, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-50; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; Francis JJ, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18250; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; French SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065471; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gainforth H, 2016, J APPL ENV ED COMMUN, V15, P4; Glaser B. G., 1967, DISCOVERY GROUNDED T; Heslehurst N, 2014, OBES REV, V15, P462, DOI 10.1111/obr.12160; Honigh-de Vlaming R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-984; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-11; Islam R, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-93; Johnston, 2004, CONSTRUCTING QUESTIO; Kolehmainen N, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-100; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawton R, 2012, BMJ QUAL SAF, V21, P369, DOI 10.1136/bmjqs-2011-000443; Little EA, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0280-7; Marks D. F., 2004, RES METHODS CLIN HLT; Marshall AP, 2014, HEART LUNG, V43, P13, DOI 10.1016/j.hrtlng.2013.09.002; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McKenzie JE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-86; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; McSherry LA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-73; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2014, BEHAV CHANGE WHEEL G; Michie S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-8; Michie S, 2008, J HEALTH SERV RES PO, V13, P64, DOI 10.1258/jhsrp.2008.008014; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2010, ADDICTION, V105, P1897, DOI 10.1111/j.1360-0443.2010.03161.x; Michie S, 2010, HEALTH PSYCHOL, V29, P1, DOI 10.1037/a0016939; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Morse J., 2000, QUAL HEALTH RES, V10, P305; Murphy K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-31; Nicholson SL, 2014, DISABIL REHABIL, V36, P1857, DOI 10.3109/09638288.2013.874506; O'Cathain A, 2010, BMJ-BRIT MED J, V341, P4587, DOI DOI 10.1136/BMJ.C4587; Page MJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-35; Patey AM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-52; Phillips CJ, 2015, J MULTIDISCIP HEALTH, V8, P139, DOI 10.2147/JMDH.S78458; Presseau J, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-73; Ritchie J, 2003, QUALITATIVE RES PRAC, P219; Rushforth B, 2016, BRIT J GEN PRACT, V66, pE114, DOI 10.3399/bjgp16X683509; Squires JE, 2014, INFECT CONT HOSP EP, V35, P1511, DOI 10.1086/678597; Squires JE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-16; Steinmo S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0300-7; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Taylor N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0648-4; Taylor N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-123; Taylor N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-81; Taylor N, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-74; ZUCKERMAN M, 1979, J PERS, V47, P245, DOI 10.1111/j.1467-6494.1979.tb00202.x	83	450	452	5	67	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	JUN 21	2017	12								77	10.1186/s13012-017-0605-9			18	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	EY2WI	WOS:000403833000002	28637486	DOAJ Gold, Green Published, Green Accepted	Y	N	2021-06-18	
J	Maas, AIR; Hukkelhoven, CWPM; Marshall, LF; Steyerberg, EW				Maas, AIR; Hukkelhoven, CWPM; Marshall, LF; Steyerberg, EW			Prediction of outcome in traumatic brain injury with computed tomographic characteristics: A comparison between the computed tomographic classification and combinations of computed tomographic predictors	NEUROSURGERY			English	Article						computed tomography; computed tomography classification; outcome; prognosis; statistical models; traumatic brain injury	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; SUBARACHNOID HEMORRHAGE; INTRAVENTRICULAR HEMORRHAGE; EXPERIENCE; MANAGEMENT; REGRESSION; IMPACT; LESION; SCORE	BACKGROUND AND OBJECTIVE: The Marshall computed tomographic (CT) classification identifies six groups of patients with traumatic brain injury (TBI), based on morphological abnormalities on the CT scan. This classification is increasingly used as a predictor of outcome. We aimed to examine the predictive value of the Marshall CT classification in comparison with alternative CT models. METHODS: The predictive value was investigated in the Tirilazad trials (n = 2269). Alternative models were developed with logistic regression analysis and recursive partitioning. Six month mortality was used as outcome measure. Internal validity was assessed with bootstrapping techniques and expressed as the area under the receiver operating curve (AUC). RESULTS: The Marshall CT classification indicated reasonable discrimination (AUC = 0.67), which could be improved by rearranging the underlying individual CT characteristics (AUC = 0.71). Performance could be further increased by adding intraventricular and traumatic subarachnoid hemorrhage and by a more detailed differentiation of mass lesions and basal cisterns (AUC = 0.77). Models developed with logistic regression analysis and recursive partitioning showed similar performance. For clinical application we propose a simple CT score, which permits a more clear differentiation of prognostic risk, particularly in patients with mass lesions. CONCLUSION: It is preferable to use combinations of individual CT predictors rather than the Marshall CT classification for prognostic purposes in TBI. Such models should include at least the following parameters: status of basal cisterns, shift, traumatic subarachnoid or intraventricular hemorrhage, and presence of different types of mass lesions.	Erasmus MC, Dept Neurol Surg, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Ctr Clin Decis Sci, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Univ Calif San Diego, Dept Neurol Surg, San Diego, CA 92103 USA	Maas, AIR (corresponding author), Erasmus MC, Dept Neurosurg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	airmaas@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Hukkelhoven, Chantal/0000-0002-0015-1883; Steyerberg, Ewout/0000-0002-7787-0122	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 42691] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER		Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; Efron B., 1983, INTRO BOOTSTRAP; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell Frank E., 2001, REGRESSION MODELING; HUKKELHOVEN C, IN PRESS J NEUROTRAU; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Olshen RA, 1984, CLASSIFICATION REGRE; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; TITTERINGTON DM, 1981, J ROY STAT SOC A STA, V144, P145, DOI 10.2307/2981918; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	34	450	467	0	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2005	57	6					1173	1181		10.1227/neu.0000186013.6304668			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	991PQ	WOS:000233826300034	16331165				2021-06-18	
J	Denny-Brown, D; Russell, WR				Denny-Brown, D; Russell, WR			Experimental cerebral concussion	BRAIN			English	Article																ABERNETHY J, 1825, SURG OBSERVATIONS IN; BECK B, 1865, SCHADELVERLETZUNGEN; Berner O, 1930, VIRCHOWS ARCH A, V277, P386, DOI 10.1007/BF02275335; BOIREL A, 1677, TRAITE PLAIES TETE; Bright R., 1831, REPORTS MED CASES 1, V2; BRYANT T, 1888, LANCET, V2, P405; BRYANT T, 1888, LANCET, V2, P507; Cannon WB, 1902, AM J PHYSIOL, V6, P251; Cassasa CB, 1924, P NEW YORK PATH SOC, P101; CHIPAULT A, 1895, ARCH GEN MED, V176, P665; CHIPAULT A, 1895, ARCH GEN MED, V176, P279; CHIPAULT A, 1895, ARCH GEN MED, V176, P394; Chorobski J, 1932, ARCH NEURO PSYCHIATR, V28, P1257, DOI 10.1001/archneurpsyc.1932.02240060016002; Cobb S, 1932, ARCH NEURO PSYCHIATR, V28, P1243, DOI 10.1001/archneurpsyc.1932.02240060002001; Courtney JW, 1900, BOSTON MED SURG J, V142, P345, DOI 10.1056/NEJM190004051421401; COURTNEY JW, 1899, BOSTON M S J, V140, P373; COURTNEY JW, 1899, BOSTON MED SURG J, V140, P397; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE, P200; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; Denny-Brown D, 1941, LANCET, V1, P371; DENNYBROWN D, 1940, J PHYSL, V99, pP6; DENNYBROWN D, 1940, J PHYSL, V99, pP153; DUPLAY S, 1868, TRAITE ELEMENTAIRE P, V3, P491; DURET H, 1920, TRAUMATISMES CRANIOC, V2; DURET H, 1878, TRAUMATISMES CEREBRA; FANO S, 1853, MEM SOC CHIR PARIS, V3, P162; FELIZET, 1873, THESIS PARIS; FISCHER H, 1871, VOLKMANNS SAMMLUNG, V27, P119; Forbes HS, 1928, ARCH NEURO PSYCHIATR, V19, P1057, DOI 10.1001/archneurpsyc.1928.02210120090008; Forbes HS, 1937, ARCH NEURO PSYCHIATR, V37, P776, DOI 10.1001/archneurpsyc.1937.02260160076008; FRANCOISFRANK CA, 1877, TRAV LAB MAREY; GAMA JP, 1830, TRAITE PLAIES TETE; GOLTZ F, 1863, VIRCHOWS ARCH, V26, P1; GUSSENBAUER, 1880, TRAUMATISCHEN VERLET; HASSIN GB, 1940, INJURIES SKULL BRAIN; Henderson Y, 1935, LANCET, V2, P178; Henderson Y, 1934, SCIENCE, V79, P508, DOI 10.1126/science.79.2057.508; HEWITT P, 1861, SYSTEM SURG, V2; Hill L.S., 1896, PHYSL PATHOLOGY CERE; HUNTER J, 1786, WORKS J HUNTER, V1, P486; HUTCHINSON J, 1877, ILLUSTRATIONS CLIN S, V1; Jakob A., 1912, HISTOL HISTOPATH ARB, V5, P182; Jefferson G, 1933, BRIT MED J, V1933, P807, DOI 10.1136/bmj.2.3800.807; KNAUER A, 1922, J PSYCHOL NEUROL, V29, P1; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; KOCHER T, 1901, SPEC PATH THERAPIE; Kramer S P, 1896, Ann Surg, V23, P163, DOI 10.1097/00000658-189601000-00031; LeCount ER, 1920, J AMER MED ASSOC, V74, P501, DOI 10.1001/jama.1920.02620080003002; LERI A, 1917, REV NEUROL, V2, P449; LEYDEN E, 1866, VIRCHOWS ARCH, V37, P519; LITTRE M, 1705, HIST ACAD ROYALE SCI, P54; MARCHANT G, 1891, TRAITE CHIRURG, V3; McDowall RJS, 1933, BRIT MED J, V1933, P690; MILES A, 1892, BRAIN, V15, P153; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; Munro D., 1938, CRANIO CEREBRAL INJU; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PARE A, 1579, OEUVRES COMPLETS, V2, P23; POLIS A, 1894, REV CHIR, V17, P273; POLIS A, 1894, REV CHIR, V17, P645; Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004; Ricker G, 1919, VIRCHOWS ARCH A, V226, P180, DOI 10.1007/BF02039959; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SAVORY WS, 1869, ST BARTH HOSP REP, V5, P72; Scagliosi G., 1898, VIRCHOWS ARCH, V152, P487; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; Schaller WF, 1941, ARCH NEURO PSYCHIATR, V45, P1; Schaller WT, 1937, ARCH NEURO PSYCHIATR, V37, P1048, DOI 10.1001/archneurpsyc.1937.02260170076004; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Sherrington CS, 1917, J PHYSIOL-LONDON, V51, P404; STROMEYER L, 1864, HDB CHIRURG, V2; Trotter W, 1924, LANCET, V1, P935; TROTTER W, 1932, SYSTEM SURG, V3; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005; VONBERGMANN E, 1880, LEHRE KOPFVERLETZUNG; VONHOLDER H, 1904, PATHOLOGISCHE ANATOM; WITKOWSKI L, 1877, VIRCHOWS ARCH, V69, P498	78	449	449	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain		1941	64						93	164		10.1093/brain/64.2-3.93			76	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V20IW	WOS:000201375000006					2021-06-18	
J	Schochl, H; Nienaber, U; Hofer, G; Voelckel, W; Jambor, C; Scharbert, G; Kozek-Langenecker, S; Solomon, C				Schoechl, Herbert; Nienaber, Ulrike; Hofer, Georg; Voelckel, Wolfgang; Jambor, Csilla; Scharbert, Gisela; Kozek-Langenecker, Sibylle; Solomon, Cristina			Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM (R))-guided administration of fibrinogen concentrate and prothrombin complex concentrate	CRITICAL CARE			English	Article							FRESH-FROZEN PLASMA; RED-BLOOD-CELL; RECEIVING MASSIVE TRANSFUSIONS; HYDROXYETHYL STARCH; SURGICAL-PATIENTS; ANTITHROMBIN-I; WHOLE-BLOOD; COAGULOPATHY; RATIO; THROMBELASTOGRAPHY	Introduction: The appropriate strategy for trauma-induced coagulopathy management is under debate. We report the treatment of major trauma using mainly coagulation factor concentrates. Methods: This retrospective analysis included trauma patients who received >= 5 units of red blood cell concentrate within 24 hours. Coagulation management was guided by thromboelastometry (ROTEM(R)). Fibrinogen concentrate was given as first-line haemostatic therapy when maximum clot firmness (MCF) measured by FibTEM (fibrin-based test) was < 10 mm. Prothrombin complex concentrate (PCC) was given in case of recent coumarin intake or clotting time measured by extrinsic activation test (EXTEM) > 1.5 times normal. Lack of improvement in EXTEM MCF after fibrinogen concentrate administration was an indication for platelet concentrate. The observed mortality was compared with the mortality predicted by the trauma injury severity score (TRISS) and by the revised injury severity classification (RISC) score. Results: Of 131 patients included, 128 received fibrinogen concentrate as first-line therapy, 98 additionally received PCC, while 3 patients with recent coumarin intake received only PCC. Twelve patients received FFP and 29 received platelet concentrate. The observed mortality was 24.4%, lower than the TRISS mortality of 33.7% (P = 0.032) and the RISC mortality of 28.7% (P > 0.05). After excluding 17 patients with traumatic brain injury, the difference in mortality was 14% observed versus 27.8% predicted by TRISS (P = 0.0018) and 24.3% predicted by RISC (P = 0.014). Conclusions: ROTEM(R)-guided haemostatic therapy, with fibrinogen concentrate as first-line haemostatic therapy and additional PCC, was goal-directed and fast. A favourable survival rate was observed. Prospective, randomized trials to investigate this therapeutic alternative further appear warranted.	[Solomon, Cristina] Salzburger Landeskliniken SALK, Dept Anaesthesiol & Intens Care, A-5020 Salzburg, Austria; [Schoechl, Herbert; Hofer, Georg; Voelckel, Wolfgang] AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, A-5010 Salzburg, Austria; [Schoechl, Herbert] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Nienaber, Ulrike] Univ Witten Herdecke, Inst Res Operat Med, Cologne Merheim Med Ctr, D-51109 Cologne, Germany; [Jambor, Csilla] Munich Univ Hosp, Dept Anaesthesiol & Intens Care, D-80336 Munich, Germany; [Scharbert, Gisela; Kozek-Langenecker, Sibylle] Vienna Med Univ, Dept Anaesthesiol & Gen Intens Care, Clin Div B, A-1090 Vienna, Austria	Solomon, C (corresponding author), Salzburger Landeskliniken SALK, Dept Anaesthesiol & Intens Care, 48 Mullner Hauptstr, A-5020 Salzburg, Austria.	solomon.cristina@googlemail.com			Essex Pharma; CSL Behring; Tem International GmbH; Astra ZenecaAstraZeneca; Baxter; Biotest; Dynabyte,; Ekomed; Fresenius Kabi; Mitsubishi Pharma; NovoNordiskNovo Nordisk; B. Braun	This study was performed without external funding. The article-processing charge is to be supported by the research group. Drs. Schochl and Jambor have received honoraria as speakers from CSL Behring (manufacturer of fibrinogen concentrate and PCC) and Tem International GmbH (manufacturer of the ROTEM device). Dr. Solomon has received honoraria as a speaker and research support from Essex Pharma, CSL Behring, and Tem International GmbH. Dr. Kozek-Langenecker has received honoraria as a speaker and research support from Astra Zeneca, Baxter (manufacturer of PCC), B. Braun, Biotest, CSL Behring, Dynabyte, Ekomed, Fresenius Kabi, GlaxoSmithKline, Mitsubishi Pharma, NovoNordisk, and Tem International GmbH. All other authors declare that they have no competing interests.	Bolliger D, 2009, BRIT J ANAESTH, V102, P793, DOI 10.1093/bja/aep098; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Chaiwat O, 2009, ANESTHESIOLOGY, V110, P351, DOI 10.1097/ALN.0b013e3181948a97; Chowdhury P, 2004, BRIT J HAEMATOL, V125, P69, DOI 10.1111/j.1365-2141.2004.04868.x; Craig J, 2008, HEALTH TECHNOL ASSES, V11, P1; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Davis EG, 2003, J TRAUMA, V55, P53, DOI 10.1097/01.TA.0000075340.22097.B5; Dempfle CE, 2008, SEMIN THROMB HEMOST, V34, P445, DOI 10.1055/s-0028-1092874; DICKNEITE G, 2009, BLOOD COAGU IN PRESS; Dzik Walter H, 2004, Curr Hematol Rep, V3, P324; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Danes AF, 2008, VOX SANG, V94, P221, DOI 10.1111/j.1423-0410.2007.01024.x; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P1099, DOI 10.1111/j.1538-7836.2009.03460.x; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P795, DOI 10.1111/j.1538-7836.2009.03331.x; Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270; Fries D, 2006, BRIT J ANAESTH, V97, P460, DOI 10.1093/bja/ael191; Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Geeraedts LMG, 2007, RESUSCITATION, V73, P382, DOI 10.1016/j.resuscitation.2006.10.005; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Haas T, 2008, ANESTH ANALG, V106, P725, DOI 10.1213/ane.0b013e318163fb26; Hess JR, 2008, TRANSFUSION, V48, P1763, DOI 10.1111/j.1537-2995.2008.01743.x; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Hirschmann MT, 2007, ANAESTHESIST, V56, P673, DOI 10.1007/s00101-007-1192-y; Jackson GNB, 2009, ANAESTHESIA, V64, P212, DOI 10.1111/j.1365-2044.2008.05752.x; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; Kashuk JL, 2009, J SURG RES, V156, P133, DOI 10.1016/j.jss.2009.03.046; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kheirabadi BS, 2007, J TRAUMA, V62, P1352, DOI 10.1097/TA.0b013e318047b805; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Kitchens CS, 2005, J THROMB HAEMOST, V3, P2607, DOI 10.1111/j.1538-7836.2005.01552.x; Lampl L, 1992, Anasthesiol Intensivmed Notfallmed Schmerzther, V27, P31, DOI 10.1055/s-2007-1000248; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Manco-Johnson MJ, 2009, J THROMB HAEMOST, V7, P2064, DOI 10.1111/j.1538-7836.2009.03633.x; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; Moore L, 2009, ANN SURG, V249, P1040, DOI 10.1097/SLA.0b013e3181a6cd97; Mosesson MW, 2003, THROMB HAEMOSTASIS, V89, P9; Nielsen VG, 2007, ANESTH ANALG, V105, P902, DOI 10.1213/01.ane.0000286775.33975.6e; Plotkin AJ, 2008, J TRAUMA, V64, pS64, DOI 10.1097/TA.0b013e318160772d; Rahe-Meyer N, 2009, BRIT J ANAESTH, V102, P785, DOI 10.1093/bja/aep089; Rahe-Meyer N, 2009, J THORAC CARDIOV SUR, V138, P694, DOI 10.1016/j.jtcvs.2008.11.065; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sanson G, 1999, Eur J Emerg Med, V6, P285; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Scalea TM, 2008, ANN SURG, V248, P578, DOI 10.1097/SLA.0b013e31818990ed; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2006, Hamostaseologie, V26, pS52; Sniecinski RM, 2008, BLOOD COAGUL FIBRIN, V19, P178, DOI 10.1097/MBC.0b013e3282f40d4a; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Stanworth SJ, 2007, TRANSFUS CLIN BIOL, V14, P551, DOI 10.1016/j.tracli.2008.03.008; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Teixeira PGR, 2009, J TRAUMA, V66, P693, DOI 10.1097/TA.0b013e31817e5c77; Theusinger OM, 2009, CURR OPIN ANESTHESIO, V22, P305, DOI 10.1097/ACO.0b013e3283212c7c; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; SERIOUS HAZARDS TRAN	67	447	458	0	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2010	14	2							R55	10.1186/cc8948			11	Critical Care Medicine	General & Internal Medicine	611LO	WOS:000278816800030	20374650	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	GLOBUS, MYT; ALONSO, O; DIETRICH, WD; BUSTO, R; GINSBERG, MD				GLOBUS, MYT; ALONSO, O; DIETRICH, WD; BUSTO, R; GINSBERG, MD			GLUTAMATE RELEASE AND FREE-RADICAL PRODUCTION FOLLOWING BRAIN INJURY - EFFECTS OF POSTTRAUMATIC HYPOTHERMIA	JOURNAL OF NEUROCHEMISTRY			English	Article						TRAUMA; GLUTAMATE; HYDROXYL RADICALS; MICRODIALYSIS; HYPOTHERMIA	EXPERIMENTAL HEAD-INJURY; GAMMA-AMINOBUTYRIC-ACID; CEREBRAL BLOOD-FLOW; MODERATE HYPOTHERMIA; INTRACEREBRAL MICRODIALYSIS; LIQUID-CHROMATOGRAPHY; SUPEROXIDE-DISMUTASE; EXTRACELLULAR LEVELS; NEURONAL INJURY; NMDA RECEPTORS	Posttraumatic hypothermia reduces the extent of neuronal damage in remote cortical and subcortical structures following traumatic brain injury (TBI). We evaluated whether excessive extracellular release of glutamate and generation of hydroxyl radicals are associated with remote traumatic injury, and whether posttraumatic hypothermia modulates these processes, Lateral fluid percussion was used to induce TBI in rats. The salicylate-trapping method was used in conjunction with microdialysis and HPLC to detect hydroxyl radicals by measurement of the stable adducts 2,3- and 2,5-dihydroxybenzoic acid (DHBA). Extracellular glutamate was measured from the same samples, Following trauma, brain temperature was maintained for 3 h at either 37 or 30 degrees C. Sham-trauma animals were treated in an identical manner. In the normothermic group, TBI induced significant elevations in 2,3-DHBA (3.3-fold, p < 0.01), 2,5-DHBA (2.5-fold, p < 0.01), and glutamate (2.8-fold, p < 0.01) compared with controls. The levels of 2,3-DHBA and glutamate remained high for approximately 1 h after trauma, whereas levels of 2,5-DHBA remained high for the entire sampling period (4 h). Linear regression analysis revealed a significant positive correlation between integrated 2,3-DHBA and glutamate concentrations (p < 0.05). Posttraumatic hypothermia resulted in suppression of both 2,3- and 2,5-DHBA elevations and glutamate release. The present data indicate that TBI is followed by prompt increases in both glutamate release and hydroxyl radical production from cortical regions adjacent to the impact site. The magnitude of glutamate release is correlated with the extent of the hydroxyl radical adduct, raising the possibility that the two responses are associated. Posttraumatic hypothermia blunts both responses, suggesting a mechanism by which hypothermia confers protection following TBI.		GLOBUS, MYT (corresponding author), UNIV MIAMI,SCH MED,DEPT NEUROL D45,NEUROTRAUMA CLIN RES CTR,POB 016960,MIAMI,FL 33101, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS005820, P50NS005820, P50NS030291, R01NS026784] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-26784, NS-30291, NS-05820] Funding Source: Medline		ALLISON LA, 1984, ANAL CHEM, V56, P1089, DOI 10.1021/ac00271a010; BENERT H, 1992, SOC NEUR ABSTR, V18, P1087; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BOISVERT DPJ, 1992, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1992, P311; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLOYD R A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P13, DOI 10.1016/0748-5514(86)90118-2; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; GINSBERG MD, 1995, PHARM CEREBRAL ISCHE, P255; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GLOBUS MYT, 1992, EMERGING STRATEGIES, P289; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; HALLIWELL B, 1991, FREE RADICAL BIO MED, V10, P439, DOI 10.1016/0891-5849(91)90052-5; HAMMER B, 1993, NEUROREPORT, V5, P72, DOI 10.1097/00001756-199310000-00018; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; INGELMANSUNDBERG M, 1991, BIOCHEM J, V276, P753, DOI 10.1042/bj2760753; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MARTON DW, 1993, J NEUROSURG, V79, P354; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OBATA T, 1992, J NEURAL TRANSM-GEN, V89, P139, DOI 10.1007/BF01245361; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; PELLEGRINIGIAMP.DE, 1990, J NEUROSCI, V10, P1035; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SMITH DH, 1993, J NEUROSCI, V13, P5383; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	49	447	456	1	13	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	1995	65	4					1704	1711					8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	RW335	WOS:A1995RW33500033	7561868				2021-06-18	
J	Conti, AC; Raghupathi, R; Trojanowski, JQ; McIntosh, TK				Conti, AC; Raghupathi, R; Trojanowski, JQ; McIntosh, TK			Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period	JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; traumatic brain injury; delayed cell death; DNA fragmentation; neurodegeneration; programmed cell death; rat; TUNEL	CELL-DEATH; DNA FRAGMENTATION; UP-REGULATION; HEAD-INJURY; RAT-BRAIN; C-JUN; ISCHEMIA; DEFICITS; NEURONS; PROTEIN	The temporal pattern of apoptosis in the adult rat brain after lateral fluid-percussion (FP) brain injury was characterized using terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labeling (TUNEL) histochemistry and agarose gel electrophoresis. Male Sprague Dawley rats were subjected to brain injury and killed for histological analysis at intervals from 12 hr to 2 months after injury (n = 3/time point). Sham (uninjured) controls were subjected to anesthesia with (n = 3) or without (n = 3) surgery. Apoptotic TUNEL-positive cells were defined using stringent morphological criteria including nuclear shrinkage and fragmentation and condensation of chromatin and cytoplasm. Double-labeled immunocytochemistry was performed to identify TUNEL-positive neurons (anti-neurofilament monoclonal antibody RM044), astrocytes (anti-glial fibrillary acidic protein polyclonal antibody), and oligodendrocytes (anti-cyclic nucleotide phosphohydrolase polyclonal antibody). Compared with that seen with sham controls, in the injured cortex, significant apoptosis occurred at 24 hr (65 +/- 19 cells; p < 0.05) with a second, more pronounced response at 1 week after injury (91 +/- 24 cells; p < 0.05). The number of apoptotic cells in the white matter was increased as early as 12 hr after injury and peaked by 1 week (33 +/- 6 cells; p < 0.05). An increase in apoptotic cells was observed in the hippocampus at 48 hr (13 +/- 8), whereas in the thalamus, the apoptotic response was delayed, peaking at 2 weeks after injury(151 +/- 71 cells; p < 0.05). By 2 months, the number of apoptotic cells in most regions had returned to uninjured levels. At 24 hr after injury, TUNEL-labeled neurons and oligodendrocytes were localized primarily to injured cortex. By 1 week after injury, populations of TUNEL-labeled astrocytes and oligodendrocytes were present in the injured cortex, while double-labeled neurons were present predominantly in injured cortex and thalamus, with a few scattered in the hippocampus. DNA agarose gels confirmed morphological identification of apoptosis. These data suggest that the apoptotic response to trauma is regionally distinct and may be involved in both acute and delayed patterns of cell death.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	McIntosh, TK (corresponding author), 3320 Smith Walk,Room 102B, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P01NS008803] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG009215, P30 AG010124] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS008803, P01-NS08803, R01-NS26818] Funding Source: Medline		BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CHEN J, 1995, NEUROREPORT, V6, P394, DOI 10.1097/00001756-199501000-00040; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FUNG KM, 1995, AM J PATHOL, V146, P1376; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; GROWASSERREIDER I, 1993, AM J ROENTGENOL, V160, P147; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HOVDA DA, 1990, ACT NEUR S, V51, P331; IIZUKA H, 1990, STROKE, V21, P7990; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NITATORI T, 1995, J NEUROSCI, V15, P1001; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PAXINOS G, 1985, RAT NERVOUS SYSTEM, V1; Pierce JES, 1996, J NEUROSCI, V16, P1083; PIERCE JES, 1998, IN PRESS NEUROSCIENC; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RAGHUPATHI R, 1995, J NEUROTRAUM, V12, P966; RAIBLE DW, 1989, DEV BIOL, V133, P437, DOI 10.1016/0012-1606(89)90047-X; RINK A, 1995, AM J PATHOL, V147, P1575; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Schmidt ML, 1997, AM J PATHOL, V151, P69; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; TILLY JL, 1993, J CELL PHYSIOL, V154, P519, DOI 10.1002/jcp.1041540310; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; WILCOX BJ, 1995, J COMP NEUROL, V359, P573, DOI 10.1002/cne.903590405; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Young W, 1992, J NEUROTRAUMA S1, V9, P9	70	443	462	0	14	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 1	1998	18	15					5663	5672					10	Neurosciences	Neurosciences & Neurology	103RN	WOS:000074971800011	9671657				2021-06-18	
J	Fitch, MT; Doller, C; Combs, CK; Landreth, GE; Silver, J				Fitch, MT; Doller, C; Combs, CK; Landreth, GE; Silver, J			Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma	JOURNAL OF NEUROSCIENCE			English	Article						chondroitin sulfate proteoglycan; inflammation; gliosis; microglia; macrophage; astrocyte; injury; trauma; regeneration; necrosis; cavitation; mannose receptor; CR3; beta-integrin; CD11b/CD18; Mac-1	SPINAL-CORD INJURY; MACROPHAGE MANNOSE RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CHONDROITIN-SULFATE PROTEOGLYCAN; BLOOD-BRAIN-BARRIER; KAPPA-B ACTIVATION; EXTRACELLULAR-MATRIX; NEURITE OUTGROWTH; RAT-BRAIN; COMPLEMENT RECEPTOR-TYPE-3	Post-traumatic cystic cavitation, in which the size and severity of a CNS injury progress from a small area of direct trauma to a greatly enlarged secondary injury surrounded by glial scar tissue, is a poorly understood complication of damage to the brain and spinal cord. Using minimally invasive techniques to avoid primary physical injury, this study demonstrates in vivo that inflammatory processes alone initiate a cascade of secondary tissue damage, progressive cavitation, and glial scarring in the CNS. An in vitro model allowed us to test the hypothesis that specific molecules that stimulate macrophage inflammatory activation are an important step in initiating secondary neuropathology. Time-lapse video analyses of inflammation-induced cavitation in our in vitro model revealed that this process occurs primarily via a previously undescribed cellular mechanism involving dramatic astrocyte morphological changes and rapid migration. The physical process of cavitation leads to astrocyte abandonment of neuronal processes, neurite stretching, and secondary injury. The macrophage mannose receptor and the complement receptor type 3 beta 2-integrin are implicated in the cascade that induces cavity and scar formation. We also demonstrate that anti-inflammatory agents modulating transcription via the nuclear hormone receptor peroxisome proliferator-activated receptor-gamma may be therapeutic in preventing progressive cavitation by limiting inflammation and subsequent secondary damage after CNS injury.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Alzheimer Res Lab, Cleveland, OH 44106 USA	Fitch, MT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025713, R37NS025713] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS25713] Funding Source: Medline		Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; BALENTINE JD, 1978, LAB INVEST, V39, P236; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Battle J, 1998, BIOCHEM BIOPH RES CO, V249, P499, DOI 10.1006/bbrc.1998.9175; Bethea JR, 1998, J NEUROSCI, V18, P3251; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; Burudi EME, 1999, GLIA, V25, P44, DOI 10.1002/(SICI)1098-1136(19990101)25:1<44::AID-GLIA5>3.0.CO;2-C; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Davies SJA, 1997, NATURE, V390, P680; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; DOU CL, 1994, J NEUROSCI, V14, P7616; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; FITCH MT, 1999, IN PRESS DEGENERATIO; FITCH MT, 1999, CNS REGENERATION BAS, P55; Freshney R, 1987, CULTURE ANIMAL CELLS; Gary SC, 1998, CURR OPIN NEUROBIOL, V8, P576, DOI 10.1016/S0959-4388(98)80083-4; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Gelderman MP, 1998, P SOC EXP BIOL MED, V217, P81, DOI 10.3181/00379727-217-44208; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; GUTH L, 1975, EXP NEUROL, V48, P3, DOI 10.1016/0014-4886(75)90168-5; GUTH L, 1994, EXP NEUROL, V126, P76, DOI 10.1006/exnr.1994.1043; HAZENBOS WLW, 1995, J IMMUNOL, V155, P3972; HAZENBOS WLW, 1993, J IMMUNOL, V151, P6274; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Ishihara C, 1998, IMMUNOPHARMACOLOGY, V38, P223, DOI 10.1016/S0162-3109(97)00054-4; Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117; Jiang CY, 1998, NATURE, V391, P82; KAO CC, 1977, EXP NEUROL, V54, P591, DOI 10.1016/0014-4886(77)90259-X; KINSELLA MG, 1986, J CELL BIOL, V102, P679, DOI 10.1083/jcb.102.3.679; KLEGERIS A, 1994, J NEUROIMMUNOL, V53, P83, DOI 10.1016/0165-5728(94)90067-1; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; LazarovSpiegler O, 1996, FASEB J, V10, P1296; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liu XZ, 1997, J NEUROSCI, V17, P5395; LOMBARD Y, 1994, J IMMUNOL METHODS, V174, P155, DOI 10.1016/0022-1759(94)90018-3; MacLaren RE, 1996, BRIT J OPHTHALMOL, V80, P458, DOI 10.1136/bjo.80.5.458; MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKay PF, 1998, EUR J IMMUNOL, V28, P4071, DOI 10.1002/(SICI)1521-4141(199812)28:12<4071::AID-IMMU4071>3.0.CO;2-O; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Michalek M, 1998, J LEUKOCYTE BIOL, V64, P337; MONTEROMENEI CN, 1994, BRAIN RES, V653, P101, DOI 10.1016/0006-8993(94)90377-8; MULLER E, 1983, H-S Z PHYSIOL CHEM, V364, P1419, DOI 10.1515/bchm2.1983.364.2.1419; Murai M, 1996, IMMUNOLOGY, V89, P436, DOI 10.1046/j.1365-2567.1996.d01-765.x; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; POPOVICH PG, 1994, BRAIN RES, V633, P348, DOI 10.1016/0006-8993(94)91560-1; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; RABB H, 1993, J IMMUNOL, V151, P990; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Ramon y Cajal S, 1928, DEGENERATION REGENER; Reier PJ, 1983, SPINAL CORD RECONSTR, P163; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; ROSS GD, 1985, J IMMUNOL, V134, P3307; Schnitzler N, 1999, NAT MED, V5, P231; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; STEWART J, 1989, J CLIN LAB IMMUNOL, V28, P103; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Szczepanik AM, 1996, NEUROSCIENCE, V70, P57, DOI 10.1016/0306-4522(95)00296-U; TAYLOR ME, 1993, BIOCHEM SOC T, V21, P468, DOI 10.1042/bst0210468; Thomas LB, 1996, GLIA, V17, P1; Thornton BP, 1996, J IMMUNOL, V156, P1235; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; Weintraub BC, 1998, CURR BIOL, V8, pR575, DOI 10.1016/S0960-9822(07)00365-X; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; WILLIAMS B, 1981, PARAPLEGIA, V19, P67, DOI 10.1038/sc.1981.18; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Xia Y, 1999, J IMMUNOL, V162, P2281; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355	89	441	460	2	52	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 1	1999	19	19					8182	8198					17	Neurosciences	Neurosciences & Neurology	240BG	WOS:000082805400007	10493720				2021-06-18	
J	Myburgh, J; Cooper, J; Finfer, S; Bellomo, R; Norton, R; Bishop, N; Lo, SK; Vallance, S				Myburgh, John; Cooper, James; Finfer, Simon; Bellomo, Rinaldo; Norton, Robyn; Bishop, Nicole; Lo, Sing Kai; Vallance, Shirley		SAFE Study Investigators	Saline or albumin for fluid resuscitation in patients with traumatic brain injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; INTRACRANIAL-PRESSURE; VOLUME REGULATION; PRINCIPLES; THERAPY; EDEMA; GUIDELINES; SEVERITY; COMA	Background: The Saline versus Albumin Fluid Evaluation study suggested that patients with traumatic brain injury resuscitated with albumin had a higher mortality rate than those resuscitated with saline. We conducted a post hoc follow-up study of patients with traumatic brain injury who were enrolled in the study. Methods: For patients with traumatic brain injury (i.e., a history of trauma, evidence of head trauma on a computed tomographic [CT] scan, and a score of lessthan/equal 13 on the Glasgow Coma Scale [GCS]), we recorded baseline characteristics from case-report forms, clinical records, and CT scans and determined vital status and functional neurologic outcomes 24 months after randomization. Results: We followed 460 patients, of whom 231 (50.2%) received albumin and 229 (49.8%) received saline. The subgroup of patients with GCS scores of 3 to 8 were classified as having severe brain injury (160 [69.3%] in the albumin group and 158 [69.0%] in the saline group). Demographic characteristics and indexes of severity of brain injury were similar at baseline. At 24 months, 71 of 214 patients in the albumin group (33.2%) had died, as compared with 42 of 206 in the saline group (20.4%) (relative risk, 1.63; 95% confidence interval [CI], 1.17 to 2.26; P=0.003). Among patients with severe brain injury, 61 of 146 patients in the albumin group (41.8%) died, as compared with 32 of 144 in the saline group (22.2%) (relative risk, 1.88; 95% CI, 1.31 to 2.70; P<0.001); among patients with GCS scores of 9 to 12, death occurred in 8 of 50 patients in the albumin group (16.0%) and 8 of 37 in the saline group (21.6%) (relative risk, 0.74; 95% CI, 0.31 to 1.79; P=0.50). Conclusions: In this post hoc study of critically ill patients with traumatic brain injury, fluid resuscitation with albumin was associated with higher mortality rates than was resuscitation with saline. (Current Controlled Trials number, ISRCTN76588266.) N Engl J Med 2007;357:874-84.	ANZICS Clin Trials Grp, Carlton, Vic 3053, Australia; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Alfred Hosp, Melbourne, Vic, Australia; Auckland Hosp, Auckland, New Zealand; Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Australian Red Cross Blood Serv, Melbourne, Vic, Australia; Freemantle Hosp, Fremantle, Australia; John Hunter Hosp, Newcastle, NSW, Australia; Middlemore Hosp, Auckland 6, New Zealand; Nepean Hosp, Penrith, Australia; Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; Royal Adelaide Hosp, Adelaide, SA 5000, Australia; Royal Darwin Hosp, Darwin, NT, Australia; Royal Hobart Hosp, Hobart, Tas, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Royal N Shore Hosp, Sydney, NSW, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia; St George Hosp, Sydney, NSW, Australia; Western Hosp, Melbourne, Vic, Australia	Myburgh, J (corresponding author), ANZICS Clin Trials Grp, Level 3,10 Levers Terrace, Carlton, Vic 3053, Australia.	j.myburgh@unsw.edu.au	Joyce, Christopher/B-7437-2013; Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Neal, Bruce/0000-0002-0490-7465; LO, Sing Kai/0000-0001-8401-1759; Bellomo, Rinaldo/0000-0002-1650-8939; Finfer, Simon/0000-0002-2785-5864			*ACS COMM TRAUM, 2004, ADV TRAUM LIF SUPP P; *ANZICS CLIN TRIAL, 2003, BMJ; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barzo P, 1997, ACT NEUR S, V70, P119; Belayev L, 2004, BRAIN RES, V998, P243, DOI 10.1016/j.brainres.2003.11.015; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Eker C, 2000, BRAIN INJURY, V14, P605; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Is M, 2005, NEUROL RES, V27, P67, DOI 10.1179/016164105X18296; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2001, J NEUROSURG, V94, P349; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MYBURGH JA, IN PRESS J TRAUMA; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P591; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J Neurotrauma, V17, P563, DOI 10.1089/neu.2000.17.563; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023; Zornow M H, 1995, New Horiz, V3, P488	37	435	452	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					874	884					11	Medicine, General & Internal	General & Internal Medicine	204TA	WOS:000249065700006	17761591				2021-06-18	
J	Steiner, LA; Czosnyka, M; Piechnik, SK; Smielewski, P; Chatfield, D; Menon, DK; Pickard, JD				Steiner, LA; Czosnyka, M; Piechnik, SK; Smielewski, P; Chatfield, D; Menon, DK; Pickard, JD			Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						craniocerebral trauma; cerebrovascular circulation; homeostasis; autoregulation; computer-assisted signal processing; cerebral perfusion pressure; blood pressure; intracranial pressure; critical care; adult; human	SEVERE HEAD-INJURY; PIAL ARTERIOLAR CALIBER; BLOOD-FLOW; INTRACRANIAL-PRESSURE; AUTOREGULATION; HYPERTENSION; MICROCIRCULATION; METABOLISM; MANAGEMENT; SCALE	Objectives. To define optimal cerebral perfusion pressure (CPPOPT) in individual head-injured patients using continuous monitoring of cerebrovascular pressure reactivity. To test the hypothesis that patients with poor outcome were managed at a cerebral perfusion pressure (CPP) differing more from their CPPOPT than were patients with good outcome. Design. Retrospective analysis of prospectively collected data. Setting. Neurosciences critical care unit of a university hospital. Patients. A total of 114 head-injured patients admitted between January 1997 and August 2000 with continuous monitoring of mean arterial blood pressure (MAP) and intracranial pressure (ICP). Measurements and Main Results., MAP, ICP, and CPP were continuously recorded and a pressure reactivity index (PRx) was calculated online. PRx is the moving correlation coefficient recorded over 4-min periods between averaged values (6-sec periods) of MAP and ICP representing cerebrovascular pressure reactivity. When cerebrovascular reactivity is intact, PRx has negative or zero values, otherwise PRx is positive. Outcome was assessed at 6 months using the Glasgow Outcome Scale. A total of 13,633 hrs of data were recorded. CPPOPT was defined as the CPP where PRx reaches its minimum value when plotted against CPP. Identification of CPPOPT was possible in 68 patients (60%). In 22 patients (27%), CPPOPT was not found because it presumably lay outside the studied range of CPP. Patients' outcome correlated with the difference between CPP and CPPOPT for patients who were managed on average below CPPOPT (r = .53, p < .001) and for patients whose mean CPP was above CPPOPT (r = -.40, p < .05). Conclusions. CPPOPT could be identified in a majority of patients. Patients with a mean CPP close to CPPOPT were more likely to have a favorable outcome than those whose mean CPP was more different from CPPOPT. We propose use of the criterion of minimal achievable PRx to guide future trials of CPP oriented treatment in head injured patients.	Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England	Steiner, LA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Box 167, Cambridge CB2 2QQ, England.		Steiner, Luzius/J-1987-2019; Steiner, Luzius/C-9836-2011	Smielewski, Peter/0000-0001-5096-3938; Piechnik, Stefan K./0000-0002-0268-5221	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		BARZO P, 1993, NEUROSURGERY, V32, P611; Chesnut R M, 1995, New Horiz, V3, P581; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	435	442	4	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	APR	2002	30	4					733	738		10.1097/00003246-200204000-00002			6	Critical Care Medicine	General & Internal Medicine	540YB	WOS:000174957500002	11940737				2021-06-18	
J	Gualtieri, CT; Johnson, LG				Gualtieri, C. Thomas; Johnson, Lynda G.			Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						test development; reliability; concurrent validity; normative data; computerized test; memory; psychomotor speed; reaction time; complex attention; cognitive flexibility; CNS Vital Signs	RECOGNITION MEMORY TEST; TEST-RETEST RELIABILITY; TEST-PERFORMANCE; COGNITIVE IMPAIRMENT; HYPERACTIVE-CHILDREN; ASSESSMENT SYSTEM; INJURED PATIENTS; DRUG RESEARCH; ATTENTION; VALIDATION	CNS Vital Signs (CNSVS) is a computerized neurocognitive test battery that was developed as a routine clinical screening instrument. It is comprised of seven tests: verbal and visual memory, finger tapping, symbol digit coding, the Stroop Test, a test of shifting attention and the continuous performance test. Because CNSVS is a battery of well-known neuropsychological tests, one should expect its psychometric properties to resemble those of the conventional tests upon which it is based. 1069 subjects age 7-90 participated in the normative database for CNSVS. Test-retest reliability (TRT) was evaluated in 99 Ss who took the battery on two separate occasions, separated, on the average, by 62 days; the results were comparable to those achieved by equivalent conventional and computerized tests. Concurrent validity studies in 180 subjects, normals and neuropsychiatric patients, indicate correlations that are comparable to the concurrent validity of similar tests. Discriminant validity is supported by studies of patients with mild cognitive impairment and dementia, post-concussion syndrome and severe traumatic brain injury, ADHD (treated and untreated) and depression (treated and untreated). The tests in CNSVS are also sensitive to malingerers and patients with conversion disorders. The psychometric characteristics of the tests in the CNSVS battery are very similar to the characteristics of the conventional neuropsychological tests upon which they are based. CNSVS is suitable for use as ascreening instrument, or as a serial assessment measure. But it is not a substitute for formal neuropsychological testing, it is not diagnostic, and it will have only a limited role in the medical setting, absent the active participation of consulting neuropsychologists. (c) 2006 Published by Elsevier Ltd on behalf of National Academy of Neuropsychology.	N Carolina Neuropsychiat Clin, Dept Neuropsychiat, Chapel Hill, NC USA; N Carolina Neuropsychiat Clin, Dept Neuropsychol, Chapel Hill, NC USA	Gualtieri, CT (corresponding author), N Carolina Neuropsychiat Clin, Dept Neuropsychiat, 400 Franklin Sq,1829 E Franklin St, Chapel Hill, NC USA.	tg@neneuropsych.com					BAKER EL, 1985, NEUROBEH TOXICOL TER, V7, P369; BARKLEY RA, 1977, J CHILD PSYCHOL PSYC, V18, P137, DOI 10.1111/j.1469-7610.1977.tb00425.x; Bird CM, 2003, BRIT J CLIN PSYCHOL, V42, P407, DOI 10.1348/014466503322528946; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; COUGHLAN AK, 1984, BRIT J PSYCHIAT, V145, P164, DOI 10.1192/bjp.145.2.164; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; DODRILL CB, 1975, J NERV MENT DIS, V161, P185, DOI 10.1097/00005053-197509000-00006; Dougherty DM, 2000, ALCOHOL CLIN EXP RES, V24, P1702, DOI 10.1111/j.1530-0277.2000.tb01972.x; DULCAN M, 1991, CONCISE GUIDE  CHILD; Elwood RW, 2001, NEUROPSYCHOL REV, V11, P89, DOI 10.1023/A:1016671201211; Epstein JN, 2001, J CLIN EXP NEUROPSYC, V23, P362, DOI 10.1076/jcen.23.3.362.1186; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Forbes GB, 1998, J CLIN PSYCHOL, V54, P461, DOI 10.1002/(SICI)1097-4679(199806)54:4<461::AID-JCLP8>3.0.CO;2-Q; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; GILL DM, 1986, PERCEPT MOTOR SKILL, V62, P675, DOI 10.2466/pms.1986.62.2.675; Goldstein G, 1989, CLIN NEUROPSYCHOL, V3, P265, DOI DOI 10.1080/13854048908404088; Gonzalez HM, 2002, CLIN NEUROPSYCHOL, V16, P439, DOI 10.1076/clin.16.4.439.13908; GREEN RC, 1994, ARCH NEUROL-CHICAGO, V51, P779, DOI 10.1001/archneur.1994.00540200055017; GUALTIERI C, 2005, J ATTEN DISORD, V9, P534; GUALTIERI CT, 2006, J ALZHEIMERS RELATED, V20, P359; Gur RC, 2001, NEUROPSYCHOPHARMACOL, V25, P766, DOI 10.1016/S0893-133X(01)00278-0; HINDMARCH I, 1980, BRIT J CLIN PHARMACO, V10, P189, DOI 10.1111/j.1365-2125.1980.tb01745.x; HUTT SJ, 1968, DEV MED CHILD NEUROL, V10, P626; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945; KLEE SH, 1983, J ABNORM CHILD PSYCH, V11, P487, DOI 10.1007/BF00917077; Krengel M, 1996, NEUROTOXICOL TERATOL, V18, P435, DOI 10.1016/0892-0362(96)00022-0; Le TH, 1998, J NEUROPHYSIOL, V79, P1535; Lemay M, 2004, MOTOR CONTROL, V8, P16, DOI 10.1123/mcj.8.1.16; Levin ED, 2001, EXP CLIN PSYCHOPHARM, V9, P83, DOI 10.1037//1064-1297.9.1.83; LEZAK MD, 1994, NEBR SYM MOTIV, V41, P23; Lopez SJ, 2001, PERCEPT MOTOR SKILL, V93, P825; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; MCCAFFREY RJ, 1992, NEUROPSYCHOL REV, V3, P235, DOI 10.1007/BF01109049; Mirksy AF, 1965, ELECTROENCEPHALOGRAP, V18, P348; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P351, DOI 10.1002/1097-4679(199105)47:3<351::AID-JCLP2270470305>3.0.CO;2-S; Mitrushina M., 1999, HDB NORMATIVE DATA N; Nagahama Y, 1998, NEUROREPORT, V9, P2633, DOI 10.1097/00001756-199808030-00038; Proctor SP, 2000, NEUROTOXICOLOGY, V21, P703; Rey A, 1964, EXAMEN CLIN PSYCHOL; Riccio CA, 2001, ANN NY ACAD SCI, V931, P113; Riccio CA, 2001, J NEUROPSYCH CLIN N, V13, P326, DOI 10.1176/appi.neuropsych.13.3.326; Ringendahl H, 2002, J CLIN EXP NEUROPSYC, V24, P491, DOI 10.1076/jcen.24.4.491.1031; Rohlman DS, 2000, NEUROTOXICOLOGY, V21, P715; ROSVOLD HE, 1956, J COMP PHYSIOL PSYCH, V49, P365, DOI 10.1037/h0087991; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Salinsky MC, 2001, J INT NEUROPSYCH SOC, V7, P597, DOI 10.1017/S1355617701755075; Schweiger A., 2003, ACTA NEUROPSYCHOLOGI, V1, P407, DOI DOI 10.5604/17307503/9168; Shapiro D M, 1990, Arch Clin Neuropsychol, V5, P405, DOI 10.1016/0887-6177(90)90018-K; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith D.W., 1982, RECOGNIZABLE PATTERN, V3rd ed.; Soukup VM, 1999, J CLIN PSYCHOL MED S, V6, P287, DOI 10.1023/A:1026243822356; Spreen O., 1991, COMPENDIUM NEUROPSYC; SYKES DH, 1971, J CHILD PSYCHOL PSYC, V12, P129, DOI 10.1111/j.1469-7610.1971.tb01056.x; Taylor JL, 2000, AVIAT SPACE ENVIR MD, V71, P373; Tornatore JB, 2005, J NEUROPSYCH CLIN N, V17, P98, DOI 10.1176/appi.neuropsych.17.1.98; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Vadhan NP, 2001, J NERV MENT DIS, V189, P637, DOI 10.1097/00005053-200109000-00011; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Weber B, 1998, ACTA PSYCHIAT SCAND, V98, P140, DOI 10.1111/j.1600-0447.1998.tb10056.x; WOHLBERG GW, 1973, ARCH GEN PSYCHIAT, V28, P533	64	429	433	1	36	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2006	21	7					623	643		10.1016/j.acn.2006.05.007			21	Psychology, Clinical; Psychology	Psychology	112JR	WOS:000242522400003	17014981	Bronze			2021-06-18	
J	Jorge, RE; Robinson, RG; Moser, D; Tateno, A; Crespo-Facorro, B; Arndt, S				Jorge, RE; Robinson, RG; Moser, D; Tateno, A; Crespo-Facorro, B; Arndt, S			Major depression following traumatic brain injury	ARCHIVES OF GENERAL PSYCHIATRY			English	Article							SUBGENUAL PREFRONTAL CORTEX; STRUCTURED CLINICAL INTERVIEW; MOOD DISORDERS; MAGNETIC-RESONANCE; PSYCHIATRIC-DISORDERS; BIPOLAR DISORDER; FRONTAL-LOBE; UNIPOLAR DEPRESSION; HEAD-INJURIES; AXIS-I	Backgroud: Major depression is a frequent psychiatric complication among patients with traumatic brain injury (TBI). To our knowledge, however, the clinical correlates of major depression have not been extensively studied. Objective: To determine the clinical, neuropsychological, and structural neuroimaging correlates of major depression occurring after TBI. Design: Prospective, case-controlled, surveillance study conducted during the first year after the traumatic episode occurred. Settings: University hospital level I trauma center and a specialized rehabilitation unit. Methods: The study group consisted of 91 patients with TBI. In addition, 27 patients with multiple traumas but without evidence of central nervous system injury constituted the control group. The patients' conditions were evaluated at baseline and at 3, 6, and 12 months after the traumatic episode. Psychiatric diagnosis was made using a structured clinical interview and DSM-IV criteria. Neuropsychological testing and quantitative magnetic resonance imaging were performed at the 3-month follow-up visit. Results: Major depressive disorder was observed in 30 (33%) of 91 patients during the first year after sustaining a TBI. Major depressive disorder was significantly more frequent among patients with TBI than among the controls. Patients with TBI who had major depression were more likely to have a personal history of mood and anxiety disorders than patients who did not have major depression. Patients with major depression exhibited comorbid anxiety (76.7%) and aggressive behavior (56.7%). Patients with major depression had significantly greater impairment in executive functions than their nondepressed counterparts. Major depression was also associated with poorer social functioning at the 6-and 12-month follow-up, as well as significantly reduced left prefrontal gray matter volumes, particularly in the ventrolateral and dorsolateral regions. Conclusions: Major depression is a frequent complication of TBI that hinders a patient's recovery. It is associated with executive dysfunction, negative affect, and prominent anxiety symptoms. The neuropathological changes produced by TBI may lead to deactivation of lateral and dorsal prefrontal cortices and increased activation of ventral limbic and paralimbic structures including the amygdala.	Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA	Jorge, RE (corresponding author), MEB Psychiat Res, 500 Newton Rd, Iowa City, IA 52242 USA.	ricardo-jorge@uiowa.edu	Robinson, Robert/AAF-6191-2021; Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204; , BENEDICTO/0000-0003-0033-7132; Moser, David/0000-0003-4102-5266	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH053592, R01MH040355, R01MH052879] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 52879, MH 40355, MH 53592] Funding Source: Medline		Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P687, DOI 10.1176/appi.ajgp.10.6.687; ANDREASEN NC, 1994, P NATL ACAD SCI USA, V91, P93, DOI 10.1073/pnas.91.1.93; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; Andreasen NC, 1996, J COMPUT ASSIST TOMO, V20, P98, DOI 10.1097/00004728-199601000-00018; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Benton A., 1994, MULTILINGUAL APHASIA; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowen A, 1999, BRAIN INJURY, V13, P547; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; COHEN G, 1992, PSYCHIAT RES-NEUROIM, V45, P33, DOI 10.1016/0925-4927(92)90012-S; Crespo-Facorro B, 1999, NEUROIMAGE, V10, P500, DOI 10.1006/nimg.1999.0489; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fava M, 1998, J CLIN PSYCHIAT, V59, P18; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forer S., 1987, FUNCTIONAL INDEPENDE; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; Golarai G, 2001, J NEUROSCI, V21, P8523; Golden C., 1978, STROOP COLOR WORD TE; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harris G, 1999, J COMPUT ASSIST TOMO, V23, P144, DOI 10.1097/00004728-199901000-00030; Heaton R., 1993, WISCONSIN CARD SORTI; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kesler SR, 2000, BRAIN INJURY, V14, P851; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krishnan KRR, 2002, BIOL PSYCHIAT, V52, P559, DOI 10.1016/S0006-3223(02)01472-5; Levin H. S., 1997, SEMINARS CLIN NEUROP, V2, P207; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1991, FRONTAL LOBE FUNCTIO, V15, P427; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Lopez-Larson MP, 2002, BIOL PSYCHIAT, V52, P93, DOI 10.1016/S0006-3223(02)01350-1; Magnotta VA, 1999, RADIOLOGY, V211, P781, DOI 10.1148/radiology.211.3.r99ma07781; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MAYBERG HS, 1992, NEUROLOGY, V42, P1791, DOI 10.1212/WNL.42.9.1791; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Parsey RV, 2002, BRAIN RES, V954, P173, DOI 10.1016/S0006-8993(02)03243-2; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; SALLOWAY S, 2001, FRONTAL LOBES NEUROP, V10, P264; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soares JC, 1997, J PSYCHIATR RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Starr L B, 1982, Soc Work Res Abstr, V18, P28; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; Strakowski SM, 2002, BIPOLAR DISORD, V4, P80, DOI 10.1034/j.1399-5618.2002.01160.x; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	84	429	440	0	51	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0003-990X			ARCH GEN PSYCHIAT	Arch. Gen. Psychiatry	JAN	2004	61	1					42	50		10.1001/archpsyc.61.1.42			9	Psychiatry	Psychiatry	761GW	WOS:000187894000005	14706943	Bronze			2021-06-18	
J	McKee, AC; Cairns, NJ; Dickson, DW; Folkerth, RD; Keene, CD; Litvan, I; Perl, DP; Stein, TD; Vonsattel, JP; Stewart, W; Tripodis, Y; Crary, JF; Bieniek, KF; Dams-O'Connor, K; Alvarez, VE; Gordon, WA				McKee, Ann C.; Cairns, Nigel J.; Dickson, Dennis W.; Folkerth, Rebecca D.; Keene, C. Dirk; Litvan, Irene; Perl, Daniel P.; Stein, Thor D.; Vonsattel, Jean-Paul; Stewart, William; Tripodis, Yorghos; Crary, John F.; Bieniek, Kevin F.; Dams-O'Connor, Kristen; Alvarez, Victor E.; Gordon, Wayne A.		TBI CTE Grp	The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA			English	Article						Chronic traumatic encephalopathy; Traumatic brain injury; Tauopathy; Brain trauma; Neurodegenerative disorders	NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; PATHOLOGY; BRAIN; DEGENERATION; AFTERMATH; TAUOPATHY; INJURY; PART	Chronic traumatic encephalopathy (CTE) is a neurodegeneration characterized by the abnormal accumulation of hyperphosphorylated tau protein within the brain. Like many other neurodegenerative conditions, at present, CTE can only be definitively diagnosed by post-mortem examination of brain tissue. As the first part of a series of consensus panels funded by the NINDS/NIBIB to define the neuropathological criteria for CTE, preliminary neuropathological criteria were used by 7 neuropathologists to blindly evaluate 25 cases of various tauopathies, including CTE, Alzheimer's disease, progressive supranuclear palsy, argyrophilic grain disease, corticobasal degeneration, primary age-related tauopathy, and parkinsonism dementia complex of Guam. The results demonstrated that there was good agreement among the neuropathologists who reviewed the cases (Cohen's kappa, 0.67) and even better agreement between reviewers and the diagnosis of CTE (Cohen's kappa, 0.78). Based on these results, the panel defined the pathognomonic lesion of CTE as an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern. The group also defined supportive but non-specific p-tau-immunoreactive features of CTE as: pretangles and NFTs affecting superficial layers (layers II-III) of cerebral cortex; pretangles, NFTs or extracellular tangles in CA2 and pretangles and proximal dendritic swellings in CA4 of the hippocampus; neuronal and astrocytic aggregates in subcortical nuclei; thorn-shaped astrocytes at the glial limitans of the subpial and periventricular regions; and large grain-like and dot-like structures. Supportive non-p-tau pathologies include TDP-43 immunoreactive neuronal cytoplasmic inclusions and dot-like structures in the hippocampus, anteromedial temporal cortex and amygdala. The panel also recommended a minimum blocking and staining scheme for pathological evaluation and made recommendations for future study. This study provides the first step towards the development of validated neuropathological criteria for CTE and will pave the way towards future clinical and mechanistic studies.	[McKee, Ann C.; Alvarez, Victor E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.; Alvarez, Victor E.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.; Tripodis, Yorghos; Alvarez, Victor E.] Boston Univ, Sch Med, Alzheimers Dis Ctr, CTE Program, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.; Alvarez, Victor E.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [McKee, Ann C.; Stein, Thor D.] Dept Veteran Affairs Med Ctr, Bedford, MA 01730 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Dickson, Dennis W.; Bieniek, Kevin F.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Folkerth, Rebecca D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Keene, C. Dirk] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98104 USA; [Litvan, Irene] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Dept Pathol, Bethesda, MD 20814 USA; [Vonsattel, Jean-Paul] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Queen Elizabeth Univ Hosp, Glasgow G51 4TF, Lanark, Scotland; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Crary, John F.] Icahn Sch Med Mt Sinai Sch, Ronald M Loeb Ctr Alzheimers Dis, Friedman Brain Inst, Fishberg Dept Neurosci,Dept Pathol, New York, NY 10029 USA; [Dams-O'Connor, Kristen; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA	McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 East Concord St, Boston, MA 02118 USA.	amckee@bu.edu	Litvan, Irene/X-9319-2018; Cairns, Nigel/AAB-9713-2020; Keene, Christopher D/N-1806-2015; Lang, Steven/AAE-8102-2021	Litvan, Irene/0000-0002-3485-3445; Cairns, Nigel/0000-0001-9858-3344; Lang, Steven/0000-0003-1669-9146; Stewart, William/0000-0003-2199-2582; Keene, Christopher/0000-0002-5291-1469; Stein, Thor/0000-0001-6954-4477; Tripodis, Yorghos/0000-0003-2190-7608; Bieniek, Kevin/0000-0003-4922-864X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01, R01NS078337, R56NS078337, R01NS095252]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064, W81XWH-14-1-0399]; Department of Veterans Affairs, the Veterans Affairs BiorepositoryUS Department of Veterans Affairs [CSP 501]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, supplement 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP) [13267017]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; National Institute on Aging (NJC) [P50 AG05681, P01 AG03991]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, U01NS086625, R01NS095252, R56NS078337, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681, P30AG013846, P01AG003991, K23AG046377] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA), the Boston University School of Medicine, and the Mayo Clinic Jacksonville. We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, the Boston VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1U01NS086659-01, R01NS078337, R56NS078337, R01NS095252), Department of Defense (W81XWH-13-2-0064, W81XWH-14-1-0399), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP # 13267017), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), the National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League. This work was supported by grants P50 AG05681 and P01 AG03991 from the National Institute on Aging (NJC).	Ahmed Z, 2013, ACTA NEUROPATHOL, V126, P537, DOI 10.1007/s00401-013-1171-0; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Critchley M, 1949, PUNCH DRUNK SYNDROME; Darby A, 2015, J NEUROPATH EXP NEUR, V74, P615; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Fleiss JL, 2003, WILEY SERIES PROBABI; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grahmann H, 1956, PSYCHIAT NEUROL BASE, V134, P261; HAUW JJ, 1994, NEUROLOGY, V44, P2015, DOI 10.1212/WNL.44.11.2015; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kouri N, 2011, NAT REV NEUROL, V7, P263, DOI 10.1038/nrneurol.2011.43; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kuzuhara S, 2001, ANN NEUROL, V49, P501, DOI 10.1002/ana.100.abs; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh J, 1937, US NAVAL MED B, V35; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyanagi K, 2011, PARKINSONISM DEMENTI, P171; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stewart W, 2015, QJM; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tolnay M, 2004, NEUROPATHOLOGY, V24, P269, DOI 10.1111/j.1440-1789.2004.00591.x; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653	48	428	430	1	80	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JAN	2016	131	1					75	86		10.1007/s00401-015-1515-z			12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	DA2CB	WOS:000367601800005	26667418	Green Published, Green Accepted, Other Gold	Y	N	2021-06-18	
J	Bergsneider, M; Hovda, DA; Shalmon, E; Kelly, DF; Vespa, PM; Martin, NA; Phelps, ME; McArthur, DL; Caron, MJ; Kraus, JF; Becker, DP				Bergsneider, M; Hovda, DA; Shalmon, E; Kelly, DF; Vespa, PM; Martin, NA; Phelps, ME; McArthur, DL; Caron, MJ; Kraus, JF; Becker, DP			Cerebral hyperglycolysis following severe traumatic brain injury in humans: A positron emission tomography study	JOURNAL OF NEUROSURGERY			English	Article						head injury; metabolic ratio; seizure; lumped constant; cerebral blood flow; positron emission tomography	EXPERIMENTAL HEAD-INJURY; BLOOD-FLOW; GLUCOSE-UTILIZATION; CEREBROSPINAL-FLUID; METABOLIC-RATE; PARTIAL SEIZURES; DYNAMIC CHANGES; AMINO-ACIDS; BARRIER; FLUORODEOXYGLUCOSE	Experimental traumatic brain injury studies have shown that cerebral hyperglycolysis is a pathophysiological response to injury-induced ionic and neurochemical cascades. This finding has important implications regarding cellular viability, vulnerability to secondary insults, and the functional capability of affected regions. Prior to this study, posttraumatic hyperglycolysis had not been detected in humans. The characteristics and incidence of cerebral hyperglycolysis were determined in 28 severely head injured patients using [F-18]fluorodeoxyglucose-positron emission tomography (FDG-PET). The local cerebral metabolic rate of glucose (CMRG) was calculated using a standard compartmental model. In six of the 28 patients, the global cerebral metabolic rate of oxygen (CMRO(2)) was determined by the simultaneous measurements of arteriovenous differences of oxygen and cerebral blood flow (xenon-133). Hyperglycolysis, defined as an increase in glucose utilization that measures two standard deviations above expected levels, was documented in all six patients in whom both FDG-PET and CMRO(2) determinations were made within 8 days of injury. Five additional patients were found to have localized areas of hyperglycolysis adjacent to focal mass lesions. Within the Ist week following the injury, 56% of patients studied had presumptive evidence of hyperglycolysis. The results of this study indicate that the metabolic state of the traumatically injured brain should be defined differentially in terms of glucose and oxygen metabolism. The use of FDG-PET demonstrates that hyperglycolysis occurs both regionally and globally following severe head injury in humans. The results of this clinical study directly complement those previously reported in experimental brain-injury studies, indicating the capability of imaging a fundamental component of cellular pathophysiology characteristic of head injury.	UNIV CALIF LOS ANGELES,CEREBRAL BLOOD FLOW LAB,DEPT MOL & MED PHARMACOL,BRAIN RES INST,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT EPIDEMIOL,LOS ANGELES,CA 90024	Bergsneider, M (corresponding author), UNIV CALIF LOS ANGELES,BRAIN INJURY RES CTR,DIV NEUROSURG,LOS ANGELES,CA 90024, USA.		McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314; Martin, Neil/0000-0002-6565-4131	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER		ACKERMANN RF, 1989, J CEREBR BLOOD F MET, V9, P774, DOI 10.1038/jcbfm.1989.111; ALAVI A, 1986, J NUCL MED, V27, P919; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ANDERSEN BJ, 1989, INTRACRANIAL PRESSUR, V7, P575; Ashford CA, 1935, BIOCHEM J, V29, P157, DOI 10.1042/bj0290157; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BENYOSEPH O, 1995, J NEUROCHEM, V64, P1336; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; BETZ AL, 1974, BRAIN RES, V67, P307; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRODERSEN P, 1974, J NEUROL NEUROSUR PS, V37, P384, DOI 10.1136/jnnp.37.4.384; BULLOCK R, 1990, ACT NEUR S, V51, P286; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; CHUGANI HT, 1993, PEDIATR NEUROL, V9, P10, DOI 10.1016/0887-8994(93)90003-U; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; ENGEL J, 1983, NEUROLOGY, V33, P400, DOI 10.1212/WNL.33.4.400; EVANS MC, 1984, BRAIN RES, V297, P235, DOI 10.1016/0006-8993(84)90565-1; GINSBERG MD, 1979, ACTA NEUROL SCAND, V70, P226; GONZALEZ MF, 1985, J COMP NEUROL, V231, P457, DOI 10.1002/cne.902310405; GOODMAN JC, 1995, NEUROCHEMICAL MONITO, P78; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hovda DA, 1993, ROLE NEUROTRANSMITTE, P327; HOVDA DA, 1996, NEUROTRAUMA, P1459; HUANG SC, 1981, J CEREBR BLOOD F MET, V1, P391, DOI 10.1038/jcbfm.1981.43; HUANG SC, 1980, AM J PHYSIOL, V238, pE69; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1989, INTRACRANIAL PRESSUR, V7, P584; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIPNIS DM, 1959, J BIOL CHEM, V234, P165; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Lee S. M., 1994, Society for Neuroscience Abstracts, V20, P846; LEWIS LD, 1974, J NEUROCHEM, V23, P659, DOI 10.1111/j.1471-4159.1974.tb04389.x; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin N A, 1994, Neurosurg Clin N Am, V5, P607; Mayevsky A., 1995, Journal of Neurotrauma, V12, P449; MAZZIOTTA J C, 1986, P493; MCILWAIN H, 1952, BIOCHEM J, V52, P289, DOI 10.1042/bj0520289; MUIZELAAR JP, 1993, ANN EMERG MED, V22, P1014, DOI 10.1016/S0196-0644(05)82744-1; Nakai H, 1988, Neurol Med Chir (Tokyo), V28, P11, DOI 10.2176/nmc.28.11; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; NEDERGAARD M, 1988, J CEREBR BLOOD F MET, V8, P100, DOI 10.1038/jcbfm.1988.13; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Rappaport Z H, 1981, Prog Neurol Surg, V10, P1, DOI 10.1159/000384765; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROBINSON PJ, 1986, AM J PHYSIOL, V250, pR127; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SHAH KR, 1983, NEUROSCI LETT, V40, P287, DOI 10.1016/0304-3940(83)90053-8; SHALMON E, 1995, J NEUROTRAUM, V12, P140; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soares HD, 1995, J NEUROSCI, V15, P8223; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; TABADDOR K, 1972, J TRAUMA, V12, P1053, DOI 10.1097/00005373-197212000-00006; TALAIRACH J, 1988, COPLANAR STEREOTAXIC, P81; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; THEODORE WH, 1983, ANN NEUROL, V14, P429, DOI 10.1002/ana.410140406; TODD NV, 1990, ACT NEUR S, V51, P296; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; WISE RJS, 1983, ANN NEUROL, V14, P627, DOI 10.1002/ana.410140605; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZANE CJ, 1992, J NEUROSURG, V76, pA399	80	425	429	0	23	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1997	86	2					241	251		10.3171/jns.1997.86.2.0241			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	WD677	WOS:A1997WD67700012	9010426				2021-06-18	
J	Pellman, EJ; Viano, DC; Tucker, AM; Casson, IR; Waeckerle, JF				Pellman, EJ; Viano, DC; Tucker, AM; Casson, IR; Waeckerle, JF			Concussion in professional football: Reconstruction of game impacts and injuries	NEUROSURGERY			English	Article						biomechanics; concussion; football helmets; head injury criteria; impact tolerances; sport injury prevention; traumatic brain injury	INTRACRANIAL PRESSURE; BRAIN-INJURY; 2ND IMPACT; ACCELERATION	OBJECTIVE: Concussion in professional football was studied with respect to impact types and injury biomechanics. A combination of video surveillance and laboratory reconstruction of game impacts was used to evaluate concussion biomechanics. METHODS: Between 1996 and 2001, videotapes of concussions and significant head impacts were collected from National Football League games. There were clear views of the direction and location of the helmet impact for 182 cases. In 31 cases, the speed of impact could be determined with analysis of multiple videos. Those cases were reconstructed in laboratory tests using helmeted Hybrid III dummies and the same impact velocity, direction, and head kinematics as in the game. Translational and rotational accelerations were measured, to define concussion biomechanics. Several studies were performed to ensure the accuracy and reproducibility of the video analysis and laboratory methods used. RESULTS: Concussed players experience head impacts of 9.3 +/- 1.9 m/s (20.8 +/- 4.2 miles/h). There was a rapid change in head velocity of 7.2 +/- 1.8 m/s (16.1 +/- 4.0 miles/h), which was significantly greater than that for uninjured struck players (5.0 +/- 1.1 m/s, 11.2 +/- 2.5 miles/h; t = 2.9, P < 0.005) or striking players (4.0 +/- 1.2 m/s, 8.9 +/- 2.7 miles/h; t = 7.6, P < 0.001). The peak head acceleration in concussion was 98 +/- 24 g for uninjured struck players (t = 3.1, P < 0.005). Concussion was primarily related to translational acceleration resulting from impacts on the facemask or side, or falls on the back of the helmet. Concussion could be assessed with the severity index or head injury criterion (the conventional measures of head injury risk). Nominal tolerance levels for concussion were a severity index of 300 and a head injury criterion of 250. CONCLUSION: Concussion occurs with considerable head impact velocity and velocity changes in professional football. Current National Operating Committee on Standards for Athletic Equipment standards primarily address impacts to the periphery and crown of the helmet, whereas players are experiencing injuries in impacts to the facemask, side, and back of the helmet. New tests are needed to assess the performance of helmets in reducing concussion risks involving high-velocity and long-duration injury biomechanics.	ProBiomech LLC, Bloomfield Hills, MI 48304 USA; ProHEALTH Care Assoc LLP, Lake Success, NY USA; Univ Maryland, Sch Med, Lutherville Timonium, MD USA; NYU, Med Ctr, Dept Neurol, New York, NY 10016 USA; Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY 11042 USA; Acute Care & Emergency Specialists, Leawood, KS USA	Viano, DC (corresponding author), ProBiomech LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net					ALLSOP DL, 1993, ACCIDENTAL INJURY BI, P247; AUBRY M, 2000, BRIT J SPORT MED, V36, P6; BACKAITIS SH, 1994, 1 HUMAN LIKE CRASH T; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; DIMASI FP, 1995, HS808 DOT NAT HIGHW; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Goldsmith W, 1984, BIOMECHANICS IMPACT, P149; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; HODGSON VR, 1980, REDUCING SERIOUS INJ, V7; HODGSON VR, 1985, UTILITY HEAD INJURY; Holbourn AHS, 1943, LANCET, V2, P438; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING AI, 1995, BIOMEDICAL ENG HDB, P357; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MERTZ HJ, 1996, SOC AUTOMOTIVE ENG P; *NAT OP COMM STAND, 00196 NOCSAE; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Newman J. A., 1999, P INT RESEAR C BIOME, P17; NEWMAN JA, IN PRESS J BIOMECH; Newman JA, 1993, ACCIDENTAL INJURY BI, P292; NEWMAN JA, 2000, P INT RES C BIOM IMP, P223; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; OMMAYA AK, 1966, P 10 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; PARTRICK LM, 1965, P 7 STAPP CAR CRASH, P483; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pincemaille Y, 1989, P 33 STAPP CAR CRASH, P177; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; STAPP JP, 1961, CRAVITATIONAL STRESS, P165; Vastag B, 2002, JAMA-J AM MED ASSOC, V287, P437, DOI 10.1001/jama.287.4.437; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	46	424	427	1	93	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2003	53	4					799	812		10.1093/neurosurgery/53.3.799			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	731QP	WOS:000185898200020	14519212				2021-06-18	
J	Kang, SK; Murphy, RKJ; Hwang, SW; Lee, SM; Harburg, DV; Krueger, NA; Shin, JH; Gamble, P; Cheng, HY; Yu, S; Liu, ZJ; McCall, JG; Stephen, M; Ying, HZ; Kim, J; Park, G; Webb, RC; Lee, CH; Chung, SJ; Wie, DS; Gujar, AD; Vemulapalli, B; Kim, AH; Lee, KM; Cheng, JJ; Huang, YG; Lee, SH; Braun, PV; Ray, WZ; Rogers, JA				Kang, Seung-Kyun; Murphy, Rory K. J.; Hwang, Suk-Won; Lee, Seung Min; Harburg, Daniel V.; Krueger, Neil A.; Shin, Jiho; Gamble, Paul; Cheng, Huanyu; Yu, Sooyoun; Liu, Zhuangjian; McCall, Jordan G.; Stephen, Manu; Ying, Hanze; Kim, Jeonghyun; Park, Gayoung; Webb, R. Chad; Lee, Chi Hwan; Chung, Sangjin; Wie, Dae Seung; Gujar, Amit D.; Vemulapalli, Bharat; Kim, Albert H.; Lee, Kyung-Mi; Cheng, Jianjun; Huang, Younggang; Lee, Sang Hoon; Braun, Paul V.; Ray, Wilson Z.; Rogers, John A.			Bioresorbable silicon electronic sensors for the brain	NATURE			English	Article							INTRACRANIAL-PRESSURE; TRANSIENT; MANAGEMENT; FRACTURES; MORTALITY	Many procedures in modern clinical medicine rely on the use of electronic implants in treating conditions that range from acute coronary events to traumatic injury(1,2). However, standard permanent electronic hardware acts as a nidus for infection: bacteria form biofilms along percutaneous wires, or seed haematogenously, with the potential to migrate within the body and to provoke immune-mediated pathological tissue reactions(3,4). The associated surgical retrieval procedures, meanwhile, subject patients to the distress associated with re-operation and expose them to additional complications(5-8). Here, we report materials, device architectures, integration strategies, and in vivo demonstrations in rats of implantable, multifunctional silicon sensors for the brain, for which all of the constituent materials naturally resorb via hydrolysis and/or metabolic action(9-12), eliminating the need for extraction. Continuous monitoring of intracranial pressure and temperature illustrates functionality essential to the treatment of traumatic brain injury(2,13); the measurement performance of our resorbable devices compares favourably with that of non-resorbable clinical standards. In our experiments, insulated percutaneous wires connect to an externally mounted, miniaturized wireless potentiostat for data transmission. In a separate set-up, we connect a sensor to an implanted (but only partially resorbable) data-communication system, proving the principle that there is no need for any percutaneous wiring. The devices can be adapted to sense fluid flow, motion, pH or thermal characteristics, in formats that are compatible with the body's abdomen and extremities, as well as the deep brain, suggesting that the sensors might meet many needs in clinical medicine.	[Kang, Seung-Kyun; Lee, Seung Min; Harburg, Daniel V.; Krueger, Neil A.; Ying, Hanze; Kim, Jeonghyun; Webb, R. Chad; Chung, Sangjin; Cheng, Jianjun; Braun, Paul V.; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA; [Kang, Seung-Kyun; Lee, Seung Min; Harburg, Daniel V.; Shin, Jiho; Yu, Sooyoun; Kim, Jeonghyun; Webb, R. Chad; Chung, Sangjin; Wie, Dae Seung; Braun, Paul V.; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Murphy, Rory K. J.; Gamble, Paul; Stephen, Manu; Gujar, Amit D.; Vemulapalli, Bharat; Kim, Albert H.; Ray, Wilson Z.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Hwang, Suk-Won] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136701, South Korea; [Shin, Jiho; Yu, Sooyoun] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Cheng, Huanyu] Penn State Univ, Mat Res Inst, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Liu, Zhuangjian] Inst High Performance Comp, Singapore 138632, Singapore; [McCall, Jordan G.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Park, Gayoung] Korea Univ, Dept Biomicrosyst Technol, Seoul 136701, South Korea; [Park, Gayoung; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 136713, South Korea; [Lee, Chi Hwan] Purdue Univ, Weldon Sch Biomed Engn, Sch Mech Engn, Ctr Implantable Devices,Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Wie, Dae Seung] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Huang, Younggang] Northwestern Univ, Dept Mech Engn Civil & Environm Engn, Mat Sci & Engn, Evanston, IL 60208 USA; [Huang, Younggang] Northwestern Univ, Skin Dis Res Ctr, Evanston, IL 60208 USA; [Lee, Sang Hoon] Korea Univ, Coll Hlth Sci, Dept Biomed Engn, Seoul 136703, South Korea; [Braun, Paul V.; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.; Rogers, JA (corresponding author), Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.; Ray, WZ (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA.	rayz@wudosis.wustl.edu; jrogers@illinois.edu	Cheng, Huanyu/J-7379-2015; huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016; Huang, Yonggang/B-6998-2009; Kang, Seung-Kyun/L-3053-2017; Cheng, Jianjun/AAF-4301-2019; HWANG, SUKWON/Q-8329-2018	Cheng, Huanyu/0000-0001-6075-4208; Cheng, Jianjun/0000-0003-2561-9291; Gujar, Amit/0000-0003-0689-6680; HWANG, SUKWON/0000-0002-6883-201X	Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH101956]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1C1A1A02037560]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2007-00107, NRF-2013M3A9D3045719]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH101956] Funding Source: NIH RePORTER	S.-K.K. and co-workers are funded by the Defense Advanced Research Projects Agency. J.G.M. is supported by the National Institute of Mental Health, grant F31MH101956. The authors thank M. R. Bruchas at Washington University School of Medicine for providing immunohistochemistry facilities; M. R. MacEwan at Washington University School of Medicine for discussions on animal protocols; A. Manocchi at Transient Electronics Inc. for performing the dissolution test of polyanhydride; and H. Ning at Xerion Advanced Battery Corporation for assistance with running the BET measurements. H.C. was a Howard Hughes Medical Institute International Student Research Fellow. S.-W.H. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant NRF-2015R1C1A1A02037560). G.P. and K.M.L. were supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (grants NRF-2007-00107 and NRF-2013M3A9D3045719).	BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Boutry CM, 2012, PHILOS T R SOC A, V370, P2418, DOI 10.1098/rsta.2011.0439; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brogan ME, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0327-0; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chang H, 2004, NANO LETT, V4, P1551, DOI 10.1021/nl049267c; Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Haure P, 2003, J NEUROSURG ANESTH, V15, P297, DOI 10.1097/00008506-200310000-00001; Huang X, 2014, ADV MATER, V26, P7371, DOI 10.1002/adma.201403164; Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g; Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d; Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293; Liu C., 2011, FDN MEMS; Luo MD, 2014, J MICROELECTROMECH S, V23, P4, DOI 10.1109/JMEMS.2013.2290111; Maytin M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P413, DOI 10.1161/CIRCEP.110.954107; Meldrum DR, 1997, AM J SURG, V174, P667, DOI 10.1016/S0002-9610(97)00201-8; Mittal R, 2005, INJURY, V36, P333, DOI 10.1016/j.injury.2004.09.015; MORGAN PW, 1953, IND ENG CHEM, V45, P2296, DOI 10.1021/ie50526a044; Moseley P. T., 1994, SENS MATER; Olson SA, 2005, J AM ACAD ORTHOP SUR, V13, P436, DOI 10.5435/00124635-200511000-00003; OTT K, 1976, J NEUROSURG, V44, P80, DOI 10.3171/jns.1976.44.1.0080; Poole JE, 2014, CIRCULATION, V129, P383, DOI 10.1161/CIRCULATIONAHA.112.000762; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Uslaner JM, 2012, NEUROPHARMACOLOGY, V62, P1413, DOI 10.1016/j.neuropharm.2010.11.015; Vajramani GV, 2005, BRIT J NEUROSURG, V19, P496, DOI 10.1080/02688690500495299; Ye TW, 2011, J AM PODIAT MED ASSN, V101, P307, DOI 10.7547/1010307; Yin L, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905321; Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	35	423	431	40	629	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					71	+		10.1038/nature16492			9	Multidisciplinary Sciences	Science & Technology - Other Topics	DC6BK	WOS:000369304500034	26779949		Y	N	2021-06-18	
J	YOSHINO, A; HOVDA, DA; KAWAMATA, T; KATAYAMA, Y; BECKER, DP				YOSHINO, A; HOVDA, DA; KAWAMATA, T; KATAYAMA, Y; BECKER, DP			DYNAMIC CHANGES IN LOCAL CEREBRAL GLUCOSE-UTILIZATION FOLLOWING CEREBRAL CONCUSSION IN RATS - EVIDENCE OF A HYPERMETABOLIC AND SUBSEQUENT HYPOMETABOLIC STATE	BRAIN RESEARCH			English	Article						CONCUSSION; METABOLISM; GLYCOLYSIS; HYPERMETABOLISM; HYPOMETABOLISM; AUTORADIOGRAPHY; EXCITATORY AMINO ACID; ION FLUX	TRAUMATIC BRAIN INJURY; CORTICAL SPREADING DEPRESSION; FLUID-PERCUSSION MODEL; METABOLIC CHANGES; AMINO-ACIDS; BLOOD-FLOW; RECOVERY; POTASSIUM; CORTEX; CAT	Following cerebral concussion, in which there is no evidence of direct morphological damage, cells are exposed to an increase in extracellular potassium as well as an accumulation of calcium. This concussion-induced ionic flux most likely alters the cellular energy demands thereby modifying metabolic processes. To investigate the metabolic changes after cerebral concussion, local cerebral metabolic rates for glucose (1CMRglc) utilizing [C-14]2-deoxy-D-glucose were studied in rats (n = 98; 250-300 g) immediately, 30 min, 6 h, 1, 2, 3, 5 and 10 days following a unilateral frontoparietal fluid percussion (F-P) injury (3.7-4.3 atm). Compared to sham controls, animals exhibited bilateral hypermetabolism immediately following brain injury. However, this effect was more pronounced in structures ipsilateral to the site of F-P and was especially marked for the cerebral cortex (46.6-30.1% higher than control) and hippocampus (90.1-84.4% higher than control). By 30 min post-trauma many ipsilateral regions still showed evidence of hypermetabolism, although their 1CMRglc had subsided. Beginning as early as 6 h following injury many regions within the ipsilateral cortex and hippocampus went into a state of metabolic depression (16.4-33.7% of control) which lasted for as long as 5 days. These results indicate that, although not mechanically damaged from the insult, cells exposed to concussive injury dramatically alter their metabolic functioning. This period of post-concussive metabolic dysfunction may delineate a period of time, following injury, during which cells are functionally compromised.	UNIV CALIF LOS ANGELES,SCH MED,DIV NEUROSURG,CHS 74-140,LOS ANGELES,CA 90024					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308, R01NS027544] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS27544, NS30308-01] Funding Source: Medline		ANDERSEN BJ, 1989, J CEREB BLOOD FLOW M, V9, pS386; ANDERSEN BJ, 1989, INTRACRANIAL PRESSUR, V7, P575; BECKER DP, 1987, PHYSL BASIS MODERN S, P763; BECKER DP, 1985, CENTRAL NERVOUS SYST, P229; BECKER DP, 1985, CESIL TXB MED, P2170; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BOYESON MG, 1989, J NEUROL REHABIL, V3, P35; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CSIBA L, 1985, BRAIN RES, V336, P167, DOI 10.1016/0006-8993(85)90430-5; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DESALLES A A F, 1986, Society for Neuroscience Abstracts, V12, P967; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; FINEMAN I, 1990, Society for Neuroscience Abstracts, V16, P778; GINSBERG M D, 1979, Acta Neurologica Scandinavica Supplementum, V60, P226; GRAYBIEL AM, 1971, ANAT REC, V169, P328; HAYES RL, 1984, SCIENCE, V233, P301; HAYES RL, 1988, J NEUROTRAUM, V5, P121; HOVDA DA, IN PRESS BRAIN RES; HOVDA DA, IN PRESS NEUROTRAUMA; INAO S, 1990, J NEUROTRAUM, V7, P100; KATAYAMA Y, 1988, Society for Neuroscience Abstracts, V14, P1154; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1989, NEUROTRAUMA SOC, V6, P200; KATO M, 1980, ANN NEUROL, V7, P204, DOI 10.1002/ana.410070303; KAWAMATA T, 1990, Society for Neuroscience Abstracts, V16, P778; KAWAMATA T, IN PRESS NEUROTRAUMA; KRIVANEK J, 1961, J NEUROCHEM, V6, P183, DOI 10.1111/j.1471-4159.1961.tb13463.x; KUSHNER M, 1984, ANN NEUROL, V15, P425, DOI 10.1002/ana.410150505; LOTHMAN E, 1975, BRAIN RES, V88, P15, DOI 10.1016/0006-8993(75)90943-9; MAYEVSKY A, 1974, BRAIN RES, V65, P529, DOI 10.1016/0006-8993(74)90243-1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nakai H, 1988, Neurol Med Chir (Tokyo), V28, P11, DOI 10.2176/nmc.28.11; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAPPIUS HM, 1983, J CEREBR BLOOD F MET, V3, P448, DOI 10.1038/jcbfm.1983.71; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; PAPPIUS HM, 1988, METAB BRAIN DIS, V3, P303, DOI 10.1007/BF00999542; PAPPIUS HM, 1982, ANN NEUROL, V12, P157, DOI 10.1002/ana.410120205; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; ROMHANYI RS, IN PRESS NEUR SOC AB; SHAH KR, 1983, NEUROSCI LETT, V40, P287, DOI 10.1016/0304-3940(83)90053-8; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; SMITH M, IN PRESS NEUR SOC AB; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; SUTTON R L, 1989, Society for Neuroscience Abstracts, V15, P128; TANDIAN D, IN PRESS NEUR SOC AB; THOMAS M J, 1990, Society for Neuroscience Abstracts, V16, P777; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YOSHINO A, 1990, J CEREB BLOOD FLOW M, V10, P5343; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	59	420	423	1	33	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 4	1991	561	1					106	119		10.1016/0006-8993(91)90755-K			14	Neurosciences	Neurosciences & Neurology	GM588	WOS:A1991GM58800014	1797338				2021-06-18	
J	Wright, DW; Kellermann, AL; Hertzberg, VS; Clark, PL; Frankel, M; Goldstein, FC; Salomone, JP; Dent, LL; Harris, OA; Ander, DS; Lowery, DW; Patel, MM; Denson, DD; Gordon, AB; Wald, MM; Gupta, S; Hoffman, SW; Stein, DG				Wright, David W.; Kellermann, Arthur L.; Hertzberg, Vicki S.; Clark, Pamela L.; Frankel, Michael; Goldstein, Felicia C.; Salomone, Jeffrey P.; Dent, L. Leon; Harris, Odette A.; Ander, Douglas S.; Lowery, Douglas W.; Patel, Manish M.; Denson, Donald D.; Gordon, Angelita B.; Wald, Marlena M.; Gupta, Sanjay; Hoffman, Stuart W.; Stein, Donald G.			ProTECT: A randomized clinical trial of progesterone for acute traumatic brain injury	ANNALS OF EMERGENCY MEDICINE			English	Article							HIGH-DOSE PROGESTERONE; SEVERE HEAD-INJURY; PERIPHERAL NERVOUS SYSTEMS; OUTCOME MEASURES; FEMALE RATS; CELL-DEATH; CORTICAL CONTUSION; CEREBRAL-ISCHEMIA; PREFRONTAL CORTEX; STEROID-HORMONES	Study objective: Laboratory evidence indicates that progesterone has potent neuroprotective effects. We conducted a pilot clinical trial to assess the safety and potential benefit of administering progesterone to patients with acute traumatic brain injury. Methods: This phase II, randomized, double-blind, placebo-controlled trial was conducted at an urban Level I trauma center. One hundred adult trauma patients who arrived within 11 hours of injury with a postresuscitation Glasgow Coma Scale score of 4 to 12 were enrolled with proxy consent. Subjects were randomized on a 4:1 basis to receive either intravenous progesterone or placebo. Blinded observers assessed patients daily for the occurrence of adverse events and signs of recovery. Neurologic outcome was assessed 30 days postinjury. The primary safety measures were differences in adverse event rates and 30-day mortality. The primary measure of benefit was the dichotomized Glasgow Outcome Scale-Extended 30 days postinjury. Results: Seventy-seven patients received progesterone; 23 received placebo. The groups had similar demographic and clinical characteristics. Laboratory and physiologic characteristics were similar at enrollment and throughout treatment. No serious adverse events were attributed to progesterone. Adverse and serious adverse event rates were similar in both groups, except that patients randomized to progesterone had a lower 30-day mortality rate than controls (rate ratio 0.43; 95% confidence interval 0.18 to 0.99). Thirty days postinjury, the majority of severe traumatic brain injury survivors in both groups had relatively poor Glasgow Outcome Scale-Extended and Disability Rating Scale scores. However, moderate traumatic brain injury survivors who received progesterone were more likely to have a moderate to good outcome than those randomized to placebo. Conclusion: In this small study, progesterone caused no discernible harm and showed possible signs of benefit.	Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA USA; Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA	Wright, DW (corresponding author), 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	David.Wright@Emory.edu	Stein, Donald/AAJ-5139-2020; Wright, David/F-1209-2013; Lowery-North, Douglas/B-7626-2013	Wright, David/0000-0002-7145-9105; Salomone, Jeffrey/0000-0002-1322-202X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039097] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 R01 NS-39097-01A1] Funding Source: Medline		Aebi S, 1999, CANCER CHEMOTH PHARM, V44, P259, DOI 10.1007/s002800050976; AlDahan MI, 1996, BRAIN RES, V727, P40; Alderson P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001048.PUB2, 10.1002/14651858.CD001048.pub2]; ALDERSON P, 2002, COCHRANE DB SYST REV; Allolio B, 1995, EUR J ENDOCRINOL, V133, P696, DOI 10.1530/eje.0.1330696; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; BACKSTROM T, 1984, ACTA NEUROL SCAND, V69, P240; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; Behl C, 1997, EUR J NEUROSCI, V9, P912, DOI 10.1111/j.1460-9568.1997.tb01442.x; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bergeron R, 1996, J NEUROSCI, V16, P1193; BETZ AL, 1990, ACT NEUR S, V51, P256; Bullock MR, 1996, J NEUROTRAUM, V13, P715; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Centers for Disease Control and Prevention, VIT STAT; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; CHRISTEN RD, 1993, J CLIN ONCOL, V11, P2417, DOI 10.1200/JCO.1993.11.12.2417; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; *COCHR COLL, 2005, BRAIN INJ; COHADON F, 1991, J NEUROL SCI, V103, pS27; Concas A, 1999, EUR J PHARMACOL, V375, P225, DOI 10.1016/S0014-2999(99)00232-0; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; GENTLEMAN D, 1992, INJURY, V23, P471, DOI 10.1016/0020-1383(92)90066-2; Goldfien A, 1989, BASIC CLIN PHARM, P493; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hunt JS, 1997, J REPROD IMMUNOL, V35, P87, DOI 10.1016/S0165-0378(97)00060-0; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; KRAUS J, 1997, HEAD INJURY, P1; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MAYO W, 1993, BRAIN RES, V607, P324, DOI 10.1016/0006-8993(93)91524-V; McCullagh P., 1989, GEN LINEAR MODELS; MCEWEN BS, 1991, J STEROID BIOCHEM, V39, P223, DOI 10.1016/0960-0760(91)90067-F; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; MURAD F, 1990, P1384; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; SAKATA R, 1991, BRAIN INJURY, V4, P411; Schumacher M, 1995, CIBA F SYMP, V191, P90; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; STEIN DG, 1999, COGNITIVE NEUROREHAB, P73; Sugino N, 1996, ENDOCRINOLOGY, V137, P749, DOI 10.1210/en.137.2.749; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Thurman DJ, 2001, HEAD TRAUMA, P327; *US FOOD DRUG ADM, 1996, DEADL DIS PEOPL COL, P1; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	78	418	427	0	36	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2007	49	4					391	402		10.1016/j.annemergmed.2006.07.932			12	Emergency Medicine	Emergency Medicine	151ME	WOS:000245293700001	17011666				2021-06-18	
J	Halstead, ME; Walter, KD				Halstead, Mark E.; Walter, Kevin D.		Council Sports Med Fitness	Clinical Report-Sport-Related Concussion in Children and Adolescents	PEDIATRICS			English	Article						concussion; sports; head injury; mild traumatic brain injury; return to play; athletes; second-impact syndrome; postconcussion syndrome	TRAUMATIC BRAIN-INJURY; CATASTROPHIC HEAD-INJURIES; SCHOOL FOOTBALL PLAYERS; TEST-RETEST RELIABILITY; ERROR SCORING SYSTEM; RETURN-TO-PLAY; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; MONITORING RESOLUTION; PROFESSIONAL FOOTBALL	Sport-related concussion is a "hot topic" in the media and in medicine. It is a common injury that is likely underreported by pediatric and adolescent athletes. Football has the highest incidence of concussion, but girls have higher concussion rates than boys do in similar sports. A clear understanding of the definition, signs, and symptoms of concussion is necessary to recognize it and rule out more severe intracranial injury. Concussion can cause symptoms that interfere with school, social and family relationships, and participation in sports. Recognition and education are paramount, because although proper equipment, sport technique, and adherence to rules of the sport may decrease the incidence or severity of concussions, nothing has been shown to prevent them. Appropriate management is essential for reducing the risk of long-term symptoms and complications. Cognitive and physical rest is the mainstay of management after diagnosis, and neuropsychological testing is a helpful tool in the management of concussion. Return to sport should be accomplished by using a progressive exercise program while evaluating for any return of signs or symptoms. This report serves as a basis for understanding the diagnosis and management of concussion in children and adolescent athletes. Pediatrics 2010; 126: 597-615								Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; *BOST U CTR STUD T, CAS STUD; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; *CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; *CO MED SOC, 1991, REP SPORTS MED COMM; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; COLLINS MW, 2009, AM ORTH SOC SPORTS M; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2005, BRIT MED J, V330, P345; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee Bruce, 2005, NeuroRx, V2, P372; Lee Michael A, 2009, Conn Med, V73, P171; Lee Michael A, 2006, Conn Med, V70, P377; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2005, BRIT J SPORT MED, V39, P116, DOI 10.1136/bjsm.2004.015958; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Onate JA, 2007, J ATHL TRAINING, V42, P446; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Solomon GS, 2007, J NEUROPSYCH CLIN N, V19, P195, DOI 10.1176/appi.neuropsych.19.2.195; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; *US DEP HHS, HEADS FACTS PHYS MIL; *US DEP HHS, 2005, HEADS UP TOOLK; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; *WA STAT DEP HLTH, CONC MAN SCH SPORTS; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; World Health Organization, 1992, ICD 10 CLASS MENT BE; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	150	416	418	5	116	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2010	126	3					597	611		10.1542/peds.2010-2005			15	Pediatrics	Pediatrics	646JK	WOS:000281535700024	20805152	Bronze			2021-06-18	
J	Mac Donald, CL; Johnson, AM; Cooper, D; Nelson, EC; Werner, NJ; Shimony, JS; Snyder, AZ; Raichle, ME; Witherow, JR; Fang, R; Flaherty, SF; Brody, DL				Mac Donald, Christine L.; Johnson, Ann M.; Cooper, Dana; Nelson, Elliot C.; Werner, Nicole J.; Shimony, Joshua S.; Snyder, Abraham Z.; Raichle, Marcus E.; Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.; Brody, David L.			Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; WHITE-MATTER INJURY; CLOSED-HEAD INJURY; MILD; VETERANS; MEMORY; MODEL; TIME; IRAQ	Background Blast-related traumatic brain injuries have been common in the Iraq and Afghanistan wars, but fundamental questions about the nature of these injuries remain unanswered. Methods We tested the hypothesis that blast-related traumatic brain injury causes traumatic axonal injury, using diffusion tensor imaging (DTI), an advanced form of magnetic resonance imaging that is sensitive to axonal injury. The subjects were 63 U. S. military personnel who had a clinical diagnosis of mild, uncomplicated traumatic brain injury. They were evacuated from the field to the Landstuhl Regional Medical Center in Landstuhl, Germany, where they underwent DTI scanning within 90 days after the injury. All the subjects had primary blast exposure plus another, blast-related mechanism of injury (e. g., being struck by a blunt object or injured in a fall or motor vehicle crash). Controls consisted of 21 military personnel who had blast exposure and other injuries but no clinical diagnosis of traumatic brain injury. Results Abnormalities revealed on DTI were consistent with traumatic axonal injury in many of the subjects with traumatic brain injury. None had detectible intracranial injury on computed tomography. As compared with DTI scans in controls, the scans in the subjects with traumatic brain injury showed marked abnormalities in the middle cerebellar peduncles (P<0.001), in cingulum bundles (P=0.002), and in the right orbitofrontal white matter (P=0.007). In 18 of the 63 subjects with traumatic brain injury, a significantly greater number of abnormalities were found on DTI than would be expected by chance (P<0.001). Follow-up DTI scans in 47 subjects with traumatic brain injury 6 to 12 months after enrollment showed persistent abnormalities that were consistent with evolving injuries. Conclusions DTI findings in U. S. military personnel support the hypothesis that blast-related mild traumatic brain injury can involve axonal injury. However, the contribution of primary blast exposure as compared with that of other types of injury could not be determined directly, since none of the subjects with traumatic brain injury had isolated primary blast injury. Furthermore, many of these subjects did not have abnormalities on DTI. Thus, traumatic brain injury remains a clinical diagnosis. (Funded by the Congressionally Directed Medical Research Program and the National Institutes of Health; ClinicalTrials.gov number, NCT00785304.)	[Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Flaherty, Stephen F.] Walter Reed Army Med Ctr, Washington, DC 20307 USA	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, Biotech Bldg,Rm 201,660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0061]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32NS062529, 5K23HD053212, P30NS048056, P50NS06833, 5K08NS49237]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD053212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS006833, F32NS062529, P30NS048056, K08NS049237] Funding Source: NIH RePORTER	Supported by a grant from the Congressionally Directed Medical Research Program (W81XWH-08-2-0061, to Dr. Brody) and the National Institutes of Health (F32NS062529, to Dr. Mac Donald; 5K23HD053212, to Dr. Shimony; P30NS048056, to Dr. Snyder; P50NS06833, to Drs. Raichle and Snyder; and 5K08NS49237, to Dr. Brody.)	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Casscells SW, 2007, TRAUMATIC BRAIN INJU; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mott F. W., 1917, J ROY ARMY MED CORPS, V29, P662; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	43	415	416	1	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2091	2100		10.1056/NEJMoa1008069			10	Medicine, General & Internal	General & Internal Medicine	772AB	WOS:000291200700007	21631321	Green Accepted, Green Published	Y	N	2021-06-18	
J	Nistor, GI; Totoiu, MO; Haque, N; Carpenter, MK; Keirstead, HS				Nistor, GI; Totoiu, MO; Haque, N; Carpenter, MK; Keirstead, HS			Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation	GLIA			English	Article						human embryonic stem cells; differentiation; oligodendrocyte; progenitor; transplantation; remyelination	CENTRAL-NERVOUS-SYSTEM; SHIVERER MOUSE-BRAIN; IN-VITRO; GROWTH-FACTOR; NEURAL PRECURSORS; HUMAN BLASTOCYSTS; PROGENITOR CELLS; GLIAL-CELLS; NEURONS; LINEAGE	Human embryonic stem cells (hESCs) demonstrate remarkable proliferative and developmental capacity. Clinical interest arises from their ability to provide an apparently unlimited cell supply for transplantation, and from the hope that they can be directed to desirable phenotypes in high purity. Here we present for the first time a method for obtaining oligodendrocytes and their progenitors in high yield from hESCs. We expanded hESCs, promoted their differentiation into oligodendroglial progenitors, amplified those progenitors, and then promoted oligodendroglial differentiation using positive selection and mechanical enrichment. Transplantation into the shiverer model of dysmyelination resulted in integration, differentiation into oligodendrocytes, and compact myelin formation, demonstrating that these cells display a functional phenotype. This differentiation protocol provides a means of generating human oligodendroglial lineage cells in high purity, for use in studies of lineage development, screening assays of oligodendroglial-specific compounds, and treating neurodegenerative diseases and traumatic injuries to the adult CNS. (C) 2004 Wiley-Liss, Inc.	Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Reeve Irvine Res Ctr,Gillespie NeuroSci Res Facil, Irvine, CA 92697 USA; Geron Corp, Menlo Pk, CA USA	Keirstead, HS (corresponding author), Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Reeve Irvine Res Ctr,Gillespie NeuroSci Res Facil, Irvine, CA 92697 USA.	hansk@uci.edu					ABNEY ER, 1983, DEV BIOL, V100, P166, DOI 10.1016/0012-1606(83)90207-5; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BARONVANEVERCOOREN A, 1991, J NEUROSCI RES, V28, P244, DOI 10.1002/jnr.490280212; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.3.CO;2-2; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Deacon T, 1998, EXP NEUROL, V149, P28, DOI 10.1006/exnr.1997.6674; Engelhard HH, 2003, SURG NEUROL, V60, P443, DOI 10.1016/S0090-3019(03)00167-8; Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1; GANSMULLER A, 1991, GLIA, V4, P580, DOI 10.1002/glia.440040605; GANSMULLER A, 1986, DEV NEUROSCI-BASEL, V8, P197, DOI 10.1159/000112253; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Grinspan J, 2002, J NEUROPATH EXP NEUR, V61, P297, DOI 10.1093/jnen/61.4.297; GUMPEL M, 1987, ANN NY ACAD SCI, V495, P71, DOI 10.1111/j.1749-6632.1987.tb23666.x; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Ibarrola N, 1996, DEV BIOL, V180, P1, DOI 10.1006/dbio.1996.0280; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Keirstead HS, 2001, J NEUROSCI RES, V63, P233, DOI 10.1002/1097-4547(20010201)63:3<233::AID-JNR1016>3.0.CO;2-B; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; LEVINE JM, 1987, J NEUROSCI, V7, P2721; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; MAJOR EO, 1992, CLIN MICROBIOL REV, V5, P49, DOI 10.1128/CMR.5.1.49-73.1992; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; Nakagaito Y, 1998, IN VITRO CELL DEV-AN, V34, P585; Nishimura F, 2003, STEM CELLS, V21, P171, DOI 10.1634/stemcells.21-2-171; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399; RODRIGUEZ M, 1993, MAYO CLIN PROC, V68, P627, DOI 10.1016/S0025-6196(12)60597-7; Schulze D, 2000, IMECHE CONF TRANS, V2000, P97; Seilhean D, 1996, ACTA NEUROPATHOL, V91, P82; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WILES MV, 1991, DEVELOPMENT, V111, P259; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	61	412	430	2	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2005	49	3					385	396		10.1002/glia.20127			12	Neurosciences	Neurosciences & Neurology	888DS	WOS:000226355000007	15538751				2021-06-18	
J	Ragnarsson, KT; Moses, LG; Clarke, WR; Daling, JR; Garber, SL; Gustafson, CF; Holland, AL; Jordan, BD; Parker, JC; Riddle, MA; Roth, EJ; Seltzer, MM; Small, SL; Therrien, B; Wexler, BE; Yawn, BP				Ragnarsson, KT; Moses, LG; Clarke, WR; Daling, JR; Garber, SL; Gustafson, CF; Holland, AL; Jordan, BD; Parker, JC; Riddle, MA; Roth, EJ; Seltzer, MM; Small, SL; Therrien, B; Wexler, BE; Yawn, BP		NIH Consensus Dev Panel Rehabil Persons Traumat	Rehabilitation of persons with traumatic brain injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE HEAD-INJURY; REMEDIATION; ADOLESCENTS; ATTENTION; OUTCOMES; RECOVERY; DEFICITS; CHILDREN; PROGRAM; ISSUES	Objective To provide biomedical researchers and clinicians with information regarding and recommendations for effective rehabilitation measures for persons who have experienced a traumatic brain injury (TBI). Participants A nonfederal, nonadvocate, 16-member panel representing the fields of neuropsychology, neurology, psychiatry, behavioral medicine, family medicine, pediatrics, physical medicine and rehabilitation, speech and hearing, occupational therapy, nursing, epidemiology, biostatistics, and the public. In addition, 31 experts from these same fields presented data to the panel and a conference audience of 883 members of the public. The conference consisted of (1) presentations by investigators working in areas relevant to the consensus questions during a 2-day public session; (2) questions and statements from conference attendees during open discussions that were part of the public session; and (3) closed deliberations by the panel during the remainder of the second day and part of the third. Primary sponsors of the conference were the National Institute of Child Health and Human Development and the National Institutes of Health Office of Medical Applications of Research. Evidence The literature was searched through MEDLINE for articles from January 1988 through August 1998 and an extensive bibliography of 2563 references was provided to the panel and the conference audience. Experts prepared abstracts for their conference presentations with relevant citations from the literature. The panel prepared a compendium of evidence, including a patient contribution and reports from federal agencies. Scientific evidence was given precedence over clinical anecdotal experience. Consensus Process The panel, answering predefined questions, developed their conclusions based on the scientific evidence presented during the open forum (October 26-28, 1998) and in the scientific literature. The panel composed a draft statement that was read in its entirety and circulated to the experts and the audience for comment. Thereafter the panel resolved conflicting recommendations and released a revised statement at the end of the conference. The panel finalized the revisions within a few weeks after the conference. The draft statement was made available on the internet immediately following its release at the conference and was updated with the panel's final revisions. Conclusions Traumatic brain injury results principally from vehicular incidents, falls, acts of violence, and sports injuries and is more than twice as likely to occur in men as in women. The estimated incidence rate is 100 per 100 000 persons, with 52 000 annual deaths. The highest incidence is among persons aged 15 to 24 years and 75 years or older, with a less striking peak in incidence in children aged 5 years or younger. Since TBI may result in lifelong impairment of physical, cognitive, and psychosocial functioning and prevalence is estimated at 2.5 million to 6.5 million individuals, TBI is a disorder of major public health significance. Mild TBI is significantly underdiagnosed and the likely societal burden is therefore even greater. Given the large toll of TBI and absence of a cure, prevention is of paramount importance. However, the focus of this conference was the evaluation of rehabilitative measures for the cognitive and behavioral consequences of TBI. Evidence supports the use of certain cognitive and behavioral rehabilitation strategies for individuals with TBI. This research needs to be replicated in larger, more definitive clinical trials and, thus, funding for research on TBI needs to be increased.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; Univ Iowa, Dept Prevent Med, Iowa City, IA 52242 USA; Fred Hutchinson Canc Res Ctr, Dept Epidemiol, Seattle, WA 98104 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Inst Cognit Prosthet, Bala Cynwyd, PA USA; Univ Arizona, Dept Speech & Hearing Sci, Tucson, AZ 85721 USA; Charles R Drew Univ Med & Sci, Biobehav Res Ctr, Los Angeles, CA 90059 USA; Univ Missouri, Sch Med, Columbia, MO USA; Harry S Truman Mem Vet Hosp, Dept Vet Affairs, Columbia, MO 65201 USA; Johns Hopkins Univ, Sch Med, Div Child & Adolescent Psychiat, Baltimore, MD USA; Northwestern Univ, Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Univ Michigan, Sch Nursing, Ctr Enhancement & Restorat Cognit Funct, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat, New Haven, CT 06508 USA; Olmsted Med Ctr, Rochester, MN USA	Ragnarsson, KT (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA.		Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Thurman, David/0000-0002-0533-7062; Parker, Jerry/0000-0001-7784-1199; Whyte, John/0000-0002-4381-1474; Ottenbacher, Kenneth/0000-0001-5990-3982			ARNSTEN AFT, 1999, COGNITIVE NEUROREHAB; ARONOW HU, 1995, J HEAD TRAUMA REHAB, V10, P24; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BLACK JE, 1998, HDB CHILD ADOLESCENT, V6, P31; Brandt E. N., 1997, ENABLING AM ASSESSIN; *CDCP, TRAUM INJ US INT REP; Conti AC, 1998, J NEUROSCI, V18, P5663; CORCORAN M, 1997, OCCUPATIONAL THERAPY; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Damasio A. R., 1994, DESCARTESERROR; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dresser R, 1996, JAMA-J AM MED ASSOC, V276, P67, DOI 10.1001/jama.276.1.67; ERB DE, 1991, EXP BRAIN RES, V83, P253; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; GREENOUGH WT, 1999, CHANGING NERVOUS SYS; GREENOUGH WT, IN PRESS ADV RES DEV; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; GRONWALL D, 1974, LANCET, V2, P605; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; Haimowitz S, 1997, HASTINGS CENT REP, V27, P9, DOI 10.2307/3527712; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, IN PRESS REHABILITAT; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; HELFFENSTEIN DA, 1982, CLIN NEUROPSYCHOLOGY, V4, P139; JONES TA, IN PRESS MENTAL RETA; KRAMER MS, 1984, JAMA-J AM MED ASSOC, V252, P2739, DOI 10.1001/jama.252.19.2739; KRAUSE J, IN PRESS HEAD INJURY; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK M, 1978, J CLIN PSYCHIAT, V39, P111; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MANN L, 1979, TRAIL PROCESS HIST P; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MERZENICH M, 1996, COLD SPRING HARBOR S, V41; *NAT CTR HLTH STAT, 1997, DAT FIL DOC; *NAT CTR MED REH R, 1993, RES PLAN NAT CTR MED; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; OTTENBACHER KJ, 1995, ARCH PHYS MED REHAB, V76, P123, DOI 10.1016/S0003-9993(95)80021-2; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PHILLIPS LL, IN PRESS HIPPOCAMPUS; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POPE AM, 1991, DISABILITY AM NATL A; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Ruff RM, 1996, NEUROREHABILITATION, V7, P39, DOI 10.3233/NRE-1996-7105; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SHAMOO AE, 1998, HLTH CARE ETHICS CRI, P239; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Whitehead J., 1997, DESIGN ANAL SEQUENTI; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P428, DOI 10.1097/00002060-199411000-00008; Whyte J, 1998, REHABILITATION MED P, P1191; WHYTE J, 1999, REHABILITATION ADULT; Whyte J., 1997, PROMISE OUTCOMES RES, P43; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Ylvisaker M., 1998, COLLABORATIVE BRAIN	65	412	417	2	74	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1999	282	10					974	983					10	Medicine, General & Internal	General & Internal Medicine	231XD	WOS:000082335900037					2021-06-18	
J	Vandierendonck, A; Liefooghe, B; Verbruggen, F				Vandierendonck, Andre; Liefooghe, Baptist; Verbruggen, Frederick			Task Switching: Interplay of Reconfiguration and Interference Control	PSYCHOLOGICAL BULLETIN			English	Article						task switching; cognitive control; task-set reconfiguration; interference	PSYCHOLOGICAL REFRACTORY PERIOD; ADULT AGE-DIFFERENCES; CLOSED-HEAD INJURY; SET RECONFIGURATION; EXECUTIVE CONTROL; COGNITIVE CONTROL; WORKING-MEMORY; RESPONSE SELECTION; ARTICULATORY SUPPRESSION; BACKWARD INHIBITION	The task-switching paradigm is being increasingly used as a tool for studying cognitive control and task coordination. Different procedural variations have been developed. They have in common that a comparison is made between transitions in which the previous task is repeated and transitions that involve a change toward another task. In general, a performance switch cost is observed such that switching to a new task results in a slower and more error-prone execution of the task. The present article reviews the theoretical explanations of the switch cost and the findings collected in support of those explanations. Resolution and protection from interference by previous events explain part of the switching cost, but processes related to task setting and task preparation also play a prominent role, as testified by faster execution and lower switch costs when the preparation time is longer. The authors discuss the evidence in favor of each of these sets of accounts and raise a number of questions that situate task switching in a broader context of cognitive control processes. The role of several aspects of the task set, including task variations, task-set overlap, and task-set structure, is addressed, as is the role of knowledge about probability of task changes and about the structure of task sequences.	[Vandierendonck, Andre; Liefooghe, Baptist; Verbruggen, Frederick] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Vandierendonck, A (corresponding author), Univ Ghent, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium.	Andre.Vandierendonck@UGent.be	Vandierendonck, Andre/A-6502-2008; Liefooghe, Baptist/C-7336-2018; Verbruggen, Frederick/R-6357-2017	Vandierendonck, Andre/0000-0002-9493-8862; Liefooghe, Baptist/0000-0001-5896-2884; Verbruggen, Frederick/0000-0002-7958-0719	Research Foundation-FlandersFWO	The research reported in this article was supported by a sabbatical leave to Andre Vandierendonck by the Research Foundation-Flanders. We are indebted to Marcel Brass and Arnaud Szmalec for their helpful comments on an earlier draft of this paper.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Altmann EM, 2005, PSYCHON B REV, V12, P535, DOI 10.3758/BF03193801; Altmann EM, 2004, PSYCHOL SCI, V15, P616, DOI 10.1111/j.0956-7976.2004.00729.x; Altmann EM, 2004, MEM COGNITION, V32, P153, DOI 10.3758/BF03195828; Altmann EM, 2002, PSYCHOL SCI, V13, P27, DOI 10.1111/1467-9280.00405; Altmann EM, 2002, PSYCHOL RES-PSYCH FO, V66, P287, DOI 10.1007/s00426-002-0102-9; Altmann EM, 2008, PSYCHOL REV, V115, P602, DOI 10.1037/0033-295X.115.3.602; Altmann EM, 2007, J EXP PSYCHOL LEARN, V33, P892, DOI 10.1037/0278-7393.33.5.892; Altmann EM, 2007, J EXP PSYCHOL LEARN, V33, P475, DOI 10.1037/0278-7393.33.3.475; Altmann EM, 2006, PSYCHON B REV, V13, P1016, DOI 10.3758/BF03213918; Anderson JR., 1998, ATOMIC COMPONENTS TH; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arbuthnott KD, 2008, CAN J EXP PSYCHOL, V62, P91, DOI 10.1037/1196-1961.62.2.91; Arbuthnott KD, 2005, J EXP PSYCHOL LEARN, V31, P1030, DOI 10.1037/0278-7393.31.5.1030; Arbuthnott KD, 2002, CAN J EXP PSYCHOL, V56, P18, DOI 10.1037/h0087382; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Arrington CM, 2008, MEM COGNITION, V36, P991, DOI 10.3758/MC.36.5.991; Arrington CM, 2007, J EXP PSYCHOL LEARN, V33, P484, DOI 10.1037/0278-7393.33.3.484; Arrington CM, 2010, LATERALITY, V15, P501, DOI 10.1080/13576500902984695; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Arrington CM, 2004, MEM COGNITION, V32, P965, DOI 10.3758/BF03196874; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; Arrington CM, 2003, MEM COGNITION, V31, P781, DOI 10.3758/BF03196116; Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Band GPH, 2006, EUR J COGN PSYCHOL, V18, P593, DOI 10.1080/09541440500423244; Barton JJS, 2006, EXP BRAIN RES, V168, P76, DOI 10.1007/s00221-005-0091-1; Barton JJS, 2002, ANN NY ACAD SCI, V956, P250, DOI 10.1111/j.1749-6632.2002.tb02824.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Brown S, 2006, PSYCHON B REV, V13, P152, DOI 10.3758/BF03193827; Bryck RL, 2008, PSYCHON B REV, V15, P128, DOI 10.3758/PBR.15.1.128; Bryck RL, 2005, MEM COGNITION, V33, P611, DOI 10.3758/BF03195328; Burgess P, 2005, CURR ISS THINK REASO, P199; Campbell J.I.D., 2005, HDB MATH COGNITION; CASE R, 1982, J EXP CHILD PSYCHOL, V33, P386, DOI 10.1016/0022-0965(82)90054-6; Cherkasova MV, 2002, EXP BRAIN RES, V144, P528, DOI 10.1007/s00221-002-1075-z; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Cowan N., 2005, WORKING MEMORY CAPAC; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Jong R, 1999, ACTA PSYCHOL, V101, P379, DOI 10.1016/S0001-6918(99)00012-8; De Jong R, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P357; De Jong R, 2001, EUR J COGN PSYCHOL, V13, P71, DOI 10.1080/09541440042000223; DEMANET J, PSYCHONOMIC IN PRESS; Dreisbach G, 2002, J EXP PSYCHOL LEARN, V28, P468, DOI 10.1037//0278-7393.28.3.468; Dreisbach G, 2007, PSYCHOL RES-PSYCH FO, V71, P383, DOI 10.1007/s00426-005-0041-3; Dreisbach G, 2006, PSYCHON B REV, V13, P334, DOI 10.3758/BF03193853; Druey MD, 2008, PSYCHOL RES-PSYCH FO, V72, P515, DOI 10.1007/s00426-007-0127-1; Druey MD, 2007, PSYCHON B REV, V14, P749, DOI 10.3758/BF03196832; Duncan J, 2008, J EXP PSYCHOL GEN, V137, P131, DOI 10.1037/0096-3445.137.1.131; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Ellefson MR, 2006, COGNITIVE DEV, V21, P108, DOI 10.1016/j.cogdev.2006.01.002; Emerson MJ, 2003, J MEM LANG, V48, P148, DOI 10.1016/S0749-596X(02)00511-9; Engle R.W., 1999, MODELS WORKING MEMOR, P102, DOI DOI 10.1017/CBO9781139174909.007; Forstmann BU, 2007, COGN AFFECT BEHAV NE, V7, P286, DOI 10.3758/CABN.7.4.286; Forstmann BU, 2007, PSYCHOL RES-PSYCH FO, V71, P393, DOI 10.1007/s00426-005-0040-4; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/jocn.2006.18.3.388; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gade M, 2005, PSYCHON B REV, V12, P530, DOI 10.3758/BF03193800; Gade M, 2007, Q J EXP PSYCHOL, V60, P762, DOI 10.1080/17470210701268005; Garavan H, 1998, MEM COGNITION, V26, P263, DOI 10.3758/BF03201138; Gilbert SJ, 2005, J EXP PSYCHOL HUMAN, V31, P92, DOI 10.1037/0096-1523.31.1.92; Gilbert SJ, 2002, COGNITIVE PSYCHOL, V44, P297, DOI 10.1006/cogp.2001.0770; Gopher D, 2000, J EXP PSYCHOL GEN, V129, P308, DOI 10.1037/0096-3445.129.3.308; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Gotler A, 2003, PSYCHON B REV, V10, P890, DOI 10.3758/BF03196549; Hahn S, 2003, PSYCHON B REV, V10, P503, DOI 10.3758/BF03196513; Hernandez AE, 1999, AGING NEUROPSYCHOL C, V6, P69, DOI 10.1076/anec.6.2.69.783; Houghton G, 2009, J EXP PSYCHOL LEARN, V35, P466, DOI 10.1037/a0014648; Hsieh S, 2002, PERCEPT MOTOR SKILL, V94, P407, DOI 10.2466/PMS.94.2.407-414; Hubner M, 2004, J EXP PSYCHOL HUMAN, V30, P1043, DOI 10.1037/0096-1523.30.6.1043; Hubner R, 2001, J EXP PSYCHOL LEARN, V27, P640, DOI 10.1037//0278-7393.27.3.640; Hunt AR, 2006, PSYCHON B REV, V13, P923, DOI 10.3758/BF03194020; Hunt AR, 2002, MEM COGNITION, V30, P529, DOI 10.3758/BF03194954; Hunt AR, 2004, BRAIN COGNITION, V55, P325, DOI 10.1016/j.bandc.2004.02.072; Ivry RB, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P401; Jersild AT, 1927, ARCH PSYCHOL, V89, P5; Jiang YH, 2004, PSYCHOL SCI, V15, P390, DOI 10.1111/j.0956-7976.2004.00690.x; Jost K, 2008, COGN AFFECT BEHAV NE, V8, P74, DOI 10.3758/CABN.8.1.74; Kane M.J., 2007, VARIATION WORKING ME, P21, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0002; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kiesel A, 2007, PSYCHOL RES-PSYCH FO, V71, P117, DOI 10.1007/s00426-005-0004-8; KLEIN LG, 2002, KAUFFMAN EARLY ED EX, V1, P1, DOI DOI 10.2139/SSRN.2355477; Kleinsorge T, 2004, PSYCHON B REV, V11, P302, DOI 10.3758/BF03196574; Kleinsorge T, 2004, EXP PSYCHOL, V51, P145, DOI 10.1027/1618-3169.51.2.145; Kleinsorge T, 2004, PSYCHOL RES-PSYCH FO, V68, P31, DOI 10.1007/s00426-003-0134-9; Kleinsorge T, 1999, PSYCHOL RES-PSYCH FO, V62, P300, DOI 10.1007/s004260050060; Kleinsorge T, 2001, PSYCHOL RES-PSYCH FO, V65, P192, DOI 10.1007/s004260000051; Kleinsorge T, 2008, PSYCHOL RES-PSYCH FO, V72, P501, DOI 10.1007/s00426-008-0137-7; Kleinsorge T, 2007, ACTA PSYCHOL, V125, P334, DOI 10.1016/j.actpsy.2006.09.002; Koch I, 2005, PSYCHOL RES-PSYCH FO, V69, P252, DOI 10.1007/s00426-004-0180-y; Koch I, 2004, EXP PSYCHOL, V51, P52, DOI 10.1027/1618-3169.51.1.52; Koch I, 2003, PSYCHON B REV, V10, P488, DOI 10.3758/BF03196511; Koch I, 2001, J EXP PSYCHOL LEARN, V27, P1474, DOI 10.1037//0278-7393.27.6.1474; Koch I, 2008, PSYCHON B REV, V15, P448, DOI 10.3758/PBR.15.2.448; Koch I, 2006, MEM COGNITION, V34, P433, DOI 10.3758/BF03193420; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Lemaire P, 2010, MEM COGNITION, V38, P322, DOI 10.3758/MC.38.3.322; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Liefooghe B, 2005, MEMORY, V13, P550, DOI 10.1080/09658210444000250; LIEFOOGHE B, PSYCHONOMIC IN PRESS; LIEFOOGHE B, 2010, DOES COMPOSITI UNPUB; Liefooghe B, 2008, J EXP PSYCHOL LEARN, V34, P478, DOI 10.1037/0278-7393.34.3.478; Liefooghe B, 2007, EUR J COGN PSYCHOL, V19, P1, DOI 10.1080/09541440500492033; Liefooghe B, 2009, CAN J EXP PSYCHOL, V63, P323, DOI 10.1037/a0016725; Liefooghe B, 2009, Q J EXP PSYCHOL, V62, P850, DOI 10.1080/17470210802570994; Lien MC, 2005, J EXP PSYCHOL HUMAN, V31, P299, DOI 10.1037/0096-1523.31.2.299; Lien MC, 2004, J EXP PSYCHOL LEARN, V30, P697, DOI 10.1037/0278-7393.30.3.697; Lien MC, 2003, J EXP PSYCHOL HUMAN, V29, P692, DOI 10.1037/0096-1523.29.3.692; Lien MC, 2006, PSYCHON B REV, V13, P530, DOI 10.3758/BF03193881; Logan GD, 2006, PSYCHON B REV, V13, P139; Logan GD, 2006, J EXP PSYCHOL LEARN, V32, P347, DOI 10.1037/0278-7393.32.3.347; Logan GD, 2004, PSYCHON B REV, V11, P832, DOI 10.3758/BF03196709; Logan GD, 2004, J EXP PSYCHOL GEN, V133, P218, DOI 10.1037/0096-3445.133.2.218; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan GD, 2007, MEM COGNITION, V35, P591, DOI 10.3758/BF03193297; Logan GD, 2007, J EXP PSYCHOL HUMAN, V33, P978, DOI 10.1037/0096-1523.33.4.978; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Luria R, 2003, J EXP PSYCHOL HUMAN, V29, P556, DOI 10.1037/0096-1523.29.3.556; Luwel K, 2009, BRIT J PSYCHOL, V100, P753, DOI 10.1348/000712609X402801; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Manoach DS, 2007, J NEUROSCI, V27, P1791, DOI 10.1523/JNEUROSCI.3662-06.2007; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mayr U, 2005, J EXP PSYCHOL LEARN, V31, P337, DOI 10.1037/0278-7393.31.2.337; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Mayr U, 2002, PSYCHON B REV, V9, P93, DOI 10.3758/BF03196261; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Mayr U, 2007, PSYCHOL RES-PSYCH FO, V71, P107, DOI 10.1007/s00426-005-0039-x; Mayr U, 2006, PSYCHON B REV, V13, P794, DOI 10.3758/BF03193999; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; Mayr U, 2009, COGNITIVE PSYCHOL, V59, P123, DOI 10.1016/j.cogpsych.2009.02.004; Meier B, 2009, CAN J EXP PSYCHOL, V63, P201, DOI 10.1037/a0014311; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 2005, Q J EXP PSYCHOL-A, V58, P1023, DOI 10.1080/02724980443000421; Meiran N, 2005, EXP PSYCHOL, V52, P109, DOI 10.1027/1618-3169.52.2.109; Meiran N, 2002, MEM COGNITION, V30, P540, DOI 10.3758/BF03194955; Meiran N, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P377; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Meiran N, 2008, PSYCHOL RES-PSYCH FO, V72, P473, DOI 10.1007/s00426-008-0136-8; Meiran N, 2008, EXP PSYCHOL, V55, P251, DOI 10.1027/1618-3169.55.4.251; Meiran N, 2008, J EXP PSYCHOL HUMAN, V34, P137, DOI 10.1037/0096-1523.34.1.137; Meuter RFI, 1999, J MEM LANG, V40, P25, DOI 10.1006/jmla.1998.2602; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Milan EG, 2005, ACTA PSYCHOL, V118, P319, DOI 10.1016/j.actpsy.2004.10.015; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller GA., 1960, PLANS STRUCTURE BEHA; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; Monsell S, 2000, PSYCHOL RES-PSYCH FO, V63, P250, DOI 10.1007/s004269900005; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; Monsell S, 2006, J EXP PSYCHOL HUMAN, V32, P493, DOI 10.1037/0096-1523.32.3.493; Mueller SC, 2007, BRAIN RES, V1157, P56, DOI 10.1016/j.brainres.2007.04.046; Murray MM, 2009, BRAIN COGNITION, V69, P47, DOI 10.1016/j.bandc.2008.05.004; Nicholson R, 2006, BRAIN RES, V1121, P160, DOI 10.1016/j.brainres.2006.08.101; Nieuwenhuis S, 2002, PSYCHON B REV, V9, P86, DOI 10.3758/BF03196259; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Oriet C, 2003, J EXP PSYCHOL HUMAN, V29, P1036, DOI 10.1037/0096-1523.29.5.1036; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P20, DOI 10.1037/0278-7393.17.1.20; PASHLER H, 1994, J EXP PSYCHOL HUMAN, V20, P330, DOI 10.1037/0096-1523.20.2.330; Philipp AM, 2005, Q J EXP PSYCHOL-A, V58, P1325, DOI 10.1080/02724980443000656; Philipp AM, 2007, J EXP PSYCHOL LEARN, V33, P1062, DOI 10.1037/0278-7393.33.6.1062; Philipp AM, 2007, EUR J COGN PSYCHOL, V19, P395, DOI 10.1080/09541440600758812; Philipp AM, 2006, EUR J COGN PSYCHOL, V18, P624, DOI 10.1080/09541440500423269; Poljac E, 2006, EXP PSYCHOL, V53, P260, DOI 10.1027/1618-3169.53.4.260; Rapoport A, 1997, PSYCHOL REV, V104, P603, DOI 10.1037/0033-295X.104.3.603; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Reuter B, 2006, BIOL PSYCHOL, V72, P88, DOI 10.1016/j.biopsycho.2005.08.005; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rubin O, 2005, J EXP PSYCHOL LEARN, V31, P1477, DOI 10.1037/0278-7393.31.6.1477; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2002, J COGNITIVE NEUROSCI, V14, P1139, DOI 10.1162/089892902760807159; Ruthruff E, 2001, J EXP PSYCHOL HUMAN, V27, P1404, DOI 10.1037//0096-1523.27.6.1404; Saeki E, 2004, PSYCHOLOGIA, V47, P35, DOI 10.2117/psysoc.2004.35; Saeki E, 2004, MEMORY, V12, P257, DOI 10.1080/09658210244000649; Saeki E, 2006, MEMORY, V14, P965, DOI 10.1080/09658210601008973; Saeki E, 2009, MEM COGNITION, V37, P1040, DOI 10.3758/MC.37.7.1040; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schneider DW, 2007, PSYCHON B REV, V14, P118, DOI 10.3758/BF03194038; Schneider DW, 2007, J EXP PSYCHOL LEARN, V33, P370, DOI 10.1037/0278-7393.33.2.370; Schneider DW, 2006, J EXP PSYCHOL GEN, V135, P623, DOI 10.1037/0096-3445.135.4.623; Schneider DW, 2008, Q J EXP PSYCHOL, V61, P1629, DOI 10.1080/17470210802138511; Schneider DW, 2006, PSYCHON B REV, V13, P145; Schneider DW, 2005, J EXP PSYCHOL GEN, V134, P343, DOI 10.1037/0096-3445.134.3.343; Schuch S, 2003, J EXP PSYCHOL HUMAN, V29, P92, DOI 10.1037/0096-1523.29.1.92; Sdoia S, 2008, EXP PSYCHOL, V55, P322, DOI 10.1027/1618-3169.55.5.322; Siegler RS, 1997, J EXP PSYCHOL GEN, V126, P71, DOI 10.1037/0096-3445.126.1.71; Sigman M, 2006, PLOS BIOL, V4, P1227, DOI 10.1371/journal.pbio.0040220; Sohn MH, 2003, MEM COGNITION, V31, P775, DOI 10.3758/BF03196115; Sohn MH, 2001, J EXP PSYCHOL GEN, V130, P764, DOI 10.1037//0096-3445.130.4.764; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Steinhauser M, 2008, MEM COGNITION, V36, P979, DOI 10.3758/MC.36.5.979; Steinhauser M, 2007, MEM COGNITION, V35, P138, DOI 10.3758/BF03195950; Steinhauser M, 2009, NEUROPSYCHOLOGIA, V47, P1826, DOI 10.1016/j.neuropsychologia.2009.02.022; Stoet G, 1999, J EXP PSYCHOL HUMAN, V25, P1625, DOI 10.1037/0096-1523.25.6.1625; Stoet G, 2007, COGN AFFECT BEHAV NE, V7, P192, DOI 10.3758/CABN.7.3.192; STRAYER DL, 1994, J EXP PSYCHOL LEARN, V20, P342, DOI 10.1037/0278-7393.20.2.342; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SUDEVAN P, 1987, J EXP PSYCHOL HUMAN, V13, P89, DOI 10.1037/0096-1523.13.1.89; Sumner P, 2006, Q J EXP PSYCHOL, V59, P1255, DOI 10.1080/02724980543000187; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; TIPPER SP, 1988, MEM COGNITION, V16, P64, DOI 10.3758/BF03197746; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tornay FJ, 2001, Q J EXP PSYCHOL-A, V54, P785, DOI 10.1080/02724980042000499; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; VANDIERENDONCK A, COGNITION N IN PRESS, V1, P35; Vandierendonck A, 2008, MEM COGNITION, V36, P1248, DOI 10.3758/MC.36.7.1248; VANLOY B, Q J EXPT PS IN PRESS; Verbruggen F, 2006, EXP PSYCHOL, V53, P48, DOI 10.1027/1618-3169.53.1.48; Verbruggen F, 2005, PSYCHOL RES-PSYCH FO, V69, P262, DOI 10.1007/s00426-004-0177-6; Verbruggen F, 2005, EXP PSYCHOL, V52, P125, DOI 10.1027/1618-3169.52.2.125; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P1212, DOI 10.1037/0096-1523.34.5.1212; Verbruggen F, 2007, J EXP PSYCHOL LEARN, V33, P342, DOI 10.1037/0278-7393.33.2.342; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Waszak F, 2003, COGNITIVE PSYCHOL, V46, P361, DOI 10.1016/S0010-0285(02)00520-0; Waszak F, 2005, MEM COGNITION, V33, P595, DOI 10.3758/BF03195327; Waszak F, 2004, PSYCHON B REV, V11, P1027, DOI 10.3758/BF03196732; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; Wendt M, 2008, PSYCHOL RES-PSYCH FO, V72, P425, DOI 10.1007/s00426-007-0117-3; Woodward TS, 2008, NEUROIMAGE, V40, P1311, DOI 10.1016/j.neuroimage.2007.12.049; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Wylie GR, 2009, J COGNITIVE NEUROSCI, V21, P105, DOI 10.1162/jocn.2009.21009; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118; Yehene E, 2007, ACTA PSYCHOL, V126, P169, DOI 10.1016/j.actpsy.2006.11.007; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P919, DOI 10.1037/0096-1523.29.5.919; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P455, DOI 10.1037/0096-1523.29.2.455; Yeung N, 2010, J EXP PSYCHOL LEARN, V36, P348, DOI 10.1037/a0017894	247	411	415	4	116	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0033-2909	1939-1455		PSYCHOL BULL	Psychol. Bull.	JUL	2010	136	4					601	626		10.1037/a0019791			26	Psychology; Psychology, Multidisciplinary	Psychology	616CY	WOS:000279187100007	20565170				2021-06-18	
J	BOUMA, GJ; MUIZELAAR, JP; STRINGER, WA; CHOI, SC; FATOUROS, P; YOUNG, HF				BOUMA, GJ; MUIZELAAR, JP; STRINGER, WA; CHOI, SC; FATOUROS, P; YOUNG, HF			ULTRA-EARLY EVALUATION OF REGIONAL CEREBRAL BLOOD-FLOW IN SEVERELY HEAD-INJURED PATIENTS USING XENON-ENHANCED COMPUTERIZED-TOMOGRAPHY	JOURNAL OF NEUROSURGERY			English	Article						CEREBRAL BLOOD FLOW; CEREBRAL ISCHEMIA; CEREBRAL SWELLING; HEAD INJURY; INTRACRANIAL HEMATOMA; XENON-ENHANCED COMPUTERIZED TOMOGRAPHY	STABLE XENON; BRAIN INJURY; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; ACUTE PHASE; ISCHEMIA; METABOLISM; ICP; TRAUMA; CT	The role of cerebral ischemia in the pathophysiology of traumatic brain injury is unclear. Cerebral blood flow (CBF) measurements with Xe-133 have thus far revealed ischemia in a substantial number of patients only when performed between 4 and 12 hours postinjury. But these studies cannot be performed sooner after injury, they cannot be done in patients with intracranial hematomas still in place, and they cannot detect focal ischemia. Therefore, the authors performed CBF measurements in 35 comatose head-injured patients using stable xenon-enhanced computerized tomography (CT), simultaneously with the initial CT scan (at a mean (+/-standard error of the mean) interval of 3.1 +/- 2.1 hours after injury). Seven patients with diffuse cerebral swelling had significantly lower flows in all brain regions measured as compared to patients without swelling or with focal contusions; in four of the seven, cerebral ischemia (CBF less-than-or-equal-to 18 ml/100 gm . min-1) was present. Acute intracranial hematomas were associated with decreased CBF and regional ischemia in the ipsilateral hemisphere, but did not disproportionately impair brain-stem blood flow. Overall, global or regional ischemia was found in 11 patients (31.4%). There was no correlation between the presence of hypoxia or hypertension before resuscitation and the occurrence of ischemia, neither could ischemia be attributed to low pCO2. Ischemia was significantly associated with early mortality (p < 0.02), whereas normal or high CBF values were not predictive of favorable short-term outcome. These data support the hypothesis that ischemia is an important secondary injury mechanism after traumatic brain injury, and that trauma may share pathophysiological mechanisms with stroke in a large number of cases; this may have important implications for the use of hyperventilation and antihypertensive drugs in the acute management of severely head-injured patients, and may lead to testing of drugs that are effective or have shown promise in the treatment of ischemic stroke.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT RADIOL, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT BIOSTAT, RICHMOND, VA 23298 USA	BOUMA, GJ (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, MCV STN BOX 631, RICHMOND, VA 23298 USA.			Bouma, Gerrit/0000-0002-2772-7475			ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; DARBY JM, 1989, SURG NEUROL, V32, P343, DOI 10.1016/0090-3019(89)90136-5; ENEVOLDSEN EM, 1977, J NEUROSURG, V47, P699, DOI 10.3171/jns.1977.47.5.0699; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; GRAHAM DI, 1971, LANCET, V1, P265; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; HANSON EJ, 1975, CIRC RES, V36, P18, DOI 10.1161/01.RES.36.1.18; HARRINGTON T., 1986, INTRACRANIAL PRESSUR, VVI, P680; HUGHES RL, 1989, STROKE, V20, P754, DOI 10.1161/01.STR.20.6.754; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1973, CEREBROVASC DIS, P163; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KONTOS HA, 1978, AM J PHYSIOL, V234, pH582; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, J CEREBR BLOOD F MET, V11, P347, DOI 10.1038/jcbfm.1991.69; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARSHALL LF, 1990, CURR OPIN NEUROL NEU, V3, P4; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MEYER JS, 1980, AM J NEURORADIOL, V1, P213; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Nilsson B, 1980, CEREBRAL ARTERIAL SP, V488-95; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OBRIST WD, 1985, J CEREB BLOOD FLOW M, V5, P557; OBRIST WD, 1979, NEURAL TRAUMA, P41; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; SABATINI U, 1991, STROKE, V22, P324, DOI 10.1161/01.STR.22.3.324; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; STRINGER WA, 1992, CEREBRAL BLOOD FLOW MEASUREMENT WITH STABLE XENON-ENHANCED COMPUTED TOMOGRAPHY, P233; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; VANDELLEN JR, 1988, CURRENT CONCEPTS CRA, P1; YONAS H, 1984, STROKE, V15, P443, DOI 10.1161/01.STR.15.3.443; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	57	410	415	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	1992	77	3					360	368		10.3171/jns.1992.77.3.0360			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	JK676	WOS:A1992JK67600003	1506882				2021-06-18	
J	Lovell, MR; Iverson, GL; Collins, MW; Podell, K; Johnston, KM; Pardini, D; Pardini, J; Norwig, J; Maroon, JC				Lovell, Mark R.; Iverson, Grant L.; Collins, Michael W.; Podell, Kenneth; Johnston, Karen M.; Pardini, Dustin; Pardini, Jamie; Norwig, John; Maroon, Joseph C.			Measurement of symptoms following sports-related concussion: Reliability and normative data for the Post-Concussion Scale	APPLIED NEUROPSYCHOLOGY			English	Article; Proceedings Paper	31st Annual Meeting of the International-Neuropsychological-Society	FEB 05-08, 2003	HONOLULU, HI	Int Neuropsychol Soc		concussion; symptoms; traumatic brain injury; sports	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COLLEGIATE FOOTBALL PLAYERS; RECOVERY; INJURY; RETURN	It is important to carefully evaluate self-reported symptoms in athletes with known or suspected concussions. This article presents data on the psychometric and clinical properties of a commonly used concussion symptom inventory-the Post-Concussion Scale. Normative and psychometric data are presented for large samples of young men (N = 1,391) and young women (N = 355). In addition, data gathered from a concussed sample of athletes (N = 260) seen within 5 days of injury are presented. These groups represent samples of both high school and collegiate athletes. Data from a subsample of 52 concussed athletes seen 3 times post-injury are presented to illustrate symptom reporting patterns during the initial recovery period. General guidelines for the clinical use of the scale are provided.	Univ Pittsburgh, Med Ctr, Ctr Sports Med, ABPN, Pittsburgh, PA 15203 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Riverview Hosp, Vancouver, BC V5Z 1M9, Canada; Henry Ford Hlth Syst, Detroit, MI USA; McGill Univ, Montreal, PQ, Canada; Pittsburgh Steelers Football Club, Pittsburgh, PA USA	Lovell, MR (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Sports Med, ABPN, 3200 S Water St, Pittsburgh, PA 15203 USA.	lovellmr@upmc.edu	Pardini, Dustin/E-3615-2013	Iverson, Grant/0000-0001-7348-9570			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Franzen MD, 2000, RELIABILITY VALIDITY, V2nd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2004, STUD NEUROPSYCHOL DE, P221; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; LOVELL MR, 1996, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; OLVEY S, 2002, NEW DEV SPORTS REL C; Piland SG, 2003, J ATHL TRAINING, V38, P104; *SPSS INC, 1998, STAT PACK SOC SCI	30	409	409	2	40	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2006	13	3					166	174		10.1207/s15324826an1303_4			9	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	112KG	WOS:000242524000004	17361669				2021-06-18	
J	Giacobini, E				Giacobini, E			Cholinesterase inhibitors: new roles and therapeutic alternatives	PHARMACOLOGICAL RESEARCH			English	Article						Alzheimer disease; butyrylcholinesterase; cholinesterase inhibitors; Down syndrome; dementia with Lewy bodies; Parkinson dementia; vascular dementia; delirium; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; DOWNS-SYNDROME; ACETYLCHOLINESTERASE INHIBITOR; ANTICHOLINESTERASE DRUGS; DOUBLE-BLIND; DONEPEZIL; RIVASTIGMINE; EFFICACY	An important aspect of brain cholinesterase function is related to enzymatic differences. The brain of mammals contains two major forms of cholinesterases:acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The two forms differ genetically, structurally and for their kinetics. Butyrylcholine is not a physiological substrate in mammalian brain which makes the function of BuChE of difficult interpretation. In human brain, BuChE is found in neurons and glial cells as well as in neuritic plaques and tangles in Alzheimer disease (AD) patients. While AChE activity decreases progressively in the brain of AD patients, BuChE activity shows some increase. In order to study the function of BuChE, we perfused intracortically the rat brain with a selective BuChE inhibitor and found that extracellular acetylcholine increased 15 fold from 5 to 75 nM concentrations with little cholinergic side effects in the animal. Based on these data and on clinical data showing a relation between CSF BuChE inhibition and cognitive function in AD patients, we postulated that two pools of cholinesterases may be present in brain, the first mainly neuronal and AChE dependent and the second mainly glial and BuChE dependent. The two pools show different kinetic properties with regard to regulation of ACh concentration in brain and can be separated with selective inhibitors. Within particular conditions, such as in mice nullizygote for AChE or in AD patients at advanced stages of the disease, BuChE may replace AChE in hydrolyzing brain acetylcholine. Based on the changes of ChE activity in the brain of AD patients, a rational indication of selective BuChEI (or of mixed double function inhibitors) is the treatment of advanced cases. A second novel aspect of ChEI therapy is the emerging of new indications which include various forms of dementia such as dementia with Lewy Bodies, Down Syndrome, vascular dementia and Parkinson Dementia. Clinical results demonstrate examples of versatility of cholinergic enhancement. (C) 2004 Elsevier Ltd. All rights reserved.	Univ Geneva, Sch Med, Univ Hosp Geneva, Dept Geriatr, CH-1226 Thonex Geneva, Switzerland	Giacobini, E (corresponding author), Univ Geneva, Sch Med, Univ Hosp Geneva, Dept Geriatr, CH-1226 Thonex Geneva, Switzerland.	ezio.giacobini@hcuge.ch					Angunawela II, 2001, INT J GERIATR PSYCH, V16, P338, DOI 10.1002/gps.338.abs; Auriacombe S, 2002, CURR MED RES OPIN, V18, P129, DOI 10.1185/030079902125000471; Bullock R, 2002, INT J GERIATR PSYCH, V17, P288, DOI 10.1002/gps.542; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; COSTA J, 1999, P AM PSYCH ASS; CUADRA G, 1994, J PHARMACOL EXP THER, V270, P277; Darvesh S, 2001, INT PSYCHOGERIATR, V13, P461, DOI 10.1017/S1041610201007876; Emre M, 2002, INT J CLIN PRACT, P64; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Fischer P, 2001, J CLIN PSYCHOPHARM, V21, P118, DOI 10.1097/00004714-200102000-00026; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Giacobini E., 1996, Society for Neuroscience Abstracts, V22, P203; Giacobini E, 2001, DRUG AGING, V18, P891, DOI 10.2165/00002512-200118120-00001; Giacobini E, 2002, J NEURAL TRANSM, V109, P1053, DOI 10.1007/s007020200089; GOLDBERG E, 1982, Journal of Clinical Neuropsychology, V4, P219, DOI 10.1080/01688638208401131; GREIG NH, 2001, ALZ INSIGHTS, V7, P1; Gustafson Yngve, 2002, Tidsskr Nor Laegeforen, V122, P810; HAROUTUNIAN V, 2000, P 6 INT STOCKH SPRIN, P81; Hartmann S, 2002, NEUROBIOL AGING, V23, pS84; Hemingway-Eltomey JM, 1999, AM J PSYCHIAT, V156, P1470; Iga JI, 2001, ALCOHOL ALCOHOLISM, V36, P553, DOI 10.1093/alcalc/36.6.553; Inestrosa NC, 2000, ACTA NEUROL SCAND, V102, P53, DOI 10.1034/j.1600-0404.2000.00308.x; JOST U, 1982, ANAESTHESIST, V31, P21; Kishnani PS, 1999, LANCET, V353, P1064, DOI 10.1016/S0140-6736(98)05285-4; Kishnani PS, 2001, AM J PSYCHIAT, V158, P143, DOI 10.1176/appi.ajp.158.1.143; Kumar V, 2000, EUR J NEUROL, V7, P159, DOI 10.1046/j.1468-1331.2000.00046.x; LAHIRI DK, 2002, P 7 INT GEN SPRINGF, P80; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Lott IT, 2002, ARCH NEUROL-CHICAGO, V59, P1133, DOI 10.1001/archneur.59.7.1133; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; MESULAM MM, 1994, ANN NEUROL, V36, P722, DOI 10.1002/ana.410360506; Mesulam MM, 2002, NEUROSCIENCE, V110, P627, DOI 10.1016/S0306-4522(01)00613-3; Meyer JS, 2002, INT J GERIATR PSYCH, V17, P586, DOI 10.1002/gps.652; MIELKE R, 2002, P 18 INT C ALZH DIS; Moretti R, 2001, EUR J NEUROL, V8, P361, DOI 10.1046/j.1468-1331.2001.00224.x; Morris JC, 2001, CLIN THER, V23, pA31, DOI 10.1016/S0149-2918(01)80166-1; Nicolodi M, 2002, HEADACHE, V42, P596, DOI 10.1046/j.1526-4610.2002.02146.x; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; PERRY EK, 1998, INT J GERIATR PSYCHO, V1, P120; Prasher VP, 2002, INT J GERIATR PSYCH, V17, P270, DOI 10.1002/gps.587; PRATT RD, 2002, P 7 INT GEN SPRINGF; Sahin HA, 2002, CLIN NEUROPHARMACOL, V25, P16; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Silver A., 1974, BIOL CHOLINESTERASES, P426; Slatkin NE, 2001, J PAIN SYMPTOM MANAG, V21, P425, DOI 10.1016/S0885-3924(01)00270-6; Sunderland T, 1998, AM J GERIAT PSYCHIAT, V6, pS56, DOI 10.1097/00019442-199821001-00008; Taverni JP, 1998, BRAIN INJURY, V12, P77; Wengel SP, 1998, J GERIATR PSYCH NEUR, V11, P159, DOI 10.1177/089198879801100308; Werber EA, 2001, J NEURAL TRANSM, V108, P1319, DOI 10.1007/s007020100008; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312	52	408	426	9	89	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	OCT	2004	50	4					433	440		10.1016/j.phrs.2003.11.017			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	851FM	WOS:000223671000006	15304240				2021-06-18	
J	Molitch, ME; Clemmons, DR; Malozowski, S; Merriam, GR; Vance, ML				Molitch, Mark E.; Clemmons, David R.; Malozowski, Saul; Merriam, George R.; Vance, Mary Lee			Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GH-REPLACEMENT THERAPY; QUALITY-OF-LIFE; INTIMA-MEDIA THICKNESS; BONE-MINERAL DENSITY; BASE-LINE CHARACTERISTICS; TRAUMATIC BRAIN-INJURY; RECOMBINANT HUMAN GH; CARDIOVASCULAR RISK-FACTORS; GLUCAGON STIMULATION TEST; INSULIN TOLERANCE-TEST	Objective: The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. Consensus Process: Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. Conclusions: GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual. (J Clin Endocrinol Metab 96: 1587-1609, 2011)	[Molitch, Mark E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Clemmons, David R.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Malozowski, Saul] Natl Inst Diabet Digest & Kidney Dis, NIH, Bethesda, MD 20892 USA; [Merriam, George R.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98493 USA; [Merriam, George R.] Univ Washington, Sch Med, Tacoma, WA USA; [Vance, Mary Lee] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA 22908 USA	Molitch, ME (corresponding author), Endocrine Soc, 8401 Connecticut Ave,Suite 900, Chevy Chase, MD 20815 USA.	govt-prof@endo-society.org			Eli Lilly, Co.Eli Lilly; American Diabetes AssociationAmerican Diabetes Association; American College of Physicians; Pituitary Society; Sanofi AventisSanofi-Aventis; IpsenIpsen; Corcept; Pfizer, Inc.Pfizer; Genentech, Inc.Roche HoldingGenentech; Lilly Inc.Eli Lilly; Ipsen Inc.Ipsen; America Neuroendocrine Society; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Washington State Health Department; Novo Nordisk, Inc.Novo Nordisk; Novartis PharmaceuticalsNovartis	Financial Disclosures of the Task Force: Mark E. Molitch, M. D. (chair)-Financial or Business/Organizational Interests: Eli Lilly, Co., American Diabetes Association, American College of Physicians, Pituitary Society, Sanofi Aventis, Ipsen, Corcept; Significant Financial Interest or Leadership Position: none declared. David R. Clemmons, M. D.-Financial or Business/Organizational Interests: Pfizer, Inc., Genentech, Inc., Lilly Inc., Ipsen Inc.; Significant Financial Interest or Leadership Position: none declared. Saul Malozowski, M. D.-Financial or Business/Organizational Interests: none declared; Significant Financial Interest or Leadership Position: none declared. George R. Merriam, M. D.-Financial or Business/Organizational Interests: America Neuroendocrine Society, National Institutes of Health, Washington State Health Department; Significant Financial Interest or Leadership Position: Novo Nordisk, Inc., Eli Lilly, Co., American Neuroendocrine Society. Mary Lee Vance, M. D.-Financial or Business/Organizational Interests: Novartis Pharmaceuticals, Ipsen; Significant Financial Interest or Leadership Position: none declared.	Abs R, 2005, GROWTH HORM IGF RES, V15, P349, DOI 10.1016/j.ghir.2005.06.018; Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Adetunji OR, 2009, EUR J ENDOCRINOL, V161, P541, DOI 10.1530/EJE-09-0405; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Al-Shoumer KAS, 1998, CLIN ENDOCRINOL, V48, P795, DOI 10.1046/j.1365-2265.1998.00460.x; Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3191, DOI 10.1210/jc.2008-2783; AlShoumer KAS, 1996, EUR J ENDOCRINOL, V135, P559, DOI 10.1530/eje.0.1350559; ARAFAH BM, 1994, J CLIN ENDOCR METAB, V79, P348, DOI 10.1210/jc.79.2.348; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173; Arnold JR, 2009, CLIN ENDOCRINOL, V70, P435, DOI 10.1111/j.1365-2265.2008.03391.x; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Attanasio AF, 2004, J CLIN ENDOCR METAB, V89, P4857, DOI 10.1210/jc.2004-0551; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P3368, DOI 10.1210/jc.87.7.3368; Badre-Esfahani S, 2007, GROWTH HORM IGF RES, V17, P227, DOI 10.1016/j.ghir.2007.01.012; Barbosa EJ, 2009, J CLIN ENDOCR METAB, V94, P639; Baroncelli GI, 2004, CLIN ENDOCRINOL, V60, P175, DOI 10.1046/j.1365-2265.2003.01949.x; Baroncelli GI, 2003, J PEDIATR ENDOCR MET, V16, P327; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Bengtsson BA, 1999, J CLIN ENDOCR METAB, V84, P3929, DOI 10.1210/jc.84.11.3929; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P179, DOI 10.1111/j.1365-2265.1995.tb01860.x; Bex M, 2002, J BONE MINER RES, V17, P1081, DOI 10.1359/jbmr.2002.17.6.1081; Biermasz NR, 2004, CLIN ENDOCRINOL, V60, P568, DOI 10.1111/j.1365-2265.2004.02021.x; Biller BMK, 2000, J CLIN ENDOCR METAB, V85, P970, DOI 10.1210/jc.85.3.970; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Birzniece V, 2009, REV ENDOCR METAB DIS, V10, P145, DOI 10.1007/s11154-008-9089-x; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Boot AM, 2009, HORM RES, V71, P364, DOI 10.1159/000223422; Borson-Chazot F, 1999, J CLIN ENDOCR METAB, V84, P1329, DOI 10.1210/jc.84.4.1329; Brabant G, 2007, J CLIN ENDOCR METAB, V92, P2604, DOI 10.1210/jc.2007-0153; Bravenboer N, 1996, BONE, V18, P551, DOI 10.1016/8756-3282(96)00069-5; Buchfelder M, 2007, EUR J ENDOCRINOL, V157, P149, DOI 10.1530/EJE-07-0164; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; CACCIARI E, 1992, J CLIN ENDOCR METAB, V74, P1284, DOI 10.1210/jc.74.6.1284; Capalbo D, 2009, J CLIN ENDOCR METAB, V94, P3347, DOI 10.1210/jc.2008-2639; Carroll PV, 2004, J CLIN ENDOCR METAB, V89, P3890, DOI 10.1210/jc.2003-031588; Chihara K, 2007, EUR J ENDOCRINOL, V157, P19, DOI 10.1530/EJE-07-0066; Cho GY, 2007, AM J CARDIOL, V100, P1035, DOI 10.1016/j.amjcard.2007.04.051; Chrisoulidou A, 2000, J CLIN ENDOCR METAB, V85, P3762, DOI 10.1210/jc.85.10.3762; Chung TT, 2005, CLIN ENDOCRINOL, V63, P274, DOI 10.1111/j.1365-2265.2005.02338.x; CLAYTON PE, 1987, ARCH DIS CHILD, V62, P222, DOI 10.1136/adc.62.3.222; Clemmons DR, 2004, J CLIN INVEST, V113, P25, DOI 10.1172/JCI200420660; Cogan Joy Darlene, 2006, Pediatr Endocrinol Rev, V3 Suppl 3, P480; Cohen LE, 2002, ENDOCR REV, V23, P431, DOI 10.1210/er.2001-0030; COHN L, 1993, CLIN ENDOCRINOL, V39, P417, DOI 10.1111/j.1365-2265.1993.tb02388.x; Colao A, 2005, J CLIN ENDOCR METAB, V90, P2659, DOI 10.1210/jc.2004-1844; Colao A, 2004, CLIN ENDOCRINOL, V61, P360, DOI 10.1111/j.1365-2265.2004.02105.x; Colao A, 2002, J CLIN ENDOCR METAB, V87, P3650, DOI 10.1210/jc.87.8.3650; Colao A, 2001, J CLIN ENDOCR METAB, V86, P1874, DOI 10.1210/jc.86.5.1874; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3416, DOI 10.1210/jc.2007-2810; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; Columb B, 2009, CLIN ENDOCRINOL, V70, P281, DOI 10.1111/j.1365-2265.2008.03354.x; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Conway GS, 2009, EUR J ENDOCRINOL, V160, P899, DOI 10.1530/EJE-08-0436; Cook DM, 1999, J CLIN ENDOCR METAB, V84, P3956, DOI 10.1210/jc.84.11.3956; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corneli G, 2007, EUR J ENDOCRINOL, V157, P701, DOI 10.1530/EJE-07-0384; Darendeliler F, 2006, ACTA PAEDIATR, V95, P1284, DOI 10.1080/08035250600577889; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Dos Santos C, 2004, NAT GENET, V36, P720, DOI 10.1038/ng1379; Drake WM, 2003, J CLIN ENDOCR METAB, V88, P1658, DOI 10.1210/jc.2002-021541; Drake WM, 2001, CLIN ENDOCRINOL, V54, P525, DOI 10.1046/j.1365-2265.2001.01246.x; Elgzyri T, 2004, CLIN ENDOCRINOL, V61, P113, DOI 10.1111/j.1365-2265.2004.02080.x; Erfurth EM, 2004, EUR J ENDOCRINOL, V150, P497, DOI 10.1530/eje.0.1500497; Ergun-Longmire B, 2006, J CLIN ENDOCR METAB, V91, P3494, DOI 10.1210/jc.2006-0656; Ezzat S, 2002, J CLIN ENDOCR METAB, V87, P2725, DOI 10.1210/jc.87.6.2725; Feigl GC, 2002, J NEUROSURG, V97, P415, DOI 10.3171/jns.2002.97.supplement_5.0415; Fideleff HL, 2008, GROWTH HORM IGF RES, V18, P318, DOI 10.1016/j.ghir.2008.01.002; FRADKIN JE, 1993, JAMA-J AM MED ASSOC, V270, P2829, DOI 10.1001/jama.270.23.2829; Frajese G, 2001, J CLIN ENDOCR METAB, V86, P5172, DOI 10.1210/jc.86.11.5172; Franco C, 2009, GROWTH HORM IGF RES, V19, P112, DOI 10.1016/j.ghir.2008.07.001; Giavoli C, 2004, J CLIN ENDOCR METAB, V89, P5397, DOI 10.1210/jc.2004-1114; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gilchrist FJ, 2002, CLIN ENDOCRINOL, V57, P363, DOI 10.1046/j.1365-2265.2002.01608.x; Gleeson HK, 2004, J CLIN ENDOCR METAB, V89, P662, DOI 10.1210/jc.2003-031224; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Gotherstrom G, 2007, EUR J ENDOCRINOL, V156, P55, DOI 10.1530/eje.1.02317; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Hansen R, 2000, J CLIN ENDOCR METAB, V85, P2627, DOI 10.1210/jc.85.7.2627; Hansen TB, 1996, J CLIN ENDOCR METAB, V81, P3352, DOI 10.1210/jc.81.9.3352; Hartman ML, 2008, J CLIN ENDOCR METAB, V93, P125, DOI 10.1210/jc.2007-1430; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hatrick AG, 2002, EUR J ENDOCRINOL, V146, P807, DOI 10.1530/eje.0.1460807; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P3224, DOI 10.1210/jc.2003-032082; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; HOLMES SJ, 1995, CLIN ENDOCRINOL, V43, P143, DOI 10.1111/j.1365-2265.1995.tb01908.x; HOLMES SJ, 1995, CLIN ENDOCRINOL, V43, P151, DOI 10.1111/j.1365-2265.1995.tb01909.x; HOLMES SJ, 1995, CLIN ENDOCRINOL, V42, P627, DOI 10.1111/j.1365-2265.1995.tb02690.x; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; HOLMES SJ, 1995, ENDOCRINOL METAB, V2, P63; Hoybye C, 2007, EUR J ENDOCRINOL, V157, P589, DOI 10.1530/EJE-07-0364; HYER SL, 1992, ARCH DIS CHILD, V67, P1472, DOI 10.1136/adc.67.12.1472; Jallad RS, 2003, GROWTH HORM IGF RES, V13, P81, DOI 10.1016/S1096-6374(03)00006-6; Janssen YJH, 1999, J CLIN ENDOCR METAB, V84, P279, DOI 10.1210/jc.84.1.279; Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P2865, DOI 10.1210/jc.81.8.2865; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P1743, DOI 10.1210/jc.87.4.1743; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; Jorge AAL, 2009, HORM RES, V71, P55, DOI 10.1159/000192438; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; Jostel A, 2005, CLIN ENDOCRINOL, V62, P698, DOI 10.1111/j.1365-2265.2005.02282.x; Juul A, 1997, J CLIN ENDOCR METAB, V82, P1195, DOI 10.1210/jc.82.4.1195; Kaji H, 2004, EUR J ENDOCRINOL, V150, P149, DOI 10.1530/eje.0.1500149; Karavitaki N, 2006, CLIN ENDOCRINOL, V64, P556, DOI 10.1111/j.1365-2265.2006.02508.x; KAUFMAN JM, 1992, J CLIN ENDOCR METAB, V74, P118, DOI 10.1210/jc.74.1.118; Kearney T, 2003, METABOLISM, V52, P50, DOI 10.1053/meta.2003.50061; Kehely A, 2002, J CLIN ENDOCR METAB, V87, P1974, DOI 10.1210/jc.87.5.1974; Koller EA, 1998, J CLIN ENDOCR METAB, V83, P2380, DOI 10.1210/jc.83.7.2380; Koltowska-Haggstrom M, 2009, EUR J ENDOCRINOL, V161, pS51, DOI 10.1530/EJE-09-0266; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Leger J, 2005, J CLIN ENDOCR METAB, V90, P650, DOI 10.1210/jc.2004-1274; Leonsson M, 2002, CLIN ENDOCRINOL, V57, P751, DOI 10.1046/j.1365-2265.2002.01663.x; Lindholm J, 2006, CLIN ENDOCRINOL, V65, P51, DOI 10.1111/j.1365-2265.2006.02545.x; Lissett CA, 2002, CLIN ENDOCRINOL, V57, P35, DOI 10.1046/j.1365-2265.2002.01556.x; LITTLEY MD, 1989, Q J MED, V70, P145; Longobardi S, 1996, J CLIN ENDOCR METAB, V81, P1244, DOI 10.1210/jc.81.3.1244; Losa M, 2008, THYROID, V18, P1249, DOI 10.1089/thy.2008.0266; MacGillivray MH, 1994, GROWTH GENET HORM, V10, P7; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P589, DOI 10.1530/eje.1.01873; Maghnie M, 2001, J CLIN ENDOCR METAB, V86, P1574, DOI 10.1210/jc.86.4.1574; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Maiter D, 2006, EUR J ENDOCRINOL, V155, P253, DOI 10.1530/eje.1.02209; MALOZOWSKI S, 1993, NEW ENGL J MED, V329, P665, DOI 10.1056/NEJM199308263290917; MALOZOWSKI S, 1995, J PEDIATR-US, V126, P996, DOI 10.1016/S0022-3476(95)70232-6; Mantovani G, 2003, J CLIN ENDOCR METAB, V88, P4070, DOI 10.1210/jc.2002-022028; Mauras N, 2005, J CLIN ENDOCR METAB, V90, P3946, DOI 10.1210/jc.2005-0208; Meyer S, 2009, PHARMACOGENOMICS, V10, P1599, DOI [10.2217/pgs.09.91, 10.2217/PGS.09.91]; Miller KK, 2010, J CLIN ENDOCR METAB, V95, P567, DOI 10.1210/jc.2009-1611; Molitch ME, 2008, ENDOCRIN METAB CLIN, V37, P151, DOI 10.1016/j.ecl.2007.10.011; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Moock J, 2009, EUR J ENDOCRINOL, V160, P17, DOI 10.1530/EJE-08-0738; Mukherjee A, 2003, GROWTH HORM IGF RES, V13, pS130, DOI 10.1016/S1096-6374(03)00069-8; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; Murata M, 2003, EUR J ENDOCRINOL, V148, P333, DOI 10.1530/eje.0.1480333; Murray RD, 2004, J CLIN ENDOCR METAB, V89, P1124, DOI 10.1210/jc.2003-030685; Murray RD, 2002, J CLIN ENDOCR METAB, V87, P4427, DOI 10.1210/jc.2002-020430; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Newman CB, 2011, J CLIN ENDOCR METAB, V96, P122, DOI 10.1210/jc.2010-1204; Nicolson A, 1996, CLIN ENDOCRINOL, V44, P311, DOI 10.1046/j.1365-2265.1996.671492.x; Nielsen EH, 2007, CLIN ENDOCRINOL, V67, P693, DOI 10.1111/j.1365-2265.2007.02947.x; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; Norrman LL, 2008, J CLIN ENDOCR METAB, V93, P2531, DOI 10.1210/jc.2007-2673; Olney RC, 2003, MED PEDIATR ONCOL, V41, P228, DOI 10.1002/mpo.10342; Olsson DS, 2009, EUR J ENDOCRINOL, V161, P663, DOI 10.1530/EJE-09-0572; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Cenci MCP, 2009, PITUITARY, V12, P322, DOI 10.1007/s11102-009-0182-2; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Porretti S, 2002, J CLIN ENDOCR METAB, V87, P2042, DOI 10.1210/jc.87.5.2042; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Radetti G, 2000, J CLIN ENDOCR METAB, V85, P923, DOI 10.1210/jc.85.2.923; Radovick S, 2007, J CLIN ENDOCR METAB, V92, P1195, DOI 10.1210/jc.2007-0167; Ronchi CL, 2009, EUR J ENDOCRINOL, V161, P37, DOI 10.1530/EJE-09-0222; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P201, DOI 10.1530/acta.0.1290201; Rosen T, 1997, EUR J ENDOCRINOL, V137, P240, DOI 10.1530/eje.0.1370240; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4195, DOI 10.1210/jc.2009-0602; Segerlantz M, 2003, EUR J ENDOCRINOL, V149, P511, DOI 10.1530/eje.0.1490511; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P1518, DOI 10.1210/jc.86.4.1518; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; Sherlock M, 2010, ENDOCR REV, V31, P301, DOI 10.1210/er.2009-0033; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; SNYDER PJ, 1986, AM J MED, V81, P457, DOI 10.1016/0002-9343(86)90299-8; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Svensson J, 2003, J CLIN ENDOCR METAB, V88, P2061, DOI 10.1210/jc.2002-020901; Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121; Svensson J, 2009, EUR J ENDOCRINOL, V161, pS65, DOI 10.1530/EJE-09-0287; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tauber M, 1997, J CLIN ENDOCR METAB, V82, P352, DOI 10.1210/jc.82.2.352; TEEGARDEN D, 1995, J BONE MINER RES, V10, P711, DOI 10.1002/jbmr.5650100507; THUESEN L, 1994, CLIN ENDOCRINOL, V41, P615, DOI 10.1111/j.1365-2265.1994.tb01827.x; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Underwood LE, 2003, J CLIN ENDOCR METAB, V88, P5273, DOI 10.1210/jc.2003-030204; VALK NK, 1994, J CLIN ENDOCR METAB, V79, P1070, DOI 10.1210/jc.79.4.1070; van der Klaauw AA, 2008, EUR J ENDOCRINOL, V159, P105, DOI 10.1530/EJE-08-0179; van der Klaauw AA, 2008, J CLIN ENDOCR METAB, V93, P2828, DOI 10.1210/jc.2007-2728; van der Klaauw AA, 2009, PITUITARY, V12, P339, DOI 10.1007/s11102-009-0186-y; Vestergaard P, 2002, CLIN ENDOCRINOL, V56, P159, DOI 10.1046/j.0300-0664.2001.01464.x; Vi TN, 2009, PITUITARY, V12, P125, DOI 10.1007/s11102-008-0101-y; Wacharasindhu S, 1996, CLIN ENDOCRINOL, V45, P553, DOI 10.1046/j.1365-2265.1996.00850.x; Wassenaar MJE, 2009, J CLIN ENDOCR METAB, V94, P3721, DOI 10.1210/jc.2009-0425; Webb SM, 1999, J CLIN ENDOCR METAB, V84, P3696, DOI 10.1210/jc.84.10.3696; Wexler T, 2009, J CLIN ENDOCR METAB, V94, P2471, DOI 10.1210/jc.2008-2671; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; Wuster C, 2001, J BONE MINER RES, V16, P398, DOI 10.1359/jbmr.2001.16.2.398; Yuen K, 2002, CLIN ENDOCRINOL, V57, P333, DOI 10.1046/j.1365-2265.2002.01601.x; Yuen KCJ, 2008, CLIN ENDOCRINOL, V69, P292, DOI 10.1111/j.1365-2265.2008.03201.x	215	407	433	1	18	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2011	96	6					1587	1609		10.1210/jc.2011-0179			23	Endocrinology & Metabolism	Endocrinology & Metabolism	766TU	WOS:000290810200029	21602453	Other Gold	Y	N	2021-06-18	
J	Mattiasson, G; Shamloo, M; Gido, G; Mathi, K; Tomasevic, G; Yi, SL; Warden, CH; Castilho, RF; Melcher, T; Gonzalez-Zulueta, M; Nikolich, K; Wieloch, T				Mattiasson, G; Shamloo, M; Gido, G; Mathi, K; Tomasevic, G; Yi, SL; Warden, CH; Castilho, RF; Melcher, T; Gonzalez-Zulueta, M; Nikolich, K; Wieloch, T			Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma	NATURE MEDICINE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE; PERMEABILITY TRANSITION; MITOCHONDRIAL CONTROL; PROTON LEAK; BETA-CELLS; RAT-BRAIN; SUPEROXIDE; INJURY; MICE	Whereas uncoupling protein 1 (UCP-1) is clearly involved in thermogenesis, the role of UCP-2 is less clear. Using hybridization, cloning techniques and cDNA array analysis to identify inducible neuroprotective genes, we found that neuronal survival correlates with increased expression of Ucp2. In mice overexpressing human UCP-2, brain damage was diminished after experimental stroke and traumatic brain injury, and neurological recovery was enhanced. In cultured cortical neurons, UCP-2 reduced cell death and inhibited caspase-3 activation induced by oxygen and glucose deprivation. Mild mitochondrial uncoupling by 2,4-dinitrophenol (DNP) reduced neuronal death, and UCP-2 activity was enhanced by palmitic acid in isolated mitochondria. Also in isolated mitochondria, UCP-2 shifted the release of reactive oxygen species from the mitochondrial matrix to the extramitochondrial space. We propose that UCP-2 is an inducible protein that is neuroprotective by activating cellular redox signaling or by inducing mild mitochondrial uncoupling that prevents the release of apoptogenic proteins.	Wallenberg Neurosci Ctr, S-22184 Lund, Sweden; AGY Therapeut Inc, San Francisco, CA 94080 USA; Univ Calif Davis, Sch Med, Div Biol Sci, Neurobiol Sect, Davis, CA 95616 USA; State Univ Campinas, Sch Med Sci, Dept Clin Pathol, BR-13083970 Campinas, SP, Brazil	Wieloch, T (corresponding author), Wallenberg Neurosci Ctr, BMC A13, S-22184 Lund, Sweden.		Castilho, Roger F/G-3906-2012	Castilho, Roger/0000-0003-2338-8717; Wieloch, Tadeusz/0000-0002-7669-2520	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK53993] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK053993] Funding Source: NIH RePORTER		Anderson MF, 2000, BRAIN RES PROTOC, V5, P95, DOI 10.1016/S1385-299X(99)00060-4; Arnaiz SL, 1999, NITRIC OXIDE-BIOL CH, V3, P235, DOI 10.1006/niox.1999.0229; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984; CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fink BD, 2002, J BIOL CHEM, V277, P3918, DOI 10.1074/jbc.M107955200; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fuller PM, 2000, J APPL PHYSIOL, V89, P1491; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Grabb MC, 1999, J NEUROSCI, V19, P1657; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Jarmuszkiewicz W, 2002, FEBS LETT, V532, P459, DOI 10.1016/S0014-5793(02)03734-1; KATO H, 1995, J CEREBR BLOOD F MET, V15, P60, DOI 10.1038/jcbfm.1995.7; Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4; Kowaltowski AJ, 1998, ARCH BIOCHEM BIOPHYS, V359, P77, DOI 10.1006/abbi.1998.0870; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; NegreSalvayre A, 1997, FASEB J, V11, P809; NOWICKI JP, 1988, J CEREBR BLOOD F MET, V8, P462, DOI 10.1038/jcbfm.1988.87; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shamloo M, 1999, J CEREBR BLOOD F MET, V19, P173; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Teranishi M, 2000, EXP MOL PATHOL, V68, P104, DOI 10.1006/exmp.1999.2288; Wieloch T, 2001, IUBMB LIFE, V52, P247, DOI 10.1080/15216540152846064; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	48	406	423	0	24	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1078-8956			NAT MED	Nat. Med.	AUG	2003	9	8					1062	1068		10.1038/nm903			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	706ZL	WOS:000184484900031	12858170				2021-06-18	
J	Elliott, R				Elliott, R			Executive functions and their disorders	BRITISH MEDICAL BULLETIN			English	Article							LATERAL FRONTAL-CORTEX; WORKING-MEMORY; PARKINSONS-DISEASE; COGNITIVE DEFICITS; PREFRONTAL CORTEX; SCHIZOPHRENIA; CONNECTIVITY; DYSFUNCTION; NEUROPSYCHOLOGY; ORGANIZATION	The term executive function defines complex cognitive processing requiring the co-ordination of several subprocesses to achieve a particular goal. Neuropsychological evidence suggests that executive processing is intimately connected with the intact function of the frontal cortices. Executive dysfunction has been associated with a range of disorders, and is generally attributed to structural or functional frontal pathology. Neuroimaging, with PET and fMRI, has confirmed the relationship; however, attempts to link specific aspects of executive functioning to discrete prefrontal foci have been inconclusive. Instead, the emerging view suggests that executive function is mediated by dynamic and flexible networks, that can be characterised using functional integration and effective connectivity analyses. This view is compatible with the clinical presentation of executive dysfunction associated with a range of pathologies, and also with evidence that recovery of executive function can occur after traumatic brain injury, perhaps due to functional reorganisation within executive networks.	Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England	Elliott, R (corresponding author), Univ Manchester, Neurosci & Psychiat Unit, Room G907,Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.			Elliott, Rebecca/0000-0002-7602-010X			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Carpenter P A, 1999, Top Magn Reson Imaging, V10, P16, DOI 10.1097/00002142-199902000-00003; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; CUMMINGS JL, 1994, DEMENTIA, V5, P177, DOI 10.1159/000106718; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DIVAC I, 1967, J COMP PHYSIOL PSYCH, V63, P184, DOI 10.1037/h0024348; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; ELLIOTT R, 1995, PSYCHOL MED, V25, P581, DOI 10.1017/S0033291700033493; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Frith CD, 1997, SCHIZOPHRENIA BULL, V23, P525, DOI 10.1093/schbul/23.3.525; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; GOLDMANRAKIC PS, 1998, PREFRONTAL CORTEX EX, P87; Grafman J, 1999, RES PER NEUROSCI, P131; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Luria A. R., 1969, HDB CLINICAL NEUROLO, V2, P725; McIntosh AR, 1996, CEREB CORTEX, V6, P571, DOI 10.1093/cercor/6.4.571; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MILNER B, 2002, FRONTAL GRANULAR COR, P313; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Petrides M, 2000, J NEUROSCI, V20, P7496; PETRIDES M, 2002, HDB NEUROPSYCHOLOGY, V9; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; ROBERTS AC, 2002, PREFRONTAL CORTEX EX; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rubia K, 2002, BEHAV BRAIN RES, V130, P47, DOI 10.1016/S0166-4328(01)00437-5; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spence SA, 2000, BRIT J PSYCHIAT, V176, P52, DOI 10.1192/bjp.176.1.52; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Weiller C, 1998, EXP BRAIN RES, V123, P13, DOI 10.1007/s002210050539; Weinberger DR, 1997, INT CLIN PSYCHOPHARM, V12, pS29, DOI 10.1097/00004850-199709004-00006; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135	50	406	430	2	62	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-1420	1471-8391		BRIT MED BULL	Br. Med. Bull.		2003	65						49	59		10.1093/bmb/65.1.49			11	Medicine, General & Internal	General & Internal Medicine	664UN	WOS:000182080300005	12697616	Bronze			2021-06-18	
J	Fleminger, S; Oliver, DL; Lovestone, S; Rabe-Hesketh, S; Giora, A				Fleminger, S; Oliver, DL; Lovestone, S; Rabe-Hesketh, S; Giora, A			Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN INJURY; SEX-HORMONES; DEMENTIA; ONSET; POPULATION; ESTROGEN; PROGESTERONE	Objective: To determine, using a systematic review of case-control studies, whether head injury is a significant risk factor for Alzheimer's disease. We sought to replicate the findings of the meta-analysis of Mortimer et al (1991). Methods: A predefined inclusion criterion specified case-control studies eligible for inclusion. A comprehensive and systematic search of various electronic databases, up to August 2001, was undertaken. Two independent reviewers screened studies for eligibility. Fifteen case-control studies were identified that met the inclusion criteria, of which seven postdated the study of Mortimer et al. Results: We partially replicated the results of Mortimer et al. The meta-analysis of the seven studies conducted since 1991 did not reach significance. However, analysis of all 15 case-control studies was significant (OR 1.58, 95% CI 1.21 to 2.06), indicating an excess history of head injury in those with Alzheimer's disease. The finding of Mortimer et al that head injury is a risk factor for Alzheimer's disease only in males was replicated. The excess risk of head injury in those with Alzheimer's disease is only found in males (males: OR 2.29, 95% CI 1.47 to 2.06; females: OR 0.91, 95% CI 0.56 to 1.47). Conclusions: This study provides support for an association between a history of previous head injury and the risk of developing Alzheimer's disease.	Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, London SE5 8AZ, England; Inst Psychiat, Old Age Psychiat Sect, London SE5 8AF, England; Inst Psychiat, Dept Biostat & Comp, London SE5 8AF, England	Fleminger, S (corresponding author), Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, Denmark Hill, London SE5 8AZ, England.		Rabe-Hesketh, Sophia/B-1643-2008; Lovestone, Simon/E-8725-2010	Rabe-Hesketh, Sophia/0000-0002-5257-4837; Lovestone, Simon/0000-0003-0473-4565			AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; Birge Stanley J., 1997, American Journal of Medicine, V103, p36S, DOI 10.1016/S0002-9343(97)00258-1; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; FERINISTRAMBI L, 1990, NEUROEPIDEMIOLOGY, V9, P39, DOI 10.1159/000110750; FORSTER DP, 1995, J EPIDEMIOL COMMUN H, V49, P253, DOI 10.1136/jech.49.3.253; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Henderson VW, 1997, NEUROLOGY, V48, pS27, DOI 10.1212/WNL.48.5_Suppl_7.27S; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; KONDO K, 1990, PSYCHOGERIATRICS BIO; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Melton L, 2001, LANCET, V358, P818, DOI 10.1016/S0140-6736(01)06016-0; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Niino N, 1990, Nihon Ronen Igakkai Zasshi, V27, P693; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; RIMM AA, 1986, AM J EPIDEMIOL, V123, P753, DOI 10.1093/oxfordjournals.aje.a114297; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rothman K. J., 1986, MODERN EPIDEMIOLOGY; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; *STAT, 2001, STAT STAT SOFTW REL; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Tsolaki M, 1997, Int Psychogeriatr, V9, P327, DOI 10.1017/S104161029700447X; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	36	405	413	0	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2003	74	7					857	862		10.1136/jnnp.74.7.857			6	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	690JB	WOS:000183543800008	12810767	Green Published, Bronze			2021-06-18	
J	Gavett, BE; Stern, RA; McKee, AC				Gavett, Brandon E.; Stern, Robert A.; McKee, Ann C.			Chronic Traumatic Encephalopathy: A Potential Late Effect of Sport-Related Concussive and Subconcussive Head Trauma	CLINICS IN SPORTS MEDICINE			English	Article						Encephalopathy; Post-traumatic; Neurodegenerative disorders; Concussion; Athletic injuries; Dementia; Motor neuron disease	FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOID PROTEIN DEPOSITION; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; AXONAL INJURY; BRAIN-INJURY; PRECURSOR PROTEIN; PUNCH DRUNK; HUMAN TAU; BETA-APP	Chronic traumatic encephalopathy (CTE) is a form of neurodegeneration believed to result from repeated head injuries. Originally termed dementia pugilistica because of its association with boxing, the neuropathology of CTE was first described by Corsellis in 1973 in a case series of 15 retired boxers. CTE has recently been found to occur after other causes of repeated head trauma, suggesting that any repeated blows to the head, such as those that occur in American football, hockey, soccer, professional wrestling, and physical abuse, can also lead to neurodegenerative changes. These changes often include cerebral atrophy, cavum septi pellucidi with fenestrations, shrinkage of the mammillary bodies, dense tau immunoreactive inclusions (neurofibrillary tangles, glial tangles, and neuropil neurites), and, in some cases, a TDP-43 proteinopathy. In association with these pathologic changes, disordered memory and executive functioning, behavioral and personality disturbances (eg, apathy, depression, irritability, impulsiveness, suicidality), parkinsonism, and, occasionally, motor neuron disease are seen in affected individuals. No formal clinical or pathologic diagnostic criteria for CTE currently exist, but the distinctive neuropathologic profile of the disorder lends promise for future research into its prevention, diagnosis, and treatment.	[McKee, Ann C.] Bedford Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Gavett, Brandon E.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Gavett, Brandon E.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Gavett, Brandon E.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA	McKee, AC (corresponding author), Bedford Vet Affairs Med Ctr, 200 Springs Rd,Bldg 18,Room 118, Bedford, MA 01730 USA.	amckee@bu.edu	, Bob/ABA-8507-2020	Stern, Robert/0000-0002-5008-077X; Gavett, Brandon/0000-0003-1938-1854	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG13846, 0572063345-5]; National Operating Committee; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This work was supported by NIA P30AG13846, Supplement 0572063345-5, National Operating Committee on Standards for Athletic Equipment, and by the Department of Veterans Affairs. This work was also supported by an unrestricted gift from the National Football League. The funding sources were not involved in the preparation, review, or approval of this article.	Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Cajigal S., 2007, NEUROL TODAY, V7, P1; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hall GF, 2000, J CELL SCI, V113, P1373; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; Hill JM, 2007, EXP EYE RES, V84, P801, DOI 10.1016/j.exer.2006.08.001; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; MILLSPAUGH JA, 1937, DEMENTIA, V35, P297; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; OLDEST LIVING PROFOO	62	403	408	15	265	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					179	+		10.1016/j.csm.2010.09.007			11	Sport Sciences	Sport Sciences	691XR	WOS:000285114800016	21074091	Green Accepted	Y	N	2021-06-18	
J	Niogi, SN; Mukherjee, P; Ghajar, J; Johnson, C; Kolster, RA; Sarkar, R; Lee, H; Meeker, M; Zimmerman, RD; Manley, GT; McCandliss, BD				Niogi, S. N.; Mukherjee, P.; Ghajar, J.; Johnson, C.; Kolster, R. A.; Sarkar, R.; Lee, H.; Meeker, M.; Zimmerman, R. D.; Manley, G. T.; McCandliss, B. D.			Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: A 3T diffusion tensor imaging study of mild traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CLOSED-HEAD-INJURY; AXONAL INJURY; FOCAL LESIONS; ANISOTROPY; RECOVERY; MODERATE; MRI; ABNORMALITIES; PERFORMANCE; POSTINJURY	BACKGROUND AND PURPOSE: Diffusion tensor imaging (DTI) may be a useful index of microstructural changes implicated in diffuse axonal injury (DAI) linked to persistent postconcussive symptoms, especially in mild traumatic brain injury (TBI), for which conventional MR imaging techniques may lack sensitivity. We hypothesized that for mild TBI, DTI measures of DAI would correlate with impairments in reaction time, whereas the number of focal lesions on conventional 3T MR imaging would not. MATERIALS AND METHODS: Thirty-four adult patients with mild TBI with persistent symptoms were assessed for DAI by quantifying traumatic microhemorrhages detected on a conventional set of T2*-weighted gradient-echo images and by DTI measures of fractional anisotropy (FA) within a set of a priori regions of interest. FA values 2.5 SDs below the region average, based on a group of 26 healthy control adults, were coded as exhibiting DAI. RESULTS: DTI measures revealed several predominant regions of damage including the anterior corona radiata (41 % of the patients), uncinate fasciculus (29%), genu of the corpus callosum (21 %), inferior longitudinal fasciculus (21 %), and cingulum bundle (18%). The number of damaged white matter structures as quantified by DTI was significantly correlated with mean reaction time on a simple cognitive task (r = 0.49, P =.012). In contradistinction, the number of traumatic microhemorrhages was uncorrelated with reaction time (r = -0.08, P =.71). CONCLUSION: Microstructural white matter lesions detected by DTI correlate with persistent cognitive deficits in mild TBI, even in populations in which conventional measures do not. DTI measures may thus contribute additional diagnostic information related to DAI.	[Niogi, S. N.; Kolster, R. A.; McCandliss, B. D.] Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10065 USA; [Mukherjee, P.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Ghajar, J.; Kolster, R. A.; Sarkar, R.] Brain Trauma Fdn, New York, NY USA; [Ghajar, J.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY USA; [Johnson, C.; Zimmerman, R. D.] Cornell Univ, Weill Med Coll, Dept Radiol, New York, NY USA; [Lee, H.; Meeker, M.; Manley, G. T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	McCandliss, BD (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst, 525 E 68th St, New York, NY 10065 USA.	bdm2001@med.cornell.edu	Arfanakis, Konstantinos/AAN-3148-2021; Mukherjee, Pratik/A-5446-2008	Arfanakis, Konstantinos/0000-0001-9705-597X; Mukherjee, Pratik/0000-0001-7473-7409			Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GANNARELLI TA, 1998, SEMIN CLIN NEUROPSYC, V3, P160; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nakamura M, 2005, BIOL PSYCHIAT, V58, P468, DOI 10.1016/j.biopsych.2005.04.016; Nestor PG, 2004, NEUROPSYCHOLOGY, V18, P629, DOI 10.1037/0894-4105.18.4.629; Niogi SN, 2006, NEUROPSYCHOLOGIA, V44, P2178, DOI 10.1016/j.neuropsychologia.2006.01.011; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Ulug AM, 1999, JMRI-J MAGN RESON IM, V9, P804; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Watts R, 2003, MENT RETARD DEV D R, V9, P168, DOI 10.1002/mrdd.10077	56	403	420	0	31	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2008	29	5					967	973		10.3174/ajnr.A0970			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	302KI	WOS:000255966800027	18272556	Green Published, Other Gold			2021-06-18	
J	Ho, KKY				Ho, Ken K. Y.		2007 GH Deficiency Consensus Works	Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article								Objective: The GH Research Society held a Consensus Workshop in Sydney, Australia, 2007 to incorporate the important advances in the management of GH deficiency (GHD) in adults. which have taken place since the inaugural 1997 Consensus Workshop. Method: Two commissioned review papers, previously published Consensus Statements of the Society and key questions were circulated before the Workshop, which comprised a rigorous structure of review with breakout discussion groups. A writing group transcribed the summary group reports for drafting in a plenary forum on the last day. All participants were sent a polished draft for additional comments and gave signed approval to the final revision. Conclusion: Testing for GHD should be extended from hypothalamic-pituitary disease and cranial irradiation to include traumatic brain injury. Testing may indicate isolated GHD; however, idiopathic isolated GHD occurring de novo in the adult is not a recognized entity. The insulin tolerance test, combined administration of GHRH with arginine or growth hormone-releasing peptide, and glucagon are validated GH stimulation tests in the adult. A low IGF-I is a reliable diagnostic indicator of GHD in the presence of hypopituitarism, but a normal IGF-I does not rule out GHD. GH status should be reevaluated in the transition age for continued treatment to complete somatic development. Interaction of GH with other axes may influence thyroid, glucocorticoid, and sex hormone requirements. Response should be assessed clinically by monitoring biochemistry, body composition, and quality of life. There is no evidence that GH replacement increases the risk of tumor recurrence or de novo malignancy.	[Ho, Ken K. Y.] Garvan Inst Med Res, Pituitary Res Uni, Sydney, NSW 2010, Australia	Ho, KKY (corresponding author), Garvan Inst Med Res, Pituitary Res Uni, 384 Victoria St, Sydney, NSW 2010, Australia.	k.ho@garvan.org.au	Ho, Ken/AAA-7428-2019; Ho, Ken KY/E-5832-2011	Ho, Ken/0000-0002-2508-9588; 			Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; GHIGO E, 2007, GROWTH HORMONE IGF R; NILSSON A, 2007, GROWTH HORMONE IGF R	4	403	415	1	10	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	DEC	2007	157	6					695	700		10.1530/EJE-07-0631			6	Endocrinology & Metabolism	Endocrinology & Metabolism	247PV	WOS:000252092700001	18057375	Bronze			2021-06-18	
J	Czosnyka, M; Pickard, JD				Czosnyka, M; Pickard, JD			Monitoring and interpretation of intracranial pressure	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CEREBRAL PERFUSION-PRESSURE; HEAD-INJURED PATIENTS; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBROSPINAL-FLUID OUTFLOW; CRITICAL CLOSING PRESSURE; CLINICAL-EXPERIENCE; COMPLIANCE DEVICE; VOLUME-PRESSURE; AUTO-REGULATION; FLOW VELOCITY	Intracranial pressure (ICP) is derived from cerebral blood and cerebrospinal fluid (CSF) circulatory dynamics and can be affected in the course of many diseases of the central nervous system. Monitoring of ICP requires an invasive transducer, although some attempts have been made to measure it non-invasively. Because of its dynamic nature, instant CSF pressure measurement using the height of a fluid column via lumbar puncture may be misleading. An averaging over 30 minutes should be the minimum, with a period of overnight monitoring in conscious patients providing the optimal standard. Computer-aided recording with online waveform analysis of ICP is very helpful. Although there is no "Class I" evidence, ICP monitoring is useful, if not essential, in head injury, poor grade subarachnoid haemorrhage, stroke, intracerebral haematoma, meningitis, acute liver failure, hydrocephalus, benign intracranial hypertension, craniosynostosis etc. Information which can be derived from ICP and its waveforms includes cerebral perfusion pressure (CPP), regulation of cerebral blood flow and volume, CSF absorption capacity, brain compensatory reserve, and content of vasogenic events. Some of these parameters allow prediction of prognosis of survival following head injury and optimisation of "CPP-guided therapy". In hydrocephalus CSF dynamic tests aid diagnosis and subsequent monitoring of shunt function.	Univ Cambridge, Acad Neurosurg Unit, Sch Clin, Cambridge, England	Czosnyka, M (corresponding author), Addenbrookes Hosp, Box 167, Cambridge CB2 2QQ, England.	MC141@medschl.cam.ac.uk			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R, 1986, INTRACRANIAL PRESSUR, VVI, P229; ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; AVEZAAL CJJ, 1984, THESIS HAGUE JONGBLO; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; BALESTRERI M, 2004, IN PRESS ACTA NEUROC; Boon AJW, 1997, J NEUROSURG, V87, P687, DOI 10.3171/jns.1997.87.5.0687; BORGESEN SE, 1987, J NEUROSURG, V67, P535, DOI 10.3171/jns.1987.67.4.0535; BORGESEN SE, 1982, BRAIN, V105, P65, DOI 10.1093/brain/105.1.65; Bullock R, 1995, New Horiz, V3, P448; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Czosnyka M, 1999, J NEUROSURG, V90, P752, DOI 10.3171/jns.1999.90.4.0752; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Czosnyka ZH, 2002, ACT NEUR S, V81, P27; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; EKSTEDT J, 1977, J NEUROL NEUROSUR PS, V40, P105, DOI 10.1136/jnnp.40.2.105; FOLTZ E L, 1990, Neurological Research, V12, P67; Ghajar J, 1995, New Horiz, V3, P395; GUILLAUME J, 1951, REV NEUROL, V84, P131; Higgins JNP, 2002, LANCET, V359, P228, DOI 10.1016/S0140-6736(02)07440-8; Kahlon B, 2002, J NEUROL NEUROSUR PS, V73, P721, DOI 10.1136/jnnp.73.6.721; KATZMAN R, 1970, NEUROLOGY, V20, P534, DOI 10.1212/WNL.20.6.534; KEAYS RT, 1993, J HEPATOL, V18, P205, DOI 10.1016/S0168-8278(05)80247-8; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1546, DOI 10.1136/jnnp.57.12.1546; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1972, Prog Brain Res, V35, P411; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Owler BK, 2001, BRIT J NEUROSURG, V15, P439, DOI 10.1080/02688690120082477; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Patel HC, 2003, ACRA NEUROCHIR WEIN; Petkus V, 2002, ULTRASONICS, V40, P829, DOI 10.1016/S0041-624X(02)00216-0; Pickard J.D., 1980, INTRACRANIAL PRESSUR, P498; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PIPER IR, 1990, ACT NEUR S, V51, P387; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2000, ACT NEUR S, V76, P451; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sussman JD, 1998, ADV TECH STAND NEUR, V24, P261; SYMON L, 1972, LANCET, V2, P1291; TAKIZAWA H, 1987, NEUROSURGERY, V20, P355, DOI 10.1227/00006123-198703000-00001; Tisell M, 2002, NEUROSURGERY, V50, P70, DOI 10.1097/00006123-200201000-00013; Tuite GF, 1996, NEUROSURGERY, V39, P691, DOI 10.1097/00006123-199610000-00007; Tuli S, 2000, J NEUROSURG, V92, P31, DOI 10.3171/jns.2000.92.1.0031; Walchenbach R, 2002, J NEUROL NEUROSUR PS, V72, P503; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; Yau YH, 2002, ACT NEUR S, V81, P171	73	403	432	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2004	75	6					813	821		10.1136/jnnp.2003.033126			9	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	824GX	WOS:000221675700004	15145991	Bronze, Green Published			2021-06-18	
J	Henry, JD; Crawford, JR				Henry, JD; Crawford, JR			A meta-analytic review of verbal fluency performance following focal cortical lesions	NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; LEFT FRONTAL-LOBE; WORD FLUENCY; TEMPORAL-LOBE; ALZHEIMERS-DISEASE; CATEGORY FLUENCY; WORKING-MEMORY; IMPAIRMENT; ANTERIOR	A meta-analysis of 3 1 studies with 1.791 participants was conducted to investigate the sensitivity of tests of verbal fluency to the presence of focal cortical lesions. Relative to healthy controls, participants with focal frontal injuries had large and comparable deficits on phonemic (r = .52) and semantic (r = .54) fluency. For frontal but not nonfrontal patients, phonemic fluency deficits qualified as differential deficits when compared with IQ and psychomotor speed: phonemic fluency was also more strongly and more specifically related to the presence of frontal lesions than the Wisconsin Card Sorting Test scores. In contrast, temporal damage was associated with a lesser deficit on phonemic fluency (r = .44) but a larger deficit on semantic fluency (r = .61).	Univ Aberdeen, Kings Coll, Dept Psychol, Aberdeen AB24 3HN, Scotland	Henry, JD (corresponding author), Univ Aberdeen, Kings Coll, Dept Psychol, Aberdeen AB24 3HN, Scotland.	j.d.henry@abdn.ac.uk	Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428; Henry, Julie/0000-0002-2081-3717			ALBERT ML, 1986, CORTEX, V22, P103, DOI 10.1016/S0010-9452(86)80035-1; American Psychological Association, 2001, PUBL MAN AM PSYCH AS, V5; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Beldarrain MG, 1999, NEUROLOGY, V52, P1853, DOI 10.1212/WNL.52.9.1853; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BOLTER JF, 1983, INT J CLIN NEUROPSYC, V5, P77; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Butler R.W., 1993, NEUROPSYCHOLOGY, V7, DOI [DOI 10.1037/0894-4105.7.4.519, https://doi.org/10.1037/0894-4105.7.4.519]; Cardebat D, 1996, BRAIN LANG, V52, P305, DOI 10.1006/brln.1996.0013; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; CRAWFORD JR, 1993, PSYCHOL MED, V23, P787, DOI 10.1017/S0033291700025563; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Crawford JR, 2000, AGING NEUROPSYCHOL C, V7, P9, DOI 10.1076/anec.7.1.9.806; CRAWFORD JR, IN PRESS EFFECTIVENE; Crowe SF, 1996, AUST PSYCHOL, V31, P204, DOI 10.1080/00050069608260207; DeVreese LP, 1996, APHASIOLOGY, V10, P801, DOI 10.1080/02687039608248451; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; Fisher R.A., 1928, STAT METHODS RES WOR; Flowers KA, 1995, J NEUROLINGUIST, V9, P33, DOI 10.1016/0911-6044(95)00004-6; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Goulet P, 1997, NEUROPSYCHOLOGIA, V35, P1565, DOI 10.1016/S0028-3932(97)00081-X; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEDGES LV, 1985, STAT METHODS META AN; Helmstaedter C, 1998, NEUROPSYCHOLOGIA, V36, P681, DOI 10.1016/S0028-3932(97)00134-6; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Hunter J.E., 1990, METHODS META ANAL CO; Hunter J.E., 1994, HDB RES SYNTHESIS ME, P323; Hunter JE., 1982, META ANAL CUMULATING; JOANETTE Y, 1986, NEUROPSYCHOLOGIA, V24, P875, DOI 10.1016/0028-3932(86)90087-4; Jurado MA, 2000, BRAIN INJURY, V14, P789; Laws K R, 1999, Cogn Neuropsychiatry, V4, P1, DOI 10.1080/135468099396025; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LORING DW, 1994, ARCH CLIN NEUROPSYCH, V9, P229, DOI 10.1016/0887-6177(94)90028-0; Luckhurst L, 2001, BRAIN LANG, V79, P266, DOI 10.1006/brln.2001.2485; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; MARTIN RC, 1990, NEUROPSYCHOLOGIA, V28, P823, DOI 10.1016/0028-3932(90)90006-A; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Milner B, 1964, FRONTAL GRANULAR COR, P313; Monsch AU, 1997, ACTA NEUROL SCAND, V95, P81, DOI 10.1111/j.1600-0404.1997.tb00073.x; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; National Research Council, 1992, COMB INF STAT ISS OP; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PARKER DM, 1992, HDB NEUROPSYCHOLOGIC, P267; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Phillips LH, 1997, Methodology of frontal " and executive function, P191; Pujol J, 1996, ACTA NEUROL SCAND, V93, P403; RAMIER AM, 1970, REV NEUROL, V123, P17; RAUDENBUSH SW, 1994, HDB RES SYNTHESIS, P301, DOI DOI 10.1111/ACPS.12078; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; REITAN W, 1990, HALSTEADREITAN NEURO; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Schwartz S, 2001, NEUROPSYCHOLOGIA, V39, P1209, DOI 10.1016/S0028-3932(01)00053-7; SHADISH WR, 1994, HDB RES SYNTHESIS, P261; Snedecor G.W., 1989, STAT METHODS, V8th; Stanhope N, 1998, NEUROPSYCHOLOGIA, V36, P1387, DOI 10.1016/S0028-3932(98)00040-2; Stefanova ED, 2002, J CLIN EXP NEUROPSYC, V24, P687, DOI 10.1076/jcen.24.5.687.1010; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [DOI 10.1037/0894-4105.8.3.355, 10.1037/0894-4105.8.3.355]; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Sylvester CYC, 2002, NEUROPSYCHOLOGY, V16, P197, DOI 10.1037//0894-4105.16.2.197; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; Thomson AM, 1998, BRIT J NEUROSURG, V12, P423, DOI 10.1080/02688699844628; THURSTONE LL, 1941, PSYCHOMETRIC MONOGR, V2, P94; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Tucha O, 1999, J CLIN EXP NEUROPSYC, V21, P229, DOI 10.1076/jcen.21.2.229.928; VARLEY R, 1995, EUR J DISORDER COMM, V30, P362; Wechsler, 1981, WAIS R MANUAL; Wechsler D., 1955, WAIS MANUAL; Welsh MC, 1999, BRAIN COGNITION, V41, P231, DOI 10.1006/brcg.1999.1123; WERTZ RT, 1986, CLIN APHASIOLOGY, V16, P257	84	402	419	2	33	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	2004	18	2					284	295		10.1037/0894-4105.18.2.284			12	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	810SX	WOS:000220725100010	15099151	Green Published			2021-06-18	
J	FODA, MAA; MARMAROU, A				FODA, MAA; MARMAROU, A			A NEW MODEL OF DIFFUSE BRAIN INJURY IN RATS .2. MORPHOLOGICAL CHARACTERIZATION	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; EXPERIMENTAL MODEL; NEURONAL INJURY; TRAUMATIC BRAIN EDEMA; DIFFUSE AXONAL INJURY; IMMUNOCYTOCHEMISTRY; RAT		A new model producing diffuse brain injury, without focal brain lesions, has been developed in rats. This has been achieved by allowing a weight of 450 gm to fall onto a metallic disc fixed to the intact skull of the animal which is supported by a foam bed. Two levels of injury were examined by adjusting the height of the falling weight to either 1 m or 2 m. Two groups of animals were studied. Group 1 animals were separated into three subgroups: 10 received a 1-m weight drop, 58 received a 2-m weight drop, and 13 served as controls; all were allowed to breathe spontaneously. Group 2 animals were separated into the same subgroups: four received a 1-m weight drop, six received a 2-m weight drop, and four served as controls; all of these were mechanically ventilated during the procedure. In Group 1, morphological studies using light and electron microscopy were performed at 1, 6, 24, or 72 hours, or 10 days after insult; all Group 2 rats were studied at 24 hours after injury. Results from Group 1 animals showed that no mortality occurred with the 1-m level injury, while 59% mortality was seen with the 2-m level injury. On the other hand, no mortality occurred in Group 2 animals regardless of the level of trauma induced. However, the morphological changes observed in both groups were similar. Gross pathological examination did not reveal any supratentorial focal brain lesion regardless of the severity of the trauma. Petechial hemorrhages were noticed in the brain item at the 2-m level injury. Microscopically, the model produced a graded wide spread injury of the neurons, axons, and microvasculature. Neuronal injury was mainly observed bilaterally in the cerebral cortex. Brain edema, in the form of pericapillary astrocytic swelling, was also noted in these areas of the cerebral cortex and in the brain stem. Most importantly, the trauma resulted in a massive diffuse axonal injury that primarily involved the corpus callosum, internal capsule, optic tracts, cerebral and cerebellar peduncles, and the long tracts in the brain stem. lt is concluded that this model would be suitable for studying neuronal, axonal, and vascular changes associated with diffuse brain injury.		FODA, MAA (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, RICHMOND, VA 23298 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587, NS-19235] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS019235, P50NS012587, R01NS019235, P01NS012587] Funding Source: NIH RePORTER		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AGARDH CD, 1980, ACTA NEUROPATHOL, V50, P31, DOI 10.1007/BF00688532; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRIERLEY JB, 1981, ACTA NEUROPATHOL, V55, P319, DOI 10.1007/BF00690996; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Graham D I, 1983, Acta Neurochir Suppl (Wien), V32, P65; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; KAMILO H, 1980, ACTA NEUROPATHOL, V50, P43; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1991, NEUROPATHOLOGY S, V4, P749; POVLISHOCK JT, 1990, ADV NEUROTRAUMA RES, V2, P1; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TORNHEIM PA, 1985, CENTRAL NERVOUS SYST, P431; VANDENBRINK W, 1993, INTRACRANIAL PRESSUR, V7, P221; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	51	402	432	0	21	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	1994	80	2					301	313		10.3171/jns.1994.80.2.0301			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	MR795	WOS:A1994MR79500017	8283270				2021-06-18	
J	Inglese, M; Makani, S; Johnson, G; Cohen, BA; Silver, JA; Gonen, O; Grossman, RI				Inglese, M; Makani, S; Johnson, G; Cohen, BA; Silver, JA; Gonen, O; Grossman, RI			Diffuse axonal injury in mild traumatic brain injury: a diffusion tensor imaging study	JOURNAL OF NEUROSURGERY			English	Article						mild traumatic brain injury; diffusion tensor imaging; diffuse axonal injury	CLOSED-HEAD INJURY; WHITE-MATTER INJURY; WEIGHTED MR; DAMAGE; COEFFICIENT; ANISOTROPY; SCORE	Object. Diffuse axonal injury (DAI) is a major complication of traumatic brain injury (TBI) that leads to functional and psychological deficits. Although DAI is frequently underdiagnosed by conventional imaging modalities, it can be demonstrated using diffusion tensor imaging. The aim of this study was to assess the presence and extent of DAI in patients with mild TBI. Methods. Forty-six patients with mild TBI and 29 healthy volunteers underwent a magnetic resonance (MR) imaging protocol including: dual-spin echo, fluid-attenuated inversion recovery, T-weighted gradient echo, and diffusion tensor imaging sequences. In 20 of the patients, MR imaging was performed at a mean of 4.05 days after injury. In the remaining 26, MR imaging was performed at a mean of 5.7 years after injury. In each case, mean diffusivity and fractional anisotropy were measured using both whole-brain histograms and regions of interest analysis. No differences in any of the histogram-derived measures were found between patients and control volunteers. Compared with controls, a significant reduction of fractional anisotropy was observed in patients' corpus callosum, internal capsule, and centrum sermovale, and there were significant increases of mean diffusivity in the corpus callosum and internal capsule. Neither histogram-derived nor regional diffusion tensor imaging metrics differed between the two groups. Conclusions. Although mean diffusivity and fractional anisotropy abnormalities in these patients with TBI were too subtle to be detected with the whole-brain histogram analysis, they are present in brain areas that are frequent sites of DAI. Because diffusion tensor imaging changes are present at both early and late time points following injury, they may represent an early indicator and a prognostic measure of subsequent brain damage.	NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; Lenox Hill Hosp, New York, NY 10021 USA	Inglese, M (corresponding author), NYU, Sch Med, Dept Radiol, 650 1st Ave, New York, NY 10016 USA.	matilde.inglese@med.nyu.edu	Inglese, Matilde/AAH-3189-2020	Inglese, Matilde/0000-0002-9610-0297; Gonen, Oded/0000-0002-3148-2028; Johnson, Glyn/0000-0001-6826-5054	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00096] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39135] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Iannucci G, 2001, STROKE, V32, P643, DOI 10.1161/01.STR.32.3.643; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1034/j.1600-0455.2001.420404.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; vanBuchem MA, 1997, AM J NEURORADIOL, V18, P1287	29	400	409	2	29	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	AUG	2005	103	2					298	303		10.3171/jns.2005.103.2.0298			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	957KI	WOS:000231368300016	16175860				2021-06-18	
J	Mez, J; Daneshvar, DH; Kiernan, PT; Abdolmohammadi, B; Alvarez, VE; Huber, BR; Alosco, ML; Solomon, TM; Nowinski, CJ; McHale, L; Cormier, KA; Kubilus, CA; Martin, BM; Murphy, L; Baugh, CM; Montenigro, PH; Chaisson, CE; Tripodis, Y; Kowall, N; Weuve, J; McClean, MD; Cantu, RC; Goldstein, LE; Katz, DI; Stern, RA; Stein, TD; McKee, AC				Mez, Jesse; Daneshvar, Daniel H.; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Alvarez, Victor E.; Huber, Bertrand R.; Alosco, Michael L.; Solomon, Todd M.; Nowinski, Christopher J.; McHale, Lisa; Cormier, Kerry A.; Kubilus, Caroline A.; Martin, Brett M.; Murphy, Lauren; Baugh, Christine M.; Montenigro, Phillip H.; Chaisson, Christine E.; Tripodis, Yorghos; Kowall, Neilw.; Weuve, Jennifer; McClean, Michael D.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; Stein, Thor D.; McKee, Ann C.			Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; REPETITIVE HEAD-INJURY; MOTOR-NEURON DISEASE; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; LEAGUE PLAYER; 1ST EXPOSURE; CRITERIA; ASSOCIATION; RELIABILITY	IMPORTANCE Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE). OBJECTIVE To determine the neuropathological and clinical features of deceased football players with CTE. DESIGN, SETTING, AND PARTICIPANTS Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history. EXPOSURES Participation in American football at any level of play. MAIN OUTCOMES AND MEASURES Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia. RESULTS Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia. CONCLUSIONS AND RELEVANCE In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.	[Mez, Jesse; Daneshvar, Daniel H.; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Alvarez, Victor E.; Huber, Bertrand R.; Alosco, Michael L.; Solomon, Todd M.; Nowinski, Christopher J.; Cormier, Kerry A.; Kubilus, Caroline A.; Chaisson, Christine E.; Tripodis, Yorghos; Kowall, Neilw.; Cantu, Robert C.; Goldstein, Lee E.; Stern, Robert A.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Mez, Jesse; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Huber, Bertrand R.; Alosco, Michael L.; Cormier, Kerry A.; Kubilus, Caroline A.; Murphy, Lauren; Montenigro, Phillip H.; Kowall, Neilw.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Daneshvar, Daniel H.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Kowall, Neilw.; Stein, Thor D.; McKee, Ann C.] US Dept Vet Affairs, VA Boston Healthcare Syst, Boston, MA USA; [Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Nowinski, Christopher J.; McHale, Lisa; Cantu, Robert C.] Concuss Legacy Fdn, Waltham, MA USA; [Martin, Brett M.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Tripodis, Yorghos; Weuve, Jennifer; McClean, Michael D.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Kowall, Neilw.; Goldstein, Lee E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Weuve, Jennifer] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [McClean, Michael D.] Boston Univ, Dept Environm Hlth, Boston, MA 02215 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Dept Biomed Engn, Coll Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Boston, MA 02118 USA	McKee, AC (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, VA Boston Healthcare Syst,Neuropathol Serv,CTE Ct, 150 S Huntington Ave, Boston, MA 02118 USA.	amckee@bu.edu	, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020; Lang, Steven/AAE-8102-2021	Baugh, Christine/0000-0002-9340-6338; Lang, Steven/0000-0003-1669-9146; Tripodis, Yorghos/0000-0003-2190-7608; Daneshvar, Daniel/0000-0003-3691-9513; Stein, Thor/0000-0001-6954-4477	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, F32 NS096803]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG046377, P30AG13846, 0572063345-5, R01 AG1649]; US Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001038]; Veterans Affairs Biorepository [CSP 501]; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; Department of Defense Peer Reviewed Alzheimer's Research Program [13267017]; National Operating Committee on Standards for Athletic Equipment; Alzheimer's AssociationAlzheimer's Association [NIRG-15-362697, NIRG-305779]; Concussion Legacy Foundation; Andlinger Family Foundation; WWE; NFL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, K23AG046377, RF1AG057902] Funding Source: NIH RePORTER	This study received support from NINDS (grants U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, and F32 NS096803), the National Institute on Aging (grants K23 AG046377, P30AG13846 and supplement 0572063345-5, R01 AG1649), the US Department of Defense (grant W81XWH-13-2-0064), the US Department of Veterans Affairs (I01 CX001038), the Veterans Affairs Biorepository (CSP 501), the Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (grant B6796-C), the Department of Defense Peer Reviewed Alzheimer's Research Program (grant 13267017), the National Operating Committee on Standards for Athletic Equipment, the Alzheimer's Association (grants NIRG-15-362697 and NIRG-305779), the Concussion Legacy Foundation, the Andlinger Family Foundation, the WWE, and the NFL.	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Love S., 2008, GREENFIELDS NEUROPAT, V8th; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42	36	399	401	16	170	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					360	370		10.1001/jama.2017.8334			11	Medicine, General & Internal	General & Internal Medicine	FB7BS	WOS:000406296700016	28742910	Green Accepted, Bronze, Green Published	Y	N	2021-06-18	
J	Hutchinson, PJ; Kolias, AG; Timofeev, IS; Corteen, EA; Czosnyka, M; Timothy, J; Anderson, I; Bulters, DO; Belli, A; Eynon, CA; Wadley, J; Mendelow, AD; Mitchell, PM; Wilson, MH; Critchley, G; Sahuquillo, J; Unterberg, A; Servadei, F; Teasdale, GM; Pickard, JD; Menon, DK; Murray, GD; Kirkpatrick, PJ				Hutchinson, P. J.; Kolias, A. G.; Timofeev, I. S.; Corteen, E. A.; Czosnyka, M.; Timothy, J.; Anderson, I.; Bulters, D. O.; Belli, A.; Eynon, C. A.; Wadley, J.; Mendelow, A. D.; Mitchell, P. M.; Wilson, M. H.; Critchley, G.; Sahuquillo, J.; Unterberg, A.; Servadei, F.; Teasdale, G. M.; Pickard, J. D.; Menon, D. K.; Murray, G. D.; Kirkpatrick, P. J.		RESCUEicp Trial Collaborators	Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MIDDLE-CEREBRAL-ARTERY; GLASGOW OUTCOME SCALE; BRAIN-INJURY; HEAD-INJURY; DISABILITY; PRESSURE	BACKGROUND The effect of decompressive craniectomy on clinical outcomes in patients with refractory traumatic intracranial hypertension remains unclear. METHODS From 2004 through 2014, we randomly assigned 408 patients, 10 to 65 years of age, with traumatic brain injury and refractory elevated intracranial pressure (>25 mm Hg) to undergo decompressive craniectomy or receive ongoing medical care. The primary outcome was the rating on the Extended Glasgow Outcome Scale (GOS-E) (an 8-point scale, ranging from death to "upper good recovery" [no injury-related problems]) at 6 months. The primary-outcome measure was analyzed with an ordinal method based on the proportional-odds model. If the model was rejected, that would indicate a significant difference in the GOS-E distribution, and results would be reported descriptively. RESULTS The GOS-E distribution differed between the two groups (P<0.001). The proportional-odds assumption was rejected, and therefore results are reported descriptively. At 6 months, the GOS-E distributions were as follows: death, 26.9% among 201 patients in the surgical group versus 48.9% among 188 patients in the medical group; vegetative state, 8.5% versus 2.1%; lower severe disability (dependent on others for care), 21.9% versus 14.4%; upper severe disability (independent at home), 15.4% versus 8.0%; moderate disability, 23.4% versus 19.7%; and good recovery, 4.0% versus 6.9%. At 12 months, the GOS-E distributions were as follows: death, 30.4% among 194 surgical patients versus 52.0% among 179 medical patients; vegetative state, 6.2% versus 1.7%; lower severe disability, 18.0% versus 14.0%; upper severe disability, 13.4% versus 3.9%; moderate disability, 22.2% versus 20.1%; and good recovery, 9.8% versus 8.4%. Surgical patients had fewer hours than medical patients with intracranial pressure above 25 mm Hg after randomization (median, 5.0 vs. 17.0 hours; P<0.001) but had a higher rate of adverse events (16.3% vs. 9.2%, P=0.03). CONCLUSIONS At 6 months, decompressive craniectomy in patients with traumatic brain injury and refractory intracranial hypertension resulted in lower mortality and higher rates of vegetative state, lower severe disability, and upper severe disability than medical care. The rates of moderate disability and good recovery were similar in the two groups. (Funded by the Medical Research Council and others; RESCUEicp Current Controlled Trials number, ISRCTN66202560.)	[Hutchinson, P. J.; Kolias, A. G.; Timofeev, I. S.; Corteen, E. A.; Czosnyka, M.; Pickard, J. D.; Kirkpatrick, P. J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Menon, D. K.] Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; Univ Cambridge, Cambridge, England; [Timothy, J.; Anderson, I.] Leeds Gen Infirm, Dept Neurosurg, Leeds, W Yorkshire, England; [Bulters, D. O.] Southampton Univ Hosp, Dept Neurosurg, Wessex Neurol Ctr, Southampton, Hants, England; [Eynon, C. A.] Southampton Univ Hosp, Neurosci Intens Care Unit, Wessex Neurol Ctr, Southampton, Hants, England; [Belli, A.] Univ Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Wadley, J.] St Bartholomews & Royal London Hosp, Dept Neurosurg, London, England; [Wilson, M. H.] St Marys Hosp, Dept Neurosurg, London, England; [Mendelow, A. D.] Newcastle Univ, Neurosurg Trials Grp, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Mitchell, P. M.] Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Critchley, G.] Brighton & Sussex Univ Hosp, Hurstwood Pk Neurosci Ctr, Haywards Heath, England; [Teasdale, G. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Murray, G. D.] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Sahuquillo, J.] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Unterberg, A.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Servadei, F.] Univ Parma, Azienda Osped Univ Parma, Arcispedale S Maria Nuova IRCCS Reggio Emilia, Neurosurg Neurotraumatol Unit, Parma, Italy	Hutchinson, PJ (corresponding author), Univ Cambridge, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk	Abdullah, J/C-2828-2011; Mrlian, Andrej/ABD-5480-2020; Belli, Antonio/I-3799-2015; GANESAN, DHARMENDRA/B-8437-2010; Sahuquillo, Juan/B-3577-2008; NARAYANAN, VAIRAVAN/B-9191-2010; Bulters, Diederik/ABH-3573-2020; SABANCI, PULAT AKIN/AAT-1325-2020; Idris, Badrisyah/E-3201-2012; Chan, Matthew T. V./J-2884-2013; Idris, Badrisyah/C-8355-2016	Abdullah, J/0000-0002-0258-7410; Mrlian, Andrej/0000-0002-5362-1084; Belli, Antonio/0000-0002-3211-9933; Sahuquillo, Juan/0000-0003-0713-5875; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; Idris, Badrisyah/0000-0002-7753-7389; Chan, Matthew T. V./0000-0002-3574-7855; Idris, Badrisyah/0000-0002-7753-7389; Samandouras, George/0000-0001-7166-5729; Solodov, Aleksandr/0000-0002-8263-1433; Papadopoulos, Marios/0000-0001-9174-4176; Timofeev, Ivan/0000-0002-1168-0393; Whitfield, Peter/0000-0003-0566-1820; Bulters, Diederik/0000-0001-9884-9050; King, Andrew/0000-0002-6546-7248; Wilson, Mark/0000-0002-2346-4911; Servadei, Franco/0000-0002-3595-3464; Kolias, Angelos/0000-0003-3992-0587	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986, G1000183B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, NF-SI-0512-10090, 12/35/57, NF-SI-0508-10327] Funding Source: researchfish	Funded by the Medical Research Council and others; RESCUEicp Current Controlled Trials number, ISRCTN66202560.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hutchinson P, LANCET; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Mahmoodpoor A, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	20	399	415	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2016	375	12					1119	1130		10.1056/NEJMoa1605215			12	Medicine, General & Internal	General & Internal Medicine	DW3JE	WOS:000383537100005	27602507	Green Published, Green Accepted	Y	N	2021-06-18	
J	FRISEN, J; JOHANSSON, CB; TOROK, C; RISLING, M; LENDAHL, U				FRISEN, J; JOHANSSON, CB; TOROK, C; RISLING, M; LENDAHL, U			RAPID, WIDESPREAD, AND LONG-LASTING INDUCTION OF NESTIN CONTRIBUTES TO THE GENERATION OF GLIAL SCAR TISSUE AFTER CNS INJURY	JOURNAL OF CELL BIOLOGY			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA; RAT-BRAIN; MONOCLONAL-ANTIBODIES; PRECURSOR CELLS; SPINAL-CORD; STEM-CELL; EXPRESSION; DIFFERENTIATION	Neuronal regeneration does generally not occur in the central nervous system (CNS) after injury, which has been attributed to the generation of glial scar tissue. In this report we show that the composition of the glial scar after traumatic CNS injury in rat and mouse is more complex than previously assumed: expression of the intermediate filament nestin is induced in reactive astrocytes. Nestin induction occurs within 48 hours in the spinal cord both at the site of lesion and in degenerating tracts and lasts for at least 13 months. Nestin expression is induced with similar kinetics in the crushed optic nerve. In addition to the expression in reactive astrocytes, we also observed nestin induction within 48 hours after injury in cells close to the central canal in the spinal cord, while nestin expressing cells at later timepoints were found progressively further out from the central canal. This dynamic pattern of nestin induction after injury was mimicked by lacZ expressing cells in nestin promoter/lacZ transgenic mice, suggesting that defined nestin regulatory regions mediate the injury response. We discuss the possibility that the spatiotemporal pattern of nestin expression reflects a population of nestin positive cells, which proliferates and migrates from a region close to the central canal to the site of lesion in response to injury.	KAROLINSKA INST, MED NOBEL INST, DEPT MOLEC & CELL BIOL, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA INST, MED NOBEL INST, DEPT NEUROSCI, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA INST, MED NOBEL INST, DEPT PROSTHET DENT, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA INST, MED NOBEL INST, DEPT WOMEN & CHILD HLTH, S-17177 STOCKHOLM, SWEDEN				Lendahl, Urban/0000-0001-9543-8141			AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CRIPE L, 1993, P NATL ACAD SCI USA, V90, P2724, DOI 10.1073/pnas.90.7.2724; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENG LF, 1992, PROG BRAIN RES, V94, P353; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; FUCHS C, 1994, J COMP NEUROL, V343, P332, DOI 10.1002/cne.903430211; GIORDANO S, 1989, NEURON, V2, P1507, DOI 10.1016/0896-6273(89)90197-9; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOLDER N, 1990, J NEUROCYTOL, V19, P915, DOI 10.1007/BF01186819; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; ISHIKAWA R, 1991, NEUROSCI LETT, V127, P70, DOI 10.1016/0304-3940(91)90897-3; KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; NILSSON E, 1993, MOL REPROD DEV, V34, P149, DOI 10.1002/mrd.1080340206; OSBORN M, 1989, CYTOSKELETAL PROTEIN, P1; PENY M, 1995, EMBO J, V14, P1590; PETERS A, 1991, FINE STRUCTURE NERVO, P1; Ramon y Cajal S, 1928, DEGENERATION REGENER; REDIES C, 1991, J NEUROSCI RES, V30, P601, DOI 10.1002/jnr.490300403; Reier P.J., 1989, NEURAL REGENERATION, P183; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RISLING M, 1994, J COMP NEUROL, V339, P365, DOI 10.1002/cne.903390306; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SEJERSEN T, 1993, J CELL SCI, V106, P1291; SHARP G, 1982, EXP CELL RES, V141, P385, DOI 10.1016/0014-4827(82)90227-0; SJOBERG G, 1994, J NEUROPATH EXP NEUR, V53, P416; SJOBERG G, 1994, EXP CELL RES, V214, P447, DOI 10.1006/excr.1994.1281; SOTELO C, 1994, J NEUROSCI, V14, P124; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TOHYAMA T, 1992, LAB INVEST, V66, P303; TOLLE HG, 1986, EXP CELL RES, V162, P462, DOI 10.1016/0014-4827(86)90350-2; WILLIAMS BP, 1995, IN PRESS NEURON; WOOD JN, 1981, BIOSCIENCE REP, V1, P263, DOI 10.1007/BF01114913; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	53	399	420	0	14	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0021-9525	1540-8140		J CELL BIOL	J. Cell Biol.	OCT	1995	131	2					453	464		10.1083/jcb.131.2.453			12	Cell Biology	Cell Biology	RZ595	WOS:A1995RZ59500014	7593171	Green Published, Bronze			2021-06-18	
J	CLIFTON, GL; JIANG, JY; LYETH, BG; JENKINS, LW; HAMM, RJ; HAYES, RL				CLIFTON, GL; JIANG, JY; LYETH, BG; JENKINS, LW; HAMM, RJ; HAYES, RL			MARKED PROTECTION BY MODERATE HYPOTHERMIA AFTER EXPERIMENTAL TRAUMATIC BRAIN INJURY	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						HYPOTHERMIA; PERFORMANCE DEFICITS; TRAUMATIC BRAIN INJURY; MORTALITY	GLOBAL CEREBRAL-ISCHEMIA; CIRCULATORY ARREST; PROLONGED HYPOTHERMIA; DEEP HYPOTHERMIA; MILD HYPOTHERMIA; SURGERY; HYPOXIA; RAT; HYPERTHERMIA; METABOLISM	These experiments examined the effects of moderate hypothermia on mortality and neurological deficits observed after experimental traumatic brain injury (TBI) in the rat. Brain temperature was measured continuously in all experiments by intraparenchymal probes. Brain cooling was induced by partial immersion (skin protected by a plastic barrier) in a water bath (0-degrees-C) under general anesthesia (1.5% halothane/70% nitrous oxide/30% oxygen). In experiment I, we examined the effects of moderate hypothermia induced prior to injury on mortality following fluid percussion TBI. Rats were cooled to 36-degrees-C (n = 16), 33-degrees-C (n = 17), or 30-degrees-C (n = 11) prior to injury and maintained at their target temperature for 1 h after injury. There was a significant (p < 0.04) reduction in mortality by a brain temperature of 30-degrees-C. The mortality rate at 36-degrees-C was 37.5%, at 33-degrees-C was 41%, and at 30-degrees-C was 9.1%. In experiment II, we examined the effects of moderate hypothermia or hyperthermia initiated after TBI on long-term behavioral deficits. Rats were cooled to 36-degree-C (n = 10), 33-degrees-C (n = 10), or 30-degrees-C (n = 10) or warmed to 38-degrees-C (n = 10) or 40-degrees-C (n = 12) starting at 5 min after injury and maintained at their target temperatures for 1 h. Hypothermia-treated rats had significantly less beam-walking, beam-balance, and body weight loss deficits compared to normothermic (38-degrees-C) rats. The greatest protection was observed in the 30-degrees-C hypothermia group. Since a temperature of 30-degrees-C can be induced in humans by surface cooling without coagulopathy or ventricular fibrillation, hypothermia to 30-degrees-C may have potential clinical value for treatment of human brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298				Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21587, NS 21458] Funding Source: Medline		BADEER HS, 1967, J THORAC CARDIOV SUR, V53, P651, DOI 10.1016/S0022-5223(19)43151-6; BLAIR E, 1984, CLIN HYPOTHERMIA; BRUNBERG JA, 1973, PEDIATR RES, V7, P419; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CARLSSON C, 1976, ANESTHESIOLOGY, V44, P27, DOI 10.1097/00000542-197601000-00006; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; CHOPP M, 1988, STROKE, V19, P1521, DOI 10.1161/01.STR.19.12.1521; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; CLIFTON GL, 1989, STROKE, V20, P1545, DOI 10.1161/01.STR.20.11.1545; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; CRAWFORD ES, 1981, ANN SURG, V194, P180, DOI 10.1097/00000658-198108000-00012; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DICKINSON DF, 1979, ARCH DIS CHILD, V54, P1, DOI 10.1136/adc.54.1.1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAYES RL, 1988, J NEUROTRAUM, V5, P287; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; JIANG JY, 1990, IN PRESS J NEUROSURG; KATAYAMA Y, 1988, Society for Neuroscience Abstracts, V14, P1154; LASKOWSKI EJ, 1960, NEUROLOGY, V10, P499, DOI 10.1212/WNL.10.5.499; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MINAMISAWA H, 1989, J CEREB BLOOD FLO S1, V9, pS265; Mohri H, 1969, SURG CHEST, P643; MOURITZEN CV, 1966, J THORAC CARDIOV SUR, V51, P585, DOI 10.1016/S0022-5223(19)43326-6; NORWOOD WI, 1982, AM J PHYSIOL, V243, pC62; PATTERSON RH, 1962, ANN SURG, V156, P377, DOI 10.1097/00000658-196209000-00005; RITTENHOUSE EA, 1974, ANN THORAC SURG, V17, P63, DOI 10.1016/S0003-4975(10)65062-X; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; SADE RM, 1975, AM HEART J, V90, P656, DOI 10.1016/0002-8703(75)90230-6; Siesj_o B K, 1978, BRAIN ENERGY METABOL; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; UIHLEIN A, 1966, JAMA-J AM MED ASSOC, V195, P127; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; WRIGHT JS, 1979, J THORAC CARDIOV SUR, V77, P466; YOUNG R S K, 1983, Stroke, V14, P929	41	399	414	0	20	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	1991	11	1					114	121		10.1038/jcbfm.1991.13			8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EP738	WOS:A1991EP73800013	1983995	Bronze			2021-06-18	
J	Hoofien, D; Gilboa, A; Vakil, E; Donovick, PJ				Hoofien, D; Gilboa, A; Vakil, E; Donovick, PJ			Traumatic brain injury (TBI) 10-20 years later: a comprehensive outcome study of psychiatric symptomatology, cognitive abilities and psychosocial functioning	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BLUNT HEAD-INJURY; RELATIVES; REHABILITATION; INDIVIDUALS; PREVALENCE; ADJUSTMENT; RECOVERY; ADULTS	The goal of this study was to measure the very long- term mental and psychosocial outcomes of severe traumatic brain injury (TBI). Seventy- six persons with severe TBI were evaluated extensively by means of standardized scales, neuropsychological tests and evaluations by family members, at an average of 14.1 (SD = 5.5) years post- injury. Six mental and functional domains were examined: psychiatric symptomatology, cognitive abilities, vocational status, family integration, social functioning, and independence in daily routines. The findings indicate a long- term differential effect of severe TBI, with seriously affected psychiatric symptomatology, family and social domains, as compared to moderately influenced cognitive, vocational and independent functioning. Relatively high rates of depression, psychomotor slowness, loneliness and family members' sense of burden were found. In addition to their epidemiological importance, the results indicate that persons with TBI and their families may need professional assistance to maintain a reasonable psychosocial quality of life, even more than a decade post- injury.	Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; Bar Ilan Univ, Ramat Gan, Israel; SUNY Binghamton, Binghamton, NY USA	Hoofien, D (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, Mt Scopus, IL-91905 Jerusalem, Israel.	mshoofi@mscc.huji.ac.il		Gilboa, Asaf/0000-0002-4530-7490			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Bond M R, 1975, Ciba Found Symp, P141; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BOND MR, 1990, REHABILITATION ADULT, P59; BORNSTEIN RA, 1982, J CLIN NEUROPSYCHOL, V4, P319, DOI 10.1080/01688638208401140; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; Chamberlain M. A., 1995, TRAUMATIC BRAIN INJU, P3; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DEROGATIS L, 1977, SCL90 MANUAL SCORING; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; GROSWASSER Z, 1995, TRAUMATIC BRAIN INJU, P25; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HOOFIEN D, 1994, FINAL REPORT COMPREH; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P171; LINKOWSKI DC, 1972, REHABILITATION COUNS, V14, P236; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MCFARLANE AC, 1995, ANN NY ACAD SCI, V821, P10; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Melamed S, 1999, SCAND J REHABIL MED, V31, P23; MELAMED S, 1985, SCAND J REHABIL MED, P129; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Newburn G, 1998, CNS DRUGS, V9, P441, DOI 10.2165/00023210-199809060-00003; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1997, NEUROLOGICAL REHABIL, P423; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Roe A., 1956, PSYCHOL OCCUPATIONS, P76; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SOLOMON Z, 1988, BEHAV MED, V14, P171, DOI 10.1080/08964289.1988.9935142; SOLOMON Z, 1989, SOC PSYCH PSYCH EPID, V24, P41, DOI 10.1007/BF01788199; SOLOMON Z, 1992, BRIT J CLIN PSYCHOL, V31, P21, DOI 10.1111/j.2044-8260.1992.tb00965.x; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; *STAT ISR CENTR BU, 1997, ANN STAT REP; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TIFFIN J, 1968, PURDUE PEG BOARD EXA; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; VANZOMEREN AH, 1990, TRAUMATIC BRAIN INJU, P86; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]	52	397	401	2	57	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2001	15	3					189	209					21	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	407ZM	WOS:000167302100001	11260769				2021-06-18	
J	Powell, JW; Barber-Foss, KD				Powell, JW; Barber-Foss, KD			Traumatic brain injury in high school athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOTBALL PLAYERS; CONCUSSION	Context The potential seriousness of mild traumatic brain injury (MTBI) is increasingly recognized; however, information on the frequency of MTBI among high school athletes is limited. Objective To identify the type, frequency, and severity of MTBI in selected high school sports activities. Design Observational cohort study.. Setting and Participants Two hundred forty-six certified athletic trainers recorded injury and exposure data for high school varsity athletes participating in boys' football, wrestling, baseball and field hockey, girls' volleyball and softball, boys' and girls' basketball, and boys' and girls' soccer at 235 US high schools during 1 or more of the 1995-1997 academic years. Main Outcome Measures Rates of reported MTBI, defined as a head-injured player who was removed from participation and evaluated by an athletic trainer or physician prior to returning to participation. National incidence figures for MTBI also were estimated. Results Of 23 566 reported injuries in the 10 sports during the 3-year study period, 1219 (5.5 %) were MTBIs. Of the MTBIs, football accounted for 773 (63.4%) of cases; wrestling, 128 (10.5%); girls' soccer, 76 (6.2%); boys' soccer, 69 (5.7%); girls' basketball, 63 (5.2%); boys' basketball, 51 (4.2%); softball, 25 (2.1%); baseball, 15 (1.2%); field hockey, 13 (1.1%); and volleyball, 6 (0.5%). The injury rates per 100 player-seasons were 3.66 for football, 1.58 for wrestling, 1.14 for girls' soccer, 1.04 for girls' basketball, 0.92 for boys' soccer, 0.75 for boys' basketball, 0.46 for softball, 0.46 for field hockey, 0.23 for baseball, and 0.14 for volleyball. The median time lost from participation for all MTBIs was 3 days. There were 6 cases of subdural hematoma and intracranial injury reported in football. Based on these data, an estimated 62 816 cases of MTBI occur annually among high school varsity athletes participating in these sports, with football accounting for about 63 % of cases. Conclusions Rates of MTBI vary among sports and none of the 10 popular high school sports we studied is without the occurrence of an MTBI. Continued involvement of high school sports sponsors, researchers, medical professionals, coaches, and sports participants is essential to help minimize the risk of MTBI.	Med Sports Syst, Iowa City, IA USA	Powell, JW (corresponding author), Michigan State Univ, Dept Kinesiol, IM Sports Circle, E Lansing, MI 48824 USA.						Barth JT., 1989, MILD HEAD INJURY, P257; BUCKLEY WE, 1985, THESIS PENNSYLVANIA; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; CLARKE KS, 1979, MED SCI SPORTS EXERC, V2, P138; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; GAHLINGER PM, 1993, RATRES2 VERSION 1 4C; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; Hovda D. A., 1994, Society for Neuroscience Abstracts, V20, P845; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KIRKWOOD B, 1988, ESSENTIALS MED STAT, P129; Kleinbaum D, 1982, EPIDEMIOLOGIC RES PR; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; *NAT ATHL TRAIN AS, 1991, P MILD BRAIN INJ NAT; *NAT CTR ED STAT, 1994, US DHEW NCES PUBL; Powell JW, 1999, J ATHL TRAINING, V34, P277; POWELL JW, 1988, AM J SPORTS MED S, V16, P134; *QUAL STAND SUBC A, 1997, NEUROBIOLOGY, V48, P1	21	397	401	0	58	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1999	282	10					958	963		10.1001/jama.282.10.958			6	Medicine, General & Internal	General & Internal Medicine	231XD	WOS:000082335900034	10485681	Bronze			2021-06-18	
J	Ponsford, J; Willmott, C; Rothwell, A; Cameron, P; Kelly, AM; Nelms, R; Curran, C; Ng, K				Ponsford, J; Willmott, C; Rothwell, A; Cameron, P; Kelly, AM; Nelms, R; Curran, C; Ng, K			Factors influencing outcome following mild traumatic brain injury in adults	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						mild head injury; mild traumatic brain injury; outcome	MINOR HEAD-INJURY; RISK-FACTORS; CONCUSSION; SYMPTOMS	This study aimed to investigate outcome in adults with mild traumatic brain injury (TBI) at 1 week and 3 months postinjury and to identify factors associated with persisting problems. A total of 84 adults with mild TBI were compared with 53 adults with other minor injuries as controls in terms of postconcussional symptomatology, behavior, and cognitive performance at 1 week and 3 months postinjury. At 1 week postinjury, adults with mild TBI were reporting symptoms, particularly headaches, dizziness, fatigue, visual disturbance, and memory difficulties. They exhibited slowing of information processing on neuropsychological measures, namely the WAIS-R Digit Symbol subtest and the Speed of Comprehension Test. By 3 months postinjury, the symptoms reported at 1 week had largely resolved, and no impairments were evident on neuropsychological measures. However, there was a subgroup of 24% of participants who were still suffering many symptoms, who were highly distressed, and whose lives were still significantly disrupted. These individuals did not have longer posttraumatic amnesia (PTA) duration. They were more likely to have a history of previous head injury, neurological or psychiatric problems, to be students, females, and to have been injured in a motor vehicle accident. The majority were showing significant levels of psychopathology. A range of factors, other than those directly reflecting the severity of injury, appear to be associated with outcome following mild TBI.	Epworth Hosp, Dept Psychol, Bethesda Rehabil Unit, Richmond, Vic 3121, Australia; Julia Farr Serv S Australia, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Western Hosp, Melbourne, Vic, Australia; Monash Univ, Melbourne, Vic 3004, Australia	Ponsford, J (corresponding author), Epworth Hosp, Dept Psychol, Bethesda Rehabil Unit, 30 Erin St, Richmond, Vic 3121, Australia.		Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Cameron, Peter/0000-0002-1443-557X			Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Baddeley A.D., 1992, SPEED CAPACITY LANGU; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BERROL S, 1992, REHABILITATION POST, P1; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Cicerone K. D., 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Daniel A. E., 1983, POWER PRIVILEGE PRES; Derogatis LR, 1975, SYMPTOM CHECKLIST SC; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Gronwall D, 1991, NEUROPSYCHOLOGY, V5, P253, DOI DOI 10.1037/0894-4105.5.4.253; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KAY T, 1992, REHABILITATION POST, P109; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; LEININGER B, 1992, REHABILITATION POST, P169; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MATEER CA, 1990, COGNITIVE REHABILITA, P68; MATEER CA, 1992, REHABILITATION POSTC, P143; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Rey A, 1964, EXAMEN CLIN PSYCHOL; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROY C, 1987, INJURY, V17, P220; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wilson, 1991, NATL ADULT READING T; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; WRIGHTSON P, 1981, HEAD INJURIES INTEGR, P83	47	396	397	0	50	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2000	6	5					568	579		10.1017/S1355617700655066			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	333HD	WOS:000088124100006	10932476				2021-06-18	
J	[Anonymous]				[Anonymous]			2020 Alzheimer's disease facts and figures	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Alzheimer's dementia; Alzheimer's disease continuum; Biomarkers; Caregivers; Dementia care training; Dementia; Family caregiver; Geriatrician; Health care professional; Health care costs; Health care expenditures; Incidence; Long-term care costs; Medicare spending; Medicaid spending; Mortality; Morbidity; Prevalence; Primary care physician; Risk factors; Spouse caregiver	MILD COGNITIVE IMPAIRMENT; NURSING-HOME RESIDENTS; VASCULAR RISK-FACTORS; APOLIPOPROTEIN-E GENOTYPE; TRAUMATIC BRAIN-INJURY; HEALTH-CARE USE; AGE-OF-ONSET; DEMENTIA CAREGIVER INTERVENTION; LONG-TERM RISK; UNITED-STATES	This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report discusses the future challenges of meeting care demands for the growing number of people living with Alzheimer's dementia in the United States with a particular emphasis on primary care. By mid-century, the number of Americans age 65 and older with Alzheimer's dementia may grow to 13.8 million. This represents a steep increase from the estimated 5.8 million Americans age 65 and older who have Alzheimer's dementia today. Official death certificates recorded 122,019 deaths from AD in 2018, the latest year for which data are available, making Alzheimer's the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age 65 and older. Between 2000 and 2018, deaths resulting from stroke, HIV and heart disease decreased, whereas reported deaths from Alzheimer's increased 146.2%. In 2019, more than 16 million family members and other unpaid caregivers provided an estimated 18.6 billion hours of care to people with Alzheimer's or other dementias. This care is valued at nearly $244 billion, but its costs extend to family caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Average per-person Medicare payments for services to beneficiaries age 65 and older with AD or other dementias are more than three times as great as payments for beneficiaries without these conditions, and Medicaid payments are more than 23 times as great. Total payments in 2020 for health care, long-term care and hospice services for people age 65 and older with dementia are estimated to be $305 billion. As the population of Americans living with Alzheimer's dementia increases, the burden of caring for that population also increases. These challenges are exacerbated by a shortage of dementia care specialists, which places an increasing burden on primary care physicians (PCPs) to provide care for people living with dementia. Many PCPs feel underprepared and inadequately trained to handle dementia care responsibilities effectively. This report includes recommendations for maximizing quality care in the face of the shortage of specialists and training challenges in primary care.								AARP, FAM CAR OUT POCK COS, DOI 10.26419%252Fres.00138.002.pdf; Abell JG, 2018, EUR HEART J, V39, P3119, DOI 10.1093/eurheartj/ehy288; Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Aguirre E, 2013, AGEING RES REV, V12, P253, DOI 10.1016/j.arr.2012.07.001; Ahmadi-Abhari S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2856; Aigbogun MS, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1260-3; Akarsu NE, 2019, INT J GERIATR PSYCH, V34, P790, DOI 10.1002/gps.5070; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert S. M., 2010, METLIFE STUDY WORKIN; Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Alsaeed D, 2016, INT J PHARMACEUT, V512, P396, DOI 10.1016/j.ijpharm.2015.12.050; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Alzheimer's Association, ISS BRIEF LGBT DEM; Alzheimer's Association, ALZH ASS DEM CAR PRA; Alzheimer's Association, ALZH IMP MOV US MED; Alzheimer's Association, 2018, ALZHEIMERS DEMENT, V14, P408; Alzheimer's Association, CHANG TRAJ ALZH DIS; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; American Association of Nurse Practitioners, NP FACT SHEET; American Health Care Association, 2011, STAFF SURV REP; Amjad H, 2016, JAMA INTERN MED, V176, P1371, DOI 10.1001/jamainternmed.2016.3553; Amjad H, 2016, J AM GERIATR SOC, V64, P1223, DOI 10.1111/jgs.14164; [Anonymous], 2015 2018 BEH UNPUB; [Anonymous], 2016, TABULATIONS BA UNPUB; [Anonymous], DAT 2015 2016 UNPUB; [Anonymous], 2019 ANN REP; [Anonymous], 2016, PROF OLD AM; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; Arthur PB, 2018, INT PSYCHOGERIATR, V30, P1099, DOI 10.1017/S104161021700237X; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Aston L, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0638-6; Atteih S, 2015, INT J STROKE, V10, P918, DOI 10.1111/ijs.12535; Auerbach DI, 2011, HEALTH AFFAIR, V30, P2286, DOI 10.1377/hlthaff.2011.0588; Austrom MG, 2016, AGING MENT HEALTH, V20, P781, DOI 10.1080/13607863.2015.1119802; Badana ANS, 2019, J AGING HEALTH, V31, P925, DOI 10.1177/0898264317743611; Bahar-Fuchs A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013069.pub2; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes LL, 2015, NEUROLOGY, V85, P528, DOI 10.1212/WNL.0000000000001834; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Barrett AM, 2006, J AM GERIATR SOC, V54, P1968, DOI 10.1111/j.1532-5415.2006.00992.x; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; BAUMGARTEN M, 1992, J CLIN EPIDEMIOL, V45, P61, DOI 10.1016/0895-4356(92)90189-T; Beck C, 1999, INT J GERIATR PSYCH, V14, P197, DOI 10.1002/(SICI)1099-1166(199903)14:3<197::AID-GPS972>3.0.CO;2-Q; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bernard SM, 2003, PEDIATRICS, V112, P1308, DOI 10.1542/peds.112.6.1308; Beydoun MA, 2015, J ALZHEIMERS DIS, V48, P361, DOI 10.3233/JAD-150228; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bloudek LM, 2011, J ALZHEIMERS DIS, V26, P627, DOI 10.3233/JAD-2011-110458; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Borson S, 2016, ALZHEIMERS DEMENT, V12, P334, DOI 10.1016/j.jalz.2016.01.005; Borson S, 2014, CLIN GERIATR MED, V30, P395, DOI 10.1016/j.cger.2014.05.001; Bott NT, 2019, AM J GERIAT PSYCHIAT, V27, P149, DOI 10.1016/j.jagp.2018.09.015; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Boustani M, 2019, HEALTH AFFAIR, V38, P54, DOI 10.1377/hlthaff.2018.05154; Boustani M, 2018, J AM GERIATR SOC, V66, P1372, DOI 10.1111/jgs.15283; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Bray Jennifer, 2015, Nurs Older People, V27, P29, DOI 10.7748/nop.27.10.29.s21; Bremer P, 2015, HEALTH POLICY, V119, P1459, DOI 10.1016/j.healthpol.2015.09.014; Brenowitz WD, 2017, ALZHEIMERS DEMENT, V13, P654, DOI 10.1016/j.jalz.2016.09.015; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Brody DJ, NATL HLTH STAT REPOR; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P121, DOI 10.1016/j.jalz.2017.10.009; Brown EL, 2019, J APPL GERONTOL, V38, P73, DOI 10.1177/0733464817723088; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Buchman AS, 2019, NEUROLOGY, V92, pE811, DOI 10.1212/WNL.0000000000006954; Buckley RF, 2018, ALZHEIMERS DEMENT, V14, P1193, DOI 10.1016/j.jalz.2018.04.010; Buckley RF, 2016, ALZHEIMERS DEMENT, V12, P796, DOI 10.1016/j.jalz.2015.12.013; Burgio LD, 2009, GERONTOLOGIST, V49, P103, DOI 10.1093/geront/gnp012; BURNS A, 1990, AGE AGEING, V19, P341, DOI 10.1093/ageing/19.5.341; Burton A, 2019, CURR OPIN PSYCHIATR, V32, P557, DOI 10.1097/YCO.0000000000000548; Butler M, 2018, ANN INTERN MED, V168, P52, DOI 10.7326/M17-1530; Bynum J., 2009, CHARACTERISTICS COST; Callahan CM, 2017, J AM GERIATR SOC, V65, P892, DOI 10.1111/jgs.14808; Callahan CM, 2014, HEALTH AFFAIR, V33, P626, DOI 10.1377/hlthaff.2013.1260; Callahan CM, 2012, J AM GERIATR SOC, V60, P813, DOI 10.1111/j.1532-5415.2012.03905.x; Camp CJ, 2019, CLIN GERONTOLOGIST, V42, P221, DOI 10.1080/07317115.2019.1591056; Carter CL, 2012, J WOMENS HEALTH, V21, P1018, DOI 10.1089/jwh.2012.3789; Centers for Disease Control and Prevention, 2014, REP TRAUM BRAIN INJ; Centers for Disease Control and Prevention, POT EFF; Centers for Disease Control and Prevention, CURR CIG SMOK AD US; Centers for Disease Control and Prevention National Center for Health Statistics (CDC), 2018, UND CAUS DEATH 1999; Centers for Medicare & Medicaid Services. Center for Medicare & Medicaid Innovation, 2019, GRAD NURS ED DEM PRO; Cerasuolo JO, 2017, ALZHEIMERS DEMENT, V13, P1081, DOI 10.1016/j.jalz.2017.02.010; Chene G, 2015, ALZHEIMERS DEMENT, V11, P310, DOI 10.1016/j.jalz.2013.10.005; Cheng ST, 2016, GERONTOLOGIST, V56, P451, DOI 10.1093/geront/gnu118; Cheung KSL, 2015, INT J GERIATR PSYCH, V30, P460, DOI 10.1002/gps.4160; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Choi D, 2018, ANN CLIN TRANSL NEUR, V5, P1192, DOI 10.1002/acn3.633; Choi H, 2018, J GERONTOL B-PSYCHOL, V73, pS29, DOI 10.1093/geronb/gbx155; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Clark PC, 2005, J AM GERIATR SOC, V53, P2012, DOI 10.1111/j.1532-5415.2005.53569.x; Clarkson P, 2017, VALUE HEALTH, V20, P1198, DOI 10.1016/j.jval.2017.04.004; Clevenger CK, 2018, J AM GERIATR SOC, V66, P2401, DOI 10.1111/jgs.15528; Collins RN, 2020, AGEING SOC, V40, P2355, DOI 10.1017/S0144686X19000527; Corrada MM, 2017, ALZHEIMERS DEMENT, V13, P103, DOI 10.1016/j.jalz.2016.09.007; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740; Crimmins EM, 2018, J GERONTOL B-PSYCHOL, V73, pS20, DOI 10.1093/geronb/gbx135; Cross AJ, 2018, PSYCHOL HEALTH, V27, P1; Czaja SJ, 2018, GERONTOLOGIST, V58, pE130, DOI 10.1093/geront/gny001; Czaja SJ, 2013, AM J GERIAT PSYCHIAT, V21, P1071, DOI 10.1016/j.jagp.2013.02.019; Dall TM, 2013, NEUROLOGY, V81, P470, DOI 10.1212/WNL.0b013e318294b1cf; Dassel KB, 2016, GERONTOLOGIST, V56, P444, DOI 10.1093/geront/gnu078; Dassel KB, 2017, GERONTOLOGIST, V57, P319, DOI 10.1093/geront/gnv148; Davydow DS, 2014, J GEN INTERN MED, V29, P1362, DOI 10.1007/s11606-014-2916-8; De Reuck J, 2018, FOLIA NEUROPATHOL, V56, P81, DOI 10.5114/fn.2018.76610; De Vleminck A, 2018, J AM MED DIR ASSOC, V19, P633, DOI 10.1016/j.jamda.2017.10.003; Deb A, 2017, EXPERT REV PHARM OUT, V17, P189, DOI 10.1080/14737167.2017.1313118; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Dekhtyar S, GENETIC RISK DEMENTI; Demirovic J, 2003, ANN EPIDEMIOL, V13, P472, DOI 10.1016/S1047-2797(02)00437-4; Derby CA, 2017, JAMA NEUROL, V74, P1345, DOI 10.1001/jamaneurol.2017.1964; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Dilworth-Anderson P, 2008, ALZHEIMERS DEMENT, V4, P305, DOI 10.1016/j.jalz.2008.03.001; Drabo EF, 2019, ALZHEIMERS DEMENT, V15, P1402, DOI 10.1016/j.jalz.2019.07.005; Dreier-Wolfgramm A, 2017, Z GERONTOL GERIATR, V50, pS68, DOI 10.1007/s00391-017-1220-8; Duffrin C, 2014, SOUTH MED J, V107, P728, DOI 10.14423/SMJ.0000000000000196; Dwibedi N, 2018, MED CARE, V56, P240, DOI 10.1097/MLR.0000000000000869; Eiken S, 2016, MED EXPENDITURES LON; Eldercare Workforce Alliance, 2012, GER WORKF SHORT LOOM; Elvish R, 2016, DEMENTIA; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Farina N, 2014, INT PSYCHOGERIATR, V26, P9, DOI 10.1017/S1041610213001385; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fauth EB, 2019, J APPL GERONTOL, V38, P1253, DOI 10.1177/0733464817714564; Feast A, 2016, INT PSYCHOGERIATR, V28, P1761, DOI 10.1017/S1041610216000922; Feng ZL, 2014, HEALTH AFFAIR, V33, P683, DOI 10.1377/hlthaff.2013.1179; Fernandez-Blazquez MA, 2016, J ALZHEIMERS DIS, V52, P271, DOI 10.3233/JAD-150956; Fields NL, 2020, DEMENTIA-LONDON, V19, P453, DOI 10.1177/1471301216685626; Fisher GG, 2014, J OCCUP HEALTH PSYCH, V19, P231, DOI 10.1037/a0035724; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Fishman P, 2019, AM J MANAG CARE, V25, pE247; Fitten LJ, 2001, J AM GERIATR SOC, V49, P1301, DOI 10.1046/j.1532-5415.2001.49257.x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fonareva I, 2014, INT PSYCHOGERIATR, V26, P725, DOI 10.1017/S1041610214000039; Fortinsky RH, 2016, CONTEMP CLIN TRIALS, V49, P155, DOI 10.1016/j.cct.2016.07.006; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fredman L, 2006, PREV MED, V43, P226, DOI 10.1016/j.ypmed.2006.04.009; Fredriksen-Goldsen KI, 2018, J APPL GERONTOL, V37, P545, DOI 10.1177/0733464816672047; Freedman VA, 2018, J GERONTOL B-PSYCHOL, V73, pS48, DOI 10.1093/geronb/gbx144; French DD, 2014, HEALTH AFFAIR, V33, P613, DOI 10.1377/hlthaff.2013.1221; Friedman EM, 2015, HEALTH AFFAIR, V34, P1637, DOI 10.1377/hlthaff.2015.0510; Froehlich TE, 2001, J AM GERIATR SOC, V49, P477, DOI 10.1046/j.1532-5415.2001.49096.x; Fukushima Raiana Lídice Mór, 2016, Dement. neuropsychol., V10, P178, DOI 10.1590/S1980-5764-2016DN1003003; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Gao CL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9891; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; Gaugler J.E., 2015, FAMILY CAREGIVING NE; Gaugler JE, 2002, INT J AGING HUM DEV, V54, P205, DOI 10.2190/FACK-QE61-Y2J8-5L68; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gaugler Joseph E, 2019, Alzheimers Dement (N Y), V5, P388, DOI 10.1016/j.trci.2019.02.008; Gaugler Joseph E, 2018, Alzheimers Dement (N Y), V4, P688, DOI 10.1016/j.trci.2018.08.010; Gaugler JE, 2018, INT J AGING HUM DEV, V87, P347, DOI 10.1177/0091415017752936; Gaugler JE, 2019, GERONTOLOGIST, V59, P78, DOI 10.1093/geront/gny078; Gaugler JE, 2017, INT PSYCHOGERIATR, V29, P19, DOI 10.1017/S1041610216001514; Gaugler JE, 2016, GERONTOLOGIST, V56, P1161, DOI 10.1093/geront/gnv150; Gaugler JE, 2016, INT PSYCHOGERIATR, V28, P1029, DOI 10.1017/S1041610215002318; Gaugler JE, 2014, CLIN GERIATR MED, V30, P493, DOI 10.1016/j.cger.2014.04.003; Gaugler JE, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-85; Geldmacher DS, 2013, APPL HEALTH ECON HEA, V11, P407, DOI 10.1007/s40258-013-0038-9; Gifford KA, 2014, ALZHEIMERS DEMENT, V10, P319, DOI 10.1016/j.jalz.2013.02.007; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P144; Gillespie R, 2014, J CLIN NURS, V23, P3296, DOI 10.1111/jocn.12519; Gilligan AM, 2013, AM J ALZHEIMERS DIS, V28, P84, DOI 10.1177/1533317512467679; Gilmore-Bykovskyi A, 2018, AM J ALZHEIMERS DIS, V33, P145, DOI 10.1177/1533317517749465; Gitlin LN, 2019, CONTEMP CLIN TRIALS, V83, P97, DOI 10.1016/j.cct.2019.06.010; Gitlin LN, 2015, GERONTOLOGIST, V55, P210, DOI 10.1093/geront/gnu123; Gitlin LN, 2010, GERONTOLOGIST, V50, P847, DOI 10.1093/geront/gnq057; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Godard-Sebillotte C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218426; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Gonyea JG, 2016, GERONTOLOGIST, V56, P292, DOI 10.1093/geront/gnu045; Gonzalez HM, 2019, ALZHEIMERS DEMENT, V15, P1507, DOI 10.1016/j.jalz.2019.08.202; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Goren A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0298-y; Gottesman RF, 2017, JAMA NEUROL, V74, P1246, DOI 10.1001/jamaneurol.2017.1658; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Gozalo P, 2015, NEW ENGL J MED, V372, P1823, DOI 10.1056/NEJMsa1408705; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Graham-Phillips A, 2016, J AM GERIATR SOC, V64, P1662, DOI 10.1111/jgs.14204; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Greenwood N, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1185-0; Griffith M, 2007, INT J HEALTH SERV, V37, P259, DOI 10.2190/R410-7263-4811-4415; Griffiths PC, 2016, GERONTOLOGIST, V56, P145, DOI 10.1093/geront/gnv123; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Grossberg GT, 2010, J CLIN PSYCHIAT, V12; Grossman MR, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9345; Grzywacz JG, 2016, J OCCUP ENVIRON MED, V58, P535, DOI 10.1097/JOM.0000000000000727; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Guerreiro R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0232-5; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Guterman EL, 2019, JAMA NEUROL, V76, P1166, DOI 10.1001/jamaneurol.2019.1820; Guure CB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9016924; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hall KS, 2009, ALZHEIMERS DEMENT, V5, P227, DOI 10.1016/j.jalz.2009.01.026; Hanseeuw BJ, 2019, JAMA NEUROL, V76, P915, DOI 10.1001/jamaneurol.2019.1424; Hardman RJ, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00022; Harrington LA, 2019, NAT CONSERV-BULGARIA, P17, DOI 10.3897/natureconservation.36.33842; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Harris-Kojetin L, 2019, VITAL HLTH STAT, V3; Harris-Kojetin L, 2016, VITAL HLTH STAT, V3, P1; Harwood D G, 2000, Curr Psychiatry Rep, V2, P40, DOI 10.1007/s11920-000-0040-4; He W, 2016, INT POPULATION REPOR; Healthy People 2020, 2020, DEM INCL ALZH DIS; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Hebert LE, 2001, AM J EPIDEMIOL, V153, P132, DOI 10.1093/aje/153.2.132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; Hendrie HC, 2018, J GERONTOL B-PSYCHOL, V73, pS82, DOI 10.1093/geronb/gbx143; Hendrie HC, 2014, INT PSYCHOGERIATR, V26, P977, DOI 10.1017/S1041610214000167; Hicken BL, 2017, J RURAL HEALTH, V33, P305, DOI 10.1111/jrh.12195; Nguyen H, 2019, J CLIN NURS, V28, P1050, DOI 10.1111/jocn.14697; Hoffman D, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160233; Hogan DB, 2016, CAN J NEUROL SCI, V43, pS96, DOI 10.1017/cjn.2016.25; Hohman TJ, 2018, JAMA NEUROL, V75, P989, DOI 10.1001/jamaneurol.2018.0821; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hopwood J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9548; Hudomiet P, 2019, J ECON AGEING, V14, DOI 10.1016/j.jeoa.2018.11.006; Hudomiet P, 2018, J GERONTOL B-PSYCHOL, V73, pS10, DOI 10.1093/geronb/gbx169; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Institute of Medicine, 2015, COGN AG PROGR UND OP; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jack CR, 2019, JAMA NEUROL, V76, P1174, DOI 10.1001/jamaneurol.2019.1971; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jacobson G, 2017, INCOME ANDASSETS MED; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; JANSEN, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI DOI 10.1001/JAMA.2015.4668; Jellinger KA, 2007, J NEUROL SCI, V257, P80, DOI 10.1016/j.jns.2007.01.045; Jellinger KA, 2007, ALZHEIMERS DEMENT, V3, P40, DOI 10.1016/j.jalz.2006.09.002; Jennings LA, 2019, JAMA INTERN MED, V179, P161, DOI 10.1001/jamainternmed.2018.5579; Jennings LA, 2018, J AM GERIATR SOC, V66, P2120, DOI 10.1111/jgs.15541; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.06.001, 10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007]; Jones Adrienne L, 2009, Vital Health Stat 13, P1; Jones RW, 2017, DEMENT GER COGN D EX, V7, P87, DOI 10.1159/000461577; Jutkowitz E, 2017, J AM GERIATR SOC, V65, P2169, DOI 10.1111/jgs.15043; Jutten LH, 2018, J ALZHEIMERS DIS, V66, P149, DOI 10.3233/JAD-180508; Kaddour L, 2019, INT PSYCHOGERIATR, V31, P961, DOI 10.1017/S1041610218001436; Kally Z, 2014, J GERONTOL SOC WORK, V57, P681, DOI 10.1080/01634372.2013.850584; Kally Z, 2014, J GERONTOL SOC WORK, V57, P710, DOI 10.1080/01634372.2013.854856; Kane, 2015, FAMILY CAREGIVING NE, P305, DOI DOI 10.1016/B978-0-12-417046-9.00017-9; Kang JH, 2012, NEUROBIOL AGING, V33, P1129, DOI 10.1016/j.neurobiolaging.2010.10.007; Kapasi A, 2017, ACTA NEUROPATHOL, V134, P171, DOI 10.1007/s00401-017-1717-7; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kasper JD., 2014, DISABILITY CARE NEED; Kasper JD, 2015, HEALTH AFFAIR, V34, P1642, DOI 10.1377/hlthaff.2015.0536; Kaup AR, 2015, NEUROLOGY, V85, P1852, DOI 10.1212/WNL.0000000000002153; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kiely DK, 2010, J AM GERIATR SOC, V58, P2284, DOI 10.1111/j.1532-5415.2010.03185.x; Kirson NY, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0303-5; Kishita N, 2020, J GERIATR PSYCH NEUR, V33, P28, DOI 10.1177/0891988719856690; Kishita N, 2018, INT PSYCHOGERIATR, V30, P1679, DOI 10.1017/S1041610218000947; Kivimaki M, 2018, ALZHEIMERS DEMENT, V14, P601, DOI 10.1016/j.jalz.2017.09.016; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Koran MEI, 2017, BRAIN IMAGING BEHAV, V11, P205, DOI 10.1007/s11682-016-9523-8; Kotagal V, 2015, NEUROLOGY, V84, P64, DOI 10.1212/WNL.0000000000001096; Kramer NA., 2000, PROFESSIONAL PSYCHOL, P227; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kulmala J, 2018, J ALZHEIMERS DIS, V64, pS191, DOI 10.3233/JAD-179919; LaMantia MA, 2015, J AM GERIATR SOC, V63, P1209, DOI 10.1111/jgs.13447; Landon BE, 2018, JAMA INTERN MED, V178, P66, DOI 10.1001/jamainternmed.2017.5034; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Langa KM, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0118-1; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Larson EB, 2004, ANN INTERN MED, V140, P501, DOI 10.7326/0003-4819-140-7-200404060-00008; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Leggett A, 2019, J AM MED DIR ASSOC, V20, P1307, DOI 10.1016/j.jamda.2019.04.006; Leggett AN, 2020, J AGING HEALTH, V32, P871, DOI 10.1177/0898264319860975; Leibson CL, 2015, ALZHEIMERS DEMENT, V11, P917, DOI 10.1016/j.jalz.2015.01.007; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; Liew TM, 2019, GERONTOLOGIST, V59, pE380, DOI 10.1093/geront/gny061; Lin PJ, 2017, ALZHEIMERS DEMENT, V13, P1174, DOI 10.1016/j.jalz.2017.08.010; Lin PJ, 2016, J AM GERIATR SOC, V64, P1549, DOI 10.1111/jgs.14227; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Lines L.M, 2014, RACIAL ETHNIC DISPAR; Liu JL, 2017, ASSESSING PREPARED N; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Llanque SM, 2012, AM J ALZHEIMERS DIS, V27, P23, DOI 10.1177/1533317512439794; Lloyd J, 2016, DEMENTIA-LONDON, V15, P1534, DOI 10.1177/1471301214564792; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Luchsinger JA, 2018, J AM GERIATR SOC, V66, P1708, DOI 10.1111/jgs.15450; Lykens K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089290; MacNeil-Vroomen JL, 2020, AM J EMERG MED, V38, P127, DOI 10.1016/j.ajem.2019.07.023; Manly J, 2004, CRITICAL PERSPECTIVE, P95; Martindale-Adams J, 2017, TRANSL BEHAV MED, V7, P427, DOI 10.1007/s13142-017-0505-1; Maslow K., 2012, TRANSLATING INNOVATI; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; Mausbach BT, 2017, PSYCHOSOM MED, V79, P735, DOI 10.1097/PSY.0000000000000497; Mausbach BT, 2014, PSYCHOL AGING, V29, P776, DOI 10.1037/a0037626; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; Mausbach BT, 2010, J AM COLL CARDIOL, V55, P2599, DOI 10.1016/j.jacc.2009.11.093; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; Mayeda ER, 2017, ALZ DIS ASSOC DIS, V31, P181, DOI 10.1097/WAD.0000000000000189; Mayeda ER, 2016, ALZHEIMERS DEMENT, V12, P216, DOI 10.1016/j.jalz.2015.12.007; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; McCabe MP, 2007, AGING MENT HEALTH, V11, P505, DOI 10.1080/13607860601086405; McCurry SM, 2018, J GERONTOL SOC WORK, V61, P45, DOI 10.1080/01634372.2017.1400486; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKhann GM, 2012, ADV BIOL PSYCH-KARG, V28, P115; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Medicare, GLOSSARY; Mehta KM, 2017, ALZHEIMERS DEMENT, V13, P72, DOI 10.1016/j.jalz.2016.06.2360; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Menne HL, 2017, J APPL GERONTOL, V36, P537, DOI 10.1177/0733464815591212; Menne HL, 2014, J GERONTOL SOC WORK, V57, P626, DOI 10.1080/01634372.2013.870276; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Meyer OL, 2017, AGING MENT HEALTH, V24, P1; Meyers D, 2002, Am Fam Physician, V66, P554; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P1101, DOI 10.1016/j.jalz.2018.08.003; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mikati I, 2018, AM J PUBLIC HEALTH, V108, P480, DOI [10.2105/AJPH.2017.304297, 10.2105/ajph.2017.304297]; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2012, J PALLIAT MED, V15, P43, DOI 10.1089/jpm.2011.0210; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mitchell SL, 2016, JAMA-J AM MED ASSOC, V316, P769, DOI 10.1001/jama.2016.9374; Mittelman MS, 2014, HEALTH AFFAIR, V33, P587, DOI 10.1377/hlthaff.2013.1334; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Monin JK, 2015, GERONTOLOGIST, V55, P981, DOI 10.1093/geront/gnu001; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1007, DOI 10.1016/j.jalz.2014.11.009; Murman DL, 2002, NEUROLOGY, V59, P1721, DOI 10.1212/01.WNL.0000036904.73393.E4; Najar J, 2019, NEUROLOGY, V92, pE1322, DOI 10.1212/WNL.0000000000007021; Napoles AM, 2010, AM J ALZHEIMERS DIS, V25, P389, DOI 10.1177/1533317510370957; National Academies of Sciences Engineering and Medicine, 2016, FAM CAR AG AM; National Alliance for Caregiving and AARP, 2009, CAR US DAT AN UNPUB; National Alliance for Caregiving in Partnership with the Alzheimer's Association, DEM CAR US; National Association of Insurance Commissioners and the Center for Insurance Policy and Research, 2016, CIPR STUD SER; National Down Syndrome Society, ALZH DIS SYNDR; National Institute on Aging, WHAT AR FRONT DIS; National Poll on Healthy Aging, DEM CAR JUGGL DEL LO; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Nichols LO, 2016, GERONTOLOGIST, V56, P135, DOI 10.1093/geront/gnu112; Nickel F, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0751-1; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Noel MA, 2017, J APPL GERONTOL, V36, P195, DOI 10.1177/0733464815589986; Odenheimer G, 2013, AM J OCCUP THER, V67, P704, DOI 10.5014/ajot.2013.676004; Official Data Foundation, CPI INFL CALC; Ogino E, 2019, ALZHEIMERS DEMENT, V15, P1603, DOI 10.1016/j.jalz.2019.07.013; Ohara T, 2015, J AM GERIATR SOC, V63, P2332, DOI 10.1111/jgs.13794; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Ornstein KA, 2019, HEALTH AFFAIR, V38, P964, DOI 10.1377/hlthaff.2019.00087; Romero JP, 2014, J ALZHEIMERS DIS, V39, P741, DOI 10.3233/JAD-131622; Palmer JL, 2014, J CONTIN EDUC NURS, V45, P416, DOI 10.3928/00220124-20140825-20; Patel A, 2015, CIRC-HEART FAIL, V8, P8, DOI 10.1161/CIRCHEARTFAILURE.114.001438; Paul M, 2019, J ENDOCR SOC S1, V3, P190; Peacock SC, 2013, PALLIAT SUPPORT CARE, V11, P155, DOI 10.1017/S1478951512000831; Peng HL, 2013, PERSPECT PSYCHIATR C, V49, P135, DOI 10.1111/ppc.12005; Perkins M, 2013, J GERONTOL B-PSYCHOL, V68, P504, DOI 10.1093/geronb/gbs084; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; Petriceks AH, 2018, GERONTOL GERIATRIC M, V4, P1; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polenick CA, 2020, GERONTOLOGIST, V60, P165, DOI 10.1093/geront/gny130; Pool LR, 2016, NEUROLOGY, V86, P1386, DOI 10.1212/WNL.0000000000002569; Port CL, 2005, GERONTOLOGIST, V45, P87, DOI 10.1093/geront/45.suppl_1.87; Possin KL, 2019, JAMA INTERN MED, V179, P1658, DOI 10.1001/jamainternmed.2019.4101; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Prentice, 2017, AGING MENT HEALTH, V5, P1; Primetica B, 2015, J APPL GERONTOL, V34, P652, DOI 10.1177/0733464813508888; Prince M., 2015, WORLD ALZHEIMER REPO; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Quinn C, 2019, GERONTOLOGIST, V59, pE584, DOI 10.1093/geront/gny168; Rabarison KM, 2018, AM J PUBLIC HEALTH, V108, P1370, DOI 10.2105/AJPH.2018.304573; Rajan KB, 2019, ALZHEIMERS DEMENT, V15, P1, DOI 10.1016/j.jalz.2018.07.216; Rajan KB, 2017, J AM GERIATR SOC, V65, P2425, DOI 10.1111/jgs.15059; Ralph SJ, 2018, J ALZHEIMERS DIS REP, V2, P1, DOI 10.3233/ADR-170042; Rattinger GB, 2016, ALZHEIMERS DEMENT, V12, P917, DOI 10.1016/j.jalz.2016.03.008; Rattinger GB, 2015, ALZHEIMERS DEMENT, V11, P946, DOI 10.1016/j.jalz.2014.11.004; Reaves EL, 2012, MED LONG TERM SERVIC; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1038/nrneurol.2011.2; Reschovsky JD, 2014, HEALTH SERV RES, V49, P32, DOI 10.1111/1475-6773.12087; Reuben DB, 2019, J AM GERIATR SOC, V67, P2267, DOI 10.1111/jgs.16085; Reuben DB, 2013, J AM GERIATR SOC, V61, P2214, DOI 10.1111/jgs.12562; Rhoads JM., 2016, OUR PARENTS OURSELVE; Riedel O, 2016, RES GERONTOL NURS, V9, P167, DOI 10.3928/19404921-20160531-02; Riffin C, 2017, J AM GERIATR SOC, V65, P1821, DOI 10.1111/jgs.14910; Rocca WA, 2017, ALZ DIS ASSOC DIS, V31, P76, DOI 10.1097/WAD.0000000000000187; Rocca WA, 2014, MATURITAS, V79, P196, DOI 10.1016/j.maturitas.2014.05.008; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Ronnemaa E, 2011, DEMENT GERIATR COGN, V31, P460, DOI 10.1159/000330020; Rosalynn Carter Institute for Caregiving, CAR INT DAT; Rosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006; Rote SM, 2019, INNOV AGING, V3, DOI 10.1093/geroni/igz033; Roth DL, 2019, GERONTOLOGIST, V59, pE521, DOI 10.1093/geront/gnz015; Roth DL, 2015, J GERONTOL B-PSYCHOL, V70, P813, DOI 10.1093/geronb/gbv034; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Russ TC, 2013, BRIT J PSYCHIAT, V203, P10, DOI 10.1192/bjp.bp.112.119479; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Sajeev G, ALZRISK DATABASE; Samia LW, 2014, J GERONTOL SOC WORK, V57, P640, DOI 10.1080/01634372.2013.859201; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Samper-Ternent R, 2012, J AM MED DIR ASSOC, V13, P254, DOI 10.1016/j.jamda.2010.07.010; Sando SB, 2008, INT J GERIATR PSYCH, V23, P1156, DOI 10.1002/gps.2043; Sanjeev G, 2016, EPIDEMIOLOGY, V27, P732; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Sato C, 2018, NEURON, V98, P861, DOI 10.1016/j.neuron.2018.04.035; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheckel CJ, 2019, J AM OSTEOPATH ASSOC, V119, P227, DOI 10.7556/jaoa.2019.038; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2004, JAMA-J AM MED ASSOC, V292, P961, DOI 10.1001/jama.292.8.961; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1998, HEALTH PSYCHOL, V17, P107, DOI 10.1037/h0092707; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Serrano-Pozo A, 2014, ANN NEUROL, V75, P597, DOI 10.1002/ana.24125; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Shaw WS, 1999, J PSYCHOSOM RES, V46, P215, DOI 10.1016/S0022-3999(98)00084-1; Sheffield KM, 2011, AM J EPIDEMIOL, V174, P274, DOI 10.1093/aje/kwr074; Shega JW, 2008, J PAIN SYMPTOM MANAG, V35, P499, DOI 10.1016/j.jpainsymman.2007.06.011; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Soni M, 2019, AGING MENT HEALTH, V23, P15, DOI 10.1080/13607863.2017.1390731; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Spector A, 2013, AGEING RES REV, V12, P354, DOI 10.1016/j.arr.2012.06.005; Squillace MR., 2011, UNDERSTANDING DIRECT; Tejada-Vera B., 2019, NATL VITAL STAT REPO, V68; The American Geriatrics Society, PROJ FUT NEED GER; The American Geriatrics Society, CURR GER SHORTF; The Lewin Group, 2016, PROC EV OLD AM ACT T; The National Alliance for Caregiving and the AARP Public Policy Institute, 2015, CAR US; U.S. Census Bureau, 2014 NAT POP PROJ DO; U.S. Centers for Medicare & Medicaid Services, POST CAR HOSP PROV D; U.S. Centers for Medicare & Medicaid Services, YOUR MED COV; U.S. Centers for Medicare & Medicaid Services, NURS HOM DAT COMP 20; U.S. Centers for Medicare & Medicaid Services, 2007, STAT LEV CHRON COND; U.S. Centers for Medicare & Medicaid Services. Medicare Program, FY 2020 HOSP WAG IND; U.S. Department of Health and Human Services, NAT RES SUMM CAR SER; U.S. Department of Health and Human Services, WHAT IS LONG TERM CA; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 1999, CDC WOND ONL DAT UND; U.S. Department of Health and Human Services Health Resources and Services Administration National Center for Health Workforce Analysis, NAT REG PROJ SUPPL D; U.S. Department of Labor Bureau of Labor Statistics, 2018, US DEP LAB SER; United States Census Bureau, 2017 NATL POPULATION; WHO, 2004, INT STAT CLASS DIS R; World Health Organization, RISK RED COGN DECL D; Zarit, 2009, AGING FAMILIES CAREG, P85; Kane RL., 2015, FAMILY CAREGIVING NE, P193; Kane RL., 2015, FAMILY CAREGIVING NE, P57, DOI DOI 10.1016/B978-0-12-417046-9.00006-4; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spillman B., INFORMAL CAREGIVING; Spillman BC, 2020, J GERONTOL B-PSYCHOL, V75, P1563, DOI 10.1093/geronb/gbz065; Spinney L, 2014, NATURE, V510, P26, DOI 10.1038/510026a; Staff RT, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4925; Stall NM, 2019, J AM GERIATR SOC, V67, P609, DOI 10.1111/jgs.15690; Steenland K, 2016, J ALZHEIMERS DIS, V50, P71, DOI 10.3233/JAD-150778; Stephen R, 2017, J GERONTOL A-BIOL, V72, P733, DOI 10.1093/gerona/glw251; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2018, ALZHEIMERS DEMENT; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stojkovska I, 2018, CELL TISSUE RES, V373, P51, DOI 10.1007/s00441-017-2704-y; Stone R.I., 2012, UNIVERSAL COVERAGE L, P155; Suehs BT, 2013, AM J ALZHEIMERS DIS, V28, P384, DOI 10.1177/1533317513488911; Sullivan KJ, 2019, J GERONTOL A-BIOL, V74, P1439, DOI 10.1093/gerona/gly236; Surr CA, 2016, INT J NURS STUD, V53, P144, DOI 10.1016/j.ijnurstu.2015.09.009; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Tan ZS, 2014, HEALTH AFFAIR, V33, P619, DOI 10.1377/hlthaff.2013.1294; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1; Taylor DH, 2018, J PALLIAT MED, V21, P645, DOI 10.1089/jpm.2017.0485; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; TEASDALE G, 1974, LANCET, V2, P81; Teno J, 2014, HEALTH AFFAIR, V33, P675, DOI 10.1377/hlthaff.2013.1248; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Teri L, 2020, GERONTOLOGIST, V60, P548, DOI 10.1093/geront/gny122; Teri L, 2012, GERONTOLOGIST, V52, P452, DOI 10.1093/geront/gnr132; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Thunyadee C, 2015, NURS HEALTH SCI, V17, P412, DOI 10.1111/nhs.12205; Thyrian JR, 2017, JAMA PSYCHIAT, V74, P996, DOI 10.1001/jamapsychiatry.2017.2124; Tivadar BK, 2017, BIOGERONTOLOGY, V18, P477, DOI 10.1007/s10522-017-9708-6; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Tom SE, 2015, AM J PUBLIC HEALTH, V105, P408, DOI 10.2105/AJPH.2014.301935; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; Vaingankar JA, 2016, COMPR PSYCHIAT, V68, P178, DOI 10.1016/j.comppsych.2016.04.017; Valimaki TH, 2016, QUAL LIFE RES, V25, P687, DOI 10.1007/s11136-015-1100-x; van den Kommer TN, 2018, J GERONTOL B-PSYCHOL, V73, pS57, DOI 10.1093/geronb/gbx151; Van Mierlo LD, 2016, INT PSYCHOGERIATR, V28, P801, DOI 10.1017/S1041610215001817; Vermunt L, 2019, ALZHEIMERS DEMENT, V15, P888, DOI 10.1016/j.jalz.2019.04.001; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Vitaliano PP, 2017, GERONTOLOGIST, V57, P637, DOI 10.1093/geront/gnv690; Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; von Kanel R, 2006, J GERONTOL A-BIOL, V61, P963, DOI 10.1093/gerona/61.9.963; von Kanel R, 2014, BEHAV SLEEP MED, V12, P358, DOI 10.1080/15402002.2013.819470; Waller A, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0654-6; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Ward A, 2013, DEMENT GER COGN D EX, V3, P320, DOI 10.1159/000354370; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Warshaw GA, 2014, HEALTH AFFAIR, V33, P633, DOI 10.1377/hlthaff.2013.1232; Watt JA, 2019, ANN INTERN MED, V171, P633, DOI 10.7326/M19-0993; Werner P, 2019, INT PSYCHOGERIATR, V31, P307, DOI 10.1017/S1041610219000346; Weuve J, 2018, J GERONTOL B-PSYCHOL, V73, pS73, DOI 10.1093/geronb/gbx167; Weuve J, 2018, EPIDEMIOLOGY, V29, P151, DOI [10.1097/EDE.0000000000000747, 10.1097/ede.0000000000000747]; Weuve J, 2015, EPIDEMIOLOGY, V26, pE4, DOI 10.1097/EDE.0000000000000199; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; White L, 2019, HEALTH SERV RES, V54, P773, DOI 10.1111/1475-6773.13134; Whitlatch CJ, 2018, GERONTOLOGIST, V58, pS58, DOI 10.1093/geront/gnx162; Wiberg P, 2013, PSYCHOL MED, V43, P2627, DOI 10.1017/S0033291713000299; Willey JZ, 2016, NEUROLOGY, V86, P1897, DOI 10.1212/WNL.0000000000002582; Williams F, 2019, AGING MENT HEALTH, V23, P1629, DOI 10.1080/13607863.2018.1515886; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Wilson RS, 2012, PSYCHOL AGING, V27, P1008, DOI 10.1037/a0029857; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wimo A, 2016, J ALZHEIMERS DIS, V50, P387, DOI 10.3233/JAD-150708; Wolff JL, 2018, GERONTOLOGIST, V58, P1021, DOI 10.1093/geront/gnx093; Wolfsgruber S, 2016, J ALZHEIMERS DIS, V54, P1135, DOI 10.3233/JAD-160407; Wolters FJ, 2017, NEUROLOGY, V88, P1642, DOI 10.1212/WNL.0000000000003871; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051; Yang Z, 2015, WOMEN HEALTH ISS, V25, P436, DOI 10.1016/j.whi.2015.06.001; Yang Z, 2012, HEALTH SERV RES, V47, P1660, DOI 10.1111/j.1475-6773.2011.01365.x; Yates LA, 2016, INT PSYCHOGERIATR, V9, P1; Yu DSF, 2018, INT J NURS STUD, V79, P1, DOI 10.1016/j.ijnurstu.2017.10.008; Zahodne LB, 2014, NEUROPSYCHOLOGY, V28, P238, DOI 10.1037/neu0000014; Zaleta AK, 2012, ALZ DIS ASSOC DIS, V26, P232, DOI 10.1097/WAD.0b013e3182351c04; Zarit SH, 2017, AGING MENT HEALTH, V16, P1; Zarit SH, 2009, AGING FAMILIES CAREG, P131; Zarit SH, 2013, AGING MENT HEALTH, V17, P197, DOI 10.1080/13607863.2012.717252; Zarit SH, 2012, AGING MENT HEALTH, V16, P673, DOI 10.1080/13607863.2012.692768; Zhang ZM, 2016, J HEALTH SOC BEHAV, V57, P184, DOI 10.1177/0022146516645925; Zhu CW, 2015, J GERONTOL A-BIOL, V70, P1448, DOI 10.1093/gerona/glv124; Zhu CW, 2015, ALZHEIMERS DEMENT, V11, P444, DOI 10.1016/j.jalz.2013.12.018; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25	597	395	402	110	194	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2020	16	3					391	460		10.1002/alz.12068			70	Clinical Neurology	Neurosciences & Neurology	LI3TL	WOS:000529408700001	32157811	Bronze	Y	Y	2021-06-18	
J	Vespa, P; Bergsneider, M; Hattori, N; Wu, HM; Huang, SC; Martin, NA; Glenn, TC; McArthur, DL; Hovda, DA				Vespa, P; Bergsneider, M; Hattori, N; Wu, HM; Huang, SC; Martin, NA; Glenn, TC; McArthur, DL; Hovda, DA			Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain injury; ischemia; lactate; lactate/pyruvate ratio; microdialysis; positron emission tomography; pyruvate	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; OXYGEN-SATURATION; ARTERY OCCLUSION; GLUCOSE; LACTATE; DAMAGE; PET; HYPERVENTILATION; DYSFUNCTION	Brain trauma is accompanied by regional alterations of brain metabolism, reduction in metabolic rates and possible energy crisis. We hypothesize that microdialysis markers of energy crisis are present during the critical period of intensive care despite the absence of brain ischemia. In all, 19 brain injury patients (mean GCS 6) underwent combined positron emission tomography (PET) for metabolism of glucose (CMRglu) and oxygen (CMRO2) and cerebral microdialysis (MD) at a mean time of 36h after injury. Microdialysis values were compared with the regional mean PET values adjacent to the probe. Longitudinal MD data revealed a 25% incidence rate of metabolic crisis (elevated lactate/pyruvate ratio (LPR)> 40) but only a 2.4% incidence rate of ischemia. Positron emission tomography imaging revealed a 1% incidence of ischemia across all voxels as measured by oxygen extraction fraction (OEF) and cerebral venous oxygen content (CvO(2)). In the region of the MD probe, PET imaging revealed ischemia in a single patient despite increased LPR in other patients. Lactate/pyruvate ratio correlated negatively with CMRO2 (P < 0.001), but not with OEF or CvO(2). Traumatic brain injury leads to a state of persistent metabolic crisis as reflected by abnormal cerebral microdialysis LPR that is not related to ischemia.	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Med Ctr, Los Angeles, CA 90095 USA	Vespa, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Med Ctr, CHS 18-218, Los Angeles, CA 90095 USA.	PVespa@mednet.ucla.edu	McArthur, David/E-6442-2013; Hattori, Naoya/G-2298-2012; Hattori, Naoya/AAR-6405-2020	McArthur, David/0000-0003-3385-1314; Martin, Neil/0000-0002-6565-4131; Glenn, Thomas/0000-0003-4273-3408	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 03039, NS02089, P01 NS058489, K08 NS002089] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, K08NS002089] Funding Source: NIH RePORTER		Ackerman RH, 1989, J CEREB BLOOD FLO S1, V9, pS359; ANDERSEN BJ, 1989, INTRACRANIAL PRESSUR, V7, P575; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; deDeyne C, 1996, ACTA NEUROCHIR, V138, P1409, DOI 10.1007/BF01411119; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LANDOLT H, 1994, ACTA NEUROCHIR, V60, P47578; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Marchal G, 1999, BRAIN, V122, P2387, DOI 10.1093/brain/122.12.2387; MINTUN MA, 1984, J NUCL MED, V25, P177; OHTA S, 1992, J CEREBR BLOOD F MET, V12, P179, DOI 10.1038/jcbfm.1992.28; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; SENDA M, 1989, J CEREBR BLOOD F MET, V9, P859, DOI 10.1038/jcbfm.1989.120; Sutton-Smith B, 1990, CHILDRENS ENV Q, V7, P3; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6	48	392	399	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2005	25	6					763	774		10.1038/sj.jcbfm.9600073			12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	928BK	WOS:000229245900010	15716852	Bronze, Green Accepted			2021-06-18	
J	Schretlen, DJ; Shapiro, AM				Schretlen, DJ; Shapiro, AM			A quantitative review of the effects of traumatic brain injury on cognitive functioning	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CLOSED-HEAD-INJURY; MILD HEAD; NEUROPSYCHOLOGICAL DEFICITS; DIVIDED ATTENTION; REACTION-TIME; MODERATE; PERFORMANCE; MEMORY; CONCUSSION; RECOVERY	Changes in cognitive functioning often result from traumatic brain injury (TBI) and predict other important aspects of psychosocial recovery. Despite this pivotal role, no quantitative review of cognitive functioning across the spectrum of TBI severity has been reported. We therefore conducted a meta-analysis of 39 mostly cross-sectional studies of the cognitive effects of mild head injury (MHI) and moderate-severe TBI from the acute phase through long-term follow-up. The studies reported 48 comparisons of patients (n = 1716) and control subjects (n = 1164). Averaged across all follow-up periods, the effect of moderate-severe TBI (weighted mean Cohen's d = -0.74) was more than three times the effect of MHI (weighted mean d = -0.24) on overall cognitive functioning. Further, the natural logarithm of the follow-up interval correlated very strongly with estimates of d among patients with MHI, but less so among those with moderate-severe TBI. In short, findings from published research suggest that overall cognitive functioning recovers most rapidly during the first few weeks following MHI, and essentially returns to baseline within 1-3 months. Cognitive functioning also improves during the first two years after moderate-severe TBI, but remains markedly impaired even among patients tested > 2 years post-injury.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Schretlen, DJ (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Meyer 218, Baltimore, MD 21287 USA.	dschret@jhmi.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH60504-07, R01 MH43775-12] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38927] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH043775, R01MH060504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038927] Funding Source: NIH RePORTER		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM AC NEUR, NEUROLOGY, V48, P581; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BROOKS DN, 1987, NEUROBEHAVIORAL RECO, P57; CANTU RC, 1991, ADOLESCENT MED STATE, V2, P17; Cohen J, 1988, STAT POWER ANAL SOCI; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Ferland MB, 1998, J CLIN EXP NEUROPSYC, V20, P473, DOI 10.1076/jcen.20.4.473.1475; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GOLEBURN CR, 2001, J CLIN GEROPSYCHOLOG, V7, P161; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Torg JS, 1982, ATHLETIC INJURIES HE; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	54	389	393	0	47	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					341	349		10.1080/09540260310001606728			9	Psychiatry	Psychiatry	739UD	WOS:000186364100006	15276955				2021-06-18	
J	Bethea, JR; Castro, M; Keane, RW; Lee, TT; Dietrich, WD; Yezierski, RP				Bethea, JR; Castro, M; Keane, RW; Lee, TT; Dietrich, WD; Yezierski, RP			Traumatic spinal cord injury induces nuclear factor-kappa B activation	JOURNAL OF NEUROSCIENCE			English	Article						nuclear factor-kappa B; spinal cord injury; inflammation; secondary injury; nitric oxide synthase; CNS; EMSA	NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC CELL-DAMAGE; FACTOR-ALPHA; BRAIN INJURY; GLIAL-CELLS; TNF-ALPHA; TRANSCRIPTION	Inflammatory responses are a major component of secondary injury and play a central role in mediating the pathogenesis of acute and chronic spinal cord injury (SCI). The nuclear factor-kappa B (NF-kappa B) family of transcription factors is required for the transcriptional activation of a variety of genes regulating inflammatory, proliferative, and cell death responses of cells. In this study we examined the temporal and cellular expression of activated NF-kappa B after traumatic SCI. We used a contusion model (N.Y.U. Impactor) to initiate the early biochemical and molecular changes that occur after traumatic injury to reproduce the pathological events associated with acute inflammation after SCI. The activation and cellular distribution of activated NF-kappa B was evaluated by using a monoclonal antibody that selectively recognizes activated p65 in a NF-kappa B dimer. Immunohistochemical and Western blot analyses demonstrated that NF-kappa B activation occurred as early as 0.5 hr postinjury and persisted for at least 72 hr. Using electrophoretic mobility shift assays (EMSA), we demonstrate that NF-kappa B is activated after SCI. In our immunohistochemical, Western, and EMSA experiments there are detectable levels of activated NF-kappa B in our control animals. Using double-staining protocols, we detected activated NF-kappa B in macrophages/microglia, endothelial cells, and neurons within the injured spinal cord. Colocalization of activated NF-kappa B with the NF-kappa B-dependent gene product, inducible nitric oxide synthase (iNOS), suggests functional implications for this transcription factor in the pathogenesis of acute spinal cord injury. Although there is considerable evidence for the involvement of an inflammatory reaction after traumatic SCI, this is the first evidence for the activation of NF-kappa B after trauma. Strategies directed at blocking the initiation of this cascade may prove beneficial as a therapeutic approach for the treatment of acute SCI.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	Bethea, JR (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, 1600 NW 10th Ave R-48, Miami, FL 33136 USA.						Adams J, 1996, J NEUROCHEM, V66, P6; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1; Bethea JR, 1997, J IMMUNOL, V158, P5815; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; CLARK WM, 1991, STROKE, V22, P877, DOI 10.1161/01.STR.22.7.877; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; DIEHL JA, 1995, J BIOL CHEM, V270, P2703, DOI 10.1074/jbc.270.6.2703; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Jander S, 1996, J NEUROIMMUNOL, V70, P75, DOI 10.1016/S0165-5728(96)00109-9; KALTSCHMIDT B, 1993, MOL ASPECTS MED, V14, P171, DOI 10.1016/0098-2997(93)90004-W; KALTSCHMIDT C, 1994, J NEUROIMMUNOL, V55, P99, DOI 10.1016/0165-5728(94)90151-1; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; LINDSBERG PJ, 1995, J NEUROSURG, V82, P269, DOI 10.3171/jns.1995.82.2.0269; LLOYD RV, 1995, AM J PATHOL, V146, P86; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MIAO FJP, 1990, J CEREBR BLOOD F MET, V10, P32, DOI 10.1038/jcbfm.1990.4; MincGolomb D, 1996, J NEUROCHEM, V66, P1504; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; Nogawa S, 1997, J NEUROSCI, V17, P2746; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; POPOVICH PG, 1994, BRAIN RES, V633, P348, DOI 10.1016/0006-8993(94)91560-1; RANSOHOFF RM, 1996, CYTOKINE CNS; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; ROTHWELL NJ, 1993, CEREBROVAS BRAIN MET, V5, P178; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; Sato I, 1996, NEUROSCI LETT, V205, P45, DOI 10.1016/0304-3940(96)12377-6; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Shrikant P, 1996, J IMMUNOL, V156, P1307; Shrikant P, 1996, J IMMUNOL, V157, P1819; Stalder A. K., 1996, Society for Neuroscience Abstracts, V22, P1455; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; VANVOORHIS BJ, 1994, ENDOCRINOLOGY, V135, P1799, DOI 10.1210/en.135.5.1799; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438	55	389	414	0	27	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 1	1998	18	9					3251	3260					10	Neurosciences	Neurosciences & Neurology	ZJ036	WOS:000073173100015	9547234				2021-06-18	
J	Myer, DJ; Gurkoff, GG; Lee, SM; Hovda, DA; Sofroniew, MV				Myer, D. J.; Gurkoff, G. G.; Lee, S. M.; Hovda, D. A.; Sofroniew, M. V.			Essential protective roles of reactive astrocytes in traumatic brain injury	BRAIN			English	Article						reactive astrocytes; traumatic brain injury; inflammation; transgenic mice; neural degeneration; glial fibrillary acidic protein; contusion; controlled cortical impact	TRANSGENIC MICE; CELL-DEATH; ABLATION; NEUROPROTECTION; VULNERABILITY; MECHANISMS; EXPRESSION; INDUCTION; TISSUE; MOUSE	Astrocytes respond to traumatic brain injury (TBI) by altered gene expression, hypertrophy and proliferation that occur in a gradated fashion in relation to the severity of the injury. Both beneficial and detrimental effects have been attributed to reactive astrocytes, but their roles after brain injury are not well understood. To investigate these roles, we determined the effects on cortical tissue of ablating reactive astrocytes after contusion injury generated by controlled cortical impact (CCI) of different severities in transgenic mice that express a glial fibrillary acidic protein-herpes simplex virus-thymidine kinase transgene. Treatment of these mice with the antiviral agent, ganciclovir, conditionally ablates proliferating reactive astrocytes. Moderate or severe CCI were generated with a precisely regulated pneumatic piston, and forebrain tissue was evaluated using immunohistochemistry and quantitative morphometry. Moderate CCI in control mice triggered extensive and persisting reactive astrogliosis, with most neurons being preserved, little inflammation and an 18% loss of cortical tissue beneath the impact site. Ablation of reactive astrocytes after moderate CCI in transgenic mice caused substantial neuronal degeneration and inflammation, with a significantly greater 60% loss of cortical tissue. Severe CCI in control mice caused pronounced neuronal degeneration and loss of about 88% of cortical tissue that was not significantly altered by ablating reactive astrocytes in transgenic mice. Thus, ablation of dividing reactive astrocytes exacerbated cortical degeneration after moderate CCI, but did not alter cortical degeneration after severe CCI. These findings indicate that the reactive astrocytes play essential roles in preserving neural tissue and restricting inflammation after moderate focal brain injury.	Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS042039, R01NS027544, P01NS016333] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS42039, NS016333, NS27544] Funding Source: Medline		BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer U, 2005, ONCOGENE, V24, P1231, DOI 10.1038/sj.onc.1208290; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Imura T, 2003, J NEUROSCI, V23, P2824; Jalabi W, 2005, J NEUROSCI, V25, P2885, DOI 10.1523/JNEUROSCI.2748-04.2005; JOHNSON WB, 1995, GLIA, V13, P174, DOI 10.1002/glia.440130304; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kettenmann H, 2004, NEUROGLIA; Kolker S, 2001, EUR J NEUROSCI, V13, P2115, DOI 10.1046/j.0953-816x.2001.01595.x; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Mathis C, 2000, J NEUROSCI, V20, P7698; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	30	388	399	1	29	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2006	129		10				2761	2772		10.1093/brain/awl165			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	090BL	WOS:000240925500023	16825202	Bronze			2021-06-18	
J	Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI				Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI			Disability in young people and adults one year after head injury: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							GLASGOW OUTCOME SCALE; TRAUMATIC BRAIN INJURY; CONTROLLED TRIAL; MODERATE; MILD	Objective To determine the frequency of disability in young people and adults admitted to hospital with a head injury and to estimate the annual incidence in the community. Design Prospective, hospital based cohort study, with one year follow up of sample stratified by coma score. Setting Five acute hospitals in Glasgow. Subjects 2962 patients (aged 14 years or more) with head injury; 549 (71%) of the 769 patients selected for follow up participated. Main outcome measures Glasgow outcome scale and problem orientated questionnaire. Results Survival with moderate or severe disability was common after mild head injury (47%, 95% confidence interval 42% to 52%) and similar to that after moderate (45%, 35% to 56%) or severe injury (48%, 36% to 60%). By extrapolation from the population identified (90% of whom had mild injuries), it was estimated that annually in Glasgow (population 909 498) 1400 young people and adults are still disabled one year after head injury. Conclusion The incidence of disability in young people and adults admitted with a head injury is higher than expected. This reflects die high rate of sequelae previously unrecognised in the large number of patients admitted to hospital with an apparently mild head injury.	Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; So Gen NHS Trust, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland	Teasdale, GM (corresponding author), Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.			Murray, Gordon/0000-0001-9866-4734	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Bryden J, 1989, MODELS BRAIN INJURY, P17; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; FIELD JH, 1975, EPIDEMIOLOGY HEAD IN; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V2, P81; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Kraus JF, 1993, HEAD INJURY, P1; MacMillan R, 1979, Health Bull (Edinb), V37, P75; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; *ROYAL COLL SURG E, 1999, WORK PART MAN PAT HE; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tellier A, 1999, BRAIN INJURY, V13, P463; Wade D T, 1987, Int Rehabil Med, V8, P129; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	387	393	0	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1631	1635		10.1136/bmj.320.7250.1631			5	Medicine, General & Internal	General & Internal Medicine	326KG	WOS:000087734200021	10856063	Bronze, Green Accepted, Green Published			2021-06-18	
J	Mayeux, R; Stern, Y				Mayeux, Richard; Stern, Yaakov			Epidemiology of Alzheimer Disease	COLD SPRING HARBOR PERSPECTIVES IN MEDICINE			English	Article							VASCULAR RISK-FACTORS; AMYLOID PRECURSOR PROTEIN; BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; PLASMA HOMOCYSTEINE LEVELS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; AGE-SPECIFIC INCIDENCE; LOW BLOOD-PRESSURE; FOLLOW-UP	The global prevalence of dementia has been estimated to be as high as 24 million, and is predicted to double every 20 years until at least 2040. As the populationworldwide continues to age, the number of individuals at risk will also increase, particularly among the very old. Alzheimer disease is the leading cause of dementia beginning with impaired memory. The neuropathological hallmarks of Alzheimer disease include diffuse and neuritic extracellular amyloid plaques in brain that are frequently surrounded by dystrophic neurites and intra-neuronal neurofibrillary tangles. The etiology of Alzheimer disease remains unclear, but it is likely to be the result of both genetic and environmental factors. In this review we discuss the prevalence and incidence rates, the established environmental risk factors, and the protective factors, and briefly review genetic variants predisposing to disease.	[Mayeux, Richard; Stern, Yaakov] Columbia Univ, Gertrude H Sergievsky Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10032 USA	Stern, Y (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10032 USA.	ys11@columbia.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Stern, Yaakov/0000-0001-7542-3241	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG007232, U24AG021886, R01AG041797, R01AG037212, R01AG015473] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG037212, U24 AG021886, P01 AG007232, R01 AG041797, R01 AG015473] Funding Source: Medline		Aevarsson O, 1996, J AM GERIATR SOC, V44, P1455, DOI 10.1111/j.1532-5415.1996.tb04070.x; Aisen PS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006395; Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Andersen K, 1999, NEUROLOGY, V52, P85, DOI 10.1212/WNL.52.1.85; Angevaren M., 2008, COCHRANE DATABASE SY; Arbus C, 2008, INT J GERIATR PSYCH, V23, P1209, DOI 10.1002/gps.2044; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; Bagger YZ, 2004, OBES RES, V12, P1519, DOI 10.1038/oby.2004.189; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bohannon AD, 2002, J AM GERIATR SOC, V50, P424, DOI 10.1046/j.1532-5415.2002.50104.x; Borenstein AR, 2005, NEUROBIOL AGING, V26, P325, DOI 10.1016/j.neurobiolaging.2004.04.010; BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brubacher D, 2004, INT J OBESITY, V28, P1163, DOI 10.1038/sj.ijo.0802721; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Carro E, 2001, J NEUROSCI, V21, P5678; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; Chodosh J, 2002, J AM GERIATR SOC, V50, P1051, DOI 10.1046/j.1532-5415.2002.50260.x; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P433, DOI 10.1192/bjp.175.5.433; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; de Koning I, 2000, STROKE, V31, P1502, DOI 10.1161/01.STR.31.7.1502; de Koning I, 2005, J NEUROL NEUROSUR PS, V76, P263, DOI 10.1136/jnnp.2004.039511; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Di Carlo A, 2002, J AM GERIATR SOC, V50, P41, DOI 10.1046/j.1532-5415.2002.50006.x; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; Edland SD, 2002, ARCH NEUROL-CHICAGO, V59, P1589, DOI 10.1001/archneur.59.10.1589; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Elias PK, 2004, HYPERTENSION, V44, P631, DOI 10.1161/01.HYP.0000145858.07252.99; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Evans D A, 1993, Ann Epidemiol, V3, P71; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Faxen-Irving G, 2005, AGE AGEING, V34, P136, DOI 10.1093/ageing/afi023; Fein G, 2000, NEUROLOGY, V55, P1626, DOI 10.1212/WNL.55.11.1626; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Gamaldo A, 2006, NEUROLOGY, V67, P1363, DOI 10.1212/01.wnl.0000240285.89067.3f; Ganguli M, 2000, NEUROLOGY, V54, P1109, DOI 10.1212/WNL.54.5.1109; Geerlings MI, 1999, PSYCHOL MED, V29, P1219, DOI 10.1017/S0033291799008867; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goble AJ, 2005, BMJ-BRIT MED J, V331, P454, DOI 10.1136/bmj.331.7514.454-a; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Hall KS, 2000, NEUROLOGY, V54, P95, DOI 10.1212/WNL.54.1.95; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Helzner EP, 2007, ARCH NEUROL-CHICAGO, V64, P1749, DOI 10.1001/archneur.64.12.1749; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jellinger KA, 2002, J NEUROL SCI, V203, P153, DOI 10.1016/S0022-510X(02)00282-4; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Jeong SK, 2005, DEMENT GERIATR COGN, V19, P91, DOI 10.1159/000082659; Jin YP, 2008, NEUROLOGY, V70, P9, DOI 10.1212/01.wnl.0000284609.77385.03; Jin Ya-Ping, 2006, Alzheimers Dement, V2, P171, DOI 10.1016/j.jalz.2006.03.006; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Kilander L, 2000, AGE AGEING, V29, P243, DOI 10.1093/ageing/29.3.243; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Klimkowicz A, 2002, DEMENT GERIATR COGN, V14, P137, DOI 10.1159/000063599; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Knopman DS, 2002, ARCH NEUROL-CHICAGO, V59, P1605, DOI 10.1001/archneur.59.10.1605; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kuller LH, 2005, NEUROLOGY, V64, P1548, DOI 10.1212/01.WNL.0000160115.55756.DE; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Lee VMY, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006437; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; LETENNEUR L, 1994, INT J EPIDEMIOL, V23, P1256, DOI 10.1093/ije/23.6.1256; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liebetrau M, 2003, STROKE, V34, P2617, DOI 10.1161/01.STR.0000094420.80781.A9; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Linden T, 2004, NEUROEPIDEMIOLOGY, V23, P45, DOI 10.1159/000073974; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Lobo A, 2000, NEUROLOGY, V54, pS4; Lopez-Pousa S, 2004, NEUROEPIDEMIOLOGY, V23, P170, DOI 10.1159/000078502; Luchsinger JA, 2004, NEUROLOGY, V62, P1972, DOI 10.1212/01.WNL.0000129504.60409.88; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morris MC, 2006, J ALZHEIMERS DIS, V9, P435; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Morris MC, 2001, ARCH NEUROL-CHICAGO, V58, P1640, DOI 10.1001/archneur.58.10.1640; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241; Nourhashemi F, 2003, NEUROLOGY, V60, P117, DOI 10.1212/01.WNL.0000038910.46217.AA; Nourhashemi F, 2002, J AM GERIATR SOC, V50, P1796, DOI 10.1046/j.1532-5415.2002.50507.x; Ogunniyi A, 2000, EUR J NEUROL, V7, P485, DOI 10.1046/j.1468-1331.2000.00124.x; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; Petitti DB, 2005, ARCH NEUROL-CHICAGO, V62, P112, DOI 10.1001/archneur.62.1.112; Piguet O, 2003, NEUROEPIDEMIOLOGY, V22, P165, DOI 10.1159/000069886; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qiu CX, 2003, ARCH NEUROL-CHICAGO, V60, P223, DOI 10.1001/archneur.60.2.223; Qiu CX, 2001, ARCH NEUROL-CHICAGO, V58, P2034, DOI 10.1001/archneur.58.12.2034; Rastas S, 2010, NEUROBIOL AGING, V31, P1, DOI 10.1016/j.neurobiolaging.2008.02.020; Ravaglia G, 2005, NEUROLOGY, V64, P1525, DOI 10.1212/01.WNL.0000160107.02316.BF; Ravaglia G, 2005, AM J CLIN NUTR, V82, P636; Razay G, 2005, BMJ, V331; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reinprecht F, 2003, J HYPERTENS, V21, P57, DOI 10.1097/00004872-200301000-00014; Reitz C, 2008, STROKE, V39, P36, DOI 10.1161/STROKEAHA.107.490334; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Reitz C, 2009, DEMENT GERIATR COGN, V27, P11, DOI 10.1159/000182421; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Rottkamp CA, 2000, ALZ DIS ASSOC DIS, V14, pS62, DOI 10.1097/00002093-200000001-00010; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Ruitenberg A, 2001, DEMENT GERIATR COGN, V12, P33, DOI 10.1159/000051233; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Schneider JA, 2010, STROKE, V41, pS144, DOI 10.1161/STROKEAHA.110.598326; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; Simons LA, 2006, MED J AUSTRALIA, V184, P68, DOI 10.5694/j.1326-5377.2006.tb00120.x; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; Srikanth VK, 2006, STROKE, V37, P2479, DOI 10.1161/01.STR.0000239666.46828.d7; Srikanth VK, 2004, NEUROLOGY, V63, P785, DOI 10.1212/01.WNL.0000137042.01774.33; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Swartz RH, 2008, STROKE, V39, P822, DOI 10.1161/STROKEAHA.107.491936; Tabet N, 2005, BRIT MED J, V331, P454, DOI 10.1136/bmj.331.7514.454-b; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Tang WK, 2004, STROKE, V35, P930, DOI 10.1161/01.STR.0000119752.74880.5B; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Tarawneh R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006148; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; Traber MG, 2000, CLIN CHEST MED, V21, P173, DOI 10.1016/S0272-5231(05)70016-2; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tyas SL, 2001, INT J EPIDEMIOL, V30, P590, DOI 10.1093/ije/30.3.590; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Valenzuela MJ, 2005, PSYCHOL MED, V36, P1, DOI DOI 10.1017/S0033291704004052; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142; van Praag H, 1999, NAT NEUROSCI, V2, P266; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Verghese J, 2003, NEUROLOGY, V61, P1667, DOI 10.1212/01.WNL.0000098934.18300.BE; Waldstein SR, 2006, INT J OBESITY, V30, P201, DOI 10.1038/sj.ijo.0803114; Waldstein SR, 2005, HYPERTENSION, V45, P374, DOI 10.1161/01.HYP.0000156744.44218.74; Wang HX, 2001, NEUROLOGY, V56, P1188, DOI 10.1212/WNL.56.9.1188; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wen Y, 2007, BBA-MOL BASIS DIS, V1772, P473, DOI 10.1016/j.bbadis.2006.10.011; WHITE L, 1994, J CLIN EPIDEMIOL, V47, P363, DOI 10.1016/0895-4356(94)90157-0; WHITEHOUSE PJ, 1988, NEUROLOGY, V38, P720, DOI 10.1212/WNL.38.5.720; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Wilson RS, 2007, NEUROLOGY, V69, P1911, DOI 10.1212/01.wnl.0000271087.67782.cb; Wilson RS, 2010, NEUROLOGY, V75, P990, DOI 10.1212/WNL.0b013e3181f25b5e; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Wu CS, 2003, LIFE SCI, V72, P1125, DOI 10.1016/S0024-3205(02)02367-6; Yamada M, 2003, J AM GERIATR SOC, V51, P410, DOI 10.1046/j.1532-5415.2003.51117.x; Yamagishi S, 2005, MED HYPOTHESES, V64, P1205, DOI 10.1016/j.mehy.2005.01.016; Yip AG, 2006, AGE AGEING, V35, P154, DOI 10.1093/ageing/afj030; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Zhang X, 1999, Zhonghua Yi Xue Za Zhi, V79, P335; Zhou DHD, 2004, J NEUROL, V251, P421, DOI 10.1007/s00415-004-0337-z; Zhu L, 2000, STROKE, V31, P53, DOI 10.1161/01.STR.31.1.53	223	386	392	1	57	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	2157-1422			CSH PERSPECT MED	Cold Spring Harb. Perspect. Med.	AUG	2012	2	8							a006239	10.1101/cshperspect.a006239			18	Medicine, Research & Experimental	Research & Experimental Medicine	080YH	WOS:000314279800001	22908189	Bronze, Green Accepted, Green Published	Y	N	2021-06-18	
J	Kinnunen, KM; Greenwood, R; Powell, JH; Leech, R; Hawkins, PC; Bonnelle, V; Patel, MC; Counsell, SJ; Sharp, DJ				Kinnunen, Kirsi Maria; Greenwood, Richard; Powell, Jane Hilary; Leech, Robert; Hawkins, Peter Charlie; Bonnelle, Valerie; Patel, Maneesh Chandrakant; Counsell, Serena Jane; Sharp, David James			White matter damage and cognitive impairment after traumatic brain injury	BRAIN			English	Article						traumatic brain injury; diffuse axonal injury; diffusion tensor; brain behaviour and relationships; cognitive impairment	DIFFUSE AXONAL INJURY; ADULT AGE-DIFFERENCES; CLOSED-HEAD INJURY; MULTIPLE-SCLEROSIS; PROSPECTIVE COHORT; MEMORY DEFICITS; WATER DIFFUSION; REACTION-TIME; YOUNG-PEOPLE; TENSOR	White matter disruption is an important determinant of cognitive impairment after brain injury, but conventional neuroimaging underestimates its extent. In contrast, diffusion tensor imaging provides a validated and sensitive way of identifying the impact of axonal injury. The relationship between cognitive impairment after traumatic brain injury and white matter damage is likely to be complex. We applied a flexible technique-tract-based spatial statistics-to explore whether damage to specific white matter tracts is associated with particular patterns of cognitive impairment. The commonly affected domains of memory, executive function and information processing speed were investigated in 28 patients in the post-acute/chronic phase following traumatic brain injury and in 26 age-matched controls. Analysis of fractional anisotropy and diffusivity maps revealed widespread differences in white matter integrity between the groups. Patients showed large areas of reduced fractional anisotropy, as well as increased mean and axial diffusivities, compared with controls, despite the small amounts of cortical and white matter damage visible on standard imaging. A stratified analysis based on the presence or absence of microbleeds (a marker of diffuse axonal injury) revealed diffusion tensor imaging to be more sensitive than gradient-echo imaging to white matter damage. The location of white matter abnormality predicted cognitive function to some extent. The structure of the fornices was correlated with associative learning and memory across both patient and control groups, whilst the structure of frontal lobe connections showed relationships with executive function that differed in the two groups. These results highlight the complexity of the relationships between white matter structure and cognition. Although widespread and, sometimes, chronic abnormalities of white matter are identifiable following traumatic brain injury, the impact of these changes on cognitive function is likely to depend on damage to key pathways that link nodes in the distributed brain networks supporting high-level cognitive functions.	[Leech, Robert; Bonnelle, Valerie; Sharp, David James] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Ctr Neurosci, Div Expt Med,Dept Med, London W12 0NN, England; [Kinnunen, Kirsi Maria; Powell, Jane Hilary; Hawkins, Peter Charlie] Univ London, Dept Psychol, London, England; [Greenwood, Richard] UCL, Inst Neurol, Div Clin Neurol, London, England; [Bonnelle, Valerie] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr,Fac Med, Expt & Clin Neurosci Sect,Cognit Neuroimaging Res, London W12 0NN, England; [Patel, Maneesh Chandrakant] Imperial Coll Healthcare NHS Trust, Dept Imaging, Charing Cross Hosp, London, England; [Counsell, Serena Jane] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr,Expt & Clin Neurosci Sect, Neonatal Med Res Grp,Fac Med, London W12 0NN, England	Sharp, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Ctr Neurosci, Div Expt Med,Dept Med, 3rd Floor,Burlington Danes Bldg,Hammersmith Hosp, London W12 0NN, England.	david.sharp@imperial.ac.uk	counsell, serena j/I-9012-2014; Kinnunen, Kirsi M/D-6061-2011; Leech, Robert/AAE-8254-2019; Kinnunen, Kirsi/P-6402-2019; Lang, Steven/AAE-8102-2021; Sharp, David J/A-2119-2013	Leech, Robert/0000-0002-5801-6318; Lang, Steven/0000-0003-1669-9146; Hawkins, Peter/0000-0002-2256-1648; Counsell, Serena/0000-0002-8033-5673; Kinnunen, Kirsi M./0000-0002-8562-2866	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Hammersmith Hospital's Charity Trustees Research Grants Committee; Goldsmiths, University of London; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951] Funding Source: researchfish	The Medical Research Council (UK) (to D.J.S.); the Hammersmith Hospital's Charity Trustees Research Grants Committee (to D.J.S.); and Goldsmiths, University of London (to K.M.K.).	Aggleton JP, 2008, Q J EXP PSYCHOL, V61, P1441, DOI 10.1080/17470210802215335; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Baddeley A., 1994, DOORS PEOPLE TEST TE; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bosch B, 2010, NEUROBIOL AGING; Brasted PJ, 2003, BRAIN, V126, P1202, DOI 10.1093/brain/awg103; Brasted PJ, 2002, J NEUROPHYSIOL, V87, P631, DOI 10.1152/jn.00656.2001; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Ceccarelli A, 2009, HUM BRAIN MAPP, V30, P3009, DOI 10.1002/hbm.20725; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Delis DC, 2001, DELISKAPLAN EXECUTIV; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; GAFFAN D, 1991, BRAIN, V114, P2611, DOI 10.1093/brain/114.6.2611; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jack J., 1983, ELECT CURRENT FLOW E; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kesler SR, 2001, J INT NEUROPSYCH SOC, V7, P640, DOI 10.1017/S1355617701005112; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwok SC, 2010, HIPPOCAMPUS, V20, P413, DOI 10.1002/hipo.20643; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MCMACKIN D, 1995, ACTA NEUROCHIR, V135, P12, DOI 10.1007/BF02307408; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Park SA, 2000, NEUROLOGY, V54, P1379, DOI 10.1212/WNL.54.6.1379; Perry ME, 2009, NEUROPSYCHOLOGIA, V47, P2835, DOI 10.1016/j.neuropsychologia.2009.06.008; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wechsler D., 2011, WECHLSER ABBREVIATED; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; World Medical Association, 2008, DECL HELS	73	386	397	0	62	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2011	134		2				449	463		10.1093/brain/awq347			15	Clinical Neurology; Neurosciences	Neurosciences & Neurology	716RI	WOS:000286990800013	21193486	Green Accepted, Green Published, Bronze	Y	N	2021-06-18	
J	Swick, D; Ashley, V; Turken, U				Swick, Diane; Ashley, Victoria; Turken, U.			Left inferior frontal gyrus is critical for response inhibition	BMC NEUROSCIENCE			English	Article							GO/NO-GO DISCRIMINATION; TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; PREFRONTAL CORTEX; COGNITIVE CONTROL; NO-GO; FUNCTIONAL MRI; STOP-SIGNAL; NEUROPSYCHOLOGICAL TEST; SUSTAINED ATTENTION	Background: Lesion studies in human and non-human primates have linked several different regions of prefrontal cortex (PFC) with the ability to inhibit inappropriate motor responses. However, recent functional neuroimaging studies have specifically implicated right inferior PFC in response inhibition. Right frontal dominance for inhibitory motor control has become a commonly accepted view, although support for this position has not been consistent. Particularly conspicuous is the lack of data on the importance of the homologous region in the left hemisphere. To investigate whether the left inferior frontal gyrus (IFG) is critical for response inhibition, we used neuropsychological methodology with carefully characterized brain lesions in neurological patients. Results: Twelve individuals with damage in the left IFG and the insula were tested in a Go/NoGo response inhibition task. In alternating blocks, the difficulty of response inhibition was easy (50% NoGo trials) or hard (10% NoGo trials). Controls showed the predicted pattern of faster reaction times and more false alarm errors in the hard condition. Left IFG patients had higher error rates than controls in both conditions, but were more impaired in the hard condition, when a greater degree of inhibitory control was required. In contrast, a patient control group with orbitofrontal cortex lesions showed intact performance. Conclusion: Recent neuroimaging studies have focused on a highly specific association between right IFG and inhibitory control. The present results indicate that the integrity of left IFG is also critical for successful implementation of inhibitory control over motor responses. Our findings demonstrate the importance of obtaining converging evidence from multiple methodologies in cognitive neuroscience.	[Swick, Diane; Ashley, Victoria; Turken, U.] Vet Affairs No Calif Hlth Care Syst, Res Serv, Martinez, CA 94553 USA; [Swick, Diane] Univ Calif Davis, Dept Neurol, Martinez, CA 94553 USA	Swick, D (corresponding author), Vet Affairs No Calif Hlth Care Syst, Res Serv, Martinez, CA 94553 USA.	diane@ebire.org; victronix01@gmail.com; andturken@gmail.com			NSFNational Science Foundation (NSF) [023681]; VA Merit Review grantUS Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR019975] Funding Source: NIH RePORTER	Thanks to Kathy Baynes, Christine Davis, Nina Dronkers, and Robert T. Knight for patient referrals, and Jennifer Yang and Caitlin Roxby for their assistance. This work was supported by NSF Grant 023681 and a VA Merit Review grant.	Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bekker EM, 2005, ARCH GEN PSYCHIAT, V62, P1129, DOI 10.1001/archpsyc.62.10.1129; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; BUTTERS N, 1973, EXP NEUROL, V39, P204, DOI 10.1016/0014-4886(73)90223-9; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHIKAZOE J, 2008, CEREB CORTEX; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1280, DOI 10.1016/S0028-3932(00)00033-6; Dimitrov M, 2003, BRAIN COGNITION, V52, P258, DOI 10.1016/S0278-2626(03)00080-0; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; DREWE E A, 1975, Cortex, V11, P8; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Fellows LK, 2005, J COGNITIVE NEUROSCI, V17, P850, DOI 10.1162/0898929054021139; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Gold BT, 2005, CEREB CORTEX, V15, P1438, DOI 10.1093/cercor/bhi024; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; Kenemans JL, 2005, INT J PSYCHOPHYSIOL, V58, P59, DOI 10.1016/j.ijpsycho.2005.03.009; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Luria A. R., 1969, HDB CLINICAL NEUROLO, V2, P725; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nakata H, 2008, NEUROIMAGE, V39, P1858, DOI 10.1016/j.neuroimage.2007.10.041; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Shallice T, 2003, NEUROIMAGE, V20, pS146, DOI 10.1016/j.neuroimage.2003.09.023; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Swick D, 1999, NEUROPSYCHOLOGY, V13, P155, DOI 10.1037/0894-4105.13.2.155; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; VERFAELLIE M, 1987, ARCH NEUROL-CHICAGO, V44, P1265, DOI 10.1001/archneur.1987.00520240045010; Vollm Birgit, 2004, Crim Behav Ment Health, V14, P39, DOI 10.1002/cbm.559; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061; Zheng D, 2008, J COGNITIVE NEUROSCI, V20, P1434, DOI 10.1162/jocn.2008.20100	70	386	391	2	35	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	OCT 21	2008	9								102	10.1186/1471-2202-9-102			11	Neurosciences	Neurosciences & Neurology	379IM	WOS:000261389900002	18939997	DOAJ Gold, Green Published			2021-06-18	
J	Carlson, SL; Parrish, ME; Springer, JE; Doty, K; Dossett, L				Carlson, SL; Parrish, ME; Springer, JE; Doty, K; Dossett, L			Acute inflammatory response in spinal cord following impact injury	EXPERIMENTAL NEUROLOGY			English	Article						neutrophil; macrophage; microglia; immunocytochemistry; myeloperoxidase; inflammation; rat	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; ISCHEMIC CELL-DAMAGE; NEUTROPHIL ACCUMULATION; MONONUCLEAR PHAGOCYTES; TISSUE-DAMAGE; FOCAL STROKE; RAT; DEGENERATION	Numerous factors are involved in the spread of secondary damage in spinal cord after traumatic injury, including ischemia, edema, increased excitatory amino acids, and oxidative damage to the tissue from reactive oxygen species. Neutrophils and macrophages can produce reactive oxygen species when activated and thus may contribute to the lipid peroxidation that is known to occur after spinal cord injury. This study examined the rostral-caudal distribution of neutrophils and macrophages/microglia at 4, 6, 24, and 48 h after contusion injury to the T10 spinal cord of rat (10 g weight, 50 mm drop). Neutrophils were located predominantly in necrotic regions, with a time course that peaked at 24 h as measured with assays of myeloperoxidase activity (MPO). The sharpest peak of MPO activity was localized between 4 mm rostral and caudal to the injury. Macrophages/microglia were visualized with antibodies against ED1 and OX-42. Numerous cells with a phagocytic morphology were present by 24 h, with a higher number by 48 h. These cells were predominantly located within the gray matter and dorsal funiculus white matter. The number of cells gradually declined through 6 mm rostral and caudal to the lesion. OX-42 staining also revealed reactive microglia with blunt processes, particularly at levels distant to the lesion. The number of macrophages/microglia was significantly correlated with the amount of tissue damage at each level. Treatments to decrease the inflammatory response are likely to be beneficial to recovery of function after traumatic spinal cord injury. (C) 1998 Academic Press.	Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Lexington, KY 40536 USA	Carlson, SL (corresponding author), Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Lexington, KY 40536 USA.						ANDERSON R, 1995, S AFR MED J, V85, P1024; AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BALENTINE JD, 1978, LAB INVEST, V39, P236; BANATI RB, 1994, DEV NEUROSCI-BASEL, V16, P114, DOI 10.1159/000112098; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13, DOI 10.1007/BF03160109; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Clark G., 1981, STAINING PROCEDURES; CLARK RK, 1994, BRAIN RES BULL, V35, P387, DOI 10.1016/0361-9230(94)90119-8; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Gallin John I., 1993, P1015; GARCIA JH, 1995, AM J PATHOL, V147, P1477; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Hamada Y, 1996, J NEUROCHEM, V66, P1525; HIRSCHBERG DL, 1995, J NEUROIMMUNOL, V61, P89, DOI 10.1016/0165-5728(95)00087-I; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; Jiang N, 1995, ANN NEUROL, V38, P935, DOI 10.1002/ana.410380615; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; KREUTZBERG GW, 1995, ARZNEIMITTEL-FORSCH, V45-1, P357; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEIRISALOREPO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb01988.x; MACKAY CR, 1993, IMMUNOL TODAY, V14, P93; Mantovani A, 1997, IMMUNOL TODAY, V18, P231, DOI 10.1016/S0167-5699(97)81662-3; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SEEKAMP A, 1993, AGENT ACTION SUPPL, V41, P137; SHAPPELL SB, 1994, HDB IMMUNOPHARMACOLO, P29; Soares HD, 1995, J NEUROSCI, V15, P8223; Springer JE, 1997, J NEUROCHEM, V68, P2469; STOOLMAN LM, 1993, CHEST, V103, pS79; TAOKA T, 1997, NEUROSCIENCE, V79, P1177; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; WINN RK, 1993, AGENT ACTION SUPPL, V41, P113; Worthington Biochemical Corp, 1972, WORTH ENZ MAN, P43; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; YOUNG W, 1994, ANN NY ACAD SCI, V743, P241, DOI 10.1111/j.1749-6632.1994.tb55796.x; ZHANG RL, 1994, J NEUROL SCI, V126, P96; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8	59	386	404	1	44	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	MAY	1998	151	1					77	88		10.1006/exnr.1998.6785			12	Neurosciences	Neurosciences & Neurology	ZM959	WOS:000073593600007	9582256				2021-06-18	
J	Lew, HL; Otis, JD; Tun, C; Kerns, RD; Clark, ME; Cifu, DX				Lew, Henry L.; Otis, John D.; Tun, Carlos; Kerns, Robert D.; Clark, Michael E.; Cifu, David X.			Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: Polytrauma clinical triad	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injuries; explosions; Iraq; military personnel; pain; posttraumatic stress disorder; rehabilitation; veterans; war; wounds and injuries	TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; IRAQI FREEDOM; AFGHANISTAN; MILITARY; SOLDIERS	This study examines the prevalence and coprevalence with which returning Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) veterans were reporting symptoms consistent with chronic pain, posttraumatic stress disorder (PTSD), and persistent postconcussive symptoms (PPCS). The medical records of 340 OIF/OEF veterans seen at a Department of Veterans Affairs Polytrauma Network Site were comprehensively reviewed. Analyses indicated a high prevalence of all three conditions in this population, with chronic pain, PTSD, and PPCS present in 81.5%, 68.2%, and 66.8%, respectively. Only 12 of the veterans (3.5%) had no chronic pain, PTSD, or PPCS. The frequency at which these three conditions were present in isolation (10.3%, 2.9%, and 5.3%, respectively) was significantly lower than the frequency at which they were present in combination with one another, with 42.1% of the sample being diagnosed with all three conditions simultaneously. The most common chronic pain locations were the back (58%) and head (55%). These results underscore the complexity of the presenting complaints in OIF/OEF veterans and support the importance of a multidisciplinary team approach to assessment and treatment.	[Lew, Henry L.; Tun, Carlos] VA Boston Healthcare Syst, PM&R Serv, Dept Vet Affairs, Boston, MA 02130 USA; [Lew, Henry L.; Tun, Carlos] Harvard Univ, Sch Med, Boston, MA USA; [Lew, Henry L.] DVBIC Site, Boston, MA USA; [Otis, John D.] VA Boston Healthcare Syst, Pain Res Program, Boston, MA USA; [Kerns, Robert D.] VA Connecticut Healthcare Syst, PRIME Ctr, West Haven, CT USA; [Clark, Michael E.] James A Haley Vet Hosp, Chron Pain Rehabil Program, Tampa, FL USA; [Cifu, David X.] Richmond VA Med Ctr, PM&R Serv, Richmond, VA USA	Lew, HL (corresponding author), VA Boston Healthcare Syst, PM&R Serv, Dept Vet Affairs, 150 S Huntington Ave, Boston, MA 02130 USA.	henry.lew@va.gov		Otis, John/0000-0002-5441-7421; Cifu, David/0000-0003-1600-9387	VA Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B5008R]	This material was based on work supported by the VA Rehabilitation Research and Development Service, Merit Review Project B5008R.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blake D. D., 1990, BEHAV THER, V13, P187; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Defense and Veterans Brain Injury Center, UND TRAUM BRAIN INJ; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Merskey H, 1994, CLASSIFICATION CHRON; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P242, DOI 10.1007/0-387-25610-5_14; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WHO, 1977, MAN INT STAT CLASS D	21	385	387	0	28	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	6					697	702		10.1682/JRRD.2009.01.0006			6	Rehabilitation	Rehabilitation	531BQ	WOS:000272638100007	20104399	Bronze			2021-06-18	
J	Carmichael, ST				Carmichael, ST			Cellular and molecular mechanisms of neural repair after stroke: Making waves	ANNALS OF NEUROLOGY			English	Article							FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; ADULT-RAT; NERVE REGENERATION; NEURITE OUTGROWTH; MOTOR CORTEX; SPINAL-CORD; FUNCTIONAL REORGANIZATION; CORTICAL REORGANIZATION	Stroke is associated with a limited degree of functional recovery. Imaging studies in humans have shown that reorganization in periinfarct and connected cortical areas most closely correlates with functional recovery after stroke. On a cellular level, two major regenerative events occur in periinfarct cortex: axons sprout new connections and establish novel projection patterns, and newly born immature neurons migrate into periinfarct cortex. Stroke induces a unique microenvironment for axonal sprouting in periinfarct cortex, in which growth-inhibitory molecules are reduced for 1 month after the infarct. During this period, neurons activate growth-promoting genes in successive waves. Neurogenesis also occurs through waves of migration of immature neurons from their origin in the subventricular zone into periinfarct cortex. This migration is mediated, in part, by the cytokine erythropoietin. These data indicate that the cellular environment after stroke is far from one of just death and destruction, but rather involves a longer evolving process of neuronal regeneration. Poststroke neuronal regeneration is characterized by waves of specific cellular and molecular events. Manipulating these waves of regeneration may provide for novel therapies that will improve recovery after stroke.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Carmichael, ST (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Neurosci Res Bldg,635 Charles Young Dr S, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu		Carmichael, S Thomas/0000-0002-1169-9203	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01 NS45729] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045729] Funding Source: NIH RePORTER		*AM HEART ASS, HEART DIS STROK STAT; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Becker CG, 2001, EXP NEUROL, V169, P438, DOI 10.1006/exnr.2001.7657; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Burdick E., 1956, 9 WAVE; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Butefisch CM, 2005, NEUROLOGY, V64, P1067, DOI 10.1212/01.WNL.0000154603.48446.36; Calautti C, 2001, NEUROREPORT, V12, P3883, DOI 10.1097/00001756-200112210-00005; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Cramer SC, 2004, STROKE, V35, P2695, DOI 10.1161/01.STR.0000143326.36847.b0; Cramer SC, 2006, EXP BRAIN RES, V168, P25, DOI 10.1007/s00221-005-0082-2; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deguchi K, 2005, BRAIN RES, V1037, P194, DOI 10.1016/j.brainres.2004.12.016; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; DOBKIN BH, 2003, CLIN SCI NEUROREHABI; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Fernandez B, 2004, STROKE, V35, P2171, DOI 10.1161/01.STR.0000139323.76769.b0; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; Golub T, 2005, BIOCHEM SOC SYMP, V72, P119, DOI 10.1042/bss0720119; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; ISHIGURO H, 1993, MOL CHEM NEUROPATHOL, V20, P173, DOI 10.1007/BF02815370; Iwata T, 2002, MOL BRAIN RES, V102, P105, DOI 10.1016/S0169-328X(02)00187-0; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Kartje GL, 1999, ANN NEUROL, V45, P778, DOI 10.1002/1531-8249(199906)45:6<778::AID-ANA12>3.0.CO;2-B; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; KELLER A, 1990, EXP BRAIN RES, V80, P23; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lipton P, 1999, PHYSIOL REV, V79, P1431; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Nadareishvili Z, 2003, NEW ENGL J MED, V348, P2355, DOI 10.1056/NEJMcibr023192; Napieralski JA, 1996, J COMP NEUROL, V373, P484; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stead JDH, 2006, J NEUROSCI, V26, P345, DOI 10.1523/JNEUROSCI.2755-05.2006; STEWARD O, 1995, J COMP NEUROL, V359, P391, DOI 10.1002/cne.903590304; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Studer L, 2000, J NEUROSCI, V20, P7377; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Tanabe K, 2003, J NEUROSCI, V23, P9675; Thickbroom GW, 2004, CLIN NEUROPHYSIOL, V115, P2144, DOI 10.1016/j.clinph.2004.04.001; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Voria I, 2006, EXP NEUROL, V197, P258, DOI 10.1016/j.expneurol.2005.10.001; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; Wegner F, 2003, EXP NEUROL, V184, P705, DOI 10.1016/S0014-4886(03)00313-3; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang Y, 2000, MOL CELL NEUROSCI, V16, P71, DOI 10.1006/mcne.2000.0852; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	80	385	399	1	33	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0364-5134			ANN NEUROL	Ann. Neurol.	MAY	2006	59	5					735	742		10.1002/ana.20845			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	037RM	WOS:000237164600006	16634041				2021-06-18	
J	McKee, AC; Gavett, BE; Stern, RA; Nowinski, CJ; Cantu, RC; Kowall, NW; Perl, DP; Hedley-Whyte, ET; Price, B; Sullivan, C; Morin, P; Lee, HS; Kubilus, CA; Daneshvar, DH; Wulff, M; Budson, AE				McKee, Ann C.; Gavett, Brandon E.; Stern, Robert A.; Nowinski, Christopher J.; Cantu, Robert C.; Kowall, Neil W.; Perl, Daniel P.; Hedley-Whyte, E. Tessa; Price, Bruce; Sullivan, Chris; Morin, Peter; Lee, Hyo-Soon; Kubilus, Caroline A.; Daneshvar, Daniel H.; Wulff, Megan; Budson, Andrew E.			TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Amyotrophic lateral sclerosis; Chronic brain injury; Motor neuron disease; Sports; Tau proteins; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PARKINSONISM-DEMENTIA COMPLEX; LOU-GEHRIGS-DISEASE; HEAD-INJURY; ALZHEIMERS-DISEASE; ANTECEDENT EVENTS; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; INCREASED RISK	Epidemiological evidence suggests that the incidence of amyotrophic lateral sclerosis is increased in association with head injury. Repetitive head injury is also associated with the development of chronic traumatic encephalopathy (CTE), a tauopathy characterized by neurofibrillary tangles throughout the brain in the relative absence of beta-amyloid deposits. We examined 12 cases of CTE and, in 10, found a widespread TAR DNA-binding protein of approximately 43 kd (TDP-43) proteinopathy affecting the frontal and temporal cortices, medial temporal lobe, basal ganglia, diencephalon, and brainstem. Three athletes with CTE also developed a progressive motor neuron disease with profound weakness, atrophy, spasticity, and fasciculations several years before death. In these 3 cases, there were abundant TDP-43-positive inclusions and neurites in the spinal cord in addition to tau neurofibrillary changes, motor neuron loss, and corticospinal tract degeneration. The TDP-43 proteinopathy associated with CTE is similar to that found in frontotemporal lobar degeneration with TDP-43 inclusions, in that widespread regions of the brain are affected. Akin to frontotemporal lobar degeneration with TDP-43 inclusions, in some individuals with CTE, the TDP-43 proteinopathy extends to involve the spinal cord and is associated with motor neuron disease. This is the first pathological evidence that repetitive head trauma experienced in collision sports might be associated with the development of a motor neuron disease.	[McKee, Ann C.; Sullivan, Chris; Morin, Peter; Budson, Andrew E.] Bedford Vet Adm Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA USA; [McKee, Ann C.; Gavett, Brandon E.; Stern, Robert A.; Nowinski, Christopher J.; Cantu, Robert C.; Kowall, Neil W.; Daneshvar, Daniel H.; Wulff, Megan] Ctr Study Traumat Encephalopathy, Boston, MA USA; [McKee, Ann C.; Gavett, Brandon E.; Stern, Robert A.; Sullivan, Chris; Morin, Peter; Lee, Hyo-Soon; Kubilus, Caroline A.; Budson, Andrew E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.] Natl VA ALS Biorepository, Tucson, AZ USA; [Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA USA; [Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Kowall, Neil W.] Vet Adm Med Ctr Jamaica Plain, Geriatr Res Educ Clin Ctr, Boston, MA 02130 USA; [Perl, Daniel P.] Mt Sinai Sch Med, Dept Pathol Neuropathol, New York, NY USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Price, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Price, Bruce] McLean Hosp, Dept Neurol, Belmont, MA 02178 USA	McKee, AC (corresponding author), Bedford Vet Adm Med Ctr, 182-B 200 Springs Rd, Bedford, MA 01730 USA.	amckee@bu.edu	Hedley-Whyte, E Tessa/AAJ-9975-2021; , Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Kowall, Neil/0000-0002-6624-0213; Gavett, Brandon/0000-0003-1938-1854; Daneshvar, Daniel/0000-0003-3691-9513; Stern, Robert/0000-0002-5008-077X	Boston University Alzheimer's Disease Center [NIA P30 AG13846, 0572063345-5]; Mount Sinai Alzheimer's Disease Research Center [P50AG05138, P01AG02219]; Massachusetts Alzheimer's Disease Research Center [P50AG05134]; VA Biorepository [CSP 501]; Department of Veterans AffairsUS Department of Veterans Affairs; Sports Legacy Institute; National Operating Committee on Standards for Athletic Equipment; National Football League; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005138, P01AG002219, P30AG013846, P50AG005134] Funding Source: NIH RePORTER	This study was supported by the Boston University Alzheimer's Disease Center NIA P30 AG13846, supplement 0572063345-5; the Mount Sinai Alzheimer's Disease Research Center Grants P50AG05138 and P01AG02219; the Massachusetts Alzheimer's Disease Research Center Grant P50AG05134; the VA Biorepository (CSP 501), funded by the Department of Veterans Affairs; the Sports Legacy Institute; the National Operating Committee on Standards for Athletic Equipment; and by an unrestricted gift from the National Football League. The authors acknowledge the use of resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts.	Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; ARMON C, 1991, NEUROLOGY, V41, P1077, DOI 10.1212/WNL.41.7.1077; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Binazzi A, 2009, AMYOTROPH LATERAL SC, V10, P361, DOI 10.3109/17482960802382313; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; CAMPBELL AM, 1970, J NEUROL NEUROSUR PS, V33, P877, DOI 10.1136/jnnp.33.6.877; CHANCELLOR AM, 1993, J NEUROL NEUROSUR PS, V56, P1200, DOI 10.1136/jnnp.56.11.1200; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; DEAPEN DM, 1986, AM J EPIDEMIOL, V123, P790, DOI 10.1093/oxfordjournals.aje.a114308; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Erb W, 1879, EUR ARCH PSY CLIN N, V9, P325; FELMUS MT, 1976, NEUROLOGY, V26, P167, DOI 10.1212/WNL.26.2.167; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GAWEL M, 1983, J NEUROL NEUROSUR PS, V46, P1041, DOI 10.1136/jnnp.46.11.1041; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GRESHAM L S, 1986, Neuroepidemiology, V5, P29, DOI 10.1159/000110810; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; HANISCH R, 1976, ARCH NEUROL-CHICAGO, V33, P456, DOI 10.1001/archneur.1976.00500060062015; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; HAYNAL A, 1964, CONFIN NEUROL, V24, P189; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4; Kamel F, 1999, NEUROEPIDEMIOLOGY, V18, P194, DOI 10.1159/000026211; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; Katzman R, 1996, NEUROLOGY, V46, P889; King A, 2010, NEUROPATHOLOGY; KONDO K, 1981, ARCH NEUROL-CHICAGO, V38, P220, DOI 10.1001/archneur.1981.00510040046007; KURTZKE JF, 1980, NEUROLOGY, V30, P453, DOI 10.1212/WNL.30.5.453; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Majoor-Krakauer D, 2003, CLIN GENET, V63, P83, DOI 10.1046/j.0009-9163.2002.00001.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OKAMOTO K, 1992, J NEUROL, V30, P239; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; PIERCERUHLAND R, 1981, ANN CLIN RES, V13, P102; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; SAVETTIERI G, 1991, NEUROEPIDEMIOLOGY, V10, P242, DOI 10.1159/000110279; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Schmidt ML, 2001, J NEUROPATH EXP NEUR, V60, P1075, DOI 10.1093/jnen/60.11.1075; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; SICH W, 2009, HUM MOL GENET, V18, P3725; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Tatom JB, 2009, MOL THER, V17, P607, DOI 10.1038/mt.2009.3; UMAHARA T, 1994, ACTA NEUROPATHOL, V88, P180, DOI 10.1007/BF00294512; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; WALLIS C, 1987, TIME COM        0223; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; WIGHTMAN G, 1992, NEUROSCI LETT, V139, P269, DOI 10.1016/0304-3940(92)90569-S; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107	73	384	388	1	59	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	SEP	2010	69	9					918	929		10.1097/NEN.0b013e3181ee7d85			12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	648RT	WOS:000281712300005	20720505	Green Accepted, Bronze			2021-06-18	
J	Larrabee, GJ				Larrabee, GJ			Detection of malingering using atypical performance patterns on standard neuropsychological tests	CLINICAL NEUROPSYCHOLOGIST			English	Article							MMPI-2 VALIDITY SCALES; FAKE BAD SCALE; CARD SORTING TEST; HEAD-INJURY; RECOGNITION MEMORY; IDENTIFICATION; EXAGGERATION; VALIDATION; SIMULATION	Cut-off scores defining clinically atypical patterns of performance were identified for five standard neuropsychological and psychological tests: Benton Visual Form Discrimination (VFD), Fingertapping (FT), WAIS-R Reliable Digit Span (RDS), Wisconsin Card Sorting Failure-to-Maintain Set (FMS), and the Lees-Haley Fake Bad Scale (FBS) from the MMPI-2. All possible pair-wise combinations of scores beyond cut-off (e.g., for VFD and FT; for RDS and FBS), correctly identified 21 of 24 subjects (87.5%) meeting criteria for definite malingered neurocognitive dysfunction, and 24 of 27 (88.9%) subjects with moderate to severe closed head injury. On cross-validation, 15 of 17 subjects (88.2%) meeting criteria for probable malingered neurocognitive dysfunction were correctly identified, with 13 of 13 nonlitigating neurologic patients, and 14 of 14 nonlitigating psychiatric patients correctly classified as having motivationally-preserved performance. Combining the derivation and cross-validation samples yielded a sensitivity of 87.8%, specificity of 94.4%, and combined hit rate of 91.6%.		Larrabee, GJ (corresponding author), 630 S Orange Ave S-202, Sarasota, FL 34236 USA.	glarrabee@aol.com					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Benton A. L., 1994, CONTRIBUTIONS NEUROP; BENTON AL, 1961, ARCH GEN PSYCHIAT, V4, P79; BENTON AL, 1954, MULTILINGUAL APHASIA; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; BUTCHER JN, 1989, MANUAL ADM SCORING M, V2; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Gouvier WD, 1999, STUD NEUROPSYCHOL DE, P27; Graham JR., 2000, MMPI 2 ASSESSING PER; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; HANNAY HJ, 1989, J CLIN EXP NEUROPSYC, V11, P444, DOI 10.1080/01688638908400905; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1991, COMPREHENSIVE NORMS; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; LARRABEE GJ, 2000, HDB PSYCHOL ASSESSME, P301; Larrabee GJ, 2000, CLIN GUIDE NEUROPSYC, P301; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; ROSS SR, IN PRESS J CLIN EXPT; Sivan AB., 1992, BENTON VISUAL RETENT; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SPREEN O, 1963, AM J MENT DEF, V67, P909; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P479, DOI 10.1076/clin.14.4.479.7201; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; TRAHAN DE, 1988, PROFESSIONAL MANUAL; TRAHAN DE, 1989, CLIN NEUROPSYCHOL, V3, P169, DOI DOI 10.1080/13854048908403290; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; WECHSLER D, 1997, WAIS 3 WMS 3 MANUAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; WILKINSON GS, 1993, WART 3 WIDE RANGE AC; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; Youngjohn J.R., 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	64	384	387	2	32	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2003	17	3					410	425		10.1076/clin.17.3.410.18089			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	748DP	WOS:000186847100013	14704892				2021-06-18	
J	Bombardier, CH; Fann, JR; Temkin, NR; Esselman, PC; Barber, J; Dikmen, SS				Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Barber, Jason; Dikmen, Sureyya S.			Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHEDULED TELEPHONE INTERVENTION; COMORBIDITY SURVEY REPLICATION; PSYCHIATRIC-DISORDERS; PRIMARY-CARE; MENTAL-DISORDERS; SELF-REPORT; 1ST YEAR; SEVERITY; ALCOHOL; REHABILITATION	Context Uncertainties exist about the rates, predictors, and outcomes of major depressive disorder (MDD) among individuals with traumatic brain injury (TBI). Objective To describe MDD-related rates, predictors, outcomes, and treatment during the first year after TBI. Design Cohort from June 2001 through March 2005 followed up by structured telephone interviews at months 1 through 6, 8, 10, and 12 (data collection ending February 2006). Setting Harborview Medical Center, a level I trauma center in Seattle, Washington. Participants Five hundred fifty-nine consecutively hospitalized adults with complicated mild to severe TBI. Main Outcome Measures The Patient Health Questionnaire (PHQ) depression and anxiety modules were administered at each assessment and the European Quality of Life measure was given at 12 months. Results Two hundred ninety-seven of 559 patients (53.1%) met criteria for MDD at least once in the follow-up period. Point prevalences ranged between 31% at 1 month and 21% at 6 months. In a multivariate model, risk of MDD after TBI was associated with MDD at the time of injury (risk ratio [RR], 1.62; 95% confidence interval [CI], 1.37-1.91), history of MDD prior to injury (but not at the time of injury) (RR, 1.54; 95% CI, 1.31-1.82), age (RR, 0.61; 95% CI, 0.44-0.83 for >60 years vs 18-29 years), and lifetime alcohol dependence (RR, 1.34; 95% CI, 1.14-1.57). Those with MDD were more likely to report comorbid anxiety disorders after TBI than those without MDD (60% vs 7%; RR, 8.77; 95% CI, 5.56-13.83). Only 44% of those with MDD received antidepressants or counseling. After adjusting for predictors of MDD, persons with MDD reported lower quality of life at 1 year compared with the nondepressed group. Conclusions Among a cohort of patients hospitalized for TBI, 53.1% met criteria for MDD during the first year after TBI. Major depressive disorder was associated with history of MDD and was an independent predictor of poorer health-related quality of life. JAMA. 2010; 303(19): 1938-1945	[Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA; [Fann, Jesse R.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Temkin, Nancy R.; Barber, Jason; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Fann, Jesse R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Bombardier, CH (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA.	chb@uw.edu			National Center for Medical Rehabilitation Research; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD39415]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039415] Funding Source: NIH RePORTER	Funding/Support: This work was supported by the National Center for Medical Rehabilitation Research, the National Institute of Child Health and Human Development, and National Institutes of Health grant R01 HD39415 to Drs Bombardier and Fann (co-principal investigators). Pfizer supplied masked sertraline and placebo for the controlled trial.	Agency for Healthcare Research and Quality, CALC US POP BAS EQ 5; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Dobrez D, 2010, ARCH PHYS MED REHAB, V91, P184, DOI 10.1016/j.apmr.2009.10.020; Donker T, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1134; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; First Michael B, 2001, USERS GUIDE STRUCTUR; GENTILELLO LM, 1995, JAMA-J AM MED ASSOC, V274, P1043, DOI 10.1001/jama.274.13.1043; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gorlyn M, 2008, J NEURAL TRANSM, V115, P1213, DOI 10.1007/s00702-008-0084-x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huddleston Mary, 2004, J Healthc Qual, V26, P12; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P395, DOI 10.1001/archpsyc.58.4.395; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	49	383	389	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1938	1945		10.1001/jama.2010.599			8	Medicine, General & Internal	General & Internal Medicine	597NJ	WOS:000277764500020	20483970	Bronze, Green Accepted			2021-06-18	
J	Hutchison, JS; Ward, RE; Lacroix, J; Hebert, PC; Barnes, MA; Bohn, DJ; Dirks, PB; Doucette, S; Fergusson, D; Gottesman, R; Joffe, AR; Kirpalani, HM; Meyer, PG; Morris, KP; Moher, D; Singh, RN; Skippen, PW				Hutchison, James S.; Ward, Roxanne E.; Lacroix, Jacques; Hebert, Paul C.; Barnes, Marcia A.; Bohn, Desmond J.; Dirks, Peter B.; Doucette, Steve; Fergusson, Dean; Gottesman, Ronald; Joffe, Ari R.; Kirpalani, Haresh M.; Meyer, Philippe G.; Morris, Kevin P.; Moher, David; Singh, Ram N.; Skippen, Peter W.		Hypothermia Pediat Head Injury Tri; Canadian Crit Care Trials Grp	Hypothermia therapy after traumatic brain injury in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODERATE HYPOTHERMIA; HEAD-INJURY; MANAGEMENT; SEVERITY; TRIAL	Background: Hypothermia therapy improves survival and the neurologic outcome in animal models of traumatic brain injury. However, the effect of hypothermia therapy on the neurologic outcome and mortality among children who have severe traumatic brain injury is unknown. Methods: In a multicenter, international trial, we randomly assigned children with severe traumatic brain injury to either hypothermia therapy (32.5 degreesC for 24 hours) initiated within 8 hours after injury or to normothermia (37.0 degreesC). The primary outcome was the proportion of children who had an unfavorable outcome (i.e., severe disability, persistent vegetative state, or death), as assessed on the basis of the Pediatric Cerebral Performance Category score at 6 months. Results: A total of 225 children were randomly assigned to the hypothermia group or the normothermia group; the mean temperatures achieved in the two groups were 33.1+/-1.2 degreesC and 36.9+/-0.5 degreesC, respectively. At 6 months, 31% of the patients in the hypothermia group, as compared with 22% of the patients in the normothermia group, had an unfavorable outcome (relative risk, 1.41; 95% confidence interval [CI], 0.89 to 2.22; P=0.14). There were 23 deaths (21%) in the hypothermia group and 14 deaths (12%) in the normothermia group (relative risk, 1.40; 95% CI, 0.90 to 2.27; P=0.06). There was more hypotension (P=0.047) and more vasoactive agents were administered (P<0.001) in the hypothermia group during the rewarming period than in the normothermia group. Lengths of stay in the intensive care unit and in the hospital and other adverse events were similar in the two groups. Conclusions: In children with severe traumatic brain injury, hypothermia therapy that is initiated within 8 hours after injury and continued for 24 hours does not improve the neurologic outcome and may increase mortality. (Current Controlled Trials number, ISRCTN77393684.).	[Hutchison, James S.; Bohn, Desmond J.] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.; Bohn, Desmond J.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Dirks, Peter B.] Hosp Sick Children, Dept Surg Neurosurg, Toronto, ON M5G 1X8, Canada; [Hutchison, James S.; Bohn, Desmond J.] Univ Toronto, Interdept Div Crit Care, Fac Med, Toronto, ON, Canada; [Hutchison, James S.; Barnes, Marcia A.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON M5G 1X8, Canada; [Ward, Roxanne E.; Moher, David] Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; [Hebert, Paul C.; Doucette, Steve; Fergusson, Dean] Ottawa Gen Hosp, Dept Crit Care Med, Clin Epidemiol Program, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; [Moher, David] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON K1N 6N5, Canada; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Fac Med, Ottawa, ON K1N 6N5, Canada; [Lacroix, Jacques] Hop St Justine, Div Intens Care, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Gottesman, Ronald] Montreal Childrens Hosp, Dept Pediat Intens Care, Montreal, PQ H3H 1P3, Canada; [Barnes, Marcia A.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; [Joffe, Ari R.] Stollery Childrens Hosp, Dept Pediat Intens Care, Edmonton, AB, Canada; [Kirpalani, Haresh M.] McMaster Childrens Hosp, Intens Care Unit, Hamilton, ON, Canada; [Meyer, Philippe G.] Grp Hosp Necker Enfants Malad, Neurointens Care Unit, Paris, France; [Morris, Kevin P.] Birmingham Childrens Hosp, Intens Care Unit, Birmingham, W Midlands, England; [Singh, Ram N.] Childrens Hosp Western Ontario, Dept Pediat Intens Care, London, ON N6A 5A5, Canada; [Skippen, Peter W.] British Columbia Childrens Hosp, Dept Pediat Intens Care, Vancouver, BC V6H 3V4, Canada	Hutchison, JS (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jamie.hutchison@sickkids.ca	Adelson, David/W-2083-2019; Meyer, Philippe/ABE-4242-2020; Kirkham, Fenella/C-2442-2009; kasyan, george/M-4263-2014	Meyer, Philippe/0000-0002-3829-6631; Kirkham, Fenella/0000-0002-2443-7958; kasyan, george/0000-0001-7919-2217; Fergusson, Dean/0000-0002-3389-2485; Moher, David/0000-0003-2434-4206			ABRAMSON NS, 1986, JAMA-J AM MED ASSOC, V255, P2466, DOI 10.1001/jama.255.18.2466; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alderson P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001048.PUB2, 10.1002/14651858.CD001048.pub2]; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Atkins DL, 2006, PEDIATRICS, V117, pE955, DOI 10.1542/peds.2006-0206; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COHEN MJ, 1995, CHILDRENS MEMORY SCA; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; Gioia G.A., 2000, BEHAV RATING INVENTO; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D., 1997, WECHSLER INTELLIGENC; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M	34	383	398	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2008	358	23					2447	2456		10.1056/NEJMoa0706930			10	Medicine, General & Internal	General & Internal Medicine	308HY	WOS:000256380700004	18525042				2021-06-18	
J	Iliff, JJ; Chen, MJ; Plog, BA; Zeppenfeld, DM; Soltero, M; Yang, LJ; Singh, I; Deane, R; Nedergaard, M				Iliff, Jeffrey J.; Chen, Michael J.; Plog, Benjamin A.; Zeppenfeld, Douglas M.; Soltero, Melissa; Yang, Lijun; Singh, Itender; Deane, Rashid; Nedergaard, Maiken			Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						AQP4; aquaporin-4; cerebrospinal fluid; neurodegeneration; tauopathy; traumatic brain injury	AMYLOID PROTEIN DEPOSITION; SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; MOUSE MODEL; NEURODEGENERATIVE DISEASES; EXTRACELLULAR-SPACE; IN-VIVO; AQUAPORIN-4; EDEMA; MECHANISMS	Traumatic brain injury (TBI) is an established risk factor for the early development of dementia, including Alzheimer's disease, and the post-traumatic brain frequently exhibits neurofibrillary tangles comprised of aggregates of the protein tau. We have recently defined a brain-wide network of paravascular channels, termed the "glymphatic" pathway, along which CSF moves into and through the brain parenchyma, facilitating the clearance of interstitial solutes, including amyloid-beta, from the brain. Here we demonstrate in mice that extracellular tau is cleared from the brain along these paravascular pathways. After TBI, glymphatic pathway function was reduced by similar to 60%, with this impairment persisting for at least 1 month post injury. Genetic knock-out of the gene encoding the astroglial water channel aquaporin-4, which is importantly involved in paravascular interstitial solute clearance, exacerbated glymphatic pathway dysfunction after TBI and promoted the development of neurofibrillary pathology and neurodegeneration in the post-traumatic brain. These findings suggest that chronic impairment of glymphatic pathway function after TBI may be a key factor that renders the post-traumatic brain vulnerable to tau aggregation and the onset of neurodegeneration.	[Iliff, Jeffrey J.; Chen, Michael J.; Plog, Benjamin A.; Yang, Lijun; Singh, Itender; Deane, Rashid; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA; [Iliff, Jeffrey J.; Zeppenfeld, Douglas M.; Soltero, Melissa] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Iliff, Jeffrey J.; Zeppenfeld, Douglas M.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA	Iliff, JJ (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, 3181 SW Sam Jackson Pk Rd,Mail Code HRC5N, Portland, OR 97239 USA.	iliffj@ohsu.edu		Soltero, Melissa/0000-0002-8154-2244	National Institutes of Health-National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS078167, NS078304, NS073373]; American Heart AssociationAmerican Heart Association [12SDG11820014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD076892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078167, R01NS078304, R01NS075177, F32NS073373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG048769] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health-National Institute of Neurological Disorders and Stroke (NS078167 and NS078304 to M.N. and NS073373 to J.J.I.) and the American Heart Association (12SDG11820014 to J.J.I.). We thank Dr. Marjorie Grafe, Xiao Jing Nie, and Dr. Lijunan Liu of the Oregon Health & Science University Department of Anesthesiology and Peri-Operative Medicine Histology Core for expert technical assistance performing histological studies.	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; CSERR HF, 1971, PHYSIOL REV, V51, P273; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lu DC, 2011, J NEUROTRAUM, DOI [10.1089/neu.2011.2114, DOI 10.1089/NEU.2011.2114.MEDLINE]; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Smith AJ, 2014, J CELL BIOL, V204, P559, DOI 10.1083/jcb.201308118; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Thrane AS, 2014, TRENDS NEUROSCI; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamada K, 2013, SOC NEUR ABSTR, V39; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yang J, 2011, J ALZHEIMERS DIS, V27, P711, DOI 10.3233/JAD-2011-110725; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	61	381	393	2	82	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	DEC 3	2014	34	49					16180	16193		10.1523/JNEUROSCI.3020-14.2014			14	Neurosciences	Neurosciences & Neurology	AW2WJ	WOS:000346147100003	25471560	Green Published, Bronze	Y	N	2021-06-18	
S	Mattson, MP		Goetzl, EJ		Mattson, Mark P.			Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease	NEURAL SIGNALING: OPPORTUNITIES FOR NOVEL DIAGNOSTIC APPROACHES AND THERAPIES	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	International Conference on Neural Signaling - Opportunities for Novel Diagnostic Approaches and Therapies	FEB 16-20, 2008	Pacific Grove, CA			Alzheimer's disease; AMPA receptors; BDNF; calcium homeostasis; GDNF; Huntington's disease; NMDA; Parkinson's disease	FIBROBLAST-GROWTH-FACTOR; LONG-TERM POTENTIATION; TRAUMATIC BRAIN-INJURY; BDNF MESSENGER-RNA; STRESS-INDUCED IMPAIRMENT; RECEPTOR SUBUNIT GLUR1; DIETARY RESTRICTION; HIPPOCAMPAL-NEURONS; PARKINSONS-DISEASE; NMDA RECEPTOR	Glutamate's role as a neurotransmitter at synapses has been known for 40 years, but glutamate has since been shown to regulate neurogenesis, neurite outgrowth, synaptogenesis, and neuron survival in the developing and adult mammalian nervous system. Cell-surface glutamate receptors are coupled to Ca2+. influx and release from endoplasmic reticulum stores, which causes rapid (kinase- and protease-mediated) and delayed (transcription-dependent) responses that change the structure and function of neurons. Neurotrophic factors and glutamate interact to regulate developmental and adult neuroplasticity. For example, glutamate stimulates the production of brain-derived neurotrophic factor (BDNF), which, in turn, modifies neuronal glutamate sensitivity, Ca2+ homeostasis, and plasticity. Neurotrophic factors may modify glutamate signaling directly, by changing the expression of glutamate receptor subunits and Ca2+-regulating proteins, and also indirectly by inducing the production of antioxidant enzymes, energy-regulating proteins, and antiapoptotic Bcl-2 family members. Excessive activation of glutamate receptors, under conditions of oxidative and metabolic stress, may contribute to neuronal dysfunction and degeneration in diseases ranging from stroke and Alzheimer's disease to psychiatric disorders. By enhancing neurotrophic factor signaling, environmental factors such as exercise and dietary energy restriction, and chemicals such as antidepressants may optimize glutamatergic signaling and protect against neurological disorders.	NIA, Intramural Res Program, Neurosci Lab, Baltimore, MD 21221 USA	Mattson, MP (corresponding author), NIA, Intramural Res Program, Neurosci Lab, Baltimore, MD 21221 USA.		Mattson, Mark P/F-6038-2012		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000317, ZIAAG000314] Funding Source: NIH RePORTER	This work was supported by the Intramural Research Program of the National Institute on Aging of the National Institutes of Health. I thank K.C. Alexander for preparing the figures, and the many postdocs and students who contributed to the original research from my laboratory, described in this article.	Aebischer P, 1996, HUM GENE THER, V7, P851, DOI 10.1089/hum.1996.7.7-851; Akaneya Y, 1997, J NEUROSCI, V17, P6707; Aleisa AM, 2006, NEUROBIOL DIS, V22, P453, DOI 10.1016/j.nbd.2005.12.005; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Alt A, 2006, BIOCHEM PHARMACOL, V71, P1273, DOI 10.1016/j.bcp.2005.12.022; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Beal MF, 1998, ANN NEUROL, V44, pS110; BEAL MF, 1988, J NEUROSCI, V8, P3901; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Beister A, 2004, J NEURAL TRANSM-SUPP, P117; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Bemelmans AP, 1999, HUM GENE THER, V10, P2987, DOI 10.1089/10430349950016393; Bhatt JM, 2007, EXPERT OPIN INV DRUG, V16, P1197, DOI 10.1517/13543784.16.8.1197; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Canudas AM, 2005, MOL BRAIN RES, V134, P147, DOI 10.1016/j.molbrainres.2004.11.012; Carlsson A, 1999, BRIT J PSYCHIAT, V174, P2, DOI 10.1192/S0007125000293574; Cheng AW, 2007, J NEUROSCI, V27, P3722, DOI 10.1523/JNEUROSCI.0590-07.2007; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHENG B, 1992, J NEUROSCI, V12, P1558; CHENG B, 1995, J NEUROCHEM, V65, P2525; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; CLINE HT, 1990, J NEUROSCI, V10, P1197; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Duan WZ, 2001, J NEUROCHEM, V76, P619, DOI 10.1046/j.1471-4159.2001.00071.x; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Escartin C, 2004, NEUROREPORT, V15, P2251, DOI 10.1097/00001756-200410050-00022; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Fernandes HB, 2007, J NEUROSCI, V27, P13614, DOI 10.1523/JNEUROSCI.3455-07.2007; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; FESTOFF BW, 1995, J NEUROL SCI, V129, P114, DOI 10.1016/0022-510X(95)00080-L; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; FORD LM, 1989, ARCH NEUROL-CHICAGO, V46, P1090, DOI 10.1001/archneur.1989.00520460072016; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Glazner GW, 2000, J NEUROSCI, V20, P3641; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Grunewald T, 1999, ANN NY ACAD SCI, V893, P203, DOI 10.1111/j.1749-6632.1999.tb07827.x; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Guo ZH, 2000, CEREB CORTEX, V10, P50, DOI 10.1093/cercor/10.1.50; HALBERSTADT AL, 1995, CLIN NEUROPHARMACOL, V18, P237, DOI 10.1097/00002826-199506000-00004; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IKEDA Y, 2008, SCHIZOPHR RES   0219; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kawahara Y, 2005, AMYOTROPH LATERAL SC, V6, P131, DOI 10.1080/14660820510037872; Kelly A, 1998, NEUROPHARMACOLOGY, V37, P561, DOI 10.1016/S0028-3908(98)00048-3; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; KOKAIA Z, 1994, EUR J NEUROSCI, V6, P587, DOI 10.1111/j.1460-9568.1994.tb00303.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kress GJ, 2005, NEUROBIOL DIS, V20, P639, DOI 10.1016/j.nbd.2005.04.019; Kruman II, 1999, EXP NEUROL, V160, P28, DOI 10.1006/exnr.1999.7190; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee S, 1997, MOL BRAIN RES, V47, P183, DOI 10.1016/S0169-328X(97)00043-0; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Levivier M, 1995, J NEUROSCI, V15, P7810, DOI 10.1523/jneurosci.15-12-07810.1995; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin TN, 1997, MOL BRAIN RES, V49, P255, DOI 10.1016/S0169-328X(97)00152-6; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LIU Z, 1993, BRAIN RES, V626, P335, DOI 10.1016/0006-8993(93)90598-H; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; Lotz B, 1996, NEUROLOGY, V46, P1244; Lu CB, 2002, NEUROMOL MED, V1, P69; Lu CB, 2006, J NEUROCHEM, V97, P1104, DOI 10.1111/j.1471-4159.2006.03800.x; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; Mark RJ, 1997, BRAIN RES, V756, P205, DOI 10.1016/S0006-8993(97)00196-0; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Martinez-Turrillas R, 2005, NEUROPHARMACOLOGY, V49, P1178, DOI 10.1016/j.neuropharm.2005.07.006; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martins RAP, 2005, J NEUROCHEM, V95, P244, DOI 10.1111/j.1471-4159.2005.03360.x; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; MATTSON MP, 1988, J NEUROSCI, V8, P2087; Mattson MP, 1997, NEUROSCI BIOBEHAV R, V21, P193, DOI 10.1016/S0149-7634(96)00010-3; MATTSON MP, 1993, STROKE, V24, pI136; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, J NEUROSCI, V13, P4575; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; MATTSON MP, 1992, EXP GERONTOL, V27, P29, DOI 10.1016/0531-5565(92)90027-W; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Mattson MP, 1996, PERSPECT DEV NEUROBI, V3, P79; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MCCULLOCH J, 1992, BRIT J CLIN PHARMACO, V34, P106, DOI 10.1111/j.1365-2125.1992.tb04118.x; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; MOGHADDAM B, 1994, PROG NEURO-PSYCHOPH, V18, P859, DOI 10.1016/0278-5846(94)90102-3; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Palucha A, 2004, NEUROPHARMACOLOGY, V46, P151, DOI 10.1016/j.neuropharm.2003.09.006; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Perez-Navarro E, 2005, J NEUROCHEM, V92, P678, DOI 10.1111/j.1471-4159.2004.02904.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Pittenger Christopher, 2007, CNS & Neurological Disorders-Drug Targets, V6, P101, DOI 10.2174/187152707780363267; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Rao VLR, 2001, BRAIN RES, V911, P96; Ribotta MGY, 1997, J NEUROSCI RES, V48, P281; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Russo-Neustadt Amelia, 2003, Semin Clin Neuropsychiatry, V8, P109, DOI 10.1053/scnp.2003.50014; Santi S, 2006, EMBO J, V25, P4372, DOI 10.1038/sj.emboj.7601303; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schurr A, 2004, CURR DRUG TARGETS, V5, P603, DOI 10.2174/1389450043345209; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SHIMOHAMA S, 1993, BRAIN RES, V632, P296, DOI 10.1016/0006-8993(93)91164-N; Sim YJ, 2005, PHYSIOL BEHAV, V84, P733, DOI 10.1016/j.physbeh.2005.02.019; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tomac AC, 2002, P NATL ACAD SCI USA, V99, P9521, DOI 10.1073/pnas.152535899; TOOYAMA I, 1993, NEUROLOGY, V43, P372, DOI 10.1212/WNL.43.2.372; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; USHERWOO.PN, 1968, NATURE, V219, P1169, DOI 10.1038/2191169a0; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Yoo YM, 2006, EXP NEUROL, V200, P407, DOI 10.1016/j.expneurol.2006.02.132; Young D, 1999, NAT MED, V5, P448; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	173	380	399	1	71	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-704-7	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2008	1144						97	112		10.1196/annals.1418.005			16	Multidisciplinary Sciences; Neurosciences	Science & Technology - Other Topics; Neurosciences & Neurology	BIT17	WOS:000262481000014	19076369	Green Accepted			2021-06-18	
J	Huber, AB; Weinmann, O; Brosamle, C; Oertle, T; Schwab, ME				Huber, AB; Weinmann, O; Brosamle, C; Oertle, T; Schwab, ME			Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions	JOURNAL OF NEUROSCIENCE			English	Article						oligodendrocyte; myelin; neurite growth inhibition; development; spinal cord injury; regeneration	NEURITE GROWTH-INHIBITORS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; MONOCLONAL-ANTIBODY IN-1; WHITE-MATTER; POSTNATAL-DEVELOPMENT; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEURONAL MIGRATION; CEREBELLAR CORTEX	Nogo-A is a neurite growth inhibitor involved in regenerative failure and restriction of structural plasticity in the adult CNS. Three major protein products (Nogo-A, -B, and -C) are derived from the nogo gene. Here we describe the embryonic and postnatal expression of the three Nogo isoforms in the rat by in situ hybridization and immunohistochemistry. Northern and Western blot analysis indicated that Nogo-A is predominantly expressed in the nervous system with lower levels also present in testis and heart. In CNS myelin, confocal and immunoelectron microscopy revealed that Nogo-A is expressed in oligodendrocyte cell bodies and processes and localized in the innermost adaxonal and outermost myelin membranes. Additionally, we find Nogo-A to be expressed by projection neurons, in particular during development, and by postmitotic cells in the developing cortex, spinal cord, and cerebellum. The expression levels of Nogo-A/B were not changed significantly after traumatic lesions to the cortex or spinal cord. Nogo-B showed widespread expression in the central and peripheral nervous systems and other peripheral tissues. Nogo-C was mainly found in skeletal muscle, but brain and heart were also found to express this isoform. The localization of Nogo-A in oligodendrocytes fits well with its role as a myelin-associated inhibitor of regenerative fiber growth and structural plasticity. However, expression of Nogo-A in other tissues and, in particular, in neurons and the widespread expression of the two shorter isoforms, Nogo-B and -C, suggest that the Nogo family of proteins might have function(s) additional to the neurite growth-inhibitory activity.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland	Huber, AB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ahuber@jhmi.edu	Schwab, Martin E/B-6818-2016				Alcantara S, 2000, DEVELOPMENT, V127, P1359; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q; BENKE D, 1995, J RECEPT SIGNAL TR R, V15, P393, DOI 10.3109/10799899509045229; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buffo A, 2000, J NEUROSCI, V20, P2275; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, PROG BRAIN RES, V78, P363; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1; Davies SJA, 1997, NATURE, V390, P680; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frank M, 1998, J NEUROSCI, V18, P4901; Frei E, 2000, EXP NEUROL, V163, P373, DOI 10.1006/exnr.2000.7379; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Klein R, 1999, CURR BIOL, V9, pR691, DOI 10.1016/S0960-9822(99)80441-2; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; OERTLE T, 2000, SOC NEUR ABSTR, V26, P573; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; RUBIN BP, 1994, J NEUROCYTOL, V23, P209, DOI 10.1007/BF01275525; SAVIO T, 1989, J NEUROSCI, V9, P1126; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schwab ME, 1996, PHYSIOL REV, V76, P319; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; VANDERHAAR ME, 2001, SOC NEUR ABSTR, V27; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Wu W, 1999, NATURE, V400, P331; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zagrebelsky M, 1998, J NEUROSCI, V18, P7912	48	380	429	0	12	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 1	2002	22	9					3553	3567					15	Neurosciences	Neurosciences & Neurology	546VN	WOS:000175296200033	11978832				2021-06-18	
J	Bullock, R; Zauner, A; Woodward, JJ; Myseros, J; Choi, SC; Ward, JD; Marmarou, A; Young, HF				Bullock, R; Zauner, A; Woodward, JJ; Myseros, J; Choi, SC; Ward, JD; Marmarou, A; Young, HF			Factors affecting excitatory amino acid release following severe human head injury	JOURNAL OF NEUROSURGERY			English	Article						severe head injury; microdialysis; glutamate; intracranial pressure; outcome; glutamate antagonist	ACUTE SUBDURAL-HEMATOMA; MIDDLE CEREBRAL-ARTERY; CONCUSSIVE BRAIN INJURY; ISCHEMIA-INDUCED ACCUMULATION; BLOOD-FLOW; INTRACEREBRAL MICRODIALYSIS; RAT-BRAIN; GLUCOSE-UTILIZATION; NEURONAL DAMAGE; GLUTAMATE	Recent animal studies demonstrate that excitatory amino acids (EAAs) play a major role in neuronal damage after brain trauma and ischemia. However, the role of EAAs in patients who have suffered severe head injury is not understood. Excess quantities of glutamate in the extracellular space may lead to uncontrolled shifts of sodium, potassium, and calcium, disrupting ionic homeostasis, which may lead to severe cell swelling and cell death. The authors evaluated the role of EEAs in human traumatic brain injury. Methods. In SO consecutive severely head injured patients, a microdialysis probe was placed into the gray matter along with a ventriculostomy catheter or an intracranial pressure (ICP) monitor for 4 days. Levels of EAAs and structural amino acids were analyzed using high-performance liquid chromatography. Multifactorial analysis of the amino acid pattern was performed and its correlations with clinical parameters and outcome were tested. The levels of EAAs were increased up to 50 times normal in 30% of the patients and were significantly correlated to levels of structural amino acids both in each patient and across the whole group (p < 0.01). Secondary ischemic brain injury and focal contusions were most strongly associated with high EAA levels (27 +/- 22 mu mol/L). Sustained high ICP and poor outcome were significantly correlated to high levels of EAAs (glutamate > 20 mu mol/L; p < 0.01). Conclusions. The release of EAAs is closely linked to the release of structural amino acids and may thus reflect nonspecific development of membrane micropores, rather than presynaptic neuronal vesicular exocytosis. The magnitude of EAA release in patients with focal contusions and ischemic events may be sufficient to exacerbate neuronal damage, and these patients may be the best candidates for treatment with glutamate antagonists in the future.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23298 USA	Bullock, R (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980631, Richmond, VA 23298 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009986] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA009986] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; BULLOCK R, 1991, J CEREB BLOOD FLO S2, V11, pS109; BULLOCK R, 1994, INTRACRANIAL PRESSUR, P264; BULLOCK R, 1992, J NEUROTRAUMA, V9, P5443; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CHOI DW, 1987, J NEUROSCI, V7, P357; CHOI SC, 1989, MULTIVARIATE STAT MO, P77; DURING MJ, 1993, LANCET, V341, P1607; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTLEMAN D, 1981, LANCET, V2, P853; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HEISS WD, 1976, ARCH NEUROL-CHICAGO, V33, P813, DOI 10.1001/archneur.1976.00500120017003; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hillered L, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p695A; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; MEYER JS, 1980, AM J ROENTGENOL, V135, P239, DOI 10.2214/ajr.135.2.239; MUIZELAAR JP, 1994, CAN J NEUROL SCI, V21, P1; NEHLS DG, 1990, BRAIN RES, V511, P271, DOI 10.1016/0006-8993(90)90172-8; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHIMADA N, 1990, STROKE, V21, P1445, DOI 10.1161/01.STR.21.10.1445; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; Smith D.H., 1991, J CEREB BLOOD FLO S2, V11, pS300; SMITH DH, 1990, J FASEB, V4, P400; SMITH DH, 1990, SOC NEUR ABSTR, V2, P779; SMITH JA, 1991, J MED ETHICS, V17, P167, DOI 10.1136/jme.17.3.167; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zauner A, 1996, ACT NEUR S, V67, P40	58	377	386	0	21	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	1998	89	4					507	518		10.3171/jns.1998.89.4.0507			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	122LL	WOS:000076073000001	9761042				2021-06-18	
J	Kaufman, RM; Djulbegovic, B; Gernsheimer, T; Kleinman, S; Tinmouth, AT; Capocelli, KE; Cipolle, MD; Cohn, CS; Fung, MK; Grossman, BJ; Mintz, PD; O'Malley, BA; Sesok-Pizzini, DA; Shander, A; Stack, GE; Webert, KE; Weinstein, R; Welch, BG; Whitman, GJ; Wong, EC; Tobian, AAR				Kaufman, Richard M.; Djulbegovic, Benjamin; Gernsheimer, Terry; Kleinman, Steven; Tinmouth, Alan T.; Capocelli, Kelley E.; Cipolle, Mark D.; Cohn, Claudia S.; Fung, Mark K.; Grossman, Brenda J.; Mintz, Paul D.; O'Malley, Barbara A.; Sesok-Pizzini, Deborah A.; Shander, Aryeh; Stack, Gary E.; Webert, Kathryn E.; Weinstein, Robert; Welch, Babu G.; Whitman, Glenn J.; Wong, Edward C.; Tobian, Aaron A. R.			Platelet Transfusion: A Clinical Practice Guideline From the AABB	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC INTRACRANIAL HEMORRHAGE; PROGENITOR-CELL TRANSPLANT; VENOUS CATHETER PLACEMENT; BRAIN-INJURY PATIENTS; ACUTE LUNG INJURY; ACUTE-LEUKEMIA; LUMBAR PUNCTURE; ANTIPLATELET THERAPY; BLEEDING DIATHESES	Background: The AABB (formerly, the American Association of Blood Banks) developed this guideline on appropriate use of platelet transfusion in adult patients. Methods: These guidelines are based on a systematic review of randomized, clinical trials and observational studies (1900 to September 2014) that reported clinical outcomes on patients receiving prophylactic or therapeutic platelet transfusions. An expert panel reviewed the data and developed recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Recommendation 1: The AABB recommends that platelets should be transfused prophylactically to reduce the risk for spontaneous bleeding in hospitalized adult patients with therapyinduced hypoproliferative thrombocytopenia. The AABB recommends transfusing hospitalized adult patients with a platelet count of 10 x 10(9) cells/L or less to reduce the risk for spontaneous bleeding. The AABB recommends transfusing up to a single apheresis unit or equivalent. Greater doses are not more effective, and lower doses equal to one half of a standard apheresis unit are equally effective. (Grade: strong recommendation; moderate-quality evidence) Recommendation 2: The AABB suggests prophylactic platelet transfusion for patients having elective central venous catheter placement with a platelet count less than 20 x 10(9) cells/L. (Grade: weak recommendation; low-quality evidence) Recommendation 3: The AABB suggests prophylactic platelet transfusion for patients having elective diagnostic lumbar puncture with a platelet count less than 50 x 10(9) cells/L. (Grade: weak recommendation; very-low-quality evidence) Recommendation 4: The AABB suggests prophylactic platelet transfusion for patients having major elective nonneuraxial surgery with a platelet count less than 50 x 10(9) cells/L. (Grade: weak recommendation; very-low-quality evidence) Recommendation 5: The AABB recommends against routine prophylactic platelet transfusion for patients who are nonthrombocytopenic and have cardiac surgery with cardiopulmonary bypass. The AABB suggests platelet transfusion for patients having bypass who exhibit perioperative bleeding with thrombocytopenia and/or evidence of platelet dysfunction. (Grade: weak recommendation; very-low-quality evidence) Recommendation 6: The AABB cannot recommend for or against platelet transfusion for patients receiving antiplatelet therapy who have intracranial hemorrhage (traumatic or spontaneous). (Grade: uncertain recommendation; very-low-quality evidence)	Brigham & Womens Hosp, Boston, MA 02115 USA; [Djulbegovic, Benjamin] Univ S Florida, Tampa, FL 33612 USA; [Gernsheimer, Terry] Univ Washington, Seattle, WA 98195 USA; [Kleinman, Steven] Univ British Columbia, Victoria, BC V9A 4W4, Canada; Ottawa Hosp Res Inst, Ottawa, ON, Canada; Childrens Hosp Colorado, Aurora, CO 80045 USA; Christiana Care Hlth Syst, Wilmington, DE USA; Univ Minnesota, Minneapolis, MN USA; Univ Vermont, Burlington, VT USA; Washington Univ, Sch Med, St Louis, MO USA; US FDA, Silver Spring, MD USA; Wayne State Univ, Detroit, MI USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Englewood Hosp & Med Ctr, Englewood, NJ USA; Yale Univ, Sch Med, West Haven, CT 06516 USA; McMaster Univ, Hamilton, ON, Canada; [Weinstein, Robert] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Welch, Babu G.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Johns Hopkins Univ, Baltimore, MD USA; Childrens Natl Med Ctr, Washington, DC 20010 USA	Kaufman, RM (corresponding author), Brigham & Womens Hosp, Dept Pathol, Blood Bank, Amory 260,75 Francis St, Boston, MA 02115 USA.	rmkaufman@partners.org	Stack, Gary/E-9646-2014; Djulbegovic, Benjamin/I-3661-2012; Kaufman, Richard M/E-8890-2018	Djulbegovic, Benjamin/0000-0003-0671-1447; Kaufman, Richard M/0000-0003-1520-4535; Fung, Mark/0000-0001-6081-4151; Grossman, Brenda/0000-0002-1500-8211			Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Barrera R, 1996, CANCER, V78, P2025, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2025::AID-CNCR26>3.3.CO;2-T; BISHOP JF, 1987, AM J HEMATOL, V26, P147, DOI 10.1002/ajh.2830260205; BREUER AC, 1982, CANCER-AM CANCER SOC, V49, P2168, DOI 10.1002/1097-0142(19820515)49:10<2168::AID-CNCR2820491031>3.0.CO;2-O; Choi S, 2009, ANESTH ANALG, V109, P648, DOI 10.1213/ane.0b013e3181ac13d1; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; Diedrich B, 2005, TRANSFUSION, V45, P1064, DOI 10.1111/j.1537-2995.2005.04157.x; Doerfler ME, 1996, CHEST, V110, P185, DOI 10.1378/chest.110.1.185; Downey DM, 2009, AM SURGEON, V75, P1100; Duffy SM, 2013, J CLIN APHERESIS, V28, P356, DOI 10.1002/jca.21279; Eder AF, 2013, TRANSFUSION, V53, P1442, DOI 10.1111/j.1537-2995.2012.03935.x; Estcourt L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004269.pub3; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Feusner J, 2004, PEDIATR BLOOD CANCER, V43, P793, DOI 10.1002/pbc.20201; Fisher NC, 1999, INTENS CARE MED, V25, P481, DOI 10.1007/s001340050884; FRITZ RD, 1959, NEW ENGL J MED, V261, P59, DOI 10.1056/NEJM195907092610202; Fuller AK, 2011, TRANSFUSION, V51, P1469, DOI 10.1111/j.1537-2995.2010.03039.x; Greeno E, 2007, TRANSFUSION, V47, P201, DOI 10.1111/j.1537-2995.2007.01089.x; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haas B, 2010, J VASC INTERV RADIOL, V21, P212, DOI 10.1016/j.jvir.2009.10.032; Haas FJ, 2011, BLOOD TRANSFUSION GU; HAN T, 1966, CANCER, V19, P1937, DOI 10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO;2-G; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Heddle NM, 2009, BLOOD, V113, P1564, DOI 10.1182/blood-2008-09-178236; Heddle NM, 2002, TRANSFUSION, V42, P556, DOI 10.1046/j.1537-2995.2002.00094.x; Heddle NM, 1999, TRANSFUSION, V39, P231, DOI 10.1046/j.1537-2995.1999.39399219278.x; Howard SC, 2000, JAMA-J AM MED ASSOC, V284, P2222, DOI 10.1001/jama.284.17.2222; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; JPAC - Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, 2013, TRANSF HDB TRANSF SU; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kitanovski L, 2008, ZDR VESTN, V77, pI111; Kumar A, 2015, TRANSFUSION, V55, P1116, DOI 10.1111/trf.12943; Lozano M, 2014, VOX SANG, V106, P330, DOI 10.1111/vox.12110; Malloy PC, 2009, J VASC INTERV RADIOL, V20, pS240, DOI 10.1016/j.jvir.2008.11.027; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mumtaz H, 2000, AM J SURG, V180, P503, DOI 10.1016/S0002-9610(00)00552-3; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Patel IJ, 2012, J VASC INTERV RADIOL, V23, P727, DOI 10.1016/j.jvir.2012.02.012; Qureshi HY, 2008, ANAL BIOCHEM, V382, P138, DOI 10.1016/j.ab.2008.07.027; Ray CE, 1997, RADIOLOGY, V204, P97, DOI 10.1148/radiology.204.1.9205228; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Riley W, 2012, TRANSFUSION, V52, P1957, DOI 10.1111/j.1537-2995.2011.03539.x; ROY AJ, 1973, TRANSFUSION, V13, P283, DOI 10.1111/j.1537-2995.1973.tb05490.x; Ruell J, 2007, BRIT J HAEMATOL, V136, P347, DOI 10.1111/j.1365-2141.2006.06433.x; Samama CM, 2006, MINERVA ANESTESIOL, V72, P447; Samama CM, 2005, CAN J ANAESTH, V52, P30, DOI 10.1007/BF03018577; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Segal HC, 2005, BRIT J HAEMATOL, V128, P520, DOI 10.1111/j.1365-2141.2004.05352.x; Sensebe L, 2005, BLOOD, V105, P862, DOI 10.1182/blood-2004-05-1841; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; SLICHTER SJ, 1978, CLIN HAEMATOL, V7, P523; SOLOMON J, 1978, LANCET, V1, P267; Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x; Stanworth SJ, 2014, TRANSFUSION, V54, P2385, DOI 10.1111/trf.12646; Stanworth SJ, 2013, NEW ENGL J MED, V368, P1771, DOI 10.1056/NEJMoa1212772; Stramer SL, 2007, ARCH PATHOL LAB MED, V131, P702; Tinmouth A, 2004, TRANSFUSION, V44, P1711, DOI 10.1111/j.0041-1132.2004.04118.x; Tosetto A, 2009, THROMB RES, V124, pE13, DOI 10.1016/j.thromres.2009.06.009; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; van Veen JJ, 2004, BRIT J HAEMATOL, V127, P233, DOI 10.1111/j.1365-2141.2004.05178.x; van Veen JJ, 2010, BRIT J HAEMATOL, V148, P15, DOI 10.1111/j.1365-2141.2009.07899.x; Vavricka SR, 2003, ANN HEMATOL, V82, P570, DOI 10.1007/s00277-003-0707-0; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Whitaker BI, 2013, 2011 NATL BLOOD COLL; Whitlock R, 2005, CRIT CARE CLIN, V21, P589, DOI 10.1016/j.ccc.2005.04.003; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zeidler K, 2011, TRANSFUSION, V51, P2269, DOI 10.1111/j.1537-2995.2011.03147.x; Zumberg MS, 2002, BIOL BLOOD MARROW TR, V8, P569, DOI 10.1053/bbmt.2002.v8.pm12434952	72	376	395	2	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					205	U118		10.7326/M14-1589			17	Medicine, General & Internal	General & Internal Medicine	CC1NP	WOS:000350108100006	25383671		Y	N	2021-06-18	
J	Polin, RS; Shaffrey, ME; Bogaev, CA; Tisdale, N; Germanson, T; Bocchicchio, B; Jane, JA				Polin, RS; Shaffrey, ME; Bogaev, CA; Tisdale, N; Germanson, T; Bocchicchio, B; Jane, JA			Decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema	NEUROSURGERY			English	Article						brain edema; brain trauma; intracranial pressure; Traumatic Coma Data Bank	MANAGEMENT; HEMICRANIECTOMY	OBJECTIVE: The management of malignant posttraumatic cerebral edema remains a frustrating endeavor for the neurosurgeon and the intensivist Mortality and morbidity rates remain high despite refinements in medical and pharmacological means of controlling elevated intracranial pressure; therefore, a comparison of medical management versus decompressive craniectomy in the management of malignant posttraumatic cerebral edema was undertaken. METHODS: At the University of Virginia Health Sciences Center, 35 bifrontal decompressive craniectomies were performed on patients suffering from malignant posttraumatic cerebral edema. A control population was formed of patients whose data was accrued in the Traumatic Coma Data Bank. Patients who had undergone surgery were matched with one to four control patients based on sex, age, preoperative Glasgow Coma Scale scores, and maximum preoperative intracranial pressure (ICP). RESULTS: The overall rate of good recovery and moderate disability for the patients who underwent craniectomies was 37% (13 of 35 patients), whereas the mortality rate was 23% (8 of 35 patients). Pediatric patients had a higher rate of favorable outcome (44%, 8 of 18 patients) than did adult patients. Postoperative ICP was lower than preoperative ICP in patients who underwent decompression (P = 0.0003). Postoperative ICP was lower in patients who underwent surgery than late measurements of ICP in the matched control population. A statistically significant increased rate of favorable outcomes was seen in the patients who underwent surgery compared to the matched control patients (15.4%) (P = 0.014). All patients who exhibited sustained ICP values above 40 torr and those who underwent surgery more than 48 hours after the time of injury did poorly. Evaluation of the 20 patients who did not fit into either of those categories revealed a 60% rate of favorable outcome and a statistical advantage over control patients (P = 0.0001). CONCLUSION: Decompressive bifrontal craniectomy provides a statistical advantage over medical treatment of intractable posttraumatic cerebral hypertension and should be considered in the management of malignant posttraumatic cerebral swelling. If the operation can be accomplished before the ICP value exceeds 40 torr for a sustained period and within 48 hours of the time of injury, the potential to influence outcome is greatest.		Polin, RS (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, DEPT NEUROSURG, BOX 212, CHARLOTTESVILLE, VA 22908 USA.						Breslow N, 1980, STATISTICAL METHODS, P248; Burkert W, 1988, Zentralbl Neurochir, V49, P318; Burkert W, 1989, Zentralbl Neurochir, V50, P106; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Da Silva J A, 1976, Arq Neuropsiquiatr, V34, P232; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB M, 1979, CHILD BRAIN, V5, P484; GAAB MR, 1990, ACT NEUR S, V51, P326; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miyazaki Y, 1966, Shujutsu, V20, P845; Miyazaki Y, 1971, Jpn J Surg, V1, P83, DOI 10.1007/BF02468891; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RINALDI A, 1990, ACT NEUR S, V51, P394; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429	23	376	399	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	1997	41	1					84	92		10.1097/00006123-199707000-00018			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	XH585	WOS:A1997XH58500045	9218299				2021-06-18	
J	Kozai, TDY; Langhals, NB; Patel, PR; Deng, XP; Zhang, HN; Smith, KL; Lahann, J; Kotov, NA; Kipke, DR				Kozai, Takashi D. Yoshida; Langhals, Nicholas B.; Patel, Paras R.; Deng, Xiaopei; Zhang, Huanan; Smith, Karen L.; Lahann, Joerg; Kotov, Nicholas A.; Kipke, Daryl R.			Ultrasmall implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces	NATURE MATERIALS			English	Article							TRAUMATIC BRAIN-INJURY; TISSUE; ARRAYS; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); ASTROCYTES; ELECTRODES; INSERTION; COATINGS; NEURONS; ALBUMIN	Implantable neural microelectrodes that can record extracellular biopotentials from small, targeted groups of neurons are critical for neuroscience research and emerging clinical applications including brain-controlled prosthetic devices. The crucial material-dependent problem is developing microelectrodes that record neural activity from the same neurons for years with high fidelity and reliability. Here, we report the development of an integrated composite electrode consisting of a carbon-fibre core, a poly(p-xylylene)-based thin-film coating that acts as a dielectric barrier and that is functionalized to control intrinsic biological processes, and a poly(thiophene)-based recording pad. The resulting implants are an order of magnitude smaller than traditional recording electrodes, and more mechanically compliant with brain tissue. They were found to elicit much reduced chronic reactive tissue responses and enabled single-neuron recording in acute and early chronic experiments in rats. This technology, taking advantage of new composites, makes possible highly selective and stealthy neural interface devices towards realizing long-lasting implants.	[Kozai, Takashi D. Yoshida; Langhals, Nicholas B.; Patel, Paras R.; Kipke, Daryl R.] Univ Michigan, Coll Engn, Dept Biomed Engn, Neural Engn Lab, Ann Arbor, MI 48109 USA; [Deng, Xiaopei; Zhang, Huanan; Lahann, Joerg; Kotov, Nicholas A.] Univ Michigan, Coll Engn, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Smith, Karen L.] New York State Dept Hlth, Ctr Neural Commun Technol, Wadsworth Ctr, Albany, NY 12201 USA	Kozai, TDY (corresponding author), Univ Michigan, Coll Engn, Dept Biomed Engn, Neural Engn Lab, Ann Arbor, MI 48109 USA.	tkozai@umich.edu; kotov@umich.edu; dkipke@umich.edu	Deng, Xiaopei/E-3546-2014; Lahann, Joerg/J-7663-2013; Langhals, Nicholas/C-2123-2008; Kozai, Takashi/I-2214-2012	Deng, Xiaopei/0000-0002-5668-024X; Langhals, Nicholas/0000-0003-0644-9020; Kozai, Takashi/0000-0002-2507-3295; Zhang, Huanan/0000-0002-3437-2510; Kotov, Nicholas/0000-0002-6864-5804; Patel, Paras/0000-0001-6146-718X	National Institutes of Health Challenge Grant in Health and Science Research from the National Institute of Neurological Disorders and Stroke [1RC1NS068396-0110]; Center for Neural Communication Technology, a P41 Resource Center; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB002030]; DARPA STTR grant [W31P4Q-08-C-0426]; NeuroNexus Technologies; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS068396] Funding Source: NIH RePORTER	This work was financially supported by a National Institutes of Health Challenge Grant in Health and Science Research from the National Institute of Neurological Disorders and Stroke (1RC1NS068396-0110) and the Center for Neural Communication Technology, a P41 Resource Center funded by the National Institute of Biomedical Imaging and Bioengineering (P41 EB002030). A. Agarwal and F. S. Midani assisted in chronic probe assembly/packaging, chronic surgery and chronic electrophysiological recordings. A. L. Ryan and S. Saha conducted ATRP. H-Y. Chen carried out Raman spectroscopy. Multiphoton imaging of chronically implanted tissue was conducted by Wadsworth Center Advanced Light Microscopy & Image Analysis Core. L. Hains cut the tissue and conducted preliminary immunohistochemistry. Confocal images were collected on the Zeiss LSM510 at the University of Michigan Microscopy and Image Analysis Laboratory. N.A.K. and D.R.K. acknowledge partial financial support of this work from a DARPA STTR grant (W31P4Q-08-C-0426).; D.R. Kipke has a significant financial and leadership interest in NeuroNexus Technologies, a company specializing in neural interface devices. At the time of this study, N.B. Langhals was a consultant for NeuroNexus Technologies.	Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/nmeth.1412, 10.1038/NMETH.1412]; Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I; Cul XT, 2007, IEEE T NEUR SYS REH, V15, P502, DOI 10.1109/TNSRE.2007.909811; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gilgunn P. J., 2012, MICR SYST MEMS 2012, P56; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011; Hosseini NH, 2007, P ANN INT IEEE EMBS, P4711, DOI 10.1109/IEMBS.2007.4353391; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jan E, 2009, NANO LETT, V9, P4012, DOI 10.1021/nl902187z; Jiang XW, 2008, ADV FUNCT MATER, V18, P27, DOI 10.1002/adfm.200700789; Katira P, 2007, ADV MATER, V19, P3171, DOI 10.1002/adma.200701982; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984; Kozai TDY, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046011; Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Lahann J, 2006, POLYM INT, V55, P1361, DOI 10.1002/pi.2098; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Luo XL, 2011, BIOMATERIALS, V32, P5551, DOI 10.1016/j.biomaterials.2011.04.051; Matsumura M, 1996, J NEUROSCI, V16, P7757; NADAL A, 1995, P NATL ACAD SCI USA, V92, P1426, DOI 10.1073/pnas.92.5.1426; NAJAFI K, 1989, THIN SOLID FILMS, V181, P251, DOI 10.1016/0040-6090(89)90492-6; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Purcell EK, 2009, J NEUROSCI METH, V183, P149, DOI 10.1016/j.jneumeth.2009.06.026; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; SCHMIDT EM, 1976, EXP NEUROL, V52, P496, DOI 10.1016/0014-4886(76)90220-X; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Shim BS, 2007, CHEM MATER, V19, P5467, DOI 10.1021/cm070442a; STRUMWASSER F, 1958, SCIENCE, V127, P469, DOI 10.1126/science.127.3296.469; Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VANHORNE CG, 1990, NEUROSCI LETT, V120, P249, DOI 10.1016/0304-3940(90)90051-A; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3	51	375	381	16	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	DEC	2012	11	12					1065	1073		10.1038/NMAT3468			9	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	041WO	WOS:000311432600026	23142839	Green Accepted	Y	N	2021-06-18	
J	Hukkelhoven, CWPM; Steyerberg, EW; Rampen, AJJ; Farace, E; Habbema, JDF; Marshall, LF; Murray, GD; Maas, AIR				Hukkelhoven, CWPM; Steyerberg, EW; Rampen, AJJ; Farace, E; Habbema, JDF; Marshall, LF; Murray, GD; Maas, AIR			Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; metaanalysis; age; outcome; association	SEVERE HEAD-INJURY; ANEURYSM-SURGERY; PREDICTION; COMPLICATIONS; METAANALYSIS; COMORBIDITY; MANAGEMENT; MORTALITY; HEMATOMA	Object. Increasing age is associated with poorer outcome in patients with closed traumatic brain injury (TBI). It is uncertain whether critical age thresholds exist, however, and the strength of the association has yet to be investigated across large series. The authors studied the shape and strength of the relationship between age and outcome, that is, the 6-month mortality rate and unfavorable outcome based on the Glasgow Outcome Scale. Methods. The shape of the association was examined in four prospective series with individual patient data (2664 cases). All patients had a closed TBI and were of adult age (96% < 65 years of age). The strength of the association was investigated in a metaanalysis of the aforementioned individual patient data (2664 cases) and aggregate data (2948 cases) from TBI studies published between 1980 and 2001 (total 5612 cases). Analyses were performed with univariable and multivariable logistic regression. Proportions of mortality and unfavorable outcome increased with age: 21 and 39%, respectively, for patients younger than 35 years and 52 and 74%, respectively, for patients older than 55 years. The association between age and both mortality and unfavorable outcome was continuous and could be adequately described by a linear term and expressed even better statistically by a linear and a quadratic term. The use of age thresholds (best fitting threshold 39 years) in the analysis resulted in a considerable loss of information. The strength of the association, expressed as an odds ratio per 10 years of age, was 1.47 (95% confidence interval [CI] 1.34-1.63) for death and 1.49 (95% Cl 1.43-1.56) for unfavorable outcome in univariable analyses, and 1.39 (95% Cl 1.3-1.5) and 1.46 (95% CI 1.36-1.56), respectively, in multivariable analyses. Thus, the odds for a poor outcome increased by 40 to 50% per 10 years of age. Conclusions. An older age is continuously associated with a worsening outcome after TBI; hence, it is disadvantageous to define the effect of age on outcome in a discrete manner when we aim to estimate prognosis or adjust for confounding variables.	Erasmus MC, Ctr Clin Decis Sci, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Ctr Clin Decis Sci, Dept Neurol Surg, NL-3000 DR Rotterdam, Netherlands; Univ Virginia, Hlth Sci Ctr, Dept Neurol Surg, Charlottesville, VA 22908 USA; Univ Calif San Diego, Dept Neurol Surg, San Diego, CA USA; Univ Edinburgh, Dept Community Hlth Sci Epidemiol & Stat, Edinburgh, Midlothian, Scotland	Hukkelhoven, CWPM (corresponding author), Erasmus MC, Ctr Clin Decis Sci, Dept Publ Hlth, Ee2075,POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.hukkelhoven@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Hukkelhoven, Chantal/0000-0002-0015-1883; Steyerberg, Ewout/0000-0002-7787-0122; Murray, Gordon/0000-0001-9866-4734			BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Clayton DH M, 1993, STAT MODELS EPIDEMIO; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GENTLEMAN D, 1992, INT SURG, V77, P297; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hastie T.J., 1990, GEN ADDITIVE MODELS; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERGAARD J, 1973, LANCET, V2, P631; Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Seeman T E, 1989, J Aging Health, V1, P50, DOI 10.1177/089826438900100104; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STEYERBERG EW, 1995, ARCH INTERN MED, V155, P1998, DOI 10.1001/archinte.155.18.1998; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; van Reekum R, 1999, J PSYCHIATR NEUROSCI, V24, P413; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	46	375	389	0	21	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2003	99	4					666	673		10.3171/jns.2003.99.4.0666			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	726XV	WOS:000185627600007	14567601				2021-06-18	
J	Friedman, G; Froom, P; Sazbon, L; Grinblatt, I; Shochina, M; Tsenter, J; Babaey, S; Ben Yehuda, A; Groswasser, Z				Friedman, G; Froom, P; Sazbon, L; Grinblatt, I; Shochina, M; Tsenter, J; Babaey, S; Ben Yehuda, A; Groswasser, Z			Apolipoprotein E-epsilon 4 genotype predicts a poor outcome in survivors of traumatic brain injury	NEUROLOGY			English	Article							SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; E POLYMORPHISM; PROTEIN; EXPRESSION; LIPOPROTEINS; CHOLESTEROL; ASSOCIATION; APOE	Objective: To determine the ability of apolipoprotein E (APOE) genotypes to predict days of unconsciousness and a suboptimal functional outcome in traumatic brain injury (TBI) survivors. Background: TBI is known to be associated with neuropsychological deficits and functional disability. Recent evidence indicates that APOE plays a pivotal role in CNS response to injury. Methods: In this prospective study the authors determined the APOE genotypes and tested their ability to predict days of unconsciousness and functional outcome after at least 6 months in 69 survivors of TBI. A good functional outcome was defined as no dysarthria, behavioral abnormalities, or dysphasia; no severe cognitive abnormalities; and the ability to live independently. Results: The odds ratio of more than 7 days of unconsciousness was 5.69 in those with the APOE-epsilon 4 allele compared with those without the epsilon 4 allele (95% CI, 1.69 to 20.0; p = 0.001). Only 1 of 27 subjects (3.7%) with the epsilon 4 allele had a good functional outcome compared with 13 of 42 (31.0%) of those without the epsilon 4 allele (p = 0.006). The OR of a suboptimal outcome (fair or unfavorable) was 13.93 for those with the epsilon 4 allele compared with those without the allele after controlling for age and time of unconsciousness (95% CI, 1.45 to 133.97; p = 0.02). Conclusion: The results demonstrate a strong association between the APOE-epsilon 4 allele and a poor clinical outcome, implying genetic susceptibility to the effect of brain injury. Additional studies of TBI patients are warranted to confirm their findings.	Loewenstein Hosp & Rehabil Ctr, Dept Brain Injury Rehabil, IL-43100 Raanana, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Rehabil, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Div Med, Geriatr Unit, Jerusalem, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Groswasser, Z (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Brain Injury Rehabil, 278 Achuza St, IL-43100 Raanana, Israel.			Froom, Paul/0000-0001-5126-8590			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; HIXSON JE, 1990, J LIPID RES, V31, P545; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, LIPID RES, V25, P1255; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STEHENSON DT, 1992, BRAIN RES, V593, P128; TARDIFF B, 1994, CIRCULATION, V90, P201; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TOMIMOTO H, 1994, J CEREBR BLOOD F MET, V14, P565, DOI 10.1038/jcbfm.1994.70; UEKI A, 1993, NEUROSCI LETT, V163, P166, DOI 10.1016/0304-3940(93)90373-S; Wilson B, 1994, BRAIN INJURY NEUROPS, P85; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423	29	375	388	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 15	1999	52	2					244	248		10.1212/WNL.52.2.244			5	Clinical Neurology	Neurosciences & Neurology	161DV	WOS:000078274200005	9932938				2021-06-18	
J	MARION, DW; OBRIST, WD; CARLIER, PM; PENROD, LE; DARBY, JM				MARION, DW; OBRIST, WD; CARLIER, PM; PENROD, LE; DARBY, JM			THE USE OF MODERATE THERAPEUTIC HYPOTHERMIA FOR PATIENTS WITH SEVERE HEAD-INJURIES - A PRELIMINARY-REPORT	JOURNAL OF NEUROSURGERY			English	Article						HYPOTHERMIA; SEVERE HEAD INJURY; CEREBRAL BLOOD FLOW; INTRACRANIAL PRESSURE; CEREBRAL METABOLIC RATE FOR OXYGEN	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; ISCHEMIC BRAIN; RAT-BRAIN; METABOLISM; COMA; RECEPTORS; RELEASE; COMMON; ACIDS	Animal research suggests that moderate therapeutic hypothermia may improve outcome after a severe head injury, but its efficacy has not been established in humans. The authors randomly assigned 40 consecutively treated patients with a severe closed head injury (Glasgow Coma Scale score 3 to 7) to either a hypothermia or a normothermia group. Using cooling blankets and cold saline gastric lavage, patients in the hypothermia group were cooled to 32-degrees to 33-degrees-C (brain temperature) within a mean of 10 hours after injury, maintained at that temperature for 24 hours, and rewarmed to 37-degrees to 38-degrees-C over 12 hours. Patients in the normothermia group were maintained at 37-degrees to 38-degrees-C during this time. Deep-brain temperatures were monitored directly and used for all temperature determinations. Intracranial pressure (ICP), cerebral blood flow (CBF), and cerebral metabolic rate for oxygen (CMRO2) were measured serially for all patients. Hypothermia significantly reduced ICP (40%) and CBF (26%) during the cooling period, and neither parameter showed a significant rebound increase after patients were rewarmed. Compared to the normothermia group, the mean CMRO2 in the hypothermia group was lower during cooling and higher 5 days after injury. Three months after injury, 12 of the 20 patients in the hypothermia group had moderate, mild, or no disabilities; eight of the 20 patients in the normothermia group had improved to the same degree. Both groups had a similar incidence of systemic complications, including cardiac arrhythmias, coagulopathies, and pulmonary complications. It is concluded that therapeutic moderate hypothermia is safe and has sustained favorable effects on acute derangements of cerebral physiology and metabolism caused by severe closed head injury. The trend toward better outcome with hypothermia may indicate that its beneficial physiological and metabolic effects limit secondary brain injury.	UNIV PITTSBURGH, SCH MED, DEPT NEUROL SURG, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROL SURG, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT ORTHOPAED SURG, DIV PHYS & REHABIL MED, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT ANESTHESIA CRIT CARE, PITTSBURGH, PA 15261 USA			Marion, Donald/AAR-5749-2021		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318] Funding Source: NIH RePORTER		ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DARBY J M, 1992, Anesthesiology (Hagerstown), V77, pA295, DOI 10.1097/00000542-199209001-00295; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAY T, 1945, TRAUMA CENTRAL NERVO, P611; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1975, LANCET, V1, P480; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KRAMER RS, 1968, J THORAC CARDIOV SUR, V56, P699, DOI 10.1016/S0022-5223(19)42797-9; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MICHENFELDER JD, 1970, ANESTHESIOLOGY, V33, P315, DOI 10.1097/00000542-197009000-00008; MILLER JD, 1983, INTRACRANIAL PRESSUR, V5, P44; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; MOURITZEN CV, 1966, J THORAC CARDIOV SUR, V51, P585, DOI 10.1016/S0022-5223(19)43326-6; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; PALMER AM, 1993, IN PRESS J NEUROCHEM; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1991, J Neurotrauma, V8 Suppl 1, pS53; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WILLIAMS WM, 1984, BRAIN RES REV, V7, P191, DOI 10.1016/0165-0173(84)90024-9; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	50	375	389	1	17	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	1993	79	3					354	362		10.3171/jns.1993.79.3.0354			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	LU690	WOS:A1993LU69000006	8360731				2021-06-18	
J	Hibbard, MR; Uysal, S; Kepler, K; Bogdany, J; Silver, J				Hibbard, MR; Uysal, S; Kepler, K; Bogdany, J; Silver, J			Axis I psychopathology in individuals with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEVERE HEAD-INJURY; FOLLOW-UP; PSYCHIATRIC-DISORDERS; SOCIAL-ADJUSTMENT; SUBSTANCE-ABUSE; DEPRESSION; MANIA; RELATIVES; SEQUELAE	Objectives: To assess the incidence, comorbidity, and patterns of resolution of DSM-IV mood, anxiety, and substance use disorders in individuals with traumatic brain injury (TBI). Design: The Structured Clinical Interview for DSM-IV Diagnoses (SCID) was utilized. Diagnoses were determined for three onset points relative to TBI onset: pre-TBI, post-TBI, and current diagnosis. Contrasts of prevalence rates with community based samples, as well as chi-square analysis and analysis of variance were used. Demographics considered in analyses included Sender, marital status, severity of injury, and years since TBI onset. Setting: Urban, suburban, and rural New York state. Participants: 100 adults with TBI who were between the ages of 18 and 65 years and mho were, on average, 8 years post onset at time of interview, Main Outcome Measures: SCID Axis I mood diagnoses of major depression, dysthymia, and bipolar disorder; anxiety diagnoses of panic disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAB), and phobia; and substance use disorders. Results: Prior to TBI, a significant percentage of individuals presented with substance use disorders. Mer TBI, the most frequent Axis I diagnoses were major depression and select anxiety disorders (ie, PTSD, OCD, and panic disorder). Comorbidity was high, with 44% of individuals presenting with two or more. Axis I diagnoses post TBI. Individuals without a pre-TDI Axis I disorder were more likely to develop post-TBI major depression and substance use disorders. Rates of resolution were similar for individuals regardless of previous psychiatric histories. Major depression and substance use disorders were more likely than were anxiety disorders to remit. Conclusion: TBI is a risk factor for subsequent psychiatric disabilities. The need for proactive psychiatric assessment and timely interventions in individuals post TBI is indicated.	Mt Sinai Med Ctr, Dept Rehabil Med, Res & Training Ctr, New York, NY 10029 USA; Lenox Hill Hosp, Dept Psychiat, Ambulatory Serv, New York, NY 10021 USA	Hibbard, MR (corresponding author), Mt Sinai Med Ctr, Dept Rehabil Med, Res & Training Ctr, Box 1240,1425 Madison Ave, New York, NY 10029 USA.						American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BAKCHINE S, 1989, NEUROLOGY, V39, P777, DOI 10.1212/WNL.39.6.777; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; BOND M, 1984, CLOSED HEAD INJURY P; BOND MR, 1975, CIBA FDN S OUTCOME S, V34; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; BRACKEN P, 1987, BRIT J PSYCHIAT, V150, P690, DOI 10.1192/bjp.150.5.690; BROOCKS N, 1986, J NEUROL NEUROSUR PS, V46, P336; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bruckner F E, 1972, Rheumatol Phys Med, V11, P344, DOI 10.1093/rheumatology/11.7.344; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DICESARE A, 1990, COGNITIVE REHABILITA, V8, P14; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; Epstein R. S., 1994, NEUROPSYCHIATRY TRAU; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First M.B., 1996, STRUCTURED CLIN INTE; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GLENN MB, 1989, J HEAD TRAUMA REHAB, V4, P85; GROBER S, 1993, ADV STROKE REHABILIT; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HIBBARD MR, 1986, COGNITIVE THERAPY AP; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Lewis L, 1991, J HEAD TRAUMA REHAB, V6, P22; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NIZAMIE SH, 1988, ACTA PSYCHIAT SCAND, V77, P637, DOI 10.1111/j.1600-0447.1988.tb05181.x; O'Shanick G J, 1986, Adv Psychosom Med, V16, P173; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ORLY A, 1996, BRAIN INT, V10, P687; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; ROBERTS AH, 1979, SEVERE ACCIDENTAL HE; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SILVER JM, 1992, AM PSYCHIAT PRESS TX; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; *SPSS INC, 1996, SPSS WIND 95; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	62	373	378	0	23	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1998	13	4					24	39		10.1097/00001199-199808000-00003			16	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	110DZ	WOS:000075366000003	9651237				2021-06-18	
J	Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH				Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH			A population-based study of inflicted traumatic brain injury in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHAKEN IMPACT SYNDROME; ABUSIVE HEAD TRAUMA; BABY SYNDROME; INFANTS; RISK	Context Physical abuse is a leading cause of serious head injury and death in children aged 2 years or younger. The incidence of inflicted traumatic brain injury (TBI) in US children is unknown. Objective To determine the incidence of serious or fatal inflicted TBI in a defined US population of approximately 230000 children aged 2 years or younger. Design, Setting, and Subjects All North Carolina children aged 2 years or younger who were admitted to a pediatric intensive care unit or who died with a TBI in 2000 and 2001 were identified prospectively. Injuries were considered inflicted if accompanied by a confession or a medical and social service agency determination of abuse. Main Outcome Measure Incidence of inflicted TBI. Multivariate logistic regression models were used to compare children with inflicted injuries with those with non-inflicted injuries and with the general state population aged 2 years or younger. Results A total of 152 cases of serious or fatal TBI were identified, with 80 (53%) incurring inflicted TBI. The incidence of inflicted traumatic brain injury in the first 2 years of life was 17.0 (95% confidence interval [CI], 13.3-20.7) per 100000 person-years. Infants had a higher incidence than children in the second year of life (29.7 [95% CI, 22.9-36.7] vs 3.8 [95% CI, 1.3-6.4] per 100000 person-years). Boys had a higher incidence than girls (21.0 [95% CI, 15.1-26.6] vs 13.0 [95% CI, 8.4-17.7] per 100000 person-years). Relative to the general population, children who incurred an increased risk of inflicted injury were born to young mothers (less than or equal to21 years), non-European American, or products of multiple births. Conclusions In this population of North Carolina children, the incidence of inflicted TBI varied by characteristics of the injured children and their mothers. These data may be helpful for informing preventive interventions.	Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Wake Forest Univ, Bowman Gray Sch Med, Brenner Childrens Hosp, Dept Pediat, Winston Salem, NC USA	Keenan, HT (corresponding author), Univ N Carolina, Sch Med, Dept Social Med, Wing D,CB7240, Chapel Hill, NC 27599 USA.		Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Marshall, Stephen/0000-0002-2664-9233	ODCDC CDC HHS [R49/CCR402444] Funding Source: Medline		Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; GROOTHUIS JR, 1982, PEDIATRICS, V70, P769; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LUDWIG S, 1990, AJDC, V144, P724; *NC CTR HLTH STAT, HLTH STAT STAT CTR; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Sinal SH, 2000, CHILD ABUSE NEGLECT, V24, P1241, DOI 10.1016/S0145-2134(00)00177-0; STARLING SP, 1995, PEDIATRICS, V95, P259; STIER DM, 1993, PEDIATRICS, V91, P642; *US DEP HHS, 1988, INT CLASS DIS 9 REV	20	371	378	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					621	626		10.1001/jama.290.5.621			6	Medicine, General & Internal	General & Internal Medicine	708GH	WOS:000184558500016	12902365	Bronze			2021-06-18	
J	Anderson, V; Catroppa, C; Morse, S; Haritou, F; Rosenfeld, J				Anderson, V; Catroppa, C; Morse, S; Haritou, F; Rosenfeld, J			Functional plasticity or vulnerability after early brain injury?	PEDIATRICS			English	Article						traumatic brain injury; children; recovery	CLOSED HEAD-INJURY; CHILDREN; CHILDHOOD; RECOVERY; AGE; SEVERITY; SEQUELAE; INFANTS	Context. Traumatic brain injury (TBI) is a common, acquired, childhood disability that may be used as a model to understand more completely the impact of early brain injury on both brain structure and day-to-day function. Contrary to previously held views of the "plasticity" of the young brain, recent research suggests that such early insults may have a profound impact on development. To date, these suggestions remain largely untested. Objectives. To plot changes in cognitive abilities after childhood TBI over the 30 months after injury and to examine the impact of age at injury on cognitive outcomes. Design. Prospective longitudinal study. Setting. Royal Children's Hospital, Victoria, Australia. Main Outcome Measures. Global intellectual ability, verbal and nonverbal skills, attention, and processing speed. Participants. A total of 122 children admitted to the hospital with a diagnosis of TBI were divided according to injury age, ie, young (age: 3-7 years) or old (age: 8-12 years), and injury severity (mild, moderate, or severe) and were evaluated acutely and at 12 and 30 months after injury. An additional sample of children injured before 3 years of age (n = 27) was compared with these groups with respect to global intellectual ability only. Results. A clear relationship was documented between injury severity and cognitive performance. For children who sustained severe injury, younger age at injury was associated with minimal, if any, recovery after injury, but better outcomes were observed after severe TBI among older children. Age at injury was not predictive of outcomes for children with mild or moderate TBI, although infants (age: 0-2.11 years) with moderate TBI showed poorer outcomes than did older children with injury of similar severity. Conclusions. Findings support a "double-hazard" model for severe and early brain insults and add to the ongoing debate regarding cerebral plasticity, suggesting that, contrary to traditional views, young children who sustain severe TBI in early childhood or moderate or severe TBI in infancy may be particularly vulnerable to significant residual cognitive impairment. From a clinical perspective, results indicate that long-term follow-up monitoring and management should be targeted to this high-risk group.	Univ Melbourne, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2000, BRIT J CANCER, V82, P255; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; Bayley N., 1969, BAYLEY SCALES INFANT; BEGALI V, 1992, HEAD INJURY CHILDREN; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DANIEL S, 1983, POWER PRIVILEGE PRES; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; ESCALONA SK, 1982, PEDIATRICS, V70, P670; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kraus J., 1995, TRAUMATIC HEAD INJUR, P117; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lenneberg Eric H., 1967, BIOL FDN LANGUAGE; Noller P, 1988, ICPS FAMILY FUNCTION; Rutter M, 1983, DEV NEUROPSYCHIATRY, P83; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sparrow S., 1984, VINELAND ADAPTIVE BE; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; Wechsler D, 1991, MANUAL WECHSLER SCAL; WECHSLER D, 1987, MANUAL PRESCHOOL PRI	33	369	373	3	55	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2005	116	6					1374	1382		10.1542/peds.2004-1728			9	Pediatrics	Pediatrics	989JH	WOS:000233668200016	16322161				2021-06-18	
J	McDonald, S; Flanagar, S; Rollins, J; Kinch, J				McDonald, S; Flanagar, S; Rollins, J; Kinch, J			A new clinical tool for assessing social perception after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						emotional expression; social perception; traumatic brain injury	CLOSED HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; NONVERBAL CUES; CHILDHOOD; DEFICITS; IMPAIRMENT; ADJUSTMENT; BEHAVIOR; ABILITY; MIND	Objective: To develop a clinically sensitive test of social perception for people with traumatic brain injury (TBI). Design: An assessment tool comprising videotaped vignettes and response probes was developed in successive stages and tested on both normal participants and those with TBI. Subjects: A total of 169 normal adults and 7 adults with severe TBI (pilot studies), 283 normal adults, and 12 people with severe TBI (main studies). Main outcome measures: "The Awareness of Social Inference Test" (TASIT) comprises videotaped vignettes of everyday social interactions and has three parts, each with alternate forms. The Emotion Evaluation Test (EET) assesses recognition of spontaneous emotional expression (happy, surprised, sad, anxious, angry, disgusted, and neutral). The Social Inference-Minimal (SI-M) test assesses comprehension of sincere versus sarcastic exchanges, whereas the Social Inference-Enriched test (SI-E) assesses lies versus sarcasm. In both SI-M and SI-E speaker demeanor (voice, facial expression) indicate the intended meaning of the exchange. In addition, the SI-E vignettes have other contextual clues that reveal the speakers' intentions. Performance on SI-E and SI-E is assessed via four standard questions per item probing for understanding of the emotions, intentions, beliefs, and meanings of the speakers and their exchanges. Results: Groups taken from the pool of 283 normal adults achieved a high level of performance on all aspects of the test with some influence from both education and intelligence. The 12 people with TBI were poorer at judging emotions than were matched controls, with particular difficulties recognizing neutral items, fear, and disgust. They were as capable as matched controls when understanding sincere exchanges and lies but had difficulty with sarcasm. Conclusions: TASIT is straightforward for people with a normal range of social skills while being sensitive to social perception deficits after traumatic brain injury.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Commonwealth Rehabil Serv, Sydney, NSW, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ARCHER D, 1977, J PERS SOC PSYCHOL, V35, P443, DOI 10.1037/0022-3514.35.6.443; ARGYLE M, 1986, HDB SOCIAL SKILLS TR, V2, P185; Baddeley A.D., 1992, SPEED CAPACITY LANGU; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373; BELLACK AS, 1982, INTERPERSONAL HDB BE; BOAKE C, 1991, COGNITIVE REHABILITI; BODY R, 1999, BRAIN DAM B, P81; BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BULLMER K, 1972, J COUNS PSYCHOL, V19, P37, DOI 10.1037/h0032037; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Curran J.P, 1979, J BEHAVIORAL ASSESSM, V1, P55; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; EDINGER JA, 1983, PSYCHOL BULL, V93, P30; Ekman P., 1973, DARWIN FACIAL EXPRES, P169; Ekman P., 1976, PICTURES FACIAL AFFE; FLANAGAN S, 1995, J INT NEUROPSYCH SOC, V1, P319; FLANAGAN S, 1999, BRAIN IMPAIRMENT REH; Heaton R., 1993, WISCONSIN CARD SORTI; HERSEN M, 1976, COMPR PSYCHIAT, V17, P559, DOI 10.1016/0010-440X(76)90038-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; KAGAN C, 1984, BRIT J CLIN PSYCHOL, V23, P161, DOI 10.1111/j.2044-8260.1984.tb00643.x; KAHN M, 1970, FAM PROCESS, V9, P449, DOI 10.1111/j.1545-5300.1970.00449.x; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonald S, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; McDonald S., 2002, AWARENESS SOCIAL INF; MCFALL RM, 1982, BEHAV ASSESS, V4, P1; MEICHENBAUM D, 1974, SELF CONTROL POWER P; MILTON SB, 1986, CLIN NEUROPSYCHOLOGY; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; MUEHLENHARD CL, 1986, BEHAV THER, V17, P404, DOI 10.1016/S0005-7894(86)80071-5; Nelson HE, 1982, NATL ADULT READING T; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; *PSYCH CORP, 1997, WECHSL MEM SCAL, V3; Rosenthal R., 1979, SENSITIVITY NONVERBA; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Slugoski B. R., 1988, J LANG SOC PSYCHOL, V7, P101, DOI DOI 10.1177/0261927X8800700202; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; SULLIVAN K, 1995, BRIT J DEV PSYCHOL, V13, P191, DOI 10.1111/j.2044-835X.1995.tb00673.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1991, BRAIN IMPAIRMENT ADV, P219; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889	67	367	377	1	39	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2003	18	3					219	238		10.1097/00001199-200305000-00001			20	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	682HM	WOS:000183085700001	12802165				2021-06-18	
J	CHILDS, NL; MERCER, WN; CHILDS, HW				CHILDS, NL; MERCER, WN; CHILDS, HW			ACCURACY OF DIAGNOSIS OF PERSISTENT VEGETATIVE STATE	NEUROLOGY			English	Article							CONSCIOUSNESS; RECOVERY; COMA	We reviewed pre-admission diagnosis in all patients referred for inpatient brain injury neurorehabilitation over a 5-year period (n = 193). All patients more than 1 month postinjury with diagnosis of coma or persistent vegetative state were selected for review (n = 49). We found that 18 (37%) of these patients were diagnosed inaccurately. Inaccurate diagnosis was more likely if the injury was more than 3 months before admission and the etiology of injury was trauma (48%). Results were statistically significant when traumatic injuries were compared with anoxic injuries (p < 0.10). Errors in diagnosis may result from confusion in terminology, lack of extended observation of patients, and lack of skill or training in the assessment of neurologically devastated patients.	UNIV N TEXAS,DEPT PSYCHOL,DENTON,TX	CHILDS, NL (corresponding author), HEALTHCARE REHABIL CTR,1106 W DITTMAR,AUSTIN,TX 78745, USA.						ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; [Anonymous], 1989, NEUROLOGY, V39, P125; BERROL S, 1986, ARCH PHYS MED REHAB, V67, P283; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; CRANFORD RE, 1988, HASTINGS CENT REP, V18, P27, DOI 10.2307/3562014; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Hagen C, 1981, TOP LANG DIS, V1, P73; HAYS WL, 1963, STATISTICS, P585; JENNETT B, 1972, LANCET, V1, P734; LEHMAN LB, 1990, POSTGRAD MED, V88, P150; LEHMAN LB, 1990, POSTGRAD MED, V88, P152; Plum F, 1980, DIAGNOSIS STUPOR COM, P1; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1985, PROGR CLIN NEUROSCIE, V2, P65; SHESKIN D, 1984, STATISTICAL TESTS EX, P23; SPUDIS EV, 1991, J NEUROL SCI, V102, P128, DOI 10.1016/0022-510X(91)90060-K; TEASDALE G, 1974, LANCET, V2, P81; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; WHYTE J, 1989, COMPREHENSIVE NEUROL, V2, P13; 1986, AM MED NEWS, V1, P45; 1990, JAMA-J AM MED ASSOC, V263, P426	22	367	379	0	18	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0028-3878			NEUROLOGY	Neurology	AUG	1993	43	8					1465	1467		10.1212/WNL.43.8.1465			3	Clinical Neurology	Neurosciences & Neurology	LR500	WOS:A1993LR50000003	8350997				2021-06-18	
J	Lincoln, AE; Caswell, SV; Almquist, JL; Dunn, RE; Norris, JB; Hinton, RY				Lincoln, Andrew E.; Caswell, Shane V.; Almquist, Jon L.; Dunn, Reginald E.; Norris, Joseph B.; Hinton, Richard Y.			Trends in Concussion Incidence in High School Sports A Prospective 11-Year Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						high school; injury; concussion; sports	UNITED-STATES; HEAD ACCELERATION; ATHLETIC-TRAINERS; SEX-DIFFERENCES; INJURIES; EPIDEMIOLOGY	Background: Understanding the risk and trends of sports-related concussion among 12 scholastic sports may contribute to concussion detection, treatment, and prevention. Purpose: To examine the incidence and relative risk of concussion in 12 high school boys' and girls' sports between academic years 1997-1998 and 2007-2008. Study Design: Descriptive epidemiology study. Methods: Data were prospectively gathered for 25 schools in a large public high school system. All schools used an electronic medical record-keeping program. A certified athletic trainer was on-site for games and practices and electronically recorded all injuries daily. Results: In sum, 2651 concussions were observed in 10 926 892 athlete-exposures, with an incidence rate of 0.24 per 1000. Boys' sports accounted for 53% of athlete-exposures and 75% of all concussions. Football accounted for more than half of all concussions, and it had the highest incidence rate (0.60). Girls' soccer had the most concussions among the girls' sports and the second-highest incidence rate of all 12 sports (0.35). Concussion rate increased 4.2-fold (95% confidence interval, 3.4-5.2) over the 11 years (15.5% annual increase). In similar boys' and girls' sports (baseball/softball, basketball, and soccer), girls had roughly twice the concussion risk of boys. Concussion rate increased over time in all 12 sports. Conclusion: Although the collision sports of football and boys' lacrosse had the highest number of concussions and football the highest concussion rate, concussion occurred in all other sports and was observed in girls' sports at rates similar to or higher than those of boys' sports. The increase over time in all sports may reflect actual increased occurrence or greater coding sensitivity with widely disseminated guidance on concussion detection and treatment. The high-participation collision sports of football and boys' lacrosse warrant continued vigilance, but the findings suggest that focus on concussion detection, treatment, and prevention should not be limited to those sports traditionally associated with concussion risk.	[Lincoln, Andrew E.; Caswell, Shane V.; Almquist, Jon L.; Dunn, Reginald E.; Norris, Joseph B.; Hinton, Richard Y.] MedStar Hlth Res Inst, Baltimore, MD USA	Lincoln, AE (corresponding author), Care of Camire L, Union Mem Orthopaed, Johnston Profess Bldg 400,3333 N Calvert St, Baltimore, MD 21218 USA.	lyn.camire@medstar.net			US Lacrosse Sports Science and Safety Committee	One or more authors has declared a potential conflict of interest or source of funding: Nonrestrictive research support was provided by the US Lacrosse Sports Science and Safety Committee. The funding source had no other role in the study.	[Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P733; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; *BRAIN INJ ASS WA, NEW PARTN HELP WASH; *BRAIN INJ ASS WA, LYST LAW SPORTS CONC; *CDCP, CONC SPORTS; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645; 2006, MMWR MORB MORTAL WKL, V55, P1037; 2009, NY TIMES        1215, pB19	20	366	368	2	82	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	MAY	2011	39	5					958	963		10.1177/0363546510392326			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	759NC	WOS:000290252200010	21278427		Y	N	2021-06-18	
J	Li, Y; Chopp, M; Chen, JL; Wang, L; Gautam, SC; Xu, SX; Zhang, ZG				Li, Y; Chopp, M; Chen, JL; Wang, L; Gautam, SC; Xu, SX; Zhang, ZG			Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						bone marrow cells; transplantation; stroke; mice	FETAL MESENCEPHALIC TISSUE; FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; STROMAL CELLS; PARKINSONS-DISEASE; HEMATOPOIETIC-CELLS; OSTEOGENESIS IMPERFECTA; PROGENITOR CELLS; STEM-CELLS; RAT	The authors transplanted adult bone marrow nonhematopoietic cells into the striatum after embolic middle cerebral artery occlusion (MCAO). Mice (n = 23; C57BL/6J) were divided into four groups: (1) mice (n = 5) were subjected to MCAO and transplanted with bone marrow nonhematopoietic cells (prelabeled by bromodeoxyuridine, BrdU) into the ischemic striatum, (2) MCAO alone (n = 8), (3) MCAO with injection of phosphate buffered saline (n = 5), and (4) bone marrow nonhematopoietic cells injected into the normal striatum (n = 5). Mice were killed at 28 days after stroke. BrdU reactive cells survived and migrated a distance of approximately 2.2 mm from the grafting areas toward the ischemic areas. BrdU reactive cells expressed the neuronal specific protein NeuN in 1% of BrdU stained cells and the astrocytic specific protein glial fibrillary acidic protein (GFAP) in 8% of the BrdU stained cells. Functional recovery from a rotarod test (P < 0.05) and modified neurologic severity score tests (including motor, sensory, and reflex; P < 0.05) were significantly improved in the mice receiving bone marrow nonhematopoietic cells compared with MCAO alone. The current findings suggest that the intrastriatal transplanted bone marrow nonhematopoietic cells survived in the ischemic brain and improved functional recovery of adult mice even though infarct volumes did not change significantly. Bone marrow nonhematopoietic cells may provide a new avenue to promote recovery of injured brain.	Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI USA; Henry Ford Hlth Sci Ctr, Div Hematol Oncol, Detroit, MI USA; Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035504, P01NS023393] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS23393, R01 NS35504] Funding Source: Medline		AIHARA N, 1994, BRAIN RES BULL, V33, P483, DOI 10.1016/0361-9230(94)90072-8; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BANKIEWICZ K, 1993, EXP NEUROL, V124, P140, DOI 10.1006/exnr.1993.1185; Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580; Bjorklund A, 1999, Lakartidningen, V96, P3407; BONNER H, 1999, PATHOLOGY, P1051; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Borlongan CV, 1998, NEUROREPORT, V9, P3703, DOI 10.1097/00001756-199811160-00025; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P79, DOI 10.1016/0149-7634(95)00063-1; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Defer GL, 1996, BRAIN, V119, P41, DOI 10.1093/brain/119.1.41; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; EAVES CJ, 1991, BLOOD, V78, P110; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; FREED CR, 1995, NEW ENGL J MED, V333, P730; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; Gage FH, 1998, NATURE, V392, P18; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Goto S, 1997, EXP NEUROL, V147, P503, DOI 10.1006/exnr.1997.6628; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEALTON EB, 1982, NEUROLOGY, V32, P776, DOI 10.1212/WNL.32.7.776; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; KANG UJ, 1993, J NEUROSCI, V13, P5203; KARLSSON S, 1991, BLOOD, V78, P2481; KELEMEN F, 1979, ATLAS HUMAN HEMOPOIE; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Li WW, 1998, J NEUROSCI, V18, P8853; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LopezLozano JJ, 1997, TRANSPL P, V29, P977, DOI 10.1016/S0041-1345(96)00333-8; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703; Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138; NISHINO H, 1993, BRAIN RES BULL, V32, P517, DOI 10.1016/0361-9230(93)90300-Z; Onizuka K, 1996, EXP NEUROL, V137, P324, DOI 10.1006/exnr.1996.0033; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; POLLAK A, 1977, J NEUROPATH EXP NEUR, V36, P712, DOI 10.1097/00005072-197707000-00006; Prockop DJ, 1998, J CELL BIOCHEM, P284, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<284::AID-JCB34>3.0.CO;2-I; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Riew KD, 1998, CALCIFIED TISSUE INT, V63, P357, DOI 10.1007/s002239900540; Schallert T, 1997, ADV NEUROL, V73, P229; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; UNSICKER K, 1993, EXP NEUROL, V123, P167, DOI 10.1006/exnr.1993.1149; Unsicker Klaus, 1994, Progress in Growth Factor Research, V5, P73, DOI 10.1016/0955-2235(94)90018-3; Vogel G, 2000, SCIENCE, V287, P1418, DOI 10.1126/science.287.5457.1418; WALSH CE, 1994, J CLIN INVEST, V94, P1440, DOI 10.1172/JCI117481; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010	62	366	468	0	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2000	20	9					1311	1319		10.1097/00004647-200009000-00006			9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	349XA	WOS:000089069800006	10994853	Bronze			2021-06-18	
J	Feigin, VL; Theadom, A; Barker-Collo, S; Starkey, NJ; McPherson, K; Kahan, M; Dowell, A; Brown, P; Parag, V; Kydd, R; Jones, K; Jones, A; Ameratunga, S				Feigin, Valery L.; Theadom, Alice; Barker-Collo, Suzanne; Starkey, Nicola J.; McPherson, Kathryn; Kahan, Michael; Dowell, Anthony; Brown, Paul; Parag, Varsha; Kydd, Robert; Jones, Kelly; Jones, Amy; Ameratunga, Shanthi		BIONIC Study Grp	Incidence of traumatic brain injury in New Zealand: a population-based study	LANCET NEUROLOGY			English	Article							UNITED-STATES; HEAD-INJURY; EPIDEMIOLOGY; PERSPECTIVE; COMMUNITY; TRENDS; IMPACT; SCALE; REHABILITATION; CHALLENGES	Background Traumatic brain injury (TBI) is the leading cause of long-term disability in children and young adults worldwide. However, accurate information about its incidence does not exist. We aimed to estimate the burden of TBI in rural and urban populations in New Zealand across all ages and TBI severities. Methods We did a population-based incidence study in an urban (Hamilton) and rural (Waikato District) population in New Zealand. We registered all cases of TB! (admitted to hospital or not, fatal or non-fatal) that occurred in the population between March 1, 2010, and Feb 28, 2011, using multiple overlapping sources of information. We calculated incidence per 100 000 person-years with 95% CIs using a Poisson distribution. We calculated rate ratios [RRs] to compare the age-standardised rates between sex, ethnicity, and residency (urban, rural) groups. We used direct standardisation to age-standardise the rates to the world population. Results The total incidence of TB! per 100 000 person-years was 790 cases (95% CI 749-832); incidence per 100 000 person-years of mild TBI was 749 cases (709-790) and of moderate to severe TBI was 41 cases (31-51). Children (aged 0-14 years) and adolescents and young adults (aged 15-34 years) constituted almost 70% of all TBI cases. TBI affected boys and men more than women and girls (RR 1.77,95% CI 1.58-1.97). Most TBI cases were due to falls (38% [516 of 1369]), mechanical forces (21% [288 of 1369]), transport accidents (20% [277 of 1369]), and assaults (17% [228 of 1369]). Compared with people of European origin, Maori people had a greater risk of mild TB! (RR 1.23, 95% CI 1.08-1.39). Incidence of moderate to severe TBI in the rural population (73 per 100 000 person-years [95% CI 50-107]) was almost 2.5 times greater than in the urban population (31 per 100 000 person-years [23-42]). Interpretation Our findings suggest that the incidence of TBI, especially mild TBI, in New Zealand is far greater than would be estimated from the findings of previous studies done in other high-income countries. Our age-specific and residency-specific data for TBI incidence overall and by mechanism of injury should be considered when planning prevention and TBI care services.	[Feigin, Valery L.; Theadom, Alice; Jones, Kelly; Jones, Amy] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand; [McPherson, Kathryn] Auckland Univ Technol, Hlth & Rehabil Res Inst, Fac Hlth & Environm Studies, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Auckland 1, New Zealand; [Parag, Varsha] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Kydd, Robert] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Starkey, Nicola J.] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand; [Kahan, Michael] Waikato Occupat Serv Ltd, Concuss Clin, Hamilton, New Zealand; [Kahan, Michael] Waikato Occupat Serv Ltd, TBI Rehabil Unit, Hamilton, New Zealand; [Dowell, Anthony] Univ Otago, Wellington, New Zealand; [Brown, Paul] Univ Calif San Diego, Sch Social Sci, La Jolla, CA USA	Feigin, VL (corresponding author), AUT Univ, Fac Hlth & Environm Studies, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci,Sch Rehabil & Oc, AUT N Shore Campus,AA254,90 Akoranga Dr,Northcote, Auckland 1142, New Zealand.	valery.feigin@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019; Jones, Kelly/G-4127-2015	Starkey, Nicola/0000-0002-4370-8186; McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497; Jones, Kelly/0000-0001-5692-653X; Ameratunga, Shanthi/0000-0001-8042-2251; Feigin, Valery L./0000-0002-6372-1740; Theadom, Alice/0000-0003-0351-6216	Health Research Council of New ZealandHealth Research Council of New Zealand; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A]	Funding Health Research Council of New Zealand.; This study was funded by the Health Research Council of New Zealand (HRC 09/063A). We thank the research team for their dedication and performance; the staff at the Coroner's Office in Hamilton; the staff of the New Zealand Accident Compensation Corporation and Health Information Service; Waikato District Health Board, and Waikato University staff at the BIONIC Hamilton office; the many doctors, nurses, and TBI service providers such as ABI Management and administrative staff within and outside Hamilton; and the BIONIC participants and their families and friends. We also thank Helen McDonald for secretarial support for the study. Alice Theadom was cofunded by ABI Rehabilitation Management. Kathryn McPherson holds the Laura Fergusson Trust Chair.	Ahmad OB, 2000, GPE DISCUSSION PAPER, V31; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Common Data Elements NINDS, HARM INF STREAML RES; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holder Y, 2001, INJURY SURVEILLANCE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Martin J, 1998, NEW ZEAL MED J, V111, P158; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Myburgh JA, EPIDEMIOLOGY 12 MONT; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rivara F, 2011, INJURY PREV, V17, P149, DOI 10.1136/injuryprev-2011-040035; Runyan DK, 2008, AM J PREV MED, V34, pS163, DOI 10.1016/j.amepre.2008.01.010; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schootman M, 1999, BRAIN INJURY, V13, P995; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; *STAT NZ, 2009, 2006 CENS DAT; Stephenson S, 2005, ACCIDENT ANAL PREV, V37, P825, DOI 10.1016/j.aap.2005.03.024; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	52	365	376	4	64	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2013	12	1					53	64		10.1016/S1474-4422(12)70262-4			12	Clinical Neurology	Neurosciences & Neurology	055PR	WOS:000312429400020	23177532		Y	N	2021-06-18	
J	Murray, GD; Butcher, I; McHugh, GS; Lu, J; Mushkudiani, NA; Maas, AIR; Marmarou, A; Steyerberg, EW				Murray, Gordon D.; Butcher, Isabella; McHugh, Gillian S.; Lu, Juan; Mushkudiani, Nino A.; Maas, Andrew I. R.; Marmarou, Anthony; Steyerberg, Ewout W.			Multivariable prognostic analysis in traumatic brain injury: Results from the IMPACT study	JOURNAL OF NEUROTRAUMA			English	Article						GOS; multivariable analysis; multivariate analysis; prognosis; traumatic brain injury	SEVERE HEAD-INJURY; PRACTICAL SCALE; PREDICTION; CLASSIFICATION	We studied the prognostic value of a wide range of conventional and novel prognostic factors on admission after traumatic brain injury (TBI) using both univariate and multivariable analysis. The outcome measure was Glasgow Outcome Scale at 6 months after injury. Individual patient data were available on a cohort of 8686 patients drawn from eight randomized controlled trials and three observational studies. The most powerful independent prognostic variables were age, Glasgow Coma Scale (GCS) motor score, pupil response, and computerized tomography (CT) characteristics, including the Marshall CT classification and traumatic subarachnoid hemorrhage. Prothrombin time was also identified as a powerful independent prognostic factor, but it was only available for a limited number of patients coming from three of the relevant studies. Other important prognostic factors included hypotension, hypoxia, the eye and verbal components of the GCS, glucose, platelets, and hemoglobin. These results on prognostic factors will underpin future work on the IMPACT project, which is focused on the development of novel approaches to the design and analysis of clinical trials in TBI. In addition, the results provide pointers to future research, including further analysis of the prognostic value of prothrombin time, and the evaluation of the clinical impact intervening aggressively to correct abnormalities in hemoglobin, glucose, and coagulation.	Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; Virginia Commonwealth Univ, Dept Neurosurg, Sch Med, Richmond, VA USA; Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	Murray, GD (corresponding author), Univ Edinburgh, Sch Med, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	Gordon.Murray@ed.ac.uk	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Murray, Gordon/0000-0001-9866-4734; Steyerberg, Ewout/0000-0002-7787-0122; Lu, Juan/0000-0002-5389-7603	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-042691] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER		BANBEEK J, 2007, J NEUROTRAUM, V24, P315; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; HARRELL FE, 2001, REGRESSION MODELING; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; TEASDALE G, 1974, LANCET, V2, P81; TITTERINGTON DM, 1981, J ROY STAT SOC A STA, V144, P145, DOI 10.2307/2981918	23	365	381	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2007	24	2					329	337		10.1089/neu.2006.0035			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	150AL	WOS:000245187900012	17375997				2021-06-18	
J	Thurman, D; Guerrero, J				Thurman, D; Guerrero, J			Trends in hospitalization associated with traumatic brain injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE-PAYMENT SYSTEM; HEAD-INJURY; ACCURACY	Context Traumatic brain injury (TBI) is associated with more than 50 000 deaths in the United States each year, and recent observations suggest a substantial decline in TBI-related hospitalizations and deaths. Objective To analyze long-term trends in TBI-related hospitalization in the United States. Design, Setting, and Participants Analysis of existing data from 1980 through 1995 from the National Hospital Discharge Survey, an annual survey representing the US general population. The number of participating hospitals ranged from 400 to 494. Main Outcome Measures Annual rates of TBI-related hospitalization, stratified by age, sex, severity of injury, and outcome. Results The annual number of TBI cases identified from the sample during the study : period ranged from 1611 to 3129. Overall rates of hospitalization for TBI declined an estimated 51 %, from 199 to 98 per 100 000 per year. When analyzed by severity of injury, mild TBIs declined most during this period, from 130 to 51 hospitalizations per 100 000 per year (61 % decline; P<.001 compared with intermediate and severe TBI); The decline was greatest among those aged 5-14 years (-66%) and least among those. aged 65 years or older (-9%). The ratio of male to female rates showed little variation during the study period (ratio, 1.8; 95% confidence interval [CI], 1.6-2.0), as did the in-hospital mortality rate (mean, 5.3 per 100 000; 95% CI, 3.6-7.1). Conclusions Changes in hospital practices may be a major factor in the declining rates of TBI-related hospital admissions. These practices increasingly appear to exclude persons with less severe TBI from hospital admission and shift: their care to outpatient settings.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA	Thurman, D (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Mailstop F-41,4770 Buford Hwy NE, Atlanta, GA 30341 USA.			Thurman, David/0000-0002-0533-7062			*ASS ADV AUT MED, 1990, ABBR INJ SCAL; ASSAF AR, 1993, NEW ENGL J MED, V329, P931, DOI 10.1056/NEJM199309233291307; Burt C W, 1998, Vital Health Stat 13, P1; *CDCP, 1997, DAT FIL DOC NAT HOSP; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; *CTR INJ RES POL J, 1997, ICDMAP90 SOTW; GOLDFARB MG, 1992, HEALTH SERV RES, V27, P385; Graves E J, 1997, Vital Health Stat 13, P1; Gronwall D, 1989, MILD HEAD INJURY, P153; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; KISH L, 1965, SURVEY SAMPLING, P206; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; *NAT CTR HLTH STAT, 1997, DAT FIL DOC NAT HOSP; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Robinson JC, 1996, JAMA-J AM MED ASSOC, V276, P1060, DOI 10.1001/jama.276.13.1060; Ruff R.M., 1989, MILD HEAD INJURY, P176; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; THURMAN DJ, IN PRESS J HEAD TRAU; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US DHHS, 1989, FED INT HEAD INJ TAS; *US DHHS, 1996, INT CLASS DIS	24	364	372	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1999	282	10					954	957		10.1001/jama.282.10.954			4	Medicine, General & Internal	General & Internal Medicine	231XD	WOS:000082335900033	10485680	Bronze			2021-06-18	
J	MITTENBERG, W; DIGIULIO, DV; PERRIN, S; BASS, AE				MITTENBERG, W; DIGIULIO, DV; PERRIN, S; BASS, AE			SYMPTOMS FOLLOWING MILD HEAD-INJURY - EXPECTATION AS ETIOLOGY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							BODILY COMPLAINTS; SEQUELAE; HYPOCHONDRIASIS; CONCUSSION; TRAUMA	An affective, somatic, and memory check-list of symptoms was administered to subjects who had no personal experience or knowledge of head injury. Subjects indicated their current experiences of symptoms, then imagined having sustained a mild head injury in a motor vehicle accident, and endorsed symptoms they expected to experience six months after the injury. The checklist of symptoms was also administered to a group of patients with head injuries for comparison. Imaginary concussion reliably showed expectations in controls of a coherent cluster of symptoms virtually identical to the postconcussion syndrome reported by patients with head trauma. Patients consistently underestimated the premorbid prevalence of these symptoms compared with the base rate in controls. Symptom expectations appear to share as much variance with postconcussion syndrome as head injury itself. An aetiological role is suggested.	MED COLL WISCONSIN, FT LAUDERDALE, FL USA; UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA	MITTENBERG, W (corresponding author), NOVA UNIV, SCH PSYCHOL, 3301 COLL AVE, FT LAUDERDALE, FL 33314 USA.		Perrin, Sean/W-8413-2019; Perrin, Sean G/F-7723-2010	Perrin, Sean/0000-0002-5468-4706; Perrin, Sean G/0000-0002-5468-4706			Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARSKY AJ, 1983, AM J PSYCHIAT, V140, P273; BARTH JT, 1989, MILD HEAD INJURY, P142; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; CASEY R, 1986, PEDIATRICS, V78, P497; Cook J. B, 1969, LATE EFFECTS HEAD IN, P408; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; KELLNER R, 1985, ARCH GEN PSYCHIAT, V42, P821; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kelly R., 1972, PAHLAVI MED J, V3, P530; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 1989, MILD HEAD INJURY; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LIDVALL HF, 1974, ACTA NEUROL SCAN S56, V50; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MECHANIC D, 1972, NEW ENGL J MED, V286, P1132, DOI 10.1056/NEJM197205252862105; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; REISENZEIN R, 1983, PSYCHOL BULL, V94, P239, DOI 10.1037/0033-2909.94.2.239; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; SHOENHUBER R, 1989, MILD HEAD INJURY, P142; 1978, MENTAL DISORDERS GLO	30	364	364	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	1992	55	3					200	204		10.1136/jnnp.55.3.200			5	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	HH684	WOS:A1992HH68400010	1564481	Green Published, Bronze			2021-06-18	
J	ODDY, M; COUGHLAN, T; TYERMAN, A; JENKINS, D				ODDY, M; COUGHLAN, T; TYERMAN, A; JENKINS, D			SOCIAL-ADJUSTMENT AFTER CLOSED HEAD-INJURY - A FURTHER FOLLOW-UP 7 YEARS AFTER INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									ST JAMES UNIV HOSP, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND; WOLFSON MED REHABIL CTR, LONDON, ENGLAND	ODDY, M (corresponding author), LEYBOURNE GRANGE, DEPT PSYCHOL, W MALLING ME19 5HS, KENT, ENGLAND.						Bond M R, 1975, Ciba Found Symp, P141; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BOND MR, 1970, INT REHABIL MED, V1, P155; Brooks D N, 1979, Int Rehabil Med, V1, P166; BROWN JC, 1975, PSYCHOL MED, V5, P239, DOI 10.1017/S0033291700056592; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LUNDHOLM J, 1975, SCAND J REHABIL MED, V7, P97; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PECK DF, 1970, J CLIN PSYCHOL, V26, P67, DOI 10.1002/1097-4679(197001)26:1<67::AID-JCLP2270260117>3.0.CO;2-T; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Raven J., 1960, GUIDE STANDARD PROGR; Raven JC, 1965, GUIDE USING MILL HIL; ROSENBAUM M, 1978, SCAND J REHABIL MED, V10, P1; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	19	364	370	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1985	48	6					564	568		10.1136/jnnp.48.6.564			5	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AKM18	WOS:A1985AKM1800010	4009193	Green Published, Bronze			2021-06-18	
J	Lee, BB; Cripps, RA; Fitzharris, M; Wing, PC				Lee, B. B.; Cripps, R. A.; Fitzharris, M.; Wing, P. C.			The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate	SPINAL CORD			English	Article						incidence; prevalence; survival; spinal cord injury; mapping	PREVALENCE; MORTALITY; LESIONS; NEUROTRAUMA; SURVIVAL; PERIOD	Study design: Literature review. Objectives: Update the global maps for traumatic spinal cord injury (TSCI) and incorporate methods for extrapolating incidence data. Setting: An initiative of the International Spinal Cord Society (ISCoS) Prevention Committee. Methods: A search of Medline/Embase was performed (1959-Jun/30/2011). Enhancement of data-quality 'zones' including individual data-ranking as well as integrating regression techniques to provide a platform for continued regional and global estimates. Results: A global-incident rate (2007) is estimated at 23 TSCI cases per million (179 312 cases per annum). Regional data are available from North America (40 per million), Western Europe (16 per million) and Australia (15 per million). Extrapolated regional data are available for Asia-Central (25 per million), Asia-South (21 per million), Caribbean (19 per million), Latin America, Andean (19 per million), Latin America, Central (24 per million), Latin America-Southern (25 per million), Sub-Saharan Africa-Central (29 per million), Sub-Saharan Africa-East (21 per million). Discussion: It is estimated that globally in 2007, there would have been between 133 and 226 thousand incident cases of TSCI from accidents and violence. The proportion of TSCI from land transport is decreasing/stable in developed but increasing in developing countries due to trends in transport mode (transition to motorised transport), poor infrastructure and regulatory challenges. TSCIs from low falls in the elderly are increasing in developed countries with ageing populations. In some developing countries low falls, resulting in TSCI occur while carrying heavy loads on the head in young people. In developing countries high-falls feature, commonly from trees, balconies, flat roofs and construction sites. TSCI is also due to crush-injuries, diving and violence. Conclusion: The online global maps now inform an extrapolative statistical model, which estimates incidence for areas with insufficient TSCI data. The accuracy of this methodology will be improved through the use of prospective, standardised-data registries.	[Lee, B. B.] Prince Wales Hosp, Spinal Med Dept, Sydney, NSW 2031, Australia; [Lee, B. B.] Univ New S Wales, Neurosci Res Australia NEURA, Sydney, NSW, Australia; [Cripps, R. A.] Flinders Univ S Australia, Sch Med, Prevent Promot & Primary Hlth Care Cluster, Adelaide, SA 5001, Australia; [Fitzharris, M.] Monash Injury Res Inst, Accident Res Ctr, Melbourne, Vic, Australia; [Fitzharris, M.] Monash Injury Res Inst, Injury Outcomes Res Unit, Melbourne, Vic, Australia; [Wing, P. C.] Univ British Columbia, Div Spine, Vancouver, BC V5Z 1M9, Canada; [Wing, P. C.] Rick Hansen Inst, Vancouver, BC, Canada	Lee, BB (corresponding author), Prince Wales Hosp, Spinal Med Dept, Lvl 2 High St Entrance, Sydney, NSW 2031, Australia.	guslogie@gmail.com		Lee, Bonne/0000-0002-0433-2913; Fitzharris, Michael/0000-0002-3691-6868	Prince of Wales Hospital Training, Education and Study Leave fund (New South Wales Department of Health, Australia)	The members of the ISCoS prevention committee and the ISCoS membership for their continuing enthusiasm. Dr Lee and the Myriad Mapping were funded by the Prince of Wales Hospital Training, Education and Study Leave fund (New South Wales Department of Health, Australia). Many thanks to Hanan Youssef for helping us with reference coordination. In press data for this paper was made available by Vanessa Noonan, James Middleton, Anna Dayton and John Walsh.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; ACTON PA, 1993, ARCH PHYS MED REHAB, V74, P1035, DOI 10.1016/0003-9993(93)90058-I; Aito S, 2003, SPINAL CORD, V41, P629, DOI 10.1038/sj.sc.3101513; Alshahri SS, 2012, SPINAL CORD, V50, P882, DOI 10.1038/sc.2012.65; Amin A, 2005, SPINAL CORD, V43, P434, DOI 10.1038/sj.sc.3101734; Bajracharya Suraj, 2007, Indian J Orthop, V41, P286, DOI 10.4103/0019-5413.36988; Barros F, 1990, REV HOSP CLIN FM SAO, V45, P123; BIERINGSORENSEN F, 1990, PARAPLEGIA, V28, P105, DOI 10.1038/sc.1990.13; BLUMER CE, 1995, NEUROEPIDEMIOLOGY, V14, P258, DOI 10.1159/000109801; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; Calancie B, 2005, J SPINAL CORD MED, V28, P92, DOI 10.1080/10790268.2005.11753804; Chen HY, 1997, NEUROEPIDEMIOLOGY, V16, P241, DOI 10.1159/000109693; Cripps R, 2008, INJURY RES STAT SERI, V48; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Dahlberg A, 2005, SPINAL CORD, V43, P47, DOI 10.1038/sj.sc.3101616; DEVIVO MJ, 1980, ARCH NEUROL-CHICAGO, V37, P707, DOI 10.1001/archneur.1980.00500600055011; DITUNNO JF, 1994, NEW ENGL J MED, V330, P550, DOI 10.1056/NEJM199402243300808; Divanoglou A, 2009, SPINAL CORD, V47, P796, DOI 10.1038/sc.2009.28; DIXON GS, 1993, NEUROEPIDEMIOLOGY, V12, P88, DOI 10.1159/000110305; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Exner G, 1997, SPINAL CORD, V35, P415, DOI 10.1038/sj.sc.3100410; Farry Baxter, 2010, INCIDENCE PREVALENCE, P1; Fitzharris M, 2011, SPINAL CORD; Goebert D A, 1991, Hawaii Med J, V50, P47; GRIFFIN MR, 1985, J CHRON DIS, V38, P643, DOI 10.1016/0021-9681(85)90018-9; HART C, 1994, PARAPLEGIA, V32, P709, DOI 10.1038/sc.1994.115; Harvard University Institute for Health Metrics and Evaluation at the University of Wasington Johns Hopkins University University of Queensland World Health Organization (WHO), 2009, GLOB BURD DIS OP MAN; HARVEY C, 1990, PARAPLEGIA, V28, P537, DOI 10.1038/sc.1990.73; Hoque MF, 1999, SPINAL CORD, V37, P858, DOI 10.1038/sj.sc.3100938; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Ide Makoto, 1993, Journal of UOEH (University of Occupational and Environmental Health), V15, P209; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Karacan I, 2000, SPINAL CORD, V38, P697, DOI 10.1038/sj.sc.3101064; Key AG, 1968, PARAPLEGIA, P243; KNUTSDOTTIR S, 1993, PARAPLEGIA, V31, P68, DOI 10.1038/sc.1993.10; Kondakov E N, 2002, Zh Vopr Neirokhir Im N N Burdenko, P50; KOVINDHA A, 1993, CHIANG MAI MED B, V32, P85; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P1708, DOI 10.1016/j.apmr.2009.04.020; KURTZKE JF, 1975, EXP NEUROL, V48, P163, DOI 10.1016/0014-4886(75)90175-2; LASFARGUES JE, 1995, PARAPLEGIA, V33, P62, DOI 10.1038/sc.1995.16; Lee BB, 2010, SPINAL CORD, V48, P498, DOI 10.1038/sc.2009.168; Levy LF, 1998, SPINAL CORD, V36, P213, DOI 10.1038/sj.sc.3100574; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; Maharaj JC, 1996, SPINAL CORD, V34, P549, DOI 10.1038/sc.1996.99; Masood Z, 2008, PAK J MED SCI, V24, P368; Middleton JW, 2012, SPINAL CORD, V50, P803, DOI 10.1038/sc.2012.55; Mukhida K, 2006, CHILD NERV SYST, V22, P352, DOI 10.1007/s00381-005-1235-0; *NAT SPIN CORD INJ, 2008, SPIN CORD INJ FACTS; National Spinal Cord Injury Statistical Center, 2005, J Spinal Cord Med, V28, P379; Ning GZ, 2011, SPINAL CORD, V49, P386, DOI 10.1038/sc.2010.130; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Norton L., 2010, INJURY RES STAT SERI, pCanberra; Nwadinigwe C U, 2004, Niger J Med, V13, P161; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P37, DOI 10.1016/j.apmr.2004.03.018; O'Connor PJ, 2005, SPINAL CORD, V43, P42, DOI 10.1038/sj.sc.3101666; O'Connor RJ, 2006, SPINAL CORD, V44, P445, DOI 10.1038/sj.sc.3101856; Otom AS, 1997, SPINAL CORD, V35, P253, DOI 10.1038/sj.sc.3100402; Pajareya K, 1996, SPINAL CORD, V34, P608, DOI 10.1038/sc.1996.108; PEDERSEN V, 1989, PARAPLEGIA, V27, P345, DOI 10.1038/sc.1989.52; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Quinones M, 2002, MIDDLE E J EMERGENCY, V2, P1; Raja IA, 2001, WORLD J SURG, V25, P1230; RAZDAN S, 1994, NEUROEPIDEMIOLOGY, V13, P113, DOI 10.1159/000110368; Rick Hansen Spinal Cord Injury Registry, 2006, SPIN CORD INJ FACTS, P1; Sabre L, 2009, TRAUMATIC SPINAL COR; Schiller MD, 2011, ANZCOS BRISB AUSTR; SHINGU H, 1995, PARAPLEGIA, V33, P183, DOI 10.1038/sc.1995.42; SILBERSTEIN B, 1995, PARAPLEGIA, V33, P322, DOI 10.1038/sc.1995.72; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; United Nations, 2009, WORLD POP AG 2009; Van Den Berg M, 2011, J NEUROTRAUM, V28, P469, DOI 10.1089/neu.2010.1608; WALSH J, 1988, PARAPLEGIA, V26, P380, DOI 10.1038/sc.1988.58; Wang D., 2010, ISCOS WORKSH 111 28, V111; Weerts E, 2009, FIN REP REP PROJ OUT, P1; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628; Yousefzadeh Chabok Shahrokh, 2010, Acta Med Iran, V48, P308	83	363	401	7	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	FEB	2014	52	2					110	116		10.1038/sc.2012.158			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AA4RC	WOS:000331082700012	23439068	Other Gold	Y	N	2021-06-18	
J	Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK				Micu, I; Jiang, Q; Coderre, E; Ridsdale, A; Zhang, L; Woulfe, J; Yin, X; Trapp, BD; McRory, JE; Rehak, R; Zamponi, GW; Wang, W; Stys, PK			NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia	NATURE			English	Article							WHITE-MATTER; GLIAL-CELLS; GLUTAMATE; EXCITOTOXICITY; OLIGODENDROCYTES; MECHANISMS; DISORDERS; GLYCINE; INJURY	Central nervous system myelin is a specialized structure produced by oligodendrocytes that ensheaths axons, allowing rapid and efficient saltatory conduction of action potentials(1). Many disorders promote damage to and eventual loss of the myelin sheath, which often results in significant neurological morbidity. However, little is known about the fundamental mechanisms that initiate myelin damage, with the assumption being that its fate follows that of the parent oligodendrocyte. Here we show that NMDA (N-methyl-D-aspartate) glutamate receptors mediate Ca2+ accumulation in central myelin in response to chemical ischaemia in vitro. Using two-photon microscopy, we imaged fluorescence of the Ca2+ indicator X-rhod-1 loaded into oligodendrocytes and the cytoplasmic compartment of the myelin sheath in adult rat optic nerves. The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptor antagonist NBQX(2) completely blocked the ischaemic Ca2+ increase in oligodendroglial cell bodies, but only modestly reduced the Ca2+ increase in myelin. In contrast, the Ca2+ increase in myelin was abolished by broad-spectrum NMDA receptor antagonists (MK-801, 7-chlorokynurenic acid, D-AP5(3,4)), but not by more selective blockers of NR2A and NR2B subunit-containing receptors (NVP-AAM077(5) and ifenprodil(2,4)). In vitro ischaemia causes ultrastructural damage to both axon cylinders and myelin(6). NMDA receptor antagonism greatly reduced the damage to myelin. NR1, NR2 and NR3 subunits were detected in myelin by immunohistochemistry and immunoprecipitation, indicating that all necessary subunits are present for the formation of functional NMDA receptors. Our data show that the mature myelin sheath can respond independently to injurious stimuli. Given that axons are known to release glutamate(7-9), our finding that the Ca2+ increase was mediated in large part by activation of myelinic NMDA receptors suggests a new mechanism of axo-myelinic signalling. Such a mechanism may represent a potentially important therapeutic target in disorders in which demyelination is a prominent feature, such as multiple sclerosis, neurotrauma, infections (for example, HIV encephalomyelopathy) and aspects of ischaemic brain injury.	Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4K9, Canada; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA; Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	Stys, PK (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Div Neurosci, Ottawa, ON K1Y 4K9, Canada.	pstys@ohri.ca	Micu, Ileana/M-9468-2016	Micu, Ileana/0000-0001-7112-0075; Zamponi, Gerald/0000-0002-0644-9066			Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dingledine R, 1999, PHARMACOL REV, V51, P7; Hinman JD, 2004, J NEUROCHEM, V89, P430, DOI 10.1046/j.1471-4159.2004.02348.x; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; Li S, 1999, J Neurosci, V19, pRC16; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MRSULJA BJ, 1985, BRAIN RES, V343, P154, DOI 10.1016/0006-8993(85)91170-9; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; QUARLES RH, IN PRESS BASIC NEURO, P51; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Wallstrom E, 1996, J NEUROL SCI, V137, P89, DOI 10.1016/0022-510X(95)00339-4; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1995, AXON STRUCTURE FUNCT; Ziak D, 1998, PHYSIOL RES, V47, P365	30	362	376	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2006	439	7079					988	992		10.1038/nature04474			5	Multidisciplinary Sciences	Science & Technology - Other Topics	014NE	WOS:000235486100050	16372019				2021-06-18	
J	Broglio, SP; Cantu, RC; Gioia, GA; Guskiewicz, KM; Kutcher, J; Palm, M; McLeod, TCV				Broglio, Steven P.; Cantu, Robert C.; Gioia, Gerard A.; Guskiewicz, Kevin M.; Kutcher, Jeffrey; Palm, Michael; McLeod, Tamara C. Valovich			National Athletic Trainers' Association Position Statement: Management of Sport Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; pediatric concussions; education; assessment; evaluation; documentation	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; ERROR SCORING SYSTEM; MILD HEAD-INJURY; STABILITY FOLLOWING CONCUSSION; RANDOMIZED CONTROLLED-TRIAL; TEST-RETEST RELIABILITY; RETURN-TO-PLAY; NEUROCOGNITIVE PERFORMANCE; POSTURAL STABILITY	Objective: To provide athletic trainers, physicians, and other health care professionals with best-practice guidelines for the management of sport-related concussions. Background: An estimated 3.8 million concussions occur each year in the United States as a result of sport and physical activity. Athletic trainers are commonly the first medical providers available onsite to identify and evaluate these injuries. Recommendations: The recommendations for concussion management provided here are based on the most current research and divided into sections on education and prevention, documentation and legal aspects, evaluation and return to play, and other considerations.	[Broglio, Steven P.; Kutcher, Jeffrey] Univ Michigan, Ann Arbor, MI 48109 USA; [Cantu, Robert C.] Emerson Hosp, Dept Surg, Concord, MA USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Palm, Michael] Athlet Phys Therapy, Oak Brook, IL USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ USA	Broglio, SP (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		McLeod, Tamara/AAU-9435-2020	Guskiewicz, Kevin/0000-0002-8682-2130			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Blignaut J B, 1987, Br J Sports Med, V21, P5; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Curnow WJ, 2008, HEALTH PROMOT J AUST, V19, P10; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dobbs DB, 1993, TORTS COMPENSATION; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ebell MH, 2004, AM FAM PHYSICIAN, V69, P548; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Fischer K. W., 1996, DEV NEUROIMAGING MAP, P263; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2010, ATHL TRAIN SPORTS HL, V2, P248; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Halstead PD, 2001, J ATHL TRAINING, V36, P322; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hrysomallis C, 2004, J SCI MED SPORT, V7, P156, DOI 10.1016/S1440-2440(04)80005-7; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, 31 ANN C INT NEUR SO; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kahanov Leamor, 2005, Res Sports Med, V13, P77, DOI 10.1080/15438620590956025; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; National Collegiate Athletic Association, 2007, J ATHL TRAINING, V42, P165; O'Donoghue EM., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Osborne B, 2001, J ATHL TRAINING, V36, P316; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patel AV, 2007, J ATHL TRAINING, V42, P66; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Quandt EF, 2009, SPORTS HEALTH, V1, P84, DOI 10.1177/1941738108327530; Ragan BG, 2007, ATHLET THER TODAY, V12, P2; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Ray R, 2005, MANAGEMENT STRATEGIE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sefton J. M., 2004, J ATHL TRAINING, V39, pS52; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Susco TM, 2004, J ATHL TRAINING, V39, P241; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Talavage T, J NEUROTRAUMA; Thomas R, 1997, MCN Am J Matern Child Nurs, V22, P198, DOI 10.1097/00005721-199707000-00008; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; WILLIAMS SJ, 1994, BRIT J SPORT MED, V28, P96, DOI 10.1136/bjsm.28.2.96; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yakovlev P.I., 1967, RETIONAL DEV BRAIN E, P3; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	191	361	361	5	91	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR-APR	2014	49	2					245	265		10.4085/1062-6050-49.1.07			21	Sport Sciences	Sport Sciences	AQ3MH	WOS:000342697600012	24601910	Green Published	Y	N	2021-06-18	
J	Beattie, MS; Farooqui, AA; Bresnahan, JC				Beattie, MS; Farooqui, AA; Bresnahan, JC			Review of current evidence for apoptosis after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						cell death; secondary injury; SCI; apoptosis	TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN INJURY; NERVE GROWTH-FACTOR; KAPPA-B ACTIVATION; INDUCED NEURONAL APOPTOSIS; MONKEY MACACA-MULATTA; PROGRAMMED CELL-DEATH; COMPRESSION TRAUMA; DNA FRAGMENTATION; CONTROLLED TRIAL	The initial mechanical tissue disruption of spinal cord injury (SCI) is followed by a period of secondary injury that increases the size of the lesion. The secondary injury has long been thought to be due to the continuation of cellular destruction through necrotic (or passive) cell death. Recent evidence from brain injury and ischemia suggested that cellular apoptosis, an active form of programmed cell death seen during development, could play a role in CNS injury in adulthood. Here, we review the evidence that apoptosis may be important in the pathophysiology of SCI. There is now strong morphological and biochemical evidence from a number of laboratories demonstrating the presence of apoptosis after SCI. Apoptosis occurs in populations of neurons, oligodendrocytes, microglia, and, perhaps, astrocytes. The death of oligodendrocytes in white matter tracts continues for many weeks after injury and may contribute to post-injury demyelination. The mediators of apoptosis after SCI are not well understood, but there is a close relationship between microglia and dying oligodendrocytes, suggesting that microglial activation may be involved. There is also evidence for the activation of important intracellular pathways known to be involved in apoptosis in other cells and systems. For example, some members of the caspase family of cysteine proteases are activated after SCI. It appears that the evolution of the lesion after SCI involves both necrosis and apoptosis. It is likely that better understanding of apoptosis after SCI will lead to novel strategies for therapeutic interventions that can diminish secondary injury.	Ohio State Univ, Med Ctr, Dept Neurosci, Lab CNS Repair, Columbus, OH 43212 USA	Beattie, MS (corresponding author), Ohio State Univ, Med Ctr, Dept Neurosci, Lab CNS Repair, Room 4068,Graves Hall,333 W 10th Ave, Columbus, OH 43212 USA.	beattie.2@osu.edu	Beattie, Michael S/A-8953-2009				Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Arnold PM, 2000, J NEUROCHEM, V74, pS73; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie M. S., 1995, Society for Neuroscience Abstracts, V21, P1305; Beattie M. S., 1999, Society for Neuroscience Abstracts, V25, P762; Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; Beattie MS, 2000, CONT NEUROS, P1; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bethea JR, 1998, J NEUROSCI, V18, P3251; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; Blight AR, 1997, J NEUROTRAUM, V14, P89, DOI 10.1089/neu.1997.14.89; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; BRESNAHAN JC, 1976, J NEUROL SCI, V28, P521, DOI 10.1016/0022-510X(76)90122-2; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CasacciaBonnefil P, 1996, J NEUROSCI RES, V43, P382, DOI 10.1002/(SICI)1097-4547(19960201)43:3<382::AID-JNR13>3.0.CO;2-7; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Crowe M. J., 1995, Society for Neuroscience Abstracts, V21, P232; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DSOUZA S, 1995, J NEUROSCI, V15, P7293; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; HALL ED, 1996, NEUROTRAUMA, P1405; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; Hisahara S, 1997, J NEUROCHEM, V69, P10; Honmou O, 1996, J NEUROSCI, V16, P3199; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; Krenz NR, 2000, J NEUROCHEM, V74, P730, DOI 10.1046/j.1471-4159.2000.740730.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kruman I, 1997, J NEUROSCI, V17, P5089; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li Y, 1999, J NEUROCYTOL, V28, P417, DOI 10.1023/A:1007026001189; LI Y, 1995, AM J PATHOL, V146, P1045; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; MAJNO G, 1995, AM J PATHOL, V146, P3; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Pan WH, 1999, J NEUROSCI, V19, P3649; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RINK A, 1995, AM J PATHOL, V147, P1575; Rosenberg LJ, 1999, J NEUROSCI, V19, P464; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 1997, J NEUROCHEM, V68, P2469; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	73	361	381	1	32	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2000	17	10					915	925		10.1089/neu.2000.17.915			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	364LR	WOS:000089894300010	11063057				2021-06-18	
J	Hurst, RS; Hajos, M; Raggenbass, M; Wall, TM; Higdon, NR; Lawson, JA; Rutherford-Root, KL; Berkenpas, MB; Hoffmann, WE; Piotrowski, DW; Groppi, VE; Allaman, G; Ogier, R; Bertrand, S; Bertrand, D; Arneric, SP				Hurst, RS; Hajos, M; Raggenbass, M; Wall, TM; Higdon, NR; Lawson, JA; Rutherford-Root, KL; Berkenpas, MB; Hoffmann, WE; Piotrowski, DW; Groppi, VE; Allaman, G; Ogier, R; Bertrand, S; Bertrand, D; Arneric, SP			A novel positive allosteric modulator of the alpha 7 neuronal nicotinic acetylcholine receptor: In vitro and in vivo characterization	JOURNAL OF NEUROSCIENCE			English	Article						allosteric modulator; nicotinic receptor; alpha 7; hippocampus; auditory gating; PNU-120596	RAT HIPPOCAMPAL SLICES; INHIBITORY SYNAPTIC-TRANSMISSION; AGONIST GTS-21; COGNITIVE FUNCTION; ANESTHETIZED RATS; GABA RELEASE; SCHIZOPHRENIA; INTERNEURONS; MEMORY; SUBTYPES	Several lines of evidence suggest a link between the alpha 7 neuronal nicotinic acetylcholine receptor ( nAChR) and brain disorders including schizophrenia, Alzheimer's disease, and traumatic brain injury. The present work describes a novel molecule, 1-(5-chloro-2,4-dimethoxy-phenyl)- 3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), which acts as a powerful positive allosteric modulator of the alpha 7 nAChR. Discovered in a high-throughput screen, PNU-120596 increased agonist-evoked calcium flux mediated by an engineered variant of the human alpha 7 nAChR. Electrophysiology studies confirmed that PNU-120596 increased peak agonist-evoked currents mediated by wild-type receptors and also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist. In contrast, PNU-120596 produced no detectable change in currents mediated by alpha 4 beta 2, beta 3 beta 4, and alpha 9 alpha 10 nAChRs. PNU-120596 increased the channel mean open time of alpha 7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance. When applied to acute hippocampal slices, PNU-120596 increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by TTX, suggesting that PNU-120596 modulated the function of alpha 7 nAChRs located on the somatodendritic membrane of hippocampal interneurons. Accordingly, PNU-120596 greatly enhanced the ACh-evoked inward currents in these interneurons. Systemic administration of PNU-120596 to rats improved the auditory gating deficit caused by amphetamine, a model proposed to reflect a circuit level disturbance associated with schizophrenia. Together, these results suggest that PNU-120596 represents a new class of molecule that enhances alpha 7 nAChR function and thus has the potential to treat psychiatric and neurological disorders.	Pfizer Inc, Dept Neurosci, Global Res & Dev, Groton, CT 06340 USA; Univ Geneva, Dept Neurosci, CH-1211 Geneva, Switzerland	Hurst, RS (corresponding author), Pfizer Inc, Dept Neurosci, Global Res & Dev, Eastern Point Rd 8220-4060, Groton, CT 06340 USA.	raymond.s.hurst@pfizer.com	Hajos, Mihaly/A-8287-2008				Albuquerque EX, 2001, ALZ DIS ASSOC DIS, V15, pS19, DOI 10.1097/00002093-200108001-00004; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Alkondon M, 2004, PROG BRAIN RES, V145, P109, DOI 10.1016/S0079-6123(03)45007-3; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BERTRAND D, 1991, METHODS NEUROSCIENCE, V4, P174; Bettany JH, 2001, PHARMACOL BIOCHEM BE, V70, P467, DOI 10.1016/S0091-3057(01)00643-8; BICKFORDWIMER PC, 1990, BIOL PSYCHIAT, V27, P183, DOI 10.1016/0006-3223(90)90648-L; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Conroy WG, 2003, MOL PHARMACOL, V63, P419, DOI 10.1124/mol.63.2.419; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; De Luca V, 2004, NEUROPSYCHOPHARMACOL, V29, P1522, DOI 10.1038/sj.npp.1300466; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; Hogg RC, 2004, CNS NEUROL DISORD-DR, V3, P123, DOI 10.2174/1568007043482507; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Kofalvi A, 2000, J PHARMACOL EXP THER, V295, P453; Krause M, 2003, BIOL PSYCHIAT, V53, P244, DOI 10.1016/S0006-3223(02)01463-4; Krause RM, 1998, MOL PHARMACOL, V53, P283; Levin ED, 2002, J NEUROBIOL, V53, P633, DOI 10.1002/neu.10151; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Li XY, 1998, J NEUROSCI, V18, P1904; Maelicke A, 2000, DEMENT GERIATR COGN, V11, P11, DOI 10.1159/000051227; Maggi L, 2001, J PHYSIOL-LONDON, V536, P89, DOI 10.1111/j.1469-7793.2001.00089.x; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Meyer EM, 1998, J PHARMACOL EXP THER, V284, P1026; O'Neill HC, 2003, PSYCHOPHARMACOLOGY, V169, P332, DOI 10.1007/s00213-003-1482-2; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; Ogier R, 2003, EUR J NEUROSCI, V17, P2639, DOI 10.1046/j.1460-9568.2003.02708.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; SEGUELA P, 1993, J NEUROSCI, V13, P596; Smith RC, 2002, NEUROPSYCHOPHARMACOL, V27, P479, DOI 10.1016/S0893-133X(02)00324-X; Stevens KE, 1999, BIOL PSYCHIAT, V46, P1443, DOI 10.1016/S0006-3223(99)00200-0; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Stevens KE, 1997, PHARMACOL BIOCHEM BE, V57, P869, DOI 10.1016/S0091-3057(96)00466-2; Summers KL, 1997, JPN J PHARMACOL, V74, P139, DOI 10.1254/jjp.74.139; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; White HK, 2004, PSYCHOPHARMACOLOGY, V171, P465, DOI 10.1007/s00213-003-1614-8; Woodruff-Pak DS, 2003, BEHAV BRAIN RES, V143, P159, DOI 10.1016/S0166-4328(03)00039-1; WOODRUFFPAK DS, 1994, BRAIN RES, V645, P309, DOI 10.1016/0006-8993(94)91665-9; Zaninetti M, 2000, EUR J NEUROSCI, V12, P3975, DOI 10.1046/j.1460-9568.2000.00290.x; Zarei MM, 1999, NEUROSCIENCE, V88, P755, DOI 10.1016/S0306-4522(98)00246-2; Zbarsky V, 2004, NEUROBIOL DIS, V16, P283, DOI 10.1016/j.nbd.2004.02.009; Zwart R, 2002, NEUROPHARMACOLOGY, V43, P374, DOI 10.1016/S0028-3908(02)00094-1	63	360	366	0	33	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 27	2005	25	17					4396	4405		10.1523/JNEUROSCI.5269-04.2005			10	Neurosciences	Neurosciences & Neurology	920PP	WOS:000228702900021	15858066	Green Published, Bronze			2021-06-18	
J	Vespa, PM; O'Phelan, K; Shah, M; Mirabelli, J; Starkman, S; Kidwell, C; Saver, J; Nuwer, MR; Frazee, JG; McArthur, DA; Martin, NA				Vespa, PM; O'Phelan, K; Shah, M; Mirabelli, J; Starkman, S; Kidwell, C; Saver, J; Nuwer, MR; Frazee, JG; McArthur, DA; Martin, NA			Acute seizures after intracerebral hemorrhage - A factor in progressive midline shift and outcome	NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; INTENSIVE-CARE UNIT; SURGICAL-TREATMENT; VENTRICULAR BLOOD; EDEMA FORMATION; MODEL; THROMBIN; STROKE; MORTALITY; HEMATOMA	Objective: To determine whether early seizures that occur frequently after intracerebral hemorrhage (ICH) lead to increased brain edema as manifested by increased midline shift. Methods: A total of 109 patients with ischemic stroke (n = 46) and intraparenchymal hemorrhage (n = 63) prospectively underwent continuous EEG monitoring after admission. The incidence, timing, and factors associated with seizures were defined. Serial CT brain imaging was conducted at admission, 24 hours, and 48 to 72 hours after hemorrhage and assessed for hemorrhage volume and midline shift. Outcome at time of discharge was assessed using the Glasgow Outcome Scale score. Results: Electrographic seizures occurred in 18 of 63 (28%) patients with ICH, compared with 3 of 46 (6%) patients with ischemic stroke (OR = 5.7, 95% CI 1.4 to 26.5, p < 0.004) during the initial 72 hours after admission. Seizures were most often focal with secondary generalization. Seizures were more common in lobar hemorrhages but occurred in 21% of subcortical hemorrhages. Posthemorrhagic seizures were associated with neurologic worsening on the NIH Stroke Scale (14.8 vs 18.6, p < 0.05) and with an increase in midline shift (+ 2.7 mm vs -2.4 mm, p < 0.03). There was a trend toward increased poor outcome (p < 0.06) in patients with posthemorrhagic seizures. On multivariate analysis, age and initial NIH Stroke Scale score were independent predictors of outcome. Conclusion: Seizures occur commonly after ICH and may be nonconvulsive. Seizures are independently associated with increased midline shift after intraparenchymal hemorrhage.	Univ Calif Los Angeles, Sch Med, UCLA Stroke Ctr,UCLA Brain Injury Res Ctr, Dept Neurol,Div Neurosurg, Los Angeles, CA 90095 USA	Vespa, PM (corresponding author), Univ Calif Los Angeles, Sch Med, UCLA Stroke Ctr,UCLA Brain Injury Res Ctr, Dept Neurol,Div Neurosurg, 10833 Le Conte Ave,CHS 18-218, Los Angeles, CA 90095 USA.			Martin, Neil/0000-0002-6565-4131; Saver, Jeffrey/0000-0001-9141-2251	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS02089, NS0306] Funding Source: Medline		Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BATJER HH, 1990, ARCH NEUROL-CHICAGO, V47, P1103, DOI 10.1001/archneur.1990.00530100071015; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Clasen R A, 1980, Adv Neurol, V28, P395; FAUGHT E, 1989, NEUROLOGY, V39, P1089, DOI 10.1212/WNL.39.8.1089; Felberg RA, 2002, ANN NEUROL, V51, P517, DOI 10.1002/ana.10160; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Jauch E, 1999, STROKE, V30, P249; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Kidwell CS, 2001, NEUROLOGY, V57, P1611, DOI 10.1212/WNL.57.9.1611; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Mayer SA, 1998, STROKE, V29, P1791, DOI 10.1161/01.STR.29.9.1791; MCKISSOCK W, 1961, LANCET, V2, P221; Morgenstern LB, 1998, NEUROLOGY, V51, P1359, DOI 10.1212/WNL.51.5.1359; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; ROSEN AD, 1979, EXP NEUROL, V66, P277, DOI 10.1016/0014-4886(79)90080-3; SHINTON RA, 1988, J NEUROL NEUROSUR PS, V51, P273, DOI 10.1136/jnnp.51.2.273; SUNG CY, 1989, J NEUROL NEUROSUR PS, V52, P1273, DOI 10.1136/jnnp.52.11.1273; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; TUHRIM S, 1991, ANN NEUROL, V29, P658, DOI 10.1002/ana.410290614; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WEISBERG LA, 1991, NEUROLOGY, V41, P1197, DOI 10.1212/WNL.41.8.1197; WIGGINS WS, 1978, ARCH NEUROL-CHICAGO, V35, P832, DOI 10.1001/archneur.1978.00500360056011; Young GB, 1996, NEUROLOGY, V47, P83; YOUNG WB, 1990, NEUROLOGY, V40, P616, DOI 10.1212/WNL.40.4.616; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	39	360	366	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	MAY 13	2003	60	9					1441	1446		10.1212/01.WNL.0000063316.47591.B4			6	Clinical Neurology	Neurosciences & Neurology	676LT	WOS:000182754100010	12743228				2021-06-18	
J	Lovell, MR; Collins, MW; Iverson, GL; Field, M; Maroon, JC; Cantu, R; Podell, K; Powell, JW; Belza, M; Fu, FH				Lovell, MR; Collins, MW; Iverson, GL; Field, M; Maroon, JC; Cantu, R; Podell, K; Powell, JW; Belza, M; Fu, FH			Recovery from mild concussion in high school athletes	JOURNAL OF NEUROSURGERY			English	Article						concussion; traumatic brain injury; adolescent	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CEREBRAL CONCUSSION; SPORTS	Object. A computerized neuropsychological test battery was conducted to evaluate memory dysfunction and self-reporting of symptoms in a group of high school athletes who had suffered concussion. Methods. Neuropsychological performance prior to and following concussion was compared with the test performance of an age-matched control group. Potentially important diagnostic markers of concussion severity are discussed and linked to recovery within the 1st week of injury. Conclusions. High school athletes who had suffered mild concussion demonstrated significant declines in memory processes relative to a noninjured control group. Statistically significant differences between preseason and postinjury memory test results were still evident in the concussion group at 4 and 7 days postinjury. Self-reported neurological symptoms such as headache, dizziness, and nausea resolved by Day 4. Duration of on-field mental status changes such as retrograde amnesia and posttraumatic confusion was related to the presence of memory impairment at 36 hours and 4 and 7 days postinjury and was also related to slower resolution of self-reported symptoms. The results of this study suggest that caution should be exercised in returning high school athletes to the playing field following concussion. On-field mental status changes appear to have prognostic utility and should be taken into account when making return-to-play decisions following concussion. Athletes who exhibit on-field mental status changes for more than 5 minutes have longer-lasting postconcussion symptoms and memory decline.	Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15203 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; Emerson Hosp, Dept Neurol Surg, Concord, MA USA; Henry Ford Hlth Syst, Div Neuropsychol, Detroit, MI USA; Michigan State Univ, Dept Phys Educ & Exercise Sci, E Lansing, MI 48824 USA; Orthoped & Neurosurg Ctr Cascades, Dept Neurosurg, Bend, OR USA	Lovell, MR (corresponding author), Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	lovellmr@msx.upmc.edu		Iverson, Grant/0000-0001-7348-9570			CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, 2000, NEUROLOGIC ATHLETIC; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; PERRIN DH, 2001, J ATHL TRAINING, V36, P213; Pipe AL, 2001, CLIN J SPORT MED, V11, P1, DOI 10.1097/00042752-200101000-00001; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958	22	359	364	1	51	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2003	98	2					296	301		10.3171/jns.2003.98.2.0296			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	643RB	WOS:000180873300006	12593614				2021-06-18	
J	Sidaros, A; Engberg, A; Sidaros, K; Liptrot, MG; Herning, M; Petersen, P; Paulson, OB; Jernigan, TL; Rostrup, E				Sidaros, Annette; Engberg, Aasew.; Sidaros, Karam; Liptrot, Matthew G.; Herning, Margrethe; Petersen, Palle; Paulson, Olaf B.; Jernigan, Terry L.; Rostrup, Egill			Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study	BRAIN			English	Article						diffusion tensor imaging ( DTI); traumatic brain injury ( TBI); magnetic resonance imaging ( MRI); outcome prediction; neuroplasticity	WHITE-MATTER INJURY; AXONAL INJURY; PRACTICAL SCALE; HEAD-INJURY; WALLERIAN DEGENERATION; ANISOTROPY; WATER; CONSCIOUSNESS; LESIONS; DAMAGE	Diffusion tensor imaging ( DTI) has been proposed as a sensitive biomarker of traumatic white matter injury, which could potentially serve as a tool for prognostic assessment and for studying microstructural changes during recovery from traumatic brain injury ( TBI). However, there is a lack of longitudinal studies on TBI that follow DTI changes over time and correlate findings with long-term clinical outcome. We performed a prospective longitudinal study of 30 adult patients admitted for subacute rehabilitation following severe traumatic brain injury. DTI and conventional MRI were acquired at mean 8 weeks ( 5-11weeks), and repeated in 23 of the patients at mean 12 months ( 9-15 months) post-trauma. Using a region-of-interest-based approach, DTI parameters were compared to those of healthy matched controls, scanned during the same time period and rescanned with a similar interval as that of patients. At the initial scan, fractional anisotropy was reduced in all the investigated white matter regions in patients compared to controls (P <= 40.01) due to decreased diffusivity parallel (lambda(||)) and increased diffusivity perpendicular (lambda(perpendicular to)) to axonal fibre direction. Fractional anisotropy in the cerebral peduncle correlated with similar to 1 year Glasgow outcome scale score ( r= 0.60, P< 0.001) and in this sample predicted dichotomized outcome with 76% accuracy when taken alone, and with 100% accuracy in combination with clinical evaluation by functional independence measure at the time of the first scan. At follow-up DTI, fractional anisotropy in patients had increased in the internal capsule and in centrum semiovale ( P <= 0.01) due to an interval increase of lambda(||) with unchanged lambda(perpendicular to). In these regions, fractional anisotropy and lambda(||) reached normal or supranormal levels, primarily in patients with favourable outcome. In the cerebral peduncle and in corpus callosum, lambda(||) and lambda(perpendicular to) both increased during the scan interval and, particularly in patients with unfavourable outcome, fractional anisotropy remained depressed. No significant DTI parameter changes over time were found in controls, or in CSF of patients. These findings support that DTI is a clinically relevant biomarker in TBI, which may have prognostic value and also might serve as a tool for revealing changes in the neural tissue during recovery.	[Sidaros, Annette; Sidaros, Karam; Liptrot, Matthew G.; Herning, Margrethe; Paulson, Olaf B.; Jernigan, Terry L.; Rostrup, Egill] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Dept 340, DK-2650 Hvidovre, Denmark; [Sidaros, Annette; Engberg, Aasew.] Copenhagen Univ Hosp, Dept Neurorehabil, Brain Injury unit, DK-2650 Hvidovre, Denmark; [Petersen, Palle] Copenhagen Univ Hosp, Dept Neurol, Rigshospitalet, Denmark; [Paulson, Olaf B.] Copenhagen Univ Hosp, Neurobiol Res Unit, Rigshospitalet, Denmark; [Jernigan, Terry L.] Univ Calif San Diego, Dept Psychiat, Lab Cognit Imaging, San Diego, CA 92103 USA	Sidaros, A (corresponding author), Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Dept 340, DK-2650 Hvidovre, Denmark.	annettes@drcmr.dk	Rostrup, Egill/D-8622-2017; Paulson, Olaf B./N-6924-2016; Liptrot, Matthew/C-2384-2009	Rostrup, Egill/0000-0001-5015-5244; Paulson, Olaf B./0000-0001-7712-8596; Liptrot, Matthew/0000-0002-3381-4380			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; GENTRY LR, 2002, MAGNETIC RESONANCE I, P1059; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Le Bihan Denis, 1995, P181; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; TEASDALE G, 1974, LANCET, V2, P81; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021	39	357	376	31	67	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2008	131		2				559	572		10.1093/brain/awm294			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	258XO	WOS:000252903900025	18083753	Bronze, Green Published			2021-06-18	
J	Huang, YY; Sharma, SK; Carroll, J; Hamblin, MR				Huang, Ying-Ying; Sharma, Sulbha K.; Carroll, James; Hamblin, Michael R.			BIPHASIC DOSE RESPONSE IN LOW LEVEL LIGHT THERAPY - AN UPDATE	DOSE-RESPONSE			English	Article						low level laser therapy; photobiomodulation; biphasic dose response; reactive oxygen species; nitric oxide; traumatic brain injury	HELIUM-NEON LASER; HUMAN SKIN FIBROBLASTS; NF-KAPPA-B; NITRIC-OXIDE; CELLULAR-RESPONSES; IN-VITRO; IRRADIATION; RADIATION; FLUENCE; RATS	Low-level laser (light) therapy (LLLT) has been known since 1967 but still remains controversial due to incomplete understanding of the basic mechanisms and the selection of inappropriate dosimetric parameters that led to negative studies. The biphasic dose-response or Arndt-Schulz curve in LLLT has been shown both in vitro studies and in animal experiments. This review will provide an update to our previous (Huang et al. 2009) coverage of this topic. In vitro mediators of LLLT such as adenosine triphosphate (ATP) and mitochondrial membrane potential show biphasic patterns, while others such as mitochondrial reactive oxygen species show a triphasic dose-response with two distinct peaks. The Janus nature of reactive oxygen species (ROS) that may act as a beneficial signaling molecule at low concentrations and a harmful cytotoxic agent at high concentrations, may partly explain the observed responses in vivo. Transcranial LLLT for traumatic brain injury (TBI) in mice shows a distinct biphasic pattern with peaks in beneficial neurological effects observed when the number of treatments is varied, and when the energy density of an individual treatment is varied. Further understanding of the extent to which biphasic dose responses apply in LLLT will be necessary to optimize clinical treatments.	[Huang, Ying-Ying; Sharma, Sulbha K.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Ying-Ying; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Guilin, Guangxi, Peoples R China	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA.	Hamblin@helix.mgh.harvard.edu	Carroll, James/AAL-1739-2021; Huang, yingying/J-7329-2012; Hamblin, Michael R/H-2758-2019; Huang, Ying-ying/G-3153-2011	Carroll, James/0000-0002-9205-1061; Huang, yingying/0000-0002-4038-0277; Hamblin, Michael R/0000-0001-6431-4605; Huang, Ying-ying/0000-0003-3066-6981	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRP Program in TBI [W81XWH-09-1-0514]; Air Force Office of Scientific ResearchUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9950-04-1-0079]	This work was supported by NIH grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research (FA9950-04-1-0079).	Al-Watban FAH, 2001, LASER MED SCI, V16, P267, DOI 10.1007/PL00011363; ANDERS J, 2007, NAALT C P 2007; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; BOLTON P, 1991, Laser Therapy, V3, P105; BOLTON P A, 1990, Laser Therapy, V2, P101; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Brea-Calvo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005301; Brondon P, 2005, LASER SURG MED, V36, P409, DOI 10.1002/lsm.20183; Castano AP, 2007, LASER SURG MED, V39, P543, DOI 10.1002/lsm.20516; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chen ACH, 2009, PROC SPIE, V7165, DOI 10.1117/12.809605; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; Lopes NNF, 2009, SUPPORT CARE CANCER, V17, P1409, DOI 10.1007/s00520-009-0603-9; Gal P, 2009, LASER MED SCI, V24, P539, DOI 10.1007/s10103-008-0604-9; Ginsbach G, 1979, P LAS 79 OPT EL C MU, P5; GRECO M, 1989, BIOCHEM BIOPH RES CO, V163, P1428, DOI 10.1016/0006-291X(89)91138-8; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI [10.1089/ars.2009.2728, 10.1089/ARS.2009.2728]; HASHIMOTO K, 1997, LASER THERAPY, V7, P5; Hawkins D, 2005, PHOTOMED LASER SURG, V23, P251, DOI 10.1089/pho.2005.23.251; Hawkins D, 2006, PHOTOMED LASER SURG, V24, P705, DOI 10.1089/pho.2006.24.705; Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271; Hirst DG, 2010, CURR PHARM DESIGN, V16, P45, DOI 10.2174/138161210789941838; Huang L, 2011, J CELL PHYSIOL, V226, P588, DOI 10.1002/jcp.22367; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1989, Journal of Photochemistry and Photobiology B Biology, V3, P638, DOI 10.1016/1011-1344(89)80088-0; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lanzafame RJ, 2007, LASER SURG MED, V39, P534, DOI 10.1002/lsm.20519; LOEVSCHALL H, 1994, LASER SURG MED, V14, P347, DOI 10.1002/lsm.1900140407; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Lopes-Martins RAB, 2005, PHOTOMED LASER SURG, V23, P377, DOI 10.1089/pho.2005.23.377; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; MESTER E, 1978, ARCH DERMATOL RES, V263, P241, DOI 10.1007/BF00446940; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Poyton RO, 2011, DISCOV MED, V11, P154; Prabhu V, 2010, PHOTOCHEM PHOTOBIOL, V86, P1364, DOI 10.1111/j.1751-1097.2010.00791.x; Shiva S, 2009, J MOL CELL CARDIOL, V46, P1, DOI 10.1016/j.yjmcc.2008.10.005; Skopin MD, 2009, PHOTODERMATOL PHOTO, V25, P75, DOI 10.1111/j.1600-0781.2009.00406.x; Sutherland JC, 2002, PHOTOCHEM PHOTOBIOL, V76, P164, DOI 10.1562/0031-8655(2002)076<0164:BEOPL>2.0.CO;2; TUMILTY S, 2009, LOW LEVEL LASER TREA; Wu SN, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804923; Wu SN, 2009, J CELL PHYSIOL, V218, P603, DOI 10.1002/jcp.21636; Yamaura M, 2009, LASER SURG MED, V41, P282, DOI 10.1002/lsm.20766; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x	50	356	367	4	43	INT DOSE-RESPONSE SOC	AMHERST	UNIV MASSACHUSETTS SPH, MORRILL SCI CTR 1, N344, 639 N PLEASANT ST, AMHERST, MA 01003-9298 USA	1559-3258			DOSE-RESPONSE	Dose-Response		2011	9	4					602	618		10.2203/dose-response.11-009.Hamblin			17	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	858NN	WOS:000297806500009	22461763	DOAJ Gold, Green Published	Y	N	2021-06-18	
J	Veiel, HOF				Veiel, HOF			A preliminary profile of neuropsychological deficits associated with major depression	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CEREBRAL BLOOD-FLOW; FRONTAL-LOBE FUNCTIONS; COGNITIVE FUNCTION; PSYCHOMOTOR RETARDATION; AFFECTIVE-DISORDERS; RECOGNITION-MEMORY; IMPAIRMENT; DEMENTIA; RECALL; ABNORMALITIES	A profile of neuropsychological deficits of clinically depressed (major depression) but otherwise unimpaired individuals is presented, based on a meta-analysis of all studies published since 1975 and meeting stringent methodological and sample selection criteria. Deficits are discussed separately for different cognitive areas in terms of mean size of deficit, variability between studies, variability of individual scores in depressed populations relative to that of controls, and expected proportion of depressed individuals scoring two standard deviations or more below the mean of controls. The neuropsychological deficits of individuals with major depression are shown to be consistent with a global-diffuse impairment of brain functions with particular involvement of the frontal lobes. Recent neuro-imaging studies also indicating frontal dysfunction in clinical (functional) depression are referred to. Both the severity and the profile of cognitive deficiencies in depression are postulated to be similar to those seen in moderately severe traumatic brain injury.		Veiel, HOF (corresponding author), HV PSYCHOL CONSULTANTS INC, 1315-750 W BROADWAY, VANCOUVER, BC V5Z 1H5, CANADA.						ABAS MA, 1990, PSYCHOL MED, V20, P507, DOI 10.1017/S0033291700017025; ALEXOPOULOS GS, 1993, BIOL PSYCHIAT, V34, P141, DOI 10.1016/0006-3223(93)90383-O; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AUSTIN MP, 1992, J AFFECT DISORDERS, V25, P21, DOI 10.1016/0165-0327(92)90089-O; BANGERTDROWNS RL, 1986, PSYCHOL BULL, V99, P388, DOI 10.1037/0033-2909.99.3.388; BAUER RM, 1993, CLIN NEUROPSYCHOLOGY, P523; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BENCH CJ, 1992, PSYCHOL MED, V22, P607, DOI 10.1017/S003329170003806X; BENCH CJ, 1993, PSYCHOL MED, V23, P579, DOI 10.1017/S0033291700025368; Benton A, 1989, MULTILINGUAL APHASIA; BRAND AN, 1992, J AFFECT DISORDERS, V25, P77, DOI 10.1016/0165-0327(92)90095-N; BROWN RG, 1994, PSYCHOL MED, V24, P829, DOI 10.1017/S0033291700028932; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; CAINE ED, 1984, AM J PSYCHIAT, V141, P116; CALEV A, 1985, BRIT J CLIN PSYCHOL, V24, P127, DOI 10.1111/j.2044-8260.1985.tb01323.x; Cassens G, 1990, J Neuropsychiatry Clin Neurosci, V2, P202; CAVENAR J O JR, 1979, American Journal of Psychiatry, V136, P521; COFFEY CE, 1990, AM J PSYCHIAT, V147, P187; COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593; CORNELL DG, 1984, J ABNORM PSYCHOL, V93, P150; COUGHLAN AK, 1984, BRIT J PSYCHIAT, V145, P164, DOI 10.1192/bjp.145.2.164; Crosson B., 1992, SUBCORTICAL FUNCTION; Delis DC, 1987, CALIFORNIA VERBAL LE; DELVENNE V, 1990, BRIT J PSYCHIAT, V157, P359, DOI 10.1192/bjp.157.3.359; DEPTULA D, 1991, J CLIN EXP NEUROPSYC, V13, P854, DOI 10.1080/01688639108405103; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; DREVETS W C, 1989, Society for Neuroscience Abstracts, V15, P30; DUNBAR GC, 1984, BRIT J PSYCHIAT, V144, P376, DOI 10.1192/bjp.144.4.376; FISHER DG, 1986, INT J CLIN NEUROPSYC, V8, P14; Glass G.V., 1976, EDUC RES, P3, DOI DOI 10.3102/0013189X005010003; GOLDEN CJ, 1982, LURIA NEBRASKA NEURO; GOLINKOFF M, 1989, J AFFECT DISORDERS, V17, P105, DOI 10.1016/0165-0327(89)90032-3; Gronwall D, 1989, MILD HEAD INJURY, P153; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; KNOTT VJ, 1991, PROG NEURO-PSYCHOPH, V15, P249, DOI 10.1016/0278-5846(91)90088-I; KNOTT VJ, 1987, BIOL PSYCHIAT, V22, P313, DOI 10.1016/0006-3223(87)90149-1; KRAL VA, 1989, CAN J PSYCHIAT, V34, P445, DOI 10.1177/070674378903400515; LAMBERTY GJ, 1993, ARCH CLIN NEUROPSYCH, V8, P149, DOI 10.1016/0887-6177(93)90032-V; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P399; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; MAYBERG HS, 1994, J NUCL MED, V35, P929; NEWMAN J, 1986, APPL LINGUIST, V7, P109, DOI 10.1093/applin/7.1.109; POPKIN SJ, 1982, EXPT AGING RES, V8, P1982; REDING M, 1985, ARCH NEUROL-CHICAGO, V42, P894, DOI 10.1001/archneur.1985.04060080080019; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; RICHARDS PM, 1989, J CONSULT CLIN PSYCH, V57, P396, DOI 10.1037/0022-006X.57.3.396; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; ROSSI A, 1990, ACTA PSYCHIAT SCAND, V81, P245, DOI 10.1111/j.1600-0447.1990.tb06489.x; ROYBYRNE PP, 1986, ARCH GEN PSYCHIAT, V43, P265; SACKEIM HA, 1992, J CLIN EXP NEUROPSYC, V14, P268, DOI 10.1080/01688639208402828; SACKEIM HA, 1990, ARCH GEN PSYCHIAT, V47, P60; SPITZER RL, 1975, AM J PSYCHIAT, V132, P1187; STARKSTEIN SE, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P288; STERNBERG DE, 1976, ARCH GEN PSYCHIAT, V33, P219; Strauss E, 1991, COMPENDIUM NEUROPSYC; SUNG KM, 1992, BIOL PSYCHIAT, V31, P255, DOI 10.1016/0006-3223(92)90048-5; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; SWEET JJ, 1983, CLIN NEUROPSYCHOLOGY, V5, P103; THIER P, 1986, ELECTROEN CLIN NEURO, V63, P570, DOI 10.1016/0013-4694(86)90144-6; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WILLIAMS KM, 1990, BRIT J PSYCHIAT, V157, P366, DOI 10.1192/bjp.157.3.366; WOLFE J, 1987, J AFFECT DISORDERS, V13, P83, DOI 10.1016/0165-0327(87)90077-2; Wolfson D., 1993, HALSTEAD REITAN NEUR	71	355	372	0	47	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1997	19	4					587	603		10.1080/01688639708403745			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	YA413	WOS:A1997YA41300009	9342691				2021-06-18	
J	Olver, JH; Ponsford, JL; Curran, CA				Olver, JH; Ponsford, JL; Curran, CA			Outcome following traumatic brain injury: A comparison between 2 and 5 years after injury	BRAIN INJURY			English	Article							HEAD-INJURY	This study examined long-term outcome in traumatically brain-injured individuals following discharge from a comprehensive rehabilitation programme. Of 254 traumatic brain injury (TBI) patients reviewed at 2 years, 103 have been followed up at 5 years using a structured interview format detailing neurological symptoms, mobility, independence in ADL, productivity status, relationship issues, communication and the presence of cognitive, behavioural and emotional changes. Visual difficulties, headache and fatigue were persistent in a significant number of patients. Between 2 and 5 years there was increased independence in personal, domestic and community ADL and the use of transport. Ten more patients had returned to driving. On the other hand there was a slightly higher incidence of cognitive, behavioural and emotional changes reported at 5 years. Thirty-two per cent of those working at 2 years were not employed at 5 years. Many students had also become unemployed. These findings suggest the need for intermittent lifelong intervention following TBI. Systems of rehabilitation need to be adapted to provide this.	BETHESDA HOSP,MELBOURNE,VIC,AUSTRALIA				Olver, John/0000-0001-7069-1191			BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047	6	353	357	0	30	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1996	10	11					841	848		10.1080/026990596123945			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	VM779	WOS:A1996VM77900005	8905161				2021-06-18	
J	Wilde, EA; McCauley, SR; Hunter, JV; Bigler, ED; Chu, Z; Wang, ZJ; Hanten, GR; Troyanskaya, M; Yallampalli, R; Li, X; Chia, J; Levin, HS				Wilde, E. A.; McCauley, S. R.; Hunter, J. V.; Bigler, E. D.; Chu, Z.; Wang, Z. J.; Hanten, G. R.; Troyanskaya, M.; Yallampalli, R.; Li, X.; Chia, J.; Levin, H. S.			Diffusion tensor imaging of acute mild traumatic brain injury in adolescents	NEUROLOGY			English	Article							AXONAL INJURY; HEAD-INJURY; CORPUS-CALLOSUM; CELLULAR EDEMA; CONCUSSION; ANISOTROPY; SYMPTOMS; CHILDREN; MODERATE; LESIONS	Background: Despite normal CT imaging and neurologic functioning, many individuals report postconcussion symptoms following mild traumatic brain injury (MTBI). This dissociation has been enigmatic for clinicians and investigators. Methods: Diffusion tensor imaging tractography of the corpus callosum was performed in 10 adolescents (14 to 19 years of age) with MTBI 1 to 6 days postinjury with Glasgow Coma Scale score of 15 and negative CT, and 10 age- and gender-equivalent uninjured controls. Subjects were administered the Rivermead Post Concussion Symptoms Questionnaire and the Brief Symptom Inventory to assess self-reported cognitive, affective, and somatic symptoms. Results: The MTBI group demonstrated increased fractional anisotropy and decreased apparent diffusion coefficient and radial diffusivity, and more intense postconcussion symptoms and emotional distress compared to the control group. Increased fractional anisotropy and decreased radial diffusivity were correlated with severity of postconcussion symptoms in the MTBI group, but not in the control group. Conclusions: In adolescents with mild traumatic brain injury (MTBI) with Glasgow Coma Scale score of 15 and negative CT, diffusion tensor imaging (DTI) performed within 6 days postinjury showed increased fractional anisotropy and decreased diffusivity suggestive of cytotoxic edema. Advanced MRI-based DTI methods may enhance our understanding of the neuropathology of TBI, including MTBI. Additionally, DTI may prove more sensitive than conventional imaging methods in detecting subtle, but clinically meaningful, changes following MTBI and may be critical in refining MTBI diagnosis, prognosis, and management.	[Wilde, E. A.; McCauley, S. R.; Hanten, G. R.; Troyanskaya, M.; Yallampalli, R.; Li, X.; Levin, H. S.] Univ Texas Houston, Sch Med, Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77025 USA; [Hunter, J. V.; Chu, Z.; Wang, Z. J.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Hunter, J. V.] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Bigler, E. D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Bigler, E. D.] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Bigler, E. D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT 84112 USA; [Chia, J.] Philips Med Syst, Cleveland, OH USA	Wilde, EA (corresponding author), Univ Texas Houston, Sch Med, Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 725, Houston, TX 77025 USA.	ewilde@bcm.edu	Wang, Zhiyue J/L-3851-2014	Wang, Zhiyue J/0000-0002-5649-2900	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS021889] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Derogatis L. R., 1993, ADM SCORING PROCEDUR; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Gallucci M, 2007, NEURORADIOLOGY, V49, P541, DOI 10.1007/s00234-007-0235-z; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; TEASDALE G, 1974, LANCET, V2, P81; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	43	352	358	0	41	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 18	2008	70	12					948	955		10.1212/01.wnl.0000305961.68029.54			8	Clinical Neurology	Neurosciences & Neurology	275IQ	WOS:000254065500009	18347317				2021-06-18	
J	Junk, AK; Mammis, A; Savitz, SI; Singh, M; Roth, S; Malhotra, S; Rosenbaum, PS; Cerami, A; Brines, M; Rosenbaum, DM				Junk, AK; Mammis, A; Savitz, SI; Singh, M; Roth, S; Malhotra, S; Rosenbaum, PS; Cerami, A; Brines, M; Rosenbaum, DM			Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							TRANSIENT GLOBAL-ISCHEMIA; RAT RETINA; MEDIATED NEUROPROTECTION; AURINTRICARBOXYLIC ACID; DNA FRAGMENTATION; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; UP-REGULATION; CELL-DEATH; IN-VIVO	Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury. Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury after middle cerebral artery occlusion, traumatic brain injury, neuroinflammation, and excitotoxicity. Protection is in part mediated by antiapoptotic mechanisms. We conducted parallel studies of rhEPO in a model of transient global retinal ischemia induced by raising intraocular pressure, which is a clinically relevant model for retinal diseases. We observed abundant expression of EPO receptor (EPO-R) throughout the ischemic retina. Neutralization of endogenous EPO with soluble EPO-R exacerbated ischemic injury, which supports a crucial role for an endogenous EPO/EPO-R system in the survival and recovery of neurons after an ischemic insult. Systemic administration of rhEPO before or immediately after retinal ischemia not only reduced histopathological damage but also promoted functional recovery as assessed by electroretinography. Exogenous EPO also significantly diminished terminal deoxynucleotidyltransferase-mediated dUTP end labeling labeling of neurons in the ischemic retina, implying an antiapoptotic mechanism of action. These results further establish EPO as a neuroprotective agent in acute neuronal ischemic injury.	Yeshiva Univ Albert Einstein Coll Med, Kennedy Ctr, Dept Neurol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10461 USA; Kenneth S Warren Inst, Kitchawan, NY 10592 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Rosenbaum, DM (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Kennedy Ctr, Dept Neurol, 1410 Pelham Pkwy S, Bronx, NY 10461 USA.		Brinesd, Michael/AAE-6072-2020; Roth, Steven/V-8135-2019; Junk, Anna/L-2620-2017	Roth, Steven/0000-0002-4955-9855; Brines, Michael/0000-0003-4151-4449; Mammis, Antonios/0000-0003-0892-9888; Junk, Anna/0000-0001-6612-0118	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY11257, EY10343, R01 EY010343] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY010343] Funding Source: NIH RePORTER		Antonawich FJ, 1998, J CEREBR BLOOD F MET, V18, P882, DOI 10.1097/00004647-199808000-00008; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bhat RV, 1996, J NEUROSCI, V16, P4146; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUCHI ER, 1992, EXP EYE RES, V55, P605, DOI 10.1016/S0014-4835(05)80173-3; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; DAVIS M, 1969, CLIN OBSERVATIONS CO; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; FOOS RY, 1976, A GRAEF ARCH KLIN EX, V200, P183, DOI 10.1007/BF01028533; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Klocker N, 2000, J NEUROSCI, V20, P6962, DOI 10.1523/JNEUROSCI.20-18-06962.2000; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Lewczuk P, 2000, NEUROREPORT, V11, P3485, DOI 10.1097/00001756-200011090-00017; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NITATORI T, 1995, J NEUROSCI, V15, P1001; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rosenbaum DM, 1998, ANN NEUROL, V43, P654, DOI 10.1002/ana.410430515; Rosenbaum DM, 1997, VISION RES, V37, P3445, DOI 10.1016/S0042-6989(96)00328-8; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; SCHWARTZ B, 1991, PHOTOGRAMMETRY IMAGE; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166	33	352	396	0	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 6	2002	99	16					10659	10664		10.1073/pnas.152321399			6	Multidisciplinary Sciences	Science & Technology - Other Topics	582HC	WOS:000177343200080	12130665	Bronze, Green Published			2021-06-18	
J	Cruse, D; Chennu, S; Chatelle, C; Bekinschtein, TA; Fernandez-Espejo, D; Pickard, JD; Laureys, S; Owen, AM				Cruse, Damian; Chennu, Srivas; Chatelle, Camille; Bekinschtein, Tristan A.; Fernandez-Espejo, Davinia; Pickard, John D.; Laureys, Steven; Owen, Adrian M.			Bedside detection of awareness in the vegetative state: a cohort study	LANCET			English	Article							BRAIN-COMPUTER INTERFACES; MOTOR IMAGERY; BCI; COMMUNICATION; ACCURACY	Background Patients diagnosed as vegetative have periods of wakefulness, but seem to be unaware of themselves or their environment. Although functional MRI (fMRI) studies have shown that some of these patients are consciously aware, issues of expense and accessibility preclude the use of fMRI assessment in most of these individuals. We aimed to assess bedside detection of awareness with an electroencephalography (EEG) technique in patients in the vegetative state. Methods This study was undertaken at two European centres. We recruited patients with traumatic brain injury and non-traumatic brain injury who met the Coma Recovery Scale-Revised definition of vegetative state. We developed a novel EEG task involving motor imagery to detect command-following-a universally accepted clinical indicator of awareness-in the absence of overt behaviour. Patients completed the task in which they were required to imagine movements of their right-hand and toes to command. We analysed the command-specific EEG responses of each patient for robust evidence of appropriate, consistent, and statistically reliable markers of motor imagery, similar to those noted in healthy, conscious controls. Findings We assessed 16 patients diagnosed in the vegetative state, and 12 healthy controls. Three (19%) of 16 patients could repeatedly and reliably generate appropriate EEG responses to two distinct commands, despite being behaviourally entirely unresponsive (classification accuracy 61-78%). We noted no significant relation between patients' clinical histories (age, time since injury, cause, and behavioural score) and their ability to follow commands. When separated according to cause, two (20%) of the five traumatic and one (9%) of the 11 non-traumatic patients were able to successfully complete this task. Interpretation Despite rigorous clinical assessment, many patients in the vegetative state are misdiagnosed. The EEG method that we developed is cheap, portable, widely available, and objective. It could allow the widespread use of this bedside technique for the rediagnosis of patients who behaviourally seem to be entirely vegetative, but who might have residual cognitive function and conscious awareness.	[Cruse, Damian; Fernandez-Espejo, Davinia; Owen, Adrian M.] Univ Western Ontario, Ctr Brain & Mind, London, ON N6A 5B7, Canada; [Cruse, Damian; Bekinschtein, Tristan A.; Owen, Adrian M.] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge, England; [Chennu, Srivas] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Chatelle, Camille; Laureys, Steven] Univ & Univ Hosp Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Chatelle, Camille; Laureys, Steven] Univ & Univ Hosp Liege, Dept Neurol, Liege, Belgium; [Pickard, John D.] Addenbrookes Hopsital, Div Acad Neurosurg, Cambridge, England	Cruse, D (corresponding author), Univ Western Ontario, Ctr Brain & Mind, London, ON N6A 5B7, Canada.	dcruse@uwo.ca	Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Owen, Adrian M/B-4997-2015	Laureys, Steven/0000-0002-3096-3807; Fernandez-Espejo, Davinia/0000-0001-5941-7546; Chatelle, Camille/0000-0002-7526-2107; Chennu, Srivas/0000-0002-6840-2941; Bekinschtein, Tristan/0000-0001-5501-8628	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; James S McDonnell Foundation; Canada Excellence Research Chairs ProgramCanada Research Chairs; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Fonds de la Recherche ScientifiqueFonds de la Recherche Scientifique - FNRS; Mind Science Foundation; Belgian French-Speaking Community Concerted Research Action; University Hospital of Liege; University of LiegeUniversity of Liege; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, MC_U105559847, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	Medical Research Council, James S McDonnell Foundation, Canada Excellence Research Chairs Program, European Commission, Fonds de la Recherche Scientifique, Mind Science Foundation, Belgian French-Speaking Community Concerted Research Action, University Hospital of Liege, University of Liege.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pfurtscheller G, 2008, EUR J NEUROSCI, V28, P1419, DOI 10.1111/j.1460-9568.2008.06441.x; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pfurtscheller Gert, 1994, Brain Topography, V6, P269, DOI 10.1007/BF01211172; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Scholkopf B., 2002, LEARNING KERNELS; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	20	351	360	5	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					2088	2094		10.1016/S0140-6736(11)61224-5			7	Medicine, General & Internal	General & Internal Medicine	865EL	WOS:000298293600030	22078855		Y	N	2021-06-18	
J	Daneshvar, DH; Nowinski, CJ; McKee, AC; Cantu, RC				Daneshvar, Daniel H.; Nowinski, Christopher J.; McKee, Ann C.; Cantu, Robert C.			The Epidemiology of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Epidemiology; Equipment; Traumatic brain injury; Sport	CHEERLEADING-RELATED INJURIES; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; UNITED-STATES; ICE HOCKEY; HEAD-INJURIES; RISK-FACTORS; DESCRIPTIVE EPIDEMIOLOGY; EMERGENCY-DEPARTMENTS; SURVEILLANCE SYSTEM	Concussions and head injuries may never be completely eliminated from sports. However, with better data comes an improved understanding of the types of actions and activities that typically result in concussions. With this knowledge can come improved techniques and rule changes to minimize the rate and severity of concussions in sports. This article identifies the factors that affect concussion rate.	[Daneshvar, Daniel H.; Nowinski, Christopher J.; Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurol, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA USA; [McKee, Ann C.] Bedford Vet Affairs Med Ctr, Dept Neuropathol, Bedford, MA 01730 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA; [Cantu, Robert C.] Emerson Hosp, Dept Surg, Concord, MA 01742 USA; [Cantu, Robert C.] Brigham & Womens Hosp, Dept Neurosurg, Neurol Sports Injury Ctr, Boston, MA 02115 USA	Daneshvar, DH (corresponding author), Boston Univ, Sch Med, Dept Neurol, Ctr Study Traumat Encephalopathy, 72 E Concord St,B7800, Boston, MA 02118 USA.	ddanesh@bu.edu		Daneshvar, Daniel/0000-0003-3691-9513	Boston University Alzheimer's Disease Center [NIA P30 AG13846, 0572063345-5]; National Operating Committee on Standards for Athletic Equipment; National Collegiate Athletic Association; National Federation of State High School Associations; American Football Coaches Association; Sports Legacy Institute; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This work was supported by the Boston University Alzheimer's Disease Center NIA P30 AG13846, supplement 0572063345-5, the National Operating Committee on Standards for Athletic Equipment, the National Collegiate Athletic Association, the National Federation of State High School Associations, the American Football Coaches Association, and the Sports Legacy Institute.	[Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; [Anonymous], 2001, REP TRENDS PART YOUT; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bridges EJ, 2003, BRIT J SPORT MED, V37, P511, DOI 10.1136/bjsm.37.6.511; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giannone L., 2006, AM ASS CHEERLEADING, P1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Mueller F, 2009, CATASTROPHIC FOOTBAL; Mueller F. O., 2010, ANN SURVEY FOOTBALL; Mueller FO, 1982, CATASTROPHIC SPORT I; Mueller FO, 2003, CATASTROPHIC SPORT I; *NAT CTR CHRON DIS, 2006, BEH RISK FACT SURV S; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Yard EE, 2006, J ATHL TRAINING, V41, P441	48	351	352	5	114	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					1	+		10.1016/j.csm.2010.08.006			18	Sport Sciences	Sport Sciences	691XR	WOS:000285114800003	21074078	Green Accepted	Y	N	2021-06-18	
J	Barlow, KM; Crawford, S; Stevenson, A; Sandhu, SS; Belanger, F; Dewey, D				Barlow, Karen Maria; Crawford, Susan; Stevenson, Andrea; Sandhu, Sandeep Sona; Belanger, Francois; Dewey, Deborah			Epidemiology of Postconcussion Syndrome in Pediatric Mild Traumatic Brain Injury	PEDIATRICS			English	Article						mild traumatic brain injury; children; cerebral concussion; postconcussion syndrome; epidemiology; outcome	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; FOLLOW-UP; CHILDREN; VALIDITY; RELIABILITY; RECOVERY; ADULTS	BACKGROUND: Much disagreement exists as to whether postconcussion syndrome (PCS) is attributable to brain injury or to other factors such as trauma alone, preexisting psychosocial problems, or medicolegal issues. We investigated the epidemiology and natural history of PCS symptoms in a large cohort of children with a mild traumatic brain injury (mTBI) and compared them with children with an extracranial injury (ECI). METHODS: This investigation was a prospective, consecutive controlled-cohort study of 670 children who presented to a tertiary referral emergency department with mTBI and 197 children who presented with ECI. For all participants, data were collected by use of a telephone interview of a parent 7 to 10 days after injury. If a change from preinjury symptoms was reported by a parent, follow-up continued monthly until symptom resolution. Outcomes were measured by using the Post Concussion Symptom Inventory, Rivermead Postconcussion Symptom Questionnaire, Brief Symptom Inventory, and Family Assessment Device. RESULTS: There was a significant difference between the mTBI and ECI groups in their survival curves for time to symptom resolution (log rank [Mantel-Cox] 11.15, P < .001). Three months after injury, 11% of the children in the mTBI group were symptomatic (13.7% of children older than 6 years) compared with 0.5% of the children in the ECI group. The prevalence of persistent symptoms at 1 year was 2.3% in the mTBI group and 0.01% in the ECI group. Family functioning and maternal adjustment did not differ between groups. CONCLUSIONS: Among school-aged children with mTBI, 13.7% were symptomatic 3 months after injury. This finding could not be explained by trauma, family dysfunction, or maternal psychological adjustment. The results of this study provide clear support for the validity of the diagnosis of PCS in children. Pediatrics 2010; 126: e374-e381	[Barlow, Karen Maria; Crawford, Susan; Dewey, Deborah] Alberta Childrens Prov Gen Hosp, Res Inst Children & Maternal Hlth, Calgary, AB T2B 6A8, Canada; [Barlow, Karen Maria; Belanger, Francois; Dewey, Deborah] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Barlow, Karen Maria; Sandhu, Sandeep Sona] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Stevenson, Andrea; Sandhu, Sandeep Sona] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Dewey, Deborah] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Crawford, Susan; Dewey, Deborah] Alberta Childrens Prov Gen Hosp, Behav Res Unit, Dept Pediat, Calgary, AB T2B 6A8, Canada; [Belanger, Francois] Alberta Childrens Prov Gen Hosp, Div Pediat Emergency, Dept Pediat, Calgary, AB T2B 6A8, Canada	Barlow, KM (corresponding author), Alberta Childrens Prov Gen Hosp, Res Inst Children & Maternal Hlth, C4-335,2888 Shaganappi Trail NW, Calgary, AB T2B 6A8, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Dewey, Deborah/0000-0002-1323-5832; Barlow, Karen/0000-0003-2612-8507	Alberta Children's Hospital Foundation	This research was supported by a grant from the Alberta Children's Hospital Foundation.	ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Burton LJ, 1997, PEDIATR EMERG CARE, V13, P1, DOI 10.1097/00006565-199702000-00001; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; GLASS KL, 2005, ANN M INT NEUR SOC F; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MATEER CA, 1992, DISORDERS PHYS MED R, P143; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Newcombe RG, 2006, STAT MED, V25, P543, DOI 10.1002/sim.2323; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Von Wild K, 2001, BRAIN INJURY, V15, P273; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; YEATES KO, 2005, ANN M INT NEUR SOC F	35	351	352	1	37	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2010	126	2					E374	E381		10.1542/peds.2009-0925			8	Pediatrics	Pediatrics	634FO	WOS:000280565700041	20660554				2021-06-18	
J	Zaloshnja, E; Miller, T; Langlois, JA; Selassie, AW				Zaloshnja, Eduard; Miller, Ted; Langlois, Jean A.; Selassie, Anbesaw W.			Prevalence of Long-Term Disability From Traumatic Brain Injury in the Civilian Population of the United States, 2005	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						life expectancy; long-term disability; long-term disability incidence; long-term disability prevalence; traumatic brain injury	MODEL SYSTEMS; HOSPITALIZATION; MORTALITY; MATRIX	To estimate the prevalence of long-term disability associated with traumatic brain injury (TBI) in the civilian population of the United States. Methods: We first estimated how many people experienced long-term disability from TBI each year in the past 70 years. Then, accounting for the increased mortality among TBI surviors, we estimated their life expectancy and calculated how many were expected to be alive in 2005. Results: An estimated 1.1 % of the US civilian population or 3.17 million people (95% CI: 3.02-3.32 million) were living with a long-term disability from TBI at the beginning of 2005. Under less conservative assumptions about TBI's impact on lifespan, this estimate is 3.32 million (95% CI: 3.16-3.48 million). Conclusion: Substantial long-term disability occurs among the US civilians hospitalized with a TBI.	[Zaloshnja, Eduard; Miller, Ted] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Langlois, Jean A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Selassie, Anbesaw W.] Med Univ S Carolina, Charleston, SC 29425 USA	Zaloshnja, E (corresponding author), Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Calverton, MD 20705 USA.	zaloshnja@pire.org		Miller, Ted/0000-0002-0958-2639			ARIAS E, 2007, US LIFE TABLES 2003, V54; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Butler J, 2001, CENTRAL NERVOUS SYST; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Finkelstein E, 2000, INCIDENCE EC BURDEN; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVY PS, 1999, SAMPLING POPULATIONS; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; US Census Bureau, 2008, 2008 STAT ABSTR NAT	15	351	354	1	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					394	400		10.1097/01.HTR.0000341435.52004.ac			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300005	19033832				2021-06-18	
J	LYETH, BG; JENKINS, LW; HAMM, RJ; DIXON, CE; PHILLIPS, LL; CLIFTON, GL; YOUNG, HF; HAYES, RL				LYETH, BG; JENKINS, LW; HAMM, RJ; DIXON, CE; PHILLIPS, LL; CLIFTON, GL; YOUNG, HF; HAYES, RL			PROLONGED MEMORY IMPAIRMENT IN THE ABSENCE OF HIPPOCAMPAL CELL-DEATH FOLLOWING TRAUMATIC BRAIN INJURY IN THE RAT	BRAIN RESEARCH			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298	LYETH, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587, NS21458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587, R01NS021458] Funding Source: NIH RePORTER		ABE K, 1987, J CEREB BLOOD FLO S1, V7, pS70; AUER RN, 1989, J NEUROSCI, V9, P1641; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; DAVIS HP, 1987, PHYSIOL BEHAV, V39, P783, DOI 10.1016/0031-9384(87)90267-8; DEWITT DS, 1989, J CEREB BLOOD FLO S1, V9, pS93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GRONWALL D, 1974, LANCET, V2, P605; HAYES R L, 1988, Society for Neuroscience Abstracts, V14, P1153; HAYES RL, 1988, J NEUROTRAUM, V5, P287; Hayes RL, 1989, MILD HEAD INJURY, P54; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, IN PRESS NEUROTRAUMA, V4; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; JENKINS LW, 1989, CONT ISSUES NEUROLOG, V1; KATAYAMA Y, 1988, Society for Neuroscience Abstracts, V14, P1154; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LYETH B G, 1987, Society for Neuroscience Abstracts, V13, P1253; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MALENKA RC, 1989, TRENDS NEUROSCI, V12, P444, DOI 10.1016/0166-2236(89)90094-5; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MIAZAKI S, 1989, INTRACRANIAL PRESSUR, V7, P651; MILLER LG, IN PRESS BRAIN RES; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; OLTON DS, 1978, PHYSIOL BEHAV, V20, P597, DOI 10.1016/0031-9384(78)90252-4; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; ONODERA H, 1989, BRAIN RES, V481, P1, DOI 10.1016/0006-8993(89)90478-2; Povlishock JT, 1985, CENTRAL NERVOUS SYST, P443; RASMUSSEN H, 1983, REV PHYSL BIOCH PHAR, V95, P111; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUSSELL WR, 1946, BRAIN, V69, P183; RUTHERFORD WH, 1977, LANCET, V1, P1; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; THIBAULT LE, 1985, CENTRAL NERVOUS SYST, P443; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558; WESTERLAIN CG, 1989, BASIC NEUROCHEMISTRY, P797; YOSHIDOMI M, 1989, J CEREB BLOOD FLOW M, V9, pS186; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	53	351	358	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	SEP 3	1990	526	2					249	258		10.1016/0006-8993(90)91229-A			10	Neurosciences	Neurosciences & Neurology	EC087	WOS:A1990EC08700011	2257484				2021-06-18	
J	Ehde, DM; Dillworth, TM; Turner, JA				Ehde, Dawn M.; Dillworth, Tiara M.; Turner, Judith A.			Cognitive-Behavioral Therapy for Individuals With Chronic Pain Efficacy, Innovations, and Directions for Research	AMERICAN PSYCHOLOGIST			English	Article						chronic pain; cognitive-behavioral therapy	LOW-BACK-PAIN; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; PRIMARY-CARE; PHYSICAL-THERAPY; PSYCHOLOGICAL INTERVENTIONS; MUSCULOSKELETAL PAIN; MANAGEMENT PROGRAM; RANDOMIZED-TRIAL; START BACK	Over the past three decades, cognitive-behavioral therapy (CBT) has become a first-line psychosocial treatment for individuals with chronic pain. Evidence for efficacy in improving pain and pain-related problems across a wide spectrum of chronic pain syndromes has come from multiple randomized controlled trials. CBT has been tailored to, and found beneficial for, special populations with chronic pain, including children and older adults. Innovations in CBT delivery formats (e. g., Web-based, telephone-delivered) and treatments based on CBT principles that are delivered by health professionals other than psychologists show promise for chronic pain problems. This article reviews (a) the evidence base for CBT as applied to chronic pain, (b) recent innovations in target populations and delivery methods that expand the application of CBT to underserved populations, (c) current limitations and knowledge gaps, and (d) promising directions for improving CBT efficacy and access for people living with chronic pain.	[Ehde, Dawn M.; Turner, Judith A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Dillworth, Tiara M.; Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA	Ehde, DM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA.	ehde@uw.edu	Ehde, Dawn/K-1883-2016	Ehde, Dawn/0000-0002-9555-2347	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057916] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD057916] Funding Source: Medline		Agency for Healthcare Research and Quality, 2004, AHRQ PUBLICATION, V04-E022-2; Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Alsaadi SM, 2011, EUR SPINE J, V20, P737, DOI 10.1007/s00586-010-1661-x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrasik F, 2007, NEUROL SCI, V28, pS70, DOI 10.1007/s10072-007-0754-8; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Archer KR, 2013, PHYS THER, V93, P1130, DOI 10.2522/ptj.20120426; Astin JA, 2002, ARTHRIT RHEUM-ARTHR, V47, P291, DOI 10.1002/art.10416; Barber JP, 2007, PROF PSYCHOL-RES PR, V38, P493, DOI 10.1037/0735-7028.38.5.493; Barkin RL, 2010, DRUG AGING, V27, P775, DOI 10.2165/11539430-000000000-00000; Beck A. T., 1979, COGNITIVE THERAPY DE; Beissner K, 2009, PHYS THER, V89, P456, DOI 10.2522/ptj.20080163; Bell KR, 2006, TRAUMA REHABILITATION, P91; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Beneciuk JM, 2013, PHYS THER, V93, P321, DOI 10.2522/ptj.20120207; Burns DD, 2000, J CONSULT CLIN PSYCH, V68, P46, DOI 10.1037/0022-006X.68.1.46; Burns JW, 1998, J CONSULT CLIN PSYCH, V66, P434, DOI 10.1037/0022-006X.66.2.434; Campbell LC, 2011, PAIN, V152, P2679, DOI 10.1016/j.pain.2011.09.004; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Dalton JA, 2004, PAIN MANAG NURS, V5, P3, DOI 10.1016/S1524-9042(03)00027-4; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; DeVore S, 2011, HEALTH AFFAIR, V30, P41, DOI 10.1377/hlthaff.2010.0935; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Dobscha SK, 2008, PAIN MED, V9, P1050, DOI 10.1111/j.1526-4637.2008.00457.x; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin SF, 2002, J OROFAC PAIN, V16, P48; Dysvik E, 2012, J ADV NURS, V68, P1061, DOI 10.1111/j.1365-2648.2011.05810.x; Eccleston C, 2002, PAIN, V99, P157, DOI 10.1016/S0304-3959(02)00072-6; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003968.pub2; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Ehde DM, 2004, REHABIL PSYCHOL, V49, P254, DOI 10.1037/0090-5550.49.3.254; Ehde DM, 2003, CLIN J PAIN, V19, P3, DOI 10.1097/00002508-200301000-00002; Ersek M, 2008, PAIN, V138, P29, DOI 10.1016/j.pain.2007.11.003; FLOR H, 1985, J CONSULT CLIN PSYCH, V53, P354, DOI 10.1037/0022-006X.53.3.354; Flor H., 2011, CHRONIC PAIN INTEGRA; Gardner-Nix J, 2008, J TELEMED TELECARE, V14, P88, DOI 10.1258/jtt.2007.070811; Gatchel RJ, 2006, J AM DENT ASSOC, V137, P339, DOI 10.14219/jada.archive.2006.0183; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; George SZ, 2003, SPINE, V28, P2551, DOI 10.1097/01.BRS.0000096677.84605.A2; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Glombiewski JA, 2010, PAIN, V151, P280, DOI 10.1016/j.pain.2010.06.011; Goertz M, 2012, I CLIN SYSTEMS IMPRO; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Green SM, 2009, BEHAV COGN PSYCHOTH, V37, P221, DOI 10.1017/S1352465809005177; Grumbach K, 2010, OUTCOMES IMPLEMENTIN; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Heutink M, 2012, PAIN, V153, P120, DOI 10.1016/j.pain.2011.09.029; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hill JC, 2010, CLIN J PAIN, V26, P783, DOI 10.1097/AJP.0b013e3181f18aac; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jensen MP, 2011, PAIN, V152, P717, DOI 10.1016/j.pain.2010.09.002; Jensen MP, 2011, INT J CLIN EXP HYP, V59, P45, DOI 10.1080/00207144.2011.522892; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; Jones L, 2007, JAMA-J AM MED ASSOC, V297, P407, DOI 10.1001/jama.297.4.407; Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001; Kazantzis N, 2002, J CLIN PSYCHOL, V58, P577, DOI 10.1002/jclp.10034; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Keefe FJ, 2005, ANNU REV PSYCHOL, V56, P601, DOI 10.1146/annurev.psych.56.091103.070302; Keogh E, 2010, PAIN, V151, P18, DOI 10.1016/j.pain.2010.07.014; King S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Knittle K, 2010, ARTHRIT CARE RES, V62, P1460, DOI 10.1002/acr.20251; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lieberman G, 2012, TRANSL BEHAV MED, V2, P93, DOI 10.1007/s13142-012-0115-x; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; Linton SJ, 2001, PAIN, V90, P83, DOI 10.1016/S0304-3959(00)00390-0; Lorig K, 2005, ARTHRIT RHEUM-ARTHR, V53, P950, DOI 10.1002/art.21604; Lunde LH, 2009, J CLIN PSYCHOL MED S, V16, P254, DOI 10.1007/s10880-009-9162-y; Macea DD, 2010, J PAIN, V11, P917, DOI 10.1016/j.jpain.2010.06.005; Main CJ, 2011, PHYS THER, V91, P820, DOI 10.2522/ptj.20110060; Mallen CD, 2007, BRIT J GEN PRACT, V57, P655; McBeth J, 2012, ARCH INTERN MED, V172, P48, DOI 10.1001/archinternmed.2011.555; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Merskey H, 1994, CLASSIF CHRONIC PAIN, P209; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Muse K, 2013, CLIN PSYCHOL REV, V33, P484, DOI 10.1016/j.cpr.2013.01.010; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Nestoriuc Y, 2008, J CONSULT CLIN PSYCH, V76, P379, DOI 10.1037/0022-006X.76.3.379; Nestoriuc Y, 2007, PAIN, V128, P111, DOI 10.1016/j.pain.2006.09.007; Nicholas MK, 2013, PAIN, V154, P824, DOI 10.1016/j.pain.2013.02.009; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Nielson WR, 2004, PAIN, V109, P233, DOI 10.1016/j.pain.2004.01.002; Palermo TM, 2010, PAIN, V148, P387, DOI 10.1016/j.pain.2009.10.004; Park J, 2012, J AM GERIATR SOC, V60, P555, DOI 10.1111/j.1532-5415.2011.03846.x; Perepletchikova F, 2007, J CONSULT CLIN PSYCH, V75, P829, DOI 10.1037/0022-006X.75.6.829; Perry KN, 2010, CLIN J PAIN, V26, P206, DOI 10.1097/AJP.0b013e3181bff8f3; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Reid MC, 2008, PAIN MED, V9, P409, DOI 10.1111/j.1526-4637.2008.00428.x; Rotheram-Borus MJ, 2012, AM PSYCHOL, V67, P463, DOI 10.1037/a0028180; Ruehlman LS, 2012, PAIN, V153, P319, DOI 10.1016/j.pain.2011.10.025; Sia C, 2004, PEDIATRICS, V113, P1473; Simons AD, 2010, J CONSULT CLIN PSYCH, V78, P751, DOI 10.1037/a0020569; Slater MA, 2009, ARCH PHYS MED REHAB, V90, P545, DOI 10.1016/j.apmr.2008.10.032; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Spinhoven P, 2004, EUR J PAIN, V8, P211, DOI 10.1016/j.ejpain.2003.08.003; Stowell AW, 2007, J AM DENT ASSOC, V138, P202, DOI 10.14219/jada.archive.2007.0137; Strunk DR, 2010, J CONSULT CLIN PSYCH, V78, P429, DOI 10.1037/a0019631; Sue S, 2006, J COMMUNITY PSYCHOL, V34, P237, DOI 10.1002/jcop.20095; Sullivan MJL, 2010, PHYSIOTHER CAN, V62, P180, DOI 10.3138/physio.62.3.180; Sullivan MJL, 2006, PHYS THER, V86, P8, DOI 10.1093/ptj/86.1.8; Sullivan MJL, 2003, CLIN J PAIN, V19, P97, DOI 10.1097/00002508-200303000-00004; Thorn BE, 2004, COGNITIVE THERAPY CH; Thorn BE, 2011, PAIN, V152, P2710, DOI 10.1016/j.pain.2011.07.007; Thorn BE, 2011, PAIN, V152, P705, DOI 10.1016/j.pain.2010.12.017; Trautmann E, 2006, CEPHALALGIA, V26, P1411, DOI 10.1111/j.1468-2982.2006.01226.x; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Turk D.C., 1983, PAIN BEHAV MED COGNI; Turk DC, 2008, CAN J PSYCHIAT, V53, P213; TURNER JA, 1995, CLIN J PAIN, V11, P177, DOI 10.1097/00002508-199509000-00004; TURNER JA, 2001, BONICAS MANAGEMENT P, P1751; Turner JA, 2007, PAIN, V127, P276, DOI 10.1016/j.pain.2006.09.005; Turner JA, 2011, PAIN, V152, P2074, DOI 10.1016/j.pain.2011.05.005; Unutzer J, 2006, PSYCHIAT SERV, V57, P37, DOI 10.1176/appi.ps.57.1.37; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036; Wells-Federman Carol, 2002, Pain Manag Nurs, V3, P131, DOI 10.1053/jpmn.2002.127178; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Williams DA, 2010, PAIN, V151, P694, DOI 10.1016/j.pain.2010.08.034; Yates SL, 2005, PAIN, V117, P314, DOI 10.1016/j.pain.2005.06.018	129	350	354	3	113	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0003-066X	1935-990X		AM PSYCHOL	Am. Psychol.	FEB-MAR	2014	69	2			SI		153	166		10.1037/a0035747			14	Psychology, Multidisciplinary	Psychology	AB5BF	WOS:000331803200005	24547801		Y	N	2021-06-18	
J	Wu, A; Ying, Z; Gomez-Pinilla, F				Wu, A; Ying, Z; Gomez-Pinilla, F			Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						BDNF; fish oil; hippocampus; learning; traumatic brain injury	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; DOCOSAHEXAENOIC ACID IMPROVES; POLYUNSATURATED FATTY-ACIDS; NEUROTROPHIC FACTOR; SYNAPTIC-TRANSMISSION; NEURONAL PLASTICITY; SYNAPSIN-I; PHOSPHOLIPID DEGRADATION; COGNITIVE DEFICITS	Omega-3 fatty acids (i.e., docosahexaenoic acid; DHA) regulate signal transduction and gene expression, and protect neurons from death. In this study we examined the capacity of dietary omega3 fatty acids supplementation to help the brain to cope with the effects of traumatic injury. Rats were fed a regular diet or an experimental diet supplemented with omega-3 fatty acids, for 4 weeks before a mild fluid percussion injury (FPI) was performed. FPI increased oxidative stress, and impaired learning ability in the Morris water maze. This type of lesion also reduced levels of brain-derived neurotrophic factor (BDNF), synapsin I, and cAMP responsive element-binding protein (CREB). It is known that BDNF facilitates synaptic transmission and learning ability by modulating synapsin I and CREB. Supplementation of omega-3 fatty acids in the diet counteracted all of the studied effects of FPI, that is, normalized levels of BDNF and associated synapsin I and CREB, reduced oxidative damage, and counteracted learning disability. The reduction of oxidative stress indicates a benevolent effect of this diet on mechanisms that maintain neuronal function and plasticity. These results imply that omega-3 enriched dietary supplements can provide protection against reduced plasticity and impaired learning ability after traumatic brain injury.	Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Injury Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, 621 Charles E Young Dr, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39522, NS38978] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039522, R01NS038978] Funding Source: NIH RePORTER		BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolton MM, 2000, PROG BRAIN RES, V128, P203; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BROCK TO, 1987, J NEUROSCI, V7, P931; de Urquiza AM, 2000, SCIENCE, V290, P2140; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; FAROOQUI AA, 1994, INT REV NEUROBIOL, V36, P267, DOI 10.1016/S0074-7742(08)60306-2; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hossain MS, 1999, J NEUROCHEM, V72, P1133, DOI 10.1046/j.1471-4159.1999.0721133.x; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Ikemoto A, 2000, NEUROSCI LETT, V285, P99, DOI 10.1016/S0304-3940(00)01035-1; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelly A, 2003, J NEUROSCI, V23, P5354; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Lim SY, 2001, J NUTR, V131, P319; Lim SY, 2000, J NUTR, V130, P1629; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; McGahon BM, 1999, NEUROSCIENCE, V94, P305, DOI 10.1016/S0306-4522(99)00219-5; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Puskas LG, 2003, P NATL ACAD SCI USA, V100, P1580, DOI 10.1073/pnas.0337683100; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Sugaya K, 1996, J NEUROSCI, V16, P3427; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VAIDYANATHAN VV, 1994, NEUROSCI LETT, V179, P171, DOI 10.1016/0304-3940(94)90961-X; WANG T, 1995, J NEUROSCI, V15, P4796; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	63	350	359	0	38	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2004	21	10					1457	1467		10.1089/neu.2004.21.1457			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	867BT	WOS:000224817800009	15672635				2021-06-18	
J	Wilhelmsson, U; Bushongt, EA; Price, DL; Smarr, BL; Phung, V; Terada, M; Ellisman, MH; Pekny, M				Wilhelmsson, Ulrika; Bushongt, Eric A.; Price, Diana L.; Smarr, Benjamin L.; Phung, Van; Terada, Masako; Ellisman, Mark H.; Pekny, Milos			Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						astrocyte domains; astrocyte hypertrophy	FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; TIME COURSE; GLIAL SCAR; ADULT-RAT; SYNAPTOGENESIS; REINNERVATION; REGENERATION; HYPERTROPHY	Reactive astrocytes in neurotrauma, stroke, or neurodegeneration are thought to undergo cellular hypertrophy, based on their morphological appearance revealed by immunohistochemical detection of glial fibrillary acidic protein, vimentin, or nestin, all of them forming intermediate filaments, a part of the cytoskeleton. Here, we used a recently established dye-filling method to reveal the full three-dimensional shape of astrocytes assessing the morphology of reactive astrocytes in two neurotrauma models. Both in the denervated hippocampal region and the lesioned cerebral cortex, reactive astrocytes increased the thickness of their main cellular processes but did not extend to occupy a greater volume of tissue than nonreactive astrocytes. Despite this hypertrophy of glial fibrillary acidic protein-containing cellular processes, interdigitation between adjacent hippocampal astrocytes remained minimal. This work helps to redefine the century-old concept of hypertrophy of reactive astrocytes.	Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Pekny, M (corresponding author), Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Box 440, SE-40530 Gothenburg, Sweden.	milos.pekny@medkem.gu.se		Smarr, Benjamin/0000-0003-4442-3956	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA040843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS014718, R01NS046068] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA4084314] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41 RR004050, RR004050] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS046068, NS014718, NS046068, R01 NS014718] Funding Source: Medline		BELICHENKO PV, 1995, J NEUROSCI METH, V57, P55, DOI 10.1016/0165-0270(94)00125-Z; BUHL EH, 1993, MICROSC RES TECHNIQ, V24, P15, DOI 10.1002/jemt.1070240104; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2003, J COMP NEUROL, V462, P241, DOI 10.1002/cne.10728; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chao TI, 2002, TRIPARTITE SYNAPSE G, P3; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; DISTLER C, 1991, GLIA, V4, P484, DOI 10.1002/glia.440040508; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Enge M, 2003, NEUROCHEM RES, V28, P271, DOI 10.1023/A:1022421001288; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Grosche J, 1999, NAT NEUROSCI, V2, P139; Haber M, 2006, NEURON GLIA BIOL, V2, P59, DOI 10.1017/S1740925X06000032; Harlow E., 1988, ANTIBODIES LAB MANUA; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; MATTHEWS DA, 1976, BRAIN RES, V115, P1, DOI 10.1016/0006-8993(76)90819-2; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rohlmann A., 1996, GAP JUNCTIONS NERVOU, P175; ROSE G, 1976, BRAIN RES BULL, V1, P87, DOI 10.1016/0361-9230(76)90052-6; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403; STEWARD O, 1990, J NEUROSCI, V10, P2373; Stone DJ, 1998, J NEUROSCI, V18, P3180; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	32	348	354	0	16	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 14	2006	103	46					17513	17518		10.1073/pnas.0602841103			6	Multidisciplinary Sciences	Science & Technology - Other Topics	108OP	WOS:000242249400080	17090684	Bronze, Green Published			2021-06-18	
J	Huisman, TAGM; Schwamm, LH; Schaefer, PW; Koroshetz, WJ; Shetty-Alva, N; Ozsunar, Y; Wu, O; Sorensen, AG				Huisman, TAGM; Schwamm, LH; Schaefer, PW; Koroshetz, WJ; Shetty-Alva, N; Ozsunar, Y; Wu, O; Sorensen, AG			Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Neuroradiology	MAY 11-17, 2002	Vancouver, CANADA	Amer Soc Neuroradiol			WATER-DIFFUSION; BRAIN-INJURY; HEAD TRAUMA; MR; ANISOTROPY; CT	BACKGROUND AND PURPOSE: Multiple biomarkers are used to quantify the severity of traumatic brain injury (TBI) and to predict outcome. Few are satisfactory. CT and conventional MR imaging underestimate injury and correlate poorly with outcome. New MR imaging techniques, including diffusion tensor imaging (DTI), can provide information about brain ultrastructure by quantifying isotropic and anisotropic water diffusion. Our objective was to determine if changes in anisotropic diffusion in TBI correlate with acute Glasgow coma scale (GCS) and/or Rankin scores at discharge. METHODS: Twenty patients (15 male, five Female; mean age, 31 years) were evaluated. Apparent diffusion coefficients (ADCs) and fractional anisotropy (FA) values were measured at multiple locations and correlated with clinical scores. Results were compared with those of 15 healthy control subjects. RESULTS: ADC values were significantly reduced within the splenium (Delta18%, P = .001). FA values were significantly reduced in the internal capsule (Delta14%; P < .001) and splenium (Delta16%; P = .002). FA values were significantly correlated with GCS (r = 0.65-0.74; P < .001) and Rankin (r = 0.68-0.71; P < .001) scores for the internal capsule and splenium. The correlation between FA and clinical markers was better than for the corresponding ADC values. No correlation was found between ADC of the internal capsule and GCS/Rankin scores. CONCLUSION: DTI reveals changes in the white matter that are correlated with both acute GCS and Rankin scores at discharge. DTI may be a valuable biomarker for the severity of tissue injury and a predictor for outcome.	Univ Zurich, Childrens Hosp, Dept Radiol, CH-8032 Zurich, Switzerland; Massachusetts Gen Hosp, MGH NMR Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Huisman, TAGM (corresponding author), Univ Zurich, Childrens Hosp, Dept Radiol, Steinweisstr 75, CH-8032 Zurich, Switzerland.		Schaefer, Pamela/AAA-1323-2019	Schwamm, Lee/0000-0003-0592-9145; Wu, Ona/0000-0002-5509-9461	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038477] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41 RR014075, P41 RR 14075] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 38477, R01 NS038477] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gentry LR., 1996, MAGNETIC RESONANCE I, P611; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Lai SM, 1999, STROKE, V30, P1840, DOI 10.1161/01.STR.30.9.1840; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Melhem ER, 2000, AM J NEURORADIOL, V21, P1813; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Papadakis NG, 2002, MAGNET RESON MED, V48, P394, DOI 10.1002/mrm.10204; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; STRICH SJ, 1961, LANCET, V2, P443; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J Neurotrauma, V17, P563, DOI 10.1089/neu.2000.17.563; Ulug AM, 1999, AM J NEURORADIOL, V20, P1044; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P1269, DOI 10.1016/S0730-725X(99)00082-X; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382	26	345	367	0	22	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2004	25	3					370	376					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	804TR	WOS:000220321500005	15037457				2021-06-18	
J	Schatz, P; Pardini, JE; Lovell, MR; Collins, MW; Podell, K				Schatz, P; Pardini, JE; Lovell, MR; Collins, MW; Podell, K			Sensitivity and specificity of the ImPACT Test Battery for concussion in	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						processing speed; impulse control; ImPACT; concussion	HIGH-SCHOOL; CURRENT ISSUES; SPORTS; RECOVERY	This study explored the diagnostic utility of the composite scores of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and Post Concussion Symptom Scale scores (PCSS). Recently concussed high school athletes (N=72) were tested within 72 h of sustaining a concussion, and data were compared to non-concussed high school athletes with no history of concussion (N = 66). Between-groups MANOVA revealed a significant multivariate effect of concussion on test performance (p < .001); univariate ANOVAS revealed all six measures contributed to the between-groups differences. A discriminant function analyses was conducted to measure the ability of the five ImPACT composite scores, as well as the PCSS to classify concussion status. One discriminant function was identified that consisted of the Visual Memory, Processing Speed, and Impulse Control composite scores PCSS, which correctly classified 85.5% of the cases. Approximately 82% of participants in the concussion group and 89% of participants in the control group were correctly classified. Using these data, the sensitivity of ImPACT was 81.9%, and the specificity was 89.4%. As part of a formal concussion management program, ImPACT is a useful tool for the assessment of the neurocognitive and neurobehavioral sequelae of concussion, and can also provide post-injury cognitive and symptom data that can assist a practitioner in making safer return to play decisions. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	St Josephs Univ, Philadelphia, PA 19131 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Henry Ford Hlth Syst, Detroit, MI USA	Schatz, P (corresponding author), St Josephs Univ, 5600 City Ave,Post Hall 222, Philadelphia, PA 19131 USA.	pscjatz@sju.edu		Schatz, Philip/0000-0002-6222-6545			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT., 1989, MILD HEAD INJURY, P257; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; COLLINS M, 2004, CURR OPIN ORTHOP, V15, P100; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; IVERSON G, 2004, J INT NEUROPSYCH SOC, V10, P1; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M., 2004, IMPACT VERSION 2 0 C; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR., 2000, IMPACT IMMEDIATE POS; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2004, BRIT J SPORT MED, V29, P196; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Podell K, 2004, STUD NEUROPSYCHOL DE, P375; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6	30	344	345	1	38	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2006	21	1					91	99		10.1016/j.acn.2005.08.001			9	Psychology, Clinical; Psychology	Psychology	006EA	WOS:000234877100009	16143492	Bronze			2021-06-18	
J	Levine, B; Robertson, IH; Clare, L; Carter, G; Hong, J; Wilson, BA; Duncan, J; Stuss, DT				Levine, B; Robertson, IH; Clare, L; Carter, G; Hong, J; Wilson, BA; Duncan, J; Stuss, DT			Rehabilitation of executive functioning: An experimental-clinical validation of Goal Management Training	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						traumatic brain injury; frontal lobes; strategy application; goal neglect	TRAUMATIC BRAIN INJURY; CLOSED HEAD-INJURY; FRONTAL-LOBE DAMAGE; STRATEGY APPLICATION; BEHAVIOR; DYSFUNCTION; WORK	Two studies assessed the effects of a training procedure (Goal Management Training, GMT), derived from Duncan's theory of goal neglect, on disorganized behavior following TBI. In Study 1, patients with traumatic brain injury (TBI) were randomly assigned to brief trials of GMT or motor skills training. GMT, but not motor skills training, was associated with significant gains on everyday paper-and-pencil tasks designed to mimic tasks that are problematic for patients with goal neglect. In Study 2, GMT was applied in a postencephalitic patient seeking to improve her meal-preparation abilities. Both naturalistic observation and self-report measures revealed improved meal preparation performance following GMT. These studies provide both experimental and clinical support for the efficacy of GMT toward the treatment of executive functioning deficits that compromise independence in patients with brain damage.	Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Neurol, Toronto, ON M5S 1A1, Canada; MRC, Appl Psychol Unit, Cambridge CB2 2EF, England	Robertson, IH (corresponding author), Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland.		Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Robertson, Ian H/0000-0001-8637-561X; Duncan, John S/0000-0002-1373-0681; Duncan, John/0000-0002-9695-2764; Clare, Linda/0000-0003-3989-5318			Baddeley A.D., 1992, SPEED CAPACITY LANGU; BADDELEY AD, 1994, DOORS PEOPLE TEST VI; Burgess P. W., 1990, COGNITIVE REHABILITA, P183; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DeLuca J, 1996, DISABIL REHABIL, V18, P265, DOI 10.3109/09638289609166312; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; GREENE J, 1982, LEARNING USE STAT TE; JENNETT B, 1975, LANCET, V1, P480; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; Kopelman M. D., 1990, AUTOBIOGRAPHICAL MEM; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B, 1999, NEUROCASE, V5, P263, DOI 10.1080/13554799908402731; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI [10.1097/00001199-198709000-00009, DOI 10.1097/00001199-198709000-00009]; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Meichenbaum D., 1977, COGNITIVE BEHAV MODI; Miller GA., 1960, PLANS STRUCTURE BEHA; Newell A., 1963, COMPUTERS THOUGHT, P279; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Robertson I. R., 1999, COGNITIVE NEUROREHAB, P302; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Siegel S., 1956, NONPARAMETRIC STAT B; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Warrington E., 1991, VISUAL OBJECT SPACE; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Wilson, 1991, NATL ADULT READING T; Wilson B.A, 1987, REHABILITATION MEMOR; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 1996, BEHAV ASSESSMENT DYS	48	344	350	1	52	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2000	6	3					299	312		10.1017/S1355617700633052			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	304DH	WOS:000086467200005	10824502				2021-06-18	
J	POVLISHOCK, JT				POVLISHOCK, JT			TRAUMATICALLY INDUCED AXONAL INJURY - PATHOGENESIS AND PATHOBIOLOGICAL IMPLICATIONS	BRAIN PATHOLOGY			English	Article							MINOR HEAD-INJURY; CALCIUM-ACTIVATED PROTEOLYSIS; RAT PERIPHERAL-NERVE; SPINAL-CORD TRAUMA; HORSERADISH-PEROXIDASE; BRAIN INJURY; NEUROFILAMENTS; FIBERS; DAMAGE; DEGENERATION	This work reviews the pathobiology of traumatically induced axonal injury. Drawing upon literature gleaned from the experimental and clinical setting, this review attempts to emphasize that, other than the most destructive insults, traumatic brain injury does not typically cause direct mechanical disruption of the axon. Rather, this review documents that with traumatic injury focal, subtle axonal change occurs, and that over time, such change leads to impaired axoplasmic transport, continued axonal swelling, and ultimate disconnection. The initial intra-axonal events that trigger the above described sequence of reactive axonal change are considered with focus on the possibility of either traumatically altered axolemmal permeability, direct cytoskeletal damage/perturbation, or more overt metabolic/functional disturbances. Not only does this review focus on the sequence of traumatically induced axonal change, but also, it considers its attendant consequences in terms of Wallerian degeneration and subsequent deafferentation. The concept that traumatically induced diffuse axonal injury leads to diffuse deafferentation is emphasized together with its pathobiological implications for morbidity and recovery. The potential for either adaptive or maladaptive neuroplasticity subsequent to such diffuse deafferentation is considered in the context of mild, moderate and severe traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROL SURG,RICHMOND,VA 23298	POVLISHOCK, JT (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,POB 709,MED COLL VIRGINIA STN,RICHMOND,VA 23298, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020193] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS20193] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1977, BRAIN, V100, P487; ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; BALENTINE JD, 1988, J NEUROPATH EXP NEUR, V47, P77, DOI 10.1097/00005072-198803000-00001; BALENTINE JD, 1977, ANN NEUROL, V2, P520, DOI 10.1002/ana.410020612; BALENTINE JD, 1980, J NEUROPATH EXP NEUR, V39, P339, DOI 10.1097/00005072-198005000-00015; BALENTINE JD, 1980, LAB INVEST, V42, P99; Balentine JD, 1985, CENTRAL NERVOUS SYST, P455; BALLENTINE JD, 1978, LAB INVEST, V39, P254; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; ERB DE, 1991, EXP BRAIN RES, V83, P253; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRIEDE RL, 1970, BRAIN RES, V19, P165, DOI 10.1016/0006-8993(70)90432-4; FRIEDE RL, 1980, J NEUROL SCI, V44, P181, DOI 10.1016/0022-510X(80)90126-4; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRIFFIN JW, 1977, J NEUROPATH EXP NEUR, V36, P214, DOI 10.1097/00005072-197703000-00002; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; HAYES RL, 1988, J NEUROTRAUM, V5, P121; HAYES RL, 1991, CENTRAL NERVOUS SYST, P165; HAYES RL, 1988, J NEUROTRAUM, V5, P287; Hayes RL, 1989, MILD HEAD INJURY, P54; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; KRISTENSSON K, 1978, ANNU REV PHARMACOL, V18, P97, DOI 10.1146/annurev.pa.18.040178.000525; LAMPERT PW, 1967, J NEUROPATH EXP NEUR, V26, P345, DOI 10.1097/00005072-196707000-00001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MALMGREN LT, 1979, NEUROSCI LETT, V13, P13, DOI 10.1016/0304-3940(79)90067-3; MARTINEZ AJ, 1970, BRAIN RES, V19, P183, DOI 10.1016/0006-8993(70)90433-6; MATA M, 1986, J NEUROBIOL, V17, P449, DOI 10.1002/neu.480170508; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; MEIRI H, 1983, BRAIN RES, V263, P1, DOI 10.1016/0006-8993(83)91195-2; MILLER K, 1987, CELL TIS RES, V250, P663; OLSSON TP, 1978, J NEUROCYTOL, V7, P323, DOI 10.1007/BF01176997; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; Povlishock JT, 1985, CENTRAL NERVOUS SYST, P443; POVLISHOCK JT, 1991, 11TH P INT C NEUR NE, V4, P749; POVLISHOCK JT, 1990, ADV NEUROTRAUMA RES, V2, P1; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SCHLAEPFER WW, 1978, J CELL BIOL, V78, P369, DOI 10.1083/jcb.78.2.369; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; SCHLAEPFER WW, 1985, PROG BRAIN RES, V63, P185; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; SCHLAEPFER WW, 1977, J CELL BIOL, V74, P226, DOI 10.1083/jcb.74.1.226; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1; YAGHMAI A, 1991, IN PRESS J NEUROPATH; ZELENA J, 1968, Z ZELLFORSCH MIK ANA, V91, P200, DOI 10.1007/BF00364311	63	344	350	0	12	INT SOC NEUROPATHOLOGY	ZURICH	ISN JOURNAL PO BOX, CH-8033 ZURICH, SWITZERLAND	1015-6305			BRAIN PATHOL	Brain Pathol.	JAN	1992	2	1					1	12					12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	HG941	WOS:A1992HG94100001	1341941				2021-06-18	
J	Bonnelle, V; Ham, TE; Leech, R; Kinnunen, KM; Mehta, MA; Greenwood, RJ; Sharp, DJ				Bonnelle, Valerie; Ham, Timothy E.; Leech, Robert; Kinnunen, Kirsi M.; Mehta, Mitul A.; Greenwood, Richard J.; Sharp, David J.			Salience network integrity predicts default mode network function after traumatic brain injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							INFERIOR FRONTAL-CORTEX; STOP-SIGNAL INHIBITION; RESTING-STATE NETWORKS; RESPONSE-INHIBITION; CINGULATE CORTEX; STRUCTURAL CONNECTIVITY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ATTENTION; TASK	Efficient behavior involves the coordinated activity of large-scale brain networks, but the way in which these networks interact is uncertain. One theory is that the salience network (SN)-which includes the anterior cingulate cortex, presupplementary motor area, and anterior insulae-regulates dynamic changes in other networks. If this is the case, then damage to the structural connectivity of the SN should disrupt the regulation of associated networks. To investigate this hypothesis, we studied a group of 57 patients with cognitive impairments following traumatic brain injury (TBI) and 25 control subjects using the stop-signal task. The pattern of brain activity associated with stop-signal task performance was studied by using functional MRI, and the structural integrity of network connections was quantified by using diffusion tensor imaging. Efficient inhibitory control was associated with rapid deactivation within parts of the default mode network (DMN), including the precuneus and posterior cingulate cortex. TBI patients showed a failure of DMN deactivation, which was associated with an impairment of inhibitory control. TBI frequently results in traumatic axonal injury, which can disconnect brain networks by damaging white matter tracts. The abnormality of DMN function was specifically predicted by the amount of white matter damage in the SN tract connecting the right anterior insulae to the presupplementary motor area and dorsal anterior cingulate cortex. The results provide evidence that structural integrity of the SN is necessary for the efficient regulation of activity in the DMN, and that a failure of this regulation leads to inefficient cognitive control.	[Bonnelle, Valerie; Ham, Timothy E.; Leech, Robert; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Ctr Neurosci, Div Expt Med, London W12 0NN, England; [Bonnelle, Valerie] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, London W12 0NN, England; [Kinnunen, Kirsi M.] Univ London, London SE14 6NW, England; [Mehta, Mitul A.] Kings Coll London, Dept Neuroimaging, Ctr Neuroimaging Sci, Inst Psychiat, London SE5 8AF, England; [Greenwood, Richard J.] UCL, Inst Neurol, London WC1N 3BG, England	Sharp, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Ctr Neurosci, Div Expt Med, London W12 0NN, England.	david.sharp@imperial.ac.uk	Sharp, David J/A-2119-2013; Leech, Robert/AAE-8254-2019	Leech, Robert/0000-0002-5801-6318; Kinnunen, Kirsi M./0000-0002-8562-2866	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Imperial College Healthcare Charity; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951] Funding Source: researchfish	This work was supported by grants from the Medical Research Council (to D.J.S.) and the Imperial College Healthcare Charity (to D.J.S.).	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bekker EM, 2005, PHARMACOL BIOCHEM BE, V82, P539, DOI 10.1016/j.pbb.2005.10.009; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Frings L, 2010, DEMENT GERIATR COGN, V30, P334, DOI 10.1159/000320991; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; Lerner A, 2009, CEREB CORTEX, V19, P218, DOI 10.1093/cercor/bhn074; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesulam M, 2009, NEURON, V62, P1, DOI 10.1016/j.neuron.2009.04.001; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Posner MI, 2009, PHYS LIFE REV, V6, P103, DOI 10.1016/j.plrev.2009.02.001; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	58	343	350	0	76	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 20	2012	109	12					4690	4695		10.1073/pnas.1113455109			6	Multidisciplinary Sciences	Science & Technology - Other Topics	911JH	WOS:000301712600068	22393019	Green Published, Bronze	Y	N	2021-06-18	
J	POVLISHOCK, JT; CHRISTMAN, CW				POVLISHOCK, JT; CHRISTMAN, CW			THE PATHOBIOLOGY OF TRAUMATICALLY INDUCED AXONAL INJURY IN ANIMALS AND HUMANS - A REVIEW OF CURRENT THOUGHTS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, D.C.	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		DIFFUSE AXONAL INJURY; DELAYED AXOTOMY; CYTOSKELETAL DISRUPTION; AXOPLASMIC TRANSPORT; DEAFFERENTATION	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; SPINAL-CORD TRAUMA; NEUROFILAMENT SUBUNITS; BRAIN-DAMAGE; OPTIC-NERVE; AXOPLASM; NEURONS; PHOSPHORYLATION; PATHOGENESIS	This manuscript provides a review of those factors involved in the pathogenesis of traumatically induced axonal injury in both animals and man. The review comments on the issue of primary versus secondary, or delayed, axotomy, pointing to the fact that in eases of experimental traumatic brain injury, secondary, or delayed, axotomy predominates. This review links the process of secondary axotomy to an impairment of axoplasmic transport which is initiated, depending upon the severity of the injury, by either focal cytoskeletal misalignment or axolemmal permeability change with concomitant cytoskeletal collapse, Data are provided to show that these focal axonal changes are related to the focal impairment of axoplasmic transport which, in turn, triggers the progression of reactive axonal change, leading to disconnection, In the context of experimental studies, evidence is also provided to explain the damaging consequences of diffuse axonal injury, The implications of diffuse axonal injury and its attendant deafferentation are considered by noting that with mild injury such deafferentation may lead to an adaptive neuroplastic recovery, whereas in more severe injury a disordered and/or maladaptive neuroplastic re-organization occurs, consistent with the enduring morbidity associated with severe injury. In closing, the review focuses on the implications of the findings made in experimental animals for our understanding of those events ongoing ire traumatically brain-injured humans, It is noted that the findings made in experimental animals have been confirmed, in large part, in humans, suggesting the relevance of animal models for continued study of human traumatically induced axonal injury.		POVLISHOCK, JT (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT ANAT, RICHMOND, VA 23298 USA.						ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; BADALAMENTE MA, 1986, J HAND SURG-BRIT EUR, V11B, P337, DOI 10.1016/0266-7681(86)90153-1; BALENTINE JD, 1988, J NEUROPATH EXP NEUR, V47, P77, DOI 10.1097/00005072-198803000-00001; BALENTINE JD, 1977, ANN NEUROL, V2, P520, DOI 10.1002/ana.410020612; Balentine JD, 1985, CENTRAL NERVOUS SYST, P455; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BROWN A, 1986, BIOCHEM J, V239, P191, DOI 10.1042/bj2390191; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CROOKS DA, 1992, MED SCI LAW, V32, P109, DOI 10.1177/106002809203200204; ERB DE, 1991, EXP BRAIN RES, V83, P253; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Evans JP, 1944, J NEUROSURG, V1, P306, DOI 10.3171/jns.1944.1.5.0306; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GORDON D, 1994, 24TH SOC NEUR ABSTR; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; IMAJO T, 1984, AM J FOREN MED PATH, V5, P217, DOI 10.1097/00000433-198409000-00005; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; Jellinger KA, 1977, APALLIC SYNDROME, P88; LASEK RJ, 1976, CELL MOTILITY, V3, P1021; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; MITCHELL DE, 1973, LANCET, V2, P215; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PETTUS EH, 1995, IN PRESS 25TH SOC NE; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1995, IN PRESS 25TH SOC NE; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; SCHLAEPFER WW, 1985, PROG BRAIN RES, V63, P185; SHERRIFF FE, 1994, NEUROREPORT, V5, P1085, DOI 10.1097/00001756-199405000-00016; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P37; SIMPSON RHW, 1985, FORENSIC SCI INT, V27, P229, DOI 10.1016/0379-0738(85)90142-2; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Steward O., 1994, NEUROBIOLOGY CENTRAL, P266; Strich S J, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P166; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	73	343	354	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					555	564		10.1089/neu.1995.12.555			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000006	8683606				2021-06-18	
J	Carloni, S; Buonocore, G; Balduini, W				Carloni, Silvia; Buonocore, Giuseppe; Balduini, Walter			Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Hypoxia; Ischemia; Autophagy; Apoptosis; Necrosis; Neurodegeneration; Development; Rat	ISOLATED RAT HEPATOCYTES; CELL-DEATH; UP-REGULATION; MORPHOLOGICAL CONSEQUENCES; SIMVASTATIN PROTECTS; NEWBORN RAT; BECLIN-1; APOPTOSIS; MACROAUTOPHAGY; ACTIVATION	Autophagy, an intracellular bulk degradation process of cellular constituents, plays a key role in cell homeostasis and can be induced by stresses, such as nutrient depletion, closed head injury or focal cerebral ischemia. This study focuses on the role of autophagy in neonatal hypoxia-ischemia (HI). Enhanced beclin 1 expression, a Bcl-2-interacting protein required for autophagy, has been used as a marker of autophagy. Beclin I was significantly increased at short times after HI, both in the hippocampus and in the cerebral cortex. Beclin 1-positive cells were found in the injured but not in the contralateral side and co-localized with MAP2 but not with GFAP or ED1, indicating that the protein is over-expressed in neurons. Beclin 1-positive cells were also TUNEL-positive. 3-Methyladenine and wortmannin, that inhibit autophagy, significantly reduced beclin I expression and switched the mechanism of the cell death mode from apoptosis to necrosis. Conversely, rapamycin, that increases autophagy, augmented beclin I expression, reduced necrotic cell death, and decreased brain injury. A prophylactic treatment with simvastatin or hypoxic preconditioning also increased beclin I expression. Taken together. these data indicate that autophagy is increased in neuronal cells after neonatal hypoxia-ischemia and suggest that over-activation of autophagic pathways represents a potential protective mechanism in the early stage of the brain injury. (C) 2008 Elsevier Inc. All rights reserved.	[Carloni, Silvia; Balduini, Walter] Univ Urbino Carlo Bo, Ist Farmacol & Farmacognosia, I-61029 Urbino, PS, Italy; [Buonocore, Giuseppe] Univ Siena, Dept Paediat Obstet & Reprod Med, I-53100 Siena, Italy	Balduini, W (corresponding author), Univ Urbino Carlo Bo, Ist Farmacol & Farmacognosia, Via S Chiara 27, I-61029 Urbino, PS, Italy.	walterbalduini@uniurb.it	Balduini, Walter/AAE-7130-2020; Buonocore, Giuseppe/U-3873-2019	Balduini, Walter/0000-0001-8438-9559; Buonocore, Giuseppe/0000-0002-7921-7485	Universtity of Urbino; Ministero dell'Universita e della Ricerca Scientifica e TecnologicaMinistry of Education, Universities and Research (MIUR); European CommissionEuropean CommissionEuropean Commission Joint Research Centre [LSHM-CT-2006-036534]	We thank Claudia Scopa for the excellent technical assistance. This research was supported by grants from the Universtity of Urbino to W. Balduini, the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Progetti di Ricerca di Interesse Nazionale to W. Balduini and Giuseppe Buonocore, and the NEOBRAIN project funded under the Sixth Framework Programme of the European Commission (LSHM-CT-2006-036534).	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Balduini W, 2001, STROKE, V32, P2185, DOI 10.1161/hs0901.094287; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carloni S, 2006, NEUROBIOL DIS, V21, P119, DOI 10.1016/j.nbd.2005.06.014; Carloni S, 2007, NEUROBIOL DIS, V27, P354, DOI 10.1016/j.nbd.2007.06.009; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Joashi UC, 1999, EUR J NEUROSCI, V11, P91, DOI 10.1046/j.1460-9568.1999.00409.x; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakajima W, 2000, J NEUROSCI, V20, P7994; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Wang XT, 2007, CELL SIGNAL, V19, P1844, DOI 10.1016/j.cellsig.2007.04.005; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Yan L, 2006, CELL CYCLE, V5, P1175, DOI 10.4161/cc.5.11.2787; Yang PC, 2008, J BIOL CHEM, V283, P2631, DOI 10.1074/jbc.M706954200; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	45	342	399	1	40	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	DEC	2008	32	3					329	339		10.1016/j.nbd.2008.07.022			11	Neurosciences	Neurosciences & Neurology	382JQ	WOS:000261602500001	18760364				2021-06-18	
J	McAllister, TW; Saykin, AJ; Flashman, LA; Sparling, MB; Johnson, SC; Guerin, SJ; Mamourian, AC; Weaver, JB; Yanofsky, N				McAllister, TW; Saykin, AJ; Flashman, LA; Sparling, MB; Johnson, SC; Guerin, SJ; Mamourian, AC; Weaver, JB; Yanofsky, N			Brain activation during working memory 1 month after mild traumatic brain injury - A functional MRI study	NEUROLOGY			English	Article						mild traumatic brain injury; working memory; functional MRI	TOMOGRAPHY; CORTEX; LOAD	Objective: To assess patterns of regional brain activation in response to varying working memory loads shortly after mild traumatic brain injury (MTBI). Background: Many individuals complain of memory difficulty shortly after MTBI. Memory performance in these individuals can be normal despite these complaints. Methods: Brain activation patterns in response to a working memory task (auditory n-back) were assessed with functional MRI in 12 MTBI patients within 1 month of their injury and in 11 healthy control subjects. Results: Brain activation patterns differed between MTBI patients and control subjects in response to increasing working memory processing loads. Maximum intensity projections of statistical parametric maps in control subjects showed bifrontal and biparietal activation in response to a low processing load, with little additional increase in activation associated with the high load task. MTBI patients showed some activation during the low processing load task but significantly increased activation during the high load condition, particularly in the right parietal and right dorsolateral frontal regions. Task performance did not differ significantly between groups. Conclusion: MTBI patients differed from control subjects in activation pattern of working memory circuitry in response to different processing loads, despite similar task performance. This suggests that injury-related changes in ability to activate or to modulate working memory processing resources may underlie some of the memory complaints after MTBI.	Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dept Emergency Med, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Sect Neuropsychiat, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Brain Imaging Lab, Lebanon, NH 03756 USA	McAllister, TW (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.		Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133G70031] Funding Source: Medline		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baddeley A. D., 1994, Neuropsychology, V8, P485, DOI [10.1037/0894-4105.8.4.485., 10.1037/0894-4105.8.4.485]; Baddeley A. D., 1986, WORKING MEMORY; CURRY LM, 1991, PHILADELPHIA HEAD IN; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; *DEP HHS, 1989, INT HEAD INJ TASK FO; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; First MB., 1997, STRUCTURED CLIN INTE; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; GENTILINI M, 1989, MILD HEAD INJURY, P163; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Jonides J, 1998, J NEUROSCI, V18, P5026; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Masdeu J C, 1994, J Neuroimaging, V4, P177; Ruff R.M., 1989, MILD HEAD INJURY, P176; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Saykin AJ, 1999, J INT NEUROPSYCH SOC, V5, P377, DOI 10.1017/S135561779955501X; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; SQUIRE LR, 1979, BIOL PSYCHIAT, V14, P791	24	342	350	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	OCT 12	1999	53	6					1300	1308		10.1212/WNL.53.6.1300			9	Clinical Neurology	Neurosciences & Neurology	243UT	WOS:000083016200025	10522888				2021-06-18	
J	Vespa, PM; Nuwer, MR; Nenov, V; Ronne-Engstrom, E; Hovda, DA; Bergsneider, M; Kelly, DF; Martin, NA; Becker, DP				Vespa, PM; Nuwer, MR; Nenov, V; Ronne-Engstrom, E; Hovda, DA; Bergsneider, M; Kelly, DF; Martin, NA; Becker, DP			Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring	JOURNAL OF NEUROSURGERY			English	Article						brain trauma; seizure; neurointensive care; head injury; nonconvulsive seizure; status epilepticus; continuous electroencephalography	CEREBRAL BLOOD-FLOW; CLOSED-HEAD-INJURY; COMA DATA-BANK; STATUS-EPILEPTICUS; AMINO-ACIDS; METABOLISM; MORTALITY; EEG; FEATURES; THERAPY	Object. The early pathophysiological features of traumatic brain injury observed in the intensive care unit (ICU) have been described in terms of altered cerebral blood flow, altered brain metabolism, and neurochemical excitotoxicity. Seizures occur in animal models of brain injury and in human brain injury. Previous studies of posttraumatic seizures in humans have been based principally on clinical observations without a systematic approach to electroencephalographic (EEG) recording of seizures. The purpose of this study was to determine prospectively the incidence of convulsive and nonconvulsive seizures by using continuous EEG monitoring in patients in the ICU during the initial 14 days postinjury. Methods. Ninety-four patients with moderate-to-severe brain injuries underwent continuous EEG monitoring beginning at admission to the ICU (mean delay 9.6 +/- 5.4 hours) and extending up to 14 days postinjury. Convulsive and non convulsive seizures occurred in 21 (22%) of the 94 patients, with six of them displaying status epilepticus. In more than half of the patients (52%) the seizures were nonconvulsive and were diagnosed on the basis of EEG studies alone. All six patients with status epilepticus died, compared with a mortality rate of 24% (18 of 73) in the nonseizure group (p < 0.001). The patients with Status epilepticus had a. shorter mean length of stay (9.14 +/- 5.9 days compared with 14 +/- 9 days [t-test. p < 0.03]). Seizures occurred despite initiation of prophylactic phenytoin on admission to the emergency room, with maintenance at mean levels of 16.6 +/- 2.8 mg/dl. No differences in key prognostic factors (such as the Glasgow Coma Scale score, early hypoxemia, early hypotension, or I-month Glasgow Outcome Scale score) were found between the patients with seizures and those without. Conclusions. Seizures occur in more than one in five patients during the 1st week after moderate-to-severe brain injury and may play a role in the pathobiological conditions associated with brain injury.	Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Uppsala Univ, Dept Neurosurg, Uppsala, Sweden	Vespa, PM (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, 10833 LeConte Ave,CHS 18-218, Los Angeles, CA 90024 USA.			Martin, Neil/0000-0002-6565-4131	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS002089, P50 NS030308, NS30308] Funding Source: Medline		ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; AMINOFF MJ, 1980, AM J MED, V69, P657, DOI 10.1016/0002-9343(80)90415-5; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Beni L, 1996, J TRAUMA, V40, P449, DOI 10.1097/00005373-199603000-00022; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Black P, 1975, CIBA F S, V34, P215; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; CARLSON H, 1992, NEUROSCI LETT, V140, P30, DOI 10.1016/0304-3940(92)90674-V; COLLINS RC, 1983, BRAIN RES, V280, P25, DOI 10.1016/0006-8993(83)91170-8; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; DAWSON RE, 1951, J NEUROSURG, V8, P613, DOI 10.3171/jns.1951.8.6.0613; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ENGEL J, 1983, NEUROLOGY, V33, P400, DOI 10.1212/WNL.33.4.400; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GOTMAN J, 1982, ELECTROEN CLIN NEURO, V54, P530, DOI 10.1016/0013-4694(82)90038-4; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; HANDFORTH A, 1994, EPILEPSIA, V35, P876, DOI 10.1111/j.1528-1157.1994.tb02526.x; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; JENNETT B, 1975, LANCET, V1, P480; JENNETT WB, 1975, EPILEPSY NONMISSILE; JENNETT WB, 1980, J NEUROL NEUROSUR PS, V23, P295; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Lee S. M., 1995, Society for Neuroscience Abstracts, V21, P762; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; Nuwer M R, 1994, Neurosurg Clin N Am, V5, P647; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RaeGrant AD, 1996, J TRAUMA, V40, P401, DOI 10.1097/00005373-199603000-00013; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHOLTES FB, 1994, EPILEPSIA, V35, P1104, DOI 10.1111/j.1528-1157.1994.tb02562.x; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TREIMAN DM, 1995, J CLIN NEUROPHYSIOL, V12, P343; Uzzell B P, 1990, Adv Neurol, V52, P269; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VESPA PM, 1997, J CEREB BLOOD FLO S1, V17, pS31; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YAFFE K, 1993, NEUROLOGY, V43, P895, DOI 10.1212/WNL.43.5.895; Young GB, 1996, NEUROLOGY, V47, P83	58	341	350	2	17	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1999	91	5					750	760		10.3171/jns.1999.91.5.0750			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	247ZX	WOS:000083251800005	10541231	Green Accepted			2021-06-18	
J	Selassie, AW; Zaloshnja, E; Langlois, JA; Miller, T; Jones, P; Steiner, C				Selassie, Anbesaw W.; Zaloshnja, Eduard; Langlois, Jean A.; Miller, Ted; Jones, Paul; Steiner, Claudia			Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; long-term disabiliy	HEALTH SURVEY SF-36; PREEXISTING CONDITIONS; MORTALITY; RELIABILITY; COMPLAINTS; PROGNOSIS; SURVIVAL; VALIDITY; OUTCOMES; QUALITY	Objective: Develop and validate a predictive model of the incidence of long-term disability following traumatic brain injury (TBI) and obtain national estimates for the United States in 2003. Data/methods: A logistic regression model was built, using a population-based sample of persons with TBI from the South Carolina Traumatic Brain Injury Follow-up Registry. The regression coefficients were applied to the 2003 Healthcare Cost and Utilization Project-Nationwide Inpatient Sample data to estimate the incidence of long-term disability following traumatic brain injury hospitalization. Results: Among 288,009 (95% CI, 287,974-288,043) hospitalized TBI survivors in the United States in 2003, an estimated 124,626 (95% CI, 123,706-125,546) had developed long-term disability. Conclusion: TBI-related disability is a significant public health problem in the United States. The substantial incidence suggests the need for comprehensive rehabilitative care and services to maximize the potential of persons with TBI.	[Zaloshnja, Eduard; Miller, Ted; Jones, Paul] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Selassie, Anbesaw W.] Med Univ S Carolina, Charleston, SC 29425 USA; [Langlois, Jean A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Steiner, Claudia] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD USA	Zaloshnja, E (corresponding author), Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Calverton, MD 20705 USA.	zaloshnja@pire.org		Miller, Ted/0000-0002-0958-2639			Adams P F, 1995, Vital Health Stat 10, P1; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Butler J, 2001, CENTRAL NERVOUS SYST; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Damiano AM, 1996, SICKNESS IMPACT PROF; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farace E, 2000, Neurosurg Focus, V8, pe6; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; *HCUP AG HEALTHC R, HCUP NIS DAT DOC; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lawrence BA, 2007, ACCIDENT ANAL PREV, V39, P319, DOI 10.1016/j.aap.2006.08.001; Levy P.S., 1999, WILEY S PRO STAT SUR, V3rd; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MILLER TR, 2004, REHABILITATION COSTS; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Olson CJ, 2003, J TRAUMA, V55, P45, DOI 10.1097/01.TA.0000071291.17287.57; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; SACCO WJ, 1993, J TRAUMA, V35, P538, DOI 10.1097/00005373-199310000-00007; Selassie A, 2004, S CAROLINA TRAUMATIC; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; SHEPPARD MA, 2002, THESIS J HOPKINS J B; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE., 1993, SF 36 HLTH SURVEY MA; Ware JE., 1994, SF 36 PHYS MENTAL HL, V1st; WHITNECK G, 2001, COLORADO TRAUMATIC B; ZOU KH, 2001, STAT EPIDEMIOLOGY RE, P1	52	339	341	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					123	131		10.1097/01.HTR.0000314531.30401.39			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700007	18362766				2021-06-18	
J	Springer, JE; Azbill, RD; Knapp, PE				Springer, JE; Azbill, RD; Knapp, PE			Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury	NATURE MEDICINE			English	Article							CYTOCHROME-C; DNA FRAGMENTATION; BRAIN INJURY; CONTUSION; PROTEOLYSIS; INHIBITOR; CLEAVAGE; PROTEIN; RATS	Traumatic spinal cord injury often results in complete loss of voluntary motor and sensory function below the site of injury. The long-term neurological deficits after spinal cord trauma may be due in part to widespread apoptosis of neurons and oligodendroglia in regions distant from and relatively unaffected by the initial injury(1-4). The caspase family of cysteine proteases regulates the execution of the mammalian apoptotic cell death program(5-7). Caspase-3 cleaves several essential downstream substrates involved in the expression of the apoptotic phenotype in vitro, including gelsolin, PAK2, fodrin, nuclear lamins and the inhibitory subunit of DNA fragmentation facto(8-12). Caspase-3 activation in vitro can be triggered by upstream events, leading to the release of cytochrome c from the mitochondria and the subsequent transactivation of procaspase-9 by Apaf-1 (refs. 13-15). We report here that these upstream and downstream components of the caspase-3 apoptotic pathway are activated after traumatic spinal cord injury in rats, and occur early in (sic) the injury site and hours to days later in oligodendroglia adjacent to and distant from the injury site. Given these findings, targeting the upstream events of the caspase-3 cascade has therapeutic potential in the treatment of acute traumatic injury to the spinal cord.	Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Lexington, KY 40536 USA	Springer, JE (corresponding author), Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, 800 Rose St, Lexington, KY 40536 USA.			Azbill, David/0000-0001-7989-1771	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30248] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030248] Funding Source: NIH RePORTER		Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Enari M, 1998, NATURE, V391, P43; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu N, 1996, J MOL NEUROSCI, V7, P1, DOI 10.1007/BF02736844; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Liu XZ, 1997, J NEUROSCI, V17, P5395; NAKAMURA S, 1998, J NEUROSCI, V18, P3659; Pan GH, 1998, FEBS LETT, V426, P151, DOI 10.1016/S0014-5793(98)00330-5; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sakahira H, 1998, NATURE, V391, P96; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	25	339	364	2	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1078-8956			NAT MED	Nat. Med.	AUG	1999	5	8					943	946		10.1038/11387			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	220TR	WOS:000081684000040	10426320				2021-06-18	
J	Johnson, VE; Stewart, W; Smith, DH				Johnson, Victoria E.; Stewart, William; Smith, Douglas H.			Widespread Tau and Amyloid-Beta Pathology Many Years After a Single Traumatic Brain Injury in Humans	BRAIN PATHOLOGY			English	Article						amyloid beta plaques; head injury; long-term survival; neurodegeneration; neurofibrillary tangles; traumatic brain injury	SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; PROTEIN DEPOSITION; TERM SURVIVORS; RISK-FACTOR; PLAQUES; ENCEPHALOPATHY; ONSET	While a history of a single traumatic brain injury (TBI) is associated with the later development of syndromes of cognitive impairment such as Alzheimer's disease, the long-term pathology evolving after single TBI is poorly understood. However, a progressive tauopathy, chronic traumatic encephalopathy, is described in selected cohorts with a history of repetitive concussive/mild head injury. Here, post-mortem brains from long-term survivors of just a single TBI (147 years survival; n = 39) vs. uninjured, age-matched controls (n = 47) were examined for neurofibrillary tangles (NFTs) and amyloid-beta (A beta) plaques using immunohistochemistry and thioflavine-S staining. Detailed maps of findings permitted classification of pathology using semiquantitative scoring systems. NFTs were exceptionally rare in young, uninjured controls, yet were abundant and widely distributed in approximately one-third of TBI cases. In addition, A beta-plaques were found in a greater density following TBI vs. controls. Moreover, thioflavine-S staining revealed that while all plaque-positive control cases displayed predominantly diffuse plaques, 64% of plaque-positive TBI cases displayed predominantly thioflavine-S-positive plaques or a mixed thioflavine-S-positive/diffuse pattern. These data demonstrate that widespread NFT and A beta plaque pathologies are present in up to a third of patients following survival of a year or more from a single TBI. This suggests that a single TBI induces long-term neuropathological changes akin to those found in neurodegenerative disease.	[Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Stewart, William] Univ Glasgow, Div Clin Neurosci, Glasgow G12 8QQ, Lanark, Scotland; [Stewart, William] So Gen Hosp, Inst Neurol Sci, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu		Stewart, William/0000-0003-2199-2582	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS038104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG038911] Funding Source: NIH RePORTER	This work was supported by NIH grants NS038104 and NS056202. We would like to express our gratitude to Ms Janice E. Stewart who assisted with the tissue preparation and immunohistochemical techniques described in this study.	Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAAK H, 1990, ACTA NEUROPATHOL, V80, P479, DOI 10.1007/BF00294607; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GUNTERN R, 1992, EXPERIENTIA, V48, P8, DOI 10.1007/BF01923594; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Huber A., 1993, J NEUROTRAUMA S1, V10, pS180; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Troncoso JC, 1996, NEUROBIOL AGING, V17, P365, DOI 10.1016/0197-4580(96)00028-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	45	338	341	5	60	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	MAR	2012	22	2					142	149		10.1111/j.1750-3639.2011.00513.x			8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	899RR	WOS:000300834300002	21714827	Green Accepted	Y	N	2021-06-18	
J	Beghi, E; Carpio, A; Forsgren, L; Hesdorffer, DC; Malmgren, K; Sander, JW; Tomson, T; Hauser, WA				Beghi, Ettore; Carpio, Arturo; Forsgren, Lars; Hesdorffer, Dale C.; Malmgren, Kristina; Sander, Josemir W.; Tomson, Torbjorn; Hauser, W. Allen			Recommendation for a definition of acute symptomatic seizure	EPILEPSIA			English	Article						Epidemiology; Definition; Acute symptomatic seizure	EPILEPTIC SEIZURES; RISK; ROCHESTER; EPIDEMIOLOGY; PREVALENCE; MINNESOTA	P>Purpose: To consider the definition of acute symptomatic seizures for epidemiological studies, and to refine the criteria used to distinguish these seizures from unprovoked seizures for specific etiologies. Methods: Systematic review of the literature and of epidemiologic studies. Results: An acute symptomatic seizure is defined as a clinical seizure occurring at the time of a systemic insult or in close temporal association with a documented brain insult. Suggestions are made to define acute symptomatic seizures as those events occurring within 1 week of stroke, traumatic brain injury, anoxic encephalopathy, or intracranial surgery; at first identification of subdural hematoma; at the presence of an active central nervous system (CNS) infection; or during an active phase of multiple sclerosis or other autoimmune diseases. In addition, a diagnosis of acute symptomatic seizure should be made in the presence of severe metabolic derangements (documented within 24 h by specific biochemical or hematologic abnormalities), drug or alcohol intoxication and withdrawal, or exposure to well-defined epileptogenic drugs. Discussion: Acute symptomatic seizures must be distinguished from unprovoked seizures and separately categorized for epidemiologic purposes. These recommendations are based upon the best available data at the time of this report. Systematic studies should be undertaken to better define the associations in question, with special reference to metabolic and toxic insults, for which the time window for the occurrence of an acute symptomatic seizure and the absolute values for toxic and metabolic dysfunction still require a clear identification.	[Hauser, W. Allen] Columbia Univ, Gertrude H Sergievsky Ctr, Dept Epidemiol, P&S Unit 16, New York, NY 10032 USA; [Hesdorffer, Dale C.; Hauser, W. Allen] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Beghi, Ettore] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; [Carpio, Arturo] Univ Cuenca, Dept Neurol, Cuenca, Ecuador; [Forsgren, Lars] Umea Univ, Dept Neurol, S-90187 Umea, Sweden; [Malmgren, Kristina] Univ Gothenburg, Gothenburg, Sweden; [Sander, Josemir W.] UCL Inst Neurol, London, England; [Sander, Josemir W.] Netherlands Fdn, Epilepsy Inst, SEIN, Heemstede, Netherlands; [Tomson, Torbjorn] Karolinska Inst, Stockholm, Sweden	Hauser, WA (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Dept Epidemiol, P&S Unit 16, 630 W 168th St, New York, NY 10032 USA.	wah1@columbia.edu	Sander, Ley/C-1576-2008; Hauser, W Allen/AAB-5277-2020; Beghi, Ettore/AAA-7426-2020	Sander, Ley/0000-0001-6041-9661; Beghi, Ettore/0000-0003-2542-0469; Carpio, Arturo/0000-0002-5821-6379			ANNEGERS JF, 1995, EPILEPSIA, V36, P327, DOI 10.1111/j.1528-1157.1995.tb01005.x; ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BERG AT, 1992, NEW ENGL J MED, V327, P1122, DOI 10.1056/NEJM199210153271603; Brathen G, 2005, EUR J NEUROL, V12, P575, DOI 10.1111/j.1468-1331.2005.01247.x; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Castilla-Guerra L, 2006, EPILEPSIA, V47, P1990, DOI 10.1111/j.1528-1167.2006.00861.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; JENNETT B, 1973, LANCET, V2, P652; LOISEAU J, 1990, EPILEPSIA, V31, P391, DOI 10.1111/j.1528-1157.1990.tb05493.x; LUHDORF K, 1986, EPILEPSIA, V27, P135, DOI 10.1111/j.1528-1157.1986.tb03516.x; PLACENCIA M, 1992, BRAIN, V115, P771, DOI 10.1093/brain/115.3.771; Posner JB, 2007, CONT NEUROLOGY SERIE, V71; Riggs JE, 2002, NEUROL CLIN, V20, P227, DOI 10.1016/S0733-8619(03)00060-4; Ruffmann Claudio, 2006, Expert Rev Neurother, V6, P575, DOI 10.1586/14737175.6.4.575	22	337	345	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2010	51	4					671	675		10.1111/j.1528-1167.2009.02285.x			5	Clinical Neurology	Neurosciences & Neurology	577SZ	WOS:000276245600020	19732133	Bronze			2021-06-18	
J	Schabitz, WR; Kollmar, R; Schwaninger, M; Juettler, E; Bardutzky, J; Scholzke, MN; Sommer, C; Schwab, S				Schabitz, WR; Kollmar, R; Schwaninger, M; Juettler, E; Bardutzky, J; Scholzke, MN; Sommer, C; Schwab, S			Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia	STROKE			English	Article						colony-stimulating factor, granulocyte; excitotoxicity; growth factors; ischemia; neuroprotection	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; REDUCES INFARCT SIZE; NEUROTROPHIC FACTOR; ARTERY OCCLUSION; IN-VITRO; RECEPTOR; REPERFUSION; EXPRESSION; STAT3	Background and Purpose-The potential neuroprotective effect of the granulocyte colony-stimulating factor (G-CSF) after glutamate-induced excitotoxicity in cell culture and after focal cerebral ischemia in rats was studied. We hypothesized the existence of the G-CSF receptor (G-CSFR) as a main G-CSF effector on neurons, and immunohistochemistry, immunoblotting, and polymerase chain reaction were performed. The G-CSFR-mediated action was studied by activation of signal transducer(s) and activator(s) of transcription-3 (STAT3) in the periphery of the infarction. Methods-Neuroprotection of various G-CSF concentrations on glutamate-induced excitotoxicity was studied in cell culture. In vivo, ischemia was induced by use of a suture occlusion model of the middle cerebral artery (90-minute occlusion) in the rat. Thirty minutes after the induction of ischemia, the animals (n=12 per group) received G-CSF at 60 mug/kg body wt IV for 90 minutes or vehicle (saline). Infarct volume was calculated on the basis of 2,3,5-triphenyltetrazolium chloride staining 24 hours after ischemia. Expression of the G-CSFR was studied by immunohistochemistry and verified by reverse transcription-polymerase chain reaction and immunoblotting. Expression of STAT3 was determined by immunohistochemistry. Results-In cell culture, G-CSF exhibited a significant neuroprotective effect after glutamate-induced excitotoxicity (P<0.05). A G-CSF concentration of 10 ng/mL was maximally effective, resulting in a nearly complete protection. In vivo, G-CSF reduced infarct volume to 47% (132.0 +/- 112.7 mm(3) versus 278.9 +/- 91.6 mm(3) [P<0.05] in the control group). Immunohistochemistry, Western blotting, and reverse transcription-polymerase chain reaction revealed the existence of G-CSFRs in neurons and glial cells. Animals treated with G-CSF significantly upregulated STAT3 in the periphery of the infarction compared with control animals (P<0.05). Conclusions-G-CSF achieved a significant neuroprotective effect in cell culture and after intravenous administration after stroke. Increased STAT3 expression in the penumbra of G-CSF-treated rats suggests mediation by G-CSFR.	Heidelberg Univ, Dept Neurol, Heidelberg, Germany; Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany	Sommer, C (corresponding author), Univ Ulm, Neuropathol Lab, Albert Einstein Allee 11, D-89081 Ulm, Germany.	clemens.sommer@medizin.uni-ulm.de		Schwaninger, Markus/0000-0002-4510-9718			Arvidsson A, 2001, NEUROSCIENCE, V106, P27, DOI 10.1016/S0306-4522(01)00268-8; Ashihara E, 1997, J CELL PHYSIOL, V171, P343, DOI 10.1002/(SICI)1097-4652(199706)171:3<343::AID-JCP13>3.3.CO;2-L; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; GORGEN I, 1992, J IMMUNOL, V149, P918; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Heard SO, 1999, CRIT CARE MED, V27, P1019, DOI 10.1097/00003246-199905000-00051; HEBERT JC, 1990, ARCH SURG-CHICAGO, V125, P1075; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Kernie SG, 2000, ARCH NEUROL-CHICAGO, V57, P654, DOI 10.1001/archneur.57.5.654; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lundblad R, 1996, CRIT CARE MED, V24, P820, DOI 10.1097/00003246-199605000-00016; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Planas AM, 1996, EUR J NEUROSCI, V8, P2612, DOI 10.1111/j.1460-9568.1996.tb01556.x; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Semkova I, 1999, BRAIN RES REV, V30, P176, DOI 10.1016/S0165-0173(99)00013-2; Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Squadrito F, 1997, BRIT J PHARMACOL, V120, P333, DOI 10.1038/sj.bjp.0700904; TANAKA R, 1995, STROKE, V26, P2154, DOI 10.1161/01.STR.26.11.2154	30	337	372	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	MAR	2003	34	3					745	751		10.1161/01.STR.0000057814.70180.17			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	653ZJ	WOS:000181466700037	12624302	Bronze			2021-06-18	
J	PALMER, AM; MARION, DW; BOTSCHELLER, ML; SWEDLOW, PE; STYREN, SD; DEKOSKY, ST				PALMER, AM; MARION, DW; BOTSCHELLER, ML; SWEDLOW, PE; STYREN, SD; DEKOSKY, ST			TRAUMATIC BRAIN INJURY-INDUCED EXCITOTOXICITY ASSESSED IN A CONTROLLED CORTICAL IMPACT MODEL	JOURNAL OF NEUROCHEMISTRY			English	Article						ASPARTATE; CEREBRAL CORTEX; EXCITOTOXICITY; GLUTAMATE; MICRODIALYSIS; TRAUMATIC BRAIN INJURY	FLUID-PERCUSSION MODEL; D-ASPARTATE RECEPTORS; AMINO-ACIDS; CEREBRAL-ISCHEMIA; RAT HIPPOCAMPUS; INTRACEREBRAL MICRODIALYSIS; GLUTAMATE TOXICITY; DENTATE GYRUS; NEUROTOXICITY; DIFFUSION	Using a controlled cortical impact model of traumatic brain injury (TBI) coupled with tissue microdialysis, interstitial concentrations of aspartate and glutamate (together with serine and glutamine) were assessed in rat frontal cortex. Histological analysis indicated that the severity of injury following severe TBI (depth of deformation = 3.5 mm) was approximately twice that occurring following moderate TBI (depth of deformation = 1.5 mm). Both groups demonstrated significant postinjury maximal increases in excitatory amino acid (EAA) concentration, which were proportional to the severity of injury. The mean +/- SEM fold increase in dialysate concentrations of aspartate was 38 +/- 13 (n = 5) for moderate TBI and 74 +/- 12 (n = 5) for severe TBI. Fold increases in glutamate concentrations were 81 +/- 26 and 144 +/- 23 for moderate and severe TBI, respectively. Although these increases normalized within 20-30 min following moderate TBI, concentrations of aspartate and glutamate took >60 min to normalize after severe TBI. Changes in levels of nontransmitter amino acids were much smaller. Fold increases for serine concentrations were 4.6 +/- 0.6 and 7.6 +/- 1.7 in moderate and severe TBI, respectively; glutamine concentrations had similar small fold increases (2.6 +/- 0.2 and 4.1 +/- 0.6, respectively). Calculation of interstitial concentrations following severe TBI indicated that aspartate and glutamate maximally increased to 123 +/- 20 and 414 +/- 66 muM, respectively. To determine the extent to which such tissue concentrations of EAAs could contribute to the injury seen in TBI, the EAA receptor agonists N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid were slowly injected into rat cortex. Remarkably similar histological injuries were produced by this procedure, supporting the notion that TBI is an excitotoxic injury.	UNIV PITTSBURGH, SCH MED, DEPT PHARMACOL, PITTSBURGH, PA 15213 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROL SURG, PITTSBURGH, PA 15213 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROL, PITTSBURGH, PA 15213 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROBIOL ANAT & CELL SCI, PITTSBURGH, PA 15213 USA	PALMER, AM (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT PSYCHIAT, W1642 BIOMED SCI TOWER, 3811 O HARA ST, PITTSBURGH, PA 15213 USA.		Marion, Donald/AAR-5749-2021	DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; AUER R, 1985, ACTA NEUROPATHOL, V67, P279, DOI 10.1007/BF00687813; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; BERNERT H, 1992, SOC NEUR ABSTR, V18; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BUCHAN AM, 1991, NEUROSCI LETT, V132, P255, DOI 10.1016/0304-3940(91)90314-J; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; CHOI DW, 1987, J NEUROSCI, V7, P369; COHADON F, 1991, J NEUROL SCI, V103, pS27; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; COWBURN RF, 1987, NEUROCHEM INT, V10, P339, DOI 10.1016/0197-0186(87)90108-2; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARTHWAITE G, 1987, NEUROSCI LETT, V83, P241, DOI 10.1016/0304-3940(87)90093-0; GARTHWAITE G, 1992, EUR J NEUROSCI, V4, P353, DOI 10.1111/j.1460-9568.1992.tb00882.x; GARTHWAITE J, 1985, BRIT J PHARMACOL, V85, P297, DOI 10.1111/j.1476-5381.1985.tb08860.x; GENNARELLI TA, 1992, J NEUROTRAUM, V9, P60; GRIFFITHS T, 1983, NEUROSCIENCE, V10, P385, DOI 10.1016/0306-4522(83)90141-0; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HENNEBERRY RC, 1989, ANN NY ACAD SCI, V568, P225; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JOHANSEN FF, 1986, BRAIN RES, V377, P344, DOI 10.1016/0006-8993(86)90878-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; NICHOLSON C, 1979, BRAIN RES, V169, P580, DOI 10.1016/0006-8993(79)90408-6; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P1, DOI 10.1016/0306-4522(88)90123-6; ONODERA H, 1986, NEUROSCI LETT, V68, P169, DOI 10.1016/0304-3940(86)90136-9; RICE ME, 1985, NEUROSCIENCE, V15, P891, DOI 10.1016/0306-4522(85)90087-9; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; SCHOUSBOE A, 1977, J NEUROCHEM, V29, P999, DOI 10.1111/j.1471-4159.1977.tb06503.x; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; SMITH DH, 1991, SOC NEUR ABSTR, V17, P66; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STICH SJ, 1970, J CLIN PATHOL S, V4, P166; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; Wieloch T, 1985, Neurol Res, V7, P24; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; YOUNG AMJ, 1986, J NEUROCHEM, V47, P1399, DOI 10.1111/j.1471-4159.1986.tb00771.x	57	337	343	0	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	1993	61	6					2015	2024		10.1111/j.1471-4159.1993.tb07437.x			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	MH022	WOS:A1993MH02200004	7504079				2021-06-18	
J	Giacino, JT; Whyte, J; Bagiella, E; Kalmar, K; Childs, N; Khademi, A; Eifert, B; Long, D; Katz, DI; Cho, S; Yablon, SA; Luther, M; Hammond, FM; Nordenbo, A; Novak, P; Mercer, W; Maurer-Karattup, P; Sherer, M				Giacino, Joseph T.; Whyte, John; Bagiella, Emilia; Kalmar, Kathleen; Childs, Nancy; Khademi, Allen; Eifert, Bernd; Long, David; Katz, Douglas I.; Cho, Sooja; Yablon, Stuart A.; Luther, Marianne; Hammond, Flora M.; Nordenbo, Annette; Novak, Paul; Mercer, Walt; Maurer-Karattup, Petra; Sherer, Mark			Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMALLY CONSCIOUS STATE; RECOVERY; COMA; REHABILITATION; DISORDERS; SCALE	BACKGROUND Amantadine hydrochloride is one of the most commonly prescribed medications for patients with prolonged disorders of consciousness after traumatic brain injury. Preliminary studies have suggested that amantadine may promote functional recovery. METHODS We enrolled 184 patients who were in a vegetative or minimally conscious state 4 to 16 weeks after traumatic brain injury and who were receiving inpatient rehabilitation. Patients were randomly assigned to receive amantadine or placebo for 4 weeks and were followed for 2 weeks after the treatment was discontinued. The rate of functional recovery on the Disability Rating Scale (DRS; range, 0 to 29, with higher scores indicating greater disability) was compared over the 4 weeks of treatment (primary outcome) and during the 2-week washout period with the use of mixed-effects regression models. RESULTS During the 4-week treatment period, recovery was significantly faster in the amantadine group than in the placebo group, as measured by the DRS score (difference in slope, 0.24 points per week; P=0.007), indicating a benefit with respect to the primary outcome measure. In a prespecified subgroup analysis, the treatment effect was similar for patients in a vegetative state and those in a minimally conscious state. The rate of improvement in the amantadine group slowed during the 2 weeks after treatment (weeks 5 and 6) and was significantly slower than the rate in the placebo group (difference in slope, 0.30 points per week; P=0.02). The overall improvement in DRS scores between baseline and week 6 (2 weeks after treatment was discontinued) was similar in the two groups. There were no significant differences in the incidence of serious adverse events. CONCLUSIONS Amantadine accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness. (Funded by the National Institute on Disability and Rehabilitation Research; ClinicalTrials.gov number, NCT00970944.)	[Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Giacino, Joseph T.; Kalmar, Kathleen; Khademi, Allen] JFK Johnson Rehabil Inst, Edison, NJ USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Whyte, John; Cho, Sooja] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Long, David] Bryn Mawr Rehab Hosp, Brain Injury Program, Malvern, PA USA; [Bagiella, Emilia] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Childs, Nancy; Mercer, Walt] Texas NeuroRehab Ctr, Austin, TX USA; [Eifert, Bernd; Maurer-Karattup, Petra] SRH Fachkrankenhaus, Neresheim, Germany; [Luther, Marianne] Schon Klin Bad Aibling, Bad Aibling, Germany; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Yablon, Stuart A.; Sherer, Mark] Methodist Rehabil Ctr, Jackson, MS USA; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Hammond, Flora M.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Nordenbo, Annette] Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Glostrup, Denmark; [Nordenbo, Annette] Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark; [Novak, Paul] Sunnyview Rehabil Hosp, Schenectady, NY USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA	Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 125 Nashua St, Boston, MA 02114 USA.	jgiacino@partners.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Katz, Douglas/0000-0002-7502-8505; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A031713]	Supported by a grant from the National Institute on Disability and Rehabilitation Research (H133A031713).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2005, REHABILITATION TRAUM, P305; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schneider WN, 1999, BRAIN INJURY, V13, P863; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Zafonte RD, 1998, BRAIN INJURY, V12, P617	24	335	350	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					819	826		10.1056/NEJMoa1102609			8	Medicine, General & Internal	General & Internal Medicine	900GI	WOS:000300874300008	22375973		Y	N	2021-06-18	
J	Manly, T; Robertson, IH; Galloway, M; Hawkins, K				Manly, T; Robertson, IH; Galloway, M; Hawkins, K			The absent mind: further investigations of sustained attention to response	NEUROPSYCHOLOGIA			English	Article						supervisory attention; frontal lobes; executive function; inhibition	CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; VIGILANCE TASK; PERFORMANCE; FAILURES; AROUSAL; SYSTEM	We have previously demonstrated that performance on a brief and conceptually simple laboratory task (the Sustained Attention to Response Test: SART) was predictive of everyday attentional failures and action slips in brain injured patients and normal control participants. The SART is a go-no-go paradigm in which the no-go target appears rarely and unpredictably. Performance on this measure was previously interpreted as requiring sustained attention to response rather than a putative 'response inhibition' capacity. Three further studies are presented which support this claim. They demonstrate that performance is crucially determined by the duration of time over which attention must be maintained on one's own actions that this demand underpins the task's relationship to everyday attentional lapses. In keeping with a number of recent studies it suggests that inefficiencies in the maintenance of attentional control may be apparent over much briefer periods than is traditionally considered using vigilance measures and analysis. (C) 1999 Elsevier Science Ltd. All rights reserved.	MRC, Cognit & Brain Sci Unit, Cambridge, England	Manly, T (corresponding author), Addenbrookes Hosp, MRC, CBU, Hills Rd, Cambridge CB2 2QQ, England.			Robertson, Ian H/0000-0001-8637-561X			BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROADBENT DE, 1986, BRIT J CLIN PSYCHOL, V25, P285, DOI 10.1111/j.2044-8260.1986.tb00708.x; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; James W., 1890, PRINCIPLES PSYCHOL, V1; JASTROW J, 1905, POPULAR SCI MONTHLY, V67, P481; JONES DL, 1994, J CLIN EXP NEUROPSYC, V16, P117, DOI 10.1080/01688639408402622; Larson GE, 1997, BRIT J PSYCHOL, V88, P29, DOI 10.1111/j.2044-8295.1997.tb02618.x; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Luria A. R., 1966, HIGHER CORTICAL FUNC; Norman D. A., 1980, 99 CHIP U CAL; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; RABBITT P, 1990, BRIT J PSYCHOL, V81, P1, DOI 10.1111/j.2044-8295.1990.tb02342.x; Reason J.T., 1984, VARIETIES ATTENTION, P515; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SAINTCYR JA, 1993, CURRENT CONCEPTS PAR, P41; Shallice T., 1988, NEUROPSYCHOLOGY MENT; SPIKMAN JM, 1996, J CLIN EXPT NEUROPSY, V18, P1; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1989, J NEUROL NEUROSUR PS, V79, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Wilson, 1991, NATL ADULT READING T	29	333	337	1	36	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUN	1999	37	6					661	670		10.1016/S0028-3932(98)00127-4			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	201QC	WOS:000080605600004	10390027				2021-06-18	
J	Lighthall, JW				Lighthall, James W.			Controlled Cortical Impact: A New Experimental Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article								A new experimental model of mechanical brain injury was produced in the laboratory ferret (Mustela putorius furo) using a stroke-constrained pneumatic impactor. Cortical impacts were made on vertex to the intact dura mater overlying the cerebral cortex with contact velocities ranging from 2.0 to 4.0 m/sec and with deformations of 2.0 to 5.0 mm. The dwell time of the impact and the stability of the skull during impact were verified with high speed (1000 to 3000 frames/sec) cineradiography. Systemic arterial blood pressure, heart rate, and respiration were monitored, and postinjury changes were recorded. Anatomic brain injury, including subdural hematoma, subarachnoid hemorrhage, tears or rents of the dura mater, and contusions of the cortex, brainstem, cervical spinal cord, and cerebellum was observed. Injury responses ranged from no apparent anatomic injury or alterations in the systemic physiology at low severity impact (2.0 m/sec, 2.0 mm) to immediate fatality in the highest severity impact groups (4.0 m/sec, 4.0 mm). The range of changes in systemic physiology and of pathology in the brain, brainstem, and spinal cord was a function of both contact velocity and the amount of brain deformation. In two cases where postinjury time was 8-10 h, diffuse axonal injury, indicated by beaded axons and retraction balls, was present in subcortical regions underlying the site of impact. The spectrum of anatomic injury and systemic physiologic responses closely resembled aspects of closed head injury seen clinically. This procedure complements and improves on existing techniques by allowing independent control of contact velocity and level of deformation of the brain to facilitate biomechanical and analytic modeling of brain trauma. Graded cortical contusions and subcortical injury are produced by precisely controlled brain deformations, thereby allowing questions to be addressed regarding the influence of contact velocity and level of deformation on the anatomic and functional severity of brain injury.	Gen Motors Res Labs, Dept Biomed Sci, Warren, MI 48090 USA	Lighthall, JW (corresponding author), Gen Motors Res Labs, Dept Biomed Sci, Warren, MI 48090 USA.						Adams J.H., 1986, ARCH PATHOL LAB MED, V10, P485; ADAMS JH, 1985, CENTRAL NERVOUS SYST; ADAMS JH, 1984, RECENT ADV HISTOPATH, P241; ANDERSON TE, 1982, J NEUROSCI METH, V6, P327, DOI 10.1016/0165-0270(82)90033-4; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; Kontos H.A., 1980, CLIN ASS T, V92, P111; Lindgren S., 1965, BIOPHYSIK, V2, P20; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; MORELAND AF, 1985, LAB ANIM SCI, V35, P287; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OCHS S, 1965, EXP NEUROL, V12, P84, DOI 10.1016/0014-4886(65)90100-7; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Povlishock J. T., 1987, CENTRAL NINCDS PUBLI; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Teasdale G., 1976, BRIT J ANAESTH, V49, P520; Tomlinson B, 1970, J CLIN PATHOL S4, V23, P154	33	331	341	1	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma		1988	5	1					1	15		10.1089/neu.1988.5.1			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	V22HC	WOS:000208265300001	3193461				2021-06-18	
J	McAllister, TW; Sparling, MB; Flashman, LA; Guerin, SJ; Mamourian, AC; Saykin, AJ				McAllister, TW; Sparling, MB; Flashman, LA; Guerin, SJ; Mamourian, AC; Saykin, AJ			Differential working memory load effects after mild traumatic brain injury	NEUROIMAGE			English	Article							CORTEX; ACTIVATION	The objective of this study was to explore the effects of increasing working memory (WM) processing load on previously observed abnormalities in activation of WM circuitry shortly after mild traumatic brain injury (AMI). Brain activation patterns in response to increasing WM processing load (auditory n-back: 0-, 1-, 2-, and 3-back conditions) were assessed with fMRI in 18 MTBI patients within 1 month of their injury and in 12 healthy controls. Performance accuracy on these tasks was also measured. Brain activation patterns differed between MTBI patients and controls in response to increasing WM processing loads. Controls maintained their ability to increase activation in regions of WM circuitry with each increase in WM processing load. MTBI patients showed disproportionately increased activation during the moderate processing load condition, but very little increase in activation associated with the highest processing load condition. Task performance did not differ significantly between groups on any task condition. MTBI patients showed a different pattern of allocation of processing resources associated with a high processing load condition compared to healthy controls, despite similar task performance. This suggests that injury-related changes in ability to activate or modulate WM processing resources might underlie some of the memory complaints after MTBI. (C) 2001 Academic Press.	Dartmouth Coll, Hitchcock Med Ctr, Sect Neuropsychiat, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Brian Imaging Lab, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA	McAllister, TW (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Sect Neuropsychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.		Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R0I NS40472] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133G000136, H133G70031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040472] Funding Source: NIH RePORTER		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Baddeley A. D., 1986, WORKING MEMORY; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; CURRY LM, 1991, PHILADELPHIA HEAD IN; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; *DEP HLTH HUM SERV, 1989, INT HEAD INJ TASK FO; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; First MB., 1997, STRUCTURED CLIN INTE; Fletcher PC, 1998, ARCH GEN PSYCHIAT, V55, P1001, DOI 10.1001/archpsyc.55.11.1001; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; GENTILINI M, 1989, MILD HEAD INJURY, P163; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI DOI 10.1016/S1053-8119(18)31587-8; Jonides J, 1998, J NEUROSCI, V18, P5026; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kimberg DY, 2001, HUM BRAIN MAPP, V12, P246, DOI 10.1002/1097-0193(200104)12:4<246::AID-HBM1019>3.0.CO;2-9; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McAllister Thomas W., 1994, P357; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Ruff R.M., 1989, MILD HEAD INJURY, P176; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; SQUIRE LR, 1979, BIOL PSYCHIAT, V14, P791; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101	31	330	335	0	39	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV	2001	14	5					1004	1012		10.1006/nimg.2001.0899			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	490QT	WOS:000172063100006	11697932				2021-06-18	
J	Corps, KN; Roth, TL; McGavern, DB				Corps, Kara N.; Roth, Theodore L.; McGavern, Dorian B.			Inflammation and Neuroprotection in Traumatic Brain Injury	JAMA NEUROLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NADPH OXIDASE; IN-VIVO; RECRUITMENT; MICROGLIA; NEUTROPHILS; ACTIVATION; EXPRESSION; BARRIER	IMPORTANCE Traumatic brain injury (TBI) is a significant public health concern that affects individuals in all demographics. With increasing interest in the medical and public communities, understanding the inflammatory mechanisms that drive the pathologic and consequent cognitive outcomes can inform future research and clinical decisions for patients with TBI. OBJECTIVES To review known inflammatory mechanisms in TBI and to highlight clinical trials and neuroprotective therapeutic manipulations of pathologic and inflammatory mechanisms of TBI. EVIDENCE REVIEW We searched articles in PubMed published between 1960 and August 1, 2014, using the following keywords: traumatic brain injury, sterile injury, inflammation, astrocytes, microglia, monocytes, macrophages, neutrophils, T cells, reactive oxygen species, alarmins, danger-associated molecular patterns, purinergic receptors, neuroprotection, and clinical trials. Previous clinical trials or therapeutic studies that involved manipulation of the discussed mechanisms were considered for inclusion. The final list of selected studies was assembled based on novelty and direct relevance to the primary focus of this review. FINDINGS Traumatic brain injury is a diverse group of sterile injuries induced by primary and secondary mechanisms that give rise to cell death, inflammation, and neurologic dysfunction in patients of all demographics. Pathogenesis is driven by complex, interacting mechanisms that include reactive oxygen species, ion channel and gap junction signaling, purinergic receptor signaling, excitotoxic neurotransmitter signaling, perturbations in calcium homeostasis, and damage-associated molecular pattern molecules, among others. Central nervous system resident and peripherally derived inflammatory cells respond to TBI and can provide neuroprotection or participate in maladaptive secondary injury reactions. The exact contribution of inflammatory cells to a TBI lesion is dictated by their anatomical positioning as well as the local cues to which they are exposed. CONCLUSIONS AND RELEVANCE The mechanisms that drive TBI lesion development as well as those that promote repair are exceedingly complex and often superimposed. Because pathogenic mechanisms can diversify over time or even differ based on the injury type, it is important that neuroprotective therapeutics be developed and administered with these variables in mind. Due to its complexity, TBI has proven particularly challenging to treat; however, a number of promising therapeutic approaches are now under pre-clinical development, and recent clinical trials have even yielded a few successes. Given the worldwide impact of TBI on the human population, it is imperative that research remains active in this area and that we continue to develop therapeutics to improve outcome in afflicted patients.	[Corps, Kara N.; Roth, Theodore L.; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bethesda, MD 20892 USA	McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov		Roth, Theodore/0000-0002-3970-9573; McGavern, Dorian/0000-0001-9568-545X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003112] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health intramural program.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Cohen IR, 1999, J NEUROIMMUNOL, V100, P111, DOI 10.1016/S0165-5728(99)00190-3; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soares HD, 1995, J NEUROSCI, V15, P8223; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhang JF, 2014, NEURON, V82, P195, DOI 10.1016/j.neuron.2014.01.043	59	329	340	2	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	MAR	2015	72	3					355	362		10.1001/jamaneurol.2014.3558			8	Clinical Neurology	Neurosciences & Neurology	CE9IJ	WOS:000352157200017	25599342	Green Accepted, Bronze	Y	N	2021-06-18	
J	Nori, S; Okada, Y; Yasuda, A; Tsuji, O; Takahashi, Y; Kobayashi, Y; Fujiyoshi, K; Koike, M; Uchiyama, Y; Ikeda, E; Toyama, Y; Yamanaka, S; Nakamura, M; Okano, H				Nori, Satoshi; Okada, Yohei; Yasuda, Akimasa; Tsuji, Osahiko; Takahashi, Yuichiro; Kobayashi, Yoshiomi; Fujiyoshi, Kanehiro; Koike, Masato; Uchiyama, Yasuo; Ikeda, Eiji; Toyama, Yoshiaki; Yamanaka, Shinya; Nakamura, Masaya; Okano, Hideyuki			Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						stem-cell-based medicine; cell transplantation; neurotrauma; synaptic connection	NEURAL STEM/PROGENITOR CELLS; HUMAN IPS CELLS; GROWTH-FACTOR; ADULT RATS; DIRECTED DIFFERENTIATION; NEUROLOGICAL DISORDERS; LOCOMOTOR FUNCTION; ENDOGENOUS REPAIR; HUMAN ASTROCYTES; MESSENGER-RNA	Once their safety is confirmed, human-induced pluripotent stem cells (hiPSCs), which do not entail ethical concerns, may become a preferred cell source for regenerative medicine. Here, we investigated the therapeutic potential of transplanting hiPSC-derived neurospheres (hiPSC-NSs) into nonobese diabetic (NOD)severe combined immunodeficient (SCID) mice to treat spinal cord injury (SCI). For this, we used a hiPSC clone (201B7), established by transducing four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc) into adult human fibroblasts. Grafted hiPSC-NSs survived, migrated, and differentiated into the three major neural lineages (neurons, astrocytes, and oligodendrocytes) within the injured spinal cord. They showed both cell-autonomous and noncell-autonomous (trophic) effects, including synapse formation between hiPSC-NS-derived neurons and host mouse neurons, expression of neurotrophic factors, angiogenesis, axonal regrowth, and increased amounts of myelin in the injured area. These positive effects resulted in significantly better functional recovery compared with vehicle-treated control animals, and the recovery persisted through the end of the observation period, 112 d post-SCI. No tumor formation was observed in the hiPSC-NS-grafted mice. These findings suggest that hiPSCs give rise to neural stem/progenitor cells that support improved function post-SCI and are a promising cell source for its treatment.	[Nori, Satoshi; Yasuda, Akimasa; Tsuji, Osahiko; Takahashi, Yuichiro; Kobayashi, Yoshiomi; Fujiyoshi, Kanehiro; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Nori, Satoshi; Okada, Yohei; Yasuda, Akimasa; Takahashi, Yuichiro; Kobayashi, Yoshiomi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan; [Ikeda, Eiji] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Yamaguchi 7558505, Japan; [Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan	Nakamura, M (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan.	masa@sc.itc.keio.ac.jp; hidokano@a2.keio.jp	Nakamura, Masaya/K-4111-2013; Koike, Masato/F-9584-2010; Kobayashi, Yoshiomi/W-5573-2019; Toyama, Yoshiaki/K-5743-2013; Okano, Hideyuki/I-7584-2019; Nori, Satoshi/K-3260-2019; Okada, Yohei/L-1662-2013	Koike, Masato/0000-0002-3174-5684; 	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Project for Realization of Regenerative MedicineMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Keio Gijuku Academic Development Funds; Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19002014, 22791401, 23689017, 23650194] Funding Source: KAKEN	We thank Drs. K. Kitamura, N. Nagoshi, M. Mukaino, A. Iwanami, F. Renault-Mihara, S. Shibata, H. Shimada, T. Harada, S. Miyao, and H.J. Okano for technical assistance and scientific discussions; S. Kaneko for critical proofreading of the manuscript; and all the members of the H.O. and S.Y. laboratories for encouragement and generous support. We also thank Dr. K. Takahashi for the undifferentiated iPS cells. This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (SPS) and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Project for Realization of Regenerative Medicine; and Support for Core Institutes for iPS Cell Research from the MEXT; Japan Science and Technology-California Institute for Regenerative Medicine collaborative program; the Kanrinmaru project from Keio University; Research Fellowships for Young Scientists from JSPS; Keio Gijuku Academic Development Funds; by a Grant-in-Aid for the Global COE program from MEXT to Keio University; and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; BREGMAN BS, 1987, DEV BRAIN RES, V34, P265, DOI 10.1016/0165-3806(87)90214-8; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim BG, 2006, J COMP NEUROL, V497, P182, DOI 10.1002/cne.20980; Kim DS, 2010, STEM CELLS, V28, P2099, DOI 10.1002/stem.526; Kim DH, 1999, J NEUROSCI, V19, P6213, DOI 10.1523/JNEUROSCI.19-14-06213.1999; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Krenz NR, 1998, NEUROSCIENCE, V85, P443, DOI 10.1016/S0306-4522(97)00622-2; Krenz NR, 1999, J NEUROSCI, V19, P7405, DOI 10.1523/JNEUROSCI.19-17-07405.1999; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P397; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Tuszynski MH, 1997, ANN NY ACAD SCI, V835, P1, DOI 10.1111/j.1749-6632.1997.tb48613.x; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2004, DEV NEUROSCI-BASEL, V26, P275, DOI 10.1159/000082144; White TE, 2010, EXP NEUROL, V225, P231, DOI 10.1016/j.expneurol.2010.06.006; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yoshida H, 2002, BRAIN RES, V944, P65, DOI 10.1016/S0006-8993(02)02708-7; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	57	328	344	3	90	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 4	2011	108	40					16825	16830		10.1073/pnas.1108077108			6	Multidisciplinary Sciences	Science & Technology - Other Topics	828WX	WOS:000295536000067	21949375	Green Published, Bronze	Y	N	2021-06-18	
J	Prozorovski, T; Schulze-Topphoff, U; Glumm, R; Baumgart, J; Schroter, F; Ninnemann, O; Siegert, E; Bendix, I; Brustle, O; Nitsch, R; Zipp, F; Aktas, O				Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Baumgart, Jan; Schroeter, Friederike; Ninnemann, Olaf; Siegert, Elise; Bendix, Ivo; Bruestle, Oliver; Nitsch, Robert; Zipp, Frauke; Aktas, Orhan			Sirt1 contributes critically to the redox-dependent fate of neural progenitors	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; CENTRAL-NERVOUS-SYSTEM; LIFE-SPAN; MULTIPLE-SCLEROSIS; BHLH REPRESSORS; STEM-CELL; KAPPA-B; EGF; PROTEIN; BRAIN	Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a failure to replenish neurons and by astrogliosis. The underlying molecular pathways, however, are poorly understood. Here, we show that subtle alterations of the redox state, found in different brain pathologies, regulate the fate of mouse neural progenitor cells ( NPCs) through the histone deacetylase ( HDAC) Sirt1. Mild oxidation or direct activation of Sirt1 suppressed proliferation of NPCs and directed their differentiation towards the astroglial lineage at the expense of the neuronal lineage, whereas reducing conditions had the opposite effect. Under oxidative conditions in vitro and in vivo, Sirt1 was upregulated in NPCs, bound to the transcription factor Hes1 and subsequently inhibited pro-neuronal Mash1. In utero shRNA-mediated knockdown of Sirt1 in NPCs prevented oxidation-mediated suppression of neurogenesis and caused upregulation of Mash1 in vivo. Our results provide evidence for an as yet unknown metabolic master switch that determines the fate of neural progenitors.	[Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany; [Prozorovski, Timour; Schulze-Topphoff, Ulf; Glumm, Robert; Schroeter, Friederike; Siegert, Elise; Bendix, Ivo; Zipp, Frauke; Aktas, Orhan] Max Delbruck Ctr Mol Med, D-10117 Berlin, Germany; [Baumgart, Jan; Ninnemann, Olaf; Nitsch, Robert] Charite Univ Med Berlin, Inst Cell & Neurobiol, D-10117 Berlin, Germany; [Bruestle, Oliver] Univ Bonn, Med Ctr, Inst Reconstruct Neurobiol, D-53105 Bonn, Germany; [Bruestle, Oliver] Hertie Fdn, D-53105 Bonn, Germany	Zipp, F (corresponding author), Charite Univ Med Berlin, Cecilie Vogt Clin Neurol, Helios Klinikum Berlin Buch, D-10117 Berlin, Germany.	frauke.zipp@charite.de	Nitsch, Robert/AAI-9129-2021; Zipp, Frauke/C-9968-2015; Aktas, Orhan/B-7623-2009	Zipp, Frauke/0000-0002-1231-1928; Aktas, Orhan/0000-0002-2020-9210; Bendix, Ivo/0000-0002-9751-3640; Siegert, Elise/0000-0002-9594-0446; Baumgart, Jan/0000-0003-1996-4267			Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Merad-Saidoune M, 1999, EXP NEUROL, V158, P428, DOI 10.1006/exnr.1999.7108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wernig M, 2002, J NEUROPATH EXP NEUR, V61, P101, DOI 10.1093/jnen/61.2.101; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	328	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2008	10	4					385	U35		10.1038/ncb1700			25	Cell Biology	Cell Biology	282IS	WOS:000254561700008	18344989				2021-06-18	
J	Smith, DH; Chen, XH; Pierce, JES; Wolf, JA; Trojanowski, JQ; Graham, DI; McIntosh, TK				Smith, DH; Chen, XH; Pierce, JES; Wolf, JA; Trojanowski, JQ; Graham, DI; McIntosh, TK			Progressive atrophy and neuron death for one year following brain trauma in the rat	JOURNAL OF NEUROTRAUMA			English	Article						brain atrophy; brain trauma; cell death; degeneration; long-term ventriculomegaly	ALZHEIMERS-DISEASE; AMYLOID PROTEIN; HEAD-INJURY; DECLINE; HIPPOCAMPUS; AFTERMATH; FOREBRAIN; PEPTIDE	Although atrophic changes have been well described following traumatic brain injury (TBI) in humans, little is known concerning the mechanisms or progression of brain tissue loss. In the present study, we evaluated the temporal profile of histopathological changes following parasagittal fluid-percussion (FP) brain injury in rats over 1 year postinjury. Anesthetized 3-4 month-old Sprague-Dawley Rats (n = 51) were subjected to FP brain injury of high severity (2.5-2.9 atm, n = 51) or sham treatment (n = 27). At 1 h, 2 h, 48 h, 1 week, 2 weeks, 1 month, 2 months, 6 months and 1 year after brain injury or sham treatment, these animals were humanely euthanized. Brain sections were analyzed with image-processing techniques to determine the extent of cortical tissue loss and shrinkage of the hippocampal pyramidal cell layer. In addition, cell counting was performed to determine the number of neurons in the dentate hilus of the hippocampus, and glial fibrillary acidic protein (GFAP) immunostaining was used to reveal reactive astrocytosis. Examination of the injured brains revealed substantial and progressive tissue loss with concomitant ventriculomegaly in the hemisphere ipsilateral to injury. The regions with the most notable progressive atrophy included the cortex, hippocampus, thalamus, and septum. Quantitative analysis demonstrated a significantly progressive loss of cortical tissue as well as shrinkage of the hippocampal pyramidal cell layer ipsilateral to injury over 1 year following injury. In addition, reactive astrocytosis in regions of atrophy and progressive bilateral death of neurons in the dentate hilus was observed for 1 year following injury. These results suggest that a chronically progressive degenerative process may be initiated by brain trauma. Thus, there is a temporally broad window within which to introduce novel therapeutic strategies designed to ameliorate the short and long-term consequences of brain trauma.	UNIV PENN, DEPT PATHOL & LAB MED, PHILADELPHIA, PA 19104 USA; SO GEN HOSP, INST NEUROL SCI, DEPT NEUROPATHOL, GLASGOW G51 4TF, LANARK, SCOTLAND	Smith, DH (corresponding author), UNIV PENN, DEPT NEUROSURG, 3320 SMITH WALK, 105 HAYDEN HALL, PHILADELPHIA, PA 19104 USA.		Ritter, Stefanie L/D-9312-2012; Wolf, John A/A-1034-2007; smith, douglas/A-1321-2007	Wolf, John A/0000-0002-6950-2303; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803, R55NS026818, R01NS026818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG021527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG21527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS26818] Funding Source: Medline		ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CHROBAK JJ, 1995, BEHAV NEUROSCI, V109, P241; CORKIN S, 1989, J NEUROSCI, V9, P3876; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FISCHER W, 1992, NEUROBIOL AGING, V13, P9, DOI 10.1016/0197-4580(92)90003-G; Fox NC, 1996, ANN NY ACAD SCI, V777, P226, DOI 10.1111/j.1749-6632.1996.tb34423.x; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GROSWASSERREIDE.I, 1993, AJR, V160, P147; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HIGGINS GA, 1990, P NATL ACAD SCI USA, V87, P3032, DOI 10.1073/pnas.87.8.3032; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; MURAI H, UNPUB 2 FOLD OVEREXP; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; Pierce JES, 1996, J NEUROSCI, V16, P1083; PIERCE JES, UNPUB ENDURING COGNI; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Schmitt U, 1996, J NEUROTRAUM, V13, P791, DOI 10.1089/neu.1996.13.791; SEAB JP, 1988, MAGN RESON MED, V8, P200, DOI 10.1002/mrm.1910080210; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; TEASDALE E, 1990, HDB CLIN NEUROLOGY, P143; TIMMING R, 1982, ARCH PHYS MED REHAB, V63, P154; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813	43	328	334	1	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	1997	14	10					715	727		10.1089/neu.1997.14.715			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	YE057	WOS:A1997YE05700003	9383090				2021-06-18	
J	Binder, LM; Rohling, ML				Binder, LM; Rohling, ML			Money matters: A meta-analytic review of the effects of financial incentives on recovery after closed-head injury	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							SEQUELAE; SYMPTOMS; DEFICITS; TRAUMA	Objective: The authors evaluated the impact of financial incentives on disability, symptoms, and objective findings after closed-head injury. Method: Meta-analysis was used to review the literature. Seventeen reports, covering 18 study groups and a total of 2,353 subjects, contained data from which effect sizes could be calculated. Effect sizes were aggregated Lifter weighting for group size. After discussion, there was 100% agreement between the authors on all calculations. Results: A moderate overall effect size, 0.47, was found. The effect was particularly strong for mild head trauma. The data showed more abnormality and disability in patients with financial incentives despite less severe injuries. Conclusions: Clinical evaluation of patients after closed-head injury, particularly mild head trauma, must include consideration of the effect of financial incentives on symptoms and disability.	UNIV NEBRASKA,DEPT PSYCHOL,LINCOLN,NE 68588	Binder, LM (corresponding author), VET ADM MED CTR,PSYCHIAT SERV 116BP,POB 1034,PORTLAND,OR 97207, USA.						ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; BENTON AL, 1989, HIST NOTES POSTCONCU, P3; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Cartlidge N E, 1981, HEAD INJURY; COHEN J, 1988, STATISTICAL POWER AN; Cook J B, 1972, Scand J Rehabil Med, V4, P27; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ERICHSEN JE, 1882, CONCUSSION SPINE NER; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Glass GV., 1981, METAANALYSIS SOCIAL; GUILMETTE TJ, 1994, PERCEPT MOTOR SKILL, V78, P1179, DOI 10.2466/pms.1994.78.3c.1179; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1989, NEUROBEHAVIORAL OUTC, P153; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P405; PAGE H, 1885, INJURIES SPINE SPINA; Rosenthal R., 1991, META ANAL PROCEDURES, V1st; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; RUTHERFORD WH, 1989, POSTCONCUSSION SYMPT, P217; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TRIMBLE MR, 1981, POST TRAUMATIC NEURO; TSUSHIMA WT, 1992, FORENSIC REPORTS, V5, P359; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]	40	328	329	0	7	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	JAN	1996	153	1					7	10					4	Psychiatry	Psychiatry	TN397	WOS:A1996TN39700004	8540596				2021-06-18	
J	Iverson, GL; Lovell, MR; Collins, MW				Iverson, GL; Lovell, MR; Collins, MW			Interpreting change on ImPACT following sport concussion	CLINICAL NEUROPSYCHOLOGIST			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CLINICALLY SIGNIFICANT CHANGE; PSYCHOTHERAPY; RECOVERY; IMPROVEMENT; DIFFERENCE; MANAGEMENT; STATEMENT; PRECISION; JACOBSON	The purpose of this study was to examine the psychometric characteristics of Version 2.0 of ImPACT (Immediate Postconcussion Assessment and Cognitive Testing). The focus was on the stability of the test scores and the calculation of reliable change confidence intervals for the test-retest difference scores. A sample of 56 nonconcussed adolescents and young adults completed the test battery on two occasions. Test-retest coefficients, reliable change difference scores, and confidence intervals for measurement error are provided. These reliable change parameters were applied to a second sample of 41 concussed amateur athletes who were tested preseason and within 72 hr of injury. Applying these confidence intervals allows more precise determinations of deterioration, improvement, and recovery in the initial days following concussion.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Riverview Hosp, Vancouver, BC, Canada; Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Sports Med Concuss Program, Pittsburgh, PA USA	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; DELIS DC, 2000, CALIFORNIA VERBAL LE; DELIS DC, 2001, D KAPLAN EXECUTIVE; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Hageman WJJM, 1999, BEHAV RES THER, V37, P1169; HAGEMAN WJJM, 1993, BEHAV RES THER, V31, P693, DOI 10.1016/0005-7967(93)90122-B; Hageman WJJM, 1999, BEHAV RES THER, V37, P1219; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HSU LM, 1989, BEHAV ASSESS, V11, P459; Hsu LM, 1999, BEHAV RES THER, V37, P1195; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson G. L., 1999, J COGNITIVE REHA JUL, P16; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Iverson GL, 2001, PSYCHOL REP, V89, P457, DOI 10.2466/pr0.2001.89.2.457; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Jacobson NS, 1999, J CONSULT CLIN PSYCH, V67, P300, DOI 10.1037/0022-006X.67.3.300; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1988, BEHAV ASSESS, V10, P133; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LOVELL MR, IN PRESS AM J SPORTS; Moritz S, 2003, APPL NEUROPSYCHOL, V10, P115, DOI 10.1207/S15324826AN1002_07; OGLES BM, 1996, ASSESSING OUTCOME CL; *PSYCH CORP, 1997, WAIS III WMS III TEC; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; SPEER DC, 1995, J CONSULT CLIN PSYCH, V63, P1044, DOI 10.1037/0022-006X.63.6.1044; SPEER DC, 1992, J CONSULT CLIN PSYCH, V60, P402, DOI 10.1037/0022-006X.60.3.402; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068	37	327	328	0	21	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					460	467		10.1076/clin.17.4.460.27934			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400003	15168911				2021-06-18	
J	SMITH, DH; SOARES, HD; PIERCE, JS; PERLMAN, KG; SAATMAN, KE; MEANEY, DF; DIXON, CE; MCINTOSH, TK				SMITH, DH; SOARES, HD; PIERCE, JS; PERLMAN, KG; SAATMAN, KE; MEANEY, DF; DIXON, CE; MCINTOSH, TK			A MODEL OF PARASAGITTAL CONTROLLED CORTICAL IMPACT IN THE MOUSE - COGNITIVE AND HISTOPATHOLOGIC EFFECTS	JOURNAL OF NEUROTRAUMA			English	Article						BRAIN INJURY; COGNITION; CONTROLLED CORTICAL IMPACT; HIPPOCAMPUS	TRAUMATIC BRAIN INJURY; VASCULAR DISRUPTION; PARIETAL CORTEX; RAT; LESIONS; INFORMATION; CONTUSION; ALBUMIN; MEMORY	Controlled cortical impact (CCI), using a pneumatically driven impactor to produce traumatic brain injury, has been characterized previously in both the ferret and in the rat. In the present study, we applied this technique to establish and characterize the CCI model of brain injury in another species, the mouse, evaluating cognitive and histopathologic outcome. In anesthetized (sodium pentobarbital, 65 mg/kg) male C57BL mice, we performed sham treatment (no injury, n = 12) or CCI injury (n = 12) at a velocity of 5.7-6.2 m/sec and depth of 1 mm, using a 3-mm diameter rounded-tip impounder, positioned over the left parietotemporal cortex (parasagittal). At this level of injury, we observed highly significant deficits in memory retention of a Morris water maze task 2 days following injury (p < 0.001). Postmortem histopathologic analysis performed at 48 h following injury revealed substantial cortical tissue loss in the region of impact and selective hippocampal neuronal cell loss in the CA2, CA3, and CA3c regions, using Nissl staining. Analysis of degenerating neurons using modified Gallyas silver staining techniques demonstrated consistent ipsilateral injury of neurons in the cortex adjacent to the impact site and in the dentate gyrus of the ipsilateral hippocampus. Bilateral degeneration was observed at the gray matter-white matter interface along the corpus callosum. Glial fibrillary acidic protein (GFAP) immunohistochemistry revealed extensive reactive gliosis appearing diffusely through the bilateral cortices, hippocampi, and thalami at 48 h postinjury. Breakdown of the blood-brain barrier was demonstrated with antimouse IgG immunohistochemistry, revealing extravasation of endogenous IgG throughout the ipsilateral cortex, hippocampus, and thalamus. These results suggest that this new model of parasagittal CCI in the mouse mimics a number of well-established sequelae observed in previously characterized brain injury models using other rodent species. This mouse model may be a particularly useful experimental tool for comparing behavioral and histopathologic characteristics of traumatic brain injury in wild-type and genetically altered mice.	ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; UNIV PENN,DEPT BIOENGN,PHILADELPHIA,PA 19104; UNIV TEXAS,DEPT NEUROSURG,HOUSTON,TX	SMITH, DH (corresponding author), UNIV PENN,DEPT SURG,DIV NEUROSURG,3320 SMITH WALK,SUITE 105,PHILADELPHIA,PA 19104, USA.		smith, douglas/A-1321-2007	Meaney, David/0000-0002-0954-4122	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS026818, P50NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, R01-NS26818] Funding Source: Medline		ANDERSON TE, 1982, J NEUROSCI METH, V6, P327, DOI 10.1016/0165-0270(82)90033-4; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CROWNE DP, 1989, NEUROPSYCHOLOGIA, V27, P1119, DOI 10.1016/0028-3932(89)90095-X; DIMATTIA BV, 1988, BEHAV NEUROSCI, V102, P397, DOI 10.1037/0735-7044.102.3.397; DIXON CE, 1991, J NEUROSCI METH, V39, P1; EIMERL S, 1991, BRAIN RES, V560, P282, DOI 10.1016/0006-8993(91)91244-U; FADEN AI, 1989, SCIENCE, V244, P789; FAN L, IN PRESS MOL BRAIN R; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1995, IN PRESS BRAIN RES; JUCKER M, 1990, PHYSIOL BEHAV, V47, P207, DOI 10.1016/0031-9384(90)90062-9; KAMETANI H, 1989, BEHAV NEUROSCI, V103, P84, DOI 10.1037/0735-7044.103.1.84; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PARKIN AJ, 1984, CORTEX, V20, P479, DOI 10.1016/S0010-9452(84)80053-2; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROTRAUM, V10, pS59; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sutton R. L., 1992, Society for Neuroscience Abstracts, V18, P170; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Taft W. C., 1993, Society for Neuroscience Abstracts, V19, P1880; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M	38	327	334	1	12	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1995	12	2					169	178		10.1089/neu.1995.12.169			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	QZ508	WOS:A1995QZ50800003	7629863				2021-06-18	
J	Corrigan, JD; Bogner, J				Corrigan, John D.; Bogner, Jennifer			Initial reliability and validity of the Ohio State University TBI identification method	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						screening; substance use disorders; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CALIFORNIA PSYCHOLOGICAL INVENTORY; INTERPERSONAL-BEHAVIOR SIB; SICKNESS IMPACT PROFILE; SOCIALIZATION SCALE; FOLLOW-UP; ALCOHOL; STUDENTS	Objectives: Evaluate the psychometric properties of indices of a lifetime history of traumatic brain injury (TBI). Participants: Convenience samples recruited from 2 treatment programs for persons with substance use disorders: N = 119 (study 1) and N = 103 (study 2) Design: Test Interrater reliability (study 1) and predictive validity (Study 2). Measures: Summary indices of the number, severity, timing, and effects of lifetime TBIs calculated from data elicited via a structured interview. Results: Interrater reliability was high. Factor analysis showed indices could be characterized by severity weighted counts of the number of injuries, both lifetime and in childhood, number of symptoms persisting, worst injury, time since last TBI with loss of consciousness, and age at first TBI with loss of consciousness. Age at injury and symptoms persisting contributed independently to the prediction of common cognitive and behavioral consequences of TBI. Conclusion: These results provide preliminary support for the reliability and validity of summary indices of lifetime history of TBI elicited via a structured interview.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011; Bogner, Jennifer/E-2773-2011				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arrindell WA, 1999, PERS INDIV DIFFER, V27, P417, DOI 10.1016/S0191-8869(98)00252-9; Arrindell WA, 2001, BEHAV RES THER, V39, P1461, DOI 10.1016/S0005-7967(01)00009-2; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; DEFRANCESCO JJ, 1993, J PSYCHOPATHOL BEHAV, V15, P53, DOI 10.1007/BF00964323; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gough Harrison G., 1957, MANUAL CALIFORNIA PS; GOUGH HG, 1992, J CLIN PSYCHOL, V48, P298, DOI 10.1002/1097-4679(199205)48:3<298::AID-JCLP2270480306>3.0.CO;2-X; GOUGH HG, 1994, PSYCHOL REP, V75, P651, DOI 10.2466/pr0.1994.75.1.651; Gough HG, 1987, MANUAL CALIFORNIA PS; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Heaton R., 1993, WISCONSIN CARD SORTI; *HLTH RES SERV ADM, TRAUM BRAIN INJ SCRE; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; Kadden RM, 1996, PSYCHOL ADDICT BEHAV, V10, P131, DOI 10.1037/0893-164X.10.3.131; LENNEBERG EH, 1967, BIOL FORMULATIONS LA; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; MCLELLAN AT, 1990, ADDICTION SEVERITY I; MEGARGEE EI, 1971, J ABNORM PSYCHOL, V77, P76, DOI 10.1037/h0030429; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; *PSYCH CORP INC, 1997, WAIS III WMS III TEC; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruff RM, 1999, BRAIN INJURY, V13, P943; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Spreen O., 1998, COMPENDIUM NEUROPSYC; THURMAN D, 1995, GUIDLINES SURVEILLAN; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; Winer BJ, 1971, STAT PRINCIPLES EXPE	41	326	326	1	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					318	329		10.1097/01.HTR.0000300227.67748.77			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500002	18025964				2021-06-18	
J	Griesbach, GS; Hovda, DA; Molteni, R; Wu, A; Gomez-Pinilla, F				Griesbach, GS; Hovda, DA; Molteni, R; Wu, A; Gomez-Pinilla, F			Voluntary exercise following traumatic brain injury: Brain-derived neurotrophic factor upregulation and recovery of function	NEUROSCIENCE			English	Article						fluid-percussion injury; synapsin 1; CREB; plasticity; rehabilitation; vulnerability	FLUID-PERCUSSION INJURY; CEREBRAL GLUCOSE-UTILIZATION; SENSORIMOTOR CORTEX LESIONS; USE-DEPENDENT EXAGGERATION; LONG-TERM POTENTIATION; REDUCES INFARCT SIZE; SYNAPSIN-I; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; PHYSICAL-ACTIVITY	Voluntary exercise leads to an upregulation of brain-derived neurotrophic factor (BDNF) and associated proteins involved in synaptic function. Activity-induced enhancement of neuroplasticity may be considered for the treatment of traumatic brain injury (TBI). Given that during the first postinjury week the brain is undergoing dynamic restorative processes and energetic changes that may influence the outcome of exercise, we evaluated the effects of acute and delayed exercise following experimental TBI. Male Sprague-Dawley rats underwent either sham or lateral fluid-percussion injury (FPI) and were housed with or without access to a running wheel (RW) from postinjury days 0-6 (acute) or 14-20 (delayed). FPI alone resulted in significantly elevated levels of hippocampal phosphorylated synapsin I and phosphorylated cyclic AMP response element-binding-protein (CREB) at postinjury day 7, of which phosphorylated CREB remained elevated at postinjury day 21. Sham and delayed FPI-RW rats showed increased levels of BDNF, following exercise. Exercise also increased phosphorylated synapsin I and CREB in sham rats. In contrast to shams, the acutely exercised FPI rats failed to show activity-dependent BDNF upregulation and had significant decreases of phosphorylated synapsin I and total CREB. Additional rats were cognitively assessed (learning acquisition and memory) by utilizing the Morris water maze after acute or delayed RW exposure. Shams and delayed FPI-RW animals benefited from exercise, as indicated by a significant decrease in the number of trials to criterion (ability to locate the platform in 7 s or less for four consecutive trials), compared with the delayed FPI-sedentary rats. In contrast, cognitive performance in the acute FPI-RW rats was significantly impaired compared with all the other groups. These results suggest that voluntary exercise can endogenously upregulate BDNF and enhance recovery when it is delayed after TBI. However, when exercise is administered to soon after TBI, the molecular response to exercise is disrupted and recovery may be delayed. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Calif Los Angeles, Med Ctr, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA	Griesbach, GS (corresponding author), Univ Calif Los Angeles, Med Ctr, David Geffen Sch Med, Div Neurosurg, 18-228A NPI,Box 957039, Los Angeles, CA 90095 USA.	ggriesbach@mednet.ucla.edu	Molteni, Raffaella/Q-5011-2017	Molteni, Raffaella/0000-0002-5481-7572			Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bareyre FM, 2001, J NEUROCHEM, V77, P173, DOI 10.1046/j.1471-4159.2001.t01-1-00215.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Chu D, 2000, NEUROPEDIATRICS, V31, P63, DOI 10.1055/s-2000-7475; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DEBRUIN LA, 1990, AM J PHYSIOL, V259, pR773; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Finkbeiner S, 2000, CELL MOL LIFE SCI, V57, P394, DOI 10.1007/PL00000701; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GROSS PM, 1980, J APPL PHYSIOL, V48, P213; Hicks A, 1997, NEUROSCIENCE, V79, P329, DOI 10.1016/S0306-4522(96)00700-2; HOVDA DA, 1996, NEUROTRAUMA COMPREHE, P896; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Ivanco TL, 2000, NEUROPHARMACOLOGY, V39, P765, DOI 10.1016/S0028-3908(00)00004-6; Jansen EM, 1996, BRAIN RES, V708, P93, DOI 10.1016/0006-8993(95)01288-5; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MELLONI RH, 1994, NEUROSCIENCE, V58, P683, DOI 10.1016/0306-4522(94)90448-0; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; ORGOGOZO JM, 1979, SCIENCE, V206, P847, DOI 10.1126/science.493986; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; SAMORAJSKI T, 1985, NEUROBIOL AGING, V6, P17, DOI 10.1016/0197-4580(85)90066-1; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shen H, 2001, NEUROSCIENCE, V107, P219, DOI 10.1016/S0306-4522(01)00315-3; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; STUMMER W, 1994, STROKE, V25, P1862, DOI 10.1161/01.STR.25.9.1862; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vissing J, 1996, J CEREBR BLOOD F MET, V16, P729, DOI 10.1097/00004647-199607000-00025; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	61	326	338	1	37	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2004	125	1					129	139		10.1016/j.neuroscience.2004.01.030			11	Neurosciences	Neurosciences & Neurology	812SA	WOS:000220858000014	15051152				2021-06-18	
J	Taylor, A; Butt, W; Rosenfeld, J; Shann, F; Ditchfield, M; Lewis, E; Klug, G; Wallace, D; Henning, R; Tibballs, J				Taylor, A; Butt, W; Rosenfeld, J; Shann, F; Ditchfield, M; Lewis, E; Klug, G; Wallace, D; Henning, R; Tibballs, J			A randomized trial of very early decompressive craniectomy in children with traumatic brain injury and sustained intracranial hypertension	CHILDS NERVOUS SYSTEM			English	Article						decompressive; craniectomy; traumatic brain injury; intracranial pressure; outcome	SEVERE HEAD-INJURY; CEREBRAL EDEMA; AGGRESSIVE TREATMENT; MANAGEMENT; PRESSURE; SUPPORT	Object: The object of our study was to determine, in children with traumatic brain injury and sustained intracranial hypertension, whether very early decompressive craniectomy improves control of intracranial hypertension and long-term function and quality of life. Methods: All children were managed from admission onward according to a standardized protocol for head injury management. Children with raised intracranial pressure (ICP) were randomized to standardized management alone or standardized management plus cerebral decompression. A decompressive bitemporal craniectomy was performed at a median of 19.2 h (range 7.3-29.3 h) from the time of injury. ICP was recorded hourly via an intraventricular catheter. Compared with the ICP before randomization, the mean ICP was 3.69 mmHg lower in the 48 h after randomization in the control group, and 8.98 mmHg lower in the 48 hours after craniectomy in the decompression group (P = 0.057), Outcome was assessed 6 months after injury using a modification of the Glasgow Outcome Score (GOS) and the Health State Utility Index (Mark 1). Two (14%) of the 14 children in the control group were normal or had a mild disability after 6 months, compared with 7 (54%) of the 13 children in the decompression group. Our conclusion was that when children with traumatic brain injury and sustained intracranial hypertension are treated with a combination of very early decompressive craniectomy and conventional medical management, it is more likely that ICP will be reduced, fewer episodes of intracranial hypertension will occur, and functional outcome and quality of life may be better than in children treated with medical management alone (P=0.046; owing to multiple significance testing P <0.0221 is required for statistical significance). This pilot study suggests that very early decompressive craniectomy may be indicated in the treatment of traumatic brain injury.	Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Dept Intens Care, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurosurg, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Radiol, Melbourne, Vic, Australia; Monash Med Ctr, Dept Neurosurg, Melbourne, Vic, Australia	Butt, W (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Ausman J I, 1976, Surg Neurol, V6, P97; *AUSTR NZ INT CAR, 1988, REC BRAIN DEATH ORG; Bagley RS, 1996, AM J VET RES, V57, P116; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; BUTT W, 1990, CRIT CARE MED, V18, P961, DOI 10.1097/00003246-199009000-00011; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB M, 1979, CHILD BRAIN, V5, P484; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Harrington ML, 1996, AM J VET RES, V57, P1659; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hieu PD, 1996, CHILD NERV SYST, V12, P270; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MARSHALL LD, 1991, J NEUROSURG, V75, P514; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, P528; MCPHERSON K, 1974, NEW ENGL J MED, V290, P501, DOI 10.1056/NEJM197402282900907; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; PUTTS LH, 1980, INTRACRANIAL PRESSUR, V4, P5; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; SHANN F, 1998, DRUG DOSES; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; VULCAN P, 1995, VEH ACC THEIR CAUS R; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	46	326	348	0	14	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2001	17	3					154	162		10.1007/s003810000410			9	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	410CL	WOS:000167422400007	11305769				2021-06-18	
J	Taber, KH; Warden, DL; Hurley, RA				Taber, Katherine H.; Warden, Deborah L.; Hurley, Robin A.			Blast-related traumatic brain injury: What is known?	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							DIFFUSE AXONAL INJURY; NEUROTRAUMA; EXPERIENCE; VETERANS; NEURONS		Salisbury Vet Affairs Med Ctr, Vet Affairs Mid Atlantic Mental Illness Res, Educ & Clin Ctr, Salisbury, NC USA; Salisbury Vet Affairs Med Ctr, Mental Hlth Serv, Salisbury, NC USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; Wake Forest Univ, Sch Med, Dept Psychiat, Winston Salem, NC 27109 USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Hurley, RA (corresponding author), Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Hurley@med.va.gov	Taber, Katherine H/B-8260-2011	Taber, Katherine H/0000-0001-7382-6151			Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; CERNAK I, 2005, RESTORATIVE NEUROLOG, V23, P139; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; FABING HD, 1947, ARCH NEURO PSYCHIATR, V57, P14, DOI 10.1001/archneurpsyc.1947.02300240030002; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; Guy R J, 2000, J R Nav Med Serv, V86, P27; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; Macleod AD, 2004, J ROY SOC MED, V97, P86, DOI 10.1258/jrsm.97.2.86; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mott F. W., 1917, J ROY ARMY MED CORPS, V29, P662; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1916, LANCET, V1, P545; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; ORRISON WW, 2000, NEUROIMAGING HEAD TR, P885; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Sylvia FR, 2001, MIL MED, V166, P918; Taber KH, 2005, IMAGING INTRACRANIAL, P555; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	38	325	329	0	23	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2006	18	2					141	145		10.1176/appi.neuropsych.18.2.141			5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	044KU	WOS:000237672000001	16720789				2021-06-18	
J	Li, Y; Chen, J; Wang, L; Lu, M; Chopp, M				Li, Y; Chen, J; Wang, L; Lu, M; Chopp, M			Treatment of stroke in rat with intracarotid administration of marrow stromal cells	NEUROLOGY			English	Article							CEREBRAL-ARTERY OCCLUSION; HEMATOPOIETIC STEM-CELLS; CLOSED-HEAD INJURY; BONE-MARROW; ADULT MICE; DIFFERENTIATE; NEURONS; EXPRESSION; DEFICITS; ISCHEMIA	Objective: To measure the therapeutic efficacy for the treatment of stroke with intra-arterial administration of bone marrow stromal cells (MSC). Background: MSC have characteristics of stem and progenitor cells. The hypothesis that MSC injected into the internal carotid artery after stroke enter into ischemic brain and improve neurologic recovery was tested. Methods: Twenty-five adult Wistar rats were subjected to transient (2-hour) middle cerebral artery occlusion alone (n = 9), or treated with intracarotid arterial injection of 200 muL phosphate-buffered saline (n = 8) or 2 x 10(6) MSC in 200 muL phosphate-buffered saline (n = 8) 1 day after ischemia. MSC were harvested and isolated from additional adult rats and then cultured and labeled with bromodeoxyuridine. Rats were subjected to neurologic functional tests (adhesive-removal, modified neurologic severity scores) before and at 1, 7, and 14 days after middle cerebral artery occlusion. Immunohistochemistry was used to identify cell-specific proteins of bromodeoxyuridine-reactive MSG. Results: Bromodeoxyuridine-reactive cells (similar to 21% of 2 x 106 injected MSG) distributed throughout the territory of the middle cerebral artery by 14 days after ischemia. Some bromodeoxyuridine-reactive cells expressed proteins characteristic of astrocytes and neurons. Rats with intra-arterial transplantation of MSC exhibited improvement on the adhesive-removal test (p < 0.05) and the modified neurologic severity scores (p < 0.05) at 14 days compared with controls. Conclusions: MSC injected intra-arterially are localized and directed to the territory of the middle cerebral artery, and these cells foster functional improvement after cerebral ischemia.	Henry Ford Hlth Sci Ctr, Dept Neurol E&R3056, Detroit, MI 48202 USA; Henry Ford Hlth Sci Ctr, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hlth Sci Ctr, Dept Neurol E&R3056, 2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS023393, R01NS035504] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS23393, R01 NS35504] Funding Source: Medline		Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Barinaga M, 2000, SCIENCE, V287, P1421, DOI 10.1126/science.287.5457.1421; BONNER H, 1999, PATHOLOGY; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; EAVES CJ, 1991, BLOOD, V78, P110; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; GAGE FH, 1986, NEUROSCIENCE, V17, P89, DOI 10.1016/0306-4522(86)90227-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GARCIA JH, 1993, AM J PATHOL, V142, P623; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HEALTON EB, 1982, NEUROLOGY, V32, P776, DOI 10.1212/WNL.32.7.776; HEFTI F, 1986, J NEUROSCI, V6, P2155; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Kelemen E., 1979, ATLAS HUMAN HEMOPOIE; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lemieux ME, 1996, BLOOD, V88, P1639; Li Y, 1997, J CEREBR BLOOD F MET, V17, P846, DOI 10.1097/00004647-199708000-00003; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; POLLAK A, 1977, J NEUROPATH EXP NEUR, V36, P712, DOI 10.1097/00005072-197707000-00006; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Riew KD, 1998, CALCIFIED TISSUE INT, V63, P357, DOI 10.1007/s002239900540; Schallert T, 1997, ADV NEUROL, V73, P229; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Suzumura A, 1995, Tanpakushitsu Kakusan Koso, V40, P691; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C	48	325	389	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 26	2001	56	12					1666	1672		10.1212/WNL.56.12.1666			7	Clinical Neurology	Neurosciences & Neurology	444WZ	WOS:000169424200010	11425931				2021-06-18	
J	Beck, KD; Nguyen, HX; Galvan, MD; Salazar, DL; Woodruff, TM; Anderson, AJ				Beck, Kevin D.; Nguyen, Hal X.; Galvan, Manuel D.; Salazar, Desiree L.; Woodruff, Trent M.; Anderson, Aileen J.			Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment	BRAIN			English	Article						spinal cord injury; inflammation; flow cytometry; immunohistology; complement	CENTRAL-NERVOUS-SYSTEM; CONTUSION INJURY; MATRIX METALLOPROTEINASES; MONOCLONAL-ANTIBODY; CNS REMYELINATION; NEUTROPHIL INFILTRATION; MONONUCLEAR PHAGOCYTES; SECONDARY DEGENERATION; MOTOR FUNCTION; BRAIN-INJURY	Traumatic injury to the central nervous system results in the disruption of the blood brain/spinal barrier, followed by the invasion of cells and other components of the immune system that can aggravate injury and affect subsequent repair and regeneration. Although studies of chronic neuroinflammation in the injured spinal cord of animals are clinically relevant to most patients living with traumatic injury to the brain or spinal cord, very little is known about chronic neuroinflammation, though several studies have tested the role of neuroinflammation in the acute period after injury. The present study characterizes a novel cell preparation method that assesses, quickly and effectively, the changes in the principal immune cell types by flow cytometry in the injured spinal cord, daily for the first 10 days and periodically up to 180 days after spinal cord injury. These data quantitatively demonstrate a novel time-dependent multiphasic response of cellular inflammation in the spinal cord after spinal cord injury and are verified by quantitative stereology of immunolabelled spinal cord sections at selected time points. The early phase of cellular inflammation is comprised principally of neutrophils (peaking 1 day post-injury), macrophages/microglia (peaking 7 days post-injury) and T cells (peaking 9 days post-injury). The late phase of cellular inflammation was detected after 14 days post-injury, peaked after 60 days post-injury and remained detectable throughout 180 days post-injury for all three cell types. Furthermore, the late phase of cellular inflammation (14-180 days post-injury) did not coincide with either further improvements, or new decrements, in open-field locomotor function after spinal cord injury. However, blockade of chemoattractant C5a-mediated inflammation after 14 days post-injury reduced locomotor recovery and myelination in the injured spinal cord, suggesting that the late inflammatory response serves a reparative function. Together, these data provide new insight into cellular inflammation of spinal cord injury and identify a surprising and extended multiphasic response of cellular inflammation. Understanding the role of this multiphasic response in the pathophysiology of spinal cord injury could be critical for the design and implementation of rational therapeutic treatment strategies, including both cell-based and pharmacological interventions.	[Nguyen, Hal X.; Anderson, Aileen J.] Univ Calif Irvine, Gillespie Neurosci Res Facil 1105, Irvine, CA 92697 USA; [Nguyen, Hal X.; Salazar, Desiree L.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Anderson, Aileen J.] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA	Anderson, AJ (corresponding author), Univ Calif Irvine, Gillespie Neurosci Res Facil 1105, Irvine, CA 92697 USA.	aja@uci.edu	Woodruff, Trent M./B-4861-2009; W, T/ABF-1428-2020; Woodruff, Trent/AAS-4629-2020; Anderson, Aileen J/H-5926-2012	Woodruff, Trent M./0000-0003-1382-911X; W, T/0000-0003-1382-911X; Woodruff, Trent/0000-0003-1382-911X; Salazar, Desiree L./0000-0003-2912-6611	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS43428-01]; Paralysis Project of America [PPA-32574]; California Institute for Regenerative Medicine (CIRM) Stem Cell Training AwardCalifornia Institute for Regenerative Medicine [T1-00008]; University of California Alliance for Graduate Education; NSFNational Science Foundation (NSF) [HRD0450366];  [T32 NS007444]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007444, R01NS043428] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (RO1 NS43428-01 to A.J.A.); Paralysis Project of America (PPA-32574 to H.X.N.); California Institute for Regenerative Medicine (CIRM) Stem Cell Training Award (T1-00008 to H.X.N. and D. L. S.); training program in molecular and cellular neuroscience at UC Irvine (T32 NS007444 to K. D. B.); University of California Alliance for Graduate Education and the Professoriate fellowship (NSF HRD0450366 to D. L. S.).	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bagamery K, 2005, CYTOM PART A, V65A, P84, DOI 10.1002/cyto.a.20133; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brana C, 1999, AIDS, V13, P1443, DOI 10.1097/00002030-199908200-00002; CANTINI M, 1995, J NEUROPATH EXP NEUR, V54, P121, DOI 10.1097/00005072-199501000-00014; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CARTWRIGHT GE, 1964, BLOOD, V24, P780, DOI 10.1182/blood.V24.6.780.780; CICCO NA, 1990, BLOOD, V75, P2049; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conta AC, 2008, SPINAL CORD, V46, P39, DOI 10.1038/sj.sc.3102057; Crutcher KA, 2006, J NEUROIMMUNE PHARM, V1, P195, DOI 10.1007/s11481-006-9021-7; de Castro R, 2004, EXP NEUROL, V190, P414, DOI 10.1016/j.expneurol.2004.05.046; Diemel LT, 1998, NEUROCHEM RES, V23, P341, DOI 10.1023/A:1022405516630; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; GUIZARSAHAGUN G, 1994, SURG NEUROL, V41, P241, DOI 10.1016/0090-3019(94)90131-7; GUTH L, 1994, EXP NEUROL, V126, P76, DOI 10.1006/exnr.1994.1043; Hains BC, 2001, J NEUROTRAUM, V18, P409, DOI 10.1089/089771501750170994; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI12837; Hendrix S, 2007, J NEUROIMMUNOL, V184, P100, DOI 10.1016/j.jneuroim.2006.11.019; HOGASEN AKM, 1995, J IMMUNOL, V154, P4734; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Jablonska E, 2005, CYTOKINE, V30, P93, DOI 10.1016/j.cyto.2004.12.004; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; JOHNSON E, 1988, SCAND J IMMUNOL, V27, P489, DOI 10.1111/j.1365-3083.1988.tb02375.x; Jones TB, 2005, J NEUROSCI, V25, P6576, DOI 10.1523/JNEUROSCI.0305-05.2005; Kappelmayer J, 2000, J IMMUNOL METHODS, V242, P53, DOI 10.1016/S0022-1759(00)00220-9; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Krickhahn M, 2001, Ann Transplant, V6, P48; LaFleur M, 1996, J EXP MED, V184, P2311; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lipton HL, 2005, J IMMUNOL METHODS, V299, P107, DOI 10.1016/j.jim.2005.01.017; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Robinson S, 1999, DEV BIOL, V216, P359, DOI 10.1006/dbio.1999.9466; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; TANAKA T, 1989, J IMMUNOL, V142, P2791; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tjoa T, 2003, J NEUROSCI METH, V129, P49, DOI 10.1016/S0165-0270(03)00205-X; Tonai T, 2001, J NEUROCHEM, V78, P1064, DOI 10.1046/j.1471-4159.2001.00488.x; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Weaver KD, 2000, J TRAUMA, V48, P1081, DOI 10.1097/00005373-200006000-00014; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Wu D, 2005, ACTA MED OKAYAMA, V59, P121; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701	76	323	343	7	41	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2010	133		2				433	447		10.1093/brain/awp322			15	Clinical Neurology; Neurosciences	Neurosciences & Neurology	558VY	WOS:000274777700011	20085927	Green Published, Bronze			2021-06-18	
J	Dash, PK; Mach, SA; Moore, AN				Dash, PK; Mach, SA; Moore, AN			Enhanced neurogenesis in the rodent hippocampus following traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain injury; hippocampus; neurogenesis; BrdU; progenitor cells	SPATIAL MEMORY DEFICITS; CORTICAL IMPACT INJURY; DENTATE GYRUS; ADULT NEUROGENESIS; NEURONAL DEATH; GRANULE CELLS; RAT; PROLIFERATION; MODEL	Recent studies have shown that neurogenesis in the dentate gyrus of the rodent hippocampus continues throughout life. Several physiological and pathological conditions have been reported to alter the rate of progenitor cell division resulting in the increased production of mature granule neurons. Excitotoxic and mechanical lesions of the granule cell layer also stimulate the proliferation of precursor cells suggesting that the death of pre-existing granule neurons may act as a trigger for enhanced neurogenesis. Hippocampal pyramidal neurons, and to a lesser extent granule neurons, have been reported to die as a result of traumatic brain injury in rodents. To determine if the proliferation of precursor cells is enhanced as a result of brain injury in rodents, newly divided cells were labeled with the thymidine analog, bromodeoxyuridine (BrdU), Traumatic brain injury increased the production of BrdU-labeled cells in the dentate gyrus with a maximal rate observed at 3 days post-injury. These cells, a proportion of which co-localize with the immature neuronal marker TOAD-64, implanted themselves into the granule cell layer where they accumulated over time. When examined 1 month post-injury, the majority of BrdU-labeled cells co-labeled with the mature neuronal marker calbindin. These findings show that traumatic brain injury increases neurogenesis in the granule cell layer and suggests that these new cells may contribute to the function of the hippocampus, (C) 2001 Wiley-Liss, Inc.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA	Dash, PK (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH49662] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS23327, NS35457] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035457, P50NS023327] Funding Source: NIH RePORTER		Aberg MAI, 2000, J NEUROSCI, V20, P2896; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DASH PK, 1995, J NEUROSCI, V15, P2030; DeWitt D S, 1995, New Horiz, V3, P376; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Englander EW, 1999, J NEUROSCI RES, V58, P262, DOI 10.1002/(SICI)1097-4547(19991015)58:2<262::AID-JNR6>3.3.CO;2-N; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kolb B, 1999, J NEUROSCI, V19, P2337; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Liu JL, 1998, J NEUROSCI, V18, P7768; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Parent JM, 1997, J NEUROSCI, V17, P3727; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; RINK A, 1995, AM J PATHOL, V147, P1575; WEST MJ, 1988, BRAIN RES, V448, P167, DOI 10.1016/0006-8993(88)91114-6; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137	30	323	350	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 15	2001	63	4					313	319		10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4			7	Neurosciences	Neurosciences & Neurology	398EQ	WOS:000166744300002	11170181				2021-06-18	
J	Hegazy, HM; Carrau, RL; Snyderman, CH; Kassam, A; Zweig, J				Hegazy, HM; Carrau, RL; Snyderman, CH; Kassam, A; Zweig, J			Transnasal endoscopic repair of cerebrospinal fluid rhinorrhea: A meta-analysis	LARYNGOSCOPE			English	Article						cerebrospinal fluid leak; endoscopic surgery; meta-analysis; complications; surgical outcome	SINUS SURGERY; SKULL BASE; LEAKS; MANAGEMENT; FISTULAS; FLAP	Objectives/Hypothesis: Trauma and surgery are the most common causes of cerebrospinal fluid (CSF) rhinorrhea. Surgical repair is recommended for patients with CSF leaks that do not respond to conservative measures, traumatic CSF leaks that require transcranial surgery for associated brain injuries, and iatrogenic defects that are discovered intraoperatively. The purpose of our study was to ascertain the outcome after transnasal endoscopic repair of CSF leaks and to identify factors regarding the patient, CSF fistula, and treatment that may influence the results of the repair. Methods: We performed a metaanalysis of all studies published in English between 1990 and 1999 that reported a minimum of five patients with CSF fistulae that were repaired using an endoscopic approach. We analyzed data that included type of graft and technique used during the repair, surgical complications, the use of packing, and the use of lumbar drains and antibiotics. The success rate was monitored and correlated with the other variables. The meta-analysis database was compared with and added to a database comprising our own patients. Results: Fourteen studies comprising 289 CSF fistulae met the inclusion criteria Endoscopic repair of CSF leaks was successful in 90% (259/289) of the cases after a first attempt. Seventeen of 30 persistent leaks (52%) were closed after a second attempt. Thus ultimately 97% (276/289) of the leaks were repaired using an endoscopic approach. The success rate of repairs using any of the reported techniques and materials was high and not statistically different. The incidence of major complications such a meningitis, subdural hematoma, and intracranial abscess was less than 1% for each complication. Conclusion: The endoscopic approach is highly effective and is associated with low morbidity. The literature supports the endoscopic approach using a variety of techniques and materials for the repair of CSF leaks.	Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Cranial Base Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA	Carrau, RL (corresponding author), Univ Pittsburgh, Med Ctr, Dept Otolaryngol, 200 Lothrop St, Pittsburgh, PA 15213 USA.						AMEDEE RG, 1993, AM J RHINOL, V7, P1, DOI 10.2500/105065893781976537; Anand Vijay K., 1995, Rhinology (Utrecht), V33, P212; Burns JA, 1996, LARYNGOSCOPE, V106, P1080, DOI 10.1097/00005537-199609000-00007; CARRAU RL, 1991, HEAD NECK-J SCI SPEC, V13, P311, DOI 10.1002/hed.2880130407; Carrau RL, 1996, LARYNGOSCOPE, V106, P914, DOI 10.1097/00005537-199607000-00025; Casiano RR, 1999, OTOLARYNG HEAD NECK, V121, P745, DOI 10.1053/hn.1999.v121.a98754; DAGI FT, 1988, OPERATIVE NEUROSURGI, P49; DODSON EE, 1994, OTOLARYNG HEAD NECK, V111, P600, DOI 10.1016/S0194-5998(94)70527-5; FRIEDMAN M, 1995, HEAD NECK-J SCI SPEC, V17, P414, DOI 10.1002/hed.2880170510; Hao SP, 1996, LARYNGOSCOPE, V106, P501; HUGHES RMG, 1996, LARYNGOSCOPE, V106, P1119; KAINZ J, 1989, AM J RHINOL, V3, P191; Kelley TF, 1996, NEUROSURGERY, V39, P743, DOI 10.1097/00006123-199610000-00019; Lanza DC, 1996, LARYNGOSCOPE, V106, P1119, DOI 10.1097/00005537-199609000-00015; Mackay I S, 1992, Rhinol Suppl, V14, P151; Marks SC, 1998, AM J RHINOL, V12, P417, DOI 10.2500/105065898780707900; MATTOX DE, 1990, LARYNGOSCOPE, V100, P857; MAY M, 1990, LARYNGOSCOPE, V100, P430; MCGUIRT WF, 1994, OPERATIVE TECHNIQUES, V5, P45; Montgomery W W, 1973, Otolaryngol Clin North Am, V6, P757; Sethi D. S., 1996, Annals Academy of Medicine Singapore, V25, P724; STANKIEWICZ JA, 1991, LARYNGOSCOPE, V101, P250; Weber R, 1996, ARCH OTOLARYNGOL, V122, P732; WIGAND ME, 1991, J OTOLARYNGOL, V20, P385; Wormald PJ, 1997, J LARYNGOL OTOL, V111, P1042, DOI 10.1017/S0022215100139295; YESSENOW RS, 1989, OTOLARYNG HEAD NECK, V101, P555, DOI 10.1177/019459988910100507; Yoon Joo-Heon, 1995, Rhinology (Utrecht), V33, P208; ZWEIG JL, 2000, IN PRESS OTOLARYNGOL	28	323	344	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-852X			LARYNGOSCOPE	Laryngoscope	JUL	2000	110	7					1166	1172		10.1097/00005537-200007000-00019			7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	330NZ	WOS:000087969300019	10892690	Bronze			2021-06-18	
J	Emery, E; Aldana, P; Bunge, MB; Puckett, W; Srinivasan, A; Keane, RW; Bethea, J; Levi, ADO				Emery, E; Aldana, P; Bunge, MB; Puckett, W; Srinivasan, A; Keane, RW; Bethea, J; Levi, ADO			Apoptosis after traumatic human spinal cord injury	JOURNAL OF NEUROSURGERY			English	Article						apoptosis; human spinal cord injury; caspase-3	PROGRAMMED CELL-DEATH; ACTIVATED MICROGLIA; DNA FRAGMENTATION; BRAIN INJURY; RAT; NECROSIS; BCL-2; OLIGODENDROCYTES; 4-AMINOPYRIDINE; MECHANISMS	Object. Apoptosis is a form of programmed cell death seen in a variety of developmental and disease states, including traumatic injuries. The main objective of this study was to determine whether apoptosis is observed after human spinal cord injury (SCI). The spatial and temporal expression of apoptotic cells as well as the nature of the cells involved in programmed cell death were also investigated. Methods. The authors examined the spinal cords of 15 patients who died between 3 hours and 2 months after a traumatic SCI. Apoptotic cells were found at the edges of the lesion epicenter and in the adjacent white matter, particularly in the ascending tracts, by using histological (cresyl violet, hematoxylin and eosin) and nuclear staining (Hoechst 33342). The presence of apoptotic cells was supported by staining with the terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick-end labeling technique and confirmed by immunostaining for the processed form of caspase-3 (CPP-32), a member of the interleukin-lp-converting enzyme/Caenorhabditis elegans D 3 (ICE/CED-3) family of proteases that plays an essential role in programmed cell death. Apoptosis in this series of human SCIs was a prominent pathological finding in 14 of the 15 spinal cords examined when compared with five uninjured control spinal cords. To determine the type of cells undergoing apoptosis, the authors immunostained specimens with a variety of antibodies, including glial fibrillary acidic protein, 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNPase), and CD45/68. Oligodendrocytes stained with CNPase and a number of apoptotic nuclei colocalized with positive staining for this antibody. Conclusions. These results support the hypothesis that apoptosis occurs in human SCIs and is accompanied by the activation of caspase-3 of the cysteine protease family. This mechanism of cell death contributes to the secondary injury processes seen after human SCI and may have important clinical implications for the further development of protease inhibitors to prevent programmed cell death.	Miami Project Cure Paralysis, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL USA; IDUN Pharmaceut Inc, La Jolla, CA USA	Levi, ADO (corresponding author), Miami Project Cure Paralysis, Sch Med, Dept Neurol Surg, 1600 NW 10th Ave,R-48, Miami, FL 33136 USA.	alevi@mednet.med.miami.edu					ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Armstrong RC, 1997, J NEUROSCI, V17, P553; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Bauer J, 1995, CURR OPIN IMMUNOL, V7, P839, DOI 10.1016/0952-7915(95)80057-3; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUNGE RP, 1993, ADV NEUROL, V59, P75; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Crowe M. J., 1995, Society for Neuroscience Abstracts, V21, P232; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; DUVALL E, 1985, IMMUNOLOGY, V56, P351; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Furukawa K, 1997, J CELL BIOL, V136, P1137, DOI 10.1083/jcb.136.5.1137; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; HALL ED, 1992, J NEUROTRAUM, V9, pS425; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Henderson CE, 1996, NEURON, V17, P579, DOI 10.1016/S0896-6273(00)80191-9; Hisahara S, 1997, J NEUROCHEM, V69, P10; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HORWITZ HR, 1982, NEUROSCI COMMENT, V1, P56; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; KANE AB, 1995, AM J PATHOL, V146, P1; Katoh K, 1996, NEUROSCI LETT, V216, P9; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Liu XZ, 1997, J NEUROSCI, V17, P5395; MAJNO G, 1995, AM J PATHOL, V146, P3; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Namura S, 1998, J NEUROSCI, V18, P3659; NGUYEN KB, 1994, J AUTOIMMUN, V7, P145, DOI 10.1006/jaut.1994.1011; Nicotera P, 1997, Adv Neurol, V72, P95; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; PRINEAS JW, 1989, LAB INVEST, V61, P489; RINK A, 1995, AM J PATHOL, V147, P1575; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vela JM, 1996, BRAIN RES, V712, P134, DOI 10.1016/0006-8993(95)01422-5; Weedon D, 1979, Am J Dermatopathol, V1, P133; WOOD PL, 1995, NEUROL RES, V17, P242, DOI 10.1080/01616412.1995.11740321; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	55	323	356	0	22	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	1998	89	6					911	920		10.3171/jns.1998.89.6.0911			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	168TF	WOS:000078708200002	9833815				2021-06-18	
J	Bazarian, JJ; Zhong, J; Blyth, B; Zhu, T; Kavcic, V; Peterson, D				Bazarian, Jeffrey J.; Zhong, Jianhui; Blyth, Brian; Zhu, Tong; Kavcic, Voyko; Peterson, Derick			Diffusion tensor imaging detects clinically important axonal damage after mild traumatic brain injury: A pilot study	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; diffusion tensor imaging; mild traumatic brain injury; neurobehavioral testing; post-concussive syndrome	AMYLOID PRECURSOR PROTEIN; POST-CONCUSSION SYMPTOMS; BLUNT-HEAD TRAUMA; WHITE-MATTER; FOLLOW-UP; ABNORMALITIES; QUESTIONNAIRE; PREDICTORS; ANISOTROPY; RECOVERY	The goal of the current investigation was to detect clinically important axonal damage in cerebral white matter after mild traumatic brain injury (TBI) using diffusion tensor imaging (DTI). To this end, we evaluated a prospective, pilot study of six subjects with isolated mild TBI and six matched orthopedic controls. All subjects underwent DTI scanning, post-concussive symptom (PCS) assessment, and neurobehavioral testing within 72 h of injury. Fractional anisotropy (FA) and trace values in white matter voxels of whole brain and five preslected regions of interest (ROI) were compared in mild TBI and control subjects using a quantile approach. In addition, whole brain images were analyzed using voxel-based morphometry. All subjects underwent quality of life and repeat PCS assessment at 1 month. Whole brain images revealed significantly lower 1(st) percentile trace values (mean 0.465 vs. 0.488, p = 0.049) among mild TBI subjects. These trace values correlated with PCS scores at both 72 h (r = -0.57, p = 0.05) and 1 month (r = -0.61, p = 0.04). Analysis of ROIs showed mild TBI subjects to have significantly lower mean trace in the left anterior internal capsule (0.536 vs. 0.574, p = 0.007) and higher maximum ROI-specific median FA values (mean 0.801 vs. 0.756, p = 0.035) in the posterior corpus callosum. These FA values correlated with 72-h PCS score (r = 0.63, p = 0.03), and two neurobehavioral tests (visual motor speed [r = -0.63, p = 0.03] and impulse control [r = 0.59, p = 0.04]). Collectively, DTI detected significantly lower trace and elevated FA values in mild TBI subjects compared to controls. These abnormalities correlated to poor clinical outcome. We believe these findings represent axonal swelling, an early step in the process of axonal injury.	Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY 14627 USA; Univ Rochester, Sch Med, Dept Neurol, Rochester, NY USA; Univ Rochester, Sch Med, Dept Radiol, Rochester, NY USA; Univ Rochester, Sch Med, Dept Biomed Engn, Rochester, NY USA; Univ Rochester, Sch Med, Dept Phys, Rochester, NY USA; Univ Rochester, Sch Med, Dept Biostat, Rochester, NY USA; Univ Rochester, Sch Med, Dept Computat Biol, Rochester, NY USA	Bazarian, JJ (corresponding author), Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY 14627 USA.	jeff_bazarian@urmc.rochester.edu	Zhu, Tong/A-9402-2011; Peterson, Derick/W-5240-2019	Peterson, Derick/0000-0001-8603-660X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23NS41952-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER		Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CDC, 2003, REP C MILD TRAUM BRA; *CDC, 2004, BRAIN INJ MASS TRAUM; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; *DVBIC, 2004, BLAST INJ; Essink-Bot M L, 1993, Health Econ, V2, P237, DOI 10.1002/hec.4730020307; Field AS, 2003, AM J NEURORADIOL, V24, P1461; GE Y, 2006, 14 ANN M ISMRM SEATT; GROUP TE, 1990, HLTH POLICY, V19, P199; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Parker GJM, 2003, LECT NOTES COMPUT SC, V2732, P684; PARKER GJM, 2002, INT SOC MAGN RES MED; Roberts TPL, 2005, AM J NEURORADIOL, V26, P2183; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Westfall P. H, 1993, RESAMPLING BASED MUL; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2	45	322	331	1	23	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2007	24	9					1447	1459		10.1089/neu.2007.0241			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	214ZT	WOS:000249777600004	17892407				2021-06-18	
J	WILLER, B; OTTENBACHER, KJ; COAD, ML				WILLER, B; OTTENBACHER, KJ; COAD, ML			THE COMMUNITY INTEGRATION QUESTIONNAIRE - A COMPARATIVE-EXAMINATION	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN INJURIES; OUTCOME ASSESSMENT; QUALITY OF LIFE		The community integration questionnaire (CIQ) was designed to assess home integration, social integration and productive activity in persons with acquired brain injury. The instrument consists of 15 items and can be completed by self report or with the assistance of a family member or caregiver familiar with the person's health status and social activities. Previous research has demonstrated adequate test-retest reliability and internal consistency. This study was designed to examine further, the psychometric characteristics of the CIQ and begin the process of establishing the instrument's validity. The CIQ was administered to 341 persons with traumatic brain injury (TBI) and 210 persons without TBI or any other apparent disabilities. The results indicate that the total scores are normally distributed for both persons with and without TBI. A statistically significant difference (P < 0.01) was found between subjects with TBI and those without TBI for all three subscales of the CIQ and for total scores. Data analysis also revealed that the total CIQ scores statistically differentiated among subjects with TBI living in three different settings: (1) living independently; (2) living in a supported community situation and (3) living in an institution. Intercorrelations among the three subscales (home, social and productivity) demonstrated that the CIQ provides unique information in the assessment of community integration for persons with TBI. Areas of future research necessary to expand the research and program evaluation usefulness of the CIQ are identified.	SUNY BUFFALO,DEPT PSYCHIAT & REHABIL MED,BUFFALO,NY 14260; SUNY BUFFALO,SCH HLTH RELATED PROFESS,BUFFALO,NY 14260				Ottenbacher, Kenneth/0000-0001-5990-3982; Coad, Mary Lou/0000-0002-5791-9240			DEJONG G, 1987, REHABILITATION OUTCO, P261; Dunn G., 1989, DESIGN ANAL RELIABIL; FRASER R, 1988, REHAB COUN BUL, V31, P277; HOAGLIN DC, 1980, UNDERSTANDING ROBUST; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JOHNSTON MV, 1993, ARCH PHYS MED REHAB, V73, pS12; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; ROESSLER RT, 1992, J REHABIL, V58, P17; ROSENTHAL M, 1990, REHABILITATION ADULT; THOMAS RL, 1988, TOXIC CONTAMINATION, V3, P1; Tukey J.W., 1977, EXPLORATORY DATA ANA; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Willer B., 1993, BRAIN INJURY REHABIL, P355; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; 1990, INT CLASSIFICATION I	17	322	323	0	17	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	1994	73	2					103	111					9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	NG542	WOS:A1994NG54200006	8148099				2021-06-18	
J	GRONWALL, D; WRIGHTSON, P				GRONWALL, D; WRIGHTSON, P			CUMULATIVE EFFECT OF CONCUSSION	LANCET			English	Article									AUCKLAND HOSP,DEPT NEUROSURG,PK RD,AUCKLAND 3,NEW ZEALAND							GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1974, PSYCHOLOGICAL EFFECT; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; KIRK RE, 1969, EXPTL DESIGN PROCEDU; Roberts AH., 1969, BRAIN DAMAGE BOXERS; Siegel S., 1956, NONPARAMETRIC STAT B; SNEDECOR GW, 1952, STATISTICAL METHODS	7	321	321	0	20	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet		1975	2	7943					995	997					3	Medicine, General & Internal	General & Internal Medicine	AW974	WOS:A1975AW97400001	53547				2021-06-18	
J	Bazarian, JJ; McClung, J; Shah, MN; Cheng, YT; Flesher, W; Kraus, J				Bazarian, JJ; McClung, J; Shah, MN; Cheng, YT; Flesher, W; Kraus, J			Mild traumatic brain injury in the United States, 1998-2000	BRAIN INJURY			English	Article							MINOR HEAD-INJURY	Primary objective: To determine the incidence and epidemiology of emergency department (ED)-attended mild traumatic brain injury (mTBI) in the US. Research design: Secondary analysis of ED visits for niTBI in the National Hospital Ambulatory Medical Care Survey for 1998-2000. Methods and procedures: MTBI defined by International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes for 'skull fracture', 'concussion', 'intracranial injury of unspecified nature' and 'head injury, unspecified'. Main outcome and results: The average incidence of mTBI was 503.1/100000, with peaks among males (590/100000), American Indians/Alaska Natives (1,026/100000) and those <5 years of age (1,115.2/100000). MTBI incidence was highest in the Midwest region (578.4/10 000) and in non-urban areas (530.9/100 000) of the US. Bicycles and sports accounted for 26.4% of mTBI in the 5-14 age group. Conclusions: The national burden of mTBI is significant and the incidence higher than that reported by others. Possible explanations are discussed. Bicycle and sports-related injuries are an important and highly preventable cause of mTBI underscoring the need to promote prevention programmes on a national level.	Univ Rochester, Med Ctr, Dept Emergency Med, Sch Med & Dent, Rochester, NY 14642 USA; Univ Rochester, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; Univ Rochester, Dept Community & Prevent Med, Sch Med & Dent, Rochester, NY 14642 USA; Univ So Calif, Sch Publ Hlth, So Calif Injury Prevent & Res Ctr, Los Angeles, CA USA; Hosp Max Peralta, San Jose, Costa Rica	Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Emergency Med, Sch Med & Dent, Box 655,601 Elmwood Ave, Rochester, NY 14642 USA.	jef_bazarian@urmc.rochester.edu		Shah, Manish/0000-0001-6331-1074	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23 NS4195-03] Funding Source: Medline		Adekoya N, 2002, JAMA-J AM MED ASSOC, V288, P37; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; *CDCP, 2002, NAT HOSP AMB MED CAR; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; McCaig L F, 2001, Adv Data, P1; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; *NAT CTR HLTH STAT, 1999, NHAMCS MICR DAT FIL; *NAT CTR HLTH STAT, 2000, NHAMCS MICR DAT FIL; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thompson DC, 2000, COCHRANE DB SYST REV, V2; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US BUR CENS, 2003, NAT POP EST; Wright C.H., 1915, FLORA CAPENSIS 1, V5, P1	23	320	324	0	29	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2005	19	2					85	91		10.1080/02699050410001720158			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	990JR	WOS:000233739600002	15841752				2021-06-18	
J	CHESNUT, RM; MARSHALL, SB; PIEK, J; BLUNT, BA; KLAUBER, MR; MARSHALL, LF				CHESNUT, RM; MARSHALL, SB; PIEK, J; BLUNT, BA; KLAUBER, MR; MARSHALL, LF			EARLY AND LATE SYSTEMIC HYPOTENSION AS A FREQUENT AND FUNDAMENTAL SOURCE OF CEREBRAL-ISCHEMIA FOLLOWING SEVERE BRAIN INJURY IN THE TRAUMATIC COMA DATA-BANK	ACTA NEUROCHIRURGICA			English	Article						SEVERE HEAD INJURY; OUTCOME; SYSTEMIC HYPOTENSION; COMA DATA BANK	DAMAGE	The outcome from severe head injury (GCS less-than-or-equal-to 8 mmHg) was prospectively studied in patients from the Traumatic Coma Data Bank. We investigated the impact on outcome of hypotension (SBP < 90 mmHg) occurring from injury through resuscitation (early hypotension; N = 717) or in the Intensive Care Unit [ICU] (late hypotension; N = 493). Early hypotension occurred in 248 patients (34.6%) and was associated with a doubling of mortality (55% vs. 27%). If shock was present on admission, the mortality was 65%. These effects were independent of age, admission GCS motor score, presence of hypoxia, or associated severe extracranial trauma, suggesting that the influence of multiple system trauma in head injured patients is primarily due to associated hypotension. Late hypotension occurred in 156 of 493 patients (32%) and was the only hypotensive episode in 117 (24%). For 117 patients whose only hypotensive episode occurred in the ICU, 66% either died or were vegetative survivors, compared to 17% of patients who never suffered an hypotensive episode. Logistic regression modelling suggested that early and late shock were the most powerful independent predictors of mortality in this group of patients. These data demonstrate that hypotension is a common and devastating secondary brain insult in severe head injury patients, occurring not only during transport and resuscitation but also ''right under our noses'' in the ICU. We suggest that vigorous attention to eliminate or minimize such insults has the potential of markedly improving outcome from severe head injury.	UNIV CALIF SAN DIEGO,SAN DIEGO MED CTR,DEPT COMMUNITY & FAMILY MED,SAN DIEGO,CA 92107; UNIV DUSSELDORF,NEUROCHIRURG KLIN,W-4000 DUSSELDORF 1,GERMANY	CHESNUT, RM (corresponding author), UNIV CALIF SAN DIEGO,SAN DIEGO MED CTR,DIV NEUROL SURG,SAN DIEGO,CA 92107, USA.			Chesnut, Randall/0000-0001-6377-3666	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS N01-NS-3-2341, NINDS N01-NS-3-2340, NINDS N01-NS-3-2339] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032341, N01NS032339, N01NS032340] Funding Source: NIH RePORTER		CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hosmer D. W., 1989, APPLIED LOGISTIC REG; JENNETT B, 1975, LANCET, V1, P480; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; TEASDALE G, 1974, LANCET, V2, P81	9	320	329	0	3	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1993				59			121	125					5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	MV622	WOS:A1993MV62200022	8310858				2021-06-18	
J	Vang, O; Ahmad, N; Baile, CA; Baur, JA; Brown, K; Csiszar, A; Das, DK; Delmas, D; Gottfried, C; Lin, HY; Ma, QY; Mukhopadhyay, P; Nalini, N; Pezzuto, JM; Richard, T; Shukla, Y; Surh, YJ; Szekeres, T; Szkudelski, T; Walle, T; Wu, JM				Vang, Ole; Ahmad, Nihal; Baile, Clifton A.; Baur, Joseph A.; Brown, Karen; Csiszar, Anna; Das, Dipak K.; Delmas, Dominique; Gottfried, Carmem; Lin, Hung-Yun; Ma, Qing-Yong; Mukhopadhyay, Partha; Nalini, Namasivayam; Pezzuto, John M.; Richard, Tristan; Shukla, Yogeshwer; Surh, Young-Joon; Szekeres, Thomas; Szkudelski, Tomasz; Walle, Thomas; Wu, Joseph M.			What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE AGENT; ACTIVATED PROTEIN-KINASE; TRAUMATIC BRAIN-INJURY; ABERRANT CRYPT FOCI; INDUCED DIABETIC-RATS; FATTY LIVER-DISEASE; KAPPA-B ACTIVATION; SPINAL-CORD-INJURY; CELLS IN-VITRO; RED WINE	Background: Resveratrol is a natural compound suggested to have beneficial health effects. However, people are consuming resveratrol for this reason without having the adequate scientific evidence for its effects in humans. Therefore, scientific valid recommendations concerning the human intake of resveratrol based on available published scientific data are necessary. Such recommendations were formulated after the Resveratrol 2010 conference, held in September 2010 in Helsingor, Denmark. Methodology: Literature search in databases as PubMed and ISI Web of Science in combination with manual search was used to answer the following five questions: (1)Can resveratrol be recommended in the prevention or treatment of human diseases?; (2)Are there observed "side effects" caused by the intake of resveratrol in humans?; (3)What is the relevant dose of resveratrol?; (4)What valid data are available regarding an effect in various species of experimental animals?; (5)Which relevant (overall) mechanisms of action of resveratrol have been documented? Conclusions/Significance: The overall conclusion is that the published evidence is not sufficiently strong to justify a recommendation for the administration of resveratrol to humans, beyond the dose which can be obtained from dietary sources. On the other hand, animal data are promising in prevention of various cancer types, coronary heart diseases and diabetes which strongly indicate the need for human clinical trials. Finally, we suggest directions for future research in resveratrol regarding its mechanism of action and its safety and toxicology in human subjects.	[Vang, Ole] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Baile, Clifton A.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Baur, Joseph A.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Baur, Joseph A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Brown, Karen] Univ Leicester, Dept Canc Studies & Mol Med, Bioctr, Leicester, Great Britain, England; [Csiszar, Anna] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Das, Dipak K.] Univ Connecticut, Sch Med, Cardiovasc Res Ctr, Farmington, CT USA; [Delmas, Dominique] Univ Burgundy, INSERM, U866, Dijon, France; [Gottfried, Carmem] Univ Fed Rio Grande do Sul, Dept Biochem, Postgrad Programme Biochem, Inst Basic Hlth Sci, Porto Alegre, RS, Brazil; [Lin, Hung-Yun] Ordway Res Inst, Signal Transduct Lab, Albany, NY USA; [Ma, Qing-Yong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi Prov, Peoples R China; [Mukhopadhyay, Partha] NIH, Lab Physiol Studies, Sect Oxidat Stress Tissue Injury, Rockville, MD USA; [Nalini, Namasivayam] Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Pezzuto, John M.] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA; [Richard, Tristan] Univ Bordeaux, UFR Pharmacie, Villenave Dornon, France; [Shukla, Yogeshwer] Indian Inst Toxicol Res, Prote Lab, Lucknow, Uttar Pradesh, India; [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Szekeres, Thomas] Med Univ Vienna, Gen Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; [Szkudelski, Tomasz] Agr Univ Poznan, Dept Anim Physiol & Biochem, Poznan, Poland; [Walle, Thomas] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Wu, Joseph M.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	Vang, O (corresponding author), Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark.	ov@ruc.dk	Gottfried, Carmem/AAG-2355-2019; Baur, Joseph A/D-8163-2011; Shukla, Yogeshwer/B-4144-2012; Delmas, Dominique/AAD-9749-2019; Vang, Ole/K-9842-2015; MUKHOPADHYAY, PARTHA/G-3890-2010; Ahmad, Nihal/AAR-4249-2021	Gottfried, Carmem/0000-0001-8838-1300; Delmas, Dominique/0000-0003-3576-0248; Vang, Ole/0000-0002-3901-8545; MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Ahmad, Nihal/0000-0002-4239-9887; Brown, Karen/0000-0002-5217-1501; Szkudelski, Tomasz/0000-0002-9067-6682; Richard, Tristan/0000-0002-5308-8697; Baur, Joseph/0000-0001-8262-6549	European UnionEuropean Commission; Cancer Research UKCancer Research UK [13101] Funding Source: researchfish	This study was made as a part of the Resveratrol 2010 conference (www.resveratrol2010.com) and did not receive any specific funding from third parties. The conference was organized by Roskilde University, Danish Society for Biochemistry and Molecular Biology, The Danish Society of Engineers, Oresund Food with support from The European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar F, 2011, CARDIOVASC DRUG THER, V25, P119, DOI 10.1007/s10557-010-6255-7; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Ates O, 2007, J CLIN NEUROSCI, V14, P256, DOI 10.1016/j.jocn.2005.12.010; Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; Aubin MC, 2008, J PHARMACOL EXP THER, V325, P961, DOI 10.1124/jpet.107.135061; Banerjee S, 2002, CANCER RES, V62, P4945; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Behbahani J, 2010, AM J HYPERTENS, V23, P1273, DOI 10.1038/ajh.2010.161; Berge G, 2004, BRIT J CANCER, V91, P1380, DOI 10.1038/sj.bjc.6602125; Bhat KPL, 2001, CANCER RES, V61, P7456; Binienda ZK, 2010, NEUROSCI LETT, V480, P117, DOI 10.1016/j.neulet.2010.06.020; Bishayee A, 2009, CHEM-BIOL INTERACT, V179, P131, DOI 10.1016/j.cbi.2008.11.015; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Bove K, 2002, BIOCHEM BIOPH RES CO, V291, P1001, DOI 10.1006/bbrc.2002.6554; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Bujanda L, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-40; Burkon A, 2008, MOL NUTR FOOD RES, V52, P549, DOI 10.1002/mnfr.200700290; Burstein B, 2007, J PHARMACOL EXP THER, V323, P916, DOI 10.1124/jpet.107.127548; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Chen Y, 2004, SURGERY, V136, P57, DOI 10.1016/j.surg.2004.01.017; Chen YR, 2008, CARDIOVASC DRUG THER, V22, P479, DOI 10.1007/s10557-008-6141-8; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Das S, 2006, J PHARMACOL EXP THER, V317, P980, DOI 10.1124/jpet.105.095133; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dudley J, 2009, J NUTR BIOCHEM, V20, P443, DOI 10.1016/j.jnutbio.2008.05.003; El-Mowafy AM, 2010, CHEMOTHERAPY, V56, P60, DOI 10.1159/000298821; Elliott PJ, 2009, DRUG FUTURE, V34, P291, DOI 10.1358/dof.2009.034.04.1360696; Fukuda S, 2006, CELL BIOCHEM BIOPHYS, V44, P43, DOI 10.1385/CBB:44:1:043; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Harper CE, 2009, PROSTATE, V69, P1668, DOI 10.1002/pros.21017; Hebbar V, 2005, LIFE SCI, V76, P2299, DOI 10.1016/j.lfs.2004.10.039; Hecht SS, 1999, CANCER LETT, V137, P123, DOI 10.1016/S0304-3835(98)00326-7; Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y; Horn TL, 2007, FOOD CHEM TOXICOL, V45, P55, DOI 10.1016/j.fct.2006.07.015; Huang HP, 2010, FREE RADICAL BIO MED, V49, P1710, DOI 10.1016/j.freeradbiomed.2010.08.032; Inanaga K, 2009, HYPERTENS RES, V32, P466, DOI 10.1038/hr.2009.47; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Juan ME, 2002, J NUTR, V132, P257; Kapadia GJ, 2002, PHARMACOL RES, V45, P499, DOI 10.1006/phrs.2002.0992; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim YH, 2010, DIABETES, V59, P1825, DOI 10.2337/db09-1431; Kimura Y, 2001, J NUTR, V131, P1844; Kineman BD, 2007, NUTR CANCER, V58, P66, DOI 10.1080/01635580701308208; Kiziltepe U, 2004, J VASC SURG, V40, P138, DOI 10.1016/j.jvs.2004.03.032; Kowalczyk MC, 2010, CANCER PREV RES, V3, P170, DOI 10.1158/1940-6207.CAPR-09-0196; Kumar A, 2007, PHARMACOLOGY, V79, P17, DOI 10.1159/000097511; Kumar A, 2010, BIOCHEM BIOPH RES CO, V394, P360, DOI 10.1016/j.bbrc.2010.03.014; Kumar P, 2006, BEHAV PHARMACOL, V17, P485, DOI 10.1097/00008877-200609000-00014; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larrosa M, 2010, J MED CHEM, V53, P7365, DOI 10.1021/jm1007006; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Lekli I, 2008, AM J PHYSIOL-HEART C, V294, pH859, DOI 10.1152/ajpheart.01048.2007; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Liu HS, 2003, WORLD J GASTROENTERO, V9, P1474, DOI 10.3748/wjg.v9.i7.1474; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI 10.1021/JF053011Q; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Macarulla MT, 2009, J PHYSIOL BIOCHEM, V65, P369, DOI 10.1007/BF03185932; Martin AR, 2006, BRIT J PHARMACOL, V147, P873, DOI 10.1038/sj.bjp.0706469; Meng XF, 2004, J AGR FOOD CHEM, V52, P935, DOI 10.1021/jf030582e; Miatello R, 2005, AM J HYPERTENS, V18, P864, DOI 10.1016/j.amjhyper.2004.12.012; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Niles RM, 2006, J NUTR, V136, P2542; Oomen CA, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.004.2009; Palsamy P, 2008, BIOMED PHARMACOTHER, V62, P598, DOI 10.1016/j.biopha.2008.06.037; Palsamy P, 2010, J CELL PHYSIOL, V224, P423, DOI 10.1002/jcp.22138; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Provinciali M, 2005, INT J CANCER, V115, P36, DOI 10.1002/ijc.20874; Ramadori G, 2009, ENDOCRINOLOGY, V150, P5326, DOI 10.1210/en.2009-0528; Ranney A, 2009, BEHAV PHARMACOL, V20, P330, DOI 10.1097/FBP.0b013e32832f0193; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Robb EL, 2008, BIOCHEM BIOPH RES CO, V372, P254, DOI 10.1016/j.bbrc.2008.05.028; Robich MP, 2010, CIRCULATION, V122, pS142, DOI 10.1161/CIRCULATIONAHA.109.920132; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; Roy P, 2009, PHARM RES-DORDR, V26, P211, DOI 10.1007/s11095-008-9723-z; Sakata Y, 2010, EXP NEUROL, V224, P325, DOI 10.1016/j.expneurol.2010.03.032; Sale S, 2005, INT J CANCER, V115, P194, DOI 10.1002/ijc.20884; Saleh MC, 2010, NEUROSCIENCE, V166, P445, DOI 10.1016/j.neuroscience.2009.12.060; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Sato M, 2003, CANCER LETT, V202, P137, DOI 10.1016/j.canlet.2003.08.016; Schmatz R, 2009, BRAIN RES BULL, V80, P371, DOI 10.1016/j.brainresbull.2009.08.019; Schneider Y, 2001, NUTR CANCER, V39, P102, DOI 10.1207/S15327914nc391_14; Seeni A, 2008, ASIAN PAC J CANCER P, V9, P7; Sener G, 2007, PULM PHARMACOL THER, V20, P642, DOI 10.1016/j.pupt.2006.07.003; Sengottuvelan M, 2006, BRIT J NUTR, V96, P145, DOI 10.1079/BJN20061789; Sengottuvelan M, 2009, NUTRITION, V25, P1169, DOI 10.1016/j.nut.2009.03.009; Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x; Sharma S, 2007, PHYTOTHER RES, V21, P278, DOI 10.1002/ptr.2070; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Soleas GJ, 2002, CLIN BIOCHEM, V35, P119, DOI 10.1016/S0009-9120(02)00275-8; Soleas GJ, 2001, J CHROMATOGR B, V757, P161, DOI 10.1016/S0378-4347(01)00142-6; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Stervbo U, 2007, FOOD CHEM, V101, P449, DOI 10.1016/j.foodchem.2006.01.047; Sutra T, 2008, J AGR FOOD CHEM, V56, P11683, DOI 10.1021/jf802357g; Tessitore L, 2000, CARCINOGENESIS, V21, P1619, DOI 10.1093/carcin/21.8.1619; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Tunali-Akbay T, 2010, J PHARM PHARM SCI, V13, P303, DOI 10.18433/J30K5Q; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vaz-Da-Silva M, 2008, INT J CLIN PHARM TH, V46, P564; Vazquez-Agell M, 2007, J NUTR, V137, P2279; Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Watzl B, 2004, EUR J CLIN NUTR, V58, P40, DOI 10.1038/sj.ejcn.1601742; Watzl B, 2002, EUR J NUTR, V41, P264, DOI 10.1007/s00394-002-0384-0; Whitsett Timothy, 2006, J Carcinog, V5, P15, DOI 10.1186/1477-3163-5-15; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002; Wojciechowski P, 2010, J NUTR, V140, P962, DOI 10.3945/jn.109.115006; Wong RHX, 2011, NUTR METAB CARDIOVAS, V21, P851, DOI 10.1016/j.numecd.2010.03.003; Wong YT, 2009, FREE RADICAL BIO MED, V46, P799, DOI 10.1016/j.freeradbiomed.2008.12.016; Woodall CE, 2009, ANTI-CANCER DRUG, V20, P437, DOI 10.1097/CAD.0b013e32832afb95; Wu Z, 2009, NEUROCHEM RES, V34, P1393, DOI 10.1007/s11064-009-9920-0; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Yang DL, 2010, CLIN EXP PHARMACOL P, V37, P150, DOI 10.1111/j.1440-1681.2009.05231.x; Yang YB, 2003, ACTA PHARMACOL SIN, V24, P703; Yao J, 2010, ARCH MED RES, V41, P288, DOI 10.1016/j.arcmed.2010.05.002; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Yu L, 2003, WORLD J GASTROENTERO, V9, P2341; Yusuf N, 2009, MOL CARCINOGEN, V48, P713, DOI 10.1002/mc.20517; Zamora-Ros R, 2006, CLIN CHEM, V52, P1373, DOI 10.1373/clinchem.2005.065870; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010; Zhou HB, 2005, WORLD J GASTROENTERO, V11, P280, DOI 10.3748/wjg.v11.i2.280; Ziegler CC, 2004, J NUTR, V134, P5	144	317	327	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e19881	10.1371/journal.pone.0019881			11	Multidisciplinary Sciences	Science & Technology - Other Topics	778UW	WOS:000291734100003	21698226	DOAJ Gold, Green Published	Y	N	2021-06-18	
J	Maruff, P; Thomas, E; Cysique, L; Brew, B; Collie, A; Snyder, P; Pietrzak, RH				Maruff, Paul; Thomas, Elizabeth; Cysique, Lucette; Brew, Bruce; Collie, Alex; Snyder, Peter; Pietrzak, Robert H.			Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Computer cognitive; Assessment; Neuropsychiatric	WORKING-MEMORY; STATISTICAL APPROACH; CORONARY SURGERY; PERFORMANCE; DECLINE; DEPRESSION; ATTENTION; CHILDREN; DEFICIT; PEOPLE	This study examined the validity of the four standard psychological paradigms that have been operationally defined within the CogState brief computerized cognitive assessment battery. Construct validity was determined in a large group of healthy adults. CogState measures of processing speed, attention, working memory, and learning showed strong correlations with conventional neuropsychological measures of these same constructs (r's = .49 to .83). Criterion validity was determined by examining patterns of performance on the CogState tasks in groups of individuals with mild head injury, schizophrenia, and AIDS dementia complex. Each of these groups was impaired on the CogState performance measures (Cohen's d's = -.60 to -1.80) and the magnitude and nature of this impairment was qualitatively and quantitatively similar in each group. Taken together, the results suggest that the cognitive paradigms operationally defined in the CogState brief battery have acceptable construct and criterion validity in a neuropsychological context.	[Maruff, Paul] CogState Ltd, Melbourne, Vic 3000, Australia; [Maruff, Paul; Collie, Alex] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Thomas, Elizabeth] Univ Melbourne, Sch Behav Sci, Parkville, Vic 3052, Australia; [Cysique, Lucette] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Cysique, Lucette; Brew, Bruce] Univ New S Wales, St Vincents Hosp, Dept Neurol, Sydney, NSW, Australia; [Snyder, Peter] Brown Univ, Dept Clin Neurosci, Warren Alpert Med Sch, Providence, RI 02912 USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Maruff, P (corresponding author), CogState Ltd, 7-21 Victoria St, Melbourne, Vic 3000, Australia.	pmaruff@cogstate.com	Cysique, Lucette/U-1357-2017; Maruff, Paul/ABA-1673-2020; Snyder, Peter J./W-2609-2019; Maruff, Paul/AAD-2454-2021; Brew, Bruce/J-6513-2012; McLean, Emma/F-4616-2012	Cysique, Lucette/0000-0002-7711-6373; Maruff, Paul/0000-0002-6947-9537; Snyder, Peter/0000-0003-0555-4654; Collie, Alex/0000-0003-2617-9339; brew, bruce/0000-0003-0622-1392			Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Cairney S, 2007, ADDICTION, V102, P909, DOI 10.1111/j.1360-0443.2007.01840.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; COHEN DJ, 1994, J AM ACAD CHILD PSY, V33, P2, DOI 10.1097/00004583-199401000-00002; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2002, ANN THORAC SURG, V73, P2005, DOI 10.1016/S0003-4975(01)03375-6; Collie A, 2001, NEUROLOGY, V56, P1533, DOI 10.1212/WNL.56.11.1533; Collie A, 2007, CONTEMP CLIN TRIALS, V28, P391, DOI 10.1016/j.cct.2006.10.010; Cummings JL, 2006, CNS SPECTRUMS, V11, P3; Cysique LAJ, 2006, ARCH CLIN NEUROPSYCH, V21, P185, DOI 10.1016/j.acn.2005.07.011; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; DARBY D, 2005, CLIN NEUROPSYCHOLOGY; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Fossella J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1255; GRANT I, 1996, NEUROPSYCHOLOGICAL A; HARRISON JE, 2002, COGNITIVE DEFICITS B; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Jansma JM, 2000, NEUROIMAGE, V12, P688, DOI 10.1006/nimg.2000.0645; Koss E, 1996, NEUROLOGY, V46, P136, DOI 10.1212/WNL.46.1.136; LEWIS D, 2002, NEUROPSYCHOPHARMACOL; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luce R.D., 1986, RESPONSE TIMES THEIR; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2006, PSYCHOPHARMACOLOGY, V186, P7, DOI 10.1007/s00213-006-0331-5; Maruff P, 2004, DEMENT GERIATR COGN, V18, P342, DOI 10.1159/000080229; MARUFF P, 1994, ARCH NEUROL-CHICAGO, V51, P689, DOI 10.1001/archneur.1994.00540190069017; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mild Traumatic Brain Injury Committee of the Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHABI, V8, P86; Mollica CM, 2004, HUM PSYCHOPHARM CLIN, V19, P445, DOI 10.1002/hup.624; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murkin JM, 1997, ANN THORAC SURG, V64, P904, DOI 10.1016/S0003-4975(97)00743-1; Nelson HE, 1982, NATL ADULT READING T; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Phillips KA, 2003, JNCI-J NATL CANCER I, V95, P190, DOI 10.1093/jnci/95.3.190; Pietrzak RH, 2008, ARCH CLIN NEUROPSYCH, V23, P433, DOI 10.1016/j.acn.2008.03.002; Posner M.I., 1994, IMAGES MIND; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Salthouse TA, 2006, DEV REV, V26, P31, DOI 10.1016/j.dr.2005.09.001; SELNES OA, 1995, NEUROLOGY, V45, P267, DOI 10.1212/WNL.45.2.267; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Silbert BS, 2004, BRIT J ANAESTH, V92, P814, DOI 10.1093/bja/aeh157; Spreen O., 1998, COMPENDIUM NEUROPSYC; Squire L.R., 2000, MEMORY MIND MOL; Thein HH, 2007, HIV MED, V8, P520, DOI 10.1111/j.1468-1293.2007.00505.x; Thein HH, 2007, HIV MED, V8, P192, DOI 10.1111/j.1468-1293.2007.00452.x; UZZELL BP, 2007, INT HDB CROSS CULTUR; VERHAGEN P, 2002, NEUROSCI BIOBEHAV R, V26, P846; WALSH K, 2002, NEUROPSYCHOLOGY; Winer BJ., 1971, STAT PRINCIPLES EXPT; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	60	317	319	0	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2009	24	2					165	178		10.1093/arclin/acp010			14	Psychology, Clinical; Psychology	Psychology	454TL	WOS:000266705500005	19395350	Green Published, Bronze			2021-06-18	
J	Xiao, GM; Wei, J; Yan, WQ; Wang, WM; Lu, ZH				Xiao, Guomin; Wei, Jing; Yan, Weiqi; Wang, Weimin; Lu, Zhenhui			Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial	CRITICAL CARE			English	Article							CEREBRAL-ARTERY OCCLUSION; CONTUSION INJURY; MALE-RATS; ISCHEMIA; INFUSION; PROTECTS; EDEMA; DEATH	Background Severe traumatic brain injury (TBI) has been increasing with greater incidence of injuries from traffic or sporting accidents. Although there are a number of animal models of TBI using progesterone for head injury, the effects of progesterone on neurologic outcome of acute TBI patients remain unclear. The aim of the present clinical study was to assess the longer-term efficacy of progesterone on the improvement in neurologic outcome of patients with acute severe TBI. Methods A total of 159 patients who arrived within 8 hours of injury with a Glasgow Coma Score <= 8 were enrolled in the study. A prospective, randomized, placebo-controlled trial of progesterone was conducted in the Neurotrauma Center of our teaching hospital. The patients were randomized to receive either progesterone or placebo. The primary endpoint was the Glasgow Outcome Scale score 3 months after brain injury. Secondary efficacy endpoints included the modified Functional Independence Measure score and mortality. In a follow-up protocol at 6 months, the Glasgow Outcome Scale and the modified Functional Independence Measure scores were again determined. Results Of the 159 patients randomized, 82 received progesterone and 77 received placebo. The demographic characteristics, the mechanism of injury, and the time of treatment were compared for the two groups. After 3 months and 6 months of treatment, the dichotomized Glasgow Outcome Scale score analysis exhibited more favorable outcomes among the patients who were given progesterone compared with the control individuals (P = 0.034 and P = 0.048, respectively). The modified Functional Independence Measure scores in the progesterone group were higher than those in the placebo group at both 3-month and 6-month follow-up (P < 0.05 and P < 0.01). The mortality rate of the progesterone group was significantly lower than that of the placebo group at 6-month follow-up (P < 0.05). The mean intracranial pressure values 72 hours and 7 days after injury were lower in the progesterone group than in the placebo group, but there was no statistical significance between the two groups (P > 0.05). Instances of complications and adverse events associated with the administration of progesterone were not found. Conclusion Our data suggest that acute severe TBI patients with administration of progesterone hold improved neurologic outcomes for up to 6 months. These results provide information important for further large and multicenter clinical trials on progesterone as a promising neuroprotective drug.	[Yan, Weiqi; Lu, Zhenhui] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310009, Zhejiang, Peoples R China; [Xiao, Guomin; Wang, Weimin] Hangzhou Normal Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Hangzhou 310015, Zhejiang, Peoples R China; [Xiao, Guomin; Wang, Weimin] Hangzhou Normal Univ, Coll Med, Affiliated Hosp, Neurotrauma Ctr, Hangzhou 310015, Zhejiang, Peoples R China; [Wei, Jing] Hangzhou Normal Univ, Coll Med, Affiliated Hosp, Dept Hlth Ctr, Hangzhou 310015, Zhejiang, Peoples R China	Yan, WQ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310009, Zhejiang, Peoples R China.	wyan@zju.edu.cn		Yan, Weiqi/0000-0002-3298-7677			Allolio B, 1995, EUR J ENDOCRINOL, V133, P696, DOI 10.1530/eje.0.1330696; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; GOLDFIEN A, 1989, BASIC CLIN PHARM, V4, P493; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	31	317	323	2	26	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2008	12	2							R61	10.1186/cc6887			10	Critical Care Medicine	General & Internal Medicine	326BM	WOS:000257632900033	18447940	DOAJ Gold, Green Published			2021-06-18	
J	Bain, AC; Meaney, DF				Bain, AC; Meaney, DF			Tissue-level thresholds for axonal damage in an experimental model of central nervous system white matter injury	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						traumatic brain injury; diffuse axonal injury; injury tolerance	VISUAL-EVOKED-POTENTIALS; TRAUMATIC BRAIN INJURY; OPTIC-NERVE; HEAD-INJURY; NEUROFILAMENT SUBUNITS; DIAGNOSTIC-TESTS; PREDICTIVE VALUE; CANCER; JUDGMENTS; SEVERITY	In vivo, tissue-level, mechanical thresholds for axonal injury were determined by comparing morphological injury and electrophysiological impairment to estimated tissue strain in an in vivo model of axonal injury. Axonal injury was produced by-dynamically stretching the right optic nerve of an adult male guinea pig to one of seven levels of ocular displacement (N-level=10; N-total=70). Morphological injury was detected with neurofilament immunohistochemical staining (NF68, SM132). Simultaneously, functional injury was determined by the magnitude of the latency shift of the N-35 peak of the the visual evoked potentials (VEPs) recorded before and after stretch. A companion set of in situ experiments (N-level=5) was used to determine the empirical relationship between the applied ocular displacement and the magnitude of optic nerve stretch. Logistic regression analysis, combined with sensitivity and specificity measures and receiver operating characteristic (ROC) curves were used to predict strain thresholds for axonal injury. From this analysis, we determined three Lagrangian strain-based thresholds for morphological damage to white matter The liberal threshold, intended to minimize the detection of false positives, was a strain of 0.34, and the conservative threshold strain that minimized the false negative rate was 0.14. The optimal threshold strain criterion that balanced the specificity and sensitivity measures was 0.21. Similar comparisons for electrophysiological impairment produced liberal, conservative; and optimal strain thresholds of 0.28 0.13, and 0.18, respectively. With these threshold data, it is now possible to predict more accurately the conditions that cause axonal injury in human white matter.	Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 120 Hayden Hall, Philadelphia, PA 19104 USA.		Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Meaney, David/0000-0002-0954-4122	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35712] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR312712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035712] Funding Source: NIH RePORTER		Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1983, ADV NEUROTRAUMATOLOG, P53; Allaouchiche B, 1996, CHEST, V110, P1558, DOI 10.1378/chest.110.6.1558; Altman D, 1991, PRACTICAL STAT MED R; APAYDIN C, 1993, ACTA OPHTHALMOL, V71, P623; Bain A.C., 1996, AGARD SPEC M MESC NM; Bandak F.A., 1994, P 38 STAPP CAR CRASH; Brenneman FD, 1998, J TRAUMA, V44, P580, DOI 10.1097/00005373-199804000-00003; Bytzer P, 1997, SCAND J GASTROENTERO, V32, P118, DOI 10.3109/00365529709000181; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; CREEL DJ, 1972, EXP NEUROL, V36, P411, DOI 10.1016/0014-4886(72)90002-7; CREEL DJ, 1973, EXP NEUROL, V40, P351, DOI 10.1016/0014-4886(73)90079-4; DIAMOND GA, 1992, J CLIN EPIDEMIOL, V45, P9, DOI 10.1016/0895-4356(92)90181-L; DUCATI A, 1988, ELECTROEN CLIN NEURO, V71, P89, DOI 10.1016/0168-5597(88)90010-X; Duke TD, 1997, INTENS CARE MED, V23, P684, DOI 10.1007/s001340050394; Einstein AJ, 1997, ARCH PATHOL LAB MED, V121, P110; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; Fine BS, 1979, OCULAR HISTOLOGY; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Garber BG, 1996, J TRAUMA, V40, P733, DOI 10.1097/00005373-199605000-00008; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli T.A., 1982, HEAD INJURY BASIC CL, P129; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAY JAB, 1954, J PHYSIOL-LONDON, V124, P84, DOI 10.1113/jphysiol.1954.sp005087; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; HAFTEK J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P354; HajianTilaki KO, 1997, MED DECIS MAKING, V17, P94, DOI 10.1177/0272989X9701700111; HARDING GFA, 1984, OPHTHAL PHYSL OPT, V4, P293; Heshner D., 1981, APPL DISCRETE CHOICE; KOIKE H, 1987, J PHYSIOL-LONDON, V390, P469, DOI 10.1113/jphysiol.1987.sp016712; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; MAHAPATRA AK, 1989, SURG NEUROL, V31, P339, DOI 10.1016/0090-3019(89)90064-5; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh TK, 1996, LAB INVEST, V74, P315; Mendis K., 1992, THESIS OHIO STATE U; Myers B.S., 1995, P 39 STAPP CAR CRASH; MYERS BS, 1994, P 22 ANN INT WORKSH; OMMAYA AK, 1967, P 13 STAPP CAR CRASH; Pastor A, 1997, EUR RESPIR J, V10, P603; Peipert JF, 1996, OBSTET GYNECOL, V87, P730, DOI 10.1016/0029-7844(96)00040-3; POPE AM, 1991, DISABILITY AM NATL A; Reid MC, 1998, AM J MED, V104, P374, DOI 10.1016/S0002-9343(98)00054-0; ROSENFELD J, 1987, J NEUROPATH EXP NEUR, V46, P269, DOI 10.1097/00005072-198705000-00004; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Saatman K. E., 1993, THESIS U PENNSYLVANI; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558; SHREIBER DI, 1998, UNPUB ASME; SIMA AAF, 1992, DIABETOLOGIA, V35, P602, DOI 10.1007/BF00400249; SLOAN KE, 1991, CELL TISSUE RES, V263, P265, DOI 10.1007/BF00318768; SOKOL S, 1976, Survey of Ophthalmology, V21, P18, DOI 10.1016/0039-6257(76)90046-1; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Steinberg D., 1991, LOGIT SUPPLEMENTARY; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; SUZUKI M, 1991, J VET MED SCI, V53, P301, DOI 10.1292/jvms.53.301; SUZUKI M, 1991, J VET MED SCI, V53, P911, DOI 10.1292/jvms.53.911; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; TAKEUCHI T, 1992, J VET MED SCI, V54, P813, DOI 10.1292/jvms.54.813; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Ukimura O, 1998, J UROLOGY, V159, P1251, DOI 10.1016/S0022-5347(01)63575-4; Varela AS, 1997, CANCER LETT, V121, P139, DOI 10.1016/S0304-3835(97)00340-6; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; ZHOU C, 1994, P 38 STAPP CAR CRASH	71	317	325	2	31	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2000	122	6					615	622		10.1115/1.1324667			8	Biophysics; Engineering, Biomedical	Biophysics; Engineering	404QE	WOS:000167111300009	11192383				2021-06-18	
J	Wright, DW; Yeatts, SD; Silbergleit, R; Palesch, YY; Hertzberg, VS; Frankel, M; Goldstein, FC; Caveney, AF; Howlett-Smith, H; Bengelink, EM; Manley, GT; Merck, LH; Janis, LS; Barsan, WG				Wright, David W.; Yeatts, Sharon D.; Silbergleit, Robert; Palesch, Yuko Y.; Hertzberg, Vicki S.; Frankel, Michael; Goldstein, Felicia C.; Caveney, Angela F.; Howlett-Smith, Harriet; Bengelink, Erin M.; Manley, Geoffrey T.; Merck, Lisa H.; Janis, L. Scott; Barsan, William G.		NETT Investigators	Very Early Administration of Progesterone for Acute Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; PRACTICAL SCALE; NEUROPROTECTION; COMA	BACKGROUND Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Progesterone has been shown to improve neurologic outcome in multiple experimental models and two early-phase trials involving patients with TBI. METHODS We conducted a double-blind, multicenter clinical trial in which patients with severe, moderate-to-severe, or moderate acute TBI (Glasgow Coma Scale score of 4 to 12, on a scale from 3 to 15, with lower scores indicating a lower level of consciousness) were randomly assigned to intravenous progesterone or placebo, with the study treatment initiated within 4 hours after injury and administered for a total of 96 hours. Efficacy was defined as an increase of 10 percentage points in the proportion of patients with a favorable outcome, as determined with the use of the stratified dichotomy of the Extended Glasgow Outcome Scale score at 6 months after injury. Secondary outcomes included mortality and the Disability Rating Scale score. RESULTS A total of 882 of the planned sample of 1140 patients underwent randomization before the trial was stopped for futility with respect to the primary outcome. The study groups were similar with regard to baseline characteristics; the median age of the patients was 35 years, 73.7% were men, 15.2% were black, and the mean Injury Severity Score was 24.4 (on a scale from 0 to 75, with higher scores indicating greater severity). The most frequent mechanism of injury was a motor vehicle accident. There was no significant difference between the progesterone group and the placebo group in the proportion of patients with a favorable outcome (relative benefit of progesterone, 0.95; 95% confidence interval [CI], 0.85 to 1.06; P = 0.35). Phlebitis or thrombophlebitis was more frequent in the progesterone group than in the placebo group (relative risk, 3.03; CI, 1.96 to 4.66). There were no significant differences in the other prespecified safety outcomes. CONCLUSIONS This clinical trial did not show a benefit of progesterone over placebo in the improvement of outcomes in patients with acute TBI.	[Wright, David W.; Howlett-Smith, Harriet] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Frankel, Michael; Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Grady Mem Hosp, Atlanta, GA USA; [Hertzberg, Vicki S.] Emory Univ, Dept Biostat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Yeatts, Sharon D.; Palesch, Yuko Y.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Silbergleit, Robert; Bengelink, Erin M.; Barsan, William G.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Caveney, Angela F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Merck, Lisa H.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Janis, L. Scott] NINDS, NIH, Bethesda, MD 20892 USA	Wright, DW (corresponding author), 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	david.wright@emory.edu	Shutter, Lori A/G-2957-2013; Meurer, William J/A-7547-2010; Milling, Truman J/N-6601-2017; Pascual, Jose/ABI-2291-2020; Bebarta, Vikhyat S/M-1513-2015; Rosenthal, Eric/A-2085-2017	Meurer, William J/0000-0002-1158-5302; Milling, Truman J/0000-0002-5588-0426; Pascual, Jose/0000-0002-1613-7912; Jallo, Jack/0000-0002-5512-1729; McMullan, Jason/0000-0002-7656-7447; Foreman, Brandon/0000-0002-5418-674X; Rosenthal, Eric/0000-0003-3900-356X; Brandler, Ethan/0000-0003-4647-8483; Shutter, Lori/0000-0002-1390-0628	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine; Grady Memorial Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS080377, U10NS059032, U01NS059041, U01NS062778, U10NS080369, U01NS056975, U10NS058927, U10NS058960, U10NS058940, U10NS059012] Funding Source: NIH RePORTER	Supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454) and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P549; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dmitrienko A, 2005, ANAL CLIN TRIALS USI; Ducharme N, 2010, EUR J PHARMACOL, V641, P128, DOI 10.1016/j.ejphar.2010.05.033; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	17	316	323	13	184	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2457	2466		10.1056/NEJMoa1404304			10	Medicine, General & Internal	General & Internal Medicine	AX4RZ	WOS:000346920300005	25493974	Green Accepted	Y	N	2021-06-18	
J	Xiong, Y; Gu, Q; Peterson, PL; Muizelaar, JP; Lee, CP				Xiong, Y; Gu, Q; Peterson, PL; Muizelaar, JP; Lee, CP			Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						brain mitochondria; Ca2+; oxidative phosphorylation; rat; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; LIPID-PEROXIDATION; FOREBRAIN MITOCHONDRIA; ELECTRON-TRANSPORT; HEAD-INJURY; DAMAGE; RATS; NEURONS; MODEL	Traumatic brain injury (TBI) is associated with primary and secondary injury. A thorough understanding of secondary injury will help to develop effective treatments and improve patient outcome. In this study, the GM model of controlled cortical impact injury (CCII) of Lighthall (1988) was used with modification to induce lateral TBI in rats. Forebrain mitochondria isolated from ipsilateral (IH) and contralateral (CH) hemispheres to impact showed a distinct difference. With glutamate + malate as substrates, mitochondria from the IH showed a significant decrease in State 3 respiratory rates, respiratory control indices (RCI), and P/O ratios. This decrease occurred as early as 1 h and persisted for at least 14 days following TBI. The State 3 respiratory rates, RCI, and P/O ratios could be restored to sham values by the addition of EGTA to the assay mixture. A significant amount of Ca2+ was found to be adsorbed to the mitochondria of both the IH and the CH with higher values seen in the IH. The rate of energy-linked Ca2+ transport in the IH was significantly decreased at 6 and 12 h. These data indicate that CCII-induced TBI perturbs cellular Ca2+ homeostasis and results in excessive Ca2+ adsorption to the mitochondrial membrane, which subsequently inhibits the respiratory chain-linked electron transfer and energy transduction.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM & MOL BIOL,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT NEUROL,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT NEUROSURG,DETROIT,MI 48201				Xiong, Ye/0000-0001-9770-6031			BINDOLI A, 1988, FREE RADICAL BIO MED, V5, P247, DOI 10.1016/0891-5849(88)90018-4; BRAUGHLER JM, 1985, J NEUROCHEM, V45, P1288, DOI 10.1111/j.1471-4159.1985.tb05555.x; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CASTILHO RF, 1994, ARCH BIOCHEM BIOPHYS, V308, P158, DOI 10.1006/abbi.1994.1022; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COHADON F, 1991, J NEUROL SCI, V103, pS27; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P252; DUGAN LL, 1995, J NEUROSCI, V15, P6377; ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1; ForsmarkAndree P, 1997, FREE RADICAL BIO MED, V22, P391, DOI 10.1016/S0891-5849(96)00330-9; GLINN M, 1991, ARCH BIOCHEM BIOPHYS, V290, P57, DOI 10.1016/0003-9861(91)90591-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GU Q, 1996, FASEB J, V10, pA1493; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HILLERED L, 1988, J NEUROSCI RES, V19, P94, DOI 10.1002/jnr.490190113; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KOCHANEK PM, 1995, J NEUROTRAUM, V12, P1015; Lee C. P., 1993, V2, P41; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALENKA RC, 1989, TRENDS NEUROSCI, V12, P444, DOI 10.1016/0166-2236(89)90094-5; MALIS CD, 1986, J BIOL CHEM, V261, P14201; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; NAKAHARA I, 1991, J NEUROCHEM, V57, P839, DOI 10.1111/j.1471-4159.1991.tb08227.x; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PETERSON PL, 1996, J NEUROTRAUM, V13, P590; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; XIONG Y, 1996, FASEB J, V10, pA1493; XIONG Y, 1996, J NEUROTRAUM, V13, P590; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; ZHANG Y, 1990, J BIOL CHEM, V265, P16330	45	316	324	1	13	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1997	14	1					23	34		10.1089/neu.1997.14.23			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	WK032	WOS:A1997WK03200003	9048308				2021-06-18	
J	MARSHALL, LF; GAUTILLE, T; KLAUBER, MR; EISENBERG, HM; JANE, JA; LUERSSEN, TG; MARMAROU, A; FOULKES, MA				MARSHALL, LF; GAUTILLE, T; KLAUBER, MR; EISENBERG, HM; JANE, JA; LUERSSEN, TG; MARMAROU, A; FOULKES, MA			THE OUTCOME OF SEVERE CLOSED HEAD-INJURY	JOURNAL OF NEUROSURGERY			English	Article						TRAUMATIC COMA DATA BANK; HEAD INJURY; INTRACRANIAL PRESSURE; OUTCOME; COMA	COMA DATA-BANK; MANAGEMENT; HEMATOMA	The outcome of severe head injury was prospectively studied in patients enrolled in the Traumatic Coma Data Bank (TCDB) during the 45-month period from January 1, 1984, through September 30, 1987. Data were collected on 1030 consecutive patients admitted with severe head injury (defined as a Glasgow Coma Scale (GCS) score of 8 or less following nonsurgical resuscitation). Of these, 284 either were brain-dead on admission or had a gunshot wound to the brain. Patients in these two groups were excluded, leaving 746 patients available for this analysis. The overall mortality rate for the 746 patients was 36%, determined at 6 months postinjury. As expected. the mortality rate progressively decreased from 76% in patients with a postresuscitation GCS score of 3 to approximately 18% for patients with a GCS score of 6, 7, or 8. Among the patients with nonsurgical lesions (overall mortality rate, 31 %), the mortality rate was higher in those having an increased likelihood of elevated intracranial pressure as assessed by a new classification of head injury based on the computerized tomography findings. In the 276 patients undergoing craniotomy, the mortality rate was 39%. Half of the patients with acute subdural hematomas died - a substantial improvement over results in previous reports. Outcome differences between the four TCDB centers were small and were, in part, explicable by differences in patient age and the type and severity of injury. This study describes head injury outcome in four selected head-injury centers. It indicates that a mortality rate of approximately 35% is to be expected in such patients admitted to experienced neurosurgical units.	UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550; UNIV VIRGINIA,MED CTR,SCH MED,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22901; INDIANA UNIV,MED CTR,DIV NEUROSURG,INDIANAPOLIS,IN 46204; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23298; NINCDS,BIOMETRY & FIELD STUDIES BRANCH,BETHESDA,MD 20892	MARSHALL, LF (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DIV NEUROSURG,225 DICKINSON ST H-501,SAN DIEGO,CA 92103, USA.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Cox D.R., 2018, ANAL BINARY DATA; COX DR, 1972, J R STAT SOC B, V34, P187; DIXON WJ, 1985, BMDP STATISTICAL SOF; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SELECKI BR, 1977, EPIDEMIOLOGY NEUROTR; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; 1985, ABBREVIATED INJURY S	23	316	323	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1991	75			S			S28	S36		10.3171/sup.1991.75.1s.0s28			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GN584	WOS:A1991GN58400006					2021-06-18	
J	Omalu, BI; DeKosky, ST; Hamilton, RL; Minster, RL; Kamboh, MI; Shakir, AM; Wecht, CH				Omalu, Bennet I.; DeKosky, Steven T.; Hamilton, Ronald L.; Minster, Ryan L.; Kamboh, M. Ilyas; Shakir, Abdulrezak M.; Wecht, Cyril H.			Chronic traumatic encephalopathy in a national football league player: Part II	NEUROSURGERY			English	Article						chronic traumatic encephalopathy; national football league; professional football players	APOLIPOPROTEIN-E POLYMORPHISM; AMYLOID BETA-PROTEIN; PROFESSIONAL FOOTBALL; NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; SOCCER INJURIES; BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; CONCUSSION	OBJECTIVE: We present the second reported case of autopsy-confirmed chronic traumatic encephalopathy in a retired professional football player, with neuropathological features that differ from those of the first reported case. These differing pathological features underscore the need for further empirical elucidation of the pathoetiology and pathological cascades of long-term neurodegenerative sequelae of professional football. METHODS: A psychological autopsy was performed with the next-of-kin and wife. Medical and hospital records were reviewed. A complete autopsy was accompanied by a comprehensive forensic neuropathological examination. Restriction fragment length polymorphism analysis was performed to determine apolipoprotein-E genotype. RESULTS: Pertinent premortem history included a 14-year span of play in organized football starting from the age of 18 years. The subject was diagnosed with severe major depressive disorder without psychotic features after retirement, attempted suicide multiple times and finally committed suicide 12 years after retirement by ingestion of ethylene glycol. Autopsy revealed cardiomegaly, mild to moderate coronary artery disease, and evidence of acute ethylene glycol overdose. The brain showed no atrophy, a cavum septi pellucidi was present, and the substantia nigra showed mild pallor. The hippocampus and cerebellum were not atrophic. Amyloid plaques, cerebral amyloid angiopathy, and Lewy bodies were completely absent. Sparse to frequent tau-positive neurofibrillary tangles and neuropil threads were present in all regions of the brain. Tufted and thorn astrocytes, as well as astrocytic plaques, were absent. The apolipoprotein-E genotype was E3/E4. CONCLUSION: Our first and second cases both had long careers without multiple recorded concussions. Both manifested Major Depressive Disorder after retirement. Amyloid plaques were present in the first case and completely absent in the second case. Both cases exhibited neurofibrillary tangles, neuropil threads, and coronary atherosclerotic disease. Apolipoprotein-E4 genotypes were different. Reasons for the contrasting features in these two cases are not clear. Further studies are needed to identify and define the neuropathological cascades of chronic traumatic encephalopathy in football players, which may form the basis for prophylaxis and therapeutics.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15261 USA	Omalu, BI (corresponding author), 7520 Penn Bridge Court, Pittsburgh, PA 15221 USA.	bennet.omalu@verizon.net		Minster, Ryan/0000-0001-7382-6717; Kamboh, M. Ilyas/0000-0002-3453-1438; DeKosky, Steven/0000-0003-3743-2758			Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; ALLSOP D, 1990, AM J PATHOL, V136, P255; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Ellison DLS, 2004, NEUROPATHOLOGY REFER; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; GENTLEMAN SM, 1993, NEUROBIOLOGY ISCHEMI, P237; GREENFIELD JG, 2002, GREENFIELDS NEUROPAT, V1, P823; GREENFIELD JG, 2002, GREENFIELDS NEUROPAT, V2, P195; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Omalu BI, 2004, AM J FOREN MED PATH, V25, P270, DOI 10.1097/01.paf.0000136642.17300.8b; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; TYSVAER A T, 1992, Tidsskrift for den Norske Laegeforening, V112, P1268; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	54	315	316	2	105	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2006	59	5					1086	1092		10.1227/01.NEU.0000245601.69451.27			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	128GI	WOS:000243645800027	17143242				2021-06-18	
J	Stern, RA; Riley, DO; Daneshvar, DH; Nowinski, CJ; Cantu, RC; McKee, AC				Stern, Robert A.; Riley, David O.; Daneshvar, Daniel H.; Nowinski, Christopher J.; Cantu, Robert C.; McKee, Ann C.			Long-term Consequences of Repetitive Brain Trauma: Chronic Traumatic Encephalopathy	PM&R			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; SPORT-RELATED CONCUSSION; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PUNCH-DRUNK; TAU PATHOLOGY; DISEASE; MILD	Chronic traumatic encephalopathy (CTE) has been linked to participation in contact sports such as boxing and American football. CTE results in a progressive decline of memory and cognition, as well as depression, suicidal behavior, poor impulse control, aggressiveness, parkinsonism, and, eventually, dementia. In some individuals, it is associated with motor neuron disease, referred to as chronic traumatic encephalomyelopathy, which appears clinically similar to amyotrophic lateral sclerosis. Results of neuropathologic research has shown that CTE may be more common in former contact sports athletes than previously believed. It is believed that repetitive brain trauma, with or possibly without symptomatic concussion, is responsible for neurodegenerative changes highlighted by accumulations of hyperphosphorylated tau and TDP-43 proteins. Given the millions of youth, high school, collegiate, and professional athletes participating in contact sports that involve repetitive brain trauma, as well as military personnel exposed to repeated brain trauma from blast and other injuries in the military, CTE represents an important public health issue. Focused and intensive study of the risk factors and in vivo diagnosis of CTE will potentially allow for methods to prevent and treat these diseases. Research also will provide policy makers with the scientific knowledge to make appropriate guidelines regarding the prevention and treatment of brain trauma in all levels of athletic involvement as well as the military theater. PM R 2011;3:S460-S467	[Stern, Robert A.; Riley, David O.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr Clin Core, Dept Neurol & Neurosurg, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA USA; [Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Surg, Concord, MA USA; [Cantu, Robert C.] Emerson Hosp, Neurosurg Serv, Concord, MA USA; [McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy Neurol & Pathol, Boston, MA 02118 USA	Stern, RA (corresponding author), Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Dept Neurol, 72 E Concord St,7380, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020	Stern, Robert/0000-0002-5008-077X; Daneshvar, Daniel/0000-0003-3691-9513	Boston University Alzheimer's Disease Center NIA [P30 AG13846, 0572063345-5]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS078337]; National Operating Committee on Standards for Athletic Equipment; Sports Legacy Institute	Research support: This work was supported by the Boston University Alzheimer's Disease Center NIA P30 AG13846, supplement 0572063345-5; NIH R01 NS078337; a grant from the National Operating Committee on Standards for Athletic Equipment; the Sports Legacy Institute; and an unrestricted gift from the National Football League	[Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Aotsuka A, 1990, Rinsho Shinkeigaku, V30, P1243; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern RA, 2011, WILEY-BL HB BEHAV SC, P369; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Talavage TM, 2010, J NEUROTRAUMA   1001; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	55	314	314	18	263	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S460	S467		10.1016/j.pmrj.2011.08.008			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YK	WOS:000305873100015	22035690		Y	N	2021-06-18	
J	Smith, DH; Meaney, DF; Shull, WH				Smith, DH; Meaney, DF; Shull, WH			Diffuse axonal injury in head trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amyloid-beta; coma; diffuse axonal injury; diffuse brain injury; inertial brain injury; neurofilament; traumatic axonal injury	AMYLOID PRECURSOR PROTEIN; EXPERIMENTAL BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; CYCLOSPORINE-A; POSTTRAUMATIC HYPOTHERMIA; CEREBRAL CONCUSSION; CORPUS-CALLOSUM; OPTIC-NERVE; BETA-APP; CALPAIN	Background: Diffuse axonal injury (DAI) is one of the most common and important pathologic features of traumatic brain injury (TBI). The susceptibility of axons to mechanical injury appears to be due to both their viscoelastic properties and their high organization in white matter tracts. Although axons are supple under normal conditions, they become brittle when exposed to rapid deformations associated with brain trauma. Accordingly, rapid stretch of axons can damage the axonal cytoskeleton resulting in a loss of elasticity and impairment of axoplasmic transport. Subsequent swelling of the axon occurs in discrete bulb formations or in elongated varicosities that accumulate transported proteins. Calcium entry into damaged axons is thought to initiate further damage by the activation of proteases. Ultimately, swollen axons may become disconnected and contribute to additional neuropathologic changes in brain tissue. DAI may largely account for the clinical manifestations of brain trauma. However, DAI is extremely difficult to detect noninvasively and is poorly defined as clinical syndrome. Conclusions: Future advancements in the diagnosis and treatment of DAI will be dependent on our collective understanding of injury biomechanics, temporal axonal pathophysiology, and its role in patient outcome.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Univ Penn, Dept Rehabil Med, Philadelphia, PA 19104 USA	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	Lang, Steven/AAE-8102-2021; smith, douglas/A-1321-2007	Lang, Steven/0000-0003-1669-9146; Meaney, David/0000-0002-0954-4122	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 08803, NS 38104] Funding Source: Medline; ODCDC CDC HHS [R49 CCR 312712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS038104, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; ARNSTEN FT, 1999, COGNITIVE NEUROREHAB, P113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; COPE ND, 1990, KRUSENS HDB PHYSICAL, P1217; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAHAM DI, 1983, ACTA NEUROCHIR SUPP, V32, P6; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.3.CO;2-Y; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raby CA, 1998, J NEUROCHEM, V71, P2505; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P1, DOI 10.1097/00001199-199902000-00003	76	313	331	3	36	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2003	18	4					307	316		10.1097/00001199-200307000-00003			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	705GN	WOS:000184387500003	16222127				2021-06-18	
J	Zhang, YL; Chopp, M; Meng, YL; Katakowski, M; Xin, HQ; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Meng, Yuling; Katakowski, Mark; Xin, Hongqi; Mahmood, Asim; Xiong, Ye			Effect of exosomes derived from multipluripotent mesenchyrnal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						angiogenesis; exosomes; functional recovery; mesenchymal stromal cell; neurogenesis; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; EXTRACELLULAR VESICLES; COGNITIVE RECOVERY; COMBINATION THERAPY; MICROGLIAL CELLS; SPATIAL MEMORY; ADULT RATS; STROKE	OBJECT Transplanted multipotent mesenchymal stromal cells (MSCs) improve functional recovery in rats after traumatic brain injury (TBI). In this study the authors tested a novel hypothesis that systemic administration of cell-free exosomes generated from MSCs promotes functional recovery and neurovascular remodeling in rats after TBI. METHODS Two groups of 8 Wistar rats were subjected to TBI, followed 24 hours later by tail vein injection of 100 12g protein of exosomes derived from MSCs or an equal volume of vehicle (phosphate-buffered saline). A third group of 8 rats was used as sham-injured, sham-treated controls. To evaluate cognitive and sensorimotor functional recovery, the modified Morris water maze, modified Neurological Severity Score, and foot-fault tests were performed. Animals were killed at 35 days after TBI. Histopathological and immunohistochemical analyses were performed for measurements of lesion volume, neurovascular remodeling (angiogenesis and neurogenesis), and neuroinflammation. RESULTS Compared with the saline-treated group, exosome-treated rats with TBI showed significant improvement in spatial learning at 34-35 days as measured by the Modified Morris water maze test (p < 0.05), and sensorimotor functional recovery (i.e., reduced neurological deficits and foot-fault frequency) was observed at 14-35 days postinjury (p < 0.05). Exosome treatment significantly increased the number of newly generated endothelial cells in the lesion boundary zone and dentate gyrus and significantly increased the number of newly formed immature and mature neurons in the dentate gyrus as well as reducing neuroinflammation. CONCLUSIONS The authors demonstrate for the first time that MSC-generated exosomes effectively improve functional recovery, at least in part, by promoting endogenous angiogenesis and neurogenesis and by reducing inflammation in rats after TBI. Thus, MSC-generated exosomes may provide a novel cell-free therapy for TBI and possibly for other neurological diseases.	[Zhang, Yanlu; Meng, Yuling; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Katakowski, Mark; Xin, Hongqi] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Rm 3096,2799 W Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xin, Hongqi/0000-0003-3172-416X; Xiong, Ye/0000-0001-9770-6031	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS081189]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081189] Funding Source: NIH RePORTER	This work was partially supported by NIH Grant No. R01NS081189 (Dr. Xin). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amano T, 2001, J BIOCHEM-TOKYO, V129, P739, DOI 10.1093/oxfordjournals.jbchem.a002914; [Anonymous], CANC LETT; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Barteneva NS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00049; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Borges FT, 2013, BRAZ J MED BIOL RES, V46, P824, DOI 10.1590/1414-431X20132964; Braccioli L, 2014, MOL NEUROBIOL, V49, P113, DOI 10.1007/s12035-013-8504-9; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cosme J, 2013, PROTEOMICS, V13, P1654, DOI 10.1002/pmic.201200441; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cvjetkovic A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23111; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denzer K, 2000, J CELL SCI, V113, P3365; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Joyce N, 2010, REGEN MED, V5, P933, DOI [10.2217/rme.10.72, 10.2217/RME.10.72]; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/RME.13.4, 10.2217/rme.13.4]; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017; Lei J, 2013, J NEUROTRAUM, V30, P529, DOI 10.1089/neu.2012.2548; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; Singh S, 2011, INT J NEUROSCI, V121, P589, DOI 10.3109/00207454.2011.598981; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Tsai MJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-5; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; van Doormaal FF, 2009, NETH J MED, V67, P266; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu L, 2013, J CELL PHYSIOL, V228, P1713, DOI 10.1002/jcp.24344; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang X, 2012, CURR GENE THER, V12, P423, DOI 10.2174/156652312802762590; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	107	312	346	7	105	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2015	122	4					856	867		10.3171/2014.11.JNS14770			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2PW	WOS:000351658500017	25594326	Bronze, Green Accepted	Y	N	2021-06-18	
J	Temkin, NR				Temkin, NR			Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials	EPILEPSIA			English	Article						meta-analysis; clinical trials; antiepileptogenesis; seizure prevention; antiepileptic drugs	POST-TRAUMATIC EPILEPSY; ALCOHOL-WITHDRAWAL SEIZURES; PROPHYLACTIC ANTICONVULSANT DRUGS; PLACEBO-CONTROLLED TRIAL; DIAGNOSED BRAIN-TUMORS; 1ST FEBRILE SEIZURE; POSTTRAUMATIC SEIZURES; DOUBLE-BLIND; HEAD-INJURY; DIAZEPAM PROPHYLAXIS	Purpose: To synthesize evidence concerning the effect of antiepileptic drugs (AEDs) for seizure prevention and to contrast their effectiveness for provoked versus unprovoked seizures. Methods: Medline, Embase. and The Cochrane Clinical Trials Register were the primary sources of trials, but all trials found were included. Minimal requirements: seizure-prevention outcome given as fraction of cases; AED or control assigned by random or quasi-random mechanism. Single abstracter. Aggregate relative risk and heterogeneity evaluated using Mantel-Haenszel analyses; random effects model used if heterogeneity was significant. Results: Forty-seven trials evaluated seven drugs or combinations for preventing seizures associated with fever, alcohol, malaria, perinatal asphyxia, contrast media, tumors, craniotomy, and traumatic brain injury. Effective: Phenobarbital for recurrence of febrile seizures [relative risk (RR), 0.51; 95% confidence interval (CI), 0.32-0.82) and cerebral malaria (RR, 0.36; CI, 0.23-0.56). Diazepam for contrast media-associated seizures (RR. 0.10; CI, 0.01-0.79). Phenytoin for provoked seizures after craniotomy or traumatic brain injury (craniotomy: RR, 0.42; CI, 0.25-0.71: TBI: RR. 0.33; CI, 0.19-0.59). Carbamazepine for provoked seizures after traumatic brain injury (RR, 0.39: CI, 0.17-0.92). Lorazepam for alcohol-related seizures (RR, 0.17, CI, 0.03-0.40). More than 25% reduction ruled out valproate for unprovoked seizures after traumatic brain injury (RR, 1.28; CI, 0.76-2.16), and carbamazepine for unprovoked seizures after craniotomy (RR, 1.30; CI, 0.75-2.25). Conclusions: Effective or promising results predominate for provoked (acute, symptomatic) seizures. For unprovoked (epileptic) seizures. no drug has been shown to be effective, and some have had a clinically important effect ruled out.	Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Dept Biostat, Seattle, WA 98104 USA	Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg, Box 359924,325 9th Ave, Seattle, WA 98104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019463] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19463] Funding Source: Medline		*AANS PUBL COMM, 1995, GUID MAN SEV HEAD IN; ALLDREDGE BK, 1989, AM J MED, V87, P645, DOI 10.1016/S0002-9343(89)80397-3; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ANNEGERS JF, 1986, EPILEPSIA, V27, P43, DOI 10.1111/j.1528-1157.1986.tb03499.x; Applegate CD, 1997, EPILEPSIA, V38, P631, DOI 10.1111/j.1528-1157.1997.tb01231.x; AUTRET E, 1990, J PEDIATR-US, V117, P490, DOI 10.1016/S0022-3476(05)81104-7; BACON CJ, 1981, LANCET, V2, P600; CAMFIELD PR, 1980, J PEDIATR-US, V97, P16, DOI 10.1016/S0022-3476(80)80122-3; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; CHANCE JF, 1991, ANN EMERG MED, V20, P520, DOI 10.1016/S0196-0644(05)81606-3; *COCHR COLL, 2000, REV MAN REVM VERS 4; *COCHR CONTR TRIAL, 2000, COCHR LIB; COTTON DB, 1993, AM J OBSTET GYNECOL, V168, P974, DOI 10.1016/S0002-9378(12)90855-8; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; D'Onofrio G, 1999, NEW ENGL J MED, V340, P915, DOI 10.1056/NEJM199903253401203; Dalby NO, 1997, NEUROSCI LETT, V229, P135; DAVIS LJ, 1983, J NEUROSURG, V59, P729; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; EVANS DJ, 2000, COCHRANE DATABASE SY, P2; FARWELL JR, 1990, NEW ENGL J MED, V322, P364, DOI 10.1056/NEJM199002083220604; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; FOY PM, 1992, J NEUROL NEUROSUR PS, V55, P753, DOI 10.1136/jnnp.55.9.753; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; GLOTZNER FL, 1983, NEUROCHIRURGIA STUTT, P26; HAINES SJ, 1983, J NEUROSURG, V59, P730; Hall RT, 1998, J PEDIATR-US, V132, P345, DOI 10.1016/S0022-3476(98)70458-5; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HECKMATT JZ, 1976, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.6009.559; HILLBOM M, 1989, ALCOHOL, V6, P223, DOI 10.1016/0741-8329(89)90022-0; Hoff H, 1947, MON PSYCHIATR NEUROL, V114, P105; HOLLAND JP, 1995, J NEUROL NEUROSUR PS, V58, P116; JENNETT WB, 1962, EPILEPSY BLUNT HEAD; JOHNSON AL, 1983, J NEUROSURG, V59, P727; KNUDSEN FU, 1985, ARCH DIS CHILD, V60, P1045, DOI 10.1136/adc.60.11.1045; Knudsen FU, 1996, ARCH DIS CHILD, V74, P13, DOI 10.1136/adc.74.1.13; Kuijlen JMA, 1996, SEIZURE, V5, P291; LAMBIE DG, 1980, AUST NZ J PSYCHIAT, V14, P213, DOI 10.3109/00048678009159381; LEE ST, 1989, SURG NEUROL, V31, P361, DOI 10.1016/0090-3019(89)90067-0; LOCKARD JS, 1976, EPILEPSIA, V17, P49, DOI 10.1111/j.1528-1157.1976.tb03381.x; Loscher W, 1998, EUR J PHARMACOL, V342, P1, DOI 10.1016/S0014-2999(97)01514-8; MACKINTOSH TF, 1970, CLIN PEDIATR, V9, P283, DOI 10.1177/000992287000900515; MAMELLE N, 1984, NEUROPEDIATRICS, V15, P37, DOI 10.1055/s-2008-1052338; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MASON BA, 1994, AM J OBSTET GYNECOL, V171, P999, DOI 10.1016/0002-9378(94)90022-1; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; MCKINLAY I, 1989, DEV MED CHILD NEUROL, V31, P617; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; *MED ED TRIAL AMN, 2000, COCHR LIB; NEWTON RW, 1988, ARCH DIS CHILD, V63, P1189, DOI 10.1136/adc.63.10.1189; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; PAGANI JJ, 1983, AM J ROENTGENOL, V140, P787, DOI 10.2214/ajr.140.4.787; PAGANI JJ, 1984, CANCER, V54, P2200, DOI 10.1002/1097-0142(19841115)54:10<2200::AID-CNCR2820541022>3.0.CO;2-2; PECHADRE JC, 1991, PRESSE MED, V20, P841; PENRY JK, 1979, NEUROLOGY, V29, P600; Popek K, 1969, Cas Lek Cesk, V108, P133; RACINE R, 1975, ELECTROEN CLIN NEURO, V38, P355, DOI 10.1016/0013-4694(75)90260-6; Rantala H, 1997, J PEDIATR-US, V131, P922, DOI 10.1016/S0022-3476(97)70045-3; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; RATHLEV NK, 1994, ANN EMERG MED, V23, P513, DOI 10.1016/S0196-0644(94)70070-2; ROSMAN NP, 1993, NEW ENGL J MED, V329, P79, DOI 10.1056/NEJM199307083290202; ROTHSTEIN E, 1973, AM J PSYCHIAT, V130, P1381, DOI 10.1176/ajp.130.12.1381; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SAMPLINER R, 1974, JAMA-J AM MED ASSOC, V230, P1430, DOI 10.1001/jama.230.10.1430; *SAS I INC, 1989, SAS STAT US GUID VER; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SCHMUTZ M, 1988, J NEURAL TRANSM, V72, P245, DOI 10.1007/BF01243423; SCHWARTZKROIN PA, ENCY NEUROLOGICAL SC; SHAW MDM, 1991, J ROY SOC MED, V84, P221; SHIN C, 1986, BRAIN RES, V398, P3704; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; TEMKIN NR, 1991, CHANGES MANAGEMENT H, P425; Temkin NRHM, 1996, NEUROLOGICAL SURG, P1834; Thilothammal N, 1993, Indian Pediatr, V30, P637; UHARI M, 1995, J PEDIATR-US, V126, P991, DOI 10.1016/S0022-3476(95)70231-8; WADA JA, 1976, ARCH NEUROL-CHICAGO, V33, P426, DOI 10.1001/archneur.1976.00500060032008; WALLACE SJ, 1980, BRIT MED J, V280, P353, DOI 10.1136/bmj.280.6211.353; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WHITTLE KJ, 1988, TRENDS MOD MEAT TECH, V2, P65; WILLIAMS AJ, 1979, CLIN PEDIATR, V18, P426, DOI 10.1177/000992287901800710; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; WOLF G, 1990, NEUROSCI LETT, V117, P207, DOI 10.1016/0304-3940(90)90145-Y; WOLF SM, 1989, ACTA PAEDIATR SCAND, V78, P291, DOI 10.1111/j.1651-2227.1989.tb11072.x; WOLF SM, 1977, PEDIATRICS, V59, P378; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P23	93	310	317	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0013-9580			EPILEPSIA	Epilepsia	APR	2001	42	4					515	524		10.1046/j.1528-1157.2001.28900.x			10	Clinical Neurology	Neurosciences & Neurology	423RA	WOS:000168189500009	11440347				2021-06-18	
J	Schnell, L; Fearn, S; Klassen, H; Schwab, ME; Perry, VH				Schnell, L; Fearn, S; Klassen, H; Schwab, ME; Perry, VH			Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						blood-brain barrier; macrophage recruitment; neutrophil recruitment	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; NEUTROPHIL ACCUMULATION; VASCULAR ARCHITECTURE; NEURONAL DEGENERATION; BARRIER PROPERTIES; ENDOTHELIAL-CELLS; MESSENGER-RNA; FREE-RADICALS	Lesion-induced inflammatory responses in both brain and spinal cord have recently become a topic of active investigation. Using C57BL/6J mice, we compared the tissue reaction in these two central nervous system (CNS) compartments with mechanical lesions of similar size involving both grey and white matter. This evaluation included the quantitative assessment of neutrophils, lymphocytes and activated macrophages/microglia, as well as astrocyte activation, upregulation of vascular cel adhesin molecules (ICAM-1, VCAM-1, PECAM) and the extent of blood-brain barrier (BBB) breakdown. Time points analysed post-lesion in included 1, 2, 4 and 7 days (as well as 10 and 14 days for the BBB). We found clear evidence that the acute inflammatory response to traumatic injury is significantly greater in the spinal cord than in the cerebral cortex. The numbers of both neutrophils and macrophases recruited to the lesion site were significantly higher in the spinal cord than in the brain, and the recruitment of these cells into the surrounding parenchyma was also more widespread in the cord. The area of BBB breakdown was substantially larger in the spinal cord and vascular damage persisted for a longer period. In the brain, as in spinal cord, the area to which neutrophils were recruited correlated well with the area of BB breakdown. It will be of interest to determine the extent to which the infiltration of inflammatory cells contributes, either directly or indirectly, to the vascular permeability and secondary tissue damage or, conversely, to local tissue repair in the brain and the spinal cord.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Oxford, Dept Pharmacol, Oxford OX1 2JD, England; Childrens Hosp Orange Cty, Orange, CA 92668 USA	Schnell, L (corresponding author), Univ Zurich, Dept Neurophysiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Schwab, Martin E/B-6818-2016; Perry, V. Hugh/Y-2935-2019				ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; Chao CC, 1996, GLIA, V16, P276, DOI 10.1002/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLAUDIO L, 1990, AM J PATHOL, V137, P1033; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; ENGELHARDT B, 1994, J NEUROIMMUNOL, V51, P199, DOI 10.1016/0165-5728(94)90082-5; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hamada Y, 1996, J NEUROCHEM, V66, P1525; HAWKINS CP, 1990, BRAIN, V113, P365, DOI 10.1093/brain/113.2.365; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kilgore KS, 1997, LAB INVEST, V76, P191; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; KOYANAGI I, 1993, NEUROSURGERY, V33, P277; KUNKEL SL, 1995, SEMIN CELL BIOL, V6, P327, DOI 10.1016/S1043-4682(05)80003-0; LAWSON LJ, 1993, CLIN NEUROPATHOL, V12, P310; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lindholm D, 1990, Neuroreport, V1, P9; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416; Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Ogata H, 1997, J PATHOL, V182, P106; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; POUSSET F, 1994, DEV BRAIN RES, V81, P143, DOI 10.1016/0165-3806(94)90078-7; RABINOWITZ SS, 1992, J EXP MED, V175, P309; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; Schnell L, 1997, EUR J NEUROSCI, V9, P1000, DOI 10.1111/j.1460-9568.1997.tb01450.x; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwab ME, 1996, PHYSIOL REV, V76, P319; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; Soares HD, 1995, J NEUROSCI, V15, P8223; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Toulmond S, 1996, TRENDS NEUROSCI, V19, P409; Wisniewski HM, 1991, BRAIN PATHOL, V1, P89, DOI 10.1111/j.1750-3639.1991.tb00645.x; YONG VW, 1996, CYTOKINES CNS DEV DE, P309	60	310	317	0	14	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	OCT	1999	11	10					3648	3658		10.1046/j.1460-9568.1999.00792.x			11	Neurosciences	Neurosciences & Neurology	246DT	WOS:000083149700029	10564372				2021-06-18	
J	Talavage, TM; Nauman, EA; Breedlove, EL; Yoruk, U; Dye, AE; Morigaki, KE; Feuer, H; Leverenz, LJ				Talavage, Thomas M.; Nauman, Eric A.; Breedlove, Evan L.; Yoruk, Umit; Dye, Anne E.; Morigaki, Katherine E.; Feuer, Henry; Leverenz, Larry J.			Functionally-Detected Cognitive Impairment in High School Football Players without Clinically-Diagnosed Concussion	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessment; cognitive function; human studies; magnetic resonance imaging; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REPETITIVE HEAD-INJURY; WORKING-MEMORY; ALZHEIMERS-DISEASE; LEAGUE PLAYER; IMPACT; MILD; ENCEPHALOPATHY; RISK; ACCELERATION	Head trauma and concussion in football players have recently received considerable media attention. Postmortem evidence suggests that accrual of damage to the brain may occur with repeated blows to the head, even when the individual blows fail to produce clinical symptoms. There is an urgent need for improved detection and characterization of head trauma to reduce future injury risk and promote development of new therapies. In this study we examined neurological performance and health in the presence of head collision events in high school football players, using longitudinal measures of collision events (the HIT System), neurocognitive testing (ImPACT), and functional magnetic resonance imaging MRI (fMRI). Longitudinal assessment (including baseline) was conducted in 11 young men (ages 15-19 years) participating on the varsity and junior varsity football teams at a single high school. We expected and observed subjects in two previously described categories: (1) no clinically-diagnosed concussion and no changes in neurological behavior, and (2) clinically-diagnosed concussion with changes in neurological behavior. Additionally, we observed players in a previously undiscovered third category, who exhibited no clinically-observed symptoms associated with concussion, but who demonstrated measurable neurocognitive (primarily visual working memory) and neurophysiological (altered activation in the dorsolateral prefrontal cortex [DLPFC]) impairments. This new category was associated with significantly higher numbers of head collision events to the top-front of the head, directly above the DLPFC. The discovery of this new category suggests that more players are suffering neurological injury than are currently being detected using traditional concussion-assessment tools. These individuals are unlikely to undergo clinical evaluation, and thus may continue to participate in football-related activities, even when changes in brain physiology (and potential brain damage) are present, which will increase the risk of future neurological injury.	[Talavage, Thomas M.; Nauman, Eric A.; Breedlove, Evan L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.; Yoruk, Umit] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.; Dye, Anne E.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Morigaki, Katherine E.; Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Feuer, Henry] Indiana Univ Sch Med, Dept Neurosurg, Indianapolis, IN 46202 USA	Talavage, TM (corresponding author), 465 Northwestern Ave, W Lafayette, IN 47907 USA.	tmt@purdue.edu			Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; General Electric HealthcareGE Healthcare	This work was supported by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, and General Electric Healthcare. The authors thank Dr. Charles A. Bouman and Mr. Dennis A. Miller of Purdue University, Dr. Randall R. Benson of Wayne State University, and Drs. Michael W. Collins and Mark J. Lovell of the University of Pittsburgh Medical Center, for their feedback and encouragement. The authors additionally thank Dr. Gregory G. Tamer, Jr., for his assistance with data collection.	Agresti A., 1992, STAT SCI, V7, P131, DOI [10.1214/ss/1177011454, DOI 10.1214/SS/1177011454]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beckwith JG, 2010, 8TH WORLD CONGRESS O; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Brett M, 2002, 8TH INTERNATIONAL CO; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gregory S., 2010, TIME; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; King AI, 2003, IRCOBI CONFERENCE; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Ritter M., 2009, HS FOOTBALL CONCUSSI; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schwarz A., 2010, NEW YORK TIMES; Schwarz A., 2009, NEW YORK TIMES; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zazryn T, 2007, SPORTS MED, V37, P467	47	309	310	3	103	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					327	338		10.1089/neu.2010.1512			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600005	20883154	Green Published	Y	N	2021-06-18	
J	Mayer, AR; Ling, J; Mannell, MV; Gasparovic, C; Phillips, JP; Doezema, D; Reichard, R; Yeo, RA				Mayer, A. R.; Ling, J.; Mannell, M. V.; Gasparovic, C.; Phillips, J. P.; Doezema, D.; Reichard, R.; Yeo, R. A.			A prospective diffusion tensor imaging study in mild traumatic brain injury	NEUROLOGY			English	Article							AXONAL INJURY; DETECTS; DAMAGE; EDEMA; TIME; MRI; ABNORMALITIES; DEGENERATION; CONCUSSION; ANISOTROPY	Objectives: Only a handful of studies have investigated the nature, functional significance, and course of white matter abnormalities associated with mild traumatic brain injury (mTBI) during the semi-acute stage of injury. The present study used diffusion tensor imaging (DTI) to investigate white matter integrity and compared the accuracy of traditional anatomic scans, neuropsychological testing, and DTI for objectively classifying mTBI patients from controls. Methods: Twenty-two patients with semi-acute mTBI (mean = 12 days postinjury), 21 matched healthy controls, and a larger sample (n = 32) of healthy controls were studied with an extensive imaging and clinical battery. A subset of participants was examined longitudinally 3-5 months after their initial visit. Results: mTBI patients did not differ from controls on clinical imaging scans or neuropsychological performance, although effect sizes were consistent with literature values. In contrast, mTBI patients demonstrated significantly greater fractional anisotropy as a result of reduced radial diffusivity in the corpus callosum and several left hemisphere tracts. DTI measures were more accurate than traditional clinical measures in classifying patients from controls. Longitudinal data provided preliminary evidence of partial normalization of DTI values in several white matter tracts. Conclusions: Current findings of white matter abnormalities suggest that cytotoxic edema may be present during the semi-acute phase of mild traumatic brain injury (mTBI). Initial mechanical damage to axons disrupts ionic homeostasis and the ratio of intracellular and extracellular water, primarily affecting diffusion perpendicular to axons. Diffusion tensor imaging measurement may have utility for objectively classifying mTBI, and may serve as a potential biomarker of recovery. Neurology(R) 2010; 74: 643-650	[Mayer, A. R.; Ling, J.; Mannell, M. V.; Gasparovic, C.; Phillips, J. P.; Yeo, R. A.] Mind Res Network, Albuquerque, NM 87106 USA; [Mayer, A. R.; Phillips, J. P.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Doezema, D.] Univ New Mexico, Sch Med, Dept Emergency Med, Albuquerque, NM 87131 USA; [Gasparovic, C.; Yeo, R. A.] Univ New Mexico, Sch Med, Dept Psychol, Albuquerque, NM 87131 USA; [Reichard, R.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Gasparovic, Charles/E-7289-2010		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 P20 RR021938-01, R21NS064464, R24HD050836, 1 R03 DA022435-01A1, R03 DA022435-01A1, 1R01 NS052305-01, R01-NS35708-04, 1R21AA017313-01, NCRR 1P20RR021938-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS064464] Funding Source: NIH RePORTER	Dr. Mayer has received/receives research support from the NIH (1 P20 RR021938-01 [Co-I, Project PI], R21NS064464 [PI], R24HD050836 [PI], Clinical LRP [PI], 1 R03 DA022435-01A1 [PI], and R03 DA022435-01A1 [PI]). J. Ling and M. V. Mannell report no disclosures. Dr. Gasparovic has received/receives research support from the NIH (R21NS064464 [Co-I], 1R01 NS052305-01 [Co-I], R01-NS35708-04 [Co-I], 1R21AA017313-01 [Co-I], and NCRR 1P20RR021938-01 [Co-I]). Dr. Phillips reports no disclosures. Dr. Doezema receives research support from the NIH (R21NS064464 [Sub-contract PI]). Dr. Reichard reports no disclosures. Dr. Yeo serves on the editorial advisory boards of Laterality and Frontiers in Neuroscience.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Cohen J, 1988, STAT POWER ANAL BEHA; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; GASPAROVIC C, 2009, J NEUROTRAUMA; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MAYER AR, 2009, HUM BRAIN MAPP; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	40	309	318	0	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	FEB 23	2010	74	8					643	650		10.1212/WNL.0b013e3181d0ccdd			8	Clinical Neurology	Neurosciences & Neurology	559CE	WOS:000274796900006	20089939	Green Published			2021-06-18	
J	Macciocchi, SN; Barth, JT; Alves, W; Rimel, RW; Jane, JA				Macciocchi, SN; Barth, JT; Alves, W; Rimel, RW; Jane, JA			Neuropsychological functioning and recovery after mild head injury in collegiate athletes	NEUROSURGERY			English	Article						mild head injury; neuropsychological tests; postconcussive symptoms	CONCUSSION; SEQUELAE	OBJECTIVE: This study prospectively examined neuropsychological functioning in 2300 collegiate football players from 10 National Collegiate Athletic Association Division A universities. The study was designed to determine the presence and duration of neuropsychological symptoms after mild head injury. METHODS: A nonequivalent repeated measures control group design was used to compare the neuropsychological test scores and symptoms of injured players (n = 183) with those of gender, age, and education matched controls. A number of neuropsychological tests, including the Paced Auditory Serial Addition Test, the Digit Symbol Test, and the Trail Making Test, as well as a symptom checklist were used. TECHNIQUE: Players and controls were assessed before engaging in game activity and 24 hours, 5 days, and 10 days after injury, using the standardized test battery and symptom checklist. RESULTS: Players with head injuries displayed impaired performance and increased symptoms in comparison to controls, but this impairment resolved within 5 days in most players. Players with head injuries showed significant improvement between 24 hours and 5 days, as well as between 5 and 10 days. CONCLUSION: Although single, uncomplicated mild head injuries do cause limited neuropsychological impairment, injured players generally experience rapid resolution of symptoms with minimal prolonged sequelae.	UNIV VIRGINIA,SCH MED,DEPT PHYS MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT PSYCHIAT MED,CHARLOTTESVILLE,VA 22908; PEW FDN,GLENN MEAD CHARITABLE TRUST,PHILADELPHIA,PA							ALVES WA, 1993, J HEAD TRAUMA REHAB, V3, P48; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT., 1989, MILD HEAD INJURY, P257; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BOHENEN N, 1992, NEUROSURGERY, V30, P692; BOHENEN N, 1992, J NEUROL NEUROSUR PS, V55, P222; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V6, P649; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ETTLIN TM, 1992, CEREBRAL SYMPTOMS WH, V55, P945; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V5, P628; MEYERS AW, 1979, COGNITIVE THER RES, V3, P361, DOI 10.1007/BF01184450; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Strub RL, 1977, MENTAL STATUS EXAMIN; Wechsler D., 2008, WECHSLER ADULT INTEL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	27	308	309	1	18	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	SEP	1996	39	3					510	514		10.1097/00006123-199609000-00014			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	VE304	WOS:A1996VE30400031	8875480				2021-06-18	
J	Dikmen, SS; Machamer, JE; Powell, JM; Temkin, NR				Dikmen, SS; Machamer, JE; Powell, JM; Temkin, NR			Outcome 3 to 5 years after moderate to severe traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY; QUALITY-OF-LIFE; SELF-REPORT; RECOVERY; COMA; PREVENTION; SCALE; TBI	Objective: To investigate neuropsychologic, emotional, and functional status and quality of life (QOL) 3 to 5 years after moderate to severe traumatic brain injury (TBI). Design: Observational cohort. Setting: Level I trauma center. Participants: Consecutive adult admissions with TBI involving intracranial abnormalities, prospectively followed up for 3 to 5 years, with 80% follow-up. Interventions: Not applicable. Main Outcome Measures: Neuropsychologic functioning (Paced Auditory Serial Addition Test, California Verbal Learning Test), emotional status (Center for Epidemiologic Studies Depression Scale, Brief Symptom Inventory), functional status (Functional Status Examination, Glasgow Outcome Scale, Medical Outcomes Study 36-Item Short-Form Health Survey, employment), and perceived QOL. Results: Significant functional limitations were observed in all areas. Recovery to preinjury levels ranged from 65% of cases in personal care to approximately 40% in cognitive competency, major activity, and leisure and recreation. Brain injury severity, measured by the modified Abbreviated Injury Scale, related to functional status and neuropsychologic functioning, but not to emotional or QOL measures. Length of impaired consciousness appeared to contribute to outcome more than did anatomic lesions. Conclusions: The results provide representative estimates of long-term morbidity in patients with TBI involving intracranial lesions. The magnitude of morbidity was high. Although direct costs of TBI have received the most attention, the long-term consequences and their cost implications are much larger, unfold over time, and are home by the survivors, their families, and the public subsidy system.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Dikmen, SS (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	dikynen@u.washington.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD 33677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643] Funding Source: Medline		*ASS ADV AUT MED, 1990, ABBR INJ SCAL; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Delis DC, 1987, CALIFORNIA VERBAL LE; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1975, LANCET, V1, P480; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROSS SE, 1992, ACCIDENT ANAL PREV, V24, P181, DOI 10.1016/0001-4575(92)90035-H; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Ware JE., 1993, SF 36 HLTH SURVEY MA; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	50	306	312	0	27	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2003	84	10					1449	1457		10.1016/S0003-9993(03)00287-9			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	731JG	WOS:000185880100005	14586911				2021-06-18	
J	Eastridge, BJ; Hardin, M; Cantrell, J; Oetjen-Gerdes, L; Zubko, T; Mallak, C; Wade, CE; Simmons, J; Mace, J; Mabry, R; Bolenbaucher, R; Blackbourne, LH				Eastridge, Brian J.; Hardin, Mark; Cantrell, Joyce; Oetjen-Gerdes, Lynne; Zubko, Tamara; Mallak, Craig; Wade, Charles E.; Simmons, John; Mace, James; Mabry, Robert; Bolenbaucher, Rose; Blackbourne, Lorne H.			Died of Wounds on the Battlefield: Causation and Implications for Improving Combat Casualty Care	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Military; War; Combat; Injury; Trauma; Died of wounds; Survivability	OPERATION-IRAQI-FREEDOM; BLOOD-PRODUCTS; TOURNIQUET USE; TRAUMA SYSTEM; MORTALITY; DEATH; INJURY; LESSONS; WAR; EPIDEMIOLOGY	Background: Understanding the epidemiology of death after battlefield injury is vital to combat casualty care performance improvement. The current analysis was undertaken to develop a comprehensive perspective of deaths that occurred after casualties reached a medical treatment facility. Methods: Battle injury died of wounds (DOW) deaths that occurred after casualties reached a medical treatment facility from October 2001 to June 2009 were evaluated by reviewing autopsy and other postmortem records at the Office of the Armed Forces Medical Examiners (OAFME). A panel of military trauma experts classified the injuries as nonsurvivable (NS) or potentially survivable (PS), in consultation with an OAFME forensic pathologist. Data including demographics, mechanism of injury, physiologic and laboratory variables, and cause of death were obtained from the Joint Theater Trauma Registry and the OAFME Mortality Trauma Registry. Results: DOW casualties (n = 558) accounted for 4.56% of the nonreturn to duty battle injuries over the study period. DOW casualties were classified as NS in 271 (48.6%) cases and PS in 287 (51.4%) cases. Traumatic brain injury was the predominant injury leading to death in 225 of 271 (83%) NS cases, whereas hemorrhage from major trauma was the predominant mechanism of death in 230 of 287 (80%) PS cases. In the hemorrhage mechanism PS cases, the major body region bleeding focus accounting for mortality were torso (48%), extremity (31%), and junctional (neck, axilla, and groin) (21%). Fifty-one percent of DOW casualties presented in extremis with cardiopulmonary resuscitation upon presentation. Conclusions: Hemorrhage is a major mechanism of death in PS combat injuries, underscoring the necessity for initiatives to mitigate bleeding, particularly in the prehospital environment.	[Eastridge, Brian J.; Hardin, Mark; Wade, Charles E.; Simmons, John; Mace, James; Mabry, Robert; Bolenbaucher, Rose; Blackbourne, Lorne H.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Cantrell, Joyce; Oetjen-Gerdes, Lynne; Zubko, Tamara; Mallak, Craig] Off Armed Forces Med Examiner, Rockville, MD USA	Eastridge, BJ (corresponding author), USA, Inst Surg Res, 3400 Rawley E Chambers Ave, Ft Sam Houston, TX 78234 USA.	brian.eastridge@amedd.army.mil					Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7; BELLAMY RF, 1986, ANN EMERG MED, V15, P1384, DOI 10.1016/S0196-0644(86)80920-9; BELLAMY RF, 1985, MIL MED, V150, P405; BELLAMY RF, 1984, MIL MED, V149, P55; Blackbourne LH, 2010, J TRAUMA, V69, pS1, DOI 10.1097/TA.0b013e3181e4206f; Blackbourne LH, 2009, J TRAUMA, V66, pS27, DOI 10.1097/TA.0b013e31819cdf83; Blood CG, 2002, J TRAUMA, V53, P1160, DOI 10.1097/00005373-200212000-00021; Bochicchio G, 2007, SURGERY, V142, pS78, DOI 10.1016/j.surg.2007.06.028; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Cancio LC, 2008, J TRAUMA, V64, pS51, DOI 10.1097/TA.0b013e3181608c21; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Claridge JA, 2010, J AM COLL SURGEONS, V210, P788, DOI 10.1016/j.jamcollsurg.2009.12.035; *COMM TRAUM DIV ME, 1966, ACC DEATH DIS NEGL D; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eastridge BJ, 2006, J TRAUMA, V60, pS20, DOI 10.1097/01.ta.0000199544.63879.5d; Eastridge BJ, 2010, J TRAUMA, V69, pS5, DOI 10.1097/TA.0b013e3181e421f3; Eastridge Brian J, 2009, Am J Surg, V198, P852, DOI 10.1016/j.amjsurg.2009.04.029; Flaherty S, 2003, J TRAUMA, V54, P70; Gerhardt RT, 2009, ANN EMERG MED, V53, P169, DOI 10.1016/j.annemergmed.2008.04.013; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holcomb JB, 2007, J TRAUMA, V62, pS36, DOI 10.1097/TA.0b013e3180654134; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2010, HEMATOL-AM SOC HEMAT, P465, DOI 10.1182/asheducation-2010.1.465; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kheirabadi BS, 2010, J TRAUMA, V68, P269, DOI 10.1097/TA.0b013e3181c97ef1; Kheirabadi BS, 2010, J TRAUMA, V69, P1062, DOI 10.1097/TA.0b013e3181fa0f21; KRAGH JF, 2009, J EMERG MED; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; MacLeod JBA, 2007, AM J SURG, V193, P195, DOI 10.1016/j.amjsurg.2006.09.010; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; NATHENS AB, 2010, NATL TRAUMA DATA BAN; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Schreiber M, 2010, J TRAUMA, V69, P1072; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; White CE, 2009, J TRAUMA, V66, pS86, DOI 10.1097/TA.0b013e31819ce22c; Whitty JA, 2011, APPL HEALTH ECON HEA, V9, P73, DOI [10.1097/SLA.0b013e31820752e3, 10.2165/11537150-000000000-00000]	49	305	322	1	42	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71			1			S4	S8		10.1097/TA.0b013e318221147b			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RW	WOS:000292607900002	21795876		Y	N	2021-06-18	
J	Yi, JH; Hazell, AS				Yi, JH; Hazell, AS			Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						glutamate; excitotoxicity; neurodegenerative disease; glutamate transporter; GLT-1; brain edema; glutamate receptor; brain energy metabolism; brain trauma	AMYOTROPHIC-LATERAL-SCLEROSIS; EXCITATORY AMINO-ACIDS; CEREBRAL-BLOOD-FLOW; FLUID-PERCUSSION INJURY; RAT NERVOUS-SYSTEM; 2 SPLICE VARIANTS; SPINAL-CORD; N-ACETYLCYSTEINE; MILD HYPOTHERMIA; DOWN-REGULATION	Glutamate excitotoxicity plays an important role in the development of secondary injuries that occur following traumatic brain injury (TBI), and contributes significantly to expansion of the total volume of injury. Acute increases in extracellular glutamate levels have been detected in both experimental brain trauma models and in human patients, and can lead to over-stimulation of glutamate receptors, resulting in a cascade of excitotoxic-related mechanisms culminating in neuronal damage. These elevated levels of glutamate can be effectively controlled by the astrocytic glutamate transporters GLAST (EAAT1) and GLT-I (EAAT2). However, evidence indicate these transporters and splice variant are downregulated shortly following the insult, which then precipitates glutamate-mediated excitotoxic conditions. Lack of success with glutamate receptor antagonists as a potential source of clinical intervention treatment following TBI has resulted in the necessity for a better understanding of the mechanisms that underlie the process of excitotoxicity, including the function and regulation of glutamate transporters. Such new insight should improve the likelihood of development of novel avenues for therapeutic intervention following TBI. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Hazell, AS (corresponding author), CHUM, NeuroRescue Lab, Hop St Luc, 1058 St Denis St, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca					Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Berger UV, 1998, ANAT EMBRYOL, V198, P13, DOI 10.1007/s004290050161; Bouma G J, 1995, New Horiz, V3, P384; BRUNO V, 1995, EUR J NEUROSCI, V7, P1906, DOI 10.1111/j.1460-9568.1995.tb00712.x; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHEN W, 2002, INTERACTION GLUTAMAT; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; CHOI DW, 1987, J NEUROSCI, V7, P369; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Dingledine R, 1999, PHARMACOL REV, V51, P7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gegelashvili G, 2000, NEUROCHEM INT, V37, P163, DOI 10.1016/S0197-0186(00)00019-X; GEMBA T, 1994, NEUROSCIENCE, V63, P789, DOI 10.1016/0306-4522(94)90523-1; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kugler P, 1999, GLIA, V27, P129, DOI 10.1002/(SICI)1098-1136(199908)27:2<129::AID-GLIA3>3.0.CO;2-Y; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Marie H, 2002, MOL CELL NEUROSCI, V19, P152, DOI 10.1006/mcne.2001.1066; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Mendelow A D, 1984, Neurol Res, V6, P189; MENDELOW AD, 1997, HEAD INJURY PATHOPHY, P71; Meyer T, 1999, J NEUROL SCI, V170, P45, DOI 10.1016/S0022-510X(99)00196-3; Miyamoto M, 1997, NEUROSCIENCE, V77, P131, DOI 10.1016/S0306-4522(96)00442-3; Nagai M, 1998, NEUROSCI LETT, V244, P165, DOI 10.1016/S0304-3940(98)00158-X; OBRENOVITCH TP, 1994, BRIT J PHARMACOL, V113, P1295, DOI 10.1111/j.1476-5381.1994.tb17139.x; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; OLNEY JW, 1990, PROG BRAIN RES, V86, P37; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2000, NEUROCHEM INT, V36, P531, DOI 10.1016/S0197-0186(99)00153-9; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Reye P, 2002, GLIA, V38, P246, DOI 10.1002/glia.10059; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Springer JE, 1997, J NEUROCHEM, V68, P2469; Statistics Canada, 1994, NAT POP HLTH SURV; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Susarla BTS, 2004, J NEUROCHEM, V91, P1151, DOI 10.1111/j.1471-4159.2004.02791.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TORP R, 1995, EXP BRAIN RES, V103, P51; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Weight DG, 1998, PSYCHIAT CLIN N AM, V21, P609, DOI 10.1016/S0193-953X(05)70026-5; Wilson JMB, 2003, NEUROMOL MED, V3, P105, DOI 10.1385/NMM:3:2:105; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zwienenberg M, 2001, NEUROSURGERY, V48, P1119, DOI 10.1097/00006123-200105000-00031	86	305	314	0	40	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	APR	2006	48	5					394	403		10.1016/j.neuint.2005.12.001			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	030FD	WOS:000236618700008	16473439				2021-06-18	
J	Sundgren, PC; Dong, Q; Gomez-Hassan, D; Mukherji, SK; Maly, P; Welsh, R				Sundgren, PC; Dong, Q; Gomez-Hassan, D; Mukherji, SK; Maly, P; Welsh, R			Diffusion tensor imaging of the brain: review of clinical applications	NEURORADIOLOGY			English	Article						magnetic resonance imaging; diffusion tensor imaging; brain	APPEARING WHITE-MATTER; MULTIPLE-SCLEROSIS LESIONS; GRADE CEREBRAL GLIOMAS; MAGNETIC-RESONANCE; WATER DIFFUSION; WEIGHTED MR; ISCHEMIC-STROKE; IN-VIVO; SELF-DIFFUSION; FIBER TRACKING	We review the theoretical background to diffusion tensor imaging (DTI) and some of its commoner clinical applications, such as cerebral ischemia, brain maturation and traumatic brain injury. We also review its potential use in diseases such as epilepsy, multiple sclerosis, and Alzheimer's disease. The value of DTI in the investigation of brain tumors and metabolic disorders is assessed.	Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI 48109 USA	Sundgren, PC (corresponding author), Univ Michigan Hlth Syst, Dept Radiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	sundgren@umich.edu		Sundgren, Pia/0000-0001-9237-1236			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bastin ME, 2002, NEUROREPORT, V13, P1335, DOI 10.1097/00001756-200207190-00024; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; BROOKS BS, 1990, AM J NEURORADIOL, V11, P93; BROWN MM, 1995, LACUNAR OTHER SUBCOR, P47; Brown W.J., 1987, EPILEPSY, P300; BRUNBERG JA, 1995, AM J NEURORADIOL, V16, P361; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chabriat H, 1999, STROKE, V30, P263; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; CHRISTIANSEN P, 1993, ACTA NEUROL SCAND, V87, P195; Copen WA, 2001, RADIOLOGY, V221, P27, DOI 10.1148/radiol.2211001397; Droogan AG, 1999, MAGN RESON IMAGING, V17, P653, DOI 10.1016/S0730-725X(99)00011-9; Eichler FS, 2002, RADIOLOGY, V225, P245, DOI 10.1148/radiol.2251011040; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; Filippi CG, 2001, AM J NEURORADIOL, V22, P277; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; GIDEON P, 1994, NEURORADIOLOGY, V36, P210, DOI 10.1007/BF00588133; GIDEON P, 1994, JMRI-J MAGN RESON IM, V4, P185, DOI 10.1002/jmri.1880040216; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Guo AC, 2002, RADIOLOGY, V222, P729, DOI 10.1148/radiol.2223010311; Guo AC, 2001, RADIOLOGY, V218, P809, DOI 10.1148/radiology.218.3.r01mr14809; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hanyu H, 1998, J NEUROL SCI, V156, P195, DOI 10.1016/S0022-510X(98)00043-4; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Horsfield MA, 1996, MAGN RESON MED, V36, P393, DOI 10.1002/mrm.1910360310; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huppi PS, 1998, PEDIATR RES, V44, P584; Ito R, 2001, NEUROLOGY, V56, P544, DOI 10.1212/WNL.56.4.544; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; Lansberg MG, 2000, ARCH NEUROL-CHICAGO, V57, P1311, DOI 10.1001/archneur.57.9.1311; LARSSON HBW, 1992, MAGN RESON IMAGING, V10, P7, DOI 10.1016/0730-725X(92)90367-9; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 1991, Magn Reson Q, V7, P1; Le Bihan D, 1995, DIFFUSION PERFUSION; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Lu S, 2003, AM J NEURORADIOL, V24, P937; Lutsep HL, 1997, ANN NEUROL, V41, P574, DOI 10.1002/ana.410410505; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Molko N, 2002, J COGNITIVE NEUROSCI, V14, P629, DOI 10.1162/08989290260045864; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2002, ANN NEUROL, V51, P377, DOI 10.1002/ana.10137; Morriss MC, 1999, NEURORADIOLOGY, V41, P929, DOI 10.1007/s002340050869; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1034/j.1600-0455.2001.420404.x; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; Nusbaum AO, 2000, AM J ROENTGENOL, V175, P821, DOI 10.2214/ajr.175.3.1750821; Ono J, 1997, PEDIATR NEUROL, V16, P63, DOI 10.1016/S0887-8994(96)00249-4; ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pipe JG, 2002, MAGNET RESON MED, V47, P42, DOI 10.1002/mrm.10014; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; SAKUMA H, 1991, RADIOLOGY, V180, P229, DOI 10.1148/radiology.180.1.2052700; SCHAUMBURG HH, 1975, ARCH NEUROL-CHICAGO, V32, P577, DOI 10.1001/archneur.1975.00490510033001; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schneider JFL, 2003, AM J NEURORADIOL, V24, P819; Sinha S, 2002, AM J NEURORADIOL, V23, P520; Sorensen AG, 1996, RADIOLOGY, V199, P391, DOI 10.1148/radiology.199.2.8668784; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Sundgren PC, 2002, NEURORADIOLOGY, V44, P299, DOI 10.1007/s00234-001-0721-7; Sundgren PC, 2002, NEURORADIOLOGY, V44, P674, DOI 10.1007/s00234-002-0777-z; TIEN RD, 1993, RADIOLOGY, V189, P835, DOI 10.1148/radiology.189.3.8234712; Weber J, 2000, NEURORADIOLOGY, V42, P184, DOI 10.1007/s002340050042; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P29, DOI 10.1016/S0730-725X(98)00153-2; Wieshmann UC, 2000, J NEUROL NEUROSUR PS, V68, P501, DOI 10.1136/jnnp.68.4.501; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yoo SY, 2002, AM J NEURORADIOL, V23, P809; Zelaya F, 1999, MAGN RESON IMAGING, V17, P331, DOI 10.1016/S0730-725X(98)00192-1	98	305	327	0	28	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAY	2004	46	5					339	350		10.1007/s00234-003-1114-x			12	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	820EH	WOS:000221369500001	15103435				2021-06-18	
J	Lehman, EJ; Hein, MJ; Baron, SL; Gersic, CM				Lehman, Everett J.; Hein, Misty J.; Baron, Sherry L.; Gersic, Christine M.			Neurodegenerative causes of death among retired National Football League players	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; CONCUSSION; COLLEGIATE; MORTALITY; DISEASE	Objective: To analyze neurodegenerative causes of death, specifically Alzheimer disease (AD), Parkinson disease, and amyotrophic lateral sclerosis (ALS), among a cohort of professional football players. Methods: This was a cohort mortality study of 3,439 National Football League players with at least 5 pension-credited playing seasons from 1959 to 1988. Vital status was ascertained through 2007. For analysis purposes, players were placed into 2 strata based on characteristics of position played: nonspeed players (linemen) and speed players (all other positions except punter/kicker). External comparisons with the US population used standardized mortality ratios (SMRs); internal comparisons between speed and nonspeed player positions used standardized rate ratios (SRRs). Results: Overall player mortality compared with that of the US population was reduced (SMR 0.53, 95% confidence interval [CI] 0.48-0.59). Neurodegenerative mortality was increased using both underlying cause of death rate files (SMR 2.83, 95% CI 1.36-5.21) and multiple cause of death (MCOD) rate files (SMR 3.26, 95% CI 1.90-5.22). Of the neurodegenerative causes, results were elevated (using MCOD rates) for both ALS (SMR 4.31, 95% CI 1.73-8.87) and AD (SMR 3.86, 95% CI 1.55-7.95). In internal analysis (using MCOD rates), higher neurodegenerative mortality was observed among players in speed positions compared with players in nonspeed positions (SRR 3.29, 95% CI 0.92-11.7). Conclusions: The neurodegenerative mortality of this cohort is 3 times higher than that of the general US population; that for 2 of the major neurodegenerative subcategories, AD and ALS, is 4 times higher. These results are consistent with recent studies that suggest an increased risk of neurodegenerative disease among football players. Neurology (R) 2012;79:1970-1974	[Lehman, Everett J.; Hein, Misty J.; Baron, Sherry L.; Gersic, Christine M.] NIOSH, Ctr Dis Control & Prevent, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA	Lehman, EJ (corresponding author), NIOSH, Ctr Dis Control & Prevent, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA.	elehman@cdc.gov			National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)	Supported by the Intramural Research Program of the National Institute for Occupational Safety and Health. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health. The sponsor reviewed and approved final submission but did not have a role in design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript.	Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH), 1994, NAT FOOTB LEAG PLAYE; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Robinson CF, 2006, J OCCUP ENVIRON MED, V48, P662, DOI 10.1097/01.jom.0000229968.74906.8f; Schubauer-Berigan MK, 2011, AM J IND MED, V54, P915, DOI 10.1002/ajim.20999; Steenland K, 2006, EPIDEMIOLOGY, V17, P8, DOI 10.1097/01.ede.0000190707.51536.2b; STEENLAND K, 1992, AM J EPIDEMIOL, V136, P855, DOI 10.1093/aje/136.7.855; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008	24	304	305	3	68	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV	2012	79	19					1970	1974		10.1212/WNL.0b013e31826daf50			5	Clinical Neurology	Neurosciences & Neurology	032US	WOS:000310745200011	22955124	Green Published	Y	N	2021-06-18	
J	Peng, WG; Cotrina, ML; Han, XN; Yu, HM; Bekar, L; Blum, L; Takano, T; Tian, GF; Goldman, SA; Nedergaard, M				Peng, Weiguo; Cotrina, Maria L.; Han, Xiaoning; Yu, Hongmei; Bekar, Lane; Blum, Livnat; Takano, Takahiro; Tian, Guo-Feng; Goldman, Steven A.; Nedergaard, Maiken			Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						astrocytes; inflammation; microglia; motor neurons; purinergic signaling	BRILLIANT-BLUE-G; P2X(7) RECEPTOR; INFLAMMATION; DISEASE; MICE; MINOCYCLINE; ASTROCYTES; MICROGLIA; RELEASE; RATS	Traumatic spinal cord injury is characterized by an immediate, irreversible loss of tissue at the lesion site, as well as a secondary expansion of tissue damage over time. Although secondary injury should, in principle, be preventable, no effective treatment options currently exist for patients with acute spinal cord injury (SCI). Excessive release of ATP by the traumatized tissue, followed by activation of high-affinity P2X7 receptors, has previously been implicated in secondary injury, but no clinically relevant strategy by which to antagonize P2X7 receptors has yet, to the best of our knowledge, been reported. Here we have tested the neuroprotective effects of a systemically administered P2X7R antagonist, Brilliant blue G (BBG), in a weight-drop model of thoracic SCI in rats. Administration of BBG 15 min after injury reduced spinal cord anatomic damage and improved motor recovery without evident toxicity. Moreover, BBG treatment directly reduced local activation of astrocytes and microglia, as well as neutrophil infiltration. These observations suggest that BBG not only protected spinal cord neurons from purinergic excitotoxicity, but also reduced local inflammatory responses. Importantly, BBG is a derivative of a commonly used blue food color (FD& C blue No. 1), which crosses the blood-brain barrier. Systemic administration of BBG may thus comprise a readily feasible approach by which to treat traumatic SCI in humans.	[Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA; [Peng, Weiguo; Cotrina, Maria L.; Han, Xiaoning; Yu, Hongmei; Bekar, Lane; Blum, Livnat; Takano, Takahiro; Tian, Guo-Feng; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Div Glial Dis & Therapeut,Ctr Translat Neuromed, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu; nedergaard@urmc.rochester.edu	Bekar, Lane K./AAI-2645-2021	Bekar, Lane/0000-0001-5083-0967; Goldman, Steven/0000-0002-5498-4303	NY State Spinal Cord Injury program; Miriam and Sheldon Adelson Medical Research Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	We thank Dr. Glenn Rechtine for helpful conversations. This work was supported by the NY State Spinal Cord Injury program, the Miriam and Sheldon Adelson Medical Research Foundation, and National Institutes of Health grants.	Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P221, DOI 10.1016/0278-6915(90)90034-K; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SN, 1980, GEOPHYS ASTROPHYS FL, V14, P1; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gourine AV, 2007, J PHYSIOL-LONDON, V585, P305, DOI 10.1113/jphysiol.2007.143933; HESS SM, 1955, J PHARMACOL EXP THER, V114, P38; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jabs R, 2007, GLIA, V55, P1648, DOI 10.1002/glia.20580; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Kukley M, 2001, GLIA, V36, P11, DOI 10.1002/glia.1091; Lee JM, 2008, J NEUROSCI, V28, P3141, DOI 10.1523/JNEUROSCI.5547-07.2008; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Yu Y, 2008, BRAIN RES, V1194, P45, DOI 10.1016/j.brainres.2007.11.064; 2006, FED REG, V71, P70	34	303	314	1	29	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 28	2009	106	30					12489	12493		10.1073/pnas.0902531106			5	Multidisciplinary Sciences	Science & Technology - Other Topics	476KV	WOS:000268440200052	19666625	Green Published, Bronze			2021-06-18	
J	Millis, SR; Rosenthal, M; Novack, TA; Sherer, M; Nick, TG; Kreutzer, JS; High, WM; Ricker, JH				Millis, SR; Rosenthal, M; Novack, TA; Sherer, M; Nick, TG; Kreutzer, JS; High, WM; Ricker, JH			Long-term neuropsychological outcome after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						inpatient medical rehabilitation; neuropsychological tests; traumatic brain injury	SEVERE HEAD-INJURY; RECOVERY; MODERATE; PATTERNS	Objective: To describe neuropsychological outcome 5 years after injury in persons with traumatic brain injury (TBI) who received inpatient medical rehabilitation. To determine the magnitude and pattern neuropsychological recovery from 1 year to 5 years after injury Design: Longitudinal cohort study with inclusion based on the availability If neuropsychological data at I year and 5 years after injury. Setting: National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems of Care. Participants: One hundred eighty-two persons with complicated mild to severe traumatic brain injury. Primary Outcome Measures: Digits Forward and Backward, Logical Memory I and II, Token Test, Controlled Oral Word Association Test, Symbol Digit Modalities Test, Trail Making Test, Rey Auditory Verbal Learning Test, Visual Form Discrimination, Block Design, Wisconsin Card Sorting Test, and Grooved Pegboard. Results: Significant variability in outcome was found 5 years after TBI, ranging from no measurable impairment to severe impairment on neuropsychological tests. improvement from I year after injury to 5 years was also variable. Using the Reliable Change Index, 22.2% improved, 15.2% declined, and 62.6% were unchanged on test measures. Conclusions: Neuropsychological recovery after TBI is not uniform across individuals and neuropsychological domains. For a subset of persons with moderate to severe TBI, neuropsychological recovery may continue several years after injury with substantial recovery. For other persons, measurable impairment remains 5 years after injury. Improvement was most apparent on measures of cognitive speed, visuoconstruction, and verbal memory.	Univ Med & Dent New Jersey, Kessler Med Rehabil Res & Educ Corp, New Jersey Med Sch, W Orange, NJ 07052 USA; Univ Alabama, Dept Phys Med & Rehabil, Spain Rehabil Ctr, Birmingham, AL USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Baylor Coll Med, Inst Rehabil & Res, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Millis, SR (corresponding author), Univ Med & Dent New Jersey, Kessler Med Rehabil Res & Educ Corp, New Jersey Med Sch, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.			Ricker, Joseph/0000-0003-3415-991X			BENTON AL, 1994, CONTRIBUTION NEUROPS; Benton AL, 1978, MULTILINGUAL APHASIA; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Heaton R.K., 1991, COMPREHENSIVE NORMS; Hedges L.V., 1985, STAT METHODS META AN; HOLM S, 1979, SCAND J STAT, V6, P65; Hosmer D. W., 2000, APPL LOGISTIC REGRES; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kreutzer JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1993, HEAD INJURY; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MEHTA C, 1999, LOGXACT 4 WINDOWS; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1988, TRAUMATIC BRAIN INJU, VII; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; SCHAEFER JL, 1996, ANAL INCOMPLETE MULT; Smith A., 1982, SYMBOL DIGIT MODALIT; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	34	303	305	0	41	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2001	16	4					343	355		10.1097/00001199-200108000-00005			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	459YA	WOS:000170278000005	11461657				2021-06-18	
J	Scherbel, U; Raghupathi, R; Nakamura, M; Saatman, KE; Trojanowski, JQ; Neugebauer, E; Marino, MW; McIntosh, TK				Scherbel, U; Raghupathi, R; Nakamura, M; Saatman, KE; Trojanowski, JQ; Neugebauer, E; Marino, MW; McIntosh, TK			Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						cytokines; cognition; neuromotor function; histopathology; central nervous system trauma	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; FACTOR-ALPHA; TNF-ALPHA; TRANSGENIC MICE; CELL-DEATH; RAT-BRAIN; CEREBRAL-ISCHEMIA; PERIPHERAL-NERVE; CYTOKINES	The present study evaluated behavioral and histopathological outcome after controlled cortical impact (CCI) brain injury in mice deficient in tumor necrosis factor [TNF(-/-)] and their wild-type (wt) littermates. Mice were subjected to CCI brain injury [TNF(-/-), n = 10; wt, n = 10] or served as uninjured controls [TNF(-/-), n = 10; wt, n = 10] and were evaluated for deficits in memory retention at 7 days postinjury, Although both brain-injured wt and TNF(-/-) mice exhibited significant memory dysfunction compared to uninjured controls (P < 0.02), the deficits in memory retention in injured TNF(-/-) mice were significantly less severe than in injured wt mice (P < 0.02). A second group of mice was subjected to CCI brain injury [TNF(-/-), n = 20; wt, n = 20] or served as uninjured controls [TNF(-/-), n = 15; wt, n = 15] and were evaluated over a 4-week period for neurological motor function. In the acute posttraumatic period (48 h postinjury), brain-injured TNF(-/-) mice were significantly less impaired than injured wt mice on composite neuroscore (P < 0.001), rotarod (P < 0.05), and beam balance (P < 0.02) tests. However, wt mice recovered from brain injury by 2-3 weeks postinjury, whereas TNF(-/-) mice continued to demonstrate persistent motor deficits up to 4 weeks postinjury, Histopathological analysis at 2 and 4 weeks postinjury revealed that brain-injured TNF(-/-) mice had significantly more cortical tissue loss than wt mice (P < 0.02). Our results suggest that although the presence of TNF in the acute posttraumatic period may be deleterious, this cytokine may play a role in facilitating long-term behavioral recovery and histological repair after brain injury.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Cologne, Dept Surg 2, Biochem & Expt Div, D-51109 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA	McIntosh, TK (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS026818, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010124, P01AG009215] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG010124, P01 AG009215] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, P50 NS008803, P01-NS08803] Funding Source: Medline		ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; Appel E, 1997, NEUROREPORT, V8, P3309, DOI 10.1097/00001756-199710200-00023; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Baldwin RL, 1996, P NATL ACAD SCI USA, V93, P1021, DOI 10.1073/pnas.93.3.1021; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Bizette C, 1996, Chirurgie, V121, P474; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Chen LE, 1996, NEUROCHEM INT, V29, P197; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/0304-3940(96)13116-5; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GORDON HM, 1992, J IMMUNOL, V148, P4021; GRASSI F, 1994, BRAIN RES, V659, P226, DOI 10.1016/0006-8993(94)90883-4; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HATTORI A, 1993, J BIOL CHEM, V268, P2577; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; KAGAN BL, 1992, SCIENCE, V255, P1427, DOI 10.1126/science.1371890; LaFleur M, 1996, J EXP MED, V184, P2311; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Lindner H, 1997, BLOOD, V89, P1931, DOI 10.1182/blood.V89.6.1931; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MARTIN D, 1995, EXP NEUROL, V131, P221, DOI 10.1016/0014-4886(95)90044-6; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; MCCARTHY PL, 1994, BAILLIERE CLIN HAEM, V7, P153, DOI 10.1016/S0950-3536(05)80011-3; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; PROBERT L, 1997, J NEUROIMMUNOL, V72, P117; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RINK A, 1995, AM J PATHOL, V147, P1575; ROBBINS DS, 1987, J IMMUNOL, V139, P2593; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SHAPIRA Y, 1989, Neurological Research, V11, P169; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Sipe KJ, 1996, MOL BRAIN RES, V38, P222, DOI 10.1016/0169-328X(95)00310-O; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SMITH KE, 1991, J PSYCHOSOC ONCOL, V8, P59; Soares HD, 1995, J NEUROSCI, V15, P8223; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TCHELINGERIAN JL, 1994, NEUROREPORT, V5, P585, DOI 10.1097/00001756-199401000-00013; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; VILLARROYA H, 1997, J NEUROSCI RES, V49, P975; Westmoreland SV, 1996, J NEUROVIROL, V2, P118, DOI 10.3109/13550289609146545; WONG GHW, 1995, BBA-MOL BASIS DIS, V1271, P205, DOI 10.1016/0925-4439(95)00029-4; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004	72	303	316	0	10	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 20	1999	96	15					8721	8726		10.1073/pnas.96.15.8721			6	Multidisciplinary Sciences	Science & Technology - Other Topics	219CB	WOS:000081589400079	10411942	Green Published, Bronze			2021-06-18	
J	O'Connor, T; Sadleir, KR; Maus, E; Velliquette, RA; Zhao, J; Cole, SL; Eimer, WA; Hitt, B; Bembinster, LA; Lammich, S; Lichtenthaler, SF; Hebert, SS; De Strooper, B; Haass, C; Bennett, DA; Vassar, R				O'Connor, Tracy; Sadleir, Katherine R.; Maus, Erika; Velliquette, Rodney A.; Zhao, Jie; Cole, Sarah L.; Eimer, William A.; Hitt, Brian; Bembinster, Leslie A.; Lammich, Sven; Lichtenthaler, Stefan F.; Hebert, Sbastien S.; De Strooper, Bart; Haass, Christian; Bennett, David A.; Vassar, Robert			Phosphorylation of the Translation Initiation Factor eIF2 alpha Increases BACE1 Levels and Promotes Amyloidogenesis	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; TRAUMATIC BRAIN-INJURY; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; ENERGY-METABOLISM; CLEAVING ENZYME; TRANSGENIC MICE; MEMORY DEFICITS; GAMMA-SECRETASE	beta-site APP cleaving enzyme-1 (BACE1), the rate-limiting enzyme for beta-amyloid (A beta) production, is elevated in Alzheimer's disease (AD). Here, we show that energy deprivation induces phosphorylation of the translation initiation factor eIF2 alpha (eIF2 alpha-P), which increases the translation of BACE1. Salubrinal, an inhibitor of eIF2 alpha-P phosphatase PP1c, directly increases BACE1 and elevates A beta production in primary neurons. Preventing eIF2 alpha phosphorylation by transfection with constitutively active PP1c regulatory subunit, dominant-negative eIF2 alpha kinase PERK, or PERK inhibitor P58(IPK) blocks the energy-deprivation-induced BACE1 increase. Furthermore, chronic treatment of aged Tg2576 mice with energy inhibitors increases levels of eIF2 alpha-P, BACE1, A beta, and amyloid plaques. Importantly, eIF2 alpha-P and BACE1 are elevated in aggressive plaque-forming 5XFAD transgenic mice, and BACE1, eIF2 alpha-P, and amyloid load are correlated in humans with AD. These results strongly suggest that eIF2 alpha phosphorylation increases BACE1 levels and causes A beta overproduction, which could be an early, initiating molecular mechanism in sporadic AD.	[O'Connor, Tracy; Sadleir, Katherine R.; Maus, Erika; Velliquette, Rodney A.; Zhao, Jie; Cole, Sarah L.; Eimer, William A.; Hitt, Brian; Bembinster, Leslie A.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Lammich, Sven; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, Lab Neurodegenerat Dis Res, Dept Biochem, D-80539 Munich, Germany; [Lammich, Sven; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80539 Munich, Germany; [Hebert, Sbastien S.; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Lichtenthaler, Stefan F/B-6587-2016; Hebert, Sebastien S./Q-2729-2017; De Strooper, Bart/F-6507-2012; Sadleir, Katherine R/N-1199-2019; de+Strooper, Bart/Z-1638-2019	Lichtenthaler, Stefan F/0000-0003-2211-2575; De Strooper, Bart/0000-0001-5455-5819; Sadleir, Katherine R/0000-0001-8310-841X; Eimer, William/0000-0003-1067-9339; Hitt, Brian/0000-0001-8720-6762; Hebert, Sebastien/0000-0002-0391-9325	John Douglas French Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32AGO20506-04, 1F31AG030965-01A1, 5T32AGO00260, R01 AG022560, R01 AG030142]; Deutsche ForschungsgerneinschaftGerman Research Foundation (DFG) [SFB 596]; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); Flemisch Government; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG017917, T32AG000260, R01AG030142, T32AG020506, F31AG030965, R01AG022560] Funding Source: NIH RePORTER	We thank Richard Scarpulla for key intellectual contributions to this work and general expertise in the area of energy metabolism, Adriana Ferreira for expertise in neuronal cultures, and Marina Yasvoina and Peizhen Shao for performing tissue sectioning and immunohistochemistry. Human AD brain tissue samples were a gift from participants in Rush Hospital Memory and Aging Project (R01 AG17917; Bennett, David A.; PI). GADD34 Delta N, GADD34 transfection control, PERKDN, and P58<SUP>IPK</SUP> constructs were generous gifts from David Ron (New York University) and the GCN2DN construct was a gift from Dr. Ron Welk (University of Indiana). The PS1-NT antibody was a gift of Gopal Thinakaran (University of Chicago). This work was supported by the John Douglas French Foundation (S.L.C.), and NIH grants 5T32AGO20506-04 (T.O.), 1F31AG030965-01A1 (T.O.), 5T32AGO00260 (K.R.S. and R.A.V.), R01 AG022560 (R.V.), and R01 AG030142 (R.V.). C.H., S.F.L., and S.L. are supported by grants from the Deutsche Forschungsgerneinschaft (SFB 596) and the Federal Ministry of Education and Research (NGFN-Alzheimer Disease Ig), and B.D.S. and S.H. by a Methusalem grant from the Flemisch Government.	BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Carnevalli LS, 2006, BIOCHEM J, V397, P187, DOI 10.1042/BJ20051643; CHENG B, 1995, J NEUROSCI, V15, P7095; Chiocco MJ, 2007, NEUROBIOL AGING, V28, P75, DOI 10.1016/j.neurobiolaging.2005.11.011; Chiocco MJ, 2004, J BIOL CHEM, V279, P52535, DOI 10.1074/jbc.M409680200; CIGAN AM, 1993, P NATL ACAD SCI USA, V90, P5350, DOI 10.1073/pnas.90.11.5350; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clemens MJ, 2001, PROG MOLEC, V27, P57; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DEALDANA CRV, 1993, P NATL ACAD SCI USA, V90, P7215; DeCarli C, 2004, J NEUROL SCI, V226, P19, DOI 10.1016/j.jns.2004.09.005; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Gasparini L, 1997, NEUROSCI LETT, V231, P113, DOI 10.1016/S0304-3940(97)00536-3; Gietzen DW, 2004, J NUTR, V134, P717; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hoyer A, 2005, J NEURAL TRANSM, V112, P239, DOI 10.1007/s00702-004-0176-1; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Mitchell SL, 1999, AGE AGEING, V28, P401, DOI 10.1093/ageing/28.4.401; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ozmen L, 2005, NEURODEGENER DIS, V2, P284, DOI 10.1159/000092314; Paschen W, 2005, PHARMACOL THERAPEUT, V108, P362, DOI 10.1016/j.pharmthera.2005.05.008; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Polak P, 2006, ONCOGENE, V25, P665, DOI 10.1038/sj.onc.1209114; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rao GN, 2000, J BIOL CHEM, V275, P16993, DOI 10.1074/jbc.275.22.16993; Rapoport SI, 1999, ANN NY ACAD SCI, V893, P138, DOI 10.1111/j.1749-6632.1999.tb07823.x; Rapoport SI, 1999, EUR ARCH PSY CLIN N, V249, P46; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Sennvik K, 2004, J CELL MOL MED, V8, P127, DOI 10.1111/j.1582-4934.2004.tb00267.x; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Sood R, 2000, GENETICS, V154, P787; Spruill LS, 2008, J MOL CELL CARDIOL, V44, P69, DOI 10.1016/j.yjmcc.2007.10.011; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tanahashi H, 2001, NEUROSCI LETT, V307, P9, DOI 10.1016/S0304-3940(01)01912-7; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vardimon L, 2006, MOL CELL ENDOCRINOL, V252, P142, DOI 10.1016/j.mce.2006.03.012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Webster MT, 1998, J NEURAL TRANSM, V105, P839, DOI 10.1007/s007020050098; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Willem M, 2004, AM J PATHOL, V165, P1621, DOI 10.1016/S0002-9440(10)63419-0; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolf H, 2003, ACTA NEUROL SCAND, V107, P52, DOI 10.1034/j.1600-0404.107.s179.10.x; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	112	302	304	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2008	60	6					988	1009		10.1016/j.neuron.2008.10.047			22	Neurosciences	Neurosciences & Neurology	391BW	WOS:000262208900008	19109907	Green Accepted			2021-06-18	
J	Mac Donald, CL; Dikranian, K; Bayly, P; Holtzman, D; Brody, D				Mac Donald, Christine L.; Dikranian, Krikor; Bayly, Philip; Holtzman, David; Brody, David			Diffusion tensor imaging reliably detects experimental traumatic axonal injury and indicates approximate time of injury	JOURNAL OF NEUROSCIENCE			English	Article						magnetic resonance imaging; diffusion tensor imaging; traumatic brain injury; axonal injury; white matter injury; forensic imaging	WHITE-MATTER INJURY; HUMAN BRAIN-INJURY; BLUNT-HEAD TRAUMA; MOUSE MODEL; COEFFICIENT; DIAGNOSIS; STROKE; DAMAGE; RATS; MRI	Traumatic axonal injury (TAI) may contribute greatly to neurological impairments after traumatic brain injury, but it is difficult to assess with conventional imaging. We quantitatively compared diffusion tensor imaging (DTI) signal abnormalities with histological and electron microscopic characteristics of pericontusional TAI in a mouse model. Two DTI parameters, relative anisotropy and axial diffusivity, were significantly reduced 6 h to 4 d after trauma, corresponding to relatively isolated axonal injury. One to 4 weeks after trauma, relative anisotropy remained decreased, whereas axial diffusivity "pseudo-normalized" and radial diffusivity increased. These changes corresponded to demyelination, edema, and persistent axonal injury. At every time point, DTI was more sensitive to injury than conventional magnetic resonance imaging, and relative anisotropy distinguished injured from control mice with no overlap between groups. Remarkably, DTI changes strongly predicted the approximate time since trauma. These results provide an important validation of DTI for pericontusional TAI and suggest novel clinical and forensic applications.	Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; Washington Univ, Dept Mech Engn, St Louis, MO 63130 USA	Brody, D (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu		Bayly, Philip/0000-0003-4303-0704	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS045237, K08NS049237, P30NS057105, P01NS032636] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS045237-02, K08 NS049237-04, K08 NS049237, P01 NS032636, R21 NS045237-01A1, R21 NS45237, R21 NS045237, P30 NS057105, NS049237] Funding Source: Medline		ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Copen WA, 2001, RADIOLOGY, V221, P27, DOI 10.1148/radiol.2211001397; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kahana T, 1999, BRIT J RADIOL, V72, P129, DOI 10.1259/bjr.72.854.10365061; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; OPPRNHEIMER DR, 1968, J NEUROL NEUROSUR PS, V31, P299; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schaefer PW, 2005, NEUROIMAG CLIN N AM, V15, P503, DOI 10.1016/j.nic.2005.08.011; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Silver JM, 2005, TXB TRAUMATIC BRAIN; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Zakaria N, 2007, J NEUROTRAUM, V24, P1233	55	302	303	0	20	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 31	2007	27	44					11869	11876		10.1523/JNEUROSCI.3647-07.2007			8	Neurosciences	Neurosciences & Neurology	226HB	WOS:000250577600016	17978027	Green Accepted, Green Published, Bronze			2021-06-18	
J	Koponen, S; Taiminen, T; Portin, R; Himanen, L; Isoniemi, H; Heinonen, H; Hinkka, S; Tenovuo, I				Koponen, S; Taiminen, T; Portin, R; Himanen, L; Isoniemi, H; Heinonen, H; Hinkka, S; Tenovuo, I			Axis I and II psychiatric disorders after traumatic brain injury: A 30-year follow-up study	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							BLUNT HEAD-INJURY; PERSONALITY-DISORDER; DEPRESSION; COMMUNITY; PSYCHOPATHOLOGY; INDIVIDUALS; POPULATION; RELATIVES; AGE	Objective: Patients who had suffered traumatic brain injury were evaluated to determine the occurrence of psychiatric disorders during a 30-year follow-up. Method: Sixty patients were assessed on average 30 years after traumatic brain injury. DSM-IV axis I disorders were diagnosed on a clinical basis with the aid of the Schedules for Clinical Assessment in Neuropsychiatry (version 2.1), and axis 11 disorders were diagnosed with the Structured Clinical Interview for DSM-III-R Personality Disorders. Cognitive impairment was measured with a neuropsychological test battery and the Mini-Mental State Examination. Results: of the 60 patients, 29 (48.3%) had had an axis I disorder that began after traumatic brain injury, and 37 (61.7%) had had an axis I disorder during their lifetimes. The most common novel disorders after traumatic brain injury were major depression (26.7%), alcohol abuse or dependence (11.7%), panic disorder (8.3%), specific phobia (8.3%), and psychotic disorders (6.7%). Four-teen patients (23.3%) had at least one personality disorder. The most prevalent individual disorders were avoidant (15.0%), paranoid (8.3%), and schizoid (6.7%) personality disorders. Nine patients (15.0%) had DSM-III-R organic personality syndrome. Conclusions: The results suggest that traumatic brain injury may cause decades-lasting vulnerability to psychiatric illness in some individuals. Traumatic brain injury seems to make patients particularly susceptible to depressive episodes, delusional disorder, and personality disturbances. The high rate of psychiatric disorders found in this study emphasizes the importance of psychiatric follow-up after traumatic brain injury.	Turku Univ, Dept Psychiat, Cent Hosp, FIN-20521 Turku, Finland; Turku Univ, Cent Hosp, Dept Neurol, FIN-20521 Turku, Finland; Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; Univ Turku, Dept Biostat, FIN-20520 Turku, Finland	Koponen, S (corresponding author), Turku Univ, Dept Psychiat, Cent Hosp, PL 52, FIN-20521 Turku, Finland.			Himanen, Leena/0000-0001-7261-8027			ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; BENTON AL, 1963, REVISED VISUAL RETEN; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; COHEN BJ, 1994, BRIT J PSYCHIAT, V165, P493, DOI 10.1192/bjp.165.4.493; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Deb S, 1999, AM J PSYCHIAT, V156, P374; DEGIROLAMO G, 1993, EPIDEMIOLOGY MENTAL; DEUTSCH LH, 1991, AM J PSYCHIAT, V148, P1159; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOGEL BS, 1990, J CLIN PSYCHIAT, V51, P232; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franulic A, 2000, BRAIN INJURY, V14, P431; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Portin R, 2001, SCAND J PSYCHOL, V42, P359, DOI 10.1111/1467-9450.00247; REICH J, 1988, COMPR PSYCHIAT, V29, P298, DOI 10.1016/0010-440X(88)90052-1; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; SAMUELS JF, 1994, AM J PSYCHIAT, V151, P1055; *SAS I, 1999, SAS SYST WIND VERS 8; Spitzer R.L., 1989, STRUCTURED CLIN INTE; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vaillant GE, 1996, ARCH GEN PSYCHIAT, V53, P243; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Wechsler D., 1955, MANUAL WECHSLER ADUL; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	33	302	317	0	28	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	AUG	2002	159	8					1315	1321		10.1176/appi.ajp.159.8.1315			7	Psychiatry	Psychiatry	582AJ	WOS:000177327300009	12153823				2021-06-18	
J	Taylor, HG; Yeates, KO; Wade, SL; Drotar, D; Stancin, T; Minich, N				Taylor, HG; Yeates, KO; Wade, SL; Drotar, D; Stancin, T; Minich, N			A prospective study of short- and long-term outcomes after traumatic brain injury in children: Behavior and achievement	NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; ACADEMIC-PERFORMANCE; FULL-TERM; RECOVERY; ADOLESCENTS; SEVERITY; FAMILY; CHILDHOOD; SEQUELAE	Longitudinal behavior and achievement outcomes of traumatic brain injury (TBI) were investigated in 53 children with severe TBI, 56 children with moderate TBI, and 80 children with orthopedic injuries not involving brain insult. Measures of preinjury child and family status and of postinjury achievement skills were administered shortly after injury. Assessments were repeated 3 times across a mean follow-up interval of 4 years. Results from mixed model analysis revealed persisting sequelae of TBI. Recovery of math skills was observed in the severe TBI group but only for children from less stressed families. Social disadvantage in children with TBI predicted more adverse behavioral sequelae, and less favorable changes in some outcome measures. The findings suggest that pediatric TBI has long-term effects on behavior and achievement but that postinjury progress is influenced by the family environment.	Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Columbus Childrens Hosp, Dept Pediat, Columbus, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; Childrens Hosp, Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH 45229 USA; Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA	Taylor, HG (corresponding author), Rainbow Babies & Childrens Hosp, Dept Pediat, 11100 Euclid Ave, Cleveland, OH 44106 USA.	hgt2@po.cwru.edu	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-390611] Funding Source: Medline		Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Achenbach T.M., 1991, MANUAL TEACHERS REPO; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; BACHYRITA P, 1990, NEUROPSYCHOLOGIA, V28, P547, DOI 10.1016/0028-3932(90)90033-K; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BURCHINAL MR, 1994, J EARLY INTERVENTION, V18, P403, DOI 10.1177/105381519401800409; Catroppa C, 1999, Pediatr Rehabil, V3, P167; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CICCHETTI DV, 1994, J CLIN EXP NEUROPSYC, V16, P339, DOI 10.1080/01688639408402644; DeGarmo DS, 1999, CHILD DEV, V70, P1231, DOI 10.1111/1467-8624.00089; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1999, COGNITIVE ASPECTS OF CHRONIC ILLNESS IN CHILDREN, P262; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher J M, 1991, Brain Inj, V5, P337, DOI 10.3109/02699059109008106; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; FRANCIS DJ, 1994, NEUROPSYCHOL REV, V4, P199, DOI 10.1007/BF01874892; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GREENBERG MT, 1988, CHILD DEV, V59, P554, DOI 10.2307/1130557; Greenough WT, 1999, CHANGING NERVOUS SYSTEM, P51; Gutman LM, 1999, CHILD DEV, V70, P1464, DOI 10.1111/1467-8624.00106; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Keogh BK, 1997, AM J MENT RETARD, V101, P365; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KOLB B, 1989, AM PSYCHOL, V44, P1203, DOI 10.1037/0003-066X.44.9.1203; Landry SH, 1998, CHILD DEV, V69, P105, DOI 10.2307/1132074; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; MOOS R, 1994, LIFE STRESORS SOCIAL; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; PUTMAN SH, 1992, CLIN NEUROPSYCHOL, V6, P383; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosenzweig MR, 1999, CHANGING NERVOUS SYSTEM, P25; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1994, J CONSULT CLIN PSYCH, V62, P928, DOI 10.1037/0022-006X.62.5.928; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RUTTER M, 1985, J CHILD PSYCHOL PSYC, V26, P349, DOI 10.1111/j.1469-7610.1985.tb01938.x; Rutter M, 1983, DEV NEUROPSYCHIATRY, P83; *SAS I INC, 1990, STAT AN SYST VERS 6; Sigman M, 1999, CHANGING NERVOUS SYSTEM, P274; Sparrow S., 1984, VINELAND ADAPTIVE BE; Spieker SJ, 1999, CHILD DEV, V70, P443, DOI 10.1111/1467-8624.00032; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; STEIN DG, 1988, NEUROPSYCHOL REHABIL, P1; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; STREISSGUTH AP, 1994, DRUG ALCOHOL DEPEN, V36, P89, DOI 10.1016/0376-8716(94)90090-6; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; TAYLOR HG, 2001, UNPUB LONG TERM ED I; TAYLOR HG, 1997, J INT NEUROPSYCH SOC, V3, P1; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; Wachs T.D., 2000, NECESSARY NOT SUFFIC; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; YEATES KO, 2001, UNPUB PROSPECTIVE ST; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P369	87	302	305	2	58	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2002	16	1					15	27		10.1037//0894-4105.16.1.15			13	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	520RK	WOS:000173794700003	11853353				2021-06-18	
J	Mayo, NE; Wood-Dauphinee, S; Ahmed, S; Gordon, C; Higgins, J; McEwen, S; Salbach, N				Mayo, NE; Wood-Dauphinee, S; Ahmed, S; Gordon, C; Higgins, J; McEwen, S; Salbach, N			Disablement following stroke	DISABILITY AND REHABILITATION			English	Article							QUALITY-OF-LIFE; SPINAL-CORD INJURY; RANDOMIZED CONTROLLED TRIAL; TRAUMATIC BRAIN INJURY; ACUTE-CARE HOSPITALS; ARM FUNCTION; IMPROVED SURVIVAL; PHYSICAL THERAPY; NORMATIVE DATA; GRIP STRENGTH	Purpose: Stroke is the most disabling chronic condition, newly affecting 35000 persons in Canada each year. Because of declining fatality, a growing number of persons will have to cope with stroke-related disability. The purpose of this paper is to describe the disabilities experienced by persons with stroke during the first year and explore the evolution of impairment, disability, handicap and health-related quality of life. Subjects: The data for this paper come from a series of longitudinal and cross-sectional studies, collectively known as the McGill Stroke Rehabilitation Research Program. Results: Within the first week post-stroke, getting out of bed and walking over a short distance, even with assistance, was a strong predictor of discharge home. Most of the improvement in measures of impairment and disability occurred during the first month and, by 3 months, there was still considerable room for improvement in all measures: 85 % of persons were still impaired on gait speed, 78 % had not reached age-specific norms for upper extremity function, 68 % still demonstrated slow physical mobility, 37 % needed some assistance with basic activities of daily living and 29 % were still impaired on balance. By 1 year, 73 % of persons scored the maximum for basic activities of daily living but 51 and 67 % of persons reported their physical health and mental health to be lower than expected. Among a hardy group of stroke survivors, still living in the community 1 year post-stroke, the most striking area of difficulty was endurance, as measured by the 6 minute walk test. Those subjects well enough to complete this task (50 % of sample) were able to walk, on average, only 250 metres, equivalent to 40 % of their predicted ability. This series of snapshots taken at different points in time suggests that much of the improvement in impairment and disability occurs during the first month and then reaches a plateau. Handicap and quality of life continue to be issues later. Rehabilitation strategies need to consider the multifaceted nature of disablement, which in itself changes with time post-stroke.	Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada	Mayo, NE (corresponding author), Royal Victoria Hosp, Div Clin Epidemiol, R4-29,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.		Higgins, Johanne/AAF-3672-2019	Higgins, Johanne/0000-0003-1513-6587; McEwen, Sara/0000-0002-8529-7717			AHLSIO B, 1984, STROKE, V15, P886, DOI 10.1161/01.STR.15.5.886; ANGELERI F, 1993, STROKE, V24, P1478, DOI 10.1161/01.STR.24.10.1478; Annoni J M, 1992, Disabil Rehabil, V14, P23; Badley E M, 1993, Disabil Rehabil, V15, P161; BADLEY EM, 1995, DISABIL REHABIL, V17, P53, DOI 10.3109/09638289509166628; Barker WH, 1997, STROKE, V28, P284, DOI 10.1161/01.STR.28.2.284; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERGNER M, 1989, MED CARE, V27, pS148, DOI 10.1097/00005650-198903001-00012; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BOWLING A, 1995, MEASURING DIS REV DI; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; CONDIE E, 1992, Physiotherapy Canada, V44, P7; DALEY K, 1997, IN PRESS PHYSIOTHERA; DAVERAT P, 1995, PARAPLEGIA, V33, P665, DOI 10.1038/sc.1995.139; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DEHAAN R, 1993, STROKE, V24, P320, DOI 10.1161/01.STR.24.2.320; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; DESROSIERS J, 1995, AM J OCCUP THER, V49, P637, DOI 10.5014/ajot.49.7.637; EBRAHIM S, 1995, SOC SCI MED, V41, P1383, DOI 10.1016/0277-9536(95)00116-O; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; FOUGEYROLLAS P, 1995, DISABIL REHABIL, V17, P145, DOI 10.3109/09638289509166709; FOUGEYROLLAS P, 1997, REVISION QUEBEC CLAS; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; GARRAWAY WM, 1983, MAYO CLIN PROC, V58, P520; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; GREER S, 1984, SOC SCI MED, V18, P345, DOI 10.1016/0277-9536(84)90124-2; GUYATT G, 1991, CONTROL CLIN TRIALS, V12, P81; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HAERER AF, 1986, ARCH NEUROL-CHICAGO, V43, P1000, DOI 10.1001/archneur.1986.00520100022009; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; KALRA L, 1994, STROKE, V25, P821, DOI 10.1161/01.STR.25.4.821; Kaplan RM, 1985, MEASUREMENT STRATEGI; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; Kwa VIH, 1996, J NEUROL, V243, P599, DOI 10.1007/BF00900948; LAWRENCE L, 1979, AGE AGEING, V8, P167, DOI 10.1093/ageing/8.3.167; Leathem J, 1996, BRAIN INJURY, V10, P27; Lindmark B, 1988, Scand J Rehabil Med Suppl, V21, P1; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; MAYO NE, 1989, STROKE, V20, P351, DOI 10.1161/01.STR.20.3.351; Mayo NE, 1996, STROKE, V27, P1215, DOI 10.1161/01.STR.27.7.1215; Mayo NE, 1997, STROKE, V28, P543, DOI 10.1161/01.STR.28.3.543; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P5, DOI 10.1097/00002060-199102000-00003; MAYO NE, 1993, LONG TERM CONSEQUENC, V7, P1; McDowell I, 1996, MEASURING HLTH GUIDE; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; NEWMAN GC, 1995, STROKE, V26, P1302; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; OBERG T, 1993, J REHABIL RES DEV, V30, P210; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Patrick D., 1993, HLTH STATUS HLTH POL; PATRICK DL, 1973, J HEALTH SOC BEHAV, V14, P6, DOI 10.2307/2136932; PATRICK DL, 1989, MED CARE S, V27, P217; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; QUIGLEY MC, 1995, AM J OCCUP THER, V49, P780, DOI 10.5014/ajot.49.8.780; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; SEGAL ME, 1994, STROKE, V25, P2391, DOI 10.1161/01.STR.25.12.2391; SHAAR K, 1994, EPIDEMIOL REV, V16, P228, DOI 10.1093/oxfordjournals.epirev.a036152; SHAHAR E, 1995, STROKE, V26, P1; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; SMITH DS, 1981, BMJ-BRIT MED J, V282, P517, DOI 10.1136/bmj.282.6263.517; SMITH DS, 1990, STROKE S, V21, P1156; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; *STAT CAN, 1992, AV LENGTH STAY HOSP; STEGMAYR B, 1994, STROKE, V25, P1738, DOI 10.1161/01.STR.25.9.1738; SUNDERLAND A, 1992, J NEUROL NEUROSUR PS, V55, P530, DOI 10.1136/jnnp.55.7.530; SUNDERLAND A, 1989, J NEUROL NEUROSUR PS, V52, P1267, DOI 10.1136/jnnp.52.11.1267; THORNGREN M, 1990, STROKE, V21, P236, DOI 10.1161/01.STR.21.2.236; VANASBECK FWA, 1994, PARAPLEGIA, V32, P330, DOI 10.1038/sc.1994.56; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; vanBennekom CAM, 1996, J CLIN EPIDEMIOL, V49, P39, DOI 10.1016/0895-4356(95)00559-5; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; VISSER MC, 1995, J EPIDEMIOL COMMUN H, V49, P513, DOI 10.1136/jech.49.5.513; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WADE DT, 1996, MEASUREMENT NEUROLOG; Ware JE., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1994, SF 36 PHYSICAL MENTA; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WIDENHOLMQVIST L, 1993, SCAND J REHABIL MED, V25, P173; WOO J, 1992, NEUROEPIDEMIOLOGY, V11, P143, DOI 10.1159/000110924; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; World Health Organization, 1980, INT CLASS IMP DIS HA; YOUNG JB, 1992, BRIT MED J, V304, P1085, DOI 10.1136/bmj.304.6834.1085	90	302	311	1	33	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	MAY-JUN	1999	21	5-6					258	268					11	Rehabilitation	Rehabilitation	203BK	WOS:000080687300008	10381238				2021-06-18	
J	Wilhelmsson, U; Li, LZ; Pekna, M; Berthold, CH; Blom, S; Eliasson, C; Renner, O; Bushong, E; Ellisman, M; Morgan, TE; Pekny, M				Wilhelmsson, U; Li, LZ; Pekna, M; Berthold, CH; Blom, S; Eliasson, C; Renner, O; Bushong, E; Ellisman, M; Morgan, TE; Pekny, M			Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration	JOURNAL OF NEUROSCIENCE			English	Article						GFAP; vimentin; intermediate filaments; astrocytes; regeneration; hippocampus; endothelin B receptor	ELECTRON-MICROSCOPIC ANALYSIS; INTERMEDIATE-FILAMENTS; REACTIVE ASTROCYTES; DENTATE GYRUS; ADULT-RAT; NEURITE OUTGROWTH; TRANSGENIC MICE; DEVELOP; DISEASE; INJURY	The regenerative capacity of the CNS is extremely limited. The reason for this is unclear, but glial cell involvement has been suspected, and oligodendrocytes have been implicated as inhibitors of neuroregeneration ( Chen et al., 2000, GrandPre et al., 2000; Fournier et al., 2001). The role of astrocytes in this process was proposed but remains incompletely understood ( Silver and Miller, 2004). Astrocyte activation ( reactive gliosis) accompanies neurotrauma, stroke, neurodegenerative diseases, or tumors. Two prominent hallmarks of reactive gliosis are hypertrophy of astrocytic processes and upregulation of intermediate filaments. Using the entorhinal cortex lesion model in mice, we found that reactive astrocytes devoid of the intermediate filament proteins glial fibrillary acidic protein and vimentin (GFAP(-/-) Vim(-/-)), and consequently lacking intermediate filaments ( Colucci-Guyon et al., 1994; Pekny et al., 1995; Eliasson et al., 1999), showed only a limited hypertrophy of cell processes. Instead, many processes were shorter and not straight, albeit the volume of neuropil reached by a single astrocyte was the same as in wild-type mice. This was accompanied by remarkable synaptic regeneration in the hippocampus. On a molecular level, GFAP(-/-) Vim(-/-) reactive astrocytes could not upregulate endothelin B receptors, suggesting that the upregulation is intermediate filament dependent. These findings show a novel role for intermediate filaments in astrocytes and implicate reactive astrocytes as potent inhibitors of neuroregeneration.	Univ Gothenburg, Sahlgrenska Acad, Dept Biochem Med, SE-40530 Gothenburg, Sweden; Univ Gothenburg, Sahlgrenska Acad, Dept Anat & Cell Biol, SE-40530 Gothenburg, Sweden; Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Spanish Natl Canc Ctr, E-28029 Madrid, Spain; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Pekny, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Biochem Med, Box 440, SE-40530 Gothenburg, Sweden.	Milos.Pekny@medkem.gu.se	Renner, Oliver/M-7002-2015; Pekna, Marcela/AAM-3249-2021; Pekna, Marcela/AAM-3261-2021	Renner, Oliver/0000-0002-4046-0517; Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41 RR004050, P41 RR04050] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR004050] Funding Source: NIH RePORTER		Baba A, 1998, LIFE SCI, V62, P1711, DOI 10.1016/S0024-3205(98)00133-7; BERTHOLD CH, 1982, J ULTRA MOL STRUCT R, V80, P23, DOI 10.1016/S0022-5320(82)80029-4; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2003, J COMP NEUROL, V462, P241, DOI 10.1002/cne.10728; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CACERES A, 1983, J COMP NEUROL, V214, P387, DOI 10.1002/cne.902140404; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Delaney CL, 1996, J NEUROSCI, V16, P6908; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Harlow E, 1988, ANTIBODIES LAB MANUA, P418; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 1998, EXP CELL RES, V239, P332, DOI 10.1006/excr.1997.3922; Pekny M, 2001, Prog Brain Res, V132, P23; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403; Stone DJ, 1998, J NEUROSCI, V18, P3180	34	301	309	1	14	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 26	2004	24	21					5016	5021		10.1523/JNEUROSCI.0820-04.2004			6	Neurosciences	Neurosciences & Neurology	823ZZ	WOS:000221654400014	15163694	Bronze, Green Published			2021-06-18	
J	Wang, XY; Jung, JC; Asahi, M; Chwang, W; Russo, L; Moskowitz, MA; Dixon, CE; Fini, ME; Lo, EH				Wang, XY; Jung, JC; Asahi, M; Chwang, W; Russo, L; Moskowitz, MA; Dixon, CE; Fini, ME; Lo, EH			Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury	JOURNAL OF NEUROSCIENCE			English	Article						brain trauma; controlled cortical impact; extracellular matrix; proteolysis; neurodegeneration; mouse	CONTROLLED CORTICAL IMPACT; SPINAL-CORD INJURY; CENTRAL-NERVOUS-SYSTEM; KAPPA-B ACTIVATION; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; RAT-BRAIN; EXPRESSION; MOUSE; DEFICITS	Matrix metalloproteinases (MMPs) belong to a class of extracellular proteinases responsible for maintaining and remodeling the extracellular matrix. In addition to multiple functions in normal physiology, abnormal MMP expression and activity may also participate in the pathophysiology of cerebral disease. Here, we show that MMP-9 (gelatinase B; EC. 3.4.24.35) contributes to the pathophysiology of traumatic brain injury. After controlled cortical impact in mice, MMP-9 was increased in traumatized brain. Total MMP-9 levels at 24 hr were significantly increased as measured by a substrate cleavage assay. Zymograms showed that MMP-9 was elevated as early as 3 hr after traumatic brain injury, reaching a maximum at aproximate 24 hr. Increased MMP-9 levels persisted for up to 1 week. Western blot analysis indicated increased profiles of MMP-9 expression that corresponded with the zymographic data. Knock-out mice deficient in MMP-9 gene expression were compared with wild-type littermates in terms of morphological and motor outcomes after trauma. Motor outcomes were measured at 1, 2, and 7 d after traumatic brain injury by the use of a rotarod device. MMP-9 knock-out mice had less motor deficits than wild-type mice. At 7 d, traumatic brain lesion volumes on Nissl-stained histological sections were significantly smaller in MMP-9 knock-out mice. These data demonstrate that MMP-9 contributes to the pathophysiology of traumatic brain injury and suggest that interruption of the MMP proteolytic cascade may be a possible therapeutic approach for preventing the secondary progression of damage after brain trauma.	Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Program Neurosci, Charlestown, MA 02129 USA; Tufts Univ, Sch Med, New England Eye Ctr, Vis Res Labs, Boston, MA 02111 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Charlestown, MA USA; Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA	Lo, EH (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp E 149 2322, Dept Neurol,Neuroprotect Res Lab, Charlestown, MA 02129 USA.	Lo@helix.mgh.harvard.edu	Moskowitz, Michael A/D-9916-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040529, R01NS037074, R01NS038731] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS37074, R01-NS38731, R01-NS40529] Funding Source: Medline		Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Bethea JR, 1998, J NEUROSCI, V18, P3251; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cuzner ML, 1999, J NEUROIMMUNOL, V94, P1, DOI 10.1016/S0165-5728(98)00241-0; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fini ME, 1998, BIOL EXTRAC, P299; Fini ME, 1996, AM J PATHOL, V149, P1287; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; HAGG T, 1989, NEURON, V3, P721, DOI 10.1016/0896-6273(89)90241-9; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; MURTOMAKI S, 1995, DEV BIOL, V168, P635, DOI 10.1006/dbio.1995.1108; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh LYS, 1999, J NEUROSCI, V19, P8464; Pagenstecher A, 1998, AM J PATHOL, V152, P729; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3; RINK A, 1995, AM J PATHOL, V147, P1575; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tsirka SE, 1997, J NEUROSCI, V17, P543; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Westermarck J, 1999, FASEB J, V13, P781; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zuo J, 1998, J NEUROSCI, V18, P5203	54	301	320	0	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	SEP 15	2000	20	18					7037	7042		10.1523/JNEUROSCI.20-18-07037.2000			6	Neurosciences	Neurosciences & Neurology	355GY	WOS:000089379000035	10995849	Bronze, Green Published			2021-06-18	
J	Zemek, R; Barrowman, N; Freedman, SB; Gravel, J; Gagnon, I; McGahern, C; Aglipay, M; Sangha, G; Boutis, K; Beer, D; Craig, W; Burns, E; Farion, KJ; Mikrogianakis, A; Barlow, K; Dubrovsky, AS; Meeuwisse, W; Gioia, G; Meehan, WP; Beauchamp, MH; Kamil, Y; Grool, AM; Hoshizaki, B; Anderson, P; Brooks, BL; Yeates, KO; Vassilyadi, M; Klassen, T; Keightley, M; Richer, L; DeMatteo, C; Osmond, MH				Zemek, Roger; Barrowman, Nick; Freedman, Stephen B.; Gravel, Jocelyn; Gagnon, Isabelle; McGahern, Candice; Aglipay, Mary; Sangha, Gurinder; Boutis, Kathy; Beer, Darcy; Craig, William; Burns, Emma; Farion, Ken J.; Mikrogianakis, Angelo; Barlow, Karen; Dubrovsky, Alexander S.; Meeuwisse, Willem; Gioia, Gerard; Meehan, William P., III; Beauchamp, Miriam H.; Kamil, Yael; Grool, Anne M.; Hoshizaki, Blaine; Anderson, Peter; Brooks, Brian L.; Yeates, Keith Owen; Vassilyadi, Michael; Klassen, Terry; Keightley, Michelle; Richer, Lawrence; DeMatteo, Carol; Osmond, Martin H.		Pediat Emergency Res Canada PERC	Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; RECOVERY; SCHOOL; EPIDEMIOLOGY; PREDICTORS	IMPORTANCE Approximately one-third of children experiencing acute concussion experience ongoing somatic, cognitive, and psychological or behavioral symptoms, referred to as persistent postconcussion symptoms (PPCS). However, validated and pragmatic tools enabling clinicians to identify patients at risk for PPCS do not exist. OBJECTIVE To derive and validate a clinical risk score for PPCS among children presenting to the emergency department. DESIGN, SETTING, AND PARTICIPANTS Prospective, multicenter cohort study (Predicting and Preventing Postconcussive Problems in Pediatrics [5P]) enrolled young patients (aged 5-<18 years) who presented within 48 hours of an acute head injury at 1 of 9 pediatric emergency departments within the Pediatric Emergency Research Canada (PERC) network from August 2013 through September 2014 (derivation cohort) and from October 2014 through June 2015 (validation cohort). Participants completed follow-up 28 days after the injury. EXPOSURES All eligible patients had concussions consistent with the Zurich consensus diagnostic criteria. MAIN OUTCOMES AND MEASURES The primary outcomewas PPCS risk score at 28 days, which was defined as 3 or more new or worsening symptoms using the patient-reported Postconcussion Symptom Inventory compared with recalled state of being prior to the injury. RESULTS In total, 3063 patients (median age, 12.0 years [interquartile range, 9.2-14.6 years]; 1205 [39.3%] girls) were enrolled (n = 2006 in the derivation cohort; n = 1057 in the validation cohort) and 2584 of whom (n = 1701 [85%] in the derivation cohort; n = 883 [84%] in the validation cohort) completed follow-up at 28 days after the injury. Persistent postconcussion symptoms were present in 801 patients (31.0%) (n = 510 [30.0%] in the derivation cohort and n = 291 [33.0%] in the validation cohort). The 12-point PPCS risk score model for the derivation cohort included the variables of female sex, age of 13 years or older, physician-diagnosed migraine history, prior concussion with symptoms lasting longer than 1 week, headache, sensitivity to noise, fatigue, answering questions slowly, and 4 or more errors on the Balance Error Scoring System tandem stance. The area under the curve was 0.71 (95% CI, 0.69-0.74) for the derivation cohort and 0.68 (95% CI, 0.65-0.72) for the validation cohort. CONCLUSIONS AND RELEVANCE A clinical risk score developed among children presenting to the emergency department with concussion and head injury within the previous 48 hours had modest discrimination to stratify PPCS risk at 28 days. Before this score is adopted in clinical practice, further research is needed for external validation, assessment of accuracy in an office setting, and determination of clinical utility.	[Barrowman, Nick; McGahern, Candice; Aglipay, Mary; Kamil, Yael; Grool, Anne M.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd,Room R-139, Ottawa, ON K1H 8L1, Canada; [Zemek, Roger; Farion, Ken J.; Osmond, Martin H.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada; [Freedman, Stephen B.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Hosp Ste Justine, Montreal, PQ H3C 3J7, Canada; [Gagnon, Isabelle; Dubrovsky, Alexander S.] McGill Univ, Dept Pediat, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Sangha, Gurinder] Univ Western Ontario, Dept Pediat, Childrens Hosp ofWestern Ontario, London, ON N6A 3K7, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Beer, Darcy; Klassen, Terry] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Craig, William] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen] Univ Calgary, Dept Pediat & Clin Neurosci, Albertas Childrens Hosp, Calgary, AB, Canada; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Gioia, Gerard] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Dept Neuropsychol, Rockville, MD USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Beauchamp, Miriam H.] Univ Montreal, Ste Justine Res Ctr, Montreal, PQ, Canada; [Hoshizaki, Blaine] Univ Ottawa, Dept Kinesiol, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Dept Psychol, Ottawa, ON K1H 8L1, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neurosurg, Ottawa, ON K1H 8L1, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Richer, Lawrence] Stollery Childrens Hosp, Dept Neurol, Edmonton, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada	Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd,Room R-139, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Barrowman, Nick/AAL-3166-2020; Yeates, Keith/AAJ-4223-2020; Meijer, Anna/K-5118-2016; Zemek, Roger/H-1039-2018; Barlow, Karen/I-6492-2019; Richer, Lawrence/D-3622-2009; Barlow, Karen/C-1323-2014; Freedman, Stephen/H-9102-2012	Barrowman, Nick/0000-0002-4704-9595; Richer, Lawrence/0000-0002-6897-8668; Klassen, Terry/0000-0002-5309-7091; Yeates, Keith/0000-0001-7680-2892; Barlow, Karen/0000-0003-2612-8507; Freedman, Stephen/0000-0003-2319-6192; Osmond, Martin/0000-0001-8275-8381; Craig, William/0000-0002-4804-194X; Gravel, Jocelyn/0000-0001-5901-4990	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [126197, 119829]; Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury TeamCanadian Institutes of Health Research (CIHR) [127047]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness	This study was supported by operating grant 126197 from the Canadian Institutes of Health Research; grant TM1:#127047 from the Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team; and planning grant MRP: #119829 from the Canadian Institutes of Health Research. Dr Freedman is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.	[Anonymous], 2013, Br J Sports Med, V47, P263; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Belisario JSM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000042.pub2; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Graham R, 2013, SPORTS RELATED CONCU; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Harrell Frank E., 2001, REGRESSION MODELING; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zemek R., 2014, GUIDELINES DIAGNOSIN; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	43	300	300	3	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1014	1025		10.1001/jama.2016.1203			12	Medicine, General & Internal	General & Internal Medicine	DF7LW	WOS:000371540200014	26954410	Bronze	Y	N	2021-06-18	
J	Kyritsis, N; Kizil, C; Zocher, S; Kroehne, V; Kaslin, J; Freudenreich, D; Iltzsche, A; Brand, M				Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael			Acute Inflammation Initiates the Regenerative Response in the Adult Zebrafish Brain	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; IN-VIVO; INJURY; PROLIFERATION; TELENCEPHALON; ANTAGONIST; RECEPTOR-1; CELLS	The zebrafish regenerates its brain after injury and hence is a useful model organism to study the mechanisms enabling regenerative neurogenesis, which is poorly manifested in mammals. Yet the signaling mechanisms initiating such a regenerative response in fish are unknown. Using cerebroventricular microinjection of immunogenic particles and immunosuppression assays, we showed that inflammation is required and sufficient for enhancing the proliferation of neural progenitors and subsequent neurogenesis by activating injury-induced molecular programs that can be observed after traumatic brain injury. We also identified cysteinyl leukotriene signaling as an essential component of inflammation in the regenerative process of the adult zebrafish brain. Thus, our results demonstrate that in zebrafish, in contrast to mammals, inflammation is a positive regulator of neuronal regeneration in the central nervous system.	[Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, D-01307 Dresden, Germany; [Kaslin, Jan] Monash Univ, ARMI, Clayton, Vic 3800, Australia	Brand, M (corresponding author), Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, Fetscherstasse 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kyritsis, Nikos/AAD-5187-2021; Brand, Michael/A-5509-2010; Kizil, Caghan/J-6923-2015	Kyritsis, Nikos/0000-0001-7801-5796; Brand, Michael/0000-0001-5711-6512; Kizil, Caghan/0000-0002-8164-9762; Zocher, Sara/0000-0001-8211-5490; Kaslin, Jan/0000-0002-6207-1889; Kroehne, Volker/0000-0002-5610-0866	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB-655]; European Union (ZF Health, EC) [HEALTH-F4-2010-242048]; Technical University of Dresden	We thank A. Menge for cryosections and paraffin sections, G. Kempermann and C. L. Antos for useful discussions, T. Chavakis for discussions and critical reading on the manuscript, N. Trede for discussion and assistance with the immunosuppression assay, and M. Redd for kindly providing us the L-plastin antibody. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB-655), European Union (ZF Health, EC Grant Agreement HEALTH-F4-2010-242048), and Technical University of Dresden.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martin P, 2009, NATURE, V459, P921, DOI 10.1038/459921a; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Zhang WP, 2002, ACTA PHARMACOL SIN, V23, P871	26	299	305	4	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1353	1356		10.1126/science.1228773			4	Multidisciplinary Sciences	Science & Technology - Other Topics	049NZ	WOS:000311991200070	23138980		Y	N	2021-06-18	
J	Djebaili, M; Guo, QM; Pettus, EH; Hoffman, SW; Stein, DG				Djebaili, M; Guo, QM; Pettus, EH; Hoffman, SW; Stein, DG			The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; cell death; cortical impact injury; inflammation; neuroprotection; neurosteroids; progesterone	CORTICAL CONTUSION; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; BASAL FOREBRAIN; RECOVERY; HORMONES; CORTEX; DAMAGE; DEHYDROEPIANDROSTERONE; PLASTICITY	This report compares the effects of progesterone and its metabolite, allopregnanolone, on the early injury cascade (apoptosis) and long-term functional deficits after TBI. Progesterone (16 mg/kg) or allopregnanolone (4, 8, or 16 mg/kg) were injected at 1 h, 6 h, and then for 5 consecutive days after bilateral contusions of the frontal cortex in adult male rats. Within one day after injury, progesterone and allopregnanolone reduced both the expression of pro-apoptotic proteins caspase-3 and Bax, and apoptotic DNA fragmentation. Progesterone and allopregnanolone also reduced the size of glial fibrillary acid protein (GFAP)-positive astrocytes at the lesion site 24 h after injury. Compared to sham-operated controls at 19 days after injury, injured rats given either progesterone or any of three doses of allopregnanolone had equivalent numbers of ChAT-positive cells in the nucleus basalis magnocellularis. At 19 days post-injury, rats given progesterone or allopregnanolone (8 mg/kg) showed improved performance in a spatial learning task compared to injured rats given only the vehicle. These results provide evidence of the anti-apoptotic and anti-astrogliotic effects of progesterone and allopregnanolone and help to explain why better cognitive performance is observed after injury when animals are given either neurosteroid.	Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, Atlanta, GA 30322 USA	Hoffman, SW (corresponding author), Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, 1648 Pierce Dr,Evans Bldg,Rm 261, Atlanta, GA 30322 USA.	swhoffm@emory.edu	Stein, Donald/AAJ-5139-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 R01 NS38664, 1 R01 NS40825] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038664, R01NS040825] Funding Source: NIH RePORTER		Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; DENICOLA AF, 1993, ADV NEUROL, V59, P199; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Ghashghaei HT, 2001, NEUROSCIENCE, V103, P593, DOI 10.1016/S0306-4522(00)00585-6; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Jacobson NA, 1997, NEUROREPORT, V8, P2529, DOI 10.1097/00001756-199707280-00022; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Namura S, 2001, STROKE, V32, P1906, DOI 10.1161/01.STR.32.8.1906; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; ORCHINIK M, 1994, BRAIN RES, V646, P258, DOI 10.1016/0006-8993(94)90087-6; PAUL SM, 1992, FASEB J, V6, P2311; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; SENGSTOCK GJ, 1992, EXP BRAIN RES, V90, P163; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	40	298	305	1	29	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2005	22	1					106	118		10.1089/neu.2005.22.106			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	889OF	WOS:000226451600007	15665606				2021-06-18	
J	Collins, MW; Lovell, MR; Iverson, GL; Cantu, RC; Maroon, JC; Field, M				Collins, MW; Lovell, MR; Iverson, GL; Cantu, RC; Maroon, JC; Field, M			Cumulative effects of concussion in high school athletes	NEUROSURGERY			English	Article						anterograde amnesia; cerebral concussion; head injury; high school; ImPACT; retrograde amnesia; sports	TRAUMATIC BRAIN-INJURY; FOOTBALL; PERFORMANCE; COLLEGIATE; SPORTS	OBJECTIVE: A common assumption in sports medicine is that a history of concussion is predictive of a lower threshold for, as well as a worse outcome after, subsequent concussive injury. The current study was conducted to investigate the relationship between concussion history in high school athletes and the on-field presentation of symptoms after subsequent concussion. METHODS: One hundred seventy-three athletes who experienced sports-related concussion composed the initial study group. Binary groups were subsequently created on the basis of concussion history. Sixty athletes with no concussion history were compared with 28 athletes with a history of three or more concussions: The groups were compared in terms of the on-field presentation of symptoms after an in-study concussion. Dependent variables included the postinjury presence of loss of consciousness,. anterograde amnesia, retrograde amnesia, and confusion. RESULTS: Athletes with three or more prior concussions were more likely to experience on-field positive loss of consciousness (chi(2) = 8.0, P = 0.005), anterograde amnesia (chi(2) = 5.5, P = 0.019), and confusion (chi(2) = 5.1, P = 0.024) after a subsequent cerebral concussion. An odds ratio revealed that, athletes with a history of three, concussions were 9.3 times more. likely than athletes with no history of concussion to demonstrate three to four abnormal on-field markers of concussion severity: CONCLUSION: This study is the first to suggest a cumulative effect of concussion in high school athletes. A more severe on-field presentation of concussion markers is evidenced in high school athletes with a pronounced history of concussion. This study's findings highlight the need for more long-term outcome studies in high school athletes who sustain sports-related concussions.	Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15203 USA; Emerson Hosp, Dept Neurol Surg, Concord, MA USA; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	Collins, MW (corresponding author), Univ Pittsburgh, Med Ctr, Med Concussion Program, 3200 S Water Str, Pittsburgh, PA 15203 USA.	collinsmw@msx.upmc.edu		Iverson, Grant/0000-0001-7348-9570			Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; PERRIN DH, 2001, J ATHL TRAINING, V36, P213; Pipe AL, 2001, CLIN J SPORT MED, V11, P1, DOI 10.1097/00042752-200101000-00001; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; THORNDIKE A, 1952, NEW ENGL J MED, V247, P554, DOI 10.1056/NEJM195210092471504	21	298	303	2	59	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2002	51	5					1175	1179		10.1097/00006123-200211000-00011			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	610WL	WOS:000178984700017	12383362				2021-06-18	
J	Kelly, DF; Gonzalo, ITG; Cohan, P; Berman, N; Swerdloff, R; Wang, C				Kelly, DF; Gonzalo, ITG; Cohan, P; Berman, N; Swerdloff, R; Wang, C			Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; aneurysmal subarachnoid hemorrhage; hypopituitarism; growth hormone deficiency; cerebral swelling	SEVERE HEAD-INJURY; GROWTH-HORMONE DEFICIENCY; CLINICAL RESEARCH-CENTER; PITUITARY-STALK RUPTURE; RECOMBINANT HUMAN GH; QUALITY-OF-LIFE; COMA DATA-BANK; HYPOGONADAL MEN; REPLACEMENT THERAPY; DIABETES-INSIPIDUS	Object. Recognition of pituitary hormonal insufficiencies after head injury and aneurysmal subarachnoid hemorrhage (SAH) may be important, especially given that hypopituitarism-related neurobehavioral problems are typically alleviated by hormone replacement. In this prospective study the authors sought to determine the rate and risk factors of pituitary dysfunction after head injury and SAH in patients at least 3 months after insult. Methods. Patients underwent dynamic anterior and posterior pituitary function testing. Results of the tests were compared with those of 18 age-, sex-, and body mass index-matched healthy volunteers. The 22 head-injured patients included 18 men and four women (mean age 28 +/- 10 years at the time of injury) with initial Glasgow Coma Scale (GCS) scores of 3 to 15. Eight patients (36.4%) had a subnormal response in at least one hormonal axis. Four were growth hormone (GH) deficient. Five patients (four men, all with normal testosterone levels, and one woman with a low estradiol level) exhibited an inadequate gonadotroph response. One patient had both GH and thyrotroph deficiency and another had both GH deficiency and borderline cortisol deficiency. At the time of injury, all eight patients with pituitary dysfunction had an initial GCS score of 10 or less and, compared with the 14 patients without dysfunction, were more likely to have had diffuse swelling, seen on initial computerized tomography scans (p < 0.05), and to have sustained a hypotensive or hypoxic insult (p = 0.07). Of two patients with SAH who were studied (Hunt and Hess Grade IV) both had GH deficiency. Conclusions. From this preliminary study, some degree of hypopituitarism appears to occur in approximately 40% of patients with moderate or severe head injury, with GH and gonadotroph deficiencies being most common. A high degree of injury severity and secondary cerebral insults are Likely risk factors for hypopituitarism. Pituitary dysfunction also occurs in patients with poor-grade aneurysms. Postacute pituitary function testing may be warranted in most patients with moderate or severe head injury, particularly those with diffuse brain swelling and those sustaining hypotensive or hypoxic insults. The neurobehavioral effects of GH replacement in patients suffering from head injury or SAH warrant further study.	Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Div Endocrinol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Harbor Med Ctr, Div Neurosurg, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Harbor Med Ctr, Div Endocrinol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Harbor Med Ctr, Dept Pediat, Los Angeles, CA 90024 USA; Res & Educ Inst, Los Angeles, CA USA	Kelly, DF (corresponding author), Univ Calif Los Angeles, Div Neurosurg, Box 957039,Room 18-218 NPI, Los Angeles, CA 90095 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000425] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 00425] Funding Source: Medline		Abboud Charles F., 1995, P341; ADAMS JH, 1966, J NEUROL NEUROSUR PS, V29, P545, DOI 10.1136/jnnp.29.6.545; Alexander GM, 1998, HORM BEHAV, V33, P85, DOI 10.1006/hbeh.1998.1439; Asa Sylvia L., 1995, P3; BASAVARAJU N, 1989, J AM GERIATR SOC, V37, P49, DOI 10.1111/j.1532-5415.1989.tb01568.x; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Burman P, 1996, CLIN ENDOCRINOL, V44, P319, DOI 10.1046/j.1365-2265.1996.617439.x; Ceballos R, 1966, Ala J Med Sci, V3, P185; Costa MM, 1999, BIOL PSYCHIAT, V46, P182, DOI 10.1016/S0006-3223(98)00355-2; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; DANIEL PM, 1959, LANCET, V2, P927; DANIEL PM, 1961, MOD TRENDS ENDOCRINO, V2, P55; Deijen J. B., 1999, Journal of Endocrinological Investigation, V22, P127; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Della Corte F, 1998, CRIT CARE MED, V26, P1419; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; DESANTIS A, 1989, J NEUROL NEUROSUR PS, V52, P1135, DOI 10.1136/jnnp.52.10.1135; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; EDWARDS OM, 1986, MEDICINE, V65, P281; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FERNANDEZREAL JM, 1994, CLIN INVESTIGATOR, V72, P302; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GIRARD J, 1977, J PEDIATR-US, V90, P241, DOI 10.1016/S0022-3476(77)80637-9; Giusti M, 1998, EUR J CLIN INVEST, V28, P13; GORCZYCA W, 1987, NEUROSURGERY, V20, P369, DOI 10.1227/00006123-198703000-00003; GUZMAN AL, 1992, ACTA PAEDIATR, V81, P698, DOI 10.1111/j.1651-2227.1992.tb12337.x; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HALIMI P, 1988, J COMPUT ASSIST TOMO, V12, P135, DOI 10.1097/00004728-198801000-00026; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1992, ACTA NEUROCHIR, V116, P6, DOI 10.1007/BF01541247; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Jacobs DM, 1998, NEUROLOGY, V50, P368, DOI 10.1212/WNL.50.2.368; JENNETT B, 1975, LANCET, V1, P480; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; KAISER FE, 1988, J AM GERIATR SOC, V36, P511, DOI 10.1111/j.1532-5415.1988.tb04021.x; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LITTLEY MD, 1989, Q J MED, V70, P145; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; Mavaddat N, 1999, J NEUROSURG, V91, P402, DOI 10.3171/jns.1999.91.3.0402; MCGAULEY GA, 1990, HORM RES, V33, P52, DOI 10.1159/000181584; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; Murray RD, 1999, CLIN ENDOCRINOL, V50, P749; NASS R, 1995, J CLIN ENDOCR METAB, V80, P52; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROLIH CA, 1993, ENDOCRIN METAB CLIN, V22, P291, DOI 10.1016/S0889-8529(18)30167-1; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SHEEHAN HL, 1961, ACTA ENDOCRINOL-COP, V37, P479, DOI 10.1530/acta.0.0370479; Soares CDN, 1999, ARQ NEURO-PSIQUIAT, V57, P182; SWERDLOFF RS, 1993, EXP GERONTOL, V28, P435, DOI 10.1016/0531-5565(93)90069-P; TEASDALE G, 1974, LANCET, V2, P81; TIDSWELL P, 1995, NEUROLOGY, V45, P875; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3654, DOI 10.1210/jc.81.10.3654; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578	68	298	310	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	2000	93	5					743	752		10.3171/jns.2000.93.5.0743			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	366YL	WOS:000090033800003	11059653				2021-06-18	
J	Oz, G; Alger, JR; Barker, PB; Bartha, R; Bizzi, A; Boesch, C; Bolan, PJ; Brindle, KM; Cudalbu, C; Dincer, A; Dydak, U; Emir, UE; Frahm, J; Gonzalez, RG; Gruber, S; Gruetter, R; Gupta, RK; Heerschap, A; Henning, A; Hetherington, HP; Howe, FA; Huppi, PS; Hurd, RE; Kantarci, K; Klomp, DWJ; Kreis, R; Kruiskamp, MJ; Leach, MO; Lin, AP; Luijten, PR; Marjanska, M; Maudsley, AA; Meyerhoff, DJ; Mountford, CE; Nelson, SJ; Pamir, MN; Pan, JW; Peet, AC; Poptani, H; Posse, S; Pouwels, PJW; Ratai, EM; Ross, BD; Scheenen, TWJ; Schuster, C; Smith, ICP; Soher, BJ; Tkac, I; Vigneron, DB; Kauppinen, RA				OZ, Gulin; Alger, Jeffry R.; Barker, Peter B.; Bartha, Robert; Bizzi, Alberto; Boesch, Chris; Bolan, Patrick J.; Brindle, Kevin M.; Cudalbu, Cristina; Dincer, Alp; Dydak, Ulrike; Emir, Uzay E.; Frahm, Jens; Gonzalez, Ramon Gilberto; Gruber, Stephan; Gruetter, Rolf; Gupta, Rakesh K.; Heerschap, Arend; Henning, Anke; Hetherington, Hoby P.; Howe, Franklyn A.; Hueppi, Petra S.; Hurd, Ralph E.; Kantarci, Kejal; Klomp, Dennis W. J.; Kreis, Roland; Kruiskamp, Marijn J.; Leach, Martin O.; Lin, Alexander P.; Luijten, Peter R.; Marjanska, Malgorzata; Maudsley, Andrew A.; Meyerhoff, Dieter J.; Mountford, Carolyn E.; Nelson, Sarah J.; Pamir, M. Necmettin; Pan, Jullie W.; Peet, Andrew C.; Poptani, Harish; Posse, Stefan; Pouwels, Petra J. W.; Ratai, Eva-Maria; Ross, Brian D.; Scheenen, Tom W. J.; Schuster, Christian; Smith, Ian C. P.; Soher, Brian J.; Tkac, Ivan; Vigneron, Daniel B.; Kauppinen, Risto A.		MRS Consensus Grp	Clinical Proton MR Spectroscopy in Central Nervous System Disorders	RADIOLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; LOCALIZED H-1-NMR SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; BRAIN N-ACETYLASPARTATE; WHITE-MATTER DISORDERS; T-2 RELAXATION-TIMES; IN-VIVO; MULTIPLE-SCLEROSIS; SHORT-ECHO; H-1 MRS	A large body of published work shows that proton (hydrogen 1 [H-1]) magnetic resonance (MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality. Herein, the authors present a summary of brain disorders in which MR spectroscopy has an impact on patient management, together with a critical consideration of common data acquisition and processing procedures. The article documents the impact of 1H MR spectroscopy in the clinical evaluation of disorders of the central nervous system. The clinical usefulness of 1H MR spectroscopy has been established for brain neoplasms, neonatal and pediatric disorders (hypoxia-ischemia, inherited metabolic diseases, and traumatic brain injury), demyelinating disorders, and infectious brain lesions. The growing list of disorders for which 1H MR spectroscopy may contribute to patient management extends to neurodegenerative diseases, epilepsy, and stroke. To facilitate expanded clinical acceptance and standardization of MR spectroscopy methodology, guidelines are provided for data acquisition and analysis, quality assessment, and interpretation. Finally, the authors offer recommendations to expedite the use of robust MR spectroscopy methodology in the clinical setting, including incorporation of technical advances on clinical units. (c) RSNA, 2014	[OZ, Gulin; Bolan, Patrick J.; Marjanska, Malgorzata; Tkac, Ivan] Univ Minnesota, Ctr Magnet Resonance Res, 2021 6th St SE, Minneapolis, MN 55455 USA; [Alger, Jeffry R.] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA 90024 USA; [Barker, Peter B.] Johns Hopkins Univ, Dept Radiol, Sch Med, Baltimore, MD 21218 USA; [Bartha, Robert] Univ Western Ontario, Robarts Res Inst, London, ON N6A 3K7, Canada; [Bizzi, Alberto] Inst Clin Humanitas IRCCS, Neuroradiol Unit, Milan, Italy; [Boesch, Chris; Kreis, Roland] Univ Bern, Dept Radiol, CH-3012 Bern, Switzerland; [Boesch, Chris; Kreis, Roland] Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland; [Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England; [Cudalbu, Cristina; Gruetter, Rolf] Ecole Polytech Fed Lausanne, CIBM, LIFMET, Lausanne, Switzerland; [Dincer, Alp; Pamir, M. Necmettin] Acibadem Univ, Sch Med, Istanbul, Turkey; [Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Emir, Uzay E.] John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Oxford, England; [Frahm, Jens] Max Planck Inst Biophys Chem, Biomed NMR Forschungs GmbH, Gottingen, Germany; [Gonzalez, Ramon Gilberto; Ratai, Eva-Maria] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Gruber, Stephan] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Gupta, Rakesh K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Radiol, Lucknow, Uttar Pradesh, India; [Heerschap, Arend; Scheenen, Tom W. J.] Radboud Univ Nijmegen, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Henning, Anke] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Henning, Anke] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Hetherington, Hoby P.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Howe, Franklyn A.] St George Univ London, Clin Sci, London WC1E 7HU, England; [Hueppi, Petra S.] Univ Geneva, Dept Pediat, CH-1211 Geneva 4, Switzerland; [Hurd, Ralph E.] Gen Elect Healthcare, Menlo Pk, CA USA; [Kantarci, Kejal] Mayo Clin, Dept Radiol, Rochester, MI USA; [Klomp, Dennis W. J.; Luijten, Peter R.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Kruiskamp, Marijn J.] Philips Healthcare, Best, Netherlands; [Leach, Martin O.] Univ London, Inst Canc Res, EPSRC Canc Imaging Ctr, Sutton, Surrey, England; [Leach, Martin O.] Univ London, Inst Canc Res, CR UK, Sutton, Surrey, England; [Lin, Alexander P.; Mountford, Carolyn E.] Harvard Univ Med Sch, Brigham & Womens Hosp, Ctr Clin Spectroscopy, Ctr MR Hlth, Boston, MA USA; [Maudsley, Andrew A.] Miami Univ, Dept Radiol, Miami, FL USA; [Meyerhoff, Dieter J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Meyerhoff, Dieter J.] Univ Calif San Francisco, DVA Med Ctr, San Francisco, CA 94143 USA; [Mountford, Carolyn E.] Univ Newcastle, Ctr MR Hlth, Newcastle, NSW, Australia; [Nelson, Sarah J.; Vigneron, Daniel B.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Pan, Jullie W.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Peet, Andrew C.] Univ Birmingham, Dept Canc Sci, Birmingham B15 2TT, W Midlands, England; [Poptani, Harish] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Posse, Stefan] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Pouwels, Petra J. W.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Ross, Brian D.] Huntington Med Res Ctr, Pasadena, CA USA; [Schuster, Christian] Siemens Healthcare, Erlangen, Germany; [Smith, Ian C. P.] Innovat Biodiagnost, Winnipeg, MB, Canada; [Soher, Brian J.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Kauppinen, Risto A.] Univ Bristol, Clin Res & Imaging Ctr, Bristol BS8 1TH, Avon, England; [Kauppinen, Risto A.] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TH, Avon, England	Oz, G (corresponding author), Univ Minnesota, Ctr Magnet Resonance Res, 2021 6th St SE, Minneapolis, MN 55455 USA.	gulin@cmrr.umn.edu	Bartha, Robert/K-3611-2013; Huppi, Petra S/A-4079-2009; Gruetter, Rolf/H-6260-2011; Mountford, Carolyn E/N-2007-2013; Tkac, Ivan/A-6742-2008; Scheenen, Tom W.J./I-5921-2013; Howe, Franklyn A/C-3307-2008; Heerschap, Arend/G-5228-2010; leach, martin o/C-2248-2008; Emir, Uzay/ABB-9979-2020; Dincer, Alp/D-3658-2015; Tkac, Ivan/AAO-8881-2020; Oz, Gulin/L-1306-2016; Boesch, Chris/F-2577-2010; Kreis, Roland/F-2550-2010; Bizzi, Alberto/K-3141-2016; Huppi, Petra/A-4079-2009; meyerhoff, dieter/A-7659-2017	Bartha, Robert/0000-0002-7118-9096; Huppi, Petra S/0000-0002-7383-6648; Gruetter, Rolf/0000-0003-1870-4025; Mountford, Carolyn E/0000-0002-3870-4658; Tkac, Ivan/0000-0001-5054-0150; leach, martin o/0000-0002-0756-5368; Dincer, Alp/0000-0001-9158-8353; Tkac, Ivan/0000-0001-5054-0150; Oz, Gulin/0000-0002-5769-183X; Boesch, Chris/0000-0001-8498-8543; Kreis, Roland/0000-0002-8618-6875; Bizzi, Alberto/0000-0002-0253-5274; Howe, Franklyn/0000-0002-7135-3351; Ratai, Eva-Maria/0000-0001-9476-6207; Kantarci, Kejal/0000-0002-8001-2081; Huppi, Petra/0000-0002-7063-4215; Bolan, Patrick/0000-0002-4194-3975; Soher, Brian/0000-0003-2750-7277; Peet, Andrew/0000-0002-4846-5152; Maudsley, Andrew/0000-0001-7653-3063; Poptani, Harish/0000-0002-0593-3235; Henning, Anke/0000-0002-2267-4861; Pamir, M Necmettin/0000-0002-5958-8625; Cudalbu, Cristina/0000-0003-4582-2465; emir, uzay/0000-0001-5376-0431; Marjanska, Malgorzata/0000-0002-4727-2447; meyerhoff, dieter/0000-0002-2433-7826	Swiss National FoundationSwiss National Science Foundation (SNSF) [320030_135743]; Centre d'Imagerie Biomedicale (CIBM) of the University of Lausanne (UNIL); University de Geneva (UNIGE); University of Geneva Hospitals (HUG); Centre Hospitalier Universitaire Vaudois (CHUV); Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards Foundation; Louis-Jeantet Foundations; CR-UKCancer Research UK; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Department of Health (England) [C1060/A10334]; National Health Service (NHS); Cancer Research UKCancer Research UK [17242, 16465, 16464, 10342] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701533] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-02-12-019, NF-SI-0512-10162] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS076408] Funding Source: NIH RePORTER	Supported in part by the Swiss National Foundation (320030_135743), Centre d'Imagerie Biomedicale (CIBM) of the University of Lausanne (UNIL), University de Geneva (UNIGE), University of Geneva Hospitals (HUG), Centre Hospitalier Universitaire Vaudois (CHUV), Ecole Polytechnique Federale de Lausanne (EPFL), Leenaards Foundation, and Louis-Jeantet Foundations. The Cancer Research UK (CR-UK) and Engineering and Physical Sciences Research Council (EPSRC) Cancer Imaging Centre received support from the CR-UK, EPSRC, Medical Research Council (MRC) and the Department of Health (England) Grant C1060/A10334; the National Institute for Health Research (NIHR) Biomedical Research Centre received funding from the National Health Service (NHS).	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Adalsteinsson E, 2000, LANCET, V355, P1696, DOI 10.1016/S0140-6736(00)02246-7; Agarwal M, 2004, NEURORADIOLOGY, V46, P211, DOI 10.1007/s00234-003-1149-z; Al-Okaili RN, 2007, RADIOLOGY, V243, P539, DOI 10.1148/radiol.2432060493; ARNOLD DL, 1990, MAGNET RESON MED, V14, P154, DOI 10.1002/mrm.1910140115; AUSTIN SJ, 1991, MAGNET RESON MED, V19, P439, DOI 10.1002/mrm.1910190235; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bartha R, 2008, PROG NEURO-PSYCHOPH, V32, P786, DOI 10.1016/j.pnpbp.2007.12.011; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Bizzi A, 2008, AM J NEURORADIOL, V29, P1270, DOI 10.3174/ajnr.A1106; Bizzi A, 2002, ANN NEUROL, V52, P227, DOI 10.1002/ana.10246; Bizzi A, 2001, AM J NEURORADIOL, V22, P1125; Bluml S, 2011, NEURO-ONCOLOGY, V13, P1107, DOI 10.1093/neuonc/nor087; BOTTOMLEY P, 1984, Patent No. 4480228; BOTTOMLEY PA, 1991, RADIOLOGY, V181, P344, DOI 10.1148/radiology.181.2.1924769; BRUHN H, 1989, MAGNET RESON MED, V9, P126, DOI 10.1002/mrm.1910090115; BRUHN H, 1989, RADIOLOGY, V172, P541, DOI 10.1148/radiology.172.2.2748837; BRUHN H, 1992, J COMPUT ASSIST TOMO, V16, P335, DOI 10.1097/00004728-199205000-00001; Capizzano AA, 2001, RADIOLOGY, V218, P144, DOI 10.1148/radiology.218.1.r01ja48144; Cartier N, 2008, CURR OPIN MOL THER, V10, P471; Chang KH, 1998, AM J NEURORADIOL, V19, P401; Chang SM, 2009, J NEURO-ONCOL, V92, P401, DOI 10.1007/s11060-009-9845-0; Chawla S, 2010, J COMPUT ASSIST TOMO, V34, P836, DOI 10.1097/RCT.0b013e3181ec554e; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; CONNELLY A, 1994, NEUROLOGY, V44, P1411, DOI 10.1212/WNL.44.8.1411; Crawford FW, 2009, J NEURO-ONCOL, V91, P337, DOI 10.1007/s11060-008-9719-x; Cross JH, 1996, ANN NEUROL, V39, P107, DOI 10.1002/ana.410390116; Dali CI, 2010, NEUROLOGY, V75, P1896, DOI 10.1212/WNL.0b013e3181feb217; DAVIE CA, 1993, LANCET, V341, P630, DOI 10.1016/0140-6736(93)90390-3; Davies NP, 2010, NMR BIOMED, V23, P80, DOI 10.1002/nbm.1432; Davison JE, 2010, J INHERIT METAB DIS, V33, pS395, DOI 10.1007/s10545-010-9197-0; Davison JE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-19; de Graaf RA., 2007, IN VIVO NMR SPECTROS; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; de Kamp JMV, 2012, J INHERIT METAB DIS, V35, P141, DOI 10.1007/s10545-011-9345-1; De Stefano N, 2007, NEUROLOGY, V69, P1942, DOI 10.1212/01.wnl.0000291557.62706.d3; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Deelchand DK, 2010, J MAGN RESON, V206, P74, DOI 10.1016/j.jmr.2010.06.006; Del Felice A, 2010, EPILEPSIA, V51, P37, DOI 10.1111/j.1528-1167.2009.02141.x; DETRE JA, 1991, ANN NEUROL, V29, P218, DOI 10.1002/ana.410290219; Ding XQ, 2012, AM J MED GENET A, V158A, P257, DOI 10.1002/ajmg.a.34389; Eichler F, 2009, AM J NEURORADIOL, V30, P1893, DOI 10.3174/ajnr.A1739; Eichler FS, 2002, NEUROLOGY, V58, P901, DOI 10.1212/WNL.58.6.901; Einstein DB, 2012, INT J RADIAT ONCOL, V84, P668, DOI 10.1016/j.ijrobp.2012.01.020; Emir UE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030918; Engelke U.F.H., 2007, HDB 1H NMR SPECTROSC; Englot DJ, 2012, J NEUROSURG, V116, P1042, DOI 10.3171/2012.1.JNS111620; Fein G, 2000, ALCOHOL CLIN EXP RES, V24, P1227, DOI 10.1111/j.1530-0277.2000.tb02088.x; Fink JR, 2012, J MAGN RESON IMAGING, V35, P56, DOI 10.1002/jmri.22801; Florian CL, 1995, NMR BIOMED, V8, P253, DOI 10.1002/nbm.1940080605; Fountas KN, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11327; FRAHM J, 1987, J MAGN RESON, V72, P502, DOI 10.1016/0022-2364(87)90154-5; FRAHM J, 1989, MAGNET RESON MED, V11, P47, DOI 10.1002/mrm.1910110105; FRAHM J, 1997, MAGNETIC RESONANCE S, P329; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Garcia-Gomez JM, 2009, MAGN RESON MATER PHY, V22, P5, DOI 10.1007/s10334-008-0146-y; Gasparovic C, 2011, MAGN RESON MED, V66, P324, DOI 10.1002/mrm.22858; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; GILL SS, 1990, J COMPUT ASSIST TOMO, V14, P497, DOI 10.1097/00004728-199007000-00001; Godbolt AK, 2006, NEUROLOGY, V66, P718, DOI 10.1212/01.wnl.0000201237.05869.df; Gonzalez RG, 2012, J MAGN RESON IMAGING, V36, P259, DOI 10.1002/jmri.23595; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2009, INT REV NEUROBIOL, V84, P105, DOI [10.1016/S0074-7742(09)00406-I, 10.1016/S0074-7742(09)00406-1]; GROENENDAAL F, 1994, PEDIATR RES, V35, P148, DOI 10.1203/00006450-199402000-00004; Gruetter R, 1998, J MAGN RESON, V135, P260, DOI 10.1006/jmre.1998.1542; Gu M, 2008, MAGN RESON MED, V60, P542, DOI 10.1002/mrm.21713; Gupta RK, 2010, CLIN MR NEUROIMAGING, P426; Hammen T, 2005, NMR BIOMED, V18, P195, DOI 10.1002/nbm.958; HANEFELD F, 1991, BRAIN DEV-JPN, V13, P410, DOI 10.1016/S0387-7604(12)80038-6; Hannoun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032525; Hanrahan JD, 1998, PEDIATR RES, V44, P304, DOI 10.1203/00006450-199809000-00007; HEINDEL W, 1993, AM J NEURORADIOL, V14, P629; Hock A, 2013, AM J NEURORADIOL, V34, P1682, DOI 10.3174/ajnr.A3342; Hofmann L, 2002, MAGNET RESON MED, V48, P440, DOI 10.1002/mrm.10246; Hourani R, 2008, AM J NEURORADIOL, V29, P366, DOI 10.3174/ajnr.A0810; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; HUPPI PS, 1991, PEDIATR RES, V30, P574; Julia-Sape M, 2012, NMR BIOMED, V25, P661, DOI 10.1002/nbm.1782; Kallenberg K, 2009, RADIOLOGY, V253, P805, DOI 10.1148/radiol.2533071654; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kantarci K, 2010, NEUROLOGY, V75, P771, DOI 10.1212/WNL.0b013e3181f073c7; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Klijn CJM, 2000, STROKE, V31, P3001, DOI 10.1161/01.STR.31.12.3001; Kovanlikaya A, 2005, RADIOLOGY, V236, P1020, DOI 10.1148/radiol.2363040856; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; KRUSE B, 1993, J NEUROL, V241, P68, DOI 10.1007/BF00869766; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lange T, 2006, AM J NEURORADIOL, V27, P895; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Law M, 2003, AM J NEURORADIOL, V24, P1989; Li BSY, 2002, MAGNET RESON MED, V47, P439, DOI 10.1002/mrm.10081; Licata SC, 2010, ANN NY ACAD SCI, V1187, P148, DOI 10.1111/j.1749-6632.2009.05143.x; Lin AP, 2006, NMR BIOMED, V19, P476, DOI 10.1002/nbm.1058; Lodygensky GA, 2013, NEUROLOGY NEONATOLOG; Manley BJ, 2010, PEDIATR NEUROL, V42, P219, DOI 10.1016/j.pediatrneurol.2009.10.013; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Martin E, 2001, ANN NEUROL, V49, P518, DOI 10.1002/ana.102.abs; Matsusue E, 2010, NEURORADIOLOGY, V52, P297, DOI 10.1007/s00234-009-0613-9; Maudsley AA, 2010, EPILEPSY RES, V88, P127, DOI 10.1016/j.eplepsyres.2009.10.009; McKnight TR, 2007, J NEUROSURG, V106, P660, DOI 10.3171/jns.2007.106.4.660; Mekle R, 2009, MAGN RESON MED, V61, P1279, DOI 10.1002/mrm.21961; Mercimek-Mahmutoglu S, GENEREVIEWS; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; MILLER BL, 1993, RADIOLOGY, V187, P433, DOI 10.1148/radiology.187.2.8475286; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; Murphy PS, 2004, BRIT J CANCER, V90, P781, DOI 10.1038/sj.bjc.6601593; Murphy PS, 2003, BRIT J RADIOL, V76, P459, DOI 10.1259/bjr/16316438; Ndika JDT, 2012, MOL GENET METAB, V106, P48, DOI 10.1016/j.ymgme.2012.01.017; Oakden WK, 2005, J COMPUT ASSIST TOMO, V29, P136, DOI 10.1097/01.rct.0000145860.13963.2f; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; Oz G, 2011, MAGN RESON MED, V65, P901, DOI 10.1002/mrm.22708; Ohlenbusch A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-69; Opstad KS, 2007, NMR BIOMED, V20, P763, DOI 10.1002/nbm.1147; Ordidge R., 1985, MAGNETIC RESONANCE B, P387; Otazo R, 2006, MAGN RESON MED, V56, P1200, DOI 10.1002/mrm.21067; Oz G, 2005, NEUROLOGY, V64, P434, DOI 10.1212/01.WNL.0000150906.52208.E7; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Pamir MN, 2010, J NEUROSURG, V112, P57, DOI 10.3171/2009.3.JNS081139; Pan JW, 2013, MAGN RESON MED, V69, P310, DOI 10.1002/mrm.24283; Pan JW, 2010, MAGN RESON MED, V64, P1237, DOI 10.1002/mrm.22534; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; PEELING J, 1992, MAGNET RESON MED, V24, P123, DOI 10.1002/mrm.1910240113; Penner J, 2010, PROG NEURO-PSYCHOPH, V34, P104, DOI 10.1016/j.pnpbp.2009.10.007; PETROFF OAC, 1992, NEUROLOGY, V42, P1349, DOI 10.1212/WNL.42.7.1349; POPTANI H, 1995, AM J NEURORADIOL, V16, P1593; Pouwels PJW, 1998, NEUROPEDIATRICS, V29, P254, DOI 10.1055/s-2007-973571; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; Prat R, 2010, J CLIN NEUROSCI, V17, P50, DOI 10.1016/j.jocn.2009.02.035; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; RICHARDS TL, 1991, AM J ROENTGENOL, V157, P1073, DOI 10.2214/ajr.157.5.1927795; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Ross BD, 1998, NEUROIMAG CLIN N AM, V8, P809; Rupsingh R, 2011, NEUROBIOL AGING, V32, P802, DOI 10.1016/j.neurobiolaging.2009.05.002; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Saunders DE, 2000, BRIT MED BULL, V56, P334, DOI 10.1258/0007142001903256; Scheenen TWJ, 2008, MAGN RESON MATER PHY, V21, P95, DOI 10.1007/s10334-007-0094-y; Scheenen TWJ, 2008, MAGN RESON MED, V59, P1, DOI 10.1002/mrm.21302; Scheidegger O, 2013, MAGN RESON MED, V70, P25, DOI 10.1002/mrm.24455; Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L; Siesj_o B K, 1978, BRAIN ENERGY METABOL; Simister RJ, 2009, EPILEPSY RES, V83, P168, DOI 10.1016/j.eplepsyres.2008.11.006; Smith Ian C P, 2011, Biophys Rev, V3, P47, DOI 10.1007/s12551-011-0045-8; Soher B.J., 2011, PROC, V19, P1410; Somorjai R L, 2009, Biophys Rev, V1, P201, DOI 10.1007/s12551-009-0023-6; Stadlbauer A, 2004, NEUROIMAGE, V23, P454, DOI 10.1016/j.neuroimage.2004.06.022; Steffen-Smith EA, 2011, J NEURO-ONCOL, V105, P365, DOI 10.1007/s11060-011-0601-x; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; Sturrock A, 2010, NEUROLOGY, V75, P1702, DOI 10.1212/WNL.0b013e3181fc27e4; TALLAN HH, 1957, J BIOL CHEM, V224, P41; Tartaglia MC, 2002, J NEUROL, V249, P1382, DOI 10.1007/s00415-002-0846-6; Tate AR, 2006, NMR BIOMED, V19, P411, DOI 10.1002/nbm.1016; Terpstra M, 2012, P 20 M INT SOC MAGN, P1739; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Unschuld PG, 2012, MOVEMENT DISORD, V27, P895, DOI 10.1002/mds.25010; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; Van der Knaap M.S., 2005, MAGNETIC RESONANCE M, P859; van der Voorn JP, 2006, RADIOLOGY, V241, P510, DOI 10.1148/radiol.2412051345; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; VANDERTOORN A, 1994, MAGNET RESON MED, V32, P685, DOI 10.1002/mrm.1910320602; Vicente J, 2013, EUR J CANCER, V49, P658, DOI 10.1016/j.ejca.2012.09.003; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; Wardlaw JM, 1998, STROKE, V29, P1618, DOI 10.1161/01.STR.29.8.1618; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wiebe S, 2012, CURR OPIN NEUROL, V25, P187, DOI 10.1097/WCO.0b013e328350baa6; Wijnen JP, 2012, J MAGN RESON IMAGING, V36, P1072, DOI 10.1002/jmri.23737; Wijnen JR, 2010, J MAGN RESON IMAGING, V31, P61, DOI 10.1002/jmri.21999; Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500; Wilken B, 2003, NEUROPEDIATRICS, V34, P237; Willmann O, 2006, EPILEPSY RES, V71, P149, DOI 10.1016/j.eplepsyres.2006.06.004; Wilson M, 2013, EUR J CANCER, V49, P457, DOI 10.1016/j.ejca.2012.09.002; Zand DJ, 2003, AM J NEURORADIOL, V24, P1471	177	297	304	1	91	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAR	2014	270	3					658	679		10.1148/radiol.13130531			22	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AG0WQ	WOS:000335136800005	24568703	Green Published	Y	N	2021-06-18	
J	Zhuang, SG; Schnellmann, RG				Zhuang, Shougang; Schnellmann, Rick G.			A death-promoting role for extracellular signal-regulated kinase	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED CELL-DEATH; CISPLATIN-INDUCED APOPTOSIS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; ERK ACTIVATION; DEPENDENT ACTIVATION; EPITHELIAL-CELLS; MAP KINASE; IN-VIVO	Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), which are members of the mitogen-activated protein kinase superfamily, have been well characterized and are known to be involved in cell survival; however, recent evidence suggests that the activation of ERK1/2 also contributes to cell death in some cell types and organs under certain conditions. For example, ERK1/2 is activated in neuronal and renal epithelial cells upon exposure to oxidative stress and toxicants and deprivation of growth factors, and inhibition of the ERK pathway blocks apoptosis. ERK activation also occurs in animal models of ischemia- and trauma-induced brain injury and cisplatin-induced renal injury, and inactivation of ERK reduces the extent of tissue damage. In some studies, ERK has been implicated in apoptotic events upstream of mitochondrial cytochrome c release, whereas other studies have suggested the converse that ERK acts downstream of mitochondrial events and upstream of caspase-3 activation. ERK also can contribute to cell death through the suppression of the antiapoptotic signaling molecule Akt. Here we summarize the evidence and mechanism of ERK-induced apoptosis in both cell culture and in animal models.	Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	Schnellmann, RG (corresponding author), Med Univ S Carolina, Dept Pharmaceut Sci, 280 Calhoun St,POB 250140, Charleston, SC 29425 USA.	schnell@musc.edu					Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Brown L, 2006, J BIOL CHEM, V281, P3832, DOI 10.1074/jbc.M507951200; Cagnol S, 2006, APOPTOSIS, V11, P337, DOI 10.1007/s10495-006-4065-y; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chen J, 2001, TOXICOL APPL PHARM, V171, P1, DOI 10.1006/taap.2000.9105; Chen M, 2004, J INFECT DIS, V190, P127, DOI 10.1086/421243; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; COLUMBANO A, 1995, J CELL BIOCHEM, V58, P181, DOI 10.1002/jcb.240580207; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195; Dong J, 2004, AM J PHYSIOL-RENAL, V287, pF1049, DOI 10.1152/ajprenal.00132.2004; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Harriman JF, 2002, CELL DEATH DIFFER, V9, P734, DOI 10.1038/sj.cdd.4401029; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kim GS, 2003, J BIOL CHEM, V278, P21920, DOI 10.1074/jbc.M204598200; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kohda Y, 2005, BIOCHEM PHARMACOL, V70, P1408, DOI 10.1016/j.bcp.2005.08.002; Kohda Y, 2003, TOXICOL LETT, V143, P185, DOI 10.1016/S0378-4274(03)00174-7; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Lee KM, 2005, APPL PHYS A-MATER, V80, P337, DOI 10.1007/s00339-003-2217-2; Lee SR, 2003, STROKE, V34, P2704, DOI 10.1161/01.STR.0000096540.40826.BA; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; MAGNUSON NS, 1994, SEMIN CANCER BIOL, V5, P247; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsunaga Yoshiko, 2005, Journal of Toxicological Sciences, V30, P135, DOI 10.2131/jts.30.135; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miyajima A, 1997, BRIT J CANCER, V76, P206, DOI 10.1038/bjc.1997.363; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Park BG, 2005, TOXICOLOGY, V215, P115, DOI 10.1016/j.tox.2005.07.003; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Ramachandiran S, 2002, CHEM RES TOXICOL, V15, P1635, DOI 10.1021/tx0200663; Rennefahrt U, 2005, CANCER LETT, V217, P1, DOI 10.1016/j.canlet.2004.08.003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Runden E, 1998, J NEUROSCI, V18, P7296; Sasada T, 1996, J CLIN INVEST, V97, P2268, DOI 10.1172/JCI118668; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Slevin M, 2000, NEUROREPORT, V11, P2759, DOI 10.1097/00001756-200008210-00030; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Sturla LM, 2005, CANCER RES, V65, P5683, DOI 10.1158/0008-5472.CAN-04-2283; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Tikoo K, 2001, MOL PHARMACOL, V60, P394; Ulisse S, 2000, CELL DEATH DIFFER, V7, P916, DOI 10.1038/sj.cdd.4400716; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang S, 2004, J TRIBOL-T ASME, V126, P1, DOI 10.1115/1.1609493; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Woessmann W, 2002, CANCER CHEMOTH PHARM, V50, P397, DOI 10.1007/s00280-002-0502-y; Wong JK, 2003, J NEUROSCI, V23, P4984; Wu Z, 2005, CHINESE MED J-PEKING, V118, P671; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	95	297	318	0	13	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC	2006	319	3					991	997		10.1124/jpet.106.107367			7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	105QX	WOS:000242048500001	16801453				2021-06-18	
J	Krain, AL; Castellanos, FX				Krain, Amy L.; Castellanos, F. Xavier			Brain development and ADHD	CLINICAL PSYCHOLOGY REVIEW			English	Article						ADHD; development; brain; magnetic resonance imaging; phenotypes; basal ganglia; cerebellum	DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; BASAL GANGLIA; CAUDATE-NUCLEUS; CORPUS-CALLOSUM; FUNCTIONAL MRI; QUANTITATIVE MORPHOLOGY; MORPHOMETRIC ANALYSIS; LONGITUDINAL MRI	Attention-Deficit/Hyperactiviiy'Disorder (ADHD) is characterized by excessive inattention, hyperactivity, and impulsivity, either alone or in combination. Neuropsychological findings suggest that these behaviors result from underlying deficits in response inhibition, delay aversion, and executive functioning which, in turn, are presumed to be linked to dysfunction of frontal-striatal-cerebellar circuits. Over the past decade, magnetic resonance imaging (MRI) has been used to examine anatomic differences in these regions between ADHD and control children. In addition to quantifying differences in total cerebral volume, specific areas of interest have been prefrontal. regions, basal ganglia, the corpus callosum, and cerebellum. Differences in gray and white matter have also been examined. The ultimate goal of this research is to determine the underlying neurophysiology of ADHD and how specific phenotypes may be related to alterations in brain structure. (c) 2006 Published by Elsevier Ltd.	NYU, Inst Pediat Neurosci, Child Study Ctr, New York, NY 10016 USA	Castellanos, FX (corresponding author), NYU, Inst Pediat Neurosci, Child Study Ctr, 215 Lexington Ave, New York, NY 10016 USA.	Castef01@med.nyu.edu	Castellanos, Francisco Xavier/K-1892-2014	Castellanos, Francisco Xavier/0000-0001-9192-9437			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson CM, 2002, AM J PSYCHIAT, V159, P1322, DOI 10.1176/appi.ajp.159.8.1322; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Aylward EH, 1996, J CHILD NEUROL, V11, P112, DOI 10.1177/088307389601100210; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; BULLMORE E, 1995, PSYCHIAT RES-NEUROIM, V61, P121, DOI 10.1016/0925-4927(95)02618-8; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Castagnino JM, 2004, ACTA BIOQUIM CLIN L, V38, P1; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1292, DOI 10.1016/S0028-3932(00)00026-9; DeLong GR, 2002, NEUROLOGY, V59, P54, DOI 10.1212/WNL.59.1.54; Desmond JE, 1997, J NEUROSCI, V17, P9675; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Durston S, 2003, MENT RETARD DEV D R, V9, P184, DOI 10.1002/mrdd.10079; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Gerring J, 2000, BRAIN INJURY, V14, P205; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; GIEDD JN, 1994, AM J PSYCHIAT, V151, P665; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hill DE, 2003, NEUROPSYCHOLOGY, V17, P496, DOI 10.1037/0894-4105.17.3.496; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; HYND GW, 1993, J CHILD NEUROL, V8, P339, DOI 10.1177/088307389300800409; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Mataro M, 1997, ARCH NEUROL-CHICAGO, V54, P963, DOI 10.1001/archneur.1997.00550200027006; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 1997, BRAIN INJURY, V11, P699; Melchitzky DS, 2000, NEUROPSYCHOPHARMACOL, V22, P466, DOI 10.1016/S0893-133X(99)00139-6; Mostofsky SH, 1998, J CHILD NEUROL, V13, P434, DOI 10.1177/088307389801300904; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pineda DA, 2002, J CHILD NEUROL, V17, P97, DOI 10.1177/088307380201700202; Pontius A A, 1973, J Am Med Womens Assoc (1972), V28, P285; Rao SM, 1997, NEUROREPORT, V8, P1987, DOI 10.1097/00001756-199705260-00038; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; ROSSI JS, 1990, J CONSULT CLIN PSYCH, V58, P646, DOI 10.1037/0022-006X.58.5.646; Schrimsher GW, 2002, J CHILD NEUROL, V17, P877, DOI 10.1177/08830738020170122001; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; SEMRUDCLIKEMAN M, 1994, J AM ACAD CHILD PSY, V33, P875, DOI 10.1097/00004583-199407000-00014; Sharp WS, 1999, J AM ACAD CHILD PSY, V38, P40, DOI 10.1097/00004583-199901000-00018; SHAYWITZ BA, 1983, NEUROLOGY, V33, P1500, DOI 10.1212/WNL.33.11.1500; SINGER HS, 1993, NEUROLOGY, V43, P950, DOI 10.1212/WNL.43.5.950; Solanto M V, 2000, CNS Spectr, V5, P45; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Teicher MH, 2000, NAT MED, V6, P470, DOI 10.1038/74737; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Tracy JI, 2000, NEUROIMAGE, V11, P228, DOI 10.1006/nimg.2000.0535; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; Wilke M, 2003, NEUROREPORT, V14, P1887, DOI 10.1097/00001756-200310270-00001; Yeo RA, 2003, J AM ACAD CHILD PSY, V42, P303, DOI 10.1097/00004583-200303000-00010	69	297	305	2	75	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0272-7358	1873-7811		CLIN PSYCHOL REV	Clin. Psychol. Rev.	AUG	2006	26	4					433	444		10.1016/j.cpr.2006.01.005			12	Psychology, Clinical	Psychology	069XA	WOS:000239481300004	16480802				2021-06-18	
J	Guerra, WKW; Gaab, MR; Dietz, H; Mueller, JU; Piek, J; Fritsch, MJ				Guerra, WKW; Gaab, MR; Dietz, H; Mueller, JU; Piek, J; Fritsch, MJ			Surgical decompression for traumatic brain swelling: indications and results	JOURNAL OF NEUROSURGERY			English	Article						brain trauma; brain edema; decompressive craniectomy; decompression surgery; intracranial pressure; B waves	SEVERE HEAD-INJURIES; RAISED INTRACRANIAL-PRESSURE; CEREBRAL EDEMA; TRANSCRANIAL DOPPLER; BARBITURATE THERAPY; HYPERTENSION; CRANIECTOMY; HYPOTHERMIA; MANAGEMENT; COMA	Object. Decompressive craniectomy has been performed since 1977 in patients with traumatic brain injury. The authors assess the efficacy of this treatment and the indications for its use. Methods. The clinical status of the 57 patients, their computerized tomography (CT) scans, and intracranial pressure (ICP) levels were documented prospectively in a standard protocol. At the beginning of the study, all patients older than 30 years were excluded. As of 1989 patients older than 40 years were excluded until 1991; since that time patients older than 50 years have been excluded. Primary brain or brainstem injury with fully developed bulbar brain syndrome, loss of auditory evoked potentials (AEPs), and/or oscillation flow in a transcranial Doppler ultrasound examination were contraindications to decompressive craniectomy. A positive indication for decompression was given in the case of progressive therapy-resistant intracranial hypertension in correlation with clinical (Glasgow Coma Scale [GCS] score, decerebrate posturing, dilating of pupils) and electrophysiological (electroencephalography, somatosensory evoked potentials, and AEPs) parameters and with findings on CT scans. Unilateral decompressive craniectomy was performed in 31 patients and bilateral craniectomy in 26 patients. In all cases, a wide frontotemporoparietal craniectomy was followed by a dura enlargement covered with temporal muscle fascia. The outcomes of the treatment were surprisingly good. Only 11 patients (19%) died, three of whom died of acute respiratory disease syndrome. Five patients (9%) survived, but remained in a persistent vegetative state; six patients (11%) survived with a severe permanent neurological deficit, and 33 patients (58%) attained social rehabilitation. Two patients (3.5%) did not have a follow-up examination. The GCS score on the 1st day posttrauma and the mean ICP turned out to be the best predictors for a good prognosis. The results demonstrate the importance of decompressive craniectomy in the treatment of traumatic brain swelling. Conclusions. Surgical decompression should be routinely performed when indicated before irreversible ischemic brain damage occurs.	Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Neurochirurg, Dept Neurosurg, D-17487 Greifswald, Germany; Hannover Med Sch, Dept Neurosurg, Hannover, Germany	Guerra, WKW (corresponding author), Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Neurochirurg, Dept Neurosurg, Sauerbruchstr 8, D-17487 Greifswald, Germany.	neurosur@rz.uni-greifswald.de					Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; ALEXANDER RS, 1946, J NEUROPHYSIOL, V9, P205; Baethmann A, 1997, ZBL NEUROCHIR, V58, P20; Bauer KH, 1932, DTSCH Z CHIR, V237, P401; BROWNING JL, 1992, ANESTH ANALG, V74, P643; Burkert W, 1989, Zentralbl Neurochir, V50, P106; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CRONE KR, 1985, NEUROSURGERY, V16, P726; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Da Silva J A, 1976, Arq Neuropsiquiatr, V34, P232; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Droste DW, 1996, ACTA NEUROL SCAND, V94, P347, DOI 10.1111/j.1600-0404.1996.tb07078.x; DROSTE DW, 1994, ACTA NEUROL SCAND, V90, P99; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB M, 1979, CHILD BRAIN, V5, P484; GAAB M R, 1986, Neurological Research, V8, P44; GAAB MR, 1990, ACT NEUR S, V51, P326; GAAB MR, 1981, INTENSIVBEHANDLUNG, V6, P34; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HEPPNER F, 1976, MED WOCHENSCHR, V126, P105; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Horsley V, 1906, BRIT MED J, V1906, P411; Horsley V, 1893, BMJ-BRIT MED J, V2, P1365; JENNETT B, 1975, LANCET, V1, P480; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; KARLEN J, 1987, NEUROCHIRURGIA, V30, P35; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KIRKHAM FJ, 1986, DEV MED CHILD NEUROL, V28, P506; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Kocher T, 1901, HIRNERSCHUTTERUNG HI, P262; MACHLEIDT W, 1980, EEG-EMG-Z ELEK ELEKT, V11, P148; MAEDA M, 1988, Neurological Research, V10, P87; Makino H, 1979, Acta Neurochir Suppl (Wien), V28, P193; MARCOTTE CA, 1886, HEMICRANIECTOMIE TEM; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MELLERGARD P, 1992, J NEUROSURG ANESTH, V4, P85, DOI 10.1097/00008506-199204000-00003; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Newell D W, 1994, Neurosurg Clin N Am, V5, P619; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; PIEK J, 1993, ADV NEUROS, V21, P178; Piek J, 1997, ANASTH INTENSIVMED, V38, P428; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RINALDI A, 1990, ACT NEUR S, V51, P394; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schregel W, 1997, ZBL NEUROCHIR, V58, P43; SEYDEL K, 1886, ANTISEPTIK TREPANATI; Shigemori M, 1979, Acta Neurochir Suppl (Wien), V28, P195; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; Spiss CK, 1997, ANASTH INTENSIVMED, V38, P423; TEASDALE G, 1974, LANCET, V2, P81; Unterberg A, 1997, ANASTH INTENSIVMED, V38, P381; Unterberg A, 1997, ZBL NEUROCHIR, V58, P47; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Werner C, 1997, ANASTH INTENSIVMED, V38, P406; WHITFIELD P, 1995, STROKE, V26, P1125; Wobker G, 1997, ANASTH INTENSIVMED, V38, P410; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	71	297	332	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	1999	90	2					187	196		10.3171/jns.1999.90.2.0187			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	168RU	WOS:000078707100001	9950487				2021-06-18	
J	PONSFORD, J; KINSELLA, G				PONSFORD, J; KINSELLA, G			ATTENTIONAL DEFICITS FOLLOWING CLOSED-HEAD INJURY	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								Aimed to assess, in the light of current attentional theories, the nature of the attentional deficit in a group of severely traumatically head-injured subjects, relative to a group of orthopaedic rehabilitation patients, and to establish which neuropsychological measures best reflected the deficit. Three separate studies were conducted in order to meet these aims. The first study focused on selective attention; the second, on vigilance or sustained attention; the third, on the Supervisory Attentional System. Results provided no evidence for the presence of deficits of focused attention, sustained attention, or supervisory attentional control, but ample evidence for the presence of a deficit in speed of information processing. Those neuropsychological measures shown to be the best measures of this deficit included the Symbol Digit Modalities Test, simple and choice reaction-time tasks, colour naming and word reading scores on the Stroop, and the Paced Auditory Serial Addition Test.	LA TROBE UNIV,BUNDOORA,VIC 3083,AUSTRALIA	PONSFORD, J (corresponding author), BETHESDA HOSP,30 ERIN ST,RICHMOND,VIC 3121,AUSTRALIA.		Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			ANDERSON RP, 1973, EXCEPT CHILDREN, V39, P534; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; COSTA LD, 1962, PERCEPT MOTOR SKILL, V14, P391; FLETCHER JM, 1978, CORTEX, V14, P564, DOI 10.1016/S0010-9452(78)80031-8; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; Luria A. R., 1966, HIGHER CORTICAL FUNC; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miller E, 1970, Cortex, V6, P121; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHALLICE T, 1982, NEUROPSYCHOLOGY COGN, P199; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1973, SYMBOL DIGIT MODALIT; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VONZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21	19	297	302	0	18	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	1992	14	5					822	838		10.1080/01688639208402865			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	JY191	WOS:A1992JY19100013	1474148				2021-06-18	
J	Gorio, A; Gokmen, N; Erbayraktar, S; Yilmaz, O; Madaschi, L; Cichetti, C; Di Giulio, AM; Vardar, E; Cerami, A; Brines, M				Gorio, A; Gokmen, N; Erbayraktar, S; Yilmaz, O; Madaschi, L; Cichetti, C; Di Giulio, AM; Vardar, E; Cerami, A; Brines, M			Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							NF-KAPPA-B; BLOOD-FLOW; RATS; ACTIVATION; RECEPTOR; BRAIN; CONTUSION; OCCLUSION; PROTECTS; NEURONS	Erythropoietin (EPO) functions as a tissue-protective cytokine in addition to its crucial hormonal role in red cell production. In the brain, for example, EPO and its receptor are locally produced, are modulated by metabolic stressors, and provide neuroprotective and antiinflammatory functions. We have previously shown that recombinant human EPO (rhEPO) administered within the systemic circulation enters the brain and is neuroprotective. At present, it is unknown whether rhEPO can also improve recovery after traumatic injury of the spinal cord. To evaluate whether rhEPO improves functional outcome if administered after cord injury, two rodent models were evaluated. First, a moderate compression of 0.6 N was produced by application of an aneursym clip at level T3 for 1 min. RhEPO (1,000 units per kg of body weight i.p.) administered immediately after release of compression was associated with partial recovery of motor function within 12 h after injury, which was nearly complete by 28 days. In contrast, saline-treated animals exhibited only poor recovery. In the second model used, rhEPO administration (5,000 units per kg of body weight i.p. given once 1 h after injury) also produced a superior recovery of function compared with saline-treated controls after a contusion of 1 N at level T9. In this model of more severe spinal cord injury, secondary inflammation was also markedly attenuated by rhEPO administration and associated with reduced cavitation within the cord. These observations suggest that rhEPO provides early recovery of function, especially after spinal cord compression, as well as longer-latency neuroprotective, antiinflammatory and antiapoptotic functions.	Univ Milan, Fac Med, Pharmacol Lab, Dept Med Surg & Odontoiatry, I-20142 Milan, Italy; Dokuz Eylul Univ, Sch Med, TR-35340 Izmir, Turkey; SSK Training Hosp, Dept Pathol, Izmir, Turkey; Kenneth S Warren Inst, Kitchawan, NY 10562 USA	Brines, M (corresponding author), Univ Milan, Fac Med, Pharmacol Lab, Dept Med Surg & Odontoiatry, I-20142 Milan, Italy.		YILMAZ, Osman/V-3632-2019; vardar, enver/AAB-1508-2020; Brinesd, Michael/AAE-6072-2020; Gokmen, Necati/J-9761-2019; Gokmen, Necati/B-1775-2008	Gokmen, Necati/0000-0002-3225-7666; Gokmen, Necati/0000-0002-3225-7666; Brines, Michael/0000-0003-4151-4449; Gokmen, Necati/0000-0003-1835-4133; Di Giulio, Anna Maria/0000-0002-5702-4623			Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bittorf T, 2000, CELL SIGNAL, V12, P23, DOI 10.1016/S0898-6568(99)00063-7; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Bravo G, 2001, LIFE SCI, V68, P1527, DOI 10.1016/S0024-3205(01)00952-3; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; KHAN M, 1983, CAN J NEUROL SCI, V10, P161, DOI 10.1017/S031716710004484X; KHAN M, 1985, CAN J NEUROL SCI, V12, P259, DOI 10.1017/S0317167100047120; Lacombe C, 1999, NEPHROL DIAL TRANSPL, V14, P22, DOI 10.1093/ndt/14.suppl_2.22; Mayorov DN, 2001, J NEUROTRAUM, V18, P727, DOI 10.1089/089771501750357663; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sasaki R, 2000, BIOSCI BIOTECH BIOCH, V64, P1775, DOI 10.1271/bbb.64.1775; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Squadrito F, 1999, BRIT J PHARMACOL, V127, P482, DOI 10.1038/sj.bjp.0702521; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Yoshimura A, 1998, Curr Opin Hematol, V5, P171, DOI 10.1097/00062752-199805000-00004	39	296	337	0	12	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 9	2002	99	14					9450	9455		10.1073/pnas.142287899			6	Multidisciplinary Sciences	Science & Technology - Other Topics	572LE	WOS:000176775400068	12082184	Bronze, Green Published			2021-06-18	
J	Valadka, AB; Gopinath, SP; Contant, CF; Uzura, M; Robertson, CS				Valadka, AB; Gopinath, SP; Contant, CF; Uzura, M; Robertson, CS			Relationship of brain tissue Po-2 to outcome after severe head injury	CRITICAL CARE MEDICINE			English	Article						brain; head injury; human; ischemia; monitoring; outcome; oxygen; survival; threshold; traumatic brain injury	NEUROSURGICAL PATIENTS; OXYGEN; PH; TEMPERATURE; PRESSURE	Objective: To determine thresholds of brain tissue Po-2 (PbtO(2)) that are critical for survival after severe head injury. Design: Prospective data collection. Setting: Neurosurgical intensive care unit of Ben Taub General Hospital, a comprehensive academic neurosurgical facility and Level I trauma center. Patients: Forty-three severely head-injured patients who were not obeying commands on presentation or whose condition deteriorated to this level shortly after admission. Interventions: Intracerebral placement of Licox (n = 39) or Paratrend (n = 4) Po-2 probes during craniotomy or in the intensive care unit. Measurements and Main Results: Pbto(2) monitoring continued for an average of 84.6 +/- 41.8 hrs. The probes were calibrated before insertion according to the manufacturer's specifications. After removal, probes were tested in room air and in blood gas standard calibration solutions. Pbto(2) data were analyzed by comparing the average time that Pbto(2) was below the values of 20, 15, 10, 8, 6, 4, and 2 ton (2.7, 2.0, 1.3, 1.0, 0.8, 0.5, and 0.3 kPa, respectively) in patients who were living 3 mos after injury vs. those who died. A Tobit regression analysis using maximum likelihood methods was utilized. Both Licox and Paratrend probes functioned well in room air and in the Level I control. However, in the zero-oxygen solution, the Paratrend probes gave an average reading of 7.0 +/- 1.4 torr (0.9 +/- 0.2 kPa), compared with 0.3 +/- 0.3 torr (0.04 +/- 0.04 kPa) for the Licox probes. Conclusions: Analysis of the PbtO(2) monitoring data suggested that the likelihood of death increased with increasing duration of time at or below a Pbto(2) of 15 torr (2.0 kPa) or with the occurrence of any Pbto(2) values of less than or equal to 6 torr (less than or equal to 0.8 kPa).	Baylor Coll Med, Dept Neurosurg, Coll Med, Houston, TX 77030 USA	Valadka, AB (corresponding author), Baylor Coll Med, Dept Neurosurg, Coll Med, 6560 Fannin,Suite 944, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hoffman WE, 1997, NEUROSURGERY, V40, P294, DOI 10.1097/00006123-199702000-00012; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MAAS AIR, 1993, INTRACRANIAL PRESSUR, V8, P233; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; Muizelaar JP, 1996, NEUROTRAUMA, P553; THEWS G, 1963, SELECTIVE VULNERABIL, P27; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A., 1996, J NEUROTRAUM, V13, P619	16	296	304	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	1998	26	9					1576	1581		10.1097/00003246-199809000-00029			6	Critical Care Medicine	General & Internal Medicine	123WX	WOS:000076149500026	9751596				2021-06-18	
J	Ikonomovic, MD; Uryu, K; Abrahamson, EE; Ciallella, JR; Trojanowski, JQ; Lee, VMY; Clark, RS; Marion, DW; Wisniewski, SR; DeKosky, ST				Ikonomovic, MD; Uryu, K; Abrahamson, EE; Ciallella, JR; Trojanowski, JQ; Lee, VMY; Clark, RS; Marion, DW; Wisniewski, SR; DeKosky, ST			Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Alzheimer's disease; A beta plaque; glial cell	AMYLOID-BETA-PROTEIN; APOLIPOPROTEIN-E GENOTYPE; SEVERE HEAD-INJURY; E EPSILON-4 ALLELE; PRECURSOR PROTEIN; SENILE PLAQUES; NEUROFIBRILLARY TANGLES; NONDEMENTED SUBJECTS; ENTORHINAL CORTEX; MOUSE MODEL	Traumatic brain injury (TBI) is a risk factor for the development of Alzheimer's disease (AD). This immunohistochemical study determined the extent of AD-related changes in temporal cortex resected from individuals treated surgically for severe TBI. Antisera generated against Abeta species (total Abeta, Abeta(1-42), and Abeta(1-40)), the C-terminal of the Abeta precursor protein (APP), apolipoprotein E (apoE), and markers of neuron structure and degeneration (tau, ubiquitin, alpha-, beta-, and gamma-synuclein) were used to examine the extent of Abeta plaque deposition and neurodegenerative changes in 18 TBI subjects (ages 18-64 years). Diffuse cortical Abeta deposits were observed in one third of subjects (aged 35-62 years) as early as 2 h after injury, with only one (35-year old) individual exhibiting "mature", dense-cored plaques. Plaque-like deposits, neurons, glia, and axonal changes were also immunostained with APP and apoE antibodies. In plaque-positive cases, the only statistically significant change in cellular immunostaining was increased neuronal APP (P = 0.013). There was no significant correlation between the distribution of Abeta plaques and markers of neuronal degeneration. Diffuse tau immunostaining was localized to neuronal cell soma, axons or glial cells in a larger subset of individuals. Tau-positive, neurofibrillary tangle (NFT)-like changes were detected in only two subjects, both of more advanced age and who were without Abeta deposits. Other neurodegenerative changes, evidenced by ubiquitin- and synuclein-immunoreactive neurons, were abundant in the majority of cases. Our results demonstrate a differential distribution and course of intra- and extra-cellular AD-like changes during the acute phase following severe TBI in humans. Abeta plaques and early evidence of neuronal degenerative changes can develop rapidly after TBI, while fully developed NFTs most likely result from more chronic disease- or injury-related processes. These observations lend further support to the hypothesis that head trauma significantly increases the risk of developing pathological and clinical symptoms of AD, and provide insight into the molecular mechanisms that initiate these pathological cascades very early during severe brain injury. (C) 2004 Elsevier Inc. All rights reserved.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Penn, Inst Aging, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Grad Sch Publ Hlth, Epidemiol Data Ctr, Pittsburgh, PA 15213 USA	DeKosky, ST (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, 3471 5th Ave,Suite 811, Pittsburgh, PA 15213 USA.	DeKoskyST@upmc.edu	Marion, Donald/AAR-5749-2021	Wisniewski, Stephen/0000-0002-3877-9860; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133, P01AG011542] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 11542, AG 05133] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 18273] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline		ALTSTIEL LD, 1991, PROG NEURO-PSYCHOPH, V15, P481, DOI 10.1016/0278-5846(91)90023-T; Arai T, 1999, ACTA NEUROPATHOL, V97, P82, DOI 10.1007/s004010050958; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; DAYAN AD, 1970, ACTA NEUROPATHOL, V16, P85, DOI 10.1007/BF00687663; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HARDY J, 1992, TRENDS NEUROSCI, V15, P200, DOI 10.1016/0166-2236(92)90033-5; Hartman RE, 2002, J NEUROSCI, V22, P10083; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P520; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; McNamara MJ, 1998, ARCH NEUROL-CHICAGO, V55, P1001, DOI 10.1001/archneur.55.7.1001; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROBERTS GW, 1993, NEUROREPORT, V4, P7, DOI 10.1097/00001756-199301000-00001; ROBERTS GW, 1988, LANCET, V2, P1456; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; TEASDALE G, 1974, LANCET, V2, P81; Trojanowski JQ, 2002, NEUROTOXICOLOGY, V23, P457, DOI 10.1016/S0161-813X(02)00065-7; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	71	295	296	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2004	190	1					192	203		10.1016/j.expneurol.2004.06.011			12	Neurosciences	Neurosciences & Neurology	867DJ	WOS:000224822100017	15473992				2021-06-18	
J	Rodriques, SG; Stickels, RR; Goeva, A; Martin, CA; Murray, E; Vanderburg, CR; Welch, J; Chen, LLM; Chen, F; Macosko, EZ				Rodriques, Samuel G.; Stickels, Robert R.; Goeva, Aleksandrina; Martin, Carly A.; Murray, Evan; Vanderburg, Charles R.; Welch, Joshua; Chen, Linlin M.; Chen, Fei; Macosko, Evan Z.			Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution	SCIENCE			English	Article							CEREBELLAR CORTEX; GENE-EXPRESSION; CELLS; RAT; ORGANIZATION; RNA; VESTIBULOCEREBELLUM; COMPARTMENTS; ACTIVATION; DIVERSITY	Spatial positions of cells in tissues strongly influence function, yet a high-throughput, genome-wide readout of gene expression with cellular resolution is lacking. We developed Slide-seq, a method for transferring RNA from tissue sections onto a surface covered in DNA-barcoded beads with known positions, allowing the locations of the RNA to be inferred by sequencing. Using Slide-seq, we localized cell types identified by single-cell RNA sequencing datasets within the cerebellum and hippocampus, characterized spatial gene expression patterns in the Purkinje layer of mouse cerebellum, and defined the temporal evolution of cell type-specific responses in a mouse model of traumatic brain injury. These studies highlight how Slide-seq provides a scalable method for obtaining spatially resolved gene expression data at resolutions comparable to the sizes of individual cells.	[Rodriques, Samuel G.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Rodriques, Samuel G.] MIT, Media Lab, Cambridge, MA 02139 USA; [Rodriques, Samuel G.; Stickels, Robert R.; Goeva, Aleksandrina; Martin, Carly A.; Murray, Evan; Vanderburg, Charles R.; Welch, Joshua; Chen, Linlin M.; Chen, Fei; Macosko, Evan Z.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Stickels, Robert R.] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Stickels, Robert R.] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Macosko, Evan Z.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Chen, F; Macosko, EZ (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Macosko, EZ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	chenf@broadinstitute.org; emacosko@broadinstitute.org	Macosko, Evan/X-4664-2019; Vanderburg, Charles/C-4516-2013	Stickels, Robert/0000-0003-4326-4084; Goeva, Aleksandrina/0000-0001-9425-6573; Martin, Carly/0000-0002-8191-4968; Rodriques, Samuel/0000-0002-2509-0861; Chen, Fei/0000-0003-2308-3649; Vanderburg, Charles/0000-0001-8979-5054; Macosko, Evan/0000-0002-2794-5165	NIH New Innovator AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2 AG058488-01]; NIH Early Independence AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP5OD024583]; Schmidt Fellows Program at the Broad Institute; Stanley Center for Psychiatric Research; Hertz Graduate Fellowship; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [1122374]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R21HG009749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [DP2AG058488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP5OD024583] Funding Source: NIH RePORTER	This work was supported by an NIH New Innovator Award (DP2 AG058488-01), an NIH Early Independence Award (DP5, 1DP5OD024583), the Schmidt Fellows Program at the Broad Institute, and the Stanley Center for Psychiatric Research. S.G.R. acknowledges funding through the Hertz Graduate Fellowship and the National Science Foundation Graduate Research Fellowship Program (award 1122374).	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Carter RA, 2018, CURR BIOL, V28, P2910, DOI 10.1016/j.cub.2018.07.062; Cerminara NL, 2015, NAT REV NEUROSCI, V16, P79, DOI 10.1038/nrn3886; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chung C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006042; Demilly A, 2011, CEREBELLUM, V10, P409, DOI 10.1007/s12311-010-0156-y; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; HONKANIEMI J, 1995, MOL BRAIN RES, V28, P157, DOI 10.1016/0169-328X(94)00200-X; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kim CH, 2012, J PHYSIOL-LONDON, V590, P273, DOI 10.1113/jphysiol.2011.221846; Kong Qiongman, 2008, Biotechnology Journal, V3, P1041, DOI 10.1002/biot.200800122; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MAEKAWA K, 1973, J NEUROPHYSIOL, V36, P649; Muller D, 2014, SCIENCE, V343, P1264, DOI 10.1126/science.1246448; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Roberts MT, 2010, J NEUROPHYSIOL, V104, P2462, DOI 10.1152/jn.00312.2010; ROBINSON GA, 1994, MOL BRAIN RES, V24, P43, DOI 10.1016/0169-328X(94)90116-3; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Storer PD, 2003, J COMP NEUROL, V458, P326, DOI 10.1002/cne.10623; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Trussell LO, 2018, SPRINGER HANDB AUDIT, V65, P73, DOI 10.1007/978-3-319-71798-2_4; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Wylie DRW, 2003, J COMP NEUROL, V465, P179, DOI 10.1002/cne.10857; Xiao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105633; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	37	294	297	14	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2019	363	6434					1463	+		10.1126/science.aaw1219			50	Multidisciplinary Sciences	Science & Technology - Other Topics	HQ9HP	WOS:000462738000039	30923225	Green Accepted, Bronze	Y	Y	2021-06-18	
J	JONES, PA; ANDREWS, PJD; MIDGLEY, S; ANDERSON, SI; PIPER, IR; TOCHER, JL; HOUSLEY, AM; CORRIE, JA; SLATTERY, J; DEARDEN, NM; MILLER, JD				JONES, PA; ANDREWS, PJD; MIDGLEY, S; ANDERSON, SI; PIPER, IR; TOCHER, JL; HOUSLEY, AM; CORRIE, JA; SLATTERY, J; DEARDEN, NM; MILLER, JD			MEASURING THE BURDEN OF SECONDARY INSULTS IN HEAD-INJURED PATIENTS DURING INTENSIVE-CARE	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						HEAD INJURY, ADULT; INSULT, SECONDARY CEREBRAL; INTENSIVE CARE; OUTCOME	ISCHEMIC BRAIN-DAMAGE; INTRACRANIAL-PRESSURE; MANAGEMENT; SEVERITY; DEATH	Primary traumatic brain damage may be compounded by secondary pathophysiological insults that can occur soon after trauma, during transfer to hospital or subsequent treatment of the head-injured patient. The aim of this prospective study was to quantify the burden of a wide range of secondary insults occurring after head injury and to relate these to 12-month outcome. In 124 adult head-injured patients studied during intensive care using a computerized data collection system, less-than-or-equal-to 14 clinically indicated physiological variables were measured minute-by-minute. Verified values falling outside threshold limits for greater-than-or-equal-to 5 min, as defined by the Edinburgh University Secondary Insult Grading scheme, were analysed by insult grade and duration. A greater incidence of secondary insults was detected than previous studies have indicated. Insults were found in 91% of patients and occurred in all severities of head trauma, at all ages, and at every level of Injury Severity Score (ISS). The cumulative durations were much greater than previously recorded although 85% of the total time was at the least severe grade. Short duration insults were common. In 71 patients, in whom 8 insults could be assessed (intracranial pressure, arterial hypo- and hypertension, cerebral perfusion pressure, hypoxemia, pyrexia, brady- and tachycardia), outcome at 12 months was analysed using logistic regression to determine the relative influence of age, admission Glasgow Coma Sumscore, ISS, pupil response on admission, and insult duration on both mortality and morbidity. The most significant predictors of mortality in this patient set were durations of hypotensive (p = .0064), pyrexic (p = .0 1 37), and hypoxemic (p = .0244) insults. When good versus poor outcome was considered, hypotensive insults (p = .0118) and pupil response on admission (p = .0226) were significant.	UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND							ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BRAAKMAN R, IN PRESS J NEUROSURG; BULL JP, 1978, INJURY, V9, P184, DOI 10.1016/0020-1383(78)90004-9; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CORRIE J, 1993, BRIT J INTENSIVE CAR, V6, P225; DEARDEN NM, 1986, BRIT J HOSP MED, V36, P94; DEARDEN NM, 1991, CURR OPIN ANESTHESIO, V4, P279; GENNARELLI TA, 1985, ABBREVIATED INJURY S, P2; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GENTLEMAN D, 1981, LANCET, V2, P853; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Mannarou A, 1991, J NEUROSURG S, V75, P21; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1991, J NEUROL SCI S, V103, P33; MILLER JD, 1992, J NEUROTRAUMA S1, V9, P317; MIYAZAWA P, 1993, ACTA NEUROPATHOL, V85, P488; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; PIPER IR, 1991, BR J INTENS CARE, V1, P73; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; REILLY PL, 1975, LANCET, V2, P375; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	35	294	302	0	5	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	1994	6	1					4	14					11	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	MM416	WOS:A1994MM41600002	8298263				2021-06-18	
J	Smith, DH; Okiyama, K; Thomas, MJ; Claussen, B; McIntosh, TK				Smith, Douglas H.; Okiyama, Koichi; Thomas, Mark J.; Claussen, Brian; McIntosh, Tracey K.			Evaluation of Memory Dysfunction Following Experimental Brain Injury Using the Morris Water Maze	JOURNAL OF NEUROTRAUMA			English	Article								Memory dysfunction, a common clinical feature of traumatic brain injury (TBI), is thought to be related to secondary damage of key anatomic structures in the brain, including the hippocampus. In the present study, we have characterized and evaluated a novel experimental paradigm using the Morris water maze (MWM) technique, to measure post-TBI memory retention after lateral (parasagittal) fluid percussion (FP) brain injury in rats. Male Sprague-Dawley rats (n = 37) received a total of 20 training trials over 2 days in the MWM. Two and a half hours after the last training trial, the animals received FP brain injury of moderate severity (2.3 atmospheres, n = 12), high severity (2.6 atm, n = 13), or no injury (n = 12). Forty-two hours after FP brain injury, we observed a highly sufficient memory dysfunction in animals from both injury groups compared to the uninjured group (p < 0.001). The degree of memory dysfunction was found to be directly related to the severity of injury, with the high severity group scoring significantly worse than the moderately injured group (p = 0.15). In addition, hippocampal cell loss was observed after brain injury, but only unilaterally. These data suggest that lateral FP brain injury causes memory dysfunction possibly related to concurrent hippocampal cell loss and that posttraumatic memory deficits may be sensitively quantitated using the memory testing paradigm described.	[Smith, Douglas H.; Okiyama, Koichi; Thomas, Mark J.; Claussen, Brian; McIntosh, Tracey K.] Univ Connecticut, CNS Injury Lab, Surg Res Ctr, Dept Surg,Hlth Ctr, Farmington, CT 06030 USA	Smith, DH (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg L 1096, Farmington, CT 06030 USA.		smith, douglas/A-1321-2007		Brain Trauma Foundation [RO1 NS26810]	This study was supported, in part, by the Brain Trauma Foundation, a PHS grant RO1 NS26810, a Veterans Administration Merit Review (74R), and a University of Connecticut Health Center Faculty Research Grant. We would like to thank Bernarda Ostaszewska, Holly Soares, David Serwanski, and James Moore for their excellent technical assistance and Mrs. Joanne D'Aprile for preparation of this manuscript. In these studies, we carefully adhered to the animal welfare guidelines set forth in the Guide for the Care and Use of Laboratory Animals, U. S. Department of Health and Human Services, Publication Number 85-23, 1985.	AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BRIERLEY JB, 1976, GREENFIELDS NEUROPAT, P43; CHOI DW, 1987, J NEUROSCI, V7, P357; COLLINGRIDGE GL, 1989, NMDA RECEPTOR, P123; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DISBREY BD, 1970, HISTOLOGICAL LAB MET, P230; FADEN AI, 1989, SCIENCE, V244, P789; Halgren E, 1984, NEUROPSYCHOLOGY MEMO, P165; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LEVIN HS, 1985, STATUS REPORT CENTRA, P281; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH T, 1989, Society for Neuroscience Abstracts, V15, P132; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCNAUGHTON B L, 1989, P285; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MIZAKI S, 1989, INTRACRANIAL PRESSUR, V7, P651; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1983, NEUROPSYCHOLOGY MEMO, P521; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; PARKIN AJ, 1984, CORTEX, V20, P479, DOI 10.1016/S0010-9452(84)80053-2; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; ROMAN F, 1987, BRAIN RES, V418, P221, DOI 10.1016/0006-8993(87)90089-8; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; SWAN JH, 1990, J CEREBR BLOOD F MET, V10, P343, DOI 10.1038/jcbfm.1990.63; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	40	294	307	0	8	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	WIN	1991	8	4					259	269		10.1089/neu.1991.8.259			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	V07UU	WOS:000207286900004	1803034				2021-06-18	
J	Schabitz, WR; Schwab, S; Spranger, M; Hacke, W				Schabitz, WR; Schwab, S; Spranger, M; Hacke, W			Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain-derived neurotrophic factor; neurotrophins; focal cerebral ischemia; MCAO; histology	NERVE GROWTH-FACTOR; GLUTAMATE-INDUCED NEUROTOXICITY; TRK PROTOONCOGENE PRODUCT; ARTERY OCCLUSION; NEURONAL DEATH; FOREBRAIN ISCHEMIA; SUBSTANTIA-NIGRA; CORTICAL-NEURONS; FACTOR PREVENTS; BDNF	Brain-derived neurotrophic factor (BDNF), acting through the high-affinity receptor tyrosine kinase (TrkB), is widely distributed throughout the central nervous system and displays in vitro trophic effects on a wide range of neuronal cells, including hippocampal, cerebellar, and cortical neurons. In vivo, BDNF rescues motorneurons, hippocampal, and substantia nigral dopaminergic cells from traumatic and toxic brain injury. After transient middle cerebral artery occlusion (MCAO), upregulation of BDNF-mRNA in cortical neurons suggests that BDNF potentially plays a neuroprotective role in focal cerebral ischemia. In the current study, BDNF (2.1 mu g/d) in vehicle or vehicle alone (controls) was delivered intraventricularly for 8 days, beginning 24 hours before permanent middle cerebral artery occlusion by intraluminal suture in Wistar rats (n = 13 per group). There were no differences in physiological variables recorded during surgery for the two groups. Neurological deficit (0 to 4 scale), which was assessed on a daily basis, improved in BDNF-treated animals compared with controls (P < 0.05; analysis of variance and Scheffe's test). There were no significant differences in weight in BDNF-treated animals and controls during the experiment. After elective killing on day 7 after MCAO, brains underwent 2,3,5-triphenyltetrazolium chloride staining for calculation of the infarct volume and for histology (hematoxylin and eosin and glial fibrillary acid protein). The mean total infarct volume was 83.1 +/- 27.1 mm(3) in BDNF-treated animals and 139.2 +/- 56.4 mm(3) in controls (mean +/- SD; P < 0.01, unpaired, two-tailed t-test), The cortical infarct volume was 10.8 +/- 7.1 mm(3) in BDNF-treated animals and 37.9 +/- 19.8 mm(3) in controls (mean +/- SD; P < 0.05; unpaired, two-tailed t-test), whereas ischemic lesion volume in caudoputaminal infarction was not significantly different. These results show that pretreatment with intraventricular BDNF reduces infarct size after focal cerebral ischemia in rats and support the hypothesis of a neuroprotective role for BDNF in stoke.	UNIV HEIDELBERG, DEPT NEUROL, D-69120 HEIDELBERG, GERMANY			Hacke, Werner/ABE-8661-2020				BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHOI DW, 1993, RES P ARNMD, V71, P23; Dittrich F, 1996, EXP NEUROL, V141, P225, DOI 10.1006/exnr.1996.0157; EBENDAL T, 1992, J NEUROSCI RES, V32, P461, DOI 10.1002/jnr.490320402; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; GARCIA JH, 1993, AM J PATHOL, V142, P623; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HSU CY, 1993, STROKE, V24, pI78; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IP NY, 1993, J NEUROSCI, V13, P3394; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAPCHAK PA, 1992, NEUROREPORT, V3, P405, DOI 10.1097/00001756-199205000-00007; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; MINEMATSU K, 1992, NEUROLOGY, V42, P235, DOI 10.1212/WNL.42.1.235; MORELLI A, 1986, J NEUROCHEM, V47, P375; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; ROBACK JD, 1995, EUR J NEUROSCI, V7, P849, DOI 10.1111/j.1460-9568.1995.tb01072.x; ROSENBLATT S, 1994, J CEREBR BLOOD F MET, V14, P70, DOI 10.1038/jcbfm.1994.11; Schabitz WR, 1996, J NEUROL SCI, V138, P21, DOI 10.1016/0022-510X(95)00341-X; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SHIMOHAMA S, 1993, NEUROSCI LETT, V164, P55, DOI 10.1016/0304-3940(93)90856-G; Tanaka K, 1994, J Clin Neurosci, V1, P125, DOI 10.1016/0967-5868(94)90088-4; TANAKA R, 1995, STROKE, V26, P2154, DOI 10.1161/01.STR.26.11.2154; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076	52	293	309	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	1997	17	5					500	506		10.1097/00004647-199705000-00003			7	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	XC697	WOS:A1997XC69700003	9183287	Bronze			2021-06-18	
J	Clifton, GL; Valadka, A; Zygun, D; Coffey, CS; Drever, P; Fourwinds, S; Janis, LS; Wilde, E; Taylor, P; Harshman, K; Conley, A; Puccio, A; Levin, HS; McCauley, SR; Bucholz, RD; Smith, KR; Schmidt, JH; Scott, JN; Yonas, H; Okonkwo, DO				Clifton, Guy L.; Valadka, Alex; Zygun, David; Coffey, Christopher S.; Drever, Pamala; Fourwinds, Sierra; Janis, L. Scott; Wilde, Elizabeth; Taylor, Pauline; Harshman, Kathy; Conley, Adam; Puccio, Ava; Levin, Harvey S.; McCauley, Stephen R.; Bucholz, Richard D.; Smith, Kenneth R.; Schmidt, John H.; Scott, James N.; Yonas, Howard; Okonkwo, David O.			Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial	LANCET NEUROLOGY			English	Article							TERM MILD HYPOTHERMIA; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; ADMISSION; EFFICACY; THERAPY	Background The inconsistent effect of hypothermia treatment on severe brain injury in previous trials might be because hypothermia was induced too late after injury. We aimed to assess whether very early induction of hypothermia improves outcome in patients with severe brain injury. Methods The National Acute Brain Injury Study: Hypothermia II (NABIS: H II) was a randomised, multicentre clinical trial of patients with severe brain injury who were enrolled within 2.5 h of injury at six sites in the USA and Canada. Patients with non-penetrating brain injury who were 16-45 years old and were not responsive to instructions were randomly assigned (1:1) by a random number generator to hypothermia or normothermia. Patients randomly assigned to hypothermia were cooled to 35 degrees C until their trauma assessment was completed. Patients who had none of a second set of exclusion criteria were either cooled to 33 degrees C for 48 h and then gradually rewarmed or treated at normothermia, depending upon their initial treatment assignment. Investigators who assessed the outcome measures were masked to treatment allocation. The primary outcome was the Glasgow outcome scale score at 6 months. Analysis was by modified intention to treat. This trial is registered with ClinicalTrials.gov, NCT00178711. Findings Enrolment occurred from December, 2005, to June, 2009, when the trial was terminated for futility. Follow-up was from June, 2006, to December, 2009. 232 patients were initially randomised a mean of 1.6 h (SD 0.5) after injury: 119 to hypothermia and 113 to normothermia. 97 patients (52 in the hypothermia group and 45 in the normothermia group) did not meet any of the second set of exclusion criteria. The mean time to 35 C for the 52 patients in the hypothermia group was 2.6 h (SD 1.2) and to 33 degrees C was 4.4 h (1.5). Outcome was poor (severe disability, vegetative state, or death) in 31 of 52 patients in the hypothermia group and 25 of 56 in the normothermia group (relative risk [RR] 1.08, 95% CI 0.76-1.53; p=0.67). 12 patients in the hypothermia group died compared with eight in the normothermia group (RR 1.30, 95% CI 0.58-2.52; p=0.52). Interpretation This trial did not confirm the utility of hypothermia as a primary neuroprotective strategy in patients with severe traumatic brain injury.	[Clifton, Guy L.; Valadka, Alex; Drever, Pamala; Conley, Adam] Univ Texas Houston, Vivian L Smith Ctr Neurol Res, Dept Neurosurg, Med Sch Houston, Houston, TX USA; [Valadka, Alex] Seton Brain & Spine Inst, Austin, TX USA; [Zygun, David; Taylor, Pauline] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Scott, James N.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Coffey, Christopher S.] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Coffey, Christopher S.] Univ Alabama Birmingham, Dept Biostat, Sch Publ Hlth, Birmingham, AL 35294 USA; [Fourwinds, Sierra] Silverwind Res, La Veta, CO USA; [Janis, L. Scott] NINDS, Rockville, MD USA; [Wilde, Elizabeth; Levin, Harvey S.; McCauley, Stephen R.] Baylor Coll Med, Houston, TX 77030 USA; [Bucholz, Richard D.; Smith, Kenneth R.] St Louis Univ, Div Neurosurg, St Louis, MO 63103 USA; [Schmidt, John H.] Neurol Associates, Charleston, WV USA; [Yonas, Howard] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Harshman, Kathy; Puccio, Ava; Okonkwo, David O.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA	Clifton, GL (corresponding author), 6431 Fannin St,Suite 7-130, Houston, TX 77030 USA.	guy.l.clifton@uth.tmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5U01 NS043353-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	This study was supported by a grant (5U01 NS043353-06) from the National Institute of Neurological Disorders and Stroke.	[Anonymous], 1971, JAMA-J AM MED ASSOC, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Janata A, 2009, PROG CARDIOVASC DIS, V52, P168, DOI 10.1016/j.pcad.2009.07.001; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; KURODA Y, 1992, NEUROSURGERY, V30, P687; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Myles G L, 1995, J Neurosci Nurs, V27, P35; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Yan Y, 2010, J CLIN NEUROSCI, V17, P196, DOI 10.1016/j.jocn.2009.05.022	23	292	310	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2011	10	2					131	139		10.1016/S1474-4422(10)70300-8			9	Clinical Neurology	Neurosciences & Neurology	721IT	WOS:000287347500008	21169065	Green Accepted			2021-06-18	
J	Pierce, JES; Smith, DH; Trojanowski, JQ; McIntosh, TK				Pierce, JES; Smith, DH; Trojanowski, JQ; McIntosh, TK			Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats	NEUROSCIENCE			English	Article						traumatic brain injury; fluid-percussion brain injury; Morris water maze; neurologic motor score; neurodegeneration; amyloid precursor protein	SEVERE HEAD-INJURY; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; NEOCORTICAL DAMAGE; CEREBRAL EDEMA; CELL-DEATH; TRAUMA; MEMORY; DEPOSITION; IMMUNOREACTIVITY	Clinical studies have demonstrated that patients sustain prolonged behavioral deficits following traumatic brain injury, in some cases culminating in the cognitive and histopathological hallmarks of Alzheimer's disease. However, few studies have examined the long-term consequences of experimental traumatic brain injury. In the present study, anesthetized male Sprague-Dawley rats (,n=185) were subjected to severe lateral fluid-percussion brain injury (n=115) or sham injury (n=70) and evaluated up to one year post-injury for cognitive and neurological deficits and histopathological changes. Compared with sham-injured controls, brain-injured animals showed a spatial learning impairment that persisted up to one year post-injury. In addition, deficits in specific neurologic motor function tasks also persisted up to one year post-injury. Immunohistochemistry using multiple antibodies to the amyloid precursor protein and/or amyloid precursor protein-like proteins revealed novel axonal degeneration in the striatum, corpus callosum and injured cortex up to one year post-injury and in the thalamus up to six months post-injury. Histologic evaluation of injured brains demonstrated a progressive expansion of the cortical cavity, enlargement of the lateral ventricles, deformation of the hippocampus, and thalamic calcifications. Taken together, these findings indicate that experimental traumatic brain injury can cause long-term cognitive and neurologic motor dysfunction accompanied by continuing neurodegeneration. (C) 1998 IBRO. Published by Elsevier Science Ltd.	Univ Penn, Sch Med, Div Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Connecticut, Ctr Hlth, Ctr Neurol Sci, Farmington, CT 06030 USA	Smith, DH (corresponding author), Univ Penn, Sch Med, Div Neurosurg, Philadelphia, PA 19104 USA.		smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R55NS026818, R01NS026818, P01NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS26818] Funding Source: Medline		AdleBiassette H, 1996, NEUROBIOL AGING, V17, P415, DOI 10.1016/0197-4580(96)00029-2; ALKON DL, 1991, BRAIN RES REV, V16, P193, DOI 10.1016/0165-0173(91)90005-S; Blumbergs P. C., 1995, Journal of Neurotrauma, V12, P353; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CORKIN S, 1989, J NEUROSCI, V9, P3876; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P134; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRONWALL D, 1974, LANCET, V2, P605; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; IIZUKA H, 1990, STROKE, V21, P7990; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Levin HS, 1996, ARCH NEUROL-CHICAGO, V53, P88, DOI 10.1001/archneur.1996.00550010108024; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARMAROU A, 1985, BRAIN EDEMA, P88; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCLEAN A JR, 1991, Brain Injury, V5, P375, DOI 10.3109/02699059109008110; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; Pierce JES, 1996, J NEUROSCI, V16, P1083; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RINK A, 1995, AM J PATHOL, V147, P1575; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SINSON G, 1995, J NEUROCHEM, V65, P2209; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMITH SA, 1993, P AQUACULTURE ASS CA, V10, P62; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P281; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	61	292	295	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	NOV	1998	87	2					359	369		10.1016/S0306-4522(98)00142-0			11	Neurosciences	Neurosciences & Neurology	110JU	WOS:000075378300005	9740398				2021-06-18	
J	Mahad, DJ; Ziabreva, I; Campbell, G; Lax, N; White, K; Hanson, PS; Lassmann, H; Turnbull, DM				Mahad, Don J.; Ziabreva, Iryna; Campbell, Graham; Lax, Nichola; White, Katherine; Hanson, Peter S.; Lassmann, Hans; Turnbull, Douglass M.			Mitochondrial changes within axons in multiple sclerosis	BRAIN			English	Article						Mitochondria; axonal degeneration; multiple sclerosis	SODIUM-CHANNELS; NITRIC-OXIDE; OPTIC-NERVE; DEMYELINATED AXONS; DAMAGE; MECHANISMS; INJURY; ENERGY; DNA; DYSFUNCTION	Multiple sclerosis is the most common cause of non-traumatic neurological impairment in young adults. An energy deficient state has been implicated in the degeneration of axons, the pathological correlate of disease progression, in multiple sclerosis. Mitochondria are the most efficient producers of energy and play an important role in calcium homeostasis. We analysed the density and function of mitochondria using immunohistochemistry and histochemistry, respectively, in chronic active and inactive lesions in progressive multiple sclerosis. As shown before in acute pattern III and Balos lesions, the mitochondrial respiratory chain complex IV activity is reduced despite the presence of mitochondria in demyelinated axons with amyloid precursor protein accumulation, which are predominantly located at the active edge of chronic active lesions. Furthermore, the strong non-phosphorylated neurofilament (SMI32) reactivity was associated with a significant reduction in complex IV activity and mitochondria within demyelinated axons. The complex IV defect associated with axonal injury may be mediated by soluble products of innate immunity, as suggested by an inverse correlation between complex IV activity and macrophage/microglial density in chronic lesions. However, in inactive areas of chronic multiple sclerosis lesions the mitochondrial respiratory chain complex IV activity and mitochondrial mass, judged by porin immunoreactivity, are increased within approximately half of large (2.5 m diameter) chronically demyelinated axons compared with large myelinated axons in the brain and spinal cord. The axon-specific mitochondrial docking protein (syntaphilin) and phosphorylated neurofilament-H were increased in chronic lesions. The lack of complex IV activity in a proportion of Na/K ATPase -1 positive demyelinated axons supports axonal dysfunction as a contributor to neurological impairment and disease progression. Furthermore, in vitro studies show that inhibition of complex IV augments glutamate-mediated axonal injury (amyloid precursor protein and SMI32 reactivity). Our findings have important implications for both axonal degeneration and dysfunction during the progressive stage of multiple sclerosis.	[Mahad, Don J.; Ziabreva, Iryna; Campbell, Graham; Lax, Nichola; Turnbull, Douglass M.] Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [White, Katherine] Univ Newcastle, EM Res Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hanson, Peter S.] Univ Newcastle, Med Toxicol Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Mahad, DJ (corresponding author), Univ Newcastle, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.j.mahad@ncl.ac.uk	Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052; Campbell, Graham/0000-0003-4828-421X	Welcome TrustWellcome Trust; Multiple Sclerosis Society of Great Britain and Northern Ireland; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700718] Funding Source: researchfish	Welcome Trust and Multiple Sclerosis Society of Great Britain and Northern Ireland.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668; Andrews H, 2006, J NEUROSCI RES, V83, P1533, DOI 10.1002/jnr.20842; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664; Black JA, 2007, J NEUROPATH EXP NEUR, V66, P828, DOI 10.1097/nen.0b013e3181462841; Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; CALDWELL PC, 1960, J PHYSIOL-LONDON, V152, P561, DOI 10.1113/jphysiol.1960.sp006509; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Clements RJ, 2008, EXP BRAIN RES, V187, P459, DOI 10.1007/s00221-008-1317-9; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; COMPSTON A, 2005, MCALPINES MULTIPLE S, V1; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; HILDEBRAND C, 1983, BRAIN RES, V258, P23, DOI 10.1016/0006-8993(83)91222-2; HODGKIN AL, 1964, SCIENCE, V145, P1148, DOI 10.1126/science.145.3637.1148; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SHINTAKU M, 1988, NEUROPATH APPL NEURO, V14, P505, DOI 10.1111/j.1365-2990.1988.tb01341.x; Smith KJ, 2007, BRAIN PATHOL, V17, P230, DOI 10.1111/j.1750-3639.2007.00066.x; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Smith KJ, 2001, ANN NEUROL, V49, P470; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; TAYLOR RW, 1997, ORGANELLE DIS, P341; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Wagner OI, 2003, J NEUROSCI, V23, P9046; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1982, NEW ENGL J MED, V306, P1529, DOI 10.1056/NEJM198206243062505; Waxman SG, 2008, ANN NEUROL, V63, P411, DOI 10.1002/ana.21361; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Waxman SG, 2006, TRENDS MOL MED, V12, P192, DOI 10.1016/j.molmed.2006.03.001; Wei JP, 2002, J IMMUNOL, V168, P4721, DOI 10.4049/jimmunol.168.9.4721; Young EA, 2008, ANN NEUROL, V63, P428, DOI 10.1002/ana.21381	55	291	297	0	28	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2009	132		5				1161	1174		10.1093/brain/awp046			14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	444AB	WOS:000265950900006	19293237	Green Accepted, Bronze			2021-06-18	
J	Di Giovanni, S; Movsesyan, V; Ahmed, F; Cernak, L; Schinelli, S; Stoica, B; Faden, AI				Di Giovanni, S; Movsesyan, V; Ahmed, F; Cernak, L; Schinelli, S; Stoica, B; Faden, AI			Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						flavopiridol; glial scar; neuron; trauma	NEURONAL APOPTOSIS; DNA-DAMAGE; DEPENDENT KINASES; GENE-EXPRESSION; IN-VITRO; DEATH; PATHWAYS; ISCHEMIA; D1; ACTIVATION	Traumatic brain injury (TBI) causes neuronal apoptosis, inflammation, and reactive astrogliosis, which contribute to secondary tissue loss, impaired regeneration, and associated functional disabilities. Here, we show that up-regulation of cell cycle components is associated with caspase-mediated neuronal apoptosis and glial proliferation after TBI in rats. In primary neuronal and astrocyte cultures, cell cycle inhibition (including the cyclin-dependent kinase inhibitors flavopiridol, roscovitine, and olomoucine) reduced upregulation of cell cycle proteins, limited neuronal cell death after etoposide-induced DNA damage, and attenuated astrocyte proliferation. After TBI in rats, flavopiridol reduced cyclin D1 expression in neurons and glia in ipsilateral cortex and hippocampus. Treatment also decreased neuronal cell death and lesion volume, reduced astroglial scar formation and microglial activation, and improved motor and cognitive recovery. The ability of cell cycle inhibition to decrease both neuronal cell death and reactive gliosis after experimental TBI suggests that this treatment approach may be useful clinically.	Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20057 USA; Univ Pavia, Fac Farm, Dipartimento Farmacol Sperimentale & Appl, I-27100 Pavia, Italy	Faden, AI (corresponding author), Georgetown Univ, Sch Med, Dept Neurosci, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	fadena@georgetown.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Ibolja, Cernak/0000-0003-3214-698X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036537] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD4-0677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 36537-03, R01 NS036537, NS-1-2339] Funding Source: Medline		Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Boutillier AL, 2000, ONCOGENE, V19, P2171, DOI 10.1038/sj.onc.1203532; Campagne MV, 1998, NEUROSCIENCE, V84, P1097, DOI 10.1016/S0306-4522(97)00580-0; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Di Giovanni S, 2004, ANN NEUROL, V55, P195, DOI 10.1002/ana.10811; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Frantseva M, 2002, PROG BRAIN RES, V137, P171; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Ino H, 2001, J NEUROSCI, V21, P6086; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Xiang ZM, 2002, NEUROBIOL AGING, V23, P327, DOI 10.1016/S0197-4580(01)00282-2; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	42	291	294	0	14	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 7	2005	102	23					8333	8338		10.1073/pnas.0500989102			6	Multidisciplinary Sciences	Science & Technology - Other Topics	933RL	WOS:000229650500047	15923260	Green Published, Bronze			2021-06-18	
J	Lovell, MR; Collins, MW				Lovell, MR; Collins, MW			Neuropsychological assessment of the college football player	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						athletes concussion; neuropsychological assessment; sports	CONCUSSION; RECOVERY; TASK	The application of neuropsychological assessment procedures to the evaluation of athletes has recently become an area of intense interest and debate and has led to the development of research initiatives at both the amateur and the professional level. However, to date, only a handful of research studies have been completed that have addressed the special issues that accompany the use of neuropsychological assessment instruments with athletes. This article reviews the past use of psychological testing in sports and presents a model of neuropsychological assessment that is currently being utilized in the National Football League. In addition, the extension of this approach to major college football is discussed and test-retest data from a sample presented to provide the basis for comparison of athletes who have suffered a concussion. Recommendations of a national panel of neuropsychologists who are involved in the evaluation of athletes are presented in hopes of encouraging new research initiatives in this area.	Henry Ford Hlth Syst, Div Neuropsychol, Detroit, MI 48202 USA; Natl Football League, New York, NY 10022 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Lovell, MR (corresponding author), Henry Ford Hlth Syst, Div Neuropsychol, 1 Ford Pl 1E, Detroit, MI 48202 USA.						Barth JT, 1989, MILD HEAD INJURY; Benton AL, 1978, MULTILINGUAL APHASIA; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; CONNERS J, 1967, CONNERS CONTINUOUS P; DELIS D, 1987, CALIFORNIA VERBAL LE; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Golden C., 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; KAY G, 1995, COGSCREEN; KELLY J, 1995, CURRENT THERAPY SPOR; KELLY J, 1991, NEUROLOGY, V48, P581; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KLOVE H, 1974, CLIN NEUROPSYCHOLOGY; Lacy MA, 1996, CLIN NEUROPSYCHOL, V10, P305, DOI 10.1080/13854049608406692; LOVELL M, 1989, ANN CONV INT NEUR SO; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon J C, 1980, Clin Neurosurg, V27, P414; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Powell DH, 1993, MICROCOG ASSESSMENT; *PSYCH CORP, 1997, VIG; REEVES DL, 1995, AUTOMATED NEUROPSYCH; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1964, EXAMEN CLIN PSYCHOL; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Smith A., 1982, SYMBOL DIGIT MODALIT; SMITH TW, 1997, NY TIMES        0716, pB14; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII	31	291	292	0	14	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1998	13	2					9	26		10.1097/00001199-199804000-00004			18	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ZF451	WOS:000072898800004	9575253				2021-06-18	
J	HAMM, RJ; DIXON, CE; GBADEBO, DM; SINGHA, AK; JENKINS, LW; LYETH, BG; HAYES, RL				HAMM, RJ; DIXON, CE; GBADEBO, DM; SINGHA, AK; JENKINS, LW; LYETH, BG; HAYES, RL			COGNITIVE DEFICITS FOLLOWING TRAUMATIC BRAIN INJURY PRODUCED BY CONTROLLED CORTICAL IMPACT	JOURNAL OF NEUROTRAUMA			English	Article							MINOR HEAD-INJURY; SPATIAL LOCALIZATION; RAT; MEMORY; HIPPOCAMPAL; IMPAIRMENT; RECOVERY; ISCHEMIA; BLOCKADE; CUES	Traumatic brain injury produces significant cognitive deficits in humans. This experiment used a controlled cortical impact model of experimental brain injury to examine the effects of brain injury on spatial learning and memory using the Morris water maze task. Rats (n = 8) were injured at a moderate level of cortical impact injury (6 m/sec, 1.5 - 2.0 mm deformation). Eight additional rats served as a sham-injured control group. Morris water maze performance was assessed on days 11 - 15 and 30 - 34 following injury. Results revealed that brain-injured rats exhibited significant deficits (p < 0.05) in maze performance at both testing intervals. Since the Morris water maze task is particularly sensitive to hippocampal dysfunction, the results of the present experiment support the hypothesis that the hippocampus is preferentially vulnerable to damage following traumatic brain injury. These results demonstrate that controlled cortical impact brain injury produces enduring cognitive deficits analogous to those observed after human brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT REHABIL MED,RICHMOND,VA 23298	HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,1101 E MARSHALL ST,ROOM B2002,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12857, NS21458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458] Funding Source: NIH RePORTER		BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GRONWALL D, 1974, LANCET, V2, P605; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MIYAZAKI S, IN PRESS BRAIN RES; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NAPPER C H, 1989, Society for Neuroscience Abstracts, V15, P134; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SUTHERLAND RJ, 1982, J COMP PHYSIOL PSYCH, V96, P563, DOI 10.1037/h0077914; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558; WINOCUR G, 1990, BEHAV NEUROSCI, V104, P544, DOI 10.1037/0735-7044.104.4.544	29	291	294	1	20	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	SPR	1992	9	1					11	20		10.1089/neu.1992.9.11			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HQ469	WOS:A1992HQ46900002	1619672				2021-06-18	
J	Seal, KH; Maguen, S; Cohen, B; Gima, KS; Metzler, TJ; Ren, L; Bertenthal, D; Marmar, CR				Seal, Karen H.; Maguen, Shira; Cohen, Beth; Gima, Kristian S.; Metzler, Thomas J.; Ren, Li; Bertenthal, Daniel; Marmar, Charles R.			VA Mental Health Services Utilization in Iraq and Afghanistan Veterans in the First Year of Receiving New Mental Health Diagnoses	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMORBIDITY SURVEY REPLICATION; PRIMARY-CARE PATIENTS; RANDOMIZED CONTROLLED-TRIAL; WAR; DEPRESSION; INTERVENTION; MANAGEMENT; SYMPTOMS	Little is known about mental health services utilization among Iraq and Afghanistan veterans receiving care tit Department of Veterans Affairs (VA)facilities. Of 49,425 veterans with newly diagnosed Posttraumatic stress disorder (PTSD), only 9.5% attended 9 or more VA mental health sessions in 15 weeks or less in the first year of diagnosis. In addition, engagement in 9 or more VA treatment sessions for PTSD within 15 weeks varied by predisposing variables (age and gender), enabling variables (clinic of first mental health diagnosis and distance from VA facility), and need (type and complexity of mental health diagnoses). Thus, only a minority of Iraq and Afghanistan veterans with new PTSD diagnoses received a recommended number and intensity of VA menial health treatment sessions within the first year of diagnosis.	[Seal, Karen H.; Maguen, Shira; Bertenthal, Daniel] San Francisco VA Med Ctr, Hlth Serv Res & Dev Res Enhancement Award Program, San Francisco, CA 94121 USA; [Seal, Karen H.; Cohen, Beth] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Seal, Karen H.; Maguen, Shira; Marmar, Charles R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Seal, KH (corresponding author), San Francisco VA Med Ctr, Hlth Serv Res & Dev Res Enhancement Award Program, 4150 Clement St,Box 111A-1, San Francisco, CA 94121 USA.	Karen.Seal@va.gov	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024130] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024130] Funding Source: Medline		*AM PSYCH ASS, 2000, PRACT GUID TREATM PA; American Psychiatric Association, 2002, PRACT GUID TREATM PA; American Psychiatric Association, 2004, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Arean PA, 2002, GERONTOLOGIST, V42, P392, DOI 10.1093/geront/42.3.392; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Bortolotti B, 2008, GEN HOSP PSYCHIAT, V30, P293, DOI 10.1016/j.genhosppsych.2008.04.001; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Chen HT, 2006, AM J GERIAT PSYCHIAT, V14, P371, DOI 10.1097/01.JGP.0000196632.65375.b9; Elhai JD, 2008, J PSYCHIATR RES, V42, P858, DOI 10.1016/j.jpsychires.2007.09.006; Elhai JD, 2007, PSYCHIAT SERV, V58, P1108, DOI 10.1176/appi.ps.58.8.1108; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Foa EB, 2007, PROLONGED EXPOSURE T; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Friedman MJ, 2005, NEW ENGL J MED, V352, P1287, DOI 10.1056/NEJMp058028; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gray Matt J, 2004, Prehosp Disaster Med, V19, P64; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700; *I MED, 2007, TREATM PTSD ASS EV C; International Classification of Diseases, 2008, INT CLASS DIS; KANG H, 2008, OPERATION IRAQI FREE; Katon W, 2002, J GEN INTERN MED, V17, P741, DOI 10.1046/j.1525-1497.2002.11051.x; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kulka R. A., 1990, TRAUMA VIETNAM WAR G; Kulka RA., 1990, NATL VIETNAM VETERAN; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; *MHAT V, 2008, OP IR FREED 06 IR OP; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Movig KLL, 2003, J CLIN EPIDEMIOL, V56, P530, DOI 10.1016/S0895-4356(03)00006-4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pols H, 2007, AM J PUBLIC HEALTH, V97, P2132, DOI 10.2105/AJPH.2006.090910; Resick P.A., 2006, COGNITIVE PROCESSING; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; StataCorp, 2007, STAT STAT SOFTW REL; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Tanielian T, 2008, INVISIBLE WOUNDS WAR; *VET HLTH ADM DEP, 2004, VA DOD CLIN PRACT GU; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4	53	290	291	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	FEB	2010	23	1					5	16		10.1002/jts.20493			12	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	571FW	WOS:000275738100003	20146392				2021-06-18	
J	Casha, S; Yu, WR; Fehlings, MG				Casha, S; Yu, WR; Fehlings, MG			Oligodendroglial apoptosis occurs along degenerating axons and is associated with Fas and p75 expression following spinal cord injury in the rat	NEUROSCIENCE			English	Article						programmed cell death; neurotrauma; glia; caspases; death receptors; beta-amyloid precursor	AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; GLUTAMATE RECEPTORS; CALCIUM HOMEOSTASIS; MULTIPLE-SCLEROSIS; COMPRESSION TRAUMA; SECONDARY INJURY; CORTICAL-NEURONS	Apoptosis or programmed cell death has been reported after CNS trauma. However, the significance of this mechanism in the pathophysiology of spinal cord injury, in particular at the cervical level, requires further investigation. In the present study, we used the extradural clip compression model in the rat to examine the cellular distribution of apoptosis following cervical spinal cord injury, the relationship between glial apoptosis and post-traumatic axonal degeneration and the possible role of apo[apoptosis]-1, CD95 (FAS) and p75 in initiating post-traumatic glial apoptosis. In situ terminal-deoxy-transferase mediated dUTP nick end labeling revealed apoptotic cells, largely oligodendrocytes as identified by cell specific markers. in grey and white matter following spinal cord injury. Apoptotic cell death was confirmed using electron microscopy and by the demonstration of DNA laddering on agarose gel electrophoresis. P-Amyloid precursor protein was used as a molecular marker of axonal degeneration on western blots and immunohistochemistry. Degeneration of axons was temporally and spatially co-localized with glial apoptosis. FAS and p75 protein expression was seen in astrocytes, oligodendrocytes and microglia, and was also seen in some apoptotic glia after cord injury. Both FAS and p75 increased in expression in a temporal course, which mirrored the development of cellular apoptosis. The downstream caspases 3 and 8, which are linked to FAS and p75, demonstrated activation at times of maximal apoptosis, while FLIP-L an inhibitor of caspase 8. decreased at times of maximal apoptosis. We conclude that axonal degeneration after traumatic spinal cord injury is associated with glial, in particular oligo dendroglial, apoptosis. Activation of the FAS and p75 death receptor pathways may be involved in initiating this process. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Div Neurosurg, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5T 2S8, Canada	Fehlings, MG (corresponding author), Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Div Neurosurg, Toronto, ON M5T 2S8, Canada.			Fehlings, Michael/0000-0002-5722-6364			Agrawal SK, 1997, J NEUROTRAUM, V14, P81, DOI 10.1089/neu.1997.14.81; Agrawal SK, 1996, J NEUROSCI, V16, P545; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Banasiak KJ, 1998, BRAIN RES, V797, P295, DOI 10.1016/S0006-8993(98)00286-8; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; BLACK P, 1988, NEUROSURGERY, V22, P51, DOI 10.1227/00006123-198801000-00008; Blight A, 1988, J Am Paraplegia Soc, V11, P26; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chopp M, 1996, STROKE, V27, P363, DOI 10.1161/01.STR.27.3.363; Colbourne F, 1999, J NEUROSCI, V19, P4200; Condorelli DF, 1995, J MOL NEUROSCI, V6, P237, DOI 10.1007/BF02736783; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DEPASQUALE B, 1991, BIOCHEM BIOPH RES CO, V181, P1442; DOLAN EJ, 1979, J NEUROSURG, V51, P229, DOI 10.3171/jns.1979.51.2.0229; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; GRIFFITHS IR, 1976, J NEUROL SCI, V27, P247, DOI 10.1016/0022-510X(76)90065-4; Gu CH, 1999, J NEUROSCI, V19, P3043; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; HAASS C, 1993, J BIOL CHEM, V268, P3021; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katoh K, 1996, NEUROSCI LETT, V216, P9; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KROEMER G, 1995, FASEB J, V9, P1277; LANE DP, 1994, PHILOS T ROY SOC B, V345, P277, DOI 10.1098/rstb.1994.0106; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Okuda Y, 1998, MOL IMMUNOL, V35, P317, DOI 10.1016/S0161-5890(98)00049-2; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; PETERS A, 1991, FINE STRUCTURE NERVO, P273; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Revest JM, 1999, ADV EXP MED BIOL, V468, P309; RINK A, 1995, AM J PATHOL, V147, P1575; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH C, 1994, NEUROPATH APPL NEURO, V20, P322, DOI 10.1111/j.1365-2990.1994.tb00977.x; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Tator CH, 1999, J NEUROSURG, V91, P12, DOI 10.3171/spi.1999.91.1.0012; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Vogt M, 1998, FEBS LETT, V429, P67, DOI 10.1016/S0014-5793(98)00562-6; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Yoon SO, 1998, J NEUROSCI, V18, P3273; Yoon SO, 1996, P NATL ACAD SCI USA, V93, P11974, DOI 10.1073/pnas.93.21.11974; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zeine R, 1998, J NEUROIMMUNOL, V87, P49, DOI 10.1016/S0165-5728(98)00047-2	82	290	315	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2001	103	1					203	218		10.1016/S0306-4522(00)00538-8			16	Neurosciences	Neurosciences & Neurology	411JH	WOS:000167494600020	11311801				2021-06-18	
J	Riemann, BL; Guskiewicz, KM				Riemann, BL; Guskiewicz, KM			Effects of mild head injury on postural stability as measured through clinical balance testing	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; postural equilibrium; postural control	2ND IMPACT; SPORTS; GUIDELINES; CONCUSSION; RETURN	Objective: Although force-platform measures of postural stability provide objective information concerning mild head injury (MHI) resolution, their application has remained limited due to the high costs and impracticality for sideline use. Therefore, we investigated the efficacy of a clinical balance testing procedure for the detection of acute postural stability disruptions after MHI. Design and Setting: We used a posttest control group design with repeated measures. Postural stability was tested at 3 postinjury time intervals (days 1, 3, and 5) using 2 procedures in a sports medicine laboratory: 1) a clinical balance battery consisting of 3 stances (double leg, single leg, and tandem) on 2 surfaces (firm and foam), and 2) the Sensory Organization Test using a sophisticated force-platform system. Subjects: Sixteen MHI and 16 matched control subjects participated in this study. Measurements: We measured performance with the Balance Error Scoring System for each of the clinical balance tests and the NeuroCom Smart Balance Master for Sensory Organization Testing. Results: We found significantly higher postural instability in the MHI subjects revealed through the clinical test battery, with the 3 stances on the foam surface eliciting significant differences through day 3 postinjury. Results of the Sensory Organization Test revealed significant group differences on day 1 postinjury. Conclusions: Our results revealed that the Balance Error Scoring System may be a useful clinical procedure to assist clinicians in making return-to-play decisions in athletes with Mi-ii in the absence of force-platform equipment.	Univ N Carolina, Sports Med Res Lab, Chapel Hill, NC 27599 USA	Riemann, BL (corresponding author), Univ N Carolina, Sports Med Res Lab, Fetzer CB 8700, Chapel Hill, NC 27599 USA.			Guskiewicz, Kevin/0000-0002-8682-2130			ARNHEIM DD, 1997, PRINCIPLES ATHLETIC; BOOHER JM, 1994, ATHLETIC INJURY ASSE; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Goebel JA, 1997, OTOLARYNG HEAD NECK, V117, P293, DOI 10.1016/S0194-5998(97)70116-5; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; HAMID MA, 1991, ACTA OTO-LARYNGOL, P596; Huck SW, 1996, READING STAT RES; Jacobson G P, 1991, J Am Acad Audiol, V2, P253; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LEBLANC KE, 1994, AM FAM PHYSICIAN, V50, P801; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Nashner LM., 1993, HDB BALANCE FUNCTION, P280; PANOSIAN MMS, 1995, OTOLARYNG HEAD NECK, V112, P399, DOI 10.1016/S0194-5998(95)70273-3; RIEMANN B, 1997, THESIS U N CAROLINA; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 1997, J SPORT REHABIL, V6, P283, DOI 10.1123/jsr.6.3.283; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0	26	290	290	0	20	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN-MAR	2000	35	1					19	25					7	Sport Sciences	Sport Sciences	296UC	WOS:000086043900002	16558603				2021-06-18	
J	Bethea, JR; Nagashima, H; Acosta, MC; Briceno, C; Gomez, F; Marcillo, AE; Loor, K; Green, J; Dietrich, WD				Bethea, JR; Nagashima, H; Acosta, MC; Briceno, C; Gomez, F; Marcillo, AE; Loor, K; Green, J; Dietrich, WD			Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						spinal cord injury; interleukin-10; inflammation; behavioral recovery; axonal growth	NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; MESSENGER-RNA; BRAIN INJURY; TNF-ALPHA; CONTROLLED TRIAL; PROTECT NEURONS	In these studies, we examined the neuroprotective effects of the potent antiinflammatory cytokine interleukin-10 (IL-10) following spinal cord injury (SCI). Neuroprotection was assessed by using behavioral and morphological end points. We hypothesized that injury-induced inflammation contributes to the resulting neuropathology and subsequent loss of function. Therefore, by attenuating injury-induced inflammation, we should promote functional recovery. The New York University device was used to induce moderate SCI and study the resulting inflammatory response and functional consequences of inhibiting this response in rats. We determined that SCI induces the expression of tumor necrosis factor-alpha (TNF-alpha) in the spinal cord and by SCI-activated monocytes isolated from the peripheral circulation. IL-10 (5.0 mu g) administered 30 minutes after-injury significantly reduced the expression of TNF-alpha protein in the spinal cord and in vitro by SCI-activated monocytes. Next, we investigated whether IL-10 would improve functional recovery after SCI. Randomized, double-blinded studies demonstrated that a single injection of IL-10 significantly improves hind limb motor function 2 months after injury, as determined by the Basso, Beattie and Bresnahan (BBB) open-field behavioral test. IL-10-treated animals had a mean BBB score of 18.0 +/- 0.5 (SEM, n = 9) compared with a score of 12.9 +/- 0.6 (SEM, n = 9) for the saline-treated controls. Morphological analysis demonstrated that IL-10 reduces lesion volume by approximately 49% 2 months after injury. These data suggest that acute administration of IL-10 reduces TNF-alpha synthesis in the spinal cord and by activated macrophages, is neuroprotective, and promotes functional recovery following SCI.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Tottori Univ, Fac Med, Dept Orthoped Surg, Tottori 680, Japan	Bethea, JR (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, 1600 NW 10th Ave R-48, Miami, FL 33136 USA.			Green, Jeremy/0000-0002-6102-2620			AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Balasingam V, 1996, J NEUROSCI, V16, P2945; BARBIERI I, 1998, J NEUR ABSTR; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; BARNA BP, 1994, J NEUROIMMUNOL, V50, P101, DOI 10.1016/0165-5728(94)90220-8; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BEG AA, 1996, SCIENCE, V274, P272; BENVENISTE EN, 1992, AM J PHYSIOL, V263, P1; BERKMAN N, 1995, J IMMUNOL, V155, P4412; Berman JW, 1996, J IMMUNOL, V156, P3017; Bethea JR, 1998, J NEUROSCI, V18, P3251; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brodie C, 1996, FEBS LETT, V394, P117, DOI 10.1016/0014-5793(96)00911-8; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; CRISI GM, 1995, EUR J IMMUNOL, V25, P3035, DOI 10.1002/eji.1830251108; CUNHA FG, 1992, BIOCHEM BIOPH RES CO, V183, P1155; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FREI K, 1994, J IMMUNOL, V152, P2720; GHENG Y, 1994, P NATL ACAD SCI USA, V91, P8602; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Issazadeh S, 1996, J NEUROIMMUNOL, V69, P103; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Koedel U, 1996, J IMMUNOL, V157, P5185; Lafortune L, 1996, J NEUROPATH EXP NEUR, V55, P515, DOI 10.1097/00005072-199605000-00003; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Minghetti L, 1998, J NEUROIMMUNOL, V82, P31, DOI 10.1016/S0165-5728(97)00185-9; MIZUNO T, 1994, BIOCHEM BIOPH RES CO, V205, P1907, DOI 10.1006/bbrc.1994.2893; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Pan WH, 1999, J NEUROSCI, V19, P3649; POPOVICH PG, 1997, J COMP NEUROL, V377, P433; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Romano MF, 1996, J IMMUNOL, V156, P2119; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; ROTT O, 1994, EUR J IMMUNOL, V24, P1434, DOI 10.1002/eji.1830240629; SANNA A, 1998, J NEUR ABSTR; SHRIKANT P, 1995, J IMMUNOL, V155, P1489; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Taoka Y, 1998, J NEUROSCI, V18, P1393; Toulmond S, 1996, TRENDS NEUROSCI, V19, P409; TUREEN J, 1995, J CLIN INVEST, V95, P1086, DOI 10.1172/JCI117755; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355	57	290	299	0	22	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1999	16	10					851	863		10.1089/neu.1999.16.851			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	246JD	WOS:000083159900001	10547095				2021-06-18	
J	Soares, HD; Hicks, RR; Smith, D; McIntosh, TK				Soares, HD; Hicks, RR; Smith, D; McIntosh, TK			Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury	JOURNAL OF NEUROSCIENCE			English	Article						traumatic brain injury; inflammation; fluid percussion; leukocytes; neuronal degeneration; RP-1; neutrophils; macrophages; rat	CENTRAL-NERVOUS-SYSTEM; FLUID-PERCUSSION MODEL; TUMOR-NECROSIS-FACTOR; SPINAL-CORD INJURY; POLYMORPHONUCLEAR LEUKOCYTES; ENDOTHELIAL-CELLS; ISCHEMIC-INJURY; HEAD-INJURY; BLOOD-FLOW; RAT	The present study characterized whether inflammatory leukocytic infiltration is temporally and regionally correlated with neuronal degeneration and/or blood brain barrier (BBB) breakdown resulting from traumatic brain injury. Adult rats were sacrificed at 5 min, 2, 4, 12, 24, and 72 hr after lateral fluid percussion brain injury. BBB breakdown, neuronal degeneration and leukocyte infiltration were assessed using immunocytochemistry silver impregnation and toluidine blue and eosin staining. BBB breakdown and neuronal degeneration occurred concomitantly in injured cortex, hippocampus, and along the dorsolateral quadrant of the diencephalon. However, neuronal degeneration within deep diencephalic structures transpired in the absence of IgG extravasation. Neutrophils were observed only in regions exhibiting BBB damage and were first apparent in injured cortex and hippocampus between 2-12 hr posttrauma lining the vasculature and filling subarachnoid/subdural spaces. Neutrophils then migrated from damaged vasculature into traumatized cortical and hippocampal parenchyma by 24 hr after lateral fluid percussion injury. Macrophages were also observed within cortical parenchyma at 24 hr and completely filled the cortical lesion site by 72 hr after injury. Macrophages were not as abundant throughout hippocampal parenchyma and were found only in hippocampal regions exhibiting focal hemorrhage at 72 hr. Finally, neutrophils did not migrate to deep diencephalic structures that showed no BBB damage despite extensive neuronal degeneration. Indeed, lateral fluid percussion elicits inflammatory leukocytic recruitment only in regions experiencing concomitant BBB damage and neuronal degeneration. In summary, inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury.	UNIV KENTUCKY, DIV PHYS THERAPY, LEXINGTON, KY 40536 USA; UNIV PENN, DIV NEUROSURG, PHILADELPHIA, PA 19104 USA	Soares, HD (corresponding author), ST JUDE CHILDRENS RES HOSP, DEPT DEV BIOL, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA.		smith, douglas/A-1321-2007		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26818, NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R55NS026818, R01NS026818, P01NS008803, P50NS008803] Funding Source: NIH RePORTER		AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; ALBELDA SM, 1994, FASEB J, V8, P504; ARNOULD T, 1993, AM J PHYSIOL, V264, pC1102; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BEDNAR MM, 1991, STROKE, V22, P44, DOI 10.1161/01.STR.22.1.44; BEYNON HLC, 1993, CLIN EXP IMMUNOL, V91, P314; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BOWMAN CM, 1983, AM REV RESPIR DIS, V128, P469, DOI 10.1164/arrd.1983.128.3.469; BROADWELL RD, 1994, MICROSC RES TECHNIQ, V27, P471, DOI 10.1002/jemt.1070270603; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; BROADWELL RD, 1992, PROG BRAIN RES, V91, P95; BURKEGAFFNEY A, 1993, IMMUNOPHARMACOLOGY, V25, P1, DOI 10.1016/0162-3109(93)90025-L; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLARK WM, 1991, STROKE, V22, P877, DOI 10.1161/01.STR.22.7.877; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FLARIS NA, 1993, GLIA, V7, P34, DOI 10.1002/glia.440070108; GALLYAS F, 1980, STAIN TECHNOL, V55, P299, DOI 10.3109/10520298009067258; GARCIA JH, 1994, AM J PATHOL, V144, P188; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; GOTOH S, 1986, J IMMUNOL, V137, P643; Graham D.I., 1993, HEAD INJURY, P91; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HARLAN JM, 1985, BLOOD, V65, P513; HICKS R, 1995, IN PRESS ACTA NEUROP; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOLTZ A, 1990, Journal of Neurotrauma, V7, P155, DOI 10.1089/neu.1990.7.155; HORGAN MJ, 1990, AM J PHYSIOL, V259, pL315; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KOCHANEK PM, 1990, LIPID MEDIATORS ISCH, P220; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LUCCHESI BR, 1986, ANNU REV PHARMACOL, V26, P201, DOI 10.1146/annurev.pa.26.040186.001221; MA XL, 1991, J CLIN INVEST, V88, P1237, DOI 10.1172/JCI115427; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MORENOFLORES MT, 1993, GLIA, V7, P146, DOI 10.1002/glia.440070204; MORI T, 1990, BRAIN RES, V527, P55, DOI 10.1016/0006-8993(90)91059-P; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; OBRIEN RF, 1984, AM REV RESPIR DIS, V130, P103; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PERSSON L, 1976, VIRCHOWS ARCH B, V22, P21; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SLOAN DJ, 1992, TRENDS NEUROSCI, V15, P276, DOI 10.1016/0166-2236(92)90075-J; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TATE RM, 1983, AM REV RESPIR DIS, V128, P552, DOI 10.1164/arrd.1983.128.3.552; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TONNESEN MG, 1988, MOL CELLULAR BIOL WO, P149; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	79	290	295	1	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	DEC	1995	15	12					8223	8233					11	Neurosciences	Neurosciences & Neurology	TP154	WOS:A1995TP15400040	8613756				2021-06-18	
J	Dewan, MC; Rattani, A; Gupta, S; Baticulon, RE; Hung, YC; Punchak, M; Agrawal, A; Adeleye, AO; Shrime, MG; Rubiano, AM; Rosenfeld, JV; Park, KB				Dewan, Michael C.; Rattani, Abbas; Gupta, Saksham; Baticulon, Ronnie E.; Hung, Ya-Ching; Punchak, Maria; Agrawal, Amit; Adeleye, Amos O.; Shrime, Mark G.; Rubiano, Andres M.; Rosenfeld, Jeffrey V.; Park, Kee B.			Estimating the global incidence of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						epidemiology; global; incidence; prevalence; traumatic brain injury; volume; worldwide	PEDIATRIC HEAD-INJURIES; US EMERGENCY-DEPARTMENTS; ROAD TRAFFIC INJURIES; IN-HOSPITAL FATALITY; INTENSIVE-CARE-UNIT; SPINAL-CORD-INJURY; RISK-FACTORS; YOUNG-ADULTS; NEW-ZEALAND; RETROSPECTIVE ANALYSIS	OBJECTIVE Traumatic brain injury (TBI)-the "silent epidemic"-contributes to worldwide death and disability more than any other traumatic insult. Yet, TBI incidence and distribution across regions and socioeconomic divides remain unknown. In an effort to promote advocacy, understanding, and targeted intervention, the authors sought to quantify the case burden of TBI across World Health Organization (WHO) regions and World Bank (WB) income groups. METHODS Open-source epidemiological data on road traffic injuries (RTIs) were used to model the incidence of TBI using literature-derived ratios. First, a systematic review on the proportion of RTIs resulting in TBI was conducted, and a meta-analysis of study-derived proportions was performed. Next, a separate systematic review identified primary source studies describing mechanisms of injury contributing to TBI, and an additional meta-analysis yielded a proportion of TBI that is secondary to the mechanism of RTI. Then, the incidence of RTI as published by the Global Burden of Disease Study 2015 was applied to these two ratios to generate the incidence and estimated case volume of TBI for each WHO region and WB income group. RESULTS Relevant articles and registries were identified via systematic review; study quality was higher in the high-income countries (HICs) than in the low-and middle-income countries (LMICs). Sixty-nine million (95% CI 64-74 million) individuals worldwide are estimated to sustain a TBI each year. The proportion of TBIs resulting from road traffic collisions was greatest in Africa and Southeast Asia (both 56%) and lowest in North America (25%). The incidence of RTI was similar in Southeast Asia (1.5% of the population per year) and Europe (1.2%). The overall incidence of TBI per 100,000 people was greatest in North America (1299 cases, 95% CI 650-1947) and Europe (1012 cases, 95% CI 9111113) and least in Africa (801 cases, 95% CI 732-871) and the Eastern Mediterranean (897 cases, 95% CI 771-1023). The LMICs experience nearly 3 times more cases of TBI proportionally than HICs. CONCLUSIONS Sixty-nine million (95% CI 64-74 million) individuals are estimated to suffer TBI from all causes each year, with the Southeast Asian and Western Pacific regions experiencing the greatest overall burden of disease. Head injury following road traffic collision is more common in LMICs, and the proportion of TBIs secondary to road traffic collision is likewise greatest in these countries. Meanwhile, the estimated incidence of TBI is highest in regions with higher-quality data, specifically in North America and Europe.	[Dewan, Michael C.; Rattani, Abbas; Hung, Ya-Ching; Punchak, Maria; Shrime, Mark G.; Park, Kee B.] Harvard Med Sch, Global Neurosurg Initiat, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Gupta, Saksham] Harvard Med Sch, Boston, MA 02115 USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Off Global Surg & Hlth, Boston, MA 02114 USA; [Dewan, Michael C.] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Neurol Surg, Nashville, TN USA; [Rattani, Abbas] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA; [Baticulon, Ronnie E.] Univ Philippines, Coll Med, Philippine Gen Hosp, Manila, Philippines; [Punchak, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Agrawal, Amit] Narayana Med Coll, Dept Neurosurg, Nellore, Andhra Pradesh, India; [Adeleye, Amos O.] Univ Ibadan, Coll Med, Dept Surg, Div Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos O.] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria; [Rubiano, Andres M.] El Bosque Univ, El Bosque Clin, MEDITECH INUB Res Grp, Neurosci Inst,Neurosurg Serv, Bogota, Colombia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, Dept Surg, F Edward Hebert Sch Med, Bethesda, MD 20814 USA	Dewan, MC (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.	michael.dewan@vanderbilt.edu	RUBIANO, ANDRES M/K-6704-2012; Baticulon, Ronnie/AAW-7768-2020; Agrawal, Amit/C-1511-2011	RUBIANO, ANDRES M/0000-0001-8931-3254; Baticulon, Ronnie/0000-0002-2781-1845; Agrawal, Amit/0000-0002-3287-5448	Vanderbilt Medical Scholars Program	We thank Andrew Hale, Olivia Ahearn, Kaya Garringer, Desmond Jumbam, and Tessa Varvares for their early technical assistance with the systematic review. We acknowledge the Vanderbilt Medical Scholars Program for providing Abbas Rattani with support on this project.	Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Agarwal-Harding KJ, 2015, J BONE JOINT SURG AM, V97A, DOI 10.2106/JBJS.N.00314; Agius S, 2012, BRIT J NEUROSURG, V26, P212, DOI 10.3109/02688697.2011.609920; Agrawal A, 2008, Afr J Paediatr Surg, V5, P15, DOI 10.4103/0189-6725.41630; Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Agrawal Deepak, 2016, Asian J Neurosurg, V11, P143, DOI 10.4103/1793-5482.145081; Akama M K, 2007, East Afr Med J, V84, P287; Al-Habib A, 2014, ANN SAUDI MED, V34, P91; Ala-Seppala H, 2016, BRAIN INJURY, V30, P1062, DOI 10.3109/02699052.2016.1170880; Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Aldawood AS, 2012, ANN SAUDI MED, V32, P498, DOI 10.5144/0256-4947.2012.498; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bachani AM, 2012, TRAFFIC INJ PREV, V13, P24, DOI 10.1080/15389588.2011.633136; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bahloul Mabrouk, 2009, Tunis Med, V87, P28; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Banthia P, 2006, JNMA J Nepal Med Assoc, V45, P238; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Bener Abdulbari, 2011, Sultan Qaboos Univ Med J, V11, P244; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bhatti JA, 2015, BMC EMERG MED, V15, DOI 10.1186/1471-227X-15-S2-S12; Boniface R, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.46.7487; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brazinova A, 2015, AGE AGEING, V44, P502, DOI 10.1093/ageing/afu194; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Burrows P, 2015, ARCH DIS CHILD, V100, P1032, DOI 10.1136/archdischild-2014-307119; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Centers for Disease C Prevention, 2006, MMWR-MORBID MORTAL W, V55, P201; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Chan H. C., 2005, SMJ Singapore Medical Journal, V46, P219; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Chiavaroli F, 2016, DISABIL REHABIL, V38, P2038, DOI 10.3109/09638288.2015.1111439; Chinda J Y, 2013, Afr J Paediatr Surg, V10, P358, DOI 10.4103/0189-6725.125448; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Chong SL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010618; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dias C, 2014, ACTA MEDICA PORT, V27, P349, DOI 10.20344/amp.4892; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; du Toit-Prinsloo L, 2014, AM J FOREN MED PATH, V35, P212, DOI 10.1097/PAF.0000000000000113; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Emejulu JKC, 2010, NIGER J CLIN PRACT, V13, P276; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Fabbri A, 2010, INJURY, V41, P913, DOI 10.1016/j.injury.2010.03.002; Fakharian E, 2014, CHIN J TRAUMATOL, V17, P153, DOI 10.3760/cma.j.issn.1008-1275.2014.03.006; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; Feitas Juliana Pontes Pinto, 2007, Cad. Saúde Pública, V23, P3055, DOI 10.1590/S0102-311X2007001200028; Fekih Hassen Amjed, 2012, Tunis Med, V90, P25; Fernandez Mara L, 2010, Bol Asoc Med P R, V102, P26; Ferreros I, 2012, REV NEUROLOGIA, V54, P719, DOI 10.33588/rn.5412.2011701; Finnerty F, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-36; Firsching R, 2001, WORLD J SURG, V25, P1221; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frohlich S, 2011, IRISH J MED SCI, V180, P423, DOI 10.1007/s11845-011-0674-8; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gisladottir EH, 2014, LAEKNABLADID, V100, P331, DOI 10.17992/lbl.2014.06.547; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guillén-Pinto Daniel, 2013, Rev. perú. med. exp. salud publica, V30, P630; Gupta S, 2017, WORLD NEUROSURG, V100, P267, DOI 10.1016/j.wneu.2016.12.104; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Halldorsson Jonas G, 2007, Neuropsychiatr Dis Treat, V3, P935; Hamann C, 2015, INJURY PREV, V21, P84, DOI 10.1136/injuryprev-2014-041266; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison JE, 2012, BRAIN INJURY, V26, P996, DOI 10.3109/02699052.2012.660515; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley C, 2013, INJURY, V44, P1855, DOI 10.1016/j.injury.2013.07.021; Heim C, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13958; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Hu JH, 2013, J NEUROTRAUM, V30, P1755, DOI 10.1089/neu.2013.2857; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Institute of Health Metrics and Evaluation, 2016, GLOB BURD DIS STUD 2; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P166, DOI 10.5505/tjtes.2011.22800; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P46, DOI 10.5505/tjtes.2011.57431; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagnoor J, 2012, INJURY, V43, P1996, DOI 10.1016/j.injury.2011.08.004; Jaja BNR, 2014, ANN AFR MED, V13, P204, DOI 10.4103/1596-3519.142292; Jamieson LM, 2007, INJURY PREV, V13, P243, DOI 10.1136/ip.2007.015354; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Ji Cuirong, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P360; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kaptigau WM, 2007, PAPUA NEW GUINEA MED, V50, P50; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; Katsaragakis S, 2010, BRAIN INJURY, V24, P871, DOI 10.3109/02699051003789237; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Khan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132229; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; King J, 2009, SCOT MED J, V54, P34, DOI 10.1258/rsmsmj.54.2.34; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kool B, 2013, NEUROEPIDEMIOLOGY, V41, P189, DOI 10.1159/000354782; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kramer AH, 2013, CAN MED ASSOC J, V185, pE838, DOI 10.1503/cmaj.130271; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Lagolago W, 2015, NEW ZEAL MED J, V128, P29; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lasry Oliver, 2016, CMAJ Open, V4, pE249, DOI 10.9778/cmajo.20150105; Le Roux AA, 2007, BRIT J NEUROSURG, V21, P16, DOI 10.1080/02688690601170692; Lee KS, 2001, J KOREAN MED SCI, V16, P342, DOI 10.3346/jkms.2001.16.3.342; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Lin CM, 2014, INJURY, V45, P690, DOI 10.1016/j.injury.2013.09.031; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Majdan M, 2015, CENT EUR J PUBL HEAL, V23, P142; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Marchio PS, 2006, NEUROCIRUGIA, V17, P14; Marlow R, 2015, ARCH DIS CHILD, V100, P1136, DOI 10.1136/archdischild-2015-308615; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2014, BRAIN INJURY, V28, P1295, DOI 10.3109/02699052.2014.916418; Mauritz W, 2014, BRAIN INJURY, V28, P1096, DOI 10.3109/02699052.2014.904522; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Miekisiak G, 2016, BRAIN INJURY, V30, P79, DOI 10.3109/02699052.2015.1104550; Mishra B, 2016, INDIAN J COMMUNITY M, V35, P115; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Mitra B, 2006, ANZ J SURG, V76, P343, DOI 10.1111/j.1445-2197.2006.03723.x; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI [10.1186/2046-4053-4-1, 10.14306/renhyd.20.2.223]; Moore L, 2017, ANN SURG, V265, P212, DOI 10.1097/SLA.0000000000001614; Moorin R, 2014, J NEUROL, V261, P1726, DOI 10.1007/s00415-014-7411-y; Morisse E, 2014, BRAIN INJURY, V28, P1436, DOI 10.3109/02699052.2014.919526; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muyembe VM, 1999, E AFR MED J, V76, P200; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Odebode TO, 2008, NIGER J CLIN PRACT, V11, P265; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; Oluwole OSA, 2011, BRAIN INJURY, V25, P980, DOI 10.3109/02699052.2011.589798; Ovalle Fernando Jr, 2014, Inj Epidemiol, V1, P15; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Phillips LA, 2009, CAN J NEUROL SCI, V36, P605, DOI 10.1017/S0317167100008118; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Pruthi N, 2012, INDIAN J MED RES, V136, P1039; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Melo JRT, 2006, ARQ NEURO-PSIQUIAT, V64, P994, DOI 10.1590/S0004-282X2006000600020; Robertson Brian D, 2013, J Inj Violence Res, V5, P51, DOI 10.5249/jivr.v5i1.205; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Ramos MR, 2013, MEDICC REV, V15, P30; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rus D, 2016, INT J INJ CONTROL SA, V23, P206, DOI 10.1080/17457300.2013.872671; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryu MS, 2006, J KOREAN CHILD NEURO, V14, P87; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Seid M, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0035-4; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shao JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048127; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Shukri AA, 2006, ZH VOPR NEIROKHIR IM, V40-42; Siman-Tov M, 2016, BRAIN INJURY, V30, P83, DOI 10.3109/02699052.2015.1104551; Slesak G, 2015, TROP MED INT HEALTH, V20, P1578, DOI 10.1111/tmi.12562; Solagberu BA, 2014, PEDIATR SURG INT, V30, P625, DOI 10.1007/s00383-014-3516-8; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sudlow A, 2013, INJURY, V44, P1237, DOI 10.1016/j.injury.2011.11.021; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Suominen JS, 2011, SCAND J SURG, V100, P129, DOI 10.1177/145749691110000212; Szarpak Lukasz, 2011, Pol Przegl Chir, V83, P646, DOI 10.2478/v10035-011-0103-8; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Tay EL, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0590-1; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Twagirayezu E, 2008, E CENT AFR J SURG, V13, p73 ; Uche E O, 2013, Niger J Med, V22, P274; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Younis R, 2011, BRAIN INJURY, V25, P282, DOI 10.3109/02699052.2010.546823; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493; Zubovic A, 2018, IRAN MED J, V99, P121; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	266	289	294	13	23	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2019	130	4					1080	1097		10.3171/2017.10.JNS17352			18	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	HR1CV	WOS:000462866700006	29701556	Other Gold	Y	Y	2021-06-18	
J	Yeates, KO; Swift, E; Taylor, HG; Wade, SL; Drotar, D; Stancin, T; Minich, N				Yeates, KO; Swift, E; Taylor, HG; Wade, SL; Drotar, D; Stancin, T; Minich, N			Short- and long-term social outcomes following pediatric traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						traumatic brain injury; children; social outcomes	CLOSED-HEAD-INJURY; CHILDREN; BEHAVIOR; FAMILY; COMPETENCE; ADOLESCENTS; RELIABILITY; ADJUSTMENT; CHILDHOOD; CONSTRUCT	The social outcomes of pediatric traumatic brain injury (TBI) were examined in a prospective, longitudinal study that included 53 children with severe TBI, 56 with moderate TBI, and 80 with orthopedic injuries, recruited between 6 and 12 years of age. Child and family functioning were assessed at baseline, at 6- and 12-month follow-ups, and at an extended follow-up a mean of 4 years post injury. Growth curve analyses revealed that pediatric TBI yields negative social outcomes that are exacerbated by family environments characterized by lower socioeconomic status, fewer family resources, and poorer family functioning. After controlling for group membership, age, race, socioeconomic status, and IQ, path analyses indicated that long-term social outcomes were accounted for in part by specific neurocognitive skills, including executive functions and pragmatic language, and by social problem-solving. Deficits in these domains among children with TBI are likely to reflect damage to a network of brain regions that have been implicated in social cognition.	Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Childrens Res Inst, Columbus, OH USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Childrens Hosp, Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; MetroHlth Med Ctr, Cleveland, OH USA	Yeates, KO (corresponding author), Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43220 USA.	yeates.1@osu.edu	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 R01 NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ 390611] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER		Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson P., 2000, CLIN NEUROPSYCHOL AS, V1, P247, DOI DOI 10.1076/chin.8.4.231.13509; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BERUBE RL, 2003, BIBLIOGRAPHY PUBLISH; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; BURCHINAL MR, 1994, J EARLY INTERVENTION, V18, P403, DOI 10.1177/105381519401800409; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Cacioppo JT, 2000, PSYCHOL BULL, V126, P829, DOI 10.1037//0033-2909.126.6.829; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CICCHETTI DV, 1994, J CLIN EXP NEUROPSYC, V16, P339, DOI 10.1080/01688639408402644; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; DROTAR D, 1995, J CLIN CHILD PSYCHOL, V24, P184, DOI 10.1207/s15374424jccp2402_6; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; FRANCIS DJ, 1994, NEUROPSYCHOL REV, V4, P199, DOI 10.1007/BF01874892; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gest SD, 2001, SOC DEV, V10, P23, DOI 10.1111/1467-9507.00146; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331; Guralnick MJ, 1999, MENT RETARD DEV D R, V5, P21; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; KAMPHAUS RW, 1987, J SCHOOL PSYCHOL, V25, P97, DOI 10.1016/0022-4405(87)90066-5; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Klem L., 2000, READING UNDERSTANDIN, P227; Kolb B, 2003, CURR DIR PSYCHOL SCI, V12, P1, DOI 10.1111/1467-8721.01210; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MCGANN W, 1995, BRAIN INJURY, V9, P93, DOI 10.3109/02699059509004575; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moos R, 1994, LIFE STRESSORS SOCIA; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Parker JG, 1995, DEV PSYCHOPATHOL, V2, P96; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rubin K. H., 2006, SOCIAL EMOTIONAL PER, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Rutter ML, 1999, BRIT J PSYCHIAT, V174, P480, DOI 10.1192/bjp.174.6.480; *SAS I, 1990, STAT AN SYST VERS 6; Sattler J. M., 1992, ASSESSMENT CHILDREN; Schultz L.H., 1988, INTERPERSONAL NEGOTI; Sobel M. E., 1988, COMMON PROBLEMS PROP, P46; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 1991, WECHSLER INTELLIGENC; WIIG EH, 1989, TEST LANGUAGES COMPE; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T	70	289	289	0	51	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2004	10	3					412	426		10.1017/S1355617704103093			15	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	817MB	WOS:000221180500011	15147599				2021-06-18	
J	Sneeuw, KCA; Sprangers, MAG; Aaronson, NK				Sneeuw, KCA; Sprangers, MAG; Aaronson, NK			The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						quality of life; assessment; proxy; agreement; reliability; validity	NURSING-HOME RESIDENTS; TRAUMATIC BRAIN-INJURY; FUNCTIONAL STATUS; CANCER-PATIENTS; PROXY RESPONSE; MEDICAL OUTCOMES; CLINICAL-TRIALS; OLDER PATIENTS; SELF-REPORTS; SURVEY SF-36	Health-related quality of life (HRQL) studies sometimes rely, in part, on proxy information obtained from patients' significant others (spouse or close companion) or health care providers. This review: (1) provides a quantitative analysis of the results that have been reported in recent studies assessing the level of agreement between patient and proxy HRQL ratings, and (2) addresses a number of key methodological issues surrounding the use of proxy raters in HRQL research. This review concentrates on 23 studies, published between 1991-2000, that describe patient-proxy agreement for a number of well-known multidimensional HRQL instruments. In general, moderate to high levels of patient-proxy agreement were reported. Lower levels of agreement were found predominantly in studies employing a small sample size (approximately 50 patient-proxy pairs or less) In larger studies comparing patients and their significant others, median correlations were between 0.60-0.70 for physical HRQL domains and about 0.50 for psychosocial domains. Mixed results were reported in studies comparing patients and their health care providers, but most of these studies employed a relatively small sample size. Proxy raters tended to report more HRQL problems than patients themselves, but the magnitude of observed differences was modest (median standardized differences of about 0.20). Based on the current evidence, we conclude that judgements made by significant others and health care providers about several aspects of patients' HRQL are reasonably accurate. Substantial discrepancies between patient and proxy ratings occur in a minority of cases. We recommend that future studies focus on: (a) the reliability and validity of proxy ratings according to common psychometric methods, and (b) the balance between information bias due to proxy ratings and potential selection bias due to exclusion of important patient subgroups from HRQL studies. (C) 2002 Elsevier Science Inc. All rights reserved.	Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands; TNO Prevent & Hlth, Child Hlth Div, NL-2301 CE Leiden, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands	Aaronson, NK (corresponding author), Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	naaron@nki.nl					AARONSON NK, 1991, CANCER, V67, P844, DOI 10.1002/1097-0142(19910201)67:3+<844::AID-CNCR2820671416>3.0.CO;2-B; AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aaronson NK, 1991, EFFECT CANC QUALITY, P185; Albert SM, 1996, J AM GERIATR SOC, V44, P1342, DOI 10.1111/j.1532-5415.1996.tb01405.x; Albertsen PC, 1997, UROLOGY, V49, P207, DOI 10.1016/S0090-4295(96)00485-2; BASSETT SS, 1990, PSYCHOL AGING, V5, P127, DOI 10.1037/0882-7974.5.1.127; BERGER R, 1998, J CLIN BAS CARDIOL, V1, P19; BERLOWITZ DR, 1995, J AM GERIATR SOC, V43, P799, DOI 10.1111/j.1532-5415.1995.tb07055.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BLAZEBY JM, 1995, BRIT J SURG, V82, P1200, DOI 10.1002/bjs.1800820916; Brunelli C, 1998, J PAIN SYMPTOM MANAG, V15, P151, DOI 10.1016/S0885-3924(97)00351-5; Chin MH, 1999, ANN EMERG MED, V34, P595, DOI 10.1016/S0196-0644(99)70161-7; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P19; Corder LS, 1996, J CLIN EPIDEMIOL, V49, P173, DOI 10.1016/0895-4356(95)00507-2; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DEHAAN R, 1993, STROKE, V24, P320, DOI 10.1161/01.STR.24.2.320; DEHAAN RJ, 1995, STROKE, V26, P402, DOI 10.1161/01.STR.26.3.402; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Dorman PJ, 1997, STROKE, V28, P1883, DOI 10.1161/01.STR.28.10.1883; EPSTEIN AM, 1989, MED CARE, V27, pS91, DOI 10.1097/00005650-198903001-00008; Farrow D C, 1990, Epidemiology, V1, P370, DOI 10.1097/00001648-199009000-00006; Forjaz MJ, 1999, PSYCHO-ONCOL, V8, P546, DOI 10.1002/(SICI)1099-1611(199911/12)8:6<546::AID-PON410>3.0.CO;2-Q; GOLDSTEIN M, 1987, MULTILEVEL MODELS ED, P1; Gotay C, 1996, QUALITY LIFE PHARMAC, P413; Grassi L, 1996, J PSYCHOSOC ONCOL, V14, P31, DOI 10.1300/J077v14n03_03; Hackett ML, 2000, STROKE, V31, P440, DOI 10.1161/01.STR.31.2.440; HAYS RD, 1995, QUAL LIFE RES, V4, P159, DOI 10.1007/BF01833609; Iezzoni LI, 2000, MED CARE, V38, P1051, DOI 10.1097/00005650-200010000-00009; Kempen GIJM, 1997, HEALTH PSYCHOL, V16, P539, DOI 10.1037/0278-6133.16.6.539; Kempen GIJM, 1996, AGE AGEING, V25, P458, DOI 10.1093/ageing/25.6.458; Lampic C, 2000, ACTA ONCOL, V39, P9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; le Coq EM, 2000, J CLIN EPIDEMIOL, V53, P139, DOI 10.1016/S0895-4356(99)00158-4; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Long K, 1998, J AM GERIATR SOC, V46, P1103, DOI 10.1111/j.1532-5415.1998.tb06648.x; Magaziner J, 1997, AM J EPIDEMIOL, V146, P418, DOI 10.1093/oxfordjournals.aje.a009295; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; Magaziner J, 1997, ALZ DIS ASSOC DIS, V11, P168; Magaziner Jay, 1992, P120; Mathias SD, 1997, STROKE, V28, P1888, DOI 10.1161/01.STR.28.10.1888; McCusker J, 1999, J CLIN EPIDEMIOL, V52, P1023, DOI 10.1016/S0895-4356(99)00084-0; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MEERS C, 1995, DIALYSIS TRANSPLANT, V24, P120; Moinpour CM, 2000, QUAL LIFE RES, V9, P219, DOI 10.1023/A:1008978512572; Murrell R, 1999, NEUROPSYCHOL REV, V9, P209, DOI 10.1023/A:1021686606648; NELSON E, 1987, J CHRON DIS, V40, pS55, DOI 10.1016/S0021-9681(87)80033-4; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Osoba D, 1997, QUAL LIFE RES, V6, P103; Osoba D, 1996, QUAL LIFE RES, V5, P139, DOI 10.1007/BF00435979; Pierre U, 1998, J CLIN EPIDEMIOL, V51, P983, DOI 10.1016/S0895-4356(98)00090-0; Rogers J, 1997, ANAESTHESIA, V52, P1137, DOI 10.1111/j.1365-2044.1997.240-az0374.x; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; Sainfort F, 1996, AM J PSYCHIAT, V153, P497; Santos-Eggimann B, 1999, J CLIN EPIDEMIOL, V52, P181, DOI 10.1016/S0895-4356(98)00155-3; SEGAL ME, 1994, STROKE, V25, P2391, DOI 10.1161/01.STR.25.12.2391; SEMAAN S, 1994, J APPL GERONTOL, V13, P341, DOI 10.1177/073346489401300401; Sigurdardottir V, 1996, QUAL LIFE RES, V5, P375, DOI 10.1007/BF00433922; SLEVIN ML, 1988, BRIT J CANCER, V57, P109, DOI 10.1038/bjc.1988.20; Sneeuw KCA, 1999, BRIT J CANCER, V81, P87, DOI 10.1038/sj.bjc.6690655; Sneeuw KCA, 1997, MED CARE, V35, P490, DOI 10.1097/00005650-199705000-00006; Sneeuw KCA, 1998, J CLIN EPIDEMIOL, V51, P617, DOI 10.1016/S0895-4356(98)00040-7; Sneeuw KCA, 1997, STROKE, V28, P1541, DOI 10.1161/01.STR.28.8.1541; Sneeuw KCA, 1997, J CLIN ONCOL, V15, P1206, DOI 10.1200/JCO.1997.15.3.1206; Sneeuw KCA, 2001, J UROLOGY, V165, P478, DOI 10.1097/00005392-200102000-00029; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; Sprangers MAG, 2000, ACTA ONCOL, V39, P5; Stephens RJ, 1997, QUAL LIFE RES, V6, P225; TAMBURINI M, 1992, ANN ONCOL, V3, P565, DOI 10.1093/oxfordjournals.annonc.a058263; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Todorov A, 2000, AM J PUBLIC HEALTH, V90, P1248, DOI 10.2105/AJPH.90.8.1248; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Van Weel C, 1993, Disabil Rehabil, V15, P96; Verrips GHW, 2000, CHILD CARE HLTH DEV, V26, P457, DOI 10.1046/j.1365-2214.2000.00181.x; VonDras DD, 1997, SOC SCI MED, V44, P1491, DOI 10.1016/S0277-9536(96)00269-9; Wallander JL, 2001, J CLIN PSYCHOL, V57, P571, DOI 10.1002/jclp.1029; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WOODDAUPHINEE S, 1991, EFFECT CANCER QUALIT, P169; Wu AW, 1997, QUAL LIFE RES, V6, P3, DOI 10.1023/A:1026471020698; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; ZIMMERMAN SI, 1994, ALZ DIS ASSOC DIS, V8, pS281	86	289	293	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	NOV	2002	55	11					1130	1143	PII S0895-4356(02)00479-1	10.1016/S0895-4356(02)00479-1			14	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	628TM	WOS:000180012700012	12507678				2021-06-18	
J	Flierl, MA; Stahel, PF; Beauchamp, KM; Morgan, SJ; Smith, WR; Shohami, E				Flierl, Michael A.; Stahel, Philip F.; Beauchamp, Kathryn M.; Morgan, Steven J.; Smith, Wade R.; Shohami, Esther			Mouse closed head injury model induced by a weight-drop device	NATURE PROTOCOLS			English	Article							TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; APOLIPOPROTEIN-E-DEFICIENT; GLASGOW OUTCOME SCALE; NEURONAL CELL-DEATH; NF-KAPPA-B; CORTICAL INJURY; COMPLEMENT ACTIVATION; COGNITIVE DEFICITS; DYNAMIC CHANGES	Traumatic brain injury represents the leading cause of death in young individuals. Various animal models have been developed to mimic human closed head injury (CHI). Widely used models induce head injury by lateral fluid percussion, a controlled cortical impact or impact acceleration. The presented model induces a CHI by a standardized weight-drop device inducing a focal blunt injury over an intact skull without pre-injury manipulations. The resulting impact triggers a profound neuroinflammatory response within the intrathecal compartment with high consistency and reproducibility, leading to neurological impairment and breakdown of the blood-brain barrier. In this protocol, we define standardized procedures for inducing CHI in mice and determine various severity grades of CHI through modulation of the weight falling height. In experienced hands, this CHI model can be carried out in as little as 30 s per animal, with additional time required for subsequent posttraumatic analysis and data collection.	[Flierl, Michael A.; Stahel, Philip F.; Morgan, Steven J.; Smith, Wade R.] Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO 80202 USA; [Stahel, Philip F.; Beauchamp, Kathryn M.] Univ Colorado, Sch Med, Dept Neurosurg, Denver Hlth Med Ctr, Denver, CO 80202 USA; [Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel	Flierl, MA (corresponding author), Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO 80202 USA.	michael.flierl@dhha.org	Ritter, Stefanie L/D-9312-2012				Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; [Anonymous], 2004, WORLD REP TRAFF INJ; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gore DC, 2005, BURNS, V31, P998, DOI 10.1016/j.burns.2005.06.005; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Lee EJ, 2009, J APPL PHYSIOL, V107, P290, DOI 10.1152/japplphysiol.91255.2008; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Maas A. I., 2000, CURR OPIN CRIT CARE, V6, P281; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Muessel MJ, 2000, BRAIN RES, V870, P211, DOI 10.1016/S0006-8993(00)02450-1; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Newsom DM, 2004, CONTEMP TOP LAB ANIM, V43, P13; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pratt J, 1999, NEUROSCI LETT, V272, P143, DOI 10.1016/S0304-3940(99)00005-1; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; Teasdale GM, 1999, ACT NEUR S, V73, P111; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	59	288	297	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189			NAT PROTOC	Nat. Protoc.		2009	4	9					1328	1337		10.1038/nprot.2009.148			10	Biochemical Research Methods	Biochemistry & Molecular Biology	504FQ	WOS:000270601700010	19713954				2021-06-18	
J	Stern, RA; Daneshvar, DH; Baugh, CM; Seichepine, DR; Montenigro, PH; Riley, DO; Fritts, NG; Stamm, JM; Robbins, CA; McHale, L; Simkin, I; Stein, TD; Alvarez, VE; Goldstein, LE; Budson, AE; Kowall, NW; Nowinski, CJ; Cantu, RC; McKee, AC				Stern, Robert A.; Daneshvar, Daniel H.; Baugh, Christine M.; Seichepine, Daniel R.; Montenigro, Philip H.; Riley, David O.; Fritts, Nathan G.; Stamm, Julie M.; Robbins, Clifford A.; McHale, Lisa; Simkin, Irene; Stein, Thor D.; Alvarez, Victor E.; Goldstein, Lee E.; Budson, Andrew E.; Kowall, Neil W.; Nowinski, Christopher J.; Cantu, Robert C.; McKee, Ann C.			Clinical presentation of chronic traumatic encephalopathy	NEUROLOGY			English	Article							ALZHEIMERS-DISEASE; BRAIN-INJURY; EPSILON 4; DEMENTIA; FOOTBALL; ASSOCIATION; DIAGNOSIS; PLAYERS	Objective: The goal of this study was to examine the clinical presentation of chronic traumatic encephalopathy (CTE) in neuropathologically confirmed cases. Methods: Thirty-six adult male subjects were selected from all cases of neuropathologically confirmed CTE at the Boston University Center for the Study of Traumatic Encephalopathy brain bank. Subjects were all athletes, had no comorbid neurodegenerative or motor neuron disease, and had next-of-kin informants to provide retrospective reports of the subjects' histories and clinical presentations. These interviews were conducted blind to the subjects' neuropathologic findings. Results: A triad of cognitive, behavioral, and mood impairments was common overall, with cognitive deficits reported for almost all subjects. Three subjects were asymptomatic at the time of death. Consistent with earlier case reports of boxers, 2 relatively distinct clinical presentations emerged, with one group whose initial features developed at a younger age and involved behavioral and/or mood disturbance (n = 22), and another group whose initial presentation developed at an older age and involved cognitive impairment (n = 11). Conclusions: This suggests there are 2 major clinical presentations of CTE, one a behavior/mood variant and the other a cognitive variant.	[Stern, Robert A.; Daneshvar, Daniel H.; Baugh, Christine M.; Seichepine, Daniel R.; Montenigro, Philip H.; Riley, David O.; Fritts, Nathan G.; Stamm, Julie M.; Robbins, Clifford A.; Stein, Thor D.; Alvarez, Victor E.; Nowinski, Christopher J.; Cantu, Robert C.; McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA; [Stern, Robert A.; Stein, Thor D.; Goldstein, Lee E.; Budson, Andrew E.; Kowall, Neil W.; McKee, Ann C.] Boston Univ, Sch Med, BU Alzheimers Dis Ctr, Boston, MA 02215 USA; [Stern, Robert A.; Baugh, Christine M.; Seichepine, Daniel R.; Alvarez, Victor E.; Budson, Andrew E.; Kowall, Neil W.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Stern, Robert A.; Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02215 USA; [Stein, Thor D.; Kowall, Neil W.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Simkin, Irene] Boston Univ, Sch Med, Mol Genet Core Facil, Boston, MA 02215 USA; [McHale, Lisa; Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA USA; [Stein, Thor D.; Alvarez, Victor E.; Budson, Andrew E.; Kowall, Neil W.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Biomed Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Elect & Comp Engn, Boston, MA 02215 USA	Stern, RA (corresponding author), Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA.	bobstern@bu.edu	Kowall, Neil/M-5378-2019; Baugh, Christine/AAG-2324-2020; , Bob/ABA-8507-2020	Kowall, Neil/0000-0002-6624-0213; Baugh, Christine/0000-0002-9340-6338; Stern, Robert/0000-0002-5008-077X; Daneshvar, Daniel/0000-0003-3691-9513; Montenigro, Philip/0000-0003-4442-9207; Stein, Thor/0000-0001-6954-4477	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS078337, P30 AG13846]; Department of Veterans AffairsUS Department of Veterans Affairs [CSP 501, B6796-C]; Sports Legacy Institute; National Operating Committee on Standards for Athletic Equipment; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA129769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, F31NS081957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG010483, P30AG013846, T32AG036697, U01AG015477] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	Supported by NIH (R01 NS078337, P30 AG13846), Department of Veterans Affairs (CSP 501, B6796-C), Sports Legacy Institute, National Operating Committee on Standards for Athletic Equipment, and unrestricted gifts from the National Football League and the Andlinger Foundation.	Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; BARBER R, 1995, J NEUROL NEUROSUR PS, V59, P61, DOI 10.1136/jnnp.59.1.61; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DAVIS PB, 1991, ARCH NEUROL-CHICAGO, V48, P613, DOI 10.1001/archneur.1991.00530180069019; Deep-Soboslay A, 2005, BIOL PSYCHIAT, V57, P96, DOI 10.1016/j.biopsych.2004.10.016; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gandy S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004274; Goldstein L.E., 2012, SCI TRANSL MED, V4; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jokl E, 1931, MUNCH MED WOCH, V1, P560; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katzman R, 1996, NEUROLOGY, V46, P889; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; MAWDSLEY C, 1963, LANCET, V2, P795; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKay GJ, 2011, AM J EPIDEMIOL, V173, P1357, DOI 10.1093/aje/kwr015; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SOEDER M, 1954, DEUT MED WOCHENSCHR, V79, P1792; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607	39	287	288	11	69	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 24	2013	81	13					1122	1129		10.1212/WNL.0b013e3182a55f7f			8	Clinical Neurology	Neurosciences & Neurology	AA0EL	WOS:000330768000010	23966253	Green Published	Y	N	2021-06-18	
J	Mayer, AR; Mannell, MV; Ling, J; Gasparovic, C; Yeo, RA				Mayer, Andrew R.; Mannell, Maggie V.; Ling, Josef; Gasparovic, Charles; Yeo, Ronald A.			Functional Connectivity in Mild Traumatic Brain Injury	HUMAN BRAIN MAPPING			English	Article						mild TBI; attention; connectivity; fMRI; DTI	DIFFUSE AXONAL INJURY; RESTING-STATE; DEFAULT NETWORK; WORKING-MEMORY; GLOBAL SIGNAL; MRI; DYSFUNCTION; FMRI; ACTIVATION; MODE	Objectives: Research suggests that the majority of mild traumatic brain injury (mTBI) patients exhibit both cognitive and emotional dysfunction within the first weeks of injury, followed by symptom resolution 36 months postinjury. The neuronal correlates of said dysfunction are difficult to detect with standard clinical neuroimaging, complicating differential diagnosis and early identification of patients who may not recover. This study examined whether resting state functional magnetic resonance imaging (fMRI) provides objective markers of injury and predicts cognitive, emotional, and somatic complaints in mTBI patients semiacutely (<3 weeks postinjury) and in late recovery (3-5 month) phases. Methods: Twenty-seven semiacute mTBI patients and 26 gender, age, and education-matched controls were studied. Fifteen of 27 patients returned for a follow-up visit 3-5 months postinjury. The main dependent variables were spontaneous fluctuations (temporal correlation) in the default-mode (DMN) and fronto-parietal task-related networks as measured by fMRI. Results: Significant differences in self-reported cognitive, emotional, and somatic complaints were observed (all P < 0.05), despite normal clinical (T1 and T2) imaging and neuropsychological testing results. Mild TBI patients demonstrated decreased functional connectivity within the DMN and hyper-connectivity between the DMN and lateral prefrontal cortex. Measures of functional connectivity exhibited high levels of sensitivity and specificity for patient classification and predicted cognitive complaints in the semi-acute injury stage. However, no changes in functional connectivity were observed across a 4-month recovery period. Conclusions: Abnormal connectivity between the DMN and frontal cortex may provide objective biomarkers of mTBI and underlie cognitive impairment. Hum Brain Mapp 32:1825-1835, 2011. (C) 2011 Wiley Periodicals, Inc.	[Mayer, Andrew R.; Mannell, Maggie V.; Ling, Josef; Gasparovic, Charles; Yeo, Ronald A.] Mind Res Network, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Gasparovic, Charles; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd, Albuquerque, NM 87106 USA.	amayer@mrn.org			Department of Energy (The Mind Research Network)United States Department of Energy (DOE) [DE-FG02-99ER62764]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD050836, R21-NS064464-01A1, 3 R21 NS064464-01S1]; NCRR (Center on Neural Mechanisms of Schizophrenia)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR021938]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS064464] Funding Source: NIH RePORTER	Contract grant sponsor: Department of Energy (The Mind Research Network); Contract grant number: DE-FG02-99ER62764; Contract grant sponsor: National Institutes of Health; Contract grant number: R24-HD050836, R21-NS064464-01A1, 3 R21 NS064464-01S1; Contract grant sponsor: NCRR (Center on Neural Mechanisms of Schizophrenia); Contract grant number: P20 RR021938.	Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franco AR, 2008, IEEE J-STSP, V2, P986, DOI 10.1109/JSTSP.2008.2006718; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hua KG, 2009, CEREB CORTEX, V19, P1889, DOI 10.1093/cercor/bhn215; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2000, NEUROLOGY, V54, P1625, DOI 10.1212/WNL.54.8.1625; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Talairach J, 1988, COPLANAR STERIOTAXIC; Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	70	287	294	1	73	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2011	32	11					1825	1835		10.1002/hbm.21151			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	845VA	WOS:000296850700005	21259381	Green Published, Green Accepted			2021-06-18	
J	Strong, AJ; Fabricius, M; Boutelle, MG; Hibbins, SJ; Hopwood, SE; Jones, R; Parkin, MC; Lauritzen, M				Strong, AJ; Fabricius, M; Boutelle, MG; Hibbins, SJ; Hopwood, SE; Jones, R; Parkin, MC; Lauritzen, M			Spreading and synchronous depressions of cortical activity in acutely injured human brain	STROKE			English	Article						brain injuries; electroencephalography; head injury; hemorrhage; penumbra; spreading cortical depression; trauma	CEREBRAL-BLOOD-FLOW; PERIINFARCT DEPOLARIZATIONS; MIGRAINE ATTACKS; GAP-JUNCTIONS; ISCHEMIA; PROPAGATION; CORTEX; FLUORESCENCE; OXYGENATION; ASTROCYTES	Background and Purpose-Cortical spreading depression (CSD) has been much studied experimentally but never demonstrated unequivocally in human neocortex by direct electrophysiological recording. A similar phenomenon, peri-infarct depolarization, occurs in experimental models of stroke and causes the infarct to enlarge. Our current understanding of the mechanisms of deterioration in the days after major traumatic or ischemic brain injury in humans has not yielded any effective, novel drug treatment. This study sought clear evidence for the occurrence and propagation of CSD in the injured human brain. Methods-In 14 patients undergoing neurosurgery after head injury or intracranial hemorrhage, we placed electrocorticographic (ECoG) electrodes near foci of damaged cortical tissue. Results-Transient episodes of depressed ECoG activity that propagated across the cortex at rates in the range of 0.6 to 5.0 mm/min were observed in 5 patients; this rate of propagation is characteristic of CSD. We also observed, in 8 of the 14 patients, transient depressions of ECoG amplitude that appeared essentially simultaneous in all recording channels, without clear evidence of spread. Conclusions-These results indicate that CSD or similar events occur in the injured human brain and are more frequent than previously suggested. On the basis of these observations, we suggest that the related phenomenon, peri-infarct depolarization, is indeed likely to occur in boundary zones in the ischemic human cerebral cortex.	Kings Coll London, Dept Neurosurg, London WC2R 2LS, England; Kings Coll London, Dept Chem, London WC2R 2LS, England; Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, Copenhagen, Denmark	Strong, AJ (corresponding author), Kings Coll Hosp London, Dept Neurosurg, Denmark Hill, London SE5 9RS, England.	Anthony.strong@kcl.ac.uk		Lauritzen, Martin/0000-0002-1517-1131			ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Back T, 2000, STROKE, V31, P2901, DOI 10.1161/01.STR.31.12.2901; Bowyer SM, 1999, BRAIN RES, V843, P79, DOI 10.1016/S0006-8993(99)01893-4; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; COOPER R., 1966, MED BIOL ENG, V4, P575, DOI 10.1007/BF02474827; Dirnagl U, 2001, KEIO UNIV SYMP LIFE, V6, P232; Gorji A, 2001, BRAIN RES, V906, P74, DOI 10.1016/S0006-8993(01)02557-4; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1984, AN ACAD BRAS CIENC, V56, P457; Higuchi T, 2002, J CEREBR BLOOD F MET, V22, P71, DOI 10.1097/00004647-200201000-00009; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; KOBAYASHI S, 1995, J CEREBR BLOOD F MET, V15, P721, DOI 10.1038/jcbfm.1995.92; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; LAURITZEN M, 1984, BRAIN, V107, P447, DOI 10.1093/brain/107.2.447; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; MANTZ J, 1993, ANESTHESIOLOGY, V78, P892, DOI 10.1097/00000542-199305000-00014; Matsushima K, 1998, BRAIN RES, V807, P47, DOI 10.1016/S0006-8993(98)00716-1; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MCLACHLAN RS, 1994, BRAIN RES, V666, P133, DOI 10.1016/0006-8993(94)90295-X; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Somjen GG, 2001, PHYSIOL REV, V81, P1065; SRAMKA M, 1978, APPL NEUROPHYSIOL, V40, P48; Strong AJ, 1996, J CEREBR BLOOD F MET, V16, P367, DOI 10.1097/00004647-199605000-00003; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265	29	287	289	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2002	33	12					2738	2743		10.1161/01.STR.0000043073.69602.09			6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	625QL	WOS:000179827100009	12468763	Green Published, Bronze			2021-06-18	
J	Taub, E; Ramey, SL; DeLuca, S; Echols, K				Taub, E; Ramey, SL; DeLuca, S; Echols, K			Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment	PEDIATRICS			English	Article						hemiparesis; cerebral palsy; pediatric rehabilitation; pediatric CI therapy; learned nonuse; upper extremity; CI therapy	PHYSICAL THERAPY; UPPER-EXTREMITY; CONTROLLED TRIAL; STROKE; REHABILITATION; RECOVERY; INFANT	Objective. Constraint-Induced Movement (CI) therapy has been found to be a promising treatment for substantially increasing the use of extremities affected by such neurologic injuries as stroke and traumatic brain injury in adults. The purpose of this study was to determine the applicability of this intervention to young children with cerebral palsy. Methods. A randomized, controlled clinical trial of pediatric CI therapy in which 18 children with diagnosed hemiparesis associated with cerebral palsy(7-96 months old) were randomly assigned to receive either pediatric CI therapy or conventional treatment. Pediatric CI therapy involved promoting increased use of the more-affected arm and hand by intensive training (using shaping) of the more-impaired upper extremity for 6 hours/day for 21 consecutive days coupled with bivalved casting of the child's less-affected upper extremity for that period. Children's functional upper-extremity skills were assessed in the laboratory (blinded scoring) and at home (parent ratings) just prior, after, and 3 weeks post-treatment. Treated children were followed for 6 months. Results. Children receiving pediatric CI therapy compared with controls acquired significantly more new classes of motoric skills (9.3 vs 2.2); demonstrated significant gains in the mean amount (2.1 vs 0.1) and quality (1.7 vs 0.3) of more-affected arm use at home; and in a laboratory motor function test displayed substantial improvement including increases in unprompted use of the more-affected upper extremity (52.1% vs 2.1% of items). Benefits were maintained over 6 months, with supplemental evidence of quality-of-life changes for many children. Conclusion. Pediatric CI therapy produced major and sustained improvement in motoric function in the young children with hemiparesis in the study.	Univ Alabama, Dept Psychol, CPM 712, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Birmingham, AL 35294 USA; Georgetown Univ, Ctr Hlth & Educ, Washington, DC USA	Taub, E (corresponding author), Univ Alabama, Dept Psychol, CPM 712, 1530 3rd Ave S, Birmingham, AL 35294 USA.	etaub@uab.edu		DeLuca, Stephanie/0000-0002-7366-7477			BATSHAW ML, 1996, CHILDREN HANDICAPS M; BOWER E, 1994, CHILD CARE HLTH DEV, V20, P409, DOI 10.1111/j.1365-2214.1994.tb00402.x; Campbell SK., 1990, PEDIAT PHYS THER, V2, P123; CAPUTE A, 1990, DEV DISABILITIES INF; CINCINELLI P, 1997, ELECTROENCEPHALOGR C, V105, P438; Crocker MD, 1997, AM J OCCUP THER, V51, P824, DOI 10.5014/ajot.51.10.824; DeLuca SC, 2003, PHYS THER, V83, P1003, DOI 10.1093/ptj/83.11.1003; Fewell R., 1984, DEV ACTIVITIES SCREE; Guralnick MJ., 1997, EFFECTIVENESS EARLY; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; HOCHLEITNER M, 1977, OSTERREICHISCHER ARZ, V32, P1108; KOPP B, 1977, NEUROREPORT, V12, P335; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; KURTZ LA, 2000, YOUR CHILD HAS DISAB, P109; LAW M, 1991, DEV MED CHILD NEUROL, V33, P379; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; NWAOBI OM, 1987, ARCH PHYS MED REHAB, V68, P837; PALMER FB, 1988, NEW ENGL J MED, V318, P803, DOI 10.1056/NEJM198803313181302; Pellegrino L, 2000, YOUR CHILD HAS DISAB, P275; PIPER MC, 1986, PEDIATRICS, V78, P216; RAMEY SL, 2000, YOUR CHILD HAS DISAB, P83; SCHERZER AL, 1976, PEDIATRICS, V58, P47; SKINNER BF, 1983, TECHNOLOGY TEACHING; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; Taub E, 1996, COMP NEUR R, V9, P133; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; TAUB E, 1995, SFI STUDIES SCI COMP, V23, P201; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; YASUKAWA A, 1990, AM J OCCUP THER, V44, P840, DOI 10.5014/ajot.44.9.840	34	286	304	2	54	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	FEB 1	2004	113	2					305	312		10.1542/peds.113.2.305			8	Pediatrics	Pediatrics	769AK	WOS:000188603800024	14754942				2021-06-18	
J	Herman, ST				Herman, ST			Epilepsy after brain insult - Targeting epileptogenesis	NEUROLOGY			English	Article							UNPROVOKED SEIZURES; POPULATION; INJURY; RISK; PREVENTION; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; PHENYTOIN; ROCHESTER	Seizures and epilepsy are common sequelae of acute brain insults such as stroke, traumatic brain injury, and central nervous system infections. Early, or acute symptomatic, seizures occur at the time of the brain insult and may be a marker of severity of injury. A cascade of morphologic and biologic changes in the injured area over months to years leads to hyperexcitability and epileptogenesis. After a variable latency period, late unprovoked seizures and epilepsy occur. The latent period may offer a therapeutic window for the prevention of epileptogenesis and the development of unprovoked seizures and epilepsy. Administration of anticonvulsant drugs following acute brain insults has thus far failed to prevent late epilepsy. Proper choice of disease models and target populations will aid in the development of putative antiepileptogenic agents. The incidence, timing, and pathophysiology of common epileptogenic brain injuries, including head trauma, cerebrovascular disease, brain tumors, neurosurgical procedures, neurodegenerative conditions, status epilepticus, and febrile seizures, are reviewed.	Univ Penn, Dept Neurol, Penn Epilepsy Ctr, Philadelphia, PA 19104 USA	Herman, ST (corresponding author), Univ Penn, Dept Neurol, Penn Epilepsy Ctr, 3 West Gates,3400 Spruce St, Philadelphia, PA 19104 USA.	susan.herman@uphs.upenn.edu		Herman, Susan/0000-0002-6556-083X			Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beaumont A, 2000, ACTA NEUROCHIR, V142, P1, DOI 10.1007/s007010050001; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; De Santis A, 2002, EPILEPSIA, V43, P175, DOI 10.1046/j.1528-1157.2002.24801.x; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; FAUGHT E, 1989, NEUROLOGY, V39, P1089, DOI 10.1212/WNL.39.8.1089; FORSGREN L, 1990, EPILEPSIA, V31, P292, DOI 10.1111/j.1528-1157.1990.tb05379.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; HeutsvanRaak L, 1996, SEIZURE-EUR J EPILEP, V5, P185; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, V47, P157, DOI 10.1001/archneur.1990.00530020053014; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lote K, 1998, EUR J CANCER, V34, P98, DOI 10.1016/S0959-8049(97)00374-2; Lowenstein D H, 1996, Epilepsy Res Suppl, V11, P45; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1995, J NEUROSURG, V82, P220, DOI 10.3171/jns.1995.82.2.0220; MEDINA MT, 1990, ARCH INTERN MED, V150, P325, DOI 10.1001/archinte.150.2.325; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Olafsson E, 2000, EPILEPSIA, V41, P1201, DOI 10.1111/j.1528-1157.2000.tb00326.x; Olsen T S, 2001, Curr Atheroscler Rep, V3, P340, DOI 10.1007/s11883-001-0029-4; Paolucci S, 1997, EPILEPSIA, V38, P266, DOI 10.1111/j.1528-1157.1997.tb01115.x; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Tandon PN, 2001, NEUROL INDIA, V49, P55; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vaughan CJ, 2002, CUR CLIN NEUROL, P7; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x	41	286	294	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 12	2002	59	9		5			S21	S26		10.1212/WNL.59.9_suppl_5.S21			6	Clinical Neurology	Neurosciences & Neurology	614QG	WOS:000179200400005	12428028				2021-06-18	
J	Ling, G; Bandak, F; Armonda, R; Grant, G; Ecklund, J				Ling, Geoffrey; Bandak, Faris; Armonda, Rocco; Grant, Gerald; Ecklund, James			Explosive Blast Neurotrauma	JOURNAL OF NEUROTRAUMA			English	Article						clinical management of CNS injury; decompressive craniectomy; military injury; penetrating ballistic-like brain injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CRANIOCEREBRAL MISSILE WOUNDS; OPERATION DESERT-STORM; FEBRUARY 20; AMERICAN; SOLDIERS; CORPS; IRAQ; CARE; VII	Explosive blast traumatic brain injury (TBI) is one of the more serious wounds suffered by United States service members injured in the current conflicts in Iraq and Afghanistan. Some military medical treatments for blast TBI that have been introduced successfully in the war theater include decompressive craniectomy, cerebral angiography, transcranial Doppler, hypertonic resuscitation fluids, among others. Stateside neurosurgery, neurocritical care, and rehabilitation for these patients have similarly progressed. With experience, military physicians have been able to clinically describe blast TBI across the entire severity spectrum. One important clinical finding is that a significant number of severe blast TBI victims develop pseudoaneurysms and vasospasm, which can lead to delayed decompensation. Another is that mild blast TBI shares clinical features with post-traumatic stress disorder (PTSD). Observations suggest that the mechanism by which explosive blast injures the central nervous system may be more complex than initially assumed. Rigorous study at the basic science and clinical levels, including detailed biomechanical analysis, is needed to improve understanding of this disease. A comprehensive epidemiological study is also warranted to determine the prevalence of this disease and the factors that contribute most to the risk of developing it. Sadly, this military-specific disease has significant potential to become a civilian one as well.	[Ling, Geoffrey; Bandak, Faris] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Ling, Geoffrey; Armonda, Rocco; Ecklund, James] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Grant, Gerald] Duke Univ, Med Ctr, Div Neurosurg, Durham, NC 27710 USA; [Ecklund, James] Inova Fairfax Hosp, Dept Neurosci, Fairfax, VA USA; [Bandak, Faris] Integrated Serv Grp Inc, Potomac, MD USA	Ling, G (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gling@usuhs.mil					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Baker WE., 1973, EXPLOSIONS AIR; BANDAK FA, 1996, TRAUMATIC BRAIN INJU; Bellah RN, 1995, BOST THEO I, V4, P1; BELLAMY RF, 1986, ANN EMERG MED, V15, P1384, DOI 10.1016/S0196-0644(86)80920-9; BELLAMY RF, 1992, WORLD J SURG, V16, P888, DOI 10.1007/BF02066987; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; CAREY ME, 1987, MIL MED, V152, P6; Carey ME, 1998, MIL MED, V163, P581; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1970, MIL MED, V135, P1161; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; CAREY ME, 1974, MIL MED, V139, P281; Centers for Disease Control and Prevention, 2006, EXPL BLAST INJ PRIM; Geocadin R., 2004, HDB NEURO CRITICAL C, P73; Grant GA, 2007, J TRAUMA, V62, pS100, DOI 10.1097/TA.0b013e318065b42c; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holcomb JB, 2005, J TRAUMA, V58, P1298, DOI 10.1097/01.TA.0000169871.29748.95; Jaffe G., 2004, WALL STREET J, pA1; Jarell Abel D., 2003, P351; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; Knuth T., 2005, GUIDELINES FIELD MAN; LING G, 2008, EXPLOSION BLAST RELA, P91; LING G, 2007, CECILS TXB MED, P2646; Ling G, 2007, J TRAUMA, V62, pS102, DOI 10.1097/TA.0b013e318065b442; Ling G, 2006, NEUROLOGY, V67, P14, DOI 10.1212/01.wnl.0000227781.79800.93; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pesik N, 2001, ANN EMERG MED, V37, P642, DOI 10.1067/mem.2001.114316; Phillips Y. Y., 1991, CONVENTIONAL WARFARE, P221; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; RICHMOND DR, 1968, ANN NY ACAD SCI, V152, P103, DOI 10.1111/j.1749-6632.1968.tb11970.x; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schlifka B, 2007, J TRAUMA, V62, pS103, DOI 10.1097/TA.0b013e318065b4e5; SHANKER T, 2007, NY TIMES        0602, P1; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Warden DL, 2005, NEW ENGL J MED, V353, P633; ZOROYA G, 2006, US TODAY        0608, V8, pA13; ZOROYA G, 2007, US TODAY        0308, V8, pA1; ZOROYA G, 2007, US TODAY        0504, V4, pA10; ZOROYA G, 2005, US TODAY        0303, V3, pA1	53	285	295	1	46	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2009	26	6					815	825		10.1089/neu.2007.0484			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	455OV	WOS:000266773600002	19397423				2021-06-18	
J	Verge, GM; Milligan, ED; Maier, SF; Watkins, LR; Naevel, GS; Foster, AC				Verge, GM; Milligan, ED; Maier, SF; Watkins, LR; Naevel, GS; Foster, AC			Fractakine (CX3CL1) and fractakine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						CX3CL1; CX3CR1; dorsal horn; fractalkine; microglia; spinal cord	HIV-1 ENVELOPE GLYCOPROTEIN; INFLAMMATORY NEURITIS SIN; CENTRAL-NERVOUS-SYSTEM; MICROGLIAL ACTIVATION; RAT-BRAIN; FRACTALKINE; ALLODYNIA; GLIA; EXPRESSION; NEUROTOXICITY	Fractalkine is a unique chemokine reported to be constitutively expressed by neurons. Its only receptor, CX3CR1, is expressed by microglia. Little is known about the expression of fractalkine and CX3CR1 in spinal cord. Given that peripheral nerve inflammation and/or injury gives rise to neuropathic pain, and neuropathic pain may be partially mediated by spinal cord glial activation and consequent glial proinflammatory cytokine release, there must be a signal released by affected neurons that triggers the activation of glia. We sought to determine whether there is anatomical evidence implicating spinal fractalkine as such a neuron-to-glia signal. We mapped the regional and cellular localization of fractalkine and CX3CR1 in the rat spinal cord and dorsal root ganglion, under basal conditions and following induction of neuropathic pain, employing both an inflammatory (sciatic inflammatory neuropathy; SIN) as well as a traumatic (chronic constriction injury; CCI) model. Fractalkine immunoreactivity and mRNA were observed in neurons, but not glia, in the rat spinal cord and dorsal root ganglia, and levels did not change following either CCI or SIN. By contrast, CX3CR1 was expressed by microglia in the basal state, and the microglial cellular concentration was up-regulated in a regionally specific manner in response to neuropathy. CX3CR1-expressing cells were identified as microglia by their cellular morphology and positive OX-42 and CD4 immunostaining. The cellular distribution of fractalkine and CX3CR1 in the spinal circuit associated with nociceptive transmission supports a potential role in the mechanisms that contribute to the exaggerated pain state in these models of neuropathy.	Neurocrine Biosci, San Diego, CA 92130 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Verge, GM (corresponding author), Neurocrine Biosci, 12790 El Camino Real, San Diego, CA 92130 USA.	Gverge@neurocrine.com			NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA015642] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40696, NS38020] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040696, R01NS038020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K02DA015642] Funding Source: NIH RePORTER		Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Buttini M, 1998, NAT MED, V4, P441, DOI 10.1038/nm0498-441; Chacur M, 2001, PAIN, V94, P231, DOI 10.1016/S0304-3959(01)00354-2; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chapman GA, 2000, J NEUROSCI, V20; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; Eng LF, 2003, NEUROCHEM RES, V28, P95, DOI 10.1023/A:1021652229667; Gazda LS, 2001, J PERIPHER NERV SYST, V6, P111, DOI 10.1046/j.1529-8027.2001.006001111.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2004, METH MOLEC MED, P67; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Milligan ED, 2000, BRAIN RES, V861, P105, DOI 10.1016/S0006-8993(00)02050-3; MILLIGAN ED, 2002, AM PAIN SOC ANN M BA; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Rutkowski MD, 2002, SPINE, V27, P1604, DOI 10.1097/00007632-200208010-00003; Schwaeble WJ, 1998, FEBS LETT, V439, P203, DOI 10.1016/S0014-5793(98)01384-2; Stuesse SL, 2000, NEUROSCI LETT, V287, P121, DOI 10.1016/S0304-3940(00)01142-3; Sweitzer SM, 2002, J NEUROIMMUNOL, V125, P82, DOI 10.1016/S0165-5728(02)00036-X; Tarozzo G, 2003, J NEUROSCI RES, V73, P81, DOI 10.1002/jnr.10645; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; TWINING CM, 2002, SOC NEUR ABSTR; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; WATKINS LR, 2002, 10 WORLD C PAIN SAN; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	41	285	313	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	SEP	2004	20	5					1150	1160		10.1111/j.1460-9568.2004.03593.x			11	Neurosciences	Neurosciences & Neurology	856JK	WOS:000224041300002	15341587				2021-06-18	
J	Tong, KA; Ashwal, S; Holshouser, BA; Shutter, LA; Herigault, G; Haacke, EM; Kido, DK				Tong, KA; Ashwal, S; Holshouser, BA; Shutter, LA; Herigault, G; Haacke, EM; Kido, DK			Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: Improved detection and initial results	RADIOLOGY			English	Article						brain, hemorrhage; brain, injuries; brain, MR; magnetic resonance (MR), technology	CLOSED-HEAD-INJURY; MR; VENOGRAPHY; TRAUMA; BRAIN; DEOXYHEMOGLOBIN; RESOLUTION; MODERATE	PURPOSE: To compare the effectiveness of a high-spatial-resolution susceptibility-weighted (SW) magnetic resonance (MR) imaging technique with that of a conventional gradient-recalled-echo (GRE) MR imaging technique for detection of hemorrhage in children and adolescents with diffuse axonal injury (DAI). MATERIALS AND METHODS: Seven young patients with a mean Glasgow Coma Scale score of 7 +/- 4 (SD) at admission were imaged a mean of 5 days 3 after injury. High-spatial-resolution three-dimensional GRE imaging performed with post-processing by using a normalized phase mask was compared with conventional GRE MR imaging. The total and mean values of lesion number and apparent hemorrhage volume load determined with both examinations were compared. Mean values were compared by using paired t test analysis. Differences were considered to be significant at P less than or equal to.05. RESULTS: Hemorrhagic lesions were much more visible on SW MR images than on conventional GRE MR images. SW MR imaging depicted 1,038 hemorrhagic DAI lesions with an apparent total hemorrhage volume of 57,946 mm(3). GRE MR imaging depicted 162 lesions with an apparent total hemorrhage volume of 28,893 mm3. SW MR imaging depicted a significantly higher mean number of lesions in all patients than did GRE MR imaging, according to results of visual (P =.004) and computer (P =.004) counting analyses. The mean hemorrhage volume load for all patients also was significantly greater (P =.014) by using SW MR imaging according to computer analysis. SW MR imaging appeared to depict much smaller hemorrhagic lesions than GRE MR imaging. The majority (59%) of individual hemorrhagic DAI lesions seen on SW MR images were small in area (<10 mm(2)), whereas the majority (43%) of lesions seen on GRE images were larger in area (10-20 mm(2)). CONCLUSION: SW MR imaging depicts significantly more small hemorrhagic lesions than does conventional GRE MR imaging and therefore has the potential to improve diagnosis of DAI.	Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA 92354 USA; Loma Linda Univ, Med Ctr, Dept Pediat, Loma Linda, CA 92354 USA; Loma Linda Univ, Med Ctr, Dept Neurol, Loma Linda, CA 92354 USA; MRI Inst Biomed Res, St Louis, MO USA	Tong, KA (corresponding author), Loma Linda Univ, Med Ctr, Dept Radiol, 11234 Anderson St, Loma Linda, CA 92354 USA.		Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Cheng YCN, 2001, NMR BIOMED, V14, P468, DOI 10.1002/nbm.727; Chiaretti A, 1998, Pediatr Med Chir, V20, P393; CHO ZH, 1992, MAGNET RESON MED, V28, P25, DOI 10.1002/mrm.1910280104; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; JENNETT B, 1975, LANCET, V1, P480; Kurihara Mana, 1999, No To Hattatsu, V31, P408; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lee BCP, 1999, AM J NEURORADIOL, V20, P1239; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185	23	285	327	0	6	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAY	2003	227	2					332	339		10.1148/radiol.2272020176			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	672RH	WOS:000182534900005	12732694				2021-06-18	
J	Clark, RSB; Kochanek, PM; Watkins, SC; Chen, MZ; Dixon, CE; Seidberg, NA; Melick, J; Loeffert, JE; Nathaniel, PD; Jin, KL; Graham, SH				Clark, RSB; Kochanek, PM; Watkins, SC; Chen, MZ; Dixon, CE; Seidberg, NA; Melick, J; Loeffert, JE; Nathaniel, PD; Jin, KL; Graham, SH			Caspase-3 mediated neuronal death after traumatic brain injury in rats	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; cysteine protease; N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone; programmed cell death	CONTROLLED CORTICAL IMPACT; APOPTOTIC CELL-DEATH; INTERLEUKIN-1-BETA CONVERTING-ENZYME; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; TRANSGENIC MICE; MESSENGER-RNA; EXPRESSION; INHIBITION; PROTEIN	During programmed cell death, activation of caspase-3 leads to proteolysis of DNA repair proteins, cytoskeletal proteins, and the inhibitor of caspase-activated deoxyribonuclease, culminating in morphologic changes and DNA damage defining apoptosis, The participation of caspase-3 activation in the evolution of neuronal death after traumatic brain injury in rats was examined. Cleavage of pro-caspase-3 in cytosolic cellular fractions and an increase in caspase-3-like enzyme activity were seen in injured brain versus control. Cleavage of the caspase-3 substrates DNA-dependent protein kinase and inhibitor of caspase-activated deoxyribonuclease and co-localization of cytosolic caspase-3 in neurons with evidence of DNA fragmentation were also identified. Intracerebral administration of the caspase-3 inhibitor N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluomethyl ketone (480 ng) after trauma reduced caspase-3-like activity and DNA fragmentation in injured brain versus vehicle at 24 h. Treatment with N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone for 72 h (480 ng/day) reduced contusion size and ipsilateral dorsal hippocampal tissue loss at 3 weeks but had no effect on functional outcome versus vehicle. These data demonstrate that caspase-3 activation contributes to brain tissue loss and downstream biochemical events that execute programmed cell death after traumatic brain injury. Caspase inhibition may prove efficacious in the treatment of certain types of brain injury where programmed cell death occurs.	Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Neurol, Pittsburgh, PA 15260 USA; VA Pittsburgh Hlth Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA	Clark, RSB (corresponding author), Univ Pittsburgh, Brain Trauma Res Ctr, Safar Ctr Resuscitat Res, Dept Anesthesiol & Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clark@smtp.anes.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, K08NS001946, R01NS038620] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38620, P50 NS30318, KO8 NS01946] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Asahi M, 1997, J CEREBR BLOOD F MET, V17, P11, DOI 10.1097/00004647-199701000-00003; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Chen J, 1998, J NEUROSCI, V18, P4914; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Enari M, 1998, NATURE, V391, P43; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1997, J CEREBR BLOOD F MET, V17, P370, DOI 10.1097/00004647-199704000-00002; Jenkins LW, 1999, BRAIN RES, V817, P132, DOI 10.1016/S0006-8993(98)01237-2; Kim CN, 1997, CANCER RES, V57, P3115; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Namura S, 1998, J NEUROSCI, V18, P3659; Ni BH, 1998, J CEREBR BLOOD F MET, V18, P248, DOI 10.1097/00004647-199803000-00003; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RINK A, 1995, AM J PATHOL, V147, P1575; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Samali A, 1998, FEBS LETT, V431, P167, DOI 10.1016/S0014-5793(98)00740-6; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	53	285	302	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2000	74	2					740	753		10.1046/j.1471-4159.2000.740740.x			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	274KU	WOS:000084765700032	10646526	Bronze			2021-06-18	
J	Cantu, RC				Cantu, RC			Second-impact syndrome	CLINICS IN SPORTS MEDICINE			English	Article							HEAD TRAUMA; 2ND IMPACT	Second impact syndrome (SIS) occurs when an athlete who has sustained an initial head injury, most often a concussion, sustains a second head injury before symptoms associated with the first have fully cleared. While most commonly reported in football, the SIS can occur during any sport that can produce head blows. Any athlete still complaining of post-concussion symptoms after a head injury must not be allowed to return to play.	Emerson Hosp, Serv Sports Med, Concord, MA 01742 USA; Emerson Hosp, Neurosurg Serv, Concord, MA 01742 USA	Cantu, RC (corresponding author), Emerson Hosp, Serv Sports Med, Concord, MA 01742 USA.						BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P10; CANTU RC, 1991, ADOLESCENT MED STATE; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; JENKINS A, 1986, LANCET, V2, P445; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LANGFITT TW, 1978, AM J PHYSIOL, V215, P90; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MUELLER F O, 1985, Physician and Sportsmedicine, V13, P75; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schneider R., 1973, HEAD NECK INJURIES F; SCHNITKER MT, 1949, J PEDIATR-US, V35, P557, DOI 10.1016/S0022-3476(49)80138-7	20	285	289	0	52	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					37	+		10.1016/S0278-5919(05)70059-4			9	Sport Sciences	Sport Sciences	YU153	WOS:000071687600005	9475969				2021-06-18	
J	Vendrame, M; Cassady, J; Newcomb, J; Butler, T; Pennypacker, KR; Zigova, T; Sanberg, CD; Sanberg, PR; Willing, AE				Vendrame, M; Cassady, J; Newcomb, J; Butler, T; Pennypacker, KR; Zigova, T; Sanberg, CD; Sanberg, PR; Willing, AE			Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume	STROKE			English	Article						acute stroke; cell transplantation; neuroprotection	MARROW STROMAL CELLS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; TRANSPLANTATION; EXPRESSION; MECHANISM; MARKERS; NEURONS	Background and Purpose-Intravenously delivered human umbilical cord blood cells (HUCBC) have been previously shown to improve functional recovery of stroked rats. To extend these findings, we examined the behavioral recovery and stroke infarct volume in the presence of increasing doses of HUCBC after permanent middle cerebral artery occlusion (MCAO). Methods-Rats were subjected to MCAO and allowed to recover for 24 hours before intravenous infusion of 10(4) up to 3 to 5x10(7) HUCBC. Behavioral tests ( spontaneous activity, step test, elevated body swing test) were performed 1 week before MCAO and at 2 and 4 weeks after HUCBC infusion. On completion of behavioral testing, animals were euthanized and brain infarct volumes quantified. HUCBC were identified by immunofluorescence for human nuclei and by polymerase chain reaction (PCR) using primers specific for human glycerol 3-phosphate dehydrogenase. Results-At 4 weeks after infusion, there was a significant recovery in behavioral performance when 10(6) or more HUCBC were delivered (p=0.001 to p=0.05). Infarct volume measurements revealed an inverse relationship between HUCBC dose and damage volume, which reached significance at the higher HUCBC doses (10(7) cells, p<0.01; 3 to 5X10(7) cells, p<0.05). Moreover, HUCBC were localized by immunohistochemistry and PCR analysis only in the injured brain hemisphere and spleen. Conclusions-These results extend previous observations of HUCBC infusion in the MCAO rat stroke model by demonstrating a dose relationship between HUCBC, behavioral improvement, and neuronal sparing.	Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Anat, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pharmacol & Therapeut, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Saneron CCEL Therapeut Inc, Temple Terrace, FL USA	Willing, AE (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, MDC 78,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	awilling@hsc.usf.edu	Willing, Alison/I-4946-2012; Willing, Alison/AAP-7759-2021; Ward, Tanya/J-4882-2015; Pennypacker, Keith/I-5092-2012	Ward, Tanya/0000-0003-1576-521X; 			Becker K, 2003, STROKE, V34, P1809, DOI 10.1161/01.STR.0000078308.77727.EA; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Borlongan CV, 1999, CELL TRANSPLANT, V8, P153, DOI 10.1177/096368979900800107; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; GROTTA JC, 1988, STROKE, V19, P447, DOI 10.1161/01.STR.19.4.447; Lewis ID, 2002, INTERN MED J, V32, P601, DOI 10.1046/j.1445-5994.2002.00276.x; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2003, NEUROSURGERY, V53, P702; Newman M, 2003, EXP NEUROL, V181, P84; OBANA WG, 1988, J NEUROSURG, V69, P98, DOI 10.3171/jns.1988.69.1.0098; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Padovan CS, 2003, CELL TRANSPLANT, V12, P839, DOI 10.3727/000000003771000183; PERSSON L, 1989, STROKE, V20, P641, DOI 10.1161/01.STR.20.5.641; Pomyje J, 2003, EUR J HAEMATOL, V70, P143, DOI 10.1034/j.1600-0609.2003.00040.x; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Sorg RV, 2001, EXP HEMATOL, V29, P1289, DOI 10.1016/S0301-472X(01)00735-4; STEELE A, 2004, IN PRESS STEM CELLS; Studer L, 1998, NAT NEUROSCI, V1, P290; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885	27	284	304	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	OCT	2004	35	10					2390	2395		10.1161/01.STR.0000141681.06735.9b			6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	856NL	WOS:000224051800037	15322304	Bronze			2021-06-18	
J	Susman, M; DiRusso, SM; Sullivan, T; Risucci, D; Nealon, P; Cuff, S; Haider, A; Benzil, D				Susman, M; DiRusso, SM; Sullivan, T; Risucci, D; Nealon, P; Cuff, S; Haider, A; Benzil, D			Traumatic brain injury in the elderly: Increased mortality and worse functional outcome at discharge despite lower injury severity	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	15th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 16-19, 2002	ORLANDO, FL	Eastern Assoc Surg Trauma		elderly; closed head injury; trauma; traumatic brain injury; outcome	PREDICTING SURVIVAL; HEAD-INJURIES; EPIDEMIOLOGY	Objective: the purpose of this study was to compare data obtained from a statewide data set for elderly patients (age > 64 years) that presented with traumatic brain injury with data from nonelderly patients (age > 15 and < 65 years) with similar injuries. Methods: The New York State Trauma Registry from January 1994 through December 1995, from trauma centers and community hospitals excluding New York City (45,982 patients), was examined. Head-injured patients were identified by International Classification of Diseases, Ninth Revision diagnosis codes. A relative head injury severity scale (RHISS) was constructed on the basis of groups of these codes (range, 0 = none to 3 = severe). Comparisons were made with nonelderly patients for mortality, Glasgow Coma Scale (GCS) score at admission and discharge, Injury Severity Score, New Injury Severity Score, and RHISS. Outcome was assessed by a Functional Independence Measure score in three major domains: expression, locomotion, and feeding. Data were analyzed by the chi(2) test and Mann-Whitney U test, with p<0.05 considered significant. Results: There were 11,772 patients with International Classification of Diseases, Ninth Revision diagnosis of head injury, of which 3,244 (27%) were elderly. There were more male subjects in the nonelderly population (78% male subjects) compared with the elderly population (50% men). Mortality was 24.0% in the elderly population compared with 12.8% in the nonelderly population (risk ratio, 2.2; 95% confidence interval, 1.99-2.43). The elderly nonsurvivors were statistically older, and mortality rate increased with age. Stratified by GCS score, there was a higher percentage of nonsurvivors in the elderly population, even in the group with only moderately depressed GCS score (GCS score of 13-15; risk ratio, 7.8; 95% confidence interval, 6.1-9.9 for elderly vs. nonelderly). Functional outcome in all three domains was significantly worse in the elderly survivors compared with the nonelderly survivors. Conclusion: Elderly traumatic brain injury patients have a worse mortality and functional outcome than nonelderly patients who present with head injury even though their head injury and overall injuries are seemingly less severe.	New York Med Coll, Dept Surg, Valhalla, NY 10595 USA; New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; Westchester Cty Med Ctr, Valhalla, NY 10595 USA	DiRusso, SM (corresponding author), New York Med Coll, Dept Surg, 2nd Floor,Munger Pavilion, Valhalla, NY 10595 USA.	sdirusso@worldnet.att.net					Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Hannan EL, 1999, J TRAUMA, V47, P8, DOI 10.1097/00005373-199907000-00003; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; KRAUS JF, 1993, HEAD INJURY; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Nagurney J T, 1998, J Emerg Med, V16, P709, DOI 10.1016/S0736-4679(98)00083-3; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; U.S. Census Bureau, 2000, CENS 2000; *US CENS BUR, 2000, POP PROJ PROGR POP D	19	284	293	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2002	53	2					219	223		10.1097/00005373-200208000-00004			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	585TQ	WOS:000177541000003	12169925				2021-06-18	
J	Murray, GD; Teasdale, GM; Braakman, R; Cohadon, F; Dearden, M; Iannotti, F; Karimi, A; Lapierre, F; Maas, A; Ohman, J; Persson, L; Servadei, F; Stocchetti, N; Trojanowski, T; Unterberg, A				Murray, GD; Teasdale, GM; Braakman, R; Cohadon, F; Dearden, M; Iannotti, F; Karimi, A; Lapierre, F; Maas, A; Ohman, J; Persson, L; Servadei, F; Stocchetti, N; Trojanowski, T; Unterberg, A			The European Brain Injury Consortium survey of head injuries	ACTA NEUROCHIRURGICA			English	Article							COMA DATA-BANK; CT SCAN; MANAGEMENT; TRIAL; MULTICENTER; NIMODIPINE	To provide a picture of contemporary practice, a survey was carried out of severely and moderately head injured patients admitted to 67 'neuro' centres in 12 European countries. 1,005 adult head injuries were recruited over a three month period. Sixty items of information on demography, clinical features, investigations, management and early complications were captured on a simple, two-page questionnaire and, information on outcome at six months on a third page. The median age of the subjects was 38 years, 74% were male and 51% injured in road traffic accidents; 57% of patients were transferred to the 'neuro' centre from another hospital. Assessment of clinical responsiveness was limited by the use of sedation and intubation and information from four early time points (pre-hospital, arrival at the Accident and Emergency department, post-resuscitation, and arrival at the 'neuro' unit) was combined to stratify the subjects as severe (58%), moderate (17%) or intermediate (19%). In 48% of patients classified the CT scan showed features of a 'mass lesion' and in 40% showed a subarachnoid haemorrhage. Fifty-five centres provided the data on outcome for 94% of the cases recruited in these centres six months after injury. 31% died, 3% were vegetative, 16% severely disabled, 20% moderately disabled and 31% had made a good recovery. Comparison of the data from different parts of Europe showed differences in the frequency of secondary transfer, cause of injury, occurrence of major extracranial injury, CT scan findings, intracranial operation, clinical severity of injury and utilisation of the components of intensive care and the occurrence of a favourable outcome, although the latter difference was not statistically significant;when variations in the initial severity of injury were taken into account. The findings in the present survey are compared with newly analysed information for three previous large series: the International Data Bank involving the UK, the Netherlands and the USA, the North American Traumatic Coma Data Bank, and data from four centres in the UK. The comparisons showed substantial similarities and also differences that may reflect variations in policy for admission of the head injury to 'neuro' units, and evolution in methods of assessment, investigation and management. The effects of these differences on, outcome requires further, rigorous prospective study.	Univ Edinburgh, Sch Med, Med Stat Unit, Edinburgh EH8 9AG, Midlothian, Scotland; So Gen Hosp, Inst Neurol Sci, Univ Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; Hosp Pellegrin, Dept Neurosurg, Bordeaux, France; Gen Infirm, Dept Anaesthet, Leeds LS1 3EX, W Yorkshire, England; Southampton Gen Hosp, Dept Clin Neurosci, Southampton SO9 4XY, Hants, England; Univ Cologne, Neurochirurg Klin, Cologne, Germany; CHU Poitiers, Serv Neurochirurg, Poitiers, France; Univ Rotterdam Hosp, Dept Neurosurg, Rotterdam, Netherlands; Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; Akademiska Hosp, Dept Neurosurg, Uppsala, Sweden; Osped Gen Provinciale M Bufalini, Div Neurochirurg, Cesena, Italy; IRCCS, Terapia Intens Neurochirurg Serv Anestesia & Rian, Osped Maggiore Policlin, Milan, Italy; Univ Med Sch, Dept Neurosurg, Lublin, Poland; Humboldt Univ, Dept Neurosurg, Virchow Klinkum, Fak Med, Berlin, Germany	Murray, GD (corresponding author), Univ Edinburgh, Sch Med, Med Stat Unit, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.		Stocchetti, Nino/O-7444-2017; Maas, Andrew IR/C-5584-2013	Stocchetti, Nino/0000-0003-3250-6834; Maas, Andrew IR/0000-0003-1612-1264; Ohman, Juha/0000-0002-6592-1367; Servadei, Franco/0000-0002-3595-3464; Murray, Gordon/0000-0001-9866-4734; Trojanowski, Tomasz/0000-0002-4914-1838			BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; BARLOW P, 1987, MED APPL MICROCOMPUT, P105; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; El Tabou M., 1995, Journal of Neurotrauma, V12, P488; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENTLEMAN D, 1986, BRIT MED J, V292, P449, DOI 10.1136/bmj.292.6518.449; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KOZIOL JA, 1990, J NEUROL, V237, P416; LANGHAM J, 1998, ASSESSING EFFECT CAL; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MAAS AIR, 1998, UNPUB NEUROSURGERY; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Marshall SB, 1991, J NEUROSURG S, V75, P14; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MURRAY GD, 1986, STAT MED, V5, P102; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; MURRAY LS, 1998, UNPUB BR J NEUROSURG; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale GM, 1997, ACTA NEUROCHIR, V139, P797, DOI 10.1007/BF01411397; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; VOLMER DG, 1991, J NEUROSURG S, V75, P37; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WINDLER JV, 1984, J EMER MED, V2, P1; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	46	284	290	0	15	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1999	141	3					223	236		10.1007/s007010050292			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	181HD	WOS:000079434700001	10214478				2021-06-18	
J	FANN, JR; KATON, WJ; UOMOTO, JM; ESSELMAN, PC				FANN, JR; KATON, WJ; UOMOTO, JM; ESSELMAN, PC			PSYCHIATRIC-DISORDERS AND FUNCTIONAL DISABILITY IN OUTPATIENTS WITH TRAUMATIC BRAIN INJURIES	AMERICAN JOURNAL OF PSYCHIATRY			English	Article; Proceedings Paper	147th Annual Meeting of the American-Psychiatric-Association	MAY 21-27, 1994	PHILADELPHIA, PA	Amer Psychiat Assoc			POST-STROKE DEPRESSION; SEVERE HEAD-INJURY; FOLLOW-UP; POSTSTROKE DEPRESSION; HEALTH; DISTURBANCE; CONCUSSION; RECOVERY; SEQUELAE; VALIDITY	Objective: This study examined psychiatric sequelae of traumatic brain injuries in outpatients and their relation to functional disability. Method: Fifty consecutive outpatients with traumatic brain injuries who came to a brain injury rehabilitation clinic for initial evaluation were examined for DSM-III-R diagnoses with the use of the National Institute of Mental Health Diagnostic Interview Schedule. The patients completed the Medical Outcomes Study Health Survey to assess functional disability and a questionnaire to assess postconcussion symptoms and self-perceptions of the severity of their brain injuries and cognitive functioning. Results: Thirteen (26%) of the patients had current major depression, and an additional 14 (28%) reported a first-onset major depressive episode after the injury that had resolved. Twelve (24%) had current generalized anxiety, disorder, and four (8%) reported current substance abuse. The group with depression and/or anxiety teas significantly more impaired than the nondepressed/nonanxious patients according to the Medical Outcomes Study Health Survey measures of emotional role functioning, mental health, and general health perceptions. The depressed/anxious group also rated their injuries as significantly more severe and their cognitive functioning as significantly worse, despite the lack of significant differences in objective measures of severity of injury and Mini-Mental State examination scores. The depressed patients reported significantly more postconcussion symptoms that were increasing in severity over time. Conclusions: Depression and anxiety are common in outpatients with traumatic brain injuries. Patients with depression or anxiety are more functionally disabled and perceive their injury and cognitive impairment as more severe. Depressed patients report more increasingly severe postconcussion symptoms.	UNIV WASHINGTON,MED CTR,DEPT REHABIL MED,SEATTLE,WA 98195	FANN, JR (corresponding author), UNIV WASHINGTON,MED CTR,DEPT PSYCHIAT & BEHAV SCI,BOX 356560,SEATTLE,WA 98195, USA.		Uomoto, Jay/AAF-4809-2019				Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BALLARD CG, 1993, J AFFECT DISORDERS, V29, P1, DOI 10.1016/0165-0327(93)90111-V; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN JB, 1994, J NEUROPSYCHIATRY CL, V6, P15; CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443; DEROGATIS LR, 1974, MOD PROBL PHARMACOPS, V7, P43; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DWORKIN SF, 1990, ARCH GEN PSYCHIAT, V47, P239; EASTWOOD MR, 1989, BRIT J PSYCHIAT, V154, P195, DOI 10.1192/bjp.154.2.195; Edna T H, 1987, J Oslo City Hosp, V37, P41; ESCOBAR JI, 1987, ARCH GEN PSYCHIAT, V44, P713; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; FEIBEL JH, 1982, ARCH PHYS MED REHAB, V63, P276; FINKLESTEIN SP, 1987, ARCH PHYS MED REHAB, V68, P772; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; HANTZ P, 1994, AM J PSYCHIAT, V151, P1010; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KATON W, 1989, J FAM PRACTICE, V29, P65; KATON W, 1990, Journal of Clinical Psychiatry, V51, P3; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LIPSEY JR, 1984, LANCET, V1, P297; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; REDING MJ, 1986, ARCH NEUROL-CHICAGO, V43, P763, DOI 10.1001/archneur.1986.00520080011011; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; ROBINSON RG, 1987, STROKE, V18, P837, DOI 10.1161/01.STR.18.5.837; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SINYOR D, 1986, STROKE, V17, P1102, DOI 10.1161/01.STR.17.6.1102; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; VONKORFF MR, 1982, J AFFECT DISORDERS, V4, P369; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914	47	283	287	0	22	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	OCT	1995	152	10					1493	1499					7	Psychiatry	Psychiatry	RX730	WOS:A1995RX73000013	7573589				2021-06-18	
J	Roth, TL; Nayak, D; Atanasijevic, T; Koretsky, AP; Latour, LL; McGavern, DB				Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.			Transcranial amelioration of inflammation and cell death after brain injury	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; STERILE INFLAMMATION; HEAD-INJURY; MICE; BIOMARKERS; INSERTION; RELEASE; CORTEX; FLUID	Traumatic brain injury (TBI) is increasingly appreciated to be highly prevalent and deleterious to neurological function(1,2). At present, no effective treatment options are available, and little is known about the complex cellular response to TBI during its acute phase. To gain insights into TBI pathogenesis, we developed a novel murine closed-skull brain injury model that mirrors some pathological features associated with mild TBI in humans and used long-term intravital microscopy to study the dynamics of the injury response from its inception. Here we demonstrate that acute brain injury induces vascular damage, meningeal cell death, and the generation of reactive oxygen species (ROS) that ultimately breach the glial limitans and promote spread of the injury into the parenchyma. In response, the brain elicits a neuroprotective, purinergic-receptor-dependent inflammatory response characterized by meningeal neutrophil swarming and microglial reconstitution of the damaged glial limitans. We also show that the skull bone is permeable to small-molecular-weight compounds, and use this delivery route to modulate inflammation and therapeutically ameliorate brain injury through transcranial administration of the ROS scavenger, glutathione. Our results shed light on the acute cellular response to TBI and provide a means to locally deliver therapeutic compounds to the site of injury.	[Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.] NINDS, NIH, Bethesda, MD 20892 USA	McGavern, DB (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Latour, Larry/AAH-5663-2021; Koretsky, Alan P/C-7940-2015	Latour, Larry/0000-0001-6160-5263; Koretsky, Alan P/0000-0002-8085-4756; Roth, Theodore/0000-0002-3970-9573; McGavern, Dorian/0000-0001-9568-545X; Nayak, Debasis/0000-0002-4762-4553	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of DefenseUnited States Department of Defense; Walter Reed National Military Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120, ZIANS002989] Funding Source: NIH RePORTER	The study was supported by the National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS), and the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences-a collaborative effort between the NIH, the Department of Defense and the Walter Reed National Military Medical Center to develop innovative approaches for brain injury diagnosis and recovery.	Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Faust N, 2000, BLOOD, V96, P719; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	26	282	289	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					223	+		10.1038/nature12808			13	Multidisciplinary Sciences	Science & Technology - Other Topics	286CG	WOS:000329441500040	24317693	Green Accepted	Y	N	2021-06-18	
J	Barkhoudarian, G; Hovda, DA; Giza, CC				Barkhoudarian, Garni; Hovda, David A.; Giza, Christopher C.			The Molecular Pathophysiology of Concussive Brain Injury	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Traumatic brain injury; Pathophysiology; Molecular mechanisms	FLUID PERCUSSION INJURY; LONG-TERM POTENTIATION; PROFESSIONAL FOOTBALL PLAYERS; POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC AXONAL INJURY; CORTICAL IMPACT INJURY; EXCITATORY AMINO-ACIDS; TEMPORAL WINDOW; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION	Concussion or mild traumatic brain injury (mTBI) is a condition that affects hundreds of thousands of patients worldwide. Understanding the pathophysiology of this disorder can help manage its acute and chronic repercussions. Immediately following mTBI, there are several metabolic, hemodynamic, structural, and electric changes that alter normal cerebral function. These alterations can increase the brain's vulnerability to repeat injury and long-term disability. This review evaluates current studies from the bench to the bedside of mTBI. Acute and chronic effects of concussion are measured in both animal and clinical studies. Also, the effect of repeat concussions is analyzed. Concussion-induced pathophysiology with regards to glucose metabolism changes, mitochondrial dysfunction, axonal injury, and structural damage are evaluated. Translational studies such as functional magnetic resonance imaging, magnetic resonance spectroscopy and diffusion tensor imaging prove to be effective clinical tools for both prognostic and treatment parameters. Understanding the neurobiology of concussion will lead to development and validation of physiological biomarkers of this common injury. These biomarkers (eg, laboratory tests, imaging, electrophysiology) will then allow for improved detection, better functional assessment and evidence-based return to play recommendations.	[Barkhoudarian, Garni; Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr,Semel Inst, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Brain Injury Res Ctr,Semel Inst, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Neurosci, Brain Injury Res Ctr,Semel Inst, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Brain Injury Res Ctr,Semel Inst,Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp,Div Pediat Neurol, Brain Injury Res Ctr,Semel Inst,Dept Pediat, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Neurosci, Brain Injury Res Ctr,Semel Inst,Mattel Childrens, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Biomed Engn, Brain Injury Res Ctr,Semel Inst,Mattel Childrens, Los Angeles, CA 90095 USA	Barkhoudarian, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr,Semel Inst, 10833 Le Conte Blvd, Los Angeles, CA 90095 USA.	gbarkhoudarian@mednet.ucla.edu			UCLA Brain Injury Research Center [NS057420, NS27544, NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R01NS027544, K02NS057420] Funding Source: NIH RePORTER	This work was supported by: NS057420, NS27544, NS058489 and by the UCLA Brain Injury Research Center.	ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gurkoff GG, 2009, NEUROSCIENCE, V164, P862, DOI 10.1016/j.neuroscience.2009.08.021; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hartings J, 2009, J NEUROTRAUM, V26, pA42; Hartman RE, 2002, J NEUROSCI, V22, P10083; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kalimo H, 1981, Acta Neuropathol Suppl, V7, P20; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; KUBOTA M, 1989, Neurosurgical Review, V12, P393, DOI 10.1007/BF01790681; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MATA M, 1986, J NEUROBIOL, V17, P449, DOI 10.1002/neu.480170508; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NAKAMURA Y, 1990, BIOCHEM BIOPH RES CO, V169, P744, DOI 10.1016/0006-291X(90)90394-3; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; NIXON RA, 1993, BRAIN PATHOL, V3, P29, DOI 10.1111/j.1750-3639.1993.tb00723.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Povlishock JT, 1996, ACT NEUR S, V66, P81; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; PRINS ML, 2010, DEV NEUROSCI, V32; Putukian Margot, 2006, Curr Sports Med Rep, V5, P15; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1098; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; STERNBERGER NH, 1983, ANN NY ACAD SCI, V420, P90, DOI 10.1111/j.1749-6632.1983.tb22192.x; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	111	282	288	3	117	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					33	+		10.1016/j.csm.2010.09.001			18	Sport Sciences	Sport Sciences	691XR	WOS:000285114800005	21074080		Y	N	2021-06-18	
J	Malec, JF; Brown, AW; Leibson, CL; Flaada, JT; Mandrekar, JN; Diehl, NN; Perkins, PK				Malec, James F.; Brown, Allen W.; Leibson, Cynthia L.; Flaada, Julie Testa; Mandrekar, Jayawant N.; Diehl, Nancy N.; Perkins, Patricia K.			The Mayo classification system for traumatic brain injury severity	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; classification	SEVERE HEAD-INJURY; NEUROPSYCHOLOGICAL RECOVERY; POPULATION; COMA; TOMOGRAPHY; PREDICTION; SEIZURES; MODERATE; RISKS	Purpose: To develop a single TBI severity classification system based on commonly used TBI severity measures and indicators that (1) maximally uses available positive evidence to classify TBI severity in three categories: (a) Moderate- evere (Definite) TBI, (b) Mild (Probable) TBI, ( c) Symptomatic (Possible) TBI; (2) reflects current clinical knowledge and relevance; and (3) classifies a larger number of cases than single indicator systems with reasonable accuracy. Main Findings: The study sample of a defined population consisted of 1501 unique Olmsted County residents with at least one confirmed TBI event from 1985 to 1999. Within the sample, 1678 TBI events were confirmed. Single measures of TBI severity were not available in a large percentage of these events, i.e., Glasgow Coma Scale (GCS) was absent in 1242 (74.0%); loss of consciousness, absent in 178 (70.2%), post-traumatic amnesia (PTA), absent in 974 (58.1%), head CT, not done in 827 (49.3%). The Mayo Classification System for TBI Severity was developed to classify cases based on available indicators that included death due to TBI, trauma-related neuroimaging abnormalities, GCS, PTA, loss of consciousness and specified post-concussive symptoms. Using the Mayo system, all cases were classified. For the Moderate- Severe ( Definite) TBI classification, estimated sensitivity was 89% and estimated specificity was 98%. Conclusions: By maximally using relevant available positive evidence, the Mayo system classifies a larger number of cases than single indicator systems with reasonable accuracy. This system may be of use in retrospective research and for determination of TBI severity for planning postacute clinical care.	Coll Med, Dept Psychiat & Psychol, Mayo Clin, Rochester, MN 55905 USA; Coll Med, Dept Phys Med & Rehabil, Mayo Clin, Rochester, MN USA; Coll Med, Dept Epidemiol, Mayo Clin, Rochester, MN USA; Coll Med, Dept Biostat, Mayo Clin, Rochester, MN USA	Malec, JF (corresponding author), Coll Med, Dept Psychiat & Psychol, Mayo Clin, Rochester, MN 55905 USA.	malec.james@mayo.edu		Brown, Allen W./0000-0001-7228-3351			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Brown AW, 2004, NEUROREHABILITATION, V19, P37; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Evans RW., 2006, NEUROLOGY TRAUMA, P95; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Graham DI, 2006, NEUROLOGY TRAUMA, P45; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Malec JF, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P15; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	32	282	283	2	23	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2007	24	9					1417	1424		10.1089/neu.2006.0245			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	214ZT	WOS:000249777600001	17892404				2021-06-18	
J	Broshek, DK; Kaushik, T; Freeman, JR; Erlanger, D; Webbe, F; Barth, JT				Broshek, DK; Kaushik, T; Freeman, JR; Erlanger, D; Webbe, F; Barth, JT			Sex differences in outcome following sports-related concussion	JOURNAL OF NEUROSURGERY			English	Article						sports-related concussion; mild head injury; sex-based difference; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; RETURN; PREDICTORS; ESTROGEN; MEMORY	Object. Females comprise an increasing percentage of the athlete population across all age groups, and analysis of recent literature reveals that they sustain more concussions in collegiate sports. Results of human and animal studies indicate that females may have poorer outcomes after traumatic brain injury; however, no return-to-play guideline takes sex or other individual differences into account. In the present study the authors evaluated the influence of patient sex on objective neuro-cognitive performance and subjective reporting of symptoms following sports-related concussion. Methods. According to preseason baseline neurocognitive computerized testing in 2340 male and female high school and collegiate athletes, individuals who sustained sports-related concussions (155 persons) were reevaluated using an alternate form of the cognitive test. Sex differences in the magnitude of cognitive change from baseline levels and the subjective experience of symptoms were analyzed. To account for the possible protective effects of helmets, comparisons were performed among females, males with helmets, and males without helmets; none of the female athletes wore helmets. Female athletes had significantly greater declines in simple and complex reaction times relative to preseason baseline levels, and they reported more postconcussion symptoms compared with males. As a group, females were cognitively impaired approximately 1.7 times more frequently than males following concussions. Furthermore, females experienced more objective and subjective adverse effects from concussion even after adjusting for the use of helmets by some groups of male athletes (for example, in football). Conclusions. Return-to-play decisions and concussion management must be objective and made on an individual basis, including consideration of factors such as patient sex rather than relying on a one-size-fits-all guideline.	Univ Virginia, Sch Med, Dept Psychiat Med, Neuropsychol Lab, Charlottesville, VA 22908 USA; HeadMinder Inc, New York, NY USA; Albert Einstein Coll Med, Dept Psychiat, New York, NY USA; Florida Inst Technol, Dept Psychol, Melbourne, Vic, Australia	Broshek, DK (corresponding author), Univ Virginia, Sch Med, Dept Psychiat Med, Neuropsychol Lab, Box 800203, Charlottesville, VA 22908 USA.	broshek@virginia.edu	Webbe, Frank/A-8074-2009	Webbe, Frank/0000-0002-4370-5698			ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; BARTH JT, 2002, ENCY HUMAN BRAIN, V3, P81; Barth JT., 1989, MILD HEAD INJURY, P257; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brooks J, 2004, STUD NEUROPSYCHOL DE, P443; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; *CDCP, TBI RISKS GROUP RISK; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2003, J ATHL TRAINING, V38, P238; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Esposito G, 1996, J NUCL MED, V37, P559; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Kelly JP, 1997, NEUROLOGY, V48, P581; KOZNIEWSKA E, 1995, CIRC RES, V76, P551, DOI 10.1161/01.RES.76.4.551; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrea M., 1997, STANDARDIZED ASSESSM; Mueller FO, 2001, J ATHL TRAINING, V36, P312; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan JP, 2004, CLIN J SPORT MED, V14, P18, DOI 10.1097/00042752-200401000-00004; *US DEP ED, TITL 9 25 YEARS PROG; VRIEZEN ER, 2004, 32 ANN M PROGR COL I, P50; Waber DP, 2000, SCI PRACT NEUROPSYCH, P300; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; WEBBE FM, SPORTS NEUROPSYCHOLO; *WOM SPORTS FDN, TIT 9 OV CURR DEV	42	282	283	1	51	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2005	102	5					856	863		10.3171/jns.2005.102.5.0856			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	954KO	WOS:000231154200009	15926710				2021-06-18	
J	Iverson, GL; Lange, RT				Iverson, GL; Lange, RT			Examination of "postconcussion-like" symptoms in a healthy sample	APPLIED NEUROPSYCHOLOGY			English	Article; Proceedings Paper	154th Annual Meeting of the American-Psychiatric-Association	MAY 05-10, 2001	NEW ORLEANS, LA	Amer Psychiat Assoc		post-concussion syndrome; mild traumatic brain injury; base rates	MILD HEAD-INJURY; COMPLAINT BASE RATES; RESPONSE BIAS	The post-concussion syndrome (PCS) is relatively common following mild traumatic brain injury (MTBI). However, the factors that cause and maintain this syndrome continue to be debated. The purpose of this investigation was to examine the prevalence of postconcussion-like symptoms in a sample of healthy individuals. Participants (N = 104) completed the British Columbia Postconcussion Symptom Inventory-Short Form (BC-PSI-Sf), a test designed to measure both the frequency and intensity of ICD-10 criteria for PCS, and the Beck Depression Inventory (2nd ed.). Specific endorsement rates of postconcussion-like symptoms ranged from 35.9% to 75.7% for any experience of the symptoms in the past 2 weeks, and from 2.9% to 15.5% for the experience of more severe symptoms. Symptoms reported on the BC-PSI-Sf also showed a moderately high correlation with self-reported depressive symptoms [r(102) = .76, p <. 01]. This study illustrates that the presence of postconcussion-like symptoms: (a) are not unique to mild head injury and are commonly found in healthy individuals, and (b) are highly correlated with depressive symptoms.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Riverview Hosp, Vancouver, BC, Canada	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beck A., 1996, MANUAL BDI 2; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Heilbronner RL, 1993, TRIAL DIPLOMACY J, V16, P161; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P315; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; TRAHAN DE, 2001, ARCH CLIN NEUROPSYCH; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 1992, ICD 10 INT STAT CLAS; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	34	282	285	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	3					137	144		10.1207/S15324826AN1003_02			8	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	780NL	WOS:000189387500002	12890639				2021-06-18	
J	Alkayed, NJ; Murphy, SJ; Traystman, RJ; Hurn, PD				Alkayed, NJ; Murphy, SJ; Traystman, RJ; Hurn, PD			Neuroprotective effects of female gonadal steroids in reproductively senescent female rats	STROKE			English	Article						cerebral ischemia; estrogens; menopause; progesterone; stroke	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN INJURY; EXPERIMENTAL STROKE; FOREBRAIN ISCHEMIA; NEURONAL DAMAGE; AGED RATS; ESTROGEN; PROGESTERONE; 17-BETA-ESTRADIOL; RECEPTORS	Background and Purpose-Young adult female rats sustain smaller infarcts after experimental stroke than age-matched males. This sex difference in ischemic brain injury in young animals disappears after surgical ovariectomy and can be restored by estrogen replacement. We sought to determine whether ischemic brain injury continues to be smaller in middle-aged, reproductively senescent female rats compared with age-matched males and to test the effect of ovarian steroids on brain injury after experimental stroke in females. Methods-Four groups of 16-month old Wistar rats (males [n=9], untreated females [n=9], and females pretreated with 17 beta-estradiol [25-mu g pellets administered subcutaneously for 7 days; n=9] or progesterone [10-mg pellets administered subcutaneously for 7 days; n=9] were subjected to 2 hours of middle cerebral artery occlusion with the intraluminal filament technique, followed by 22 hours of reperfusion. Physiological variables and laser-Doppler cerebral cortical perfusion were monitored throughout ischemia and early reperfusion. In a separate cohort of males (n=3), untreated females (n=3), females pretreated with 17 beta-estradiol (n=3), and females pretreated with progesterone (n=3), end-ischemic regional cerebral blood flow was measured by [C-14]iodoantipyrine autoradiography. Results-As predicted, infarct size was not different between middle-aged male and female rats. Cortical infarcts were 21+/-5% and 31+/-6% of ipsilateral cerebral cortex, and striatal infarcts were 44+/-7% and 43+/-5% of ipsilateral striatum in males and females, respectively. Both estrogen and progesterone reduced cortical infarct in reproductively senescent females (5+/-2% and 16+/-4% in estrogen- and progesterone-treated groups. respectively, compared with 31+/-6% in untreated group), Striatal infarct was smaller in the estrogen- but not in the progesterone-treated group. Relative change in laser-Doppler cerebral cortical perfusion from preischemic baseline and absolute end-ischemic regional cerebral blood flow were not affected by hormonal treatments. Conclusions-We conclude that the protection against ischemic brain injury found in young adult female rats disappears after reproductive senescence in middle-aged females and that ovarian hormones alleviate stroke injury in reproductively senescent female rats by a blood flow-independent mechanism. These findings support a role for hormone replacement therapy in stroke injury prevention in postmenopausal women.	Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Div Comparat Med, Baltimore, MD 21287 USA	Alkayed, NJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 600 N Wolfe St,Blalock 1404, Baltimore, MD 21287 USA.	nalkayed@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS020020, R01NS033668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR003521] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS33668, NS20020] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [NR03521] Funding Source: Medline		Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Auer RN, 1996, STROKE, V27, P743, DOI 10.1161/01.STR.27.4.743; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; BAUGHMAN VL, 1988, ANESTH ANALG, V67, P677; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Canese R, 1998, MAGN RESON MATER PHY, V7, P28; Chen J, 1998, NEUROSCIENCE, V87, P817, DOI 10.1016/S0306-4522(98)00198-5; Davis M, 1997, ACT NEUR S, V70, P56; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; FUTRELL N, 1991, STROKE, V22, P1582, DOI 10.1161/01.STR.22.12.1582; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Herzog AG, 1999, NEUROLOGY, V52, P1917, DOI 10.1212/WNL.52.9.1917-a; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUM PD, 1998, PHARM CEREBRAL ISCHE; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Kume-Kick J, 1998, BRAIN RES, V803, P105, DOI 10.1016/S0006-8993(98)00628-3; LU JKH, 1994, NEUROBIOL AGING, V15, P541, DOI 10.1016/0197-4580(94)90094-9; McMillan PJ, 1996, J NEUROSCI, V16, P1860; Miranda P, 1999, J NEUROSCI, V19, P3316; Moffat CA, 1998, J NEUROSCI, V18, P9556; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SAWADA M, IN PRESS J CEREB BLO; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; Singh M, 1999, J NEUROSCI, V19, P1179; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Stein DG, 1998, NEUROSCIENTIST, V4, P435, DOI 10.1177/107385849800400615; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Wang Q, 1999, STROKE, V30, P630, DOI 10.1161/01.STR.30.3.630; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; World Hlth Org, 1998, CONTRACEPTION, V57, P315; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7	48	282	287	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2000	31	1					161	167		10.1161/01.STR.31.1.161			7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	271HX	WOS:000084589100029	10625733	Bronze			2021-06-18	
J	Chen, Y; Constantini, S; Trembovler, V; Weinstock, M; Shohami, E				Chen, Y; Constantini, S; Trembovler, V; Weinstock, M; Shohami, E			An experimental model of closed head injury in mice: Pathophysiology, histopathology, and cognitive deficits	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; closed head injury; edema; histopathology; mice; trauma model; water maze	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; QUANTITATIVE-EVALUATION; PARIETAL CORTEX; RAT; EDEMA; PERMEABILITY; ISCHEMIA; LESIONS	The present study describes the characterization of an experimental model of closed head injury (CHI) in the mouse. This model is a modification of a setup described and used previously in the rat. The weight-drop device was modified and adapted to the size and weight of the mouse and the typical parameters that define the severity of the injury and its outcome were evaluated. The post-traumatic accumulation of water, i.e., cerebral edema, the disruption of the blood-brain barrier (BBB), histopathology, motor and cognitive functions were studied up to 30 days following CHI. Increases in cerebral water content and of BBB permeability were observed in the injured hemisphere at 4 h (p < 0.05) and 24 h (p < 0.01) postinjury, respectively. By 7 days, edema disappeared, while the BBB remained open for up to 30 days. The motor function was evaluated by a set of criteria termed neurological severity score (NSS). NSS was severely impaired immediately after CHI and later showed a spontaneous progressive recovery, although some residual deficits, mainly of beam-walk and balance, mere still present at 30 days. Mice trained in the Morris water maze before the injury demonstrated highly significant deficits in memory retention up to at least 11 days postinjury (p < 0.01). Histopathological analysis revealed significant neuronal cell death in CA(1), CA(2), and CA(3) regions of the left hippocampus following CHI. However, in the right hippocampus, overt neuronal cell death was observed only in area CA3 at 7 days after CHI. These results suggest that the modified model of CHI in mice can reproduce the posttraumatic sequelae observed in rats and show that some of the data obtained in this model are essentially similar to those observed in human head injury. The experimental model of CHI in mice may be a useful tool for studies in animals that carry specific genetic alterations, aimed at manipulating neurochemical pathways involved in the pathophysiology of brain damage.	HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARMACOL,IL-91120 JERUSALEM,ISRAEL; TEL AVIV MED CTR & SCH MED,DIV PEDIAT NEUROSURG,TEL AVIV,ISRAEL							ANTAL J, 1992, LIFE SCI, V51, P185, DOI 10.1016/0024-3205(92)90074-Y; ASSAF Y, 1996, IN PRESS MAGN RESON; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; BODSCH W, 1982, BRAIN RES, V249, P111, DOI 10.1016/0006-8993(82)90175-5; Cartlidge N E, 1981, HEAD INJURY; CHAN PH, 1994, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1994, P277; CONSTANTINI S, 1995, PRINCIPLES PRACTICE; DEMEDIUK P, 1988, Journal of Neurotrauma, V5, P105, DOI 10.1089/neu.1988.5.105; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; JUCKER M, 1990, PHYSIOL BEHAV, V47, P207, DOI 10.1016/0031-9384(90)90062-9; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; KAMETANI H, 1989, BEHAV NEUROSCI, V103, P84, DOI 10.1037/0735-7044.103.1.84; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOMNITSKI L, 1996, 24 M FED EUR BIOCH S; LUCHTER S, 1995, J NEUROTRAUM, V12, P517, DOI 10.1089/neu.1995.12.517; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SHOHAMI E, 1992, J BASIC CLIN PHYSL P, V3, P9; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sutton R. L., 1992, Society for Neuroscience Abstracts, V18, P170; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	41	282	315	0	19	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1996	13	10					557	568		10.1089/neu.1996.13.557			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	VQ834	WOS:A1996VQ83400002	8915907				2021-06-18	
J	LEININGER, BE; GRAMLING, SE; FARRELL, AD; KREUTZER, JS; PECK, EA				LEININGER, BE; GRAMLING, SE; FARRELL, AD; KREUTZER, JS; PECK, EA			NEUROPSYCHOLOGICAL DEFICITS IN SYMPTOMATIC MINOR HEAD-INJURY PATIENTS AFTER CONCUSSION AND MILD CONCUSSION	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,POB 2018,RICHMOND,VA 23284; NEUROPSYCHOL SERV VIRGINIA,RICHMOND,VA; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT REHABIL MED,RICHMOND,VA 23298							BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benton A., 1976, MULTILINGUAL APHASIA; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GENNARELLI TA, 1982, HEAD INJURY, P83; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; LARZELERE RE, 1977, PSYCHOL BULL, V84, P557, DOI 10.1037/0033-2909.84.3.557; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1983, UNPUB PACED AUDITORY; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Taylor E. M., 1959, APPRAISAL CHILDREN C; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	25	282	282	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1990	53	4					293	296		10.1136/jnnp.53.4.293			4	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	DA277	WOS:A1990DA27700006	2341842	Green Published, Bronze			2021-06-18	
J	Seel, RT; Sherer, M; Whyte, J; Katz, DI; Giacino, JT; Rosenbaum, AM; Hammond, FM; Kalmar, K; Pape, TLB; Zafonte, R; Biester, RC; Kaelin, D; Kean, J; Zasler, N				Seel, Ronald T.; Sherer, Mark; Whyte, John; Katz, Douglas I.; Giacino, Joseph T.; Rosenbaum, Amy M.; Hammond, Flora M.; Kalmar, Kathleen; Pape, Theresa Louise-Bender; Zafonte, Ross; Biester, Rosette C.; Kaelin, Darryl; Kean, Jacob; Zasler, Nathan			Assessment Scales for Disorders of Consciousness: Evidence-Based Recommendations for Clinical Practice and Research	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Coma; Consciousness Disorders; Brain injuries; Diagnosis; Outcome assessment; Persistent vegetative state; Practice guidelines as topic; Prognosis; Rehabilitation; Review	GLASGOW-COMA-SCALE; REACTION LEVEL SCALE; SENSORY MODALITY ASSESSMENT; WESSEX HEAD-INJURY; REHABILITATION TECHNIQUE SMART; PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; MOTOR RESPONSE; RECOVERY SCALE; MUSICOKINETIC THERAPY	Report of the American Congress of Rehabilitation Medicine, Brain Injury-Interdisciplinary Special Interest Group, Disorders of Consciousness Task Force: Seel RT, Task Force Chair, Sherer M, Whyte J, Katz DI, Giacino if, Rosenbaum AM, Hammond FM, Kalmar K, Pape TL, Zafonte R, Biester RC, Kaelin D, Kean J, Zasler N. Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Arch Phys Med Rehabil 2010;91:1795-1813. Objectives: To conduct a systematic review of behavioral assessment scales for disorders of consciousness (DOC); provide evidence-based recommendations for clinical use based on their content validity, reliability, diagnostic validity, and ability to predict functional outcomes; and provide research recommendations on DOC scale development and validation. Data Sources: Articles published through March 31, 2009, using MEDLINE, CINAHL, Psychology and Behavioral Sciences Collection, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, Biomedical Reference Collection, and PsycINFO. Thirteen primary terms that defined DOC were paired with 30 secondary terms that defined aspects of measurement. Scale names, abbreviations, and authors were also used as search terms. Task force members identified additional articles by using personal knowledge and examination of references in reviewed articles. Study Selection: Primary criteria included the following: (I) provided reliability, diagnostic validity, and/or prognostic validity data; (2) examined a cohort, case control, or case series sample of persons with DOC who were age older than or equal to 18 years; and (3) assessed in an acute care or rehabilitation setting. Articles were excluded if peer review was not conducted, original data were not reported, or an English language article was not available. The initial search yielded 580 articles. After paired rater review of study abstracts, guideline development was based on 37 articles representing 13 DOC scales. Data Extraction: Rater pairs classified studies addressing diagnostic and prognostic validity by using the American Academy of Neurology 4-tier level of evidence scheme, and reliability by using a task force developed 3-tier evidence scheme. An independent quality review of ratings was conducted, and corrections were made. Data Synthesis: The Coma Recovery Scale-Revised (CRS-R), Sensory Stimulation Assessment Measure (SSAM), Wessex Head Injury Matrix (WHIM), Western Neuro Sensory Stimulation Profile (WNSSP), Sensory Modality Assessment Technique (SMART), Disorders of Consciousness Scale (DOCS), and Coma/Near-Coma Scale (CNC) have acceptable standardized administration and scoring procedures. The CRS-R has excellent content validity and is the only scale to address all Aspen Work-group criteria. The SMART, SSAM, WHIM, and WNSSP demonstrate good content validity, containing items that could distinguish persons who are in a vegetative state, are in a minimally conscious state (MCS), or have emerged from MCS. The Full Outline of UnResponsiveness Score (FOUR), WNSSP, CRS-R, Comprehensive Levels of Consciousness Scale (CLOCS), and Innsbruck Coma Scale (INNS) showed substantial evidence of internal consistency. The FOUR and the CRS-R showed substantial evidence of good interrater reliability. Evidence of diagnostic validity and prognostic validity in brain injury survivor samples had very high levels of potential bias because of methodologic issues such as lack of rater masking. Conclusions: The CRS-R may be used to assess DOC with minor reservations, and the SMART, WNSSP, SSAM, WHIM, and DOCS may be used to assess DOC with moderate reservations. The CNC may be used to assess DOC with major reservations. The FOUR, INNS, Glasgow-Liege Coma Scale, Swedish Reaction Level Scale-1985, Loewenstein Communication Scale, and CLOCS are not recommended at this time for bedside behavioral assessment of DOC because of a lack of content validity, lack of standardization, and/or unproven reliability.	[Seel, Ronald T.; Kaelin, Darryl] Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA; [Seel, Ronald T.; Kaelin, Darryl] Shepherd Ctr, Brain Injury Program, Atlanta, GA 30309 USA; [Sherer, Mark] Univ Texas Med Sch Houston, Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Sherer, Mark] Univ Texas Med Sch Houston, TIRR Mem Hermann, Houston, TX USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Brain Injury Program, Braintree, MA USA; [Rosenbaum, Amy M.] Pk Terrace Care Ctr, Queens, NY USA; [Giacino, Joseph T.; Zafonte, Ross] Harvard Univ, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Hammond, Flora M.; Kean, Jacob] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Giacino, Joseph T.; Kalmar, Kathleen] JFK Med Ctr, Ctr Head Injuries, JFK Johnson Rehabil Inst, Edison, NJ USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Res Serv, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Edward Hines Jr Vet Affairs Hosp, Complex Chron Care Ctr Excellence,Ctr Management, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Biester, Rosette C.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Zasler, Nathan] Concuss Care Ctr Virginia, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv, Richmond, VA USA	Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Katz, Douglas/0000-0002-7502-8505; Bender Pape, Theresa/0000-0001-7738-5963; Whyte, John/0000-0002-4381-1474; Kean, Jacob/0000-0002-8577-0586	American Congress of Rehabilitation Medicine Clinical Practice Committee; National Institute on Disability and Rehabilitation Research Model Systems Knowledge Translation Center	Financial and technical support by the American Congress of Rehabilitation Medicine Clinical Practice Committee and the National Institute on Disability and Rehabilitation Research Model Systems Knowledge Translation Center.	Anastasi A., 1988, PSYCHOL TESTING; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ansell B. J., 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199309000-00011; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1995, ARCH PHYS MED REHAB, V76, P726, DOI 10.1016/S0003-9993(95)80526-5; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Bedard M, 2000, EXP AGING RES, V26, P353, DOI 10.1080/036107300750015741; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; Benzer A, 1995, Anasthesiol Intensivmed Notfallmed Schmerzther, V30, P231, DOI 10.1055/s-2007-996481; Berek K, 1997, J NEUROL, V244, P556, DOI 10.1007/s004150050143; Berger E, 2001, J CHILD NEUROL, V16, P236, DOI 10.1177/088307380101600402; Berger E, 1997, Pediatr Rehabil, V1, P229; BIDDLE AK, 2002, AHRQ EVID REP TECHNO, V52, P1; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; BORN JD, 1987, NEUROSURGERY, V20, P513, DOI 10.1227/00006123-198704000-00001; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Carmines E.G., 1980, RELIABILITY VALIDITY; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; COHEN J, 1989, APPL MULTIPLE REGRES; Cossa FM, 1999, BRAIN INJURY, V13, P583; Crocker L., 1986, INTRO CLASSICAL MODE; Davis AE, 2003, J NEUROSCI NURS, V35, P214; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; DeVellis R.F., 2003, APPL SOCIAL RES METH, V26; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; Edlund W, 2004, CLIN PRACTICE GUIDEL; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Fleiss J., 1986, DESIGN ANAL CLIN EXP; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; Frank-Stromborg Marilyn, 2004, INSTRUMENTS CLIN HLT; Freeman EA, 1997, BRAIN INJURY, V11, P837, DOI 10.1080/026990597123052; Freeman EA, 1996, BRAIN INJURY, V10, P615; Freeman Edward, 1993, NEUROPSYCHOL REHABIL, V3, P139; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, pR7, DOI 10.1097/00001199-199708000-00001; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Gill-Thwaites H, 1999, NEUROPSYCHOL REHABIL, V9, P305, DOI 10.1080/096020199389392; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; Gruner ML, 2000, BRAIN INJURY, V14, P585; Hahn EA, 2003, ARCH PHYS MED REHAB, V84, pS35, DOI 10.1053/apmr.2003.50245; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HORN S, 1993, NEUROPSYCHOL REHABIL, V3, P121; JENNETT B, 1972, LANCET, V1, P734; Johnston MD, 1996, ARCH CLIN NEUROPSYCH, V11, P703, DOI 10.1016/S0887-6177(96)80006-0; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KEENAN JE, 1989, COGN REHABIL, V7, P24; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; Matousek M, 1996, ACTA ANAESTH SCAND, V40, P824, DOI 10.1111/j.1399-6576.1996.tb04540.x; Mayer SA, 2003, NEUROLOGY, V61, P543, DOI 10.1212/01.WNL.0000078817.17321.61; Mukherjee K, 2000, NEUROL INDIA, V48, P43; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Noda R, 2003, ACTA NEUROCHIR SUPPL, V87, P23; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; ODell MW, 1996, J HEAD TRAUMA REHAB, V11, P61, DOI 10.1097/00001199-199606000-00009; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; Ohta T, 2005, ACT NEUR S, V93, P191; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Pape TLB, 2006, BRAIN INJURY, V20, P743, DOI 10.1080/02699050600676933; Pape TLB, 2009, PM&R, V1, P152, DOI 10.1016/j.pmrj.2008.11.002; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; Plum F, 1982, PATHOLOGIC PHYSL SIG; PLUM F, 1991, CEREBRAL CORTEX, V9; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Raykov T, 1997, MULTIVAR BEHAV RES, V32, P95, DOI 10.1207/s15327906mbr3202_1; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2005, NEUROPSYCHOL REHABIL, V15, P381, DOI 10.1080/09602010443000524; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shiel A, 2005, NEUROPSYCHOL REHABIL, V15, P494, DOI 10.1080/09602010443000551; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Stalhammar D, 1986, Acta Neurochir Suppl (Wien), V36, P91; STALHAMMAR D, 1988, ACTA NEUROCHIR, V90, P73, DOI 10.1007/BF01560558; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; Starmark J E, 1986, Acta Neurochir Suppl (Wien), V36, P103; Starmark J E, 1986, Acta Neurochir Suppl (Wien), V36, P121; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; STARMARK JE, 1987, ACTA NEUROCHIR, V84, P150; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; TALBOT LR, 1994, BRAIN INJURY, V8, P689, DOI 10.3109/02699059409151023; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TEASDALE G, 1974, LANCET, V2, P81; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318; Wilson FC, 2005, NEUROPSYCHOL REHABIL, V15, P431, DOI 10.1080/09602010543000091; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Wilson SL, 1998, LANCET, V352, P485, DOI 10.1016/S0140-6736(05)79220-5; Wilson SL, 1996, BRAIN INJURY, V10, P509, DOI 10.1080/026990596124223; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; Wilson SL, 1996, BRAIN INJURY, V10, P105, DOI 10.1080/026990596124593; Wilson SL, 2000, BRAIN INJURY, V14, P319; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435; 1999, N ENGL J MED, V330, P1572	132	281	297	5	54	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2010	91	12					1795	1813		10.1016/j.apmr.2010.07.218			19	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	700KY	WOS:000285738900001	21112421				2021-06-18	
J	Bonnelle, V; Leech, R; Kinnunen, KM; Ham, TE; Beckmann, CF; De Boissezon, X; Greenwood, RJ; Sharp, DJ				Bonnelle, Valerie; Leech, Robert; Kinnunen, Kirsi M.; Ham, Tim E.; Beckmann, Cristian F.; De Boissezon, Xavier; Greenwood, Richard J.; Sharp, David J.			Default Mode Network Connectivity Predicts Sustained Attention Deficits after Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; STATE FUNCTIONAL CONNECTIVITY; POSTERIOR CINGULATE CORTEX; WORKING-MEMORY; VIGILANCE DECREMENT; COGNITIVE CONTROL; WANDERING MINDS; REACTION-TIME; HEAD-INJURY; TASK	Traumatic brain injury (TBI) frequently produces impairments of attention in humans. These can result in a failure to maintain consistent goal-directed behavior. A predominantly right-lateralized frontoparietal network is often engaged during attentionally demanding tasks. However, lapses of attention have also been associated with increases in activation within the default mode network (DMN). Here, we study TBI patients with sustained attention impairment, defined on the basis of the consistency of their behavioral performance over time. We show that sustained attention impairments in patients are associated with an increase in DMN activation, particularly within the precuneus and posterior cingulate cortex. Furthermore, the interaction of the precuneus with the rest of the DMN at the start of the task, i.e., its functional connectivity, predicts which patients go on to show impairments of attention. Importantly, this predictive information is present before any behavioral evidence of sustained attention impairment, and the relationship is also found in a subgroup of patients without focal brain damage. TBI often results in diffuse axonal injury, which produces cognitive impairment by disconnecting nodes in distributed brain networks. Using diffusion tensor imaging, we demonstrate that structural disconnection within the DMN also correlates with the level of sustained attention. These results show that abnormalities in DMN function are a sensitive marker of impairments of attention and suggest that changes in connectivity within the DMN are central to the development of attentional impairment after TBI.	[Bonnelle, Valerie; Leech, Robert; Ham, Tim E.; Beckmann, Cristian F.; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Ctr Neurosci, Div Expt Med, London W12 0NN, England; [Bonnelle, Valerie] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Kinnunen, Kirsi M.] Univ London, London SE14 6NW, England; [Beckmann, Cristian F.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-6500 HB Nijmegen, Netherlands; [De Boissezon, Xavier] INSERM, Imagerie Cerebrale & Handicaps Neurol UMR 825, F-31059 Toulouse, France; [De Boissezon, Xavier] Univ Toulouse, UPS, Imagerie Cerebrale & Handicaps Neurol UMR 825, CHU Purpan, F-31059 Toulouse 9, France; [De Boissezon, Xavier] CHU Purpan, Ctr Hosp Univ Toulouse, F-31059 Toulouse 9, France; [Greenwood, Richard J.] UCL, Inst Neurol, London WC1N 3BG, England	Sharp, DJ (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	david.sharp@imperial.ac.uk	Kinnunen, Kirsi/P-6402-2019; Lang, Steven/AAE-8102-2021; Beckmann, Christian F./E-6374-2012; Sharp, David J/A-2119-2013; Leech, Robert/AAE-8254-2019	Lang, Steven/0000-0003-1669-9146; Beckmann, Christian F./0000-0002-3373-3193; Leech, Robert/0000-0002-5801-6318; Kinnunen, Kirsi M./0000-0002-8562-2866	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Hammersmith Hospitals Trustees' Research Committee; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951, MC_U120097117] Funding Source: researchfish	This work was supported by the Medical Research Council (UK) and the Hammersmith Hospitals Trustees' Research Committee.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Baddeley A., 1994, DOORS PEOPLE TEST TE; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Delis DC, 2001, DELISKAPLAN EXECUTIV; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Grottick AJ, 2002, PSYCHOPHARMACOLOGY, V164, P33, DOI 10.1007/s00213-002-1174-3; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hayden BY, 2009, P NATL ACAD SCI USA, V106, P5948, DOI 10.1073/pnas.0812035106; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Langner R, 2010, PSYCHOL RES-PSYCH FO, V74, P499, DOI 10.1007/s00426-010-0275-6; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; LISPER HO, 1974, ACTA PSYCHOL, V38, P455, DOI 10.1016/0001-6918(74)90005-5; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mori S., 2005, MRI ATLAS HUMAN WHIT; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; Wechsler D, 1999, WASI WECHSLER ABBREV; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Zhang S, 2010, NEUROIMAGE, V49, P1911, DOI 10.1016/j.neuroimage.2009.09.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	72	280	290	0	45	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 21	2011	31	38					13442	13451		10.1523/JNEUROSCI.1163-11.2011			10	Neurosciences	Neurosciences & Neurology	822XG	WOS:000295083300010	21940437	Green Published, Bronze			2021-06-18	
J	Kazak, AE; Alderfer, M; Rourke, MT; Simms, S; Streisand, R; Grossman, JR				Kazak, AE; Alderfer, M; Rourke, MT; Simms, S; Streisand, R; Grossman, JR			Posttraumatic stress disorder (PTSD) and posttraumatic stress symptoms (PTSS) in families of adolescent childhood cancer survivors	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						pediatric oncology; cancer survivors; adolescents; families; posttraumatic stress symptoms; PTSD	BONE-MARROW TRANSPLANTATION; TRAUMATIC BRAIN-INJURY; CHILDREN; MOTHERS; RESPONSES; EPIDEMIOLOGY; COMORBIDITY	Objective To describe rates and concordance of posttraumatic stress disorder (PTSD) and posttraumatic stress symptoms (PTSS) in adolescent childhood cancer survivors and their mothers and fathers. Method Participants were 150 adolescent survivors of childhood cancer, 146 mothers, and 103 fathers who completed the Impact of Events Scale-Revised, the Posttraumatic Stress Disorder Reaction Index, and the PTSD module of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Results PTSS are common in families of childhood cancer survivors. Parents reported more symptomatology than former patients. Mothers and fathers had relatively equal rates of current PTSD and levels of PTSS. Nearly 30% of mothers met diagnostic criteria since their child's diagnosis, with 13.7% currently experiencing PTSD. Nearly 20% of families had at least one parent with current PTSD. Ninety-nine percent of the sample had at least one family member reexperiencing symptoms. Conclusions Both PTSD and PTSS help in understanding the experience of adolescent cancer survivors and their families. Within families of childhood cancer survivors, it is likely that some member may be experiencing treatable bothersome memories, arousal, or avoidance specific to the cancer experience.	Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA	Kazak, AE (corresponding author), Childrens Hosp Philadelphia, Div Oncol, 34th St & Civ Ctr Blvd,Room 1486 CHOP N, Philadelphia, PA 19104 USA.	kazak@email.chop.edu	Alderfer, Melissa/A-2238-2010		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA088828, R01CA063930] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA63930, R01 CA088828] Funding Source: Medline		Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; Alderfer MA, 2003, J PEDIATR PSYCHOL, V28, P281, DOI 10.1093/jpepsy/jsg016; Alter CL, 1996, PSYCHOSOMATICS, V37, P137, DOI 10.1016/S0033-3182(96)71580-3; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Butler RW, 1996, J PEDIATR PSYCHOL, V21, P499, DOI 10.1093/jpepsy/21.4.499; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Erickson SJ, 2001, CHILD PSYCHIAT HUM D, V31, P195, DOI 10.1023/A:1026477321319; Fein JA, 2002, ARCH PEDIAT ADOL MED, V156, P836, DOI 10.1001/archpedi.156.8.836; First M., 1995, STRUCTURED CLIN INTE; FRIEDMAN D, 2002, PEDIAT CLIN N AM; Hobbie WL, 2000, J CLIN ONCOL, V18, P4060, DOI 10.1200/JCO.2000.18.24.4060; Kazak AE, 1999, FAM PROCESS, V38, P175; Kazak AE, 1997, J CONSULT CLIN PSYCH, V65, P120, DOI 10.1037/0022-006X.65.1.120; Kazak AE, 2001, J CLIN PSYCHOL MED S, V8, P307, DOI 10.1023/A:1011977031826; Kazak AE, 1994, PEDIAT PSYCHOONCOLOG, P171, DOI 10.1093/acprof:oso/9780195079319.003.0009; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Manne S, 2002, J PEDIATR PSYCHOL, V27, P607, DOI 10.1093/jpepsy/27.7.607; Manne SL, 1998, J PEDIATR PSYCHOL, V23, P357, DOI 10.1093/jpepsy/23.6.357; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Nir Y., 1985, POSTTRAUMATIC STRESS, P121; Pelcovitz D, 1996, PSYCHOSOMATICS, V37, P116, DOI 10.1016/S0033-3182(96)71577-3; POTMEES C, 1989, PSYCHOL EFFECT BONE; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; ROURKE M, 2002, 7 INT C LONG TERM CO; Seagull EA, 2000, J PEDIATR PSYCHOL, V25, P161, DOI 10.1093/jpepsy/25.3.161; SHANNON MP, 1994, J AM ACAD CHILD PSY, V33, P80, DOI 10.1097/00004583-199401000-00012; Shemesh E, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e29; Siegel S., 1988, NONPARAMETRIC STAT B; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; STREISAND R, 1999, UNDERSTANDING REASON; STUBER ML, 1991, J AM ACAD CHILD PSY, V30, P952, DOI 10.1097/00004583-199111000-00013; Stuber ML, 1998, CHILD ADOL PSYCH CL, V7, P169, DOI 10.1016/S1056-4993(18)30266-9; *US CENS BUR, 2002, COUNT EST MED HOUS I; Walker AM, 1999, J CHILD PSYCHOL PSYC, V40, P363, DOI 10.1111/1469-7610.00454; Weiss Daniel S., 1997, P399	38	280	283	0	25	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693			J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR-MAY	2004	29	3					211	219		10.1093/jpepsy/jsh022			9	Psychology, Developmental	Psychology	819EA	WOS:000221295500005	15131138	Green Published, Bronze			2021-06-18	
J	Jagoda, AS; Bazarian, JJ; Bruns, JJ; Cantrill, SV; Gean, AD; Howard, PK; Ghajar, J; Wright, DW; Wears, RL; Burgess, P; Wald, MM; Whitson, RR				Jagoda, Andy S.; Bazarian, Jeffrey J.; Bruns, John J.; Cantrill, Stephen V.; Gean, Alisa D.; Howard, Patricia Kunz; Ghajar, Jamshid; Wright, David W.; Wears, Robert L.; Burgess, Paula; Wald, Marlena M.; Whitson, Rhonda R.			Clinical Policy: Neuroimaging and Decisionmaking in Adult Mild Traumatic Brain Injury in the Acute Setting	ANNALS OF EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; EMERGENCY-DEPARTMENT DISCHARGE; DIFFUSE AXONAL INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; ELDERLY-PATIENTS; SERUM; CT; S-100B	This clinical policy provides evidence-based recommendations on select issues in the management of adult clinical policy are: (1) Which patients with mild TBI should have a noncontrast head computed tomography (CT) scan in the emergency department (ED)? (2) Is there a role for head magnetic resonance imaging over noncontrast CT in the ED evaluation of a patient with acute mild TBI? (3) In patients with mild TBI, are brain specific serum biomarkers predictive of an acute traumatic intracranial injury? (4) Can a patient with an isolated mild TBI and a normal neurologic evaluation result be safely discharged from the ED if a noncontrast head CT scan shows no evidence of intracranial injury? Inclusion criteria for application of this clinical policy's recommendations are nonpenetrating trauma to the head, presentation to the ED within 24 hours of injury a Glasgow Coma Scale score of 14 or 15 on initial evaluation in the ED, and aged 16 years or greater. The primary outcome measure for questions 1, 2, and 3 is the presence of an acute intracranial injury on noncontrast head CT scan; the primary outcome measure for question 4 is the occurrence of neurologic deterioration.	[Jagoda, Andy S.; Bazarian, Jeffrey J.; Bruns, John J.; Cantrill, Stephen V.; Gean, Alisa D.; Howard, Patricia Kunz; Ghajar, Jamshid; Wright, David W.; Wears, Robert L.; Burgess, Paula; Wald, Marlena M.] Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA	Jagoda, AS (corresponding author), Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.		Silvers, Scott/AAM-1234-2021; Wright, David/F-1209-2013; Wears, Robert/N-5959-2014	Wright, David/0000-0002-7145-9105; Wears, Robert/0000-0001-9826-954X			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergman DA, 1999, PEDIATRICS, V104, P1407; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Buduhan G, 2000, J TRAUMA, V49, P600, DOI 10.1097/00005373-200010000-00005; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; *DEF VET BRAIN INJ, 2006, 12027826345 DEF VET; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda A, 2000, EMERG MED CLIN N AM, V18, P355, DOI 10.1016/S0733-8627(05)70130-9; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVITT MA, 1995, ACAD EMERG MED, V2, P675, DOI 10.1111/j.1553-2712.1995.tb03617.x; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIZOLI SB, 1994, ACCIDENT ANAL PREV, V26, P681, DOI 10.1016/0001-4575(94)90030-2; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yates D., 2007, HEAD INJURY TRIAGE A	83	279	283	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	DEC	2008	52	6					714	748		10.1016/j.annemergmed.2008.08.021			35	Emergency Medicine	Emergency Medicine	381MJ	WOS:000261540200017	19027497				2021-06-18	
J	Hitiris, N; Mohanraj, R; Norrie, J; Sills, GJ; Brodie, MJ				Hitiris, Nikolas; Mohanraj, Rajiv; Norrie, John; Sills, Graeme J.; Brodie, Martin J.			Predictors of pharmacoresistant epilepsy	EPILEPSY RESEARCH			English	Article						pharmacoresistant epilepsy; predictive factors; seizures; psychiatric; comorbidity	NATIONAL GENERAL-PRACTICE; COMMON PATHOGENIC MECHANISMS; UNPROVOKED SEIZURES; FEBRILE SEIZURES; INTRACTABLE EPILEPSY; REFRACTORY EPILEPSY; MAJOR DEPRESSION; FOLLOW-UP; PROGNOSIS; POPULATION	Outcome data were analysed from 780 patients newly diagnosed with epilepsy and followed up at a single centre over a 20-year period to investigate which clinical factors predicted pharmacoresistance. Patients were divided at the time of analysis into those whose seizures had been controlled for at least the last 12 months of follow up (n = 462) and those whose epilepsy remained refractory (n = 318). Numbers of pre-treatment seizures were greater in uncontrolled patients. Those reporting more than 10 seizures prior to initiation of therapy were more than twice as likely to develop refractory epilepsy. Univariate and multivariate logistic regression analyses demonstrated that pharmacoresistance was also associated with family history of epilepsy, previous febrile seizures, traumatic brain injury as the cause of the epilepsy, intermittent recreational drug use, and prior or current psychiatric comorbidity, particularly depression. Factors not predicting poorer outcome included gender, neurological deficit and mental retardation. The most interesting new finding was the correlation between psychiatric comorbidity and tack of response to antiepileptic drug therapy. The deleterious neurobiological processes that underpin depression, anxiety and psychosis may interact with those producing seizures to increase the extent of brain dysfunction and thereby the likelihood of developing pharmacoresistant epilepsy. (c) 2007 Elsevier B.V. All rights reserved.	Western Infirm & Associated Hosp, Div Cardiovasc & Med Sci, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland; Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England; Univ Aberdeen, Hlth Serv Res Unit, CHaRT, Aberdeen AB9 1FX, Scotland	Brodie, MJ (corresponding author), Western Infirm & Associated Hosp, Div Cardiovasc & Med Sci, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland.	mjb2k@ctinmed.gla.ac.uk		Mohanraj, Rajiv/0000-0002-2559-148X; Sills, Graeme/0000-0002-3389-8713	Chief Scientist Office [HSRU1] Funding Source: Medline		ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BEGHI E, 1992, EPILEPSIA, V33, P45; Berg AT, 1996, EPILEPSIA, V37, P24, DOI 10.1111/j.1528-1157.1996.tb00507.x; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Berg AT, 1996, NEUROLOGY, V47, P562, DOI 10.1212/WNL.47.2.562; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; CAMFIELD P, 1994, DEV MED CHILD NEUROL, V36, P887; COCKERELL OC, 1995, LANCET, V346, P140, DOI 10.1016/S0140-6736(95)91208-8; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; Devinsky O, 1999, NEW ENGL J MED, V340, P1565, DOI 10.1056/NEJM199905203402008; ELWES RDC, 1984, NEW ENGL J MED, V311, P944, DOI 10.1056/NEJM198410113111503; FORSGREN L, 1990, EPILEPSY RES, V6, P66, DOI 10.1016/0920-1211(90)90010-S; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Hamati-Haddad A, 1998, NEUROLOGY, V50, P917, DOI 10.1212/WNL.50.4.917; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hesdorffer DC, 2000, ANN NEUROL, V47, P246, DOI 10.1002/1531-8249(200002)47:2<246::AID-ANA17>3.0.CO;2-E; Jobe PC, 2003, EPILEPSY BEHAV, V4, pS14, DOI 10.1016/j.yebeh.2003.08.020; Johnson MR, 2003, TWIN RES, V6, P140, DOI 10.1375/twin.6.2.140; Kanner AM, 2006, LANCET NEUROL, V5, P107, DOI 10.1016/S1474-4422(06)70331-3; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Kanner AM, 2006, ANN NEUROL, V60, pS19; Kjeldsen MJ, 2003, EPILEPSY RES, V55, P137, DOI 10.1016/S0920-1211(03)00117-7; Ko TS, 1999, CLIN NEUROPHYSIOL, V110, P1245, DOI 10.1016/S1388-2457(99)00068-1; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Leschziner G, 2006, LANCET NEUROL, V5, P668, DOI 10.1016/S1474-4422(06)70500-2; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U; Mattson RH, 1996, NEUROLOGY, V47, P68, DOI 10.1212/WNL.47.1.68; MENDEZ MF, 1986, ARCH NEUROL-CHICAGO, V43, P766, DOI 10.1001/archneur.1986.00520080014012; Mohanraj R, 2007, ACTA NEUROL SCAND, V115, P204, DOI 10.1111/j.1600-0404.2006.00791.x; Mohanraj R, 2006, EUR J NEUROL, V13, P277, DOI 10.1111/j.1468-1331.2006.01215.x; Mohanraj R, 2005, SEIZURE-EUR J EPILEP, V14, P318, DOI 10.1016/j.seizure.2005.04.002; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Pisani F, 2002, DRUG SAFETY, V25, P91, DOI 10.2165/00002018-200225020-00004; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Smith PEM, 1999, SEIZURE-EUR J EPILEP, V8, P441, DOI 10.1053/seiz.1999.0346; Zagnoni PG, 2002, EPILEPSIA, V43, P28, DOI 10.1046/j.1528-1157.2002.043s2028.x	41	279	294	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	JUL	2007	75	2-3					192	196		10.1016/j.eplepsyres.2007.06.003			5	Clinical Neurology	Neurosciences & Neurology	202LW	WOS:000248904200015	17628429				2021-06-18	
J	Leung, CT; Coulombe, PA; Reed, RR				Leung, Cheuk T.; Coulombe, Pierre A.; Reed, Randall R.			Contribution of olfactory neural stem cells to tissue maintenance and regeneration	NATURE NEUROSCIENCE			English	Article							GLOBOSE BASAL-CELLS; ADULT MAMMALIAN BRAIN; PROGENITOR CELLS; SUBVENTRICULAR ZONE; IN-VITRO; EPITHELIUM; LINEAGE; NEUROGENESIS; EXPRESSION; EPIDERMIS	The olfactory neuroepithelium undergoes continual neurogenesis and, after extensive lesions, fully regenerates to maintain sensory function. The stem cell population underlying this regenerative capacity remains elusive. Here we show that mouse horizontal basal cells (HBCs) function as adult olfactory neuroepithelium neural stem cells and examine their distinct dynamics in olfactory neuroepithelium maintenance and regeneration. Fate-mapping analysis after olfactory neuroepithelium lesioning shows that HBCs are competent to regenerate both neuronal and non-neuronal olfactory neuroepithelium lineages. HBCs serve as a reservoir of long-lived progenitors that remain largely quiescent during normal neuronal turnover or even after acute, selective loss of mature neurons. Under these conditions, previously identified progenitors are largely responsible for tissue maintenance. Yet after extensive injuries that deplete resident neuronal precursors, HBCs transiently proliferate and their progeny fully reconstitute the neuroepithelium. Our data support a new model of adult neurogenesis in which distinct cell populations mediate normal neuronal turnover and neuronal replacement upon traumatic injury.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, 725 N Wolfe St,PCTB 801, Baltimore, MD 21205 USA.	rreed@jhmi.edu		Leung, Cheuk/0000-0002-5838-5535			Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bergman U, 2002, ARCH TOXICOL, V76, P104, DOI 10.1007/s00204-002-0321-2; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huard JMT, 1998, J COMP NEUROL, V400, P469; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jang WC, 2003, J COMP NEUROL, V460, P123, DOI 10.1002/cne.10642; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mitchell BD, 2004, DEV NEUROSCI-BASEL, V26, P101, DOI 10.1159/000082131; Miyawaki A, 1996, EMBO J, V15, P2050, DOI 10.1002/j.1460-2075.1996.tb00558.x; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; SCHWOB JE, 1994, CHEM SENSES, V19, P671, DOI 10.1093/chemse/19.6.671; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sicard G, 1998, ANN NY ACAD SCI, V855, P223, DOI 10.1111/j.1749-6632.1998.tb10570.x; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8	38	279	291	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					720	726		10.1038/nn1882			7	Neurosciences	Neurosciences & Neurology	172JI	WOS:000246799800014	17468753				2021-06-18	
J	Fabricius, M; Fuhr, S; Bhatia, R; Boutelle, M; Hashemi, P; Strong, AJ; Lauritzen, M				Fabricius, M; Fuhr, S; Bhatia, R; Boutelle, M; Hashemi, P; Strong, AJ; Lauritzen, M			Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex	BRAIN			English	Article						brain injury; electroencephalography; electrocorticographic; penumbra; spreading depression	EPILEPTIFORM ACTIVITY; GLYCINE ANTAGONIST; ARTERY OCCLUSION; FOCAL ISCHEMIA; ACUTE STROKE; MEG SIGNALS; RAT-BRAIN; PROPAGATION; DAMAGE; NEUROPROTECTION	Electrocorticographic (ECoG) activity was recorded for up to 129 h from 12 acutely brain-injured human patients using six platinum electrodes placed near foci of damaged cortical tissue. The method probes ECoG activity in the immediate vicinity of the injured cortex and in adjacent supposedly healthy tissue. Six out of twelve patients displayed a total of 73 spontaneous episodes of spreading depression of the ECoG. Of the remaining 6 patients 1 displayed an episode of synchronous depression of ECoG during surgery. Using the same electrodes we also measured the slow potential changes (SPC) (0.005-0.05 Hz) to test the hypothesis that the ECoG depressions were identical to Leao's cortical spreading depression (CSD), and to be able to record peri-infarct depolarisations (PIDs) in electrically 'silent' cortical tissue. Changes in the SPC indicate depolarization of brain tissue. For the analysis, the SPCs were enhanced by calculating the time integral of the ECoG signal. Spreading ECoG depressions were accompanied at every single recording site by stereotyped SPCs, which spread across the cortical mantle at 3.3 (0.41-10) mm/min (median, range), i.e. at the same speed of spread as the depression of the ECoG activity. The amplitude of the SPCs was 0.06-3 mV. In 4 out of 6 patients the ECoG recovered spontaneously. In 2 patients we subsequently recorded recurrent SPCs, but without recovery of the initial ECoG background activity until 2-5 h later. This represents the first direct recording of PIDs in acutely injured human brain. Evidence from this and our previous study of 14 brain-injured patients suggests that CSDs in acute brain disorders occur at higher incidence in patients < 30 years (83%) than above (33%). CSD was recorded in 4 out of 5 traumatic brain injury patients, and in 2 out of 7 patients with spontaneous haemorrhages. We conclude that the spreading ECoG depressions recorded in patients are identical to CSDs recorded in animal experiments. We furthermore provide direct electrophysiological evidence for the existence of PIDs and hence a penumbra in the human brain. We hypothesize that the depolarization events might contribute to tissue damage in acute disorders in the human brain.	Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark; Kings Coll London, Dept Clin Neurosci, London WC2R 2LS, England; Univ London, Imperial Coll London, Dept Bioengn, London, England	Fabricius, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark.	Fabricius@dadlnet.dk		Hashemi, Parastoo/0000-0002-0180-767X; Lauritzen, Martin/0000-0002-1517-1131	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Bowyer SM, 1999, BRAIN RES, V843, P71, DOI 10.1016/S0006-8993(99)01892-2; Bowyer SM, 1999, BRAIN RES, V843, P79, DOI 10.1016/S0006-8993(99)01893-4; Bures J, 1974, MECH APPL LEAOS SPRE; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Gorji A, 2004, EUR J NEUROSCI, V19, P3371, DOI 10.1111/j.0953-816X.2004.03436.x; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Heiss WD, 1999, STROKE, V30, P1486, DOI 10.1161/01.STR.30.7.1486; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Koroleva VI, 1996, P NATL ACAD SCI USA, V93, P3710, DOI 10.1073/pnas.93.8.3710; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; LAURITZEN M, 1990, J CEREBR BLOOD F MET, V10, P115, DOI 10.1038/jcbfm.1990.14; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LEAO AAP, 1951, ELECTROEN CLIN NEURO, V3, P315, DOI 10.1016/0013-4694(51)90079-X; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEHMENKUHLER A, 1976, ION ENZYME ELECTRODE, P311; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; REBERT CS, 1970, PHYSIOL BEHAV, V5, P239, DOI 10.1016/0031-9384(70)90072-7; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Somjen GG, 2001, PHYSIOL REV, V81, P1065; SRAMKA M, 1978, APPL NEUROPHYSIOL, V40, P48; Strong AJ, 1996, J CEREBR BLOOD F MET, V16, P367, DOI 10.1097/00004647-199605000-00003; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; STRONG AJ, 2003, J CEREB BLOOD FLO S1, V23, P300; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Wolf T, 1996, J CEREBR BLOOD F MET, V16, P1100, DOI 10.1097/00004647-199611000-00003	48	279	285	1	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2006	129		3				778	790		10.1093/brain/awh716			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	013TY	WOS:000235433800022	16364954	Bronze			2021-06-18	
J	Langlois, JA; Rutland-Brown, W; Thomas, KE				Langlois, JA; Rutland-Brown, W; Thomas, KE			The incidence of traumatic brain injury among children in the United States - Differences by race	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; craniocerebral trauma; surveillance; incidence; child; race	INSURANCE STATUS; HEAD-INJURIES; EPIDEMIOLOGY; ADOLESCENTS; ADMISSION; SEVERITY; INFANTS; TRENDS	Objective: This report summarizes the epidemiology of traumatic brain injury (TBI) deaths, hospitalizations, and emergency department (ED) visits by race among children aged 0-14 years in the United States. Few other studies have reported the incidence of TBI in this population by race. Methods: Data from 3 nationally representative sources maintained by the National Center for Health Statistics were used to report the annual numbers and rates of TBI-related deaths, hospitalizations, and ED visits during 1995-2001 by race, age, and external cause of injury. Results: An estimated 475,000 TBIs occurred among children aged 0-14 each year. Rates were highest among children aged 0-4. For children aged 0-9 years, both death and hospitalization rates were significantly higher for blacks than whites for motor vehicle-traffic-related TBIs. Conclusion: With nearly half a million children affected each year, TBI is a serious public health problem. Variation in rates by race suggest the need to more closely examine the factors that contribute to these differences, such as the external causes of the injury and associated modifiable factors (e.g., the use of seat-belts and child safety seats).	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA	Langlois, JA (corresponding author), 4770 Buford Highway,NE,F-41, Atlanta, GA 30341 USA.	JAL7@cdc.gov					Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ANDERSON RN, 2004, NATL VITAL STAT REP, V5; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; *ASS ADV AUT MED, 1985, ABBR INJ SCAL; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; *CDCP, 2003, NAT HOSP DISCH SURV; *CDCP, 2003, US CENS POP BRIDG RA; *CDCP, 2001, REC FRAM EC GROUP PR; *CDCP, 2001, EXT CAUS INJ MORT MA; *CDCP NAT CTR HLTH, SURV DAT COLL SYST; *CDCP NAT CTR INJ, 2003, C MILD TRAUM BRAIN I; *CDCP NAT CTR INJ, 1999, TRAUM BRAIN INJ US; Centers for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V42, P8; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; DUNN KA, 1999, CONS DEV C NIH REH P, pB1; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kish L., 1965, SURVEY SAMPLING; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois J, 2005, TRAUMATIC BRAIN INJU; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Marr A, 2002, CENTRAL NERVOUS SYST; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; *RES TRIANGL I, 1996, SUDAAN SOFTW STAT AN; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SAS Institute Inc, 1999, SAS STAT US GUID VER; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Svenson JE, 2001, AM J EMERG MED, V19, P19, DOI 10.1053/ajem.2001.18041; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; *US CONS PROD SAF, 2001, NEISS ALL INJ PROGR; *US DEP HHS, 1989, INT CLASS DIS; Vyrostek Sara B., 2004, Morbidity and Mortality Weekly Report, V53, P1; WAGENAAR AC, 1988, ACCIDENT ANAL PREV, V20, P311, DOI 10.1016/0001-4575(88)90058-9; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 2001, INT CLASS DIS; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	50	279	280	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2005	20	3					229	238		10.1097/00001199-200505000-00006			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	926ZZ	WOS:000229163500006	15908823				2021-06-18	
J	DIETRICH, WD; ALONSO, O; HALLEY, M				DIETRICH, WD; ALONSO, O; HALLEY, M			EARLY MICROVASCULAR AND NEURONAL CONSEQUENCES OF TRAUMATIC BRAIN INJURY - A LIGHT AND ELECTRON-MICROSCOPIC STUDY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							EXCITATORY AMINO-ACIDS; FLUID-PERCUSSION MODEL; METHYL-D-ASPARTATE; CEREBRAL-ISCHEMIA; VASCULAR-PERMEABILITY; MODERATE HYPOTHERMIA; GLUCOSE-UTILIZATION; HEAD-INJURIES; BLOOD-FLOW; BARRIER	The purpose of this study was to document the early morphologic consequences of moderate traumatic brain injury (TBI) in anesthetized Sprague-Dawley rats. Normothermic rats (37 degrees C) were injured with a fluid percussion pulse (1.7-2.1 atm) administered by an injury cannula positioned parasagittally over the right cerebral cortex (n = 7). At 45 min following TBI, rats were injected with the protein tracer horseradish peroxidase (HRP) and perfusion fixed or immersion fixed 15 min later for light and electron microscopic analysis. Blood-brain barrier (BBB) breakdown to HRP was present overlying the pial surface and superficial cortical layers of the injured hemisphere. A focal area of severe HRP leakage was also present at the gray-white interface of the lateral cortex. Light microscopic examination of this site revealed petechial hemorrhages associated with small venules. Dark shrunken neurons and swollen astrocytes were detected within cortical areas overlying the evolving contusion, CA3 and CA4 hippocampal subsectors, and lateral thalamus. Ultrastructural studies obtained evidence for irreversible neuronal injury and mechanical damage to vessel walls at this early posttraumatic period. In nonperfused traumatized rats, luminal platelet aggregates were also detected at sites of hemorrhage. In this model of TBI, a consistent pattern of microvascular and neuronal abnormalities can be documented in the early posttraumatic period. Pathomechanisms underlying these early changes are discussed in terms of primary and secondary injury processes.		DIETRICH, WD (corresponding author), UNIV MIAMI, SCH MED, DEPT NEUROL D4-5, POB 016960, MIAMI, FL 33101 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027127, P50NS030291] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30291, NS-27127] Funding Source: Medline		ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1982, RECENT ADV NEUROPATH, V2, P165; ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BALENTINE JD, 1978, LAB INVEST, V39, P236; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIETRICH WD, 1992, ACTA NEUROPATHOL, V84, P630, DOI 10.1007/BF00227740; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1991, ACTA NEUROPATHOL, V81, P615, DOI 10.1007/BF00296371; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GARCIA JH, 1977, VIRCHOWS ARCH B, V25, P191; GOODMAN JH, 1979, ARCH NEUROL-CHICAGO, V36, P197, DOI 10.1001/archneur.1979.00500400051006; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1981, ACTA NEUROPATHOL, V55, P205, DOI 10.1007/BF00691320; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARMAROU A, 1985, BRAIN EDEMA, P88; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P78, DOI 10.1007/BF00427218; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MITCHELL DE, 1973, LANCET, V2, P215; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PETITO CK, 1984, J CEREBR BLOOD F MET, V4, P194, DOI 10.1038/jcbfm.1984.28; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P265; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; ROSENBLUM WI, 1982, TEX HEART I J, V9, P345; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SMITH D R, 1969, Journal of Neurosurgery, V30, P664, DOI 10.3171/jns.1969.30.6.0664; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; STRICH SJ, 1970, J CLIN PATHOL S4, V23, P166; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZILLES L, 1985, CORTEX RAT STEREOTAX	69	279	287	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	1994	11	3					289	301		10.1089/neu.1994.11.289			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	PF221	WOS:A1994PF22100005	7996583				2021-06-18	
J	LOGAN, A; FRAUTSCHY, SA; GONZALEZ, AM; BAIRD, A				LOGAN, A; FRAUTSCHY, SA; GONZALEZ, AM; BAIRD, A			A TIME COURSE FOR THE FOCAL ELEVATION OF SYNTHESIS OF BASIC FIBROBLAST GROWTH-FACTOR AND ONE OF ITS HIGH-AFFINITY RECEPTORS (FLG) FOLLOWING A LOCALIZED CORTICAL BRAIN INJURY	JOURNAL OF NEUROSCIENCE			English	Article							COMPLEMENTARY-DNA CLONING; CENTRAL-NERVOUS-SYSTEM; RAT ASTROGLIAL CELLS; MESSENGER-RNA; INSITU HYBRIDIZATION; FACTOR BFGF; NEURONS; SURVIVAL; PURIFICATION; TRANSECTION	Traumatic injury to the CNS initiates transient and unsuccessful regeneration of damaged neural pathways, accompanied by reactive gliosis, angiogenesis, and deposition of a dense fibrous glial/meningeal scar at the wound site. Basic fibroblast growth factor (basic FGF) is a CNS protein with potent effects on neurons, glia, fibroblasts, and vascular endothelial cells. Hybridization and immunocytochemical methods were used to examine temporal and spatial changes in distribution and levels of basic FGF protein and mRNA and also of its receptor mRNA (flg), following a defined wound to the cerebral cortex of adult rat brains. In the injured brain, a rapid, transient increase in basic FGF mRNA and protein is readily detectable within 7 d of surgery and thereafter declines in the tissues bordering the lesion. The increased expression is localized to multiple cell types including macrophages, neurons, astrocytes, and vascular endothelial cells. The changes in immunoreactive basic FGF parallel changes in the bioactivity of extracted heparin-binding proteins, which include basic FGF. Focal increases in flg mRNA appear 7 d after injury and subside by 14 d. The changes in local basic FGF synthesis, concentration, localization, and bioactivity suggest that this growth factor may contribute to the cascade of cellular events that occur in CNS wound repair.	UNIV BIRMINGHAM,DEPT CLIN CHEM,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND; WHITTIER INST,DEPT MOLEC & CELLULAR GROWTH BIOL,LA JOLLA,CA 92037				Logan, Ann/0000-0003-3215-5042; Baird, Andrew/0000-0003-0027-9905; Frautschy, Sally A./0000-0003-0194-0363	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG010685, R01 AG016793, P50 AG016570] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS028121, NS-28121] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK018811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS028121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016570, R01AG016793, R01AG010685] Funding Source: NIH RePORTER		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X; BAIRD A, 1990, HDB EXPT PHARM, V95, P369; BAROTTE C, 1989, NEUROSCI LETT, V101, P197, DOI 10.1016/0304-3940(89)90530-2; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; CUEVAS P, 1991, ACTA ANAT, V141, P307; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; FRAUTSCHY SA, 1991, NEUROENDOCRINOLOGY, V54, P62, DOI 10.1159/000125852; GONZALEZ AM, 1990, J CELL BIOL, V110, P347; GOSPODAROWICZ D, 1979, EXP EYE RES, V28, P501, DOI 10.1016/0014-4835(79)90038-1; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LOGAN A, 1990, BRIT J HOSP MED, V43, P428; LOGAN A, 1990, J ENDOCRINOL, V124, P47; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NATHAN CF, 1980, NEW ENGL J MED, V303, P622, DOI 10.1056/NEJM198009113031106; OTTO D, 1987, NEUROSCI LETT, V83, P156, DOI 10.1016/0304-3940(87)90233-3; PETTMANN B, 1985, FEBS LETT, V189, P102, DOI 10.1016/0014-5793(85)80851-6; PRUSS RM, 1982, DEV BRAIN RES, V2, P19; ROGISTER B, 1988, NEUROSCI LETT, V91, P321, DOI 10.1016/0304-3940(88)90700-8; SAITO H, 1991, BIOCHEM BIOPH RES CO, V174, P136, DOI 10.1016/0006-291X(91)90496-T; Sambrook J, 1989, MOL CLONING LABORATO; SENIOR RM, 1986, BIOCHEM BIOPH RES CO, V141, P67, DOI 10.1016/S0006-291X(86)80335-7; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEIBEL M, 1985, INT J DEV NEUROSCI, V3, P617, DOI 10.1016/0736-5748(85)90052-8; WOLBURG H, 1986, NEUROSCI LETT, V72, P25, DOI 10.1016/0304-3940(86)90612-9	36	279	282	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036	0270-6474			J NEUROSCI	J. Neurosci.	OCT	1992	12	10					3828	3837					10	Neurosciences	Neurosciences & Neurology	JT197	WOS:A1992JT19700012	1403086				2021-06-18	
J	Jacobi, J; Bircher, N; Krinsley, J; Agus, M; Braithwaite, SS; Deutschman, C; Freire, AX; Geehan, D; Kohl, B; Nasraway, SA; Rigby, M; Sands, K; Schallom, L; Taylor, B; Umpierrez, G; Mazuski, J; Schunemann, H				Jacobi, Judith; Bircher, Nicholas; Krinsley, James; Agus, Michael; Braithwaite, Susan S.; Deutschman, Clifford; Freire, Amado X.; Geehan, Douglas; Kohl, Benjamin; Nasraway, Stanley A.; Rigby, Mark; Sands, Karen; Schallom, Lynn; Taylor, Beth; Umpierrez, Guillermo; Mazuski, John; Schunemann, Holger			Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients	CRITICAL CARE MEDICINE			English	Article						critical care; glycemic control; glucose meter; glucose monitoring; guideline; hyperglycemia; insulin; protocol; stress hyperglycemia	INTENSIVE-CARE-UNIT; TIGHT GLYCEMIC CONTROL; POINT-OF-CARE; BLOOD-GLUCOSE CONTROL; ACUTE ISCHEMIC-STROKE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PREDICTIVE CONTROL ALGORITHM; RANDOMIZED CONTROLLED-TRIAL; INJURED TRAUMA PATIENTS; SEVERE BRAIN-INJURY	Objective: To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point. Methods: Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) methodology to assess the impact of insulin infusions on outcome for general intensive care unit patients and those in specific subsets of neurologic injury, traumatic injury, and cardiovascular surgery. Elements that contribute to safe and effective insulin infusion therapy were determined through literature review and expert opinion. The majority of the literature supporting the use of insulin infusion therapy for critically ill patients lacks adequate strength to support more than weak recommendations, termed suggestions, such that the difference between desirable and undesirable effect of a given intervention is not always clear. Recommendations: The article is focused on a suggested glycemic control end point such that a blood glucose >= 150 mg/dL triggers interventions to maintain blood glucose below that level and absolutely < 180 mg/dL. There is a slight reduction in mortality with this treatment end point for general intensive care unit patients and reductions in morbidity for perioperative patients, postoperative cardiac surgery patients, post-traumatic injury patients, and neurologic injury patients. We suggest that the insulin regimen and monitoring system be designed to avoid and detect hypoglycemia (blood glucose <= 70 mg/dL) and to minimize glycemic variability. Important processes of care for insulin therapy include use of a reliable insulin infusion protocol, frequent blood glucose monitoring, and avoidance of finger-stick glucose testing through the use of arterial or venous glucose samples. The essential components of an insulin infusion system include use of a validated insulin titration program, availability of appropriate staffing resources, accurate monitoring technology, and standardized approaches to infusion preparation, provision of consistent carbohydrate calories and nutritional support, and dextrose replacement for hypoglycemia prevention and treatment. Quality improvement of glycemic management programs should include analysis of hypoglycemia rates, run charts of glucose values < 150 and 180 mg/dL. The literature is inadequate to support recommendations regarding glycemic control in pediatric patients. Conclusions: While the benefits of tight glycemic control have not been definitive, there are patients who will receive insulin infusion therapy, and the suggestions in this article provide the structure for safe and effective use of this therapy. (Crit Care Med 2012; 40:3251-3276)	[Jacobi, Judith] Indiana Univ, Hlth Methodist Hosp, Indianapolis, IN 46204 USA; [Bircher, Nicholas] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Krinsley, James] Stamford Hosp, Stamford, CT USA; [Agus, Michael] Childrens Hosp, Intermediate Care Unit, Boston, MA 02115 USA; [Braithwaite, Susan S.] Endocrine Consults & Care, Evanston, IL USA; [Deutschman, Clifford] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Freire, Amado X.] Univ Tennessee, Ctr Hlth Sci, PCC, Memphis, TN 38163 USA; [Geehan, Douglas] Univ Missouri, Kansas City, KS USA; [Nasraway, Stanley A.] Tufts Univ New England Med Ctr, SICU, Boston, MA USA; [Rigby, Mark] James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA; [Sands, Karen] Novant Hlth, Winston Salem, NC USA; [Schallom, Lynn; Taylor, Beth] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Umpierrez, Guillermo] Emory Univ, Sch Med, Atlanta, GA USA; [Mazuski, John] Washington Univ, St Louis, MO USA; [Schunemann, Holger] McMaster Univ, Hamilton, ON, Canada	Jacobi, J (corresponding author), Indiana Univ, Hlth Methodist Hosp, Indianapolis, IN 46204 USA.	jjacobi@iuhealth.org	Deutschman, Clifford/AAN-2742-2021; Freire, Amado/M-2201-2019	Freire, Amado/0000-0001-7500-8291; Taylor, Beth/0000-0001-6944-2809	Amylin; Eli LillyEli Lilly; Edwards Life Sciences; Roche Diagnostics; Sanofi-AventisSanofi-Aventis; Department of Defense Research; MedtronicMedtronic; Roche Laboratories Speakers Bureau on Glycemic Control	Dr. Agus has consulted for the Diabetes Technology Society. He also has a pending patent on an ECMO-based glucose, sensor, which is not connected to idea discussed in this article. Dr. Braithwaite has a U.S. patent. Dr. Kohl has received grant support from Amylin and Eli Lilly. Dr. Krinsley has performed consulting work for Medtronic Inc., Edwards Life Sciences, Baxter, Roche Diagnostics, and Optiscan Biomedical and has received speaker's fees from Edwards Life Sciences, Roche Diagnostics and Sanofi-Aventis. Dr. Nasraway has consulted for Optiscan, Echo Therapeutics. Dr. Geehan has received grant support from the Department of Defense Research. Dr. Rigby has received consulting fees from Medtronic. Dr. Schallom has received honoraria/speaking fees from Roche Laboratories Speakers Bureau on Glycemic Control. The remaining authors have not disclosed any potential conflicts of interest.	Abbott Laboratories Web site, PROD INF CARTR TEST; Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Ali NA, 2009, YEARB INTENSIVE CARE, P728, DOI 10.1007/978-3-540-92276-6_67; Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Allport L, 2006, DIABETES CARE, V29, P1839, DOI 10.2337/dc06-0204; Anabtawi A, 2010, DIABETES TECHNOL THE, V12, P635, DOI 10.1089/dia.2010.0009; Anger KE, 2006, PHARMACOTHERAPY, V26, P214, DOI 10.1592/phco.26.2.214; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]; [Anonymous], 2008, REV MAN REVMAN COMP; Arabi YM, 2009, CRIT CARE MED, V37, P2536, DOI 10.1097/CCM.0b013e3181a381ad; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Aragon D, 2006, AM J CRIT CARE, V15, P370, DOI 10.4037/ajcc2006.15.4.370; ATKIN SH, 1991, ANN INTERN MED, V114, P1020, DOI 10.7326/0003-4819-114-12-1020; Aye T, 2010, ENDOCRIN METAB CLIN, V39, P609, DOI 10.1016/j.ecl.2010.05.005; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bagshaw SM, 2009, CRIT CARE MED, V37, P463, DOI 10.1097/CCM.0b013e318194b097; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Balentine JR, 1998, ACAD EMERG MED, V5, P691, DOI 10.1111/j.1553-2712.1998.tb02487.x; Bates David, 2005, Endocr Pract, V11, P197; Bell DA, 2005, BRIT J NEUROSURG, V19, P21, DOI 10.1080/02688690500089423; Ben-Ami H, 1999, ARCH INTERN MED, V159, P281, DOI 10.1001/archinte.159.3.281; Bhatia A, 2006, ANESTH ANALG, V102, P549, DOI 10.1213/01.ane.0000195236.73494.bf; Biljak Vanja Radisic, 2010, Diabetologia Croatica, V39, P105; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Blaha J, 2009, DIABETES CARE, V32, P757, DOI 10.2337/dc08-1851; Bochicchio GV, 2010, ANN SURG, V252, P597, DOI 10.1097/SLA.0b013e3181f4e499; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Boyd R, 2005, EMERG MED J, V22, P177, DOI 10.1136/emj.2003.011619; Braithwaite SS, 2008, CRIT CARE, V12, DOI 10.1186/cc6842; Branco RG, 2010, PEDIATR CRIT CARE ME, V11, P415, DOI 10.1097/PCC.0b013e3181c59144; Bridges BC, 2010, CRIT CARE, V14, DOI 10.1186/cc9280; Brown G, 2001, CRIT CARE MED, V29, P1714, DOI 10.1097/00003246-200109000-00010; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bruno A, 2004, NEUROLOGY, V62, P1441, DOI 10.1212/01.WNL.0000120754.73348.02; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Campion TR, 2010, INTENS CARE MED, V36, P1566, DOI 10.1007/s00134-010-1868-7; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carstens S, 1998, Prehosp Disaster Med, V13, P44; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Cavalcanti AB, 2009, J CRIT CARE, V24, P371, DOI 10.1016/j.jcrc.2009.05.005; Chase JG, 2008, CRIT CARE, V12, DOI 10.1186/cc6868; Clayton SB, 2006, CRIT CARE MED, V34, P2974, DOI 10.1097/01.CCM.0000248906.10399.CF; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Collier B, 2005, JPEN-PARENTER ENTER, V29, P353, DOI 10.1177/0148607105029005353; Cook A, 2009, AM J CRIT CARE, V18, P65, DOI 10.4037/ajcc2009626; Cordingley JJ, 2009, INTENS CARE MED, V35, P123, DOI 10.1007/s00134-008-1236-z; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; Cyrus RM, 2009, ANN PHARMACOTHER, V43, P1413, DOI 10.1345/aph.1M060; Datta Swati, 2007, Endocr Pract, V13, P225; Davidson PC, 2005, DIABETES CARE, V28, P2418, DOI 10.2337/diacare.28.10.2418; de Azevedo JRA, 2010, J CRIT CARE, V25, P84, DOI 10.1016/j.jcrc.2008.10.011; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Desachy A, 2008, MAYO CLIN PROC, V83, P400, DOI 10.4065/83.4.400; Dickerson RN, 2008, NUTRITION, V24, P536, DOI 10.1016/j.nut.2008.02.008; Dimopoulou I, 2005, NEUROCRIT CARE, V3, P224, DOI 10.1385/NCC:3:3:224; Donaldson S, 2006, DIABETES EDUCATOR, V32, P954, DOI 10.1177/0145721706294918; Dortch MJ, 2008, JPEN-PARENTER ENTER, V32, P18, DOI 10.1177/014860710803200118; Dossett LA, 2008, AM SURGEON, V74, P679; Dungan K, 2007, DIABETES CARE, V30, P403, DOI 10.2337/dc06-1679; Duning T, 2009, BEST PRACT RES-CLIN, V23, P473, DOI 10.1016/j.bpa.2009.09.002; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Eigsti J, 2006, DIMENS CRIT CARE NUR, V25, P62, DOI 10.1097/00003465-200603000-00004; Ellmerer M, 2006, DIABETES CARE, V29, P1275, DOI 10.2337/dc05-2377; Eslami S, 2009, INTENS CARE MED, V35, P1505, DOI 10.1007/s00134-009-1542-0; Eslami S, 2008, CRIT CARE, V12, DOI 10.1186/cc7114; Estrada CA, 2003, ANN THORAC SURG, V75, P1392, DOI 10.1016/S0003-4975(02)04997-4; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Farah R, 2007, ISRAEL MED ASSOC J, V9, P140; Faraon-Pogaceanu C, 2010, PEDIATR CRIT CARE ME, V11, P741, DOI 10.1097/PCC.0b013e3181e88cfb; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finkielman JDW, 2005, CHEST, V127, P1749, DOI 10.1378/chest.127.5.1749; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; Freire AX, 2005, CHEST, V128, P3109, DOI 10.1378/chest.128.5.3109; Furnary AP, 2006, SEMIN THORAC CARDIOV, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005; Furnary AP, 2006, AM J CARDIOL, V98, P557, DOI 10.1016/j.amjcard.2006.02.065; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Gale SC, 2007, AM SURGEON, V73, P454; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Gentile NT, 2006, ACAD EMERG MED, V13, P174, DOI 10.1197/j.aem.2005.08.009; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Goldberg PA, 2006, DIABETES TECHNOL THE, V8, P560, DOI 10.1089/dia.2006.8.560; Goldberg PA, 2006, DIABETES TECHNOL THE, V8, P598, DOI 10.1089/dia.2006.8.598; Grainger A, 2007, NUTR CLIN PRACT, V22, P545, DOI 10.1177/0115426507022005545; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; GREENWOOD BC, 2012, HOSP PHARM, V47, P367, DOI DOI 10.1310/hpj4705-367; Grey Neil J, 2004, Endocr Pract, V10 Suppl 2, P46; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; HEATH DF, 1994, J ACCID EMERG MED, V11, P67; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Hellman Richard, 2004, Endocr Pract, V10 Suppl 2, P100; Hellman Richard, 2006, Endocr Pract, V12 Suppl 3, P49; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; Hoedemaekers CW, 2010, CRIT CARE MED, V38, P339, DOI 10.1097/CCM.0b013e3181bfb27b; Hoedemaekers CWE, 2008, CRIT CARE MED, V36, P3062, DOI 10.1097/CCM.0b013e318186ffe6; Holtzinger C, 2008, POINT CARE, V7, P1, DOI 10.1097/POC.0b013e318162f4da; Holzinger U, 2009, INTENS CARE MED, V35, P1383, DOI 10.1007/s00134-009-1471-y; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Juneja R, 2007, DIABETES TECHNOL THE, V9, P232, DOI 10.1089/dia.2006.0015; Juneja R, 2009, CRIT CARE, V13, DOI 10.1186/cc8129; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Kanji S, 2004, INTENS CARE MED, V30, P804, DOI 10.1007/s00134-004-2252-2; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; Karon BS, 2007, AM J CLIN PATHOL, V127, P919, DOI 10.1309/6RFQCKAAJGKWB8M4; Karon BS, 2010, CLIN CHEM, V56, P1091, DOI 10.1373/clinchem.2010.145367; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Kondepati VR, 2007, ANAL BIOANAL CHEM, V388, P545, DOI 10.1007/s00216-007-1229-8; Korytkowski MT, 2009, DIABETES CARE, V32, P594, DOI 10.2337/dc08-1436; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Krinsley JS, 2006, SEMIN THORAC CARDIOV, V18, P317, DOI 10.1053/j.semtcvs.2006.12.003; Krinsley JS, 2011, CRIT CARE, V15, DOI 10.1186/cc10322; Krinsley JS, 2006, CHEST, V129, P644, DOI 10.1378/chest.129.3.644; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kruyt ND, 2009, STROKE, V40, pE424, DOI 10.1161/STROKEAHA.108.529974; Kulkarni A, 2005, INTENS CARE MED, V31, P142, DOI 10.1007/s00134-004-2500-5; Lacara T, 2007, AM J CRIT CARE, V16, P336; Leibowitz G, 2010, ANN THORAC SURG, V90, P1825, DOI 10.1016/j.athoracsur.2010.07.063; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Lonergan T, 2006, DIABETES TECHNOL THE, V8, P449, DOI 10.1089/dia.2006.8.449; Lopez C, 2012, ENDOCRINOL NUTR, V59, P28; Louie RF, 2000, ARCH PATHOL LAB MED, V124, P257; MACKENZIE IM, 2008, BR J INTENSIVE CARE, V18, P121; Mahoney JJ, 2007, DIABETES TECHNOL THE, V9, P545, DOI 10.1089/dia.2007.0245; Malesker MA, 2007, AM J CRIT CARE, V16, P589; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mann EA, 2008, J TRAUMA, V64, P15, DOI 10.1097/TA.0b013e318160b9e4; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Meex C, 2006, CLIN CHEM LAB MED, V44, P1376, DOI 10.1515/CCLM.2006.249; MELAMED E, 1976, J NEUROL SCI, V29, P267, DOI 10.1016/0022-510X(76)90176-3; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Meynaar IA, 2009, CRIT CARE MED, V37, P2691, DOI 10.1097/CCM.0b013e3181a564fe; Moore C, 2005, EMERG MED J, V22, P512, DOI 10.1136/emj.2004.020693; Nerenberg KA, 2012, DIABETES CARE, V35, P19, DOI 10.2337/dc11-0706; Newton Christopher A, 2006, Endocr Pract, V12 Suppl 3, P43; Newton CA, 2010, J HOSP MED, V5, P432, DOI 10.1002/jhm.816; O'Malley CW, 2008, J HOSP MED, V3, pS55, DOI 10.1002/jhm.355; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Osburne RC, 2006, DIABETES EDUCATOR, V32, P394, DOI 10.1177/0145721706288072; Otto NM, 2008, CRIT CARE, V12, DOI 10.1186/cc6989; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; Pidcoke HF, 2010, CRIT CARE MED, V38, P471, DOI 10.1097/CCM.0b013e3181bc826f; Pielmeier U, 2010, J CRIT CARE, V25, P97, DOI 10.1016/j.jcrc.2009.10.003; Piper HG, 2006, PEDIATRICS, V118, P1176, DOI 10.1542/peds.2006-0347; Plank J, 2006, DIABETES CARE, V29, P271, DOI 10.2337/diacare.29.02.06.dc05-1689; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Preissig CM, 2008, PEDIATR CRIT CARE ME, V9, P581, DOI 10.1097/PCC.0b013e31818d36cb; Preissig CM, 2010, CRIT CARE, V14, DOI 10.1186/cc8865; Preissig CM, 2009, PEDIATR CARDIOL, V30, P1098, DOI 10.1007/s00246-009-9512-4; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Quinn JA, 2006, PHARMACOTHERAPY, V26, P1410, DOI 10.1592/phco.26.10.1410; Ramos P, 2010, J HOSP MED, V5, P446, DOI 10.1002/jhm.810; Ray JG, 2001, CRIT CARE MED, V29, P2205, DOI 10.1097/00003246-200111000-00025; Reed CC, 2007, J AM COLL SURGEONS, V204, P1048, DOI 10.1016/j.jamcollsurg.2006.12.047; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sadhu AR, 2008, DIABETES CARE, V31, P1556, DOI 10.2337/dc07-2456; Scalea TM, 2007, ANN SURG, V246, P605, DOI 10.1097/SLA.0b013e318155a789; Schleis TG, 2007, PHARMACOTHERAPY, V27, P1313, DOI 10.1592/phco.27.9.1313; Schmeltz Lowell R, 2006, Endocr Pract, V12, P641; Schmeltz LR, 2007, DIABETES CARE, V30, P823, DOI 10.2337/dc06-2184; Schnipper JL, 2008, J HOSP MED, V3, pS66, DOI 10.1002/jhm.356; Schultz MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8966; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; Scott RJ, 2008, POINT CARE, V7, P43, DOI 10.1097/POC.0b013e31817278f2; Siegelaar SE, 2011, DIABETES CARE, V34, P855, DOI [10.2337/dc10-1684, 10.2337/dc10-1882]; Sinha S, 2007, ANAESTHESIA, V62, P615, DOI 10.1111/j.1365-2044.2007.04989.x; SLAMA G, 1990, ARCH INTERN MED, V150, P589, DOI 10.1001/archinte.150.3.589; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Steil GM, 2011, PEDIATR CRIT CARE ME, V12, P643, DOI 10.1097/PCC.0b013e31821926a5; Steil Garry M, 2009, J Diabetes Sci Technol, V3, P125; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Tang Z, 2000, Diabetes Technol Ther, V2, P349, DOI 10.1089/15209150050194215; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; Tang ZP, 2001, CRIT CARE MED, V29, P1062, DOI 10.1097/00003246-200105000-00038; Tang ZP, 2000, AM J CLIN PATHOL, V113, P75; Taylor BE, 2006, J AM COLL SURGEONS, V202, P1, DOI 10.1016/j.jamcollsurg.2005.09.015; Thiele RH, 2009, ANESTHESIOLOGY, V110, P603, DOI 10.1097/ALN.0b013e318198006a; Toft P, 2006, EUR J ANAESTH, V23, P705, DOI 10.1017/S0265021506000469; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2006, CRIT CARE MED, V34, P612, DOI 10.1097/01.CCM.0000201408.15502.24; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Verhoeven JJ, 2009, PEDIATR CRIT CARE ME, V10, P648, DOI 10.1097/PCC.0b013e3181ae787b; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; Vogelzang M, 2004, CRIT CARE, V8, pR122, DOI 10.1186/cc2840; Vogelzang M, 2008, INTENS CARE MED, V34, P1421, DOI 10.1007/s00134-008-1091-y; Vriesendorp TM, 2006, CRIT CARE MED, V34, P2714, DOI 10.1097/01.CCM.0000241155.36689.91; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Walters MR, 2006, CEREBROVASC DIS, V22, P116, DOI 10.1159/000093239; Weant KA, 2009, ANN PHARMACOTHER, V43, P629, DOI 10.1345/aph.1L629; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964; Yamashita K, 2008, ANESTH ANALG, V106, P160, DOI 10.1213/01.ane.0000296461.26492.3c; Yatabe T, 2011, CRIT CARE MED, V39, P575, DOI 10.1097/CCM.0b013e318206b9ad; Yeldandi RR, 2006, DIABETES TECHNOL THE, V8, P609, DOI 10.1089/dia.2006.8.609; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Zerr KJ, 1997, ANN THORAC SURG, V63, P356; Zhu CZ, 2004, J NEUROSURG, V101, P664, DOI 10.3171/jns.2004.101.4.0664	218	278	310	1	38	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2012	40	12					3251	3276		10.1097/CCM.0b013e3182653269			26	Critical Care Medicine	General & Internal Medicine	041UQ	WOS:000311427100019	23164767		Y	N	2021-06-18	
J	Aries, MJH; Czosnyka, M; Budohoski, KP; Steiner, LA; Lavinio, A; Kolias, AG; Hutchinson, PJ; Brady, KM; Menon, DK; Pickard, JD; Smielewski, P				Aries, Marcel J. H.; Czosnyka, Marek; Budohoski, Karol P.; Steiner, Luzius A.; Lavinio, Andrea; Kolias, Angelos G.; Hutchinson, Peter J.; Brady, Ken M.; Menon, David K.; Pickard, John D.; Smielewski, Peter			Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						cerebral perfusion pressure; cerebrovascular pressure reactivity; intracranial pressure; longitudinal recording clinical outcome; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; COMATOSE PATIENTS; METABOLISM; REACTIVITY; HYPERTENSION; NEUROTRAUMA; THRESHOLDS	Objectives: We have sought to develop an automated methodology for the continuous updating of optimal cerebral perfusion pressure (CPPopt) for patients after severe traumatic head injury, using continuous monitoring of cerebrovascular pressure reactivity. We then validated the CPPopt algorithm by determining the association between outcome and the deviation of actual CPP from CPPopt. Design: Retrospective analysis of prospectively collected data. Setting: Neurosciences critical care unit of a university hospital. Patients: A total of 327 traumatic head-injury patients admitted between 2003 and 2009 with continuous monitoring of arterial blood pressure and intracranial pressure. Measurements and Main Results: Arterial blood pressure, intracranial pressure, and CPP were continuously recorded, and pressure reactivity index was calculated online. Outcome was assessed at 6 months. An automated curve fitting method was applied to determine CPP at the minimum value for pressure reactivity index (CPPopt). A time trend of CPPopt was created using a moving 4-hr window, updated every minute. Identification of CPPopt was, on average, feasible during 55% of the whole recording period. Patient outcome correlated with the continuously updated difference between median CPP and CPPopt (chi-square = 45, p < .001; outcome dichotomized into fatal and nonfatal). Mortality was associated with relative "hypoperfusion" (CPP < CPPopt), severe disability with "hyperperfusion" (CPP > CPPopt), and favorable outcome was associated with smaller deviations of CPP from the individualized CPPopt. While deviations from global target CPP values of 60 mm Hg and 70 mm Hg were also related to outcome, these relationships were less robust. Conclusions: Real-time CPPopt could be identified during the recording time of majority of the patients. Patients with a median CPP close to CPPopt were more likely to have a favorable outcome than those in whom median CPP was widely different from CPPopt. Deviations from individualized CPPopt were more predictive of outcome than deviations from a common target CPP. CPP management to optimize cerebrovascular pressure reactivity should be the subject of future clinical trial in severe traumatic head-injury patients. (Crit Care Med 2012; 40:2456-2463)	[Aries, Marcel J. H.; Czosnyka, Marek; Budohoski, Karol P.; Lavinio, Andrea; Kolias, Angelos G.; Hutchinson, Peter J.; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Aries, Marcel J. H.] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Steiner, Luzius A.] Univ Lausanne Hosp, Dept Anaesthesia, Lausanne, Switzerland; [Lavinio, Andrea; Menon, David K.] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Brady, Ken M.] Texas Childrens Hosp, Dept Anesthesiol & Crit Care Med, Houston, TX 77030 USA	Aries, MJH (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.	m.j.h.aries@umcg.nl	Lavinio, Andrea/M-1778-2016; Steiner, Luzius/J-1987-2019	Smielewski, Peter/0000-0001-5096-3938; Kolias, Angelos/0000-0003-3992-0587	European Federation of Neurological Societies (EFNS); Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; Academy of Medical Sciences/Health Foundation; Medical Research Council/NIHRUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; NIHR Cambridge Biomedical Centre; NIHR Senior Investigator award; Addenbrooke's Hospital Neurocritical Care Unit; Academic Neurosurgical Unit; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000183B, G9439390, G0001354B, G0001237, G0601025, G0001354, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2011-14-003, NF-SI-0508-10327] Funding Source: researchfish	The software for brain monitoring ICM+ (http://www.neurosurg.cam.ac.uk/icmplus) is licensed by the University of Cambridge (Cambridge Enterprise). Mr. Czosnyka and Mr. Smielewski have a financial interest in a part of the licensing fee. Dr. Aries received a travel grant from the European Federation of Neurological Societies (EFNS), and is supported by the Netherlands Organisation for Health Research and Development. Dr. Steiner is supported by a grant from the Swiss National Science Foundation. Dr. Kolias is supported by an National Institute for Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. Mr. Hutchinson is supported by an Academy of Medical Sciences/Health Foundation Senior Scientist Fellowship and grants from the Medical Research Council/NIHR. Mr. Menon is supported by funding from the Medical Research Council, the NIHR Cambridge Biomedical Centre, and an NIHR Senior Investigator award. Mr. Pickard is a NIHR senior investigator awardee and a principal investigator within the NIHR Biomedical Research Centre (Cambridge University Hospital Foundation Trust) and lead principal investigator for the Medical Research Council "Acute Brain Injury Programme" grant. The authors acknowledge great support from Addenbrooke's Hospital Neurocritical Care Unit staff and Academic Neurosurgical Unit registrars, without whose help the collection of computerized data never would have succeeded. The remaining authors have not disclosed any potential conflict of interest.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CHAN KH, 1992, J NEUROSURG ANESTH, V4, P188, DOI 10.1097/00008506-199207000-00007; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P131; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Nordstrom CH, 2007, INTENS CARE MED, V33, P558, DOI 10.1007/s00134-006-0521-y; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a	36	278	282	0	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	AUG	2012	40	8					2456	2463		10.1097/CCM.0b013e3182514eb6			8	Critical Care Medicine	General & Internal Medicine	976SM	WOS:000306604900025	22622398		Y	N	2021-06-18	
J	Thompson, HJ; McCormick, WC; Kagan, SH				Thompson, Hilaire J.; McCormick, Wayne C.; Kagan, Sarah H.			Traumatic brain injury in older adults: Epidemiology, outcomes, and future implications	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						traumatic brain injury; head injury; geriatric; trauma; injury; epidemiology; outcomes; functional status	GERIATRIC TRAUMA; HEAD-INJURIES; HEMORRHAGIC HYPOTENSION; ELDERLY-PATIENTS; PRIMARY-CARE; RESOURCE USE; AGE; MORTALITY; GENDER; RISK	Traumatic brain injury (TBI) is a significant problem in older adults. In persons aged 65 and older, TBI is responsible for more than 80,000 emergency department visits each year; three-quarters of these visits result in hospitalization as a result of the injury. Adults aged 75 and older have the highest rates of TBI-related hospitalization and death. Falls are the leading cause of TBI for older adults (51%), and motor vehicle traffic crashes are second (9%). Older age is known to negatively influence outcome after TBI. Although geriatric and neurotrauma investigators have identified the prognostic significance of preadmission functional ability, comorbidities, sex, and other factors such as cerebral perfusion pressure on recovery after illness or injury, these variables remain understudied in older adults with TBI. In the absence of good clinical data, predicting outcomes and providing care in the older adult population with TBI remains problematic. To address this significant public health issue, a refocusing of research efforts on this population is Justified to prevent TBI in the older adult and to discern unique care requirements to facilitate best patient outcomes.	Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; Univ Penn, Sch Nursing, Dept Gerontol Nursing, Philadelphia, PA 19104 USA	Thompson, HJ (corresponding author), Box 357266, Seattle, WA 98195 USA.	hilairet@u.washington.edu			NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32-NR07106, T32 NR007106-07, L30 NR010534-02, L30 NR010534, T32 NR007106] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007106] Funding Source: NIH RePORTER		Abrams RC, 2005, AM J PUBLIC HEALTH, V95, P1000, DOI 10.2105/AJPH.2004.037861; ADAMS PF, 1996, VITAL HLTH STAT, V10, P1; *AG HEALTHC QUAL R, 2006, HCUPNET HEALTHC COST; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; BINDER S, 2002, INJ PREV S4, V8, P2; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; *BRAIN TRAUM FDN A, 2004, NOT GUID MAN SEV BRA; *CDCP, 2004, HLTH PEOPL 2010 INJ; Centers for Disease Control and Prevention, 2001, TRAUM BRAIN INJ US R; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; *EAST PRACT MAN GU, 2005, PRACT MAN GUID GER T; Ekelman BA, 2001, FUNCTIONAL PERFORMAN, P448; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; GARCIA CA, 1984, J AM GERIATR SOC, V32, P339, DOI 10.1111/j.1532-5415.1984.tb02036.x; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; King MB, 2003, PRINCIPLES GERIATRIC, P1517; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; McKevitt EC, 2003, CAN J SURG, V46, P211; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; *NAT CTR INJ PREV, 2002, INJ FACT BOOK; *NAT CTR INJ PREV, 2005, OLD AD DRIV FACT SHE; *NAT HIGHW TRAFF S, 2002, 809611 DOTHS NAT HIG; PASQUALE MD, 2006, SOC CRIT CAR MED 35; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P793; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SCHULTZ RJ, 1985, J TRAUMA, V25, P309, DOI 10.1097/00005373-198504000-00005; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shinoda-Tagawa T, 2003, INJURY PREV, V9, P214, DOI 10.1136/ip.9.3.214; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stevens J A, 1999, MMWR CDC Surveill Summ, V48, P27; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; THOMPSON HJ, IN PRESS CRIT CARE N; Timiras P., 2003, PHYSL BASIS AGING GE, P99, DOI DOI 10.1161/01.ATV.0000173418.42264.19; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; *US BUR CENS US AD, 2005, OLD POP AG 1900 2050; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; West CG, 2003, J AM GERIATR SOC, V51, P1348, DOI 10.1046/j.1532-5415.2003.51482.x; Yam AT, 2005, J CLIN NEUROSCI, V12, P643, DOI 10.1016/j.jocn.2004.08.017; Yu F, 2005, J NURS SCHOLARSHIP, V37, P229, DOI 10.1111/j.1547-5069.2005.00040.x; 2006, MMWR MORB MORTAL WKL, V55, P201; 2003, MMWR MORB MORTAL WKL, V52, P276	70	278	283	1	18	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0002-8614			J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2006	54	10					1590	1595		10.1111/j.1532-5415.2006.00894.x			6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	096NY	WOS:000241385300016	17038079	Green Accepted			2021-06-18	
J	RUTHERFORD, WH; MERRETT, JD; MCDONALD, JR				RUTHERFORD, WH; MERRETT, JD; MCDONALD, JR			SYMPTOMS AT ONE YEAR FOLLOWING CONCUSSION FROM MINOR HEAD-INJURIES	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article									QUEENS UNIV BELFAST,DEPT MED STAT,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	RUTHERFORD, WH (corresponding author), ROYAL VICTORIA HOSP,DEPT ACCIDENT & EMERGENCY,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND.						KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kelly R., 1972, PAHLAVI MED J, V3, P530; LIDVALL HF, 1974, ACTA NEUROL SCAN S56, V50; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; OPPENHEIMER RD, 1968, J NEUROL NEUROSURG P, V4, P229; RUTHERFORD WH, 1977, LANCET, V1, P1	6	278	278	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0020-1383			INJURY	Injury-Int. J. Care Inj.		1979	10	3					225	230		10.1016/0020-1383(79)90015-9			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GL352	WOS:A1979GL35200014	759371				2021-06-18	
J	Wilde, EA; Whiteneck, GG; Bogner, J; Bushnik, T; Cifu, DX; Dikmen, S; French, L; Giacino, JT; Hart, T; Malec, JF; Millis, SR; Novack, TA; Sherer, M; Tulsky, DS; Vanderploeg, RD; von Steinbuechel, N				Wilde, Elisabeth A.; Whiteneck, Gale G.; Bogner, Jennifer; Bushnik, Tamara; Cifu, David X.; Dikmen, Sureyya; French, Louis; Giacino, Joseph T.; Hart, Tessa; Malec, James F.; Millis, Scott R.; Novack, Thomas A.; Sherer, Mark; Tulsky, David S.; Vanderploeg, Rodney D.; von Steinbuechel, Nicole			Recommendations for the Use of Common Outcome Measures in Traumatic Brain Injury Research	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Outcome assessment; health care; Brain injuries; Neurobehavioral manifestations; Research; Rehabilitation	QUALITY-OF-LIFE; PORTLAND ADAPTABILITY INVENTORY; POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; NOS-TBI; POSTCONCUSSION SYNDROME; WORKING-MEMORY; RATING-SCALE; FOLLOW-UP; QUESTIONNAIRE	This article summarizes the selection of outcome measures by the interagency Traumatic Brain Injury (TBI) Outcomes Workgroup to address primary clinical research objectives, including documentation of the natural course of recovery from TBI, prediction of later outcome, measurement of treatment effects, and comparison of outcomes across studies. Consistent with other Common Data Elements Workgroups, the TBI Outcomes Workgroup adopted the standard 3-tier system in its selection of measures. In the first tier, core measures included valid, robust, and widely applicable outcome measures with proven utility in TBI from each identified domain, including global level of function, neuropsychological impairment, psychological status, TBI-related symptoms, executive functions, cognitive and physical activity limitations, social role participation, and perceived health-related quality of life. In the second tier, supplemental measures were recommended for consideration in TBI research focusing on specific topics or populations. In the third tier, emerging measures included important instruments currently under development, in the process of validation, or nearing the point of published findings that have significant potential to be superior to some older ("legacy") measures in the core and supplemental lists and may eventually replace them as evidence for their utility emerges.	[Wilde, Elisabeth A.; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Wilde, Elisabeth A.] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA; [Sherer, Mark] Univ Texas Med Sch Houston, Houston, TX USA; [Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bushnik, Tamara] Rusk Inst Rehabil, Dept Rehabil Med, New York, NY USA; [Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, PM&R Serv, Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [French, Louis] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA; [Giacino, Joseph T.] JFK Johnson Rehabil Inst, Edison, NJ USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Tulsky, David S.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, Psychol Serv, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL USA; [von Steinbuechel, Nicole] Univ Gottingen, Dept Med Psychol & Med Sociol, Univ Med Ctr, Gottingen, Germany	Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ewilde@bcm.edu	french, louis/AAB-2083-2020; Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Cifu, David/0000-0003-1600-9387; Bushnik, Tamara/0000-0003-3328-257X; Tulsky, David/0000-0002-4335-4509; french, louis/0000-0002-9451-0604	National Institutes of Health (NIH: National Institute of Neurological Disorders and Stroke)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); U.S. Department of Veterans Affairs (VA)US Department of Veterans Affairs; U.S. Department of Defense (DoD)United States Department of Defense; U.S. Department of Education/National Institute on Disability and Rehabilitation ResearchUS Department of Education	Supported by the National Institutes of Health (NIH: National Institute of Neurological Disorders and Stroke), U.S. Department of Veterans Affairs (VA), U.S. Department of Defense (DoD), and U.S. Department of Education/National Institute on Disability and Rehabilitation Research.	Ader DN, 2007, MED CARE, V45, pS1, DOI 10.1097/01.mlr.0000260537.45076.74; Ball JD, 2007, CLIN NEUROPSYCHOL, V21, P422, DOI 10.1080/13854040600582577; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Benedict R., 1997, BRIEF VISUOSPATIAL M; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan J, 2003, TECHNICAL REPORT PRO; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Delis DC, 2001, DELISKAPLAN EXECUTIV; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Derogatis L.R, 1994, SYMPTOM CHECKLIST 90; Derogatis LR, 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Epstein N. B., 1993, NORMAL FAMILY PROCES, P138; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, pR7, DOI 10.1097/00001199-199708000-00001; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Heaton RK, 2004, REVISED COMPREHENSIV; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; HUMENIUK R, EFFECTIVENESS BRIEF; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P83; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JENNETT B, 1975, LANCET, V1, P480; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kaloupek DG, 2010, ARCH PHYS MED REHAB, V91, P1684, DOI 10.1016/j.apmr.2010.06.032; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; McNaughton HK, 2005, ARCH PHYS MED REHAB, V86, P2184, DOI 10.1016/j.apmr.2005.06.010; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Miller DM, 2005, QUAL LIFE RES, V14, P2031; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitrushina M., 2005, HDB NORMATIVE DATA N; Murrey GJ, 2005, BRAIN INJURY, V19, P599, DOI 10.1080/02699050400025257; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Perez Lori, 2007, J Neurosci Nurs, V39, P342; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; *PSYCH CORP, 2008, WAIS 3 WMS 3 TECHN M; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Resnick B, 2001, Outcomes Manag Nurs Pract, V5, P161; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schmidt M., 1996, REY AUDITORY VERBAL; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Spreen O., 1977, NEUROSENSORY CTR COM; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STRAUSS E, 2006, REYOSTERRIETH AUDIT3, P776; Tellegen A., 2008, MMPI 2 RF MINNESOTA; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; TULSKY DS, 2009, P INT NEUR SOC FEBR; TULSKY DS, 2009, P AM AC NEUR APR 25; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F., 1993, P 9 ANN CONV INT SOC; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; World Health Organization, 2001, INT CLASS FUNCT DIS; 2008, EQ 5D VALUES SETS IN	101	277	279	1	38	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2010	91	11					1650	1660		10.1016/j.apmr.2010.06.033			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	681UQ	WOS:000284346400004	21044708				2021-06-18	
J	Greenwald, RM; Gwin, JT; Chu, JJ; Crisco, JJ				Greenwald, Richard M.; Gwin, Joseph T.; Chu, Jeffrey J.; Crisco, Joseph J.			Head impact severity measures for evaluating mild traumatic brain injury risk exposure	NEUROSURGERY			English	Article						concussion; football; head impact biomechanics; head impact tolerance; mild traumatic brain injury; sports injury prevention	FOOTBALL; ACCELERATION; CONCUSSION; SPORTS; EPIDEMIOLOGY; COLLEGIATE; CURVES; AREA	OBJECTIVE: The aims of this study were to quantify the sensitivity of various biomechanical measures (linear acceleration, rotational acceleration, impact duration, and impact location) of head impact to the clinical diagnosis of concussion in United States football players and to develop a novel measure of head impact severity combining these measures into a single score that better predicts the incidence of concussion. METHODS: On-field head impact data were collected from 449 football players at 13 organizations (n = 289,916) using in-helmet systems of six single-axis accelerometers. Concussions were diagnosed by medical staff and later associated with impact data. Principal component analysis and a weighting coefficient based on impact location were used to transform correlated head impact measures into a new composite variable, weighted principal component score (wPCS). The predictive power of linear acceleration, rotational acceleration, head injury criterion, and wPCS was quantified using receiver operating characteristic curves. The null hypothesis, that a measure was flu more predictive than guessing, was tested (alpha = 0.05). In addition, receiver operating characteristic curves for wPCS and classical measures were directly compared to test the hypothesis that wPCS was more predictive of concussion than were classic measures (alpha = 0.05). RESULTS: When all of the impacts were considered, every biomechanical measure evaluated was statistically more predictive of concussion than guessing (P < 0,005). However, for the top 1 and 2% of impacts based on linear acceleration, a subset that consisted of 82% of all diagnosed concussions, only wPCS was significantly more predictive of concussion than guessing (P < 0.03); when compared with each other, wPCS was more predictive of concussion than were classical measures for the top I and 2% of all of the data (P < 0.04). CONCLUSION: A weighted combination of several biomechanical inputs, including impact location, is more predictive of concussion than a single biomechanical measure. This study is the first to the authors' knowledge to quantify improvements in the sensitivity of a biomechanical measure to incidence of concussion when impact location is considered. KEY WORDS: Concussion, Football, Head impact biomechanics, Head impact tolerance, Mild traumatic brain injury, Sports injury prevention	[Greenwald, Richard M.; Gwin, Joseph T.; Chu, Jeffrey J.] Simbex, Lebanon, NH 03766 USA; [Crisco, Joseph J.] Rhode Isl Hosp, Brown Med Sch, Dept Orthopaed, Providence, RI USA	Greenwald, RM (corresponding author), Simbex, 10 Water St,Suite 410, Lebanon, NH 03766 USA.	rgreenwald@simbex.com			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R44HD040743] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R44HD40473, R44 HD040743-03] Funding Source: Medline		Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BANDAK FA, 1994, P 38 STAPP CAR CRASH, V279, P145; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; CHU JJ, 2006, 5 WORLD C BIOM MUN G; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; DIMASI F, 1993, 13 INT TECHN C EXP S; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; EPPINGER RH, 1996, TRAUMATIC BRAIN INJU, P19; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HODGSON VR, 1983, 27 STAPP CAR CRASH C; JACKSON JE, 1991, USERS GUIDE PRINCIPA, P189; JOLLIFE IT, 1986, PRINCIPAL COMPONENT, P167; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; NETER J, 1996, APPL LINEAR STAT MOD, P289; Newman J, 2000, 44 STAPP CAR CRASH C; NEWMAN JA, 2000, P INT RES C BIOM IMP, P223; NUSHOLTZ G, 1993, BIOMECH IMPACT INJUR, P159; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, P 10 STAPP CAR CRASH, P197; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; PRASAD P, 1985, 851246 SAE; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tosteson TD, 2005, BIOMETRICAL J, V47, P409, DOI 10.1002/bimj.200310159; Versace J, 1971, P 15 STAPP CAR CRASH, DOI [DOI 10.4271/710881, 10.4271/710881]; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	41	277	280	0	48	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2008	62	4					789	798		10.1227/01.neu.0000318162.67472.ad			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	294TR	WOS:000255429300016	18496184	Green Accepted			2021-06-18	
J	Riccio, CA; Reynolds, CR; Lowe, P; Moore, JJ				Riccio, CA; Reynolds, CR; Lowe, P; Moore, JJ			The continuous perfonnance test: a window on the neural substrates for attention?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			French	Article; Proceedings Paper	18th Annual Meeting of the National-Academy-of-Neuropsychology	NOV, 1998	WASHINGTON, D.C.	Natl Acad Neuropsychol		neural substrates; attention; continuous performance test; executive function	CONTINUOUS PERFORMANCE-TEST; DEFICIT-HYPERACTIVITY DISORDER; CLOSED-HEAD-INJURY; EVENT-RELATED POTENTIALS; POSITRON EMISSION TOMOGRAPHY; VISUAL-DISCRIMINATION TASKS; IDENTICAL PAIRS VERSION; GLUCOSE METABOLIC-RATE; SIMPLE REACTION-TIME; SUSTAINED ATTENTION	Attention is a complex process whose disturbance is considered a core deficit in a number of disorders [e.g., Attention Deficit Hyperactivity Disorder (ADHD), schizophrenia]. In 1956, Rosvold and colleagues [J. Consult. Psychol. 20 (1956) 343.] demonstrated that the continuous performance test (CPT) as a measure of sustained attention was highly sensitive to brain damage or dysfunction. These findings have been replicated with various populations and with various versions of the CPT. The CPT is now cited as the most frequently used measure of attention in both practice and research. Across studies, results are consistent with models of sustained attention that involve the interaction of cortical (frontal, temporal, parietal), subcortical (limbic, basal ganglia), and functional systems including the pathways between the basal ganglia, thalamus, and frontal lobes. Right hemisphere involvement (asymmetric response) is also evident across multiple studies. As such, the CPT demonstrates sensitivity to dysfunction of the attentional system whether this is due to diffuse or more focal damage/dysfunction or in conjunction with any specific disorder. CPT performance can be viewed as symptom specific (attentional disturbance), but it is not disorder specific (e.g., ADHD). Implications for neuropsychological interpretation of CPT results are presented. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA	Riccio, CA (corresponding author), Texas A&M Univ, Dept Educ Psychol, MS 4225, College Stn, TX 77843 USA.						ALEXANDER DA, 1973, PSYCHOL REP, V32, P229, DOI 10.2466/pr0.1973.32.1.229; AMAN MG, 1987, EPILEPSIA, V28, P115, DOI 10.1111/j.1528-1157.1987.tb03636.x; ANDERSON VE, 1969, J ABNORM PSYCHOL, V74, P358, DOI 10.1037/h0027611; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; BAKER BK, 1990, THESIS U UTAH SALT L; BEALE IL, 1987, J ABNORM CHILD PSYCH, V15, P229, DOI 10.1007/BF00916351; Begleiter, 1979, EVOKED BRAIN POTENTI, V2, P277; Benedict RHB, 1998, NEUROREPORT, V9, P121, DOI 10.1097/00001756-199801050-00024; BENTON A L, 1959, Confin Neurol, V19, P247; BRANDT J, 1984, BRAIN COGNITION, V3, P140, DOI 10.1016/0278-2626(84)90013-7; BRUMM VL, 1994, THESIS U SO CALIFORN; Brunton T.L., 1883, NATURE, V27, P419; BUCHSBAUM M, 1989, SCHIZOPHRENIA SCI PR, P247; BUCHSBAUM MS, 1992, J AUTISM DEV DISORD, V22, P115, DOI 10.1007/BF01046407; BUCHSBAUM MS, 1990, BRIT J PSYCHIAT, V156, P216, DOI 10.1192/bjp.156.2.216; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P935; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P966; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; CAMPBELL KB, 1979, BIOL PSYCHOL, V8, P45, DOI 10.1016/0301-0511(79)90004-8; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHEE P, 1989, J ABNORM CHILD PSYCH, V17, P371, DOI 10.1007/BF00915033; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE, P177; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE, P145; Cohen R.A., 1993, NEUROPSYCHOLOGY ATTE, P115; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P459; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P3; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P307; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P219; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P329; COHEN RM, 1988, LIFE SCI, V43, P1141, DOI 10.1016/0024-3205(88)90473-0; COHEN RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; Conners C. K., 1995, CONNERS CONTINUOUS P; COONS HW, 1987, J AM ACAD CHILD PSY, V26, P368, DOI 10.1097/00004583-198705000-00016; COONS HW, 1981, ELECTROEN CLIN NEURO, V51, P373, DOI 10.1016/0013-4694(81)90101-2; CORKUM PV, 1993, J CHILD PSYCHOL PSYC, V34, P1217, DOI 10.1111/j.1469-7610.1993.tb01784.x; Cornblatt B., 1989, SCHIZOPHRENIA SCI PR, P83; CORNBLATT BA, 1989, PSYCHIAT RES, V29, P65, DOI 10.1016/0165-1781(89)90188-1; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Costa L, 1997, PERCEPT MOTOR SKILL, V85, P1395, DOI 10.2466/pms.1997.85.3f.1395; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; DAVIES DR, 1977, VIGILANCE THEORY OPE, P285; DEE HL, 1973, ARCH NEUROL-CHICAGO, V28, P163, DOI 10.1001/archneur.1973.00490210043004; Denckla MB, 1996, J DEV BEHAV PEDIATR, V17, P114; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; DERENZI E, 1965, CORTEX, V1, P410; DUPAUL GJ, 1992, J CLIN CHILD PSYCHOL, V21, P394, DOI 10.1207/s15374424jccp2104_10; EARLEBOYER EA, 1991, PSYCHIAT RES, V37, P47, DOI 10.1016/0165-1781(91)90105-X; ELIASON MJ, 1987, J LEARN DISABIL, V20, P614, DOI 10.1177/002221948702001007; ERLENMEYERKIMLING L, 1978, J PSYCHIAT RES, V14, P93, DOI 10.1016/0022-3956(78)90011-0; Ernst N, 1996, PSYCHOPHARMACOL BULL, V32, P327; EWINGCOBBS L, 1988, CHILD NEUROPSYCHOL, V4, P35; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Fallgatter AJ, 1998, ALCOHOL ALCOHOLISM, V33, P475, DOI 10.1093/alcalc/33.5.475; FITZPATRICK PA, 1992, J AM ACAD CHILD PSY, V31, P226, DOI 10.1097/00004583-199203000-00008; FRIEDMAN D, 1986, PSYCHIAT RES, V18, P161, DOI 10.1016/0165-1781(86)90028-4; FRIEDMAN D, 1985, PSYCHOPHYSIOLOGY, V22, P590; FRIEDMAN D, 1981, PSYCHOPHYSIOLOGY, V18, P635, DOI 10.1111/j.1469-8986.1981.tb01838.x; FRIEDMAN D, 1985, PSYCHOPHYSIOLOGY, V22, P440, DOI 10.1111/j.1469-8986.1985.tb01630.x; FRIEDMAN D, 1978, ELECTROEN CLIN NEURO, V45, P319, DOI 10.1016/0013-4694(78)90184-0; Garfinkel BD., 1983, PSYCHIATR HOSP, V14, P163; GEVINS AS, 1989, ELECTROEN CLIN NEURO, V74, P58, DOI 10.1016/0168-5597(89)90052-X; GIRARDI NL, 1995, PEDIATR RES, V38, P539, DOI 10.1203/00006450-199510000-00011; GLASS GV, 1977, REV RES EDUC, V5, P354; GOLDBERG JO, 1981, J CHILD PSYCHOL PSYC, V22, P55, DOI 10.1111/j.1469-7610.1981.tb00531.x; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Goldstein PC, 1997, NEUROPSYCHOLOGY, V11, P309; Gordon M., 1983, GORDON DIAGNOSTIC SY; GRIBBLE MW, 1989, THESIS OHIO STATE U; GUEVREMONT DC, 1990, J SCHOOL PSYCHOL, V28, P51, DOI 10.1016/0022-4405(90)90036-7; Hager F, 1998, EUR ARCH PSY CLIN N, V248, P161; Halperin J. M., 1991, PSYCHOL ASSESSMENT, V3, P803; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HALPERIN JM, 1988, J AM ACAD CHILD PSY, V27, P326, DOI 10.1097/00004583-198805000-00010; HALPERIN JM, 1991, DEV NEUROPSYCHOL, V7, P207, DOI 10.1080/87565649109540488; Hara Hitoshi, 1992, Acta Paediatrica Japonica, V34, P416; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; HASSLER R, 1978, J NEUROL SCI, V36, P187, DOI 10.1016/0022-510X(78)90082-5; HAZLETT EA, 1993, J ABNORM PSYCHOL, V102, P39, DOI 10.1037/0021-843X.102.1.39; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEILMAN KM, 1985, CLIN NEUROPSYCHOLOGY, P243, DOI DOI 10.1002/ANA.410100433; HERRERA J, 1991, BIOL PSYCHIAT, V29, pA84; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Hoffman R E, 1991, J Neuropsychiatry Clin Neurosci, V3, P169; HOLCOMB PJ, 1985, PSYCHOPHYSIOLOGY, V22, P656, DOI 10.1111/j.1469-8986.1985.tb01663.x; HOWES D, 1975, BRAIN, V98, P317, DOI 10.1093/brain/98.2.317; JERISON HJ, 1967, HUM FACTORS, V9, P285, DOI 10.1177/001872086700900310; Katz KS, 1996, J PEDIATR PSYCHOL, V21, P841, DOI 10.1093/jpepsy/21.6.841; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Keilp JG, 1997, PSYCHIAT RES-NEUROIM, V74, P35, DOI 10.1016/S0925-4927(96)02881-8; KIRCHNER GL, 1976, J EDUC PSYCHOL, V68, P696, DOI 10.1037/0022-0663.68.6.696; KLORMAN R, 1988, J ABNORM PSYCHOL, V97, P413, DOI 10.1037/0021-843X.97.4.413; KLORMAN R, 1983, ELECTROEN CLIN NEURO, V56, P169, DOI 10.1016/0013-4694(83)90071-8; KLORMAN R, 1979, PSYCHOPHYSIOLOGY, V16, P23, DOI 10.1111/j.1469-8986.1979.tb01432.x; KLORMAN R, 1990, J AM ACAD CHILD PSY, V29, P702, DOI 10.1097/00004583-199009000-00005; KLORMAN R, 1991, J ABNORM CHILD PSYCH, V19, P263, DOI 10.1007/BF00911231; KOELEGA HS, 1991, PERCEPT MOTOR SKILL, V72, P971; KOELEGA HS, 1990, PERCEPT MOTOR SKILL, V70, P1011, DOI 10.2466/PMS.70.3.1011-1029; KOELEGA HS, 1989, HUM FACTORS, V31, P45; KOELEGA HS, 1992, PSYCHOL BULL, V112, P239, DOI 10.1037/0033-2909.112.2.239; LAIDLAW TM, 1993, INT J CLIN EXP HYP, V41, P97, DOI 10.1080/00207149308414541; LAM CM, 1991, REM SPEC EDUC, V12, P40, DOI 10.1177/074193259101200208; LANSDELL H, 1964, EXP NEUROL, V9, P463, DOI 10.1016/0014-4886(64)90054-8; LEUTHOLD H, 1993, PSYCHOPHYSIOLOGY, V30, P510, DOI 10.1111/j.1469-8986.1993.tb02074.x; LEVAV ML, 1991, THESIS U MARYLAND BA; Levin ED, 1996, PSYCHOPHARMACOLOGY, V123, P55, DOI 10.1007/BF02246281; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEVY F, 1991, AUST NZ J PSYCHIAT, V25, P277, DOI 10.3109/00048679109077746; Liu SK, 1997, SCHIZOPHR RES, V25, P211, DOI 10.1016/S0920-9964(97)00026-1; LOISELLE DL, 1980, PSYCHOPHYSIOLOGY, V17, P193, DOI 10.1111/j.1469-8986.1980.tb00134.x; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Losier BJ, 1996, J CHILD PSYCHOL PSYC, V37, P971, DOI 10.1111/j.1469-7610.1996.tb01494.x; Luria A. R., 1966, HIGHER CORTICAL FUNC; Luria A. R, 1973, WORKING BRAIN; MAHAN SM, 1996, THESIS INDIANA STATE; Mansour CS, 1996, PERS INDIV DIFFER, V20, P183, DOI 10.1016/0191-8869(95)00167-0; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MICHAEL RL, 1981, PSYCHOPHYSIOLOGY, V18, P665, DOI 10.1111/j.1469-8986.1981.tb01841.x; MILLER JM, 1996, THESIS WASHINGTON U; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A. F., 1989, INTEGRATING THEORY P, P75; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1960, EXP NEUROL, V2, P75, DOI 10.1016/0014-4886(60)90049-2; NAATANEN R, 1992, PSYCHOL BULL, V92, P605; OKADA YC, 1983, ELECTROEN CLIN NEURO, V55, P417, DOI 10.1016/0013-4694(83)90130-X; PAPANICOLAOU AC, 1985, PSYCHOPHYSIOLOGY, V22, P326, DOI 10.1111/j.1469-8986.1985.tb01608.x; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PASS HL, 1980, BIOL PSYCHIAT, V15, P9; PELOQUIN LJ, 1986, J ABNORM PSYCHOL, V95, P88, DOI 10.1037/0021-843X.95.1.88; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; POSNER MI, 1988, MASTER LECT CLIN NEU, P173; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; PRICHEP LS, 1976, PSYCHOPHYSIOLOGY, V13, P419, DOI 10.1111/j.1469-8986.1976.tb00855.x; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; REYNOLDS CR, 1998, ANN M NAT AC NEUR WA; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; RISSER AH, 1990, 18 ANN M INT NEUR SO; ROBERTS LE, 1994, ELECTROEN CLIN NEURO, V92, P44, DOI 10.1016/0168-5597(94)90006-X; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rourke BP, 1989, NONVERBAL LEARNING D; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; Sandford J.A., 1995, MANUAL INTEGRATED VI; Sax KW, 1999, AM J PSYCHIAT, V156, P139, DOI 10.1176/ajp.156.1.139; SCHEIN JD, 1962, J CONSULT PSYCHOL, V26, P115, DOI 10.1037/h0047461; SCHROEDER J, 1994, PSYCHOL MED, V24, P947, DOI 10.1017/S0033291700029032; SCHUPP HT, 1994, ELECTROEN CLIN NEURO, V90, P135, DOI 10.1016/0013-4694(94)90005-1; SELEMON LD, 1990, J COMP NEUROL, V297, P359, DOI 10.1002/cne.902970304; SIEGEL BV, 1995, SCHIZOPHR RES, V17, P85, DOI 10.1016/0920-9964(95)00033-I; SIMSON R, 1977, ELECTROEN CLIN NEURO, V43, P864, DOI 10.1016/0013-4694(77)90009-8; SLICKER EK, 1991, THESIS TEXAS A M U C; SNYDER E, 1980, PSYCHOPHYSIOLOGY, V17, P112, DOI 10.1111/j.1469-8986.1980.tb00120.x; SQUIRES NK, 1983, TUTORIALS ERP RES EN, P217; STAMM J, 1982, EVENT RELATED POTENT, P273; STRANDBURG RJ, 1994, BIOL PSYCHIAT, V35, P525, DOI 10.1016/0006-3223(94)90099-X; STRANDBURG RJ, 1990, BIOL PSYCHIAT, V27, P1103, DOI 10.1016/0006-3223(90)90047-6; Stuss D.T., 1986, FRONTAL LOBES; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TARTAGLIONE A, 1986, NEUROPSYCHOLOGIA, V24, P649, DOI 10.1016/0028-3932(86)90004-7; TEIXEIRA LCH, 1993, THESIS U RHODE ISLAN; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; TUCKER DM, 1986, DUALITY UNITY BRAIN, P75; VALENTINO DA, 1993, INT J PSYCHOPHYSIOL, V15, P123, DOI 10.1016/0167-8760(93)90070-6; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VERBATEN MN, 1994, J ABNORM CHILD PSYCH, V22, P561, DOI 10.1007/BF02168938; VOELLER KKS, 1991, J CHILD NEUROL, V6, pS2, DOI 10.1177/0883073891006001S01; WAGNER M, 1989, BIOL PSYCHIAT, V25, P792, DOI 10.1016/0006-3223(89)90252-7; WEILER MD, 1992, MEASUREMENT MODEL SP; WEINGARTNER H, 1980, J ABNORM PSYCHOL, V89, P25, DOI 10.1037/0021-843X.89.1.25; WOLFE N, 1990, ARCH NEUROL-CHICAGO, V47, P129, DOI 10.1001/archneur.1990.00530020025010; WU JC, 1991, SLEEP, V14, P155; WU JC, 1992, AM J PSYCHIAT, V149, P538; Zemishlany Z, 1996, NEUROPSYCHOBIOLOGY, V33, P127, DOI 10.1159/000119262	186	277	289	1	22	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2002	17	3					235	272	PII S0887-6177(01)00111-1	10.1016/S0887-6177(01)00111-1			38	Psychology, Clinical; Psychology	Psychology	536ZN	WOS:000174731900003	14589726	Bronze			2021-06-18	
J	Wolf, JA; Stys, PK; Lusardi, T; Meaney, D; Smith, DH				Wolf, JA; Stys, PK; Lusardi, T; Meaney, D; Smith, DH			Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels	JOURNAL OF NEUROSCIENCE			English	Article						axon; injury; calcium; sodium channels; diffuse axonal injury; mechanosensitivity; mechanoporation; brain trauma	SPINAL-CORD INJURY; CNS WHITE-MATTER; ANOXIC INJURY; BRAIN INJURY; NA+-CA2+ EXCHANGER; OPTIC-NERVE; ULTRASTRUCTURAL EVIDENCE; STRETCH INJURY; CA2+ CHANNELS; NTERA-2 CELLS	Diffuse axonal injury (DAI) is one of the most common and important pathologies resulting from the mechanical deformation of the brain during trauma. It has been hypothesized that calcium influx into axons plays a major role in the pathophysiology of DAI. However, there is little direct evidence to support this hypothesis, and mechanisms of potential calcium entry have not been explored. In the present study, we used an in vitro model of axonal stretch injury to evaluate the extent and modulation of calcium entry after trauma. Using a calcium-sensitive dye, we observed a dramatic increase in intra-axonal calcium levels immediately after injury. Axonal injury in a calcium-free extracellular solution resulted in no change in calcium concentration, suggesting an extracellular source for the increased post-traumatic calcium levels. We also found that the post-traumatic change in intra-axonal calcium was completely abolished by the application of the sodium channel blocker tetrodotoxin or by replacement of sodium with N-methyl-D-glucamine. In addition, application of the voltage-gated calcium channel (VGCC) blocker omega -conotoxin MVIIC attenuated the post-traumatic increase in calcium. Furthermore, blockade of the Na+-Ca2+ exchanger with bepridil modestly reduced the calcium influx after injury. In contrast to previously proposed mechanisms of calcium entry after axonal trauma, we found no evidence of calcium entry through mechanically produced pores (mechanoporation). Rather, our results suggest that traumatic deformation of axons induces abnormal sodium influx through mechanically sensitive Na+ channels, which subsequently triggers an increase in intraaxonal calcium via the opening of VGCCs and reversal of the Na+-Ca2+ exchanger.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Univ Ottawa, Ottawa Hosp, Loeb Hlth Res Inst, Ottawa, ON K1Y 4K9, Canada	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Room 105 hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.		smith, douglas/A-1321-2007; Wolf, John A/A-1034-2007	Wolf, John A/0000-0002-6950-2303; Meaney, David/0000-0002-0954-4122; Lusardi, Theresa/0000-0003-0699-5662	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG012527, AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35712, P50 NS008803, R01 NS038104, R01 NS035712, NS38104] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR312712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, R01NS035712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER		Agrawal SK, 1996, J NEUROSCI, V16, P545; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; BANIK NL, 1987, NEUROCHEM PATHOL, V7, P57, DOI 10.1007/BF02834292; Buki A, 2000, J NEUROSCI, V20, P2825; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FERN R, 1995, J NEUROPHYSIOL, V74, P369; GARCIA ML, 1988, BIOCHEMISTRY-US, V27, P2410, DOI 10.1021/bi00407a024; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; Imaizumi T, 1999, BRAIN RES, V817, P84, DOI 10.1016/S0006-8993(98)01214-1; Imaizumi T, 1997, J NEUROTRAUM, V14, P299, DOI 10.1089/neu.1997.14.299; LoPachin RM, 1999, J NEUROPHYSIOL, V82, P2143; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McDonough SI, 1996, J NEUROSCI, V16, P2612; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Munir M, 1995, J NEUROSCI, V15, P7847; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; SCHWARTZ G, 1999, J NEUROTRAUM, V16, P984; Shcherbatko A, 1999, BIOPHYS J, V77, P1945, DOI 10.1016/S0006-3495(99)77036-0; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; STYS PK, 1990, NEUROSCI LETT, V115, P293, DOI 10.1016/0304-3940(90)90471-K; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; STYS PK, 1992, J NEUROSCI, V12, P430; Stys PK, 1998, NEUROSCIENCE, V82, P21; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Takahashi A, 1999, PHYSIOL REV, V79, P1089; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632; Teng YD, 1997, J NEUROSCI, V17, P4359; Wallace RH, 1998, NAT GENET, V19, P366; WAXMAN SG, 1994, BRAIN RES, V644, P197, DOI 10.1016/0006-8993(94)91680-2; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; Young W, 1992, J NEUROTRAUMA S1, V9, P9	52	277	286	0	17	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 15	2001	21	6					1923	1930		10.1523/JNEUROSCI.21-06-01923.2001			8	Neurosciences	Neurosciences & Neurology	410CJ	WOS:000167422200015	11245677	Other Gold, Green Published			2021-06-18	
J	Sullivan, PG; Rabchevsky, AG; Waldmeier, PC; Springer, JE				Sullivan, PG; Rabchevsky, AG; Waldmeier, PC; Springer, JE			Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death?	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article; Proceedings Paper	6th International Meeting for Brain Energy Metabolism	MAY, 2004	Crete, GREECE			neuronal cell death; reactive oxygen species; mitochondrial permeability transition pore; mitochondrial dysfunction; traumatic brain injury; spinal cord injury	ADENINE-NUCLEOTIDE TRANSLOCASE; NERVOUS-SYSTEM TOXICITY; SPINAL-CORD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; CYTOCHROME-C RELEASE; CYCLOSPORINE-A; BRAIN-INJURY; OXIDATIVE STRESS; INNER MEMBRANE; CYCLOPHILIN-D	Experimental traumatic brain injury (TBI) and spinal cord injury (SCI) result in a rapid and significant necrosis of neuronal tissue at the site of injury. In the ensuing hours and days, secondary injury exacerbates the primary damage, resulting in significant neurologic dysfunction. It is believed that alterations in excitatory amino acids (EAA), increased reactive oxygen species (ROS), and the disruption of Ca2+ homeostasis are major factors contributing to the ensuing neuropathology. Mitochondria serve as the powerhouse of the cell by maintaining ratios of ATP:ADP that thermodynamically favor the hydrolysis of ATP to ADP + P-i, yet a byproduct of this process is the generation of ROS. Proton-pumping by components of the electron transport system (ETS) generates a membrane potential (DeltaPsi) that can then be used to phosphorylate ADP or sequester Ca2+ out of the cytosol into the mitochondrial matrix. This allows mitochondria to act as cellular Ca2+ sinks and to be in phase with changes in cytosolic Ca2+ levels. Under extreme loads of Ca2+, however, opening of the mitochondrial permeability transition pore (mPTP) results in the extrusion of mitochondrial Ca2+ and other high- and low-molecular weight components. This catastrophic event discharges DeltaPsi and uncouples the ETS from ATP production. Cyclosporin A (CsA), a potent immunosuppressive drug, inhibits mitochondrial permeability transition (mPT) by binding to matrix cyclophilin D and blocking its binding to the adenine nucleotide translocator. Peripherally administered CsA attenuates mitochondrial dysfunction and neuronal damage in an experimental rodent model of TBI, in a dose-dependent manner. The underlying mechanism of neuroprotection afforded by CsA is most likely via interaction with the mPTP because the immunosuppressant FK506, which has no effect on the mPT, was not neuroprotective. When CsA was administrated after experimental SCI at the same dosage and regimen used TBI paradigms, however, it had no beneficial neuroprotective effects. This review takes a comprehensive and critical look at the evidence supporting the role for mPT in central nervous system (CNS) trauma and highlights the differential responses of CNS mitochondria to mPT induction and the implications this has for therapeutically targeting the mPT in TBI and SCI. (C) 2004 Wiley-Liss. Inc.	Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Novartis Pharma Ltd, Nervous Syst Res, Basel, Switzerland	Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 240 HSRB, Lexington, KY 40536 USA.	PatSull@uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915			Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BERDEN JHM, 1985, LANCET, V1, P219; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Beutner G, 1996, FEBS LETT, V396, P189, DOI 10.1016/0014-5793(96)01092-7; Bindokas VP, 1998, J NEUROSCI, V18, P4570; BRAUGHLER JM, 1992, J NEUROTRAUMA, V9, P1; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Budd SL, 1998, ESSAYS BIOCHEM, V33, P43, DOI 10.1042/bse0330043; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; DUGAN LL, 1995, J NEUROSCI, V15, P6377; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAMIGLIO L, 1989, TRANSPLANTATION, V48, P316, DOI 10.1097/00007890-198908000-00025; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; GEBICKI JM, 1964, J BIOL CHEM, V239, P631; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; HALL ED, 1992, J NEUROTRAUMA S1, V9, P165; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; HUNTER FE, 1964, J BIOL CHEM, V239, P614; HUNTER FE, 1964, J BIOL CHEM, V239, P622; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kamal A, 1999, EUR J NEUROSCI, V11, P3512, DOI 10.1046/j.1460-9568.1999.00769.x; Keller JN, 1998, J NEUROSCI, V18, P687; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lu YF, 1996, BRAIN RES, V729, P142, DOI 10.1016/0006-8993(96)00568-9; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Nicholls DG, 2000, PHYSIOL REV, V80, P315; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Prehn JHM, 1998, N-S ARCH PHARMACOL, V357, P316, DOI 10.1007/PL00005173; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Scanlon JM, 1998, J NEUROCHEM, V71, P2392; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; STANTON PK, 1986, BRAIN RES, V382, P185, DOI 10.1016/0006-8993(86)90130-7; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sullivan PG, 1999, J NEUROSCI, V19, P6248; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; WALKER RW, 1988, NEUROL CLIN, V6, P261, DOI 10.1016/S0733-8619(18)30869-7; Wieloch T, 2001, IUBMB LIFE, V52, P247, DOI 10.1080/15216540152846064; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739	84	275	283	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN 1	2005	79	1-2					231	239		10.1002/jnr.20292			9	Neurosciences	Neurosciences & Neurology	888RB	WOS:000226390800031	15573402				2021-06-18	
J	Manley, G; Knudson, MM; Morabito, D; Damron, S; Erickson, V; Pitts, L				Manley, G; Knudson, MM; Morabito, D; Damron, S; Erickson, V; Pitts, L			Hypotension, hypoxia, and head injury - Frequency, duration, and consequences	ARCHIVES OF SURGERY			English	Article							BRAIN; INSULTS; TRAUMA; CARE	Background: Retrospective studies have suggested an association between systemic hypotension and hypoxia and worsened outcome from traumatic brain injury. Little is known, however, about the frequency and duration of these potentially preventable causes of secondary brain injury. Hypothesis: Early episodes of hypoxia and hypotension occurring during initial resuscitation will have a significant impact on outcome following traumatic brain injury. Design: Prospective cohort study. Setting: Urban level I trauma center. Patients: Patients with a traumatic brain injury who had a Glasgow Coma Score of 12 or less within the first 24 hours of admission to the hospital and computed tomographic scan results demonstrating intracranial pathologic features. Patients who died in the emergency department were excluded from the study. Main Outcome Measures: Automated blood pressure and pulse oximetry readings were collected prospectively from the time of arrival through initial resuscitation. The number and duration of hypotensive (systolic blood pressure, less than or equal to 90 mm Hg) and hypoxic (oxygen saturation, less than or equal to 92%) events were analyzed for their association with mortality and neurological outcome. Results: One hundred seven patients met the enrollment criteria (median Glasgow Coma Score, 7). Overall mortality was 43%. Twenty-six patients (24%) had hypotension while in the emergency department, with an average of 1.5 episodes per patient (mean duration, 9.1 minutes). Of these 26 patients with hypotension, 17 (65%) died (P=.01). When the number of hypotensive episodes increased from I to 2 or more, the odds ratio for death increased from 2. 1 to 8. 1. Forty-one patients (38%) had hypoxia, with an average of 2.1 episodes per patient (mean duration, 8.7 minutes). Of these 41 patients with hypoxia, 18 (44%) died (P=.68). Conclusions: Hypotension, but not hypoxia, occurring in the initial phase of resuscitation is significantly (P=.009) associated with increased mortality following brain injury, even when episodes are relatively short. These prospective data reinforce the need for early continuous monitoring and improved treatment of hypotension in brain-injured patients.	Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; San Francisco Injury Ctr, San Francisco, CA USA	Knudson, MM (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave, San Francisco, CA 94110 USA.	pkundson@sfghsurg.ucsf.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R499/CCR903697] Funding Source: Medline		CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; DeWitt D S, 1995, New Horiz, V3, P376; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; JEFFREYS RV, 1981, LANCET, V2, P459; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYER T, 1981, CHILD BRAIN, V8, P189; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	16	275	284	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0004-0010	1538-3644		ARCH SURG-CHICAGO	Arch. Surg.	OCT	2001	136	10					1118	1123		10.1001/archsurg.136.10.1118			6	Surgery	Surgery	478AK	WOS:000171320600004	11585502	Bronze			2021-06-18	
J	Mucha, A; Collins, MW; Elbin, RJ; Furman, JM; Troutman-Enseki, C; DeWolf, RM; Marchetti, G; Kontos, AP				Mucha, Anne; Collins, Michael W.; Elbin, R. J.; Furman, Joseph M.; Troutman-Enseki, Cara; DeWolf, Ryan M.; Marchetti, Greg; Kontos, Anthony P.			A Brief Vestibular/Ocular Motor Screening (VOMS) Assessment to Evaluate Concussions Preliminary Findings	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; vestibular; ocular motor; symptoms	POSTURAL STABILITY; STANDARDIZED ASSESSMENT; BALANCE DISORDERS; SPORT; REHABILITATION; DIZZINESS; SYMPTOMS; CHILDREN; SYSTEM	Background: Vestibular and ocular motor impairments and symptoms have been documented in patients with sport-related concussions. However, there is no current brief clinical screen to assess and monitor these issues. Purpose: To describe and provide initial data for the internal consistency and validity of a brief clinical screening tool for vestibular and ocular motor impairments and symptoms after sport-related concussions. Study Design: Cross-sectional study; Level of evidence, 2. Methods: Sixty-four patients, aged 13.9 2.5 years and seen approximately 5.5 4.0 days after a sport-related concussion, and 78 controls were administered the Vestibular/Ocular Motor Screening (VOMS) assessment, which included 5 domains: (1) smooth pursuit, (2) horizontal and vertical saccades, (3) near point of convergence (NPC) distance, (4) horizontal vestibular ocular reflex (VOR), and (5) visual motion sensitivity (VMS). Participants were also administered the Post-Concussion Symptom Scale (PCSS). Results: Sixty-one percent of patients reported symptom provocation after at least 1 VOMS item. All VOMS items were positively correlated to the PCSS total symptom score. The VOR (odds ratio [OR], 3.89; P < .001) and VMS (OR, 3.37; P < .01) components of the VOMS were most predictive of being in the concussed group. An NPC distance 5 cm and any VOMS item symptom score 2 resulted in an increase in the probability of correctly identifying concussed patients of 38% and 50%, respectively. Receiver operating characteristic curves supported a model including the VOR, VMS, NPC distance, and ln(age) that resulted in a high predicted probability (area under the curve = 0.89) for identifying concussed patients. Conclusion: The VOMS demonstrated internal consistency as well as sensitivity in identifying patients with concussions. The current findings provide preliminary support for the utility of the VOMS as a brief vestibular/ocular motor screen after sport-related concussions. The VOMS may augment current assessment tools and may serve as a single component of a comprehensive approach to the assessment of concussions.	[Mucha, Anne; Collins, Michael W.; Elbin, R. J.; Furman, Joseph M.; Troutman-Enseki, Cara; DeWolf, Ryan M.; Marchetti, Greg; Kontos, Anthony P.] Univ Pittsburgh, Pittsburgh, PA 15203 USA	Kontos, AP (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: M.W.C. is a cofounder and 10% shareholder of ImPACT Applications Inc. This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1).	Allum J H J, 2012, Front Neurol, V3, P83, DOI 10.3389/fneur.2012.00083; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hillier SL, 2007, COCHRANE DB SYST REV, V4; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; NASHNER LM, 1982, J NEUROSCI, V2, P536; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Slattery EL, 2011, NEUROREHABILITATION, V29, P143, DOI 10.3233/NRE-2011-0688	33	274	275	2	60	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2014	42	10					2479	2486		10.1177/0363546514543775			8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	AQ4XQ	WOS:000342805000027	25106780	Green Accepted	Y	N	2021-06-18	
J	Teasdale, G; Maas, A; Lecky, F; Manley, G; Stocchetti, N; Murray, G				Teasdale, Graham; Maas, Andrew; Lecky, Fiona; Manley, Geoffrey; Stocchetti, Nino; Murray, Gordon			The Glasgow Coma Scale at 40 years: standing the test of time	LANCET NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; LINEAR-REGRESSION PREDICTION; CEREBRAL-BLOOD-FLOW; PROGNOSTIC VALUE; NEUROSURGICAL INTERVENTION; IMPAIRED CONSCIOUSNESS; TRANSFORMING RESEARCH; EMERGENCY-DEPARTMENT; OUTCOME PREDICTION	Since 1974, the Glasgow Coma Scale has provided a practical method for bedside assessment of impairment of conscious level, the clinical hallmark of acute brain injury. The scale was designed to be easy to use in clinical practice in general and specialist units and to replace previous ill-defined and inconsistent methods. 40 years later, the Glasgow Coma Scale has become an integral part of clinical practice and research worldwide. Findings using the scale have shown strong associations with those obtained by use of other early indices of severity and outcome. However, predictive statements should only be made in combination with other variables in a multivariate model. Individual patients are best described by the three components of the coma scale; whereas the derived total coma score should be used to characterise groups. Adherence to this principle and enhancement of the reliable practical use of the scale through continuing education of health professionals, standardisation across different settings, and consensus on methods to address confounders will maintain its role in clinical practice and research in the future.	[Teasdale, Graham; Maas, Andrew; Lecky, Fiona; Manley, Geoffrey; Stocchetti, Nino; Murray, Gordon] Univ Glasgow, Gartnavel Royal Hosp, Mental Hlth & Wellbeing, Glasgow G12 OXH, Lanark, Scotland	Teasdale, G (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Mental Hlth & Wellbeing, Glasgow G12 OXH, Lanark, Scotland.	graham.teasdale@glasgow.ac.uk	Stocchetti, Nino/O-7444-2017	Stocchetti, Nino/0000-0003-3250-6834; Murray, Gordon/0000-0001-9866-4734	European Union FP7 programme [602150-2]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS UO1/11365885]; Department of DefenseUnited States Department of Defense [W81XWH-13-1-0441]; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Welcome Trust (UK)Wellcome Trust; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; European Brain Injury Consortium; European Union FP7 programme; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803] Funding Source: researchfish	AIM and FL receive funding from the European Union FP7 programme (grant 602150-2), and GMa receives funding from the US National Institutes of Health (NINDS UO1/11365885) and Department of Defense (W81XWH-13-1-0441). Administrative costs in Glasgow were supported by the Muriel Cooke Endowment to the University of Glasgow. We thank the initiating leadership and vision of the late Bryan Jennett, 1926-2008, University of Glasgow, UK, and the many collaborations, particularly in the field of traumatic brain injury, over 40 years. We thank all the physicians, surgeons, nurses, and other scientists who have contributed to the further development, acceptance and (on occasion, critical) analysis of the Glasgow Coma Scale. We thank past and present funding from the many major sources that have contributed to the experience and analyses underpinning this review. These include funding from Medical Research Council (MRC) and the Welcome Trust (UK), the US National Institutes of Health, the European Brain Injury Consortium, and the European Union FP7 programme. We thank Ian Roberts London School of Hygiene & Tropical Medicine (London, UK), principal investigator of the MRC CRASH trial, for access to the information used to produce table 4 and figure 3, to Alan Clark (Chandler Trauma and Acute Care Surgery, AZ, USA) and Turner Osier (University of Vermont College of Medicine, VT, USA) for providing information from the American College of Surgeons National Trauma Data Bank, to Tom Jenks (The Trauma Audit and Research Network Manchester Medical Academic Health Sciences Centre, Manchester, UK) for the information from the TARN data, to Andrew McAinsh, Information Officer, Royal College of Physicians and Surgeons of Glasgow for literature searches and citation analysis, to Mike Bell for advice on use of the Glasgow Coma Scale in children, and to Ewout Steyerberg and Hester Lingsma (Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands) for advice on dealing with missing components of the Glasgow Coma Scale. We thank Margaret Naismith, University of Glasgow, UK, for the conduct and analysis of the survey of World Federation of Neurosurgical Societies member organisations and to Veronique De Keyser, University Hospital of Antwerp, Belgium, for administrative support in preparing the manuscript.	American College of Surgeons, 1980, ADV TRAUM LIF SUPP; Ananda A, 1999, ACTA NEUROCHIR SUPPL, V73, P99; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Baker M, 2008, J NEUROSCI NURS, V4, P342; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOUZARTH WF, 1968, J TRAUM, V8, P29, DOI 10.1097/00005373-196801000-00004; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Clement CM, 2006, ANN EMERG MED, V48, P245, DOI 10.1016/j.annemergmed.2006.04.008; Edwards P, 2005, LANCET, V365, P1957; Evidence-Based Review of Moderate to Severe Acquired Brain Injury (ABIEBR), GLASG COM SCAL; Feinstein AR., 1987, CLINIMETRICS; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; GORDON NS, 1983, NEUROPEDIATRICS, V14, P3, DOI 10.1055/s-2008-1059545; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hattori N, 2003, J NUCL MED, V44, P1709; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heard K, 2004, HUM EXP TOXICOL, V23, P197, DOI 10.1191/0960327104ht436oa; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; James HE, 1985, BRAIN INSULTS INFANT, P179; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Koch D, 2000, INT MED J, V7, P51; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; Laureys S, 2005, LANCET NEUROL, V4, P789, DOI 10.1016/S1474-4422(05)70230-1; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Leteurtre S, 2013, CRIT CARE MED, V41, P1761, DOI 10.1097/CCM.0b013e31828a2bbd; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mansuy L, 1966, P 3 INT C NEUR SURG, V110, P411; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MATTHEW H, 1966, Q J MED, V35, P539; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Middleton PM, 2012, AUSTRALAS EMERG NURS, V15, P170, DOI 10.1016/j.aenj.2012.06.002; MITCHELL DE, 1973, LANCET, V2, P215; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OHTA T, 2003, J JPN C NEUROL EMERG, V16, P1; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponce FA, 2014, J NEUROSURG, V120, P1252, DOI 10.3171/2014.2.JNS14358a; Ponce FA, 2010, J NEUROSURG, V112, P233, DOI 10.3171/2009.12.JNS091600; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; REILLY PL, 1975, LANCET, V2, P375; Reith F, 2014, J NEUROTRAUM, V31, pA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; SEGATORE M, 1992, HEART LUNG, V21, P548; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SIMPSON D, 1982, LANCET, V2, P450; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1975, Nurs Times, V71, P972; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tufte E. R., 2001, VISUAL DISPLAY QUANT; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	90	274	295	0	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2014	13	8					844	854		10.1016/S1474-4422(14)70120-6			11	Clinical Neurology	Neurosciences & Neurology	AL9JB	WOS:000339456300018	25030516		Y	N	2021-06-18	
J	McCrea, M; Kelly, JP; Randolph, C; Kluge, J; Bartolic, E; Finn, G; Baxter, B				McCrea, M; Kelly, JP; Randolph, C; Kluge, J; Bartolic, E; Finn, G; Baxter, B			Standardized assessment of concussion (SAC): On-site mental status evaluation of the athlete	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; mental status; neuropsychological tests; sports injuries; Standardized Assessment of Concussion	CONTACT-SPORTS	Objective: This study investigated the clinical utility of the Standardized Assessment of Concussion (SAC) in detecting concussion in athletes. Method: Athletic trainers administered the SAC to 568 nonconcussed high school and college football players prior to the 1995 and 1996 football seasons. Thirty-three of these players experienced concussion and were tested immediately following injury; 28 of the 33 underwent additional follow-up testing 48 hours after the injury. Results: Concussed players scored significantly below nonconcussed controls on all SAC measures and significantly below their own pre-injury baseline performance. Follow-up testing documented return to preinjury baseline. Conclusion: These findings support the SAC's effectiveness in detecting concussion and tracking recovery in order to determine a player's fitness to return to play.	Waukesha Mem Hosp, Neuropsychol Serv, Waukesha, WI 53188 USA; Rehabil Inst Chicago, Brain Injury Program, Chicago, IL 60611 USA; Loyola Univ, Med Ctr, Chicago, IL 60611 USA; Covenant Med Ctr, Employer & Community Hlth Serv, Waterloo, IA USA; Allegheny Univ Hlth Sci, Philadelphia, PA 19102 USA; Bates Coll, Lewiston, ME 04240 USA; Univ Wisconsin Platteville, Platteville, WI USA	McCrea, M (corresponding author), Waukesha Mem Hosp, Neuropsychol Serv, 725 Amer Ave, Waukesha, WI 53188 USA.						Barth JT., 1989, MILD HEAD INJURY, P257; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P172; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; *CO MED SOC, 1991, REP SPORTS MED COMM; GRONWALL D, 1975, LANCET, V2, P995; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; KELLY J, 1995, CURRENT THERAPY SPOR; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LANDRY G, 1994, NAT ATHL TRAIN ASS R; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MCCREA M, 1997, MANUAL ADM SCORING I; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; *NAT ATHL TRAIN AS, 1994, P MILD BRAIN INJ SUM; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538	18	274	276	0	21	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1998	13	2					27	35		10.1097/00001199-199804000-00005			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ZF451	WOS:000072898800005	9575254				2021-06-18	
J	MARION, DW; DARBY, J; YONAS, H				MARION, DW; DARBY, J; YONAS, H			ACUTE REGIONAL CEREBRAL BLOOD-FLOW CHANGES CAUSED BY SEVERE HEAD-INJURIES	JOURNAL OF NEUROSURGERY			English	Article						CEREBRAL BLOOD FLOW; HEAD INJURY; CO2 VASORESPONSIVITY; HYPERVENTILATION	ENHANCED COMPUTED-TOMOGRAPHY; SPINAL-CORD INJURY; COMATOSE PATIENTS; XENON INHALATION; BRAIN INJURY; ACUTE PHASE; CT; METABOLISM; PRESSURE; THERAPY	To evaluate the changes in cerebral blood flow (CBF) that occur immediately after head injury and the effects of different posttraumatic lesions on CBF, 61 CBF studies were obtained using the xenon-computerized tomography method in 32 severely head-injured adults (Glasgow Coma Scale score (GCS) less-than-or-equal-to 7). The measurements were made within 7 days after injury, 43% in the first 24 hours. During the 1st day, patients with an initial GCS score of 3 or 4 and no surgical mass had significantly lower flows than did those with a higher GCS score or mass lesions (p < 0.05): in the first 1 to 4 hours, those without surgical mass lesions had a mean CBF of 27 cc/100 gm/min, which rose to 44 cc/100 gm/min by 24 hours. Patients without surgical mass lesions who died tended to have a lower global CBF than did those with better outcomes. Mass lesions were associated with a high global CBF and bihemispheric contusions with the lowest flows. By 24 hours after injury, global blood flow increased in groups that originally had low flows and decreased in those with very high initial flows, such that by 36 to 48 hours, most patients had CBF values between 32 and 55 cc/100 gm/min. Lobar, basal ganglion, and brain-stem blood flow values frequently differed by 25% or more from global averages. Brain-stem CBF varied the most but did not correlate with clinical signs of brain-stem dysfunction. Double studies were performed at two different pCO2 values in 10 patients with various postraumatic lesions, and the CO2 vasoresponsivity was calculated. Abnormal CO2 vasoresponsivity was found with acute subdural hematomas and defuse cerebral swelling but not with epidural hematomas. In patients without surgical mass lesions, the findings suggest that CBF in the first few hours after injury is often low, followed by a hyperemic phase that peaks at 24 hours. Global CBF values vary widely depending on the type of traumatic brain injury, and brain-stem flow is often not accurately reflected by global CBF values. These findings underscore the need to define regional CBF abnormalities in victims of severe head injury if treatment is intended to prevent regional ischemia.	UNIV PITTSBURGH, SCH MED, DEPT NEUROL SURG, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT ANESTHESIOL CRIT CARE MED, PITTSBURGH, PA 15261 USA			Marion, Donald/AAR-5749-2021	Marion, Donald/0000-0003-4627-7702			BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BUSIJA DW, 1986, AM J PHYSIOL, V250, pH498; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; DARBY JM, 1989, INTRACRANIAL PRESSUR, V7, P643; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FADEN AI, 1983, NEUROLOGY, V33, P673, DOI 10.1212/WNL.33.6.673; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; GUR D, 1982, SCIENCE, V215, P1267, DOI 10.1126/science.7058347; GUR D, 1984, MED PHYS, V11, P209, DOI 10.1118/1.595604; HARRINGTON T., 1986, INTRACRANIAL PRESSUR, VVI, P680; HELLMAN RS, 1986, J CEREBR BLOOD F MET, V6, P747, DOI 10.1038/jcbfm.1986.131; HOLL K, 1987, ACTA NEUROCHIR, V87, P129, DOI 10.1007/BF01476063; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KEARFOTT KJ, 1984, MED PHYS, V11, P686, DOI 10.1118/1.595552; KENDALL BE, 1981, J NEURORADIOLOGY, V8, P3; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LATCHAW RE, 1987, RADIOLOGY, V163, P251, DOI 10.1148/radiology.163.1.3823444; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MEYER JS, 1980, AM J ROENTGENOL, V135, P239, DOI 10.2214/ajr.135.2.239; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OBRIST WD, 1983, INTRACRANIAL PRESSUR, V5, P491; OBRIST WD, 1985, J CEREB BLOOD FLOW M, V5, P557; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Ward JD, 1989, INTRACRANIAL PRESSUR, P630	37	274	283	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	1991	74	3					407	414		10.3171/jns.1991.74.3.0407			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EZ166	WOS:A1991EZ16600006	1899694				2021-06-18	
J	Vasterling, JJ; Proctor, SP; Amoroso, P; Kane, R; Heeren, T; White, RF				Vasterling, Jennifer J.; Proctor, Susan P.; Amoroso, Paul; Kane, Robert; Heeren, Timothy; White, Roberta F.			Neuropsychological outcomes of army personnel following deployment to the Iraq War	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PERSIAN-GULF-WAR; DEPRESSION; IMPAIRMENT; VETERANS; STRESS; MEMORY; AFGHANISTAN; EMPLOYMENT	Context The effects of war-zone deployment on neuropsychological health remain poorly understood. Neuropsychological performance deficits serve as sensitive measures of neural dysfunction and are often associated with psychosocial and occupational problems. Previous studies have not conducted objective neuropsychological assessments both before and after a major war-zone deployment. \ Objective To examine objective neuropsychological outcomes of Iraq War deployment in a large military cohort. Design, Setting, and Participants The Neurocognition Deployment Health Study, a prospective, cohort-controlled study conducted at military installations. This report centers on 961 male and female active-duty Army soldiers drawn from the larger cohort. Deploying Army soldiers (n = 654) were examined prior to deployment to Iraq (April-December 2003) and shortly after return (within a mean of 73 days [median, 75 days]; January-May 2005) from Iraq deployment. A comparison group of soldiers (n=307) similar in military characteristics but not deploying overseas during the study was assessed in sessions timed to be as close as possible to the assessment of deployers. Military unit sampling procedures facilitated representation of combat, combat support, and combat service support functions among both deployers and nondeployers. Main Outcome Measures Individually administered, performance-based neuropsychological tasks. Estimates (P; the unstandardized parameter estimate) for the absolute differences in adjusted mean outcome scores between deployed and nondeployed groups were determined using generalized estimating equations. Results Multiple linear regression analyses adjusted for battalion membership revealed that Iraq deployment, compared with nondeployment, was associated with neuropsychological compromise on tasks of sustained attention (beta =0.11; P<.001), verbal learning (beta =-1.51; P=.003), and visual-spatial memory (beta=-3.82; P<.001). Iraq deployment was also associated with increased negative state affect on measures of confusion (beta = 1.40; P<.001) and tension (beta= 1.24; P<.001). In contrast, deployment was associated with improved simple reaction time (beta=4.30; P=.003). Deployment effects remained statistically significant after taking into account deployment-related head injury and stress and depression symptoms. Conclusions Deployment to Iraq is associated with increased risk of neuropsychological compromise. Findings point to the need to investigate further the impact of deployment on neural functioning. Public health implications include consideration of neuropsychological compromise in health prevention and postdeployment clinical and occupational management.	SE Louisiana Vet Hlth Care Syst, Res Serv COSF, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; VA Boston Healthcare Syst, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; USA, Environm Med Res Inst, Natick, MA 01760 USA; Madigan Army Med Ctr, Ft Lewis, WA USA; VA Maryland Hlth Care Syst, Baltimore, MD USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Vasterling, JJ (corresponding author), SE Louisiana Vet Hlth Care Syst, Res Serv COSF, 1601 Perdido St, New Orleans, LA 70112 USA.	jvaster@tulane.edu		Heeren, Timothy/0000-0001-5643-3559			Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Bellinger DC, 2004, ENVIRON RES, V95, P394, DOI 10.1016/j.envres.2003.07.013; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Blood CG, 2001, MIL MED, V166, P648; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *DEP VET AFF, 2002, COMB AN VA DOD GULF; Elliott R, 1998, TRENDS COGN SCI, V2, P447, DOI 10.1016/S1364-6613(98)01235-2; GRANDJEAN P, 1998, NEUROTOXICOL TERATOL, V21, P1; Habib KE, 2001, ENDOCRIN METAB CLIN, V30, P695, DOI 10.1016/S0889-8529(05)70208-5; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; King DW, 2003, MANUAL DEPLOYMENT RI; Letz R, 1996, NEUROTOXICOL TERATOL, V18, P365, DOI 10.1016/0892-0362(96)00041-4; Letz R, 2000, NES3 USERS MANUAL; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mauss IB, 2004, COGNITION EMOTION, V18, P631, DOI 10.1080/02699930341000112; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McNair D.M., 1971, MANUAL PROFILE MOOD; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; OBRYANT SE, IN PRESS CLIN NEUROP; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Papero P. H., 1992, J DEV PHYS DISABIL, V4, P317; Proctor SP, 2003, J PSYCHOPATHOL BEHAV, V25, P85, DOI 10.1023/A:1023390831355; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reeves D., 2002, ANAM 2001 USERS MANU; REEVES DL, IN PRESS MIL MED; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Sauro MD, 2003, STRESS, V6, P235, DOI 10.1080/10253890310001616482; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stewart AL, 1992, MEASURING FUNCTIONIN, P102, DOI [10.7249/cb361, DOI 10.7249/CB361]; Tombaugh TN, 1996, TEST MEMORY MALINGER; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2006, PHILOS T R SOC B, V361, P593, DOI 10.1098/rstb.2006.1819; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Weathers F., 1991, PTSD CHECKLIST MILIT; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WHITE RF, 1992, J OCCUP ENVIRON MED, V34, P140, DOI 10.1097/00043764-199202000-00013; WHITE RF, 1994, NEUROTOXICOL TERATOL, V16, P511, DOI 10.1016/0892-0362(94)90130-9; White RF, 1997, LANCET, V349, P1239, DOI 10.1016/S0140-6736(96)07218-2; WHITE RF, 2001, CLIN OCCUPATIONAL EN, V1, P577	48	273	274	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2006	296	5					519	529		10.1001/jama.296.5.519			11	Medicine, General & Internal	General & Internal Medicine	069YW	WOS:000239486900016	16882958	Bronze			2021-06-18	
J	Dunn, W				Dunn, W			The sensations of everyday life: Empirical, theoretical, and pragmatic considerations	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						sensory processing; temperament; threshold	TRAUMATIC BRAIN INJURY; SENSORY PROFILE; CHILDREN; SCHIZOPHRENIA; DEFENSIVENESS; DISABILITIES; INTEGRATION; BEHAVIORS; OUTCOMES; SEEKING	The experience of being human is embedded in sensory events Of everyday life. This lecture reviews sensory processing literature, including neuroscience and social science perspectives. Introduced is Dunn's Model of Sensory Processing, and the evidence supporting this model is summarized Specifically, using Sensory Profile questionnaires (i.e., items describing responses to sensory events in daily life, persons mark the frequency of each behavior), persons birth to 90 years of age demonstrate four sensory processing patterns: sensory seeking, sensory avoiding, sensory sensitivity, and low registration. These patterns are based on a person's neurological thresholds and self-regulation strategies. Psychophysiology studies verify these sensory processing patterns; persons with strong preferences in each pattern also have unique patterns of habituation and responsivity in skin conductance. Studies also indicate that persons with disabilities respond differently than peers on these questionnaires, suggesting underlying poor sensory processing in certain disorders, including autism, attention deficit hyperactivity disorder, developmental delays, and schizophrenia. The author proposes relationships between sensory processing and temperament and personality traits. The four categories of temperament share some consistency with the four sensory processing patterns described in Dunn model. As with temperament, each person has some level of responsiveness within each sensory processing preference (i.e., a certain amount of seeking, avoiding, etc., not one or the other). The author suggests that ones sensory processing preferences simultaneously reflect his or her nervous system needs and form the basis for the manifestation of temperament and personality. The final section of this lecture outlines parameters for developing best practice that supports interventions based on this knowledge.	Univ Kansas, Dept Occupat Therapy Educ, Kansas City, KS 66160 USA	Dunn, W (corresponding author), Univ Kansas, Dept Occupat Therapy Educ, 3901 Rainbow Blvd,3033 Robinson, Kansas City, KS 66160 USA.			dunn, winnie/0000-0001-8697-0590			Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Ayres A.J., 1989, SENSORY INTEGRATION; Ayres A.J., 1979, SENSORY INTEGRATION; AYRES AJ, 1980, AM J OCCUP THER, V34, P375, DOI 10.5014/ajot.34.6.375; Bagnato SJ, 1999, CHILD ADOL PSYCH CL, V8, P347; Baranek GT, 1997, AM J OCCUP THER, V51, P91, DOI 10.5014/ajot.51.2.91; Baranek GT, 1997, OCCUP THER J RES, V17, P173, DOI 10.1177/153944929701700302; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Belser RC, 1995, DEV BRAIN DYSFUNCT, V8, P270; Bensing JM, 1999, MED CARE, V37, P1078, DOI 10.1097/00005650-199910000-00011; Brown C, 2001, AM J OCCUP THER, V55, P75, DOI 10.5014/ajot.55.1.75; BROWN C, IN PRESS ADULT SENSO; Bunney WE, 1999, SCHIZOPHRENIA BULL, V25, P577, DOI 10.1093/oxfordjournals.schbul.a033402; CARTON S, 1995, J AFFECT DISORDERS, V34, P219, DOI 10.1016/0165-0327(95)00020-N; Case-Smith J, 1998, AM J OCCUP THER, V52, P547, DOI 10.5014/ajot.52.7.547; Caspi A, 2000, J PERS SOC PSYCHOL, V78, P158, DOI 10.1037/0022-3514.78.1.158; Cermak SA, 1997, AM J OCCUP THER, V51, P500, DOI 10.5014/ajot.51.7.500; Cohn E, 2000, AM J OCCUP THER, V54, P36, DOI 10.5014/ajot.54.1.36; Cohn ES, 1998, AM J OCCUP THER, V52, P540, DOI 10.5014/ajot.52.7.540; Cooper Jasmine, 1993, Physical and Occupational Therapy in Pediatrics, V13, P61, DOI 10.1300/J006v13n01_04; Coren SC, 1984, SENSATION PERCEPTION; Costa P T Jr, 1987, Adv Psychosom Med, V17, P71; Cromwell R.L, 1993, SCHIZOPHRENIA ORIGIN, P335; DAMASIO AR, 1999, FEELING HAPPENS BODY; DeGangi GA, 1989, TEST SENSORY FUNCTIO; Denney A, 1997, J Gerontol Nurs, V23, P16; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 1997, AM J OCCUP THER, V51, P25, DOI 10.5014/ajot.51.1.25; Dunn W, 1997, AM J OCCUP THER, V51, P490, DOI 10.5014/ajot.51.7.490; Dunn W., 1998, OCCUPATIONAL THERAPY, P182; Dunn W., 1999, SENSORY PROFILE; DUNN W, IN PRESS INFANT TODD; DUNN W, 2001, UNPUB; DUNN W, 2000, INFANT TODDLER CLIN; DUNN W, IN PRESS OCCUPATIONA; Ermer J, 1998, AM J OCCUP THER, V52, P283, DOI 10.5014/ajot.52.4.283; Eysenck H. J., 1987, J PERSONALITY DISORD, V1, P211, DOI DOI 10.1521/PEDI.1987.1.3.211; FINKELMAN JM, 1994, HUM FACTORS, V36, P232; Fisher A., 1991, SENSORY INTEGRATION; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gijsbers van Wijk C M, 1997, Ned Tijdschr Geneeskd, V141, P283; Glicksohn J, 1998, PERS INDIV DIFFER, V25, P1085, DOI 10.1016/S0191-8869(98)00096-8; Gormly A. V., 1997, LIFESPAN HUMAN DEV; HEMSLEY DR, 1993, BEHAV RES THER, V31, P633, DOI 10.1016/0005-7967(93)90116-C; HUEBNER R, 2000, AUTISM RELATED DISOR, P3; Jarus Tal, 1995, Physical and Occupational Therapy in Pediatrics, V14, P59; Jin Y, 1998, BIOL PSYCHIAT, V43, P873, DOI 10.1016/S0006-3223(98)00115-2; Johnson-Ecker CL, 2000, AM J OCCUP THER, V54, P494, DOI 10.5014/ajot.54.5.494; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Keogh B. K., 1994, PREVENTION EARLY INT, P246; KEOGH BK, 1982, TEMPERAMENTAL DIFFER, P269; Kientz MA, 1997, AM J OCCUP THER, V51, P530, DOI 10.5014/ajot.51.7.530; KIMBALL JG, 1986, AM J OCCUP THER, V40, P241, DOI 10.5014/ajot.40.4.241; KINNEALEY M, 1995, AM J OCCUP THER, V49, P444, DOI 10.5014/ajot.49.5.444; Kinnealey M., 1999, OCCUP THER INT, V6, P195, DOI [DOI 10.1002/OTI.97, 10.1002/oti.97]; Kinnealey M, 1998, OCCUPATIONAL THERAPY, V5, P293; Lai J.-S., 1999, SENSORY INTEGRATION, V22, P1; LARSON KA, 1982, AM J OCCUP THER, V36, P590, DOI 10.5014/ajot.36.9.590; Light GA, 2000, BIOL PSYCHIAT, V47, P463, DOI 10.1016/S0006-3223(99)00280-2; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MCCRAE RR, 1980, J GERONTOL, V35, P877, DOI 10.1093/geronj/35.6.877; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; McIntosh D., 1999, SENSORY PROFILE EXAM, P59; McIntosh DN, 1999, DEV MED CHILD NEUROL, V41, P608, DOI 10.1017/S0012162299001267; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Parham LD, 1998, OCCUP THER J RES, V18, P105, DOI 10.1177/153944929801800304; POHL P, 2001, UNPUB; Provost Beth, 1993, Physical and Occupational Therapy in Pediatrics, V13, P15; Ragneskog H, 1997, SCAND J CARING SCI, V11, P176, DOI 10.1111/j.1471-6712.1997.tb00451.x; RIJK AE, 1999, J BEHAV MED, V22, P549; Rothbart M. K., 2000, TEMPERAMENT PERSONAL, P85; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; ROTHBART MK, 1981, ADV DEV PSYCHOL, V1, P37; Royeen C. B., 1998, OCCUPATIONAL THERAPY, V5, P281; ROYEEN CB, 1990, AM J OCCUP THER, V44, P155, DOI 10.5014/ajot.44.2.155; SARMANYSCHULLER I, 1999, STUD PSYCHOL, V41, P73; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; STAR JL, 1997, T REMOT SEN, V5, P1; Stephens C. L., 1998, OCCUPATIONAL THERAPY, V5, P273; Stratton J, 1998, J SUBST ABUSE TREAT, V15, P89; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Venables P H, 1969, Proc Annu Meet Am Psychopathol Assoc, V58, P132; Wiener Andrea Santman, 1996, Physical and Occupational Therapy in Pediatrics, V16, P1, DOI 10.1300/J006v16n04_01; WOODBURY PP, 1997, THESIS, V57, P4651; ZUCKERMAN M, 1993, PERS INDIV DIFFER, V15, P563, DOI 10.1016/0191-8869(93)90340-9; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	86	273	275	3	55	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	2001	55	6					608	620		10.5014/ajot.55.6.608			13	Rehabilitation	Rehabilitation	493YX	WOS:000172252000002	12959225				2021-06-18	
J	SHOHAMI, E; NOVIKOV, M; BASS, R; YAMIN, A; GALLILY, R				SHOHAMI, E; NOVIKOV, M; BASS, R; YAMIN, A; GALLILY, R			CLOSED-HEAD INJURY TRIGGERS EARLY PRODUCTION OF TNF-ALPHA AND IL-6 BY BRAIN-TISSUE	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						CLOSED HEAD INJURY; EICOSANOIDS; INTERLEUKIN-6; TUMOR NECROSIS FACTOR ALPHA	TUMOR-NECROSIS-FACTOR; RAT-BRAIN; INTERLEUKIN-6; ASTROCYTES; LIPOPOLYSACCHARIDE; CYTOKINES; MICROGLIA; ENDOTOXIN; BIOLOGY; CELLS	In a model of closed head injury (CHI) in the rat we have shown the activation of phospholipase A(2) and the production of eicosanoids after injury: at 15 min, mainly 5-hydroxyeicosatetraenoic acid (5-HETE), and at 24 h, mainly prostaglandin E(2). The present study was designed to test whether CHI can also trigger the production of cytokines in the brain. CHI was induced in ether-anesthesized rats by a weight-drop device falling over the exposed skull covering the left hemisphere, 1-2 mm lateral to the midline in the midcoronal plane. In the posttraumatic period (1-24 h), the rats were decapitated, cortical tissue from the injured zone of the contused and contralateral hemispheres was removed and sonicated, and cytokine activity was assessed. Whereas no tumor necrosis factor alpha (TNF alpha) activity was found in normal brain tissue, it was detectable in the contused hemisphere (similar to 72 +/- 50 pg/mg protein) as early as 1 h post-CHI. TNF alpha levels increased at 2 h, peaked at 4 h, (similar to 609 +/- 540 pg/mg protein), and declined thereafter. At parallel intervals, only low levels of TNF alpha were detected in the contralateral hemisphere. In normal brain, interleukin-6 (IL-6) was nondetectable. Following CHI, high levels of IL-6 were present, although their accumulation lagged behind that of TNF alpha by 2-4 h, peaking at 8 h (62 +/- 31 ng/mg protein). We suggest that the rapid production of TNF alpha. and IL-6 following CHI is a local inflammatory response of brain tissue to primary insult.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT PHARMACOL, IL-91010 JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, HADASSAH MED SCH, LAUTENBERG CTR GEN & TUMOR IMMUNOL, IL-91010 JERUSALEM, ISRAEL							ABBAS AK, 1991, CELLULAR MOL IMMUNOL, P229; ANDERSSON PB, 1991, IMMUNOL LETT, V30, P177, DOI 10.1016/0165-2478(91)90022-3; BONTA IL, 1991, PHARMACOL RES, V24, P115, DOI 10.1016/1043-6618(91)90027-U; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BRENNER T, 1993, BRAIN RES, V608, P273, DOI 10.1016/0006-8993(93)91468-8; DINARELLO CA, 1988, INFLAMMATION BASIC P, P195; Feuerstein G, 1993, J CEREB BLOOD FLO S1, V13, pS26; HAMID Q, 1992, BLOOD, V80, P1496; HEIDENREICH S, 1989, J IMMUNOL, V143, P1198; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; HORI K, 1989, CANCER RES, V49, P2606; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P78, DOI 10.1007/BF00427218; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MURPHY S, 1988, GLIA, V1, P241, DOI 10.1002/glia.440010402; POBER JS, 1990, PHYSIOL REV, V70, P427; RENZ H, 1988, J IMMUNOL, V141, P2388; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SEMENZATO G, 1990, BRIT J CANCER, V61, P354, DOI 10.1038/bjc.1990.78; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHARIF SF, 1993, NEUROL RES, V15, P109; SHER T, 1990, CANCER IMMUNOL IMMUN, V31, P86, DOI 10.1007/BF01742371; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1989, ANN NY ACAD SCI, V559, P485; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; SPANGELO BL, 1990, ENDOCRINOLOGY, V127, P1779, DOI 10.1210/endo-127-4-1779; TRACEY KJ, 1991, CIRC SHOCK, V35, P123; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; YOUNG B, 1992, J NEUROTRAUM, V9, pS375	35	273	276	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	1994	14	4					615	619		10.1038/jcbfm.1994.76			5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	NT499	WOS:A1994NT49900010	8014208	Bronze			2021-06-18	
J	Gensel, JC; Zhang, B				Gensel, John C.; Zhang, Bei			Macrophage activation and its role in repair and pathology after spinal cord injury	BRAIN RESEARCH			English	Article						Microglia; Neuroinflammation; Regeneration; Axon; TLR; Alternative activation; Wound; Monocyte; Traumatic brain injury; TBI; SCI; Macrophage; Inflammation; M2; M1; Dieback; Retraction; Astrocyte; Healing; Wound; Phenotype; Neurotrauma; Reactive oxygen species; Arginase; Mannose; OPC; Oligodendrocyte; IL-10; LPS; IL-12; STAT6; STAT3; SLAM; MARCO; Proliferation; ECM; Ym1; Fizz-1; VEGF; IL-6; IL-4; Immune complex; Regulatory; M2b; M2c	MEDIATED AXONAL DIEBACK; TRAUMATIC BRAIN-INJURY; PPAR-GAMMA AGONIST; INFLAMMATORY RESPONSE; ALTERNATIVE ACTIVATION; FUNCTIONAL RECOVERY; WALLERIAN DEGENERATION; OXIDATIVE STRESS; APOPTOTIC CELLS; CNS	The injured spinal cord does not heal properly. In contrast, tissue repair and functional recovery occur after skin or muscle injuries. The reason for this dichotomy in wound repair is unclear but inflammation, and specifically macrophage activation, likely plays a key role. Macrophages have the ability to promote the repair of injured tissue by regulating transitions through different phase of the healing response. In the current review we compare and contrast the healing and inflammatory responses between spinal cord injuries and tissues that undergo complete wound resolution. Through this comparison, we identify key macrophage phenotypes that are inaptly triggered or absent after spinal cord injury and discuss spinal cord stimuli that contribute to this maladaptive response. Sequential activation of classic, pro-inflammatory, M1 macrophages and alternatively activated, M2a, M2b, and M2c macrophages occurs during normal healing and facilitates transitions through the inflammatory, proliferative, and remodeling phases of repair. In contrast, in the injured spinal cord, pro-inflammatory macrophages potentiate a prolonged inflammatory phase and remodeling is not properly initiated. The desynchronized macrophage activation after spinal cord injury is reminiscent of the inflammation present in chronic, non-healing wounds. By refining the role macrophages play in spinal cord injury repair we bring to light important areas for future neuroinflammation and neurotrauma research. This article is part of a Special Issue entitled SI: Spinal cord injury. (C) 2015 The Authors. Published by Elsevier B.V.	[Gensel, John C.; Zhang, Bei] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Dept Physiol, Lexington, KY 40536 USA	Gensel, JC (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B463 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA.	gensel.1@uky.edu	Zhang, Xiaolei/E-2761-2012	Zhang, Xiaolei/0000-0003-0117-7599; , John/0000-0001-8980-108X	Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [283051, 296772]; Spinal Cord and Brain Injury Research Center (SCoBIRC) at the University of Kentucky; Craig H. Neilsen Foundation	The Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) (postdoctoral fellowship to BZ, CHN grants #: 283051 (JCG) and 296772 (BZ)) supported this work along with the Spinal Cord and Brain Injury Research Center (SCoBIRC) at the University of Kentucky, and the Craig H. Neilsen Foundation. We would like to additionally thank Dr. George Smith, Dr. Donna Wilcock and Tiffany Sudduth for their support.	Adamson S, 2011, CURR OPIN LIPIDOL, V22, P335, DOI 10.1097/MOL.0b013e32834a97e4; Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Bratton DL, 2005, NAT MED, V11, P26, DOI 10.1038/nm0105-26; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Drew PD, 2006, NEUROCHEM INT, V49, P183, DOI 10.1016/j.neuint.2006.04.003; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Gensel JC, 2008, J NEUROSCI, V28, P8385, DOI 10.1523/JNEUROSCI.2533-08.2008; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Imai M, 2008, J NEUROSURG-SPINE, V8, P58, DOI 10.3171/SPI-08/01/058; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karlo J. C., 2012, J NEUROSCI, V32, P10117; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kuo HS, 2011, J NEUROSCI, V31, P4137, DOI 10.1523/JNEUROSCI.2592-10.2011; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nicholson AC, 2004, TRENDS CARDIOVAS MED, V14, P8, DOI 10.1016/j.tcm.2003.09.004; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; Nocentini G, 2008, MOL PHARMACOL, V73, P1610, DOI 10.1124/mol.107.044354; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Ren Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/945034; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rigamonti E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560629; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Sauerbeck A., 2013, ASN NEURO, V5; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shin T, 2013, MOL NEUROBIOL, V47, P1011, DOI 10.1007/s12035-013-8398-6; Sindrilaru A, 2013, ADV WOUND CARE, V2, P357, DOI 10.1089/wound.2012.0407; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Taoka Y, 1997, CRIT CARE MED, V25, P874, DOI 10.1097/00003246-199705000-00026; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Werdin Frank, 2009, Eplasty, V9, pe19; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhang B, 2014, EXP NEUROL, V258, P112, DOI 10.1016/j.expneurol.2014.04.007	110	272	306	6	147	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 4	2015	1619				SI		1	11		10.1016/j.brainres.2014.12.045			11	Neurosciences	Neurosciences & Neurology	CQ7IK	WOS:000360776000001	25578260	Other Gold	Y	N	2021-06-18	
J	Vos, PE; Lamers, KJB; Hendriks, JCM; van Haaren, M; Beems, T; Zimmerman, C; van Geel, W; de Reus, H; Biert, J; Verbeek, MM				Vos, PE; Lamers, KJB; Hendriks, JCM; van Haaren, M; Beems, T; Zimmerman, C; van Geel, W; de Reus, H; Biert, J; Verbeek, MM			Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury	NEUROLOGY			English	Article							FIBRILLARY ACIDIC PROTEIN; KINASE-BB ISOENZYME; CEREBROSPINAL-FLUID; S-100 PROTEIN; CREATINE-KINASE; HEAD-INJURY; ENOLASE; DAMAGE; CSF; MARKERS	Objective: To study the ability of glial ( glial fibrillary acidic protein [GFAP] and S100b) and neuronal ( neuron specific enolase [NSE]) protein levels in peripheral blood to predict outcome after severe traumatic brain injury. Methods: Eighty-five patients with severe traumatic brain injury ( admission Glasgow Coma Score [GCS] less than or equal to 8) were included. Blood samples taken at the time of hospital admission were analyzed for S100b, GFAP, and NSE. Data collected included demographic and clinical variables. Outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months post injury. Results: The median serum levels of S100b, GFAP, and NSE were raised 18.3 fold ( S100b), 4.6 fold ( GFAP), and twofold ( NSE) compared to normal reference values. S100b, GFAP, and NSE serum levels correlated significantly with the injury severity score and CT findings but not with age, sex, or GCS. S100b, GFAP, and NSE levels were significantly higher in patients who died or had a poor outcome 6 months post injury than in those who were alive or had good outcome. S100b level > 1.13 mug/L was the strongest predictor of death with 100% discrimination, but GFAP ( > 1.5 mug/L) and NSE ( > 21.7 mug/L) levels also strongly predicted death ( adjusted odds ratios 5.82 [ for GFAP] and 3.91 [ for NSE]). S100b, GFAP, and NSE all strongly predicted poor outcome ( adjusted odds ratios 5.12 [ S100b], 8.82 [ GFAP], and 3.95 [ NSE]). Conclusions: These results suggest that determination of serum levels of glial and neuronal proteins may add to the clinical assessment of the primary damage and prediction of outcome after severe traumatic brain injury.	Univ Med Ctr Nijmegen, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Epidemiol & Biostat, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Neurosurg, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Intens Care, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Lab Pediat & Neurol, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Surg, Nijmegen, Netherlands	Vos, PE (corresponding author), Univ Med Ctr Nijmegen, Dept Neurol, Hp 326,POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Vos, Pieter/A-6043-2012; Biert, J./L-4200-2015; Verbeek, Marcel M/D-1971-2010; Hendriks, J.C.M./L-4363-2015	Verbeek, Marcel M/0000-0003-4635-7876; 			Anderson RE, 1999, ANN THORAC SURG, V67, P1721, DOI 10.1016/S0003-4975(99)00318-5; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; BAKAY RAE, 1986, NEUROSURGERY, V18, P376, DOI 10.1227/00006123-198603000-00026; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bullock RM, 2000, J NEUROTRAUM, V17, P449; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Ergun R, 1998, NEUROL RES, V20, P418; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; GERBITZ KD, 1986, J CLIN CHEM CLIN BIO, V24, P1009; HANS P, 1987, J NEUROSURG, V66, P714, DOI 10.3171/jns.1987.66.5.0714; HANS P, 1983, J NEUROSURG, V58, P689, DOI 10.3171/jns.1983.58.5.0689; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENNETT B, 1975, LANCET, V1, P480; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McKeating EG, 1998, ACT NEUR S, V71, P117; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Missler U, 1999, CLIN CHEM, V45, P138; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Puri ML., 1971, NONPARAMETRIC METHOD; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2001, NEUROSURGERY, V49, P1491, DOI 10.1097/00006123-200112000-00055; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schmitt B, 1998, BRAIN DEV-JPN, V20, P536, DOI 10.1016/S0387-7604(98)00046-1; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Wallin A, 1996, DEMENTIA, V7, P267, DOI 10.1159/000106891; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Woertgen C, 2000, ACT NEUR S, V76, P371; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	54	272	299	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 27	2004	62	8					1303	1310		10.1212/01.WNL.0000120550.00643.DC			8	Clinical Neurology	Neurosciences & Neurology	815UM	WOS:000221067200011	15111666				2021-06-18	
J	Mejia, ROS; Ona, VO; Li, MW; Friedlander, RM				Mejia, ROS; Ona, VO; Li, MW; Friedlander, RM			Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction	NEUROSURGERY			English	Article						apoptosis; caspase; interleukin-1 beta; minocycline; traumatic brain injury	INTERLEUKIN-1-BETA CONVERTING-ENZYME; TROPHIC FACTOR WITHDRAWAL; DOMINANT-NEGATIVE MUTANT; SPINAL-CORD INJURY; DEATH GENE CED-3; CELL-DEATH; TRANSGENIC MICE; MOUSE MODEL; IL-1-BETA-CONVERTING ENZYME; NEURONAL APOPTOSIS	OBJECTIVE: Caspase-1 plays an important functional role mediating neuronal cell death and dysfunction after experimental traumatic brain injury (TBI) in mice. Minocycline, a derivative of the antibiotic tetracycline, inhibits caspase-1 expression. This study investigates whether minocycline can ameliorate TBI-mediated injury in mice. METHODS: Brains from mice subjected to traumatic brain injury underwent immunohistochemical analyses for caspase-1, caspase-3, and a neuronal specific marker (NeuN). Minocycline- and saline-treated mice subjected to traumatic brain injury were compared with respect to neurological function, lesion volume, and interleukin-lp production. RESULTS: Immunohistochemical analysis revealed that activated caspase-1 and caspase-3 are present in neurons 24 hours after TBI. Intraperitoneal administration of minocycline 12 hours before or 30 minutes after TBI in mice resulted in improved neurological function when compared with mice given saline control, as assessed by Rotarod performance 1 to 4 days after TBI. The lesion volume, assessed 4 days after trauma, was significantly decreased in mice treated with minocycline before or after trauma when compared with saline-treated mice. Caspase-1 activity, quantified by measuring mature interleukin-1 beta production by enzyme-linked immunosorbent assay, was considerably increased in mice that underwent TBI, and this increase was significantly diminished in minocycline-treated mice. CONCLUSION: We show for the first time that caspase-1 and caspase-3 activities localize specifically within neurons after experimental brain trauma. Further, these results indicate that minocycline is an effective pharmacological agent for reducing tissue injury and neurological deficits that result from experimental TBI, likely through a caspase-1-dependent mechanism. These results provide an experimental rationale for the evaluation of minocycline in human trauma patients.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Neurosurg,Neuroapoptosis Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA	Friedlander, RM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Neurosurg,Neuroapoptosis Lab, Boston, MA 02115 USA.	rfriedlander@rics.bwh.harvard.edu	Friedlander, Robert M/A-2845-2016	Friedlander, Robert M/0000-0003-4423-9219			Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; ANKARCRONA M, 1994, EXP CELL RES, V213, P172, DOI 10.1006/excr.1994.1187; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHAN PH, 1994, ANN NY ACAD SCI, V738, P93; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1997, J CEREBR BLOOD F MET, V17, P370, DOI 10.1097/00004647-199704000-00002; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Klevenyi P, 1999, NEUROREPORT, V10, P635, DOI 10.1097/00001756-199902250-00035; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Mao PL, 1998, J BIOL CHEM, V273, P23621, DOI 10.1074/jbc.273.37.23621; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Patel RN, 1999, J IMMUNOL, V163, P3459; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smilack JD, 1999, MAYO CLIN PROC, V74, P727, DOI 10.4065/74.7.727; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452	52	272	277	0	20	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2001	48	6					1393	1399					7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	433XG	WOS:000168785500129	11383749				2021-06-18	
J	Zhang, YF; Xu, JK; Ruan, YC; Yu, MK; O'Laughlin, M; Wise, H; Chen, D; Tian, L; Shi, DF; Wang, JL; Chen, SH; Feng, JQ; Chow, DHK; Xie, XH; Zheng, LZ; Huang, L; Huang, S; Leung, K; Lu, N; Zhao, L; Li, HF; Zhao, DW; Guo, X; Chan, KM; Witte, F; Chan, HC; Zheng, YF; Qin, L				Zhang, Yifeng; Xu, Jiankun; Ruan, Ye Chun; Yu, Mei Kuen; O'Laughlin, Micheal; Wise, Helen; Chen, Di; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Feng, Jian Q.; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Lu, Na; Zhao, Lan; Li, Huafang; Zhao, Dewei; Guo, Xia; Chan, Kaiming; Witte, Frank; Chan, Hsiao Chang; Zheng, Yufeng; Qin, Ling			Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats	NATURE MEDICINE			English	Article							GENE-RELATED PEPTIDE; TRAUMATIC BRAIN-INJURY; IN-VITRO; VIVO; OSTEOPOROSIS; ALLOYS; DIFFERENTIATION; OSTEOARTHRITIS; INNERVATION; EXPRESSION	Orthopedic implants containing biodegradable magnesium have been used for fracture repair with considerable efficacy; however, the underlying mechanisms by which these implants improve fracture healing remain elusive. Here we show the formation of abundant new bone at peripheral cortical sites after intramedullary implantation of a pin containing ultrapure magnesium into the intact distal femur in rats. This response was accompanied by substantial increases of neuronal calcitonin gene-related polypeptide-alpha (CGRP) in both the peripheral cortex of the femur and the ipsilateral dorsal root ganglia (DRG). Surgical removal of the periosteum, capsaicin denervation of sensory nerves or knockdown in vivo of the CGRP-receptor-encoding genes Cakrl or Ramp1 substantially reversed the magnesium-induced osteogenesis that we observed in this model. Overexpression of these genes, however, enhanced magnesium-induced osteogenesis. We further found that an elevation of extracellular magnesium induces magnesium transporter 1 (MAGT1)-dependent and transient receptor potential cation channel, subfamily M, member 7 (TRPM7)-dependent magnesium entry, as well as an increase in intracellular adenosine triphosphate (ATP) and the accumulation of terminal synaptic vesicles in isolated rat DRG neurons. In isolated rat periosteum-derived stem cells, CGRP induces CALCRL- and RAMP1-dependent activation of cAMP-responsive element binding protein 1 (CREB1) and SP7 (also known as osterix), and thus enhances osteogenic differentiation of these stem cells. Furthermore, we have developed an innovative, magnesium containing intramedullary nail that facilitates femur fracture repair in rats with ovariectomy-induced osteoporosis. Taken together, these findings reveal a previously undefined role of magnesium in promoting CGRP-mediated osteogenic differentiation, which suggests the therapeutic potential of this ion in orthopedics.	[Zhang, Yifeng; Xu, Jiankun; O'Laughlin, Micheal; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Li, Huafang; Chan, Kaiming; Qin, Ling] Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China; [Ruan, Ye Chun; Yu, Mei Kuen; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Wise, Helen] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Di; Zhao, Lan] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Lu, Na] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhao, Dewei] Dalian Univ, Dept Orthoped, Zhongshan Hosp, Dalian, Peoples R China; [Guo, Xia] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Witte, Frank] Charite, Julius Wolff Inst, Berlin, Germany; [Witte, Frank] Charite, Ctr Musculoskeletal Surg, Berlin, Germany; [Witte, Frank] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China; [Qin, Ling] Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China; [Zhang, Yifeng] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Qin, L (corresponding author), Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.; Zheng, YF (corresponding author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China.; Qin, L (corresponding author), Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China.	yfzheng@pku.edu.cn; lingqin@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; Qin, Ling/J-9047-2018; Zheng, Yufeng/A-4146-2010; Ruan, Ye Chun/T-7531-2019; Chen, Di/AAJ-3665-2021; Li, Huafang/D-5486-2013; RUAN, Ye Chun/T-5919-2017; Zheng, Y.F./AAE-6697-2021; Chow, Dick Ho Kiu/C-6547-2014; Witte, Frank/D-9294-2014	Qin, Ling/0000-0001-6173-6167; Zheng, Yufeng/0000-0002-7402-9979; RUAN, Ye Chun/0000-0002-4266-6789; Zheng, Y.F./0000-0002-7402-9979; Chow, Dick Ho Kiu/0000-0002-2836-3255; Witte, Frank/0000-0001-9154-6217; Zhao, Lan/0000-0003-0865-2006	Hong Kong RGC Collaborative Research Fund [C4028-14GF]; General Research Fund [14112714, 14114415]; NSFC/RGCHong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC) [N_CUHK449/13, 51361165101]; Innovation and Technology Fund [ITS/350/13]; SMART Program; National Basic Research Program of China (973 Program)National Basic Research Program of China [2012CB619102, 2012CB944903, 2013CB967401]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51225101, 51431002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR054465, R21AR067935, R01AR062136] Funding Source: NIH RePORTER	We acknowledge Li Ka Shing Institute of Health Sciences (LiHS) for providing a harmonious working environment. This work was supported by Hong Kong RGC Collaborative Research Fund (2014/2015, C4028-14GF to L.Q.), General Research Fund (no. 14112714, 14114415 to L.Q.), NSFC/RGC (N_CUHK449/13 to L.Q.; 51361165101 to Y.Z.), Innovation and Technology Fund (no. ITS/350/13 to L.Q.), SMART Program to K.C., L.Q., H.C.C. and Y.C.R. (Lui Che Woo Institute of Innovative Medicine in Faculty of Medicine, the Chinese University of Hong Kong), National Basic Research Program of China (973 Program, no. 2012CB619102 to Y.Z., no.2012CB944903 to H.C.C. and Y.C.R. and no. 2013CB967401 to H.C.C.), National Natural Science Foundation of China (no. 51225101; no. 51431002 to Y.Z.). We thank B. Hesse for collecting and analyzing the mu XRF data. We thank G. Wu and J. Lu for help with scanning electron microscopy analysis.	Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BRENNER SL, 1980, J BIOL CHEM, V255, P841; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; Chaya A, 2015, J ORAL MAXIL SURG, V73, P295, DOI 10.1016/j.joms.2014.09.007; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Chokshi R, 2012, CHANNELS, V6, P362, DOI 10.4161/chan.21628; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Ding YX, 2010, BONE, V46, P1591, DOI 10.1016/j.bone.2010.02.022; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fu SC, 2012, OSTEOARTHR CARTILAGE, V20, P1409, DOI 10.1016/j.joca.2012.08.006; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018; Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015; Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li HF, 2013, ACTA BIOMATER, V9, P8561, DOI 10.1016/j.actbio.2013.01.029; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Li R, 2001, J BONE MINER RES, V16, P1505; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Madsen JE, 1998, CLIN ORTHOP RELAT R, P230; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald AC, 2003, BONE, V33, P788, DOI 10.1016/S8756-3282(03)00244-8; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Minardi S, 2015, BIOMATERIALS, V62, P128, DOI 10.1016/j.biomaterials.2015.05.011; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Qin L, 1999, ANAT RECORD, V255, P380; Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; Tang J, 2013, J ORTHOP TRANSL, V1, P41, DOI 10.1016/j.jot.2013.06.003; Tian G, 2013, ACTA PHARMACOL SIN, V34, P1467, DOI 10.1038/aps.2013.41; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Wang XY, 2009, SPINE, V34, P2363, DOI 10.1097/BRS.0b013e3181b04e52; Weizbauer A, 2016, J BIOMED MATER RES B, V104, P525, DOI 10.1002/jbm.b.33422; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6; Zhang ZH, 2010, BIOMED PHARMACOTHER, V64, P430, DOI 10.1016/j.biopha.2009.06.009; Zhao DW, 2016, BIOMATERIALS, V81, P84, DOI 10.1016/j.biomaterials.2015.11.038; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	58	271	282	51	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1160	1169		10.1038/nm.4162			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	WOS:000384872500019	27571347	Green Accepted	Y	N	2021-06-18	
J	Cooper, DJ; Myles, PS; McDermott, FT; Murray, LJ; Laidlaw, J; Cooper, G; Tremayne, AB; Bernard, SS; Ponsford, J				Cooper, DJ; Myles, PS; McDermott, FT; Murray, LJ; Laidlaw, J; Cooper, G; Tremayne, AB; Bernard, SS; Ponsford, J		HTS Study Investigators	Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Scientific Meeting of the Australian-and-New Zealand-Intensive-Care-Society	SEP   13, 2003	Cairns, AUSTRALIA	Australia & New Zealand Intens Care Soc			SEVERE HEAD-INJURY; CRITICALLY ILL PATIENTS; GLASGOW OUTCOME SCALE; STRUCTURED INTERVIEWS; FLUID RESUSCITATION; MULTICENTER TRIAL; REHABILITATION; RELIABILITY; DEXTRAN-70; DISABILITY	Context Prehospital hypertonic saline (HTS) resuscitation of patients with traumatic brain injury (TBI) may increase survival but whether HTS improves neurological outcomes is unknown. Objective To determine whether prehospital resuscitation with intravenous HTS improves long-term neurological outcome in patients with severe TBI compared with resuscitation with conventional fluids. Design, Setting, and Patients Double-blind, randomized controlled trial of 229 patients with TBI who were comatose (Glasgow Coma Scale score, <9) and hypotensive (systolic blood pressure, <100 mm Hg). The patients were enrolled between December 14, 1998, and April 9, 2002, in Melbourne, Australia. Interventions Patients were randomly assigned to receive a rapid intravenous infusion of either 250 mL of 7.5% saline (n = 114) or 250 mL of Ringer's lactate solution (n = 115; controls) in addition to conventional intravenous fluid and resuscitation protocols administered by paramedics. Treatment allocation was concealed. Main Outcome Measure Neurological function at 6 months, measured by the extended Glasgow Outcome Score (GOSE). Results Primary outcomes were obtained in 226 (99%) of 229 patients enrolled. Baseline characteristics of the groups were equivalent. At hospital admission, the mean serum sodium level was 149 mEq/L for HTS patients vs 141 mEq/L for controls (P<.001). The proportion of patients surviving to hospital discharge was similar in both groups (n =63 [55%] for HTS group and n =57 [50%] for controls; P=32); at 6 months, survival rates were n =62 (55%) in the HTS group and n =53 (47%) in the control group (P=.23). At 6 months, the median (interquartile range) GOSE was 5 (3-6) in the HTS group vs 5 (5-6) in the control group (P=.45). There was no significant difference between the groups in favorable outcomes (moderate disability and good outcome survivors [GOSE of 5-8]) (risk ratio, 0.99; 95% confidence interval, 0.76-1.30; P=.96) or in any other measure of postinjury neurological function. Conclusion In this study, patients with hypotension and severe TBI who received prehospital resuscitation with HTS had almost identical neurological function 6 months after injury as patients who received conventional fluid.	Monash Univ, Alfred Hosp, Dept Intens Care, Melbourne, Vic 3004, Australia; Monash Univ, Alfred Hosp, Dept Anaesthesia, Melbourne, Vic 3004, Australia; Monash Univ, Dept Psychol, Melbourne, Vic 3004, Australia; Metropolitan Ambulance Serv, Melbourne, Vic, Australia; Consulat Comm Rd Traff Fatil Victoria, Melbourne, Vic, Australia	Cooper, DJ (corresponding author), Monash Univ, Alfred Hosp, Dept Intens Care, Commercial Rd, Melbourne, Vic 3004, Australia.	j.cooper@alfred.org.au	Morley, Peter/G-5280-2017; Myles, Paul/AAU-9524-2020; Cooper, D. James/G-7961-2013	Morley, Peter/0000-0003-2653-090X; Myles, Paul/0000-0002-3324-5456; Cooper, D. James/0000-0002-5872-9051			*AM COLL SURG COMM, 2003, ADV TRAUM LIF SUPP P; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; *COMM AUSTR, 1999, NAT STAT ETH COND RE; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GABRIEL EJ, 2000, GUIDELINES PREHOSPIT, P7; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; JENNETT B, 1975, LANCET, V1, P480; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; SVENSEN CH, 2002, TRAUMA CARE J INT TR, P6; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; *US NIH, 1998, REH PERS TRAUM BRAIN; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; WADE CE, 1997, J TRAUMA, V42, P561; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	32	271	289	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2004	291	11					1350	1357		10.1001/jama.291.11.1350			8	Medicine, General & Internal	General & Internal Medicine	802PF	WOS:000220174700029	15026402	Bronze			2021-06-18	
J	Robertson, CS; Hannay, HJ; Yamal, JM; Gopinath, S; Goodman, JC; Tilley, BC				Robertson, Claudia S.; Hannay, H. Julia; Yamal, Jose-Miguel; Gopinath, Shankar; Goodman, J. Clay; Tilley, Barbara C.		Epo Severe TBI Trial Investigators	Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLASGOW OUTCOME SCALE; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; HEAD-INJURY; COMA SCALE; SURVIVAL; CARE; CLASSIFICATION; REQUIREMENTS; OXYGENATION	IMPORTANCE There is limited information about the effect of erythropoietin or a high hemoglobin transfusion threshold after a traumatic brain injury. OBJECTIVE To compare the effects of erythropoietin and 2 hemoglobin transfusion thresholds (7 and 10 g/dL) on neurological recovery after traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 200 patients (erythropoietin, n = 102; placebo, n = 98) with closed head injury who were unable to follow commands and were enrolled within 6 hours of injury at neurosurgical intensive care units in 2 US level I trauma centers between May 2006 and August 2012. The study used a factorial design to test whether erythropoietin would fail to improve favorable outcomes by 20% and whether a hemoglobin transfusion threshold of greater than 10 g/dL would increase favorable outcomes without increasing complications. Erythropoietin or placebo was initially dosed daily for 3 days and then weekly for 2 more weeks (n = 74) and then the 24- and 48-hour doses were stopped for the remainder of the patients (n = 126). There were 99 patients assigned to a hemoglobin transfusion threshold of 7 g/dL and 101 patients assigned to 10 g/dL. INTERVENTIONS Intravenous erythropoietin (500 IU/kg per dose) or saline. Transfusion threshold maintained with packed red blood cells. MAIN OUTCOMES AND MEASURES Glasgow Outcome Scale score dichotomized as favorable (good recovery and moderate disability) or unfavorable (severe disability, vegetative, or dead) at 6 months postinjury. RESULTS There was no interaction between erythropoietin and hemoglobin transfusion threshold. Compared with placebo (favorable outcome rate: 34/89 [38.2%; 95% CI, 28.1% to 49.1%]), both erythropoietin groups were futile (first dosing regimen: 17/35 [48.6%; 95% CI, 31.4% to 66.0%], P=.13; second dosing regimen: 17/57 [29.8%; 95% CI, 18.4% to 43.4%], P<.001). Favorable outcome rates were 37/87 (42.5%) for the hemoglobin transfusion threshold of 7 g/dL and 31/94 (33.0%) for 10 g/dL (95% CI for the difference, -0.06 to 0.25, P=.28). There was a higher incidence of thromboembolic events for the transfusion threshold of 10 g/dL (22/101 [21.8%] vs 8/99 [8.1%] for the threshold of 7 g/dL, odds ratio, 0.32 [95% CI, 0.12 to 0.79], P=.009). CONCLUSIONS AND RELEVANCE In patients with closed head injury, neither the administration of erythropoietin nor maintaining hemoglobin concentration of greater than 10 g/dL resulted in improved neurological outcome at 6 months. The transfusion threshold of 10 g/dL was associated with a higher incidence of adverse events. These findings do not support either approach in this setting.	[Robertson, Claudia S.; Gopinath, Shankar] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Yamal, Jose-Miguel; Tilley, Barbara C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, One Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu	Rivera-Lara, Lucia/AAX-8233-2020	Rivera-Lara, Lucia/0000-0002-9053-2283; Benoit, Julia/0000-0002-2734-5477; Hannay, H. Julia/0000-0001-7023-912X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by grant P01-NS38660 from the National Institute of Neurological Disorders and Stroke.	Abrishamkar S, 2012, J RES MED SCI, V17, P51; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; [Anonymous], 2008, J NEUROTRAUMA, V25, P276; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Rubin DB., 1987, MULTIPLE IMPUTATION; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tango HK, 2010, J TRAUMA, V68, P251; Tango HK, 2009, J TRAUMA, V66, P1748; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tilley BC, 2006, NEUROLOGY, V66, P628, DOI 10.1212/01.wnl.0000201251.33253.fb; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	36	270	273	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					36	47		10.1001/jama.2014.6490			12	Medicine, General & Internal	General & Internal Medicine	AK0UK	WOS:000338131100019	25058216	Green Accepted, Bronze	Y	N	2021-06-18	
J	Sheng, JG; Bora, SH; Xu, G; Borchelt, DR; Price, DL; Koliatsos, VE				Sheng, JG; Bora, SH; Xu, G; Borchelt, DR; Price, DL; Koliatsos, VE			Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice	NEUROBIOLOGY OF DISEASE			English	Article						Alzheimer's disease; transgenic mice; LPS; neuroinflammation; microglia; APP processing; intracellular A beta	FAMILIAL ALZHEIMERS-DISEASE; TRAUMATIC BRAIN INJURY; MESSENGER-RNA; PLAQUE-FORMATION; RAT-BRAIN; IN-VIVO; MUTANT PRESENILIN-1; UP-REGULATION; INTERLEUKIN-1; EXPRESSION	The present study was designed to examine whether brain inflammation caused by systemic administration of lipopolysaccharides (LPS) alters the expression/processing of amyloid precursor protein (APP) and increases the generation of amyloid beta peptide (Abeta). APPswe transgenic (Tg) mice were treated with either LPS or phosphate-buffered saline (PBS). In LPS-treated APPswe mice, Abeta1-40/42 was 3-fold and APP was 1.8-fold higher than those in PBS-treated mice (P < 0.05) by ELISA, Western blots and immunoprecipitation-mass spectrometry (IP-MS) ProteinChip analysis. Numbers of Abeta- and APP-immunoreactive neurons (Abeta(+) and APP(+) neurons) increased significantly in LPS-treated APPswe mice; APP(+) and Abeta(+) neurons in neocortex were associated with an increased number of F4/80-immunoreactive microglia (F4/80(+) microglia) in their anatomical environment. Our findings demonstrate that experimental neuroinflammation increases APP expression/processing and causes intracellular accumulation of Abeta. It remains to be seen whether such events can cause neuronal dysfunction/degeneration and, with time, lead to extracellular Abeta deposits, as they occur in Alzheimer's disease. (C) 2003 Elsevier Science (USA). All rights reserved.	Johns Hopkins Univ, Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol & Psychiat & Behav Sci, Baltimore, MD 21205 USA	Koliatsos, VE (corresponding author), Johns Hopkins Univ, Sch Med, Div Neuropathol, Dept Pathol, Ross Bldg,Room 558,720 Rutland Ave, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007435] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 05146] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS 07435] Funding Source: Medline		Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Benveniste Etty N., 1995, P700; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Broe GA, 2000, ARCH NEUROL-CHICAGO, V57, P1586, DOI 10.1001/archneur.57.11.1586; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUTTINI M, 1995, NEUROSCIENCE, V65, P523, DOI 10.1016/0306-4522(94)00525-A; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chui DH, 1999, NAT MED, V5, P560; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Giulian Dana, 1995, P671; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Kalehua AN, 2000, GERONTOLOGY, V46, P115, DOI 10.1159/000022146; Kim EJ, 2002, BRAIN RES, V941, P1, DOI 10.1016/S0006-8993(02)02480-0; MACKENZIE IRA, 1995, NEUROBIOL AGING, V16, P797, DOI 10.1016/0197-4580(95)00092-S; Minghetti L, 1999, J NEUROPATH EXP NEUR, V58, P1184, DOI 10.1097/00005072-199911000-00008; Octave JN, 2000, J BIOL CHEM, V275, P1525, DOI 10.1074/jbc.275.3.1525; Pierce JES, 1996, J NEUROSCI, V16, P1083; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Qiao XX, 2001, EUR J NEUROSCI, V14, P474, DOI 10.1046/j.0953-816x.2001.01666.x; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sheng JG, 2002, J NEUROSCI, V22, P9794; Sheng JG, 2001, NEUROCHEM INT, V39, P341, DOI 10.1016/S0197-0186(01)00041-9; Sheng JG, 1996, NEUROBIOL AGING, V17, P761; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2000, J CLIN NEUROSCI, V7, P140; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6	53	270	279	3	27	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	OCT	2003	14	1					133	145		10.1016/S0969-9961(03)00069-X			13	Neurosciences	Neurosciences & Neurology	723NP	WOS:000185438700014	13678674				2021-06-18	
J	SHERRIFF, FE; BRIDGES, LR; SIVALOGANATHAN, S				SHERRIFF, FE; BRIDGES, LR; SIVALOGANATHAN, S			EARLY DETECTION OF AXONAL INJURY AFTER HUMAN HEAD TRAUMA USING IMMUNOCYTOCHEMISTRY FOR BETA-AMYLOID PRECURSOR PROTEIN	ACTA NEUROPATHOLOGICA			English	Article						AMYLOID BETA-PROTEIN PRECURSOR; DIAGNOSTIC TESTS, ROUTINE; DIFFUSE AXONAL INJURY; HEAD INJURIES; IMMUNOCYTOCHEMISTRY	DAMAGE; IMMUNOREACTIVITY; ANTIBODIES; INJECTION; DISEASE; NEURONS; CELLS; APP	Severe non-missile head injury commonly results in a form of brain damage known as diffuse axonal injury (DAI). The histological diagnosis of DAI is made by silver staining for the presence of axonal retraction balls. This feature takes about 24 h to develop and does not allow for the early histological diagnosis of DAI. We have used immunocytochemistry for the beta-amyloid precursor protein (beta APP) as a marker for axonal injury in formalin-fixed, paraffin-embedded sections of human brain. Axonal beta APP immunoreativity was present in all cases which had survived for 3 h or more. This was true even where the degree of head injury did not appear to be severe, supporting the theory that DAI is a severe form of a more common phenomenon of axonal injury which occurs after cerebral trauma. beta APP immunoreactivity was also found in some non-head injured cases and so cannot be considered to be a specific marker for trauma. The results show that beta APP immunocytochemistry may be useful in the detection of traumatic axonal injury in its early stages, before the formation of axonal retraction balls, provided care is taken to exclude other causes of such immunoreactivity.		SHERRIFF, FE (corresponding author), UNIV LEEDS,DEPT CLIN MED,ACAD UNIT PATHOL,NEUROPATHOL LAB,LEEDS LS2 9JT,ENGLAND.						ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; COCHRAN E, 1991, AM J PATHOL, V139, P485; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; JOACHIM C, 1991, AM J PATHOL, V138, P373; KAWARABAYASHI T, 1993, NEUROSCI LETT, V153, P73, DOI 10.1016/0304-3940(93)90080-5; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; OHGAMI T, 1992, NEUROSCI LETT, V136, P75, DOI 10.1016/0304-3940(92)90651-M; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SHIGEMATSU K, 1992, J NEUROSCI RES, V31, P443, DOI 10.1002/jnr.490310306; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	23	270	282	1	5	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	JAN	1994	87	1					55	62					8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	MP030	WOS:A1994MP03000007	8140894				2021-06-18	
J	Baugh, CM; Stamm, JM; Riley, DO; Gavett, BE; Shenton, ME; Lin, A; Nowinski, CJ; Cantu, RC; McKee, AC; Stern, RA				Baugh, Christine M.; Stamm, Julie M.; Riley, David O.; Gavett, Brandon E.; Shenton, Martha E.; Lin, Alexander; Nowinski, Christopher J.; Cantu, Robert C.; McKee, Ann C.; Stern, Robert A.			Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma	BRAIN IMAGING AND BEHAVIOR			English	Article						Chronic traumatic encephalopathy; Traumatic brain injury; Dementia; Concussion; Tauopathy; Dementia pugilistica	ALZHEIMERS ASSOCIATION WORKGROUPS; MAGNETIC-RESONANCE SPECTROSCOPY; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PREDICTIVE-VALUE; AXONAL INJURY; PUNCH-DRUNK; DISEASE	Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disease thought to be caused, at least in part, by repetitive brain trauma, including concussive and subconcussive injuries. It is thought to result in executive dysfunction, memory impairment, depression and suicidality, apathy, poor impulse control, and eventually dementia. Beyond repetitive brain trauma, the risk factors for CTE remain unknown. CTE is neuropathologically characterized by aggregation and accumulation of hyperphosphorylated tau and TDP-43. Recent postmortem findings indicate that CTE may affect a broader population than was initially conceptualized, particularly contact sport athletes and those with a history of military combat. Given the large population that could potentially be affected, CTE may represent an important issue in public health. Although there has been greater public awareness brought to the condition in recent years, there are still many research questions that remain. Thus far, CTE can only be diagnosed post-mortem. Current research efforts are focused on the creation of clinical diagnostic criteria, finding objective biomarkers for CTE, and understanding the additional risk factors and underlying mechanism that causes the disease. This review examines research to date and suggests future directions worthy of exploration.	[Baugh, Christine M.; Stamm, Julie M.; Riley, David O.; Nowinski, Christopher J.; Cantu, Robert C.; McKee, Ann C.; Stern, Robert A.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Gavett, Brandon E.] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA; [Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat,Sch Med, Boston, MA 02115 USA; [Lin, Alexander] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Clin Spect, Boston, MA 02115 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Sports Legacy Inst, Waltham, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Neurosurg Serv, Dept Surg & Sports Med, Concord, MA USA; [McKee, Ann C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA	Stern, RA (corresponding author), Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, 72 E Concord St,Suite B-7380, Boston, MA 02118 USA.	bobstern@bu.edu	Baugh, Christine/AAG-2324-2020; , Bob/ABA-8507-2020; Shenton, Martha/V-8780-2019	Baugh, Christine/0000-0002-9340-6338; Stern, Robert/0000-0002-5008-077X; Gavett, Brandon/0000-0003-1938-1854	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, R01 NS078337]; National Operating Committee on Standards for Athletic Equipment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (P30 AG13846; R01 NS078337), as well as a grant from the National Operating Committee on Standards for Athletic Equipment, and an unrestricted gift from the National Football League.	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hill JM, 2007, EXP EYE RES, V84, P801, DOI 10.1016/j.exer.2006.08.001; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katzman R, 1996, NEUROLOGY, V46, P889; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lin A., 2010, NEUROCHEMICAL CHANGE; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MANN DMA, 1990, NEUROPATH APPL NEURO, V16, P17, DOI 10.1111/j.1365-2990.1990.tb00928.x; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masterman DL, 1997, J GERIATR PSYCH NEUR, V10, P15, DOI 10.1177/089198879701000104; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stern RA, 2011, WILEY-BL HB BEHAV SC, P369; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stern Y, 2007, COGNITIVE RESERVE TH; Talavage T. M., 2010, J NEUROTRAUMA; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tubbs RS, 2011, CHILD NERV SYST, V27, P1927, DOI 10.1007/s00381-011-1457-2; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	66	269	273	4	132	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2012	6	2			SI		244	254		10.1007/s11682-012-9164-5			11	Neuroimaging	Neurosciences & Neurology	967LI	WOS:000305908900007	22552850				2021-06-18	
J	Sharp, DJ; Beckmann, CF; Greenwood, R; Kinnunen, KM; Bonnelle, V; De Boissezon, X; Powell, JH; Counsell, SJ; Patel, MC; Leech, R				Sharp, David J.; Beckmann, Christian F.; Greenwood, Richard; Kinnunen, Kirsi M.; Bonnelle, Valerie; De Boissezon, Xavier; Powell, Jane H.; Counsell, Serena J.; Patel, Maneesh C.; Leech, Robert			Default mode network functional and structural connectivity after traumatic brain injury	BRAIN			English	Article						traumatic axonal injury; attention; brain injury; functional MRI; diffusion tensor imaging	AXONAL INJURY; HEAD-INJURY; STATE; NEUROPATHOLOGY; ARCHITECTURE; ACTIVATION; RECOVERY; ANATOMY; DISEASE; CORTEX	Traumatic brain injury often results in cognitive impairments that limit recovery. The underlying pathophysiology of these impairments is uncertain, which restricts clinical assessment and management. Here, we use magnetic resonance imaging to test the hypotheses that: (i) traumatic brain injury results in abnormalities of functional connectivity within key cognitive networks; (ii) these changes are correlated with cognitive performance; and (iii) functional connectivity within these networks is influenced by underlying changes in structural connectivity produced by diffuse axonal injury. We studied 20 patients in the chronic phase after traumatic brain injury compared with age-matched controls. Network function was investigated in detail using functional magnetic resonance imaging to analyse both regional brain activation, and the interaction of brain regions within a network (functional connectivity). We studied patients during performance of a simple choice-reaction task and at 'rest'. Since functional connectivity reflects underlying structural connectivity, diffusion tensor imaging was used to quantify axonal injury, and test whether structural damage correlated with functional change. The patient group showed typical impairments in information processing and attention, when compared with age-matched controls. Patients were able to perform the task accurately, but showed slow and variable responses. Brain regions activated by the task were similar between the groups, but patients showed greater deactivation within the default mode network, in keeping with an increased cognitive load. A multivariate analysis of 'resting' state functional magnetic resonance imaging was then used to investigate whether changes in network function were present in the absence of explicit task performance. Overall, default mode network functional connectivity was increased in the patient group. Patients with the highest functional connectivity had the least cognitive impairment. In addition, functional connectivity at rest also predicted patterns of brain activation during later performance of the task. As expected, patients showed widespread white matter damage compared with controls. Lower default mode network functional connectivity was seen in those patients with more evidence of diffuse axonal injury within the adjacent corpus callosum. Taken together, our results demonstrate altered patterns of functional connectivity in cognitive networks following injury. The results support a direct relationship between white matter organization within the brain's structural core, functional connectivity within the default mode network and cognitive function following brain injury. They can be explained by two related changes: a compensatory increase in functional connectivity within the default mode network; and a variable degree of structural disconnection that modulates this change in network function.	[Sharp, David J.; Beckmann, Christian F.; Bonnelle, Valerie; Leech, Robert] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Expt Med, London W12 0NN, England; [Greenwood, Richard] UCL, Inst Neurol, London WC1N 3BG, England; [Kinnunen, Kirsi M.; Powell, Jane H.] Univ London, Dept Psychol, London SE14 6NW, England; [Bonnelle, Valerie; Counsell, Serena J.] Univ London Imperial Coll Sci Technol & Med, Cognit Neuroimaging Grp, MRC Clin Sci Ctr, London W12 0NN, England; [De Boissezon, Xavier] INSERM Imagerie Cerebrale & Handicaps Neurol UMR, F-31059 Toulouse, France; [De Boissezon, Xavier] Univ Toulouse, UPS, Imagerie Cerebrale & Handicaps Neurol UMR 825, CHU Purpan, F-31059 Toulouse, France; [De Boissezon, Xavier] CHU Purpan, Ctr Hosp Univ Toulouse, F-31059 Toulouse 9, France; [Patel, Maneesh C.] Imperial Coll Healthcare NHS Trust, Dept Imaging, Charing Cross Hosp, London, England	Sharp, DJ (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	david.sharp@imperial.ac.uk	Beckmann, Christian F./E-6374-2012; counsell, serena j/I-9012-2014; Kinnunen, Kirsi/P-6402-2019; Leech, Robert/AAE-8254-2019; Sharp, David J/A-2119-2013	Beckmann, Christian F./0000-0002-3373-3193; Leech, Robert/0000-0002-5801-6318; Kinnunen, Kirsi M./0000-0002-8562-2866; Counsell, Serena/0000-0002-8033-5673	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial College Healthcare Charity; Goldsmiths, University of London; Research Councils United Kingdom; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U120097117, G0701951] Funding Source: researchfish	This work was supported by The Medical Research Council (UK) (to D.J.S); The Imperial College Healthcare Charity (to D.J.S.); a doctoral studentship from Goldsmiths, University of London (to K. M. K.); and a fellowship from the Research Councils United Kingdom (to R. L.).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P227, DOI 10.1016/S0887-6177(00)00081-0; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; BONNELLE V, J NEUROSCI IN PRESS; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; DOCKREE PM, INT J PSYCHOPHYSIOL; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; GILBERT SJ, 2007, SCIENCE, P317; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MAYER AR, HUM BRAIN M IN PRESS; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2010, ANN NEUROL, V68, P753, DOI 10.1002/ana.21866; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZUO XN, 2009, NEUROIMAGE, V49	68	269	270	0	38	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG	2011	134		8				2233	2247		10.1093/brain/awr175			15	Clinical Neurology; Neurosciences	Neurosciences & Neurology	809OX	WOS:000294067700011	21841202	Bronze			2021-06-18	
J	Lieberman, SA; Oberoi, AL; Gilkison, CR; Masel, BE; Urban, RJ				Lieberman, SA; Oberoi, AL; Gilkison, CR; Masel, BE; Urban, RJ			Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GROWTH-HORMONE DEFICIENCY; GH DEFICIENCY; HEAD-INJURY; ADULTS; REPLACEMENT; SECRETION; HYPOPITUITARISM; ADIPOSITY	Although hypopituitarism is a known complication of head injury, it may be underrecognized due to its subtle clinical manifestations. The nonspecific symptoms may be masked by and may contribute to the physical and psychological sequelae of brain trauma. This study examines the prevalence of neuroendocrine abnormalities in patients rehabilitating from traumatic brain injury. Seventy adults (mean age, 31.5 +/- 1.1 yr; range, 18-58; 46 men and 24 women) with traumatic brain injury an average of 49 +/- 8 months before the study (median, 13 months) underwent a series of standard endocrine tests, including serum levels of TSH, free T(4), insulin-like growth factor I, PRL, testosterone (males), and cosyntropin stimulation. Abnormal results of these tests were followed by dynamic tests of gonadotropin, TSH, and GH secretion. Glucagon stimulation testing in 48 subjects revealed GH deficiency (peak, <3 <mu>g/L) in 14.6%. Free T(4) (n = 6; 8.6%), TSH (n = 7; 10%), or both (n = 2; 2.9%) were low in 21.7%, whereas 87% had both TSH and free T(4) below the midnormal level. Basal morning cortisol was below normal in 45.7% of subjects, whereas cosyntropin-stimulated levels were insufficient (peak, <500 nmol/L) in 7.1%. Hypogonadism and hyperprolactinemia were uncommon. In summary, pituitary hormone deficiencies were identified in a substantial proportion of patients with previous brain injury. GH deficiency, found in 15% by glucagon stimulation testing, may compound the physical and psychological complications of traumatic brain injury and interfere with rehabilitation.	Univ Texas, Med Branch, Transit Learning Community, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA	Lieberman, SA (corresponding author), 301 Univ Blvd,MRB 8-138, Galveston, TX 77555 USA.	steven.lieberman@utmb.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000073] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR-00073] Funding Source: Medline		*AG HLTH CAR POL R, 1998, REH TRAUM BRAIN INJ; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Baum HBA, 1996, J CLIN ENDOCR METAB, V81, P84, DOI 10.1210/jc.81.1.84; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P73, DOI 10.1111/j.1365-2265.1995.tb02601.x; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; EAMES P, 1995, BRAIN INJURY, V9, P729, DOI 10.3109/02699059509008228; EDWARDS OM, 1986, MEDICINE, V65, P281; Goetz CG., 1999, TXB CLIN NEUROLOGY; GOLDBERG E, 1982, ARCH NEUROL-CHICAGO, V39, P581, DOI 10.1001/archneur.1982.00510210051012; HO KKY, 1995, METABOLISM, V44, P91, DOI 10.1016/0026-0495(95)90227-9; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Jorgensen JOL, 1997, HORM RES, V48, P101, DOI 10.1159/000191337; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Lieberman SA, 1996, J PEDIATR-US, V128, pS58, DOI 10.1016/S0022-3476(96)70013-6; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MULLER EE, 1987, PHYSIOL REV, V67, P962; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; WEEKE J, 1974, SCAND J CLIN LAB INV, V33, P101, DOI 10.3109/00365517409082475	27	269	282	0	6	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0021-972X			J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2001	86	6					2752	2756		10.1210/jc.86.6.2752			5	Endocrinology & Metabolism	Endocrinology & Metabolism	444QX	WOS:000169412000063	11397882				2021-06-18	
J	Tombaugh, TN				Tombaugh, TN			The test of memory malingering (TOMM): Normative data from cognitively intact and cognitively impaired individuals	PSYCHOLOGICAL ASSESSMENT			English	Article							MILD HEAD-INJURY; FORCED-CHOICE METHOD; RECOGNITION MEMORY; ORGANIC AMNESIA; PICTORIAL; HISCOCK; STIMULI	Four experiments were undertaken to validate the Test of Memory Malingering (TOMM). In the first 3 experiments, the TOMM was administered to 475 community-dwelling individuals and 161 neurologically impaired patients (traumatic brain injury, aphasia, cognitive impairment, and dementia). Both clinical participants and community-dwelling adults achieved exceptionally high scores. A criterion score of 45 (90% correct) on the 2nd trial correctly classified 95% of all non-demented patients (91% of all patients) as not malingering. In a 4th experiment, the criterion score readily distinguished individuals who deliberately faked memory impairments from those who did not. The results from all 4 experiments show that the TOMM is relatively insensitive to genuine memory impairment and holds considerable promise for detecting exaggerated or deliberately faked memory impairment in clinical situations.		Tombaugh, TN (corresponding author), CARLETON UNIV, DEPT PSYCHOL, 1125 COLONEL BY DR, OTTAWA, ON K1S 5B6, CANADA.						American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BRADY JP, 1961, ARCH GEN PSYCHIAT, V4, P331; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; Brink TL., 1982, CLIN GERONTOLOGIST, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Delis DC, 1987, CALIFORNIA VERBAL LE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; FREED DM, 1989, NEUROPSYCHOLOGIA, V27, P325, DOI 10.1016/0028-3932(89)90022-5; GANSLER D, 1995, ANN M NAT AC NEUR SA; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GROSZ H, 1965, ARCH GEN PSYCHIAT, V13, P225; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HART RP, 1993, J CLIN EXP NEUROPSYC, V15, P245, DOI 10.1080/01688639308402561; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; HUBLEY AM, 1995, THESIS CARLETON U OT; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; KOPELMAN ND, 1985, NEUROPSYCHOLOGIA, V23, P62; MARTIN RC, 1992, FORENSIC REPORTS, V5, P393; MARTONE M, 1986, J CLIN EXP NEUROPSYC, V8, P161, DOI 10.1080/01688638608401309; MCINTYRE N, 1997, THESIS CARLETON U OT; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; NICKERSON RS, 1965, CAN J PSYCHOLOGY, V19, P155, DOI 10.1037/h0082899; NICKERSON RS, 1968, PSYCHON SCI, V11, P58, DOI 10.3758/BF03330991; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Park DC, 1986, PSYCHOL AGING, V1, P11, DOI 10.1037/0882-7974.1.1.11; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; REES LM, 1996, THESIS CARLETON U OT; Schmidt J. P., 1995, LEARNING MEMORY BATT; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; STANDING L, 1970, PSYCHON SCI, V19, P73, DOI 10.3758/BF03337426; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; WINOGRAD E, 1982, J GERONTOL, V37, P70, DOI 10.1093/geronj/37.1.70	49	269	270	0	28	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	1997	9	3					260	268		10.1037/1040-3590.9.3.260			9	Psychology, Clinical	Psychology	XV782	WOS:A1997XV78200011					2021-06-18	
J	Sullivan, PG; Thompson, MB; Scheff, SW				Sullivan, PG; Thompson, MB; Scheff, SW			Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						trauma; mitochondrial dysfunction; cortial contusion	CENTRAL-NERVOUS-SYSTEM; PERMEABILITY TRANSITION PORE; TRANSIENT FOREBRAIN ISCHEMIA; RAT HIPPOCAMPAL-NEURONS; EXCITATORY AMINO-ACIDS; CELL-DEATH; CORTICAL CONTUSION; LIPID-PEROXIDATION; REACTIVE OXYGEN; RECEPTOR ACTIVATION	Experimental traumatic brain injury (TBI) results in a rapid and significant necrosis of cortical tissue at the site of injury. In the ensuring hours and days, secondary injury exacerbates the primary damage, resulting in significant neurological dysfunction. Recent reports from our lab and others have demonstrated that the immunosuppressant cyclosporin A (CsA) is neuroprotective following TBI. The opening of the mitochondrial permeability transition pore (MPTP) is inhibited by CsA, thereby maintaining the mitochondrial membrane potential and calcium homeostasis in isolated mitochondrial. In the present study we utilized a unilateral controlled cortical impact model of TBI to assess mitochondrial dysfunction in both isolated mitochondria and synaptosomes to elucidate the neuroprotective role of CsA. The results demonstrate that administration of CsA 15 min postinjury significantly attenuates mitochondrial dysfunction as measured using several biochemical; assays of mitochondria integrity and energetics Following TBI, mitochondria isolated from the injured cortex of animals treated with CsA demonstrate a significant increase in mitochondria membrane potential and are resistant to the induction of mitochondrial permeability transition compared to vehicle-treated animals. Similarly, synaptosomes isolated from CsA-treated animals demonstrate a significant increase in mitochondria membrane potential, accompanied by lower levels of intramitochondrial Ca2+ and reactive oxygen species production than seen in vehicle-treated animals. These results suggest that, the neuroprotective properties of CsA are mediated through modulation of the MPTP and maintenance of mitochondria homeostasis, Amelioration of cortical damage with CsA indicates that pharmacological therapies can be devised which will significantly alter neurological outcome after injury. (C) 1999 Academic Press.	Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Sullivan, PG (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS31220] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220] Funding Source: NIH RePORTER		ALBERS GW, 1992, ARCH NEUROL-CHICAGO, V49, P418, DOI 10.1001/archneur.1992.00530280112031; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Baldwin SA, 1996, GLIA, V16, P266; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Braughler J M, 1985, Cent Nerv Syst Trauma, V2, P269; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brookes PS, 1998, J NEUROCHEM, V70, P2195; Bruce-Keller AJ, 1999, J NEUROIMMUNOL, V93, P53, DOI 10.1016/S0165-5728(98)00190-8; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Camins A, 1997, BRAIN RES, V777, P69, DOI 10.1016/S0006-8993(97)00947-5; Choi D W, 1990, Adv Exp Med Biol, V268, P501; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dawson TM, 1996, ANN NEUROL, V40, P559, DOI 10.1002/ana.410400403; DAWSON VL, 1993, J NEUROSCI, V13, P2651; Dessi F, 1995, NEUROSCI LETT, V201, P53, DOI 10.1016/0304-3940(95)12128-Q; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DUX E, 1987, NEUROSCI LETT, V78, P295, DOI 10.1016/0304-3940(87)90376-4; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Friberg H, 1998, J NEUROSCI, V18, P5151; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313; Isaev NK, 1996, FEBS LETT, V392, P143, DOI 10.1016/0014-5793(96)00804-6; ISAEV NK, 1995, B EXP BIOL MED+, V119, P365, DOI 10.1007/BF02445894; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KRAUS JF, 1996, NEUROTRAUMA, P12; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PAAKKARI I, 1995, ANN MED, V27, P369, DOI 10.3109/07853899509002590; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Prehn JHM, 1998, N-S ARCH PHARMACOL, V357, P316, DOI 10.1007/PL00005173; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Richter C, 1997, BIOSCIENCE REP, V17, P53, DOI 10.1023/A:1027387301845; Scanlon JM, 1998, J NEUROCHEM, V71, P2392; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIMS NR, 1987, J NEUROCHEM, V49, P1367, DOI 10.1111/j.1471-4159.1987.tb01001.x; Sriram K, 1998, J NEUROSCI, V18, P10287; Stout AK, 1998, NAT NEUROSCI, V1, P366; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sureda FX, 1996, N-S ARCH PHARMACOL, V354, P420, DOI 10.1007/BF00168431; SZABO I, 1991, J BIOL CHEM, V266, P3376; TAPPEL AL, 1973, FED PROC, V32, P1870; THAYER SA, 1995, CLIN EXP PHARMACOL P, V22, P303, DOI 10.1111/j.1440-1681.1995.tb02004.x; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; White RJ, 1996, J NEUROSCI, V16, P5688; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZAIDAN E, 1994, J NEUROCHEM, V63, P1812	82	268	274	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	1999	160	1					226	234		10.1006/exnr.1999.7197			9	Neurosciences	Neurosciences & Neurology	257QE	WOS:000083792400022	10630207				2021-06-18	
J	Jennett, B				Jennett, B			Epidemiology of head injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN INJURY; SAN-DIEGO-COUNTY; NEW-SOUTH-WALES; EMERGENCY DEPARTMENTS; DEFINED POPULATION; UNITED-STATES; MORTALITY; JOHANNESBURG; CALIFORNIA; FEATURES			Jennett, B (corresponding author), UNIV GLASGOW,INST NEUROL SCI,GLASGOW G61 1BD,LANARK,SCOTLAND.						ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 1977, Lancet, V2, P696; BAKER SP, 1994, AM J PUBLIC HEALTH, V84, P649, DOI 10.2105/AJPH.84.4.649; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; BRYDEN J, 1989, MODELS BRAIN INJURY; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; EDNA TH, 1985, SCAND J SOC MED, V13, P23, DOI 10.1177/140349488501300103; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FINGERHUT LA, 1989, ADV DATA VITAL HLTH, V178; FOULKES MA, 1991, J NEUROSURG, V75, pS1, DOI 10.3171/sup.1991.75.1s.00s1; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GALBRAITH S, 1976, BRIT J SURG, V63, P138; HADDON W, 1961, J CHRON DIS, V14, P655, DOI 10.1016/0021-9681(61)90122-9; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1980, CLIN RADIOL, V31, P463, DOI 10.1016/S0009-9260(80)80195-4; JENNETT B, 1979, BRIT MED J, V2, P955, DOI 10.1136/bmj.2.6196.955; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jennett B, 1990, HDB CLIN NEUROLOGY, V13; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; KRAUS JF, 1993, HEAD INJURY; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; LYLE DM, 1990, COMMUNITY HEALTH ST, V14, P118; MacKenzie E J, 1989, Md Med J, V38, P725; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; ROCKETT IRH, 1987, AM J PUBLIC HEALTH, V77, P1345, DOI 10.2105/AJPH.77.10.1345; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SELECKI PR, 1981, INJURIES HEAD SPINE; SIMPSON D, 1981, MED J AUSTRALIA, V2, P660, DOI 10.5694/j.1326-5377.1981.tb113043.x; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; STRANG I, 1978, INJURY, V10, P154; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; 1988, WORLD ROAD STATISTIC; 1987, 1985 DEMOGRAPHIC YB; 1987, MORTALITY STATIS DH4; 1980, INT CLASSIFICATION D; 1984, BRIT MED J, V288, P983; 1995, CASUALTY REPORT; 1995, TRANSPORT STATISTICS; 1987, SCOTTISH HOSPITAL IN; 1985, ABBREVIATED INJURY S; 1975, MANUAL INT STATISTIC	63	268	273	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1996	60	4					362	369		10.1136/jnnp.60.4.362			8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	UD872	WOS:A1996UD87200002	8774396	Green Published, Bronze			2021-06-18	
J	HICKS, RR; SMITH, DH; LOWENSTEIN, DH; MARIE, RS; MCINTOSH, TK				HICKS, RR; SMITH, DH; LOWENSTEIN, DH; MARIE, RS; MCINTOSH, TK			MILD EXPERIMENTAL BRAIN INJURY IN THE RAT INDUCES COGNITIVE DEFICITS ASSOCIATED WITH REGIONAL NEURONAL LOSS IN THE HIPPOCAMPUS	JOURNAL OF NEUROTRAUMA			English	Article							ENDURING MEMORY IMPAIRMENT; FLUID-PERCUSSION MODEL; CEREBRAL BLOOD-FLOW; SELECTIVE VULNERABILITY; HEAD-INJURY; HORSERADISH-PEROXIDASE; PROTEIN EXTRAVASATION; HILAR NEURONS; GRANULE CELLS; DAMAGE	Memory dysfunction following mild human traumatic brain injury (TBI) is a common clinical observation, but the pathologic substrate underlying this loss of function has not been well-characterized. In the present study, we examined the effects of a mild lateral fluid percussion (FP) brain injury on memory dysfunction, neuronal cell loss in specific regions of the hippocampus, and breakdown of the blood-brain barrier (BBB). A Morris Water Maze (MWM) memory paradigm was used to assess memory retention in rats 42 h after lateral FP brain injury (n = 11) or sham injury (n = 10). At the completion of cognitive testing, animals were sacrificed and neuronal cell loss in the hippocampi was examined with Nissl staining. Immunoreactivity to anti-rat IgG was used to evaluate the extent of BBB disruption. A significant correlation was observed between posttraumatic memory scores and neuronal loss in the hilus of the dentate gyrus (p < 0.005). To our knowledge, these observations are the first to suggest an association between cognitive deficits following a mild experimental brain injury and neuropathological changes in the hippocampus.	UNIV PENN,DEPT NEUROSURG,PHILADELPHIA,PA 19104; UNIV CONNECTICUT,CTR HLTH,DEPT ANAT,FARMINGTON,CT; UNIV CONNECTICUT,CTR HLTH,DEPT SURG,FARMINGTON,CT; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,EPILEPSY RES CTR,SAN FRANCISCO,CA; HOUSE EAR RES INST,LOS ANGELES,CA			smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, R55NS026818, K08NS001424] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS01424, NS26818] Funding Source: Medline		ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; BAYER SA, 1985, RAT NERVOUS SYSTEM, V1, P335; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Brown W.J., 1987, EPILEPSY, P300; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVIS HP, 1990, BIOL MEMORY, P477; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Graham D.I., 1992, GREENFIELDS NEUROPAT, P153; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P57; JASPERS RMA, 1990, NEUROSCI LETT, V117, P149, DOI 10.1016/0304-3940(90)90135-V; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KRUS JF, 1988, J TRAUMA, V28, P1637; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NG T, 1989, ACTA NEUROPATHOL, V78, P438, DOI 10.1007/BF00688181; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; RIMAL RW, 1981, NEUROSURGERY, V9, P221; SARA SJ, 1981, BEHAV NEURAL BIOL, V32, P504, DOI 10.1016/S0163-1047(81)90930-4; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SCHMIDTKASTNER R, 1990, NEUROSCIENCE, V38, P527, DOI 10.1016/0306-4522(90)90048-9; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMOLEN AJ, 1990, QUANTITATIVE QUALITA, P208; SOARES H, 1991, SOC NEUR ABST; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SORIANO E, 1989, BRAIN RES, V503, P170, DOI 10.1016/0006-8993(89)91722-8; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SYMONDS CP, 1960, INJURIES BRAIN SPINA, P381; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; ZOLAMORGAN S, 1992, J NEUROSCI, V12, P2582; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	52	268	273	1	13	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	WIN	1993	10	4					405	414		10.1089/neu.1993.10.405			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	MQ818	WOS:A1993MQ81800005	8145264				2021-06-18	
J	WILBERGER, JE; HARRIS, M; DIAMOND, DL				WILBERGER, JE; HARRIS, M; DIAMOND, DL			ACUTE SUBDURAL-HEMATOMA - MORBIDITY, MORTALITY, AND OPERATIVE TIMING	JOURNAL OF NEUROSURGERY			English	Article						SUBDURAL HEMATOMA; TIMING OF SURGERY; INTRACRANIAL PRESSURE	SEVERE HEAD-INJURY; PROGNOSTIC FEATURES; CLASSIFICATION; SCALE	Traumatic acute subdural hematoma remains one of the most lethal of all head injuries. Since 1981, it has been strongly held that the critical factor in overall outcome from acute subdural hematoma is timing of operative intervention for clot removal; those operated on within 4 hours of injury may have mortality rates as low as 30% with functional survival rates as high as 65%. Data were reviewed for 1150 severely head-injured patients (Glasgow Coma Scale (GCS) scores 3 to 7) treated at a Level 1 trauma center between 1982 and 1987; 101 of these patients had acute subdural hematoma. Standard treatment protocol included aggressive prehospital resuscitation measures, rapid operative intervention, and aggressive postoperative control of intracranial pressure (ICP). The overall mortality rate was 66%, and 19% had functional recovery. The following variables statistically correlated (p < 0.05) with outcome: motorcycle accident as a mechanism of injury, age over 65 years, admission GCS score of 3 or 4, and postoperative ICP greater than 45 mm Hg. The time from injury to operative evacuation of the acute subdural hematoma in regard to outcome morbidity and mortality was not statistically significant even when examined at hourly intervals although there were trends indicating that earlier surgery improved outcome. The findings of this study support the pathophysiological evidence that, in acute subdural hematoma, the extent of primary underlying brain injury is more important than the subdural clot itself in dictating outcome; therefore, the ability to control ICP is more critical to outcome than the absolute timing of subdural blood removal.	ALLEGHENY GEN HOSP,DEPT TRAUMA SURG,PITTSBURGH,PA 15212; EMORY UNIV,SCH MED,DEPT NEUROSURG,ATLANTA,GA 30322	WILBERGER, JE (corresponding author), ALLEGHENY GEN HOSP,DEPT NEUROSURG,320 E N AVE,PITTSBURGH,PA 15212, USA.						BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Browder Jefferson, 1943, BULL NEW YORK ACAD MED, V19, P168; CHAMBERS JW, 1951, J NEUROSURG, V8, P263, DOI 10.3171/jns.1951.8.3.0263; Cooper P R, 1976, Surg Neurol, V5, P25; ECHLIN F, 1949, J NEUROSURG, V6, P294, DOI 10.3171/jns.1949.6.4.0294; ECHLIN FA, 1948, JAMA-J AM MED ASSOC, V161, P1345; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Gardner JW, 1932, ARCH NEUROL PSYCHIAT, V1932, P847; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HOOPER R, 1976, HDB CLIN NEUROLOGY 2, V24, P637; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; MCKISSOCK W, 1960, LANCET, V1, P1365; MCLAURIN RL, 1961, J NEUROSURG, V18, P61, DOI 10.3171/jns.1961.18.1.0061; Munro D, 1942, NEW ENGL J MED, V227, P87, DOI 10.1056/NEJM194207162270301; Munro D., 1934, NEW ENGL J MED, V210, P1145; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; ROSENBLUTH PR, 1962, JAMA-J AM MED ASSOC, V179, P759, DOI 10.1001/jama.1962.03050100013003; SCHISANO G, 1964, Acta Chir Scand, V128, P471; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SEELIG JM, 1981, J NEUROSURG, V55, P516, DOI 10.3171/jns.1981.55.4.0516; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; TALALLA A, 1971, J TRAUM, V11, P771, DOI 10.1097/00005373-197109000-00008; TEASDALE G, 1974, LANCET, V2, P81; Voris HC, 1941, SURGERY, V10, P447; WINTZEN AR, 1980, BRAIN, V103, P855, DOI 10.1093/brain/103.4.855; YUE CP, 1983, INJURY, V14, P489, DOI 10.1016/0020-1383(83)90051-7	35	268	273	1	11	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1991	74	2					212	218		10.3171/jns.1991.74.2.0212			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EU622	WOS:A1991EU62200008	1988590				2021-06-18	
J	Henderson, ST; Vogel, JL; Barr, LJ; Garvin, F; Jones, JJ; Costantini, LC				Henderson, Samuel T.; Vogel, Janet L.; Barr, Linda J.; Garvin, Fiona; Jones, Julie J.; Costantini, Lauren C.			Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial	NUTRITION & METABOLISM			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; APOLIPOPROTEIN-E GENOTYPE; FUNCTION IMPROVING AGENT; TRAUMATIC BRAIN-INJURY; LOW-CARBOHYDRATE DIET; BETA-HYDROXYBUTYRATE; KETONE-BODIES; BODY-COMPOSITION; ENERGY-EXPENDITURE; INSULIN-RESISTANCE	Background: Alzheimer's disease (AD) is characterized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, AC-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance. Methods: Daily administration of AC-1202 was evaluated in 152 subjects diagnosed with mild to moderate AD in a US-based, 90-day, randomized, double-blind, placebo-controlled, parallel-group study. Subjects were on a normal diet and continued taking approved AD medications. Primary cognitive end points were mean change from Baseline in the AD Assessment Scale-Cognitive subscale (ADAS-Cog), and global scores in the AD Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC). AC-1202 was compared to Placebo in several population groups, including: intention-to-treat (ITT), per protocol, and dosage compliant groups. Results were also stratified by APOE4 carriage status (a predefined analysis based on the epsilon 4 (E4) variant of the apolipoprotein E gene). This trial was registered with ClinicalTrials.gov, registry number NCT00142805, information available at http://clinicaltrials.gov/ct2/show/NCT00142805 Results: AC-1202 significantly elevated a serum ketone body (beta-hydroxybutyrate) 2 hours after administration when compared to Placebo. In each of the population groups, a significant difference was found between AC-1202 and Placebo in mean change from Baseline in ADAS-Cog score on Day 45: 1.9 point difference, p = 0.0235 in ITT; 2.53 point difference, p = 0.0324 in per protocol; 2.6 point difference, p = 0.0215 in dosage compliant. Among participants who did not carry the APOE4 allele (E4(-)), a significant difference was found between AC-1202 and Placebo in mean change from Baseline in ADAS-Cog score on Day 45 and Day 90. In the ITT population, E4(-) participants (N = 55) administered AC-1202 had a significant 4.77 point difference in mean change from Baseline in ADAS-Cog scores at Day 45 (p = 0.0005) and a 3.36 point difference at Day 90 (p = 0.0148) compared to Placebo. In the per protocol population, E4(-) participants receiving AC-1202 (N = 37) differed from placebo by 5.73 points at Day 45 (p = 0.0027) and by 4.39 points at Day 90 (p = 0.0143). In the dosage compliant population, E4(-) participants receiving AC-1202 differed from placebo by 6.26 points at Day 45 (p = 0.0011, N = 38) and 5.33 points at Day 90 (p = 0.0063, N = 35). Furthermore, a significant pharmacologic response was observed between serum beta-hydroxybutyrate levels and change in ADAS-Cog scores in E4(-) subjects at Day 90 (p = 0.008). Adverse events occurred more frequently in AC-1202 subjects, were primarily restricted to the gastrointestinal system, and were mainly mild to moderate in severity and transient in nature. Conclusion: AC-1202 rapidly elevated serum ketone bodies in AD patients and resulted in significant differences in ADAS-Cog scores compared to the Placebo. Effects were most notable in APOE4(-) subjects who were dosage compliant.	[Henderson, Samuel T.; Vogel, Janet L.; Barr, Linda J.; Garvin, Fiona; Jones, Julie J.; Costantini, Lauren C.] Accera Inc, Broomfield, CO 80021 USA	Henderson, ST (corresponding author), Accera Inc, 380 Interlocken Crescent,Suite 780, Broomfield, CO 80021 USA.	shenderson@accerapharma.com; jvogel@accerapharma.com; lbarr@accerapharma.com; fgarvin@accerapharma.com; julie@jjoinc.net; lcostantini@accerapharma.com					Aerssens J, 2001, DEMENT GERIATR COGN, V12, P69, DOI 10.1159/000051238; BABAYAN VK, 1987, LIPIDS, V22, P417, DOI 10.1007/BF02537271; Bach AC, 1996, J LIPID RES, V37, P708; BACH AC, 1982, AM J CLIN NUTR, V36, P950; Boden G, 2005, ANN INTERN MED, V142, P403, DOI 10.7326/0003-4819-142-6-200503150-00006; Chiasson JL, 2003, CAN MED ASSOC J, V168, P859; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Freeman J, 2006, EPILEPSY RES, V68, P145, DOI 10.1016/j.eplepsyres.2005.10.003; Fuehrlein BS, 2004, J CLIN ENDOCR METAB, V89, P1641, DOI 10.1210/jc.2003-031796; Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.3.CO;2-Q; Greenwood CE, 2005, J GERONTOL A-BIOL, V60, P499, DOI 10.1093/gerona/60.4.499; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Harber MP, 2005, AM J PHYSIOL-ENDOC M, V289, pE306, DOI 10.1152/ajpendo.00069.2005; Henderson ST, 2008, NEUROTHERAPEUTICS, V5, P470, DOI 10.1016/j.nurt.2008.05.004; Henderson ST, 2004, MED HYPOTHESES, V62, P689, DOI 10.1016/j.mehy.2003.11.028; HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; HUTTENLOCHER PR, 1976, PEDIATR RES, V10, P536, DOI 10.1203/00006450-197605000-00006; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Keene JM, 1997, APPETITE, V28, P167, DOI 10.1006/appe.1996.0068; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Matthews HP, 2000, INT J GERIATR PSYCH, V15, P713, DOI 10.1002/1099-1166(200008)15:8<713::AID-GPS187>3.0.CO;2-I; Meckling KA, 2004, J CLIN ENDOCR METAB, V89, P2717, DOI 10.1210/jc.2003-031606; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Mosconi Lisa, 2004, Expert Rev Neurother, V4, P831, DOI 10.1586/14737175.4.5.831; MUNGAS D, 1990, J AM GERIATR SOC, V38, P999, DOI 10.1111/j.1532-5415.1990.tb04423.x; NALBANTOGLU J, 1994, ANN NEUROL, V36, P889, DOI 10.1002/ana.410360614; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Noakes M, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-7; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; ROBINSON AM, 1980, PHYSIOL REV, V60, P143; Rockwood K, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-26; ROJDMARK S, 1975, ACTA MED SCAND, V198, P123; SATO K, 1995, FASEB J, V9, P651; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Studzinski CM, 2008, BRAIN RES, V1226, P209, DOI 10.1016/j.brainres.2008.06.005; Suh GH, 2004, INT J GERIATR PSYCH, V19, P817, DOI 10.1002/gps.1168; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Traul KA, 2000, FOOD CHEM TOXICOL, V38, P79, DOI 10.1016/S0278-6915(99)00106-4; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; VanItallie TB, 2003, NUTR REV, V61, P327, DOI 10.1301/nr.2003.oct.327-341; Westman EC, 2007, AM J CLIN NUTR, V86, P276; WOLFKLEIN GP, 1991, J AM GERIATR SOC, V39, P535, DOI 10.1111/j.1532-5415.1991.tb02510.x; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	68	267	272	0	42	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-7075			NUTR METAB	Nutr. Metab.	AUG 10	2009	6								31	10.1186/1743-7075-6-31			25	Nutrition & Dietetics	Nutrition & Dietetics	486YF	WOS:000269236200001	19664276	DOAJ Gold, Green Published			2021-06-18	
J	Guskiewicz, KM; Mihalik, JP; Shankar, V; Marshall, SW; Crowell, DH; Oliaro, SM; Ciocca, MF; Hooker, DN				Guskiewicz, Kevin M.; Mihalik, Jason P.; Shankar, Viswanathan; Marshall, Stephen W.; Crowell, Dean H.; Oliaro, Scott M.; Ciocca, Mario F.; Hooker, Daniel N.			Measurement of head impacts in collegiate football players: Relationship between head impact biomechanics and acute clinical outcome after concussion	NEUROSURGERY			English	Article						acceleration; helmet; injury threshold; mild traumatic brain injury; neuropsychological function; postural stability	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; NEUROPSYCHOLOGICAL ASSESSMENT; POSTURAL STABILITY; MILD; EPIDEMIOLOGY; RETURN; PERFORMANCE; CONSUMPTION; RECOVERY	OBJECTIVE: To determine the relationship between recorded head accelerations and impact locations and acute clinical outcome of symptomatology, neuropsychological, and postural stability tests after cerebral concussion in Division I collegiate football players. METHODS: A prospective field study was used in which accelerometers were embedded in the football helmets of 88 collegiate football players. Linear and rotational accelerations of all head impacts sustained over the course of 2004 to 2006 National Collegiate Athletic Association football seasons were collected in real-time. Change scores were calculated on clinical measures from the players' preseason baseline to postinjury (within 48 h) and regressed against the recorded linear and rotational accelerations of the head at the time of the concussion. RESULTS: Thirteen concussions were recorded ranging in impact magnitudes of 60.51 to 168.71 g. Linear regression showed no significant relationships between impact magnitude (linear or rotational acceleration) or impact location and change scores for symptom severity, postural stability, or neurocognitive function (P > 0.05). CONCLUSION: Our findings suggest that football players are concussed by impacts to the head that occur at a wide range of magnitudes and that clinical measures of acute symptom severity, postural stability, and neuropsychological function all appear to be largely independent of impact magnitude and location. Because of the varying magnitudes and locations of impacts resulting in concussion as well as other factors such as the frequency of subconcussive impacts and number of previous concussions, it may be difficult to establish a threshold for concussive injury that can be applied to all football players.	[Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Curriculum Human Movement Sci, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Guskiewicz, Kevin M.; Shankar, Viswanathan; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Shankar, Viswanathan; Marshall, Stephen W.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Crowell, Dean H.; Oliaro, Scott M.; Ciocca, Mario F.; Hooker, Daniel N.] Univ N Carolina, Campus Hlth Serv, Div Sports Med, Chapel Hill, NC 27599 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Curriculum Human Movement Sci, Dept Exercise & Sport Sci, 209 Fetzer Gymnasium CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu	Viswanathan, Shankar/AAX-5281-2020; Mihalik, Jason P/E-7059-2010	Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322; Viswanathan, Shankar/0000-0003-3349-9090; Marshall, Stephen/0000-0002-2664-9233	NCIPC CDC HHS [5-R49-CE000196] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000196] Funding Source: NIH RePORTER		[Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brown CN, 2007, J ATHL TRAINING, V42, P515; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MCINTOSH T, 1989, MILD MODERATE HEAD I, P35; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Thurman DJ, 1999, TRAUMATIC BRAIN INJU; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Zhu WM, 1997, RES Q EXERCISE SPORT, V68, P44, DOI 10.1080/02701367.1997.10608865	44	267	269	1	53	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2007	61	6					1244	1252		10.1227/01.neu.0000306103.68635.1a			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	246YN	WOS:000252044400036	18162904				2021-06-18	
J	Wersinger, SR; Ginns, EI; O'Carrol, AM; Lolait, SJ; Young, WS				Wersinger, SR; Ginns, EI; O'Carrol, AM; Lolait, SJ; Young, WS			Vasopressin V1b receptor knockout reduces aggressive behavior in male mice	MOLECULAR PSYCHIATRY			English	Article						homologous recombination; aggression; memory; vasopressin 1b receptor; knockout	MESSENGER-RIBONUCLEIC-ACID; ANTERIOR HYPOTHALAMUS; RAT-BRAIN; ARGININE-VASOPRESSIN; SOCIAL RECOGNITION; OLFACTORY-BULB; OXYTOCIN; STRESS; LOCALIZATION; VOMERONASAL	Increased aggression is commonly associated with many neurological and psychiatric disorders. Current treatments are largely empirical and are often accompanied by severe side effects, underscoring the need for a better understanding of the neural bases of aggression. Vasopressin, acting through its la receptor subtype, is known to affect aggressive behaviors. The vasopressin 1b receptor (V1bR) is also expressed in the brain, but has received much less attention due to a lack of specific drugs. Here we report that mice without the V1bR exhibit markedly reduced aggression and modestly impaired social recognition. By contrast, they perform normally in all the other behaviors that we have examined, such as sexual behavior, suggesting that reduced aggression and social memory are not simply the result of a global deficit in sensorimotor function or motivation. Fos-mapping within chemosensory responsive regions suggests that the behavioral deficits in V1bR knockout mice are not due to defects in detection and transmission of chemosensory signals to the brain. We suggest that V1bR antagonists could prove useful for treating aggressive behavior seen, for example, in dementias and traumatic brain injuries.	NIMH, Sect Neural Gene Express, Bethesda, MD 20892 USA; Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA USA; Univ Bristol, Univ Res Ctr Neuroendocrinol, Bristol BS8 1TH, Avon, England	Young, WS (corresponding author), NIMH, Sect Neural Gene Express, Bldg 36,Rm 2A11,MSC 4068, Bethesda, MD 20892 USA.	scott@codon.nih.gov	Young, W Scott/N-3716-2019; Lolait, Stephen/AAG-4483-2020; Young, W Scott Scott/A-9333-2009	Young, W Scott/0000-0001-6614-5112; Young, W Scott Scott/0000-0001-6614-5112	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01MH002498, ZIAMH002498] Funding Source: NIH RePORTER		Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; AlescioLautier B, 1995, EUR J PHARMACOL, V294, P763, DOI 10.1016/0014-2999(95)00632-X; BEEMAN EA, 1947, PHYSIOL ZOOL, V20, P373, DOI 10.1086/physzool.20.4.30151969; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; BRONSON FH, 1971, BIOL REPROD, V4, P344; BUIJS RM, 1983, PROG BRAIN RES, V60, P115; Burbach JPH, 1995, CELL MOL NEUROBIOL, V15, P573, DOI 10.1007/BF02071318; Coccaro EF, 1998, ARCH GEN PSYCHIAT, V55, P708, DOI 10.1001/archpsyc.55.8.708; Crawley JN, 2000, WHATS WRONG MY MOUSE; Dantzer R, 1998, PROG BRAIN RES, V119, P409; DAVANZO JP, 1983, PHYSIOL BEHAV, V31, P857, DOI 10.1016/0031-9384(83)90284-6; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; Delville Y, 1996, PHYSIOL BEHAV, V59, P813, DOI 10.1016/0031-9384(95)02166-3; DEVRIES GJ, 1981, BRAIN RES, V218, P67, DOI 10.1016/0006-8993(81)90989-6; Dluzen DE, 1998, PEPTIDES, V19, P999, DOI 10.1016/S0196-9781(98)00047-3; EDWARDS DA, 1993, PHYSIOL BEHAV, V53, P611, DOI 10.1016/0031-9384(93)90162-9; Engelmann M, 2000, EXP PHYSIOL, V85, p125S; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Ferris CF, 1997, J NEUROSCI, V17, P4331; FERRIS CF, 1994, PSYCHONEUROENDOCRINO, V19, P593, DOI 10.1016/0306-4530(94)90043-4; Ferris CF, 2000, EXP PHYSIOL, V85, p85S, DOI 10.1111/j.1469-445X.2000.tb00011.x; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Koolhaas JM, 1998, PROG BRAIN RES, V119, P437; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LOLAIT SJ, 1995, P NATL ACAD SCI USA, V92, P6783, DOI 10.1073/pnas.92.15.6783; Ma XM, 1997, ENDOCRINOLOGY, V138, P4351, DOI 10.1210/en.138.10.4351; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; MOORE FL, 1994, PSYCHONEUROENDOCRINO, V19, P581, DOI 10.1016/0306-4530(94)90042-6; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Parmigiani S, 1999, NEUROSCI BIOBEHAV R, V23, P957, DOI 10.1016/S0149-7634(99)00029-9; POPIK P, 1992, BEHAV PHARMACOL, V3, P351; Rosenblatt A, 2000, PSYCHOSOMATICS, V41, P24, DOI 10.1016/S0033-3182(00)71170-4; SAITO M, 1995, BIOCHEM BIOPH RES CO, V212, P751, DOI 10.1006/bbrc.1995.2033; Saver JL, 1996, NEUROPSYCHIATRY, P523; SCHULTZ EF, 1973, PSYCHOL BULL, V79, P21, DOI 10.1037/h0033817; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SZOT P, 1994, MOL BRAIN RES, V24, P1, DOI 10.1016/0169-328X(94)90111-2; Tune LE, 2001, J CLIN PSYCHIAT, V62, P29; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Wood RI, 1997, HORM BEHAV, V32, P40, DOI 10.1006/hbeh.1997.1403; Yeager CA, 2000, CHILD ADOL PSYCH CL, V9, P793	53	267	274	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.		2002	7	9					975	984		10.1038/sj.mp.4001195			10	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	610GQ	WOS:000178952700012	12399951	Bronze			2021-06-18	
J	Thomas, DG; Apps, JN; Hoffmann, RG; McCrea, M; Hammeke, T				Thomas, Danny George; Apps, Jennifer N.; Hoffmann, Raymond G.; McCrea, Michael; Hammeke, Thomas			Benefits of Strict Rest After Acute Concussion: A Randomized Controlled Trial	PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ENERGY-EXPENDITURE; IMPACT; VALIDITY; RECOVERY; IMPAIRMENT	OBJECTIVES: To determine if recommending strict rest improved concussion recovery and outcome after discharge from the pediatric emergency department (ED). METHODS: Patients aged 11 to 22 years presenting to a pediatric ED within 24 hours of concussion were recruited. Participants underwent neurocognitive, balance, and symptom assessment in the ED and were randomized to strict rest for 5 days versus usual care (1-2 days rest, followed by stepwise return to activity). Patients completed a diary used to record physical and mental activity level, calculate energy exertion, and record daily postconcussive symptoms. Neurocognitive and balance assessments were performed at 3 and 10 days postinjury. Sample size calculations were powered to detect clinically meaningful differences in postconcussive symptom, neurocognitive, and balance scores between treatment groups. Linear mixed modeling was used to detect contributions of group assignment to individual recovery trajectory. RESULTS: Ninety-nine patients were enrolled; 88 completed all study procedures (45 intervention, 43 control). Postdischarge, both groups reported a 20% decrease in energy exertion and physical activity levels. As expected, the intervention group reported less school and after-school attendance for days 2 to 5 postconcussion (3.8 vs 6.7 hours total, P < .05). There was no clinically significant difference in neurocognitive or balance outcomes. However, the intervention group reported more daily postconcussive symptoms (total symptom score over 10 days, 187.9 vs 131.9, P < .03) and slower symptom resolution. CONCLUSIONS: Recommending strict rest for adolescents immediately after concussion offered no added benefit over the usual care. Adolescents' symptom reporting was influenced by recommending strict rest.	[Thomas, Danny George; Hoffmann, Raymond G.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Apps, Jennifer N.; Hammeke, Thomas] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol & Neurosurg, Milwaukee, WI 53226 USA	Thomas, DG (corresponding author), Wisconsin Corp Ctr, Childrens Hosp, Dept Pediat, 999 N 92nd St,Suite C550, Milwaukee, WI 53226 USA.	dthomas@mcw.edu		Thomas, Danny/0000-0002-7470-9835	Injury Research Center of the Medical College of Wisconsin	Injury Research Center of the Medical College of Wisconsin	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Centers for Disease Control and Prevention, ACE CAR PLAN SCH VER; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Field M, 2003, NEUROSURGERY, V53, P513; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Henry CJK, 2004, AM J HUM BIOL, V16, P346, DOI 10.1002/ajhb.20022; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P744; Iverson GL, 2009, IMPACT NORMATIVE DAT; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Langlois J, 2008, HEADS BRAIN INJURY Y; Lee Michael A, 2010, Conn Med, V74, P149; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lovell M, 2006, IMPACT NORMATIVE DAT; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reitan RM., 1985, HALSTEAD REITAN NEUR; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Wechsler D, 1997, WAIS 3 ADM SCORING M	44	266	267	0	56	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	FEB	2015	135	2					213	223		10.1542/peds.2014-0966			11	Pediatrics	Pediatrics	CA1IN	WOS:000348666300040	25560444	Bronze	Y	N	2021-06-18	
J	Ryan, LM; Warden, DL				Ryan, LM; Warden, DL			Post concussion syndrome	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							MILD HEAD-INJURY; TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; POSTCONCUSSION SYMPTOMS; BASE RATES; NEUROPSYCHOLOGICAL DEFICITS; SEQUELAE; TIME	Individuals sustaining mild traumatic brain injuries often report a constellation of physical, cognitive, and emotional/behavioral symptoms referred to as post concussion symptoms (PCS). The most commonly reported post concussion symptoms are headache, dizziness, decreased concentration, memory problems, irritability, fatigue, visual disturbances, sensitivity to noise, judgment problems, depression, and anxiety. Although these PCS often resolve within one month, in some individuals PCS can persist from months to years following injury and may even be permanent and cause disability. When this cluster of PCS is persistent in nature, it is often called the post concussion syndrome or persistent PCS. Both physiological and psychological etiologies have been suggested as causes for persistent post concussion symptoms and this has led to much controversy and debate in the literature. Most investigators now believe that a variety of pre-morbid, injury-related, and post-morbid neuropathological and psychological factors contribute to the development and continuation of these symptoms in those sustaining mild traumatic brain injury (MTBI).	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Dept Neurol, Washington, DC 20012 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Washington, DC USA; Uniformed Serv Univ Hlth Sci, Dept Psychiat, Washington, DC USA; Henry M Jackson Fdn Advancement Mil Med, Washington, DC USA	Warden, DL (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Dept Neurol, POB 59181, Washington, DC 20012 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOHNEN N, 1992, NEUROSURGERY, V30, P692; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI [10.1097/00001199-199309000-00003, DOI 10.1097/00001199-199309000-00003]; Eisenberg H. M., 1989, MILD HEAD INJURY, P133; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MARIADAS AC, 1989, NIMHANS J, V7, P37; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MOSS NEG, 1994, CLIN REHABIL, V8, P149; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 1998, ARCH CLIN NEUROPSYCH, V13, P147; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; Varney N. R., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI DOI 10.1097/00001199-199303000-00005; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	51	266	268	2	39	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0954-0261			INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					310	316		10.1080/09540260310001606692			7	Psychiatry	Psychiatry	739UD	WOS:000186364100003	15276952				2021-06-18	
J	Kiening, KL; Unterberg, AW; Bardt, TF; Schneider, GH; Lanksch, WR				Kiening, KL; Unterberg, AW; Bardt, TF; Schneider, GH; Lanksch, WR			Monitoring of cerebral oxygenation in patients with severe head injuries: Brain tissue PO2 versus jugular vein oxygen saturation	JOURNAL OF NEUROSURGERY			English	Article						head injury; cerebral oxygenation; brain tissue PO2; jugular vein oxygen saturation; cerebral hypoxia; cerebral perfusion pressure; multimodal cerebral monitoring	NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW; PERFUSION-PRESSURE; MANAGEMENT	Monitoring of cerebral oxygenation is considered to re of great importance in minimizing secondary hypoxic and ischemic brain damage following severe head injury. Although the threshold for cerebral hypoxia in jugular bulb oximetry (measurement of O-2 saturation in the jugular vein (SjvO(2))) is generally accepted to be 50% oxygen saturation, a comparable value in brain tissue PO2 (PtiO(2)) monitoring, a new method for direct assessment of PO2 in the cerebral white matter, has not yet been established. Hence, the purpose of this study was to compare brain PtiO(2) with SjvO(2) in severely head injured patients during phases of reduced cerebral perfusion pressure (CPP) to define a threshold in brain PtiO(2) monitoring. In addition, the safety and data quality of both SjvO(2) and brain PtiO(2) monitoring were studied. In 15 patients with severe head injuries, SjvO(2) and brain PtiO(2) were monitored simultaneously. For brain PtiO(2) monitoring a polarographic microcatheter was inserted in the frontal cerebral white matter, whereas for SjvO(2) measurements were obtained by using a fiberoptic catheter placed in the jugular bulb. Intracranial pressure was monitored by means of an intraparenchymal catheter. Mean arterial blood pressure, CPP, end-tidal CO2, and arterial oxygen saturation (pulse oximetry) were continuously recorded. All data were simultaneously stored and analyzed using a multimodal computer system. For specific analysis, phases of marked deterioration in systemic blood pressure and consecutive reductions in CPP were investigated. There were no complications that could be attributed to the PtiO(2) catheters, that is, no intracranial bleeding or infection. The ''time of good data quality'' was 95% in brain PtiO(2) compared to 43% in SjvO(2); PtiO(2) monitoring could be performed twice as long as SjvO(2) monitoring. During marked decreases in CPP, SjvO(2) and brain PtiO(2) correlated closely. A significant second-order regression curve of SjvO(2) versus brain PtiO(2) (p < 0.01) was plotted. At a threshold of 50% in SjvO(2), brain PtiO(2) was found to be within the range of 3 to 12 mm Hg, with a regression curve ''best fit'' value of 8.5 mm Hg. There was a close correlation between CPP and oxygenation parameters (PtiO(2) and SjvO(2)) when CPP fell below a breakpoint of 60 mm Hg, suggesting intact cerebral autoregulation in most patients. This study demonstrates that monitoring brain PtiO(2) is a safe, reliable, and sensitive diagnostic method to follow cerebral oxygenation. In comparison to SjvO(2), PtiO(2) is more suitable for long-term monitoring. It can be used to minimize episodes of secondary cerebral maloxygenation after severe head injury and may, hopefully, improve the outcome in severely head injured patients.		Kiening, KL (corresponding author), HUMBOLDT UNIV BERLIN, VIRCHOW MED CTR, DEPT NEUROSURG, AUGUSTENBURGER PL 1, D-13353 BERLIN, GERMANY.						BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; CRUZ J, 1993, CRIT CARE MED, V21, P1218, DOI 10.1097/00003246-199308000-00024; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; DEARDEN NM, 1993, ACTA NEUROCHIR, P91; DEARDEN NM, 1991, CURR OPIN ANESTHESIO, V4, P279; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KIRKPATRICK PJ, 1995, J NEUROSURG, V82, P756, DOI 10.3171/jns.1995.82.5.0756; KURTH CD, 1993, J CLIN MONITOR, V9, P163, DOI 10.1007/BF01617023; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MAAS AIR, 1993, INTRACRANIAL PRESSUR, V8, P233; Marmarou A, 1994, INTRACRANIAL PRESSUR, P302; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCCORMICK PW, 1991, STROKE, V22, P596, DOI 10.1161/01.STR.22.5.596; MCGRAW CP, 1989, INTRACRANIAL PRESSUR, V7, P3839; MENDELOW AD, 1993, INTRACRANIAL PRESSUR, V8, P548; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1993, J NEUROSURG, V59, P98; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1994, NEUROSURGERY, V34, P43; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1994, INTRACRANIAL PRESSUR, V9, P222; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SIESJO BK, 1987, BRAIN ENERGY METABOL, P68; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; UNTERBERG A, 1995, NEUROCHEMICAL MONITO, P204; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	35	266	279	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	1996	85	5					751	757		10.3171/jns.1996.85.5.0751			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	VP489	WOS:A1996VP48900002	8893710				2021-06-18	
J	Skolnick, BE; Maas, AI; Narayan, RK; van der Hoop, RG; MacAllister, T; Ward, JD; Nelson, NR; Stocchetti, N				Skolnick, Brett E.; Maas, Andrew I.; Narayan, Raj K.; van der Hoop, Roland Gerritsen; MacAllister, Thomas; Ward, John D.; Nelson, Neta R.; Stocchetti, Nino		SYNAPSE Trial Investigators	A Clinical Trial of Progesterone for Severe Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROPROTECTION; CLASSIFICATION; RECOVERY	BACKGROUND Progesterone has been associated with robust positive effects in animal models of traumatic brain injury (TBI) and with clinical benefits in two phase 2 randomized, controlled trials. We investigated the efficacy and safety of progesterone in a large, prospective, phase 3 randomized clinical trial. METHODS We conducted a multinational placebo-controlled trial, in which 1195 patients, 16 to 70 years of age, with severe TBI (Glasgow Coma Scale score, <= 8 [on a scale of 3 to 15, with lower scores indicating a reduced level of consciousness] and at least one reactive pupil) were randomly assigned to receive progesterone or placebo. Dosing began within 8 hours after injury and continued for 120 hours. The primary efficacy end point was the Glasgow Outcome Scale score at 6 months after the injury. RESULTS Proportional-odds analysis with covariate adjustment showed no treatment effect of progesterone as compared with placebo (odds ratio, 0.96; confidence interval, 0.77 to 1.18). The proportion of patients with a favorable outcome on the Glasgow Outcome Scale (good recovery or moderate disability) was 50.4% with progesterone, as compared with 50.5% with placebo. Mortality was similar in the two groups. No relevant safety differences were noted between progesterone and placebo. CONCLUSIONS Primary and secondary efficacy analyses showed no clinical benefit of progesterone in patients with severe TBI. These data stand in contrast to the robust preclinical data and results of early single-center trials that provided the impetus to initiate phase 3 trials.	[Skolnick, Brett E.; Narayan, Raj K.] Hofstra North Shore LIJ Sch Med, Cushing Neurosci Inst, Dept Neurosurg, Manhasset, NY USA; [Maas, Andrew I.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I.] Univ Antwerp, Edegem, Belgium; [van der Hoop, Roland Gerritsen; MacAllister, Thomas; Nelson, Neta R.] BHR Pharma, Herndon, VA USA; [Ward, John D.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Stocchetti, Nino] Univ Milan, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Ca Granda Osped Maggiore Policlin, Neuro Intens Care Fdn Ist Ricovero & Cura Caratte, Milan, Italy	Skolnick, BE (corresponding author), N Shore Univ Hosp, Dept Neurosurg, 300 Community Dr,9 Tower, Manhasset, NY 11030 USA.	bskolnick2@nshs.edu	Badenes, Rafael/K-6628-2019; Dominguez-Roldan, Jose-Maria/M-1728-2016; Nimsky, Christopher/E-3702-2014; Stocchetti, Nino/O-7444-2017; Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015; Verma, Vishwajit/K-8289-2019; Leone, Marc/P-4835-2016; Laha, Shondipon/AAN-9181-2020	Badenes, Rafael/0000-0001-7017-0150; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Nimsky, Christopher/0000-0002-8216-9410; Stocchetti, Nino/0000-0003-3250-6834; Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Leone, Marc/0000-0002-3097-758X; Laha, Shondipon/0000-0001-8748-9766; Barnes, Stephen/0000-0001-6186-1435; LAURENT, PETIT/0000-0003-1530-5678; Vincent, Jean-Louis/0000-0001-6011-6951; Quah, Boon Leong/0000-0001-9094-5857; Bulters, Diederik/0000-0001-9884-9050	BHR Pharma, a division of Besins Healthcare	Supported by BHR Pharma, a division of Besins Healthcare.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; WHITEHEAD J, 1994, STAT MED, V13, P871; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	29	265	276	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2467	2476		10.1056/NEJMoa1411090			10	Medicine, General & Internal	General & Internal Medicine	AX4RZ	WOS:000346920300006	25493978	Green Published, Bronze	Y	N	2021-06-18	
J	Holbrook, TL; Galarneau, MR; Dye, JL; Quinn, K; Dougherty, AL				Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.			Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENTAL-HEALTH PROBLEMS; MAJOR TRAUMA; RISK-FACTORS; PTSD; AFGHANISTAN; CARE; PHARMACOTHERAPY; INTERVENTION; PREVENTION; SYMPTOMS	BACKGROUND Post-traumatic stress disorder (PTSD) is a common adverse mental health outcome among seriously injured civilians and military personnel who are survivors of trauma. Pharmacotherapy in the aftermath of serious physical injury or exposure to traumatic events may be effective for the secondary prevention of PTSD. METHODS We identified 696 injured U. S. military personnel without serious traumatic brain injury from the Navy-Marine Corps Combat Trauma Registry Expeditionary Medical Encounter Database. Complete data on medications administered were available for all personnel selected. The diagnosis of PTSD was obtained from the Career History Archival Medical and Personnel System and verified in a review of medical records. RESULTS Among the 696 patients studied, 243 received a diagnosis of PTSD and 453 did not. The use of morphine during early resuscitation and trauma care was significantly associated with a lower risk of PTSD after injury. Among the patients in whom PTSD developed, 61% received morphine; among those in whom PTSD did not develop, 76% received morphine (odds ratio, 0.47; P<0.001). This association remained significant after adjustment for injury severity, age, mechanism of injury, status with respect to amputation, and selected injury-related clinical factors. CONCLUSIONS Our findings suggest that the use of morphine during trauma care may reduce the risk of subsequent development of PTSD after serious injury.	[Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.] Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Holbrook, Troy Lisa] EPI SOAR Consulting, San Diego, CA USA	Holbrook, TL (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	troy@epi-soar.com			U.S. Navy Bureau of Medicine and Surgery [60808]	Supported by U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured-Psychological Health-Traumatic Brain Injury Program (work unit 60808).	[Anonymous], 2000, DIAGNOSTIC STAT MANU; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P236; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P34; Davidson JRT, 2004, J CLIN PSYCHIAT, V65, P44; Ducrocq F, 2005, ENCEPHALE, V31, P212; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; Gennarelli TA, 2005, ABBREVIATED INJURY S; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Gunderson EKE, 2005, MIL MED, V170, P172; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Marmar CR, 2002, PSYCHIAT QUART, V73, P259, DOI 10.1023/A:1020459916113; MCGAUGH JL, 1988, BRAIN RES, V446, P37, DOI 10.1016/0006-8993(88)91294-2; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Morgan CA, 2003, BIOL PSYCHIAT, V53, P834, DOI 10.1016/S0006-3223(03)00116-1; *NAT CTR POSTTR ST, EP FACTS PTSD; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Zatzick D, 2006, PSYCHIAT SERV, V57, P1726, DOI 10.1176/appi.ps.57.12.1726; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P158, DOI 10.1016/S1084-3612(03)00016-9; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P168, DOI 10.1016/S1084-3612(03)00015-7; Zatzick DF, 2007, J TRAUMA STRESS, V20, P401, DOI 10.1002/jts.20256; Zhang W, 2007, EXPERT OPIN PHARMACO, V8, P1861, DOI 10.1517/14656566.8.12.1861	39	265	272	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					110	117		10.1056/NEJMoa0903326			8	Medicine, General & Internal	General & Internal Medicine	543FU	WOS:000273558500008	20071700				2021-06-18	
J	Oertel, M; Kelly, DF; McArthur, D; Boscardin, WJ; Glenn, TC; Lee, JH; Gravori, T; Obukhov, D; McBride, DQ; Martin, NA				Oertel, M; Kelly, DF; McArthur, D; Boscardin, WJ; Glenn, TC; Lee, JH; Gravori, T; Obukhov, D; McBride, DQ; Martin, NA			Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury	JOURNAL OF NEUROSURGERY			English	Article						progressive hemorrhagic injury; traumatic brain injury; intracranial hemorrhage; timing of computerized tomography scanning	BRAIN INJURY; INTRAVASCULAR COAGULATION; INTRACRANIAL HEMORRHAGE; SUBDURAL HEMATOMAS; PLATELET-FUNCTION; HYPOTHERMIA; FIBRINOLYSIS; COAGULOPATHY; PROGESTERONE; FAILURE	Object. Progressive intracranial hemorrhage after head injury is often observed on serial computerized tomography (CT) scans but its significance is uncertain. In this study, patients in whom two CT scans were obtained within 24 hours of injury were analyzed to determine the incidence, risk factors, and clinical significance of progressive hemorrhagic injury (PHI). Methods. The diagnosis of PHI was determined by comparing the first and second CT scans and was categorized as epidural hematoma (EDH), subdural hematoma (SDH), intraparenchymal contusion or hematoma (IPCH), or subarachnoid hemorrhage (SAH). Potential risk factors, the daily mean intracranial pressure (ICP), and cerebral perfusion pressure were analyzed. In a cohort of 142 patients (mean age 34 +/- 14 years; median Glasgow Coma Scale score of 8, range 3-15; male/female ratio 4.3:1), the mean time from injury to first CT scan was 2 +/- 1.6 hours and between first and second CT scans was 6.9 +/- 3.6 hours. A PHI was found in 42.3% of patients overall and in 48.6% of patients who underwent scanning within 2 hours of injury. Of the 60 patients with PHI, 87% underwent their first CT scan within 2 hours of injury and in only one with PHI was the first CT scan obtained more than 6 hours postinjury. The likelihood of PHI for a given lesion was 51% for IPCH, 22% for EDH, 17% for SAH, and 11% for SDH. Of the 46 patients who underwent craniotomy for hematoma evacuation, 24% did so after the second CT scan because of findings of PHI. Logistic regression was used to identify male sex (p = 0.01), older age (p = 0,01). time from injury to first CT scan (p = 0.02), and initial partial thromboplastin time (PTT) (p = 0.02) as the best predictors of PHI. The percentage of patients with mean daily ICP greater than 20 mm Hg was higher in those with PHI compared with those without PHI. The 6-month postinjury outcome was similar in the two patient groups. Conclusions. Early progressive hemorrhage occurs in almost 50% of head-injured patients who undergo CT scanning within 2 hours of injury, it occurs most frequently in cerebral contusions, and it is associated with ICP elevations. Male sex, older age, time from injury to first CT scan, and PTT appear to be key determinants of PHI. Early repeated CT scanning is indicated in patients with nonsurgically treated hemorrhage revealed on the first CT scan.	Univ Calif Los Angeles, Med Ctr, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Med Ctr, Dept Biostat, Los Angeles, CA 90024 USA; Harbor UCLA Med Ctr, Div Neurosurg, Torrance, CA 90509 USA	Kelly, DF (corresponding author), Univ Calif Los Angeles, Med Ctr, Div Neurosurg, Rm 18-218,Box 957039, Los Angeles, CA 90095 USA.			Glenn, Thomas/0000-0003-4273-3408; Martin, Neil/0000-0002-6565-4131	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308] Funding Source: Medline		Arboix A, 2000, CEREBROVASC DIS, V10, P229, DOI 10.1159/000016061; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bollinger O, 1891, INT BEITRAGE WEISSEN, P457; Bouchama A, 1996, THROMB HAEMOSTASIS, V76, P909; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Doughty R.G., 1938, SOUTH MED J, V31, P254; ELMER O, 1984, HAEMOSTASIS, V14, P223; Firsching R, 1997, NEUROL RES, V19, P257, DOI 10.1080/01616412.1997.11740810; FROWEIN R A, 1989, Neurosurgical Review, V12, P184, DOI 10.1007/BF01790644; Huttunen P, 1998, ALCOHOL, V15, P315, DOI 10.1016/S0741-8329(97)00136-5; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Krause KR, 2000, AM SURGEON, V66, P348; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LEE ST, 1991, ACTA NEUROCHIR, V113, P121, DOI 10.1007/BF01403196; LIAU LM, 1996, NEUROLOGICAL SURG, V3, P1549; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MCBRIDE DQ, 1993, J NEUROTRAUMA S1, V10, pS227; McCarron MO, 1999, STROKE, V30, P1643, DOI 10.1161/01.STR.30.8.1643; MERTOL T, 1991, British Journal of Neurosurgery, V5, P491, DOI 10.3109/02688699108998478; Pach J, 1996, Przegl Lek, V53, P324; PAPO I, 1980, NEUROSURGERY, V7, P337, DOI 10.1227/00006123-198010000-00005; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Peng RY, 1999, J AM COLL SURGEONS, V188, P685, DOI 10.1016/S1072-7515(99)00035-6; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2000, NEUROSURGERY, V46, P70; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; VONKAULLA KN, 1958, J THORAC SURG, V36, P857; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	46	265	289	0	18	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JAN	2002	96	1					109	116		10.3171/jns.2002.96.1.0109			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	508FY	WOS:000173079100017	11794591				2021-06-18	
J	Kreutzer, JS; Seel, RT; Gourley, E				Kreutzer, JS; Seel, RT; Gourley, E			The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination	BRAIN INJURY			English	Article							MINOR HEAD-INJURIES; INVENTORY; DISORDERS; RELATIVES; SEQUELAE; RECOVERY; ANXIETY; MOOD	Primary objective: Differing definitions of depression, limited sample sizes, and variability in methodologies have contributed to equivocal findings about the prevalence of depression among persons with traumatic brain injury. The present investigation used standardized diagnostic criteria and a large sample to identify the manifestations of depression after TBI. Methods and procedures: 722 outpatients with brain injury, referred for comprehensive assessment at a regional Level I trauma centre, were studied. Depressive symptoms were characterized utilizing standard DSM-IV criteria and the Neurobehavioural Functioning Inventory. Results: Forty-two per cent of patients with brain injury met the prerequisite number of symptoms for a DSM-IV diagnosis of major depressive disorder. Fatigue (46%), frustration (41%), and poor concentration (38%) were the most commonly cited manifestations of depression. Conclusions: Many patients with brain injury are at great risk for developing depressive disorders. Future research should focus on prognostic factors, developing protocols for identification of high risk patients, and examining the efficacy of treatment interventions.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Kreutzer, JS (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, MCV Box 980542, Richmond, VA 23298 USA.						Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ATTEBERRYBENNETT J, 1986, INT J CLIN NEUROPSYC, V8, P114; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; DAVALLO MM, 1992, BRAIN INJURY, V6, P327; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; Gasquoine PG, 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187]; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lambert MV, 1999, EPILEPSIA, V40, pS21, DOI 10.1111/j.1528-1157.1999.tb00884.x; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; Lykouras L, 1998, PSYCHOPATHOLOGY, V31, P213, DOI 10.1159/000029042; Marsh L, 2000, PSYCHOSOMATICS, V41, P15, DOI 10.1016/S0033-3182(00)71169-8; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P153; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SCHUBERT DSP, 1992, PSYCHOSOMATICS, V33, P290, DOI 10.1016/S0033-3182(92)71967-7; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; SHERER M, 1996, J INT NEUROPSYCH SOC, V2, P17; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7	35	265	268	1	27	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2001	15	7					563	576		10.1080/02699050010009108			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	444PD	WOS:000169407900002	11429086				2021-06-18	
J	van der Naalt, J; van Zomeren, AH; Sluiter, WJ; Minderhoud, JM				van der Naalt, J; van Zomeren, AH; Sluiter, WJ; Minderhoud, JM			One year outcome in mild to moderate head injury: the predictive value of acute injury characteristics related to complaints and return to work	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injury; post-traumatic amnesia; outcome	TRAUMATIC BRAIN INJURY; DIFFUSE AXONAL INJURY; COGNITIVE SEQUELAE; POSTTRAUMATIC AMNESIA; CONCUSSION; RECOVERY; SCALE; CLASSIFICATION; RELIABILITY; DISABILITY	Objectives-To determine the prognostic value of characteristics of acute injury and duration of post-traumatic amnesia (PTA) for long term outcome in patients with mild to moderate head injury in terms of complaints and return to work. Methods-Patients with a Glasgow coma score (GCS) on admission of 9-14 were included. Post-traumatic amnesia was assessed prospectively. Follow up was performed at 1, 3, 6, and 12 months after injury. Outcome was determined by the Glasgow outcome scale (GOS) 1 year after injury and compared with a more detailed outcome scale (DOS) comprising cognitive and neurobehavioural aspects. Results-Sixty seven patients were included, mean age 33.2 (SD 14.7) years and mean PTA 7.8 (SD 7.3) days. One year after injury, 73% of patients had resumed previous work although most (84%) still reported complaints. The most frequent complaints were headache (32%), irritability (34%), forgetfulness and poor concentration (42%), and fatigue (45%). According to the GOS good recovery (82%) or moderate disability (18%) was seen. Application of the DOS showed more cognitive (40%) and behavioural problems (48%), interfering with return to work. Correlation between the GOS and DOS was high (r=0.87, p<0.01). Outcome correlated with duration of PTA (r=-0.46) but not significantly with GCS on admission (r=0.19). In multiple regression analysis, PTA and the number of complaints 3 months after injury explained 49% of variance on outcome as assessed with the GOS, and 60% with the DOS. Conclusions-In mild to moderate head injury outcome is determined by duration of PTA and not by GCS on admission. Most patients return to work despite having complaints. The application of a more detailed outcome scale will increase accuracy in predicting outcome in this category of patients with head injury.	Univ Groningen Hosp, Dept Neurol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Endocrinol, NL-9700 RB Groningen, Netherlands	van der Naalt, J (corresponding author), Univ Groningen Hosp, Dept Neurol, POB 30-001, NL-9700 RB Groningen, Netherlands.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lidvall H., 1974, ACTA NEUROL SCAND, V50, P3; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; RUTHERFORD WH, 1977, LANCET, V1, P1; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON JTL, 1993, J NEUROL NEUROSUR PS, V56, P198; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	50	265	268	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	1999	66	2					207	213		10.1136/jnnp.66.2.207			7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	164EX	WOS:000078450800014	10071101	Bronze, Green Published			2021-06-18	
J	GARLAND, DE				GARLAND, DE			A CLINICAL PERSPECTIVE ON COMMON FORMS OF ACQUIRED HETEROTOPIC OSSIFICATION	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							SPINAL-CORD INJURY; TOTAL HIP-REPLACEMENT; PARA-ARTICULAR OSSIFICATIONS; ECTOPIC BONE FORMATION; LONG-TERM COMA; MYOSITIS-OSSIFICANS; DISODIUM ETIDRONATE; HLA ANTIGENS; PREVENTION; ARTHROPLASTY	The clinical courses of heterotopic ossification (HO) as a consequence of trauma and central nervous system insults have many similarities as well as dissimilarities. Detection is commonly noted at two months. The incidence of clinically significant HO is 10%-20%. Approximately 10% of the HO is massive and causes severe restriction in joint motion or ankylosis. The most common sign and symptom are decreased range of motion and pain. The locations are the proximal limbs and joints. Sites of HO about a joint may vary according to the etiology of the HO. Roentgenographic evolution of HO occurs during a six-month period in the majority of patients. Treatment modalities include diphosphonates, indomethacin, radiation, range of motion exercises, and surgical excision. Surgical timing differs according to etiology: traumatic HO may be resected at six months; spinal cord injury HO is excised at one year; and traumatic brain injury HO is removed at 1.5 years. A small number of patients have progression of HO with medicinal treatment and recurrence after resection. The patients seem recalcitrant to present treatment methods regardless of the HO etiology.		GARLAND, DE (corresponding author), RANCHO LOS AMIGOS MED CTR, 7601 E IMPERIAL HWY, DOWNEY, CA 90242 USA.						ABRAMSON AS, 1948, J BONE JOINT SURG AM, V30-A, P982, DOI 10.2106/00004623-194830040-00020; AHRENGART L, 1988, CLIN ORTHOP RELAT R, V229, P265; ARMSTRONGRESSY CT, 1957, P ANN CLIN PARAPLEGI, V6, P22; AYERS DC, 1986, J BONE JOINT SURG AM, V68A, P1423, DOI 10.2106/00004623-198668090-00016; BARRANCO VP, 1971, ARCH DERMATOL, V104, P643, DOI 10.1001/archderm.104.6.643; BASSETT CAL, 1969, LANCET, V2, P845; BETUEL H, 1980, HISTOCOMPATIBILITY T, P715; BIJVOET OLM, 1974, ACTA ORTHOP SCAND, V45, P926, DOI 10.3109/17453677408989703; BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; BOLGER JT, 1975, ARCH PHYS MED REHAB, V56, P36; BRESSLER EL, 1987, AM J ROENTGENOL, V148, P931, DOI 10.2214/ajr.148.5.931; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; BRUNNER R, 1987, ARCH ORTHOP TRAUM SU, V106, P102, DOI 10.1007/BF00435422; CHANTRAINE A, 1981, SCAND J REHABIL MED, V13, P31; CHAPCHAL GJ, 1973, CLIN ORTHOP RELAT R, P111; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76; COSTELLO FV, 1951, J BONE JOINT SURG BR, V33, P594; Couvee L M, 1971, Paraplegia, V9, P89; COVENTRY MB, 1981, J BONE JOINT SURG AM, V63, P201, DOI 10.2106/00004623-198163020-00004; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286; DELEE J, 1976, CLIN ORTHOP RELAT R, V121, P53; DRANE WE, 1984, AM J ROENTGENOL, V142, P179, DOI 10.2214/ajr.142.1.179; ELMSTEDT E, 1985, ACTA ORTHOP SCAND, V56, P25, DOI 10.3109/17453678508992973; FAHMY NRM, 1982, ACTA ORTHOP SCAND, V53, P799, DOI 10.3109/17453678208992296; FAWCETT HA, 1983, J ROY SOC MED, V76, P697; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V3, P337, DOI 10.1016/0221-8747(81)90050-3; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; FLORA L, 1981, METAB BONE DIS RELAT, V3, P289, DOI 10.1016/0221-8747(81)90045-X; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; Freehafer A A, 1966, Med Serv J Can, V22, P471; FREEMAN PA, 1973, CLIN ORTHOP RELAT R, V95, P224; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; Garland D. E., 1983, CLIN ORTHOP RELAT R, V176, P190; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V168, P38; GARLAND DE, 1984, CLIN ORTHOP RELAT R, V186, P154; GARLAND DE, 1983, CLIN ORTHOP RELAT R, V176, P197; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V245, P303; HANSSON JG, 1955, ARCH PHYS MED REHAB, V36, P506; HARDY AG, 1963, J BONE JOINT SURG BR, V45, P76; HASSARD GH, 1975, ARCH PHYS MED REHAB, V56, P355; HEILBRUN N, 1947, RADIOLOGY, V48, P579, DOI 10.1148/48.6.579; HENDRIX RW, 1981, RADIOLOGY, V138, P351, DOI 10.1148/radiology.138.2.7455114; HERNANDEZ AM, 1978, PARAPLEGIA, V16, P272, DOI 10.1038/sc.1978.52; Hossack D W, 1967, Med J Aust, V1, P326; HSU JD, 1975, CLIN ORTHOP RELAT R, V12, P165; HUNTER T, 1980, RHEUMATOL REHABIL, V19, P97, DOI 10.1093/rheumatology/19.2.97; KEENAN MAE, 1988, J HAND SURG-AM, V13A, P120, DOI 10.1016/0363-5023(88)90214-6; Kjaersgaard-Andersen P., 1988, CLIN ORTHOP RELAT R, V234, P102; KJAERSGAARDANDERSEN P, 1986, ACTA ORTHOP SCAND, V57, P12, DOI 10.3109/17453678608993206; Klein L, 1966, Med Serv J Can, V22, P524; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; LARSON JM, 1981, RHEUMATOL REHABIL, V20, P193, DOI 10.1093/rheumatology/20.4.193; LIBERSON M, 1953, JAMA-J AM MED ASSOC, V152, P1010, DOI 10.1001/jama.1953.03690110024008; Lowell JD, 1982, REVISION TOTAL HIP A, P359; MACLEAN GD, 1966, ARCH DERMATOL, V94, P168, DOI 10.1001/archderm.94.2.168; MACLENNAN I, 1984, INT J RADIAT ONCOL, V10, P49, DOI 10.1016/0360-3016(84)90411-5; MEAD S, 1963, Paraplegia, V1, P62; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; MICHELSSON JE, 1980, J BONE JOINT SURG AM, V62, P811, DOI 10.2106/00004623-198062050-00017; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; MOLLAN RAB, 1979, J BONE JOINT SURG BR, V61, P432; MORREY BF, 1984, CLIN ORTHOP RELAT R, P160; MUHEIM G, 1973, AM J ROENTGENOL, V118, P865, DOI 10.2214/ajr.118.4.865; NICHOLAS JJ, 1973, ARCH PHYS MED REHAB, V54, P354; NILSSON OS, 1986, CLIN ORTHOP RELAT R, P239; NOLLEN AJG, 1986, ACTA ORTHOP SCAND, V57, P358, DOI 10.3109/17453678608994411; NOLLEN AJG, 1973, ACTA ORTHOP SCAND, V44, P230, DOI 10.3109/17453677308988686; ORZEL JA, 1985, J NUCL MED, V26, P125; Ostrowski K., 1971, BIOCHEMISTRY PHYSIOL, P299; PATERSON D C, 1970, Journal of Bone and Joint Surgery British Volume, V52, P296; PETERSON WC, 1963, ARCH DERMATOL, V87, P626, DOI 10.1001/archderm.1963.01590170084014; PLASMANS CMT, 1978, CLIN ORTHOP RELAT R, V132, P233; Prakash V, 1978, Clin Nucl Med, V3, P167, DOI 10.1097/00003072-197805000-00001; PUZAS JE, 1989, CLIN ORTHOP RELAT R, V245, P269; RAGONE DJ, 1986, ARCH PHYS MED REHAB, V67, P339; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; RITTER MA, 1982, CLIN ORTHOP RELAT R, V167, P113; RITTER MA, 1985, CLIN ORTHOP RELAT R, V196, P217; RO J, 1976, ACTA ORTHOP SCAND, V47, P588, DOI 10.3109/17453677608988744; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; ROSSIER AB, 1973, PARAPLEGIA, V11, P36; Russell R G, 1973, J Bone Joint Surg Br, V55, P66; RUSSELL RGG, 1972, LANCET, V1, P10; RUSSELL RGG, 1975, CLIN ORTHOP RELAT R, V108, P241; RUSSELL RGG, 1975, BR J HOSP MED, P297; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120; SCHMIDT SA, 1988, J BONE JOINT SURG AM, V70A, P834, DOI 10.2106/00004623-198870060-00005; SEIGNALET J, 1983, TISSUE ANTIGENS, V21, P268; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; Stover S L, 1976, Paraplegia, V14, P146; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; Sudmann E, 1975, Acta Orthop Scand Suppl, V160, P91; SUDMANN E, 1979, ACTA ORTHOP SCAND, V50, P621, DOI 10.3109/17453677908991283; SUZUKI Y, 1974, RADIOLOGY, V111, P663, DOI 10.1148/111.3.663; SZABO Z, 1982, EUR J NUCL MED, V7, P426; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217; TESTA NN, 1988, ORTHOP REV, V27, P964; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; TIBONE J, 1978, J BONE JOINT SURG AM, V60, P769, DOI 10.2106/00004623-197860060-00007; TORNKVIST H, 1983, SCAND J RHEUMATOL, V12, P177; VANDERLINDEN AJ, 1984, INT ORTHOP, V8, P25, DOI 10.1007/BF00267736; VANDERWERF GJIM, 1985, ARCH ORTHOP TRAUM SU, V104, P85, DOI 10.1007/BF00454243; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VENIER L H, 1971, Archives of Physical Medicine and Rehabilitation, V52, P475; VENTO JA, 1985, CLIN NUCL MED, V10, P206, DOI 10.1097/00003072-198503000-00022; WAINAPEL SF, 1985, ARCH PHYS MED REHAB, V66, P512; WEISS S, 1979, J RHEUMATOL, V6, P88; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	117	265	287	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	FEB	1991		263					13	29					17	Orthopedics; Surgery	Orthopedics; Surgery	EW533	WOS:A1991EW53300003	1899635				2021-06-18	
J	FLETCHER, JM; EWINGCOBBS, L; MINER, ME; LEVIN, HS; EISENBERG, HM				FLETCHER, JM; EWINGCOBBS, L; MINER, ME; LEVIN, HS; EISENBERG, HM			BEHAVIORAL-CHANGES AFTER CLOSED HEAD-INJURY IN CHILDREN	JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY			English	Article									UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550	FLETCHER, JM (corresponding author), UNIV TEXAS,MED SCH HOUSTON,DEPT PEDIAT,MSB 3136,643 FANNIN,HOUSTON,TX 77030, USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; Beery KE, 1982, REVISED ADM SCORING; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; BLAU A, 1936, ARCH PSYCHIAT NEUROL, V35, P733; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1984, M INT NEUROPSYCHOLOG; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEVIN HS, IN PRESS MILD HEAD I; ODDY M, 1984, CLOSED HEAD INJURY P, P148; RUTTER M, 1982, Journal of Clinical Neuropsychology, V4, P91, DOI 10.1080/01688638208401121; Sparrow S., 1984, VINELAND ADAPTIVE BE; TEASDALE G, 1974, LANCET, V2, P81	19	265	265	0	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	0022-006X			J CONSULT CLIN PSYCH	J. Consult. Clin. Psychol.	FEB	1990	58	1					93	98		10.1037/0022-006X.58.1.93			6	Psychology, Clinical	Psychology	CR176	WOS:A1990CR17600012	2319050				2021-06-18	
J	Eastwood, JD; Frischen, A; Fenske, MJ; Smilek, D				Eastwood, John D.; Frischen, Alexandra; Fenske, Mark J.; Smilek, Daniel			The Unengaged Mind: Defining Boredom in Terms of Attention	PERSPECTIVES ON PSYCHOLOGICAL SCIENCE			English	Article						boredom; attention; emotion	TRAUMATIC BRAIN-INJURY; WANDERING MINDS; TIME PERCEPTION; DEFAULT NETWORK; YOUNG-ADULTS; MOODS LEAD; PRONENESS; EXPERIENCE; MODEL; CONSEQUENCES	Our central goal is to provide a definition of boredom in terms of the underlying mental processes that occur during an instance of boredom. Through the synthesis of psychodynamic, existential, arousal, and cognitive theories of boredom, we argue that boredom is universally conceptualized as "the aversive experience of wanting, but being unable, to engage in satisfying activity." We propose to map this conceptualization onto underlying mental processes. Specifically, we propose that boredom be defined in terms of attention. That is, boredom is the aversive state that occurs when we (a) are not able to successfully engage attention with internal (e.g., thoughts or feelings) or external (e.g., environmental stimuli) information required for participating in satisfying activity, (b) are focused on the fact that we are not able to engage attention and participate in satisfying activity, and (c) attribute the cause of our aversive state to the environment. We believe that our definition of boredom fully accounts for the phenomenal experience of boredom, brings existing theories of boredom into dialogue with one another, and suggests specific directions for future research on boredom and attention.	[Eastwood, John D.; Frischen, Alexandra] York Univ, Dept Psychol, Toronto, ON MJ3 1P3, Canada; [Frischen, Alexandra; Fenske, Mark J.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; [Frischen, Alexandra; Smilek, Daniel] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	Eastwood, JD (corresponding author), York Univ, Dept Psychol, 118 Behav Sci Bldg,4700 Keele St, Toronto, ON MJ3 1P3, Canada.	johneast@yorku.ca		Fenske, Mark/0000-0003-4338-7754			BAILEY JP, 1976, PERCEPT MOTOR SKILL, V43, P141, DOI 10.2466/pms.1976.43.1.141; Bar M, 2007, HIPPOCAMPUS, V17, P420, DOI 10.1002/hipo.20287; Bargdill R.W., 2000, J PHENOMENOLOGICAL P, V31, P188, DOI 10.1163/15691620051090979; Berlyne D.E., 1960, CONFLICT AROUSAL CUR; BERNSTEIN HE, 1975, SOC RES, V42, P512; Bhana H., 2010, COLLEGIATE AVIATION, V28, P9; Bloomfield LJ, 2006, P TIM US GEND SEM SY, P1; Blunt A, 1998, PERS INDIV DIFFER, V24, P837, DOI 10.1016/S0191-8869(98)00018-X; Britton A, 2010, INT J EPIDEMIOL, V39, P370, DOI 10.1093/ije/dyp404; Brown SW, 2002, J EXP PSYCHOL HUMAN, V28, P600, DOI 10.1037//0096-1523.28.3.600; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chaston A, 2004, BRAIN COGNITION, V55, P286, DOI 10.1016/j.bandc.2004.02.013; Cherrier MM, 1997, PSYCHIAT RES-NEUROIM, V76, P67, DOI 10.1016/S0925-4927(97)00045-0; *COL U NAT CTR ADD, 2003, NAT SURV AM ATT SUBS, V8; Conrad Peter, 1997, QUALITATIVE SOCIOLOG, V20, P465, DOI DOI 10.1023/A:1024747820595; Critcher CR, 2010, PERS SOC PSYCHOL B, V36, P1255, DOI 10.1177/0146167210375434; Csikszentmihalyi M, 1978, STREAM CONSCIOUSNESS, P335, DOI 10.1007/978-1-4684-2466-9_13; Csikszentmihalyi M., 1975, BOREDOM ANXIETY; Csikszentmihalyi M., 1990, FINDING FLOW PSYCHOL; D'Angiulli A, 2002, ETHICS BEHAV, V12, P167, DOI 10.1207/S15327019EB1202_4; D'Mello S, 2009, APPL ARTIF INTELL, V23, P123, DOI 10.1080/08839510802631745; DAMRADFRYE R, 1989, J PERS SOC PSYCHOL, V57, P315; Danckert JA, 2005, BRAIN COGNITION, V59, P236, DOI 10.1016/j.bandc.2005.07.002; Davies D.R., 1982, PSYCHOL VIGILANCE; DECHENNE TK, 1988, PSYCHOTHER, V25, P71, DOI 10.1037/h0085325; Dumas L., 2001, MED GLOBAL SURVIVAL, V7, P12; Eastwood JD, 2007, PERS INDIV DIFFER, V42, P1035, DOI 10.1016/j.paid.2006.08.027; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; Fahlman SA, 2009, J SOC CLIN PSYCHOL, V28, P307, DOI 10.1521/jscp.2009.28.3.307; Fenichel O., 1951, ORG PATHOLOGY THOUGH, P349, DOI DOI 10.1037/10584-018; Fenichel O., 1953, COLLECTED PAPERS OTT, V1, P292; Fenske MJ, 2006, CURR DIR PSYCHOL SCI, V15, P312, DOI 10.1111/j.1467-8721.2006.00459.x; Fisher C. D., OXFORD HDB WORK ATTI; Fisher CD, 1998, J ORGAN BEHAV, V19, P503, DOI 10.1002/(SICI)1099-1379(199809)19:5<503::AID-JOB854>3.3.CO;2-0; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Fraisse P., 1963, PSYCHOL TIME; Frankl VE., 1984, MANS SEARCH MEANING; Freeman FG, 2004, BIOL PSYCHOL, V67, P283, DOI 10.1016/j.biopsycho.2004.01.002; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Gray J. A., 1972, BIOL BASES INDIVIDUA, P182, DOI DOI 10.1016/B978-0-12-515350-8.50017-X; Greenson R. R, 1951, PSYCHOANAL QUART, V20, P346; GREENSON RR, 1953, J AM PSYCHOANAL ASS, V1, P7, DOI 10.1177/000306515300100102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; Hamilton J. A., 1981, PROGR EXPT PERSONALI, V10, P281; HAMILTON JA, 1984, PERS INDIV DIFFER, V5, P183, DOI 10.1016/0191-8869(84)90050-3; Harris MB, 2000, J APPL SOC PSYCHOL, V30, P576, DOI 10.1111/j.1559-1816.2000.tb02497.x; HARTOCOLLIS P, 1972, J AM PSYCHOANAL ASS, V20, P92, DOI 10.1177/000306517202000104; Hebb DO., 1966, TXB PSYCHOL, V2; HICKS RE, 1974, ACTA PSYCHOL, V38, P447, DOI 10.1016/0001-6918(74)90004-3; HILL AB, 1985, BRIT J PSYCHOL, V76, P235, DOI 10.1111/j.2044-8295.1985.tb01947.x; Hitchcock EM, 1999, HUM FACTORS, V41, P365, DOI 10.1518/001872099779610987; Hunter JP, 2003, J YOUTH ADOLESCENCE, V32, P27, DOI 10.1023/A:1021028306392; James W., 1913, PRINCIPLES PSYCHOL; Jiang Y, 2009, PSYCHIAT RES-NEUROIM, V173, P100, DOI 10.1016/j.pscychresns.2008.09.012; Kanevsky L., 2003, ROEPER REVIEV, V26, P20, DOI DOI 10.1080/02783190309554235; Kant I., 1785, GRUNDLEGUNG METAPHYS; Kass SJ, 2010, ACCIDENT ANAL PREV, V42, P874, DOI 10.1016/j.aap.2009.04.012; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; KLAPP O, 1986, OVERLOAD BOREDOM; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; KUHL J, 1981, J PERS SOC PSYCHOL, V40, P155, DOI 10.1037/0022-3514.40.1.155; Kuhl J., 1987, MOTIVATION INTENTION, P279, DOI DOI 10.1007/978-3-642-70967-8; Lee CM, 2007, ADDICT BEHAV, V32, P1384, DOI 10.1016/j.addbeh.2006.09.010; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15; Lewinsky H, 1943, BRIT J EDUC PSYCHOL, V13, P147, DOI 10.1111/j.2044-8279.1943.tb02734.x; Lipps T., 1903, LEITFADEN PSYCHOL; LONDON H, 1972, J ABNORM PSYCHOL, V80, P29, DOI 10.1037/h0033311; London H., 1974, THOUGHT FEELING, P44, DOI [10.4324/9781315135656-8, DOI 10.4324/9781315135656-8]; LUNDBERG U, 1993, ERGONOMICS, V36, P601, DOI 10.1080/00140139308967923; Maddi S. R., 1970, NEBRASKA S MOTIVATIO, P134; MADDI SR, 1967, J ABNORM PSYCHOL, V72, P311, DOI 10.1037/h0020103; Maltsberger JT, 2000, SUICIDE LIFE-THREAT, V30, P83; Mann S, 2009, BRIT EDUC RES J, V35, P243, DOI 10.1080/01411920802042911; Martin M., 2006, QUAL RES PSYCHOL, V3, P193, DOI [DOI 10.1191/1478088706QRP0660A, 10.1191/1478088706qrp066oa, DOI 10.1191/1478088706QRP066OA]; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MCLEOD CR, 1991, J SOC BEHAV PERS, V6, P137; Melton AMA, 2007, PSYCHOL REP, V101, P1016, DOI 10.2466/PR0.101.4.1016-1022; Mercer KB., 2010, INT GAMBL STUD, V10, P91, DOI [10.1080/1445979100 3754414, DOI 10.1080/14459791003754414, 10.1080/14459791003754414]; Mercer-Lynn KB, 2013, ASSESSMENT, V20, P585, DOI 10.1177/1073191111408229; MIKULAS WL, 1993, PSYCHOL REC, V43, P3; Nakamura J., 2002, HDB POSITIVE PSYCHOL, P89, DOI DOI 10.1007/978-94-017-9088-8_; Newell SE, 2012, INT J SOC PSYCHIATR, V58, P488, DOI 10.1177/0020764011408655; O'Connor D, 1967, J Existent, V7, P381; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OHANLON JF, 1981, ACTA PSYCHOL, V49, P53, DOI 10.1016/0001-6918(81)90033-0; Ohsuga M, 2001, INT J PSYCHOPHYSIOL, V40, P211, DOI 10.1016/S0167-8760(00)00189-6; Pagnoni G, 2012, J NEUROSCI, V32, P5242, DOI 10.1523/JNEUROSCI.4135-11.2012; Parasuraman, 1993, HUM PERFORM, V6, P71, DOI DOI 10.1207/S15327043HUP0601_; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Raymond J, 2009, PROG BRAIN RES, V176, P293, DOI 10.1016/S0079-6123(09)17617-3; Raymond JE, 2003, PSYCHOL SCI, V14, P537, DOI 10.1046/j.0956-7976.2003.psci_1462.x; Ribot T., 1890, PSYCHOL ATTENTION; Rogatko TP, 2009, J HAPPINESS STUD, V10, P133, DOI 10.1007/s10902-007-9069-y; Sackett AM, 2010, PSYCHOL SCI, V21, P111, DOI 10.1177/0956797609354832; Scerbo MW, 1998, VIEWING PSYCHOL WHOL, P135; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; SMITH RP, 1981, HUM FACTORS, V23, P329; Sommers J, 2000, J CLIN PSYCHOL, V56, P149, DOI 10.1002/(SICI)1097-4679(200001)56:1<149::AID-JCLP14>3.0.CO;2-Y; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stickney MI, 1999, INT J EAT DISORDER, V26, P195, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;195::AID-EAT9&gt;3.0.CO;2-2; SUNDBERG ND, 1991, J CROSS CULT PSYCHOL, V22, P209, DOI 10.1177/0022022191222003; Thackray R.I., 1977, VIGILANCE THEORY OPE, P203, DOI DOI 10.1007/978-1-4684-2529-1_12; THACKRAY RI, 1981, PSYCHOSOM MED, V43, P165, DOI 10.1097/00006842-198104000-00008; THOMAS EAC, 1974, PERCEPT PSYCHOPHYS, V16, P449, DOI 10.3758/BF03198571; Todman M, 2003, PSYCHIATRY, V66, P146, DOI 10.1521/psyc.66.2.146.20623; TOLOR A, 1989, J CLIN PSYCHOL, V45, P260, DOI 10.1002/1097-4679(198903)45:2<260::AID-JCLP2270450213>3.0.CO;2-G; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; van Tilburg WAP, 2012, MOTIV EMOTION, V36, P181, DOI 10.1007/s11031-011-9234-9; VODANOVICH SJ, 1991, PSYCHOL REP, V69, P1139, DOI 10.2466/PR0.69.8.1139-1146; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; WANGH M, 1975, SOC RES, V42, P538; Watt JD, 1999, J PSYCHOL, V133, P303, DOI 10.1080/00223989909599743; Weber R, 2009, COMMUN THEOR, V19, P397, DOI 10.1111/j.1468-2885.2009.01352.x; Weinger MB, 1999, J CLIN MONIT COMPUT, V15, P549, DOI 10.1023/A:1009993614060; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; White A., 1998, J SOC EXISTENTIAL AN, V9, P69; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Wiesbeck GA, 1996, EUR PSYCHIAT, V11, P87, DOI 10.1016/0924-9338(96)84785-7; WINKIELMAN P, 2002, EMOTIONAL COGNITION, P111, DOI DOI 10.1075/AICR.44.05WIN; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698; ZAKAY D, 1992, J EXP CHILD PSYCHOL, V54, P355, DOI 10.1016/0022-0965(92)90025-2; Zuckerman M., 1979, CORSINI ENCY PSYCHOL	136	264	270	7	88	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1745-6916	1745-6924		PERSPECT PSYCHOL SCI	Perspect. Psychol. Sci.	SEP	2012	7	5					482	495		10.1177/1745691612456044			14	Psychology, Multidisciplinary	Psychology	000UF	WOS:000308413600005	26168505		Y	N	2021-06-18	
J	Mahmood, A; Lu, DY; Chopp, M				Mahmood, A; Lu, DY; Chopp, M			Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						growth factors; marrow stromal cells; traumatic brain injury	NEUROTROPHIC FACTOR; BONE-MARROW; ADULT-RAT; FUNCTIONAL RECOVERY; SPINAL-CORD; INTRACEREBRAL TRANSPLANTATION; MESSENGER-RNA; UP-REGULATION; DEFICITS; MOTOR	This study was designed to investigate the effects of intravenous administration of marrow stromal cells (MSCs) on the expression of growth factors in rat brain after traumatic brain injury (TBI). The fate of transplanted MSCs and expression of growth factors was examined by immunohistochemistry. In addition, the level of growth factors was measured quantitatively using enzyme linked immunosorbent assay (ELISA). Growth factors that were studied included nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and basic fibroblast growth factor (bFGF). For immunohistochemical studies, 12 male Wistar rats were subjected to TBI and then divided into three groups with the first group receiving no treatment, the second group receiving saline (placebo) and the third group receiving MSCs intravenously 1 day after TBI. The neurological function of rats was studied by using Rotarod motor test and modified neurological severity scores. The animals were sacrificed 15 days after TBI and brain sections stained by immunohistochemistry to study the distribution of MSCs as well as expression of growth factors NGF, BDNF, and bFGF. For quantitative analysis, a second set of male Wistar rats (n = 18) was subjected to TBI and then injected with either saline (n = 9) or MSCs (n = 9) 1 day after injury. These rats were sacrificed on days 2, 5, and 8 after TBI and brain extracts used to measure NGF, BDNF, and bFGF. We found that after transplantation, MSCs preferentially migrated into the injured hemisphere and there was a statistically significant improvement in the functional outcome of MSC-treated rats compared to control rats. NGF, BDNF, and bFGF were expressed in the injured brain of both treated as well as control rats; however, quantitative ELISA studies showed that expression of NGF and BDNF was significantly increased (p < 0.05) in the treated group. This study shows that intravenous administration of MSCs after TBI increases the expression of growth factors (NGF, BDNF), which possibly contributes to the improvement in functional outcome seen in these rats.	Henry Ford Hosp, Dept Neurol & Neurosurg, Detroit, MI 48202 USA	Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nssma@neuro.hfh.edu					Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Liu Y, 1999, J NEUROSCI, V19, P4370; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McTigue DM, 1998, J NEUROSCI, V18, P5354; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Postmantur R., 1997, NEUROSCIENCE, V77, P765; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	29	264	307	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2004	21	1					33	39		10.1089/089771504772695922			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	766GU	WOS:000188368700004	14987463				2021-06-18	
J	Lu, D; Mahmood, A; Wang, L; Li, Y; Lu, M; Chopp, M				Lu, D; Mahmood, A; Wang, L; Li, Y; Lu, M; Chopp, M			Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome	NEUROREPORT			English	Article						intravenous administration; marrow stromal cells; rat; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; TRANSPLANTATION; MICROGLIA; MICE; DIFFERENTIATE; MACROPHAGES; ASTROCYTES; MOTOR	To measure effect of bone marrow stromal cells (MSCs) administered i.v, on rats subjected to traumatic brain injury (TBI), we injected MSCs labeled by BrdU into the tail vein 24 h after TBI and sacrificed rats 15 days later. The neurological severity score (NSS) and the Rotarod test were used to evaluate neurological function. The distribution of the donor cells in brain, heart, lung. kidney, liver and spleen were analyzed in recipient rats using immunohistochemical staining. MSCs injected i.v. significantly reduced motor and neurological deficits compared with control groups by day 15 after TBI. The cells preferentially entered and migrated into the parenchyma of the injured brain and expressed the neuronal marker NeuN and the astrocytic marker GFAP. MSCs were also found in other organs and primarily localized to the vascular structures, without any obvious adverse effects. Our data suggest that i.v. administration of MSCs may be useful in the treatment of TBI. NeuroReport 12:559-563 (C) 2001 Lippincott Williams & Wilkins.	Henry Ford Hlth Sci Ctr, Dept Neurosurg, Detroit, MI 48202 USA; Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI 48202 USA; Henry Ford Hlth Sci Ctr, Dept Biostat, Detroit, MI 48202 USA; Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hlth Sci Ctr, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033627, R01NS035504] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 33627, R01 NS 35504] Funding Source: Medline		Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; CANEVA L, 1995, BLOOD CELL MOL DIS, V21, P73, DOI 10.1006/bcmd.1995.0011; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; DEGROOT CJA, 1992, GLIA, V6, P301, DOI 10.1002/glia.440060408; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KRALL WJ, 1994, BLOOD, V83, P2737; Laurenzi MA, 1998, J LEUKOCYTE BIOL, V64, P228; Lenoir N, 2000, SCIENCE, V287, P1425, DOI 10.1126/science.287.5457.1425; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Postmantur R., 1997, NEUROSCIENCE, V77, P765; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RAMOS SC, 2000, IN PRESS EXP NEUROL, V163; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; WALKLEY SU, 1994, P NATL ACAD SCI USA, V91, P2970, DOI 10.1073/pnas.91.8.2970	24	264	304	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAR 5	2001	12	3					559	563		10.1097/00001756-200103050-00025			5	Neurosciences	Neurosciences & Neurology	403XT	WOS:000167069000025	11234763				2021-06-18	
J	Matser, EJT; Kessels, AG; Lezak, MD; Jordan, BD; Troost, J				Matser, EJT; Kessels, AG; Lezak, MD; Jordan, BD; Troost, J			Neuropsychological impairment in amateur soccer players	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRAIN INJURY	Context Soccer players incur concussions during matches and training sessions, as well as numerous subconcussive blows to the head from impacts with the soccer ball (headers). The combination of soccer-related concussions and the number of headers may be a risk for chronic traumatic brain injury (CTBI). Objective To determine whether amateur soccer players have evidence of CTBI. Design, Setting, and Participants Cross-sectional study of 33 amateur soccer players and 27 amateur athletes involved in swimming and track (controls) in the Netherlands who underwent interviews and neuropsychological testing. Main Outcome Measures Performance of soccer players vs controls on 16 neuropsychological tests having 27 outcomes. Results Compared with control athletes, amateur soccer players exhibited impaired performance on tests of planning (39% vs 13%; P = .001) and memory (27% vs 7%; P = .004). Among soccer players, 9 (27%) had incurred 1 soccer-related concussion and 7 (23%) had had 2 to 5 concussions during their career. The number of concussions incurred in soccer was inversely related to the neuropsychological performance on 6 of the neuropsychological tests. Conclusions Our results indicate that participation in amateur soccer in general and concussion specifically is associated with impaired performance in memory and planning functions. Due to the worldwide popularity of soccer, these observations may have important public health implications.	St Anna Hosp, Det Neuropsychol & Sports Neurol, NL-5560 AB Geldrop, Netherlands; Erasmus Univ, Fac Med & Hlth Sci, Dept Anat, NL-3000 DR Rotterdam, Netherlands; Univ Hosp Maastricht, Res Unit Patient Care, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Neurol, Maastricht, Netherlands; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA; Burke Rehabil Hosp, Traumat Brain Injury Program, White Plains, NY USA	Matser, EJT (corresponding author), St Anna Hosp, Det Neuropsychol & Sports Neurol, POB 90, NL-5560 AB Geldrop, Netherlands.						Benton A.L., 1983, CONTRIBUTIONS NEUROP; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; CORSELLIS JA, 1976, LANCET, V1, P401; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Deelman B, 1980, NEUROPSYCHOLOGIE NED; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Lauter J, 1996, BIOMETRICS, V52, P964, DOI 10.2307/2533057; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Luteyn F, 1966, DUTCH J PSYCHOL, V2, P675; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MATSER JT, 1996, GENEESKUNDE SPORT, V29, P66; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Raven J., 1960, GUIDE STANDARD PROGR; ROBBERTS AH, 1969, BRAIN DAMAGE BOXERS; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Van De Loo L., 1956, TIJIKSCHRIFT PSYCHOL, V2, P33; VANDERVLUGT H, 1979, LATERALISATIES HERSE; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Wechsler, 1981, WAIS R MANUAL; Wechsler D, 1974, WECHSLER MEMORY SCAL; WITOL A, 1994, ARCH CLIN NEUROPSYCH, V9, P104	28	264	265	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	1999	282	10					971	973		10.1001/jama.282.10.971			3	Medicine, General & Internal	General & Internal Medicine	231XD	WOS:000082335900036	10485683	Bronze			2021-06-18	
J	Barell, V; Aharonson-Daniel, L; Fingerhut, LA; Mackenzie, EJ; Ziv, A; Boyko, V; Abargel, A; Avitzour, M; Heruti, R				Barell, V; Aharonson-Daniel, L; Fingerhut, LA; Mackenzie, EJ; Ziv, A; Boyko, V; Abargel, A; Avitzour, M; Heruti, R			An introduction to the Barell body region by nature of injury diagnosis matrix	INJURY PREVENTION			English	Article								Introduction: The Barell body region by nature of injury diagnosis matrix standardizes data selection and reports, using a two dimensional array (matrix) that includes all International Classification of Diseases (ICD)-9-CM codes describing trauma. Aim: To provide a standard format for reports from trauma registries, hospital discharge data systems, emergency department data systems, or other sources of non-fatal injury data. This tool could also be used to characterize the patterns of injury using a manageable number of clinically meaningful diagnostic categories and to serve as a standard for casemix comparison across time and place. Concept: The matrix displays 12 nature of injury columns and 36 body region rows placing each ICD-9-CM code in the range from 800 to 995 in a unique cell location in the matrix. Each cell includes the codes associated with a given injury. The matrix rows and columns can easily be collapsed to get broader groupings or expanded if more specific sites are required. The current matrix offers three standard levels of detail through predefined collapsing of body regions from 36 rows to nine rows to five rows. Matrix development: This paper presents stages in the development and the major concepts and properties of the matrix, using data from the Israeli national trauma registry, and from the US National Hospital Discharge Survey. The matrix introduces new ideas such as the separation of traumatic brain injury (TBI), into three types. Injuries to the eye have been separated from other facial injuries. Other head injuries such as open wounds and burns were categorized separately. Injuries to the spinal cord and spinal column were also separated as are the abdomen and pelvis. Extremities have been divided into upper and lower with a further subdivision into more specific regions. Hip fractures were separated from other lower extremity fractures. Forthcoming developments: The matrix will be used for the development of standard methods for the analysis of multiple injuries and the creation of patient injury profiles. To meet the growing use of ICD-10 and to be applicable to a wider range of countries, the matrix will be translated to ICD-10 and eventually to ICD-10-CM. Conclusion: The Barell injury diagnosis matrix has the potential to serve as a basic tool in epidemiological and clinical analyses of injury data.	Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Off Anal Epidemiol & Hlth Promot, Hyattsville, MD 20782 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA	Aharonson-Daniel, L (corresponding author), Gertner Inst, Trauma & Emergency Med Res Unit, IL-52621 Tel Hashomer, Israel.		Aharonson-Daniel, Limor/F-1998-2012	Aharonson-Daniel, Limor/0000-0003-4585-6892			*AM COLL SURG, 1999, RES OPT CAR INJ PAT; BARELL V, 1999, P INT COLL EFF INJ S; BARELL V, 1996, PLANN SESS INT COLL; BARELL V, 1996, P INT COLL EFF INJ S, V1; MACKENZIE E, 1999, P INT COLL EFF INJ S, V3; PELES E, 2001, HAREFUAH         MAY; PELES E, UNPUB DEFINITE TRAUM; POPOVIC JR, 2001, VITAL HLTH STAT 13, V151; *PRACT MAN INF COR, 1998, INT CLASS DIS; Thurman DJ., 1995, GUIDELINES SURVEILLA; World Health Organization, 1992, ICD 10 INT STAT CLAS; 1997, MORBIDITY MORTALITY, V46, P1	12	263	266	0	7	B M J PUBLISHING INC	SAN FRANCISCO	221 MAIN ST, PO BOX 7690, SAN FRANCISCO, CA 94120-7690 USA	1353-8047			INJ PREV	Inj. Prev.	JUN	2002	8	2					91	96		10.1136/ip.8.2.91			6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	654LF	WOS:000181497800002	12120842	Green Published, Bronze			2021-06-18	
J	Uryu, K; Laurer, H; McIntosh, T; Pratico, D; Martinez, D; Leight, S; Lee, VMY; Trojanowski, JQ				Uryu, K; Laurer, H; McIntosh, T; Pratico, D; Martinez, D; Leight, S; Lee, VMY; Trojanowski, JQ			Repetitive mild brain trauma accelerates A beta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis	JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; amyloid plaques; brain injury; head trauma; APP mice; oxidative stress; cognitive function	CONTROLLED CORTICAL IMPACT; HEAD-INJURY; INCREASED 8,12-ISO-IPF(2-ALPHA)-VI; EXTRACELLULAR LEVELS; DISEASE; PROTEIN; MICE; PEPTIDE; RISK; F-2-ISOPROSTANES	Traumatic brain injury (TBI) increases susceptibility to Alzheimer's disease (AD), but it is not known how TBI contributes to the onset or progression of this common late life dementia. To address this question, we studied neuropathological and behavioral consequences of single versus repetitive mild TBI (mTBI) in transgenic (Tg) mice (Tg2576) that express mutant human Abeta precursor protein, and we demonstrate elevated brain Abeta levels and increased Abeta deposition. Nine-month-old Tg2576 and wild-type mice were subjected to single (n = 15) or repetitive (n = 39) mTBI or sham treatment (n = 37). At 2 d and 9 and 16 weeks after treatment, we assessed brain Abeta deposits and levels in addition to brain and urine isoprostanes generated by lipid peroxidation in these mice. A subset of mice also was studied behaviorally at 16 weeks after injury. Repetitive but not single mTBI increased Abeta deposition as well as levels of Abeta and isoprostanes only in Tg mice, and repetitive mTBI alone induced cognitive impairments but no motor deficits in these mice. This is the first experimental evidence linking TBI to mechanisms of AD by showing that repetitive TBI accelerates brain Abeta accumulation and oxidative stress, which we suggest could work synergistically to promote the onset or drive the progression of AD. Additional insights into the role of TBI in mechanisms of AD pathobiology could lead to strategies for reducing the risk of AD associated with previous episodes of brain trauma and for preventing progressive brain amyloidosis in AD patients.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pharmacol, Philadelphia, PA 19104 USA	Trojanowski, JQ (corresponding author), Hosp Univ Penn, Ctr Neurodegenerat Dis Res, 3rd Floor, Philadelphia, PA 19104 USA.	trojanow@mail.med.upenn.edu	Pratico, Domenico/ABA-9590-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS008803, P50-NS08803] Funding Source: Medline		Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bayer TA, 2001, BRAIN PATHOL, V11, P1; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HENSLEY K, 1995, P W PHARMACOL SOC, V38, P113; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Koppaka V, 2000, BIOCHEMISTRY-US, V39, P10011, DOI 10.1021/bi000619d; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pratico D, 2000, AM J MED, V109, P577, DOI 10.1016/S0002-9343(00)00547-7; Pratico D, 1999, ATHEROSCLEROSIS, V147, P1, DOI 10.1016/S0021-9150(99)00257-9; Pratico D, 2000, ANN NEUROL, V48, P795, DOI 10.1002/1531-8249(200011)48:5<795::AID-ANA15>3.3.CO;2-R; Pratico D, 1998, FASEB J, V12, P1777; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.3.CO;2-0; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; WISNIEWSKI T, 1994, ANN NEUROL, V35, P245, DOI 10.1002/ana.410350223; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yatin SM, 1999, NEUROBIOL AGING, V20, P325	59	263	270	0	20	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	JAN 15	2002	22	2					446	454		10.1523/JNEUROSCI.22-02-00446.2002			9	Neurosciences	Neurosciences & Neurology	510JK	WOS:000173204800015	11784789	Green Published, Bronze			2021-06-18	
J	Geddes, JF; Hackshaw, AK; Vowles, GH; Nickols, CD; Whitwell, HL				Geddes, JF; Hackshaw, AK; Vowles, GH; Nickols, CD; Whitwell, HL			Neuropathology of inflicted head injury in children I. Patterns of brain damage	BRAIN			English	Article						non-accidental head injuries; infant head injury; subdural hemorrhage; child abuse	DIFFUSE AXONAL INJURY; DIAGNOSIS; TRAUMA; INFANTS; SHAKING; LESIONS; MRI	Fifty-three cases of non-accidental head injury in children were subjected to detailed neuropathological study, which included immunocytochemistry for microscopic damage. Clinical details were available for all the cases. There were 37 infants, age at head injury ranging from 20 days to 9 months, and 16 children (range 13 months to 8 years). The most common injuries were skull fractures (36% of cases), acute subdural bleeding (72%) and retinal haemorrhages (71%); the most usual cause of death was raised intracranial pressure secondary to brain swelling (82%). On microscopy, severe hypoxic brain damage was present in 77% of cases. While vascular axonal damage was found in 21 out of 53 cases, diffuse traumatic axonal injury was present in:only three. Eleven additional cases, all of them infants, showed evidence of localized axonal injury to the craniocervical junction or the cervical cord. When the data were analysed by median age at head injury, statistically significant patterns of age related damage emerged. Our study shows that infants of 2-3 months typically present with a history of apnoea or other breathing abnormalities, show axonal damage at the craniocervical junction, and tend also to have a skull fracture, a thin film of subdural haemorrhage, but lack extracranial injury. Children over 1 year are more likely to suffer severe extracranial, particularly abdominal, injuries. They tend to have larger subdural haemorrhages, and where traumatic axonal injury is present, show patterns of hemispheric white matter damage more akin to those reported in adults. Diffuse axonal injury is an uncommon sequel of inflicted head injury in children.	Univ London, Dept Histopathol & Morbid Anat, London WC1E 7HU, England; Univ London, Dept Environm & Preventat Med, London WC1E 7HU, England; Univ Sheffield, Dept Forens Pathol, Sheffield S10 2TN, S Yorkshire, England	Geddes, JF (corresponding author), Royal London Hosp, Dept Histopathol & Morbid Anat, London E1 1BB, England.	j.f.geddes@mds.qmw.ac.uk					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1994, INTRO NEUROPATHOLGY; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; CAFFEY J, 1974, PEDIATRICS, V54, P396; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Carter J E, 1983, Child Abuse Negl, V7, P279, DOI 10.1016/0145-2134(83)90005-4; David TJ, 1999, J ROY SOC MED, V92, P556, DOI 10.1177/014107689909201105; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Feldman KW, 1997, CHILD ABUSE NEGLECT, V21, P199, DOI 10.1016/S0145-2134(96)00145-7; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; HAUSDORF G, 1984, NEUROPEDIATRICS, V15, P110, DOI 10.1055/s-2008-1052351; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P333; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Taylor D, 1999, EYE, V13, P3; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185	25	263	270	1	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2001	124		7				1290	1298		10.1093/brain/124.7.1290			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	454AA	WOS:000169949200003	11408324	Bronze			2021-06-18	
J	Brundin, P; Karlsson, J; Emgard, M; Schierle, GSK; Hansson, O; Petersen, A; Castilho, RF				Brundin, P; Karlsson, J; Emgard, M; Schierle, GSK; Hansson, O; Petersen, A; Castilho, RF			Improving the survival of grafted dopaminergic neurons: A review over current approaches	CELL TRANSPLANTATION			English	Article; Proceedings Paper	10th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR)	DEC 04-06, 1999	AMSTERDAM, NETHERLANDS	Network European CNS Transplantat & Restorat		transplantation; Parkinson's disease; neuroprotection; growth factor; cell death	FIBROBLAST GROWTH-FACTOR; EMBRYONIC MESENCEPHALIC NEURONS; TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; RAT SUBSTANTIA-NIGRA; TERT-BUTYL-NITRONE; CU/ZN SUPEROXIDE-DISMUTASE; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; IN-VITRO	Neural transplantation is developing into a therapeutic alternative in Parkinson's disease. A major limiting factor is that only 3-20% of grafted dopamine neurons survive the procedure. Recent advances regarding how and when the neurons die indicate that events preceding actual tissue implantation and during the first week thereafter are crucial, and that apoptosis plays a pivotal role. Triggers that may initiate neuronal death in grafts include donor tissue hypoxia and hypoglycemia, mechanical trauma, free radicals, growth factor deprivation, and excessive extracellular concentrations of excitatory amino acids in the host brain. Four distinct phases during grafting that can involve cell death have been identified: retrieval of the embryo; dissection and preparation of the donor tissue; implantation procedure followed by the immediate period after graft injection; and later stages of graft maturation. During these phases, cell death processes involving free radicals and caspase activation (leading to apoptosis) may be triggered, possibly involving an increase in intracellular calcium. We review different approaches that reduce cell death and increase survival of grafted neurons, typically by a factor of 2-4. For example, changes in transplantation procedure such as improved media and implantation technique can be beneficial. Calcium channel antagonists such as nimodipine and flunarizine improve nigral graft survival. Agents that counteract oxidative stress and its consequences, such as superoxide dismutase overexpression, and lazaroids can significantly increase the survival of transplanted dopamine neurons. Also, the inhibition of apoptosis by a caspase inhibitor has marked positive effects. Finally, basic fibroblast growth factor and members of the transforming growth factor-beta super-family, such as glial cell line-derived neurotrophic factor, significantly improve the outcome of nigral transplants. These recent advances provide hope for improved survival of transplanted neurons in patients with Parkinson's disease, reducing the need for human embryonic donor tissue and increasing the likelihood of a successful outcome.	Lund Univ, Wallenberg Neurosci Ctr, Dept Physiol Sci, Sect Neuronal Survival, SE-22362 Lund, Sweden	Brundin, P (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Physiol Sci, Sect Neuronal Survival, Solvegatan 17, SE-22362 Lund, Sweden.	Patrik.Brundin@neurol.lu.se	Hansson, Oskar/A-7134-2013; Castilho, Roger F/G-3906-2012; Petersen, Asa/E-6064-2011	Hansson, Oskar/0000-0001-8467-7286; Castilho, Roger/0000-0003-2338-8717			Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Apostolides C, 1998, NEUROSCIENCE, V83, P363, DOI 10.1016/S0306-4522(97)00369-2; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BARBIN G, 1985, DEV NEUROSCI-BASEL, V7, P296, DOI 10.1159/000112298; Barkats M, 1997, NEUROSCIENCE, V78, P703, DOI 10.1016/S0306-4522(96)00526-X; BARKER RA, 1995, CELL TRANSPLANT, V4, P173, DOI 10.1016/0963-6897(95)90032-2; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; BEYER C, 1991, J NEUROSCI, V11, P1325; BJORKLUND A, 1983, ACTA PHYSIOL SCAND, P1; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, P55; Bjorklund L, 1997, EXP NEUROL, V148, P324, DOI 10.1006/exnr.1997.6655; BRAUGHLER J M, 1989, Drugs of the Future, V14, P143; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; Brundin P, 1999, J NEUROSURG, V90, P804; BRUNDIN P, 1990, PROG BRAIN RES, V82, P707; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; BRUNDIN P, 1986, DEV BRAIN RES, V24, P77, DOI 10.1016/0165-3806(86)90174-4; BRUNDIN P, 1991, METHODS NEUROSCIENCE, V7, P305; BRUNDIN P, 1994, FUNCTIONAL NEURAL TR, P9; Brundin P, 1987, PROG BRAIN RES <D>, V71, P293; Burke RE, 1998, J NEUROCHEM, V71, P517; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Clarkson ED, 1995, NEUROREPORT, V7, P145, DOI 10.1097/00001756-199512290-00035; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; COSTANTINI LC, 1994, EXP NEUROL, V127, P219, DOI 10.1006/exnr.1994.1098; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; deBilbao F, 1996, NEUROREPORT, V7, P3051, DOI 10.1097/00001756-199611250-00051; DECKWERTH TL, 1993, ANN NY ACAD SCI, V679, P121, DOI 10.1111/j.1749-6632.1993.tb18293.x; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; DUAN WM, 1995, EXP BRAIN RES, V104, P227; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; EICHLER ME, 1994, J NEUROCHEM, V62, P2148; Elimadi A, 1998, EUR J PHARMACOL, V348, P115, DOI 10.1016/S0014-2999(98)00135-6; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; EMGARD M, 1999, SOC NEUR ABSTR, V25; EmgardMattson M, 1997, CELL TRANSPLANT, V6, P277, DOI 10.1016/S0963-6897(97)00038-9; EMMETT CJ, 1990, NEUROSCIENCE, V38, P213, DOI 10.1016/0306-4522(90)90387-J; ENGELE J, 1991, J NEUROSCI, V11, P3070; Engele J, 1998, J NEUROSCI RES, V53, P405, DOI 10.1002/(SICI)1097-4547(19980815)53:4<405::AID-JNR2>3.3.CO;2-V; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; Fici GJ, 1997, FREE RADICAL BIO MED, V22, P223, DOI 10.1016/S0891-5849(96)00296-1; FINGER S, 1989, EXP NEUROL, V104, P1, DOI 10.1016/0014-4886(89)90001-0; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; FRODL EM, 1994, NEUROREPORT, V5, P2393, DOI 10.1097/00001756-199411000-00045; FRODL EM, 1994, BRAIN RES, V647, P286, DOI 10.1016/0006-8993(94)91328-5; GERMAN DC, 1983, J NEURAL TRANSM, V57, P243, DOI 10.1007/BF01248996; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Glozman S, 1997, NEUROCHEM RES, V22, P201, DOI 10.1023/A:1027371725159; Granholm AC, 1997, EXP BRAIN RES, V116, P29, DOI 10.1007/PL00005741; GrasbonFrodl EM, 1997, EXP BRAIN RES, V113, P138, DOI 10.1007/BF02454149; GrasbonFrodl EM, 1996, J NEUROCHEM, V67, P1653; GrasbonFrodl EM, 1996, BRAIN RES BULL, V39, P341, DOI 10.1016/0361-9230(96)00001-9; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121; HALL ED, 1997, NEUROPROTECTION CNS, P161; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Haque NSK, 1996, BRAIN RES, V712, P45, DOI 10.1016/0006-8993(95)01427-6; HAQUE NSK, 1995, NEUROREPORT, V6, P2177, DOI 10.1097/00001756-199511000-00019; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; HEDREEN JC, 1972, BRAIN RES, V47, P1, DOI 10.1016/0006-8993(72)90248-X; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; Horger BA, 1998, J NEUROSCI, V18, P4929; HYMAN C, 1994, J NEUROSCI, V14, P335; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JANEC E, 1993, MOL CELL NEUROSCI, V4, P30, DOI 10.1006/mcne.1993.1004; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Karlsson J, 1998, BRAIN RES, V805, P155, DOI 10.1016/S0006-8993(98)00702-1; KARLSSON J, IN PRESS BRAIN RES I; Klann E, 1998, J NEUROPHYSIOL, V80, P452; Kordower JH, 1996, J COMP NEUROL, V370, P203; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Leist M, 1998, REV PHYSIOL BIOCH P, V132, P79, DOI 10.1007/BFb0004986; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MAHALIK TJ, 1994, EXP NEUROL, V129, P27, DOI 10.1006/exnr.1994.1144; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MAYER E, 1993, NEUROSCIENCE, V56, P389, DOI 10.1016/0306-4522(93)90340-L; McEnery MW, 1998, J BIOENERG BIOMEMBR, V30, P409, DOI 10.1023/A:1021997924473; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Mehta V, 1998, J NEUROSURG, V88, P1088, DOI 10.3171/jns.1998.88.6.1088; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; NAKAO N, 1995, NAT MED, V1, P226, DOI 10.1038/nm0395-226; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; Nakao N, 1996, NEUROSCIENCE, V73, P185, DOI 10.1016/0306-4522(96)00034-6; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; NIKKHAH G, 1995, BRAIN RES, V687, P22, DOI 10.1016/0006-8993(95)00472-3; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Olney J, 1978, KAINIC ACID TOOL NEU, P95; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; Othberg A, 1997, EXP NEUROL, V147, P498, DOI 10.1006/exnr.1997.6594; Othberg A, 1998, EXP NEUROL, V154, P260; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rosenblad C, 1996, NEUROSCIENCE, V75, P979; ROSENBLAD C, UNPUB NEURTURIN ENHA; SAUER H, 1991, RESTOR NEUROL NEUROS, V2, P123, DOI 10.3233/RNN-1991-2302; SAUER H, 1993, BRAIN RES, V626, P37, DOI 10.1016/0006-8993(93)90560-A; Sautter J, 1998, EXP NEUROL, V149, P230, DOI 10.1006/exnr.1997.6718; Schierle GS, 1998, NEUROREPORT, V9, P1313, DOI 10.1097/00001756-199805110-00011; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schierle GS, 1999, EUR J NEUROSCI, V11, P3073, DOI 10.1046/j.1460-9568.1999.00727.x; Schierle GS, 1999, EXP NEUROL, V157, P338, DOI 10.1006/exnr.1999.7066; Schierle GSK, 1999, NEUROSCIENCE, V94, P17, DOI 10.1016/S0306-4522(99)00324-3; Schmid-Elsaesser R, 1999, BRAIN RES, V816, P471, DOI 10.1016/S0006-8993(98)01197-4; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SIMONDS GR, 1990, BRAIN RES, V530, P12, DOI 10.1016/0006-8993(90)90652-R; Sinclair SR, 1996, NEUROREPORT, V7, P2547, DOI 10.1097/00001756-199611040-00029; Sinclair SR, 1999, NEUROREPORT, V10, P1263, DOI 10.1097/00001756-199904260-00020; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Sortwell CE, 1998, J COMP NEUROL, V399, P530, DOI 10.1002/(SICI)1096-9861(19981005)399:4<530::AID-CNE6>3.0.CO;2-2; STUDER L, 1995, EUR J NEUROSCI, V7, P223, DOI 10.1111/j.1460-9568.1995.tb01058.x; Sullivan AM, 1998, EUR J NEUROSCI, V10, P3681, DOI 10.1046/j.1460-9568.1998.00378.x; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Tabbal S, 1998, CURR OPIN NEUROL, V11, P341, DOI 10.1097/00019052-199808000-00010; TAKAYAMA H, 1995, NAT MED, V1, P53, DOI 10.1038/nm0195-53; TAKEI M, 1994, NEUROCHEM RES, V19, P1199, DOI 10.1007/BF00965156; TEPPER JM, 1994, NEUROSCIENCE, V60, P469, DOI 10.1016/0306-4522(94)90258-5; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TYTGAT J, 1988, N-S ARCH PHARMACOL, V337, P690; Van Muiswinkel FL, 1998, BRAIN RES, V792, P48, DOI 10.1016/S0006-8993(98)00120-6; Watts C, 1998, CELL TRANSPLANT, V7, P573, DOI 10.1177/096368979800700608; WATTS C, 1998, SOC NEUR ABSTR; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang LC, 1998, J NEUROSCI, V18, P8145; YUE TL, 1992, BRAIN RES, V574, P193, DOI 10.1016/0006-8993(92)90816-R; Yung KKL, 1998, NEUROCHEM INT, V33, P313, DOI 10.1016/S0197-0186(98)00034-5; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011; Yurek DM, 1998, EXP NEUROL, V153, P195, DOI 10.1006/exnr.1998.6884; YUREK DM, 1990, EXP NEUROL, V109, P191, DOI 10.1016/0014-4886(90)90073-2; Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X; Zeng BY, 1996, EXP NEUROL, V139, P214, DOI 10.1006/exnr.1996.0095	152	262	280	0	30	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	MAR-APR	2000	9	2					179	195		10.1177/096368970000900205			17	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	312GR	WOS:000086935300005	10811392	Bronze			2021-06-18	
J	ROOF, RL; DUVDEVANI, R; BRASWELL, L; STEIN, DG				ROOF, RL; DUVDEVANI, R; BRASWELL, L; STEIN, DG			PROGESTERONE FACILITATES COGNITIVE RECOVERY AND REDUCES SECONDARY NEURONAL LOSS CAUSED BY CORTICAL CONTUSION INJURY IN MALE-RATS	EXPERIMENTAL NEUROLOGY			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD; LIPID-PEROXIDATION; METHYLPREDNISOLONE; CORTEX; WATER; CAT	The ability of progesterone to reduce the cerebral edema associated with traumatic brain damage first became apparent when we observed that males had significantly more edema than females after cortical contusion. In addition, edema was almost absent in pseudopregnant female rats, a condition in which progesterone levels are high relative to estrogen. Progesterone injections given after injury also reduced edema and were equally effective in both males and females. The present experiment was done to deter mine if the progesterone induced reduction in edema could also prevent secondary neuronal degeneration and reduce the behavioral impairments that accompany contusion of the medial frontal cortex. Progesterone-treated rats were less impaired on a Morris water maze spatial navigation task than rats treated with the oil vehicle. Progesterone-treated rats also showed less neuronal degeneration 21 days after injury in the medial dorsal thalamic nucleus, a structure that has reciprocal connections with the contused area. (C) 1994 Academic Press, Inc.		ROOF, RL (corresponding author), RUTGERS STATE UNIV, INST ANIM BEHAV, BRAIN RES LAB, 101 WARREN ST, NEWARK, NJ 07102 USA.		Stein, Donald/AAJ-5139-2020		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49CCR208836] Funding Source: Medline		ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; BANGHAM AD, 1965, J MOL BIOL, V13, P253, DOI 10.1016/S0022-2836(65)80094-8; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; CORKIN S, 1965, NEUROPSYCHOLOGIA, V3, P339, DOI 10.1016/0028-3932(65)90006-0; Demopoulos H, 1979, NEURAL TRAUMA, P63; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; DEMOPOULOS HB, 1972, STEROIDS BRAIN EDEMA, P29; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; HALKSMILLER M, 1981, DEV BRAIN RES, V2, P439, DOI 10.1016/0165-3806(81)90052-3; HALL ED, 1993, RES P ARNMD, V71, P81; HALL ED, 1981, EXP NEUROL, V73, P321, DOI 10.1016/0014-4886(81)90067-4; HALL ED, 1982, J NEUROSURG, V57, P247, DOI 10.3171/jns.1982.57.2.0247; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hoffman S. W., 1992, Society for Neuroscience Abstracts, V18, P170; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KOLB B, 1990, PROG BRAIN RES, V85, P501; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Milner B, 1964, FRONTAL GRANULAR COR, P313; Mitamura J A, 1981, Neurol Res, V3, P329; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; OLSON JJ, 1988, BRAIN RES, V439, P259, DOI 10.1016/0006-8993(88)91482-5; Paxinos G., 1982, RAT BRAIN STEREOTAXI; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1993, PROGESTERONE REDUCES; SELIGMAN ML, 1979, PHOTOCHEM PHOTOBIOL, V29, P549, DOI 10.1111/j.1751-1097.1979.tb07089.x; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; SUTTON R, 1990, SOC NEUR ABSTR, V17, P165; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; WILCOX RR, 1987, ANNU REV PSYCHOL, V38, P29, DOI 10.1146/annurev.psych.38.1.29; YOUNG W, 1993, RES P ARNMD, V71, P191	42	262	264	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	1994	129	1					64	69		10.1006/exnr.1994.1147			6	Neurosciences	Neurosciences & Neurology	PM769	WOS:A1994PM76900007	7925843				2021-06-18	
J	Babikian, T; Asarnow, R				Babikian, Talin; Asarnow, Robert			Neurocognitive Outcomes and Recovery After Pediatric TBI: Meta-Analytic Review of the Literature	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; pediatric; meta analysis; neurocognitive outcomes	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; DEFICIT HYPERACTIVITY DISORDER; WORKING-MEMORY; NEUROBEHAVIORAL RECOVERY; PSYCHIATRIC-DISORDERS; BEHAVIORAL SEQUELAE; CHILDREN; ADOLESCENTS; MILD	Traumatic Brain injury (TBI) continues to be one of the leading causes of death and disability in the pediatric population. Although the literature on neurocognitive outcomes is relatively rich, studies vary significantly in the methods used to group subjects on several moderating variables, including age at injury, injury severity, and time since injury, making it difficult to combine and summarize the data for comparison. Further complicating this effort is the wide range of measures used to document functional outcomes in key neurocognitive domains. In this meta-analytic review, 28 publications (1988 to 2007) that met inclusion criteria were summarized based on three distinct injury severity and time post injury groups for 14 key neurocognitive domains. Effect sizes were calculated to reflect the extent to which the above groups differed in case-control and case-case studies, as well as address recovery based on longitudinal studies. To the best of our knowledge, this is the first published quantitative summary of the literature on neurocognitive outcomes after pediatric TBI. Limitations of the current state of the literature as well as recommendations for future studies are discussed.	[Babikian, Talin; Asarnow, Robert] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Babikian, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 760 Westwood Plaza,Room 58-217, Los Angeles, CA 90095 USA.	tbabikian@mednet.ucla.edu			NIH/NINDS fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS053169]; Della Martin Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS053169] Funding Source: NIH RePORTER	Support for this work was funded by an NIH/NINDS fellowship (F32NS053169) and a fellowship through the Della Martin Foundation awarded to the primary author.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Ayr LK, 2005, J INT NEUROPSYCH SOC, V11, P249, DOI 10.1017/S1355617705050307; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; Borenstein M., 2007, META ANAL FIXED EFFE; Borenstein MHL, 2005, COMPREHENSIVE META A; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; *CDC, 2000, TRAUM BRAIN INJ US A; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DENNIS M, 2000, PEDIAT NEUROPSYCHOLO, V3; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GILLES EE, 1999, PEDIAT NEUROLOGY PRI, P898; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HEBB DO, 1942, P AM PHILOS SOC, V85, P265; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lehnung M, 2003, BRAIN INJURY, V17, P855, DOI 10.1080/0269905031000089369; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McCartney K, 2000, CHILD DEV, V71, P173, DOI 10.1111/1467-8624.00131; Ong LC, 1998, J PAEDIATR CHILD H, V34, P363, DOI 10.1046/j.1440-1754.1998.00239.x; Parry L, 2004, CHILD NEUROPSYCHOL, V10, P248, DOI 10.1080/09297040490909279; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; STRAUSS ME, 1987, NEUROBEHAVIORAL RECO; Verger K, 2000, BRAIN INJURY, V14, P495	56	261	262	0	41	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2009	23	3					283	296		10.1037/a0015268			14	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	439XW	WOS:000265662000002	19413443	Green Accepted			2021-06-18	
J	Iverson, GL; Gaetz, M; Lovell, MR; Collins, MW				Iverson, GL; Gaetz, M; Lovell, MR; Collins, MW			Cumulative effects of concussion in amateur athletes	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; COMPLAINT BASE RATES; AXONAL INJURY; SYMPTOMS; PERFORMANCE	Primary objective : To examine the possibility that athletes with multiple concussions show cumulative effects of injury. Methods and procedures : Amateur athletes with a history of three or more concussions were carefully matched (gender, age, education and sport) with athletes with no prior concussions. All completed a computerized neuropsychological test battery at preseason (ImPACT) and then within 5 days of sustaining a concussion (mean = 1.7 days). Main outcomes and results : There were differences between groups in symptom reporting and memory performance. At baseline (i.e. preseason), athletes with multiple concussions reported more symptoms than athletes with no history of concussion. At approximately 2 days post-injury, athletes with multiple concussions scored significantly lower on memory testing than athletes with a single concussion. Athletes with multiple concussions were 7.7 times more likely to demonstrate a major drop in memory performance than athletes with no previous concussions. Conclusions : This study provides preliminary evidence to suggest that athletes with multiple concussions might have cumulative effects.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B4, Canada; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2B4, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Cantu R. C., 1995, PHYS SPORT MED, P2327; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hayes JS, 1998, ARCH CLIN NEUROPSYCH, V13, P27; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; MAWDSLEY C, 1963, LANCET, V2, P795; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Serel M, 1962, WORLD NEUROL, V3, P351; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; UNTERHARNSCHEID.FJ, 1975, HDB CLIN NEUROLOGY, P527; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	46	261	263	0	198	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2004	18	5					433	443		10.1080/02699050310001617352			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	800SS	WOS:000220048600003	15195792				2021-06-18	
J	Giannoudis, PV; MacDonald, DA; Matthews, SJ; Smith, RM; Furlong, AJ; De Boer, P				Giannoudis, PV; MacDonald, DA; Matthews, SJ; Smith, RM; Furlong, AJ; De Boer, P			Nonunion of the femoral diaphysis - The influence of reaming and non-steroidal anti-inflammatory drugs	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SHAFT FRACTURES; HETEROTOPIC OSSIFICATION; RATS; INDOMETHACIN; OSTEOTOMIES; EXPERIENCE; REPAIR	We assessed factors which may affect union in 32 patients with nonunion of a fracture of the diaphysis of the femur and 67 comparable patients whose fracture had united. These included gender, age, smoking habit, the use of non-steroidal anti-inflammatory drugs (NSAIDs) the type of fracture (AO classification), soft-tissue injury (open or closed), the type of nail, the mode of locking, reaming v non-reaming, infection, failure of the implant, distraction at the fracture site, and the time to full weight-bearing. Patients with severe head injuries were excluded. Both groups were comparable with regard to gender, Injury Severity Score and soft-tissue injury. There was no relationship between the rate of union and the type of implant, mode of locking, reaming, distraction or smoking. There were fewer cases of nonunion in more comminuted fractures (type C) and in patients who were able to bear weight early. There was a marked association between nonunion and the use of NSAIDs after injury (p = 0.000001) and delayed healing was noted in patients who took NSAIDs and whose fractures had united.	St James Univ Hosp, Dept Orthopaed & Trauma, Leeds LS9 7TF, W Yorkshire, England; York Dist Gen Hosp, Dept Orthopaed & Trauma, York YO3 7HE, N Yorkshire, England	Smith, RM (corresponding author), St James Univ Hosp, Dept Orthopaed & Trauma, Beckett St, Leeds LS9 7TF, W Yorkshire, England.		Giannoudis, Peter/AAA-3617-2020	Giannoudis, Peter/0000-0002-5205-7696			ALLEN HL, 1980, ACTA ORTHOP SCAND, V51, P595, DOI 10.3109/17453678008990848; ALTMAN RD, 1990, SEMIN ARTHRITIS RHEU, V19, P1; ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006; ANDERSON LD, 1971, CAMPBELLS OPERATIVE, P565; BABIN SR, 1983, INT ORTHOP, V7, P133; BOSTMAN O, 1989, J TRAUMA, V29, P639; BOYD HB, 1961, J BONE JOINT SURG AM, V43, P159, DOI 10.2106/00004623-196143020-00001; BOYD HB, 1960, NONUNION SHAFTS LONG; BROOKS PM, 1991, NEW ENGL J MED, V324, P1716; BRUMBACK RJ, 1988, J BONE JOINT SURG AM, V70A, P1453, DOI 10.2106/00004623-198870100-00003; BRUMBACK RJ, 1990, J BONE JOINT SURG AM, V72A, P1067, DOI 10.2106/00004623-199072070-00017; Butcher C., 1996, INJURY, V27, P375; CARR CR, 1973, J BONE JOINT SURG AM, VA 55, P690, DOI 10.2106/00004623-197355040-00002; Clatworthy MG, 1998, J BONE JOINT SURG BR, V80B, P485, DOI 10.1302/0301-620X.80B3.7493; CURYLO LJ, 1994, ORTHOP INTER, V2, P465; Dimar JR, 1996, SPINE, V21, P1870, DOI 10.1097/00007632-199608150-00006; Dorn U, 1998, ACTA ORTHOP SCAND, V69, P107, DOI 10.3109/17453679809117607; EID AM, 1980, ARCH ORTHOP TRAUM SU, V96, P213, DOI 10.1007/BF00457785; ENGESAETER LB, 1992, ACTA ORTHOP SCAND, V63, P330, DOI 10.3109/17453679209154794; Furlong AJ, 1997, INJURY, V28, P9, DOI 10.1016/S0020-1383(96)00147-7; Giannoudis PV, 1997, INJURY, V28, P15, DOI 10.1016/S0020-1383(96)00146-5; GOEL A, 1991, J BONE JOINT SURG BR, V73, P255; GRUNDNES O, 1991, ACTA ORTHOP SCAND, V62, P163, DOI 10.3109/17453679108999248; Hammacher ER, 1998, J TRAUMA, V45, P517, DOI 10.1097/00005373-199809000-00015; HOGEVOLD HE, 1992, ACTA ORTHOP SCAND, V63, P607; HUO MH, 1991, J ORTHOPAED RES, V9, P383, DOI 10.1002/jor.1100090310; KAMDAR BA, 1974, INJURY, V6, P7, DOI 10.1016/0020-1383(74)90162-4; KELLER J, 1987, ACTA ORTHOP SCAND, V58, P379, DOI 10.3109/17453678709146360; KHAN IM, 1997, AM J ORTHOPSYCHIAT, V26, P413; Krettek C, 1996, INJURY, V27, P233, DOI 10.1016/0020-1383(96)00008-3; KROPFL A, 1995, J TRAUMA, V38, P717; KYRO A, 1993, ANN CHIR GYNAECOL FE, V82, P254; LINDHOLM TS, 1981, SCAND J RHEUMATOL, V10, P38; MEADOWS TH, 1990, J BONE JOINT SURG AM, V72A, P1074, DOI 10.2106/00004623-199072070-00018; MORE RC, 1989, CLIN ORTHOP RELAT R, P306; MULLER ME, COMPREHENSIVE CLASSI, P90; NEPOLA JV, 1993, J BONE JOINT SURG AM, V75A, P1816, DOI 10.2106/00004623-199312000-00012; PRITCHETT J, 1995, CLIN ORTHOP RELAT R, P162; STREET D M, 1953, Clin Orthop, V2, P93; Webb L X, 1988, J Orthop Trauma, V2, P10, DOI 10.1097/00005131-198802000-00003; WICKSTROM J, 1968, CLIN ORTHOP RELAT R, P103; WINQUIST RA, 1984, J BONE JOINT SURG AM, V66A, P529, DOI 10.2106/00004623-198466040-00006	42	261	269	0	21	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	JUL	2000	82B	5					655	658		10.1302/0301-620X.82B5.9899			4	Orthopedics; Surgery	Orthopedics; Surgery	341QD	WOS:000088600300008	10963160				2021-06-18	
J	He, J; Evans, CO; Hoffman, SW; Oyesiku, NM; Stein, DG				He, J; Evans, CO; Hoffman, SW; Oyesiku, NM; Stein, DG			Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TBI; neurosteroids; allopregnanolone; progesterone; inflammation; cytokines; IL1 beta; TNF-alpha; CNS repair	TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH-FACTOR; CLOSED-HEAD INJURY; FACTOR-ALPHA; MESSENGER-RNA; RAT-BRAIN; CELL-DEATH; IN-VITRO	Following a traumatic brain injury (TBI), the excessive release of interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) is a major cause of cerebral edema, which, in turn, can cause permanent neuronal loss and cognitive deficits in laboratory rats. This study examined the changes in expression of the proinflammatory cytokines IL-1beta and TNF-alpha after progesterone (8 mg/kg) or allopregnanolone (4 mg/kg) treatment in brain-injured rats at 3, 8, and 12 h and 6 days post-injury. Adult male rats received either bilateral prefrontal cortical contusion or sham surgery. The hormones were given intraperitoneally at 1 and 6 h, and continued once per day for up to 5 days. The gene expression of IL-1beta and TNF-alpha was measured by mRNA using real-time quantitative reverse transcripted polymerase chain reaction (RT-PCR). The protein concentrations of IL-1beta and TNF-alpha were measured using enzyme-linked immunosorbent assay (ELISA) to confirm the translation from mRNA to protein. The results indicated that progesterone and allopregnanolone reduce both IL-1beta and TNF-alpha at 3 h post-injury, when the expression of these cytokines peaks. At 8 and 12 h post-injury, IL-1beta and TNF-alpha gene expression in injured rats was still elevated compared to shams. By the sixth day post-injury, cytokine expression was back to the level of intact rats. We conclude that progesterone and allopregnanolone may attenuate the production of proinflammatory cytokines early after TBI, and this may be one mechanism by which progesterone and allopregnanolone reduce cerebral edema and promote functional recovery from TBI. (C) 2004 Elsevier Inc. All rights reserved.	Emory Univ, Brain Res Lab, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Stein, DG (corresponding author), Emory Univ, Brain Res Lab, Dept Psychol, 1648 Pierce Dr,Evans Bldg,Room 261, Atlanta, GA 30322 USA.	junhe@med.unc.edu; cevan03@emory.edu; swhoffman@emory.edu; noyesik@emory.edu; dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038664] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38664] Funding Source: Medline		Allan SM, 2000, P NATL ACAD SCI USA, V97, P5580, DOI 10.1073/pnas.090464197; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.3.CO;2-G; BERKENBOSCH F, 1992, ANN NY ACAD SCI, V650, P186; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; DSouza SD, 1996, J NEUROSCI RES, V43, P289, DOI 10.1002/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; Ghezzi P, 2000, EUR CYTOKINE NETW, V11, P464; Goodman YD, 1996, J NEUROCHEM, V66, P1836; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koenig HL, 2000, REV REPROD, V5, P189; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MAYER M, 1994, DEVELOPMENT, V120, P143; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Miller L, 1998, J IMMUNOL, V160, P5098; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; POLAN ML, 1989, J CLIN ENDOCR METAB, V69, P1200, DOI 10.1210/jcem-69-6-1200; Raivich G, 2002, EXP NEUROL, V178, P186, DOI 10.1006/exnr.2002.8024; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Salzman AL, 2000, INT J MOL MED, V6, P209; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; STOLPEN AH, 1986, AM J PATHOL, V123, P16; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; STRIJBOS PJLM, 1995, J NEUROSCI, V15, P3468; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Uno H, 1997, J CEREBR BLOOD F MET, V17, P491, DOI 10.1097/00004647-199705000-00002; Vegeto E, 1999, FASEB J, V13, P793; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676	60	260	266	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2004	189	2					404	412		10.1016/j.expneurol.2004.06.008			9	Neurosciences	Neurosciences & Neurology	857LC	WOS:000224117100019	15380490				2021-06-18	
J	Cernak, I; Wang, ZG; Jiang, JX; Bian, XW; Savic, J				Cernak, I; Wang, ZG; Jiang, JX; Bian, XW; Savic, J			Ultrastructural and functional characteristics of blast injury-induced neurotrauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; ZINC-SUPEROXIDE-DISMUTASE; FOCAL CEREBRAL-ISCHEMIA; LIPID-PEROXIDATION; FREE-RADICALS; HEAD-INJURY; GENERATION; DAMAGE; OVEREXPRESSION; MITOCHONDRIA	Objective: The present study investigates whether whole-body or local (chest) exposure to blast overpressure can induce ultrastructural, biochemical, and cognitive impairments in the brain. Methods: Male Wistar rats were trained for an active avoidance task for 6 days. On day 6, rats that had acquired the avoidance response were subjected to whole-body blast injury (WBBI), generated by large-scale shock tube (n = 40); or local (chest) blast injury (LBI), induced by blast overpressure focused on the right middle thoracic region and generated by small-scale shock tube (n = 40) while the heads of animals were protected, At the completion of cognitive testing, rats were killed at 3 hours, 24 hours, and 5 days after injury. Ultrastructural changes in the hippocampus were analyzed electron microscopically. Parameters of oxidative stress (malondialdehyde and superoxide anion generation) and antioxidant enzyme defense (superoxide dismutase and glutathione peroxidase activity) were measured in the hippocampus to assess biochemical changes in the brain after blast. Results: Ultrastructural findings in animals subjected to WBBI or LBI demonstrated swellings of neurons, glial reaction, and myelin debris in the hippocampus. AII rats revealed significant deficits in performance of the active avoidance task 3 hours after injury, but deficits persisted up to day 5 after injury only in rats subjected to WBBI, Oxidative stress development and altered antioxidant enzyme defense was observed in animals in both groups. Cognitive impairment and biochemical changes in the hippocampus were significantly correlated with blast injury severity in both WBBI and LBI groups. Conclusion: These results confirm that exposure to blast overpressure induces ultrastructural and biochemical impairments in the brain hippocampus, with associated development of cognitive deficits.	Mil Med Acad, YU-11002 Belgrade, Serbia; 3rd Mil Med Univ, Chongqing, Peoples R China	Cernak, I (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Res Bldg Room EP04,3970 Reservoir Rd NW, Washington, DC 20007 USA.	ibicernak@hotmail.com	Cernak, Ibolja/A-6399-2008; Bian, Xiu-Wu/D-4736-2017; Bian, Xiuwu/F-1569-2011	Bian, Xiu-Wu/0000-0003-4383-0197; Ibolja, Cernak/0000-0003-3214-698X			ANDREEVA LI, 1988, LAB DELO, P41; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; AUCLAIR C, 1985, HDB METHODS OXYGEN R, P123; BEAUCHAMP CO, 1973, BIOCHIM BIOPHYS ACTA, V317, P50, DOI 10.1016/0005-2795(73)90198-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPA A, 1992, BIOCHEM INT, V27, P407; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; CLARK JB, 1970, J BIOL CHEM, V245, P4724; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimura M, 1999, J NEUROSCI, V19, P3414; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Halliwell B, 1996, PATHOL BIOL, V44, P6; *I LAB AN RES COMM, 1985, NIH PUBL, V8523; Keller JN, 1998, J NEUROSCI, V18, P687; Khil'ko V A, 1995, Vestn Khir Im I I Grek, V154, P54; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; MAATSCH JL, 1959, J COMP PHYSIOL PSYCH, V52, P408, DOI 10.1037/h0048310; MCCORD JM, 1993, CLIN BIOCHEM, V26, P351, DOI 10.1016/0009-9120(93)90111-I; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; Murakami K, 1998, J NEUROSCI, V18, P205; NASONKIN O S, 1970, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, V14, P51; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; PLANCER ZA, 1966, ANAL BIOCHEM, V16, P359; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; SUTHERLAND G, 1991, NEUROSCI LETT, V128, P169, DOI 10.1016/0304-3940(91)90253-P; TOUSSAINT O, 1993, TOXICOLOGY, V81, P89, DOI 10.1016/0300-483X(93)90001-9; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0; Yehuda R, 1999, Semin Clin Neuropsychiatry, V4, P256; Yelverton JT, 1996, J TRAUMA, V40, pS111, DOI 10.1097/00005373-199603001-00025; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	51	260	268	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2001	50	4					695	706		10.1097/00005373-200104000-00017			12	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	424QP	WOS:000168243200026	11303167				2021-06-18	
J	SHEINBERG, M; KANTER, MJ; ROBERTSON, CS; CONTANT, CF; NARAYAN, RK; GROSSMAN, RG				SHEINBERG, M; KANTER, MJ; ROBERTSON, CS; CONTANT, CF; NARAYAN, RK; GROSSMAN, RG			CONTINUOUS MONITORING OF JUGULAR VENOUS OXYGEN-SATURATION IN HEAD-INJURED PATIENTS	JOURNAL OF NEUROSURGERY			English	Article						JUGULAR VENOUS OXYGEN SATURATION; CEREBRAL BLOOD FLOW; HEAD INJURY; CEREBRAL ISCHEMIA	ENERGY PHOSPHATE-METABOLISM; TRAUMATIC BRAIN INJURY; RATS; HYPOXIA; INSULTS; DAMAGE; SCALE; COMA	The continuous measurement of jugular venous oxygen saturation (SjvO2) with a fiberoptic catheter is evaluated as a method of detecting cerebral ischemia after head injury. Forty-five patients admitted to the hospital in coma after severe head injury had continuous and simultaneous monitoring of SjvO2, intracranial pressure, arterial oxygen saturation, and end-tidal CO2. Cerebral blood flow, cerebral metabolic rates of oxygen and lactate, arterial and jugular venous blood gas levels, and hemoglobin concentration were measured every 8 hours for 1 to 11 days. Whenever SjvO2 dropped to less than 50%, a standardized protocol was followed to confirm the validity of the desaturation and to establish its cause. Correlation of SjvO2 values obtained by catheter and with direct measurement of O2 saturation by a co-oximeter on venous blood withdrawn through the catheter was excellent after in vivo calibration when there was adequate light intensity at the catheter tip (176 measurements: r = 0.87, p < 0.01). A total of 60 episodes of jugular venous oxygen desaturation occurred in 45 patients. In 20 patients the desaturation value was confirmed by the co-oximeter. There were 33 episodes of desaturation in these 20 patients, due to the following causes: intracranial hypertension in 12 episodes, hypocarbia in 10, arterial hypoxia in six, combinations of the above in three, systemic hypotension in one, and cerebral vasospasm in one. The incidence of jugular venous oxygen desaturations found in this study suggests that continuous monitoring of SjvO2 may be of clinical value in patients with head injury.	BAYLOR COLL MED,DEPT NEUROSURG,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL SURG,HOUSTON,TX 77030					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		CRUZ J, 1988, ACTA NEUROCHIR S, V42, P33; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; LASSEN NA, 1959, PHYSIOL REV, V39, P183; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; TEASDALE G, 1974, LANCET, V2, P81; Ward JD, 1989, INTRACRANIAL PRESSUR, P630	15	260	263	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1992	76	2					212	217		10.3171/jns.1992.76.2.0212			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	HB059	WOS:A1992HB05900006	1472169				2021-06-18	
J	Barzo, P; Marmarou, A; Fatouros, P; Hayasaki, K; Corwin, F				Barzo, P; Marmarou, A; Fatouros, P; Hayasaki, K; Corwin, F			Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; brain edema; brain water determination; posttraumatic ventriculomegaly; magnetic resonance imaging; diffusion-weighted imaging	SEVERE HEAD-INJURY; DAMAGE; FLUID; METABOLISM; RESOLUTION; MODEL	The contribution of brain edema to brain swelling in cases of traumatic brain injury remains a critical problem. The authors believe that cellular edema, the result of complex neurotoxic events, Is the major contributor to brain swelling and thar vasogenic edema, secondary to blood-brain barrier compromise, may be overemphasized. The objective of this study, therefore, was to quantify temporal water content changes and document the type of edema that forms during the acute and late stages of edema development following closed head injury (CHT). The measurement of brain water content was based on magnetic resonance imaging-determined values of tissue longitudinal relaxation time (T-1-weighted imaging) and their subsequent conversion to percentage of water, whereas the differentiation of edema formation (cellular vs. vasogenic) was based on the measurement of the apparent diffusion coefficient (ADC) by diffusion-weighted imaging. A new impact-acceleration model was used to induce CHI. Thirty-six adult Sprague-Dawley rats were separated Into two groups: Group I, control (six animals); and Group II, trauma (30 animals). Fast RDC measurements (localized, single-voxeI) were obtained sequentially (every minute) up to 1 hour postinjury. The T-1-weighted images, used for water content determination, and the diffusion-weighted images (ADC measurement with conventional diffusion-weighted imaging) were obtained at the end of the ist hour postinjury and on Days 1, 3, 7, 14, 28, and 32 in animals from the trauma and control groups. In the animals subjected to trauma, the authors found a significant increase in ADC (10 +/- 5%) and brain water content (1.3 +/- 0.9%) during the first 60 minutes postinjury. This is consistent with an increase in the volume of extracellular fluid and vasogenic edema formation as a result of blood-brain barrier compromise. This transient increase, however, was followed by a continuing decrease in ADC that began 40 to 60 minutes postinjury and reached a minimum value on Days 3 to 14 (10 +/- 3% reduction). Because the water content of the brain continued to increase during the first 24 hours postinjury (1.9 +/- 0.9%), it is suggested that the decreased ADC indicated cellular edema formation, which started to develop soon after injury and became dominant between 1 and 2 weeks postinjury. The study provides supportive evidence that cellular edema is the major contributor to posttraumatic swelling in diffuse CHI and defines the onset and duration of the increase in cellular volume.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT RADIOL, RICHMOND, VA 23298 USA					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019235] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19235-11] Funding Source: Medline		Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BULLOCK R, 1994, INTRACRANIAL PRESSUR, P264; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FATOUROS PP, 1991, MAGNET RESON MED, V17, P402, DOI 10.1002/mrm.1910170212; FODA M, 1994, INTRACRANIAL PRESSUR, V9, P305; GROEGER U, 1989, ACTA NEUROCHIR, V101, P134, DOI 10.1007/BF01410529; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JULOW J, 1979, ACTA NEUROCHIR, V50, P273, DOI 10.1007/BF01808524; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; Klatzo I, 1980, Adv Neurol, V28, P359; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1994, ACTA NEUROCHIR, P3; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MARMAROU A, 1990, ACT NEUR S, V51, P123; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OGATA J, 1972, J NEUROPATH EXP NEUR, V31, P454, DOI 10.1097/00005072-197207000-00005; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SIESJO BK, 1991, LIFE SCI R, V51, P35; SUZUKI S, 1977, ACTA NEUROCHIR, V39, P1, DOI 10.1007/BF01405236; TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594	39	259	269	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	1997	87	6					900	907		10.3171/jns.1997.87.6.0900			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	YH193	WOS:A1997YH19300015	9384402				2021-06-18	
J	McCrory, P; Meeuwisse, WH; Aubry, M; Cantu, RC; Dvorak, J; Echemendia, RJ; Engebretsen, L; Johnston, K; Kutcher, JS; Raftery, M; Sills, A; Benson, BW; Davis, GA; Ellenbogen, R; Guskiewicz, KM; Herring, SA; Iverson, GL; Jordan, BD; Kissick, J; McCrea, M; McIntosh, AS; Maddocks, D; Makdissi, M; Purcell, L; Putukian, M; Schneider, K; Tator, CH; Turner, M				McCrory, Paul; Meeuwisse, Willem H.; Aubry, Mark; Cantu, Robert C.; Dvorak, Jiri; Echemendia, Ruben J.; Engebretsen, Lars; Johnston, Karen; Kutcher, Jeffrey S.; Raftery, Martin; Sills, Allen; Benson, Brian W.; Davis, Gavin A.; Ellenbogen, Richard; Guskiewicz, Kevin M.; Herring, Stanley A.; Iverson, Grant L.; Jordan, Barry D.; Kissick, James; McCrea, Michael; McIntosh, Andrew S.; Maddocks, David; Makdissi, Michael; Purcell, Laura; Putukian, Margot; Schneider, Kathryn; Tator, Charles H.; Turner, Michael			Consensus Statement on Concussion in Sport: The 4th International Conference on Concussion in Sport, Zurich, November 2012	JOURNAL OF ATHLETIC TRAINING			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; HEAD-INJURIES; POSTURAL CONTROL; LONG-TERM; POSTCONCUSSION SYNDROME; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION		[McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic 3084, Australia; [Meeuwisse, Willem H.] Univ Calgary, Fac Kinesiol, Hotchkiss Brain Inst, Fac Med & Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Raftery, Martin] Int Ice Hockey Federat, Zurich, Switzerland; Int Olymp Comm Med Commiss Games Grp, Lausanne, Switzerland; Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Cantu, Robert C.] Boston Univ, Med Ctr, Dept Neurosurg, Boston, MA 02215 USA; [Cantu, Robert C.] Boston Univ, Med Ctr, Ctr Study Traumat Encephalopathy, Boston, MA 02215 USA; [Dvorak, Jiri] Univ Zurich, Dept Neurol, Schulthess Clin, Zurich, Switzerland; [Dvorak, Jiri] Federat Int Football Assoc Med Assessment & Res C, Zurich, Switzerland; [Echemendia, Ruben J.] Psychol & Neurobehav Assoc Inc, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Kansas City, MO 64110 USA; [Engebretsen, Lars] Univ Oslo, Dept Orthopaed Surg, Oslo Univ Hosp, Oslo, Norway; [Engebretsen, Lars] Univ Oslo, Fac Med, Oslo, Norway; [Engebretsen, Lars] Oslo Sports Trauma Res Ctr, Oslo, Norway; [Engebretsen, Lars] Int Olymp Comm, Lausanne, Switzerland; [Johnston, Karen] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Johnston, Karen] Athlet Edge Sports Med, Concuss Management Program, Toronto, ON, Canada; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Iverson, Grant L.] Int Rugby Board, Dublin, Ireland; [Sills, Allen] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Sills, Allen] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg, Nashville, TN USA; [Sills, Allen] Vanderbilt Univ, Med Ctr, Dept & Rehabil, Nashville, TN USA; [Sills, Allen] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Benson, Brian W.] Univ Calgary, Dept Clin Neurosci, Fac Med, Dept Family Med, Calgary, AB, Canada; [Benson, Brian W.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada; [Davis, Gavin A.] Florey Inst Neurosci & Mental Hlth, Austin & Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Theodore S Roberts Endowed Chair, Seattle, WA 98195 USA; [Ellenbogen, Richard] Natl Football League Head Neck & Spine Med Comm, New York, NY USA; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med, Seattle Sports Concuss Program, Seattle Seahawks, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Orthopaed & Sports Med, Seattle Sports Concuss Program, Seattle Seahawks, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Neurol Surg, Seattle Sports Concuss Program, Seattle Seahawks, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Seattle Mariners, Seattle, WA 98195 USA; [Iverson, Grant L.] Univ British Columbia, Neuropsychol Outcome Assessment Lab, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Jordan, Barry D.] Cornell Univ, Weill Med Coll, Dept Clin Neurol, New York, NY 10021 USA; [Jordan, Barry D.] Burke Rehabil Hosp, White Plains, NY USA; [Jordan, Barry D.] New York State Athlet Commiss, New York, NY USA; [Kissick, James] Univ Ottawa, Canadian Natl Mens Sledge Hockey Team, Ottawa Sport Med Ctr, Dept Family Med, Ottawa, ON, Canada; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Madison, WI USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Madison, WI USA; [McIntosh, Andrew S.] Monash Univ, Australian Ctr Res Injury Sports & Its Prevent, Monash Injury Res Inst, Clayton, Vic 3800, Australia; [McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Sydney, NSW, Australia; [McIntosh, Andrew S.] McIntosh Consultancy & Res Pty Ltd, Sydney, NSW, Australia; [Makdissi, Michael] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Makdissi, Michael] Univ Melbourne, Melbourne Physiotherapy Dept, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia; [Makdissi, Michael] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Makdissi, Michael] McMaster Univ, David Braley Sport Med & Rehabil Ctr, Hamilton, ON, Canada; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Putukian, Margot] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Tator, Charles H.] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada; [McCrea, Michael] ThinkFirst Canada, Krembil Neurosci Ctr, Toronto, ON, Canada; [Turner, Michael] British Horseracing Author, London, England	McCrory, P (corresponding author), Florey Inst Neurosci & Mental Hlth, 245 Burgundy St, Heidelberg, Vic 3084, Australia.	paulmccr@bigpond.net.au	McCrory, Paul/Q-8688-2019; Echemendia, Ruben/R-6939-2019	Iverson, Grant/0000-0001-7348-9570; Guskiewicz, Kevin/0000-0002-8682-2130; Schneider, Kathryn/0000-0002-5951-5899; McCrory, Paul/0000-0003-4850-0568			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg Joseph, 2005, Neurosurgery, V56, pE1166; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen JK, 2004, CLIN J SPORT MED, V14, P379; Chen JK, 2004, BRIT J SPORT MED, V38, P659; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Curnow WJ, 2008, HEALTH PROMOT J AUST, V19, P10; Davidhizar R, 2002, Accid Emerg Nurs, V10, P149, DOI 10.1054/aaen.2002.0365; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Denke NJ, 2008, J EMERG NURS, V34, P363, DOI 10.1016/j.jen.2008.04.013; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.039362; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Finch C, 2000, SPORT HLTH, V18, P35; Finch C, 1993, 51 MON U ACC RES CTR; Finch CF, 2003, J SCI MED SPORT, V6, P505, DOI 10.1016/S1440-2440(03)80275-X; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; FUKUHARA T, 1994, BRAIN RES, V657, P333, DOI 10.1016/0006-8993(94)90987-3; Gabbe B, 2003, J SCI MED SPORT, V6, P231, DOI 10.1016/S1440-2440(03)80259-1; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hansen Kari Schroder, 2003, Traffic Inj Prev, V4, P285, DOI 10.1080/714040486; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JENNETT B, 1975, LANCET, V1, P480; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lee Michael A, 2006, Conn Med, V70, P377; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, 2000, STANDARDIZED ASSESSM, P22; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McIntosh A, 2005, RUGBY HEADGEAR STUDY; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Peng Rui-yun, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P213; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shaw NH, 2004, CAN MED ASSOC J, V170, P15; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Theye Fred, 2004, Clin Med Res, V2, P165; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Weiss MR, 2005, RES Q EXERCISE SPORT, V76, pS71, DOI 10.1080/02701367.2005.10599291; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863; Yunoki M, 1998, ACT NEUR S, V71, P142	154	258	259	3	98	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-AUG	2013	48	4					554	575		10.4085/1062-6050-48.4.05			22	Sport Sciences	Sport Sciences	211GX	WOS:000323895400015	23855364	Green Published, Bronze	Y	N	2021-06-18	
J	Dikmen, SS; Corrigan, JD; Levin, HS; Machamer, J; Stiers, W; Weisskopf, MG				Dikmen, Sureyya S.; Corrigan, John D.; Levin, Harvey S.; Machamer, Joan; Stiers, William; Weisskopf, Marc G.			Cognitive Outcome Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						closed head injury; cognitive outcome; neuropsychological outcome; penetrating TBI; traumatic brain injury	PENETRATING HEAD-INJURY; PROFESSIONAL SOCCER PLAYERS; UNITED-STATES; NEUROPSYCHOLOGICAL IMPAIRMENT; VIETNAM VETERANS; TEST-PERFORMANCE; CONCUSSION; RECOVERY; MEMORY; HOSPITALIZATION	Objective: To determine whether an association exists between traumatic brain Injury (TBI) sustained in adulthood and cognitive impairment 6 months or longer after injury. Design: Systematic review of the published, peer-reviewed literature. Results: From 430 articles, we identified 11 primary and 22 secondary studies that examined cognitive impairment by using performance measures for adults who were at least 6 months post-TBI. There was clear evidence of an association between penetrating brain injury and impaired cognitive function. Factors that modified this association included preinjury intelligence, volume of brain tissue lost, and brain region injured. There was also suggestive evidence that penetrating brain injury may exacerbate the cognitive effects of normal aging. We found clear evidence for long-term cognitive deficits associated with severe TBI. There was suggestive evidence that moderately severe brain injuries are associated with cognitive impairments. There was inadequate/insufficient evidence to determine whether an association exists between a single, mild TBI and cognitive deficits 6 months or longer postinjury. Conclusion: In adults, penetrating, moderate, and severe TBIs are associated with cognitive deficits 6 months or longer postinjury. There is insufficient evidence to determine whether mild TBI is associated with cognitive deficits 6 months or longer postinjury.	[Dikmen, Sureyya S.; Machamer, Joan] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; [Stiers, William] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Dikmen, SS (corresponding author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.	dikmen@u.washington.edu	Corrigan, John D./E-2921-2011	Stiers, William/0000-0002-1826-8350	US Department of Veterans AffairsUS Department of Veterans Affairs	The study was supported by a contract from the US Department of Veterans Affairs to the National Academy of Sciences, Institute of Medicine.	Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; CORKIN S, 1989, J NEUROSCI, V9, P3876; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Finkelstein EA., 2006, INCIDENCE EC BURDEN; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.8.1120-1122; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, INT J NEUROSCI, V29, P125, DOI 10.3109/00207458608985643; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Novack TA, 2000, BRAIN INJURY, V14, P987; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; STRAUMENAESHEIM TM, 2005, BR J SPORTS MED S1, V39, P70; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1974, LANCET, V2, P81; Teuber HL, 1954, J PSYCHOL, V38, P177, DOI 10.1080/00223980.1954.9712928; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; WEINSTEIN S, 1957, J COMP PHYSIOL PSYCH, V50, P535, DOI 10.1037/h0047738; WEINSTEIN S, 1956, J PSYCHOL, V42, P249, DOI 10.1080/00223980.1956.9713038; WEINSTEIN S, 1957, SCIENCE, V125, P1036, DOI 10.1126/science.125.3256.1036; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	46	258	265	2	51	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2009	24	6					430	438		10.1097/HTR.0b013e3181c133e9			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	528VW	WOS:000272476100003	19940676				2021-06-18	
J	Bechara, A; Van der Linden, M				Bechara, A; Van der Linden, M			Decision-making and impulse control after frontal lobe injuries	CURRENT OPINION IN NEUROLOGY			English	Article						decision-making; executive function; impulsivity; inhibitory control	VENTROMEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; GAMBLING TASK; DAMAGE; LESIONS; DEFICITS; EMOTION; MEMORY; NEUROPSYCHOLOGY	Purpose of review For a long time, the prefrontal cortex has been considered a 'nonfunctional' brain area, and understanding its function has lagged behind other areas. This is no longer true since appreciation of the vital role that this brain region plays in adaptive behaviors, and especially decision-making, is now evident more than ever. The present review highlights recent progress made in this area of research. Recent findings Decision-making is a term often referred to in the psychological literature as one of the 'executive functions' that play a role in managing (like an executive) other cognitive functions, such as memory, attention, and language. Considerable research efforts have been directed towards differentiating various processes of executive functions, but much of this effort in the past has focused on the dorsolateral prefrontal cortex sector. Here we will review findings that address decision-making and its link to the ventromedial prefrontal cortex. Summary Decision-making impairments as encountered in neurological and psychiatric patients are costly in terms of individual human suffering and in financial terms. In addition to its obvious value in advancing fundamental knowledge in neuroscience, understanding the neural mechanisms of decision-making is likely to have important practical consequences, including the understanding and management of neuropsychiatric disorders such as addiction, as well as the management of a considerable number of elderly people suffering from a decline in cognitive functions critical for decision-making, in spite of relatively intact memory and general intellect, which impact real-life matters that are important to themselves and their family.	Univ Iowa, Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; Univ Geneva, FPSE, Cognit Psychopathol & Neuropsychol Unit, CH-1211 Geneva, Switzerland	Bechara, A (corresponding author), Univ Iowa, Coll Med, Dept Neurol, Div Cognit Neurosci, 200 Hawkins Dr, Iowa City, IA 52242 USA.	antoine-bechara@uiowa.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632, P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA011779, R21DA016708, R01DA012487] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA16708, DA12487-03, DA11779-02] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19632] Funding Source: Medline		Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; BRAND M, IN PRESS J CLIN EXP; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Cavedini P, 2004, PSYCHIAT RES, V127, P259, DOI 10.1016/j.psychres.2004.03.012; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Damasio A., 1994, DESCARTESERROR EMOTI; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Easdon C, 2004, BRAIN COGNITION, V54, P136; Fellows LK, 2005, NEUROPSYCHOLOGIA, V43, P1214, DOI 10.1016/j.neuropsychologia.2004.07.018; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; GLIMCHER PW, 2005, GAME ECON BEHAV, V52, P1; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LELAND JW, 2005, GAME ECON BEHAV, V52, P373; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Ptak R, 2004, NEUROCASE, V10, P52, DOI 10.1080/13554790490960495; Rogers RD, 2004, PSYCHOPHARMACOLOGY, V172, P157, DOI 10.1007/s00213-003-1641-5; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; SCHALLICE T, 1993, NEUROPSYCHOLOGY MENT; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shiv B, 2005, PSYCHOL SCI, V16, P435; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TURNBULL OH, 2005, NEUROPSYCHOLOGY 0716; Varney NR, 2004, APPL NEUROPSYCHOL, V11, P229; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Whitney KA, 2004, SCHIZOPHR RES, V69, P75, DOI 10.1016/j.schres.2003.08.013; YECHIAM E, IN RPESS PSYCHOL SCI; ZERMATTEN A, IN PRESS J NERV MENT	50	258	259	1	61	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2005	18	6					734	739		10.1097/01.wco.0000194141.56429.3c			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	989MT	WOS:000233678800017	16280687				2021-06-18	
J	Echemendia, RJ; Putukian, M; Mackin, RS; Julian, L; Shoss, N				Echemendia, RJ; Putukian, M; Mackin, RS; Julian, L; Shoss, N			Neuropsychological test performance prior to and following sports-related mild traumatic brain injury	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						neuropsychology; sports; concussion; brain injury	NEAR-INFRARED SPECTROSCOPY; MINOR HEAD-INJURIES; ALZHEIMERS-DISEASE; SOCCER PLAYERS; AMATEUR BOXERS; CONCUSSION; FOOTBALL; RISK; SEQUELAE; RETURN	Objective: To examine the utility of neuropsychological tests in assessing college athletes prior to and following a sports-related mild Traumatic Brain Injury (mTBI). Design: A prospective study of college athletes who sustained mTBI while engaged in sport. Preinjury baseline neuropsychological test data were obtained for athletes at risk for mTBI. Following an mTBI, the athlete and his or her matched noninjured control were evaluated at 2 hours, 48 hours, 1 week, and 1 month postinjury. Setting: Male and female athletes from a Division I college. Participants: Male and female athletes from the football, men's ice hockey, men's and women's soccer, and men's and women's basketball teams at Penn State University. A total of 29 injured and 20 noninjured athletes participated in the study. Interventions: Neuropsychological test batteries were administered at baseline and serially following mTBI. Main Outcome Measures: Post-Concussion Symptom Checklist, Hopkins Verbal Learning Test, Symbol Digit Modalities Test, Stroop Color-Word Test, Trail Making Test, VIGIL/W, List Learning, Digit Span, Penn State Cancellation Test, and Controlled Oral Word Association. Results: Neuropsychological test data yielded significant differences between injured athletes and controls at 2 hours and 48 hours following cerebral concussion; injured athletes performing significantly worse than controls. Injured athletes reported a significantly greater number of postconcussion symptoms 2 hours following injury but not at the 48-hour assessment. No multivariate group differences were found at 1 week, but univariate analyses suggested significant differences on a few measures. At I month postinjury, a statistically significant difference was found on one measure with injured athletes marginally outperforming controls. Conclusions: Neuropsychological tests are useful in the detection of cognitive impairment following mTBI. The test data appear to be more effective than subjective report of symptoms in differentiating between injured and noninjured athletes at 48 hours postinjury. Although significant individual variability existed, most injured athletes recovered within 1 week of injury. A battery of tests, rather than any single test. is necessary to capture the variability that exists among injured athletes.	Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Echemendia, RJ (corresponding author), Penn State Univ, Dept Psychol, 314 Bruce V Moore Bldg, University Pk, PA 16802 USA.		Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462			Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; *AD HOC COMM STUD, 1966, CLIN NEUROSURG, V12, P386; ALVES WM, 1987, CLIN SPORTS MED, V6, P208; Barth JT., 1989, MILD HEAD INJURY, P257; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; *COL MED SOC, 1991, GUID MAN CONC SPORTS; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DICK RW, 1997, HEAD NECK INJURIES S; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; James CA, 1997, CLIN NEUROSCI, V4, P137; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkpatrick PJ, 1997, PHILOS T ROY SOC B, V352, P701, DOI 10.1098/rstb.1997.0052; KRAUS JF, 1987, HEAD INJURY, P1; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lewis DH, 1997, NEUROSURG CLIN N AM, V8, P337; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; MCLATCHIE G, 1994, BRIT MED J, V308, P1620, DOI 10.1136/bmj.308.6944.1620; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F; Partington J.E., 1949, PARTINGTONS PATHWAY; Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; *PSYCH CORP, 1994, VIG W CONT PERF TEST; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Smith A., 1982, SYMBOL DIGIT MODALIT; Spear J, 1995, INT J GERIATR PSYCH, V10, P1011, DOI 10.1002/gps.930101203; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Torg JS., 1991, ATHLETIC INJURIES HE; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; Williams M., 1991, COGNITIVE BEHAV RATI	48	258	263	1	68	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2001	11	1					23	31		10.1097/00042752-200101000-00005			9	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	392EN	WOS:000166398100005	11176142				2021-06-18	
J	Deb, S; Lyons, I; Koutzoukis, C; Ali, I; McCarthy, G				Deb, S; Lyons, I; Koutzoukis, C; Ali, I; McCarthy, G			Rate of psychiatric illness 1 year after traumatic brain injury	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							SEVERE HEAD-INJURY; DEPRESSION; DISABILITY; DISORDERS; SEQUELAE	Objective: Neurobehavioral symptoms are not uncommon after a traumatic brain injury. However, psychiatric syndromes per se have rarely been studied in patients with such an injury. The purpose of this study was to evaluate the type and extent of psychiatric syndromes in patients with traumatic brain injury. Method: One hundred ninety-six hospitalized adults were studied 1 year after a traumatic brain injury with the use of a:two-stage psychiatric diagnostic procedure. Psychiatric diagnoses were made according to ICD-IO criteria on the basis of data from the Schedules for Clinical Assessment in Neuropsychiatry interview. Results: Of 164 patients interviewed, 30 (18.3%) had an ICD-IO diagnosis of a psychiatric illness. Among the 120 patients who were 18-64 years old, 21.7% had a psychiatric illness, compared with 16.4% in a study of the general population. A depressive illness was present in 13.9% of the traumatic brain injury patients, compared with 2.1% of the general population, and panic disorder was present in 9.0%, compared with 0.8% of the general population. Conclusions: In comparison with the general population, a higher proportion of adult patients had developed psychiatric illnesses 1 year after a traumatic brain injury; the rates of depressive episode and panic disorder were significantly higher in the study group. A history of psychiatric illness, an unfavorable global outcome according to the Glasgow Outcome Scale, a lower score on the Mini-Mental State examination, and fewer years of formal education seemed to be important risk factors in the development of a psychiatric illness. Compensation claims, however, were not associated with the rate of psychiatric illness.	Univ Wales Coll Med, Div Psychol Med, Cardiff CF4 4XN, S Glam, Wales	Deb, S (corresponding author), Univ Wales Coll Med, Div Psychol Med, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.			McCarthy, Geraldine/0000-0002-1312-0998; Deb, Shoumitro/0000-0002-1300-8103			BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; DEB S, IN PRESS BRAIN INJ; DEB S, IN PRESS BR J PSYCHI; Eames P, 1997, CURR OPIN PSYCHIATR, V10, P49, DOI 10.1097/00001504-199701000-00011; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldberg D., 1978, MANUAL GEN HLTH QUES; JACOBSON RR, 1991, CURRENT OPINION PSYC, V4, P116; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; MELTZER H, 1995, 1 OFF POP CENS SURV; NELSON ME, 1982, NATL ADULT READING T; Norusis M.J., 1993, SPSS WINDOWS BASE SY; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P586	26	258	273	0	12	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	MAR	1999	156	3					374	378					5	Psychiatry	Psychiatry	173FE	WOS:000078969900006	10080551				2021-06-18	
J	Massa, SM; Yang, T; Xie, YM; Shi, J; Bilgen, M; Joyce, JN; Nehama, D; Rajadas, J; Longo, FM				Massa, Stephen M.; Yang, Tao; Xie, Youmei; Shi, Jian; Bilgen, Mehmet; Joyce, Jeffrey N.; Nehama, Dean; Rajadas, Jayakumar; Longo, Frank M.			Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents	JOURNAL OF CLINICAL INVESTIGATION			English	Article							P75 NEUROTROPHIN RECEPTOR; TYROSINE-PHOSPHATASE RECEPTOR; TRAUMATIC BRAIN-INJURY; SENSORY NEURONS; HIGH-AFFINITY; BLOOD-BRAIN; MOUSE MODEL; IN-VIVO; MOTOR; LIGANDS	Brain-derived neurotrophic factor (BDNF) activates the receptor tropomyosin-related kinase B (TrkB) with high potency and specificity, promoting neuronal survival, differentiation, and synaptic function. Correlations between altered BDNF expression and/or function and mechanism(s) underlying numerous neurodegenerative conditions, including Alzheimer disease and traumatic brain injury, suggest that TrkB agonists might have therapeutic potential. Using in silico screening with a BDNF loop-domain pharmacophore, followed by low-throughput in vitro screening in mouse fetal hippocampal neurons, we have efficiently identified small molecules with nanomolar neurotrophic activity specific to TrkB versus other Trk family members. Neurotrophic activity was dependent on TrkB and its downstream targets, although compound-induced signaling activation kinetics differed from those triggered by BDNF. A selected prototype compound demonstrated binding specificity to the extracellular domain of TrkB. In in vitro models of neurodegenerative disease, it prevented neuronal degeneration with efficacy equal to that of BDNF, and when administered in vivo, it caused hippocampal and striatal TrkB activation in mice and improved motor learning after traumatic brain injury in rats. These studies demonstrate the utility of loop modeling in drug discovery and reveal what we believe to be the first reported small molecules derived from a targeted BDNF domain that specifically activate TrkB. We propose that these compounds constitute a novel group of tools for the study of TrkB signaling and may provide leads for developing new therapeutic agents for neurodegenerative diseases.	[Yang, Tao; Nehama, Dean; Rajadas, Jayakumar; Longo, Frank M.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Massa, Stephen M.; Shi, Jian] UCSF, Dept Neurol, San Francisco, CA USA; [Massa, Stephen M.; Shi, Jian] UCSF, Lab Computat Neurochem & Drug Discovery, Dept Vet Affairs, Med Ctr, San Francisco, CA USA; [Massa, Stephen M.; Shi, Jian] UCSF, Dept Neurol, San Francisco, CA USA; [Yang, Tao; Xie, Youmei; Longo, Frank M.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Bilgen, Mehmet] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Joyce, Jeffrey N.] Sun Hlth Res Inst, Thomas H Christopher Ctr Parkinsons Dis Res, Sun City, AZ USA	Longo, FM (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 300 Pasteur Dr,Room H3160, Stanford, CA 94305 USA.	longo@stanford.edu			Institute for the Study on Aging; Alzheimer's AssociationAlzheimer's Association; North Carolina Alzheimer's Association; Taube Philanthropies; Koret Foundation; Jean Perkins Foundation; Department of Defense (DOD)United States Department of Defense [DAMD17-03-1-0532]; Department of Veterans AffairsUS Department of Veterans Affairs	These studies were supported by the Institute for the Study on Aging (F.M. Longo), the Alzheimer's Association (F.M. Longo), the Eastern Chapter of the North Carolina Alzheimer's Association (F.M. Longo), Taube Philanthropies (F.M. Longo), the Koret Foundation (F.M. Longo), the Jean Perkins Foundation (F.M. Longo), and the Department of Defense (DOD DAMD17-03-1-0532) and the Department of Veterans Affairs (S.M. Massa).	Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bjugstad KB, 2001, J INHERIT METAB DIS, V24, P631, DOI 10.1023/A:1012706908779; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; D'Souza R, 2005, AAPS PHARMSCITECH, V6; Fan G, 2000, NAT NEUROSCI, V3, P350; Fletcher JM, 2006, J PEPT SCI, V12, P515, DOI 10.1002/psc.760; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P95, DOI 10.1038/sj.tpj.6500360; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; Ishibashi H, 2002, MOL BRAIN RES, V102, P110, DOI 10.1016/S0169-328X(02)00201-2; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Mischel PS, 2002, BIOPHYS J, V83, P968, DOI 10.1016/S0006-3495(02)75222-3; MORSE JK, 1993, J NEUROSCI, V13, P4146; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Presgraves SP, 2004, EXP NEUROL, V190, P157, DOI 10.1016/j.expneurol.2004.06.021; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Roux PP, 2002, J BIOL CHEM, V277, P49473, DOI 10.1074/jbc.M203428200; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sukuru SCK, 2009, J BIOMOL SCREEN, V14, P690, DOI 10.1177/1087057109335678; Tesmer JJG, 2006, SCIENCE, V312, P377, DOI 10.1126/science.1126903; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Triballeau N, 2008, NEURON, V60, P767, DOI 10.1016/j.neuron.2008.11.014; Tsao D, 2008, ENDOCRINOLOGY, V149, P1038, DOI 10.1210/en.2007-1166; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Williams G, 2005, J BIOL CHEM, V280, P5862, DOI 10.1074/jbc.M411121200; Willson ML, 2008, BRAIN, V131, P1099, DOI 10.1093/brain/awn024; Yang T, 2003, J NEUROSCI, V23, P3353; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Zhang AJ, 2001, BIOORG MED CHEM LETT, V11, P207, DOI 10.1016/S0960-894X(00)00618-1; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	64	257	267	1	33	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	MAY	2010	120	5					1774	1785		10.1172/JCI41356			12	Medicine, Research & Experimental	Research & Experimental Medicine	590SN	WOS:000277248000041	20407211	Green Published, Bronze			2021-06-18	
J	LEVIN, HS; GROSSMAN, RG; ROSE, JE; TEASDALE, G				LEVIN, HS; GROSSMAN, RG; ROSE, JE; TEASDALE, G			LONG-TERM NEUROPSYCHOLOGICAL OUTCOME OF CLOSED HEAD-INJURY	JOURNAL OF NEUROSURGERY			English	Article										LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DEPT NEUROSURG,GALVESTON,TX 77550, USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BECKER B, 1975, J CLIN PSYCHOL, V31, P307, DOI 10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benton AL, 1967, CORTEX, V3, P32, DOI [10.1016/S0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4]; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; DIKMEN S, 1977, ANN NEUROL, V2, P429; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1977, CORTEX, V13, P119, DOI 10.1016/S0010-9452(77)80003-8; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, CHILDS BRAIN; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OVERALL JE, 1962, PSYCHOL REP, V10, P799; OVERGAARD J, 1973, LANCET, V2, P631; SPREEN O, 1969, MANUAL NEUROSENSORY; TEASDALE G, 1974, LANCET, V2, P81	21	257	260	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1979	50	4					412	422		10.3171/jns.1979.50.4.0412			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GP863	WOS:A1979GP86300001	311378				2021-06-18	
J	Betke, M; Gips, J; Fleming, P				Betke, M; Gips, J; Fleming, P			The camera mouse: Visual tracking of body features to provide computer access for people with severe disabilities	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						assistive technology; communication device; real-time tracking; vision-based human-computer interface		The "Camera Mouse" system has been developed to provide computer access for people with severe disabilities. The system tracks the computer user's movements with a video camera and translates them into the movements of the mouse pointer on the screen. Body features such as the tip of the user's nose or finger can be tracked. The visual tracking algorithm is based on cropping an online template of the tracked feature from the current image frame and testing where this template correlates in the subsequent frame. The location of the highest correlation is interpreted as the new location of the feature in the subsequent frame. Various body features are examined for tracking robustness and user convenience. A group of 20 people without disabilities tested the Camera Mouse and quickly learned how to use it to spell out messages or play games. Twelve people with severe cerebral palsy or traumatic brain injury have tried the system, nine of whom have shown success. They interacted with their environment by spelling out messages and exploring the Internet.	Boston Univ, Dept Comp Sci, Boston, MA 02215 USA; Boston Coll, Dept Comp Sci, Chestnut Hill, MA 02167 USA; Accenture, Wellesley, MA 02481 USA	Betke, M (corresponding author), Boston Univ, Dept Comp Sci, 111 Cummington St, Boston, MA 02215 USA.						Altman D, 1991, PRACTICAL STAT MED R; Arabnia H. R., 1992, Proceedings of the Johns Hopkins National Search for Computing Applications to Assist Persons with Disabilities (Cat. No.92TH0429-1), P131, DOI 10.1109/CAAPWD.1992.217422; Betke M, 2000, MACH VISION APPL, V12, P69, DOI 10.1007/s001380050126; Betke M, 2001, INT J COMPUT VISION, V44, P5, DOI 10.1023/A:1011168302294; BROWN C, 1992, COMMUN ACM, V35, P36, DOI 10.1145/129875.129877; Chen Y L, 1999, IEEE Trans Rehabil Eng, V7, P474, DOI 10.1109/86.808951; DiMattia P., 2001, EYE CONTROL TEACHING; Evans DG, 2000, IEEE T REHABIL ENG, V8, P107, DOI 10.1109/86.830955; GIPS J, 1993, ADV HUM FACT ERGON, V19, P630; Gips J., 2000, Proceedings of the RESNA 2000 Annual Conference. Technology for the New Millennium, P98; GIPS J, 2001, UNIVERSAL ACCESS HCI, V3, P914; Horn Berthold Klaus Paul, 1986, ROBOT VISION; HUTCHINSON TE, 1989, IEEE T SYST MAN CYB, V19, P1527, DOI 10.1109/21.44068; JACOB RJK, 1993, COMPUTER, V26, P65, DOI 10.1109/MC.1993.274943; KEIRN ZA, 1990, IEEE ENG MED BIOL, V9, P55, DOI 10.1109/51.62907; LACOURSE JR, 1990, IEEE T BIO-MED ENG, V37, P1215, DOI 10.1109/10.64465; MORIMOTO CH, 1999, P 12 BRAZ S COMP GRA, P171; Ohtani T, 1998, 1998 SECOND INTERNATIONAL CONFERENCE ON KNOWLEDGE-BASED INTELLIGENT ELECTRONIC SYSTEMS, KES '98, PROCEEDINGS, VOL 2, P108, DOI 10.1109/KES.1998.725900; PERKINS WJ, 1986, J MED ENG TECHNOL, V10, P21, DOI 10.3109/03091908609044332; Pregenzer M, 1999, IEEE Trans Rehabil Eng, V7, P413, DOI 10.1109/86.808944; Reilly R B, 1999, IEEE Trans Rehabil Eng, V7, P174, DOI 10.1109/86.769408; RINARD GA, 1980, ISA T, V19, P3; SAKO H, 1994, INT C PATT RECOG, P320, DOI 10.1109/ICPR.1994.576928; Simpson R C, 1999, IEEE Trans Rehabil Eng, V7, P464, DOI 10.1109/86.808950; Takami O, 1996, TENCON IEEE REGION, P468, DOI 10.1109/TENCON.1996.608861; TAKAMI O, 1995, IEEE INT C SYST MAN, V2, P1119; TIPS J, 2000, P INT C COMP HELP PE, P245; VANDERHEIDEN G, 1986, P COMP HUM INT C CHI, P296; YOUNG LR, 1975, BEHAV RES METH INSTR, V7, P397, DOI 10.3758/BF03201553	29	256	262	0	32	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	MAR	2002	10	1					1	10	PII S1534-4320(02)05848-5	10.1109/TNSRE.2002.1021581			10	Engineering, Biomedical; Rehabilitation	Engineering; Rehabilitation	579ZA	WOS:000177208100001	12173734	Green Published			2021-06-18	
J	CORRIGAN, JD				CORRIGAN, JD			SUBSTANCE-ABUSE AS A MEDIATING FACTOR IN OUTCOME FROM TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							ALCOHOLISM SCREENING TEST; HEAD-INJURY; INTOXICATION	A review of recent research addressed two questions: how common are problems of substance abuse in traumatic brain injury (TBI), and to what extent does alcohol and other drug use mediate outcome? Studies showed alcohol intoxication present in one third to one half of hospitalizations; data for other drug intoxication were not available. Nearly two thirds of rehabilitation patients may have a history of substance abuse that preceded their injuries. Intoxication was related to acute complications, longer hospital stays, and poorer discharge status; however, these relationships may have been caused by colinearity with history, History of substance abuse showed the same morbidity, and was further associated with higher mortality rates, poorer neuropsychological outcome, and greater likelihood of repeat injuries and late deterioration, The effect of history may be caused by subgroups with more severe substance abuse problems, Implications for rehabilitation are discussed, including the potential negative impact of untreated substance abuse on the ability to document efficacy of rehabilitation efforts. (C) 1995 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210			Corrigan, John D./E-2921-2011				ALTERMAN AI, 1985, J STUD ALCOHOL, V46, P256, DOI 10.15288/jsa.1985.46.256; BACHYRITA P, 1989, TRAUMATIC BRAIN INJU, P81; Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; CALLAHAN D, 1968, Q J STUD ALCOHOL, V29, P130; CORRIGAN JD, 1994, 102ND ANN CONV AM PS; CORRIGAN JD, 1994, SPR M ASS AC PHYS NA; DESAI BT, 1983, J NATL MED ASSOC, V75, P875; Dikmen S. S., 1993, NEUROPSYCHOLOGIA, V7, P296, DOI DOI 10.1037/0894-4105.7.3.296; Drubach D A, 1993, Md Med J, V42, P989; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; JENSEN GB, 1993, LANCET, V342, P1201; Jones G.A., 1992, NEUROREHABILITATION, V2, P27; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER J S, 1990, Brain Injury, V4, P1, DOI 10.3109/02699059009026142; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LANGLEY M, 1991, WORK WORTH DOING ADV, P251; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; LANGLEY MJ, 1994, MAY INT SUST INT MAX; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; MOORE D, 1992, INT J ADDICT, V26, P65; Moore D, 1992, NEUROREHABILITATION, V2, P7; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; TARTER RE, 1984, J STUD ALCOHOL, V45, P1; WILLIAMS GD, 1992, BRIT J ADDICT, V87, P643; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; 1988, SUBSTANCE ABUSE TASK	39	256	256	0	11	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1995	76	4					302	309		10.1016/S0003-9993(95)80654-7			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	QR989	WOS:A1995QR98900002	7717829				2021-06-18	
J	Wang, GH; Zhang, J; Hu, XM; Zhang, LL; Mao, LL; Jiang, XY; Liou, AKF; Leak, RK; Gao, YQ; Chen, J				Wang, Guohua; Zhang, Jia; Hu, Xiaoming; Zhang, Lili; Mao, Leilei; Jiang, Xiaoyan; Liou, Anthony Kian-Fong; Leak, Rehana K.; Gao, Yanqin; Chen, Jun			Microglia/macrophage polarization dynamics in white matter after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						inflammation; macrophage; microglia; polarization; white matter injury	SPINAL-CORD; NEURODEGENERATIVE DISEASES; ACTIVATION PATTERNS; AXONAL INJURY; CELL-DEATH; MICROGLIA; INFLAMMATION; RAT; NEUROPROTECTION; IDENTIFICATION	Mononuclear phagocytes are a population of multi-phenotypic cells and have dual roles in brain destruction/reconstruction. The phenotype-specific roles of microglia/macrophages in traumatic brain injury (TBI) are, however, poorly characterized. In the present study, TBI was induced in mice by a controlled cortical impact (CCI) and animals were killed at 1 to 14 days post injury. Real-time polymerase chain reaction (RT-PCR) and immunofluorescence staining for M1 and M2 markers were performed to characterize phenotypic changes of microglia/macrophages in both gray and white matter. We found that the number of M1-like phagocytes increased in cortex, striatum and corpus callosum (CC) during the first week and remained elevated until at least 14 days after TBI. In contrast, M2-like microglia/macrophages peaked at 5 days, but decreased rapidly thereafter. Notably, the severity of white matter injury (WMI), manifested by immunohistochemical staining for neurofilannent SMI-32, was strongly correlated with the number of M1-like phagocytes. In vitro experiments using a conditioned medium transfer system confirmed that M1 microglia-conditioned media exacerbated oxygen glucose deprivation-induced oligodendrocyte death. Our results indicate that microglia/macrophages respond dynamically to TBI, experiencing a transient M2 phenotype followed by a shift to the M1 phenotype. The M1 phenotypic shift may propel WMI progression and represents a rational target for TBI treatment.	[Wang, Guohua; Zhang, Jia; Mao, Leilei; Jiang, Xiaoyan; Gao, Yanqin; Chen, Jun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Wang, Guohua; Zhang, Jia; Mao, Leilei; Jiang, Xiaoyan; Gao, Yanqin; Chen, Jun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Wang, Guohua; Hu, Xiaoming; Zhang, Lili; Mao, Leilei; Liou, Anthony Kian-Fong; Gao, Yanqin; Chen, Jun] Univ Pittsburgh, Dept Neurol, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15260 USA; [Wang, Guohua] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong, Peoples R China; [Hu, Xiaoming; Zhang, Lili; Liou, Anthony Kian-Fong; Chen, Jun] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15219 USA	Gao, YQ (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.	yqgao@shmu.edu.cn; chenj2@upmc.edu	Gao, Yanqin/I-6790-2016; Leak, Rehana K/I-2607-2019	Gao, Yanqin/0000-0002-4915-9819; Leak, Rehana K/0000-0003-2817-7417; Wang, Guohua/0000-0002-4810-8534	Chinese Ministry of Science and TechnologyMinistry of Science and Technology, China; National Institutes of Health/NINDS grants [NS36736, NS43802, NS45048]; VA Career Scientist Award; Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [30870794, 81020108021, 81171149, 81150110494, 81000497]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043802, R01NS036736, R01NS062157, R01NS045048] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [14571346] Funding Source: KAKEN	This research is supported in part by the Special Research Funds from Chinese Ministry of Science and Technology to State Key laboratories (to GH Wang, Y Gao and J Chen), National Institutes of Health/NINDS grants NS36736, NS43802 and NS45048 (to J Chen), VA Career Scientist Award (J Chen), and Chinese Natural Science Foundation grants No 30870794, No 81020108021, No 81171149, and No 81150110494 (to YG), and No 81000497 (to GW).	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Borgens RB, 2012, Q REV BIOL, V87, P89, DOI DOI 10.1086/665457; Buchkremer-Ratzmann I, 1996, STROKE, V27, P1109; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kassmann CM, 2011, FEBS LETT, V585, P2205, DOI 10.1016/j.febslet.2011.05.032; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nimmo Alan J, 2009, Recent Pat CNS Drug Discov, V4, P86; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011	43	255	263	7	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2013	33	12					1864	1874		10.1038/jcbfm.2013.146			11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	266DI	WOS:000328002200007	23942366	Bronze, Green Published	Y	N	2021-06-18	
J	Kroehne, V; Freudenreich, D; Hans, S; Kaslin, J; Brand, M				Kroehne, Volker; Freudenreich, Dorian; Hans, Stefan; Kaslin, Jan; Brand, Michael			Regeneration of the adult zebrafish brain from neurogenic radial glia-type progenitors	DEVELOPMENT			English	Article						CNS; Adult neural stem cells; Brain injury; Genetic lineage-tracing; Neurogenesis; Teleost	CENTRAL-NERVOUS-SYSTEM; TRANSGENIC ZEBRAFISH; NEURONAL PROGENITORS; STEM-CELLS; IN-VIVO; RETINAL REGENERATION; NEURAL PROGENITORS; HEART REGENERATION; PROTEIN EXPRESSION; REACTIVE GLIOSIS	Severe traumatic injury to the adult mammalian CNS leads to life-long loss of function. By contrast, several non-mammalian vertebrate species, including adult zebrafish, have a remarkable ability to regenerate injured organs, including the CNS. However, the cellular and molecular mechanisms that enable or prevent CNS regeneration are largely unknown. To study brain regeneration mechanisms in adult zebrafish, we developed a traumatic lesion assay, analyzed cellular reactions to injury and show that adult zebrafish can efficiently regenerate brain lesions and lack permanent glial scarring. Using Cre-loxP-based genetic lineage-tracing, we demonstrate that her4.1-positive ventricular radial glia progenitor cells react to injury, proliferate and generate neuroblasts that migrate to the lesion site. The newly generated neurons survive for more than 3 months, are decorated with synaptic contacts and express mature neuronal markers. Thus, regeneration after traumatic lesion of the adult zebrafish brain occurs efficiently from radial glia-type stem/progenitor cells.	[Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; Tech Univ Dresden, DFG Res Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany	Brand, M (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889; Kroehne, Volker/0000-0002-5610-0866	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 655]	We gratefully acknowledge support from the Deutsche Forschungsgemeinschaft [SFB 655 and CRTD seed grant].	Abdesselem H, 2009, J NEUROSCI, V29, P15489, DOI 10.1523/JNEUROSCI.3561-09.2009; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; ADORNATO B, 1971, ACTA NEUROPATHOL, V19, P271, DOI 10.1007/BF00692148; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Brand M., 2002, ZEBRAFISH PRACTICAL; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; Costa MR, 2010, BRAIN RES REV, V63, P47, DOI 10.1016/j.brainresrev.2010.01.002; Diekmann H, 2005, MOL BIOL EVOL, V22, P1635, DOI 10.1093/molbev/msi158; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Endo T, 2007, DEV GROWTH DIFFER, V49, P121, DOI 10.1111/j.1440-169x.2007.00914.x; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Font E, 2001, BRAIN BEHAV EVOLUT, V58, P276, DOI 10.1159/000057570; GANZ J, 2011, J COMP NEUR IN PRESS; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hans S, 2002, DEVELOPMENT, V129, P4773; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KIRSCHE W., 1961, ZEIT MIKROSKOP ANAT FORSCH, V67, P140; Kirsche W, 1965, Ergeb Anat Entwicklungsgesch, V38, P143; KIZIL C, 2011, DEV NEUROBI IN PRESS; Klinger M, 2004, MOL BIOL EVOL, V21, P76, DOI 10.1093/molbev/msg241; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LeClair EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008737; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Magavi SS, 2000, NATURE, V405, P951; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; NOACK W, 1971, ACTA NEUROPATHOL, V19, P249, DOI 10.1007/BF00684602; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Nusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; PRZYBORSKI SA, 1995, DEV BRAIN RES, V89, P187, DOI 10.1016/0165-3806(95)00117-V; Puyal J, 2002, J COMP NEUROL, V451, P374, DOI 10.1002/cne.10366; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Romero-Aleman MM, 2010, J COMP NEUROL, V518, P4067, DOI 10.1002/cne.22444; Romero-Aleman MM, 2004, EXP NEUROL, V188, P74, DOI 10.1016/j.expneurol.2004.03.014; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schwab ME, 1996, PHYSIOL REV, V76, P319; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Takke C, 1999, DEVELOPMENT, V126, P1811; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang HD, 2002, J COMP NEUROL, V443, P275, DOI 10.1002/cne.10116; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Yoshii C, 2007, DEV BIOL, V303, P45, DOI 10.1016/j.ydbio.2006.11.024; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182	87	255	262	0	43	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991			DEVELOPMENT	Development	NOV 15	2011	138	22					4831	4841		10.1242/dev.072587			11	Developmental Biology	Developmental Biology	842EZ	WOS:000296576700003	22007133	Bronze			2021-06-18	
J	Vagnozzi, R; Signoretti, S; Tavazzi, B; Floris, R; Ludovici, A; Marziali, S; Tarascio, G; Amorini, AM; Di Pietro, V; Delfini, R; Lazzarino, G				Vagnozzi, Roberto; Signoretti, Stefano; Tavazzi, Barbara; Floris, Roberto; Ludovici, Andrea; Marziali, Simone; Tarascio, Giuseppe; Amorini, Angela M.; Di Pietro, Valentina; Delfini, Roberto; Lazzarino, Giuseppe			Temporal window of metabolic brain vulnerability to concussion: A pilot H-1 magnetic resonance spectroscopic study in concussed athletes - Part III	NEUROSURGERY			English	Article						brain vulnerability; concussion; H-1-magnetic resonance spectroscopy; N-acetylaspartate; second impact syndrome	SPORT-RELATED CONCUSSION; N-ACETYLASPARTATE; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; AXONAL INJURY; CEREBRAL CONCUSSION; ENERGY-METABOLISM; OXIDATIVE STRESS; NEURONAL DAMAGE; NERVOUS-SYSTEM	OBJECTIVE: In the present study, the occurrence of the tem'! oral window of brain vulnerability was evaluated in concussed athletes by measurinj r, N-acetylaspartate (NAA) using proton magnetic resonance ('H-MR) spectroscopy. METHODS: Thirteen nonprofessional athletes who had a spc t-related concussive head injury were examined for NAA determination by means of IH]MR spectroscopy at 3, 15, and 30 days postinjury. All athletes but three suspended their,hysical activity. Those who continued their training had a second concussive event and I underwent further examination at 45 days from the initial injury. The single case of orle professional boxer, who was studied before the match and 4, 7, 15, and 30 days aft(''!r a knockout, is also presented. Before each magnetic resonance examination, patient, were asked for symptoms of mild traumatic brain injury, including physical, cognitive; lemotional, and sleep disturbances. Data for I H-MR spectroscopy recorded in five n4pal, age-matched, control volunteers, who were previously screened to exclude previolJ1 s head injuries, were used i for comparison. Serniquantitative analysis of NAA relative to creatine (Cr)- and choline (Cho)-containing compounds was performed from proton sl Iectra obtained with a 3-T magnetic resonance system. RESULTS: Regarding the values of the NAA-to-Cr ratio (2.21 ji. 0.11) recorded in control patients, singly concussed athletes, at 3 days after the concuss ion, showed a decrease of 18.5% (1.80 -_ 0.04; P < 0.001). Only a modest 3% recover was observed at 15 days j, r (1.88 0.1; P< 0.001); at 30 days postinjury, the NAA-to-Cr raio was 2.15 -_ 0.1, revealing full metabolic recovery with values not significantly clifflE I rent from those of control patients. These patients declared complete resolution of symj)tctms at the time of the 3day study. The three patients who had a second concussive inj lry before the 15-day study showed an identical decrease of the NAA-to-Cr ratio at 3 da ls (1.78 4- 0.08); however, at 15 days after the second injury, a further diminution of the NAA-to-Cr ratio occurred (1.72 0.07; P < 0.05 with respect to singly concussed athl('!tes). At 30 days, the NAAto-Cr ratio was 1.82 0. 1, and at 45 days postinjury, the NA, I -to-Cr ratio showed com1! plete recovery (2.07 0. 1; not sign if icant with respect to con irol patients). This group of patients declared a complete resolution of symptoms at the ti' I,re of the 30-day study. CONCLUSION: Results of this pilot study carried out in a c( I)hort of singly and doubly I concussed athletes, examined by I H-MR spectroscopy for the I ir NAA cerebral content at different time points after concussive events, demonstrate tha also in humans, concussion opens a temporal window of brain metabolic imbalancejl the closure of which does not coincide with resolution of clinical symptoms. The reco vpry of brain metabolism is I not linearly related to time. A second concussive event prolon ed the time of NAA nor!19 malization by 15 days. Although needing confirmation in a larger group of patients, these 1 5 results show that NAA measurement by 'H-MR spectroscopylis a valid too] in assessing the full cerebral metabolic recovery after concussion, thereb ylsuggesting its use in helpft	[Amorini, Angela M.; Lazzarino, Giuseppe] Univ Catania, Dept Chem Sci, Biochem Lab, I-95125 Catania, Italy; [Vagnozzi, Roberto] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Div Neurosurg, Rome, Italy; [Tavazzi, Barbara; Di Pietro, Valentina] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy; [Floris, Roberto; Ludovici, Andrea; Marziali, Simone] Univ Roma Tor Vergata, Dept Diagnost Imaging & Intervent Radiol, Rome, Italy; [Tarascio, Giuseppe] Fiermonte Boxing Ctr, Rome, Italy; [Delfini, Roberto] Univ Roma La Sapienza, Dept Neurol Sci Neurosurg, I-00185 Rome, Italy	Lazzarino, G (corresponding author), Univ Catania, Dept Chem Sci, Biochem Lab, Viale A Doria 6, I-95125 Catania, Italy.	lazzarig@mbox.unict.it	floris, roberto/AAC-2396-2019; TAVAZZI, BARBARA/AAB-9830-2019; Signoretti, stefano/AAL-5631-2020; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; Signoretti, stefano/0000-0002-8086-1622; Marziali, Simone/0000-0002-5805-5501; lazzarino, giuseppe/0000-0002-5917-7279; AMORINI, Angela Maria/0000-0003-3525-9955; Di Pietro, Valentina/0000-0001-9430-4723			Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BAILES JE, 2007, NEUROSURGERY, V60, P1057; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 2003, J MOL NEUROSCI, V21, P185, DOI 10.1385/JMN:21:3:185; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; CANTU RC, 2000, NEUROLOGIC ATHLETIC, P132; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Durand P, 2004, J AM ACAD ORTHOP SUR, V12, P191, DOI 10.5435/00124635-200405000-00007; ERNST T, 1991, MAGN RESON MED, V21, P82, DOI 10.1002/mrm.1910210111; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; HAYFORD S, 1975, BIOCHEM J, V151, P455; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; HOVDA DA, 1993, INTRACRANIAL PRESSUR, V8, P459; HU XP, 1988, MAGNET RESON MED, V8, P314, DOI 10.1002/mrm.1910080308; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Logan SM, 2001, J ATHL TRAINING, V36, P433; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Nugent G Robert, 2006, Neurosurg Focus, V21, pE2; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; Putukian Margot, 2006, Curr Sports Med Rep, V5, P15; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Son BC, 2000, ACT NEUR S, V76, P13; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TRUCKENMILLER ME, 1985, J NEUROCHEM, V45, P1658, DOI 10.1111/j.1471-4159.1985.tb07240.x; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	81	255	258	0	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2008	62	6					1286	1295		10.1227/01.neu.0000333300.34189.74			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	334MS	WOS:000258226500025	18824995				2021-06-18	
J	Majerske, CW; Mihalik, JP; Ren, DX; Collins, MW; Reddy, CC; Lovell, MR; Wagner, AK				Majerske, Cynthia W.; Mihalik, Jason P.; Ren, Dianxu; Collins, Michael W.; Reddy, Cara Camiolo; Lovell, Mark R.; Wagner, Amy K.			Concussion in sports: Postconcussive activity levels, symptoms, and neurocognitive performance	JOURNAL OF ATHLETIC TRAINING			English	Article						exertion; rehabilitation; mild traumatic brain injuries; student-athletes	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; SEX-DIFFERENCES; VOLUNTARY EXERCISE; FOOTBALL PLAYERS; UNITED-STATES; UP-REGULATION; HIGH-SCHOOL; BLOOD-FLOW	Context. Evidence suggests that athletes engaging in high-intensity activities after concussion have more difficulties with cognitive recovery. Objective: To examine the role postinjury activity level plays in postconcussive symptoms and performance on neurocognitive tests in a population of student-athletes. Design: Retrospective cohort study with repeated measures of neurocognitive performance and symptom reporting. Setting: University-based sports concussion clinic. Patients or Other Participants: Ninety-five student-athletes (80 males, 15 females: age = 15.88 +/- 1.35 years) were retrospectively assigned to 1 of 5 groups based on a postinjury activity intensity scale. Main Outcome Measure(s): We employed a regression analysis for repeated measures to evaluate the relationship of activity intensity to symptoms and neurocognitive outcome up to 33 days after concussion. Postconcussion symptom scores and neurocognitive (verbal memory, visual memory, visual motor speed, and reaction time) scores served as the primary outcome measures. Results: Level of exertion was significantly related to all outcome variables (P < .02 for all comparisons). With multivariate analysis, activity intensity remained significant with respect to visual memory (P = .003) and reaction time (P < .001). Conclusions: Activity level after concussion affected symptoms and neurocognitive recovery. Athletes engaging in high levels of activity after concussion demonstrated worse neurocognitive performance. For these tasks, those engaging in moderate levels of activity demonstrated the best performance.	[Majerske, Cynthia W.; Ren, Dianxu; Collins, Michael W.; Reddy, Cara Camiolo; Lovell, Mark R.; Wagner, Amy K.] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Mihalik, Jason P.] Univ N Carolina, Chapel Hill, NC USA	Wagner, AK (corresponding author), Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, 201 Kaufmann Bldg,3471 5th Ave, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD040833] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08 HD040833, K08HD40833] Funding Source: Medline		Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; HISCOCK M, 1995, J CLIN EXP NEUROPSYC, V17, P590, DOI 10.1080/01688639508405148; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mendelowitsch A, 2001, BRAIN RES, V901, P230, DOI 10.1016/S0006-8993(01)02359-9; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; *NAT FED STAT HIGH, 1997, NAT FED STAT HIGH SC; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; RADOSEVICH PM, 1989, BRAIN RES, V498, P89, DOI 10.1016/0006-8993(89)90402-2; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7	48	255	256	0	55	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2008	43	3					265	274		10.4085/1062-6050-43.3.265			10	Sport Sciences	Sport Sciences	307LS	WOS:000256321000006	18523563	Green Published			2021-06-18	
J	Stiefel, MF; Spiotta, A; Gracias, VH; Garuffe, AM; Guillamondegui, O; Maloney-Wilensky, E; Bloom, S; Grady, MS; LeRoux, PD				Stiefel, MF; Spiotta, A; Gracias, VH; Garuffe, AM; Guillamondegui, O; Maloney-Wilensky, E; Bloom, S; Grady, MS; LeRoux, PD			Reduced mortality rate in patients with severe traumatic brain injury treated with brain tissue oxygen monitoring	JOURNAL OF NEUROSURGERY			English	Article						brain tissue oxygenation; intracranial pressure; traumatic brain injury; intracranial pressure monitoring; mortality rate	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; INTRACRANIAL HYPERTENSION; CEREBRAL OXYGENATION; AGGRESSIVE TREATMENT; COMATOSE PATIENTS; MANAGEMENT; SATURATION; EXPERIENCE; ISCHEMIA	Object. An intracranial pressure (ICP) monitor, from which cerebral perfusion pressure (CPP) is estimated, is recommended in the care of severe traumatic brain injury (TBI). Nevertheless, optimal ICP and CPP management may not always prevent cerebral ischemia, which adversely influences patient outcome. The authors therefore determined whether the addition of a brain tissue oxygen tension (PO,) monitor in the treatment of TBI was associated with an improved patient outcome. Methods. Patients with severe TBI (Glasgow Coma Scale [GCS] score < 8) who had been admitted to a Level I trauma center were evaluated as part of a prospective observational database. Patients treated with ICP and brain tissue PO, monitoring were compared with historical controls matched for age, pathological features, admission GCS score, and Injury Severity Score who had undergone ICP monitoring alone. Therapy in both patient groups was aimed at maintaining an ICP less than 20 mm Hg and a CPP greater than 60 mm Hg. Among patients whose brain tissue PO2 was monitored, oxygenation was maintained at levels greater than 25 mm Hg. Twenty-five patients with a mean age of 44 +/- 14 years were treated using an ICP monitor alone. Twenty-eight patients with a mean age of 38 18 years underwent brain tissue PO2-directed care. The mean daily ICP and CPP levels were similar in each group. The mortality rate in patients treated using conventional ICP and CPP management was 44%. Patients who also underwent brain tissue PO2 monitoring had a significantly reduced mortality rate of 25% (p < 0.05). Conclusions. The use of both ICP and brain tissue PO, monitors and therapy directed at brain tissue PO2 is associated with reduced patient death following severe TBI.	Univ Penn, Dept Neurosurg, Sch Med, Philadelphia, PA 19107 USA; Univ Penn, Div Trauma Surg & Surg Crit Care, Sch Med, Philadelphia, PA 19107 USA	LeRoux, PD (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu					Bardt TF, 1998, ACT NEUR S, V71, P153; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESTNUT RM, 2000, HEAD INJURY, P229; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; HAYES C, 1992, J NEUROSURG, V76, P364; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Procaccio F, 2000, J Neurosurg Sci, V44, P11; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	50	255	260	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2005	103	5					805	811		10.3171/jns.2005.103.5.0805			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	979GN	WOS:000232930500009	16304983				2021-06-18	
J	Ho, YS; Xiong, Y; Ma, WC; Spector, A; Ho, DS				Ho, YS; Xiong, Y; Ma, WC; Spector, A; Ho, DS			Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; GLUTATHIONE-PEROXIDASE; HYPOCATALASEMIC MOUSE; HYDROGEN-PEROXIDE; MITOCHONDRIAL-FUNCTION; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; EPITHELIAL-CELLS; BLOOD CATALASE; RAT LENSES	Catalase plays a major role in cellular antioxidant defense by decomposing hydrogen peroxide, thereby preventing the generation of hydroxyl radical by the Fenton reaction. The degree of catalase deficiency in acatalasemic and hypocatalasemic mice varies from tissue to tissue. They therefore may not be suitable for studying the function of this enzyme in certain models of oxidant-mediated tissue injury. We sought to generate a new line of catalase null mice by the gene targeting technique. The mouse catalase (Cat or Cas1) gene was disrupted by replacing parts of intron 4 and exon 5 with a neomycin resistance cassette. Homozygous Cat knockout mice, which are completely deficient in catalase expression, develop normally and show no gross abnormalities. Slices of liver and lung and lenses from the knockout mice exhibited a retarded rate in decomposing extracellular hydrogen peroxide compared with those of wild-type mice. However, mice deficient in catalase were not more vulnerable to hyperoxia-induced lung injury; nor did their lenses show any increased susceptibility to oxidative stress generated by photochemical reaction, suggesting that the antioxidant function of catalase in these two models of oxidant injury is negligible. Further studies showed that cortical injury from physical impact caused a significant decrease in NAD-linked electron transfer activities and energy coupling capacities in brain mitochondria of Cat knockout mice but not wild-type mice. The observed decrease in efficiency of mitochondrial respiration may be a direct result of an increase in mitochondrion-associated calcium, which is secondary to the increased oxidative stress. These studies suggest that the role of catalase in antioxidant defense is dependent on the type of tissue and the model of oxidant-mediated tissue injury.	Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA; Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA	Ho, YS (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, 2727 2nd Ave,Rm 4000, Detroit, MI 48201 USA.	yho@wayne.edu		Xiong, Ye/0000-0001-9770-6031	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL63317, HL56421] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES06639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL063317, R01HL056421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES006639] Funding Source: NIH RePORTER		AEBI H, 1984, METHOD ENZYMOL, V105, P121; AEBI H, 1968, BIOCHEM GENET, V2, P245, DOI 10.1007/BF01474764; ARNHOLD J, 1991, J BIOLUM CHEMILUM, V6, P189, DOI 10.1002/bio.1170060309; Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8; BERG JM, 2002, BIOCHEMISTRY-US, P205; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; Brown MR, 1999, CIRC RES, V85, P524, DOI 10.1161/01.RES.85.6.524; CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031; CHANCE B, 1979, PHYSIOL REV, V59, P527; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123; Eaton J.W., 1995, METABOLIC MOL BASES, P2371; ERZURUM SC, 1993, NUCLEIC ACIDS RES, V21, P1607, DOI 10.1093/nar/21.7.1607; FEINSTEI.RN, 1967, ARCH BIOCHEM BIOPHYS, V120, P165, DOI 10.1016/0003-9861(67)90609-1; FEINSTEIN RN, 1967, ARCH BIOCHEM BIOPHYS, V122, P338, DOI 10.1016/0003-9861(67)90203-2; FEINSTEIN RN, 1966, GENETICS, V53, P923; FEINSTEIN RN, 1968, BIOCHEM GENET, V1, P277, DOI 10.1007/BF00485182; FEINSTEIN RN, 1968, SCIENCE, V159, P638, DOI 10.1126/science.159.3815.638; FLOHE L, 1972, H-S Z PHYSIOL CHEM, V353, P987, DOI 10.1515/bchm2.1972.353.1.987; Flohe L, 2003, BIOFACTORS, V19, P3, DOI 10.1002/biof.5520190102; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; FREEMAN BA, 1984, ENVIRON HEALTH PERSP, V56, P51; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; JONES GL, 1976, ARCH BIOCHEM BIOPHYS, V173, P463, DOI 10.1016/0003-9861(76)90283-6; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Keilin D, 1936, PROC R SOC SER B-BIO, V119, P141, DOI 10.1098/rspb.1936.0003; KEILIN D, 1945, BIOCHEM J, V39, P293, DOI 10.1042/bj0390293; Lee C. P., 1993, V2, P41; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LINDAUSHEPARD BA, 1993, FREE RADICAL BIO MED, V15, P581, DOI 10.1016/0891-5849(93)90160-V; MAKINO N, 1994, J BIOL CHEM, V269, P1020; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; OSHINO N, 1973, BIOCHEM J, V131, P555, DOI 10.1042/bj1310555; Povlishock J T, 1992, Hum Cell, V5, P345; RADI R, 1991, J BIOL CHEM, V266, P22028; RAMACHANDRAN S, 1991, EXP EYE RES, V53, P503, DOI 10.1016/0014-4835(91)90167-D; REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; SHAFFER JB, 1990, BIOCHEM BIOPH RES CO, V173, P1043, DOI 10.1016/S0006-291X(05)80891-5; SHAFFER JB, 1987, J BIOL CHEM, V262, P12908; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spector A, 1996, EXP EYE RES, V62, P521, DOI 10.1006/exer.1996.0063; SPECTOR A, 1981, EXP EYE RES, V33, P673, DOI 10.1016/S0014-4835(81)80107-8; SPECTOR A, 1995, FASEB J, V9, P1173; SPECTOR A, 1993, CURR EYE RES, V12, P163, DOI 10.3109/02713689308999484; SPECTOR A, 1993, P NATL ACAD SCI USA, V90, P7485, DOI 10.1073/pnas.90.16.7485; SPERANZA MJ, 1993, J BIOL CHEM, V268, P19039; SUN Y, 1988, FREE RADICAL RES COM, V5, P67, DOI 10.3109/10715768809066913; SUZUKI K, 1991, ACTA MED OKAYAMA, V45, P363; Takahara S., 1948, J OTORHINOLARYNG SOC, V51, P163; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Wang DH, 2001, BBA-GENE STRUCT EXPR, V1522, P217, DOI 10.1016/S0167-4781(01)00316-5; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yang H, 2003, AM J HYPERTENS, V16, P1, DOI 10.1016/S0895-7061(02)03086-8; YOO JH, 1994, J CLIN INVEST, V93, P297, DOI 10.1172/JCI116959	66	255	267	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2004	279	31					32804	32812		10.1074/jbc.M404800200			9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	840HW	WOS:000222849700100	15178682	Other Gold			2021-06-18	
J	Fleming, JM; Strong, J; Ashton, R				Fleming, JM; Strong, J; Ashton, R			Self-awareness of deficits in adults with traumatic brain injury: How best to measure?	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; RELATIVES; UNAWARENESS; ANOSOGNOSIA; RELIABILITY; DISABILITY; DISORDER; INSIGHT; MEMORY; LIFE	Some method of assessing self-awareness of deficits in patients with traumatic brain injury (TBI) is required to increase our understanding of the phenomenon, and to then evaluate strategies for clinical intervention with patients who lack such self-awareness. Options for the assessment of self-awareness of deficits following TBI are reviewed. The most commonly used method is comparison of patients' self-ratings on questionnaires of functional abilities with ratings by relatives or staff on the same questionnaires. An additional method of assessment, an interviewer-rated semi-structured interview is proposed (the Self-Awareness of Deficits Interview), and some preliminary inter-rater reliability data are presented. However, quantitative methods of evaluating self-awareness have shortcomings, and qualitative research may be more appropriate in some circumstances. An approach which makes use of multiple measures to evaluate self-awareness of deficits is recommended.	UNIV QUEENSLAND, DEPT PSYCHOL, ST LUCIA, QLD 4067, AUSTRALIA	Fleming, JM (corresponding author), UNIV QUEENSLAND, DEPT OCCUPAT THERAPY, ST LUCIA, QLD 4072, AUSTRALIA.		Fleming, Jennifer M/B-4436-2011; Strong, Jenny/F-1211-2010	Strong, Jenny/0000-0002-9367-8755			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Barco P.P., 1991, COGNITIVE REHABILITA, P129; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CAVELLO MM, 1992, BRAIN INJURY, V6, P327; Crisp R, 1992, Aust Occup Ther J, V39, P15, DOI 10.1111/j.1440-1630.1992.tb01730.x; CRISP R, 1991, AUSTR DISABILITY REV, V1, P37; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; DICESARE A, 1990, COGNITIVE REHABILITA, V8, P14; FAHY T, 1967, LANCET, V2, P457; Farmer J E, 1988, Brain Inj, V2, P323, DOI 10.3109/02699058809150903; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P640; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; Herbert CM, 1989, CLIN REHABIL, V3, P125; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; KARPMAN T, 1985, J APPL REHABILITATIO, V17, P28; KHILSTROM JF, 1991, AWARENESS DEFICIT BR, P198; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KREBS DE, 1984, PHYS THER, V64, P1581; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MAHER C, 1993, AUST J PHYSIOTHER, V39, P5; Malia K, 1993, CLIN REHABIL, V7, P23; MARKOVA IS, 1992, ACTA PSYCHIAT SCAND, V86, P159, DOI 10.1111/j.1600-0447.1992.tb03245.x; McGlynn S.M., 1991, AWARENESS DEFICIT BR, P84; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCWILLIAMS S, 1991, BRIT J OCCUPATIONAL, V54, P246; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; Patton MQ., 1990, QUALITATIVE EVALUATI; PONSFORD JL, 1988, AUST PSYCHOL, V23, P349, DOI 10.1080/00050068808255617; Priddy D A, 1988, Brain Inj, V2, P249, DOI 10.3109/02699058809150949; PRIGATANO G, 1986, NEUROPSYCHOL REHABIL, P143; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 1991, BNI Q, V7, P27; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1991, AWARENESS DEFICIT BR, P3; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; ROUECHE JR, 1987, COGNITIVE REHABILITA, V1, P4; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI DOI 10.1177/030802269505800204; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT., 1991, AWARENESS DEFICIT BR, P63; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; WALKER DE, 1987, J CLIN PSYCHOL, V43, P694; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; YISHAY YB, 1981, INT J REHABILITATION, V4, P208; ZEIGLER EA, 1987, J REHABIL, V53, P50	68	255	258	1	22	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1996	10	1					1	15					15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	TY049	WOS:A1996TY04900001	8680388				2021-06-18	
J	Pachter, HL; Knudson, MM; Esrig, B; Ross, S; Hoyt, D; Cogbill, T; Sherman, H; Scalea, T; Harrison, P; Shackford, S; Ochsner, MG; Mucha, P; Hofstetter, SR; Guth, A; Coffey, S; Kataju, S; Marburger, R; Garcia, J; Savage, B; Henry, S; Lippold, D; Trevesani, G; Steinig, J				Pachter, HL; Knudson, MM; Esrig, B; Ross, S; Hoyt, D; Cogbill, T; Sherman, H; Scalea, T; Harrison, P; Shackford, S; Ochsner, MG; Mucha, P; Hofstetter, SR; Guth, A; Coffey, S; Kataju, S; Marburger, R; Garcia, J; Savage, B; Henry, S; Lippold, D; Trevesani, G; Steinig, J			Status of nonoperative management of blunt hepatic injuries in 1995: A multicenter experience with 404 patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							LIVER TRAUMA; ADULTS; SPLEEN	Introduction: Nonoperative management is presently considered the treatment modality of choice in over 50% of adult patients sustaining blunt hepatic trauma who meet inclusion criteria. A multicenter study was retrospectively undertaken to assess whether the combined experiences at level I trauma centers could validate the currently reported high success rate, low morbidity, and virtually nonexistent mortality associated with this approach. Thirteen level I trauma centers accrued 404 adult patients sustaining blunt hepatic injuries managed nonoperatively over the last 5 years. Seventy-two percent of the injuries resulted from motor vehicle crashes. The mean injury severity score for the entire group was 20.2 (range, 4-75), and the American Association for the Surgery of Trauma-computerized axial tomography scan grading was as follows: grade I, 19% (n = 76); grade II, 31% (n = 124); grade III, 36% (n = 146); grade IV, 10% (n = 42); and grade V, 4% (n = 16). There were 27 deaths (7%) in the series, with 59% directly related to head trauma. Only two deaths (0.4%) could be attributed to hepatic injury. Twenty-one (5%) complications were documented, with the most common being hemorrhage, occurring in 14 (3.5%). Only 3 (0.7%) of these 14 patients required surgical intervention, 6 were treated by transfusions alone (0.5 to 5 U), 4 underwent angio-embolization, and 1 was further observed. Other complications included 2 bilomas and 3 perihepatic abscesses (all drained percutaneously). Two small bowel injuries were initially missed (0.5 %), and diagnosed 2 and 3 days after admission. Overall, 6 patients required operative intervention: 3 for hemorrhage, 2 for missed enteric injuries, and 1 for persistent sepsis after unsuccessful percutaneous drainage. Average length of stay was 13 days. Nonoperative management of blunt hepatic injuries is clearly the treatment modality of choice in hemodynamically stable patients, irrespective of grade of injury or degree of hemoperitoneum. Current data would suggest that 50 to 80% (47% in this series) of all adult patients with blunt hepatic injuries are candidates for this form of therapy. Exactly 98.5% of patients analyzed in this study successfully avoided operative intervention. Bleeding complications are infrequently encountered (3.5%) and can often be managed nonoperatively. Although grades TV and V injuries composed 14% of the series, they represented 66.6% of the patients requiring operative intervention and thus merit constant re-evaluation and close observation in critical care units. The optimal time for follow-up computerized axial tomography scanning seems to be within 7 to 10 days after injury.	NYU,BELLEVUE HOSP,DEPT SURG,NEW YORK,NY 10012; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT SURG,SAN FRANCISCO,CA 94143; HUNTINGTON MEM HOSP,DEPT SURG,PASADENA,CA; UNIV MED & DENT NEW JERSEY,COOPER HOSP,DEPT SURG,CAMDEN,NJ 08103; UNIV CALIF SAN DIEGO,DEPT SURG,SAN DIEGO,CA 92103; GUNDERSON LUTHERAN MED CTR,DEPT SURG,LA CROSSE,WI; MERCY HOSP,DEPT SURG,PITTSBURGH,PA 15219; KINGS CTY HOSP,DEPT SURG,BROOKLYN,NY; HLTH CARE CORP AMER WESLEY,DEPT SURG,WICHITA,KS; UNIV VERMONT,DEPT SURG,BURLINGTON,VT 05405; WASHINGTON HOSP CTR,DEPT SURG,WASHINGTON,DC 20010; MEM MED CTR,DEPT SURG,SAVANNAH,GA; PENN STATE UNIV,DEPT SURG,HERSHEY,PA							ANDERSSON R, 1986, ACTA CHIR SCAND, V152, P739; [Anonymous], 1990, ABBREVIATED INJURY S; BERMAN SS, 1992, J PEDIATR SURG, V27, P1546, DOI 10.1016/0022-3468(92)90503-Y; BOONE DC, 1994, JAN E ASS SURG TRAUM; BYNOE RP, 1992, J TRAUMA, V32, P308, DOI 10.1097/00005373-199203000-00008; CARMONA RH, 1982, AM J SURG, V144, P88, DOI 10.1016/0002-9610(82)90607-9; CROCE MA, 1995, ANN SURG, V221, P744, DOI 10.1097/00000658-199506000-00013; CYWES S, 1985, J PEDIATR SURG, V20, P14, DOI 10.1016/S0022-3468(85)80383-3; DURHAM RM, 1992, AM J SURG, V164, P477, DOI 10.1016/S0002-9610(05)81184-5; FARNELL MB, 1988, SURGERY, V104, P748; FEDERICO JA, 1990, ARCH SURG-CHICAGO, V125, P905; FLINT LM, 1977, ANN SURG, V185, P613, DOI 10.1097/00000658-197706000-00001; GATES JD, 1994, J TRAUMA, V36, P572, DOI 10.1097/00005373-199404000-00020; HAMMOND JC, 1992, AM SURGEON, V58, P551; HIATT JR, 1990, ARCH SURG-CHICAGO, V125, P101; HOLLANDS MJ, 1991, BRIT J SURG, V78, P968, DOI 10.1002/bjs.1800780824; JONES TK, 1983, SURG GYNECOL OBSTET, V157, P389; KARP MP, 1983, J PEDIATR SURG, V18, P512, DOI 10.1016/S0022-3468(83)80211-5; KNUDSON MM, 1990, J TRAUMA, V30, P1454; MEREDITH JW, 1994, J TRAUMA, V36, P529, DOI 10.1097/00005373-199404000-00012; MEREDITH JW, 1992, AM SURGEON, V58, P44; MIRVIS SE, 1989, RADIOLOGY, V171, P27, DOI 10.1148/radiology.171.1.2928537; MOORE EE, 1989, J TRAUMA, V29, P1664, DOI 10.1097/00005373-198912000-00013; MOORE EE, 1984, AM J SURG, V145, P712; PACHTER HL, 1995, AM J SURG, V169, P442; PACHTER HL, 1992, ANN SURG, V215, P492, DOI 10.1097/00000658-199205000-00012; POPOVSKY J, 1974, ARCH SURG-CHICAGO, V108, P184; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; RICHIE JP, 1972, ARCH SURG-CHICAGO, V104, P781; SCALFANI S, 1984, J TRAUMA, V24, P256; SHERMAN HF, 1994, J TRAUMA, V37, P616, DOI 10.1097/00005373-199410000-00015; SUGIMOTO K, 1993, J TRAUMA, V35, P192, DOI 10.1097/00005373-199308000-00004; TRUNKEY D, 1990, ARCH SURG-CHICAGO, V125, P909; WALT AJ, 1990, ARCH SURG-CHICAGO, V120, P103	34	255	267	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1996	40	1					31	38		10.1097/00005373-199601000-00007			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	TU074	WOS:A1996TU07400007	8576995				2021-06-18	
J	DIETRICH, WD; ALONSO, O; BUSTO, R; GLOBUS, MYT; GINSBERG, MD				DIETRICH, WD; ALONSO, O; BUSTO, R; GLOBUS, MYT; GINSBERG, MD			POSTTRAUMATIC BRAIN HYPOTHERMIA REDUCES HISTOPATHOLOGICAL DAMAGE FOLLOWING CONCUSSIVE BRAIN INJURY IN THE RAT	ACTA NEUROPATHOLOGICA			English	Article						TRAUMATIC BRAIN INJURY; HYPOTHERMIA; HISTOPATHOLOGY; FLUID PERCUSSION; RAT; CONTUSION	ISCHEMIC NEURONAL INJURY; FLUID-PERCUSSION MODEL; CEREBRAL-ISCHEMIA; VASCULAR-PERMEABILITY; MODERATE HYPOTHERMIA; GLUCOSE-UTILIZATION; HEAD-INJURIES; AMINO-ACIDS; TEMPERATURE; RELEASE	The purposes of this study were (1) to document the histopathological consequences of moderate traumatic brain injury (TBI) in anesthetized Sprague-Dawley rats, and (2) to determine whether posttraumatic brain hypothermia (30 degrees C) would protect histopathologically. Twenty-four hours prior to TBI, the fluid percussion interface was positioned over the right cerebral cortex. On the 2nd day, fasted rats were anesthetized with 70% nitrous oxide, 1% halothane, and 30% oxygen. Under controlled physiological conditions and normothermic brain temperature (37.5 degrees C), rats were injured with a fluid percussion pulse ranging from 1.7 to 2.2 atmospheres. In one group, brain temperature was maintained at normothermic levels for 3 h after injury. In a second group, brain temperature was reduced to 30 degrees C at 5 min post-trauma and maintained for 3 h. Three days after TBI, brains were perfusion-fixed for routine histopathological analysis. In the normothermic group, damage at the site of impact was seen in only one of nine rats. In contrast, all normothermic animals displayed necrotic neurons within ipsilateral cortical regions lateral and remote from the impact site. Intracerebral hemorrhagic contusions were present in all rats at the gray-white interface underlying the injured cortical areas. Selective neuronal necrosis was also present within the CA3 and CA4 hippocampal subsectors and thalamus. Post-traumatic brain hypothermia significantly reduced the overall sum of necrotic cortical neurons (519 +/- 122 vs 952 +/- 130, mean +/- SE, P = 0.03, Kruskal-Wallis test) as well as contusion volume (0.50 +/- 0.14 vs 2.14 +/- 0.71 mm(3), P = 0.004). These data document a consistent pattern of histopathological vulnerability following normothermic TBI and demonstrate hypothermic protection in the post-traumatic setting.		DIETRICH, WD (corresponding author), UNIV MIAMI, SCH MED, DEPT NEUROL, NEUROTRAUMA CLIN RES CTR, POB 016960, MIAMI, FL 33101 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS027127] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291, NS27127] Funding Source: Medline		ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1982, RECENT ADV NEUROPATH, V2, P165; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1991, ACTA NEUROPATHOL, V81, P615, DOI 10.1007/BF00296371; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOFFMAN WE, 1991, J NEUROSURG ANESTH, V3, P34, DOI 10.1097/00008506-199103000-00006; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; HOVA DA, 1992, J NEUROTRAUMA S1, V9, pS47; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; JENKINS A, 1989, NEUROPATH APPL NEURO, V15, P477, DOI 10.1111/j.1365-2990.1989.tb01247.x; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; LYETH B G, 1991, Society for Neuroscience Abstracts, V17, P165; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM BS, 1972, BRAIN RES, V48, P361, DOI 10.1016/0006-8993(72)90190-4; MELDRUM BS, 1984, BRAIN RES, P921; MITCHELL DE, 1973, LANCET, V2, P215; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P265; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SEELIG JM, 1985, BIOMECHANICS TRAUMA, P225; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOSHINO A, 1992, BRAIN RES, V12, P996; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZILLES L, 1985, CORTEX RAT STEREOTAX	65	255	257	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAR	1994	87	3					250	258		10.1007/BF00296740			9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	MW739	WOS:A1994MW73900004	8009957				2021-06-18	
J	Shohami, E; Gallily, R; Mechoulam, R; Bass, R; BenHur, T				Shohami, E; Gallily, R; Mechoulam, R; Bass, R; BenHur, T			Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant	JOURNAL OF NEUROIMMUNOLOGY			English	Article; Proceedings Paper	6th International TNF Congress	MAY 08-12, 1996	RHODES, GREECE			blood-brain barrier; closed head injury; dexanabinol (HU-211); edema; tumor necrosis facror-alpha (TNF-alpha)	TUMOR-NECROSIS-FACTOR; NONCOMPETITIVE NMDA ANTAGONIST; RAT-BRAIN; CEREBRAL-ISCHEMIA; ASPARTATE; RECEPTOR; MECHANISMS; ACID; DAMAGE; MICRODIALYSIS	Traumatic brain injury triggers a cascade of events resulting in delayed edema, necrosis and impaired function. Harmful mediators are accumulating in the brain after injury and recently, the role of cytokines in the pathophysiology of brain injury has been suggested. We have developed an experimental model for closed head injury (CHI), in which edema, blood-brain-barrier disruption, motor and memory dysfunctions have been demonstrated. In this study, spatial and temporal induction of IL-1, IL-6 and TNF-alpha gene mRNA transcription and of TNF-alpha and IL-6 activity in rat brain after CHI are shown. Dexanabinol, HU-211, is a synthetic cannabinoid devoid of cannabimimetic effects; it exhibits pharmacological properties of N-methyl-D-aspartate (NMDA)-receptor antagonist and is an effective cerebroprotecant. We report here that HU-211 is a novel inhibitor of TNF-alpha production at a post-transcriptional stage. HU-211, pentoxyfilline and TNF-binding protein improved the outcome of CHI. We suggest that TNF-alpha is a primary mediator of neurotoxicity after CHI, as inhibition of TNF-alpha is associated with better clinical recovery. TNF-alpha modulating agents, if given within the early time window post-injury, may improve the final neurological outcome in victims of brain trauma.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT IMMUNOL, IL-91010 JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, SCH PHARM, DEPT NAT PROD, IL-91120 JERUSALEM, ISRAEL; HADASSAH UNIV HOSP, DEPT NEUROL, IL-91120 JERUSALEM, ISRAEL	Shohami, E (corresponding author), HEBREW UNIV JERUSALEM, SCH PHARM, DEPT PHARMACOL, IL-91120 JERUSALEM, ISRAEL.						BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; Bass R, 1996, J INFECT DIS, V173, P735, DOI 10.1093/infdis/173.3.735; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BRENNER T, 1993, BRAIN RES, V608, P273, DOI 10.1016/0006-8993(93)91468-8; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1993, PROG BRAIN RES, V96, P137; Cohen PS, 1996, P NATL ACAD SCI USA, V93, P3967, DOI 10.1073/pnas.93.9.3967; DIEMER NH, 1993, PROG BRAIN RES, V96, P105; DINARELLO CA, 1988, INFLAMMATION BASIC P, P195; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; LITTLE PJ, 1989, PHARMACOL BIOCHEM BE, V32, P661, DOI 10.1016/0091-3057(89)90014-2; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MECHOULAM R, 1990, TETRAHEDRON-ASYMMETR, V1, P315, DOI 10.1016/S0957-4166(00)86322-3; MECHOULAM R, 1988, EXPERIENTIA, V44, P762, DOI 10.1007/BF01959156; MECHOULAM R, 1992, MARIJUANA CANNABINOI, P1; MIER JW, 1992, TUMOR NECROSIS FACTO, P221; MORGANTIKOSSMAN.MC, 1995, IMMUNE RESPONSES NER, P159; MORGANTIKOSSMANN MC, 1992, TRENDS PHARMACOL SCI, V13, P286, DOI 10.1016/0165-6147(92)90087-M; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; NADLER V, 1993, BRAIN RES, V622, P79, DOI 10.1016/0006-8993(93)90804-V; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; Olney J. W., 1978, KAINIC ACID TOOL NEU, P37; REMICK DG, 1989, BIOCHEM BIOPH RES CO, V161, P551, DOI 10.1016/0006-291X(89)92634-X; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; SPANGELO BL, 1990, ENDOCRINOLOGY, V127, P1779, DOI 10.1210/endo-127-4-1779; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tracey K J, 1990, Adv Surg, V23, P21; TRACEY KJ, 1991, CIRC SHOCK, V35, P123; WAAGE A, 1992, TUMOR NECROSIS FACTO, P275; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Westmoreland SV, 1996, J NEUROVIROL, V2, P118, DOI 10.3109/13550289609146545; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; ZABEL P, 1989, LANCET, V2, P1474	60	254	265	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	FEB	1997	72	2					169	177		10.1016/S0165-5728(96)00181-6			9	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	WG342	WOS:A1997WG34200011	9042110				2021-06-18	
J	LOGAN, A; BERRY, M; GONZALEZ, AM; FRAUTSCHY, SA; SPORN, MB; BAIRD, A				LOGAN, A; BERRY, M; GONZALEZ, AM; FRAUTSCHY, SA; SPORN, MB; BAIRD, A			EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA(1) ON SCAR PRODUCTION IN THE INJURED CENTRAL-NERVOUS-SYSTEM OF THE RAT	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						TRANSFORMING GROWTH FACTOR-BETA(1); CENTRAL NERVOUS SYSTEM; GLIAL SCARRING; CNS INJURY; FIBROSIS; ASTROCYTES; MESSENGER RNA	FACTOR-BETA; EXTRACELLULAR-MATRIX; MESSENGER-RNA; TGF-BETA; EXPRESSION; BRAIN; PROLIFERATION; FIBROBLASTS; LOCALIZATION; FIBRONECTIN	In the central nervous system (CNS), nerve regeneration after traumatic injury fails. The formation of a dense fibrous scar is thought to restrict in part the growth of axonal projections, providing one of the many reasons that complete lesions of neural pathways in the adult mammalian CNS are rarely followed by significant functional recovery. In order to determine which mechanisms mediate scar formation in the CNS and to investigate whether they can be modulated in vivo, we have attempted to define the potential role of trophic factors. Our previous studies have shown the focal elevation of transforming growth factor beta1 (TGFbeta1) expression in lesioned CNS tissue. In the studies described here, we demonstrate that TGFbeta1 participates in the scarring response in the rat brain. First, the elevated protein levels of TGFbeta1 are localized to specific populations of injury-responsive cells in the traumatized CNS. Furthermore, the injection of TGFbeta1 into the brains of injured rats causes a dramatic increase in the scarring response. Conversely, when neutralizing TGFbeta1 antibodies are administered, the deposition of fibrous scar tissue and the formation of a limiting glial membrane that borders the lesion is significantly attenuated, thus establishing a role for the endogenous growth factor in regulation of the non-glial component of the scar. In implicating TGFbeta1 in the scarring response in the CNS, the potential use for TGFbeta1 antagonists as inhibitors of scar formation in the injured mammalian CNS is self-evident.	WHITTIER INST DIABET & ENDOCRINOL,DEPT MOLEC & CELLULAR GROWTH BIOL,LA JOLLA,CA 92037; UNIV BIRMINGHAM,DEPT CLIN CHEM,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; NIH,CHEMOPREVENT LAB,BETHESDA,MD 20892; UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT ANAT & CELL BIOL,LONDON SE1 9RT,ENGLAND				Logan, Ann/0000-0003-3215-5042; Baird, Andrew/0000-0003-0027-9905; Frautschy, Sally A./0000-0003-0194-0363	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG010685, AG10685] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK18811] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS028121, NS28121] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK018811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS028121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG010685] Funding Source: NIH RePORTER		Aguado A, 1982, ADV CELL NEUROBIOL, V3, P215; Beck LS, 1990, GROWTH FACTORS, V2, P273, DOI 10.3109/08977199009078015; Beck LS, 1990, GROWTH FACTORS, V3, P267, DOI 10.3109/08977199009003669; BERNSTEIN EF, 1991, J INVEST DERMATOL, V97, P430, DOI 10.1111/1523-1747.ep12481258; BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; FLANDERS KC, 1989, J CELL BIOL, V108, P653, DOI 10.1083/jcb.108.2.653; FLANDERS KC, IN PRESS MOL CELL NE; GONZALEZ AM, 1990, J CELL BIOL, V110, P347; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; JOHNS LD, 1992, BRAIN RES, V585, P229, DOI 10.1016/0006-8993(92)91211-V; KLEMPT ND, 1992, MOL BRAIN RES, V13, P93, DOI 10.1016/0169-328X(92)90048-G; KSANDER GA, 1990, ANN SURG, V221, P288; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; McGee G S, 1989, Curr Surg, V46, P103; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; NICHOLS NR, 1991, J NEUROSCI RES, V28, P134, DOI 10.1002/jnr.490280114; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; SAKAI Y, 1990, P NATL ACAD SCI USA, V87, P8378, DOI 10.1073/pnas.87.21.8378; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; TORUDELBAUFFE D, 1992, EXP CELL RES, V202, P316, DOI 10.1016/0014-4827(92)90081-I; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415; WONG HL, 1990, PEPTIDE GROWTH FACTO, P509	38	254	260	1	3	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	MAR 1	1994	6	3					355	363		10.1111/j.1460-9568.1994.tb00278.x			9	Neurosciences	Neurosciences & Neurology	ND226	WOS:A1994ND22600007	8019673				2021-06-18	
J	Gioia, GA; Isquith, PK				Gioia, GA; Isquith, PK			Ecological assessment of executive function in traumatic brain injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE DAMAGE; CLOSED-HEAD-INJURY; CHILDHOOD; CHILDREN; VALIDITY; PERFORMANCE; COGNITION; RECOVERY; TESTS; ATTENTION	Executive dysfunction is a common outcome in children who have sustained traumatic brain injury (TBI). Appropriate assessment of these complex interrelated regulatory functions is critical to plan for the necessary interventions yet present a challenge to our traditional methodologies. Ecological validity has become an increasingly important focus in neuropsychological assessment with particular relevance for the executive functions, which coordinate one's cognitive and behavioral capacities with real-world demand situations. The Behavior Rating Inventory of Executive Function (BRIEF) was developed to capture the real-world behavioral manifestations of executive dysfunction. Its development and various forms of validity, including ecological validity, are described. Application of the BRIEF's methodology to the assessment of executive dysfunction in TBI is provided. We advocate a multilevel approach to understanding executive function outcome in TBI, including traditional test-based measures of executive function, real-world behavioral manifestation of executive dysfunction, and the environmental system factors that impact the child. In this model, ecologically valid assessment of executive dysfunction provides an important bridge toward understanding the impact of component-level (i.e., test-based) deficits on the child's everyday adaptive functioning, which can assist the definition of targets for intervention.	George Washington Univ, Sch Med, Pediat Neuropsychol Program, Childrens Natl Med Ctr,Dept Pediat, Rockville, MD 20850 USA; George Washington Univ, Sch Med, Dept Psychiat & Behav Sci, Rockville, MD 20850 USA; Dartmouth Hitchcock Med Ctr, Dept Pediat, Hanover, NH USA; Dartmouth Hitchcock Med Ctr, Dept Psychiat, Hanover, NH USA	Gioia, GA (corresponding author), George Washington Univ, Sch Med, Pediat Neuropsychol Program, Childrens Natl Med Ctr,Dept Pediat, 14801 Phys Lane,Suite 173, Rockville, MD 20850 USA.	ggioia@cnmc.org	Isquith, Peter/AAY-4851-2020				Achenbach T. M., 1991, MANUAL CHILD BEHAV C; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; ACKERLY SS, 1964, FRONTAL GRANULAR COR; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2000, BRAIN INJURY, V14, P679; ARMSTRONG K, 2001, UNPUB LONG TERM EXEC; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Barkley R. A., 1997, ADHD NATURE SELF CON; Barkley RA, 2000, J AM ACAD CHILD PSY, V39, P1064, DOI 10.1097/00004583-200008000-00025; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; BERNSTEIN JH, 1990, NEUROMETHODS, V17; BROWN TE, 1999, ADHD REPORT, V7, P1; BRUNSWIK E, 1955, PSYCHOL REV, V62, P193, DOI 10.1037/h0047470; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CONNERS CK, 1989, MANUAL CONNERS READI; Cripe L., 1996, ECOLOGICAL VALIDITY, P171; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; Denckla M.B., 1994, FRAMES REFERENCE ASS, P117; Denckla M.B., 1996, ATTENTION MEMORY EXE, P263; Denckla MB., 1989, INT PEDIAT, V4, P155; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dunn E J, 1990, Arch Clin Neuropsychol, V5, P103, DOI 10.1016/0887-6177(90)90032-K; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; ESLINGER PJ, 1991, DEV NEUROPSYCHOL, V7, P257, DOI 10.1080/87565649109540493; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; FUSTER JM, 1989, PREFRONTAL CORTEX AN; Gioia G.A., 2000, BEHAV RATING INVENTO; GIOIA GA, 1998, J NEUROPSYCHIATRY CL, V9, P663; GIOIA GA, IN PRESS CLIN NEUROP; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Goulden LG, 1997, ARCH CLIN NEUROPSYCH, V12, P326, DOI 10.1093/arclin/12.4.326; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; HARTLAGE LC, 1996, ECOLOGICAL VALIDITY, P301; Heaton R., 1993, WISCONSIN CARD SORTI; Isquith PK, 2000, ARCH CLIN NEUROPSYCH, V15, P780, DOI 10.1016/S0887-6177(00)80238-3; ISQUITH PK, 1999, CLIN NEUROPSYCHOL, V13, P227; JANUSZ J, 2001, UNPUB RELATIONSHIP E; Kaplan E., 1988, CLIN NEUROPSYCHOLOGY, P125; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LONG CJ, 1996, ECOLOGICAL VALIDITY, P1; LYSAKER P, 1995, PSYCHIAT RES, V56, P45, DOI 10.1016/0165-1781(94)02641-U; Mahone EM, 2001, J INT NEUROPSYCH SOC, V7, P102, DOI 10.1017/S1355617701711101; Manly T., 1999, TEST EVERYDAY ATTENT; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; Molho CE, 1997, ARCH CLIN NEUROPSYCH, V12, P370, DOI 10.1093/arclin/12.4.370a; Pennington B.F., 1996, ATTENTION MEMORY EXE; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; RABIN L, 2001, THESIS OXFORD U; REYNOLDS C, 1994, BEHAV ASSESSMENT SYS; Roberts M A, 1995, Appl Neuropsychol, V2, P161, DOI 10.1207/s15324826an0203&4_10; SBORDONE RJ, 1996, ECOLOGICAL VALIDITY, P91; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stuss D. T., 1992, J HEAD TRAUMA REHAB, V7, P40; Stuss D.T., 1986, FRONTAL LOBES; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU; YLVISAKER M, 1992, ADV CHILD NEUROPSYCH, P168; YLVISAKER M, 1998, COLLBORATIVE BRAIN I; YLVISAKER M, 1998, TRAUMATIC BRAIN JURY	87	253	266	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2004	25	1-2					135	158		10.1207/s15326942dn2501&2_8			24	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	774CG	WOS:000188961700008	14984332				2021-06-18	
J	Mahmood, A; Lu, DY; Lu, M; Chopp, M				Mahmood, A; Lu, DY; Lu, M; Chopp, M			Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells	NEUROSURGERY			English	Article						human marrow stromal cells; neural transplantation; traumatic brain injury	FUNCTIONAL RECOVERY; STEM-CELLS; DEFICITS; TRANSPLANTATION; MOTOR; MODEL	OBJECTIVE: We investigated the effect of human bone marrow stromal cells (hMSCs) administered intravenously on functional outcome after traumatic brain injury in adult rats. METHODS: hMSCs were harvested from three human donors. A controlled cortical impact was delivered to 27 adult male rats to induce traumatic brain injury, and 24 hours after injury, hMSCs were injected into the tail veins of the rats (n = 18). These rats were divided into two groups: Group 1, was administered 1 X 10(6) hMSCs, and an Group 2 was administered 2 X 10(6) hMSCs. Group 3 (control) rats received saline intravenously. Neurological function was evaluated according to the rotarod test and modified neurological severity score. All rats were killed 1 month after injury, and immunohistochemical staining was performed on the brain sections to identify donor hMSCs. To study the phenotypic differentiation of hMSCs, coronal brain sections were stained for neuronal (Tuj1) and astrocytic (glial fibrillary acidic protein) markers. RESULTS: Treatment with 2 X 10(6) hMSCs significantly improved the rats' functional outcomes (P < 0.05). The transplanted cells successfully migrated into injured brain and were preferentially localized around the injury site. Some of the donor cells also expressed the neuronal and astrocytic markers. CONCLUSION: These data suggest that hMSCs may be a potential therapy for patient who have sustained traumatic brain injuries.	Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; Henry Ford Hlth Syst, Dept Biostat, Detroit, MI USA; Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA	Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu					BERNSTEIN DC, 1988, ANN NY ACAD SCI, V532, P207, DOI 10.1111/j.1749-6632.1988.tb36339.x; Chen XG, 2002, STROKE, V33, P401; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liu Y, 1999, J NEUROSCI, V19, P4370; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Pundt LL, 1996, NEUROSCI RES, V24, P415, DOI 10.1016/0168-0102(95)01009-2; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	25	252	280	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2003	53	3					697	702		10.1227/01.NEU.0000079333.61863.AA			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	718AL	WOS:000185122900033	12943585				2021-06-18	
J	BLUMBERGS, PC; SCOTT, G; MANAVIS, J; WAINWRIGHT, H; SIMPSON, DA				BLUMBERGS, PC; SCOTT, G; MANAVIS, J; WAINWRIGHT, H; SIMPSON, DA			TOPOGRAPHY OF AXONAL INJURY AS DEFINED BY AMYLOID PRECURSOR PROTEIN AND THE SECTOR SCORING METHOD IN MILD AND SEVERE CLOSED-HEAD INJURY	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		BRAIN TRAUMA; AXONAL SWELLING; IMMUNOCYTOCHEMISTRY; AMYLOID PRECURSOR PROTEIN; TOPOGRAPHY; AXONAL INJURY SCORE; HUMAN	NEUROFILAMENT SUBUNITS; LOCALIZATION; INJECTION; SWELLINGS; NEURONS; DAMAGE	Axonal injury (AI), as defined by amyloid precursor protein (APP) positive axonal swellings, was recorded on a series of line diagrams of standard brain sections divided into 116 sectors to provide an Axonal Injury Sector Score (AISS) ranging from 0 to 116, This sector scoring method of recording axonal damage and providing a topographic overview of AI was applied to a series of 6 mild head injury cases [Glasgow Coma Scale (GCS) 13-15] and six severe head injury cases (GCS 3-8). The AISS ranged from 4 to 107 overall and varied from 4 to 88 in the mildly injured group and 76 to 107 in the severe head injury group, supporting the concept that there is a spectrum of AI in traumatic head injury and that the AISS is a measure of the extent of AI.APP immunostaining demonstrated positive axonal swellings 1.75 h after head injury and analysis of the pattern of AI in the mild and severe head injury groups showed that axons were more vulnerable than blood vessels and that the axons in the corpus callosum and fornices were the most vulnerable of all.	UNIV ADELAIDE,INST MED & VET SCI,NEUROPATHOL LAB,ADELAIDE,SA 5001,AUSTRALIA; UNIV ADELAIDE,NHMRC,RD ACCIDENT RES UNIT,ADELAIDE,SA 5001,AUSTRALIA							ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; IMAJO T, 1984, AM J FOREN MED PATH, V5, P217, DOI 10.1097/00000433-198409000-00005; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATZ DI, 1994, HDB NEUROREHABILITAT, P493; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; OHGAMI T, 1992, NEUROSCI LETT, V136, P75, DOI 10.1016/0304-3940(92)90651-M; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004; RYAN GA, 1994, J TRAUMA, V36, P469; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	32	252	258	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					565	572		10.1089/neu.1995.12.565			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000007	8683607				2021-06-18	
J	FINEMAN, I; HOVDA, DA; SMITH, M; YOSHINO, A; BECKER, DP				FINEMAN, I; HOVDA, DA; SMITH, M; YOSHINO, A; BECKER, DP			CONCUSSIVE BRAIN INJURY IS ASSOCIATED WITH A PROLONGED ACCUMULATION OF CALCIUM - A CA-45 AUTORADIOGRAPHIC STUDY	BRAIN RESEARCH			English	Article						CEREBRAL CONCUSSION; CALCIUM; CA-45; CONTUSION; TRAUMATIC BRAIN INJURY	CEREBRAL BLOOD-FLOW; FLUID-PERCUSSION MODEL; NEURONAL DAMAGE; INTRACELLULAR CALCIUM; SPINAL-CORD; GLUCOSE-UTILIZATION; CALMODULIN BINDING; ENERGY-METABOLISM; CELL-DEATH; RAT-BRAIN	In order to determine the extent and duration of calcium (Ca2+) flux following a lateral fluid percussion brain injury in the rat, Ca-45 autoradiography was used to study animals immediately, 6, 24 and 96 h after the insult. In addition, cell suspension studies were conducted to determine the extent of cellular flux of Ca-45. Optical density and/or scintillation counting was utilized to provide a relative measure of Ca-45 accumulation within 20 different structures. The results indicated that in animals who exhibited no gross morphological damage, Ca-45 accumulation following injury was exhibited primarily within the ipsilateral cerebral cortex, dorsal hippocampus and striatum. This accumulation continued for several days returning to control levels by the 4th day after injury. In animals who sustained morphological damage, the contusion site exhibited a marked accumulation of Ca-45 which did not resolve spontaneously over the course of 4 days. We conclude from this work that Ca2+ flux is a major component of this experimental model of traumatic injury. Furthermore, that depending on the extent of cell damage, the accumulation of Ca2+ is regionally different. Finally, that even in an injury which by itself does not produce gross morphological tissue damage, accumulation of Ca2+ can continue for at least 48 h.	UNIV CALIF LOS ANGELES, SCH MED, BRAIN RES INST, DIV NEUROSURG, 74-140 CHS, LOS ANGELES, CA 90024 USA			Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544, NS30308] Funding Source: Medline		ARAKI T, 1990, BRAIN RES, V528, P114, DOI 10.1016/0006-8993(90)90202-M; BADIE H, 1991, Society for Neuroscience Abstracts, V17, P165; BALESTRINO M, 1989, BRAIN RES, V497, P102, DOI 10.1016/0006-8993(89)90975-X; BETZ AL, 1989, BASIC NEUROCHEMISTRY, P591; BONDY SC, 1989, NEUROTOXICOL TERATOL, V11, P527, DOI 10.1016/0892-0362(89)90032-9; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHOI DW, 1990, J NEUROSCI, V10, P2493; COLLINS F, 1991, J NEUROSCI, V11, P2582; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doberstein C., 1992, Society for Neuroscience Abstracts, V18, P175; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FARBER JL, 1981, LIFE SCI, V29, P1289, DOI 10.1016/0024-3205(81)90670-6; FARBER JL, 1981, AM J PATHOL, V102, P271; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; GROTTA JC, 1990, STROKE, V21, P948, DOI 10.1161/01.STR.21.6.948; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HASHIMOTO K, 1992, NEUROSCI LETT, V137, P165, DOI 10.1016/0304-3940(92)90395-N; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, IN PRESS ICP; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATO H, 1989, BRAIN RES, V479, P366, DOI 10.1016/0006-8993(89)91642-9; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PICONE CM, 1989, J CEREBR BLOOD F MET, V9, P805, DOI 10.1038/jcbfm.1989.114; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; RAPPAPORT ZH, 1987, STROKE, V18, P760, DOI 10.1161/01.STR.18.4.760; SAKAMOTO N, 1986, BRAIN RES, V364, P372, DOI 10.1016/0006-8993(86)90850-4; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SCHURR A, 1989, EXPERIENTIA, V45, P684, DOI 10.1007/BF01974560; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; STEIN DT, 1988, J CEREBR BLOOD F MET, V8, P834, DOI 10.1038/jcbfm.1988.140; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; THOMAS M J, 1990, Society for Neuroscience Abstracts, V16, P777; THOMAS S, 1991, Society for Neuroscience Abstracts, V17, P166; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YAMAKAMI I, 1990, J NEUROTRAUM, V7, P101; YAMAUCHI Y, 1990, J CEREBR BLOOD F MET, V10, P207, DOI 10.1038/jcbfm.1990.36; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	55	252	257	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 8	1993	624	1-2					94	102		10.1016/0006-8993(93)90064-T			9	Neurosciences	Neurosciences & Neurology	MA059	WOS:A1993MA05900012	8252419				2021-06-18	
J	Rabinowitz, AR; Levin, HS				Rabinowitz, Amanda R.; Levin, Harvey S.			Cognitive Sequelae of Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; mTBI; Concussion; Executive functioning; Neuropsychological assessment	DIFFUSE AXONAL INJURY; DECISION-MAKING; AWARENESS; MODERATE; DAMAGE; REHABILITATION; PERFORMANCE; CONCUSSION; SEVERITY; DEFICITS	Cognitive dysfunction is the leading cause of disability following traumatic brain injury (TBI). This article provides a review of the cognitive sequelae of TBI, with a focus on deficits of executive functioning and everyday thinking skills. The pathophysiology, assessment, and treatment of TBI-related cognitive problems are also discussed.	[Rabinowitz, Amanda R.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Rabinowitz, AR (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 370 Stemmler Hall, Philadelphia, PA 19104 USA.	rabinowitz.a@gmail.com			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS021889, F32NS083284] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, R01 NS021889, P01 NS056202, F32 NS083284] Funding Source: Medline		Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; [Anonymous], 1999, JAMA, V282, P974; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Committee on Cognitive Rehabilitation Therapy for Traumatic Brain Injury, 2011, COGN REH THER TRAUM; Damasio A., 1994, SOMATIC MARKER HYPOT, P165; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GENARELLI TA, 1998, SEMINARS CLIN NEUROP, V3, P160; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giancino JT, 1998, J HEAD TRAUMA REHAB, V13, P1; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMahon PJ, 2013, J NEUROTRAUMA; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ragnarsson KT, 1999, NIH CONS DEV C REH P, P64; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ruff RM, 1989, NEUROPSYCHOLOGICAL F, P161; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stuss D. T., 2007, HUMAN FRONTAL LOBES, P292; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	50	251	258	1	41	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					1	+		10.1016/j.psc.2013.11.004			12	Psychiatry	Psychiatry	AD8UM	WOS:000333541200002	24529420	Green Accepted	Y	N	2021-06-18	
J	Greve, MW; Zink, BJ				Greve, Mark W.; Zink, Brian J.			Pathophysiology of Traumatic Brain Injury	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						pathophysiology; traumatic brain injury; primary brain injury; secondary brain injury	AXONAL INJURY; CALPAIN; PROTEIN; DAMAGE	Traumatic brain injury is a major source of death and disability worldwide. Significant success has been achieved in improving short-term outcomes in severe traumatic brain injury victims; however, there are still great limitations in our ability to return severe traumatic brain injury victims to high levels of functioning. Primary brain injury, due to initial forces, causes tissue distortion and destruction in the early post injury period. Clinical outcomes depend in large part of mediating the bimolecular and cellular changes that occur after the initial injury. These secondary injuries from trumatic brain injury lead to alterations in cell function and propagation of injury through processes such as depolarization, excitotoxicity, disruption of calcium homeostasis, free-radical generation, blood-brain barrier disruption, ischemic injury, edema formation, and intracranial hypertension. The best hope of improving outcome in traumatic brain injury patients is a better understanding of these processes and the development of therapies that can limit secondary brain injury. Mt. Sinati J Med 76.97-104, 2009 (C) 2009 Mount Sinai School of Medicine	[Greve, Mark W.; Zink, Brian J.] Brown Univ, Dept Emergency Med, Warren Alpert Sch Med, Providence, RI 02912 USA	Greve, MW (corresponding author), Brown Univ, Dept Emergency Med, Warren Alpert Sch Med, Providence, RI 02912 USA.	mgreve@lifespan.org					Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; BETZ AL, 1992, NEUROSURGERY SCI BAS, P353; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GENTRY LR, 1994, RADIOLOGY, V191, P1; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McLean A. J., 1996, TRAUMATIC BRAIN INJU, P45; OBREJA C, STEREOTACTICAL PHENO; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1989, TXB HEAD INJURY, P451; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Teasdale G, 1996, NEUROLOGICAL SURG, P1533; Thibault LE, 1990, ANN PROC ASS ADV AUT, V34, P337; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vincent JL, 2005, CRIT CARE MED, V33, P2157; WILLINGER R, 1996, TRAUMATIC BRAIN INJU, P265; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	36	251	257	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					97	104		10.1002/msj.20104			8	Medicine, General & Internal	General & Internal Medicine	427OE	WOS:000264787800002	19306379				2021-06-18	
J	Bellner, J; Romner, B; Reinstrup, P; Kristiansson, KA; Ryding, E; Brandt, L				Bellner, J; Romner, B; Reinstrup, P; Kristiansson, KA; Ryding, E; Brandt, L			Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP)	SURGICAL NEUROLOGY			English	Article						transcranial Doppler; pulsatility index; intracranial pressure; head injury; subarachnoid hemorrhage	CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW-VELOCITY; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; ULTRASONOGRAPHY; ULTRASOUND; VASOSPASM; HEMODYNAMICS; HYPEREMIA	BACKGROUND In patients with intracranial pathology, especially when comatose, it is desirable to have knowledge of the intracranial pressure (ICP). To investigate the relationship between ICP and transcranial Doppler (TCD) derived pulsatility index (PI) in neurosurgical patients, a prospective study was performed on patients admitted to our neurointensive care unit. METHODS Daily TCD mean flow velocity (mFV) measurements were made. TCD measurements were routinely performed bilaterally on the middle cerebral artery (MCA). PI (peak systolic-end diastolic velocities/mean flow velocity) was calculated. RESULTS Eighty-one patients with various intracranial disorders who had an intraventricular catheter for registration of the ICP were investigated: 46 (57%) patients had subarachnoid hemorrhage, 21 (26%) patients had closed head injury, and 14 (18%) patients had other neurosurgical disorders. A total of 658 TCD measurements were made. ICP registrations were made parallel with all TCD measurements. A significant correlation (p < 0.0001) was found between the ICP and the PI with a correlation coefficient of 0.938: ICP = 10.93 x PI - 1.28. In the ICP interval between 5 to 40 mm Hg the correlation between ICP and PI enabled an estimation of ICP from the PI values with an SD of 2.5. The correlation between the cerebral perfusion pressure (CPP) and PI was significant (p < 0.0001) with a correlation coefficient of -0.493. When separating the measurements in severely elevated (>120 cm/s) and subnormal (<50 cm/s) TCD mFV values, the correlation coefficient between ICP and PI was 0.828 (p < 0.002) and 0.942 (p < 0.638), respectively. CONCLUSIONS Independent of the type of intracranial pathology, a strong correlation between PI and ICP was demonstrated. Therefore, PI may be of guiding value in the invasive ICP placement decision in the neurointensive care patient. (C) 2004 Elsevier Inc. All rights reserved.	Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Neurophysiol, S-22185 Lund, Sweden; Univ Minnesota, Minneapolis, MN USA	Bellner, J (corresponding author), Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.						AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; GUILLAUME J, 1951, REV NEUROL, V84, P131; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; KLINGELHOFER J, 1991, J NEUROSURG, V75, P752, DOI 10.3171/jns.1991.75.5.0752; Lee KY, 2000, STROKE, V31, P1111, DOI 10.1161/01.STR.31.5.1111; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; MORENO JA, 2000, NEUROSURG FOCUS; NADVI SS, 1994, BRIT J NEUROSURG, V8, P573, DOI 10.3109/02688699409002950; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; ROTHBERG CS, 1979, NEUROSURGERY, V5, P588, DOI 10.1227/00006123-197911000-00008; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; STEIGER HJ, 1981, SURG NEUROL, V16, P459, DOI 10.1016/0090-3019(81)90247-0; STEINMEIER R, 1993, NEUROSURGERY, V33, P10; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Vajda Z, 1999, ACTA NEUROCHIR, V141, P247, DOI 10.1007/s007010050294	22	251	258	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUL	2004	62	1					45	51		10.1016/j.surneu.2003.12.007			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	836OJ	WOS:000222565000009	15226070				2021-06-18	
J	Lovell, MR; Collins, MW; Iverson, GL; Johnston, KM; Bradley, JR				Lovell, MR; Collins, MW; Iverson, GL; Johnston, KM; Bradley, JR			Grade 1 or "ding" concussions in high school athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; neuropsychological testing; mild traumatic brain injury; ImPACT	SPORT-RELATED CONCUSSION; CEREBRAL CONCUSSION; HEAD-INJURY; PERFORMANCE; MANAGEMENT; IMMATURE; MATURE	Background: Recent concussion management guidelines have suggested that athletes with mild (grade 1) concussions may be returned to play if asymptomatic for 15 minutes. The purpose of this study was to assess the utility of a current concussion management guideline in classifying and managing mild concussion. Hypothesis: High school athletes diagnosed with a grade 1 concussion will demonstrate measurable decline in neuropsychological functioning that persists during the 1st week of recovery. Study Design: Prospective study designed to evaluate neuropsychological functioning both prior to and following concussion. Methods: Forty-three high school athletes completed neuropsychological test performance and symptom ratings prior to the season and at two times during the 1 st week following mild concussion. Results: Thirty-six hours after injury, mildly concussed high school athletes demonstrated a decline in memory (P < 0.003) and a dramatic increase in self-reported symptoms (P < 0.00001) compared to baseline performance. Conclusions: Athletes with grade 1 concussion demonstrated memory deficits and symptoms that persisted beyond the context in which they were injured. These data suggest that current grade 1 return-to-play recommendations that allow for immediate return to play may be too liberal. Clinical Relevance: A reconsideration of current concussion grading systems appears to be warranted.	UPMC, Ctr Sports Med, Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; McGill Univ, Dept Neurol Surg, Montreal, PQ H3A 2T5, Canada	Lovell, MR (corresponding author), UPMC, Ctr Sports Med, Sports Med Concuss Program, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.			Iverson, Grant/0000-0001-7348-9570			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barth JT., 1989, MILD HEAD INJURY, P257; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; COLLINS MW, IN PRESS AM J SPORT; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, IN PRESS J NEUROSURG; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; SHIELDS S, 1973, NEUROLOGY, V23, P196; SPSS, 2001, STAT PACK SOC SCI; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	28	251	253	0	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN-FEB	2004	32	1					47	54		10.1177/0363546503260723			8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	810NP	WOS:000220711300005	14754723				2021-06-18	
J	RUSSELL, WR; SMITH, A				RUSSELL, WR; SMITH, A			POST-TRAUMATIC AMNESIA IN CLOSED HEAD INJURY	ARCHIVES OF NEUROLOGY			English	Article																BROCK S, 1960, INJURIES BRAIN SPINA; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Head H., 1926, APHASIA KINDRED DISO; Holbourn AHS, 1943, LANCET, V2, P438; JACKSON JH, 1932, SELECTED WRITINGS JO; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Russell W Ritchie, 1934, Edinb Med J, V41, P129; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; SMITH A, 1961, DISEASES NERVOUS SYS, V2, P1; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Symonds CP, 1943, LANCET, V1, P7	14	251	252	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.		1961	5	1					4	&		10.1001/archneur.1961.00450130006002			0	Clinical Neurology	Neurosciences & Neurology	5677A	WOS:A19615677A00011	13744864				2021-06-18	
J	Lehmann-Werman, R; Neiman, D; Zemmour, H; Moss, J; Magenheim, J; Vaknin-Dembinsky, A; Rubertsson, S; Nellgard, B; Blennow, K; Zetterberg, H; Spalding, K; Haller, MJ; Wasserfall, CH; Schatz, DA; Greenbaum, CJ; Dorrell, C; Grompe, M; Zick, A; Hubert, A; Maoz, M; Fendrich, V; Bartsch, DK; Golan, T; Ben Sasson, SA; Zamir, G; Razin, A; Cedar, H; Shapiro, AMJ; Glaser, B; Shemer, R; Dor, Y				Lehmann-Werman, Roni; Neiman, Daniel; Zemmour, Hai; Moss, Joshua; Magenheim, Judith; Vaknin-Dembinsky, Adi; Rubertsson, Sten; Nellgard, Bengt; Blennow, Kaj; Zetterberg, Henrik; Spalding, Kirsty; Haller, Michael J.; Wasserfall, Clive H.; Schatz, Desmond A.; Greenbaum, Carla J.; Dorrell, Craig; Grompe, Markus; Zick, Aviad; Hubert, Ayala; Maoz, Myriam; Fendrich, Volker; Bartsch, Detlef K.; Golan, Talia; Ben Sasson, Shmuel A.; Zamir, Gideon; Razin, Aharon; Cedar, Howard; Shapiro, A. M. James; Glaser, Benjamin; Shemer, Ruth; Dor, Yuval			Identification of tissue-specific cell death using methylation patterns of circulating DNA	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						circulating DNA; diagnosis; methylation	BRAIN-INJURY; TUMOR DNA; PLASMA; CANCER; THERAPY; SERUM; TRANSPLANTATION; ADENOCARCINOMA; EXPRESSION; BIOMARKERS	Minimally invasive detection of cell death could prove an invaluable resource in many physiologic and pathologic situations. Cell-free circulating DNA (cfDNA) released from dying cells is emerging as a diagnostic tool for monitoring cancer dynamics and graft failure. However, existing methods rely on differences in DNA sequences in source tissues, so that cell death cannot be identified in tissues with a normal genome. We developed a method of detecting tissue-specific cell death in humans based on tissue-specific methylation patterns in cfDNA. We interrogated tissue-specific methylome databases to identify cell type-specific DNA methylation signatures and developed a method to detect these signatures in mixed DNA samples. We isolated cfDNA from plasma or serum of donors, treated the cfDNA with bisulfite, PCR-amplified the cfDNA, and sequenced it to quantify cfDNA carrying the methylation markers of the cell type of interest. Pancreatic beta-cell DNA was identified in the circulation of patients with recently diagnosed type-1 diabetes and islet-graft recipients; oligodendrocyte DNA was identified in patients with relapsing multiple sclerosis; neuronal/glial DNA was identified in patients after traumatic brain injury or cardiac arrest; and exocrine pancreas DNA was identified in patients with pancreatic cancer or pancreatitis. This proof-of-concept study demonstrates that the tissue origins of cfDNA and thus the rate of death of specific cell types can be determined in humans. The approach can be adapted to identify cfDNA derived from any cell type in the body, offering a minimally invasive window for diagnosing and monitoring a broad spectrum of human pathologies as well as providing a better understanding of normal tissue dynamics.	[Lehmann-Werman, Roni; Neiman, Daniel; Zemmour, Hai; Moss, Joshua; Magenheim, Judith; Ben Sasson, Shmuel A.; Razin, Aharon; Cedar, Howard; Shemer, Ruth; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Vaknin-Dembinsky, Adi] Hadassah Hebrew Univ, Med Ctr, Dept Neurol, IL-91120 Jerusalem, Israel; [Rubertsson, Sten] Univ Uppsala Hosp, Dept Surg Sci, Anesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Nellgard, Bengt] Sahlgrens Univ Hosp, S-43180 Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Clin Neurochem Lab,Inst Neurosci & Phys, S-43180 Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London WC1N 3BG, England; [Spalding, Kirsty] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Haller, Michael J.; Wasserfall, Clive H.; Schatz, Desmond A.] Univ Florida, Coll Med, Div Endocrinol, Gainesville, FL 32610 USA; [Greenbaum, Carla J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Dorrell, Craig; Grompe, Markus] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA; [Zick, Aviad; Hubert, Ayala; Maoz, Myriam] Hadassah Hebrew Univ, Med Ctr, Dept Oncol, IL-91120 Jerusalem, Israel; [Fendrich, Volker; Bartsch, Detlef K.] Univ Marburg, Dept Surg, D-35037 Marburg, Germany; [Golan, Talia] Chaim Sheba Med Ctr, Dept Oncol, IL-52621 Tel Hashomer, Israel; [Zamir, Gideon] Hadassah Hebrew Univ, Med Ctr, Dept Expt Surg, IL-91120 Jerusalem, Israel; [Shapiro, A. M. James] Univ Alberta, Dept Surg, Edmonton, AB T6G 2R3, Canada; [Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB T6G 2R3, Canada; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel	Shemer, R; Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.; Glaser, B (corresponding author), Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel.	beng@cc.huji.ac.il; shemer.ru@mail.huji.ac.il; yuvald@ekmd.huji.ac.il	spalding, kirsty/I-6046-2017; wasserfall, clive/J-9078-2012; Glaser, Benjamin/F-8411-2017; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Glaser, Benjamin/0000-0003-4711-5000; Wasserfall, Clive/0000-0002-3522-8932; , Aviad/0000-0002-5077-9249; Moss, Joshua/0000-0003-2606-8006; Grompe, Markus/0000-0002-6616-4345; Spalding, Kirsty/0000-0002-5189-7028	T1D Exchange, a program of T1D First; American Schools and Hospitals Abroad Program of the US Agency for International DevelopmentUnited States Agency for International Development (USAID); Juvenile Diabetes Research FoundationJuvenile Diabetes Research Foundation [3-SRA-2014-38-Q-R]; Beta-Cell Biology Consortium; Human Islet Research Network of the National Institutes of Health [DK104216]; Sir Zalman Cowen Universities Fund; Trilateral German-Israel-Palestine program of the Deutsche Forschungsgemeinschaft; Soyka Pancreatic Cancer Fund; Israeli Centers for Research Excellence Program of The Israel Science Foundation [41.11]; Teva Pharmaceutical Industries Ltd. as part of the Israeli National Network of Excellence in Neuroscience; Alberta Innovates [201201154] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA210171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [UC4DK104216] Funding Source: NIH RePORTER	We thank the T1D Exchange Biobank and investigators and staff of T1D Exchange Protocols for subject recruitment, Tomer Nir and Adi Nir for discussions, and Marc Gotkine for critical reading of the manuscript. This work was supported by the T1D Exchange, a program of T1D First; in part by a grant from the American Schools and Hospitals Abroad Program of the US Agency for International Development for upgrading the Hebrew University Medical School Flow Cytometry Laboratory; and by grants from the Juvenile Diabetes Research Foundation (3-SRA-2014-38-Q-R); the Beta-Cell Biology Consortium and the Human Islet Research Network of the National Institutes of Health (DK104216); the Sir Zalman Cowen Universities Fund; a Trilateral German-Israel-Palestine program of the Deutsche Forschungsgemeinschaft; the Soyka Pancreatic Cancer Fund; and the Israeli Centers for Research Excellence Program of The Israel Science Foundation 41.11 (to Y.D.). R.L.-W. was supported by a training grant from Teva Pharmaceutical Industries Ltd. as part of the Israeli National Network of Excellence in Neuroscience. K.B. holds the Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Beck J, 2013, CLIN CHEM, V59, P1732, DOI 10.1373/clinchem.2013.210328; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; CATE RL, 1983, J BIOL CHEM, V258, P6645; Danese E, 2013, BRIT J CANCER, V109, P807, DOI 10.1038/bjc.2013.351; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Fackler MJ, 2014, CANCER RES, V74, P2160, DOI 10.1158/0008-5472.CAN-13-3392; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Fisher MM, 2015, DIABETES, V64, P3867, DOI 10.2337/db15-0430; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Herold KC, 2015, J CLIN INVEST, V125, P1163, DOI 10.1172/JCI78142; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Husseiny MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094591; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lebastchi J, 2013, DIABETES, V62, P1676, DOI 10.2337/db12-1207; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Richter-Landsberg C, 2000, J NEUROSCI RES, V59, P11, DOI 10.1002/(SICI)1097-4547(20000101)59:1<11::AID-JNR2>3.0.CO;2-O; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sigdel TK, 2013, TRANSPLANTATION, V96, P97, DOI 10.1097/TP.0b013e318295ee5a; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; STALHAMMAR D, 1988, ACTA NEUROCHIR, V90, P73, DOI 10.1007/BF01560558; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Troletti CD, 2016, BBA-MOL BASIS DIS, V1862, P452, DOI 10.1016/j.bbadis.2015.10.010; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Warton K, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00013; WATANABE T, 1990, J BIOL CHEM, V265, P7432; Wingerchuk D M, 2006, Int MS J, V13, P42; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; Zhai RH, 2012, NEOPLASIA, V14, P29, DOI 10.1593/neo.111626	47	250	253	2	85	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 29	2016	113	13					E1826	E1834		10.1073/pnas.1519286113			9	Multidisciplinary Sciences	Science & Technology - Other Topics	DH6BQ	WOS:000372876400010	26976580	Bronze, Green Published	Y	N	2021-06-18	
J	Vespa, PM; Miller, C; McArthur, D; Eliseo, M; Etchepare, M; Hirt, D; Glenn, TC; Martin, N; Hovda, D				Vespa, Paul M.; Miller, Chad; McArthur, David; Eliseo, Mathew; Etchepare, Maria; Hirt, Daniel; Glenn, Thomas C.; Martin, Neil; Hovda, David			Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intyacranial pressure and metabolic crisis	CRITICAL CARE MEDICINE			English	Article						continuous electroencephalography; intensive care; seizures; status epilepticus; nonconvulsive; traumatic brain injury; microdialysis; lactate; pyruvate; intracranial pressure	POSITRON-EMISSION-TOMOGRAPHY; INTRACEREBRAL HEMORRHAGE; MICRODIALYSIS; ISCHEMIA; LACTATE; GLUCOSE	Objective: To determine whether nonconvulsive electrographic post-traumatic seizures result in increases in intracranial pressure and microdialysis lactate/pyruvate ratio. Design: Prospective monitoring with retrospective data analysis. Setting: Single center academic neurologic intensive care unit. Patients: Twenty moderate to severe traumatic brain injury patients (Glasgow Coma Score 3-13). Measurements and Main Results: Continuous electroencephalography and cerebral microdialysis were performed for 7 days after injury. Ten patients had seizures and were compared with a matched cohort of traumatic brain injury patients without seizures. The seizures were repetitive and constituted status epilepticus in seven of ten patients. Using a within-subject design, post-traumatic seizures resulted in episodic increases in intracranial pressure (22.4 +/- 7 vs. 12.8 +/- 4.3 mm Hg; p < .001) and an episodic increase in lactate/pyruvate ratio (49.4 +/- 16 vs. 23.8 +/- 7.6; p < .001) in the seizure group. Using a between-subjects comparison, the seizure group demonstrated a higher mean intracranial pressure (17.6 +/- 6.5 vs. 12.2 +/- 4.2 mm Hg; p < .001), a higher mean lactate/pyruvate ratio (38.6 +/- 18 vs. 27 +/- 9; p < .001) compared with nonseizure patients. The intracranial pressure and lactate/pyruvate ratio remained elevated beyond postinjury hour 100 in the seizure group but not the nonseizure group (p < .02). Conclusion: Post-traumatic seizures result in episodic as well as long-lasting increases in intracranial pressure and microdialysis lactate/pyruvate ratio. These data suggest that post-traumatic seizures represent a therapeutic target for patients with traumatic brain injury.	Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	Vespa, PM (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA.			Glenn, Thomas/0000-0003-4273-3408; Martin, Neil/0000-0002-6565-4131	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049471] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 049471, NS 02089, R01 NS049471, K08 NS002089] Funding Source: Medline		ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; JENNETT WB, 1980, J NEUROL NEUROSUR PS, V23, P295; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Temkin Nancy R., 2002, Epilepsy Curr, V2, P105, DOI 10.1046/j.1535-7597.2002.00038.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	20	250	254	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	DEC	2007	35	12					2830	2836		10.1097/01.CCM.0000295667.66853.BC			7	Critical Care Medicine	General & Internal Medicine	237BD	WOS:000251346700022	18074483	Green Accepted			2021-06-18	
J	Bulger, EM; Nathens, AB; Rivara, FP; Moore, M; MacKenzie, EJ; Jurkovich, GJ				Bulger, EM; Nathens, AB; Rivara, FP; Moore, M; MacKenzie, EJ; Jurkovich, GJ			Management of severe head injury: Institutional variations in care and effect on outcome	CRITICAL CARE MEDICINE			English	Article						head injury; intracranial pressure monitoring; neurosurgery; traumatic brain injury; Glasgow Coma Scale	CEREBRAL PERFUSION-PRESSURE; GLASGOW COMA SCALE; PREDICTION; EXPERIENCE; PROGNOSIS	Objective: The purpose of this study was three-fold: a) to examine variations in care of patients with severe head injury in academic trauma centers across the United States; b) to determine the proportion of patients who received care according to the Brain Trauma Foundation guidelines; and c) to correlate the outcome from severe traumatic brain injury with the care received. Design: Retrospective data collection for consecutive patients with closed head injury and long bone fracture admitted over an 8-month period. Setting: Thirty-four academic trauma centers in the United States Patients: All patients admitted with a presenting Glasgow Coma Scale score less than or equal to8. Measurements and Main Results: Variations in care were assessed, including prehospital intubation, intracranial pressure monitoring, use of osmotic agents, hyperventilation, and computed tomography scan utilization. Aggressive centers were defined as those placing intracranial pressure monitors in >50% of patients meeting the Brain Trauma Foundation criteria for intracranial pressure monitoring. The primary outcome variables were mortality, functional status at discharge, and length of stay. Kaplan-Meier survival analysis was performed for aggressive vs. nonaggressive centers. A Cox proportional hazard model was used to evaluate the association between type of center and mortality rate. Length of stay was evaluated by using linear regression. Results: There was considerable variation in the rates of prehospital intubation, intracranial pressure monitoring, intracranial pressure-directed therapy, and head computed tomography scan utilization across centers. Management at an aggressive center was associated with a significant reduction in the risk of mortality (hazard ratio, 0.43; 95% confidence interval, 0.27-0.66). There was no statistically significant difference in functional status at the time of discharge for survivors. Adjusted length of stay for survivors at aggressive centers was shorter, compared with the length of stay at nonaggressive centers: -6 days (95% confidence interval, -14 to 2 days). Conclusion: Considerable national variation in the care of severely head-injured patients persists. An "aggressive" management strategy is associated with decreased mortality rate for patients with severe head injury, with no significant difference in functional status at discharge among survivors.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Hlth Syst Consortium, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	Bulger, EM (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.						American College of Surgeons, 1997, ADV TRAUM LIF SUPP D, V6th ed; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bullock MR, 1996, J NEUROTRAUM, V13, P667; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Celli P, 1997, Minerva Chir, V52, P1467; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; EDDY VA, 1995, AM SURGEON, V61, P24; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hardin J.W., 2001, GEN LINEAR MODELS EX; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lane PL, 2000, CAN J SURG, V43, P442; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; TEASDALE G, 1974, LANCET, V2, P81; VALADKA AB, 2000, TRAUMA, P377; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; 2000, J NEUROTRAUMA, V17, P479; 1985, INJURY AM CONTINUING	32	250	264	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2002	30	8					1870	1876		10.1097/00003246-200208000-00033			7	Critical Care Medicine	General & Internal Medicine	584GX	WOS:000177459800033	12163808				2021-06-18	
J	Gioia, GA; Isquith, PK; Kenworthy, L; Barton, RM				Gioia, GA; Isquith, PK; Kenworthy, L; Barton, RM			Profiles of everyday executive function in acquired and developmental disorders	CHILD NEUROPSYCHOLOGY			English	Article							DEFICIT HYPERACTIVITY DISORDER; LEARNING-DISABLED READERS; WORKING-MEMORY DEFICITS; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; ECOLOGICAL VALIDITY; READING-COMPREHENSION; AUTISTIC-CHILDREN; ATTENTION; PERFORMANCE	Executive function profiles were examined within and between several clinical disorders via the multidomain Behavior Rating Inventory of Executive Function (BRIEF; Gioia, Isquith, Guy, & Kenworthy, 2000). Parent ratings of children with Inattentive and Combined types of Attention-Deficit/Hyperactivity Disorder (ADHD-I, ADHD-C), Autistic Spectrum Disorders (ASD), moderate and severe Traumatic Brain Injury (TBI), and Reading Disabilities (RD) were compared with controls. Profile analysis revealed significant (p <.01) and substantial (eta(2) >. 10) differences in global elevations and in profile of scale elevations between diagnostic groups. ASD, ADHD-I and ADHD-C groups exhibited greater elevations across the BRIEF scales than did RD and Severe TBI groups, who were in turn more elevated than Moderate TBI and Control groups. The ADHD-C group was unique in its frequency and severity of inhibitory deficits, while the ASD group was distinguishable by its deficits in flexibility. Within diagnostic groups, relative risk for executive dysfunction was calculated with variability present in the frequency of clinically elevated scales. While the BRIEF captures executive profiles characteristic of specific disorders in the clinical setting, it is not diagnostic in its own right and is best used within the context of a broad based evaluation.	Childrens Natl Med Ctr, Washington, DC 20010 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; Dartmouth Coll, Hanover, NH 03755 USA	Gioia, GA (corresponding author), Childrens Natl Med Ctr, Washington, DC 20010 USA.		Isquith, Peter/AAY-4851-2020; Kenworthy, Lauren/AAI-7572-2020				Achenbach T. M., 1991, MANUAL CHILD BEHAV C; AHLUVALIA T, 2002, J INT NEUROPSYCH SOC, V8, P224; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2000, BRAIN INJURY, V14, P679; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Barkley R.A., 1996, ATTENTION MEMORY EXE, P307; Barkley R. A., 1997, ADHD NATURE SELF CON; Barkley RA, 2000, J AM ACAD CHILD PSY, V39, P1064, DOI 10.1097/00004583-200008000-00025; Bayliss DM, 2000, DEV NEUROPSYCHOL, V17, P161, DOI 10.1207/S15326942DN1702_02; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.1111/j.1467-8624.1996.tb01830.x; BERNSTEIN JH, 1990, NEUROMETHODS, V17; BORYS SV, 1982, J EXP CHILD PSYCHOL, V33, P87, DOI 10.1016/0022-0965(82)90008-X; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; COSCIA J, 2002, J INT NEUROPSYCH SOC, V8, P232; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DENCKLA MB, 1994, FRAMES REFERENCE ASS; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; FUSTER JM, 1989, PREFRONTAL CORTEX AN; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Gioia G.A., 2000, BEHAV RATING INVENTO; GIOIA GA, 2001, CLIN NEUROPSYCHOL, V2, P61; GIOIA GA, 2002, UNPUB ECOLOGICAL ASS; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Griffith EM, 1999, CHILD DEV, V70, P817, DOI 10.1111/1467-8624.00059; Harris R.J., 1985, PRIMER MULTIVARIATE, V2nd ed.; Heaton R., 1993, WISCONSIN CARD SORTI; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; KAPLAN E, 1988, CLIN NEUORPSYCHOLOGY; KENWORTHY L, 2000, UNPUB BEHAV RATING I; Klorman R, 1999, J AM ACAD CHILD PSY, V38, P1148, DOI 10.1097/00004583-199909000-00020; LANDA R, 2000, UNPUB BEHAV RATING I; Lazar JW, 1998, J NEUROPSYCH CLIN N, V10, P160, DOI 10.1176/jnp.10.2.160; LEVIN BE, 1990, DEV NEUROPSYCHOL, V6, P95, DOI 10.1080/87565649009540453; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; Liss M, 2001, J CHILD PSYCHOL PSYC, V42, P261, DOI 10.1017/S0021963001006679; LOPEZ BR, 2001, INT M AUST RES SAN D; MANGEOT S, IN PRESS CHILD NEURO; Manly T., 1999, TEA CH TEST EVERYDAY; MAUTZ W, 2002, J INT NEUROPSYCH SOC, V8, P292; Minshew N J, 1997, J Int Neuropsychol Soc, V3, P303; Minshew NJ., 1993, NEUROPSYCHOLOGY, V7, P209, DOI [10.1037/0894-4105.7.2.209, DOI 10.1037/0894-4105.7.2.209]; Nation K, 1999, J EXP CHILD PSYCHOL, V73, P139, DOI 10.1006/jecp.1999.2498; Neisser, 1967, COGNITIVE PSYCHOL; NICHOLS S, 2002, J INT NEUROPSYCH SOC, V8, P231; OZONOFF S, 1994, DEV PSYCHOPATHOL, V6, P415, DOI 10.1017/S0954579400006027; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; OZONOFF S, 1995, NEUROPSYCHOLOGY, V9, P491, DOI 10.1037/0894-4105.9.4.491; Ozonoff S, 1997, AUTISM EXECUTIVE DIS, P179, DOI DOI 10.1093/MED:PSYCH/9780198523499.003.0006; Ozonoff S., 1998, ASPERGER SYNDROME HI, P263; Pennington B.F., 1996, ATTENTION MEMORY EXE; PENNINGTON BF, 1993, DEV PSYCHOL, V29, P511, DOI 10.1037/0012-1649.29.3.511; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; PRIOR M, 1990, J AUTISM DEV DISORD, V20, P581, DOI 10.1007/BF02216063; Reid R., 1998, ADHD RATING SCALE 4; RUMSEY JM, 1985, J AUTISM DEV DISORD, V15, P23, DOI 10.1007/BF01837896; Russell J, 1997, AUTISM EXECUTIVE DIS, P256, DOI DOI 10.1093/MED:PSYCH/9780198523499.003.0008; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE; Seidman LJ, 1995, J CHILD PSYCHOL PSYC, V36, P1459, DOI 10.1111/j.1469-7610.1995.tb01675.x; Seidman LJ, 2001, NEUROPSYCHOLOGY, V15, P544, DOI 10.1037/0894-4105.15.4.544; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; SHALLICE T, 1991, FRONTAL LOBE FUNCTIO; SIEGEL LS, 1989, CHILD DEV, V60, P973, DOI 10.1111/j.1467-8624.1989.tb03528.x; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; SLICK DJ, 2002, J INT NEUROPSYCH SOC, V8, P230; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D.T., 1986, FRONTAL LOBES; Swanson HL, 2000, INTELLIGENCE, V28, P1, DOI 10.1016/S0160-2896(99)00025-2; Swanson HL, 1999, J EXP CHILD PSYCHOL, V72, P1, DOI 10.1006/jecp.1998.2477; TAGERFLUSBERG H, 1991, BRIT J DEV PSYCHOL, V9, P417, DOI 10.1111/j.2044-835X.1991.tb00886.x; Turner MA, 1999, J CHILD PSYCHOL PSYC, V40, P189, DOI 10.1017/S0021963098003515; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU; YLVISAKER M, 1992, ADV CHILD NEUROPSYCH	88	250	256	2	45	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	2002	8	2					121	137		10.1076/chin.8.2.121.8727			17	Clinical Neurology	Neurosciences & Neurology	651BB	WOS:000181299300006	12638065				2021-06-18	
J	Rovlias, A; Kotsou, S				Rovlias, A; Kotsou, S			The influence of hyperglycemia on neurological outcome in patients with severe head injury	NEUROSURGERY			English	Article						head injury; hyperglycemia; intracranial pressure; neurological outcome; severity of injury	ISCHEMIC BRAIN INFARCTION; CEREBRAL BLOOD-FLOW; CARDIAC-ARREST; SUBARACHNOID HEMORRHAGE; ACUTE STROKE; GLUCOSE; ACIDOSIS; DAMAGE; CATECHOLAMINES; METABOLISM	OBJECTIVE: Traumatic brain injury is associated with a stress response that includes hyperglycemia, which has been shown to worsen neurological outcome during cerebral ischemia and hypoxia. To better examine the relationship between hyperglycemia and outcome after head injury, we studied the clinical course of 267 head-injured patients who were admitted for treatment in the neurosurgical department of Asclepeion Hospital of Athens between January 1993 and November 1997. METHODS: We prospectively studied 267 patients with moderate or severe craniocerebral injury (Glasgow Coma Scale scores, 3-12) who were treated surgically for evacuation of an intracranial hematoma and/or placement of a device for intracranial pressure monitoring under general anesthesia to determine the relationship between serum glucose levels, severity of injury, and neurological outcome, RESULTS: Patients with severe head injury had significantly higher serum glucose levels than did those with moderate injury. Patients who subsequently had an unfavorable outcome had significantly higher glucose levels than did those with a better prognosis. Among the patients with more severe head injury, a glucose level greater than 200 mg/dl was associated with a worse outcome. In the same group of patients, a significant relationship was found between postoperative glucose levels, pupillary reaction, and maximum intracranial pressure during the first 24 hours. Multivariate analysis showed that postoperative glucose levels were an independent predictor of outcome. CONCLUSION: Early hyperglycemia is a frequent component of the stress response to head injury, a significant indicator of its severity, and a reliable predictor of outcome.	Asclepe Gen Hosp, Dept Neurosurg, Athens, Greece	Rovlias, A (corresponding author), 29 Aidiniou St, Athens 17236, Greece.						ALLISON SP, 1969, BRIT J ANAESTH, V41, P588, DOI 10.1093/bja/41.7.588; BEREK K, 1992, LANCET, V339, P68, DOI 10.1016/0140-6736(92)90202-E; Bernard C, 1849, COMPT REND SOC BIOL, V1, P60; BESSEY PQ, 1984, ANN SURG, V200, P264, DOI 10.1097/00000658-198409000-00004; BUCKELL M, 1966, J NEUROL NEUROSUR PS, V29, P293, DOI 10.1136/jnnp.29.4.293; CLARKE RSJ, 1970, BRIT J ANAESTH, V42, P45, DOI 10.1093/bja/42.1.45; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CRYER PE, 1980, NEW ENGL J MED, V303, P436; DALECY LG, 1986, SURGERY, V100, P505; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Deloof T, 1979, Acta Neurochir Suppl (Wien), V28, P113; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P115, DOI 10.1007/BF00571658; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; HOWARD JM, 1955, ANN SURG, V141, P321, DOI 10.1097/00000658-195503000-00005; JENNETT B, 1975, LANCET, V1, P480; KIM SH, 1985, J CEREBR BLOOD F MET, V5, P432, DOI 10.1038/jcbfm.1985.58; KING LR, 1971, ANN SURG, V173, P337, DOI 10.1097/00000658-197103000-00003; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; KUSHNER M, 1990, ANN NEUROL, V28, P129, DOI 10.1002/ana.410280204; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LANDSBERG L, 1985, TXB ENDOCRINOLOGY, P891; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MARSH WR, 1986, J NEUROSURG, V65, P693, DOI 10.3171/jns.1986.65.5.0693; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MATCHAR DB, 1992, ANN INTERN MED, V117, P449, DOI 10.7326/0003-4819-117-6-449; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MERGUERIAN PA, 1981, CRIT CARE MED, V9, P838, DOI 10.1097/00003246-198112000-00007; MOUAWAD E, 1973, NEUROCHIRURGIE, V19, P456; MURROS K, 1992, J NEUROL SCI, V111, P59, DOI 10.1016/0022-510X(92)90112-X; MYERS RE, 1977, ARCH NEUROL-CHICAGO, V34, P65, DOI 10.1001/archneur.1977.00500140019003; OYAMA T, 1968, ANESTHESIOLOGY, V29, P559, DOI 10.1097/00000542-196805000-00036; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; POWER MJ, 1988, AGE AGEING, V17, P164, DOI 10.1093/ageing/17.3.164; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; REHNCRONA S, 1989, J CEREBR BLOOD F MET, V9, P65, DOI 10.1038/jcbfm.1989.9; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; SIESJO BK, 1985, BRIT J ANAESTH, V57, P47, DOI 10.1093/bja/57.1.47; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; TEASDALE G, 1974, LANCET, V2, P81; WOO E, 1988, STROKE, V19, P1359, DOI 10.1161/01.STR.19.11.1359; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WORSTMAN J, 1984, AM J MED, V77, P779; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	55	250	273	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	FEB	2000	46	2					335	342		10.1097/00006123-200002000-00015			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	281ZR	WOS:000085191800039	10690722				2021-06-18	
J	OVERGAARD, J; TWEED, WA				OVERGAARD, J; TWEED, WA			CEREBRAL-CIRCULATION AFTER HEAD-INJURY .1. CEREBRAL BLOOD-FLOW AND ITS REGULATION AFTER CLOSED HEAD-INJURY WITH EMPHASIS ON CLINICAL CORRELATIONS	JOURNAL OF NEUROSURGERY			English	Article									ODENSE UNIV HOSP, NEUROSURG DEPT, ODENSE, DENMARK; HLTH SCI CTR GEN, DEPT ANESTHESIA, 700 WILLIAM AVE, WINNIPEG, MANITOBA, CANADA							AMES A, 1968, AM J PATHOL, V52, P437; BOYSEN G, 1973, ACTA NEUROL SCAND, V49, P1; BRODERSEN P, PERSONAL COMMUNICATI; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BUXTON RL, 1970, LANCET, V2, P498; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; FIESCHI C, 1972, EUR NEUROL, V8, P192, DOI 10.1159/000114577; JENNETT B, 1973, VASCULAR DIS, P163; KASOFF SS, 1972, J NEUROSURG, V36, P463, DOI 10.3171/jns.1972.36.4.0463; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; NILSSON L, 1971, ACTA NEUROL SCAND, V47, P233, DOI 10.1111/j.1600-0404.1971.tb07479.x; OLESEN J, 1973, ARCH NEUROL-CHICAGO, V28, P143, DOI 10.1001/archneur.1973.00490210023001; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; OVERGAARD J, 1973, LANCET, V2, P631; PAULSON OB, 1972, NEUROLOGY, V22, P286, DOI 10.1212/WNL.22.3.286; Ransohoff J, 1972, STEROIDS BRAIN EDEMA, P211; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; TROUPP H, 1971, ACTA NEUROCHIR, V25, P189, DOI 10.1007/BF01809100; TROUPP H, 1972, INTRACRANIAL PRESSUR, P222; TWEED WA, 1973, STROKE, V4, P348; Zwetnow N, 1968, SCAND J CLIN LA S102	23	250	250	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.		1974	41	5					531	541		10.3171/jns.1974.41.5.0531			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	U6110	WOS:A1974U611000002	4418221				2021-06-18	
J	Lee, YB; Nagai, A; Kim, SU				Lee, YB; Nagai, A; Kim, SU			Cytokines, chemokines, and cytokine receptors in human microglia	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						amyloid beta peptides; cytokines; cytokine receptors; chemokines; human microglia; lipopolysaccharide	CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; MURINE MICROGLIA; EXPRESSION; LIPOPOLYSACCHARIDE; INDUCTION; KINASE; CNS; MACROPHAGES; ASTROCYTES	Enriched populations of human microglial cells were isolated from mixed cell cultures prepared from embryonic human telencephalon tissues. Human microglial cells exhibited cell type-specific antigens for macrophage-microglia lineage cells including CD11b (Mac-1), CD68, B7-2 (CD86), HLA-ABC, HLA-DR and ricinus communis aggulutinin lectin-1 (RCA-1), and actively phagocytosed latex beads. Gene expression and protein production of cytokines, chemokines and cytokine/chemokine receptors were investigated in the purified populations of human microglia. Normal unstimulated human microglia expressed constitutively mRNA transcripts for interleukin-1beta (1L-1beta) -6, -8, -10, -12, -15, tumor necrosis factor-a (TNF-alpha), macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and monocyte chemoattractant protein-1 (MCP1), while treatment with lipopolysaccharide (LPS) or amyloid beta peptides (Abeta) led to increased expression of mRNA levels of IL-8, IL-0, IL-12, TNF-alpha, MIP-1beta, MIP-1beta, and MCP-1. Human microglia, in addition, expressed mRNA transcripts for IL-1R1I, IL-1RII, IL-5R, IL-6R, IL-8R, IL-9R, IL-10R, IL-12R, IL-13R, and IL-15R. Enzyme-linked immunosorbent assays (ELISA) showed increased protein levels in culture media of IL-1beta, IL-8, TNF-alpha, and MIP-1alpha in human microglia following treatment with LPS or Abeta. Increased TNF-a release from human microglia following LPS treatment was completely inhibited with IL-10 pretreatment, but not with IL-6, IL-9, IL-12, IL-13, or transforming growth factor-beta (TGF-beta). Present results should help in understanding the basic microglial biology, but also the pathophysiology of activated microglia in neurological diseases such as Alzheimer disease, Parkinson disease, Huntington disease, amyotrophic lateral sclerosis, stroke, and neurotrauma. (C) 2002 whey-Liss, Inc.	Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 442721, South Korea; Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada	Kim, SU (corresponding author), Ajou Univ, Sch Med, Brain Dis Res Ctr, 5 San Wonchon Dong, Suwon 442721, South Korea.	sukim@madang.ajou.ac.kr		Nagai, Atsushi/0000-0002-9280-8044			ASHWELL K, 1989, J COMP NEUROL, V287, P286, DOI 10.1002/cne.902870303; BANATI RB, 1993, GLIA, V7, P183, DOI 10.1002/glia.440070208; Bhat NR, 1998, J NEUROSCI, V18, P1633; BOYLE EA, 1990, AM J PATHOL, V137, P575; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; El Khoury J, 1998, NEUROBIOL AGING, V19, pS81, DOI 10.1016/S0197-4580(98)00036-0; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25; GELMAN BB, 1993, ANN NEUROL, V34, P65, DOI 10.1002/ana.410340112; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; KITAMURA T, 1984, J COMP NEUROL, V226, P421, DOI 10.1002/cne.902260310; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LEE SC, 1993, J IMMUNOL, V150, P2659; LEE SHC, 1992, LAB INVEST, V67, P465; LEI MG, 1991, J IMMUNOL, V147, P1925; McDonald DR, 1997, J NEUROSCI, V17, P2284; McDonald DR, 1998, J NEUROSCI, V18, P4451; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; McManus CM, 1998, J IMMUNOL, V160, P1449; Meda L, 1999, J NEUROIMMUNOL, V93, P45, DOI 10.1016/S0165-5728(98)00188-X; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; RIOHORTEGA DP, 1932, CYTOLOGY CELLULAR PA, V2, P481; Sato Y, 1995, NTT REVIEW, V7, P80; SATOH J, 1994, BRAIN RES, V653, P243, DOI 10.1016/0006-8993(94)90396-4; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; SMINIA T, 1987, IMMUNOBIOLOGY, V174, P43, DOI 10.1016/S0171-2985(87)80083-9; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Williams K, 1996, NEUROCHEM INT, V29, P55, DOI 10.1016/0197-0186(95)00138-7	37	249	269	1	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL 1	2002	69	1					94	103		10.1002/jnr.10253			10	Neurosciences	Neurosciences & Neurology	567RA	WOS:000176497400011	12111820				2021-06-18	
J	Silver, JM; Kramer, R; Greenwald, S; Weissman, M				Silver, JM; Kramer, R; Greenwald, S; Weissman, M			The association between head injuries and psychiatric disorders: findings from the New Haven NIMH Epidemiologic Catchment Area Study	BRAIN INJURY			English	Article; Proceedings Paper	9th Annual Meeting of the American-Neuropsychiatric-Association	FEB 01-03, 1998	HONOLULU, HI	Amer Neruopsychiat Assoc			BRAIN; DEPRESSION	Primary objective: To determine the association of report of any history of head injury with loss of consciousness or confusion and a lifetime diagnosis of psychiatric disorder in a general population. Research design: A probability sample of adults from the New Haven portion of the NIMH Epidemiologic Catchment Area programme were administered standardized and validated structured interviews. The main outcome measures were lifetime prevalence of psychiatric disorders and suicide attempt in individuals with and without a history of traumatic brain injury. Main outcomes and results: Among 5034 individuals interviewed, 361 admitted to a history of severe brain trauma with loss of consciousness or confusion (weighted rate of 8.5/100). When controlling for sociodemographic factors, quality of life indicators and alcohol use, risk was increased for major depression, dysthymia, panic disorder, OCD, phobic disorder and drug abuse/dependence. In addition, lifetime risk of suicide attempt was greater in those who had suffered head injury. Conclusion: Individuals with a history of traumatic brain injury have significantly higher occurrence for psychiatric disorders and suicide attempts in comparison with those without head injury and have a poorer quality of life. Future studies should examine the nature of this relationship, focusing on the severity of the brain injury and the temporal contiguity of the brain injury and psychiatric disorder.	Lenox Hill Hosp, Dept Psychiat, New York, NY 10021 USA; NYU, Sch Med, New York, NY 10016 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Silver, JM (corresponding author), Lenox Hill Hosp, Dept Psychiat, 100 E 77th St, New York, NY 10021 USA.	jonsilver@aol.com		Weissman, Myrna/0000-0003-3490-3075	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH030906, P50MH030906, U01MH046718, P01MH037592] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 37592, MH30906, MH46718] Funding Source: Medline		ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; BROOKS N, 1990, REHABILITATION ADULT, P426; BURSTEIN A, 1993, PSYCHOSOMATICS, V34, P194, DOI 10.1016/S0033-3182(93)71920-9; Deb S, 1999, AM J PSYCHIAT, V156, P374; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GORDON WA, 1998, J HEAD TRAUMA REHAB, V13, P1; HELZER JE, 1988, SOC PSYCH PSYCH EPID, V23, P6, DOI 10.1007/BF01788437; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kraus Jess F., 1994, P3; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; *NAT I MENT HLTH, 1981, NIMH DIAGN INT SCHED; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robins L, 1991, PSYCHIAT DISORDERS A; SILVER JM, 1996, AM PSYCHIAT PRESS TX, P521; Silver JM., 1994, NEUROPSYCHIATRY TRAU; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	27	249	253	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2001	15	11					935	945		10.1080/02699050110065295			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	490VF	WOS:000172073900001	11689092				2021-06-18	
J	Bigler, ED; Blatter, DD; Anderson, CV; Johnson, SC; Gale, SD; Hopkins, RO; Burnett, B				Bigler, ED; Blatter, DD; Anderson, CV; Johnson, SC; Gale, SD; Hopkins, RO; Burnett, B			Hippocampal volume in normal aging and traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article						age and aging; brain, injuries; brain, volume; hippocampus	TEMPORAL-LOBE EPILEPSY; ANATOMIC-MR CORRELATION; MEMORY IMPAIRMENT; LIMBIC LOBE; ABNORMALITIES; SCHIZOPHRENIA; MORPHOLOGY; SCLEROSIS; AMYGDALA; ATROPHY	PURPOSE: To present a normative database of hippocampal and temporal hom Volume and to clarify the relationship between these measures and cognitive outcome in patients with traumatic brain injury. METHODS: Ninety-six healthy Volunteers and 94 patients with traumatic brain injury were examined with coronal intermediate and Ta-weighted MR imaging. Multispectral segmentation and volume analyses were performed. The volumetry of the hippocampus and temporal hom was characterized in the control subjects. Volumetric measures in a group of patients with traumatic brain injury who had received MR imaging 3 months or less after injury were compared with measurements in other patients in the chronic phase of recovery, The relationship between neuropsychological testing and volumetric measures was analyzed with particular emphasis on the correlation between cognitive outcome and hippocampal and temporal horn volumes. RESULTS: No significant age group differences were found in the normative group from age 16 to 65. Left and right hippocampal Volumes were interrelated and did not differ from each other. This was also true for the temporal horns, Hippocampal and temporal horn Volumes were not significantly related. Women had larger hippocampi relative to cranial volume. Comparisons between patients with traumatic brain injury and control subjects showed significant yet modest bilateral atrophic changes in hippocampal and temporal hom enlargement in the patients with brain injury. Hippocampal and temporal hom Volumes correlated significantly with each other in the group with traumatic brain injury. Cognitive outcome was modestly related to hippocampal and temporal hom volumes. However, in a specific subgroup whose images were acquired between 71 and 210 days after injury, strong correlations were noted in which temporal horn Volume correlated highly with IQ and hippocampal Volume correlated with verbal memory function. CONCLUSION: Hippocampal and temporal hom Volumes appear to be independent variables in healthy control subjects. Traumatic brain injury results in significant hippocampal atrophy and temporal horn enlargement. The hippocampus and temporal hom Volumes were inversely correlated in the group with traumatic brain injury, suggesting a differential relationship of these structures in patients with brain injury as compared with control subjects. In the subacute phase, the Volume of the temporal hom may be indicative of intellectual outcome and that of the hippocampus appears to be indicative of verbal memory function.	LDS HOSP, SALT LAKE CITY, UT USA	Bigler, ED (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, POB 25543, PROVO, UT 84602 USA.						ASHTARI M, 1991, AM J NEURORADIOL, V12, P941; BEAURAIN J, 1994, MAGN RESON IMAGING, V12, P139, DOI 10.1016/0730-725X(94)92361-2; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BOGERTS B, 1993, BIOL PSYCHIAT, V33, P236, DOI 10.1016/0006-3223(93)90289-P; BREIER A, 1992, ARCH GEN PSYCHIAT, V49, P921; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BRONEN RA, 1991, MAGN RESON IMAGING, V9, P497, DOI 10.1016/0730-725X(91)90035-K; CENDES F, 1993, J COMPUT ASSIST TOMO, V17, P206, DOI 10.1097/00004728-199303000-00008; CLARKE LP, 1993, MAGN RESON IMAGING, V11, P95, DOI 10.1016/0730-725X(93)90417-C; DUVEMOY HM, 1991, HUMAN BRAIM, P118; Duvernoy H.M., 1988, HUMAN HIPPOCAMPUS AT; EGAN MF, 1994, SCHIZOPHR RES, V11, P259, DOI 10.1016/0920-9964(94)90020-5; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GEAN AD, 1994, IMAGING HEAD TRAUMA, P505; GEAN AD, 1994, IMAGING HEAD TRAUMA, P152; GILMORE RL, 1995, ARCH NEUROL-CHICAGO, V52, P819, DOI 10.1001/archneur.1995.00540320103017; GOLOMB J, 1994, LEARN MEMORY, V1, P45; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hasboun D, 1996, AM J NEURORADIOL, V17, P1091; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; ISAACSON RL, 1986, HIPPOCAMPUS, V3; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; JACK CR, 1990, RADIOLOGY, V176, P205, DOI 10.1148/radiology.176.1.2353093; JACK CR, 1990, RADIOLOGY, V175, P423, DOI 10.1148/radiology.175.2.2183282; JACKSON GD, 1994, NEUROLOGY, V44, P42, DOI 10.1212/WNL.44.1.42; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KIM JH, 1995, AM J NEURORADIOL, V16, P627; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; LORING DW, 1993, NEUROLOGY, V43, P1789, DOI 10.1212/WNL.43.9.1789; MCCARTHY G, 1995, NEUROSCIENTIST, V1, P155; NAIDICH TP, 1987, RADIOLOGY, V162, P755, DOI 10.1148/radiology.162.3.3809490; NAIDICH TP, 1987, RADIOLOGY, V162, P747, DOI 10.1148/radiology.162.3.3809489; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, V271, P772; PRESS GA, 1989, NATURE, V341, P54, DOI 10.1038/341054a0; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; RIEDERER SJ, 1995, MAGN RESON IMAGING, V13, P1095, DOI 10.1016/0730-725X(95)02017-N; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Rosene DL., 1987, CEREB CORTEX, P345, DOI [10.1007/978-1-4615-6616-8_9, DOI 10.1007/978-1-4615-6616-8_9]; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; SAITOH O, 1995, NEUROLOGY, V45, P317, DOI 10.1212/WNL.45.2.317; SEAB JP, 1988, MAGN RESON MED, V8, P200, DOI 10.1002/mrm.1910080210; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SOININEN H, 1995, NEUROLOGY, V45, P391, DOI 10.1212/WNL.45.2.391; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; SPENCER D, 1995, MAGN RESON IMAGING, V13, P1045, DOI 10.1016/0730-725X(95)02050-4; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SULLIVAN EV, 1995, NEUROBIOL AGING, V16, P591, DOI 10.1016/0197-4580(95)00074-O; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; WECHSLER D, 1987, MECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	62	249	253	0	9	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	1997	18	1					11	23					13	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WC668	WOS:A1997WC66800002	9010515				2021-06-18	
J	ELLIS, EF; MCKINNEY, JS; WILLOUGHBY, KA; LIANG, S; POVLISHOCK, JT				ELLIS, EF; MCKINNEY, JS; WILLOUGHBY, KA; LIANG, S; POVLISHOCK, JT			A NEW MODEL FOR RAPID STRETCH-INDUCED INJURY OF CELLS IN CULTURE - CHARACTERIZATION OF THE MODEL USING ASTROCYTES	JOURNAL OF NEUROTRAUMA			English	Article						CELL INJURY; ASTROCYTES; CELL CULTURE; TRAUMATIC BRAIN INJURY		The purpose of this study was to develop a simple, reproducible model for examining the morphologic, physiologic, and biochemical consequences of stretch-induced injury on tissue-cultured cells of brain origin. Rat cortical astrocytes from 1- to 2-day-old rats were cultured to confluency in commercially available 25-mm-diameter tissue culture wells with a 2-mm-thick flexible silastic bottom. A cell injury controller was used to produce a closed system and exert a rapid positive pressure of known amplitude (psi) and duration (msec). The deformation of the membrane, and thus the stretch of the cells growing on the membrane, was proportional to the amplitude and duration of the air pressure pulse. Extent of cell injury was qualitatively assessed by light and electron microscopy and quantitatively assessed by nuclear uptake of the fluorescent dye propidium iodide, which is excluded from cells with intact membranes. Lactate dehydrogenase (LDH) enzyme release was measured spectrophotometrically. Cell injury was found to be proportional to the extent of the silastic membrane deformation. Increasing cell stretch caused mitochondrial swelling and vacuolization as well as disruption of glial filaments. Stretching also caused increased dye uptake, with maximum dye uptake occurring with a 50 msec pressure pulse duration, whereas deformations produced over longer periods of time (seconds) caused little dye uptake. With increasing postinjury survival fewer cells took up dye, implying cell repair. LDH release was also proportional to the amplitude of cell stretch, with maximum release occurring within 2 h of injury. In summary we have developed a simple, reproducible model to produce graded, strain-related injuries in cultured cells. Our continuing experiments suggest that this model can be used to study the biochemistry and physiology of injury as well as serve as a tool to examine the efficacy of therapeutic agents.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298					NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-20193, NS-27214] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214, R01NS020193] Funding Source: NIH RePORTER		AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BANES AJ, 1990, AM BIOTECHNOL LAB, V8, P12; CHOI DW, 1987, J NEUROSCI, V7, P357; EMERY DG, 1987, EXP BRAIN RES, V67, P41, DOI 10.1007/BF00269451; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GOLDSTEIN DM, 1994, J NEUROTRAUM, V11, P110; GROSS GW, 1993, J NEUROSCI, V3, P1979; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; LAPLACA MC, 1994, J NEUROTRAUM, V11, P116; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; MURPHY EJ, 1994, NEUROBIOLOGY CENTRAL, P28; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; SAATMAN KE, 1994, J NEUROTRAUMA, V11, P125; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; TAVALIN SJ, 1995, J NEUROTRAUM, V12, P144; THIBAULT LE, 1993, J NEUROTRAUM, V10, pS68	18	249	257	1	28	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	1995	12	3					325	339		10.1089/neu.1995.12.325			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RM331	WOS:A1995RM33100010	7473807				2021-06-18	
J	Fu, RY; Shen, QY; Xu, PF; Luo, JJ; Tang, YM				Fu, Ruying; Shen, Qingyu; Xu, Pengfei; Luo, Jin Jun; Tang, Yamei			Phagocytosis of Microglia in the Central Nervous System Diseases	MOLECULAR NEUROBIOLOGY			English	Article						Microglia; Phagocytosis; Neurological diseases; Macrophages	AMYOTROPHIC-LATERAL-SCLEROSIS; FOCAL CEREBRAL-ISCHEMIA; SUPEROXIDE-DISMUTASE GENE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MEDIATED MYELIN PHAGOCYTOSIS; MANNOSE RECEPTOR EXPRESSION; AGGREGATED ALPHA-SYNUCLEIN; TRANSGENIC RAT MODEL; AMYLOID BETA-PEPTIDE	Microglia, the resident macrophages of the central nervous system, rapidly activate in nearly all kinds of neurological diseases. These activated microglia become highly motile, secreting inflammatory cytokines, migrating to the lesion area, and phagocytosing cell debris or damaged neurons. During the past decades, the secretory property and chemotaxis of microglia have been well-studied, while relatively less attention has been paid to microglial phagocytosis. So far there is no obvious concordance with whether it is beneficial or detrimental in tissue repair. This review focuses on phagocytic phenotype of microglia in neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, traumatic brain injury, ischemic and other brain diseases. Microglial morphological characteristics, involved receptors and signaling pathways, distribution variation along with time and space changes, and environmental factors that affecting phagocytic function in each disease are reviewed. Moreover, a comparison of contributions between macrophages from peripheral circulation and the resident microglia to these pathogenic processes will also be discussed.	[Fu, Ruying; Shen, Qingyu; Xu, Pengfei; Tang, Yamei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China; [Shen, Qingyu] Sun Yat Sen Univ, Dept Neurol, Zengcheng Peoples Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Luo, Jin Jun] Temple Univ, Dept Neurol, Sch Med, Philadelphia, PA 19122 USA; [Tang, Yamei] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat, Guangzhou 510120, Guangdong, Peoples R China; [Tang, Yamei] Sun Yat Sen Univ, Target Therapy Guangdong Higher Educ Inst, Guangzhou 510120, Guangdong, Peoples R China	Tang, YM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, 107 Yan Jiang Xi Rd, Guangzhou 510120, Guangdong, Peoples R China.	yameitang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272576, 81072242]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities; Funds for Pearl River Science & Technology Star of Guangzhou City [2012J2200088]	This work was supported by the National Natural Science Foundation of China (no. 81272576 and no. 81072242), the Fundamental Research Funds for the Central Universities, and the Funds for Pearl River Science & Technology Star of Guangzhou City (2012J2200088) to Yamei Tang.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Boekhoff TMA, 2012, J NEUROTRAUM, V29, P1000, DOI 10.1089/neu.2011.1821; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; BRUCK W, 1992, J NEUROIMMUNOL, V38, P9, DOI 10.1016/0165-5728(92)90085-Y; Bruck W, 1996, IMMUNOBIOLOGY, V195, P588; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Chiu TL, 2011, ONCOL REP, V25, P1373, DOI 10.3892/or.2011.1213; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; De Simone R, 2004, MOL NEUROBIOL, V29, P197, DOI 10.1385/MN:29:2:197; Deane R, 2008, CURR PHARM DESIGN, V14, P1601, DOI 10.2174/138161208784705487; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Depboylu C, 2011, J NEUROPATH EXP NEUR, V70, P125, DOI 10.1097/NEN.0b013e31820805b9; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Espejel S, 2009, ANN NEUROL, V66, P100, DOI 10.1002/ana.21670; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gilmore SA, 2003, EXP NEUROL, V182, P169, DOI 10.1016/S0014-4886(03)00118-3; Giraldi-Guimaraes A, 2012, BRAIN RES, V1452, P173, DOI 10.1016/j.brainres.2012.03.002; Gitik M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-24; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; Hadas S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-166; Han MH, 2012, J EXP MED, V209, P1325, DOI 10.1084/jem.20101974; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535; Inoue Y, 2004, J IMMUNOL, V172, P2147, DOI 10.4049/jimmunol.172.4.2147; Ito U, 2007, STROKE, V38, P2577, DOI 10.1161/STROKEAHA.107.484394; Jenrow KA, 2011, J NEURO-ONCOL, V101, P449, DOI 10.1007/s11060-010-0282-x; Jones Bryony, 2013, Nat Rev Neurol, V9, P5, DOI 10.1038/nrneurol.2012.254; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kato H, 1996, BRAIN RES, V734, P203, DOI 10.1016/S0006-8993(96)00636-1; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kiyota T, 2013, NEUROBIOL AGING, V34, P1060, DOI 10.1016/j.neurobiolaging.2012.08.009; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi K, 2012, GLIA, V60, P1529, DOI 10.1002/glia.22373; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liu J, 2007, J PROTEOME RES, V6, P3614, DOI 10.1021/pr0701512; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L; Michelakakis H, 2012, MOVEMENT DISORD, V27, P400, DOI 10.1002/mds.24886; MORIOKA T, 1993, J COMP NEUROL, V327, P123, DOI 10.1002/cne.903270110; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nathalie P, 2008, CURR ALZHEIMER RES, V5, P92, DOI 10.2174/156720508783954721; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010; Peng Y, 2013, NEURO ONCOL IN PRESS; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Polfliet MMJ, 2002, J NEUROIMMUNOL, V122, P1, DOI 10.1016/S0165-5728(01)00445-3; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Redondo-Castro E, 2013, EUR J NEUROSCI, V38, P3786, DOI 10.1111/ejn.12382; Reichert F, 2003, NEUROBIOL DIS, V12, P65, DOI 10.1016/S0969-9961(02)00008-6; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; Ribes S, 2010, GLIA, V58, P367, DOI 10.1002/glia.20929; RINNER WA, 1995, GLIA, V14, P257, DOI 10.1002/glia.440140403; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Roberts K, 2013, GLIA, V61, P409, DOI 10.1002/glia.22444; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Rojanathammanee L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-44; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; Sabha M, 2008, SYNAPSE, V62, P137, DOI 10.1002/syn.20475; SAKUMA R, 1995, EUR J NEUROL, V2, P369, DOI 10.1111/j.1468-1331.1995.tb00141.x; Sanagi T, 2010, J NEUROSCI RES, V88, P2736, DOI 10.1002/jnr.22424; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Sasaki A, 2013, NEUROPATHOLOGY, V33, P505, DOI 10.1111/neup.12015; Satoh J, 2012, NEUROPATHOLOGY, V32, P149, DOI 10.1111/j.1440-1789.2011.01256.x; Schiff D, 1998, HUM PATHOL, V29, P215, DOI 10.1016/S0046-8177(98)90038-7; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schonrock LM, 1998, NEUROPATH APPL NEURO, V24, P320; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; Shin YJ, 2011, GLIA, V59, P413, DOI 10.1002/glia.21110; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Smith ME, 1999, NEUROCHEM RES, V24, P261, DOI 10.1023/A:1022566121967; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Stefanova N, 2011, AM J PATHOL, V179, P954, DOI 10.1016/j.ajpath.2011.04.013; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zanon RG, 2010, NEUROPATH APPL NEURO, V36, P515, DOI 10.1111/j.1365-2990.2010.01095.x; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang W, 2011, NEUROTOX RES, V19, P63, DOI 10.1007/s12640-009-9140-z; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	141	248	263	3	64	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2014	49	3					1422	1434		10.1007/s12035-013-8620-6			13	Neurosciences	Neurosciences & Neurology	AG8KE	WOS:000335666500022	24395130	Green Published, Other Gold	Y	N	2021-06-18	
J	Leddy, JJ; Kozlowski, K; Donnelly, JP; Pendergast, DR; Epstein, LH; Willer, B				Leddy, John J.; Kozlowski, Karl; Donnelly, James P.; Pendergast, David R.; Epstein, Leonard H.; Willer, Barry			A Preliminary Study of Subsymptom Threshold Exercise Training for Refractory Post-Concussion Syndrome	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; exertion; symptoms; physiology; blood pressure	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; DEPRESSION; CHALLENGE; SYMPTOMS; RECOVERY	Objective: To evaluate the safety and effectiveness of subsymptom threshold exercise training for the treatment of post-concussion syndrome (PCS). Design: Prospective case series. Setting: University Sports Medicine Concussion Clinic. Participants: Twelve refractory patients with PCS (6 athletes and 6 nonathletes). Intervention: Treadmill test to symptom exacerbation threshold (ST) before and after 2 to 3 weeks of baseline. Subjects then exercised 5 to 6 days per week at 80% ST heart rate (HR) until voluntary peak exertion without symptom exacerbation. Treadmill testing was repeated every 3 weeks. Main Outcome Measures: Adverse reactions to exercise, PCS symptoms, HR, systolic blood pressure (SBP), achievement of maximal exertion, and return to work/sport. Results: Pretreatment, ST occurred at low exercise HR (147 +/- 27 bpm) and SBP (142 +/- 6 mm Hg). After treatment, subjects exercised longer (9.75 +/- 6.38 minutes to 18.67 +/- 2.53 minutes, P = .001) and achieved peak HR (179 17 bpm) and SBP (156 13 mm Hg), both P < .001 versus pretreatment, without symptom exacerbation. Time series analysis showed significant change in rate of symptom reduction for all subjects and reduced mean symptom number in 8/11. Rate of PCS symptom improvement was related to peak exercise HR (r = -0.55, P = .04). Athletes recovered faster than nonathletes (25 +/- 8.7 vs 74.8 +/- 27.2 days, P = .01). No adverse events were reported. Athletes returned to sport and nonathletes to work. Conclusions: Treatment with controlled exercise is a safe program that appears to improve PCS symptoms when compared with a notreatment baseline. A randomized controlled study is warranted.	[Leddy, John J.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY 14260 USA; [Leddy, John J.] SUNY Buffalo, Sports Med Inst, Buffalo, NY 14260 USA; [Kozlowski, Karl] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Donnelly, James P.] SUNY Buffalo, Dept Counseling, Sch & Educ Psychol, Buffalo, NY 14260 USA; [Pendergast, David R.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Epstein, Leonard H.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA	Leddy, JJ (corresponding author), Univ Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	leddy@buffalo.edu	Kozlowski, Karl/H-5253-2019; Donnelly, James/AAI-4840-2020; Epstein, Leonard/AAE-5619-2021		New York State Athletic Trainers' Association	Funding for this research was provided in part by a grant from the New York State Athletic Trainers' Association.	*AM COLL SPORTS ME, 2006, ACSMS GUID EX TEST P, P22; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Borckardt JJ, 2008, AM PSYCHOL, V63, P77, DOI 10.1037/0003-066X.63.2.77; BORCKHARDT JJ, SIMULATION MODELING; Brys M, 2003, AM J PHYSIOL-HEART C, V285, pH1048, DOI 10.1152/ajpheart.00062.2003; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Doering TJ, 1998, AM J PHYS MED REHAB, V77, P490, DOI 10.1097/00002060-199811000-00006; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; King ML, 1997, BRAIN INJURY, V11, P445; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Udupa K, 2007, J AFFECT DISORDERS, V100, P137, DOI 10.1016/j.jad.2006.10.007; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	26	248	249	1	33	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2010	20	1					21	27		10.1097/JSM.0b013e3181c6c22c			7	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	542ON	WOS:000273504100004	20051730				2021-06-18	
J	Uryu, K; Chen, XH; Martinez, D; Browne, KD; Johnson, VE; Graham, DI; Lee, VMY; Trojanowski, JQ; Smith, DH				Uryu, Kunihiro; Chen, Xiao-Han; Martinez, Dan; Browne, Kevin D.; Johnson, Victoria E.; Graham, David I.; Lee, Virginia M. -Y.; Trojanowski, John Q.; Smith, Douglas H.			Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans	EXPERIMENTAL NEUROLOGY			English	Article						traumatic brain injury; TBI; axonal injury; amyloid beta; APP; BACE; PS-1; alpha-synuclein; tau	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; LONG-TERM ACCUMULATION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; RISK-FACTOR; BETA-SECRETASE; DAMAGED AXONS; PATHOLOGY	Studies in animal models have shown that traumatic brain injury (TBI) induces the rapid accumulation of many of the same key proteins that form pathologic aggregates in neurodegenerative diseases. Here, we examined whether this rapid process also occurs in humans after TBI. Brain tissue from 18 cases who died after TBI and from 6 control cases was examined using immunohistochemistry. Following TBI, widespread axonal injury was persistently identified by the accumulation of neurofilament protein and amyloid precursor protein (APP) in axonal bulbs and varicosities. Axonal APP was found to co-accumulate with its cleavage enzymes, beta-site APP cleaving enzyme (BACE), presenilin-1 (PS1) and their product, amyloid-beta (A beta). In addition, extensive accumulation of alpha-synuclein (alpha-syn) was found in swollen axons and tau protein was found to accumulate in both axons and neuronal cell bodies. These data show rapid axonal accumulation of proteins implicated in neurodegenerative diseases including Alzheimer's disease and the synucleinopathies. The cause of axonal pathology can be attributed to disruption of axons due to trauma, or as a secondary effect of raised intracranial pressure or hypoxia. Such axonal pathology in humans may provide a unique environment whereby co-accumulation of APP, BACE, and PSI leads to intra-axonal production of A beta as well as accumulation of alpha-syn and tau. This process may have important implications for survivors of TBI who have been shown to be at greater risk of developing neurodegenerative diseases. (c) 2007 Elsevier Inc. All rights reserved.	[Chen, Xiao-Han; Browne, Kevin D.; Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Graham, David I.] Southern Gen Hosp NHS Trust, Inst Neurol Sci, Div Clin Neurosci, Acad Unit Neuropathol, Glasgow, Lanark, Scotland	Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P50NS008803, P01NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG011542, P30AG010124, R01AG012527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG10124, R01 AG012527, P30 AG010124, AG11542, AG12527, P01 AG011542] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38104, P50 NS008803, NS08803, R01 NS038104] Funding Source: Medline		Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Ben-Shlomo Y, 1997, BAILLIERE CLIN NEUR, V6, P55; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brendza RP, 2005, J CLIN INVEST, V115, P428, DOI 10.1172/JCI200523269; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; CHRISTIAN GD, 1994, J FLOW INJECTION ANA, V11, P2; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lees AJ, 1997, REV NEUROL-FRANCE, V153, P541; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MIRRA SS, 1993, ARCH PATHOL LAB MED, V117, P132; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schonheit B, 2004, NEUROBIOL AGING, V25, P697, DOI 10.1016/j.neurobioalging.2003.09.009; Selkoe DJ, 2000, P NATL ACAD SCI USA, V97, P5690, DOI 10.1073/pnas.97.11.5690; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Trojanowski JQ, 2002, NEUROTOXICOLOGY, V23, P457, DOI 10.1016/S0161-813X(02)00065-7; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	70	248	253	2	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2007	208	2					185	192		10.1016/j.expneurol.2007.06.018			8	Neurosciences	Neurosciences & Neurology	241OP	WOS:000251666000003	17826768	Green Accepted			2021-06-18	
J	Erlich, S; Alexandrovich, A; Shohami, E; Pinkas-Kramarski, R				Erlich, S.; Alexandrovich, A.; Shohami, E.; Pinkas-Kramarski, R.			Rapamycin is a neuroprotective treatment for traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						autophagy; Beclin 1; brain; neurons; rapamycin; closed head; injury	CLOSED-HEAD INJURY; UP-REGULATION; AUTOPHAGY; INHIBITION; INVOLVEMENT; NEURODEGENERATION; POLYGLUTAMINE; EXPANSIONS; REJECTION; TOXICITY	The mammalian target of rapamycin, commonly known as mTOR, is a serine/threonine kinase that regulates translation and cell division. mTOR integrates input from multiple upstream signals, including growth factors and nutrients to regulate protein synthesis. Inhibition of mTOR leads to cell cycle arrest, inhibition of cell proliferation, immunosuppression and induction of autophagy. Autophagy, a bulk degradation of sub-cellular constituents, is a process that keeps the balance between protein synthesis and protein degradation and is induced upon amino acids deprivation. Rapamycin, mTOR signaling inhibitor, mimics amino acid and, to some extent, growth factor deprivation. In the present study we examined the effect of rapamycin, on the outcome of mice after brain injury. Our results demonstrate that rapamycin injection 4 h following closed head injury significantly improved functional recovery as manifested by changes in the Neurological Severity Score, a neurobehavioral testing. To verify the activity of the injected rapamycin, we demonstrated that it inhibits p70S6K phosphorylation, reduces microglia/macrophages activation and increases the number of surviving neurons at the site of injury. We therefore suggest that rapamycin is neuroprotective following traumatic brain injury and as a drug used in the clinic for other indications, we propose that further studies on rapamycin should be conducted in order to consider it as a novel therapy for traumatic brain injury. (c) 2007 Elsevier Inc. All rights reserved.	Tel Aviv Univ, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Dept Pharmacol, IL-91120 Jerusalem, Israel	Pinkas-Kramarski, R (corresponding author), Tel Aviv Univ, Dept Neurobiochem, IL-69978 Tel Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X			BAKER H, 1978, J ANTIBIOT, V31, P539, DOI 10.7164/antibiotics.31.539; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dutcher JP, 2004, CLIN CANCER RES, V10, p6382S, DOI 10.1158/1078-0432.CCR-050008; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; GIULIAN D, 1997, PRIMER CEREBROVASCUL, P117; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARRIS TE, 2003, SCI STKE; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; OLSEN TW, 1994, ARCH OPHTHALMOL-CHIC, V112, P1471, DOI 10.1001/archopht.1994.01090230085026; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PinkasKramarski R, 1997, ONCOGENE, V15, P2803, DOI 10.1038/sj.onc.1201466; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sousa JE, 2003, TRANSPLANT P, V35, p165S, DOI 10.1016/S0041-1345(03)00215-X; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	43	248	262	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2007	26	1					86	93		10.1016/j.nbd.2006.12.003			8	Neurosciences	Neurosciences & Neurology	152PL	WOS:000245374000009	17270455				2021-06-18	
J	Schneier, AJ; Shields, BJ; Hostetler, SG; Xiang, H; Smith, GA				Schneier, Andrew J.; Shields, Brenda J.; Hostetler, Sarah Grim; Xiang, Huiyun; Smith, Gary A.			Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States	PEDIATRICS			English	Article						traumatic brain injury; pediatrics; resource utilization; length of stay; total charges; Kids' Inpatient Database	COSTS; OUTCOMES; STAY; CARE; SEVERITY; LENGTHS; CHARGES; TRENDS; MILD; TBI	OBJECTIVE. The goal was to examine the influence of sociodemographic characteristics and health care system factors on the utilization of hospital resources by US children <= 17 years of age with a diagnosis of traumatic brain injury. METHODS. A retrospective analysis of data from the Healthcare Cost and Utilization Project Kids' Inpatient Database, from January 1, 2000, to December 31, 2000, was performed. National estimates of traumatic brain injury-associated hospitalization rates and resource use were calculated with Kids' Inpatient Database sample weighting methods. RESULTS. Of 2 516 833 encounters between January 1, 2000, and December 31, 2000, 25 783 cases involved patients <= 17 years of age with a recorded diagnosis of traumatic brain injury. On the basis of these data, there were an estimated 50 658 traumatic brain injury-associated hospitalizations among children <= 17 years of age in the United States in 2000. The traumatic brain injury-associated hospitalization rate was 70 cases per 100 000 children <= 17 years of age per year; 15- to 17-year-old patients had the highest hospitalization rate ( 125 cases per 100 000 children per year). Pediatric inpatients accrued more than $1 billion in total charges for traumatic brain injury-associated hospitalizations in this study. In the multivariate regression models, older age, Medicaid insurance status, and admission to any type of children's hospital were associated with a longer length of stay for pediatric traumatic brain injury-associated hospitalizations. Older age, longer length of stay, and in-hospital death predicted higher total charges for traumatic brain injury-associated hospitalizations. CONCLUSION. Pediatric traumatic brain injury is a substantial contributor to the health resource burden in the United States, accounting for more than $1 billion in total hospital charges annually.	Columbus Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43210 USA	Smith, GA (corresponding author), Columbus Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	gsmith@chi.osu.edu	Xiang, Huiyun/E-4335-2011				*AG HEALTHC RES QU, 2003, CAR CHILDR AD US HOS; *AG HEALTHC RES QU, 2000, HEALTHC COST UT PROJ; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; *BRAIN INJ ASS, TBI INC; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Brooten D, 1997, MED CARE, V35, pNS87, DOI 10.1097/00005650-199711001-00010; *CDCP, 2000, WEB BAS INJ STAT QUE; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Dueck A, 2001, CAN J SURG, V44, P117; FIFE D, 1984, J NEUROSURG, V60, P697, DOI 10.3171/jns.1984.60.4.0697; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; *HEALTHC COST UT P, 2003, DESCR KID DAT EL INP; *HEALTHC COST UT P, 2003, OV HCUP KIDS INP DAT; Iezzoni L I, 1996, J Health Serv Res Policy, V1, P65; IEZZONI LI, 1990, JAMA-J AM MED ASSOC, V264, P1426, DOI 10.1001/jama.264.11.1426; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Kuhlthau K, 2004, PEDIATRICS, V113, P210; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Marr AL., 2004, CENTRAL NERVOUS SYST; MAYER T, 1981, JAMA-J AM MED ASSOC, V245, P719; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Merenstein D, 2005, PEDIATRICS, V115, P839, DOI 10.1542/peds.2004-1622; Meurer JR, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.6.e70; Miller TR, 2000, FUTURE CHILD, V10, P137, DOI 10.2307/1602828; MORRISON WE, 2004, PEDIAT CRIT CARE MED, V5, P193; *NAT AER SPAC ADM, CONS PRIC IND CPI IN; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Osberg JS, 1997, BRAIN INJURY, V11, P11; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Srivastava R, 2003, PEDIATRICS, V112, P278, DOI 10.1542/peds.112.2.278; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; *US CENS BUR, CENS 2000 SUMM FIL 1	46	248	250	1	15	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2006	118	2					483	492		10.1542/peds.2005-2588			10	Pediatrics	Pediatrics	069IW	WOS:000239440600007	16882799				2021-06-18	
J	Du, LN; Bayir, H; Lai, YC; Zhang, XP; Kochanek, PM; Watkins, SC; Graham, SH; Clark, RSB				Du, LN; Bayir, H; Lai, YC; Zhang, XP; Kochanek, PM; Watkins, SC; Graham, SH; Clark, RSB			Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SEXUAL-DIFFERENTIATION; NITRIC-OXIDE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; FACTOR AIF; NEURONS	Many central nervous system (CNS) diseases display sexual dimorphism. Exposure to circulating sex steroids is felt to be a chief contributor to this phenomenon; however, CNS diseases of childhood and the elderly also demonstrate gender predominance and/or a sexually dimorphic response to therapies. Here we show that XY and XX neurons cultured separately are differentially susceptible to various cytotoxic agents and treatments. XY neurons were more sensitive to nitrosative stress and excitotoxicity versus XX neurons. In contrast, XX neurons were more sensitive to etoposide- and staurosporine-induced apoptosis versus XY neurons. The responses to specific therapies were also sexually dimorphic. Moreover, gender proclivity in programmed cell death pathway was observed. After cytotoxic challenge, programmed cell death proceeded predominately via an apoptosis-inducing factor-dependent pathway in XY neurons versus a cytochrome c-dependent pathway in XX neurons. This gender-dependent susceptibility is related to the incapacity of XY neurons to maintain intracellular levels of reduced glutathione. In vivo studies further demonstrated an incapacity for male, but not female, 17-day-old rats to maintain reduced glutathione levels within cerebral cortex acutely after an 8-min asphyxial cardiac arrest. This gender difference in sensitivity to cytotoxic agents may be generalized to non-neuronal cells, as splenocytes from male and female 16-18-day-old rats show similar gender-dependent responses to nitrosative stress and staurosporine-induced apoptosis. These data support gender stratification in the evaluation of mechanisms and treatment of CNS disease, particularly those where glutathione may play a role in detoxification, such as Parkinson's disease, traumatic brain injury, and conditions producing cerebral ischemia, and may apply to non-CNS diseases as well.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Neurol, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Lai, Yi-Chen/0000-0002-9450-5506; watkins, simon/0000-0003-4092-1552	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS30318, R01 NS38620] Funding Source: Medline		Alkayed NJ, 2001, J NEUROSCI, V21, P7543; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Canals S, 2001, J NEUROCHEM, V76, P56, DOI 10.1046/j.1471-4159.2001.00010.x; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; FIX AS, 1995, BRAIN RES, V696, P194, DOI 10.1016/0006-8993(95)00842-E; Gambassi G, 1999, NEUROLOGY, V53, P508, DOI 10.1212/WNL.53.3.508; Hariz GM, 2003, ACTA NEUROL SCAND, V108, P28, DOI 10.1034/j.1600-0404.2003.00092.x; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; Hurvitz E A, 1999, Pediatr Rehabil, V3, P43; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ishii E, 2001, MED PEDIATR ONCOL, V37, P10, DOI 10.1002/mpo.1156; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Nunez JL, 2001, J COMP NEUROL, V436, P32; Picazo O, 2003, BRAIN RES, V990, P20, DOI 10.1016/S0006-8993(03)03380-8; REISERT I, 1989, CELL TISSUE RES, V255, P411; Sacco RL, 2001, NEUROLOGY, V57, pS31, DOI 10.1212/WNL.57.suppl_2.S31; Singer CA, 1999, J NEUROSCI, V19, P2455; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Szabo C, 1998, P NATL ACAD SCI USA, V95, P3867, DOI 10.1073/pnas.95.7.3867; Ueki A, 2001, INT J GERIATR PSYCH, V16, P810, DOI 10.1002/gps.419.abs; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; van Lieshout EMM, 1998, CARCINOGENESIS, V19, P1873, DOI 10.1093/carcin/19.10.1873; Vukmir RB, 2003, J WOMENS HEALTH, V12, P667, DOI 10.1089/154099903322404311; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Weil MD, 1998, JAMA-J AM MED ASSOC, V279, P1474, DOI 10.1001/jama.279.18.1474; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG J, 1995, J NEUROCHEM, V65, P1411; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	42	248	256	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2004	279	37					38563	38570		10.1074/jbc.M405461200			8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	851KN	WOS:000223684100062	15234982	Other Gold			2021-06-18	
J	Fakhry, SM; Trask, AL; Waller, MA; Watts, DD				Fakhry, SM; Trask, AL; Waller, MA; Watts, DD		IRTC Neurotrauma Task Force	Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						trauma; neurotrauma; brain injury; brain trauma foundation; protocol; guidelines; acute care; evidence based medicine; health care expenditures	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; UNITED-STATES; MORTALITY; CARE	Objective: Traumatic brain injury (TBI) is the leading cause of death from blunt trauma, with an estimated cost to society of over $40 billion annually. Evidence-based guidelines for TBI care have been widely discussed, but in-hospital treatment of these patients has been highly variable. The purpose of this study was to determine whether management of TBI patients according to a protocol based on the Brain Trauma Foundation (BTF) guidelines would reduce mortality, length of stay, charges, and disability. Methods. In 1995, a protocol following the BTF guidelines was developed by members of the Level I trauma center's interdisciplinary neurotrauma task force. Inclusion criteria for the protocol were blunt head injury, age > 14 years, and Glasgow Coma Scale score less than or equal to 8. An extensive educational process was conducted to develop compliance among all disciplines for this new management strategy. A historical control group of patients eligible for the protocol was identified by retrospective analysis of trauma registry data for 1991 to 1994. Mortality, intensive care unit days, total hospital days, total charges, Rancho Los Amigos; Scores, and Glasgow Outcome Scale scores were compared. Results. Between 1991 and 2000, over 7,000 blunt TBI patients were managed by the Trauma Service. Of these, 830 met the inclusion criteria for the TBI protocol and lived > 48 hours. After implementation, initial analysis of the 1995-96 cohort indicated only 50% compliance with the protocol. By 1997, compliance had risen to 88%. Patients were therefore compared as three groups: before the protocol (1991-94, n = 219), during low compliance (1995-96, n = 188), and during high compliance (1997-2000, n = 423). Groups did not differ significantly on Injury Severity Score, head Abbreviated Injury Scale score, or age (p > 0.05). Admission Glasgow Coma Scale score was slightly higher in the 1991-94 cohort (4.0 vs. 3.5,p = 0.001). From 1991-94 to 1997-2000, intensive care unit stay was reduced by 1.8 days (p = 0.021) and total hospital stay was reduced by 5.4 days (p < 0.001). The charge reduction (calculated in 1997 dollars) per patient for the length of stay decrease was $6,577 in 1995-96 and $8,266 in 1997-2000 (p = 0.002). This represents a total reduction over 6 years of $4.7 million in charges. In addition, the overall mortality rate showed a reduction of 4.0% from 1991-94 to 1997-2000 (17.8% vs. 13.8%), although this was not statistically significant. On the basis of the Glasgow Outcome Scale score, in 1997-2000, 61.5% of the patients had either a "good recovery" or only "moderate disability" compared with 50.3% in 1995-% and 43.3% in 1991-94 (p < 0.001). The Rancho Los Amigos Scores showed a similar trend, with 56.6% of the 1997-2000 patients having appropriate responses at 10 to 14 days, compared with only 44.0% of the 1995-96 patients and 43.9% of the 1991-94 patients (p = 0.004). Conclusion. Adherence to a protocol based on the BTF guidelines can result in a significant decrease in hospital days and charges for TBI patients who live > 48 hours. In addition, mortality and outcome may be significantly affected. This analysis suggests that increased efforts to improve adherence to national guidelines may have a significant impact on head injury care outcomes and could dramatically reduce the substantial financial resources that are currently consumed in the acute care phases for this injury.	Inova Fairfax Hosp, Inova Reg Trauma Ctr, Trauma Serv, Falls Church, VA 22042 USA	Fakhry, SM (corresponding author), Inova Fairfax Hosp, Inova Reg Trauma Ctr, Trauma Serv, 3300 Gallows Rd, Falls Church, VA 22042 USA.						*AITK BRAIN TRAUM, 1995, GUID MAN SEV HEAD IN; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BULLOCK R, 1996, J NEUROTRAUM, V13, P638; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KOLATA G, 1991, NY TIMES        1016, pC14; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MARION D, 1993, 61 ANN M AM ASS NEUR; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; National Academy of Sciences and National Research Council, 1966, ACC DEATH DIS NEGL D; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; *US DEP HHS, 1989, INT HEAD INJ TASK FO; BRAIN TRAUMA FDN GUI	26	248	256	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2004	56	3					492	499		10.1097/01.TA.0000115650.07193.66			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	808CM	WOS:000220547200007	15128118				2021-06-18	
J	Adams, JH; Graham, DI; Jennett, B				Adams, JH; Graham, DI; Jennett, B			The neuropathology of the vegetative state after an acute brain insult	BRAIN			English	Article						vegetative state; head injury; cerebral hypoxia	DIFFUSE AXONAL INJURY; MISSILE HEAD-INJURY; AMYLOID PRECURSOR PROTEIN; CARDIAC-ARREST; INTRACRANIAL-PRESSURE; STRETCH-INJURY; DAMAGE; PATHOGENESIS; SURVIVAL; SHEARING	The vegetative state is often described clinically as loss of function of the cortex while the function of the brainstem is preserved, In all attempt to define the structural basis of the vegetative state we have undertaken a detailed neuropathological study of the brains of 39 patients who remained vegetative until death, 1 month to 8 Sears after an acute brain insult. Of these, 35 had sustained a blunt head injury and 14 some type of acute non-traumatic brain damage. In the traumatic cases the commonest structural abnormalities identified mere grades 2 and 3 diffuse axonal injury (25 cases, 71%). The thalamus was abnormal in 28 cases (80 %), and in 96 % of the cases who survived fdr more than 3 months, Other abnormalities included ischaemic damage in the neocortex (13 cases, 37%) and intracranial haematoma (nine cases, 26%). In the non-traumatic cases there was diffuse ischaemic damage in the neocortex in nine cases (64%) and focal damage in four (29%); the thalamus was abnormal in every case. There were cases in both groups where the cerebral cortex, the cerebellum and the brainstem were of structurally normal appearance. In every case, however, there was profound damage to the subcortical white matter or to the major relay nuclei of the thalamus, or both, These lesions render any structurally intact cortex unable to function because connections between different cortical areas via the thalamic nuclei are no longer functional, and there is also extensive damage to afferent and efferent cerebral connections.	S Glasgow Univ Hosp, NHS Trust, So Gen Hosp, Inst Neurol Sci,Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; S Glasgow Univ Hosp, NHS Trust, Dept Neurosurg, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland	Adams, JH (corresponding author), S Glasgow Univ Hosp, NHS Trust, So Gen Hosp, Inst Neurol Sci,Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.						ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1966, BRAIN, V89, P235, DOI 10.1093/brain/89.2.235; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; AUER RN, 1989, CLIN NEUROPATHOL, V8, P63; AUER RN, 1997, GREENFIELDS NEUROPAT, V1, P263; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BRIERLEY JB, 1971, LANCET, V2, P560; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; COLE G, 1987, CLIN NEUROPATHOL, V6, P104; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P727, DOI 10.1001/archneurpsyc.1952.02320240002001; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham D.I., 1992, GREENFIELDS NEUROPAT, P153; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HART IK, 1988, POSTGRAD MED J, V64, P213, DOI 10.1136/pgmj.64.749.213; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Ingvar D H, 1978, Ann N Y Acad Sci, V315, P184; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JELLINGER KA, 1994, NEW ENGL J MED, V331, P1378; Jellinger KA, 1977, APALLIC SYNDROME, P88; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199708000-00003; KALIMO H, 1980, ACTA NEUROL SCAND, V62, P345; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; LAPRESLE J, 1966, ACTA NEUROPATHOL, V6, P327, DOI 10.1007/BF00688162; Maxwell W. L., 1995, Journal of Neurotrauma, V12, P363; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McLean SAM, 1999, J CLIN PATHOL, V52, P490, DOI 10.1136/jcp.52.7.490; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PETERS G, 1977, APALLIC SYNDROME, P78; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REILLY PL, 1975, LANCET, V2, P375; RELKIN NR, 1990, ANN NEUROL, V28, P221; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TORVIK A, 1969, J NEUROL SCI, V9, P285; VUIA O, 1967, ACTA NEUROPATHOL, V7, P305, DOI 10.1007/BF00688086; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	63	248	262	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2000	123		7				1327	1338		10.1093/brain/123.7.1327			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	334JP	WOS:000088183600003	10869046	Bronze			2021-06-18	
J	Biffl, WL; Moore, EE; Ryu, RK; Offner, PJ; Novak, Z; Coldwell, DM; Franciose, RJ; Burch, JM				Biffl, WL; Moore, EE; Ryu, RK; Offner, PJ; Novak, Z; Coldwell, DM; Franciose, RJ; Burch, JM			The unrecognized epidemic of blunt carotid arterial injuries - Early diagnosis improves neurologic outcome	ANNALS OF SURGERY			English	Article; Proceedings Paper	118th Annual Meeting of the American-Surgical-Association	APR 03, 1998	PALM BEACH, FL	Amer Surgical Assoc			TRAUMA; MANAGEMENT; ANGIOGRAPHY; DISSECTIONS	Objective To determine the benefit of screening for blunt carotid arterial injuries (BCl) in patients who are asymptomatic. Summary Background Data Blunt carotid arterial injuries have the potential for devastating complications, Published studies report 23% to 28% mortality rates, with 48% to 58% of survivors having permanent severe neurologic deficits. Most patients have neurologic deficits when the injury is diagnosed. The authors hypothesized that screening patients who are asymptomatic and instituting early therapy would improve neurologic outcome. Methods The Trauma Registry of the author's Level I Trauma Center identified patients with BCl from 1990 through 1997; Beginning in August 1996, the authors implemented a screening for BCl, Arteriography was used for diagnosis, Patients without specific contraindications were anticoagulated. Endovascular stents were deployed in the setting of pseudoaneurysms. Results Thirty-seven patients with BCl were identified among 15,331 blunt-trauma victims (0.24%). During the screening period, 25 patients were diagnosed with BCl among 2902 admissions (0.86%); 13 (52%) were asymptomatic. Overall, eight patients died, and seven of the survivors had permanent severe neurologic deficits. Excluding those dying of massive brain injury and patients admitted with coma and brain injury, mortality associated with BCl was 15%, with severe neurologic morbidity in 16% of survivors. The patients who were asymptomatic at diagnosis had a better neurologic outcome than those who were symptomatic. Symptomatic patients who were anticoagulated showed a trend toward greater neurologic improvement at the time of discharge than those who were not anticoagulated, Conclusions Screening allows the identification of asymptomatic BCl and thereby facilitates early systemic anticoagulation; which is associated with improved neurologic outcome, The role of endovascular stents in the treatment of blunt traumatic pseudoaneurysms remains to be defined.	Denver Hlth Med Ctr, Dept Surg, Denver, CO 80204 USA; Denver Hlth Med Ctr, Dept Radiol, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Biffl, WL (corresponding author), Denver Hlth Med Ctr, Dept Surg, Box 0206,777 Bannock St, Denver, CO 80204 USA.						Bernstein SM, 1997, J VASC INTERV RADIOL, V8, P1065, DOI 10.1016/S1051-0443(97)70711-5; Bok APL, 1996, J TRAUMA, V40, P968, DOI 10.1097/00005373-199606000-00017; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; Dennis JW, 1998, J TRAUMA, V44, P243, DOI 10.1097/00005373-199802000-00001; Duke BJ, 1997, J NEUROSURG, V87, P825, DOI 10.3171/jns.1997.87.6.0825; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; FAKHRY SM, 1988, J VASC SURG, V8, P501; FRY WR, 1994, AM J SURG, V168, P693, DOI 10.1016/S0002-9610(05)80147-3; HIGASHIDA RT, 1998, JVIR, V9, P84; KAPLAN JA, 1994, J FORENSIC SCI, V39, P552; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; LI MS, 1994, J TRAUMA, V36, P265, DOI 10.1097/00005373-199402000-00025; MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076; MOKRI B, 1990, J NEUROL, V237, P356, DOI 10.1007/BF00315659; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; Nagler RM, 1997, PLAST RECONSTR SURG, V100, P1697, DOI 10.1097/00006534-199712000-00008; OSBORNE DL, 1998, IN PRESS ARCH SURG; Parikh AA, 1997, J AM COLL SURGEONS, V185, P80, DOI 10.1016/S1072-7515(01)00886-9; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; PRETRE R, 1994, SURGERY, V115, P375; Punjabi AP, 1997, J ORAL MAXIL SURG, V55, P1388, DOI 10.1016/S0278-2391(97)90634-0; RAMADAN F, 1995, J VASC SURG, V21, P46, DOI 10.1016/S0741-5214(95)70243-1; RICHARDSON JD, 1988, SURGERY, V104, P673; RYU R, 1997, APPL RADIOL S, P63; WELLING RE, 1987, J TRAUMA, V27, P1221; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001	28	248	250	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	OCT	1998	228	4					462	469		10.1097/00000658-199810000-00003			8	Surgery	Surgery	129QK	WOS:000076474300005	9790336	Green Published			2021-06-18	
J	Gomez-Pinilla, F; Hillman, C				Gomez-Pinilla, Fernando; Hillman, Charles			The Influence of Exercise on Cognitive Abilities	COMPREHENSIVE PHYSIOLOGY			English	Article							GROWTH-FACTOR-I; ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; LONG-TERM POTENTIATION; BDNF VAL66MET POLYMORPHISM; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PHYSICAL-ACTIVITY; AEROBIC EXERCISE	Scientific evidence based on neuroimaging approaches over the last decade has demonstrated the efficacy of physical activity improving cognitive health across the human lifespan. Aerobic fitness spares age-related loss of brain tissue during aging, and enhances functional aspects of higher order regions involved in the control of cognition. More active or higher fit individuals are capable of allocating greater attentional resources toward the environment and are able to process information more quickly. These data are suggestive that aerobic fitness enhances cognitive strategies enabling to respond effectively to an imposed challenge with a better yield in task performance. In turn, animal studies have shown that exercise has a benevolent action on health and plasticity of the nervous system. New evidence indicates that exercise exerts its effects on cognition by affecting molecular events related to the management of energy metabolism and synaptic plasticity. An important instigator in the molecular machinery stimulated by exercise is brain-derived neurotrophic factor, which acts at the interface of metabolism and plasticity. Recent studies show that exercise collaborates with other aspects of lifestyle to influence the molecular substrates of cognition. In particular, select dietary factors share similar mechanisms with exercise, and in some cases they can complement the action of exercise. Therefore, exercise and dietary management appear as a noninvasive and effective strategy to counteract neurological and cognitive disorders. (C) 2013 American Physiological Society. Compr Physiol 3:403-428, 2013.	[Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] UCLA Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Hillman, Charles] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Hillman, Charles] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Psychol, Urbana, IL USA; [Hillman, Charles] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Internal Med, Urbana, IL USA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@mednet.ucla.edu	Hillman, Charles/AAD-4828-2019	Hillman, Charles/0000-0002-3722-5612	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS50465-06, NS068473, NS56413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS068473, R01NS050465, R01NS056413] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Awards NS50465-06, NS068473, and NS56413. The authors thank Cameron Feng, B. S. for helpful editorial assistance.	Ang ET, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00025; Anlar B, 1999, HORM METAB RES, V31, P120, DOI 10.1055/s-2007-978708; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Barrientos RM, 2011, J NEUROSCI, V31, P11578, DOI 10.1523/JNEUROSCI.2266-11.2011; BAYLOR AM, 1988, J GERONTOL, V43, pP121, DOI 10.1093/geronj/43.5.P121; Beise D, 1937, RES QUART, V8, P133, DOI 10.1080/23267402.1937.10761808; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Blair C, 2005, DEV NEUROPSYCHOL, V28, P561, DOI 10.1207/s15326942dn2802_1; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Bugg JM, 2011, NEUROBIOL AGING, V32, P506, DOI 10.1016/j.neurobiolaging.2009.03.008; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Burpee RH, 1936, RES QUART, V7, P110, DOI 10.1080/23267402.1936.10761762; Burzynski SR, 2003, MED HYPOTHESES, V60, P578, DOI 10.1016/S0306-9877(03)00050-1; Carro E, 2001, J NEUROSCI, V21, P5678; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Castelli DM, PHYS ACTIVI IN PRESS; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2011, MED SCI SPORT EXER, V43, P344, DOI 10.1249/MSS.0b013e3181e9af48; Chao HT, 2009, P NATL ACAD SCI USA, V106, P4577, DOI 10.1073/pnas.0901518106; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Clapp JF, 2002, AM J OBSTET GYNECOL, V186, P142, DOI 10.1067/mob.2002.119109; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Coles M.G.H., 1990, PRINCIPLES PSYCHOPHY, P413; COLES MGH, 1995, OX PSYCH S, P1; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cusi K, 2000, J CLIN ENDOCR METAB, V85, P3077, DOI 10.1210/jc.85.9.3077; da Silva SG, 2012, HIPPOCAMPUS, V22, P347, DOI 10.1002/hipo.20903; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Davatzikos C, 2002, CEREB CORTEX, V12, P767, DOI 10.1093/cercor/12.7.767; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Deeny SP, 2008, BIOL PSYCHOL, V78, P179, DOI 10.1016/j.biopsycho.2008.02.007; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Diamond A., 2006, LIFESPAN COGNITION M, P70, DOI DOI 10.1093/ACPROF:OSO/9780195169539.003.0006; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Dustman R. E., 1994, Journal of Aging and Physical Activity, V2, P143; DUSTMAN RE, 1990, NEUROBIOL AGING, V11, P193, DOI 10.1016/0197-4580(90)90545-B; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gilmore JH, 2003, J NEUROIMMUNOL, V138, P49, DOI 10.1016/S0165-5728(03)00095-X; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hall J, 2000, NAT NEUROSCI, V3, P533; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; Hatta A, 2005, JPN J PHYSIOL, V55, P29, DOI 10.2170/jjphysiol.R2068; Heffernan A E, 2000, Nurse Pract, V25, P53; Heffernan AE, 2000, NURSE PRACT, V25, P53; Heffernan AE, 2000, NURSE PRACT, V25, P49; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2006, INT J PSYCHOPHYSIOL, V59, P30, DOI 10.1016/j.ijpsycho.2005.04.009; Hillman CH, 2005, MED SCI SPORT EXER, V37, P1967, DOI 10.1249/01.mss.0000176680.79702.ce; Hillman CH, 2004, RES Q EXERCISE SPORT, V75, P176, DOI 10.1080/02701367.2004.10609149; Hillman CH, 2002, PSYCHOPHYSIOLOGY, V39, P303, DOI 10.1017/S0048577201393058; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Honea RA, 2009, ALZ DIS ASSOC DIS, V23, P188, DOI 10.1097/WAD.0b013e31819cb8a2; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Hugdahl K, 1995, PSYCHOPHYSIOLOGY MIN, P429; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Jung RT, 1997, BRIT MED BULL, V53, P307, DOI 10.1093/oxfordjournals.bmb.a011615; Kamijo K, 2009, CLIN NEUROPHYSIOL, V120, P511, DOI 10.1016/j.clinph.2008.11.022; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Laske C, 2010, INT J NEUROPSYCHOPH, V13, P595, DOI 10.1017/S1461145709991234; Lawther JD, 1951, PSYCHOL COACHING, P333; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Luck S. J., 2005, INTRO EVENT RELATED; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Ma YL, 1998, NEUROSCIENCE, V82, P957; Martin Jean-Luc, 2011, Commun Integr Biol, V4, P14, DOI 10.4161/cib.4.1.13761; McDowell K, 2003, NEUROBIOL AGING, V24, P597, DOI 10.1016/S0197-4580(02)00131-8; Mcnay EC, 2007, CURR OPIN PHARMACOL, V7, P628, DOI 10.1016/j.coph.2007.10.009; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Molnar E, 2011, SEMIN CELL DEV BIOL, V22, P506, DOI 10.1016/j.semcdb.2011.07.017; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Nestler EJ, 2009, BIOL PSYCHIAT, V65, P189, DOI 10.1016/j.biopsych.2008.10.030; Nichol K, 2009, ALZHEIMERS DEMENT, V5, P287, DOI 10.1016/j.jalz.2009.02.006; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parnpiansil P, 2003, NEUROSCI LETT, V352, P45, DOI 10.1016/j.neulet.2003.08.023; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; PIERSON WR, 1958, J GERONTOL, V13, P418, DOI 10.1093/geronj/13.4.418; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P747, DOI 10.1111/j.1469-8986.1996.tb02371.x; Polich J, 1997, ELECTROEN CLIN NEURO, V103, P493, DOI 10.1016/S0013-4694(97)96033-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Posner M.I., 1992, CURRENT DIRECTIONS P, V1, P11, DOI DOI 10.1111/1467-8721.EP10767759; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Raz N, 2000, HDB AGING COGNITION, P1; Reul JMHM, 2009, EPIGENETICS-US, V4, P434, DOI 10.4161/epi.4.7.9806; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; Scheibel Arnold B., 1996, P105; Scisco JL, 2008, INT J PSYCHOPHYSIOL, V69, P52, DOI 10.1016/j.ijpsycho.2008.02.009; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Smith JC, 2011, NEUROIMAGE, V54, P635, DOI 10.1016/j.neuroimage.2010.07.070; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; SPIRDUSO WW, 1975, J GERONTOL, V30, P435, DOI 10.1093/geronj/30.4.435; SPIRDUSO WW, 1978, J GERONTOL, V33, P26, DOI 10.1093/geronj/33.1.26; SPIRDUSO WW, 1980, J GERONTOL, V35, P850, DOI 10.1093/geronj/35.6.850; Squire LR, 1999, MEMORY MIND MOL, P235; Sullivan EV, 2002, CEREB CORTEX, V12, P438, DOI 10.1093/cercor/12.4.438; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Teague WE, 2002, CELL MOL BIOL LETT, V7, P262; Themanson JR, 2006, NEUROSCIENCE, V141, P757, DOI 10.1016/j.neuroscience.2006.04.004; Themanson JR, 2008, NEUROSCIENCE, V157, P319, DOI 10.1016/j.neuroscience.2008.09.014; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tonra JR, 1999, DIABETES, V48, P588, DOI 10.2337/diabetes.48.3.588; Trejo JL, 2001, J NEUROSCI, V21, P1628; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; Tsai SJ, 2010, PSYCHIAT INVEST, V7, P236, DOI 10.4306/pi.2010.7.4.236; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U; UZENDOSKI AM, 1990, J SPORT MED PHYS FIT, V30, P77; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vasuta C, 2007, HIPPOCAMPUS, V17, P1201, DOI 10.1002/hipo.20349; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WENDORF M, 1991, DIABETES, V40, P161, DOI 10.2337/diabetes.40.2.161; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; ZENOBI PD, 1993, DIABETOLOGIA, V36, P465, DOI 10.1007/BF00402285	200	247	259	3	122	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2013	3	1					403	428		10.1002/cphy.c110063			26	Physiology	Physiology	086AH	WOS:000314654900013	23720292	Green Accepted	Y	N	2021-06-18	
J	Dick, RW				Dick, R. W.			Is there a gender difference in concussion incidence and outcomes?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article; Proceedings Paper	3rd International Conference on Concussion in Sport	NOV, 2008	Zurich, SWITZERLAND				INJURY SURVEILLANCE SYSTEM; SEGMENT DYNAMIC STABILIZATION; ICE HOCKEY INJURIES; DESCRIPTIVE EPIDEMIOLOGY; HIGH-SCHOOL; BASKETBALL INJURIES; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; SOCCER INJURIES; UNITED-STATES	Objective: To determine if there is a gender difference in the incidence and outcomes of sport concussion. Design: Critical literature review of sport concussion by gender. Intervention: PubMed and major sports medicine journals were reviewed using the keywords concussion and gender. Articles included in this paper were English prospective surveillance that included concussion as an injury option conducted over the past 10 years, involved data collected by qualified medical personnel (athletic trainers/therapists or medical doctors) and used injury rates as opposed to raw counts. Only data from sports (soccer, basketball and ice hockey) where actions, equipment and most rules were similar between genders were reviewed. Results: For the PubMed search, using "concussion" and "gender" as keywords, there were 51 articles. Ten studies (four in football (soccer), four in basketball and two in ice hockey, including high school, college and professional athletes) were included in the incidence portion of the paper. Nine of the studies showed higher absolute injury rates for female concussion compared to their male counterparts with four of them reaching statistical significance. Five of the studies (two football (soccer), two basketball and one ice hockey) examined concussion mechanism and in all cases, males had a higher absolute percent of player contact concussions while females had a higher absolute percentage of surface or ball contact concussion episodes. Two brain injury and four sport concussion outcome papers were reviewed. Traumatic brain injury outcome was shown to be worse in females than in males for a majority of measured variables; females also are shown to have different baseline and post-concussion outcomes on neuropsychological testing. Conclusions: After evaluating multiple years of concussion data in comparable sports, the evidence indicates that female athletes may be at greater risk for concussion than their male counterparts. There also is some evidence that gender differences exist in outcomes of traumatic brain injury and concussions. Because concussion is a clinical diagnosis often depending on self reporting and with no established biological marker or consistent symptoms/definitions, and because there is evidence that females are more honest in reporting general injuries than males, it is unclear whether the concussion incidence data, while generally consistent in showing a higher risk in females as compared to males in similar sports, is a true difference or is influenced by a reporting bias.	Hlth & Safety Sports Consultants LLC, Carmel, IN 46033 USA	Dick, RW (corresponding author), Hlth & Safety Sports Consultants LLC, 4969 Huntington Dr, Carmel, IN 46033 USA.	rwd4969@yahoo.com					Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P194; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, NEUROSURG FOCUS, V8, pe8; FULLER CW, 2005, BR J SPORTS MED S1, V39, P3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Granito VJ., 2002, J SPORT BEHAV, V25, P243; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; National Federation of State High School Associations, PART HIGH SCH SPORTS; NCAA, NCAA SPORTS SPONS PA; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vertinsky Patricia, 1994, ETERNALLY WOUNDED WO, P1	32	247	247	2	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAY	2009	43			1			I46	I50		10.1136/bjsm.2009.058172			5	Sport Sciences	Sport Sciences	450YO	WOS:000266438100008	19433425				2021-06-18	
J	O'Connell, RG; Dockree, PM; Bellgrove, MA; Kelly, SP; Hester, R; Garavan, H; Robertson, IH; Foxe, JJ				O'Connell, Redmond G.; Dockree, Paul M.; Bellgrove, Mark A.; Kelly, Simon P.; Hester, Robert; Garavan, Hugh; Robertson, Ian H.; Foxe, John J.			The role of cingulate cortex in the detection of errors with and without awareness: a high-density electrical mapping study	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cortical arousal; ERP; error positivity; error processing; error-related negativity	TRAUMATIC BRAIN-INJURY; MEDIAL FRONTAL-CORTEX; FUNCTIONAL-SIGNIFICANCE; DECISION-MAKING; NEURAL SYSTEM; POTENTIALS; NEGATIVITY; COMPONENTS; MECHANISMS	Error-processing research has demonstrated that the brain uses a specialized neural network to detect errors during task performance but the brain regions necessary for conscious awareness of an error are poorly understood. In the present study we show that two well-known error-related event-related potential (ERP) components, the error-related negativity (ERN) and error positivity (Pe) have a differential relationship with awareness during performance of a manual response inhibition task optimized to examine error awareness. While the ERN was unaffected by the participants' conscious experience of errors, the Pe was only seen when participants were aware of committing an error. Source localization of these components indicated that the ERN was generated by a caudal region of the anterior cingulate cortex (ACC) while the Pe was associated with contributions from a more anterior ACC region and the posterior cingulate-precuneus. Tonic EEG measures of cortical arousal were correlated with individual rates of error awareness and showed a specific relationship with the amplitude of the Pe. The latter finding is consistent with evidence that the Pe represents a P3-like facilitation of information processing modulated by subcortical arousal systems. Our data suggest that the ACC might participate in both preconscious and conscious error detection and that cortical arousal provides a necessary setting condition for error awareness. These findings may be particularly important in the context of clinical studies in which a proper understanding of self-monitoring deficits requires an explicit measurement of error awareness.	Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland; Trinity Coll Dublin, Dept Psychol, Dublin 2, Ireland; St Vincents Hosp, Cognit Neurophysiol Lab, Dublin 3, Ireland; Univ Melbourne, Sch Behav Sci, Parkville, Vic 3052, Australia; Nathan S Kline Inst Psychiat Res, Cognit Neurophysiol Lab, Orangeburg, NY 10962 USA; CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA	O'Connell, RG (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland.	reoconne@tcd.ie	Hester, Robert/F-2097-2011; Bellgrove, Mark/AAB-3114-2019	Hester, Robert/0000-0003-0982-8026; Kelly, Simon/0000-0003-4981-3099; Kelly, Simon/0000-0001-9983-3595; Foxe, John/0000-0002-4300-3098; O'Connell, Redmond/0000-0001-6949-2793; Robertson, Ian H/0000-0001-8637-561X; Bellgrove, Mark/0000-0003-0186-8349	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH065350] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH65350] Funding Source: Medline		Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Brazdil M, 2005, J PSYCHOPHYSIOL, V19, P244, DOI 10.1027/0269-8803.19.4.244; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; DAMASSIO AR, 1991, FRONTAL LOBE FUNCTIO; Dawson M.E., 2000, HDB PSYCHOPHYSIOLOGY, V2nd; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Endrass T, 2005, J PSYCHOPHYSIOL, V19, P275, DOI 10.1027/0269-8803.19.4.275; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fiehler K, 2005, PSYCHOPHYSIOLOGY, V42, P72, DOI 10.1111/j.1469-8986.2005.00265.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; HOLROYD CB, 2004, COGNITIVE NEUROSCIEN; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Rabbitt P, 2002, Q J EXP PSYCHOL-A, V55, P1081, DOI 10.1080/02724980244000080; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; SWICK D, 1994, BRAIN RES BULL, V33, P79, DOI 10.1016/0361-9230(94)90051-5; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; Ullsperger M, 2006, BRAIN RES, V1105, P102, DOI 10.1016/j.brainres.2006.01.007; van Boxtel GJM, 2005, J PSYCHOPHYSIOL, V19, P1, DOI 10.1027/0269-8803.19.1.1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6	42	247	251	0	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2007	25	8					2571	2579		10.1111/j.1460-9568.2007.05477.x			9	Neurosciences	Neurosciences & Neurology	157SX	WOS:000245742300031	17445253				2021-06-18	
J	Duma, SM; Manoogian, SJ; Bussone, WR; Brolinson, PG; Goforth, MW; Donnenwerth, JJ; Greenwald, RM; Chu, JJ; Crisco, JJ				Duma, SM; Manoogian, SJ; Bussone, WR; Brolinson, PG; Goforth, MW; Donnenwerth, JJ; Greenwald, RM; Chu, JJ; Crisco, JJ			Analysis of real-time head accelerations in collegiate football players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						acceleration; helmet; football; concussion; head	PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS	Objective: To measure and analyze head accelerations during American collegiate football practices and games. sands of head impact events and providing contemporaneous head impact parameters that can be integrated with existing clinical evaluation techniques. Methods: A newly developed in-helmet 6-accelerometer system that transmits data via radio frequency to a sideline receiver and laptop computer system was implemented. From the data transfer of these accelerometer traces, the sideline staff has real-time data including the head acceleration, the head injury criteria value, the severity index value, and the impact location. Data are presented for instrumented players for the entire 2003 football season, including practices and games. Setting: American collegiate football. Subjects: Thirty-eight players from Virginia Tech's varsity football team. Main Outcome Measurements: Accelerations and pathomechanics of head impacts. Results: A total of 3312 impacts were recorded over 35 practices and 10 games for 38 players. The average peak head acceleration, Gadd Severity Index, and Head Injury Criteria were 32 g +/- 25 g, 36 g +/- 91 g, and 26 g +/- 64 g, respectively. One concussive event was observed with a peak acceleration of 81 g, a 267 Gadd Severity Index, and 200 Head Injury Criteria. Because the concussion was not reported until the day after of the event, a retrospective diagnosis based on his history and clinical evaluation suggested a mild concussion. Conclusions: The primary finding of this study is that the helmet-mounted accelerometer system proved effective at collecting thousands of head impact events and providing contemporaneous head impact parameters that can be integrated with existing clinical evaluation techniques.	Virginia Polytech Inst & State Univ, Wake Forest Ctr Injury Biomech, Blacksburg, VA 24061 USA; Edward Via Coll Osteopath Med, Blacksburg, VA USA; Virginia Polytech Inst & State Univ, Dept Sports Med, Blacksburg, VA 24061 USA; Simbex, Lebanon, NH USA; Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Orthopaed, Providence, RI 02912 USA	Duma, SM (corresponding author), Virginia Polytech Inst & State Univ, Wake Forest Ctr Injury Biomech, 114 Randolph Hall, Blacksburg, VA 24061 USA.	duma@vt.edu	Duma, Stefan/A-8368-2012	Manoogian, Sarah/0000-0001-9822-5619	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD040743] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD40743] Funding Source: Medline		CRISCO JJ, 2002, 4 WORLD C BIOM CAL A; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DIMASI FP, 1995, HS808 DOT; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HESS RL, 1981, HEAD NECK INJURY CRI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; King A.I., 2003, P INT RES C BIOM IMP; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Moon D W, 1971, Med Sci Sports, V3, P44; MORRISON WE, 1983, THESIS PENN STATE U; *NAT CTR INJ PREV, 2003, REP CONGR MILD TRAUM; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J. A., 1999, P INT RESEAR C BIOME, P17; NEWMAN JA, 2000, P INT RES C BIOM IMP, P223; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Reid S E, 1974, J Sports Med, V2, P86; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929	23	247	248	0	32	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2005	15	1					3	8		10.1097/00042752-200501000-00002			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	943CE	WOS:000230328600002	15654184				2021-06-18	
J	Roof, RL; Hoffmann, SW; Stein, DG				Roof, RL; Hoffmann, SW; Stein, DG			Progesterone protects against lipid peroxidation following traumatic brain injury in rats	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						8-isoPGF(2 alpha); free radicals; antioxidant; contusion; steroid; neuroprotection; blood-brain barrier; immunocytochemistry	NERVOUS-SYSTEM TRAUMA; EXPERIMENTAL HEAD-INJURY; EXCITATORY AMINO-ACIDS; 21-AMINOSTEROID U74006F; SUBARACHNOID HEMORRHAGE; NEUROCHEMICAL SEQUELAE; CORTICAL CONTUSION; BARRIER BREAKDOWN; ARACHIDONIC-ACID; METHYLPREDNISOLONE	The gonadal hormone, progesterone, has been shown to have neuroprotective effects in injured nervous system, including the severity of postinjury cerebral edema. Progesterone's attenuation of edema is accompanied by a sparing of neurons from secondary neuronal death and with improvements in cognitive outcome. In addition, we recently reported that postinjury blood-brain barrier (BBB) leakage, as measured by albumin immunostaining, was significantly lower in progesterone-treated than in nontreated rats, supporting a possible protective action of progesterone on the BBB. Because lipid membrane peroxidation is a major contributor to BBB breakdown, we hypothesized that progesterone Limits this free radical-induced damage. An antioxidant action, neuroprotective in itself, would also account for progesterone's effects on the BBB, edema, and cell survival after traumatic brain injury. To test progesterone's possible antiperoxidation ef-fect, we compared brain levels of 8-isoprostaglandin F-2 alpha, (8-isoPGF(2 alpha)), a marker of Lipid peroxidation, 24, 48, and 72 h after cortical contusion in male rats treated with either progesterone or the oil vehicle. The brains of progesterone-treated rats contained approximately one-third of the 8-isoPGF(2 alpha) found in oil-treated rats. These data suggest progesterone has antioxidant effects and support its potential as a treatment for brain injury.	TEXAS CHRISTIAN UNIV, NEUROSCI PROGRAM, FT WORTH, TX 76129 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHARMACOL TOXICOL, RICHMOND, VA 23298 USA; EMORY UNIV, DEPT NEUROL, ATLANTA, GA 30322 USA	Roof, RL (corresponding author), TEXAS CHRISTIAN UNIV, DEPT PSYCHOL, BOX 298920, FT WORTH, TX 76129 USA.		Stein, Donald/AAJ-5139-2020		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CR268836, R49/CR412307-02] Funding Source: Medline		AUDRUS KL, 1991, FREE RADICAL BIO MED, V11, P361; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; BELELLI D, 1989, EUR J PHARMACOL, V166, P325, DOI 10.1016/0014-2999(89)90077-0; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BRAUGHLER J M, 1989, Drugs of the Future, V14, P143; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; CHAN PH, 1985, BRAIN EDEMA, P317; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRYE CA, 1995, BRAIN RES, V696, P113, DOI 10.1016/0006-8993(95)00793-P; GEE KW, 1988, J PHARMACOL EXP THER, V246, P803; Goodman YD, 1996, J NEUROCHEM, V66, P1836; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL ED, 1993, RES P ARNMD, V71, P81; HALL ED, 1988, BRAIN RES, V451, P350, DOI 10.1016/0006-8993(88)90782-2; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Hoffman SW, 1996, J NEUROSCI METH, V68, P133; HOGSKILDE S, 1988, BRIT J ANAESTH, V61, P462, DOI 10.1093/bja/61.4.462; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1980, SCIENCE, V209, P1242, DOI 10.1126/science.7403881; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; OLSON JJ, 1988, BRAIN RES, V439, P259, DOI 10.1016/0006-8993(88)91482-5; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROOF RL, 1996, UNPUB J NEUROTRAUMA; SELIGMAN ML, 1979, PHOTOCHEM PHOTOBIOL, V29, P549, DOI 10.1111/j.1751-1097.1979.tb07089.x; Shimamura K, 1995, J REPROD FERTIL, V105, P253, DOI 10.1530/jrf.0.1050253; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Stein DG, 1996, COMP NEUR R, V9, P79; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; WALSH SW, 1994, HYPERTENS PREGNANCY, V13, P1, DOI 10.3109/10641959409084168; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WHITING KP, 1995, BIOCHEM SOC T, V23, pS438, DOI 10.1042/bst023438s; YONKERS PA, 1993, J NEUROTRAUMA, V10, pS92; ZUCCARELLO M, 1989, STROKE, V20, P367, DOI 10.1161/01.STR.20.3.367	56	247	253	1	19	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	MAY	1997	31	1					1	11		10.1007/BF02815156			11	Neurosciences; Pathology	Neurosciences & Neurology; Pathology	XN180	WOS:A1997XN18000001	9271001				2021-06-18	
J	STUSS, DT; ELY, P; HUGENHOLTZ, H; RICHARD, MT; LAROCHELLE, S; POIRIER, CA; BELL, I				STUSS, DT; ELY, P; HUGENHOLTZ, H; RICHARD, MT; LAROCHELLE, S; POIRIER, CA; BELL, I			SUBTLE NEUROPSYCHOLOGICAL DEFICITS IN PATIENTS WITH GOOD RECOVERY AFTER CLOSED HEAD-INJURY	NEUROSURGERY			English	Article									UNIV OTTAWA,DEPT PSYCHOL,OTTAWA K1H 8M5,ONTARIO,CANADA; OTTAWA GEN HOSP,OTTAWA K1H 8L6,ONTARIO,CANADA	STUSS, DT (corresponding author), UNIV OTTAWA,SCH MED,HUMAN NEUROSCI RES UNIT,451 SMYTH RD,OTTAWA K1H 8M5,ONTARIO,CANADA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; [Anonymous], 1944, ARMY INDIVIDUAL TEST; ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BARBEAU GJ, 1951, EPREUVE INDIVIDUELLE; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS N, 1984, CLOSED HEAD INJURY P, P44; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; DENCKER SJ, 1958, ACTA PSYCHIATR NEU S, V33; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; ESON ME, 1978, J NEUROL NEUROSUR PS, V41, P1036, DOI 10.1136/jnnp.41.11.1036; ESON ME, 1982, NEUROPSYCHOLOGY COGN, V2, P129; FLETCHER JM, 1978, CORTEX, V14, P564, DOI 10.1016/S0010-9452(78)80031-8; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FORDYCE WILBERT E., 1964, ARCH PHYS MED REHABIL, V45, P321; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P727, DOI 10.1001/archneurpsyc.1952.02320240002001; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GUTHKELCH AN, 1980, EUR NEUROL, V19, P91, DOI 10.1159/000115133; HAYS WL, 1963, STATISTICS PSYCHOL; HERSCOVITCH J, 1980, Journal of Clinical Neuropsychology, V2, P301, DOI 10.1080/01688638008403802; Holbourn AHS, 1943, LANCET, V2, P438; HUBERTY CJ, 1984, PSYCHOL BULL, V95, P156, DOI 10.1037/0033-2909.95.1.156; JANE JA, 1982, OUTCOME PATHOLOGY HE, P229; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1976, HEAD INJURIES, P45; Kaplan E, 1983, HOLISTIC DEV PSYCHOL, P143; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Miller E, 1970, Cortex, V6, P121; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B, 1964, FRONTAL GRANULAR COR, P313; MINDERHOUD JM, 1976, ACTA NEUROCHIR, V34, P23, DOI 10.1007/BF01405860; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1976, HEAD INJURIES, P49; OMMAYA AK, 1979, NEURAL TRAUMA, P371; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PONTIUS AA, 1972, ADOLESCENCE, V7, P289; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Spreen O, 1969, NEUROSENSORY CTR COM; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1982, J COMP PHYSIOL PSYCH, V96, P913, DOI 10.1037/0735-7036.96.6.913; STUSS DT, 1983, NEUROPSYCHOLOGIA, V21, P235, DOI 10.1016/0028-3932(83)90040-4; STUSS DT, 1982, COMA PHYSIOPATHOLOGY, P193; SYMONDS C, 1962, LANCET, V1, P1; Symonds CP, 1943, LANCET, V1, P7; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; 1957, ECHELLE INTELLIGENCE	70	247	248	0	13	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery		1985	17	1					41	47		10.1227/00006123-198507000-00007			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ALD34	WOS:A1985ALD3400007	4022286				2021-06-18	
J	Budde, MD; Janes, L; Gold, E; Turtzo, LC; Frank, JA				Budde, Matthew D.; Janes, Lindsay; Gold, Eric; Turtzo, Lisa Christine; Frank, Joseph A.			The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections	BRAIN			English	Article						anisotropy; traumatic brain injury; gliosis; axonal degeneration; diffusion tensor imaging	CONTROLLED CORTICAL IMPACT; WHITE-MATTER; REACTIVE ASTROCYTES; NERVOUS-SYSTEM; AXONAL INJURY; ORIENTATION DISTRIBUTIONS; COGNITIVE FUNCTION; WATER DIFFUSION; IMAGING DETECTS; WEIGHTED MRI	Diffusion tensor imaging is highly sensitive to the microstructural integrity of the brain and has uncovered significant abnormalities following traumatic brain injury not appreciated through other methods. It is hoped that this increased sensitivity will aid in the detection and prognostication in patients with traumatic injury. However, the pathological substrates of such changes are poorly understood. Specifically, decreases in fractional anisotropy derived from diffusion tensor imaging are consistent with axonal injury, myelin injury or both in white matter fibres. In contrast, in both humans and animal models, increases in fractional anisotropy have been suggested to reflect axonal regeneration and plasticity, but the direct histological evidence for such changes remains tenuous. We developed a method to quantify the anisotropy of stained histological sections using Fourier analysis, and applied the method to a rat controlled cortical impact model to identify the specific pathological features that give rise to the diffusion tensor imaging changes in subacute to chronic traumatic brain injury. A multiple linear regression was performed to relate the histological measurements to the measured diffusion tensor changes. The results show that anisotropy was significantly increased (P < 0.001) in the perilesioned cortex following injury. Cortical anisotropy was independently associated (standardized beta = 0.62, P = 0.04) with the coherent organization of reactive astrocytes (i.e. gliosis) and was not attributed to axons. By comparison, a decrease in white matter anisotropy (P < 0.001) was significantly related to demyelination (beta = 0.75, P = 0.0015) and to a lesser extent, axonal degeneration (beta = -0.48, P = 0.043). Gliosis within the lesioned cortex also influenced diffusion tensor tractography, highlighting the fact that spurious tracts in the injured brain may not necessarily reflect continuous axons and may instead depict glial scarring. The current study demonstrates a novel method to relate pathology to diffusion tensor imaging findings, elucidates the underlying mechanisms of anisotropy changes following traumatic brain injury and significantly impacts the clinical interpretation of diffusion tensor imaging findings in the injured brain.	[Budde, Matthew D.; Frank, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Budde, Matthew D.; Janes, Lindsay; Gold, Eric; Turtzo, Lisa Christine; Frank, Joseph A.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Budde, Matthew D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20892 USA	Budde, MD (corresponding author), C1890 Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdbudde@mcw.edu	Frank, Joseph/W-2021-2019		Centre for Neuroscience and Regenerative Medicine [300604-8.01-60855]; National Institutes of Health Clinical Centre; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	The work was supported by the Intramural Research Programme at the National Institutes of Health Clinical Centre and the Centre for Neuroscience and Regenerative Medicine (300604-8.01-60855 to J.A.F.).	Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armitage PA, 1998, MAGN RESON MATER PHY, V6, P28, DOI 10.1016/S1352-8661(98)00007-6; Armitage PA, 2000, MAGNET RESON MED, V44, P117, DOI 10.1002/1522-2594(200007)44:1<117::AID-MRM17>3.0.CO;2-D; Markus A, 2011, NEUROIMAGE, V54, P1091, DOI 10.1016/j.neuroimage.2010.08.075; Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BEAULIEU C, 1994, MAGNET RESON MED, V32, P579, DOI 10.1002/mrm.1910320506; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BITNER C, 1987, DEV BRAIN RES, V37, P167, DOI 10.1016/0165-3806(87)90238-0; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; DZIEDZICGOCLAWSKA A, 1982, HISTOCHEMISTRY, V74, P123, DOI 10.1007/BF00495058; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Gupta RK, 2010, NMR BIOMED, V23, P262, DOI 10.1002/nbm.1448; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Josso B, 2005, MECH SYST SIGNAL PR, V19, P1152, DOI 10.1016/j.ymssp.2004.07.005; Keiner S, 2008, GLIA, V56, P516, DOI 10.1002/glia.20632; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; PERNICK B, 1978, APPL OPTICS, V17, P21, DOI 10.1364/AO.17.000021; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Schwartz ED, 2005, J NEUROTRAUM, V22, P1388, DOI 10.1089/neu.2005.22.1388; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; VIDAL BD, 1980, ACTA HISTOCHEM, V66, P32, DOI 10.1016/S0065-1281(80)80079-1; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	67	246	249	3	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG	2011	134		8				2248	2260		10.1093/brain/awr161			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	809OX	WOS:000294067700012	21764818	Bronze, Green Published			2021-06-18	
J	Omalu, B; Bailes, J; Hamilton, RL; Kamboh, MI; Hammers, J; Case, M; Fitzsimmons, R				Omalu, Bennet; Bailes, Julian; Hamilton, Ronald L.; Kamboh, M. Ilyas; Hammers, Jennifer; Case, Mary; Fitzsimmons, Robert			Emerging Histomorphologic Phenotypes of Chronic Traumatic Encephalopathy in American Athletes	NEUROSURGERY			English	Article						American athletes; Chronic traumatic encephalopathy; Histologic subtyping	MILD COGNITIVE IMPAIRMENT; BRAIN-INJURY; HEAD-INJURY; FOOTBALL; POLYMORPHISM	BACKGROUND: We define chronic traumatic encephalopathy (CTE) as a progressive neurodegenerative syndrome caused by single, episodic, or repetitive blunt force impacts to the head and transfer of acceleration-deceleration forces to the brain. OBJECTIVE: We present emerging histomorphologic phenotypes of CTE that we identified in our cohort of CTE cases with apolipoprotein E genotyping and causes and manners of death. METHODS: Autopsy brain tissue of 14 professional athletes and 3 high school football players was examined after unexpected deaths. Histochemical and immunohistochemical tissue staining was performed with apolipoprotein E genotyping. RESULTS: Ten of 14 professional athletes (71%) were positive for CTE: 7 of 8 football players, 2 of 4 wrestlers, and 1 boxer. One of 3 high school players manifested incipient CTE. The age range of those with CTE was 18 to 52 years; they were all male athletes. In all cases of CTE, Alzheimer-type cerebral cortical atrophy was absent; negligible to mild neocortical neuronal dropout was present. The fundamental neuropathologic feature of CTE was the topographic distribution of sparse, moderate, and frequent band-shaped, flame-shaped, small and large globose neurofibrillary tangles and neuritic threads in the cerebral cortex, subcortical nuclei/basal ganglia, hippocampus, and brainstem nuclei. Sparse to frequent diffuse amyloid plaques may accompany tauopathy and was seen in only 2 CTE cases. No alpha-synucleinopathy was present. All 7 CTE-positive professional athletes with known apolipoprotein E genotypes had at least 1 E3 allele comprising 5 E3/E3 (71%) and 2 E3/E4 (29%). Alcohol-and drug-related deaths, suicides, and accidental deaths were overrepresented in our CTE cohort. CONCLUSION: The emerging histomorphologic features of our CTE cohort may specify histologic criteria for CTE diagnosis, may identify emerging histologic variants of CTE and may facilitate more objective surveillance and accurate identification of sentinel CTE cases.	[Omalu, Bennet] Univ Calif Davis, Davis, CA 95616 USA; [Omalu, Bennet; Bailes, Julian; Hamilton, Ronald L.; Kamboh, M. Ilyas; Hammers, Jennifer; Case, Mary; Fitzsimmons, Robert] W Virginia Univ, Brain Injury Res Inst, Morgantown, WV 26506 USA; [Hamilton, Ronald L.; Kamboh, M. Ilyas] Univ Pittsburgh, Pittsburgh, PA USA; [Hammers, Jennifer] NYU, New York, NY USA; [Case, Mary] St Louis Univ, St Louis, MO 63103 USA; [Fitzsimmons, Robert] Fitzsimmons Law Off, Wheeling, WV USA	Omalu, B (corresponding author), 1132 Junewood Court, Lodi, CA 95242 USA.	bennetomalu@comcast.net		Kamboh, M. Ilyas/0000-0002-3453-1438			Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Bancher C, 1997, ACTA NEUROPATHOL, V94, P403, DOI 10.1007/s004010050726; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Ellison DLS, 2004, NEUROPATHOLOGY REFER; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Greenfield JG, 2008, GREENFIELDS NEUROPAT; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Luck T, 2010, DEMENT GERIATR COGN, V29, P164, DOI 10.1159/000272424; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Omalu B, 2008, PLAY HARD DIE YOUNG; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Robbins S, 2010, STARS STRIPES   0123; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Yamada M, 2001, DEMENT GERIATR COGN, V12, P117, DOI 10.1159/000051245	24	246	246	6	67	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2011	69	1					173	183		10.1227/NEU.0b013e318212bc7b			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	773XK	WOS:000291344700059	21358359		Y	N	2021-06-18	
J	Sullivan, PG; Rippy, NA; Dorenbos, K; Concepcion, RC; Agarwal, AK; Rho, JM				Sullivan, PG; Rippy, NA; Dorenbos, K; Concepcion, RC; Agarwal, AK; Rho, JM			The ketogenic diet increases mitochondrial uncoupling protein levels and activity	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NEURONAL DEATH; CELL-DEATH; MICE; EPILEPSY; EFFICACY; OXYGEN; MODEL	Fatty acids are known to enhance mitochondrial uncoupling protein (UCP) activity. We asked whether a high-fat ketogenic diet (KD) increases UCP levels and activity in hippocampi of juvenile mice. Maximum mitochondrial respiration rates were significantly (p < 0.001) higher in KD- versus standard diet (SD)-treated animals, indicating increased UCP-mediated proton conductance that can reduce reactive oxygen species (ROS) production. Western blots showed significant (p < 0.05) or borderline significant increases in UCP2, UCP4, and UCP5 protein levels, and increased immunoreactivity to these three UCP isoforms was most prominently seen in the dentate gyrus of KD-fed mice. Finally, we found that oligomycin-induced ROS production was significantly (P < 0.05) lower in KD-fed mice than in SD controls. Collectively, oar data suggest that a KD may exert neuroprotective effects by diminishing ROS production through activation of mitochondrial UCPs.	Univ Calif Irvine, Med Ctr, Dept Pediat, Orange, CA 92868 USA; Univ Calif Irvine, Med Ctr, Dept Anat & Neurobiol, Orange, CA 92868 USA; Univ Calif Irvine, Med Ctr, Dept Neurol, Orange, CA 92868 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA	Rho, JM (corresponding author), Univ Calif Irvine, Med Ctr, Dept Pediat, ZC 4482,Bldg 2,3rd Floor,101 City Dr S, Orange, CA 92868 USA.	jmrho@uci.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001974, K02NS044846] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS 01974, K02 NS 044846] Funding Source: Medline		APPLETON DB, 1974, EPILEPSIA, V15, P211, DOI 10.1111/j.1528-1157.1974.tb04943.x; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; HORVATH LT, 2003, BIOCHEM PHARMACOL, P1917; Kim-Han JS, 2001, J NEUROCHEM, V79, P658, DOI 10.1046/j.1471-4159.2001.00604.x; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Pan JW, 1999, EPILEPSIA, V40, P703, DOI 10.1111/j.1528-1157.1999.tb00766.x; Rho JM, 1999, EPILEPSY RES, V37, P233, DOI 10.1016/S0920-1211(99)00068-6; Richard D, 1998, J COMP NEUROL, V397, P549; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Szot P, 2001, DEV BRAIN RES, V129, P211, DOI 10.1016/S0165-3806(01)00213-9; Todorova MT, 2000, EPILEPSIA, V41, P933, DOI 10.1111/j.1528-1157.2000.tb00275.x; Vining EPG, 1998, ARCH NEUROL-CHICAGO, V55, P1433, DOI 10.1001/archneur.55.11.1433; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x	20	246	251	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	APR	2004	55	4					576	580		10.1002/ana.20062			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	806ME	WOS:000220437200016	15048898				2021-06-18	
J	Michaels, AJ; Michaels, CE; Smith, JS; Moon, CH; Peterson, C; Long, WB				Michaels, AJ; Michaels, CE; Smith, JS; Moon, CH; Peterson, C; Long, WB			Outcome from injury: General health, work status, and satisfaction 12 months after trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	59th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 16-18, 1999	BOSTON, MASSACHUSETTS	Amer Assoc Surg Trauma			POSTTRAUMATIC-STRESS-DISORDER; SICKNESS IMPACT PROFILE; RECOVERY PROJECT; MAJOR TRAUMA; DEPRESSION; RETURN	Objective: We evaluated outcomes 12 months after trauma in terms of general health, satisfaction, and work status. Methods: Two hundred forty-seven patients without severe neurotrauma were evaluated by interview during admission and by mailed self-report 6 and 12 months after trauma. Data were obtained from the Trauma Registry, interviews, and survey instruments. Baseline assessment was obtained with the Short Form 36 (SF36) and the Sickness Impact Profile (SIP) work scale. Outcome measures were the SF36, SIP work scale, Brief Symptom Inventory (BSI) depression scale, the Civilian Mississippi Scale for Posttraumatic Stress Disorder (PTSD), and a satisfaction questionnaire. Three regressions were determined for outcome. The dependent variables were general health and work status (linear) and satisfaction (logistic), Each regression controlled for baseline status and mental health, Injury Severity Score (ISS), and 12-month SF36 physical function before evaluating the effect of outcome mental health. Results: Follow-up data were available for 75% of the patients at 6 months and 51% at 12 months. The mean age of patients was 37.2 +/- 0.9 years (+/-SEM), and 73% were male. Their average ISS was 13.9 +/- 0.6. Seventy percent of injuries were blunt force, 13.5% were penetrating, and 16.5% were burn injuries (mean total body surface area, 13.3 +/- 1.5%). Sixty-four percent of the patients had returned to work at 12 months. Follow-up SF36 mental health was associated with the dependent outcome in each regression. After controlling for baseline status and mental health, ISS, and outcome SF36 physical function, outcome mental health was associated with outcome SF36 general health (p < 0.001), SIP work, status (p = 0.017), and satisfaction with recovery (p = 0.005). Outcome SF36 mental health was related to baseline mental health, 12-month PTSD and BSI depression scores, and increased drug and alcohol use. Conclusions: Twelve months after trauma, patients' work status, general health, and overall satisfaction with recovery are dependent on outcome mental health. This dependency persists despite measured baseline status, ISS, or physical recovery, The mental disease after trauma is attributable to poor mental health, the development of symptoms of PTSD and depression, and increased substance abuse. Trauma centers that fail to recognize, assess, and treat these injury-related mental health outcomes are not fully assisting their patients to return to optimal function.	Legacy Emanuel Hosp, Trauma Serv, Portland, OR 97227 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	Michaels, AJ (corresponding author), Legacy Emanuel Hosp, Trauma Serv, 2801 Gantenbien Ave, Portland, OR 97227 USA.						*AM COLL SURG COMM, 1999, RES OPT CAR INJ PAT, P1; American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN; Baker SP, 1992, THE INJURY FACT BOOK; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; DEROGATIS LR, 1993, BSI BRIEF SYMPTOM IN; Fern KT, 1998, J TRAUMA, V45, P489, DOI 10.1097/00005373-199809000-00010; GLANCY KE, 1992, J TRAUMA, V33, P602, DOI 10.1097/00005373-199210000-00017; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; MACKENZIE EJ, 1993, J TRAUMA, V34, P528, DOI 10.1097/00005373-199304000-00009; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; MICHAELS AJ, 1998, SURG FORUM, V49, P534; MORRIS JA, 1991, J TRAUMA, V31, P827, DOI 10.1097/00005373-199106000-00014; PETERSEN M, 1995, J ORTHOP SPORT PHYS, V22, P238, DOI 10.2519/jospt.1995.22.6.238; Ponzer S, 1996, INJURY, V27, P549, DOI 10.1016/S0020-1383(96)00089-7; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; Saffle Jeffrey R., 1996, Journal of Burn Care and Rehabilitation, V17, P353, DOI 10.1097/00004630-199607000-00013; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; VREVEN DL, 1995, J TRAUMA STRESS, V8, P91, DOI 10.1007/BF02105409; Ware JE., 1993, SF 36 HLTH SURVEY MA; WIGGINS JS, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0093901; Wrigley Michael, 1995, Journal of Burn Care and Rehabilitation, V16, P445	30	246	248	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2000	48	5					841	848		10.1097/00005373-200005000-00007			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	314WH	WOS:000087080200013	10823527				2021-06-18	
J	PETTUS, EH; CHRISTMAN, CW; GIEBEL, ML; POVLISHOCK, JT				PETTUS, EH; CHRISTMAN, CW; GIEBEL, ML; POVLISHOCK, JT			TRAUMATICALLY INDUCED ALTERED MEMBRANE-PERMEABILITY - ITS RELATIONSHIP TO TRAUMATICALLY INDUCED REACTIVE AXONAL CHANGE	JOURNAL OF NEUROTRAUMA			English	Article							NONMISSILE HEAD-INJURY; CENTRAL NERVOUS-SYSTEM; BRAIN INJURY; CAT	Recent studies have suggested that severe forms of traumatic brain injury (TBI) can be associated with direct alterations of the axolemma. The present study evaluated whether injuries of mild to moderate severity are associated with comparable change. To this end, we used extracellular horseradish peroxidase (HRP) to determine if altered axolemmal permeability occurred following the traumatic event. Adult cats received intrathecal infusions of peroxidase and then were prepared for mild to moderate fluid percussion injury. At intervals ranging from 5 min to 3 h, animals were perfused with aldehydes and prepared for the histochemical visualization of the peroxidase, in addition to the immunocytochemical visualization of the neurofilament 68 kD subunit, a long recognized marker of reactive axonal change. The histochemically and immunocytochemically prepared tissue was examined at both the light and electron microscopic level. With mild TBI, the injured animals displayed a repertoire of neurofilament misalignment and axonal swelling consistent with that previously described in our laboratories, yet these changes were not associated with the passage of peroxidase from the extracellular to the intraaxonal compartment. With moderate injury, on the other hand, focal axolemmal permeability change to the extracellularly confined peroxidase was recognized. This peroxidase passage was associated with local mitochondrial abnormalities in addition to an increased packing of the neurofilaments. Over a 3 h course, these neurofilaments began to disassemble, showing a delayed progression of reactive axonal change. Collectively, the results of this investigation suggest that traumatically induced axonal injury involves complex subsets of pathobiology, one evoking rapid primary neurofilamentous change and misalignment, the other eliciting altered membrane permeability concomitant with rapid neurofilament compaction, leading to a delayed progression of reactive axonal change.	VIRGINIA COMMONWEALTH UNIV,DEPT ANAT,RICHMOND,VA 23298					NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS20193] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020193] Funding Source: NIH RePORTER		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; DAVIDSON AM, 1987, BIOCHEM J, V246, P715, DOI 10.1042/bj2460715; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; GREGORY TF, 1985, J NEUROSCI METH, V14, P5, DOI 10.1016/0165-0270(85)90110-4; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; STRICH SJ, 1970, J CLIN PATHOL S4, V23, P166; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; ZIMMERMAN UJP, 1984, PROG NEUROBIOL, V23, P63, DOI 10.1016/0301-0082(84)90012-1	25	246	251	0	5	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1994	11	5					507	522		10.1089/neu.1994.11.507			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	PR237	WOS:A1994PR23700005	7861444				2021-06-18	
J	Rosenfeld, JV; Maas, AI; Bragge, P; Morganti-Kossmann, MC; Manley, GT; Gruen, RL				Rosenfeld, Jeffrey V.; Maas, Andrew I.; Bragge, Peter; Morganti-Kossmann, M. Cristina; Manley, Geoffrey T.; Gruen, Russell L.			Early management of severe traumatic brain injury	LANCET			English	Article							EARLY DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; PROGNOSTIC MODELS; CYCLOSPORINE-A; OXYGEN; HYPOTHERMIA; ERYTHROPOIETIN; MULTICENTER; MORTALITY; OUTCOMES	Severe traumatic brain injury remains a major health-care problem worldwide. Although major progress has been made in understanding of the pathophysiology of this injury, this has not yet led to substantial improvements in outcome. In this report, we address present knowledge and its limitations, research innovations, and clinical implications. Improved outcomes for patients with severe traumatic brain injury could result from progress in pharmacological and other treatments, neural repair and regeneration, optimisation of surgical indications and techniques, and combination and individually targeted treatments. Expanded classification of traumatic brain injury and innovations in research design will underpin these advances. We are optimistic that further gains in outcome for patients with severe traumatic brain injury will be achieved in the next decade.	[Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3181, Australia; [Rosenfeld, Jeffrey V.; Bragge, Peter; Morganti-Kossmann, M. Cristina; Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3181, Australia; [Maas, Andrew I.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I.] Univ Antwerp, Edegem, Belgium; [Manley, Geoffrey T.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Rosenfeld, JV (corresponding author), Alfred Hosp, Dept Surg, Melbourne, Vic 3004, Australia.	j.rosenfeld@alfred.org.au	Maas, Andrew IR/C-5584-2013; Rosenfeld, Jeffrey V/B-7249-2011	Maas, Andrew IR/0000-0003-1612-1264; Bragge, Peter/0000-0003-0745-5131; Morganti-Kossmann, Cristina/0000-0002-0807-2063	National Health and Medical Research Council Practitioner FellowshipNational Health and Medical Research Council of Australia	We thank Ornella Clavisi for leading the searches and selection of studies; Marisa Chau, Emma Donoghue, Loyal Pattuwage and Loretta Piccenna for screening search outputs; Loyal Pattuwage for his assistance with referencing of appendix pp 3-7; and Sarah Aird for copy-editing of the manuscript. RLG is supported by a National Health and Medical Research Council Practitioner Fellowship.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; [Anonymous], 2012, NINDS COMM DAT EL TR; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2008, J NEUROSURG, V109, P421, DOI 10.3171/JNS/2008/109/9/0421; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; CLIFTON GL, 2011, OPTN SRTR ANN REP, V10, P131, DOI DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Czeiter E, 2011, ACTA NEUROCHIR, V153, P1882; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; De Deyne CS, 2010, CURR OPIN ANESTHESIO, V23, P258, DOI 10.1097/ACO.0b013e328336ea44; Diaz-Arrastia R, 2012, BRAIN TISSUE OXYGEN; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Edwards P, 2005, LANCET, V365, P1957; Farin A, 2009, NEUROSURGERY, V65, P831, DOI 10.1227/01.NEU.0000351721.81175.0B; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; HARTINGS JA, 2011, OPTN SRTR ANN REP, V10, P1058, DOI DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hutchinson PJ, 2011, RESCUEICP STUDY RAND; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kaitin KI, 2011, SCI AM, V305, P16, DOI 10.1038/scientificamerican0811-16; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lesko M, 2010, EMERG MED J, V27, pA2; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu J, 2005, ACT NEUR S, V95, P281; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Mendelow D, 2012, STITCH TRAUMA TRIAL; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Romero CM, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walker PA, 2011, THERAPY, V8, P507; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061	112	245	262	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2012	380	9847					1088	1098		10.1016/S0140-6736(12)60864-2			11	Medicine, General & Internal	General & Internal Medicine	007VL	WOS:000308916400030	22998718		Y	N	2021-06-18	
J	Agha, A; Rogers, B; Sherlock, M; O'Kelly, P; Tormey, W; Phillips, J; Thompson, CJ				Agha, A; Rogers, B; Sherlock, M; O'Kelly, P; Tormey, W; Phillips, J; Thompson, CJ			Anterior pituitary dysfunction in survivors of traumatic brain injury	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; GROWTH-HORMONE DEFICIENCY; NEUROENDOCRINE DYSFUNCTION; SUBCUTANEOUS GLUCAGON; CORTISOL SECRETION; STIMULATION TEST; ADULT PATIENTS; GH DEFICIENCY; PLUS ARGININE; ADRENAL AXIS	Recent data suggest that anterior pituitary dysfunction after traumatic brain injury (TBI) is common. We sought to confirm the results of earlier studies in a larger cohort of patients with dynamic testing of pituitary function. We studied 102 consecutive TBI survivors ( 85 males; median age 28, range 15-65 yr) who had survived severe or moderate TBI ( initial Glasgow Coma Scale score 3-13) at a median of 17 months (range 6-36) post event. GH and ACTH reserves were initially assessed using the glucagon stimulation test (GST). Normative data on GH and cortisol responses to the GST were obtained from 31 matched healthy controls. Patients with subnormal GH or cortisol responses were further evaluated, using the insulin tolerance test (ITT) or arginine + GHRH test for GH assessment and the ITT or 250-mug short synacthen test for the assessment of ACTH reserve. Patients were considered to be GH or ACTH deficient if they failed both the GST and the second provocative test. Baseline thyroid function, prolactin, IGF-I, gonadotropins, testosterone, or estradiol was performed in all patients and compared with local reference ranges. In controls, normal response to the GST was a stimulated GH peak of greater than 5 mug/liter and cortisol peak greater than 450 nmol/liter (16 mug/dl). Eighteen TBI patients (17.6%) had GH response to the GST less than 5 mug/liter, 11 of whom also failed the ITT or the arginine + GHRH tests. GH-deficient patients had significantly higher body mass index (P = 0.003), and lower IGF-I concentrations (P < 0.001), than GH-sufficient patients. Twenty-three patients (22.5%) had cortisol responses to GST less than 450 nmol/liter, 13 of whom also failed the ITT or short synacthen test. GH or ACTH deficiencies were not related to age, Glasgow Coma Scale score, or the presence of other pituitary hormone abnormalities (P > 0.05). Twelve patients (11.8%) had gonadotropin and one (1%) had thyrotrophin deficiencies. Twelve patients (11.8%) had hyperprolactinemia. Twenty-nine patients (28.4%) had at least one anterior pituitary hormone deficiency. This is the largest study, to date, of hypopituitarism after TBI and confirms a high prevalence of undiagnosed anterior pituitary hormone abnormalities in survivors of TBI. Hypopituitarism is a treatable cause of morbidity after TBI. In addition to conventional pituitary hormone replacement, the potential of GH treatment to enhance recovery needs to be examined in a prospective study.	Beaumont Hosp, Acad Dept Endocrinol, Dublin 9, Ireland; Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; Beaumont Hosp, Dept Clin Chem, Dublin 9, Ireland	Thompson, CJ (corresponding author), Beaumont Hosp, Dept Endocrinol, Beaumont Rd, Dublin 9, Ireland.	chris.thompson@beaumont.ie					Agha A, 2004, CLIN ENDOCRINOL, V60, P688, DOI 10.1111/j.1365-2265.2004.02035.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173; ASA S, 2002, PITUITARY, P4; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BESSER GM, 1976, BRIT MED J, V1, P448, DOI 10.1136/bmj.1.6007.448; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; BINNERTS A, 1992, AM J CLIN NUTR, V55, P918; BJORK S, 1989, ACTA PAEDIATR SCAND, P55; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; CAIN JP, 1972, CAN MED ASSOC J, V107, P617; Clayton RN, 1996, CLIN ENDOCRINOL, V44, P147, DOI 10.1046/j.1365-2265.1996.666478.x; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695; Cyran E, 1918, DEUT MED WOCHENSCHR, V44, P1261; Davies MJ, 1996, J ROY SOC MED, V89, pP159; DOWARD LC, 1995, QUAL LIFE RES, V4, P420; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; FISH HR, 1986, METABOLISM, V35, P763, DOI 10.1016/0026-0495(86)90245-3; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Inder WJ, 2002, J CLIN ENDOCR METAB, V87, P2745, DOI 10.1210/jc.87.6.2745; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KLASBEEK WD, 1980, J NEUROSURG, V53, P519; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; LITTLEY MD, 1989, CLIN ENDOCRINOL, V31, P527, DOI 10.1111/j.1365-2265.1989.tb01276.x; LITTLEY MD, 1989, Q J MED, V70, P145; Maccario M, 1999, J ENDOCRINOL INVEST, V22, P424, DOI 10.1007/BF03343585; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jc.77.6.1658; Molitch ME, 2002, J CLIN ENDOCR METAB, V87, P473, DOI 10.1210/jc.87.2.473; MONSON JP, 2003, EUR J ENDOCRINOL S2, V148, P9; Mukherjee JJ, 1997, CLIN ENDOCRINOL, V47, P51, DOI 10.1046/j.1365-2265.1997.2151035.x; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; PAVORD SR, 1992, CLIN ENDOCRINOL, V36, P135, DOI 10.1111/j.1365-2265.1992.tb00947.x; Pfeifer M, 2001, CLIN ENDOCRINOL, V54, P17, DOI 10.1046/j.1365-2265.2001.01179.x; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Soule SG, 1996, CLIN ENDOCRINOL, V44, P137, DOI 10.1046/j.1365-2265.1996.540363.x; SPATHIS GS, 1974, CLIN ENDOCRINOL, V3, P175, DOI 10.1111/j.1365-2265.1974.tb01793.x; STEWART PM, 1988, LANCET, V1, P1208; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; TRAINER PJ, 1995, BARTS ENDOCRINE PROT, P6; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; World Health Organization, 1980, INT CLASS IMP DIS HA	57	245	251	1	8	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	OCT	2004	89	10					4929	4936		10.1210/jc.2004-0511			8	Endocrinology & Metabolism	Endocrinology & Metabolism	860EW	WOS:000224326300024	15472187	Bronze			2021-06-18	
J	Yun, SP; Kam, TI; Panicker, N; Kim, S; Oh, Y; Park, JS; Kwon, SH; Park, YJ; Karuppagounder, SS; Park, H; Kim, S; Oh, N; Kim, NA; Lee, S; Brahmachari, S; Mao, XB; Lee, JH; Kumar, M; An, D; Kang, SU; Lee, Y; Lee, KC; Na, DH; Kim, D; Lee, SH; Roschke, VV; Liddelow, SA; Mari, Z; Barres, B; Dawson, VL; Lee, S; Dawson, TM; Ko, HS				Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Oh, Yumin; Park, Jong-Sung; Kwon, Seung-Hwan; Park, Yong Joo; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Lee, Jun Hee; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Lee, Yunjong; Lee, Kang Choon; Na, Dong Hee; Kim, Donghoon; Lee, Sang Hun; Roschke, Viktor V.; Liddelow, Shane A.; Mari, Zoltan; Barres, Ben A.; Dawson, Valina L.; Lee, Seulki; Dawson, Ted M.; Ko, Han Seok			Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease	NATURE MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; RECEPTOR AGONIST; DOPAMINERGIC-NEURONS; MOUSE MODEL; EXENDIN-4; ACTIVATION; GLP-1; EXPRESSION	Activation of microglia by classical inflammatory mediators can convert astrocytes into a neurotoxic A1 phenotype in a variety of neurological diseases(1,2). Development of agents that could inhibit the formation of A1 reactive astrocytes could be used to treat these diseases for which there are no disease-modifying therapies. Glucagon-like peptide-1 receptor (GLP1R) agonists have been indicated as potential neuroprotective agents for neurologic disorders such as Alzheimer's disease and Parkinson's disease(3-13). The mechanisms by which GLP1R agonists are neuroprotective are not known. Here we show that a potent, brain-penetrant long-acting GLP1R agonist, NLY01, protects against the loss of dopaminergic neurons and behavioral deficits in the a alpha-synuclein preformed fibril (alpha-syn PFF) mouse model of sporadic Parkinson's disease(14,15). NLY01 also prolongs the life and reduces the behavioral deficits and neuropathological abnormalities in the human A53T alpha-synuclein (hA53T) transgenic mouse model of alpha-synucle-inopathy-induced neurodegeneration(16). We found that NLY01 is a potent GLP1R agonist with favorable properties that is neuroprotective through the direct prevention of microglial-mediated conversion of astrocytes to an A1 neurotoxic phenotype. In light of its favorable properties, NLY01 should be evaluated in the treatment of Parkinson's disease and related neurologic disorders characterized by microglial activation.	[Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Kwon, Seung-Hwan; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21218 USA; [Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Kwon, Seung-Hwan; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Kim, Donghoon; Mari, Zoltan; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Yun, Seung Pil; Karuppagounder, Senthilkumar S.; Brahmachari, Saurav; Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Oh, Yumin; Park, Jong-Sung; Park, Yong Joo; Lee, Seulki] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Oh, Yumin; Park, Jong-Sung; Park, Yong Joo; Lee, Seulki] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Lee, Jun Hee] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham Sch Med, Birmingham, AL USA; [Lee, Yunjong] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol & Cell Biol,Div Pharmacol, Suwon, South Korea; [Lee, Kang Choon] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea; [Na, Dong Hee] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Kim, Donghoon; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Lee, Sang Hun] Soonchunhyang Univ, Seoul Hosp, Soonchunhyang Med Sci Res Inst, Seoul, South Korea; [Roschke, Viktor V.] Neuraly Inc, Baltimore, MD USA; [Liddelow, Shane A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Dawson, Ted M.; Ko, Han Seok] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA	Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21218 USA.; Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA.; Dawson, TM; Ko, HS (corresponding author), Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA.; Lee, S (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.; Lee, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Nanomed, Wilmer Eye Inst, Baltimore, MD 21218 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Dawson, TM; Ko, HS (corresponding author), Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA.	slee343@jhmi.edu; tdawson@jhmi.edu; hko3@jhmi.edu	Karuppagounder, Senthilkumar/I-6752-2013; lee, sang hun/Q-4650-2019; Mao, Xiaobo/A-7362-2010; Dawson, Valina/Y-9757-2019; Liddelow, Shane/ABE-6456-2020; Panicker, Nikhil/A-2770-2019; Mari, Zoltan/ABC-4879-2020	Karuppagounder, Senthilkumar/0000-0002-3281-9913; lee, sang hun/0000-0002-9005-5966; Mao, Xiaobo/0000-0001-6587-556X; Liddelow, Shane/0000-0002-0840-1437; Panicker, Nikhil/0000-0003-1752-4284; Kim, Sangjune/0000-0003-3052-3163; Na, Dong Hee/0000-0001-9313-0127; An, Daniel/0000-0001-5036-0985; Kam, Tae-In/0000-0002-7241-4902	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38377, NS082205, NS098006]; Maryland Stem Cell Research Foundation [2012-MSCRFE-0059]; JPB Foundation; NIH/National Institute on Aging grant [1K01AG056841-01]; American Parkinson Disease Association (APDA); National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2016R1D1A1B03934847]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098006, R01NS082205, P50NS038377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG056841] Funding Source: NIH RePORTER	All relevant ethical regulations were followed. This work was supported by grants from the NIH/NINDS NS38377 (H.S.K., V.L.D. and T.M.D.), NIH/NINDS NS082205 and NS098006 (H.S.K.), Maryland Stem Cell Research Foundation 2012-MSCRFE-0059 (H.S.K.), the JPB Foundation (T.M.D.), NIH/National Institute on Aging grant 1K01AG056841-01(X.M.), the American Parkinson Disease Association (APDA) Research Grant Awards (X.M.) and the National Research Foundation of Korea NRF-2016R1D1A1B03934847 (D.H.N.). We acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through their direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs M-1 (T.M.D. and V.L.D.), M-2 (T.M.D. and V.L.D.), H-2014 (T.M.D.), M-2014 (H.S.K., T.M.D. and V.L.D.), H-1 (H.S.K.), H-2013 (H.S.K.). T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. We thank Neuraly Inc. for providing NLY01.	Allen Reish HE, 2015, J PARKINSON DIS, V5, P1, DOI DOI 10.3233/JPD-140491; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Brahmachari S, 2016, J CLIN INVEST, V126, P2970, DOI 10.1172/JCI85456; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Chen S, 2014, NEUROSCIENCE, V256, P137, DOI 10.1016/j.neuroscience.2013.10.038; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Goncalves A, 2016, INVEST OPHTH VIS SCI, V57, P2584, DOI 10.1167/iovs.15-19006; Gray MT, 2015, J CEREBR BLOOD F MET, V35, P747, DOI 10.1038/jcbfm.2015.32; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Harms AS, 2018, EXP NEUROL, V300, P179, DOI 10.1016/j.expneurol.2017.11.010; Ji CH, 2016, BRAIN RES, V1634, P1, DOI 10.1016/j.brainres.2015.09.035; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kim C, 2016, EXP NEUROBIOL, V25, P113, DOI 10.5607/en.2016.25.3.113; Kim S, 2018, P NATL ACAD SCI USA, V115, P798, DOI 10.1073/pnas.1700465115; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Kim TH, 2012, BIOCONJUGATE CHEM, V23, P2214, DOI 10.1021/bc300265n; Kim TH, 2011, BIOCONJUGATE CHEM, V22, P625, DOI 10.1021/bc100404x; Lee CH, 2018, MOL NEUROBIOL, V55, P3007, DOI 10.1007/s12035-017-0550-2; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Ventorp F, 2017, J PARKINSON DIS, V7, P263, DOI 10.3233/JPD-171068; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wu HY, 2018, J NEUROIMMUNOL, V316, P17, DOI 10.1016/j.jneuroim.2017.12.005; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	44	244	253	21	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					931	+		10.1038/s41591-018-0051-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	WOS:000438187700020	29892066	Green Accepted	Y	N	2021-06-18	
J	Eierud, C; Craddock, RC; Fletcher, S; Aulakh, M; King-Casas, B; Kuehl, D; LaConte, SM				Eierud, Cyrus; Craddock, R. Cameron; Fletcher, Sean; Aulakh, Manek; King-Casas, Brooks; Kuehl, Damon; LaConte, Stephen M.			Neuroimaging after mild traumatic brain injury: Review and meta-analysis	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; DTI; fMRI; Meta-analysis; Neuropsychological assessments; Post concussion syndrome	DIFFUSE AXONAL INJURY; COLLEGIATE FOOTBALL PLAYERS; POST-CONCUSSION SYNDROME; CLOSED-HEAD-INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; FUNCTIONAL MRI; COST-EFFECTIVENESS; NCAA CONCUSSION; CT	This paper broadly reviews the study of mild traumatic brain injury (mTBI), across the spectrum of neuroimaging modalities. Among the range of imaging methods, however, magnetic resonance imaging (MRI) is unique in its applicability to studying both structure and function. Thus we additionally performed meta-analyses of MRI results to examine 1) the issue of anatomical variability and consistency for functional MRI (fMRI) findings, 2) the analogous issue of anatomical consistency for white-matter findings, and 3) the importance of accounting for the time post injury in diffusion weighted imaging reports. As we discuss, the human neuroimaging literature consists of both small and large studies spanning acute to chronic time points that have examined both structural and functional changes with mTBI, using virtually every available medical imaging modality. Two key common-alities have been used across the majority of imaging studies. The first is the comparison between mTBI and control populations. The second is the attempt to link imaging results with neuropsychological assessments. Our fMRI meta-analysis demonstrates a frontal vulnerability to mTBI, demonstrated by decreased signal in prefrontal cortex compared to controls. This vulnerability is further highlighted by examining the frequency of reported mTBI white matter anisotropy, in which we show a strong anterior-to-posterior gradient (with anterior regions being more frequently reported in mTBI). Our final DTI meta-analysis examines a debated topic arising from inconsistent anisotropy findings across studies. Our results support the hypothesis that acute mTBI is associated with elevated anisotropy values and chronic mTBI complaints are correlated with depressed anisotropy. Thus, this review and set of meta-analyses demonstrate several important points about the ongoing use of neuroimaging to understand the functional and structural changes that occur throughout the time course of mTBI recovery. Based on the complexity of mTBI, however, much more work in this area is required to characterize injury mechanisms and recovery factors and to achieve clinically-relevant capabilities for diagnosis. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.	[Eierud, Cyrus; King-Casas, Brooks; LaConte, Stephen M.] Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA; [Eierud, Cyrus; LaConte, Stephen M.] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA; [Craddock, R. Cameron] Child Mind Inst, New York, NY USA; [Craddock, R. Cameron] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Fletcher, Sean; Aulakh, Manek] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [King-Casas, Brooks] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Kuehl, Damon; LaConte, Stephen M.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [LaConte, Stephen M.] Virginia Tech, Caril Sch Med, Dept Emergency Med, Roanoke, VA USA; [LaConte, Stephen M.] Virginia Tech, Caril Sch Med, Dept Emergency Radiol, Roanoke, VA USA	LaConte, SM (corresponding author), Virginia Tech, Caril Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	slaconte@vtc.vt.edu	Craddock, Cameron/P-1980-2014	Craddock, Cameron/0000-0002-4950-1303; Eierud, Cyrus/0000-0002-9942-676X; Kuehl, Damon/0000-0001-9052-8412	DoD W81XWH-08-2-0144	We thank Dr. Anders Eklund for comments on the manuscript and data analysis. This work was supported by DoD W81XWH-08-2-0144.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dikmen S, 1992, Brain Inj, V6, P477, DOI 10.3109/02699059209008143; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Ellmore TM, 2013, J INT NEUROPSYCH SOC, V19, P723, DOI 10.1017/S1355617713000325; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Huynh T, 2006, AM SURGEON, V72, P1162; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	95	244	247	1	33	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2014	4						283	294		10.1016/j.nicl.2013.12.009			12	Neuroimaging	Neurosciences & Neurology	CB5LD	WOS:000349667600030	25061565	DOAJ Gold, Green Published	Y	N	2021-06-18	
J	Geeraerts, T; Launey, Y; Martin, L; Pottecher, J; Vigue, B; Duranteau, J; Benhamou, D				Geeraerts, Thomas; Launey, Yoann; Martin, Laurent; Pottecher, Julien; Vigue, Bernard; Duranteau, Jacques; Benhamou, Dan			Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury	INTENSIVE CARE MEDICINE			English	Article						Ocular ultrasound; Traumatic brain injury; Elevated intracranial pressure; Optic nerve sheath	SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER; ULTRASOUND; MANAGEMENT; HYPERTENSION; DIAGNOSIS; DIAMETER; EYE	Objective: To assess at admission to the ICU the relationship between optic nerve sheath diameter (ONSD) and intracranial pressure (ICP) and to investigate whether increased ONSD at patient admission is associated with raised ICP in the first 48 h after trauma. Design and setting: Prospective, blind, observational study in a surgical critical care unit, level 1 trauma center. Patients and participants: 31 adult patients with severe traumatic brain injury (TBI; Glasgow coma scale = 8) requiring sedation and ICP monitoring, and 31 control patients without brain injury requiring sedation. Measurements and results: ONSD was measured with a 7.5-MHz linear ultrasound probe. Two TBI groups were defined on the basis of ICP profile. If ICP exceeded 20 mmHg for more than 30 min in the first 48 h ( before any specific treatment), patients were considered to have high ICP; if not, they had normal ICP. The largest ONSD value (the highest value for the right and left eye) was significantly higher in high ICP patients (6.3 +/- 0.6 vs. 5.1 +/- 0.7mm in normal ICP patients and 4.9 +/- 0.3 mm in control patients). There was a significant relationship between the largest ONSD and ICP at admission (r = 0.68). The largest ONSD was a suitable predictor of high ICP (area under ROC curve 0.96). When ONSD was under 5.7 mm, the sensitivity and negative predictive values for high ICP were 100%. Conclusions: In the early posttraumatic period, ocular ultrasound scans may be useful for detecting high ICP after severe TBI.	Univ Paris Sud, Fac Med, Hop Bicetre, AP HP,Dept Anesthesiol & Crit Care Med, F-94275 Le Kremlin Bicetre, France	Geeraerts, T (corresponding author), Univ Paris Sud, Fac Med, Hop Bicetre, AP HP,Dept Anesthesiol & Crit Care Med, F-94275 Le Kremlin Bicetre, France.	thomas.geeraerts@bct.aphp.fr	Launey, Yoann/AAN-7176-2020; Pottecher, Julien/AAH-1572-2020	Launey, Yoann/0000-0001-9105-8862; Pottecher, Julien/0000-0001-6073-4354			AASLID R, 1986, NEURORADIOLOGY, V28, P11, DOI 10.1007/BF00341759; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Barnett SB, 2000, ULTRASOUND MED BIOL, V26, P355, DOI 10.1016/S0301-5629(00)00204-0; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Blaivas M, 2002, ACAD EMERG MED, V9, P791, DOI 10.1197/aemj.9.8.791; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; HASSLER W, 1988, J NEUROSURG, V68, P745; HAYREH SS, 1968, DOC OPHTHALMOL, V24, P289, DOI 10.1007/BF02550944; Helmke K, 2000, TRANSPLANTATION, V70, P392, DOI 10.1097/00007890-200007270-00029; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; HOLT GR, 1983, OTOLARYNG HEAD NECK, V91, P276, DOI 10.1177/019459988309100313; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kirkpatrick PJ, 1997, HEAD INJURY; LICHTENSTIEN D, 1992, LECHOGRAPHIE GENERAL; LIU D, 1993, AM J OPHTHALMOL, V116, P548, DOI 10.1016/S0002-9394(14)73195-2; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; The Brain Trauma Foundation The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P497; Villain MA, 2003, J FR OPHTALMOL, V26, P191; Williamson TH, 1996, SURV OPHTHALMOL, V40, P255, DOI 10.1016/S0039-6257(96)82001-7	33	244	252	1	17	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	OCT	2007	33	10					1704	1711		10.1007/s00134-007-0797-6			8	Critical Care Medicine	General & Internal Medicine	213EN	WOS:000249649100007	17668184				2021-06-18	
J	DeLuca, J; Chelune, GJ; Tulsky, DS; Lengenfelder, J; Chiaravalloti, ND				DeLuca, J; Chelune, GJ; Tulsky, DS; Lengenfelder, J; Chiaravalloti, ND			Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	31st Annual Meeting of the International-Neuropsychological-Society	FEB 05-08, 2003	HONOLULU, HI	Int Neuropsychol Soc			TRAUMATIC BRAIN-INJURY; DYSFUNCTION; IMPAIRMENTS; PERFORMANCE; INTELLIGENCE; ACQUISITION; ABILITY; SCORES; INDEX	Objective: To examine whether processing speed or working memory is the primary information processing deficit in persons with MS. Design: Case-control study. Setting: Hospital-based specialty clinic. Participants: 215 adults with clinically definite MS. Main Outcome Measure: Mean demographically corrected T-scores, prevalence rates of impairment and relative risk of impaired Processing Speed and Working Memory Index Scores from the WAIS-WMS III. Results: Deficits in Processing Speed were much more common than Working Memory in all comparisons. This was observed for both relapsing remitting (RRMS) and secondary progressive MS (SPMS) subjects, but accentuated in the latter group. Conclusions: Results strongly suggest that the primary information processing deficit in persons with MS is in speed of processing.	Kessler Med Rehabil Res & Educ Corp, Neurosci Res, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44195 USA	DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Corp, Neurosci Res, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org		Tulsky, David/0000-0002-4335-4509	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD038249, T32HD007522] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD 07522, R01 HD 38249] Funding Source: Medline		Archibald CJ, 2000, J CLIN EXP NEUROPSYC, V22, P686, DOI 10.1076/1380-3395(200010)22:5;1-9;FT686; BADDELEY AD, 2000, OXFORD HDB MEMORY; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; BRYANT DS, 2003, J INT NEUROPSYCH SOC, V9, P229; CHELUNE GJ, 2002, J INT NEUROPSYCH SOC, V8, P185; Crowe SF, 2000, ASSESSMENT, V7, P113, DOI 10.1177/107319110000700202; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Demaree HA, 2000, J CLIN EXP NEUROPSYC, V22, P865, DOI 10.1076/jcen.22.6.865.961; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; DEsposito M, 1996, NEUROPSYCHOLOGY, V10, P51, DOI 10.1037/0894-4105.10.1.51; Diamond BJ, 1997, J CLIN EXP NEUROPSYC, V19, P34, DOI 10.1080/01688639708403834; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Foong J, 1999, J NEUROPSYCH CLIN N, V11, P45, DOI 10.1176/jnp.11.1.45; Gaudino EA, 2001, NEUROPSY NEUROPSY BE, V14, P32; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton R. K., 2003, CLIN INTERPRETATION, P181, DOI [DOI 10.1016/B978-012703570-3/50010-9, 10.1016/B978-012703570-3/50010-9]; Herndon R. M., 2003, MULTIPLE SCLEROSIS I; Ivnik RJ, 2001, CLIN NEUROPSYCHOL, V15, P114, DOI 10.1076/clin.15.1.114.1904; Kail R, 1997, AGING NEUROPSYCHOL C, V4, P157, DOI 10.1080/13825589708256644; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kail R, 1998, J CLIN EXP NEUROPSYC, V20, P98, DOI 10.1076/jcen.20.1.98.1483; KALMAR JH, IN PRESS REHABILITAT; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; KUJALA P, 1995, J NEUROL NEUROSUR PS, V59, P77, DOI 10.1136/jnnp.59.1.77; Lengenfelder J, 2003, COGN BEHAV NEUROL, V16, P28, DOI 10.1097/00146965-200303000-00004; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P281, DOI 10.1001/archneur.1988.00520270059021; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P607, DOI 10.1001/archneur.1988.00520300025012; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; Miller DM, 2000, ARCH NEUROL-CHICAGO, V57, P1319, DOI 10.1001/archneur.57.9.1319; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; Rao S.M., 1993, NEUROPSYCHOLOGY, V7, P364, DOI [10.1037/0894-4105.7.3.364, DOI 10.1037/0894-4105.7.3.364]; Rao S. M., 1990, NEUROBEHAVIORAL ASPE; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RUCHKIN DS, 1994, BRAIN, V117, P289, DOI 10.1093/brain/117.2.289; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Smith GE, 2002, NEUROPSYCHOLOGY, V16, P432, DOI 10.1037//0894-4105.16.3.432; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Thornton AE, 1997, NEUROPSYCHOLOGY, V11, P357, DOI 10.1037/0894-4105.11.3.357; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; WAIS-III-WMS-III-WIAT-II Writer (Version 1.0), 2002, WAIS 3 WMS 3 WIAT 2; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Winer BJ., 1971, STAT PRINCIPLES EXPT; Wishart H, 1997, J CLIN EXP NEUROPSYC, V19, P810, DOI 10.1080/01688639708403762	51	244	245	0	13	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2004	26	4					550	562		10.1080/13803390490496641			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	859GR	WOS:000224251900009	15512942				2021-06-18	
J	Lynch, JR; Tang, W; Wang, HC; Vitek, MP; Bennett, ER; Sullivan, PM; Warner, DS; Laskowitz, DT				Lynch, JR; Tang, W; Wang, HC; Vitek, MP; Bennett, ER; Sullivan, PM; Warner, DS; Laskowitz, DT			APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; APOLIPOPROTEIN-E; MICROGLIAL ACTIVATION; IMMUNOREGULATORY LIPOPROTEIN; CHYLOMICRONS ALTER; ENDOTOXIN; ASSOCIATION; APOPROTEIN; PROTEIN	Human apolipoprotein E is the major apolipoprotein expressed in the brain and exists as three isoforms, designated E2, E3, and E4. Although evidence suggests that apolipoprotein E plays an important role in modifying systemic and brain inflammatory responses, there is little data investigating apoE isoform-specific effects in vivo. In this study, we compared the inflammatory responses of targeted-replacement mice expressing the human APOE3 and APOE4 genes after intravenous administration of lipopolysaccharide. Animals expressing the E4 allele had significantly greater systemic and brain elevations of the pro-inflammatory cytokines TNFalpha and IL-6 as compared with their APOE3 counterparts, suggesting an isoform-specific effect of the immunomodulatory properties of apoE. Furthermore, intravenous administration of a small apoE-mimetic peptide derived from the receptor-binding region of the apoE holoprotein (apoE-( 133 - 149)) similarly suppressed both systemic and brain inflammatory responses in mice after lipopolysaccharide administration. These results suggest that apoE plays an isoform- specific role in mediating the systemic and brain inflammatory responses. Moreover, because exogenous administration of this apoE mimetic peptide is effective at suppressing both systemic and brain inflammation, it may represent a novel therapeutic strategy for diseases characterized by systemic or central nervous system inflammation, such as septic shock, multiple sclerosis, and traumatic brain injury.	Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA	Laskowitz, DT (corresponding author), Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Box 2900, Durham, NC 27710 USA.	danl@neuro.duke.edu		Vitek, Michael/0000-0001-8140-8048	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG022230] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1K08-AG022230-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21 NS4487-01] Funding Source: Medline		AVILA EM, 1982, J BIOL CHEM, V257, P5900; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Brown CM, 2002, FREE RADICAL BIO MED, V32, P1071, DOI 10.1016/S0891-5849(02)00803-1; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; CURTISS LK, 1981, J IMMUNOL, V126, P1382; de Bont N, 1999, J LIPID RES, V40, P680; de Bont N, 2000, EUR J CLIN INVEST, V30, P818; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; Harris HW, 1998, HEPATOLOGY, V27, P1341, DOI 10.1002/hep.510270521; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; MISRA UK, 1994, J BIOL CHEM, V269, P18303; PEPE MG, 1986, J IMMUNOL, V136, P3716; READ TE, 1993, INFECT IMMUN, V61, P3496, DOI 10.1128/IAI.61.8.3496-3502.1993; Roselaar SE, 1998, J LIPID RES, V39, P1740; Schmidt S, 2002, AM J HUM GENET, V70, P708, DOI 10.1086/339269; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; SULLIVAN PM, 1977, J BIOL CHEM, V227, P17972; Van Oosten MV, 2001, J BIOL CHEM, V276, P8820, DOI 10.1074/jbc.M009915200; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249	30	244	253	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2003	278	49					48529	48533		10.1074/jbc.M306923200			5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	747WL	WOS:000186829000004	14507923	Other Gold			2021-06-18	
J	DiSabato, DJ; Quan, N; Godbout, JP				DiSabato, Damon J.; Quan, Ning; Godbout, Jonathan P.			Neuroinflammation: the devil is in the details	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; lipopolysaccharide; microglia; neuroinflammation; sickness behavior	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INTRACEREBRAL INFLAMMATORY RESPONSE; INDUCED SICKNESS BEHAVIOR; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; AGED MICE; WHITE-MATTER	There is significant interest in understanding inflammatory responses within the brain and spinal cord. Inflammatory responses that are centralized within the brain and spinal cord are generally referred to as neuroinflammatory'. Aspects of neuroinflammation vary within the context of disease, injury, infection, or stress. The context, course, and duration of these inflammatory responses are all critical aspects in the understanding of these processes and their corresponding physiological, biochemical, and behavioral consequences. Microglia, innate immune cells of the CNS, play key roles in mediating these neuroinflammatory responses. Because the connotation of neuroinflammation is inherently negative and maladaptive, the majority of research focus is on the pathological aspects of neuroinflammation. There are, however, several degrees of neuroinflammatory responses, some of which are positive. In many circumstances including CNS injury, there is a balance of inflammatory and intrinsic repair processes that influences functional recovery. In addition, there are several other examples where communication between the brain and immune system involves neuroinflammatory processes that are beneficial and adaptive. The purpose of this review is to distinguish different variations of neuroinflammation in a context-specific manner and detail both positive and negative aspects of neuroinflammatory processes.	[DiSabato, Damon J.; Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Quan, Ning] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA	Godbout, JP (corresponding author), Ohio State Univ, 259 IBMR Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA.	jonathan.godbout@osumc.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG033028] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [T32 DE014320] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [T32DE014320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033028] Funding Source: NIH RePORTER		Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abraham J, 2008, NEUROBIOL AGING, V29, P614, DOI 10.1016/j.neurobiolaging.2006.11.002; Abraham J., 2008, BRAIN BEHAV IMMUN, V29, P614; Abraham J, 2009, REJUV RES, V12, P445, DOI 10.1089/rej.2009.0888; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Andonova M, 1998, VET HUM TOXICOL, V40, P14; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P450, DOI 10.1016/j.bbi.2009.01.016; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; BAUGHMAN VL, 1988, ANESTHESIOLOGY, V69, P192, DOI 10.1097/00000542-198808000-00007; BAUM A, 1993, PSYCHOSOM MED, V55, P274, DOI 10.1097/00006842-199305000-00005; Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1111/j.1460-9568.2000.01348.x; Borowski T, 1998, NEUROREPORT, V9, P3797, DOI 10.1097/00001756-199812010-00006; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchanan JB, 2008, PSYCHONEUROENDOCRINO, V33, P755, DOI 10.1016/j.psyneuen.2008.02.013; Caswell LW, 2003, EXP AGING RES, V29, P303, DOI 10.1080/03610730303721; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chen Q, 2013, J INFLAMM RES, V6, P91, DOI 10.2147/JIR.S45111; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Choi JH, 2007, J VET MED SCI, V69, P1131, DOI 10.1292/jvms.69.1131; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2012, CELL TISSUE RES, V349, P249, DOI 10.1007/s00441-012-1430-8; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dunn AJ, 2006, NEUROIMMUNOMODULAT, V13, P96, DOI 10.1159/000096291; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Gebara E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00145; Genovese T, 2008, SHOCK, V29, P32, DOI 10.1097/shk.0b013e318059053a; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goldman D, 2001, INFECT IMMUN, V69, P1808, DOI 10.1128/IAI.69.3.1808-1815.2001; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Hansen MK, 2001, AM J PHYSIOL-REG I, V280, pR929; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Huang Y, 2008, NEUROBIOL AGING, V29, P1744, DOI 10.1016/j.neurobiolaging.2007.04.012; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson R., 2010, EXP NEUROL, V233, P40; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; KABIERSCH A, 1988, Brain Behavior and Immunity, V2, P267, DOI 10.1016/0889-1591(88)90028-1; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Keinan G, 1999, ANXIETY STRESS COPIN, V12, P455, DOI 10.1080/10615809908249321; Kelley KW, 2013, BRAIN BEHAV IMMUN, V32, P63, DOI 10.1016/j.bbi.2013.02.003; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kumar A., 2015, J NEUROTRAUM, V33, P1; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lacroix S, 1998, BRAIN PATHOL, V8, P625, DOI 10.1111/j.1750-3639.1998.tb00189.x; Laflamme N, 1999, J NEUROSCI, V19, P10923; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mackenzie CS, 2007, J PALLIAT MED, V10, P749, DOI 10.1089/jpm.2006.0171; Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McEwen BS, 2013, PERSPECT PSYCHOL SCI, V8, P673, DOI 10.1177/1745691613506907; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Michael B. D., 2015, J INFECT DI IN PRESS; Monahan AJ, 2008, CELL TRANSPLANT, V17, P363; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Muccigrosso M. M., 2016, BRAIN BEHAV IN PRESS; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Norden DM, 2014, GLIA, V62, P881, DOI 10.1002/glia.22647; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Ota A, 2000, J SOC GYNECOL INVEST, V7, P102, DOI 10.1016/S1071-5576(00)00038-1; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Palin K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1289, DOI 10.1152/ajpendo.90489.2008; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Ramirez K, 2016, BRAIN BEHAV IMMUN, V51, P154, DOI 10.1016/j.bbi.2015.08.011; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Riediger T, 2010, PHARMACOL BIOCHEM BE, V97, P112, DOI 10.1016/j.pbb.2010.04.015; Rimaniol AC, 2000, J IMMUNOL, V164, P5430, DOI 10.4049/jimmunol.164.10.5430; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sawicki C.M., 2014, J NEUROSCI, V302, P151; Schafer DP, 2013, CURR OPIN NEUROBIOL, V23, P1034, DOI 10.1016/j.conb.2013.09.012; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Schnieder TP, 2014, J NEUROPATH EXP NEUR, V73, P880, DOI 10.1097/NEN.0000000000000107; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Schuitemaker A, 2012, NEUROBIOL AGING, V33, P1067, DOI 10.1016/j.neurobiolaging.2010.09.016; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Sokolowski JD, 2011, AM J PATHOL, V178, P1416, DOI 10.1016/j.ajpath.2010.12.051; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stichel CC, 2007, NEUROBIOL AGING, V28, P1507, DOI 10.1016/j.neurobiolaging.2006.07.022; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tarr AJ, 2014, BRAIN BEHAV IMMUN, V42, P96, DOI 10.1016/j.bbi.2014.06.002; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x; Walsh JT, 2015, J CLIN INVEST, V125, P2547, DOI 10.1172/JCI82458; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Xie Z, 2003, EXP NEUROL, V182, P135, DOI 10.1016/S0014-4886(03)00057-8; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Ye SM, 2001, NEUROIMMUNOMODULAT, V9, P183, DOI 10.1159/000049025; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhang B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0440-3; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Zong SH, 2012, INFLAMMATION, V35, P520, DOI 10.1007/s10753-011-9341-5	200	243	249	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2016	139			2			136	153		10.1111/jnc.13607			18	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EB0ZD	WOS:000387074600010	26990767	Bronze, Green Accepted	Y	N	2021-06-18	
J	Andrews, PJD; Sinclair, HL; Rodriguez, A; Harris, BA; Battison, CG; Rhodes, JKJ; Murray, GD				Andrews, Peter J. D.; Sinclair, H. Louise; Rodriguez, Aryelly; Harris, Bridget A.; Battison, Claire G.; Rhodes, Jonathan K. J.; Murray, Gordon D.		Eurotherm3235 Trial Collaborators	Hypothermia for Intracranial Hypertension after Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; PRESSURE REDUCTION; CLINICAL-TRIALS; FEVER CONTROL; MANAGEMENT; DISORDERS; DESIGN; PHASE	BACKGROUND In patients with traumatic brain injury, hypothermia can reduce intracranial hypertension. The benefit of hypothermia on functional outcome is unclear. METHODS We randomly assigned adults with an intracranial pressure of more than 20 mm Hg despite stage 1 treatments (including mechanical ventilation and sedation management) to standard care (control group) or hypothermia (32 to 35 degrees C) plus standard care. In the control group, stage 2 treatments (e.g., osmotherapy) were added as needed to control intracranial pressure. In the hypothermia group, stage 2 treatments were added only if hypothermia failed to control intracranial pressure. In both groups, stage 3 treatments (barbiturates and decompressive craniectomy) were used if all stage 2 treatments failed to control intracranial pressure. The primary outcome was the score on the Extended Glasgow Outcome Scale (GOS-E; range, 1 to 8, with lower scores indicating a worse functional outcome) at 6 months. The treatment effect was estimated with ordinal logistic regression adjusted for prespecified prognostic factors and expressed as a common odds ratio (with an odds ratio <1.0 favoring hypothermia). RESULTS We enrolled 387 patients at 47 centers in 18 countries from November 2009 through October 2014, at which time recruitment was suspended owing to safety concerns. Stage 3 treatments were required to control intracranial pressure in 54% of the patients in the control group and in 44% of the patients in the hypothermia group. The adjusted common odds ratio for the GOS-E score was 1.53 (95% confidence interval, 1.02 to 2.30; P = 0.04), indicating a worse outcome in the hypothermia group than in the control group. A favorable outcome (GOS-E score of 5 to 8, indicating moderate disability or good recovery) occurred in 26% of the patients in the hypothermia group and in 37% of the patients in the control group (P = 0.03). CONCLUSIONS In patients with an intracranial pressure of more than 20 mm Hg after traumatic brain injury, therapeutic hypothermia plus standard care to reduce intracranial pressure did not result in outcomes better than those with standard care alone.	[Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Sinclair, H. Louise; Harris, Bridget A.; Battison, Claire G.; Rhodes, Jonathan K. J.] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rodriguez, Aryelly; Battison, Claire G.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Harris, Bridget A.; Rhodes, Jonathan K. J.] Western Gen Hosp, Crit Care, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland	Andrews, PJD (corresponding author), Western Gen Hosp, Intens Care Unit, Ward 20,Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	p.andrews@ed.ac.uk	Mellinghoff, Johannes/V-4844-2019	Mellinghoff, Johannes/0000-0002-5455-8953; Battison, Claire/0000-0001-9549-4522; Solodov, Aleksandr/0000-0002-8263-1433; Aragao, Irene/0000-0001-5750-2739; Spapen, Herbert/0000-0002-7724-886X; Vincent, Jean-Louis/0000-0001-6011-6951; Deeb, Ahmad/0000-0002-3680-7338	National Institute for Health Research Health Technology Assessment program; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [11/01/30] Funding Source: researchfish	Funded by the National Institute for Health Research Health Technology Assessment program; Current Controlled Trials number, ISRCTN34555414.	Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Ker K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a865; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	35	243	254	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2015	373	25					2403	2412		10.1056/NEJMoa1507581			10	Medicine, General & Internal	General & Internal Medicine	CY5QD	WOS:000366461400007	26444221	Green Published, Bronze	Y	N	2021-06-18	
J	Aimaretti, G; Ambrosio, MR; Di Somma, C; Gasperi, M; Cannavo, S; Scaroni, C; Fusco, A; Del Monte, P; De Menis, E; Faustini-Fustini, M; Grimaldi, F; Logoluso, F; Razzore, P; Rovere, S; Benvenga, S; degli Uberti, E; De Marinis, L; Lombardi, G; Mantero, F; Martino, E; Giordano, G; Ghigo, E				Aimaretti, G; Ambrosio, MR; Di Somma, C; Gasperi, M; Cannavo, S; Scaroni, C; Fusco, A; Del Monte, P; De Menis, E; Faustini-Fustini, M; Grimaldi, F; Logoluso, F; Razzore, P; Rovere, S; Benvenga, S; degli Uberti, E; De Marinis, L; Lombardi, G; Mantero, F; Martino, E; Giordano, G; Ghigo, E			Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; HORMONE (GH)-RELEASING HORMONE; HEAD-INJURY; GH DEFICIENCY; STIMULATION TEST; NEUROENDOCRINE DYSFUNCTION; DIAGNOSIS; TRAUMA; EPIDEMIOLOGY; ARGININE	Context: Traumatic brain injury ( TBI) and subarachnoid hemorrhage ( SAH) are conditions at high risk for the development of hypopituitarism. Objective: The objective of the study was to clarify whether pituitary deficiencies and normal pituitary function recorded at 3 months would improve or worsen at 12 months after the brain injury. Design and Patients: Pituitary function was tested at 3 and 12 months in patients who had TBI ( n = 70) or SAH ( n = 32). Results: In TBI, the 3- month evaluation had shown hypopituitarism ( H) in 32.8%. Panhypopituitarism ( PH), multiple ( MH), and isolated ( IH) hypopituitarism had been demonstrated in 5.7, 5.7, and 21.4%, respectively. The retesting demonstrated some degree of H in 22.7%. PH, MH, and IH were present in 5.7, 4.2, and 12.8%, respectively. PH was always confirmed at 12 months, whereas MH and IH were confirmed in 25% only. In 5.5% of TBI with no deficit at 3 months, IH was recorded at retesting. In 13.3% of TBI with IH at 3 months, MH was demonstrated at 12- month retesting. In SAH, the 3- month evaluation had shown H in 46.8%. MH and IH had been demonstrated in 6.2 and 40.6%, respectively. The retesting demonstrated H in 37.5%. MH and IH were present in 6.2 and 31.3%, respectively. Although no MH was confirmed at 12 months, two patients with IH at 3 months showed MH at retesting; 30.7% of SAH with IH at 3 months displayed normal pituitary function at retesting. In SAH, normal pituitary function was always confirmed. In TBI and SAH, the most common deficit was always severe GH deficiency. Conclusion: There is high risk for H in TBI and SAH patients. Early diagnosis of PH is always confirmed in the long term. Pituitary function in brain- injured patients may improve over time but, although rarely, may also worsen. Thus, brain- injured patients must undergo neuroendocrine follow- up over time.	Univ Turin, Div Endocrinol & Metab Dis, Dept Internal Med, I-10126 Turin, Italy; Univ Ferrara, Endocrinol Sect, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy; Univ Naples Federico II, Dept Mol & Clin Endocrinol, I-80138 Naples, Italy; Univ Naples Federico II, Dept Oncol, I-80138 Naples, Italy; Univ Pisa, Dept Endocrinol & Metab, I-56127 Pisa, Italy; Univ Messina, Dept Med & Pharmacol, Endocrinol Sect, I-98100 Messina, Italy; Univ Padua, Dept Surg & Med Sci, Div Endocrinol, I-35122 Padua, Italy; Galliera Hosp, Div Endocrinol, I-16128 Genoa, Italy; Univ Cattolica Sacro Cuore, Div Endocrinol, I-00168 Rome, Italy; Treviso Reg Hosp, Serv Endocrinol, I-31100 Treviso, Italy; Bellaria Hosp, Div Endocrinol, I-40139 Bologna, Italy; Osped S Maria Misericordia, Div Endocrinol, I-33100 Udine, Italy; Univ Bari, Div Endocrinol, I-70126 Bari, Italy; S Croce & Carle Hosp, Div Endocrinol, I-12100 Cuneo, Italy	Ghigo, E (corresponding author), Univ Turin, Div Endocrinol & Metab Dis, Dept Internal Med, C So Dogliotti,14, I-10126 Turin, Italy.	ezio.ghigo@unito.it	Faustini-Fustini, Marco/AAU-7933-2020; Grimaldi, Franco/AAK-5748-2020; Scaroni, Carla/G-3853-2017; Cannavo, Salvatore/D-7608-2013; Di Somma, Carolina/K-7772-2016	Scaroni, Carla/0000-0001-9396-3815; Cannavo, Salvatore/0000-0001-8779-7283; degli Uberti, Ettore/0000-0002-9441-7223; Di Somma, Carolina/0000-0002-5724-1951; ambrosio, maria rosaria/0000-0002-7911-9770; Razzore, Paola/0000-0001-9086-6614			*AG HLTH CAR POL R, 1998, REHAB TRAUM BRAIN IN; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Ceballos R, 1966, Ala J Med Sci, V3, P185; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; EDWARDS OM, 1986, MEDICINE, V65, P281; Faglia G., 2001, ENDOCRINOL METAB, P73; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; Goetz CG., 1999, TXB CLIN NEUROLOGY; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hillier SL, 1997, BRAIN INJURY, V11, P649; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lamberts SWJ, 1998, LANCET, V352, P127; LEE SC, 1994, BRAIN INJURY, V8, P571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LISSETT CA, 1996, ENDOCRINOLOGY, P145; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; THORNER MO, 1998, WILLIAMS TXB ENDOCRI, P165; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x	38	243	248	0	12	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0021-972X			J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	NOV	2005	90	11					6085	6092		10.1210/jc.2005-0504			8	Endocrinology & Metabolism	Endocrinology & Metabolism	981VI	WOS:000233115700024	16144947	Bronze			2021-06-18	
J	Loane, DJ; Kumar, A; Stoica, BA; Cabatbat, R; Faden, AI				Loane, David J.; Kumar, Alok; Stoica, Bogdan A.; Cabatbat, Rainier; Faden, Alan I.			Progressive Neurodegeneration After Experimental Brain Trauma: Association With Chronic Microglial Activation	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Chronic microglial activation; NADPH oxidase; Progressive neurodegeneration; Traumatic brain injury	INTRACEREBRAL INFLAMMATORY RESPONSE; CONTROLLED CORTICAL IMPACT; NADPH OXIDASE; LIMITS NEUROINFLAMMATION; MEDIATED NEUROTOXICITY; OXIDATIVE STRESS; INJURY; EXPRESSION; LIPOPOLYSACCHARIDE; MORPHOLOGY	Recent clinical studies indicate that traumatic brain injury (TBI) produces chronic and progressive neurodegenerative changes leadingto late neurologic dysfunction, but little is known about the mechanisms underlying such changes. Microglial-mediated neuroinflammationis an important secondary injury mechanism after TBI. In human studies, microglial activation has been found to persist for many years after the initial brain trauma, particularly after moderate to severe TBI. In the present study, adult C57Bl/6 mice were subjected to single moderate-level controlled cortical impact and were followed up by longitudinal T2-weighted magnetic resonance imaging in combination with stereologic histologic assessment of lesion volume expansion, neuronal loss, and microglial activation for up to 1 year after TBI. Persistent microglial activation was observed in the injured cortex through 1year after injury and was associated with progressive lesion expansion, hippocampal neurodegeneration, and loss of myelin. Notably, highly activated microglia that expressed major histocompatibility complex class II (CR3/43), CD68, and NADPH oxidase (NOX2) were detected at the margins of the expanding lesion at 1 year after injury; biochemical markers of neuroinflammation and oxidative stress were significantly elevated at this time point. These data support emerging clinical TBI findings and provide a mechanistic link between TBI-induced chronic microglial activation and progressive neurodegeneration.	Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res, Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA	Loane, DJ (corresponding author), 655 W Baltimore St,Bressler Res Bldg,Room 6-011, Baltimore, MD 21201 USA.	dloane@anes.umm.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Faden, Alan I./0000-0003-0128-2348	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS037313, 5R01NS052568]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052568, R01NS082308, R01NS037313] Funding Source: NIH RePORTER	This work was supported by grants from the NIH/NINDS to Alan Faden (5R01NS037313, 5R01NS052568).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bruce-Keller AJ, 2010, ANTIOXID REDOX SIGN, V12, P1371, DOI 10.1089/ars.2009.2823; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	49	241	245	1	27	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JAN	2014	73	1					14	29		10.1097/NEN.0000000000000021			16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AG8CW	WOS:000335647400002	24335533	Green Accepted, Bronze	Y	N	2021-06-18	
J	McCrea, M; Guskiewicz, K; Randolph, C; Barr, WB; Hammeke, TA; Marshall, SW; Powell, MR; Ahn, KW; Wang, Y; Kelly, JP				McCrea, Michael; Guskiewicz, Kevin; Randolph, Christopher; Barr, William B.; Hammeke, Thomas A.; Marshall, Stephen W.; Powell, Matthew R.; Ahn, Kwang Woo; Wang, Yanzhi; Kelly, James P.			Incidence, Clinical Course, and Predictors of Prolonged Recovery Time Following Sport-Related Concussion in High School and College Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Concussion; Neuropsychological tests; Sport injuries; Neurological disorders; Closed head injury	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; INTERNATIONAL-CONFERENCE; NCAA CONCUSSION; UNITED-STATES; EPIDEMIOLOGY; MANAGEMENT; METAANALYSIS; IMPACT	Sport-related concussion (SRC) is typically followed by clinical recovery within days, but reports of prolonged symptoms are common. We investigated the incidence of prolonged recovery in a large cohort (n = 18,531) of athlete seasons over a 10-year period. A total of 570 athletes with concussion (3.1%) and 166 controls who underwent pre-injury baseline assessments of symptoms, neurocognitive functioning and balance were re-assessed immediately, 3 hr, and 1, 2, 3, 5, 7, and 45 or 90 days after concussion. Concussed athletes were stratified into typical (within 7 days) or prolonged (> 7 days) recovery groups based on symptom recovery time. Ten percent of athletes (n = 57) had a prolonged symptom recovery, which was also associated with lengthier recovery on neurocognitive testing (p < .001). At 45-90 days post-injury, the prolonged recovery group reported elevated symptoms, without deficits on cognitive or balance testing. Prolonged recovery was associated with unconsciousness [odds ratio (OR), 4.15; 95% confidence interval (CI) 2.12-8.15], posttraumatic amnesia (OR, 1.81; 95% CI, 1.00-3.28), and more severe acute symptoms (p < .0001). These results suggest that a small percentage of athletes may experience symptoms and functional impairments beyond the typical window of recovery after SRC, and that prolonged recovery is associated with acute indicators of more severe injury. (JINS, 2013, 19, 22-33)	[McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Guskiewicz, Kevin] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin; Marshall, Stephen W.] Univ N Carolina, Dept Orthoped, Chapel Hill, NC USA; [Guskiewicz, Kevin; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Randolph, Christopher] Loyola Univ, Stritch Sch Med, Dept Neurol, Maywood, IL 60153 USA; [Barr, William B.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Barr, William B.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Hammeke, Thomas A.] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Powell, Matthew R.] Marshfield Clin Minocqua Ctr, Dept Neuropsychol, Minocqua, WI USA; [Ahn, Kwang Woo; Wang, Yanzhi] Med Coll Wisconsin, Div Biostat, Milwaukee, WI USA; [Kelly, James P.] US Dept Def, Natl Intrepid Ctr Excellence, Bethesda, MD USA	McCrea, M (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu		Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233; Barr, William/0000-0001-7711-7758			[Anonymous], 2007, MMWR MORBIDITY MORTA, V56, P733; [Anonymous], 1997, NEUROLOGY, V48, P581; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rubin DB., 1987, MULTIPLE IMPUTATION; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Yeates K.O., 2012, ARCH PEDIAT ADOL MED, pE1	30	241	241	1	86	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2013	19	1					22	33		10.1017/S1355617712000872			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	063NB	WOS:000313005400003	23058235				2021-06-18	
J	Covassin, T; Elbin, RJ; Harris, W; Parker, T; Kontos, A				Covassin, Tracey; Elbin, R. J.; Harris, William; Parker, Tonya; Kontos, Anthony			The Role of Age and Sex in Symptoms, Neurocognitive Performance, and Postural Stability in Athletes After Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; mTBI; neurocognitive testing; symptoms; postural stability; age; sex	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; TEST-RETEST RELIABILITY; MILD HEAD-INJURY; HIGH-SCHOOL; GENDER-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; RECOVERY; IMPACT; STATEMENT	Background: Researchers have begun to focus on age and sex differences in concussion outcomes. Results suggest that younger athletes and female athletes may take longer to recover from a concussion. However, little is known about the interactive effects of age and sex on symptoms, neurocognitive testing (NCT), and postural stability. Hypothesis/Purpose: The purpose of the study was to examine sex and age differences in symptoms, NCT, and postural stability following concussion. We hypothesized that high school and female athletes would have worse symptoms, NCT, and postural stability than college and male athletes, respectively. Study Design: Cohort study; Level of evidence, 2. Methods: A total of 296 concussed athletes from a multistate, 2-year study were enrolled in this study. Participants completed the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) and Post-Concussion Symptom Scale (PCSS) at baseline and again at 2, 7, and 14 days after concussion. Participants completed the Balance Error Scoring System (BESS) at 1, 2, and 3 days after concussion. Results: Female athletes performed worse than male athletes on visual memory (mean, 65.1% and 70.1%, respectively; P = .049) and reported more symptoms (mean, 14.4 and 10.1, respectively) after concussion (P = .035). High school athletes performed worse than college athletes on verbal (mean, 78.8% and 82.7%, respectively; P = .001) and visual (mean, 65.8% and 69.4%, respectively; P = .01) memory. High school athletes were still impaired on verbal memory 7 days after concussion compared with collegiate athletes (P = .001). High school male athletes scored worse on the BESS than college male athletes (mean, 18.8 and 13.0, respectively; P = .001). College female athletes scored worse on the BESS than high school female athletes (mean, 21.1 and 16.9, respectively; P = .001). Conclusion: The results of the current study supported age differences in memory and sex differences in memory and symptoms and an interaction between age and sex on postural stability after concussion that warrant consideration from clinicians and researchers when interpreting symptoms, specific components of NCT, and postural stability tests. Future research should develop and assess interventions tailored to age and sex differences and include younger (< 14 years) participants.	[Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA	Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 105 IM Sports Circle, E Lansing, MI 48824 USA.	covassin@msu.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Kontos, Anthony/0000-0002-3749-4310	National Operating Committee on Standards for Athletic Equipment (NOCSAE)	One or more of the authors has declared the following potential conflict of interest or source of funding: The National Operating Committee on Standards for Athletic Equipment (NOCSAE) funded this study.	ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Granito VJ., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kimura D, 2002, PSYCHOL REP, V91, P1137, DOI 10.2466/PR0.91.7.1137-1142; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	43	241	241	1	67	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	JUN	2012	40	6					1303	1312		10.1177/0363546512444554			10	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	951CA	WOS:000304697100012	22539534		Y	N	2021-06-18	
J	Vagnozzi, R; Signoretti, S; Cristofori, L; Alessandrini, F; Floris, R; Isgro, E; Ria, A; Marziali, S; Zoccatelli, G; Tavazzi, B; Del Bolgia, F; Sorge, R; Broglio, SP; McIntosh, TK; Lazzarino, G				Vagnozzi, Roberto; Signoretti, Stefano; Cristofori, Luciano; Alessandrini, Franco; Floris, Roberto; Isgro, Eugenio; Ria, Antonio; Marziali, Simone; Zoccatelli, Giada; Tavazzi, Barbara; Del Bolgia, Franco; Sorge, Roberto; Broglio, Steven P.; McIntosh, Tracy K.; Lazzarino, Giuseppe			Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients	BRAIN			English	Article						mild traumatic brain injury; H-1-magnetic resonance spectroscopy; N-acetylaspartate; metabolic brain vulnerability; sport-related concussion	SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; N-ACETYLASPARTATE; TEMPORAL WINDOW; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; POSTTRAUMATIC HEADACHE; LIPID-PEROXIDATION; ENERGY-METABOLISM; MR SPECTROSCOPY	Concussive head injury opens a temporary window of brain vulnerability due to the impairment of cellular energetic metabolism. As experimentally demonstrated, a second mild injury occurring during this period can lead to severe brain damage, a condition clinically described as the second impact syndrome. To corroborate the validity of proton magnetic resonance spectroscopy in monitoring cerebral metabolic changes following mild traumatic brain injury, apart from the magnetic field strength (1.5 or 3.0 T) and mode of acquisition, we undertook a multicentre prospective study in which a cohort of 40 athletes suffering from concussion and a group of 30 control healthy subjects were admitted. Athletes (aged 16-35 years) were recruited and examined at three different institutions between September 2007 and June 2009. They underwent assessment of brain metabolism at 3, 15, 22 and 30 days post-injury through proton magnetic resonance spectroscopy for the determination of N-acetylaspartate, creatine and choline-containing compounds. Values of these representative brain metabolites were compared with those observed in the group of non-injured controls. Comparison of spectroscopic data, obtained in controls using different field strength and/or mode of acquisition, did not show any difference in the brain metabolite ratios. Athletes with concussion exhibited the most significant alteration of metabolite ratios at Day 3 post-injury (N-acetylaspartate/creatine: -17.6%, N-acetylaspartate/choline: -21.4%; P < 0.001 with respect to controls). On average, metabolic disturbance gradually recovered, initially in a slow fashion and, following Day 15, more rapidly. At 30 days post-injury, all athletes showed complete recovery, having metabolite ratios returned to values detected in controls. Athletes self-declared symptom clearance between 3 and 15 days after concussion. Results indicate that N-acetylaspartate determination by proton magnetic resonance spectroscopy represents a non-invasive tool to accurately measure changes in cerebral energy metabolism occurring in mild traumatic brain injury. In particular, this metabolic evaluation may significantly improve, along with other clinical assessments, the management of athletes suffering from concussion. Further studies to verify the effects of a second concussive event occurring at different time points of the recovery curve of brain metabolism are needed.	[Lazzarino, Giuseppe] Univ Catania, Dept Chem Sci, Div Biochem & Mol Biol, I-95125 Catania, Italy; [Vagnozzi, Roberto; Del Bolgia, Franco; Sorge, Roberto] Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Div Neurosurg, Dept Head & Neck Surg, I-00152 Rome, Italy; [Cristofori, Luciano; Ria, Antonio] Osped Maggiore Verona Borgo Trento, Dept Neurosurg, I-37126 Verona, Italy; [Alessandrini, Franco; Zoccatelli, Giada] Osped Maggiore Verona Borgo Trento, Serv Neuroradiol, I-37126 Verona, Italy; [Floris, Roberto; Marziali, Simone] Univ Roma Tor Vergata, Dept Diagnost Imaging & Intervent Radiol, I-00133 Rome, Italy; [Isgro, Eugenio] Univ Parma, Dept Neurosci, Div Neuroradiol, I-43126 Parma, Italy; [Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Broglio, Steven P.] Univ Illinois, Neurotrauma Res Lab, Urbana, IL 61801 USA; [McIntosh, Tracy K.] Media NeuroConsultants Inc, Media, PA 19063 USA	Lazzarino, G (corresponding author), Univ Catania, Dept Chem Sci, Div Biochem & Mol Biol, Viale A Doria 6, I-95125 Catania, Italy.	lazzarig@unict.it	Signoretti, stefano/AAL-5631-2020; TAVAZZI, BARBARA/AAB-9830-2019; floris, roberto/AAC-2396-2019; lazzarino, giuseppe/K-2277-2015	Signoretti, stefano/0000-0002-8086-1622; TAVAZZI, BARBARA/0000-0001-8743-0895; lazzarino, giuseppe/0000-0002-5917-7279; Marziali, Simone/0000-0002-5805-5501	Italian Ministry of University and Research (MIUR)Ministry of Education, Universities and Research (MIUR) [2007JBHZ5F]	Italian Ministry of University and Research (MIUR) (PRIN 2007JBHZ5F).	ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Barth JT, 2001, J ATHL TRAINING, V36, P253; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 2003, J MOL NEUROSCI, V21, P185, DOI 10.1385/JMN:21:3:185; Benedetti B, 2007, AM J NEURORADIOL, V28, P72; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; GERBERDING JL, 2003, C MILD TRAUM BRAIN I, P31; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; HOVDA DA, 1993, INTRACRANIAL PRESSUR, V8, P469; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schleimer Jonathan A, 2002, Curr Sports Med Rep, V1, P323; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8	66	241	247	0	26	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	NOV	2010	133		11				3232	3242		10.1093/brain/awq200			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	673ME	WOS:000283666500013	20736189	Green Published, Bronze			2021-06-18	
J	Fann, JR; Bombardier, CH; Dikmer, S; Esselman, P; Warms, CA; Pelzer, E; Rau, H; Temkin, N				Fann, JR; Bombardier, CH; Dikmer, S; Esselman, P; Warms, CA; Pelzer, E; Rau, H; Temkin, N			Validity of the patient health questionnaire-9 in assessing depression following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; depression; diagnosis; PHQ; reliability; SCID; screening; trauma; validity	CASE-FINDING INSTRUMENTS; MAJOR DEPRESSION; PRIMARY-CARE; HEAD-INJURY; GENDER DIFFERENCES; RATING-SCALE; PRIME-MD; SYMPTOMS; TELEPHONE; INTERVIEW	Objective: To test the validity and reliability of the Patient Health Questionnaire-9 (PHQ-9) for diagnosing major depressive disorder (MDD) among persons with traumatic brain injury (TBI). Design: Prospective cohort study. Setting: Level I trauma center. Participants: 135 adults within I year of complicated mild, moderate, or severe TBI. Main Outcome Measures: PHQ-9 Depression Scale, Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). Results: Using a screening criterion of at least 5 PHQ-9 symptoms present at least several days over the last 2 weeks (with one being depressed mood or anhedonia) maximizes sensitivity (0.93) and specificity (0.89) while providing a positive predictive value of 0.63 and a negative predictive value of 0.99 when compared to SCID diagnosis of MDD. Pearson's correlation between the PHQ-9 scores and other depression measures was 0.90 with the Hopkins Symptom Checklist depression subscale and 0.78 with the Hamilton Rating Scale for Depression. Test-retest reliability of the PHQ-9 was r = 0.76 and K = 0.46 when using the optimal screening method. Conclusions: The PHQ-9 is a valid and reliable screening tool for detecting MDD in persons with TBI.	Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fann, JR (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Box 356560, Seattle, WA 98195 USA.	fann@u.Washington.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039415] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD39415] Funding Source: Medline		Allen K, 2003, J PSYCHOSOM RES, V55, P385, DOI 10.1016/S0022-3999(02)00637-2; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BURTON LA, 1988, J NEUROLOGICAL REHAB, V2, P151; Cacciola JS, 1999, ASSESSMENT, V6, P235, DOI 10.1177/107319119900600304; Christensen B., 1994, ADV MED PSYCHOTHER, V7, P23; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derogatis L.R., 1994, SCL 90 R ADM SCORING, V3rd; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First M. B., 1996, USERS GUIDE STRUCTUR; First M.B., 1996, STRUCTURED CLIN INTE; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Henkel V, 2004, EUR ARCH PSY CLIN N, V254, P215, DOI 10.1007/s00406-004-0476-3; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Novy DM, 1996, CLIN J PAIN, V12, P23, DOI 10.1097/00002508-199603000-00005; POTTS MK, 1990, J PSYCHIATR RES, V24, P335, DOI 10.1016/0022-3956(90)90005-B; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Salokangas RKR, 2002, J AFFECT DISORDERS, V68, P215, DOI 10.1016/S0165-0327(00)00315-3; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; STOMMEL M, 1993, PSYCHIAT RES, V49, P239, DOI 10.1016/0165-1781(93)90064-N; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JBW, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/BF03035120; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0	44	241	241	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2005	20	6					501	511		10.1097/00001199-200511000-00003			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	986YF	WOS:000233484900003	16304487				2021-06-18	
J	Niogi, SN; Mukherjee, P				Niogi, Sumit N.; Mukherjee, Pratik			Diffusion Tensor Imaging of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						axonal injury; diffusion tensor imaging; magnetic resonance imaging; mild traumatic brain injury	WHITE-MATTER INJURY; GLASGOW COMA SCALE; MAGNETIC-RESONANCE; AXONAL INJURY; HEAD-INJURY; CORPUS-CALLOSUM; FIBER TRACTOGRAPHY; FRACTIONAL ANISOTROPY; ATTENTIONAL NETWORKS; EXECUTIVE FUNCTION	Mild traumatic brain injury (mTBI) remains a challenge to accurately assess with conventional neuroimaging. Recent research holds out the promise that diffusion tensor imaging (DTI) can be used to predict recovery in mTBI patients. Unlike computed tomography or conventional magnetic resonance imaging, DTI is sensitive to microstructural axonal injury, the neuropathology that is thought to be most responsible for the persistent cognitive and behavioral impairments that often occur after mTBI. Through the use of newer DTI analysis techniques such as automated region of interest analysis, tract-based voxel-wise analysis, and quantitative tractography, researchers have shown that frontal and temporal association white matter pathways are most frequently damaged in mTBI and that the microstructural integrity of these tracts correlates with behavioral and cognitive measures. Future longitudinal DTI studies are needed to elucidate how symptoms and the microstructural pathology evolve over time. Moving forward, large-scale investigations will ascertain whether DTI can serve as a predictive imaging biomarker for long-term neurocognitive deficits after mTBI that would be of value for triaging patients to clinical trials of experimental cognitive enhancement therapies and rehabilitation methods, as well as for monitoring their response to these interventions.	[Mukherjee, Pratik] Univ Calif San Francisco, Neuroradiol Sect, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Niogi, Sumit N.] Weill Cornell Med Coll, New York, NY USA	Mukherjee, P (corresponding author), Univ Calif San Francisco, Neuroradiol Sect, Dept Radiol & Biomed Imaging, 505 Parnassus Ave,Box 0628, San Francisco, CA 94143 USA.	pratik@radiology.ucsf.edu	Mukherjee, Pratik/A-5446-2008	Mukherjee, Pratik/0000-0001-7473-7409			Adelson PD, 1998, ACT NEUR S, V71, P104; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; CEDERBERG D, CHILDS NERV SYST, V26, P221; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; EBISU T, 1989, RADIOLOGY, V171, P449, DOI 10.1148/radiology.171.2.2704810; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; HARTHOLT KA, 2010, J TRAUMA, DOI DOI 10.1097/TA.0B013E3181F6F5E5; Hasan KM, 2009, RADIOLOGY, V253, P571, DOI 10.1148/radiol.2532090920; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huisman TAGM, 2001, RADIOLOGE, V41, P1038, DOI 10.1007/s001170170003; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; IIZUKA H, 1989, STROKE, V20, P1396, DOI 10.1161/01.STR.20.10.1396; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; KENT DL, 1994, ANN INTERN MED, V120, P856, DOI 10.7326/0003-4819-120-10-199405150-00007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; LANDFIELD PW, 1988, NEUROBIOL AGING, V9, P571, DOI 10.1016/S0197-4580(88)80116-7; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lee Bruce, 2005, NeuroRx, V2, P372; Lee C, 2000, OPT ENG, V39, P924, DOI 10.1117/1.602449; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lin CY, 2005, NEUROIMAGE, V28, P380, DOI 10.1016/j.neuroimage.2005.06.009; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sperling R, 2007, ANN NY ACAD SCI, V1097, P146, DOI 10.1196/annals.1379.009; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Watts R, 2003, MENT RETARD DEV D R, V9, P168, DOI 10.1002/mrdd.10077; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILMS G, 1992, NEURORADIOLOGY, V34, P497, DOI 10.1007/BF00598959; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	108	240	246	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2010	25	4					241	255		10.1097/HTR.0b013e3181e52c2a			15	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	622FO	WOS:000279646900003	20611043				2021-06-18	
J	Suh, SW; Chen, JW; Motamedi, M; Bell, B; Listiak, K; Pons, NF; Danscher, G; Frederickson, CJ				Suh, SW; Chen, JW; Motamedi, M; Bell, B; Listiak, K; Pons, NF; Danscher, G; Frederickson, CJ			Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury	BRAIN RESEARCH			English	Article						zinc; brain trauma; hippocampus; TSQ; AMG	INTRACELLULAR FREE ZINC; EXCITATORY AMINO-ACIDS; DENTATE HILAR NEURONS; METHYL-D-ASPARTATE; CORTICAL-NEURONS; CEREBRAL-ISCHEMIA; PERFORANT PATH; HEAD TRAUMA; STIMULATION; TERMINALS	Prior evidence indicates that synaptically-released zinc enters postsynaptic neurons in toxic excess during ischemia and seizures, In addition, prevention of this zinc translocation has been shown to be neuroprotective in both ischemia and seizures. Here we show evidence that the same translocation of zinc from presynaptic boutons into postsynaptic neurons occurs after mechanical injury to the brain. Specifically, using a rat model of traumatic brain injury, we show that trauma is associated with (i) loss of zinc from presynaptic boutons (ii) appearance of zinc in injured neurons, and (iii) neuroprotection by intraventricular administration of a zinc chelator just prior to brain impact. The possible use of zinc chelators for neuroprotection after head trauma is considered. (C) 2000 Elsevier Science B.V. All rights reserved.	UTMB, Ctr Biomed Engn, Galveston, TX 77555 USA; Aarhus Univ, Dept Neurobiol, DK-8000 Aarhus, Denmark; NeuroBioTex, Galveston, TX 77550 USA	Frederickson, CJ (corresponding author), UTMB, Ctr Biomed Engn, Dept Anat & Neurosci, Jennie Sealy Hosp 626, Galveston, TX 77555 USA.	cjfrederickson@hotmail.com		Vincent, Kathleen/0000-0003-3051-9551			ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BEAULIEU C, 1992, NEUROREPORT, V3, P861, DOI 10.1097/00001756-199210000-00010; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Cheng CL, 1998, J NEUROCHEM, V71, P2401; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cuajungco MP, 1996, NEUROREPORT, V7, P1301, DOI 10.1097/00001756-199605170-00017; Danscher G, 1997, J HISTOCHEM CYTOCHEM, V45, P1503, DOI 10.1177/002215549704501107; DANSCHER G, 1996, J HISTOCHEM, V28, P363; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; FREDERICKSON CJ, 1998, SOC NEUR ABSTR, V24, P234; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; KOH JY, 1988, J NEUROSCI, V8, P2164; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MITCHELL CL, 1993, NEUROTOXICOL TERATOL, V15, P165, DOI 10.1016/0892-0362(93)90012-D; MORTON JD, 1990, EPILEPSIA, V31, P139, DOI 10.1111/j.1528-1167.1990.tb06298.x; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; PERRIN DD, 1979, STABILITY CONSTANTS, P399; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; Sorensen JC, 1998, BRAIN RES, V812, P265, DOI 10.1016/S0006-8993(98)00943-3; SPENCER HJ, 1976, BRAIN RES, V102, P91, DOI 10.1016/0006-8993(76)90577-1; SPIELMEYER W, 1984, SCIENCE, V226, P850; Suh S. W., 1996, Society for Neuroscience Abstracts, V22, P2101; Suh SW, 1999, J HISTOCHEM CYTOCHEM, V47, P969, DOI 10.1177/002215549904700715; THOMPSON RB, 1995, ANAL BIOCHEM, V227, P123, DOI 10.1006/abio.1995.1260; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yin HZ, 1998, BRAIN RES, V781, P45, DOI 10.1016/S0006-8993(97)01208-0; Yin HZ, 1995, NEUROREPORT, V6, P2553, DOI 10.1097/00001756-199512150-00025	42	240	246	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 10	2000	852	2					268	273		10.1016/S0006-8993(99)02095-8			6	Neurosciences	Neurosciences & Neurology	276QP	WOS:000084889100004	10678752				2021-06-18	
J	McMahon, P; Hricik, A; Yue, JK; Puccio, AM; Inoue, T; Lingsma, HF; Beers, SR; Gordon, WA; Valadka, AB; Manley, GT; Okonkw, DO; Casey, SS; Cooper, SR; Dams-O'Connor, K; Menon, DK; Sorani, MD; Yuh, EL; Mukherjee, P; Schnyer, DM; Vassar, MJ				McMahon, Paul; Hricik, Allison; Yue, John K.; Puccio, Ava M.; Inoue, Tomoo; Lingsma, Hester F.; Beers, Sue R.; Gordon, Wayne A.; Valadka, Alex B.; Manley, Geoffrey T.; Okonkw, David O.; Casey, Scott S.; Cooper, Shelly R.; Dams-O'Connor, Kristen; Menon, David K.; Sorani, Marco D.; Yuh, Esther L.; Mukherjee, Pratik; Schnyer, David M.; Vassar, Mary J.		TRACK-TBI Investigators	Symptomatology and Functional Outcome in Mild Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; health-related quality of life; postconcussion syndrome; outcome; traumatic brain injury	POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; QUALITY-OF-LIFE; STRUCTURED INTERVIEWS; RELIABILITY; SCALE; VALIDITY; QUESTIONNAIRE; SATISFACTION; RECOVERY	Mild Traumatic Brain Injury (mTBI), or concussion, is a major public health concern. There is controversy in the literature regarding the true incidence of postconcussion syndrome (PCS), with the constellation of physical, cognitive, emotional, and sleep symptoms after mTBI. In the current study, we report on the incidence and evolution of PCS symptoms and patient outcomes after mTBI at 3, 6, and 12 months in a large, prospective cohort of mTBI patients. Participants were identified as part of the prospective, multi-center Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. The study population was mTBI patients (Glasgow Coma Scale score of 13-15) presenting to the emergency department, including patients with a negative head computed tomography discharged to home without admission to hospital; 375 mTBI subjects were included in the analysis. At both 6 and 12 months after mTBI, 82% (n=250 of 305 and n=163 of 199, respectively) of patients reported at least one PCS symptom. Further, 44.5 and 40.3% of patients had significantly reduced Satisfaction With Life scores at 6 and 12 months, respectively. At 3 months after injury, 33% of the mTBI subjects were functionally impaired (Glasgow Outcome Scale-Extended score 6); 22.4% of the mTBI subjects available for follow-up were still below full functional status at 1 year after injury. The term mild continues to be a misnomer for this patient population and underscores the critical need for evolving classification strategies for TBI for targeted therapy.	[McMahon, Paul; Hricik, Allison; Puccio, Ava M.; Okonkw, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15213 USA; [McMahon, Paul] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Yue, John K.; Inoue, Tomoo; Manley, Geoffrey T.; Casey, Scott S.; Cooper, Shelly R.; Sorani, Marco D.; Vassar, Mary J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Gordon, Wayne A.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY USA; [Valadka, Alex B.] Seton Brain & Spine Inst, Austin, TX USA; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge CB2 2QQ, England; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	Okonkw, DO (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Mukherjee, Pratik/0000-0001-7473-7409; Schnyer, David/0000-0002-7472-2853; Cooper, Shelly/0000-0003-0026-6688	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RC2 NS069409]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC2NS069409] Funding Source: NIH RePORTER; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The authors thank the The Doris Duke Charitable Foundation, The National Institute of Mental Health, and Jamie Pardini, PhD. This study is registered under ClinicalTrials.gov (identifier: NCT01565551) and was funded by the National Institutes of Health (grant no.: 1RC2 NS069409).	Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Yue J.K., 2013, J NEUROTRAUMA	28	239	240	1	37	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					26	33		10.1089/neu.2013.2984			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500003	23952719	Green Published	Y	N	2021-06-18	
